Psyllid ID: psy8309
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
No hits with e-value below 0.001 by BLAST
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 494 | ||||||
| FB|FBgn0259680 | 671 | Pkcdelta "Protein kinase C del | 0.504 | 0.371 | 0.645 | 9.1e-126 | |
| UNIPROTKB|F1MZX0 | 676 | PRKCD "Uncharacterized protein | 0.408 | 0.298 | 0.594 | 1.2e-102 | |
| UNIPROTKB|F1PDX2 | 672 | PRKCD "Protein kinase C delta | 0.408 | 0.300 | 0.603 | 1.7e-101 | |
| UNIPROTKB|Q5PU49 | 674 | PRKCD "Protein kinase C delta | 0.408 | 0.299 | 0.603 | 1.7e-101 | |
| UNIPROTKB|E2RNP2 | 706 | PRKCQ "Uncharacterized protein | 0.410 | 0.287 | 0.596 | 2.1e-101 | |
| UNIPROTKB|E1BMG4 | 706 | PRKCQ "Uncharacterized protein | 0.410 | 0.287 | 0.600 | 2.1e-101 | |
| UNIPROTKB|E1C5S5 | 687 | PRKCD "Uncharacterized protein | 0.402 | 0.289 | 0.587 | 9.1e-101 | |
| UNIPROTKB|I3LR85 | 675 | PRKCD "Uncharacterized protein | 0.406 | 0.297 | 0.594 | 8e-100 | |
| MGI|MGI:97598 | 674 | Prkcd "protein kinase C, delta | 0.408 | 0.299 | 0.579 | 1e-99 | |
| ZFIN|ZDB-GENE-041210-195 | 721 | prkcq "protein kinase C, theta | 0.402 | 0.276 | 0.602 | 2.1e-99 |
| FB|FBgn0259680 Pkcdelta "Protein kinase C delta" [Drosophila melanogaster (taxid:7227)] | Back alignment and assigned GO terms |
|---|
Score = 872 (312.0 bits), Expect = 9.1e-126, Sum P(2) = 9.1e-126
Identities = 164/254 (64%), Positives = 199/254 (78%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+MEYLNGGDLMFHIQ+SGRF E RARFY AEI+SG++FLHKKGI+YRDLKLDN+LLDYEG
Sbjct: 420 VMEYLNGGDLMFHIQESGRFSEERARFYGAEIISGLKFLHKKGIIYRDLKLDNVLLDYEG 479
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
HVRIADFGMCKLQIYLDKT D+FCGTPDYMAPEIIKG KYNQ VDWWSFG+LLYEM +GQ
Sbjct: 480 HVRIADFGMCKLQIYLDKTADSFCGTPDYMAPEIIKGEKYNQNVDWWSFGVLLYEMLIGQ 539
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPFSGCDEDELFWSICNE P FP ++S EA IL LL+KD TKR+GS +GD + H
Sbjct: 540 SPFSGCDEDELFWSICNEIPWFPVYISAEATGILKGLLEKDYTKRIGSQYSPAGD-IADH 598
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEPFSSPWI-KLSSKDSAIPIQMPQVLFQLHALDVK 403
+FR +DW LEKR++EPPF+P+V P + + ++ +++ + + + L ++D K
Sbjct: 599 IFFRPIDWGLLEKRQIEPPFKPQVKHPLDTQYFDRVFTRERVRLTPIDKEI--LASMDQK 656
Query: 404 YFDKSFTAERPCLT 417
F FT P +T
Sbjct: 657 QFH-GFTYTNPHIT 669
|
|
| UNIPROTKB|F1MZX0 PRKCD "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 681 (244.8 bits), Expect = 1.2e-102, Sum P(3) = 1.2e-102
Identities = 123/207 (59%), Positives = 163/207 (78%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+ME+LNGGDLM+HIQ GRF+ RA FYAAEIV G++FLH+KGI+YRDLKLDN+LLD+ G
Sbjct: 426 VMEFLNGGDLMYHIQDKGRFELSRATFYAAEIVCGLQFLHQKGIIYRDLKLDNVLLDHSG 485
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK + D+ TFCGTPDY+APEI++GLKY+ VDWWSFG+LLYEM +GQ
Sbjct: 486 HIKIADFGMCKENMSGDRQASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQ 545
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DEDELF SI + P +P++++ E+K+IL LL++D +KRLG T ++ H
Sbjct: 546 SPFHGDDEDELFESIRLDSPYYPRWITKESKDILEKLLERDVSKRLGVT-----GNIKIH 600
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEP 371
+F+ ++W LEKR +EPPF+P+V P
Sbjct: 601 PFFKTINWVLLEKRAVEPPFKPKVKSP 627
|
|
| UNIPROTKB|F1PDX2 PRKCD "Protein kinase C delta type" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 1.7e-101, Sum P(3) = 1.7e-101
Identities = 125/207 (60%), Positives = 164/207 (79%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+ME+LNGGDLM+HIQ GRF+ RA FYAAEIV G++FLH KGI+YRDLKLDN++LD +G
Sbjct: 422 VMEFLNGGDLMYHIQDKGRFELYRATFYAAEIVCGLQFLHNKGIIYRDLKLDNVMLDQDG 481
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK I+ +K TFCGTPDY+APEI++GLKY+ VDWWSFG+LLYEM +GQ
Sbjct: 482 HIKIADFGMCKENIFGEKQASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQ 541
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DEDELF SI + P +P++++ E+K+IL LL++DTTKRLG T ++ H
Sbjct: 542 SPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLLERDTTKRLGVT-----GNIKIH 596
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEP 371
+F+ ++W LEKR +EPPF+P+V P
Sbjct: 597 PFFKTINWTLLEKRAVEPPFKPKVKSP 623
|
|
| UNIPROTKB|Q5PU49 PRKCD "Protein kinase C delta type" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 693 (249.0 bits), Expect = 1.7e-101, Sum P(3) = 1.7e-101
Identities = 125/207 (60%), Positives = 164/207 (79%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+ME+LNGGDLM+HIQ GRF+ RA FYAAEIV G++FLH KGI+YRDLKLDN++LD +G
Sbjct: 424 VMEFLNGGDLMYHIQDKGRFELYRATFYAAEIVCGLQFLHNKGIIYRDLKLDNVMLDQDG 483
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK I+ +K TFCGTPDY+APEI++GLKY+ VDWWSFG+LLYEM +GQ
Sbjct: 484 HIKIADFGMCKENIFGEKQASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQ 543
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DEDELF SI + P +P++++ E+K+IL LL++DTTKRLG T ++ H
Sbjct: 544 SPFHGDDEDELFESIRVDTPHYPRWITKESKDILEKLLERDTTKRLGVT-----GNIKIH 598
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEP 371
+F+ ++W LEKR +EPPF+P+V P
Sbjct: 599 PFFKTINWTLLEKRAVEPPFKPKVKSP 625
|
|
| UNIPROTKB|E2RNP2 PRKCQ "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)] | Back alignment and assigned GO terms |
|---|
Score = 672 (241.6 bits), Expect = 2.1e-101, Sum P(3) = 2.1e-101
Identities = 124/208 (59%), Positives = 158/208 (75%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+MEYLNGGDLM+HIQ +FD RA FYAAEI+ G++FLH KGIVYRDLKLDNILLD +G
Sbjct: 457 VMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 516
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK + D T+TFCGTPDY+APEI+ G KYN VDWWSFG+LLYEM +GQ
Sbjct: 517 HIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 576
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DE+ELF SI + P +P++L EAK++LV L ++ KRLG D+ H
Sbjct: 577 SPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVR-----GDIRQH 631
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEPF 372
FR ++W+ LE++E++PPFRP+V P+
Sbjct: 632 PLFREINWEELERKEIDPPFRPKVKSPY 659
|
|
| UNIPROTKB|E1BMG4 PRKCQ "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 670 (240.9 bits), Expect = 2.1e-101, Sum P(3) = 2.1e-101
Identities = 125/208 (60%), Positives = 158/208 (75%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+MEYLNGGDLM+HIQ +FD RA FYAAEI+ G++FLH KGIVYRDLKLDNILLD +G
Sbjct: 457 VMEYLNGGDLMYHIQSCHKFDLCRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDG 516
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK + D T+TFCGTPDY+APEI+ G KYN VDWWSFG+LLYEM VGQ
Sbjct: 517 HIKIADFGMCKENMLGDARTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLVGQ 576
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DE+ELF SI + P +P++L EAK++LV L ++ KRLG D+ H
Sbjct: 577 SPFHGQDEEELFHSIRMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVR-----GDIRQH 631
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEPF 372
FR ++W+ LE++E++PPFRP+V P+
Sbjct: 632 PLFREINWEELERKEIDPPFRPKVKSPY 659
|
|
| UNIPROTKB|E1C5S5 PRKCD "Uncharacterized protein" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 658 (236.7 bits), Expect = 9.1e-101, Sum P(3) = 9.1e-101
Identities = 121/206 (58%), Positives = 158/206 (76%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+ME+LNGGDLMFHIQ GRFD RA FY AEI+ G++FLH KGI+YRDLKLDN++LD EG
Sbjct: 435 VMEFLNGGDLMFHIQDKGRFDLYRATFYGAEILCGLQFLHSKGIIYRDLKLDNVMLDKEG 494
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPE--IIKGLKYNQCVDWWSFGILLYEMHV 282
H++IADFGMCK + + TFCGTPDY+APE I++GLKY VDWWSFG+LLYEM +
Sbjct: 495 HIKIADFGMCKENVVGENKASTFCGTPDYIAPENKILQGLKYTFSVDWWSFGVLLYEMLI 554
Query: 283 GQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342
GQSPF G DEDELF SI + P +P++++ E+K++L L ++D T+RLG T N D
Sbjct: 555 GQSPFHGDDEDELFESIRVDTPHYPRWITKESKDLLEKLFERDPTRRLGVTG-NIRD--- 610
Query: 343 AHEYFRGLDWQALEKRELEPPFRPRV 368
H +F+ ++W LEKRE++PPF+P+V
Sbjct: 611 -HPFFKTINWTTLEKREIDPPFKPKV 635
|
|
| UNIPROTKB|I3LR85 PRKCD "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 667 (239.9 bits), Expect = 8.0e-100, Sum P(3) = 8.0e-100
Identities = 123/207 (59%), Positives = 162/207 (78%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+ME+LNGGDLM+HIQ GRF+ RA FYAAEI+ G++FLH+KGI+YRDLKLDN++LD +G
Sbjct: 426 VMEFLNGGDLMYHIQDKGRFELYRATFYAAEIICGLQFLHQKGIIYRDLKLDNVMLDRDG 485
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK + DK TFCGTPDY+APEI++GLKY+ VDWWSFG+LLYEM +GQ
Sbjct: 486 HIKIADFGMCKENMLGDKQASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQ 545
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DEDELF SI + P +P++++ E+K+IL LL++DT KRLG T ++ H
Sbjct: 546 SPFHGDDEDELFESIRVDSPYYPRWITRESKDILEKLLERDTGKRLGVT-----GNIRTH 600
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEP 371
F+ ++W LEKR +EPPF+P+V P
Sbjct: 601 P-FKTINWTLLEKRAVEPPFKPKVRSP 626
|
|
| MGI|MGI:97598 Prkcd "protein kinase C, delta" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 671 (241.3 bits), Expect = 1.0e-99, Sum P(3) = 1.0e-99
Identities = 120/207 (57%), Positives = 161/207 (77%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+ME+LNGGDLMFHIQ GRF+ RA FYAAEI+ G++FLH KGI+YRDLKLDN++LD +G
Sbjct: 424 VMEFLNGGDLMFHIQDKGRFELYRATFYAAEIICGLQFLHSKGIIYRDLKLDNVMLDRDG 483
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK I+ + TFCGTPDY+APEI++GLKY+ VDWWSFG+LLYEM +GQ
Sbjct: 484 HIKIADFGMCKENIFGEGRASTFCGTPDYIAPEILQGLKYSFSVDWWSFGVLLYEMLIGQ 543
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DEDELF SI + P +P++++ E+K+I+ L ++D KRLG T ++ H
Sbjct: 544 SPFHGDDEDELFESIRVDTPHYPRWITKESKDIMEKLFERDPDKRLGVT-----GNIRIH 598
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEP 371
+F+ ++W LEKR++EPPF+P+V P
Sbjct: 599 PFFKTINWSLLEKRKVEPPFKPKVKSP 625
|
|
| ZFIN|ZDB-GENE-041210-195 prkcq "protein kinase C, theta" [Danio rerio (taxid:7955)] | Back alignment and assigned GO terms |
|---|
Score = 647 (232.8 bits), Expect = 2.1e-99, Sum P(3) = 2.1e-99
Identities = 123/204 (60%), Positives = 155/204 (75%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
+MEYLNGGDLMFHIQ RFD R+ FYAAEI+ G++FLH KGIVYRDLKLDNILLD +G
Sbjct: 471 VMEYLNGGDLMFHIQTCHRFDLPRSTFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDG 530
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H++IADFGMCK I + T TFCGTPDY+APEI+ G KY VDWWSFG+LLYEM +GQ
Sbjct: 531 HIKIADFGMCKENIIGEARTCTFCGTPDYIAPEILLGQKYGTSVDWWSFGVLLYEMLIGQ 590
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
SPF G DE+ELF SI + P +P++L+ +A++ILV L ++ +RLG G+ + H
Sbjct: 591 SPFHGHDEEELFQSIRTDDPCYPRWLTRDARDILVKLFVREPERRLGV----KGN-IRQH 645
Query: 345 EYFRGLDWQALEKRELEPPFRPRV 368
+FR DW ALE+R++EPPF+P V
Sbjct: 646 PFFRETDWSALEERQVEPPFKPTV 669
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 3rd Layer | 2.7.11.13 | LOW CONFIDENCE prediction! |
| 3rd Layer | 2.7.11 | 0.766 |
Prediction of Functionally Associated Proteins
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 494 | |||
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 0.0 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-165 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 1e-148 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 1e-145 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 1e-143 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-143 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 1e-136 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 1e-131 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-127 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 1e-125 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 1e-115 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 1e-109 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 1e-107 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 1e-106 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 3e-96 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 2e-95 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 1e-94 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 4e-94 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-93 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 4e-90 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 1e-87 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-86 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 3e-86 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 8e-85 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 2e-80 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 3e-80 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 5e-80 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 2e-79 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 2e-79 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 6e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-77 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-76 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 5e-76 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 3e-75 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 4e-75 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 4e-75 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 2e-74 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-73 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 7e-72 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 3e-69 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 4e-68 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 6e-66 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 3e-63 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-59 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 1e-58 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 1e-58 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-58 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-57 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-57 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 3e-56 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 4e-56 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 2e-55 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-54 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 3e-53 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-53 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 9e-53 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 2e-52 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 8e-52 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 8e-52 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 9e-52 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 1e-51 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 4e-50 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 5e-50 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-49 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 5e-49 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 4e-48 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 5e-48 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-47 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 1e-45 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-43 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 6e-42 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 3e-41 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-40 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 1e-40 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 4e-40 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 7e-40 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-39 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 2e-38 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 2e-37 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 1e-36 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 1e-36 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 3e-36 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 5e-36 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 8e-34 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 4e-33 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-33 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-33 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-32 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 4e-32 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 1e-31 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 2e-31 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-31 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 9e-31 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 5e-30 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 6e-30 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 9e-30 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 1e-29 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 2e-29 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 4e-29 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-29 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-27 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 1e-27 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 7e-27 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 8e-27 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-27 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-26 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 2e-26 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 6e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 7e-26 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 7e-26 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 9e-26 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 2e-25 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 6e-25 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 2e-24 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 3e-24 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-24 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 4e-24 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 9e-24 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 2e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 3e-23 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-23 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 5e-23 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 5e-23 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 6e-23 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 6e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 1e-22 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-22 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-22 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-22 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 4e-22 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 8e-22 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 1e-21 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 1e-21 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 2e-21 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 2e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-21 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 3e-21 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 3e-21 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 5e-21 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 6e-21 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 7e-21 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-21 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 9e-21 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 1e-20 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-20 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-20 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 4e-20 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 6e-20 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 1e-19 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 1e-19 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 2e-19 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 2e-19 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 3e-19 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 3e-19 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 3e-19 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-19 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 5e-19 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 5e-19 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 7e-19 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 1e-18 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 2e-18 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 2e-18 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 2e-18 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-18 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 3e-18 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 3e-18 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 4e-18 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 4e-18 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 5e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 7e-18 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 7e-18 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 9e-18 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-17 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-17 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-17 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-17 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-17 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 3e-17 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 3e-17 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-17 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 6e-17 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 7e-17 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 7e-17 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 8e-17 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-16 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-16 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 2e-16 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 2e-16 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 3e-16 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 4e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 5e-16 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 6e-16 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 9e-16 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 1e-15 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-15 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 1e-15 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 1e-15 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 1e-15 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 2e-15 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 2e-15 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-15 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 3e-15 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 3e-15 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-15 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 6e-15 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 6e-15 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 7e-15 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 7e-15 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 8e-15 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 9e-15 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 1e-14 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-14 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 3e-14 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-14 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-14 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 4e-14 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 4e-14 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-14 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 6e-14 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 6e-14 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 7e-14 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 7e-14 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 7e-14 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 8e-14 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-13 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 1e-13 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-13 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 2e-13 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 2e-13 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 2e-13 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 2e-13 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 2e-13 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 2e-13 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 3e-13 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 4e-13 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 4e-13 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 5e-13 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 9e-13 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-12 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 1e-12 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 1e-12 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-12 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 1e-12 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 2e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 2e-12 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 2e-12 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 4e-12 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 4e-12 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 5e-12 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 6e-12 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 6e-12 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 7e-12 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 2e-11 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 2e-11 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 2e-11 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 3e-11 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-11 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 3e-11 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 4e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 4e-11 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 5e-11 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 8e-11 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 9e-11 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 1e-10 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 1e-10 | |
| pfam00433 | 47 | pfam00433, Pkinase_C, Protein kinase C terminal do | 1e-10 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 1e-10 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 1e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-10 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 2e-10 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-10 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 3e-10 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 4e-10 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 5e-10 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 5e-10 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 5e-10 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-10 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 9e-10 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 1e-09 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 1e-09 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-09 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 1e-09 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 1e-09 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 2e-09 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-09 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-09 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 6e-09 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 6e-09 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 7e-09 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 2e-08 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 3e-08 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-08 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 4e-08 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 5e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 7e-08 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 9e-08 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-07 | |
| smart00133 | 64 | smart00133, S_TK_X, Extension to Ser/Thr-type prot | 3e-07 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 3e-07 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 3e-07 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 5e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 3e-06 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 5e-06 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 8e-06 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-05 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 1e-05 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 1e-05 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 2e-05 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 2e-05 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 5e-05 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 5e-04 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 6e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 7e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 7e-04 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 0.002 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.003 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 0.004 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 539 bits (1390), Expect = 0.0
Identities = 216/370 (58%), Positives = 261/370 (70%), Gaps = 54/370 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KVLGKGSFGKV LAELKGT+ ++A+K LKKDVVLEDDDVECT++ER+VLAL +HP+L H
Sbjct: 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTH 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
LFCTFQT HLFFVMEYLNGGDL MFHIQ SGRFDE RAR
Sbjct: 61 LFCTFQTKEHLFFVMEYLNGGDL---------------------MFHIQSSGRFDEARAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI+ G++FLHKKGI+YRDLKLDN+LLD +GH++IADFGMCK + + TFCGT
Sbjct: 100 FYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
PDY+APEI+KG KYN+ VDWWSFG+LLYEM +GQSPF G DEDELF SI N+RP FP+++
Sbjct: 160 PDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S EAK+ L L ++D TKRLG D+ H +FRG+DW+ LEKRE+ PPF+P+V
Sbjct: 220 SKEAKDCLSKLFERDPTKRLGVD-----GDIRQHPFFRGIDWERLEKREIPPPFKPKVKS 274
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
P D FD+ FT E+ L+PVD+ +L SMDQ
Sbjct: 275 PS----------------------------DASNFDREFTNEKVRLSPVDKKLLASMDQE 306
Query: 431 QFQGFSYTNP 440
QF+GFS+TNP
Sbjct: 307 QFRGFSFTNP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 469 bits (1210), Expect = e-165
Identities = 199/368 (54%), Positives = 241/368 (65%), Gaps = 50/368 (13%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KVLGKGSFGKV LAELKGTD YAVK LKKDV+L+DDDVECT+ E++VLAL KHP+L
Sbjct: 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQ 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L FQT LFFVMEY+NGGDL MFHIQ+SGRFDE RAR
Sbjct: 61 LHSCFQTKDRLFFVMEYVNGGDL---------------------MFHIQRSGRFDEPRAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEIV G++FLH++GI+YRDLKLDN+LLD EGH++IADFGMCK I TT TFCGT
Sbjct: 100 FYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
PDY+APEI+ Y VDWW+ G+LLYEM GQSPF G DEDELF SI + R+P++L
Sbjct: 160 PDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S EAK+IL L K+ KRLG D+ H +FR +DW LE++E++PPF+P++
Sbjct: 220 SKEAKSILKSFLTKNPEKRLGCLP-TGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIKG 278
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
F DV FD FT E+P LTP D I+ ++DQ
Sbjct: 279 RF----------------------------DVSNFDDEFTKEKPVLTPPDEAIIRNIDQE 310
Query: 431 QFQGFSYT 438
+F+GFSY
Sbjct: 311 EFRGFSYI 318
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 427 bits (1099), Expect = e-148
Identities = 190/374 (50%), Positives = 235/374 (62%), Gaps = 50/374 (13%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
DF L VLGKGSFGKV LAE KGTD YA+K LKKDV+++DDDVECT++E++VLAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKP 60
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P+L L FQT L+FVMEY+NGGDL M+HIQQ G+F
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---------------------MYHIQQVGKFK 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E A FYAAEI G+ FLH KGI+YRDLKLDN++LD EGH++IADFGMCK I+ KTT
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGKTTR 159
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305
TFCGTPDY+APEII Y + VDWW+FG+LLYEM GQ PF G DEDELF SI
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
+P+ LS EA +I LL K KRLG D+ H +FR +DW+ LE+RE++PPF+
Sbjct: 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGP-TGERDIREHAFFRRIDWEKLERREIQPPFK 278
Query: 366 PRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILE 425
P+V + FDK FT E P LTP D+ ++
Sbjct: 279 PKV----------------------------KGRRSAENFDKFFTREPPVLTPPDKLVIA 310
Query: 426 SMDQTQFQGFSYTN 439
++DQ++FQGFS+ N
Sbjct: 311 NIDQSEFQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 418 bits (1077), Expect = e-145
Identities = 198/370 (53%), Positives = 247/370 (66%), Gaps = 54/370 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
K+LGKGSFGKVFLAELKGT+ ++A+K LKKDVVL DDDVECT++E++VL+L +HP+L H
Sbjct: 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTH 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L+CTFQT +LFFVMEYLNGGDL MFHIQ +FD RA
Sbjct: 61 LYCTFQTKENLFFVMEYLNGGDL---------------------MFHIQSCHKFDLPRAT 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI+ G++FLH KGIVYRDLKLDNILLD +GH++IADFGMCK + D T TFCGT
Sbjct: 100 FYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTCTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
PDY+APEI+ G KYN VDWWSFG+LLYEM +GQSPF G DE+ELF SI + P +P++L
Sbjct: 160 PDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
+ EAK+ILV L ++ +RLG D+ H +FR +DW ALE+RE+EPPF+P+V
Sbjct: 220 TREAKDILVKLFVREPERRLGVK-----GDIRQHPFFREIDWSALEEREIEPPFKPKVKS 274
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
D FDK F E+P L+ DR ++ SMDQ
Sbjct: 275 AN----------------------------DCSNFDKEFLNEKPRLSVTDRMLINSMDQN 306
Query: 431 QFQGFSYTNP 440
F+ FS+ NP
Sbjct: 307 MFENFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 413 bits (1064), Expect = e-143
Identities = 180/370 (48%), Positives = 237/370 (64%), Gaps = 50/370 (13%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KVLGKGSFGKV LAELKGTD YA+K LKKDV+L+DDDV+CT+ E+++LAL KHP+L
Sbjct: 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTA 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L C FQT LFFVMEY+NGGDL MF IQ+S +FDE R+R
Sbjct: 61 LHCCFQTKDRLFFVMEYVNGGDL---------------------MFQIQRSRKFDEPRSR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAE+ + FLH+ G++YRDLKLDNILLD EGH ++ADFGMCK I TT TFCGT
Sbjct: 100 FYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGVTTTTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
PDY+APEI++ L+Y VDWW+ G+L+YEM GQ PF +ED+LF SI ++ +P +L
Sbjct: 160 PDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWL 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV-AHEYFRGLDWQALEKRELEPPFRPRVI 369
S EA +IL + K+ KRLG G+D + H +F+ +DW LE+R+++PPF+P++
Sbjct: 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIK 279
Query: 370 EPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQ 429
DV FD+ FT E P LTPVD +++ ++Q
Sbjct: 280 TK----------------------------RDVNNFDQDFTKEEPVLTPVDPAVIKQINQ 311
Query: 430 TQFQGFSYTN 439
+F+GFS+ N
Sbjct: 312 EEFRGFSFFN 321
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 413 bits (1062), Expect = e-143
Identities = 196/370 (52%), Positives = 251/370 (67%), Gaps = 54/370 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KVLGKGSFGKV LAELKG Y+AVK LKKDVVL DDDVECT++E++VLAL ++P+L H
Sbjct: 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTH 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L+CTFQT HLFFVME+LNGGDL MFHIQ GRFD RA
Sbjct: 61 LYCTFQTKEHLFFVMEFLNGGDL---------------------MFHIQDKGRFDLYRAT 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEIV G++FLH KGI+YRDLKLDN++LD +GH++IADFGMCK ++ D TFCGT
Sbjct: 100 FYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGDNRASTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
PDY+APEI++GLKY VDWWSFG+LLYEM +GQSPF G DEDELF SI + P +P+++
Sbjct: 160 PDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
+ E+K+IL L ++D T+RLG ++ H +F+ ++W ALEKREL+PPF+P+V
Sbjct: 220 TKESKDILEKLFERDPTRRLGVV-----GNIRGHPFFKTINWTALEKRELDPPFKPKVKS 274
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
P D FD+ F +E+P L+ D+ +++SMDQ+
Sbjct: 275 P----------------------------SDYSNFDREFLSEKPRLSYSDKNLIDSMDQS 306
Query: 431 QFQGFSYTNP 440
F GFS+ NP
Sbjct: 307 AFAGFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 395 bits (1017), Expect = e-136
Identities = 180/368 (48%), Positives = 238/368 (64%), Gaps = 49/368 (13%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+VLGKGSFGKV LA LK + YAVK LKKDV+L+DDDVECT+ E+++L+L HP+L
Sbjct: 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQ 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L+C FQT LFFVME++NGGDL MFHIQ+S RFDE RAR
Sbjct: 61 LYCCFQTPDRLFFVMEFVNGGDL---------------------MFHIQKSRRFDEARAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI S + FLH KGI+YRDLKLDN+LLD+EGH ++ADFGMCK I+ KTT TFCGT
Sbjct: 100 FYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNGKTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
PDY+APEI++ + Y VDWW+ G+LLYEM G +PF +ED+LF +I N+ +P +L
Sbjct: 160 PDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S +A +IL + K+ T RLGS + ++ H +F+ LDW+ L +R++EPPFRPR+
Sbjct: 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRI-- 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
S++ DV FD F E P LTP++ ++L ++Q
Sbjct: 278 ---------KSRE-----------------DVSNFDPDFIKEDPVLTPIEESLLPMINQD 311
Query: 431 QFQGFSYT 438
+F+ FSYT
Sbjct: 312 EFRNFSYT 319
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 383 bits (985), Expect = e-131
Identities = 157/375 (41%), Positives = 214/375 (57%), Gaps = 54/375 (14%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL--ALGTK 124
F+ L VLG+G FGKV LAE K T YA+K LKK ++ D+VE + E+++ A +
Sbjct: 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSER 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP+L +LF FQT+ H+ FVMEY GGDL M HI F
Sbjct: 61 HPFLVNLFACFQTEDHVCFVMEYAAGGDL---------------------MMHIHT-DVF 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
E RA FYAA +V G+++LH+ IVYRDLKLDN+LLD EG V+IADFG+CK + T
Sbjct: 99 SEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFGDRT 158
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304
TFCGTP+++APE++ Y + VDWW G+L+YEM VG+SPF G DE+E+F SI N+
Sbjct: 159 STFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV 218
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPF 364
R+P+FLS EA +I+ LL ++ +RLGS + +DV +FR ++W L R+++PPF
Sbjct: 219 RYPRFLSREAISIMRRLLRRNPERRLGSGE-KDAEDVKKQPFFRDINWDDLLARKIKPPF 277
Query: 365 RPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRT-I 423
P + DV FD+ FT+E P LTP +
Sbjct: 278 VPTI----------------------------KGPEDVSNFDEEFTSEAPVLTPPREPRL 309
Query: 424 LESMDQTQFQGFSYT 438
L +Q F+GF Y
Sbjct: 310 LTEEEQELFRGFDYV 324
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 373 bits (958), Expect = e-127
Identities = 185/374 (49%), Positives = 234/374 (62%), Gaps = 51/374 (13%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
DF L VLGKGSFGKV LAE KGTD YA+K LKKDVV++DDDVECT++E++VLAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKP 60
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P+L L FQT L+FVMEY+NGGDL M+ IQQ GRF
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDL---------------------MYQIQQVGRFK 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E A FYAAEI G+ FLH KGI+YRDLKLDN++LD EGH++IADFGMCK ++ TT
Sbjct: 100 EPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDGVTTK 159
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305
TFCGTPDY+APEII Y + VDWW+FG+LLYEM GQ+PF G DEDELF SI
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
+P+ +S EA I L+ K KRLG D+ H +FR +DW+ LE++E++PP++
Sbjct: 220 YPKSMSKEAVAICKGLMTKHPGKRLGCGP-EGERDIKEHAFFRYIDWEKLERKEVQPPYK 278
Query: 366 PRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILE 425
P K +D+ + FDK FT P LTP D+ ++
Sbjct: 279 P-----------KACGRDA------------------ENFDKFFTRHPPVLTPPDQEVIM 309
Query: 426 SMDQTQFQGFSYTN 439
++DQ++F+GFSY N
Sbjct: 310 NLDQSEFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 368 bits (945), Expect = e-125
Identities = 185/374 (49%), Positives = 232/374 (62%), Gaps = 51/374 (13%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
DF L VLGKGSFGKV LAE KGTD YA+K LKKDVV++DDDVECT++E++VLAL K
Sbjct: 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKP 60
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P+L L FQT L+FVMEY+NGGDL M+HIQQ G+F
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDL---------------------MYHIQQVGKFK 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E +A FYAAEI G+ FLH++GI+YRDLKLDN++LD EGH++IADFGMCK + TT
Sbjct: 100 EPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGVTTR 159
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305
TFCGTPDY+APEII Y + VDWW++G+LLYEM GQ PF G DEDELF SI
Sbjct: 160 TFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
+P+ LS EA +I L+ K +KRLG D+ H +FR +DW LE RE++PPF+
Sbjct: 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGP-EGERDIREHAFFRRIDWDKLENREIQPPFK 278
Query: 366 PRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILE 425
P+V + FDK FT +P LTP D+ ++
Sbjct: 279 PKVC-----------------------------GKGAENFDKFFTRGQPVLTPPDQLVIA 309
Query: 426 SMDQTQFQGFSYTN 439
++DQ F+GFSY N
Sbjct: 310 NIDQADFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 339 bits (871), Expect = e-115
Identities = 123/275 (44%), Positives = 167/275 (60%), Gaps = 25/275 (9%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LGKGSFGKV L K T YA+K LKK +++ +VE TL ER +L+ HP++ L
Sbjct: 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSR-INHPFIVKLH 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
FQT+ L+ V+EY GG+L H+ + GRF E RARFY
Sbjct: 60 YAFQTEEKLYLVLEYAPGGELF---------------------SHLSKEGRFSEERARFY 98
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
AAEIV + +LH GI+YRDLK +NILLD +GH+++ DFG+ K T+TFCGTP+
Sbjct: 99 AAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCGTPE 158
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSV 312
Y+APE++ G Y + VDWWS G+LLYEM G+ PF D E++ I + RFP+FLS
Sbjct: 159 YLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSP 218
Query: 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
EA++++ LL KD TKRLG +++ AH +F
Sbjct: 219 EARDLISGLLQKDPTKRLG---SGGAEEIKAHPFF 250
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 326 bits (838), Expect = e-109
Identities = 129/305 (42%), Positives = 190/305 (62%), Gaps = 28/305 (9%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ +K LG GSFG+V L KG+ YYA+K L K +++ VE L E+++L +
Sbjct: 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQS-IR 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGR 183
HP+L +L+ +FQ DS+L+ VMEY+ GG+ +F H+++SGR
Sbjct: 60 HPFLVNLYGSFQDDSNLYLVMEYVPGGE----------------------LFSHLRKSGR 97
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
F E ARFYAA++V + +LH IVYRDLK +N+LLD +G+++I DFG K +
Sbjct: 98 FPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK---RVKGR 154
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T T CGTP+Y+APEII Y + VDWW+ GIL+YEM G PF + +++ I +
Sbjct: 155 TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK 214
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363
RFP F S +AK+++ +LL D TKRLG+ + N +D+ H +F G+DW AL +R++E P
Sbjct: 215 VRFPSFFSPDAKDLIRNLLQVDLTKRLGNLK-NGVNDIKNHPWFAGIDWIALLQRKIEAP 273
Query: 364 FRPRV 368
F P+V
Sbjct: 274 FIPKV 278
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 321 bits (824), Expect = e-107
Identities = 148/378 (39%), Positives = 216/378 (57%), Gaps = 58/378 (15%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+V+G+GS+ KV L ELK T YA+K +KK++V +D+D++ E+ V + HP+L
Sbjct: 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L FQT+S LFFV+E+++GGDL MFH+Q+ + E AR
Sbjct: 61 LHSCFQTESRLFFVIEFVSGGDL---------------------MFHMQRQRKLPEEHAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FY+AEI + FLH++GI+YRDLKLDN+LLD EGH+++ D+GMCK I TT TFCGT
Sbjct: 100 FYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPGDTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC---------DEDELFWSICN 301
P+Y+APEI++G Y VDWW+ G+L++EM G+SPF ED LF I
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219
Query: 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELE 361
++ R P+ LSV+A ++L L+KD +RLG D+ +H +FR +DW LE++++
Sbjct: 220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVL 279
Query: 362 PPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDR 421
PP++P + D+ FD FT E LTP D
Sbjct: 280 PPYKPNIESDR----------------------------DLDNFDPQFTDEPVQLTPDDP 311
Query: 422 TILESMDQTQFQGFSYTN 439
++ +DQ++F+GF Y N
Sbjct: 312 DVIARIDQSEFEGFEYIN 329
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 317 bits (815), Expect = e-106
Identities = 151/373 (40%), Positives = 212/373 (56%), Gaps = 55/373 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
K+LGKG+FGKV L K T YYA+K LKK+V++ D+V TL E +VL T+HP+L
Sbjct: 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ-NTRHPFLTA 59
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L FVMEY NGG+L FH+ + F E RAR
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---------------------FFHLSRERVFSEDRAR 98
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FY AEIVS + +LH +VYRDLKL+N++LD +GH++I DFG+CK I T TFCGT
Sbjct: 99 FYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE+++ Y + VDWW G+++YEM G+ PF D ++LF I E RFP+ L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 218
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S EAK++L LL KD +RLG +++ H +F ++WQ + +++LEPPF+P+V
Sbjct: 219 SPEAKSLLAGLLKKDPKQRLGGGP-EDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVTS 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRT----ILES 426
D +YFD+ FTA+ +TP DR +L+
Sbjct: 278 ----------------------------ETDTRYFDEEFTAQSITITPPDRYDSLGLLQL 309
Query: 427 MDQTQFQGFSYTN 439
++ F FSY+
Sbjct: 310 EERPHFPQFSYSA 322
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 293 bits (752), Expect = 3e-96
Identities = 147/378 (38%), Positives = 204/378 (53%), Gaps = 67/378 (17%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KV+GKGSFGKV LA+ K +YAVK L+K +L+ + + + ER VL KHP+L
Sbjct: 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L+FV++Y+NGG+L FH+Q+ F E RAR
Sbjct: 61 LHYSFQTADKLYFVLDYVNGGEL---------------------FFHLQRERSFPEPRAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI S + +LH I+YRDLK +NILLD +GHV + DFG+CK I KTT TFCGT
Sbjct: 100 FYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSKTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE+++ Y++ VDWW G +LYEM G PF D E++ +I N+ R +
Sbjct: 160 PEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNI 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
SV A+++L LL KD TKRLG+ + ++ H +F ++W L +++ PPF P V
Sbjct: 220 SVSARHLLEGLLQKDRTKRLGAK--DDFLEIKNHVFFSSINWDDLVNKKITPPFNPNVSG 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
P +D+K+FD FT E PV ++ +S D
Sbjct: 278 P----------------------------MDLKHFDPEFTEE-----PVPNSVGKSPDSV 304
Query: 431 -----------QFQGFSY 437
F GFSY
Sbjct: 305 LVSASVKEADDAFLGFSY 322
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 291 bits (747), Expect = 2e-95
Identities = 148/376 (39%), Positives = 219/376 (58%), Gaps = 56/376 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+V+G+GS+ KV L LK D YA+K +KK++V +D+D++ E+ V + +P+L
Sbjct: 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L FQT S LF V+EY+NGG DLMFH+Q+ + E AR
Sbjct: 61 LHSCFQTTSRLFLVIEYVNGG---------------------DLMFHMQRQRKLPEEHAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI + FLH++GI+YRDLKLDN+LLD +GH+++ D+GMCK + TT TFCGT
Sbjct: 100 FYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPGDTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC-------DEDELFWSICNER 303
P+Y+APEI++G +Y VDWW+ G+L++EM G+SPF ED LF I +
Sbjct: 160 PNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363
R P+FLSV+A ++L L+KD +RLG D+ +H +FR +DW LEK+++ PP
Sbjct: 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPP 279
Query: 364 FRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTI 423
F+P++ + + ++ FD FT+E LTP D +
Sbjct: 280 FKPQITDDYG----------------------------LENFDTQFTSEPVQLTPDDEDV 311
Query: 424 LESMDQTQFQGFSYTN 439
++ +DQ++F+GF Y N
Sbjct: 312 IKRIDQSEFEGFEYIN 327
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 289 bits (741), Expect = 1e-94
Identities = 150/372 (40%), Positives = 211/372 (56%), Gaps = 55/372 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
K+LGKG+FGKV L K T YYA+K L+K+V++ D+V T+ E +VL T+HP+L
Sbjct: 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTA 59
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L FQT L FVMEY NGG+L FH+ + F E RAR
Sbjct: 60 LKYAFQTHDRLCFVMEYANGGEL---------------------FFHLSRERVFTEERAR 98
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FY AEIVS + +LH + +VYRD+KL+N++LD +GH++I DFG+CK I T TFCGT
Sbjct: 99 FYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGATMKTFCGT 158
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE+++ Y + VDWW G+++YEM G+ PF D + LF I E RFP+ L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 218
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S EAK++L LL KD +RLG + +V+ H +F ++WQ + +++L PPF+P+V
Sbjct: 219 SPEAKSLLAGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVTS 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDR----TILES 426
+D +YFD FTA+ +TP DR +LE
Sbjct: 278 ----------------------------EVDTRYFDDEFTAQSITITPPDRYDSLGLLEL 309
Query: 427 MDQTQFQGFSYT 438
+T F FSY+
Sbjct: 310 DQRTHFPQFSYS 321
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 288 bits (738), Expect = 4e-94
Identities = 148/378 (39%), Positives = 215/378 (56%), Gaps = 58/378 (15%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+V+G+GS+ KV L LK T+ YA+K +KK++V +D+D++ E+ V + HP+L
Sbjct: 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L FQT+S LFFV+EY+NGGDL MFH+Q+ + E AR
Sbjct: 61 LHSCFQTESRLFFVIEYVNGGDL---------------------MFHMQRQRKLPEEHAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FY+AEI + +LH++GI+YRDLKLDN+LLD EGH+++ D+GMCK + TT TFCGT
Sbjct: 100 FYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGDTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS---------GCDEDELFWSICN 301
P+Y+APEI++G Y VDWW+ G+L++EM G+SPF ED LF I
Sbjct: 160 PNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219
Query: 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELE 361
++ R P+ LSV+A ++L L+KD +RLG D+ H +FR +DW +E++++
Sbjct: 220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVV 279
Query: 362 PPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDR 421
PPF+P + F + FD FT E LTP D
Sbjct: 280 PPFKPNISGEFG----------------------------LDNFDAQFTNEPVQLTPDDD 311
Query: 422 TILESMDQTQFQGFSYTN 439
I+ +DQ++F+GF Y N
Sbjct: 312 DIVRKIDQSEFEGFEYIN 329
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 284 bits (728), Expect = 1e-93
Identities = 113/285 (39%), Positives = 161/285 (56%), Gaps = 35/285 (12%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+++L+ LG+GSFGKV+LA K T A+K +KK D E L E K+L KHP
Sbjct: 1 YEILEKLGEGSFGKVYLARDKKTGKLVAIKVIKKK--KIKKDRERILREIKILKK-LKHP 57
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ L+ F+ + L+ VMEY GGDL +++ GR E
Sbjct: 58 NIVRLYDVFEDEDKLYLVMEYCEGGDL---------------------FDLLKKRGRLSE 96
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
ARFY +I+S + +LH KGIV+RDLK +NILLD +GHV++ADFG+ + Q+ + T
Sbjct: 97 DEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLAR-QLDPGEKLTT 155
Query: 247 FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFWSICNERPR 305
F GTP+YMAPE++ G Y + VD WS G++LYE+ G+ PF G ELF I +P
Sbjct: 156 FVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPP 215
Query: 306 FPQF---LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
FP +S EAK+++ LL KD KRL + ++ + H +F
Sbjct: 216 FPPPEWDISPEAKDLIRKLLVKDPEKRLTA------EEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 278 bits (711), Expect = 4e-90
Identities = 149/375 (39%), Positives = 214/375 (57%), Gaps = 56/375 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
K+LGKG+FGKV L + K T YYA+K LKK+V++ D+V TL E +VL ++HP+L
Sbjct: 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTA 59
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L FVMEY NGG+L FH+ + F E RAR
Sbjct: 60 LKYSFQTHDRLCFVMEYANGGEL---------------------FFHLSRERVFSEDRAR 98
Query: 191 FYAAEIVSGMRFLH-KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG 249
FY AEIVS + +LH +K +VYRDLKL+N++LD +GH++I DFG+CK I T TFCG
Sbjct: 99 FYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCG 158
Query: 250 TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQF 309
TP+Y+APE+++ Y + VDWW G+++YEM G+ PF D ++LF I E RFP+
Sbjct: 159 TPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 218
Query: 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369
LS EAK++L LL KD +RLG + +++ H++F G+ WQ + +++L PPF+P+V
Sbjct: 219 LSPEAKSLLSGLLKKDPKQRLGGGP-DDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVT 277
Query: 370 EPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVD----RTILE 425
D +YFD+ FTA+ +TP D ++
Sbjct: 278 S----------------------------ETDTRYFDEEFTAQMITITPPDQDDSMETVD 309
Query: 426 SMDQTQFQGFSYTNP 440
+ + F FSY+
Sbjct: 310 NERRPHFPQFSYSAS 324
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 271 bits (693), Expect = 1e-87
Identities = 137/365 (37%), Positives = 199/365 (54%), Gaps = 53/365 (14%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+GKGSFGKV + T YA+K ++K ++ +V TL ER VLA P++ L
Sbjct: 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLA-QVNCPFIVPLK 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
+FQ+ L+ V+ ++NGG+L H+Q+ GRFD RARFY
Sbjct: 60 FSFQSPEKLYLVLAFINGGEL---------------------FHHLQREGRFDLSRARFY 98
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
AE++ + LHK ++YRDLK +NILLDY+GH+ + DFG+CKL + D T+TFCGTP+
Sbjct: 99 TAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDDKTNTFCGTPE 158
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSV 312
Y+APE++ G Y + VDWW+ G+LLYEM G PF + +E++ I E RFP
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDR 218
Query: 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPF 372
+AK++L+ LL +D T+RLG N ++ H +F L W+ L + ++PPF+P V
Sbjct: 219 DAKDLLIGLLSRDPTRRLGY---NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVSS-- 273
Query: 373 SSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQF 432
A+D FD+ FT E+P + VD + L Q QF
Sbjct: 274 --------------------------AIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQF 307
Query: 433 QGFSY 437
G+SY
Sbjct: 308 GGWSY 312
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 268 bits (687), Expect = 2e-86
Identities = 148/374 (39%), Positives = 211/374 (56%), Gaps = 57/374 (15%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
K+LGKG+FGKV L K + YYA+K LKK+V++ D+V TL E +VL T+HP+L
Sbjct: 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK-NTRHPFLTS 59
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L FVMEY+NGG+L FH+ + F E R R
Sbjct: 60 LKYSFQTKDRLCFVMEYVNGGEL---------------------FFHLSRERVFSEDRTR 98
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FY AEIVS + +LH IVYRDLKL+N++LD +GH++I DFG+CK I T TFCGT
Sbjct: 99 FYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAATMKTFCGT 158
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE+++ Y + VDWW G+++YEM G+ PF D ++LF I E +FP+ L
Sbjct: 159 PEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S +AK++L LL KD KRLG + +++ H +F G++WQ + ++L PPF+P+V
Sbjct: 219 SADAKSLLSGLLIKDPNKRLGGGP-DDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVTS 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMD-- 428
D +YFD+ FTA+ +TP ++ + MD
Sbjct: 278 ----------------------------ETDTRYFDEEFTAQTITITPPEKYDEDGMDCM 309
Query: 429 ----QTQFQGFSYT 438
+ F FSY+
Sbjct: 310 DNERRPHFPQFSYS 323
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 266 bits (682), Expect = 3e-86
Identities = 123/314 (39%), Positives = 178/314 (56%), Gaps = 39/314 (12%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKG---TDYYYAVKCLKK-DVVLEDDDVECTLIERKVLAL 121
+F+LL+VLG G++GKVFL G YA+K LKK +V + E T ER+VL
Sbjct: 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEA 60
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+ P+L L FQTD+ L +++Y+NGG+L H+ Q
Sbjct: 61 VRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFT---------------------HLYQR 99
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
F E R Y AEIV + LH+ GI+YRD+KL+NILLD EGHV + DFG+ K +L
Sbjct: 100 EHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSK--EFLA 157
Query: 242 KTTD---TFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDE---- 292
+ + +FCGT +YMAPE+I+G +++ VDWWS G+L +E+ G SPF+ E
Sbjct: 158 EEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217
Query: 293 DELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
E+ I +P FP+ +S EA++ + LL+KD KRLG N D++ H +F+G+DW
Sbjct: 218 SEISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLG---ANGADEIKNHPFFQGIDW 274
Query: 353 QALEKRELEPPFRP 366
L + + PF+P
Sbjct: 275 DDLAAKRIPAPFKP 288
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 263 bits (675), Expect = 8e-85
Identities = 137/375 (36%), Positives = 198/375 (52%), Gaps = 56/375 (14%)
Query: 70 LKVLGKGSFGKVFLAE-LKGTD--YYYAVKCLKK-DVVLEDDDVECTLIERKVLALGTKH 125
LKVLGKG +GKVF + G D +A+K LKK +V D T ER +L KH
Sbjct: 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE-AVKH 59
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P++ L FQT L+ ++EYL+GG+L H+++ G F
Sbjct: 60 PFIVDLIYAFQTGGKLYLILEYLSGGEL---------------------FMHLEREGIFM 98
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E A FY +EI + LH++GI+YRDLK +NILLD +GHV++ DFG+CK I+ T
Sbjct: 99 EDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305
TFCGT +YMAPEI+ + + VDWWS G L+Y+M G PF+ + + I +
Sbjct: 159 TFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
P +L+ EA+++L LL ++ + RLG+ +V +H +FR ++W L R++EPPF+
Sbjct: 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGP-GDAAEVQSHPFFRHVNWDDLLARKVEPPFK 277
Query: 366 PRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILE 425
P L S++ DV FD FT + P +P D T+ E
Sbjct: 278 P-----------LLQSEE-----------------DVSQFDSKFTRQTPVDSPDDSTLSE 309
Query: 426 SMDQTQFQGFSYTNP 440
S +Q F GF+Y P
Sbjct: 310 SANQI-FLGFTYVAP 323
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 253 bits (646), Expect = 2e-80
Identities = 147/378 (38%), Positives = 200/378 (52%), Gaps = 61/378 (16%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KV+GKGSFGKV LA+ K YAVK L+K +VL + + + ER VL KHP+L
Sbjct: 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L+FV++++NGG+L FH+Q+ F E RAR
Sbjct: 61 LHYSFQTTEKLYFVLDFVNGGEL---------------------FFHLQRERSFPEPRAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI S + +LH IVYRDLK +NILLD +GHV + DFG+CK I TT TFCGT
Sbjct: 100 FYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE+I+ Y+ VDWW G +LYEM G PF D E++ +I ++
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S+ A +IL LL+KD +RLG+ + ++ H +F L W LE++++ PPF P V
Sbjct: 220 SLTAWSILEELLEKDRQRRLGAKE--DFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVEG 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAE----RPCLTP----VDRT 422
P D+ FD FT E C + V+ +
Sbjct: 278 PD----------------------------DISNFDAVFTEETVPYSVCFSSDYSIVNAS 309
Query: 423 ILESMDQTQFQGFSYTNP 440
+LE+ D F GFSY P
Sbjct: 310 VLEADD--AFVGFSYAPP 325
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 3e-80
Identities = 113/290 (38%), Positives = 167/290 (57%), Gaps = 35/290 (12%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+ KG++G+VFLA+ K T YA+K +KK ++ + V+ L ER +L+ + PY+ L+
Sbjct: 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQ-AQSPYVVKLY 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
+FQ +L+ VMEYL GGDL A L ++ G DE AR Y
Sbjct: 60 YSFQGKKNLYLVMEYLPGGDL--ASL-------------------LENVGSLDEDVARIY 98
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-----QIYLDKTTD-- 245
AEIV + +LH GI++RDLK DNIL+D GH+++ DFG+ K+ QI L+
Sbjct: 99 IAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKED 158
Query: 246 -TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304
GTPDY+APE+I G +++ VDWWS G +LYE VG PF G +E+F +I N +
Sbjct: 159 KRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI 218
Query: 305 RFPQFLSV--EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
+P+ + V EA +++ LL D KRLG S +++ H +F+G+DW
Sbjct: 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLG---AKSIEEIKNHPFFKGIDW 265
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 251 bits (643), Expect = 5e-80
Identities = 117/340 (34%), Positives = 178/340 (52%), Gaps = 61/340 (17%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
F+ +K+LGKG G+VFL LKGT +A+K L K +++ + V+ L E+++LA H
Sbjct: 2 HFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILAT-LDH 60
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---G 182
P+L L+ +FQT+++L VM+Y GG+L F + Q
Sbjct: 61 PFLPTLYASFQTETYLCLVMDYCPGGEL----------------------FRLLQRQPGK 98
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL------ 236
E ARFYAAE++ + +LH GIVYRDLK +NILL GH+ ++DF + K
Sbjct: 99 CLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPP 158
Query: 237 ---QIYLDKT--------------------TDTFCGTPDYMAPEIIKGLKYNQCVDWWSF 273
+ + +++F GT +Y+APE+I G + VDWW+
Sbjct: 159 PVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218
Query: 274 GILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLG 331
GILLYEM G +PF G + DE F +I + FP +S A++++ LL KD +KRLG
Sbjct: 219 GILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLG 278
Query: 332 STQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEP 371
S + + ++ H +FRG++W + R PP PR +
Sbjct: 279 SKRGAA--EIKQHPFFRGVNWALI--RHTTPPIIPRPDDG 314
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 249 bits (637), Expect = 2e-79
Identities = 115/307 (37%), Positives = 175/307 (57%), Gaps = 26/307 (8%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+D + +K +G G+FG+V L + +++YYA+K + V+ + E++VL
Sbjct: 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVL-KEVS 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP++ LF T L+ LMEY+ GG+L +++ SGRF
Sbjct: 60 HPFIIRLFWTEHDQRFLYM---------------------LMEYVPGGELFSYLRNSGRF 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
FYA+EIV + +LH K IVYRDLK +NILLD EGH+++ DFG K D+T
Sbjct: 99 SNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLR--DRTW 156
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304
T CGTP+Y+APE+I+ +N+ VDWW+ GIL+YEM VG PF + ++ I +
Sbjct: 157 -TLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPF 364
FP+ L + AK+++ LL D T+RLG+ + N DDV H +F+ +DW + +R+L+PP
Sbjct: 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMK-NGADDVKNHRWFKSVDWDDVPQRKLKPPI 274
Query: 365 RPRVIEP 371
P+V
Sbjct: 275 VPKVSHD 281
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 250 bits (640), Expect = 2e-79
Identities = 142/381 (37%), Positives = 202/381 (53%), Gaps = 67/381 (17%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KV+GKGSFGKV LA K + +YAVK L+K +L+ + + + ER VL KHP+L
Sbjct: 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L+FV++Y+NGG+L +H+Q+ F E RAR
Sbjct: 61 LHFSFQTADKLYFVLDYINGGEL---------------------FYHLQRERCFLEPRAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAEI S + +LH IVYRDLK +NILLD +GH+ + DFG+CK I + TT TFCGT
Sbjct: 100 FYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNGTTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE++ Y++ VDWW G +LYEM G PF + E++ +I N+ + +
Sbjct: 160 PEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
+ A+++L LL KD TKRLG+ + ++ H +F ++W L +++ PPF P V
Sbjct: 220 TNSARHLLEGLLQKDRTKRLGAK--DDFMEIKNHIFFSPINWDDLINKKITPPFNPNVSG 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQT 430
P D+++FD FT E PV +I +S D
Sbjct: 278 PN----------------------------DLRHFDPEFTEE-----PVPNSIGQSPDSI 304
Query: 431 -----------QFQGFSYTNP 440
F GFSY P
Sbjct: 305 LVTASVKEAAEAFLGFSYAPP 325
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 249 bits (636), Expect = 6e-79
Identities = 139/371 (37%), Positives = 199/371 (53%), Gaps = 56/371 (15%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
KV+GKGSFGKV LA+ K +YAVK L+K +L+ + + ER VL KHP+L
Sbjct: 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQT L+FV++Y+NGG+L FH+Q+ F E RAR
Sbjct: 61 LHYSFQTAEKLYFVLDYVNGGEL---------------------FFHLQRERCFLEPRAR 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAAE+ S + +LH I+YRDLK +NILLD +GHV + DFG+CK + ++TT TFCGT
Sbjct: 100 FYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCGT 159
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
P+Y+APE+++ Y++ VDWW G +LYEM G PF D +++ +I ++ + P
Sbjct: 160 PEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK 219
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
+V A ++LV LL KD +RLG+ ++ H +F ++W L + + PP+ P V
Sbjct: 220 TVAACDLLVGLLHKDQRRRLGAKA--DFLEIKNHVFFSPINWDDLYHKRITPPYNPNVAG 277
Query: 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAE----RPCLTPVDRTILES 426
P D+++FD FT E TP D T S
Sbjct: 278 P----------------------------ADLRHFDPEFTQEAVSSSVGQTP-DLTASSS 308
Query: 427 MDQTQFQGFSY 437
+ F GFSY
Sbjct: 309 SASSAFLGFSY 319
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 242 bits (621), Expect = 2e-77
Identities = 101/289 (34%), Positives = 146/289 (50%), Gaps = 37/289 (12%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++LL+ LG GSFG V+ A+ KGT AVK LKK D E ++L HP
Sbjct: 1 YELLRKLGSGSFGTVYKAKHKGTGKIVAVKILKKRSEKSKKDQTARR-EIRILRR-LSHP 58
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ L F+ HL+ VMEY GGDL ++ + G E
Sbjct: 59 NIVRLIDAFEDKDHLYLVMEYCEGGDL---------------------FDYLSRGGPLSE 97
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
A+ A +I+ G+ +LH GI++RDLK +NILLD G V+IADFG+ K + + T
Sbjct: 98 DEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKLLKSSSSLTT 157
Query: 247 FCGTPDYMAPEIIK-GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305
F GTP YMAPE++ G Y VD WS G++LYE+ G+ PFSG + + I
Sbjct: 158 FVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQLQLIRRILGP 217
Query: 306 -----FPQFLSV--EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
P++ S EAK+++ L+KD +KR + + ++ H +F
Sbjct: 218 PLEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEE------ILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 242 bits (620), Expect = 2e-76
Identities = 133/381 (34%), Positives = 200/381 (52%), Gaps = 67/381 (17%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL--ALGTKHPYLCH 130
+GKG+FG+V+ K T YA+K L K ++ +V T+ ER +L L + P++
Sbjct: 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVG 60
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +FQTDS L+ V +Y++GG+L +H+Q+ GRF E RA+
Sbjct: 61 LKFSFQTDSDLYLVTDYMSGGEL---------------------FWHLQKEGRFSEDRAK 99
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FY AE+V + LHK IVYRDLK +NILLD GH+ + DFG+ K + +KTT+TFCGT
Sbjct: 100 FYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNKTTNTFCGT 159
Query: 251 PDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ- 308
+Y+APE++ K Y + VD+WS G+L++EM G SPF D +++ +I + RFP+
Sbjct: 160 TEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN 219
Query: 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRV 368
LS E + + LL+++ RLG+ + ++ H +F +DW L K+++ PPF+P V
Sbjct: 220 VLSDEGRQFVKGLLNRNPQHRLGAHR--DAVELKEHPFFADIDWDLLSKKQITPPFKPIV 277
Query: 369 IEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFT------------AERPCL 416
DS DV FD FT + P L
Sbjct: 278 --------------DS--------------DEDVSNFDPEFTNSSLLNAGIVPWEDVPGL 309
Query: 417 TPVDRTILESMDQTQFQGFSY 437
+ T L S Q F+GF++
Sbjct: 310 PGANSTPLSSSVQENFRGFTF 330
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 241 bits (616), Expect = 5e-76
Identities = 137/372 (36%), Positives = 196/372 (52%), Gaps = 59/372 (15%)
Query: 70 LKVLGKGSFGKVFLA-ELKGTD--YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
LKVLG+GSFGKVFL ++ G D YA+K LKK + D V T +ER +LA HP
Sbjct: 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLKVRDRVR-TKMERDILA-EVNHP 58
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
++ L FQT+ L+ ++++L GGDL T+ +++M F E
Sbjct: 59 FIVKLHYAFQTEGKLYLILDFLRGGDL----FTRLSKEVM-----------------FTE 97
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
+FY AE+ + LH GI+YRDLK +NILLD EGH+++ DFG+ K I +K +
Sbjct: 98 EDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYS 157
Query: 247 FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF 306
FCGT +YMAPE++ + Q DWWSFG+L++EM G PF G D E I +
Sbjct: 158 FCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217
Query: 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
PQFLS EA+++L L ++ RLG+ + +++ H +F +DW L +RE++PPF+P
Sbjct: 218 PQFLSPEAQSLLRALFKRNPANRLGAGP-DGVEEIKRHPFFSTIDWNKLYRREIKPPFKP 276
Query: 367 RVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILES 426
V P D YFD FT+ P +P I S
Sbjct: 277 AVGRPD----------------------------DTFYFDPEFTSRTPKDSP---GIPPS 305
Query: 427 MDQTQ-FQGFSY 437
+ Q F+GFS+
Sbjct: 306 ANAHQLFRGFSF 317
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 240 bits (614), Expect = 3e-75
Identities = 116/338 (34%), Positives = 177/338 (52%), Gaps = 65/338 (19%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+++KV+G+G+FG+V+L K T YA+K L+K +++ + + ER +LA
Sbjct: 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADA-D 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
P++ L+ +FQ + HL+ VMEY+ GGDL+ L+ F
Sbjct: 60 SPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNL--------LIRK-------------DVF 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK--------L 236
E ARFY AE+V + +HK G ++RD+K DNIL+D +GH+++ADFG+CK
Sbjct: 99 PEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDRE 158
Query: 237 QIYLDKTTDTFC---------------------GTPDYMAPEIIKGLKYNQCVDWWSFGI 275
D F GTPDY+APE+++G Y DWWS G+
Sbjct: 159 YYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218
Query: 276 LLYEMHVGQSPFSGCDEDELFWSICNERP--RFP--QFLSVEAKNILVHLL-DKDTTKRL 330
+LYEM G PF E + I N + RFP +S EA +++ LL D + RL
Sbjct: 219 ILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLCDPED--RL 276
Query: 331 GSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRV 368
GS + ++ +H +F+G+DW+ L RE +PPF P +
Sbjct: 277 GSFE-----EIKSHPFFKGIDWENL--RETKPPFVPEL 307
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 236 bits (605), Expect = 4e-75
Identities = 106/285 (37%), Positives = 163/285 (57%), Gaps = 28/285 (9%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LG G FG+V L ++K + +A+KC+KK ++E E E+++L HP++ L+
Sbjct: 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEE-CNHPFIVKLY 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
TF+ +++ LMEY GG+L ++ G FDE ARFY
Sbjct: 60 RTFKDKKYIYM---------------------LMEYCLGGELWTILRDRGLFDEYTARFY 98
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
A +V +LH +GI+YRDLK +N+LLD G+V++ DFG K ++ + T TFCGTP+
Sbjct: 99 IACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK-KLKSGQKTWTFCGTPE 157
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED--ELFWSI--CNERPRFPQ 308
Y+APEII Y+ VD+WS GILLYE+ G+ PF DED E++ I N + FP
Sbjct: 158 YVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217
Query: 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
++ AK+++ LL ++ +RLG+ + D+ H++F G DW+
Sbjct: 218 YIDKAAKDLIKQLLRRNPEERLGNLK-GGIKDIKKHKWFNGFDWE 261
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 239 bits (611), Expect = 4e-75
Identities = 119/320 (37%), Positives = 178/320 (55%), Gaps = 32/320 (10%)
Query: 55 TIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI 114
T P + L DF++ + LG GSFG+V +A+ KGT YYA+KCLKK +L+ V+
Sbjct: 8 TKPDTSSWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQ 67
Query: 115 ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDL 174
E+ +L + HP++ ++ C+FQ ++ ++F L+E++ GG+L
Sbjct: 68 EKSIL-MELSHPFIVNMMCSFQDENRVYF---------------------LLEFVVGGEL 105
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
H++++GRF A+FY AE+V +LH K I+YRDLK +N+LLD +GHV++ DFG
Sbjct: 106 FTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFA 165
Query: 235 KLQIYLDKTTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
K K D T CGTP+Y+APE+I+ + + VDWW+ G+LLYE G PF
Sbjct: 166 K------KVPDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDT 219
Query: 292 EDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
++ I R +FP + A++++ LL D TKRLG+ + DV H YF G +
Sbjct: 220 PFRIYEKILAGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLK-GGVADVKNHPYFHGAN 278
Query: 352 WQALEKRELEPPFRPRVIEP 371
W L R P RV P
Sbjct: 279 WDKLYARYYPAPIPVRVKSP 298
|
Length = 329 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 235 bits (603), Expect = 2e-74
Identities = 97/303 (32%), Positives = 154/303 (50%), Gaps = 43/303 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ K++G+GSF V LA+ K T+ YA+K L K ++++ V+ IE++VL
Sbjct: 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNG 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP + L+ TFQ + +L+FV+EY G+L+ +I++ G
Sbjct: 61 HPGIIKLYYTFQDEENLYFVLEYAPNGELLQ---------------------YIRKYGSL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG------------ 232
DE RFYAAEI+ + +LH KGI++RDLK +NILLD + H++I DFG
Sbjct: 100 DEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPE 159
Query: 233 --------MCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
+ + +F GT +Y++PE++ + D W+ G ++Y+M G+
Sbjct: 160 SNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGK 219
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
PF G +E F I FP +AK+++ LL D RLG D++ AH
Sbjct: 220 PPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVN--EGYDELKAH 277
Query: 345 EYF 347
+F
Sbjct: 278 PFF 280
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 235 bits (600), Expect = 2e-73
Identities = 143/385 (37%), Positives = 201/385 (52%), Gaps = 63/385 (16%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKG---TDYYYAVKCLKK-DVVLEDDDVECTLIERKVLAL 121
+F+LLKVLG G++GKVFL T YA+K L+K +V + VE T ER VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEH 60
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+ P+L L FQT++ L +++Y++GG++ H+ Q
Sbjct: 61 VRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFT---------------------HLYQR 99
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
F E RFY+ EI+ + LHK GIVYRD+KL+NILLD EGHV + DFG+ K + +
Sbjct: 100 DNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEE 159
Query: 242 KT-TDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE----DEL 295
K T +FCGT +YMAPEII+G + + VDWWS GIL++E+ G SPF+ E E+
Sbjct: 160 KERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219
Query: 296 FWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355
I P FP F+ EA+++L LL KD KRLG+ ++ H +F+GLDW+AL
Sbjct: 220 SRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP-QGASEIKEHPFFKGLDWEAL 278
Query: 356 EKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPC 415
R++ PPFRP + + LDV F + FT P
Sbjct: 279 ALRKVNPPFRPSI----------------------------RNELDVGNFAEEFTNLEPV 310
Query: 416 LTPVDRTILESMDQTQFQGFSYTNP 440
+P S + FQG+S+ P
Sbjct: 311 YSPAGTP--PSGARV-FQGYSFVAP 332
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 228 bits (583), Expect = 7e-72
Identities = 101/284 (35%), Positives = 153/284 (53%), Gaps = 30/284 (10%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+LL+V+GKG+FGKV + + + T +A+K + K +E V L ER++L HP
Sbjct: 2 FELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRIL-QELNHP 60
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+L +L+ +FQ + +++ V+ DL+ GGDL +H+ Q +F E
Sbjct: 61 FLVNLWYSFQDEENMYLVV------------------DLL---LGGDLRYHLSQKVKFSE 99
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
+ +F+ EIV + +LH KGI++RD+K DNILLD +GHV I DF + TT T
Sbjct: 100 EQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTLTTST 159
Query: 247 FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF---SGCDEDELFWSICNER 303
GTP YMAPE++ Y+ VDWWS G+ YE G+ P+ S D++
Sbjct: 160 -SGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETAD 218
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
+P S EA + + LL++D KRLG ++ D+ H YF
Sbjct: 219 VLYPATWSTEAIDAINKLLERDPQKRLG----DNLKDLKNHPYF 258
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 222 bits (567), Expect = 3e-69
Identities = 116/300 (38%), Positives = 158/300 (52%), Gaps = 30/300 (10%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LGKG FG+V ++K T YA K L K + + + L E+K+L ++ L
Sbjct: 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEK-VSSRFIVSLA 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--FDEGRAR 190
F+T L VM LM NGGDL +HI G F E RA
Sbjct: 60 YAFETKDDLCLVM------------------TLM---NGGDLKYHIYNVGEPGFPEARAI 98
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
FYAA+I+ G+ LH++ IVYRDLK +N+LLD G+VRI+D G+ +++ K GT
Sbjct: 99 FYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLA-VELKGGKKIKGRAGT 157
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF----SGCDEDELFWSICNERPRF 306
P YMAPE+++G Y+ VDW++ G LYEM G+SPF +++EL +
Sbjct: 158 PGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217
Query: 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
P S EAK++ LL KD KRLG S D+V H F+ L+W+ LE LEPPF P
Sbjct: 218 PDKFSPEAKDLCEALLQKDPEKRLGCRG-GSADEVREHPLFKDLNWRRLEAGMLEPPFIP 276
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 221 bits (565), Expect = 4e-68
Identities = 111/311 (35%), Positives = 168/311 (54%), Gaps = 41/311 (13%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
DFQ+L +G+G +G+VFLA+ K T A+K +KK ++ + ++V L ER +L TK
Sbjct: 2 DFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTT-TKS 60
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
+L L FQ D +L+ MEY+ GGD R L+ G
Sbjct: 61 EWLVKLLYAFQDDEYLYLAMEYVPGGDF---------RTLL------------NNLGVLS 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E ARFY AE+ + LH+ G ++RDLK +N L+D GH+++ DFG+ K + +
Sbjct: 100 EDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVTYANSV- 158
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF-----WSIC 300
G+PDYMAPE+++G Y+ VD+WS G +LYE G PFSG +E + W
Sbjct: 159 --VGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKET 216
Query: 301 NERPRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357
+RP + LS EA +++ L++ D ++R GS + D+ H +F+ +DW L
Sbjct: 217 LQRPVYDDPRFNLSDEAWDLITKLIN-DPSRRFGSLE-----DIKNHPFFKEVDWNEL-- 268
Query: 358 RELEPPFRPRV 368
REL+PPF P +
Sbjct: 269 RELKPPFVPEL 279
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 214 bits (545), Expect = 6e-66
Identities = 122/313 (38%), Positives = 181/313 (57%), Gaps = 35/313 (11%)
Query: 66 DFQLLKVLGKGSFGKVFLA-ELKGTDY--YYAVKCLKK-DVVLEDDDVECTLIERKVLAL 121
+F+LLKVLG G++GKVFL ++ G D YA+K LKK +V + E T ER+VL
Sbjct: 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEH 60
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+ P+L L FQTD+ L +++Y+NGG+L H+ Q
Sbjct: 61 IRQSPFLVTLHYAFQTDTKLHLILDYINGGELFT---------------------HLSQR 99
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
RF E + Y+ EIV + LHK GI+YRD+KL+NILLD GHV + DFG+ K + + D
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSK-EFHED 158
Query: 242 KTTD--TFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDED---- 293
+ +FCGT +YMAP+I++G +++ VDWWS G+L+YE+ G SPF+ E
Sbjct: 159 EVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQA 218
Query: 294 ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
E+ I P +PQ +S AK+I+ LL KD KRLG ++ D++ H +F+ ++W
Sbjct: 219 EISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGPSDA-DEIKKHPFFQKINWD 277
Query: 354 ALEKRELEPPFRP 366
L +++ PF+P
Sbjct: 278 DLAAKKVPAPFKP 290
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 205 bits (524), Expect = 3e-63
Identities = 99/287 (34%), Positives = 160/287 (55%), Gaps = 32/287 (11%)
Query: 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLC 129
LK + KG+FG V+LA+ + T Y+A+K LKK ++ + V ER ++ + + PY+
Sbjct: 1 LKPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVA 60
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189
L+ +FQ+ +L+ VMEYLN GGD I+ G E A
Sbjct: 61 KLYYSFQSKDYLYLVMEYLN---------------------GGDCASLIKTLGGLPEDWA 99
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG 249
+ Y AE+V G+ LH++GI++RD+K +N+L+D GH+++ DFG+ + +K F G
Sbjct: 100 KQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRN-GLENK---KFVG 155
Query: 250 TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP-- 307
TPDY+APE I G+ ++ DWWS G +++E G PF D +F +I + R +P
Sbjct: 156 TPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEE 215
Query: 308 --QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
+F S EA +++ LL D KRLG+ N ++ +H +F+ ++W
Sbjct: 216 VKEFCSPEAVDLINRLLCMDPAKRLGA---NGYQEIKSHPFFKSINW 259
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (499), Expect = 4e-59
Identities = 113/306 (36%), Positives = 161/306 (52%), Gaps = 30/306 (9%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+ +VLGKG FG+V +++ T YA K L+K + + L E+++L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSR 60
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--F 184
++ L ++T L V+ LM NGGDL FHI G F
Sbjct: 61 FVVSLAYAYETKDALCLVLT------------------LM---NGGDLKFHIYNMGNPGF 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
DE RA FYAAEI G+ LH++ IVYRDLK +NILLD GH+RI+D G+ ++I +T
Sbjct: 100 DEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA-VEIPEGETI 158
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSIC 300
GT YMAPE++K +Y DWW G L+YEM G+SPF E +E+ +
Sbjct: 159 RGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVK 218
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
++ + + S A++I LL KD RLG + ++V AH +FR +++ LE L
Sbjct: 219 EDQEEYSEKFSEAARSICRQLLTKDPGFRLG-CRGEGAEEVKAHPFFRTANFKRLEAGML 277
Query: 361 EPPFRP 366
EPPF P
Sbjct: 278 EPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 195 bits (498), Expect = 1e-58
Identities = 107/315 (33%), Positives = 173/315 (54%), Gaps = 43/315 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
EDF+ +K++ G++G V+L K T +A+K + K ++ + ++ +ER +L +
Sbjct: 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFA-E 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+P++ +FC+F+T HL VMEY+ GGD A L K N G L +
Sbjct: 60 NPFVVSMFCSFETKRHLCMVMEYVEGGDC--ATLLK---------NIGALPVDM------ 102
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI------ 238
AR Y AE V + +LH GIV+RDLK DN+L+ GH+++ DFG+ K+ +
Sbjct: 103 ----ARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTN 158
Query: 239 ----YLDKTTDTF-----CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+++K T F CGTP+Y+APE+I Y + VDWW+ GI+LYE VG PF G
Sbjct: 159 LYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218
Query: 290 CDEDELFWSICNERPRFP---QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346
+ELF + ++ +P + L +A++++ LL ++ +RLG+ +V H +
Sbjct: 219 DTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGT---GGAFEVKQHRF 275
Query: 347 FRGLDWQALEKRELE 361
F GLDW L +++ E
Sbjct: 276 FLGLDWNGLLRQKAE 290
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 196 bits (500), Expect = 1e-58
Identities = 116/320 (36%), Positives = 174/320 (54%), Gaps = 42/320 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF++LKV+G+G+FG+V + ++K T YA+K L K +L+ + C ER VL G +
Sbjct: 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDR 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
++ +L FQ +++L+ VM+Y GGDL+ L+K E R
Sbjct: 61 R-WITNLHYAFQDENNLYLVMDYYVGGDLLTL-LSKFED-------------------RL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
E ARFY AE+V + +H+ G V+RD+K DN+LLD GH+R+ADFG C L++ D T
Sbjct: 100 PEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKNGHIRLADFGSC-LRLLADGTV 158
Query: 245 DTF--CGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
+ GTPDY++PEI++ + +Y DWWS G+ +YEM G++PF E +
Sbjct: 159 QSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 298 SICNERPRFPQF------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
I N + F QF +S EAK+++ L+ T RLG N D H +F G+D
Sbjct: 219 KIMNHKEHF-QFPPDVTDVSEEAKDLIRRLICSPET-RLGR---NGLQDFKDHPFFEGID 273
Query: 352 WQALEKRELEPPFRPRVIEP 371
W + R P+ P V P
Sbjct: 274 WDNI--RNSTAPYVPEVSSP 291
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 190 bits (486), Expect = 5e-58
Identities = 76/210 (36%), Positives = 112/210 (53%), Gaps = 25/210 (11%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LG+G FG V+LA K T A+K +KK+ +E L E ++L HP + L+
Sbjct: 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKE--DSSSLLEELLREIEILKK-LNHPNIVKLY 57
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
F+ ++HL+ VMEY GG L +DL++ + G+ E
Sbjct: 58 GVFEDENHLYLVMEYCEGGSL---------KDLLK-----------ENEGKLSEDEILRI 97
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDY-EGHVRIADFGMCKLQIYLDKTTDTFCGTP 251
+I+ G+ +LH GI++RDLK +NILLD G V++ADFG+ KL T GTP
Sbjct: 98 LLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKSLLKTIVGTP 157
Query: 252 DYMAPEIIKGL-KYNQCVDWWSFGILLYEM 280
YMAPE++ G Y++ D WS G++LYE+
Sbjct: 158 AYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 191 bits (486), Expect = 3e-57
Identities = 108/302 (35%), Positives = 158/302 (52%), Gaps = 31/302 (10%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LGKG FG+V +++ T YA K L K + + E ++E+++LA ++ L
Sbjct: 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA-KVHSRFIVSLA 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI----QQSGRFDEGR 188
FQT + L VM +NGGDL +HI +++ F E R
Sbjct: 60 YAFQTKTDLCLVMTIMNGGDL---------------------RYHIYNVDEENPGFPEPR 98
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFC 248
A FY A+I+SG+ LH++ I+YRDLK +N+LLD +G+VRI+D G+ T +
Sbjct: 99 ACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQSKTKGYA 158
Query: 249 GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSICNERP 304
GTP +MAPE+++G +Y+ VD+++ G+ LYEM + PF E EL I N+
Sbjct: 159 GTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPF 364
+P S +K+ LL KD KRLG N D + H FR L+W+ LE L PPF
Sbjct: 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDGNC-DGLRTHPLFRDLNWRQLEAGMLPPPF 277
Query: 365 RP 366
P
Sbjct: 278 VP 279
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 193 bits (492), Expect = 4e-57
Identities = 111/353 (31%), Positives = 179/353 (50%), Gaps = 76/353 (21%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ +KV+G+G+FG+V L + K T + YA+K L+K +LE + V ER +LA
Sbjct: 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA-EAD 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+P++ L+ +FQ +++L+ +MEYL GGD++ LM+ F
Sbjct: 60 NPWVVKLYYSFQDENYLYLIMEYLPGGDMMTL--------LMKK-------------DTF 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT- 243
E RFY AE + + +HK G ++RD+K DN+LLD +GH++++DFG+C L K+
Sbjct: 99 TEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCT---GLKKSH 155
Query: 244 -----------------------------TDTF-----------CGTPDYMAPEIIKGLK 263
+T+ GTPDY+APE+
Sbjct: 156 RTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTG 215
Query: 264 YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI--CNERPRFPQ--FLSVEAKNILV 319
YN+ DWWS G+++YEM VG PF + E + I E +FP LS EAK+++
Sbjct: 216 YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIK 275
Query: 320 HLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPF 372
L + +RLG+ N +++ +H +F+G+DW+ + RE P P +
Sbjct: 276 RLC-CEAERRLGN---NGVNEIKSHPFFKGVDWEHI--RERPAPIIPELKSIT 322
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 188 bits (479), Expect = 3e-56
Identities = 111/306 (36%), Positives = 157/306 (51%), Gaps = 30/306 (9%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+ +VLGKG FG+V +++ T YA K L+K + + L E+++L
Sbjct: 2 FRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILE-KVNSR 60
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--F 184
++ L ++T L V+ +NGGDL FHI G F
Sbjct: 61 FVVSLAYAYETKDALCLVLTIMNGGDL---------------------KFHIYNMGNPGF 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
DE RA FYAAE+ G+ L ++ IVYRDLK +NILLD GH+RI+D G+ +QI +T
Sbjct: 100 DEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA-VQIPEGETV 158
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSIC 300
GT YMAPE+I KY DWW G L+YEM GQSPF E +E+ +
Sbjct: 159 RGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVK 218
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
++ + + S +AK+I LL K+ +RLG N V H F+ ++++ LE L
Sbjct: 219 EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRG-NGAAGVKQHPIFKNINFKRLEANML 277
Query: 361 EPPFRP 366
EPPF P
Sbjct: 278 EPPFCP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 190 bits (483), Expect = 4e-56
Identities = 106/318 (33%), Positives = 170/318 (53%), Gaps = 27/318 (8%)
Query: 58 RFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY-YAVKCLKKDVVLEDDDVECTLIER 116
R K EDF ++ LG GSFG+V LA K D+ A+K +K +++ V+ ER
Sbjct: 23 RKNKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSER 82
Query: 117 KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
K+L HP+ +L+ +F+ +S+L+ V+E++ GG+
Sbjct: 83 KILNY-INHPFCVNLYGSFKDESYLYLVLEFVIGGEFFT--------------------- 120
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
++++ RF FYAA+IV +L IVYRDLK +N+LLD +G +++ DFG K+
Sbjct: 121 FLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKV 180
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
+D T T CGTP+Y+APEI+ + + + DWW+ GI +YE+ VG PF + ++
Sbjct: 181 ---VDTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIY 237
Query: 297 WSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALE 356
I FP+FL K+++ LL D TKR G+ + +V H +F +DW +L
Sbjct: 238 QKILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLK-KGAQNVKEHPWFGNIDWVSLL 296
Query: 357 KRELEPPFRPRVIEPFSS 374
+ +E P++P+ F S
Sbjct: 297 HKNVEVPYKPKYKNVFDS 314
|
Length = 340 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 188 bits (478), Expect = 2e-55
Identities = 117/319 (36%), Positives = 177/319 (55%), Gaps = 40/319 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+++KV+G+G+FG+V + ++K T+ YA+K L K +L+ + C ER VL G
Sbjct: 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDC 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
++ L FQ +++L+ VM+Y GGDL+ L+K E R
Sbjct: 61 Q-WITTLHYAFQDENYLYLVMDYYVGGDLLTL-LSKFE-------------------DRL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT- 243
E ARFY AE+V + +H+ V+RD+K DN+LLD GH+R+ADFG C L++ D T
Sbjct: 100 PEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSC-LKMNQDGTV 158
Query: 244 -TDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
+ GTPDY++PEI++ + KY DWWS G+ +YEM G++PF E +
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 298 SICN--ERPRFPQFL---SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
I N ER +FP + S EAK+++ L+ +RLG N +D H +F G+DW
Sbjct: 219 KIMNHEERFQFPSHITDVSEEAKDLIQRLI-CSRERRLGQ---NGIEDFKKHAFFEGIDW 274
Query: 353 QALEKRELEPPFRPRVIEP 371
+ + R LE P+ P V P
Sbjct: 275 ENI--RNLEAPYIPDVSSP 291
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 187 bits (476), Expect = 1e-54
Identities = 107/317 (33%), Positives = 160/317 (50%), Gaps = 46/317 (14%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
EDF ++KV+G+G+FG+V L K + YA+K L K +++ D ER ++A
Sbjct: 42 AEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHAN 101
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
++ L FQ D +L+ VMEY+ GGDL+ +LM
Sbjct: 102 S-EWIVQLHYAFQDDKYLYMVMEYMPGGDLV------------------NLM------SN 136
Query: 184 FD--EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+D E ARFY AE+V + +H G ++RD+K DN+LLD GH+++ADFG C + +D
Sbjct: 137 YDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTC---MKMD 193
Query: 242 KT----TDTFCGTPDYMAPEIIKGL----KYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
DT GTPDY++PE++K Y + DWWS G+ LYEM VG +PF
Sbjct: 194 ANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 253
Query: 294 ELFWSICNERP--RFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349
+ I + + FP +S +AK+++ L D RLG N D++ +H +F+
Sbjct: 254 GTYSKIMDHKNSLTFPDDIEISKQAKDLICAFL-TDREVRLGR---NGVDEIKSHPFFKN 309
Query: 350 LDWQALEKRELEPPFRP 366
W RE P P
Sbjct: 310 DQWTFDNIRETVAPVVP 326
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 180 bits (458), Expect = 3e-53
Identities = 85/274 (31%), Positives = 132/274 (48%), Gaps = 38/274 (13%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKC--LKKDVVLEDDDVECTLIERKVLALGT 123
++++K +GKGSFGKV+L K Y +K L + + + E L E K+L
Sbjct: 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSN---MSEKEREDALNEVKILK-KL 56
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
HP + + +F+ L VMEY A+ GGDL I++ +
Sbjct: 57 NHPNIIKYYESFEEKGKLCIVMEY-------------AD--------GGDLSQKIKKQKK 95
Query: 184 ----FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
F E + + ++ +++LH + I++RD+K NI L G V++ DFG+ K+
Sbjct: 96 EGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKV--- 152
Query: 240 LDKTTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
L T D T GTP Y++PE+ + YN D WS G +LYE+ + PF G + EL
Sbjct: 153 LSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELA 212
Query: 297 WSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
I + P P S E +N++ LL KD +R
Sbjct: 213 LKILKGQYPPIPSQYSSELRNLVSSLLQKDPEER 246
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 182 bits (464), Expect = 6e-53
Identities = 109/352 (30%), Positives = 168/352 (47%), Gaps = 74/352 (21%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F +K +G G+FG+V L T+ YA+K L+K VL + ER +LA +
Sbjct: 3 FVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILA-EADNE 61
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
++ L+ +FQ +L+FVM+Y IP GGD+M + + G F+E
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDY------IP---------------GGDMMSLLIRLGIFEE 100
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM------------- 233
ARFY AE+ + +HK G ++RD+K DNIL+D +GH+++ DFG+
Sbjct: 101 DLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 234 ----------------------CKLQIY--LDKTTDTFC------GTPDYMAPEIIKGLK 263
C+L+ K C GTP+Y+APE++
Sbjct: 161 QKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTG 220
Query: 264 YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP--RFPQF--LSVEAKNILV 319
Y Q DWWS G++LYEM VGQ PF E + N P LS EA ++++
Sbjct: 221 YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLIL 280
Query: 320 HLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEP 371
L RLG N D++ AH +F+G+D+ +L +R+ + P+ P++ P
Sbjct: 281 RLC-CGAEDRLGK---NGADEIKAHPFFKGIDFASLIRRQ-KAPYIPKITHP 327
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 179 bits (455), Expect = 9e-53
Identities = 106/302 (35%), Positives = 152/302 (50%), Gaps = 32/302 (10%)
Query: 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH--PYLC 129
++G+G FG+V+ T YA+KCL K + L ER +L+L + P++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189
+ F T L F++ DLM NGGDL +H+ Q G F E
Sbjct: 61 CMSYAFHTPDKLSFIL------------------DLM---NGGDLHYHLSQHGVFSEAEM 99
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM-CKLQIYLDKTTDTFC 248
RFYAAEI+ G+ +H + +VYRDLK NILLD GHVRI+D G+ C + K
Sbjct: 100 RFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASV 156
Query: 249 GTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSG---CDEDELFWSICNERP 304
GT YMAPE++ KG+ Y+ DW+S G +L+++ G SPF D+ E+
Sbjct: 157 GTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAV 216
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPF 364
P S E +++L LL +D +RLG +V H +FR LDWQ + ++ PP
Sbjct: 217 ELPDSFSPELRSLLEGLLQRDVNRRLGC-LGRGAQEVKEHPFFRSLDWQMVFLQKYPPPL 275
Query: 365 RP 366
P
Sbjct: 276 IP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 2e-52
Identities = 109/306 (35%), Positives = 160/306 (52%), Gaps = 30/306 (9%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+ +VLGKG FG+V +++ T YA K L+K + + L E+++L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE-KVNSR 60
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--F 184
++ L ++T L V+ +NGGDL FHI G F
Sbjct: 61 FVVSLAYAYETKDALCLVLTLMNGGDL---------------------KFHIYHMGEAGF 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
+EGRA FYAAEI G+ LH++ IVYRDLK +NILLD GH+RI+D G+ + + +T
Sbjct: 100 EEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA-VHVPEGQTI 158
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS----GCDEDELFWSIC 300
GT YMAPE++K +Y DWW+ G LLYEM GQSPF +E+ +
Sbjct: 159 KGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVK 218
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
+ + + S +A+++ LL KD +RLG Q +V H F+ ++++ LE L
Sbjct: 219 EVQEEYSEKFSPDARSLCKMLLCKDPKERLG-CQGGGAREVKEHPLFKQINFKRLEAGML 277
Query: 361 EPPFRP 366
EPPF+P
Sbjct: 278 EPPFKP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 175 bits (447), Expect = 8e-52
Identities = 84/272 (30%), Positives = 134/272 (49%), Gaps = 28/272 (10%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
F++L+ +GKG FG+V+ A K T A+K +K + + + + + E ++L KH
Sbjct: 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESKEKKEKI---INEIQILKK-CKH 56
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + + ++ L+ VME+ +GG L +DL++ N
Sbjct: 57 PNIVKYYGSYLKKDELWIVMEFCSGGSL---------KDLLKSTNQ-----------TLT 96
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E + + E++ G+ +LH GI++RD+K NILL +G V++ DFG+ Q+ K +
Sbjct: 97 ESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSA-QLSDTKARN 155
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSICNERP 304
T GTP +MAPE+I G Y+ D WS GI E+ G+ P+S LF N P
Sbjct: 156 TMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGPP 215
Query: 305 RF--PQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
P+ S E K+ L L K+ KR + Q
Sbjct: 216 GLRNPEKWSDEFKDFLKKCLQKNPEKRPTAEQ 247
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 177 bits (449), Expect = 8e-52
Identities = 109/306 (35%), Positives = 161/306 (52%), Gaps = 30/306 (9%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+ +VLGKG FG+V +++ T YA K L+K + + L E+++L
Sbjct: 2 FRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE-KVNSQ 60
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--F 184
++ +L ++T L V+ +NGGDL FHI G F
Sbjct: 61 FVVNLAYAYETKDALCLVLTIMNGGDL---------------------KFHIYNMGNPGF 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
+E RA FYAAEI+ G+ LH++ VYRDLK +NILLD GH+RI+D G+ ++I ++
Sbjct: 100 EEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLA-VKIPEGESI 158
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSIC 300
GT YMAPE++ +Y D+W G L+YEM GQSPF G E +E+ +
Sbjct: 159 RGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVL 218
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
+ S EAK+I LL KD +RLG + +G +V H +FR ++++ LE L
Sbjct: 219 ETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAG-EVKRHPFFRNMNFKRLEAGML 277
Query: 361 EPPFRP 366
+PPF P
Sbjct: 278 DPPFVP 283
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 176 bits (448), Expect = 9e-52
Identities = 87/279 (31%), Positives = 141/279 (50%), Gaps = 36/279 (12%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL-ALGTK 124
++ ++LG+GSFG V+LA K T AVK ++ E++ +E E ++L +L +
Sbjct: 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDSEEE-LEALEREIRILSSL--Q 57
Query: 125 HPYLCHLFCTFQTDSHLFF--VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP + + + + + +EY++GG L L++ F G
Sbjct: 58 HPNIVRYYGSERDEEKNTLNIFLEYVSGGSL---------SSLLK-------KF-----G 96
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QIYL 240
+ E R Y +I+ G+ +LH GIV+RD+K NIL+D +G V++ADFG K I
Sbjct: 97 KLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIET 156
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
+ T + GTP +MAPE+I+G +Y + D WS G + EM G+ P+S + ++
Sbjct: 157 GEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWS--ELGNPMAALY 214
Query: 301 -----NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
E P P+ LS EAK+ L L +D KR + +
Sbjct: 215 KIGSSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRPTADE 253
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 177 bits (451), Expect = 1e-51
Identities = 117/320 (36%), Positives = 174/320 (54%), Gaps = 42/320 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
EDF++LKV+G+G+FG+V + +LK D +A+K L K +L+ + C ER VL G
Sbjct: 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNG-D 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+ ++ L FQ +++L+ VM+Y GGDL+ L+K E R
Sbjct: 60 NQWITTLHYAFQDENNLYLVMDYYVGGDLLTL-LSKFE-------------------DRL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT- 243
E ARFY AE+V + +H+ V+RD+K DNIL+D GH+R+ADFG C L++ D T
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSC-LKLMEDGTV 158
Query: 244 -TDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
+ GTPDY++PEI++ + KY DWWS G+ +YEM G++PF E +
Sbjct: 159 QSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218
Query: 298 SICNERPRFPQF------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
I N + RF QF +S +AK+++ L+ RLG N +D H +F G+D
Sbjct: 219 KIMNHKERF-QFPAQVTDVSEDAKDLIRRLI-CSREHRLGQ---NGIEDFKQHPFFTGID 273
Query: 352 WQALEKRELEPPFRPRVIEP 371
W + R E P+ P V P
Sbjct: 274 WDNI--RNCEAPYIPEVSSP 291
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 175 bits (445), Expect = 4e-50
Identities = 113/355 (31%), Positives = 166/355 (46%), Gaps = 79/355 (22%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
EDF +KV+GKG+FG+V L + K T YA+K L K + + D + ER VLA +
Sbjct: 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA-ESD 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
P++ L+ +FQ +L+ +ME+L GGDL M L D F
Sbjct: 60 SPWVVSLYYSFQDAQYLYLIMEFLPGGDL------------MTMLIKYDT---------F 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADF----GMCKL---- 236
E RFY AE V + +HK G ++RD+K DNIL+D GH++++DF G K
Sbjct: 99 SEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSA 158
Query: 237 ------------------------QIYL-----DKTTD----------TFCGTPDYMAPE 257
I L D+ + GTPDY+APE
Sbjct: 159 YYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218
Query: 258 IIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP--RFPQ--FLSVE 313
I Y Q DWWS G +++E +G PF + E + I N R FP LSVE
Sbjct: 219 IFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVE 278
Query: 314 AKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRV 368
A++++ L+ + RLG ++ +H +FRG+DW + R++ PF P++
Sbjct: 279 AEDLIRRLI-TNAENRLGR---GGAHEIKSHPFFRGVDWDTI--RQIRAPFIPQL 327
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 173 bits (440), Expect = 5e-50
Identities = 100/316 (31%), Positives = 161/316 (50%), Gaps = 43/316 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF + ++G+G FG+V + K T YA+K +KK V+L + V ER +L++
Sbjct: 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNS 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
P++ L FQ +L+ VMEY GGDL + LN + +F
Sbjct: 61 -PWIPQLQYAFQDKDNLYLVMEYQPGGDL------------LSLLN--------RYEDQF 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
DE A+FY AE+V + +H+ G V+RD+K +N+L+D GH+++ADFG ++ +K
Sbjct: 100 DEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFGSAA-RLTANKMV 158
Query: 245 DTF--CGTPDYMAPEIIKGLK------YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
++ GTPDY+APE++ + Y DWWS G++ YEM G+SPF + +
Sbjct: 159 NSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218
Query: 297 WSICN--ERPRFPQFL--SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
+I N +FP+ S + + L+ L +RLG + + H +F +DW
Sbjct: 219 NNIMNFQRFLKFPEDPKVSSDFLD-LIQSLLCGQKERLGY------EGLCCHPFFSKIDW 271
Query: 353 QALEKRELEPPFRPRV 368
+ R PPF P +
Sbjct: 272 NNI--RNSLPPFVPTL 285
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 173 bits (438), Expect = 2e-49
Identities = 111/399 (27%), Positives = 168/399 (42%), Gaps = 50/399 (12%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
+++L+ LG+GSFG+V+LA + A+K L K + + +VE L E ++LA
Sbjct: 1 SYRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILASLNHP 57
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + L+ FQ + L+ VMEY++GG L DL+ I + G
Sbjct: 58 PNIVKLYDFFQDEGSLYLVMEYVDGGSLE------------------DLLKKIGRKGPLS 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-VRIADFGMCKL------QI 238
E A F A+I+S + +LH KGI++RD+K +NILLD +G V++ DFG+ KL
Sbjct: 100 ESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTS 159
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
+ T GTP YMAPE++ GL + D WS GI LYE+ G PF G
Sbjct: 160 SIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSA 219
Query: 296 FWSI-------------CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342
P P+ +S A ++L LL KD RL S+ D++
Sbjct: 220 TSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSD-LSHDLL 278
Query: 343 AHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDV 402
AH + D L K + P R P ++ L +
Sbjct: 279 AHLKLKESDLSDLLKPDDSAPLRLS-----LPPSLEALISSLNSLAISGSDLKLDDSNFS 333
Query: 403 KYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441
K + + P + S ++ S +
Sbjct: 334 KELAPNGVSSSPHNSSSLLLSTASSKRSSLPKISARSSP 372
|
Length = 384 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 172 bits (436), Expect = 5e-49
Identities = 107/316 (33%), Positives = 165/316 (52%), Gaps = 42/316 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
ED+ ++KV+G+G+FG+V L K + YA+K L K +++ D ER ++A
Sbjct: 43 EDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANS 102
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
P++ LFC FQ D +L+ VMEY+ GGDL+ +LM +
Sbjct: 103 -PWVVQLFCAFQDDKYLYMVMEYMPGGDLV---------NLMSNYD-------------V 139
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT- 243
E A+FY AE+V + +H G+++RD+K DN+LLD GH+++ADFG C + +D+T
Sbjct: 140 PEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLDKHGHLKLADFGTC---MKMDETG 196
Query: 244 ---TDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
DT GTPDY++PE++K Y + DWWS G+ L+EM VG +PF +
Sbjct: 197 MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY 256
Query: 297 WSICNERPR--FPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
I + + FP+ +S AKN++ L D RLG N +++ H +F+ W
Sbjct: 257 SKIMDHKNSLNFPEDVEISKHAKNLICAFL-TDREVRLGR---NGVEEIKQHPFFKNDQW 312
Query: 353 QALEKRELEPPFRPRV 368
RE P P +
Sbjct: 313 NWDNIRETAAPVVPEL 328
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 4e-48
Identities = 100/302 (33%), Positives = 154/302 (50%), Gaps = 32/302 (10%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LGKG FG+V ++K T YA K L K + + + L+E+++L P++ +L
Sbjct: 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEK-VNSPFIVNLA 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--FDEGRAR 190
F++ +HL VM +NGGDL +HI G + R
Sbjct: 60 YAFESKTHLCLVMSLMNGGDL---------------------KYHIYNVGERGLEMERVI 98
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
Y+A+I G+ LH IVYRD+K +N+LLD +G+ R++D G+ +++ KT GT
Sbjct: 99 HYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA-VELKDGKTITQRAGT 157
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG----CDEDELFWSICNERPRF 306
YMAPEI+K Y+ VDW++ G +YEM G++PF ++EL + +F
Sbjct: 158 NGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217
Query: 307 P-QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
Q + E+K+I L K RLGS + N DD HE+F+ +++ LE + PPF
Sbjct: 218 EHQNFTEESKDICRLFLAKKPEDRLGSREKN--DDPRKHEFFKTINFPRLEAGLIPPPFV 275
Query: 366 PR 367
P
Sbjct: 276 PD 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 166 bits (422), Expect = 5e-48
Identities = 107/304 (35%), Positives = 153/304 (50%), Gaps = 36/304 (11%)
Query: 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH--PYLC 129
++G+G FG+V+ T YA+KCL K + L ER +L+L + P++
Sbjct: 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIV 60
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189
+ F T L F++ DLM NGGDL +H+ Q G F E
Sbjct: 61 CMTYAFHTPDKLCFIL------------------DLM---NGGDLHYHLSQHGVFSEKEM 99
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM-CKLQIYLDKTTDTFC 248
RFYA EI+ G+ +H + +VYRDLK NILLD GHVRI+D G+ C + K
Sbjct: 100 RFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD---FSKKKPHASV 156
Query: 249 GTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPF---SGCDEDELFWSICNERP 304
GT YMAPE++ KG Y+ DW+S G +L+++ G SPF D+ E+
Sbjct: 157 GTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNV 216
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSG--DDVVAHEYFRGLDWQALEKRELEP 362
P S E K++L LL +D +KRLG C +V H +F+G+DWQ + ++ P
Sbjct: 217 ELPDSFSPELKSLLEGLLQRDVSKRLG---CLGRGAQEVKEHVFFKGIDWQQVYLQKYPP 273
Query: 363 PFRP 366
P P
Sbjct: 274 PLIP 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 167 bits (423), Expect = 4e-47
Identities = 111/323 (34%), Positives = 166/323 (51%), Gaps = 38/323 (11%)
Query: 55 TIPRFR--KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT 112
TI + R + ED++++KV+G+G+FG+V L K T YA+K L K +++ D
Sbjct: 31 TINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFF 90
Query: 113 LIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGG 172
ER ++A P++ LF FQ D +L+ VMEY+ GGDL+
Sbjct: 91 WEERDIMAFANS-PWVVQLFYAFQDDRYLYMVMEYMPGGDLV------------------ 131
Query: 173 DLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232
+LM + ++ ARFY AE+V + +H G ++RD+K DN+LLD GH+++ADFG
Sbjct: 132 NLMSNYDVPEKW----ARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFG 187
Query: 233 MC-KLQIYLDKTTDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPF 287
C K+ DT GTPDY++PE++K Y + DWWS G+ LYEM VG +PF
Sbjct: 188 TCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
Query: 288 SGCDEDELFWSICNERPR--FP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343
+ I N + FP +S EAKN++ L D RLG N +++
Sbjct: 248 YADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGR---NGVEEIKR 303
Query: 344 HEYFRGLDWQALEKRELEPPFRP 366
H +F+ W R+ P P
Sbjct: 304 HLFFKNDQWAWETLRDTVAPVVP 326
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 162 bits (412), Expect = 1e-45
Identities = 102/351 (29%), Positives = 174/351 (49%), Gaps = 69/351 (19%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ LKV+G+G+FG+V L + K T + YA+K L+K +LE + V ER +L +
Sbjct: 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDIL-VEAD 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
++ +F +FQ +L+ +ME+L GGD+ M + +
Sbjct: 60 GAWVVKMFYSFQDKRNLYLIMEFLPGGDM---------------------MTLLMKKDTL 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-------KLQ 237
E +FY AE V + +H+ G ++RD+K DN+LLD +GHV+++DFG+C + +
Sbjct: 99 SEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTE 158
Query: 238 IYLDKTTD----------------------------TFCGTPDYMAPEIIKGLKYNQCVD 269
Y + T + + GTPDY+APE+ YN+ D
Sbjct: 159 FYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNER------PRFPQFLSVEAKNILVHLLD 323
WWS G+++YEM +G PF E + + N + P P +S +AK++++
Sbjct: 219 WWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVP--ISEKAKDLILRFC- 275
Query: 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSS 374
D+ R+GS N +++ +H +F G+DW + +R P + I+ S+
Sbjct: 276 TDSENRIGS---NGVEEIKSHPFFEGVDWGHIRERPAAIPIEIKSIDDTSN 323
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 153 bits (390), Expect = 2e-43
Identities = 79/234 (33%), Positives = 118/234 (50%), Gaps = 43/234 (18%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E F LL+ +GKGSFG+V+ A K T+ A+K + LE+ + E I++++ L
Sbjct: 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKV----IDLEEAEDEIEDIQQEIQFLSQC 56
Query: 125 H-PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
PY+ + +F S L+ +MEY GG DL++ G+
Sbjct: 57 RSPYITKYYGSFLKGSKLWIIMEYCGGGSC---------LDLLKP-------------GK 94
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG--------MCK 235
DE F E++ G+ +LH++G ++RD+K NILL EG V++ADFG M K
Sbjct: 95 LDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMSK 154
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+TF GTP +MAPE+IK Y++ D WS GI E+ G+ P S
Sbjct: 155 R--------NTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSD 200
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 152 bits (386), Expect = 6e-42
Identities = 99/351 (28%), Positives = 173/351 (49%), Gaps = 69/351 (19%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
EDF+ LKV+G+G+FG+V L + K T + YA+K L+K +LE + V ER +L +
Sbjct: 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDIL-VEAD 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
++ +F +FQ +L+ +ME+L GGD+ M + +
Sbjct: 60 SLWVVKMFYSFQDKLNLYLIMEFLPGGDM---------------------MTLLMKKDTL 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-------KLQ 237
E +FY AE V + +H+ G ++RD+K DN+LLD +GHV+++DFG+C + +
Sbjct: 99 TEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTE 158
Query: 238 IYLD-----------------KTTDTF-----------CGTPDYMAPEIIKGLKYNQCVD 269
Y + + +T+ GTPDY+APE+ YN+ D
Sbjct: 159 FYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218
Query: 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNER------PRFPQFLSVEAKNILVHLLD 323
WWS G+++YEM +G PF E + + N + P P +S +AK++++
Sbjct: 219 WWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVP--ISEKAKDLILRFC- 275
Query: 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSS 374
+ R+G+ +++ + +F G+DW+ + +R P + I+ S+
Sbjct: 276 CEWEHRIGAPGV---EEIKTNPFFEGVDWEHIRERPAAIPIEIKSIDDTSN 323
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 109/359 (30%), Positives = 164/359 (45%), Gaps = 78/359 (21%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F +K LG G+FG+V LA T YA+K L+K VL + V ER +LA +
Sbjct: 3 FVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA-EADNE 61
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
++ L+ +FQ +L+FVM+Y IP GGD+M + + F E
Sbjct: 62 WVVKLYYSFQDKDNLYFVMDY------IP---------------GGDMMSLLIRMEVFPE 100
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC------------ 234
ARFY AE+ + +HK G ++RD+K DNIL+D +GH+++ DFG+C
Sbjct: 101 VLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYY 160
Query: 235 -----------KLQIYLDKTTDTFC------------------------GTPDYMAPEII 259
+ D ++ C GTP+Y+APE++
Sbjct: 161 QKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVL 220
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF---PQF-LSVEAK 315
Y Q DWWS G++L+EM VGQ PF E + N PQ LS EA
Sbjct: 221 LRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAV 280
Query: 316 NILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSS 374
+++ L +RLG N DD+ AH +F +D+ + + R P+ P++ P +
Sbjct: 281 DLITKLC-CSAEERLGR---NGADDIKAHPFFSEVDFSS-DIRTQPAPYVPKISHPMDT 334
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 150 bits (379), Expect = 1e-40
Identities = 111/356 (31%), Positives = 168/356 (47%), Gaps = 78/356 (21%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F +K LG G+FG+V LA T YA+K L+K VL + V ER +LA +
Sbjct: 3 FVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA-EADNE 61
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
++ L+ +FQ +L+FVM+Y IP GGD+M + + G F E
Sbjct: 62 WVVRLYYSFQDKDNLYFVMDY------IP---------------GGDMMSLLIRMGIFPE 100
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK----------- 235
ARFY AE+ + +HK G ++RD+K DNIL+D +GH+++ DFG+C
Sbjct: 101 DLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYY 160
Query: 236 ------LQIYLD------KTTDTFCG------------------------TPDYMAPEII 259
Q +D + CG TP+Y+APE++
Sbjct: 161 QSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVL 220
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF---PQF-LSVEAK 315
Y Q DWWS G++LYEM VGQ PF E + N + PQ LS EA
Sbjct: 221 LRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEAS 280
Query: 316 NILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEP 371
++++ L + RLG N D++ AH +F+ +D+ + + R+ P+ P++ P
Sbjct: 281 DLIIKLC-RGPEDRLGK---NGADEIKAHPFFKTIDFSS-DLRQQSAPYIPKITHP 331
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-40
Identities = 78/267 (29%), Positives = 133/267 (49%), Gaps = 30/267 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++ L+ +G+G+ G+V+ A + T A+K ++ L + E + E ++ KHP
Sbjct: 21 YKNLEKIGEGASGEVYKATDRATGKEVAIKKMR----LRKQNKELIINEILIMK-DCKHP 75
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ + ++ L+ VMEY++GG L D++ Q R +E
Sbjct: 76 NIVDYYDSYLVGDELWVVMEYMDGGSLT---------DIIT-----------QNFVRMNE 115
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT-D 245
+ + E++ G+ +LH + +++RD+K DNILL +G V++ADFG Q+ +K+ +
Sbjct: 116 PQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAA-QLTKEKSKRN 174
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE--- 302
+ GTP +MAPE+IK Y VD WS GI+ EM G+ P+ + I +
Sbjct: 175 SVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTKGIP 234
Query: 303 RPRFPQFLSVEAKNILVHLLDKDTTKR 329
+ P+ S E K+ L L KD KR
Sbjct: 235 PLKNPEKWSPEFKDFLNKCLVKDPEKR 261
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 145 bits (367), Expect = 4e-40
Identities = 87/281 (30%), Positives = 138/281 (49%), Gaps = 40/281 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLALGT 123
D + +KVLG+GS G V+ K T YA+K + V D++ L+ E K L
Sbjct: 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIH---VDGDEEFRKQLLRELKTLRS-C 56
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+ PY+ + F + + V+EY++GG L DL +++ G+
Sbjct: 57 ESPYVVKCYGAFYKEGEISIVLEYMDGGSL---------ADL------------LKKVGK 95
Query: 184 FDEGRARFYAAEIVSGMRFLH-KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
E + A +I+ G+ +LH K+ I++RD+K N+L++ +G V+IADFG+ K+ L+
Sbjct: 96 IPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKV---LEN 152
Query: 243 TTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS- 298
T D TF GT YM+PE I+G Y+ D WS G+ L E +G+ PF F+
Sbjct: 153 TLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLP-PGQPSFFEL 211
Query: 299 ---ICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQ 334
IC+ P S E ++ + L KD KR + +
Sbjct: 212 MQAICDGPPPSLPAEEFSPEFRDFISACLQKDPKKRPSAAE 252
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 144 bits (366), Expect = 7e-40
Identities = 80/270 (29%), Positives = 128/270 (47%), Gaps = 30/270 (11%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECTLIERKVL-ALGTKHP 126
K LG+G+FG+V+ +LKG D AVK LK+D +++ + L E +V+ LG HP
Sbjct: 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKED--ASEEERKDFLKEARVMKKLG--HP 56
Query: 127 YLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+ L CT + L+ V+EY+ GGDL+ +YL +F +
Sbjct: 57 NVVRLLGVCT--EEEPLYLVLEYMEGGDLL------------DYLRKSRPVFPSPEKSTL 102
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
+A +I GM +L K V+RDL N L+ + V+I+DFG+ + +Y D
Sbjct: 103 SLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSR-DVYDDDYY 161
Query: 245 DTFCGTPD---YMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSIC 300
G +MAPE +K + D WSFG+LL+E+ G +P+ G +E+ +
Sbjct: 162 RKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLR 221
Query: 301 N-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
R P++ E +++ D R
Sbjct: 222 KGYRLPKPEYCPDELYELMLSCWQLDPEDR 251
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 143 bits (362), Expect = 2e-39
Identities = 74/270 (27%), Positives = 129/270 (47%), Gaps = 34/270 (12%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD--DV--ECTLIERKVLAL 121
++QL ++G+G+FG V+ T + A+K + + + E+ + E L+ K L
Sbjct: 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKIKEEALKSIMQEIDLL--KNL-- 56
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
KHP + + +T L+ ++EY G L R + I++
Sbjct: 57 --KHPNIVKYIGSIETSDSLYIILEYAENGSL---------RQI------------IKKF 93
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYL 240
G F E Y +++ G+ +LH++G+++RD+K NIL +G V++ADFG+ KL
Sbjct: 94 GPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDV- 152
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
K + GTP +MAPE+I+ + D WS G + E+ G P+ + + I
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 301 -NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
++ P P+ +S E K+ L+ KD R
Sbjct: 213 QDDHPPLPEGISPELKDFLMQCFQKDPNLR 242
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 2e-38
Identities = 67/225 (29%), Positives = 108/225 (48%), Gaps = 26/225 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E F +L+ LG+GS+G V+ A K T A+K VV ++D++ +I+ +
Sbjct: 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIK-----VVPVEEDLQ-EIIKEISILKQCD 56
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
PY+ + ++ ++ L+ VMEY G + D+M+ N
Sbjct: 57 SPYIVKYYGSYFKNTDLWIVMEYCGAGSVS---------DIMKITNK-----------TL 96
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
E + + G+ +LH ++RD+K NILL+ EG ++ADFG+
Sbjct: 97 TEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMAKR 156
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+T GTP +MAPE+I+ + YN D WS GI EM G+ P+S
Sbjct: 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSD 201
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 137 bits (347), Expect = 2e-37
Identities = 83/272 (30%), Positives = 130/272 (47%), Gaps = 34/272 (12%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDV---ECTL-IERKVLALGT-KH 125
++LG GSFG V+ ++AVK +V L DD E +E+++ L +H
Sbjct: 6 ELLGSGSFGSVYEGLNLDDGDFFAVK----EVSLADDGQTGQEAVKQLEQEIALLSKLQH 61
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + T + + +L+ +E + GG L + L +Y G F
Sbjct: 62 PNIVQYLGTEREEDNLYIFLELVPGGSL--------AKLLKKY-------------GSFP 100
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E R Y +I+ G+ +LH + V+RD+K NIL+D G V++ADFGM K Q+
Sbjct: 101 EPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAK-QVVEFSFAK 159
Query: 246 TFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN--E 302
+F G+P +MAPE+I Y D WS G + EM G+ P+S + + I E
Sbjct: 160 SFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKE 219
Query: 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
P P LS EAK+ ++ L +D + R + +
Sbjct: 220 LPPIPDHLSDEAKDFILKCLQRDPSLRPTAAE 251
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 77/274 (28%), Positives = 121/274 (44%), Gaps = 37/274 (13%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVECTLIERKVLALG 122
+L K LG+G+FG+V+ LKG AVK LK+ +++ E L E ++
Sbjct: 1 LELGKKLGEGAFGEVYKGTLKGDGEGTETKVAVKTLKEGA--SEEEREEFLEEASIMK-K 57
Query: 123 TKHPYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP + L CT L+ V EY+ GGDL +++L +
Sbjct: 58 LSHPNIVRLLGVCT--QGEPLYIVTEYMPGGDL------------LDFL--------RKH 95
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
+ A +I GM +L K V+RDL N L+ V+I+DFG+ + IY
Sbjct: 96 GEKLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRD-IYE 154
Query: 241 DKTTDTFCGTPD---YMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELF 296
D G +MAPE +K K+ D WSFG+LL+E+ +G+ P+ G +E+
Sbjct: 155 DDYYRKRGGGKLPIKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 214
Query: 297 WSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
+ + R P+ E +++ D R
Sbjct: 215 ELLEDGYRLPRPENCPDELYELMLQCWAYDPEDR 248
|
Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 135 bits (343), Expect = 1e-36
Identities = 72/240 (30%), Positives = 112/240 (46%), Gaps = 40/240 (16%)
Query: 69 LLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
L K LG+G+FG+V+ LKG AVK LK+D + + R+ +
Sbjct: 3 LGKKLGEGAFGEVYKGTLKGKGDGKEVEVAVKTLKED----ASEQQIEEFLREARIMRKL 58
Query: 124 KHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
HP + L CT + L VMEY+ GGDL ++YL +++
Sbjct: 59 DHPNIVKLLGVCT--EEEPLMIVMEYMPGGDL------------LDYL---------RKN 95
Query: 182 GRFDEGRARF--YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ + +A +I GM +L K ++RDL N L+ V+I+DFG+ + +Y
Sbjct: 96 RPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLY 154
Query: 240 LDKTTDTFCGT-P-DYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELF 296
D G P +MAPE +K K+ D WSFG+LL+E+ +G+ P+ G E+
Sbjct: 155 DDDYYKVKGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVL 214
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 134 bits (339), Expect = 3e-36
Identities = 72/239 (30%), Positives = 111/239 (46%), Gaps = 37/239 (15%)
Query: 68 QLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L K LG+G+FG+V+ +LKG AVK LK+D + + R+ +
Sbjct: 2 TLGKKLGEGAFGEVYKGKLKGKGGKKKVEVAVKTLKED----ASEQQIEEFLREARIMRK 57
Query: 124 -KHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP + L CT + L+ VMEY+ GGDL + YL +
Sbjct: 58 LDHPNVVKLLGVCT--EEEPLYIVMEYMEGGDL------------LSYL--------RKN 95
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
+ +A +I GM +L K ++RDL N L+ V+I+DFG+ + +Y
Sbjct: 96 RPKLSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSR-DLYD 154
Query: 241 DKTTDTFCGT-P-DYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELF 296
D G P +MAPE +K K+ D WSFG+LL+E+ +G+ P+ G +E+
Sbjct: 155 DDYYRKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVL 213
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 134 bits (338), Expect = 5e-36
Identities = 82/272 (30%), Positives = 127/272 (46%), Gaps = 26/272 (9%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV-VLEDDDVECTLIERKVLALGTK 124
DF++LK LGKGS+G V+ + + +YA+K + D+ + + E + E ++LA
Sbjct: 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALK--EVDLGSMSQKEREDAVNEIRILA-SVN 57
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP + F + L VMEY GDL A ++K + ++
Sbjct: 58 HPNIISYKEAFLDGNKLCIVMEYAPFGDLSKA-ISKRK----------------KKRKLI 100
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT- 243
E +++ G++ LH++ I++RDLK NILL V+I D G+ K+ L K
Sbjct: 101 PEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISKV---LKKNM 157
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T GTP YMAPE+ KG Y+ D WS G LLYEM PF +L + + +
Sbjct: 158 AKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGK 217
Query: 304 -PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
P P S + +N + +L R +
Sbjct: 218 YPPIPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 8e-34
Identities = 74/304 (24%), Positives = 135/304 (44%), Gaps = 46/304 (15%)
Query: 51 TPATTIPRFRKYDLEDFQLLKVLG--KGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD 108
++ ++ L++ +++K L G FGKV + + K T + K +K
Sbjct: 1 NMDKSLSELVQF-LKNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNF----- 54
Query: 109 VECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY 168
IE V L +P L+ + T +M+Y+ GDL
Sbjct: 55 ---NAIEPMVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLF-------------- 97
Query: 169 LNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-YEGHVR 227
DL+ ++ G+ E + ++V + LHK I++ D+KL+N+L D + +
Sbjct: 98 ----DLL---KKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDRAKDRIY 150
Query: 228 IADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
+ D+G+CK+ T + GT DY +PE IKG Y+ DWW+ G+L YE+ G+ PF
Sbjct: 151 LCDYGLCKII----GTPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
Query: 288 SGCDEDELFWSICNER----PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343
+++EL +R F + +S A + + +L + RL + ++++
Sbjct: 207 KEDEDEELDLESLLKRQQKKLPFIKNVSKNANDFVQSMLKYNINYRL-----TNYNEIIK 261
Query: 344 HEYF 347
H +
Sbjct: 262 HPFL 265
|
Length = 267 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 4e-33
Identities = 76/270 (28%), Positives = 128/270 (47%), Gaps = 32/270 (11%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LG G+FGKV+ A+ K T + A K ++ + ++++E ++E +L+ KHP + L+
Sbjct: 13 LGDGAFGKVYKAQHKETGLFAAAKIIQ---IESEEELEDFMVEIDILS-ECKHPNIVGLY 68
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
+ ++ L+ ++E+ +GG L +M L G E + R+
Sbjct: 69 EAYFYENKLWILIEFCDGGAL---------DSIMLELERG-----------LTEPQIRYV 108
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
+++ + FLH +++RDLK NILL +G V++ADFG+ + DTF GTP
Sbjct: 109 CRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQKRDTFIGTPY 168
Query: 253 YMAPEII-----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-NERPRF 306
+MAPE++ K Y+ D WS GI L E+ + P + + I +E P
Sbjct: 169 WMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLKILKSEPPTL 228
Query: 307 --PQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
P S + L L KD R + +
Sbjct: 229 DQPSKWSSSFNDFLKSCLVKDPDDRPTAAE 258
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 4e-33
Identities = 69/230 (30%), Positives = 110/230 (47%), Gaps = 28/230 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
+D++L++V+G G+ V+ A + A+K + LE + ++V A+
Sbjct: 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRID----LEKCQTSVDELRKEVQAMSQC 56
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
HP + + +F L+ VM YL+GG L+ D+M G
Sbjct: 57 NHPNVVKYYTSFVVGDELWLVMPYLSGGSLL------------------DIMKSSYPRGG 98
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG----MCKLQIY 239
DE E++ G+ +LH G ++RD+K NILL +G V+IADFG +
Sbjct: 99 LDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDR 158
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFS 288
K TF GTP +MAPE+++ + Y+ D WSFGI E+ G +P+S
Sbjct: 159 TRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 8e-33
Identities = 67/233 (28%), Positives = 111/233 (47%), Gaps = 35/233 (15%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-G 122
ED++L++ +G G++G V+ A T A+K +K + DD E +I++++ L
Sbjct: 2 QEDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLE---PGDDFE--IIQQEISMLKE 56
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
+HP + F ++ L+ VMEY GG L +D+ + G
Sbjct: 57 CRHPNIVAYFGSYLRRDKLWIVMEYCGGGSL---------QDIYQVTRGP---------- 97
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
E + + E + G+ +LH+ G ++RD+K NILL +G V++ADFG+ L
Sbjct: 98 -LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQ---LTA 153
Query: 243 TT---DTFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
T +F GTP +MAPE+ + Y+ D W+ GI E+ Q P
Sbjct: 154 TIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 130 bits (328), Expect = 3e-32
Identities = 63/173 (36%), Positives = 102/173 (58%), Gaps = 22/173 (12%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+E+F ++K + +G+FGKV+L K YAVK +KK ++ + V ER LAL +
Sbjct: 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALAL-S 61
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
K P++ HL+ + Q+ ++++ VMEYL GGD+ K+ + HI G
Sbjct: 62 KSPFIVHLYYSLQSANNVYLVMEYLIGGDV------KS-------------LLHIY--GY 100
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
FDE A Y +E+ + +LH+ GI++RDLK DN+L+ EGH+++ DFG+ K+
Sbjct: 101 FDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSKV 153
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 123 bits (311), Expect = 4e-32
Identities = 78/273 (28%), Positives = 130/273 (47%), Gaps = 33/273 (12%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG---- 122
+Q L+++G+G++G V+ + T A+K + D DDDV I+R+V L
Sbjct: 3 YQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVS--DIQREVALLSQLRQ 58
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
++ P + + ++ L+ +MEY GG + R LM+ +G
Sbjct: 59 SQPPNITKYYGSYLKGPRLWIIMEYAEGGSV---------RTLMK-------------AG 96
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
E E++ ++++HK G+++RD+K NIL+ G+V++ DFG+ L
Sbjct: 97 PIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS 156
Query: 243 TTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301
TF GTP +MAPE+I +G Y+ D WS GI +YEM G P+S D I
Sbjct: 157 KRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPK 216
Query: 302 ER-PRFP-QFLSVEAKNILVHLLDKDTTKRLGS 332
+ PR S + + LD++ +RL +
Sbjct: 217 SKPPRLEDNGYSKLLREFVAACLDEEPKERLSA 249
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 122 bits (307), Expect = 1e-31
Identities = 79/251 (31%), Positives = 127/251 (50%), Gaps = 34/251 (13%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK--VLALGTK 124
++++K +G+GSFGK++LA+ K + C+ K++ L V+ +K +L K
Sbjct: 2 YEIIKKIGEGSFGKIYLAKAKSDSEH----CVIKEIDLTKMPVKEKEASKKEVILLAKMK 57
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP + F +FQ + LF VMEY +GGDL M+ +N Q+ F
Sbjct: 58 HPNIVTFFASFQENGRLFIVMEYCDGGDL------------MKRIN-------RQRGVLF 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV-RIADFGMCKLQIYLDKT 243
E + + +I G++ +H + I++RD+K NI L G V ++ DFG+ + L+ +
Sbjct: 99 SEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQ---LNDS 155
Query: 244 TD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
+ T GTP Y++PEI + YN D WS G +LYE+ + PF G + +L IC
Sbjct: 156 MELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKIC 215
Query: 301 NER--PRFPQF 309
P P F
Sbjct: 216 QGYFAPISPNF 226
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-31
Identities = 79/271 (29%), Positives = 131/271 (48%), Gaps = 27/271 (9%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
+ +L+V+G+GSFG+ L + +D YA+K ++ VE + E +LA KH
Sbjct: 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLA-KMKH 57
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR-F 184
P + +F+ D HL+ VMEY +GGDL M+ + Q G+ F
Sbjct: 58 PNIVAFKESFEADGHLYIVMEYCDGGDL------------MQKIK--------LQRGKLF 97
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
E + ++ G++ +H+K +++RD+K NI L G V++ DFG +L
Sbjct: 98 PEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYA 157
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-- 302
T+ GTP Y+ PEI + + YN D WS G +LYE+ + PF L +C
Sbjct: 158 CTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGSY 217
Query: 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGST 333
+P P S E ++++ + ++ R +T
Sbjct: 218 KP-LPSHYSYELRSLIKQMFKRNPRSRPSAT 247
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 5e-31
Identities = 76/270 (28%), Positives = 127/270 (47%), Gaps = 33/270 (12%)
Query: 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-DDVECTLIE---RKVLALGT-KHP 126
++G GSFG V+L + AVK ++ V D + ++++ R++ L +H
Sbjct: 7 LIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHE 66
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ + HL +EY+ GG + A L + G F+E
Sbjct: 67 NIVQYLGSSLDADHLNIFLEYVPGGSV--AAL-------------------LNNYGAFEE 105
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK------LQIYL 240
R + +I+ G+ +LH +GI++RD+K NIL+D +G ++I+DFG+ K L
Sbjct: 106 TLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKT 165
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI- 299
+ + G+ +MAPE++K Y + D WS G L+ EM G+ PF C + + + I
Sbjct: 166 NGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQAIFKIG 225
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKR 329
N P P +S EA + L + D KR
Sbjct: 226 ENASPEIPSNISSEAIDFLEKTFEIDHNKR 255
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 9e-31
Identities = 79/275 (28%), Positives = 124/275 (45%), Gaps = 37/275 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI--ERKVLALG 122
+D + L LG G+ G V + T AVK + LE ++ I E +L
Sbjct: 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVK----TIRLEINEAIQKQILRELDIL-HK 55
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
PY+ + F + + MEY++GG L ++ L E G
Sbjct: 56 CNSPYIVGFYGAFYNNGDISICMEYMDGGSL--------DKILKEV------------QG 95
Query: 183 RFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
R E A ++ G+ +LH+K I++RD+K NIL++ G +++ DFG+ + +
Sbjct: 96 RIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLV--N 153
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-----ELF 296
TF GT YMAPE I+G Y+ D WS G+ L E+ G+ P+ ++ EL
Sbjct: 154 SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELL 213
Query: 297 WSICNER-PRFPQ-FLSVEAKNILVHLLDKDTTKR 329
I NE PR P S + ++ + L KD +R
Sbjct: 214 QYIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRER 248
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 5e-30
Identities = 89/286 (31%), Positives = 130/286 (45%), Gaps = 40/286 (13%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
+Y+ ++ VLGKG++G V+ A T A+K ++ D L E L
Sbjct: 4 EYEYDENGERVVLGKGTYGIVYAARDLSTQVRIAIK----EIPERDSRYVQPLHEEIAL- 58
Query: 121 LGTKHPYLCH------LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDL 174
H YL H L + F ME + GG L L+ G L
Sbjct: 59 ----HSYLKHRNIVQYLGSDSENGFFKIF-MEQVPGGSL---------SALLRS-KWGPL 103
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-YEGHVRIADFGM 233
+ E FY +I+ G+++LH IV+RD+K DN+L++ Y G V+I+DFG
Sbjct: 104 KDN--------EQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGT 155
Query: 234 CKLQIYLDKTTDTFCGTPDYMAPEII-KGLK-YNQCVDWWSFGILLYEMHVGQSPFS--G 289
K ++ T+TF GT YMAPE+I KG + Y D WS G + EM G+ PF G
Sbjct: 156 SKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELG 215
Query: 290 CDEDELF-WSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
+ +F + P P+ LS EAKN ++ + D KR +
Sbjct: 216 EPQAAMFKVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHD 261
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 6e-30
Identities = 79/272 (29%), Positives = 120/272 (44%), Gaps = 27/272 (9%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTK 124
D+++L+ +GKGSFG V K K + + E E + +V L K
Sbjct: 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNMTE---KEKQQLVSEVNILRELK 57
Query: 125 HP----YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-- 178
HP Y + L+ VMEY GGDL A L + + +Y+ + ++ I
Sbjct: 58 HPNIVRYYDRIIDRSNQT--LYIVMEYCEGGDL--AQLIQKCKKERKYI-EEEFIWRILT 112
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
Q E R G LH RDLK NI LD +V++ DFG+ K+
Sbjct: 113 QLLLALYECHNR-----SDPGNTVLH------RDLKPANIFLDANNNVKLGDFGLAKILG 161
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
+ T+ GTP YM+PE + + Y++ D WS G L+YE+ PF+ ++ +L
Sbjct: 162 HDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQLASK 221
Query: 299 ICNER-PRFPQFLSVEAKNILVHLLDKDTTKR 329
I + R P S E ++ +L+ D KR
Sbjct: 222 IKEGKFRRIPYRYSSELNEVIKSMLNVDPDKR 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 117 bits (294), Expect = 9e-30
Identities = 79/262 (30%), Positives = 132/262 (50%), Gaps = 27/262 (10%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+++GKG++G+V+LA T AVK ++ + + V AL ++ L
Sbjct: 7 ELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDS--RQKDMVKALRSEIETLKD 64
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL---MEYLNGGDLMFHIQQSGRFDEG 187
L HL V +YL G E L +EY+ GG + ++ GRF+E
Sbjct: 65 L-------DHLNIV-QYL--------GFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQ 108
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QIYLDKTTD 245
RF+ +++ G+ +LH KGI++RDLK DN+L+D +G +I+DFG+ K IY +
Sbjct: 109 LVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNM 168
Query: 246 TFCGTPDYMAPEII--KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
+ G+ +MAPE+I Y+ VD WS G ++ EM G+ P+S + + + N+R
Sbjct: 169 SMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAMFKLGNKR 228
Query: 304 --PRFPQFLSVEAKNILVHLLD 323
P P +S+ + + L+
Sbjct: 229 SAPPIPPDVSMNLSPVALDFLN 250
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 116 bits (291), Expect = 1e-29
Identities = 81/270 (30%), Positives = 125/270 (46%), Gaps = 22/270 (8%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
DF++L +GKGSFG VF K YA+K + + + E + E +VLA
Sbjct: 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKMNRREREEA-IDEARVLA-KLDS 58
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
Y+ + +F L VMEY GDL L++ G L +
Sbjct: 59 SYIIRYYESFLDKGKLNIVMEYAENGDL---------HKLLKMQRGRPLP---------E 100
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
+ RF+ +I+ G+ LH K I++RD+K N+ LD +V+I D G+ KL +
Sbjct: 101 DQVWRFFI-QILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNFAN 159
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER-P 304
T GTP Y++PE+ + YN+ D W+ G++LYE G+ PF ++ L I P
Sbjct: 160 TIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGVFP 219
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
Q S + ++ L KD +R + Q
Sbjct: 220 PVSQMYSQQLAQLIDQCLTKDYRQRPDTFQ 249
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 115 bits (290), Expect = 2e-29
Identities = 89/280 (31%), Positives = 133/280 (47%), Gaps = 48/280 (17%)
Query: 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD---VECTLIERKVLALGTK 124
Q +G G+FGKV+ A T AVK ++ ++D+D ++ E KVL L K
Sbjct: 3 QRGNKIGGGTFGKVYTAVNLDTGELMAVKEIR----IQDNDPKTIKEIADEMKVLEL-LK 57
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP L + ++ MEY +GG L E L G ++
Sbjct: 58 HPNLVKYYGVEVHREKVYIFMEYCSGG------------TLEELLEHGRIL--------- 96
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
DE R Y +++ G+ +LH GIV+RD+K NI LD+ G +++ DFG C +++ + TT
Sbjct: 97 DEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFG-CAVKLKNNTTT 155
Query: 245 -----DTFCGTPDYMAPEIIKGLK---YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
+ GTP YMAPE+I G K + + D WS G ++ EM G+ P+S D +
Sbjct: 156 MGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE--- 212
Query: 297 WSI-----CNERPRFPQ--FLSVEAKNILVHLLDKDTTKR 329
+ I +P P LS E K+ L L+ D KR
Sbjct: 213 FQIMFHVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKR 252
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 4e-29
Identities = 76/270 (28%), Positives = 124/270 (45%), Gaps = 27/270 (10%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-K 124
+++ K+LG+G+FG+V+L T AVK + D + E +E ++ L +
Sbjct: 3 NWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQ 62
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H + + + D L MEY+ GG + +D ++ G
Sbjct: 63 HERIVQYYGCLRDDETLSIFMEYMPGGSV---------KD------------QLKAYGAL 101
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLDKT 243
E R Y +I+ G+ +LH IV+RD+K NIL D G+V++ DFG K LQ
Sbjct: 102 TETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSG 161
Query: 244 T--DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC- 300
T + GTP +M+PE+I G Y + D WS G + EM + P++ + + I
Sbjct: 162 TGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKIAT 221
Query: 301 -NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
P+ P +S +A+N L ++ KR
Sbjct: 222 QPTNPQLPSHVSPDARNFLRRTFVENAKKR 251
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (289), Expect = 7e-29
Identities = 84/313 (26%), Positives = 142/313 (45%), Gaps = 63/313 (20%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
++ L+ LG+G++G V+ A K T A+K ++ D E++ + T + R++ L KH
Sbjct: 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN--EEEGIPSTAL-REISLLKELKH 57
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + L T+ L+ V EY + DL +YL+ ++ G
Sbjct: 58 PNIVKLLDVIHTERKLYLVFEYC-------------DMDLKKYLD--------KRPGPLS 96
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLDKTT 244
+ +++ G+ + H I++RDLK NIL++ +G +++ADFG+ + I L T
Sbjct: 97 PNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYT 156
Query: 245 DTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELF------ 296
T Y APEI+ G K Y+ VD WS G + EM G+ F G + D+LF
Sbjct: 157 HEVV-TLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQIL 215
Query: 297 -------W----SICNERPRFPQF-----------LSVEAKNILVHLLDKDTTKRLGSTQ 334
W + + +P FP+F L E ++L +L + KR+ + +
Sbjct: 216 GTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKE 275
Query: 335 CNSGDDVVAHEYF 347
+ H YF
Sbjct: 276 A------LKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 1e-27
Identities = 80/284 (28%), Positives = 130/284 (45%), Gaps = 45/284 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
F+L++V+G+G++GKV+ A K T A+K + ++ED++ E E +L +
Sbjct: 6 GIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMD---IIEDEEEEIKE-EYNILRKYSN 61
Query: 125 HPYLCHLFCTFQTDSH------LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
HP + + F + L+ VME GG + DL++ L
Sbjct: 62 HPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT---------DLVKGL--------R 104
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
++ R E + E + G+ +LH+ +++RD+K NILL V++ DFG+
Sbjct: 105 KKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSA--- 161
Query: 239 YLDKT---TDTFCGTPDYMAPEIIKGLK-----YNQCVDWWSFGILLYEMHVGQSPFSGC 290
LD T +TF GTP +MAPE+I + Y+ D WS GI E+ G+ P C
Sbjct: 162 QLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPL--C 219
Query: 291 DED---ELFWSICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
D LF N P P+ S + + + L K+ +R
Sbjct: 220 DMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQR 263
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 110 bits (277), Expect = 1e-27
Identities = 82/264 (31%), Positives = 124/264 (46%), Gaps = 28/264 (10%)
Query: 70 LKVLGKGSFGKVFLAELKGTDYYYAVK--CLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
++VLGKG+FG+ L D K L + E D L E +L+L +HP
Sbjct: 5 IRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRLSEKERRDA---LNEIVILSL-LQHPN 60
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ + F D+ L MEY NGG L D + Q+ F+E
Sbjct: 61 IIAYYNHFMDDNTLLIEMEYANGGTLY------------------DKIVR-QKGQLFEEE 101
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF 247
+Y +IVS + ++HK GI++RD+K NI L G +++ DFG+ K+ +T
Sbjct: 102 MVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETV 161
Query: 248 CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI--CNERPR 305
GTP YM+PE+ +G+KYN D W+ G +LYE+ + F + L I N P
Sbjct: 162 VGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTPV 221
Query: 306 FPQFLSVEAKNILVHLLDKDTTKR 329
+ S E +++ LL +D KR
Sbjct: 222 VSVY-SSELISLVHSLLQQDPEKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 78/294 (26%), Positives = 133/294 (45%), Gaps = 44/294 (14%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKC--LKKDVVLEDDDVECTLIERKV 118
+ L++F +G+GS G V +A K T AVK L+K E L V
Sbjct: 18 RSYLDNF---VKIGEGSTGIVCIATDKSTGRQVAVKKMDLRKQQRRE------LLFNEVV 68
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
+ +HP + ++ ++ L+ VME+L GG L D++ H
Sbjct: 69 IMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALT------------------DIVTH- 109
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
R +E + ++ + FLH +G+++RD+K D+ILL +G V+++DFG C Q+
Sbjct: 110 ---TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCA-QV 165
Query: 239 YLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
+ + GTP +MAPE+I L Y VD WS GI++ EM G+ P+ +
Sbjct: 166 SKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMK 225
Query: 298 SICNERPRF---PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
I + P +S ++ L +L +D +R + +++ H +
Sbjct: 226 RIRDNLPPKLKNLHKVSPRLRSFLDRMLVRDPAQRA------TAAELLNHPFLA 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 8e-27
Identities = 78/315 (24%), Positives = 133/315 (42%), Gaps = 66/315 (20%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
+Q L +G+G++G V+ A K T A+K +K + + R++ L H
Sbjct: 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLR---FESEGIPKTALREIKLLKELNH 57
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + L F+ L+ V E++ + DL + + +
Sbjct: 58 PNIIKLLDVFRHKGDLYLVFEFM-------------DTDLYKLIKD--------RQRGLP 96
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E + Y +++ G+ F H GI++RDLK +N+L++ EG +++ADFG+ +
Sbjct: 97 ESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARS-FGSPVRPY 155
Query: 246 T-FCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELFWSIC-- 300
T + T Y APE++ G K Y+ VD WS G + E+ + F G E D+LF I
Sbjct: 156 THYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLF-KIFRT 214
Query: 301 -----------------NERPRFPQF-----------LSVEAKNILVHLLDKDTTKRLGS 332
N + FP+ S +A ++L +L D KR+
Sbjct: 215 LGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI-- 272
Query: 333 TQCNSGDDVVAHEYF 347
+ + +AH YF
Sbjct: 273 ----TAEQALAHPYF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 9e-27
Identities = 64/231 (27%), Positives = 106/231 (45%), Gaps = 35/231 (15%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVK--CLKKDVVLEDDDVECTLIERKVLALGT 123
+++L +G+G+ G VF A+ + T A+K L++ LE L E K L
Sbjct: 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRR---LEGGIPNQALREIKALQA-C 56
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+HPY+ L F S VMEY+ DL +++ ++
Sbjct: 57 QHPYVVKLLDVFPHGSGFVLVMEYM-PSDL------------------SEVLRDEERP-- 95
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
E + + Y ++ G+ ++H GI++RDLK N+L+ +G ++IADFG+ +L +
Sbjct: 96 LPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARL---FSEE 152
Query: 244 TDTF----CGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSG 289
T Y APE++ G KY+ VD W+ G + E+ G F G
Sbjct: 153 EPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPG 203
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 108 bits (271), Expect = 1e-26
Identities = 74/225 (32%), Positives = 111/225 (49%), Gaps = 27/225 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
E F L+ +GKGSFG+VF KG D K + LE+ + E I++++ L
Sbjct: 4 ELFTKLEKIGKGSFGEVF----KGIDNRTQKVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
PY+ + ++ D+ L+ +MEYL GG + DL+E G
Sbjct: 60 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSAL---------DLLE-------------PGP 97
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
DE + EI+ G+ +LH + ++RD+K N+LL G V++ADFG+
Sbjct: 98 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 157
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS 288
+TF GTP +MAPE+IK Y+ D WS GI E+ G+ P S
Sbjct: 158 RNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHS 202
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 2e-26
Identities = 74/244 (30%), Positives = 118/244 (48%), Gaps = 31/244 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
E F L+ +GKGSFG+VF KG D K + LE+ + E I++++ L
Sbjct: 4 ELFTKLERIGKGSFGEVF----KGIDNRTQQVVAIKIIDLEEAEDEIEDIQQEITVLSQC 59
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
PY+ + ++ + L+ +MEYL GG + DL+ ++G
Sbjct: 60 DSPYVTKYYGSYLKGTKLWIIMEYLGGGSAL------------------DLL----RAGP 97
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
FDE + EI+ G+ +LH + ++RD+K N+LL +G V++ADFG+
Sbjct: 98 FDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIK 157
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
+TF GTP +MAPE+I+ Y+ D WS GI E+ G+ P S + + I
Sbjct: 158 RNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLI---- 213
Query: 304 PRFP 307
P+
Sbjct: 214 PKNN 217
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (268), Expect = 6e-26
Identities = 80/325 (24%), Positives = 136/325 (41%), Gaps = 82/325 (25%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVL-ALGTK 124
++ + +G+G++G+V+ A K T A+K ++ + E + T I E K+L L +
Sbjct: 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN--EKEGFPITAIREIKLLQKL--R 56
Query: 125 HPYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY-LNGGDLMFHIQQS 181
HP + L T + ++ V EY M++ L G
Sbjct: 57 HPNIVRLKEIVTSKGKGSIYMVFEY------------------MDHDLTG----LLDSPE 94
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+F E + + Y +++ G+++LH GI++RD+K NIL++ +G +++ADFG+ +
Sbjct: 95 VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLAR------ 148
Query: 242 KTTDTFCG-------TPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
T T Y PE++ G +Y VD WS G +L E+ +G+ F G E
Sbjct: 149 PYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTEL 208
Query: 294 ---ELFWSIC----------------------------NERPRFPQFLSVEAKNILVHLL 322
E + +C R F + A ++L LL
Sbjct: 209 EQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLL 268
Query: 323 DKDTTKRLGSTQCNSGDDVVAHEYF 347
D KR+ S D + HEYF
Sbjct: 269 TLDPKKRI------SADQALQHEYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 107 bits (267), Expect = 7e-26
Identities = 77/278 (27%), Positives = 133/278 (47%), Gaps = 32/278 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E ++++ LG G+FGKV+ A+ K T A K ++ ++++E ++E ++LA
Sbjct: 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILA-TCN 67
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HPY+ L F D L+ ++E+ GG + A + + +R L E
Sbjct: 68 HPYIVKLLGAFYWDGKLWIMIEFCPGG-AVDAIMLELDRGLTE----------------- 109
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
+ + +++ +++LH I++RDLK N+LL +G +++ADFG+ + +
Sbjct: 110 --PQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167
Query: 245 DTFCGTPDYMAPEII-----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
D+F GTP +MAPE++ K Y+ D WS GI L EM + P + + I
Sbjct: 168 DSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 227
Query: 300 CNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
P P S+E ++ L LDK R + Q
Sbjct: 228 AKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRPSAAQ 265
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 106 bits (267), Expect = 7e-26
Identities = 81/288 (28%), Positives = 132/288 (45%), Gaps = 53/288 (18%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCL------KKDVVLEDDDVECTLIERKVLALGTKHP 126
+G+G+ G V+ A T A+K + KK++++ + L+ R+ KHP
Sbjct: 27 IGQGASGTVYTAIDVATGQEVAIKQMNLQQQPKKELIINE-----ILVMRE-----NKHP 76
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ + ++ L+ VMEYL GG L D++ DE
Sbjct: 77 NIVNYLDSYLVGDELWVVMEYLAGGSLT------------------DVVTETC----MDE 114
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT-D 245
G+ E + + FLH +++RD+K DNILL +G V++ DFG C QI +++
Sbjct: 115 GQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRS 173
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL---FWSICNE 302
T GTP +MAPE++ Y VD WS GI+ EM G+ P+ +E+ L + N
Sbjct: 174 TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPY--LNENPLRALYLIATNG 231
Query: 303 RPRF--PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
P P+ LS ++ L L+ D KR S +++ H + +
Sbjct: 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKR------GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 9e-26
Identities = 87/313 (27%), Positives = 137/313 (43%), Gaps = 62/313 (19%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT-LIERKVLALGTKH 125
++++K LG G+FG V+LA K T A+K +KK + EC L E K L +H
Sbjct: 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKK--FYSWE-ECMNLREVKSLRKLNEH 57
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + L F+ + L+FV EY+ G N LM ++ F
Sbjct: 58 PNIVKLKEVFRENDELYFVFEYMEG-------------------NLYQLMKD-RKGKPFS 97
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E R +I+ G+ +HK G +RDLK +N+L+ V+IADFG+ + +I
Sbjct: 98 ESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR-EIRSRPPYT 156
Query: 246 TFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC---- 300
+ T Y APEI+ + Y+ VD W+ G ++ E++ + F G E + + IC
Sbjct: 157 DYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSVLG 216
Query: 301 --NERP-------------RFPQFLSV-----------EAKNILVHLLDKDTTKRLGSTQ 334
++ RFPQF EA +++ +L D KR ++Q
Sbjct: 217 TPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276
Query: 335 CNSGDDVVAHEYF 347
+ H YF
Sbjct: 277 A------LQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-25
Identities = 79/279 (28%), Positives = 131/279 (46%), Gaps = 33/279 (11%)
Query: 65 EDF-QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
E+F +++ LG G+FGKV+ A+ K T A K + ++++E ++E +LA
Sbjct: 4 EEFWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILA-SC 59
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
HP + L F +++L+ ++E+ GG + A + + ER L E
Sbjct: 60 DHPNIVKLLDAFYYENNLWILIEFCAGG-AVDAVMLELERPLTE---------------- 102
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
+ R + + + +LH+ I++RDLK NIL +G +++ADFG+ +
Sbjct: 103 ---PQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQR 159
Query: 244 TDTFCGTPDYMAPEII-----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
D+F GTP +MAPE++ K Y+ D WS GI L EM + P + +
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLK 219
Query: 299 ICNERPRF---PQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
I P P S E K+ L L+K+ R +TQ
Sbjct: 220 IAKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARWTTTQ 258
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 6e-25
Identities = 69/223 (30%), Positives = 109/223 (48%), Gaps = 27/223 (12%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
F L+ +GKGSFG+V+ KG D K + LE+ + E I++++ L
Sbjct: 6 FTKLERIGKGSFGEVY----KGIDNRTKEVVAIKIIDLEEAEDEIEDIQQEITVLSQCDS 61
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
PY+ + ++ + L+ +MEYL GG + DL+ + G +
Sbjct: 62 PYITRYYGSYLKGTKLWIIMEYLGGGSAL------------------DLL----KPGPLE 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E EI+ G+ +LH + ++RD+K N+LL +G V++ADFG+ +
Sbjct: 100 ETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQIKRN 159
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS 288
TF GTP +MAPE+IK Y+ D WS GI E+ G+ P S
Sbjct: 160 TFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNS 202
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 2e-24
Identities = 73/290 (25%), Positives = 127/290 (43%), Gaps = 39/290 (13%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLK--KDVVLEDDDVECTLIERKVLALGTKHPYL 128
+ LG G+F + A T AVK + ++ E ++V L + L HP++
Sbjct: 6 QQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHI 65
Query: 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
+ DSH +E++ GG + + L L +Y G F E
Sbjct: 66 IRMLGATCEDSHFNLFVEWMAGGSV--SHL------LSKY-------------GAFKEAV 104
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-VRIADFGMC-KLQIYLDKTTD- 245
Y +++ G+ +LH+ I++RD+K N+L+D G +RIADFG +L +
Sbjct: 105 IINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEF 164
Query: 246 --TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG---CDEDELFWSI- 299
GT +MAPE+++G +Y + D WS G ++ EM + P++ + L + I
Sbjct: 165 QGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIA 224
Query: 300 -CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
P P+ LS +++ + L+ R S +++ H FR
Sbjct: 225 SATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSR------ELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 3e-24
Identities = 78/281 (27%), Positives = 125/281 (44%), Gaps = 42/281 (14%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLK----KDVVLEDDDV-ECTLIERKV 118
L +F++ K +GKG F V+ A A+K ++ D D + E L+++
Sbjct: 1 LGNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQ-- 58
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
HP + +F ++ L V+E + GDL ++ H
Sbjct: 59 ----LDHPNVIKYLASFIENNELNIVLELADAGDL------------------SRMIKHF 96
Query: 179 QQSGR-FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
++ R E Y ++ S + +H K I++RD+K N+ + G V++ D G+ +
Sbjct: 97 KKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGR-- 154
Query: 238 IYLDKTTDTF--CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
+ KTT GTP YM+PE I YN D WS G LLYEM QSPF G D+ L
Sbjct: 155 FFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNL 213
Query: 296 FWSICN-----ERPRFP-QFLSVEAKNILVHLLDKDTTKRL 330
+ S+C + P P S E ++++ ++ D KR
Sbjct: 214 Y-SLCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKRP 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 101 bits (254), Expect = 3e-24
Identities = 79/284 (27%), Positives = 122/284 (42%), Gaps = 36/284 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E L LG+G+ G V LK T +A+K + D + D++ ++ + K
Sbjct: 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTD---PNPDLQKQILRELEINKSCK 57
Query: 125 HPYLCHLFCTF--QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
PY+ + F ++ S + MEY GG L + + ++ G
Sbjct: 58 SPYIVKYYGAFLDESSSSIGIAMEYCEGGSL--------DSIYKKVK---------KRGG 100
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
R E A ++ G+ +LH + I++RD+K NILL +G V++ DFG+ + +
Sbjct: 101 RIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELV--NS 158
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-----ELFW 297
TF GT YMAPE I+G Y+ D WS G+ L E+ + PF E EL
Sbjct: 159 LAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218
Query: 298 SICN-ERPRFPQ------FLSVEAKNILVHLLDKDTTKRLGSTQ 334
I N P S E K+ + L+KD T+R
Sbjct: 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWD 262
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 4e-24
Identities = 78/269 (28%), Positives = 124/269 (46%), Gaps = 32/269 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++ ++V+G+G+FG V L K +K + + + +D+ E +VL L HP
Sbjct: 2 YEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQMTKDER-LAAQNECQVLKL-LSHP 59
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--F 184
+ + F D L VMEY GG L EY IQ+
Sbjct: 60 NIIEYYENFLEDKALMIVMEYAPGGTL------------AEY---------IQKRCNSLL 98
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-YEGHVRIADFGMCKLQIYLDKT 243
DE + +I+ + +H K I++RDLK NILLD ++ V+I DFG+ K+ K
Sbjct: 99 DEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKA 158
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T GTP Y++PE+ +G YNQ D W+ G +LYE+ + F + L I
Sbjct: 159 Y-TVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIM--S 215
Query: 304 PRFPQF---LSVEAKNILVHLLDKDTTKR 329
F S + + +++ +L+ D +KR
Sbjct: 216 GTFAPISDRYSPDLRQLILSMLNLDPSKR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 9e-24
Identities = 74/279 (26%), Positives = 117/279 (41%), Gaps = 35/279 (12%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+G+G+ G VF A D + K + L+ + +I ++ K+P + +
Sbjct: 27 IGQGASGTVFTA----IDVATGQEVAIKQINLQKQPKKELIINEILVMKELKNPNIVNFL 82
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
+F LF VMEYL GG L + DE +
Sbjct: 83 DSFLVGDELFVVMEYLAGGSLT----------------------DVVTETCMDEAQIAAV 120
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
E + + FLH +++RD+K DN+LL +G V++ DFG C T GTP
Sbjct: 121 CRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-NERPRF--PQF 309
+MAPE++ Y VD WS GI+ EM G+ P+ + + I N P P+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEK 240
Query: 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
LS ++ L L+ D KR S +++ H + +
Sbjct: 241 LSPIFRDFLNRCLEMDVEKR------GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 99.4 bits (247), Expect = 2e-23
Identities = 70/231 (30%), Positives = 111/231 (48%), Gaps = 30/231 (12%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
R+ EDF+L++ +G G++G V+ A T A+K +K + + V+ +I K
Sbjct: 4 RRNPQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEPGEDFAVVQQEIIMMK-- 61
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
KH + F ++ L+ ME+ GG L +D+ +H+
Sbjct: 62 --DCKHSNIVAYFGSYLRRDKLWICMEFCGGGSL---------QDI----------YHV- 99
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+G E + + + E + G+ +LH KG ++RD+K NILL GHV++ADFG+
Sbjct: 100 -TGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITA 158
Query: 240 LDKTTDTFCGTPDYMAPEII----KGLKYNQCVDWWSFGILLYEMHVGQSP 286
+F GTP +MAPE+ KG YNQ D W+ GI E+ Q P
Sbjct: 159 TIAKRKSFIGTPYWMAPEVAAVERKG-GYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 99.4 bits (248), Expect = 3e-23
Identities = 79/245 (32%), Positives = 120/245 (48%), Gaps = 21/245 (8%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYY-----YAVKCLKKDVVLEDDDVECTLIERK 117
+ L K LG+G+FG+V AE G D AVK LK D + D+ + E +
Sbjct: 10 PRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDAT--EKDLSDLVSEME 67
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
++ + KH + +L + L+ V+EY G+L +A R EY + D
Sbjct: 68 MMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNL--RDFLRARRPPGEYASPDDPRPP 125
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV-RIADFGMCKL 236
+ + D +A ++ GM FL K ++RDL N+L+ E HV +IADFG+ +
Sbjct: 126 EETLTQKD---LVSFAYQVARGMEFLASKKCIHRDLAARNVLVT-EDHVMKIADFGLARD 181
Query: 237 QIYLD---KTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCD 291
++D KTT+ P +MAPE + Y D WSFG+LL+E +G SP+ G
Sbjct: 182 IHHIDYYRKTTNG--RLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 239
Query: 292 EDELF 296
+ELF
Sbjct: 240 VEELF 244
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 4e-23
Identities = 75/280 (26%), Positives = 125/280 (44%), Gaps = 37/280 (13%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+G+G+ G V+ A T A++ + L+ + +I ++ K+P + +
Sbjct: 28 IGQGASGTVYTAMDVATGQEVAIRQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 83
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
++ L+ VMEYL GG L + DEG+
Sbjct: 84 DSYLVGDELWVVMEYLAGGSLT----------------------DVVTETCMDEGQIAAV 121
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT-FCGTP 251
E + + FLH +++RD+K DNILL +G V++ DFG C QI +++ + GTP
Sbjct: 122 CRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCA-QITPEQSKRSTMVGTP 180
Query: 252 DYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-NERPRF--PQ 308
+MAPE++ Y VD WS GI+ EM G+ P+ + + I N P P+
Sbjct: 181 YWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPE 240
Query: 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
LS ++ L LD D KR S +++ H++ +
Sbjct: 241 KLSAIFRDFLNRCLDMDVEKR------GSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-23
Identities = 70/277 (25%), Positives = 127/277 (45%), Gaps = 36/277 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
++ ++L LGKG++G V+ + T A+K ++ + L++ ++E +L
Sbjct: 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILHKAVS 58
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
PY+ + F + ++ MEY++ G ++ L G + +
Sbjct: 59 -PYIVDFYGAFFIEGAVYMCMEYMDAGS-------------LDKLYAGGV-----ATEGI 99
Query: 185 DEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDK 242
E R +V G++FL ++ I++RD+K N+L++ G V++ DFG+ L L K
Sbjct: 100 PEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASLAK 159
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCV------DWWSFGILLYEMHVGQSPFSGCDEDELF 296
T G YMAPE IK NQ D WS G+ + EM +G+ P+ +F
Sbjct: 160 TN---IGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYANIF 216
Query: 297 ---WSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
+I + + P P S +A++ + L+K +R
Sbjct: 217 AQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRR 253
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 98.0 bits (244), Expect = 5e-23
Identities = 68/230 (29%), Positives = 104/230 (45%), Gaps = 27/230 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELK-GTDYYYAVK-------CLKKDVVLEDDDVECTLIERKV 118
+ +L+ LG G+FG V+ K A+K KD D + + E +
Sbjct: 2 YAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTI 61
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
+ +HP + + TF + L+ VM+ + G L + L
Sbjct: 62 IKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPL---------GEHFNSLK-------- 104
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
++ RF E R ++V +R+LHK K IV+RDL +NI+L + V I DFG+ K +
Sbjct: 105 EKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQK 164
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
K T + GT Y PEI+K Y + D W+FG +LY+M Q PF
Sbjct: 165 QPESKLT-SVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPF 213
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 6e-23
Identities = 71/267 (26%), Positives = 124/267 (46%), Gaps = 28/267 (10%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+ +K +G+GSFGK L + K Y +K + + + E + E VL+ KHP
Sbjct: 2 YVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISK-MSPKEREESRKEVAVLS-NMKHP 59
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ +F+ + +L+ VM+Y GGDL + +N Q+ F E
Sbjct: 60 NIVQYQESFEENGNLYIVMDYCEGGDL------------YKKINA-------QRGVLFPE 100
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD- 245
+ + +I ++ +H + I++RD+K NI L +G +++ DFG+ ++ L+ T +
Sbjct: 101 DQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARV---LNSTVEL 157
Query: 246 --TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-E 302
T GTP Y++PEI + YN D W+ G +LYEM + F + L I
Sbjct: 158 ARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217
Query: 303 RPRFPQFLSVEAKNILVHLLDKDTTKR 329
P S + +N++ L ++ R
Sbjct: 218 YPPVSSHYSYDLRNLVSQLFKRNPRDR 244
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 98.2 bits (244), Expect = 6e-23
Identities = 64/215 (29%), Positives = 103/215 (47%), Gaps = 26/215 (12%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+G+GS G V +A +K + AVK K D L L V+ +H + ++
Sbjct: 28 IGEGSTGIVCIATVKSSGKLVAVK--KMD--LRKQQRRELLFNEVVIMRDYQHENVVEMY 83
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
++ L+ VME+L GG L D++ H R +E +
Sbjct: 84 NSYLVGDELWVVMEFLEGGALT------------------DIVTHT----RMNEEQIAAV 121
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
++ + LH +G+++RD+K D+ILL ++G V+++DFG C + GTP
Sbjct: 122 CLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVPRRKSLVGTPY 181
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
+MAPE+I L Y VD WS GI++ EM G+ P+
Sbjct: 182 WMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 97.6 bits (243), Expect = 1e-22
Identities = 83/316 (26%), Positives = 142/316 (44%), Gaps = 68/316 (21%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
FQ ++ +G+G++G V+ A K T A+K ++ D E + V T I L HP
Sbjct: 2 FQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLD--TETEGVPSTAIREISLLKELNHP 59
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ L T++ L+ V E+L+ DL + M+ + + +S
Sbjct: 60 NIVKLLDVIHTENKLYLVFEFLHQ-DL---------KKFMDASPLSGIPLPLIKS----- 104
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-----LQIYLD 241
Y +++ G+ F H +++RDLK N+L++ EG +++ADFG+ + ++ Y
Sbjct: 105 -----YLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 159
Query: 242 KTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF--- 296
+ T Y APEI+ G K Y+ VD WS G + EM ++ F G E D+LF
Sbjct: 160 EVV-----TLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIF 214
Query: 297 ----------W----SICNERPRFPQF-----------LSVEAKNILVHLLDKDTTKRLG 331
W S+ + +P FP++ L + +++L +L D KR+
Sbjct: 215 RTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI- 273
Query: 332 STQCNSGDDVVAHEYF 347
S +AH +F
Sbjct: 274 -----SAKAALAHPFF 284
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 97.1 bits (241), Expect = 2e-22
Identities = 73/279 (26%), Positives = 119/279 (42%), Gaps = 35/279 (12%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+G+G+ G V+ A T A+K + L+ + +I ++ K+P + +
Sbjct: 27 IGQGASGTVYTAIDIATGQEVAIKQMN----LQQQPKKELIINEILVMRENKNPNIVNYL 82
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
++ L+ VMEYL GG L + DEG+
Sbjct: 83 DSYLVGDELWVVMEYLAGGSLT----------------------DVVTETCMDEGQIAAV 120
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
E + + FLH +++RD+K DNILL +G V++ DFG C T GTP
Sbjct: 121 CRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVGTPY 180
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-NERPRF--PQF 309
+MAPE++ Y VD WS GI+ EM G+ P+ + + I N P P+
Sbjct: 181 WMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPER 240
Query: 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
LS ++ L L+ D +R S +++ H + +
Sbjct: 241 LSAVFRDFLNRCLEMDVDRR------GSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 96.6 bits (241), Expect = 2e-22
Identities = 63/238 (26%), Positives = 105/238 (44%), Gaps = 39/238 (16%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDV------ECTLIERKVLA 120
++ L +G+G++G V+ A T + A+K ++ V L ++ + E L+ +++ +
Sbjct: 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVR--VPLSEEGIPLSTLREIALL-KQLES 57
Query: 121 LGTKHPYLCHLF--CTFQTDSH---LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
HP + L C L V E+ ++DL YL+
Sbjct: 58 FE--HPNIVRLLDVCHGPRTDRELKLTLVFEH-------------VDQDLATYLS----- 97
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ G + +++ G+ FLH IV+RDLK NIL+ +G V+IADFG+ +
Sbjct: 98 -KCPKPG-LPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLAR 155
Query: 236 LQIYLDKTTDTFC-GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292
IY + T T Y APE++ Y VD WS G + E+ + F G E
Sbjct: 156 --IYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 96.1 bits (239), Expect = 2e-22
Identities = 72/279 (25%), Positives = 113/279 (40%), Gaps = 41/279 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT------LIERKVLALGTK 124
+VLGKG++G V+ L AV K V L+ +V L E L K
Sbjct: 6 EVLGKGAYGTVYCG-LTNQGQLIAV----KQVELDTSNVLAAEKEYEKLQEEVDLLKSLK 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H + T D+ + ME++ GG + + + G
Sbjct: 61 HVNIVQYLGTCLDDNTISIFMEFVPGGSISSI---------------------LNRFGPL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG------MCKLQI 238
E Y +I+ G+ +LH +V+RD+K +N++L G +++ DFG L
Sbjct: 100 PEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHG 159
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
+ GTP +MAPE+I Y + D WS G ++EM G+ P + D +
Sbjct: 160 THSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFY 219
Query: 299 ICNER---PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
I R PR P S A + + L +D +R + Q
Sbjct: 220 IGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERPSALQ 258
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 97.2 bits (242), Expect = 4e-22
Identities = 85/311 (27%), Positives = 147/311 (47%), Gaps = 54/311 (17%)
Query: 41 SRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK 100
S SS S ++ + + + P K L + + + +G G+ G V+ + T YA+K +
Sbjct: 51 SSSSSSSSSSSASGSAPSAAK-SLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYG 109
Query: 101 DVVLEDDDVECTLIERKVLAL-GTKHPYL--CHLFCTFQTDSHLFFVMEYLNGGDLIPAG 157
+ +D V I R++ L HP + CH + + G++
Sbjct: 110 N---HEDTVR-RQICREIEILRDVNHPNVVKCHDM--------------FDHNGEI---- 147
Query: 158 LTKAERDLMEYLNGGDLM-FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216
+ L+E+++GG L HI DE A +I+SG+ +LH++ IV+RD+K
Sbjct: 148 -----QVLLEFMDGGSLEGTHIA-----DEQFLADVARQILSGIAYLHRRHIVHRDIKPS 197
Query: 217 NILLDYEGHVRIADFGMCKLQIYLDKTTD---TFCGTPDYMAPEII-----KGLKYNQCV 268
N+L++ +V+IADFG+ ++ L +T D + GT YM+PE I G Y+
Sbjct: 198 NLLINSAKNVKIADFGVSRI---LAQTMDPCNSSVGTIAYMSPERINTDLNHG-AYDGYA 253
Query: 269 -DWWSFGILLYEMHVGQSPFS---GCDEDELFWSIC-NERPRFPQFLSVEAKNILVHLLD 323
D WS G+ + E ++G+ PF D L +IC ++ P P S E ++ + L
Sbjct: 254 GDIWSLGVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPEAPATASREFRHFISCCLQ 313
Query: 324 KDTTKRLGSTQ 334
++ KR + Q
Sbjct: 314 REPAKRWSAMQ 324
|
Length = 353 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 94.8 bits (235), Expect = 8e-22
Identities = 73/257 (28%), Positives = 119/257 (46%), Gaps = 31/257 (12%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLC 129
K+LG+G+FG+V+L T A K ++ D + E + +E ++ L +H +
Sbjct: 8 KLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIV 67
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL---MEYLNGGDLMFHIQQSGRFDE 186
+ + +AE+ L MEY+ GG + ++ G E
Sbjct: 68 QYYGCLRD----------------------RAEKTLTIFMEYMPGGSVKDQLKAYGALTE 105
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLDKTTD 245
R Y +I+ GM +LH IV+RD+K NIL D G+V++ DFG K LQ T
Sbjct: 106 SVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 246 --TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE- 302
+ GTP +M+PE+I G Y + D WS G + EM + P++ + + I +
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIFKIATQP 225
Query: 303 -RPRFPQFLSVEAKNIL 318
P+ P +S A++ L
Sbjct: 226 TNPQLPSHISEHARDFL 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 94.3 bits (234), Expect = 1e-21
Identities = 70/231 (30%), Positives = 113/231 (48%), Gaps = 30/231 (12%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
R+ D++L++ +G G++G V+ A T AVK +K LE D + +LI++++
Sbjct: 4 RRNPQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIK----LEPGD-DFSLIQQEIF 58
Query: 120 ALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
+ KH + F ++ + L+ MEY GG L +D+ +H+
Sbjct: 59 MVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSL---------QDI----------YHV 99
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+G E + + E + G+ +LH KG ++RD+K NILL G V++ADFG+
Sbjct: 100 --TGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKIT 157
Query: 239 YLDKTTDTFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLYEMHVGQSP 286
+F GTP +MAPE+ K YNQ D W+ GI E+ Q P
Sbjct: 158 ATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 93.8 bits (233), Expect = 1e-21
Identities = 75/261 (28%), Positives = 120/261 (45%), Gaps = 24/261 (9%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE---DDDVECTLIERKVLALGTKHPYLC 129
LGKGSFG V+L + K +K LK+ V E ++ V+ E ++L+ HP +
Sbjct: 8 LGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQ-EAQLLS-KLDHPAIV 65
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189
+F + EY G DL + L E + G E +
Sbjct: 66 KFHASFLERDAFCIITEYCEGRDL--------DCKLEELKHTGK---------TLSENQV 108
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG 249
+ +++ G+ ++H++ I++RDLK NI L ++I DFG+ +L + TF G
Sbjct: 109 CEWFIQLLLGVHYMHQRRILHRDLKAKNIFLK-NNLLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 250 TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-ERPRFPQ 308
TP YM+PE +K Y+ D WS G +LYEM F G + + I P P+
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGPTPSLPE 227
Query: 309 FLSVEAKNILVHLLDKDTTKR 329
S + +I+ +L+KD + R
Sbjct: 228 TYSRQLNSIMQSMLNKDPSLR 248
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 96.9 bits (241), Expect = 2e-21
Identities = 82/282 (29%), Positives = 125/282 (44%), Gaps = 36/282 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ + + +VLG G+ G V A+ +AVK + D+E K A
Sbjct: 32 KKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVV---------DMEGMSEADKNRAQAEV 82
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM-----EYLNGGDLMFHIQ 179
C L C F F +++ D E LM +Y N GDL I+
Sbjct: 83 C---CLLNCDF------FSIVKCHE--DFAKKDPRNPENVLMIALVLDYANAGDLRQEIK 131
Query: 180 QSGR----FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ F E A +++ + +H K +++RD+K NILL G V++ DFG K
Sbjct: 132 SRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSK 191
Query: 236 LQIYLDKTTD----TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
+ Y +D TFCGTP Y+APEI + Y++ D +S G+LLYE+ + PF G +
Sbjct: 192 M--YAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
Query: 292 EDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGS 332
+E+ R P +S E + I+ LL D +R S
Sbjct: 250 MEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRPSS 291
|
Length = 496 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 2e-21
Identities = 55/186 (29%), Positives = 95/186 (51%), Gaps = 14/186 (7%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
++++ GG L HI + E + +AAE+V + LH++GIV RDL +NILLD G
Sbjct: 63 VLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRG 122
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPD---YMAPEIIKGLKYNQCVDWWSFGILLYEMH 281
H+++ F + D+ G Y APE+ + + DWWS G +L+E+
Sbjct: 123 HIQLTYFSRWS------EVEDSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELL 176
Query: 282 VGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDV 341
G++ C + + P+++S EA+++L LL + T+RLG+ +D+
Sbjct: 177 TGKT-LVECHPSGIN---THTTLNIPEWVSEEARSLLQQLLQFNPTERLGAGVAGV-EDI 231
Query: 342 VAHEYF 347
+H +F
Sbjct: 232 KSHPFF 237
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 93.9 bits (233), Expect = 2e-21
Identities = 64/215 (29%), Positives = 101/215 (46%), Gaps = 26/215 (12%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+G+GS G V +A K T AVK K D L L V+ H + ++
Sbjct: 30 IGEGSTGIVCIATEKHTGKQVAVK--KMD--LRKQQRRELLFNEVVIMRDYHHENVVDMY 85
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
++ L+ VME+L GG L D++ H R +E +
Sbjct: 86 NSYLVGDELWVVMEFLEGGALT------------------DIVTHT----RMNEEQIATV 123
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
++ + +LH +G+++RD+K D+ILL +G ++++DFG C + GTP
Sbjct: 124 CLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPY 183
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
+MAPE+I L Y VD WS GI++ EM G+ P+
Sbjct: 184 WMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPY 218
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 93.2 bits (232), Expect = 3e-21
Identities = 69/252 (27%), Positives = 108/252 (42%), Gaps = 38/252 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
E L++ LG+GSFG V+ KG + A+K + ++ + + +E L E V+
Sbjct: 6 EKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENASM-RERIE-FLNEASVM 63
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
H ++ L T VME + GDL ++ R E G
Sbjct: 64 KEFNCH-HVVRLLGVVSTGQPTLVVMELMAKGDL--KSYLRSRRPEAENNPGLGPP---- 116
Query: 180 QSGRFDEGRARFY--AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
+F AAEI GM +L K V+RDL N ++ + V+I DFGM +
Sbjct: 117 -------TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRD- 168
Query: 238 IYLDKTTDTFCGTPD--------YMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFS 288
IY TD + +MAPE +K + D WSFG++L+EM + + P+
Sbjct: 169 IY---ETDYY--RKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQ 223
Query: 289 GCDEDELFWSIC 300
G +E+ +
Sbjct: 224 GLSNEEVLKFVI 235
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-21
Identities = 68/264 (25%), Positives = 118/264 (44%), Gaps = 25/264 (9%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
+++L K+LG+G+FG+V+L T AVK + D ++ E +E ++ L
Sbjct: 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNL 61
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H + + + K +EY+ GG + ++ G
Sbjct: 62 RHDRIVQYYGCLRDPEE-------------------KKLSIFVEYMPGGSIKDQLKAYGA 102
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK--LQIYLD 241
E R Y +I+ G+ +LH IV+RD+K NIL D G+V++ DFG K I +
Sbjct: 103 LTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS 162
Query: 242 KT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
T + GTP +M+PE+I G Y + D WS + EM + P++ + + I
Sbjct: 163 GTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIFKIA 222
Query: 301 NE--RPRFPQFLSVEAKNILVHLL 322
+ +P P +S ++ L +
Sbjct: 223 TQPTKPMLPDGVSDACRDFLKQIF 246
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 92.6 bits (230), Expect = 5e-21
Identities = 76/306 (24%), Positives = 128/306 (41%), Gaps = 64/306 (20%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL-ALGT 123
ED + + LG G+ G V + T A K VV + +++L L
Sbjct: 5 EDLETISDLGAGNGGSVSKVKHIPTGTVMA-----KKVVHIGAKSS---VRKQILRELQI 56
Query: 124 KH----PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
H PY+ + F ++++ ME+++ G L + K + +++ I
Sbjct: 57 MHECRSPYIVSFYGAFLNENNICMCMEFMDCGSL--DRIYKKGGPIPV-----EILGKI- 108
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
A +V G+ +L+ I++RD+K NIL++ G +++ DFG+ I
Sbjct: 109 -------------AVAVVEGLTYLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELI 155
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED----- 293
+ DTF GT YM+PE I+G KY D WS GI + E+ +G+ PF+ + D
Sbjct: 156 --NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQD 213
Query: 294 ------ELFWSICNERP------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDV 341
+L I E P FP+ L + + + KD T+R + +
Sbjct: 214 DPMGILDLLQQIVQEPPPRLPSSDFPEDL-RDFVDACLL---KDPTER------PTPQQL 263
Query: 342 VAHEYF 347
A F
Sbjct: 264 CAMPPF 269
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 6e-21
Identities = 78/275 (28%), Positives = 128/275 (46%), Gaps = 31/275 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
+ L ++G+ F+A +G+D K + K V+L D+ + ++ L H
Sbjct: 69 YVLTTLVGRNPTTAAFVA-TRGSDP--KEKVVAKFVMLNDER-QAAYARSELHCLAACDH 124
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
+ F F++D L +MEY +GGDL + ++ L E+L F
Sbjct: 125 FGIVKHFDDFKSDDKLLLIMEYGSGGDLN----KQIKQRLKEHLP-------------FQ 167
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT- 244
E +IV + +H + +++RDLK NI L G +++ DFG K Y D +
Sbjct: 168 EYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQ--YSDSVSL 225
Query: 245 ---DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC- 300
+FCGTP Y+APE+ + +Y++ D WS G++LYE+ PF G + E+ +
Sbjct: 226 DVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285
Query: 301 -NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
P FP +S K +L LL K+ R + Q
Sbjct: 286 GKYDP-FPCPVSSGMKALLDPLLSKNPALRPTTQQ 319
|
Length = 478 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 91.7 bits (228), Expect = 7e-21
Identities = 68/244 (27%), Positives = 108/244 (44%), Gaps = 47/244 (19%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GT 123
E+F L + LG G FG+V+ K A+K LK D +L+ D +++V AL
Sbjct: 6 EEFTLERKLGSGYFGEVWEGLWKNR-VRVAIKILKSDDLLKQQD-----FQKEVQALKRL 59
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H +L LF ++ + E + G L + +L R
Sbjct: 60 RHKHLISLFAVCSVGEPVYIITELMEKGSL------------LAFL-------------R 94
Query: 184 FDEGRAR------FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL- 236
EG+ A ++ GM +L ++ ++RDL NIL+ + ++ADFG+ +L
Sbjct: 95 SPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLI 154
Query: 237 --QIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292
+YL P + APE ++ D WSFGILLYEM GQ P+ G +
Sbjct: 155 KEDVYLSSDKK----IPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210
Query: 293 DELF 296
E++
Sbjct: 211 HEVY 214
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 8e-21
Identities = 73/258 (28%), Positives = 122/258 (47%), Gaps = 23/258 (8%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
+++L K+LG+G+FG+V+L T AVK ++ D + E +E ++ L
Sbjct: 3 NWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKN-- 60
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
L H +++Y + + + ME++ GG + ++ G
Sbjct: 61 --LLHE-----------RIVQYYG---CLRDPMERTLSIFMEHMPGGSIKDQLKSYGALT 104
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQ-IYLDKT 243
E R Y +I+ G+ +LH IV+RD+K NIL D G+V++ DFG K LQ I L T
Sbjct: 105 ENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGT 164
Query: 244 -TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302
+ GTP +M+PE+I G Y + D WS G + EM + P++ + + I +
Sbjct: 165 GMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIATQ 224
Query: 303 --RPRFPQFLSVEAKNIL 318
P P +S ++ L
Sbjct: 225 PTNPVLPPHVSDHCRDFL 242
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 9e-21
Identities = 48/124 (38%), Positives = 74/124 (59%), Gaps = 3/124 (2%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
LME+L GG L + Q+ R +E + ++ + +LH +G+++RD+K D+ILL +G
Sbjct: 96 LMEFLQGGALTDIVSQT-RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDG 154
Query: 225 HVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283
V+++DFG C QI D + GTP +MAPE+I Y VD WS GI++ EM G
Sbjct: 155 RVKLSDFGFCA-QISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDG 213
Query: 284 QSPF 287
+ P+
Sbjct: 214 EPPY 217
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 1e-20
Identities = 65/228 (28%), Positives = 107/228 (46%), Gaps = 36/228 (15%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
++ +L +GKG FG V L + +G AVKCLK D + L E V+
Sbjct: 5 SKELKLGATIGKGEFGDVMLGDYRGQKV--AVKCLKDDSTA----AQAFLAEASVMT-TL 57
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+HP L L + L+ V EY+ G L+ +YL + GR
Sbjct: 58 RHPNLVQLLGVVLQGNPLYIVTEYMAKGSLV------------DYL---------RSRGR 96
Query: 184 FDEGRARF--YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
A+ +A ++ GM +L +K V+RDL N+L+ + +++DFG+ K +
Sbjct: 97 AVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAK-EASQG 155
Query: 242 KTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPF 287
+ + P + APE ++ K++ D WSFGILL+E++ G+ P+
Sbjct: 156 QDSGKL---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 3e-20
Identities = 67/240 (27%), Positives = 111/240 (46%), Gaps = 36/240 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDV-ECTLIERKVLALGT 123
+++L V+G+G++G V K T A+K K+ +D+DV + L E KVL
Sbjct: 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKE--SEDDEDVKKTALREVKVLRQ-L 57
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H + +L F+ L+ V EY+ ER L+E L G
Sbjct: 58 RHENIVNLKEAFRRKGRLYLVFEYV-------------ERTLLELLE--------ASPGG 96
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM-----CKLQI 238
R Y +++ + + H I++RD+K +NIL+ G +++ DFG +
Sbjct: 97 LPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS 156
Query: 239 YLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELF 296
L TD + T Y APE++ G Y + VD W+ G ++ E+ G+ F G D D+L+
Sbjct: 157 PL---TD-YVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLY 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 90.8 bits (225), Expect = 3e-20
Identities = 79/320 (24%), Positives = 139/320 (43%), Gaps = 65/320 (20%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+E + L+ LG+G++ VF K T+ A+K ++ + ++ CT I L
Sbjct: 5 METYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLE---HEEGAPCTAIREVSLLKDL 61
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN--GGDLMFHIQQS 181
KH + L TD L V EYL ++DL +Y++ G + H
Sbjct: 62 KHANIVTLHDIVHTDKSLTLVFEYL-------------DKDLKQYMDDCGNIMSMH---- 104
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+ + +I+ G+ + H++ +++RDLK N+L++ G +++ADFG+ + +
Sbjct: 105 ------NVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT 158
Query: 242 KTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELF--- 296
KT T Y P+++ G +Y+ +D W G + +EM G+ F G EDEL
Sbjct: 159 KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218
Query: 297 ----------WS--ICNERPR---FPQF-----------LSVEAKNILVHLLDKDTTKRL 330
W N+ + FP++ L E +L L ++ KR+
Sbjct: 219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI 278
Query: 331 GSTQCNSGDDVVAHEYFRGL 350
S ++ + H YFR L
Sbjct: 279 ------SAEEAMKHAYFRSL 292
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 4e-20
Identities = 88/318 (27%), Positives = 141/318 (44%), Gaps = 67/318 (21%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLIERKVLALG 122
LE + L LG+G++ VF K T+ A+K ++ LE ++ CT I L
Sbjct: 4 LETYVKLDKLGEGTYATVFKGRSKLTENLVALK----EIRLEHEEGAPCTAIREVSLLKN 59
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL-NGGDLM-FHIQQ 180
KH + L T+ L V EYL + DL +YL N G+LM H
Sbjct: 60 LKHANIVTLHDIIHTERCLTLVFEYL-------------DSDLKQYLDNCGNLMSMH--- 103
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
+ + +++ G+ + HK+ I++RDLK N+L++ +G +++ADFG+ + +
Sbjct: 104 -------NVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVP 156
Query: 241 DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELF-- 296
KT T Y P+++ G +Y+ +D W G +LYEM G+ F G ++EL
Sbjct: 157 TKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLI 216
Query: 297 -----------W-SIC-NERPR---FPQF-----------LSVEAKNILVHLLDKDTTKR 329
W I NE R FPQ+ L + ++L LL +T R
Sbjct: 217 FRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSR 276
Query: 330 LGSTQCNSGDDVVAHEYF 347
+ S + + H YF
Sbjct: 277 I------SAEAALRHSYF 288
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 89.7 bits (223), Expect = 6e-20
Identities = 80/279 (28%), Positives = 124/279 (44%), Gaps = 33/279 (11%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
DL D + L +G G+ G+V+ K T + AVK +++ E++ + L++ V+
Sbjct: 10 YPADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGNKEEN--KRILMDLDVV 67
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
PY+ + F TDS +F ME ++ T ++ L+ IQ
Sbjct: 68 LKSHDCPYIVKCYGYFITDSDVFICMELMS---------TCLDK----------LLKRIQ 108
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
E IV + +L +K G+++RD+K NILLD G+V++ DFG+ +
Sbjct: 109 GP--IPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLV 166
Query: 239 YLDKTTDTFCGTPDYMAPEII----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED- 293
K G YMAPE I KY+ D WS GI L E+ GQ P+ C +
Sbjct: 167 D-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225
Query: 294 ELFWSICNER-PRFP--QFLSVEAKNILVHLLDKDTTKR 329
E+ I E P P + S + + + L KD KR
Sbjct: 226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKR 264
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 1e-19
Identities = 65/238 (27%), Positives = 99/238 (41%), Gaps = 46/238 (19%)
Query: 69 LLKVLGKGSFGKVFLAELK----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
+K LG+G FGKV L T AVK L + + ER++ L T
Sbjct: 8 FIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGE----EQHRSDFEREIEILRTL 63
Query: 124 KHPYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
H + C L +MEYL G L RD YL
Sbjct: 64 DHENIVKYKGVCEKPGGRSLRLIMEYLPSGSL---------RD---YLQR--------HR 103
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+ + R ++++I GM +L + ++RDL NIL++ E V+I+DFG+ K+ L
Sbjct: 104 DQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKV---LP 160
Query: 242 KTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
+ D + + APE ++ K++ D WSFG+ LYE+ F+ D
Sbjct: 161 EDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL------FTYGDPS 212
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 88.2 bits (219), Expect = 1e-19
Identities = 69/248 (27%), Positives = 98/248 (39%), Gaps = 36/248 (14%)
Query: 71 KVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
K LG GSFG V E G AVKCLK D + + D ++ + H
Sbjct: 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLSDIMD---DFLKEAAIMHSLDHEN 57
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
L L+ T L V E G L +R G F
Sbjct: 58 LIRLYGVVLTHP-LMMVTELAPLGSL-------LDR------------LRKDALGHFLIS 97
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF 247
YA +I +GMR+L K ++RDL NILL + V+I DFG L L + D +
Sbjct: 98 TLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFG---LMRALPQNEDHY 154
Query: 248 CGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSIC 300
+ APE ++ ++ D W FG+ L+EM G+ P++G ++ I
Sbjct: 155 VMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKID 214
Query: 301 NERPRFPQ 308
E R +
Sbjct: 215 KEGERLER 222
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 70/266 (26%), Positives = 117/266 (43%), Gaps = 25/266 (9%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
+ ++V+GKGS+G+V L + Y +K L + E E++ L KH
Sbjct: 2 YCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLN---LRNASRRERKAAEQEAQLLSQLKH 58
Query: 126 PYLCHLFCTFQ-TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
P + +++ D L+ VM + GGDL L E Q+
Sbjct: 59 PNIVAYRESWEGEDGLLYIVMGFCEGGDLY--------HKLKE-----------QKGKLL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
E + + +I +++LH+K I++RDLK N+ L +++ D G+ ++
Sbjct: 100 PENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCDMA 159
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER- 303
T GTP YM+PE+ YN D W+ G +YEM + F+ D + L + I +
Sbjct: 160 STLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEGKL 219
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKR 329
P P+ S E ++ +L K KR
Sbjct: 220 PPMPKDYSPELGELIATMLSKRPEKR 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 87.3 bits (216), Expect = 2e-19
Identities = 60/227 (26%), Positives = 106/227 (46%), Gaps = 32/227 (14%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
++++ +LL+ +GKG FG V L + +G AVKC+K D + E +++ +
Sbjct: 4 NMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQAFLAEASVMTQ------ 55
Query: 123 TKHPYLCHLF-CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+H L L + L+ V EY+ G L+ ++ L GGD +
Sbjct: 56 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL-----GGDCLLK---- 106
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
++ ++ M +L V+RDL N+L+ + +++DFG+ K
Sbjct: 107 ----------FSLDVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS 153
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPF 287
T DT + APE ++ K++ D WSFGILL+E++ G+ P+
Sbjct: 154 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPY 200
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.8 bits (217), Expect = 3e-19
Identities = 76/282 (26%), Positives = 122/282 (43%), Gaps = 42/282 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGT 123
+ +++++ +GKG++GKVF K AVK L D + + D+++E E +L +
Sbjct: 18 DTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKIL--DPIHDIDEEIEA---EYNILKALS 72
Query: 124 KHPYLCHLFCTF-----QTDSHLFFVMEYLNGG---DLIPAGLTKAERDLMEYLNGGDLM 175
HP + + + + L+ V+E NGG DL+ L + ER
Sbjct: 73 DHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER------------ 120
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+E + E + G++ LH ++RD+K +NILL EG V++ DFG+
Sbjct: 121 --------MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSA 172
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290
+T GTP +MAPE+I Y+ D WS GI E+ G P +
Sbjct: 173 QLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADL 232
Query: 291 DEDELFWSICNERP---RFPQFLSVEAKNILVHLLDKDTTKR 329
+ I P P+ S E + + L KD KR
Sbjct: 233 HPMRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKR 274
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.0 bits (216), Expect = 3e-19
Identities = 68/240 (28%), Positives = 105/240 (43%), Gaps = 41/240 (17%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
IPR E +L + LG G FG+V++ GT AVK LK + E L E
Sbjct: 3 IPR------ESLKLERKLGAGQFGEVWMGTWNGT-TKVAVKTLKPGTM----SPEAFLQE 51
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+++ +H L L+ + ++ V EY++ G L +++L G+
Sbjct: 52 AQIMK-KLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSL------------LDFLKSGEGK 98
Query: 176 F-HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
+ Q AA+I GM +L + ++RDL NIL+ +IADFG+
Sbjct: 99 KLRLPQLVDM--------AAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLA 150
Query: 235 KL---QIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
+L Y + F P + APE ++ D WSFGILL E + G+ P+ G
Sbjct: 151 RLIEDDEYTAREGAKF---PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 87.5 bits (217), Expect = 3e-19
Identities = 80/317 (25%), Positives = 139/317 (43%), Gaps = 67/317 (21%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
D+ ++ +G+G++G V+ K T A+K ++ + E++ V T I L +H
Sbjct: 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLES--EEEGVPSTAIREISLLKELQH 58
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P + L +S L+ + E+L+ DL +YL+ + + D
Sbjct: 59 PNIVCLQDVLMQESRLYLIFEFLS-------------MDLKKYLDS------LPKGQYMD 99
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-----LQIYL 240
+ Y +I+ G+ F H + +++RDLK N+L+D +G +++ADFG+ + +++Y
Sbjct: 100 AELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYT 159
Query: 241 DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF-- 296
+ T Y APE++ G +Y+ VD WS G + EM + F G E D+LF
Sbjct: 160 HEVV-----TLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRI 214
Query: 297 -----------W----SICNERPRFP----QFLSVEAKNI-------LVHLLDKDTTKRL 330
W S+ + + FP L KN+ L +L D KR+
Sbjct: 215 FRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI 274
Query: 331 GSTQCNSGDDVVAHEYF 347
S + H YF
Sbjct: 275 ------SAKKALNHPYF 285
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 5e-19
Identities = 77/320 (24%), Positives = 129/320 (40%), Gaps = 64/320 (20%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ +F+ L +G+G++G V+ A + A+K ++ D E D + + + L L
Sbjct: 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDN--ERDGIPISSLREITLLLN 62
Query: 123 TKHPYLCHLFCTFQTDS--HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+HP + L +F VMEY E+DL L D M
Sbjct: 63 LRHPNIVELKEVVVGKHLDSIFLVMEY-------------CEQDLASLL---DNM----- 101
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
F E + + +++ G+++LH+ I++RDLK+ N+LL +G ++IADFG+ +
Sbjct: 102 PTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP 161
Query: 241 DKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
K T Y APE++ G Y +D W+ G +L E+ + G E E I
Sbjct: 162 AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
Query: 300 C-------------------------------NERPRFPQFLSVEAKNILVHLLDKDTTK 328
N + +FP +LS +L LL D K
Sbjct: 222 IQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFP-WLSEAGLRLLNFLLMYDPKK 280
Query: 329 RLGSTQCNSGDDVVAHEYFR 348
R + + + YF+
Sbjct: 281 RATAEEA------LESSYFK 294
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 78/279 (27%), Positives = 126/279 (45%), Gaps = 40/279 (14%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAE--LKGTDYYYAVKCLKKDVV--LEDDDVECTLIERKVL 119
L +F++ K +G+G F +V+ A L G LKK + L D I+ L
Sbjct: 1 LANFRIEKKIGRGQFSEVYRATCLLDGV-----PVALKKVQIFDLMDAKARADCIKEIDL 55
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
HP + + +F D+ L V+E + GDL ++ H +
Sbjct: 56 LKQLNHPNVIKYYASFIEDNELNIVLELADAGDL------------------SRMIKHFK 97
Query: 180 QSGRFDEGRARF-YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ R + + Y ++ S + +H + +++RD+K N+ + G V++ D G+ +
Sbjct: 98 KQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF-- 155
Query: 239 YLDKTT--DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
+ KTT + GTP YM+PE I YN D WS G LLYEM QSPF G D+ L+
Sbjct: 156 FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLY 214
Query: 297 WSICN-----ERPRFPQ-FLSVEAKNILVHLLDKDTTKR 329
S+C + P P S E + ++ ++ D KR
Sbjct: 215 -SLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKR 252
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 5e-19
Identities = 71/244 (29%), Positives = 112/244 (45%), Gaps = 30/244 (12%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--DDDVECTLIERKVLAL 121
L +FQ+ K +G+G F +V+ A A LKK + E D ++ L
Sbjct: 1 LANFQIEKKIGRGQFSEVYRATCLLDRKPVA---LKKVQIFEMMDAKARQDCVKEIDLLK 57
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
HP + +F D+ L V+E + GDL ++ + ++
Sbjct: 58 QLNHPNVIKYLDSFIEDNELNIVLELADAGDL------------------SQMIKYFKKQ 99
Query: 182 GRFDEGRARF-YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
R R + Y ++ S + +H + +++RD+K N+ + G V++ D G+ + +
Sbjct: 100 KRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF--FS 157
Query: 241 DKTT--DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
KTT + GTP YM+PE I YN D WS G LLYEM QSPF G D+ LF S
Sbjct: 158 SKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYG-DKMNLF-S 215
Query: 299 ICNE 302
+C +
Sbjct: 216 LCQK 219
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 86.2 bits (214), Expect = 7e-19
Identities = 71/239 (29%), Positives = 116/239 (48%), Gaps = 38/239 (15%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD--VECTLIERKVLALGTK 124
+Q ++ +G+G++G V+ A K T A LKK + LE +D V T I L
Sbjct: 1 YQKVEKIGEGTYGVVYKARDKLTGEIVA---LKK-IRLETEDEGVPSTAIREISLLKELN 56
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP + L +++ L+ V E+L DL DL +Y++ +G
Sbjct: 57 HPNIVRLLDVVHSENKLYLVFEFL---DL----------DLKKYMD------SSPLTG-L 96
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-----LQIY 239
D + Y +++ G+ + H +++RDLK N+L+D EG +++ADFG+ + ++ Y
Sbjct: 97 DPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTY 156
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF 296
+ T Y APEI+ G + Y+ VD WS G + EM + F G E D+LF
Sbjct: 157 THEVV-----TLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLF 210
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 1e-18
Identities = 61/232 (26%), Positives = 107/232 (46%), Gaps = 27/232 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ + LG G+ G VF K + A K + ++ + +I +
Sbjct: 5 DDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
PY+ + F +D + ME+++GG L ++++GR
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQV---------------------LKKAGRI 100
Query: 185 DEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
E + ++ G+ +L +K I++RD+K NIL++ G +++ DFG+ I D
Sbjct: 101 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSM 158
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
++F GT YM+PE ++G Y+ D WS G+ L EM +G+ P D EL
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 62/233 (26%), Positives = 108/233 (46%), Gaps = 27/233 (11%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLIERKVLALG 122
LE + L LG+G++ V+ K TD A+K ++ LE ++ CT I L
Sbjct: 5 LETYIKLDKLGEGTYATVYKGRSKLTDNLVALK----EIRLEHEEGAPCTAIREVSLLKD 60
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KH + L T+ L V EYL ++DL +YL+ ++
Sbjct: 61 LKHANIVTLHDIIHTEKSLTLVFEYL-------------DKDLKQYLDDCGNSINMHN-- 105
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+ + +++ G+ + H++ +++RDLK N+L++ G +++ADFG+ + + K
Sbjct: 106 ------VKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK 159
Query: 243 TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
T T Y P+I+ G Y+ +D W G + YEM G+ F G +E
Sbjct: 160 TYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEE 212
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 84.8 bits (210), Expect = 2e-18
Identities = 74/240 (30%), Positives = 117/240 (48%), Gaps = 37/240 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
E ++ L ++G+GS+G V + K T A+K K + EDD + + R++ L
Sbjct: 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIK---KFLESEDDKMVKKIAMREIRMLKQL 57
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H L +L F+ L+ V E+++ L DL +Y NG
Sbjct: 58 RHENLVNLIEVFRRKKRLYLVFEFVDHTVL---------DDLEKYPNG------------ 96
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-----QI 238
DE R R Y +I+ G+ F H I++RD+K +NIL+ G V++ DFG + ++
Sbjct: 97 LDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEV 156
Query: 239 YLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELF 296
Y D + T Y APE++ G KY + VD W+ G L+ EM G+ F G D D+L+
Sbjct: 157 YTD-----YVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 2e-18
Identities = 74/239 (30%), Positives = 116/239 (48%), Gaps = 19/239 (7%)
Query: 69 LLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
L K LG+G FG+V +AE G D AVK LK D + D+ + E +++ +
Sbjct: 22 LGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKM 79
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAER-DLMEYLNGGDLMFHIQQ 180
KH + +L D L+ ++EY + G+L +A R MEY + Q
Sbjct: 80 IGKHKNIINLLGACTQDGPLYVIVEYASKGNL--REYLRARRPPGMEYCYNPTQVPEEQL 137
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
S + A ++ GM +L K ++RDL N+L+ + ++IADFG+ + ++
Sbjct: 138 SFK----DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 241 DKTTDTFCG--TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSGCDEDELF 296
D T G +MAPE + Y D WSFG+LL+E+ +G SP+ G +ELF
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELF 252
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 85.2 bits (211), Expect = 2e-18
Identities = 66/237 (27%), Positives = 111/237 (46%), Gaps = 37/237 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLALGT 123
+DF+ L LG G+ G V + + A K + ++ + +I E KVL
Sbjct: 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLEIKPA---IRNQIIRELKVL---- 53
Query: 124 KH----PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
H PY+ + F +D + ME+++GG L D + ++
Sbjct: 54 -HECNSPYIVGFYGAFYSDGEISICMEHMDGGSL-------------------DQV--LK 91
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
++GR E + ++ G+ +L +K I++RD+K NIL++ G +++ DFG+ I
Sbjct: 92 KAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
D ++F GT YM+PE ++G Y D WS G+ L EM +G+ P D EL
Sbjct: 152 --DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKEL 206
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.0 bits (208), Expect = 2e-18
Identities = 63/233 (27%), Positives = 108/233 (46%), Gaps = 36/233 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D + LK LG G FG V L + +G A+K +++ + EDD +E E KV+ +
Sbjct: 2 DPSELTFLKELGSGQFGVVHLGKWRGK-IDVAIKMIREGAMSEDDFIE----EAKVM-MK 55
Query: 123 TKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP L L+ CT Q +F V EY+ G L + YL ++
Sbjct: 56 LSHPNLVQLYGVCTKQ--RPIFIVTEYMANGCL------------LNYLR--------ER 93
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
G+ +++ M +L G ++RDL N L+ + V+++DFG+ + +
Sbjct: 94 KGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARY-VLD 152
Query: 241 DKTTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289
D+ T + GT + PE+ +++ D WSFG+L++E+ G+ P+
Sbjct: 153 DQYTSSQ-GTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYER 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 85.4 bits (211), Expect = 3e-18
Identities = 74/252 (29%), Positives = 115/252 (45%), Gaps = 37/252 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLEDDDVECTLIERK 117
+ L K LG+G FG+V AE G D AVK LK + D D+ + E +
Sbjct: 12 DRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNAT--DKDLADLISEME 69
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN-----GG 172
++ L KH + +L + L+ ++EY G+L E+L G
Sbjct: 70 LMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNL------------REFLRARRPPGP 117
Query: 173 DLMFHIQQSGRFDEGRARFY-----AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227
D F I + E + F A ++ GM +L + ++RDL N+L+ + ++
Sbjct: 118 DYTFDITKV---PEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMK 174
Query: 228 IADFGMCKLQIYLDKTTDTFCG--TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQ 284
IADFG+ + +D T G +MAPE + Y D WSFGIL++E+ +G
Sbjct: 175 IADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGG 234
Query: 285 SPFSGCDEDELF 296
SP+ G +ELF
Sbjct: 235 SPYPGIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 84.4 bits (209), Expect = 3e-18
Identities = 76/264 (28%), Positives = 113/264 (42%), Gaps = 42/264 (15%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKV 118
+ L + LG+G+FGKVFL E + AVK LK + D + ER+
Sbjct: 4 RDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLK-ETASNDARKD---FEREA 59
Query: 119 LALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL--NGGDLM 175
L +H + + V EY+ GDL ++L +G D
Sbjct: 60 ELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDL------------NKFLRSHGPDAA 107
Query: 176 FHIQQ---SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232
F G + A +I SGM +L + V+RDL N L+ Y+ V+I DFG
Sbjct: 108 FLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFG 167
Query: 233 MCKLQIYLDKTTDTF--CGTP----DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQS 285
M + +Y TTD + G +M PE I K+ D WSFG++L+E+ G+
Sbjct: 168 MSR-DVY---TTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQ 223
Query: 286 PFSGCDEDELFWSICN----ERPR 305
P+ G +E+ I +RPR
Sbjct: 224 PWYGLSNEEVIECITQGRLLQRPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 84.2 bits (209), Expect = 4e-18
Identities = 63/234 (26%), Positives = 109/234 (46%), Gaps = 38/234 (16%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG--TK 124
+++L +G+G+F +V A+ + T YYA+KC+KK +E R++ AL +
Sbjct: 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHF----KSLEQVNNLREIQALRRLSP 56
Query: 125 HPYLCHLF-CTF-QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP + L F + L V E LM+ +N +L+ G
Sbjct: 57 HPNILRLIEVLFDRKTGRLALVFE------------------LMD-MNLYELI-----KG 92
Query: 183 R---FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
R E R + Y +++ + +H+ GI +RD+K +NIL+ + +++ADFG C+ IY
Sbjct: 93 RKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKDD-ILKLADFGSCR-GIY 150
Query: 240 LDKTTDTFCGTPDYMAPE-IIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292
+ T Y APE ++ Y +D W+ G + +E+ F G +E
Sbjct: 151 SKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNE 204
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 84.1 bits (208), Expect = 4e-18
Identities = 72/314 (22%), Positives = 132/314 (42%), Gaps = 64/314 (20%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+ L+ LG+G++ V+ + T A+K + D ++ T I L KH
Sbjct: 2 FKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDA---EEGTPSTAIREISLMKELKHE 58
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ L T++ L V EY+ ++DL +Y++ H + G D
Sbjct: 59 NIVRLHDVIHTENKLMLVFEYM-------------DKDLKKYMD-----THGVR-GALDP 99
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
+ + +++ G+ F H+ +++RDLK N+L++ G +++ADFG+ + +T
Sbjct: 100 NTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARA---FGIPVNT 156
Query: 247 FCG---TPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE---------- 292
F T Y AP+++ G + Y+ +D WS G ++ EM G+ F G +
Sbjct: 157 FSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRI 216
Query: 293 ----DELFW-SICNE---RPRFPQFLSVEAKNI-----------LVHLLDKDTTKRLGST 333
E W I +P FP++ + + + L LL + R+
Sbjct: 217 MGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI--- 273
Query: 334 QCNSGDDVVAHEYF 347
S D + H +F
Sbjct: 274 ---SAHDALQHPWF 284
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 83.8 bits (207), Expect = 5e-18
Identities = 60/225 (26%), Positives = 104/225 (46%), Gaps = 34/225 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+D Q ++LG G+ G V+ A T AVK + D+ +E ++ ++ +
Sbjct: 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDITVE---LQKQIMSELEILYKCD 57
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--G 182
PY+ + F ++ + E+++GG L D+ I + G
Sbjct: 58 SPYIIGFYGAFFVENRISICTEFMDGGSL-------------------DVYRKIPEHVLG 98
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
R A +V G+ +L I++RD+K N+L++ G V++ DFG+ Q+ ++
Sbjct: 99 RI--------AVAVVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST-QL-VNS 148
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
T+ GT YMAPE I G +Y D WS GI E+ +G+ P+
Sbjct: 149 IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPY 193
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 83.6 bits (207), Expect = 7e-18
Identities = 61/239 (25%), Positives = 100/239 (41%), Gaps = 37/239 (15%)
Query: 67 FQLLKVLGKGSFGKVF----LAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ +KVLG G+FG V+ + E + A+K L+++ + + + L E V+A
Sbjct: 9 LEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETSPKAN--KEILDEAYVMA-S 65
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP++ L + L+P G L++Y+
Sbjct: 66 VDHPHVVRLLGICLSSQVQLIT-------QLMPLG------CLLDYVR--------NHKD 104
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+ +I GM +L +K +V+RDL N+L+ HV+I DFG+ KL LD
Sbjct: 105 NIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKL---LDV 161
Query: 243 TTDTFCGT----P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDEL 295
+ P +MA E I Y D WS+G+ ++E M G P+ G E+
Sbjct: 162 DEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 83.0 bits (205), Expect = 7e-18
Identities = 63/236 (26%), Positives = 109/236 (46%), Gaps = 32/236 (13%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D +D LK LG G FG V + +G Y A+K +K+ + ED+ +E E KV+ +
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRG-QYDVAIKMIKEGSMSEDEFIE----EAKVM-MK 55
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
H L L+ ++ V EY++ G L + YL F Q
Sbjct: 56 LSHEKLVQLYGVCTKQRPIYIVTEYMSNGCL------------LNYLREHGKRFQPSQLL 103
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
++ GM +L K ++RDL N L+D +G V+++DFG+ + LD
Sbjct: 104 EM--------CKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRY--VLDD 153
Query: 243 TTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSGCDEDE 294
+ G+ + PE++ K++ D W+FG+L++E++ +G+ P+ + E
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSE 209
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-18
Identities = 70/239 (29%), Positives = 107/239 (44%), Gaps = 42/239 (17%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+L++V+G G++G+V+ T A+K + V ED++ E L E +L + H
Sbjct: 18 FELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMD---VTEDEEEEIKL-EINMLKKYSHHR 73
Query: 127 YLCHLFCTF------QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+ + F D L+ VME+ G + DL++ G L
Sbjct: 74 NIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT---------DLVKNTKGNAL------ 118
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
E + EI+ G+ LH +++RD+K N+LL V++ DFG + L
Sbjct: 119 ----KEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQL 171
Query: 241 DKTT---DTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
D+T +TF GTP +MAPE+I Y+ D WS GI EM G P CD
Sbjct: 172 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL--CD 228
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.5 bits (204), Expect = 1e-17
Identities = 66/227 (29%), Positives = 103/227 (45%), Gaps = 33/227 (14%)
Query: 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
QLL+ LG G FG+V+ T AVK LK + D + I +K+ +HP
Sbjct: 9 QLLRKLGAGQFGEVWEGLWNNTTPV-AVKTLKPGTMDPKDFLAEAQIMKKL-----RHPK 62
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
L L+ + ++ V E + G L+ EYL GG ++ D
Sbjct: 63 LIQLYAVCTLEEPIYIVTELMKYGSLL------------EYLQGGAGR-ALKLPQLID-- 107
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---QIYLDKTT 244
AA++ SGM +L + ++RDL N+L+ ++ADFG+ ++ IY +
Sbjct: 108 ----MAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYEAREG 163
Query: 245 DTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
F P + APE +++ D WSFGILL E + G+ P+ G
Sbjct: 164 AKF---PIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPG 207
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 1e-17
Identities = 63/231 (27%), Positives = 104/231 (45%), Gaps = 36/231 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ + +K LG G FG V L + + A+K + + + E+D +E E KV+ +
Sbjct: 2 NPSELTFMKELGSGQFGVVHLGKWR-AQIKVAIKAINEGAMSEEDFIE----EAKVM-MK 55
Query: 123 TKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP L L+ CT Q L+ V E++ G L + YL Q+
Sbjct: 56 LSHPKLVQLYGVCTQQKP--LYIVTEFMENGCL------------LNYLR--------QR 93
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
G+ + ++ GM +L + ++RDL N L+ G V+++DFGM + L
Sbjct: 94 QGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRY--VL 151
Query: 241 DKTTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPF 287
D + G + PE+ KY+ D WSFG+L++E+ G+ PF
Sbjct: 152 DDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPF 202
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 2e-17
Identities = 63/245 (25%), Positives = 115/245 (46%), Gaps = 31/245 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT-LIERKVLALGT 123
+ ++ L+ +G+G++GKV+ A K T A+K K + ++++ + T L E +L + +
Sbjct: 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALK--KTRLEMDEEGIPPTALREISLLQMLS 58
Query: 124 KHPYLCHLFCTFQTDSH-----LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
+ Y+ L + L+ V EYL + DL ++++ +
Sbjct: 59 ESIYIVRLLDVEHVEEKNGKPSLYLVFEYL-------------DSDLKKFMDS-----NG 100
Query: 179 QQSGR-FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV-RIADFGMCK- 235
+ GR + + +++ G+ HK G+++RDLK N+L+D + + +IAD G+ +
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
I + T T Y APE++ G Y+ VD WS G + EM Q F G E +
Sbjct: 161 FSIPVKSYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQ 219
Query: 295 LFWSI 299
I
Sbjct: 220 QLLHI 224
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-17
Identities = 74/251 (29%), Positives = 122/251 (48%), Gaps = 20/251 (7%)
Query: 57 PRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLEDDDV 109
PR+ ++ + L K LG+G FG+V +AE G D AVK LK D + D+
Sbjct: 8 PRW-EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDDAT--EKDL 64
Query: 110 ECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL-MEY 168
+ E +++ + KH + +L D L+ ++EY + G+L +A R MEY
Sbjct: 65 SDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL--REYLRARRPPGMEY 122
Query: 169 LNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228
D+ + F + + Y ++ GM +L + ++RDL N+L+ ++I
Sbjct: 123 --SYDIARVPDEQMTFKDLVSCTY--QVARGMEYLASQKCIHRDLAARNVLVTENNVMKI 178
Query: 229 ADFGMCKLQIYLDKTTDTFCG--TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQS 285
ADFG+ + +D T G +MAPE + Y D WSFG+L++E+ +G S
Sbjct: 179 ADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGS 238
Query: 286 PFSGCDEDELF 296
P+ G +ELF
Sbjct: 239 PYPGIPVEELF 249
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 2e-17
Identities = 66/235 (28%), Positives = 105/235 (44%), Gaps = 35/235 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLK--KDVVLEDDDVECTLIERKVLALG 122
+ +++++ +GKG++GKV+ K AVK L DV D+++E E +L
Sbjct: 22 DTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPISDV---DEEIEA---EYNILQSL 75
Query: 123 TKHPYLCHLFCTFQTDSH-----LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
HP + + F L+ V+E NGG + +L++ L
Sbjct: 76 PNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVT---------ELVKGL-------- 118
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
+ R DE + + G++ LH I++RD+K +NILL EG V++ DFG+
Sbjct: 119 LICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQL 178
Query: 238 IYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPF 287
+T GTP +MAPE+I Y+ D WS GI E+ G P
Sbjct: 179 TSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPL 233
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 3e-17
Identities = 66/233 (28%), Positives = 111/233 (47%), Gaps = 27/233 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDV-ECTLIERKVLALGTKH 125
F++L V+G+G++G V K T A+K K E+++V E TL E K+L K
Sbjct: 3 FEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSE--ENEEVKETTLRELKMLRT-LKQ 59
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
+ L F+ L+ V EY+ E++++E L +
Sbjct: 60 ENIVELKEAFRRRGKLYLVFEYV-------------EKNMLELLE--------EMPNGVP 98
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLDKTT 244
+ R Y +++ + + HK IV+RD+K +N+L+ + +++ DFG + L +
Sbjct: 99 PEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNANY 158
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF 296
+ T Y +PE++ G Y + VD WS G +L E+ GQ F G E D+LF
Sbjct: 159 TEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLF 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 82.7 bits (205), Expect = 3e-17
Identities = 78/320 (24%), Positives = 131/320 (40%), Gaps = 72/320 (22%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+Q L +G G++G+V A T A+K L + + T E ++L H
Sbjct: 17 YQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPFQSAIH-AKRTYRELRLLKH-MDHE 74
Query: 127 YLCHLFCTFQTDSHL------FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+ L F S L + V LM G DL +I +
Sbjct: 75 NVIGLLDVFTPASSLEDFQDVYLVTH------------------LM----GADL-NNIVK 111
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
+ + +F +I+ G++++H GI++RDLK NI ++ + ++I DFG+ +
Sbjct: 112 CQKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLARH---T 168
Query: 241 DKTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-------- 291
D + T Y APEI+ + YNQ VD WS G ++ E+ G++ F G D
Sbjct: 169 DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRI 228
Query: 292 -------EDELFWSICNER--------PRFPQ------FL--SVEAKNILVHLLDKDTTK 328
++EL I +E P+ P+ F + A ++L +L D K
Sbjct: 229 MNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288
Query: 329 RLGSTQCNSGDDVVAHEYFR 348
R+ + + +AH Y
Sbjct: 289 RITAAE------ALAHPYLA 302
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 4e-17
Identities = 75/248 (30%), Positives = 116/248 (46%), Gaps = 37/248 (14%)
Query: 69 LLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
L K LG+G FG+V +AE G D AVK LK D D D+ + E +++ +
Sbjct: 16 LGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDDAT--DKDLSDLVSEMEMMKM 73
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN-----GGDLMF 176
KH + +L D L+ ++EY + G+L EYL G D F
Sbjct: 74 IGKHKNIINLLGACTQDGPLYVLVEYASKGNL------------REYLRARRPPGMDYSF 121
Query: 177 HIQQSGRFDEGRARFY-----AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADF 231
+ + E + F A ++ GM +L + ++RDL N+L+ + ++IADF
Sbjct: 122 ---DTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178
Query: 232 GMCKLQIYLDKTTDTFCG--TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFS 288
G+ + +D T G +MAPE + Y D WSFG+LL+E+ +G SP+
Sbjct: 179 GLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYP 238
Query: 289 GCDEDELF 296
G +ELF
Sbjct: 239 GIPVEELF 246
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 80.9 bits (200), Expect = 6e-17
Identities = 66/238 (27%), Positives = 109/238 (45%), Gaps = 33/238 (13%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLIERKVLALG 122
LE ++ L LG+GS+ V+ K T A+K ++ LE ++ T I L
Sbjct: 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALK----EIRLEHEEGAPFTAIREASLLKD 59
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN--GGDLMFHIQQ 180
KH + L T L V EYL + DL +Y++ GG L H
Sbjct: 60 LKHANIVTLHDIIHTKKTLTLVFEYL-------------DTDLKQYMDDCGGGLSMH--- 103
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
R + +++ G+ + H++ +++RDLK N+L+ G +++ADFG+ + +
Sbjct: 104 -------NVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVP 156
Query: 241 DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCD--EDEL 295
KT T Y P+++ G +Y+ +D W G + YEM G+ F G ED+L
Sbjct: 157 SKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 7e-17
Identities = 80/334 (23%), Positives = 128/334 (38%), Gaps = 83/334 (24%)
Query: 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLK-----KDVVLEDDDV-EC-----TLIER 116
Q LG+G++GKV A T A+K +K DV + V C TL E
Sbjct: 12 QKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLREL 71
Query: 117 KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
K++ KH + L + + VM+ M DL
Sbjct: 72 KIMN-EIKHENIMGLVDVYVEGDFINLVMDI------------------MAS----DLKK 108
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK- 235
+ + R E + + +I++G+ LHK ++RDL NI ++ +G +IADFG+ +
Sbjct: 109 VVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLARR 168
Query: 236 --LQIYLDKTTDTFCGTPD-----------YMAPEIIKGL-KYNQCVDWWSFGILLYEMH 281
Y D + Y APE++ G KY+ VD WS G + E+
Sbjct: 169 YGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELL 228
Query: 282 VGQSPFSGCDE-DEL-------------FWSICNERPRFPQFLSVEAKN----------- 316
G+ F G +E D+L W + P + +F + K+
Sbjct: 229 TGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDD 288
Query: 317 ---ILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
+L LL + +R+ S + + HEYF
Sbjct: 289 AIDLLQSLLKLNPLERI------SAKEALKHEYF 316
|
Length = 335 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.8 bits (197), Expect = 7e-17
Identities = 62/222 (27%), Positives = 97/222 (43%), Gaps = 31/222 (13%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+GKG+FG V+ LKG + AVK + L D L E ++L HP + L
Sbjct: 3 IGKGNFGDVYKGVLKG-NTEVAVKTCRST--LPPDLKRKFLQEAEIL-KQYDHPNIVKLI 58
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
++ VME + GG L L F ++ R +
Sbjct: 59 GVCVQKQPIYIVMELVPGGSL--------------------LTFLRKKKNRLTVKKLLQM 98
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ---IYLDKTTDTFCG 249
+ + +GM +L K ++RDL N L+ ++I+DFGM + + IY +D
Sbjct: 99 SLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIY--TVSDGLKQ 156
Query: 250 TP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSG 289
P + APE + +Y D WS+GILL+E +G +P+ G
Sbjct: 157 IPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPG 198
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (201), Expect = 8e-17
Identities = 74/325 (22%), Positives = 129/325 (39%), Gaps = 72/325 (22%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC--TLIERKVLALGTK 124
++LLK +G G++G V A K T A+K + + DD ++ L E K+L +
Sbjct: 2 YELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISN---VFDDLIDAKRILREIKLLRH-LR 57
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL---MEYLNGGDLMFHIQQS 181
H + L D++ + D+ E + DL I+
Sbjct: 58 HENIIGLL-------------------DILRPPSPEDFNDVYIVTELM-ETDLHKVIKSP 97
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+ +++ +I+ G+++LH +++RDLK NIL++ ++I DFG+ + +
Sbjct: 98 QPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDE 157
Query: 242 KTTDTFCG---TPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCD------ 291
T Y APE++ Y + +D WS G + E+ + F G D
Sbjct: 158 DEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQLN 217
Query: 292 ---------EDELFWSICNERPR-----------------FPQFLSVEAKNILVHLLDKD 325
+E I +E+ R FP S EA ++L +L D
Sbjct: 218 LIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFP-GASPEAIDLLEKMLVFD 276
Query: 326 TTKRLGSTQCNSGDDVVAHEYFRGL 350
KR+ + D+ +AH Y L
Sbjct: 277 PKKRI------TADEALAHPYLAQL 295
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 79.9 bits (198), Expect = 1e-16
Identities = 58/230 (25%), Positives = 99/230 (43%), Gaps = 53/230 (23%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLI-ERKVLALGTK 124
++ K LG+G++ V+ A K T A+K +K E D + T + E K+L K
Sbjct: 2 YEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQ-ELK 60
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF---HIQQS 181
HP + L F S++ V E++ DL + + ++ I+
Sbjct: 61 HPNIIGLLDVFGHKSNINLVFEFMET-------------DLEKVIKDKSIVLTPADIKS- 106
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
Y + G+ +LH I++RDLK +N+L+ +G +++ADFG+ +
Sbjct: 107 ----------YMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLAR------ 150
Query: 242 KTTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYE 279
G+P+ Y APE++ G + Y VD WS G + E
Sbjct: 151 -----SFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAE 195
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 80.1 bits (197), Expect = 2e-16
Identities = 62/232 (26%), Positives = 109/232 (46%), Gaps = 27/232 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ + LG G+ G V + K + A K + ++ + +I +
Sbjct: 5 DDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI---KPAIRNQIIRELQVLHECN 61
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
PY+ + F +D + ME+++GG L L +A+R E L
Sbjct: 62 SPYIVGFYGAFYSDGEISICMEHMDGGSLDQV-LKEAKRIPEEIL--------------- 105
Query: 185 DEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
G+ + ++ G+ +L +K I++RD+K NIL++ G +++ DFG+ I D
Sbjct: 106 --GKV---SIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI--DSM 158
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
++F GT YM+PE ++G Y+ D WS G+ L E+ +G+ P D EL
Sbjct: 159 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKEL 210
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 79.0 bits (194), Expect = 2e-16
Identities = 68/239 (28%), Positives = 106/239 (44%), Gaps = 42/239 (17%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F+L++++G G++G+V+ T A+K + DV D+ E E +L + H
Sbjct: 8 FELVELVGNGTYGQVYKGRHVKTGQLAAIKVM--DVT--GDEEEEIKQEINMLKKYSHHR 63
Query: 127 YLCHLFCTF------QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+ + F D L+ VME+ G + DL++ G L
Sbjct: 64 NIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT---------DLIKNTKGNTL------ 108
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
E + EI+ G+ LH+ +++RD+K N+LL V++ DFG + L
Sbjct: 109 ----KEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFG---VSAQL 161
Query: 241 DKTT---DTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
D+T +TF GTP +MAPE+I Y+ D WS GI EM G P CD
Sbjct: 162 DRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--CD 218
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 79.0 bits (195), Expect = 2e-16
Identities = 52/168 (30%), Positives = 85/168 (50%), Gaps = 20/168 (11%)
Query: 163 RDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221
R +MEYL G L ++Q+ R D + YA++I GM +L K V+RDL NIL++
Sbjct: 83 RLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATRNILVE 142
Query: 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPD----YMAPEIIKGLKYNQCVDWWSFGILL 277
E V+I DFG+ K+ + DK + + APE + K++ D WSFG++L
Sbjct: 143 SENRVKIGDFGLTKV-LPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVL 201
Query: 278 YEMHVGQSPFSGCDEDELFWSICNERPRFPQFL--SVEAKNILVHLLD 323
YE+ F+ D+ C+ F + + + + I+ HL++
Sbjct: 202 YEL------FTYSDKS------CSPPAEFMRMMGNDKQGQMIVYHLIE 237
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-16
Identities = 69/244 (28%), Positives = 116/244 (47%), Gaps = 17/244 (6%)
Query: 59 FRKYDLEDFQLLKVLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIER 116
+ + D + V+G+G+FG+V A +K G A+K +K + +DD + E
Sbjct: 1 YPVLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMK-EYASKDDHRDFAG-EL 58
Query: 117 KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
+VL HP + +L + +L+ +EY G+L+ + R L D F
Sbjct: 59 EVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLET-----DPAF 111
Query: 177 HIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
I S + +AA++ GM +L +K ++RDL NIL+ +IADFG+
Sbjct: 112 AIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLS 171
Query: 235 KLQ-IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDE 292
+ Q +Y+ KT +MA E + Y D WS+G+LL+E+ +G +P+ G
Sbjct: 172 RGQEVYVKKTMGRL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 229
Query: 293 DELF 296
EL+
Sbjct: 230 AELY 233
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-16
Identities = 69/236 (29%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
+PR E +L+K LG G FG+V++ G A+K LK+ + E L E
Sbjct: 3 VPR------ETLKLVKKLGAGQFGEVWMGYYNGH-TKVAIKSLKQGSM----SPEAFLAE 51
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
++ +HP L L+ T ++ + EY+ G L+ D ++ G L
Sbjct: 52 ANLMK-QLQHPRLVRLYAVV-TQEPIYIITEYMENGSLV---------DFLKTPEGIKLT 100
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ D AA+I GM F+ +K ++RDL+ NIL+ +IADFG+ +
Sbjct: 101 I----NKLID------MAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLAR 150
Query: 236 LQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSG 289
L + T P + APE I + D WSFGILL E+ G+ P+ G
Sbjct: 151 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 78.3 bits (193), Expect = 5e-16
Identities = 80/292 (27%), Positives = 118/292 (40%), Gaps = 43/292 (14%)
Query: 57 PRFRKYDL------EDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLE 105
P YDL + K LG G+FGKV A G AVK LK
Sbjct: 21 PTQLPYDLKWEFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--H 78
Query: 106 DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL 165
+ E + E K+++ H + +L + + EY GDL+ K E
Sbjct: 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRES-- 136
Query: 166 MEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225
+L DL+ ++ ++ GM FL K ++RDL N+LL G
Sbjct: 137 --FLTLEDLLS---------------FSYQVAKGMAFLASKNCIHRDLAARNVLLT-HGK 178
Query: 226 V-RIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280
+ +I DFG+ + I D + +MAPE I Y D WS+GILL+E+
Sbjct: 179 IVKICDFGLAR-DIMNDSNYVVKGNARLPV-KWMAPESIFNCVYTFESDVWSYGILLWEI 236
Query: 281 -HVGQSPFSGCDEDELFWSICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
+G +P+ G D F+ + E R P+ E +I+ D D KR
Sbjct: 237 FSLGSNPYPGMPVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKR 288
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 6e-16
Identities = 55/226 (24%), Positives = 104/226 (46%), Gaps = 25/226 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ ++ L+ LG+GS+ V+ + K A+K ++ + E++ T I L G K
Sbjct: 5 DSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIR---LQEEEGTPFTAIREASLLKGLK 61
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H + L T L V EY++ DL +Y++ + G
Sbjct: 62 HANIVLLHDIIHTKETLTLVFEYVH-------------TDLCQYMD--------KHPGGL 100
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
+ + +++ G+ ++H++ I++RDLK N+L+ G +++ADFG+ + + T
Sbjct: 101 HPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSHTY 160
Query: 245 DTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289
T Y P+++ G +Y+ C+D W G + EM G + F G
Sbjct: 161 SNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 9e-16
Identities = 59/226 (26%), Positives = 102/226 (45%), Gaps = 36/226 (15%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LG G +G+V+ K AVK LK+D + ++ ++ + +++ KHP L L
Sbjct: 14 LGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLKEAAVMKEI-----KHPNLVQLL 68
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
+ + + E++ G+L ++YL + + +
Sbjct: 69 GVCTREPPFYIITEFMTYGNL------------LDYLRECN-------RQEVNAVVLLYM 109
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTP- 251
A +I S M +L KK ++RDL N L+ V++ADFG+ +L T DT+
Sbjct: 110 ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM-----TGDTYTAHAG 164
Query: 252 -----DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291
+ APE + K++ D W+FG+LL+E+ G SP+ G D
Sbjct: 165 AKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 1e-15
Identities = 44/121 (36%), Positives = 64/121 (52%), Gaps = 11/121 (9%)
Query: 249 GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN---ERPR 305
GTPDY+APE++ G + VDWW+ G+ L+E G PF+ ++F +I N P
Sbjct: 542 GTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNILNRDIPWPE 601
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
+ LSV A+N + LL D TKR G ++ H F G+DW+ L+ + PF
Sbjct: 602 GEEKLSVNAQNAIEILLTMDPTKRAGLK------ELKQHPLFHGVDWENLQNQ--TMPFI 653
Query: 366 P 366
P
Sbjct: 654 P 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 76.5 bits (188), Expect = 1e-15
Identities = 58/228 (25%), Positives = 104/228 (45%), Gaps = 36/228 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+L+ L +++G+G FG V E G AVK +K DV + +E +
Sbjct: 4 NLQKLTLGEIIGEGEFGAVLQGEYTGQK--VAVKNIKCDVTAQ------AFLEETAVMTK 55
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
H L L G ++ GL +ME ++ G+L+ ++ G
Sbjct: 56 LHHKNLVRLL------------------GVILHNGL----YIVMELMSKGNLVNFLRTRG 93
Query: 183 RFDEGRARF--YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
R + ++ ++ GM +L K +V+RDL NIL+ +G +++DFG+ ++
Sbjct: 94 RALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVG--- 150
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPF 287
D + APE +K K++ D WS+G+LL+E+ G++P+
Sbjct: 151 SMGVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 77.3 bits (190), Expect = 1e-15
Identities = 59/221 (26%), Positives = 98/221 (44%), Gaps = 25/221 (11%)
Query: 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLC 129
L+ LG+GS+ V+ + A+K + ++ V T I L G KH +
Sbjct: 10 LEKLGEGSYATVYKGISRINGQLVALKVISMKT---EEGVPFTAIREASLLKGLKHANIV 66
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189
L T L FV EY+ DL +Y+ IQ G
Sbjct: 67 LLHDIIHTKETLTFVFEYM-------------HTDLAQYM--------IQHPGGLHPYNV 105
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG 249
R + +++ G+ ++H + I++RDLK N+L+ Y G +++ADFG+ + + +T +
Sbjct: 106 RLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQTYSSEVV 165
Query: 250 TPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289
T Y P+++ G Y+ +D W G + EM GQ F G
Sbjct: 166 TLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPG 206
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 76.6 bits (188), Expect = 1e-15
Identities = 75/283 (26%), Positives = 124/283 (43%), Gaps = 47/283 (16%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
IPR E QL+K LG G FG+V++ G AVK LK + + +E I
Sbjct: 3 IPR------ESLQLIKKLGNGQFGEVWMGTWNGNTKV-AVKTLKPGTMSPESFLEEAQIM 55
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+K+ +H L L+ ++ ++ V EY++ G L +++L G+
Sbjct: 56 KKL-----RHDKLVQLYAVV-SEEPIYIVTEYMSKGSL------------LDFLKDGE-- 95
Query: 176 FHIQQSGRFDEGRARF------YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229
GRA AA++ +GM ++ + ++RDL+ NIL+ +IA
Sbjct: 96 -----------GRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIA 144
Query: 230 DFGMCKLQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPF 287
DFG+ +L + T P + APE ++ D WSFGILL E+ G+ P+
Sbjct: 145 DFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPY 204
Query: 288 SGCDEDELFWSI-CNERPRFPQFLSVEAKNILVHLLDKDTTKR 329
G + E+ + R PQ + +++ KD +R
Sbjct: 205 PGMNNREVLEQVERGYRMPCPQDCPISLHELMLQCWKKDPEER 247
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 76.8 bits (189), Expect = 1e-15
Identities = 85/321 (26%), Positives = 141/321 (43%), Gaps = 65/321 (20%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
++ ++ ++ +G+G++G V+ A + T+ A+K ++ + ED+ V T I L
Sbjct: 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLE--QEDEGVPSTAIREISLLKEM 58
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H + L ++ L+ V EYL DL DL H+ S
Sbjct: 59 QHGNIVRLQDVVHSEKRLYLVFEYL---------------DL-------DLKKHMDSSPD 96
Query: 184 F--DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-VRIADFGMCKLQIYL 240
F + + Y +I+ G+ + H +++RDLK N+L+D + +++ADFG+ +
Sbjct: 97 FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156
Query: 241 DKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP-FSGCDE-DELF- 296
+T T Y APEI+ G + Y+ VD WS G + EM V Q P F G E DELF
Sbjct: 157 VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEM-VNQKPLFPGDSEIDELFK 215
Query: 297 ------------WSICNERP----RFPQFLSVEAKNIL-------VHLLDK----DTTKR 329
W P FP++ + ++ V LL K D +KR
Sbjct: 216 IFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKR 275
Query: 330 LGSTQCNSGDDVVAHEYFRGL 350
+ + + HEYF+ L
Sbjct: 276 ITARA------ALEHEYFKDL 290
|
Length = 294 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 76.3 bits (188), Expect = 2e-15
Identities = 77/307 (25%), Positives = 133/307 (43%), Gaps = 56/307 (18%)
Query: 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD--VECTLIERKVLALGTKHPY 127
L+ +G+G++G VF A+ + T A+K V L+DDD V + + L KH
Sbjct: 5 LEKIGEGTYGTVFKAKNRETHEIVALK----RVRLDDDDEGVPSSALREICLLKELKHKN 60
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN--GGDLMFHIQQSGRFD 185
+ L+ +D L V EY ++DL +Y + GD+ I +S F
Sbjct: 61 IVRLYDVLHSDKKLTLVFEY-------------CDQDLKKYFDSCNGDIDPEIVKSFMF- 106
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
+++ G+ F H +++RDLK N+L++ G +++ADFG+ + +
Sbjct: 107 ---------QLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVRCYS 157
Query: 246 TFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP-FSGCD-EDEL------- 295
T Y P+++ G K Y+ +D WS G + E+ P F G D +D+L
Sbjct: 158 AEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRLL 217
Query: 296 ------FWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ----CN-----SGDD 340
W ++ P + + A LV+++ K + Q CN S ++
Sbjct: 218 GTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEE 277
Query: 341 VVAHEYF 347
+ H YF
Sbjct: 278 ALQHPYF 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 2e-15
Identities = 65/240 (27%), Positives = 90/240 (37%), Gaps = 59/240 (24%)
Query: 73 LGKGSFGKVFLAELKGTDYY----------------YAVKCLKKDV---VLEDDDVECTL 113
LG+G FG+V L E G + AVK L+ D ED E
Sbjct: 13 LGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDASDNAREDFLKEV-- 70
Query: 114 IERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
K+L+ P + L D L +MEY+ GDL L K G
Sbjct: 71 ---KILS-RLSDPNIARLLGVCTVDPPLCMIMEYMENGDL-NQFLQKHV-----AETSGL 120
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
S + A +I SGMR+L V+RDL N L+ ++IADFGM
Sbjct: 121 ACNSKSLS----FSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 234 CKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYEM 280
+ +Y + DY MA E + K+ D W+FG+ L+E+
Sbjct: 177 SR-NLY----------SSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 3e-15
Identities = 69/251 (27%), Positives = 109/251 (43%), Gaps = 32/251 (12%)
Query: 66 DFQLLKVLGKGSFGKV---FLAELKGTDYY--YAVKCLKKDVVLEDDDVECTLIERKVLA 120
+ L K LG+G FGKV LKG Y AVK LK++ ++ L E +L
Sbjct: 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLK 58
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLI----------PAGLTKAERDLMEYLN 170
HP++ L+ D L ++EY G L P+ L YL+
Sbjct: 59 -QVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLD 117
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
D G +A +I GM++L + +V+RDL N+L+ ++I+D
Sbjct: 118 NPDER-------ALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISD 170
Query: 231 FGMCK----LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQS 285
FG+ + Y+ ++ +MA E + Y D WSFG+LL+E+ +G +
Sbjct: 171 FGLSRDVYEEDSYVKRSKGRI--PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGN 228
Query: 286 PFSGCDEDELF 296
P+ G + LF
Sbjct: 229 PYPGIAPERLF 239
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 76.2 bits (188), Expect = 3e-15
Identities = 81/337 (24%), Positives = 129/337 (38%), Gaps = 85/337 (25%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-EDDDVECT-LIERKVLAL 121
L D+++L LG+G+FG+V+ A T A LKK ++ E D T L E K+L
Sbjct: 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVA---LKKILMHNEKDGFPITALREIKILKK 63
Query: 122 GTKHPYLCHLFCTF------QTDSH--LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
KHP + L ++ V Y+ + DL L
Sbjct: 64 -LKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYM-------------DHDLSGLLE--- 106
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
S + E + + Y +++ G+ +LH+ I++RD+K NIL+D +G ++IADFG+
Sbjct: 107 -----NPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGL 161
Query: 234 CKLQIYLDKTTDTFCGTPD------------YMAPEIIKGLK-YNQCVDWWSFGILLYEM 280
+ G Y PE++ G + Y VD W G + EM
Sbjct: 162 ARP-YDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEM 220
Query: 281 HVGQSPFSG---CDEDELFWSIC--------------------NERPRFPQFLSV----- 312
+ G D+ L + +C + +P+ L
Sbjct: 221 FTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKL 280
Query: 313 --EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
E ++L LL D KRL + D + H YF
Sbjct: 281 GPEGLDLLSKLLSLDPYKRL------TASDALEHPYF 311
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 75.8 bits (186), Expect = 3e-15
Identities = 83/282 (29%), Positives = 123/282 (43%), Gaps = 34/282 (12%)
Query: 66 DFQLLKVLGKGSFGKVFLAE---LKGTD--YYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
D L + LG+G+FGKVFLAE L T AVK LK + D + L
Sbjct: 6 DIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDFQ----REAELL 61
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+H ++ + L V EY+ GDL L D M ++G Q
Sbjct: 62 TNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDL-NKFLRAHGPDAMILVDGQPR----QA 116
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
G + A++I SGM +L + V+RDL N L+ V+I DFGM + +Y
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSR-DVY- 174
Query: 241 DKTTDTF-----CGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293
+TD + P +M PE I K+ D WSFG++L+E+ G+ P+
Sbjct: 175 --STDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 294 ELFWSICN----ERPRF-PQFLSVEAKNILVHLLDKDTTKRL 330
E+ I ERPR P+ E +I++ ++ +RL
Sbjct: 233 EVIECITQGRVLERPRVCPK----EVYDIMLGCWQREPQQRL 270
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 76.2 bits (187), Expect = 4e-15
Identities = 59/215 (27%), Positives = 99/215 (46%), Gaps = 42/215 (19%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
L+ +L G DL +I + + + +F +I+ G++++H I++RDLK N+ ++ +
Sbjct: 99 LVTHLMGADLN-NIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDC 157
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEI-IKGLKYNQCVDWWSFGILLYEMHVG 283
++I DFG+ + + D + T Y APEI + + YNQ VD WS G ++ E+ G
Sbjct: 158 ELKILDFGLAR---HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTG 214
Query: 284 QSPFSGCD---------------EDELFWSICNERPR-----FPQFLSVEAKNIL----- 318
++ F G D EL I +E R Q + N+
Sbjct: 215 RTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANP 274
Query: 319 --VHLLDK----DTTKRLGSTQCNSGDDVVAHEYF 347
V LL+K D+ KR+ + Q +AH YF
Sbjct: 275 LAVDLLEKMLVLDSDKRITAAQ------ALAHAYF 303
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 6e-15
Identities = 65/248 (26%), Positives = 103/248 (41%), Gaps = 44/248 (17%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDV---VLEDDDVECTLIE 115
L + L+ LG+G+FGKV+ EL G + A+K LK++ V ++ E L+
Sbjct: 4 LSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENAEPKVQQEFRQEAELMS 63
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+HP + L + + EYL GDL + + + +G + +
Sbjct: 64 D------LQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
F A +I +GM +L V+RDL N L+ V+I+DFG+ +
Sbjct: 118 KSSLDCSDFLH-----IAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSR 172
Query: 236 LQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYEMH- 281
IY + DY M PE I K+ D WSFG++L+E+
Sbjct: 173 D-IY----------SADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFS 221
Query: 282 VGQSPFSG 289
G P+ G
Sbjct: 222 YGLQPYYG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 75.6 bits (186), Expect = 6e-15
Identities = 58/210 (27%), Positives = 95/210 (45%), Gaps = 42/210 (20%)
Query: 169 LNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228
L G DL + S ++ +++ +I+ G++++H G+V+RDLK NIL++ ++I
Sbjct: 91 LLGTDLH-RLLTSRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKI 149
Query: 229 ADFGMCKLQIYLDKTTDTFCGTPDYMAPEI-IKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
DFG+ ++Q D + T Y APEI + KY+ VD WS G + EM G+ F
Sbjct: 150 CDFGLARIQ---DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLF 206
Query: 288 SGCDE---------------DELFWSICNE-----------RPRFP-----QFLSVEAKN 316
G D D++ +IC+E R P + A +
Sbjct: 207 PGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAID 266
Query: 317 ILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346
+L +L D KR+ S + +AH Y
Sbjct: 267 LLEKMLVFDPQKRI------SAAEALAHPY 290
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-15
Identities = 66/251 (26%), Positives = 113/251 (45%), Gaps = 43/251 (17%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
IPR E +L+K LG G FG+V++ YY AVK LK + V+
Sbjct: 3 IPR------ESIKLVKKLGAGQFGEVWMG------YYNNSTKVAVKTLKPGTM----SVQ 46
Query: 111 CTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
L E ++ +H L L+ + ++ + EY+ G L+ D ++
Sbjct: 47 AFLEEANLMKT-LQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL---------DFLKSDE 96
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
GG ++ + ++A+I GM ++ +K ++RDL+ N+L+ +IAD
Sbjct: 97 GGKVLL----------PKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIAD 146
Query: 231 FGMCKLQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFS 288
FG+ ++ + T P + APE I + D WSFGILLYE+ G+ P+
Sbjct: 147 FGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYP 206
Query: 289 GCDEDELFWSI 299
G ++ ++
Sbjct: 207 GMSNSDVMSAL 217
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 75.7 bits (186), Expect = 7e-15
Identities = 59/214 (27%), Positives = 90/214 (42%), Gaps = 32/214 (14%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+ ++K L GS G+VF+A G VVL+ TLIE +L HP
Sbjct: 68 YTVIKTLTPGSEGRVFVATKPGQ---------PDPVVLKIGQKGTTLIEAMLLQ-NVNHP 117
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ L G + L DL YL ++S
Sbjct: 118 ------SVIRMKDTLVS-------GAITCMVLPHYSSDLYTYLT--------KRSRPLPI 156
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
+A +I+ G+R+LH + I++RD+K +NI ++ V I D G + + +
Sbjct: 157 DQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPV-VAPAFLG 215
Query: 247 FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280
GT + APE++ KYN D WS GI+L+EM
Sbjct: 216 LAGTVETNAPEVLARDKYNSKADIWSAGIVLFEM 249
|
Length = 357 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 74.8 bits (184), Expect = 8e-15
Identities = 65/231 (28%), Positives = 101/231 (43%), Gaps = 40/231 (17%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLK---KDVVLEDDDV--ECT 112
F K D E F L+ +G GSFG V+ A T+ A+K + K + D+ E
Sbjct: 8 FSKDDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 113 LIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGG 172
+++ +HP + + + VMEY G + D++E
Sbjct: 68 FLQQ------LRHPNTIEYKGCYLREHTAWLVMEYCLG----------SASDILEVHKKP 111
Query: 173 DLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232
+Q+ E A + G+ +LH ++RD+K NILL G V++ADFG
Sbjct: 112 -----LQE----VEIAA--ICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFG 160
Query: 233 MCKLQIYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEM 280
L ++F GTP +MAPE+I + +Y+ VD WS GI E+
Sbjct: 161 SASLV----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 207
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 9e-15
Identities = 69/239 (28%), Positives = 117/239 (48%), Gaps = 19/239 (7%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
ED + V+G+G+FG+V A +K G A+K LK+ ++D E +VL
Sbjct: 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKE--FASENDHRDFAGELEVLCKL 59
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF---HIQ 179
HP + +L + +L+ +EY G+L+ + R L D F H
Sbjct: 60 GHHPNIINLLGACENRGYLYIAIEYAPYGNLL--DFLRKSRVLET-----DPAFAKEHGT 112
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQI 238
S + +F A+++ +GM++L +K ++RDL N+L+ +IADFG+ + ++
Sbjct: 113 ASTLTSQQLLQF-ASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEV 171
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELF 296
Y+ KT +MA E + Y D WSFG+LL+E+ +G +P+ G EL+
Sbjct: 172 YVKKTMGRL--PVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELY 228
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 75.0 bits (184), Expect = 1e-14
Identities = 40/121 (33%), Positives = 65/121 (53%), Gaps = 8/121 (6%)
Query: 172 GDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADF 231
G LM H + E R +F +++ G++++H GI++RDLK N+ ++ + ++I DF
Sbjct: 107 GKLMKH----EKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDF 162
Query: 232 GMCKLQIYLDKTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290
G+ + D + T Y APE+I + Y Q VD WS G ++ EM G+ F G
Sbjct: 163 GLAR---QTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGH 219
Query: 291 D 291
D
Sbjct: 220 D 220
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.5 bits (183), Expect = 1e-14
Identities = 51/156 (32%), Positives = 72/156 (46%), Gaps = 31/156 (19%)
Query: 192 YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTP 251
Y+ ++ GM FL + ++RDL NILL V+I DFG+ + IY D P
Sbjct: 178 YSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKD---------P 227
Query: 252 DY------------MAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWS 298
DY MAPE I Y D WSFG+LL+E+ +G SP+ G DE F
Sbjct: 228 DYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEF-- 285
Query: 299 ICNE-----RPRFPQFLSVEAKNILVHLLDKDTTKR 329
C R R P++ + E +I++ + R
Sbjct: 286 -CRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDR 320
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 3e-14
Identities = 71/255 (27%), Positives = 110/255 (43%), Gaps = 32/255 (12%)
Query: 67 FQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
F L ++LGKG FG V A+LK G+ AVK LK D+ D E +
Sbjct: 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADIFSSSDIEEF--LREAACMKEF 58
Query: 124 KHPYLCHLFCTF---QTDSHL---FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
HP + L + L ++ ++ GDL L LM +
Sbjct: 59 DHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDL-HTFL------LMSRIGEEPFTLP 111
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
+Q RF +I SGM +L K ++RDL N +L+ V +ADFG+ K +
Sbjct: 112 LQTLVRF--------MIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSK-K 162
Query: 238 IYLDKTTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDED 293
IY C + ++A E + Y D W+FG+ ++E M GQ+P++G +
Sbjct: 163 IYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222
Query: 294 ELF-WSICNERPRFP 307
E++ + I R + P
Sbjct: 223 EIYNYLIKGNRLKQP 237
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 73.5 bits (180), Expect = 3e-14
Identities = 86/330 (26%), Positives = 130/330 (39%), Gaps = 80/330 (24%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDY-----YYAVKCLKKDVVLEDDDVECTLIERKVL 119
+ +L KVLG G+FGKV A G D AVK LK+ + + + E K+L
Sbjct: 7 DRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGATASEH--KALMSELKIL 64
Query: 120 ALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM--------EYL 169
H + +L CT + + L ++E+ G+L + +A+R+ +
Sbjct: 65 IHIGNHLNVVNLLGACT-KPNGPLMVIVEFCKYGNL--SNFLRAKREFFSPYREKSPKQR 121
Query: 170 NGGDLMFHIQQSGRFDEG------RARF-----------------------------YAA 194
M + R E +RF Y+
Sbjct: 122 GRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSF 181
Query: 195 EIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY- 253
++ GM FL + ++RDL NILL V+I DFG+ + IY D PDY
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKD---------PDYV 231
Query: 254 -----------MAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSICN 301
MAPE I Y D WSFG+LL+E+ +G SP+ G +E F
Sbjct: 232 RKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLK 291
Query: 302 E--RPRFPQFLSVEAKNILVHLLDKDTTKR 329
+ R R P+ + E I++ D +R
Sbjct: 292 DGTRMRAPENATPEIYRIMLACWQGDPKER 321
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 72.6 bits (179), Expect = 3e-14
Identities = 83/320 (25%), Positives = 131/320 (40%), Gaps = 68/320 (21%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT-LIERKVLALGT 123
++++ L + +G++G V+ A K T A+K LK + E + T L E +L L
Sbjct: 5 DEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEK--EKEGFPITSLREINIL-LKL 61
Query: 124 KHPYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+HP + + ++ VMEY+ E DL LM +
Sbjct: 62 QHPNIVTVKEVVVGSNLDKIYMVMEYV-------------EHDLK------SLMETM--K 100
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYL 240
F + + +++SG+ LH I++RDLK N+LL+ G ++I DFG+ + L
Sbjct: 101 QPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL 160
Query: 241 DKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF-- 296
T T Y APE++ G K Y+ +D WS G + E+ + F G E D+L
Sbjct: 161 KPYTQLVV-TLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219
Query: 297 -----------W-----------------SICNERPRFPQ-FLSVEAKNILVHLLDKDTT 327
W R +FP LS ++L LL D
Sbjct: 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPA 279
Query: 328 KRLGSTQCNSGDDVVAHEYF 347
KR+ S +D + H YF
Sbjct: 280 KRI------SAEDALKHPYF 293
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 4e-14
Identities = 51/183 (27%), Positives = 82/183 (44%), Gaps = 19/183 (10%)
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMC- 234
+ E A V + +L ++ I++RD+K NILLD G++++ DFG+
Sbjct: 97 YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISG 156
Query: 235 KLQIYLDKTTDTFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
+L + KT D C P YMAPE I Y+ D WS GI LYE+ G+ P+ +
Sbjct: 157 QLVDSIAKTRDAGC-RP-YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWN 214
Query: 292 E--DELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345
D+L + + P + S N + L KD +KR +++ H
Sbjct: 215 SVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKR------PKYKELLEHP 268
Query: 346 YFR 348
+ +
Sbjct: 269 FIK 271
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 73.1 bits (180), Expect = 4e-14
Identities = 37/124 (29%), Positives = 62/124 (50%), Gaps = 13/124 (10%)
Query: 164 DLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
DLME DL I E R++ +++ G++++H +++RDLK N+L++ +
Sbjct: 88 DLME----SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLVNED 143
Query: 224 GHVRIADFGMCKLQIYLDKTTD------TFCGTPDYMAPEIIKGL-KYNQCVDWWSFGIL 276
+RI DFGM + T+ + T Y APE++ L +Y +D WS G +
Sbjct: 144 CELRIGDFGMARG--LSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201
Query: 277 LYEM 280
EM
Sbjct: 202 FAEM 205
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 71.5 bits (175), Expect = 6e-14
Identities = 58/229 (25%), Positives = 103/229 (44%), Gaps = 32/229 (13%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ L++ +G G FG V+L A+K +++ + E+D +E E +V+ +
Sbjct: 2 HPSELTLVQEIGSGQFGLVWLGYWLEKRKV-AIKTIREGAMSEEDFIE----EAQVM-MK 55
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP L L+ S + V E++ G L +YL Q G
Sbjct: 56 LSHPKLVQLYGVCTERSPICLVFEFMEHGCL------------SDYLRA--------QRG 95
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+F + ++ GM +L +++RDL N L+ V+++DFGM + LD
Sbjct: 96 KFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTR--FVLDD 153
Query: 243 TTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPF 287
+ GT + +PE+ KY+ D WSFG+L++E+ G++P+
Sbjct: 154 QYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPY 202
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 72.4 bits (177), Expect = 6e-14
Identities = 69/251 (27%), Positives = 104/251 (41%), Gaps = 31/251 (12%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK 117
F K D E+ F L +G GSFG V+ A T+ AVK + ++ + + E K
Sbjct: 14 FYKDDPEEIFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVK 73
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
L KHP + + + VMEY G + DL+E
Sbjct: 74 FLQ-QLKHPNTIEYKGCYLKEHTAWLVMEYCLG----------SASDLLEV--------- 113
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
E + G+ +LH +++RD+K NILL G V++ADFG
Sbjct: 114 --HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASKS 171
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
++F GTP +MAPE+I + +Y+ VD WS GI E+ + P +
Sbjct: 172 ----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 227
Query: 295 LFWSIC-NERP 304
+ I N+ P
Sbjct: 228 ALYHIAQNDSP 238
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 72.1 bits (177), Expect = 6e-14
Identities = 65/242 (26%), Positives = 112/242 (46%), Gaps = 37/242 (15%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLALG 122
++ F ++ +G+G++G+V+ A K T A+K ++ D E + T I E K+L
Sbjct: 6 VDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDN--EKEGFPITAIREIKILR-Q 62
Query: 123 TKHPYLCHLF---------CTFQTDSHLFF-VMEYLNGGDLIPAGLTKAERDLMEYLNGG 172
H + +L F+ D F+ V EY+ + DLM L G
Sbjct: 63 LNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYM-------------DHDLMGLLESG 109
Query: 173 DLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232
+ H F E + + +++ G+ + HKK ++RD+K NILL+ +G +++ADFG
Sbjct: 110 --LVH------FSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFG 161
Query: 233 MCKLQIYLDKTTDT-FCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGC 290
+ +L + T T Y PE++ G +Y +D WS G +L E+ + F
Sbjct: 162 LARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQAN 221
Query: 291 DE 292
E
Sbjct: 222 QE 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 71.9 bits (176), Expect = 7e-14
Identities = 64/227 (28%), Positives = 99/227 (43%), Gaps = 42/227 (18%)
Query: 67 FQLLKVLGKGSFGKVFLAEL----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL-AL 121
+ ++VLG+G FGKV L GT AVK LK++ ++ E +L L
Sbjct: 6 LKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKRECGQQNT--SGWKKEINILKTL 63
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
++ C+ Q L +MEY+ P G L +YL L
Sbjct: 64 YHENIVKYKGCCSEQGGKGLQLIMEYV------PLG------SLRDYLPKHKLNL----- 106
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK------ 235
+ +A +I GM +LH + ++RDL N+LLD + V+I DFG+ K
Sbjct: 107 -----AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGH 161
Query: 236 --LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280
++ D + F + A E +K K++ D WSFG+ LYE+
Sbjct: 162 EYYRVREDGDSPVF-----WYAVECLKENKFSYASDVWSFGVTLYEL 203
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 72.2 bits (177), Expect = 7e-14
Identities = 54/196 (27%), Positives = 91/196 (46%), Gaps = 41/196 (20%)
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
E + ++ +++ G++++H GI++RDLK N+ ++ + ++I DFG+ + + D
Sbjct: 114 LSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLAR---HADAE 170
Query: 244 TDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD----------- 291
+ T Y APE+I + YNQ VD WS G ++ EM G++ F G D
Sbjct: 171 MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKV 230
Query: 292 ------------EDELFWSICNERPRFPQ----FLSVEAKNILVHLLDK----DTTKRLG 331
ED+ S P++P+ L +A V LL+K D KRL
Sbjct: 231 TGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRLT 290
Query: 332 STQCNSGDDVVAHEYF 347
+T+ + H YF
Sbjct: 291 ATE------ALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 72.0 bits (176), Expect = 7e-14
Identities = 69/251 (27%), Positives = 105/251 (41%), Gaps = 31/251 (12%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK 117
F K D E F L+ +G GSFG V+ A T+ A+K + ++ + + E K
Sbjct: 18 FFKEDPEKLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVK 77
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
L KHP + + + VMEY G + DL+E
Sbjct: 78 FLQR-IKHPNSIEYKGCYLREHTAWLVMEYCLG----------SASDLLEV--------- 117
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
E + G+ +LH +++RD+K NILL G V++ADFG +
Sbjct: 118 --HKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIA 175
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
++F GTP +MAPE+I + +Y+ VD WS GI E+ + P +
Sbjct: 176 ----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 231
Query: 295 LFWSIC-NERP 304
+ I NE P
Sbjct: 232 ALYHIAQNESP 242
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 65.8 bits (161), Expect = 8e-14
Identities = 32/92 (34%), Positives = 40/92 (43%), Gaps = 28/92 (30%)
Query: 348 RGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDK 407
RG+DW LE +E+EPPF P++ SP D FD
Sbjct: 1 RGIDWDKLENKEIEPPFVPKI----KSPT------------------------DTSNFDP 32
Query: 408 SFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439
FT E P LTPVD + + Q F+GFSY
Sbjct: 33 EFTEETPVLTPVDSPLSGGIQQEPFRGFSYVF 64
|
Length = 64 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.8 bits (174), Expect = 1e-13
Identities = 62/237 (26%), Positives = 96/237 (40%), Gaps = 41/237 (17%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECTLIER--- 116
D + KV+G G FG+V LK A+K LK + +R
Sbjct: 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLK---------AGSSDKQRLDF 52
Query: 117 --KVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
+ +G HP + L + + EY+ G L ++L D
Sbjct: 53 LTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSL------------DKFLREND 100
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
F + Q G I SGM++L + V+RDL NIL++ +++DFG+
Sbjct: 101 GKFTVGQLVGMLRG--------IASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGL 152
Query: 234 CKLQIYLDKTTDTFCG-TP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPF 287
+ + T T G P + APE I K+ D WSFGI+++E M G+ P+
Sbjct: 153 SRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 70.5 bits (172), Expect = 1e-13
Identities = 69/245 (28%), Positives = 114/245 (46%), Gaps = 23/245 (9%)
Query: 72 VLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLC 129
V+G+G+FG+V A +K G A+K +K+ DD E +VL HP +
Sbjct: 2 VIGEGNFGQVLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNII 59
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF---HIQQSGRFDE 186
+L + +L+ +EY G+L+ + R L D F + S +
Sbjct: 60 NLLGACEHRGYLYLAIEYAPHGNLL--DFLRKSRVLET-----DPAFAIANSTASTLSSQ 112
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLDKTTD 245
F AA++ GM +L +K ++RDL NIL+ +IADFG+ + ++Y+ KT
Sbjct: 113 QLLHF-AADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMG 171
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSICN--- 301
+MA E + Y D WS+G+LL+E+ +G +P+ G EL+ +
Sbjct: 172 RL--PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR 229
Query: 302 -ERPR 305
E+P
Sbjct: 230 LEKPL 234
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 61/221 (27%), Positives = 100/221 (45%), Gaps = 30/221 (13%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
+G+G+FG+VF L+ + AVK ++ L D L E ++L HP + L
Sbjct: 3 IGRGNFGEVFSGRLRADNTPVAVKSCRE--TLPPDLKAKFLQEARILK-QYSHPNIVRLI 59
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
++ VME + GGD + T+ R ++ L IQ
Sbjct: 60 GVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKEL--------IQMVE---------- 101
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ---IYLDKTTDTFCG 249
+GM +L K ++RDL N L+ + ++I+DFGM + + +Y +T
Sbjct: 102 --NAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVY--ASTGGMKQ 157
Query: 250 TP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFS 288
P + APE + +Y+ D WSFGILL+E +G P++
Sbjct: 158 IPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYA 198
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 2e-13
Identities = 37/113 (32%), Positives = 58/113 (51%), Gaps = 11/113 (9%)
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
D R + +++ G++ LH GI++RDLK NI++ + ++I DFG+ +
Sbjct: 120 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TA 173
Query: 244 TDTFCGTP-----DYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
F TP Y APE+I G+ Y + VD WS G ++ E+ G F G D
Sbjct: 174 CTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 67/250 (26%), Positives = 110/250 (44%), Gaps = 32/250 (12%)
Query: 66 DFQLLKVLGKGSFGKVF----LAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
+F+ +KVLG G+FG V+ + E + A+K L++ + + + L E V+A
Sbjct: 8 EFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKAN--KEILDEAYVMA- 64
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+P++C L T + L+P G L++Y+ +
Sbjct: 65 SVDNPHVCRLLGICLTSTVQLIT-------QLMPFGC------LLDYVR--------EHK 103
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+ +I GM +L ++ +V+RDL N+L+ HV+I DFG+ KL +
Sbjct: 104 DNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADE 163
Query: 242 KTTDTFCG-TP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELFWS 298
K G P +MA E I Y D WS+G+ ++E M G P+ G E+ S
Sbjct: 164 KEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEIS-S 222
Query: 299 ICNERPRFPQ 308
I + R PQ
Sbjct: 223 ILEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.7 bits (171), Expect = 2e-13
Identities = 64/224 (28%), Positives = 93/224 (41%), Gaps = 32/224 (14%)
Query: 73 LGKGSFGKV---FLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLC 129
LG G+FG V G + AVK LK++ + L E V+A HP +
Sbjct: 3 LGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEH--IAAGKKEFLREASVMA-QLDHPCIV 59
Query: 130 HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189
L + + L VME L P G L++YL ++
Sbjct: 60 RLIGVCKGEP-LMLVME------LAPLG------PLLKYL---------KKRREIPVSDL 97
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLDKTTDTFC 248
+ A ++ GM +L K V+RDL N+LL +I+DFGM + L D T
Sbjct: 98 KELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTA 157
Query: 249 GT-P-DYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSG 289
G P + APE I K++ D WS+G+ L+E G P+
Sbjct: 158 GRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGE 201
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 71.2 bits (174), Expect = 2e-13
Identities = 41/128 (32%), Positives = 71/128 (55%), Gaps = 5/128 (3%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
L+ L G DL +I + + + +F +++ G++++H GI++RDLK N+ ++ +
Sbjct: 97 LVTNLMGADLN-NIVKCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDC 155
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEI-IKGLKYNQCVDWWSFGILLYEMHVG 283
+RI DFG+ + D + T Y APEI + + YNQ VD WS G ++ E+ G
Sbjct: 156 ELRILDFGLAR---QADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKG 212
Query: 284 QSPFSGCD 291
++ F G D
Sbjct: 213 KALFPGND 220
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 72.5 bits (178), Expect = 2e-13
Identities = 68/261 (26%), Positives = 116/261 (44%), Gaps = 67/261 (25%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKC-----LKKDVVLEDDDVECTLIERKV 118
++ + +++++GKG G+V+LA Y C LKK + +D E L++++
Sbjct: 1 MQRYDIIRLIGKGGMGEVYLA--------YDPVCSRRVALKK---IREDLSENPLLKKRF 49
Query: 119 L-----ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAER-------DLM 166
L A HP + ++ +++ M Y+ G L L K+ +L
Sbjct: 50 LREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTL--KSLLKSVWQKESLSKELA 107
Query: 167 EYLNGGDLM--FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
E + G + FH +I + + ++H KG+++RDLK DNILL G
Sbjct: 108 EKTSVGAFLSIFH-----------------KICATIEYVHSKGVLHRDLKPDNILLGLFG 150
Query: 225 HVRIADFG---MCKL----QIYLDKTTDTFC-----------GTPDYMAPEIIKGLKYNQ 266
V I D+G KL + +D C GTPDYMAPE + G+ ++
Sbjct: 151 EVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASE 210
Query: 267 CVDWWSFGILLYEMHVGQSPF 287
D ++ G++LY+M P+
Sbjct: 211 STDIYALGVILYQMLTLSFPY 231
|
Length = 932 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 70.0 bits (171), Expect = 2e-13
Identities = 75/249 (30%), Positives = 111/249 (44%), Gaps = 30/249 (12%)
Query: 73 LGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
LG+G+FGKVFLAE + AVK LK+ D + E ++L + +H +
Sbjct: 13 LGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEASESARQDFQ---REAELLTV-LQHQH 68
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ + L V EY+ GDL ++ + L GG+ G+ G
Sbjct: 69 IVRFYGVCTEGRPLLMVFEYMRHGDL--NRFLRSHGPDAKILAGGED----VAPGQLTLG 122
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF 247
+ A++I SGM +L V+RDL N L+ V+I DFGM + IY +TD +
Sbjct: 123 QMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIY---STDYY 178
Query: 248 -----CGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSIC 300
P +M PE I K+ D WSFG++L+E+ G+ P+ E I
Sbjct: 179 RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECIT 238
Query: 301 N----ERPR 305
ERPR
Sbjct: 239 QGRELERPR 247
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 70.8 bits (173), Expect = 2e-13
Identities = 50/153 (32%), Positives = 71/153 (46%), Gaps = 25/153 (16%)
Query: 192 YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTP 251
Y+ ++ GM FL + ++RDL NILL V+I DFG+ + IY D P
Sbjct: 184 YSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLAR-DIYKD---------P 233
Query: 252 DY------------MAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWS 298
DY MAPE I Y D WSFG+LL+E+ +G SP+ G DE F
Sbjct: 234 DYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCR 293
Query: 299 ICNE--RPRFPQFLSVEAKNILVHLLDKDTTKR 329
E R R P + + E ++ + ++R
Sbjct: 294 RLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQR 326
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 3e-13
Identities = 65/240 (27%), Positives = 104/240 (43%), Gaps = 37/240 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
E ++ L +G+GS+G VF + T A+K K V EDD V + R++ L
Sbjct: 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIK---KFVESEDDPVIKKIALREIRMLKQL 57
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEY-----LNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
KHP L +L F+ L V EY LN + P G+
Sbjct: 58 KHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGV-------------------- 97
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
E + + + + F HK ++RD+K +NIL+ +G +++ DFG ++
Sbjct: 98 ------PEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARILT 151
Query: 239 YLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELF 296
+ T Y APE++ G +Y VD W+ G + E+ GQ + G D D+L+
Sbjct: 152 GPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLY 211
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 69.6 bits (170), Expect = 4e-13
Identities = 65/243 (26%), Positives = 103/243 (42%), Gaps = 48/243 (19%)
Query: 73 LGKGSFGKVFLAELKGTDYYY--------------AVKCLKKDV---VLEDDDVECTLIE 115
LG+G FG+V L E +G + AVK L+ DV D E ++
Sbjct: 13 LGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRADVTKTARNDFLKEIKIMS 72
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
R K+P + L +D L + EY+ GDL ++R++ + +
Sbjct: 73 R------LKNPNIIRLLGVCVSDDPLCMITEYMENGDL---NQFLSQREIESTFTHANNI 123
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ + + A +I SGM++L V+RDL N L+ ++IADFGM +
Sbjct: 124 PSVSIANLL------YMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSR 177
Query: 236 LQIYLDKTTDTF-----CGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+Y + D + P +MA E I K+ D W+FG+ L+EM F+
Sbjct: 178 -NLY---SGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEM------FTL 227
Query: 290 CDE 292
C E
Sbjct: 228 CKE 230
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 68.9 bits (168), Expect = 4e-13
Identities = 60/221 (27%), Positives = 102/221 (46%), Gaps = 26/221 (11%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
++LGKG+FG+VF LK AVK K+D+ +++ + + HP +
Sbjct: 1 ELLGKGNFGEVFKGTLKDKTPV-AVKTCKEDL---PQELKIKFLSEARILKQYDHPNIVK 56
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L ++ VME + GGD + + L K + +L +Q +F
Sbjct: 57 LIGVCTQRQPIYIVMELVPGGDFL-SFLRKKKDEL-----------KTKQLVKF------ 98
Query: 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250
A + +GM +L K ++RDL N L+ ++I+DFGM + + ++
Sbjct: 99 --ALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSSSGLKQI 156
Query: 251 P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
P + APE + +Y+ D WS+GILL+E +G P+ G
Sbjct: 157 PIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPG 197
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 5e-13
Identities = 79/313 (25%), Positives = 143/313 (45%), Gaps = 62/313 (19%)
Query: 61 KYD-----LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
KYD L +++++K +G G FG+VFL + K T ++ K + + E + + +IE
Sbjct: 4 KYDDGESRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGLKEREKSQ-LVIE 62
Query: 116 RKVLALGTKHPYLCHLFCTF--QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
V+ KH + F + + L+ +ME+ + GDL R++ +
Sbjct: 63 VNVMR-ELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDL--------SRNIQKCYK--- 110
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLH--KKG-----IVYRDLKLDNILLD----Y 222
MF G+ +E +++ + + H K G +++RDLK NI L +
Sbjct: 111 -MF-----GKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRH 164
Query: 223 EGHV-------------RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII--KGLKYNQC 267
G + +I DFG+ K I ++ + GTP Y +PE++ + Y+
Sbjct: 165 IGKITAQANNLNGRPIAKIGDFGLSK-NIGIESMAHSCVGTPYYWSPELLLHETKSYDDK 223
Query: 268 VDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAK----NILV-HLL 322
D W+ G ++YE+ G++PF + F + +E R P L ++ K NIL+ +LL
Sbjct: 224 SDMWALGCIIYELCSGKTPFHKANN---FSQLISELKRGPD-LPIKGKSKELNILIKNLL 279
Query: 323 DKDTTKRLGSTQC 335
+ +R + QC
Sbjct: 280 NLSAKERPSALQC 292
|
Length = 1021 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 68.2 bits (167), Expect = 9e-13
Identities = 36/101 (35%), Positives = 54/101 (53%), Gaps = 8/101 (7%)
Query: 193 AAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDKTTDTFCGT 250
A IV + +LH K +++RD+K N+L++ G V++ DFG+ L + KT D G
Sbjct: 109 AVSIVKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKTIDA--GC 166
Query: 251 PDYMAPEII----KGLKYNQCVDWWSFGILLYEMHVGQSPF 287
YMAPE I Y+ D WS GI + E+ G+ P+
Sbjct: 167 KPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPY 207
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 67.7 bits (165), Expect = 1e-12
Identities = 70/258 (27%), Positives = 114/258 (44%), Gaps = 41/258 (15%)
Query: 73 LGKGSFGKVF--LAELKGTDYYYAVKCLKK---DVVLEDDDVECTLIERKVLALGTKHPY 127
LG G+FG V + ++K ++ AVK LK D L+D+ L E V+ +PY
Sbjct: 3 LGSGNFGTVKKGMYKMKKSEKTVAVKILKNDNNDPALKDE----LLREANVMQQ-LDNPY 57
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ + + +S VME A L G L +Q++ E
Sbjct: 58 IVRMIGICEAES-WMLVMEL--------AEL-------------GPLNKFLQKNKHVTEK 95
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-----QIYLDK 242
++ GM++L + V+RDL N+LL + + +I+DFG+ K Y K
Sbjct: 96 NITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAK 155
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSGCDEDELFWSICN 301
T + + APE + K++ D WSFG+L++E GQ P+ G +E+ I +
Sbjct: 156 THGKW--PVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIES 213
Query: 302 -ERPRFPQFLSVEAKNIL 318
ER PQ E +++
Sbjct: 214 GERMECPQRCPPEMYDLM 231
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 68.8 bits (169), Expect = 1e-12
Identities = 36/107 (33%), Positives = 63/107 (58%), Gaps = 8/107 (7%)
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QIYLDKT---- 243
R+ +++ ++++H +++RDLK NILL+ + V++ADFG+ + ++ +
Sbjct: 110 RYIMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVL 169
Query: 244 TDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289
TD + T Y APEI+ G +Y + VD WS G +L EM +G+ F G
Sbjct: 170 TD-YVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPG 215
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 67/269 (24%), Positives = 105/269 (39%), Gaps = 68/269 (25%)
Query: 54 TTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY-----YAVKCLKKDVVLEDDD 108
+PR + LL+ LG G+FG+V+ +G D AVK L + +D+
Sbjct: 1 PEVPR------DSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPESCSEQDES 54
Query: 109 VECTLIERKVLALGT-KHPYLCHLF-CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM 166
+ L + H + L +F+ F ++E + GGDL + R
Sbjct: 55 DFL----MEALIMSKFNHQNIVRLIGVSFERLPR-FILLELMAGGDL--KSFLRENRPRP 107
Query: 167 EY---LNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
E L DL+F A ++ G ++L + ++RD+ N LL +
Sbjct: 108 ERPSSLTMKDLLF---------------CARDVAKGCKYLEENHFIHRDIAARNCLLTCK 152
Query: 224 GH---VRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPE-IIKGLKYNQ 266
G +IADFGM + IY Y M PE + G+ +
Sbjct: 153 GPGRVAKIADFGMAR-DIY----------RASYYRKGGRAMLPIKWMPPEAFLDGI-FTS 200
Query: 267 CVDWWSFGILLYE-MHVGQSPFSGCDEDE 294
D WSFG+LL+E +G P+ G E
Sbjct: 201 KTDVWSFGVLLWEIFSLGYMPYPGRTNQE 229
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 68.2 bits (166), Expect = 1e-12
Identities = 65/251 (25%), Positives = 101/251 (40%), Gaps = 31/251 (12%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK 117
F K D E F L+ +G GSFG V+ A A+K + ++ + + E +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
L +HP + + + VMEY G + DL+E
Sbjct: 68 FLQ-KLRHPNTIQYRGCYLREHTAWLVMEYCLG----------SASDLLEV--------- 107
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
E + G+ +LH +++RD+K NILL G V++ DFG +
Sbjct: 108 --HKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
+ F GTP +MAPE+I + +Y+ VD WS GI E+ + P +
Sbjct: 166 ----APANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 295 LFWSIC-NERP 304
+ I NE P
Sbjct: 222 ALYHIAQNESP 232
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 1e-12
Identities = 69/242 (28%), Positives = 118/242 (48%), Gaps = 35/242 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLA-ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-- 121
+ ++ + +G+G++GKVF A +LK + A+K ++ V ++ + + I R+V L
Sbjct: 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVR--VQTGEEGMPLSTI-REVAVLRH 57
Query: 122 --GTKHPYLCHLF--CTF-QTD--SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDL 174
+HP + LF CT +TD + L V E++ ++DL YL+
Sbjct: 58 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-------------DQDLTTYLD---- 100
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
+ + G E + +++ G+ FLH +V+RDLK NIL+ G +++ADFG+
Sbjct: 101 --KVPEPGVPTE-TIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLA 157
Query: 235 KLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDED 293
++ + T T Y APE++ Y VD WS G + EM + F G D D
Sbjct: 158 RIYSFQMALTSVVV-TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216
Query: 294 EL 295
+L
Sbjct: 217 QL 218
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 67.4 bits (164), Expect = 2e-12
Identities = 66/236 (27%), Positives = 106/236 (44%), Gaps = 34/236 (14%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
IPR E +L LG+G FG+V++ GT A+K LK + E L E
Sbjct: 3 IPR------ESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTM----SPEAFLQE 51
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+V+ +H L L+ ++ ++ V EY++ G L +++L G
Sbjct: 52 AQVMK-KLRHEKLVQLYAVV-SEEPIYIVTEYMSKGSL------------LDFLKG---- 93
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ + AA+I SGM ++ + V+RDL+ NIL+ ++ADFG+ +
Sbjct: 94 ---EMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLAR 150
Query: 236 LQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289
L + T P + APE ++ D WSFGILL E+ G+ P+ G
Sbjct: 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 67.3 bits (164), Expect = 2e-12
Identities = 66/219 (30%), Positives = 96/219 (43%), Gaps = 36/219 (16%)
Query: 73 LGKGSFGKVFLA----ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPY 127
LG+G FGKV L E T AVK LK E +++++ L H
Sbjct: 12 LGEGHFGKVELCRYDPEGDNTGEQVAVKSLKP----ESGGNHIADLKKEIEILRNLYHEN 67
Query: 128 LCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
+ CT + + +ME+L P+G L EYL +++Q +
Sbjct: 68 IVKYKGICTEDGGNGIKLIMEFL------PSG------SLKEYLPRNKNKINLKQQLK-- 113
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
YA +I GM +L + V+RDL N+L++ E V+I DFG+ K I DK
Sbjct: 114 ------YAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTK-AIETDKEYY 166
Query: 246 TFCGTPD----YMAPEIIKGLKYNQCVDWWSFGILLYEM 280
T D + APE + K+ D WSFG+ LYE+
Sbjct: 167 TVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYEL 205
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-12
Identities = 61/230 (26%), Positives = 95/230 (41%), Gaps = 61/230 (26%)
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
D R + +++ G++ LH GI++RDLK NI++ + ++I DFG+ +
Sbjct: 123 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TA 176
Query: 244 TDTFCGTPD-----YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE------ 292
+F TP Y APE+I G+ Y + VD WS G ++ EM G F G D
Sbjct: 177 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNK 236
Query: 293 -DELFWSICNE---------------RPR---------FPQFL-----------SVEAKN 316
E + C E RP+ FP L + +A++
Sbjct: 237 VIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD 296
Query: 317 ILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
+L +L D +KR+ S D+ + H Y W + E PP P
Sbjct: 297 LLSKMLVIDASKRI------SVDEALQHPYIN--VWYDPSEAEAPPPKIP 338
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 67.8 bits (166), Expect = 2e-12
Identities = 38/112 (33%), Positives = 59/112 (52%), Gaps = 11/112 (9%)
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
D R + +++ G++ LH GI++RDLK NI++ + ++I DFG+ +
Sbjct: 116 DHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TAG 169
Query: 245 DTFCGTPD-----YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
+F TP Y APE+I G+ Y + VD WS G ++ EM G F G D
Sbjct: 170 TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 67.6 bits (165), Expect = 4e-12
Identities = 32/90 (35%), Positives = 49/90 (54%), Gaps = 2/90 (2%)
Query: 202 FLHKKGIVYRDLKLDNILLDYEGHVRIADFG-MCKLQIYLDKTTD-TFCGTPDYMAPEII 259
+LH +GI++RD+K +NI LD + + DFG CKL + D + GT + +PE++
Sbjct: 200 YLHGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELL 259
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
Y D WS G++L+EM V G
Sbjct: 260 ALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289
|
Length = 392 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 65.8 bits (160), Expect = 4e-12
Identities = 64/236 (27%), Positives = 109/236 (46%), Gaps = 34/236 (14%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
IPR E +L LG+G FG+V++ GT A+K LK ++ + ++ I
Sbjct: 3 IPR------ESLRLDVKLGQGCFGEVWMGTWNGTTKV-AIKTLKPGTMMPEAFLQEAQIM 55
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+K+ +H L L+ ++ ++ V E++ G L +++L GD
Sbjct: 56 KKL-----RHDKLVPLYAVV-SEEPIYIVTEFMGKGSL------------LDFLKEGDGK 97
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+++ D AA+I GM ++ + ++RDL+ NIL+ +IADFG+ +
Sbjct: 98 -YLKLPQLVD------MAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLAR 150
Query: 236 LQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289
L + T P + APE ++ D WSFGILL E+ G+ P+ G
Sbjct: 151 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPG 206
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 66.2 bits (161), Expect = 5e-12
Identities = 69/253 (27%), Positives = 106/253 (41%), Gaps = 32/253 (12%)
Query: 69 LLKVLGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L + LG+G+FGKVFLAE + AVK LK D+ L
Sbjct: 9 LKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKD----ASDNARKDFHREAELLTNL 64
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H ++ + L V EY+ GDL + L + LM +
Sbjct: 65 QHEHIVKFYGVCVEGDPLIMVFEYMKHGDL--------NKFLRAHGPDAVLMAEGNRPAE 116
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
+ + A +I +GM +L + V+RDL N L+ V+I DFGM + +Y +
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-DVY---S 172
Query: 244 TDTF-----CGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296
TD + P +M PE I K+ D WS G++L+E+ G+ P+ +E+
Sbjct: 173 TDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 297 WSICN----ERPR 305
I +RPR
Sbjct: 233 ECITQGRVLQRPR 245
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 66.4 bits (162), Expect = 6e-12
Identities = 23/43 (53%), Positives = 30/43 (69%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 489
D FD+ FT E+ L+PVD+ +L SMDQ QF+GFS+TNP
Sbjct: 274 SPSDASNFDREFTNEKVRLSPVDKKLLASMDQEQFRGFSFTNP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 65.5 bits (160), Expect = 6e-12
Identities = 59/250 (23%), Positives = 100/250 (40%), Gaps = 30/250 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLA---ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
ED L + +G+G FG V+ + AVK K V ++ +
Sbjct: 6 EDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT---SPSVREKFLQEAYIMR 62
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
HP++ L T++ ++ VME L P G +L YL
Sbjct: 63 QFDHPHIVKLIGVI-TENPVWIVME------LAPLG------ELRSYLQ--------VNK 101
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
D Y+ ++ + + +L K V+RD+ N+L+ V++ DFG+ +
Sbjct: 102 YSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDES 161
Query: 242 KTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELFWSI 299
+ P +MAPE I ++ D W FG+ ++E + +G PF G +++ I
Sbjct: 162 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVIGRI 221
Query: 300 CN-ERPRFPQ 308
N ER P
Sbjct: 222 ENGERLPMPP 231
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 7e-12
Identities = 48/148 (32%), Positives = 70/148 (47%), Gaps = 15/148 (10%)
Query: 192 YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT---FC 248
++ ++ GM FL K ++RDL NILL + +I DFG+ + D D+
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLAR-----DIRNDSNYVVK 273
Query: 249 GTP----DYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSICNER 303
G +MAPE I Y D WS+GILL+E+ +G SP+ G D F+ + E
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEG 333
Query: 304 PRF--PQFLSVEAKNILVHLLDKDTTKR 329
R P+ E +I+ D D KR
Sbjct: 334 YRMLSPECAPSEMYDIMKSCWDADPLKR 361
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 64.4 bits (157), Expect = 2e-11
Identities = 54/243 (22%), Positives = 98/243 (40%), Gaps = 34/243 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
+ Q + LG+G FG+VFLA+ KG + VK L+K D+ + R++
Sbjct: 5 SNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQK----TKDENLQSEFRRELD 60
Query: 120 ALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
H + L + + ++EY + GDL ++L
Sbjct: 61 MFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDL------------KQFLRATKSKDEK 108
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ + +I GM L V+RDL N L+ + V+++ + K
Sbjct: 109 LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--- 165
Query: 239 YLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCD 291
D + + ++APE ++ ++ D WSFG+L++E+ G+ PF G
Sbjct: 166 --DVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPFYGLS 223
Query: 292 EDE 294
++E
Sbjct: 224 DEE 226
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 64.2 bits (156), Expect = 2e-11
Identities = 42/128 (32%), Positives = 66/128 (51%), Gaps = 6/128 (4%)
Query: 167 EYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225
+ G L+ H++Q D R + +I GM +L + +V+R+L NILL +
Sbjct: 88 QLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAARNILLKSDSI 147
Query: 226 VRIADFGMCKLQIYLDKTTDTF--CGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MH 281
V+IADFG+ L +Y D + TP +MA E I +Y D WS+G+ ++E M
Sbjct: 148 VQIADFGVADL-LYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMS 206
Query: 282 VGQSPFSG 289
G P++G
Sbjct: 207 YGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 2e-11
Identities = 62/247 (25%), Positives = 103/247 (41%), Gaps = 39/247 (15%)
Query: 67 FQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+L K+LG+G FG V +L G+ AVK +K D+ ++E L E A
Sbjct: 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDIHTY-SEIEEFLSE----AACM 55
Query: 124 K---HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
K HP + L + F L IP + ++ ++ GDL +
Sbjct: 56 KDFDHPNVMKLI-------GVCFEASSLQK---IPKPMV-----ILPFMKHGDLHSFLLY 100
Query: 181 SGRFDEGRARF-------YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
S R + + +I GM +L + ++RDL N +L + V +ADFG+
Sbjct: 101 S-RLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGL 159
Query: 234 CKLQIYLDKTTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
K +IY ++A E + Y D W+FG+ ++E GQ+P+ G
Sbjct: 160 SK-KIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPG 218
Query: 290 CDEDELF 296
+ E++
Sbjct: 219 VENHEIY 225
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 39/105 (37%), Positives = 56/105 (53%), Gaps = 8/105 (7%)
Query: 195 EIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---QIYLDKTTDTFCGTP 251
+ + G+ FLH IV+RDLK +NIL+ G V++ADFG+ ++ Q+ L T
Sbjct: 116 QFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMALTPVVVTLW--- 172
Query: 252 DYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DEL 295
Y APE++ Y VD WS G + EM + F G E D+L
Sbjct: 173 -YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 63.8 bits (155), Expect = 3e-11
Identities = 72/244 (29%), Positives = 113/244 (46%), Gaps = 30/244 (12%)
Query: 65 EDFQLLKVLGKGSFGKVF--LAE--LKG-TDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
E LL+ LG+GSFG V+ A +KG + AVK + + L + +E L E V+
Sbjct: 6 EKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESASLRER-IE-FLNEASVM 63
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
T H ++ L VME + GDL ++ R E N G +Q
Sbjct: 64 KGFTCH-HVVRLLGVVSKGQPTLVVMELMAHGDL--KSYLRSLRPEAEN-NPGRPPPTLQ 119
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ + AAEI GM +L+ K V+RDL N ++ ++ V+I DFGM + IY
Sbjct: 120 EMIQM--------AAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTR-DIY 170
Query: 240 LDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDE 292
TD + +MAPE +K + D WSFG++L+E+ + + P+ G
Sbjct: 171 ---ETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSN 227
Query: 293 DELF 296
+++
Sbjct: 228 EQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 63.5 bits (154), Expect = 3e-11
Identities = 61/239 (25%), Positives = 109/239 (45%), Gaps = 35/239 (14%)
Query: 66 DFQLLKVLGKGSFGKVF----LAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
+ + +KVLG G+FG V+ + + + A+K L+++ + + + L E V+A
Sbjct: 8 ELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENTSPKAN--KEILDEAYVMA- 64
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
G PY+C L T + + LM Y G L+ +++++
Sbjct: 65 GVGSPYVCRLLGICLTST-------------------VQLVTQLMPY---GCLLDYVREN 102
Query: 182 -GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
R + +I GM +L + +V+RDL N+L+ HV+I DFG+ +L + +
Sbjct: 103 KDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARL-LDI 161
Query: 241 DKTTDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDEL 295
D+T G +MA E I ++ D WS+G+ ++E M G P+ G E+
Sbjct: 162 DETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAREI 220
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 63.0 bits (153), Expect = 4e-11
Identities = 72/284 (25%), Positives = 111/284 (39%), Gaps = 63/284 (22%)
Query: 71 KVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
KV+G G FG+V LK + A+K LK + L E ++ HP
Sbjct: 10 KVIGAGEFGEVCSGRLKLPGKREIPVAIKTLK--AGYTEKQRRDFLSEASIMG-QFDHPN 66
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ HL + V EY+ G L +L D F + Q G
Sbjct: 67 IIHLEGVVTKSKPVMIVTEYMENGSL------------DAFLRKHDGQFTVIQLVGMLRG 114
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF 247
I SGM++L G V+RDL NIL++ +++DFG+ ++ L+ +
Sbjct: 115 --------IASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRV---LEDDPEAA 163
Query: 248 CGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELFWSI- 299
T + APE I K+ D WS+GI+++E M G+ P+ ++ +I
Sbjct: 164 YTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIE 223
Query: 300 ----------C----------------NERPRFPQFLSVEAKNI 317
C NERP+F Q +S+ K I
Sbjct: 224 EGYRLPAPMDCPAALHQLMLDCWQKDRNERPKFEQIVSILDKLI 267
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 63.2 bits (154), Expect = 4e-11
Identities = 70/297 (23%), Positives = 112/297 (37%), Gaps = 81/297 (27%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GT 123
+ L +L +G+FG++F L + K V +++ TL+ ++ L G
Sbjct: 6 DRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDHASEIQVTLLLQESCLLYGL 65
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
H + + D FV L Y+N G+L +QQ
Sbjct: 66 SHQNILPILHVCIEDGEPPFV--------------------LYPYMNWGNLKLFLQQCRL 105
Query: 184 FDEGRAR--------FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ + A +I GM +LHK+G++++D+ N ++D E V+I D + +
Sbjct: 106 GEANNPQALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSR 165
Query: 236 LQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYE-MH 281
D F DY MA E + +Y+ D WSFG+LL+E M
Sbjct: 166 ---------DLFPM--DYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMT 214
Query: 282 VGQSPFSGCD--------------------EDELF------W-SICNERPRFPQFLS 311
+GQ+P+ D DELF W ERP F Q +
Sbjct: 215 LGQTPYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSFSQLVQ 271
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 5e-11
Identities = 66/268 (24%), Positives = 109/268 (40%), Gaps = 52/268 (19%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGT-----DYYYAVKCLKKDVVLEDDDVECTLIE 115
+Y + + ++ +G+G+FG+VF A G AVK LK++ D++
Sbjct: 1 EYPRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA---SADMQADFQR 57
Query: 116 RKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
L HP + L C L F EY+ GDL E+L
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLF--EYMAYGDL------------NEFLR--H 101
Query: 174 LMFHIQQSGRFDEGRARFY---------------AAEIVSGMRFLHKKGIVYRDLKLDNI 218
Q S AR A ++ +GM +L ++ V+RDL N
Sbjct: 102 RSPRAQCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNC 161
Query: 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWS 272
L+ V+IADFG+ + IY D + + + +M PE I +Y D W+
Sbjct: 162 LVGENMVVKIADFGLSR-NIYS---ADYYKASENDAIPIRWMPPESIFYNRYTTESDVWA 217
Query: 273 FGILLYEM-HVGQSPFSGCDEDELFWSI 299
+G++L+E+ G P+ G +E+ + +
Sbjct: 218 YGVVLWEIFSYGMQPYYGMAHEEVIYYV 245
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 63.3 bits (154), Expect = 8e-11
Identities = 89/350 (25%), Positives = 137/350 (39%), Gaps = 82/350 (23%)
Query: 50 ITPATTIPRFRKYDL--EDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDV 102
I P T +P K++ ++ Q K LG G+FGKV A G AVK LK
Sbjct: 22 IDP-TQLPYNEKWEFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA 80
Query: 103 VLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTK 160
D+ E + E K+L+ +H + +L CT + + EY GDL+ K
Sbjct: 81 --HTDEREALMSELKILSHLGQHKNIVNLLGACTH--GGPVLVITEYCCYGDLLNFLRKK 136
Query: 161 AERDLMEYLNGGDLM--------------------------------------FHIQQSG 182
AE L + ++ Q S
Sbjct: 137 AETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSD 196
Query: 183 RFDEGRA------------RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV-RIA 229
DE RF ++++ GM FL K ++RD+ N+LL +G V +I
Sbjct: 197 SKDEEDTEDSWPLDLDDLLRF-SSQVAQGMDFLASKNCIHRDVAARNVLLT-DGRVAKIC 254
Query: 230 DFGMCKLQIYLDKTTDT---FCGTP----DYMAPEIIKGLKYNQCVDWWSFGILLYEM-H 281
DFG+ + D D+ G +MAPE I Y D WS+GILL+E+
Sbjct: 255 DFGLAR-----DIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFS 309
Query: 282 VGQSPFSGCDEDELFWSICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
+G+SP+ G + F+ + + P F E +I+ + + T+R
Sbjct: 310 LGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMCWNLEPTER 359
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 62.8 bits (152), Expect = 9e-11
Identities = 37/113 (32%), Positives = 59/113 (52%), Gaps = 11/113 (9%)
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
D R + +++ G++ LH GI++RDLK NI++ + ++I DFG+ +
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR------TA 169
Query: 244 TDTFCGTP-----DYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
+F TP Y APE+I G+ Y + VD WS G ++ EM + F G D
Sbjct: 170 GTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 59/223 (26%), Positives = 97/223 (43%), Gaps = 34/223 (15%)
Query: 73 LGKGSFG----KVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYL 128
LG G+FG V+ K D A+K LK + E + + E +++ +PY+
Sbjct: 3 LGSGNFGCVKKGVYKMRKKQIDV--AIKVLKNEN--EKSVRDEMMREAEIMH-QLDNPYI 57
Query: 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
+ + ++ L VME +GG L ++D + N +LM +
Sbjct: 58 VRMIGVCEAEA-LMLVMEMASGGPL--NKFLSGKKDEITVSNVVELMHQVSM-------- 106
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDT 246
GM++L K V+RDL N+LL + + +I+DFG+ K D +
Sbjct: 107 ----------GMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARS 156
Query: 247 FCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPF 287
P + APE I K++ D WS+GI ++E GQ P+
Sbjct: 157 AGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-10
Identities = 21/44 (47%), Positives = 27/44 (61%)
Query: 398 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441
D FD FT+E P L+P D +L S+DQ +F+GFSY NP
Sbjct: 4 SPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|215917 pfam00433, Pkinase_C, Protein kinase C terminal domain | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 1e-10
Identities = 21/44 (47%), Positives = 27/44 (61%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 490
D FD FT+E P L+P D +L S+DQ +F+GFSY NP
Sbjct: 4 SPTDTSNFDPEFTSEPPKLSPPDSEVLSSIDQLEFRGFSYVNPE 47
|
Length = 47 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 62.0 bits (150), Expect = 1e-10
Identities = 69/247 (27%), Positives = 108/247 (43%), Gaps = 36/247 (14%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAEL-KGTDYYYAVKCLKKDVVLEDDDVECTLI 114
IPR E +L K LG G FG+V++A K T AVK +K + VE L
Sbjct: 3 IPR------ESLKLEKKLGAGQFGEVWMATYNKHTKV--AVKTMKPGSM----SVEAFLA 50
Query: 115 ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDL 174
E V+ +H L L T ++ + E++ G L+ D ++ G
Sbjct: 51 EANVMK-TLQHDKLVKLHAVV-TKEPIYIITEFMAKGSLL---------DFLKSDEGS-- 97
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
D ++A+I GM F+ ++ ++RDL+ NIL+ +IADFG+
Sbjct: 98 --KQPLPKLID------FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLA 149
Query: 235 KLQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDE 292
++ + T P + APE I + D WSFGILL E+ G+ P+ G
Sbjct: 150 RVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 209
Query: 293 DELFWSI 299
E+ ++
Sbjct: 210 PEVIRAL 216
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 1e-10
Identities = 63/237 (26%), Positives = 92/237 (38%), Gaps = 45/237 (18%)
Query: 73 LGKGSFGKVFLAEL----------------KGTDYYYAVKCLKKDVVLEDDDVECTLIER 116
LG+G FG+V L E+ KG AVK L+ D + L E
Sbjct: 13 LGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEV 70
Query: 117 KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
K+L+ K P + L + L + EY+ GDL + + NG D +
Sbjct: 71 KILSR-LKDPNIIRLLGVCVDEDPLCMITEYMENGDL--NQFLSSHHLDDKEENGNDAVP 127
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
A +I SGM++L V+RDL N L+ ++IADFGM +
Sbjct: 128 PAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR- 186
Query: 237 QIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYEM 280
+ + G DY MA E I K+ D W+FG+ L+E+
Sbjct: 187 --------NLYAG--DYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEI 233
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 62.7 bits (152), Expect = 1e-10
Identities = 47/145 (32%), Positives = 72/145 (49%), Gaps = 9/145 (6%)
Query: 192 YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI----YLDKTTDTF 247
+ ++ GM FL K V+RDL N+LL V+I DFG+ + + Y+ K + TF
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGS-TF 300
Query: 248 CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSICNERPRF 306
+MAPE I Y D WS+GILL+E+ +G +P+ G D F++ R
Sbjct: 301 LPV-KWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRM 359
Query: 307 --PQFLSVEAKNILVHLLDKDTTKR 329
P + E +I+V + + KR
Sbjct: 360 AKPDHATQEVYDIMVKCWNSEPEKR 384
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 62.1 bits (151), Expect = 2e-10
Identities = 38/139 (27%), Positives = 70/139 (50%), Gaps = 15/139 (10%)
Query: 166 MEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225
EY+ DL ++Q G E AR + +++ G++++H +++RDLK N+ ++ E
Sbjct: 95 QEYMET-DLANVLEQ-GPLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFINTEDL 152
Query: 226 V-RIADFGMCKL-------QIYLDKTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGIL 276
V +I DFG+ ++ + YL + T Y +P ++ Y + +D W+ G +
Sbjct: 153 VLKIGDFGLARIVDPHYSHKGYLSEGLVTKW----YRSPRLLLSPNNYTKAIDMWAAGCI 208
Query: 277 LYEMHVGQSPFSGCDEDEL 295
EM G+ F+G E E
Sbjct: 209 FAEMLTGKPLFAGAHELEQ 227
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 3e-10
Identities = 66/244 (27%), Positives = 101/244 (41%), Gaps = 31/244 (12%)
Query: 71 KVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
KV+G G FG+VF LK + A+K LK E + L E ++ + H
Sbjct: 11 KVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGYT-EKQRQD-FLSEASIMGQFS-HHN 67
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ L + EY+ G L +YL D F Q G
Sbjct: 68 IIRLEGVVTKFKPAMIITEYMENGAL------------DKYLRDHDGEFSSYQLVGMLRG 115
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF 247
I +GM++L V+RDL NIL++ +++DFG+ ++ + T T
Sbjct: 116 --------IAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTT 167
Query: 248 CGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELFWSICNER 303
G + APE I K+ D WSFGI+++E M G+ P+ E+ +I N+
Sbjct: 168 SGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAI-NDG 226
Query: 304 PRFP 307
R P
Sbjct: 227 FRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 61.2 bits (148), Expect = 3e-10
Identities = 60/256 (23%), Positives = 107/256 (41%), Gaps = 44/256 (17%)
Query: 66 DFQLLKVLGKGSFGKVF----LAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
+ + +KVLG G+FG V+ + E + A+K L + ++ ++
Sbjct: 8 ELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT---GPKANVEFMDEALIMA 64
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN------GGDLM 175
HP+L L + + L+P G L++Y++ G L+
Sbjct: 65 SMDHPHLVRLLGVCLSPTIQLVT-------QLMPHGC------LLDYVHEHKDNIGSQLL 111
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ + +I GM +L ++ +V+RDL N+L+ HV+I DFG+ +
Sbjct: 112 LN--------------WCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157
Query: 236 LQIYLDKTTDTFCGTP--DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDE 292
L +K + G +MA E I K+ D WS+G+ ++E M G P+ G
Sbjct: 158 LLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPT 217
Query: 293 DELFWSICNERPRFPQ 308
E+ + + R PQ
Sbjct: 218 REIP-DLLEKGERLPQ 232
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 60.4 bits (146), Expect = 4e-10
Identities = 64/247 (25%), Positives = 108/247 (43%), Gaps = 30/247 (12%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAEL--KGTDY--YYAVKCLKKDVVLEDDDVECTLIERKVL 119
L + ++ LG+ +FGK++ L G D+ A+K LK + + + L
Sbjct: 4 LSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKD---INNPQQWGEFQQEASL 60
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
HP + L + + + EYLN GDL + ++ D+
Sbjct: 61 MAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHS--------DVGCSSD 112
Query: 180 QSG----RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ G D G A +I +GM +L V++DL NIL+ + HV+I+D G+ +
Sbjct: 113 EDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSR 172
Query: 236 LQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFS 288
+IY + D + P +M PE I K++ D WSFG++L+E+ G P+
Sbjct: 173 -EIY---SADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYY 228
Query: 289 GCDEDEL 295
G E+
Sbjct: 229 GFSNQEV 235
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 60.3 bits (146), Expect = 5e-10
Identities = 61/247 (24%), Positives = 91/247 (36%), Gaps = 73/247 (29%)
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT--------- 123
LG+G FG+V L E +G + K + KD L+ + L+ K+L
Sbjct: 13 LGEGQFGEVHLCEAEGME-----KFMDKDFSLDVSGNQPVLVAVKMLREDANKNARNDFL 67
Query: 124 ---------KHPYLCHLFCTFQTDSHLFFVMEYLNGGDL--------IPAGLTKAERDLM 166
K P + L T L + EY+ GDL KA+ +
Sbjct: 68 KEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTI 127
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
Y F A +I SGM++L V+RDL N L+ +
Sbjct: 128 SYST------------------LIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTI 169
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSF 273
+IADFGM + +Y + DY M+ E I K+ D W+F
Sbjct: 170 KIADFGMSR-NLY----------SGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAF 218
Query: 274 GILLYEM 280
G+ L+E+
Sbjct: 219 GVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 60.4 bits (147), Expect = 5e-10
Identities = 56/246 (22%), Positives = 104/246 (42%), Gaps = 41/246 (16%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTD--YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+++ +G+G++G+V+ A+ K YA+K K D + + + L K
Sbjct: 2 YEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKE-QYTGISQSACREIALLRELK 60
Query: 125 HPYLCHLFCTFQTDSH--LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QS 181
H + L F + ++ + +Y AE DL + + FH Q +
Sbjct: 61 HENVVSLVEVFLEHADKSVYLLFDY-------------AEHDLWQIIK-----FHRQAKR 102
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----DYEGHVRIADFGMCKL- 236
+ +I++G+ +LH +++RDLK NIL+ G V+I D G+ +L
Sbjct: 103 VSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLF 162
Query: 237 -----QIY-LDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSG 289
+ LD T Y APE++ G + Y + +D W+ G + E+ + P
Sbjct: 163 NAPLKPLADLDPVVVTIW----YRAPELLLGARHYTKAIDIWAIGCIFAEL-LTLEPIFK 217
Query: 290 CDEDEL 295
E ++
Sbjct: 218 GREAKI 223
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 60.5 bits (147), Expect = 5e-10
Identities = 60/236 (25%), Positives = 106/236 (44%), Gaps = 46/236 (19%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVE----CTLIERKV 118
++ ++ L +G+G+FG+VF A K T A LKK VL +++ E L E K+
Sbjct: 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVA---LKK--VLMENEKEGFPITALREIKI 64
Query: 119 LALGTKHPYLCHLFCTFQTD--------SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
L L KH + +L +T + V E+ E DL L+
Sbjct: 65 LQL-LKHENVVNLIEICRTKATPYNRYKGSFYLVFEF-------------CEHDLAGLLS 110
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
++ +F + +++G+ ++H+ I++RD+K NIL+ +G +++AD
Sbjct: 111 --------NKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLAD 162
Query: 231 FGMCKLQIYLDKTTDTFCGTPD-----YMAPEIIKGLK-YNQCVDWWSFGILLYEM 280
FG+ + L K + T Y PE++ G + Y +D W G ++ EM
Sbjct: 163 FGLAR-AFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEM 217
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 60.8 bits (147), Expect = 5e-10
Identities = 39/112 (34%), Positives = 62/112 (55%), Gaps = 7/112 (6%)
Query: 192 YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI----YLDKTTDTF 247
++ ++ +GM FL K V+RDL N+L+ V+I DFG+ + + Y+ K + TF
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGS-TF 302
Query: 248 CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSGCDEDELFWS 298
+MAPE I Y D WSFGILL+E+ +G +P+ +E F++
Sbjct: 303 LPL-KWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYN 353
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 9e-10
Identities = 59/257 (22%), Positives = 95/257 (36%), Gaps = 79/257 (30%)
Query: 71 KVLGKGSFGKVFLAELKGTDYY------YAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
LG G+FG+V+ AVK L+K ++ + ++ L
Sbjct: 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGATDQE---KKEFLKEAHLMSNFN 57
Query: 125 HPY-LCHLFCTFQTDSHLFFVMEYLNGGDLI------------PAGLTKAERDLMEYLNG 171
HP + L + + +ME + GGDL+ P LT L E L+
Sbjct: 58 HPNIVKLLGVCLLNEP-QYIIMELMEGGDLLSYLRDARVERFGPPLLT-----LKELLD- 110
Query: 172 GDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-----V 226
++ G +L + ++RDL N L+ +G+ V
Sbjct: 111 --------------------ICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVV 150
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSF 273
+I DFG+ + IY DY MAPE + K+ D WSF
Sbjct: 151 KIGDFGLAR-DIY----------KSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSF 199
Query: 274 GILLYE-MHVGQSPFSG 289
G+L++E + +GQ P+
Sbjct: 200 GVLMWEILTLGQQPYPA 216
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 59.1 bits (143), Expect = 1e-09
Identities = 72/294 (24%), Positives = 118/294 (40%), Gaps = 65/294 (22%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
D+ ++ +V+G G FG+V LK + + A+K LK + L E ++
Sbjct: 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLK--SGYTEKQRRDFLSEASIM 59
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
HP + HL + + E++ G L D N G IQ
Sbjct: 60 G-QFDHPNIIHLEGVVTKSRPVMIITEFMENGAL----------DSFLRQNDGQFTV-IQ 107
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
G I +GM++L + V+RDL NIL++ +++DFG+ + +
Sbjct: 108 LVGML---------RGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR---F 155
Query: 240 L-DKTTD-TFCGT-----P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGC 290
L D T+D T+ + P + APE I K+ D WS+GI+++E M G+ P+
Sbjct: 156 LEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 215
Query: 291 DEDELFWSI-----------C----------------NERPRFPQFLSVEAKNI 317
++ +I C N RP+F Q +S K I
Sbjct: 216 SNQDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARPKFGQIVSTLDKMI 269
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 1e-09
Identities = 66/232 (28%), Positives = 101/232 (43%), Gaps = 36/232 (15%)
Query: 71 KVLGKGSFGKVFLAELKGTD---YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
+V+GKG FG V+ L +D + AVK L + + + ++VE L E ++ HP
Sbjct: 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNR--ITDLEEVEQFLKE-GIIMKDFSHPN 57
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ L G L G ++ Y+ GDL I+
Sbjct: 58 VLSLL-----------------GICLPSEGSPLV---VLPYMKHGDLRNFIRSETHNPTV 97
Query: 188 RARF-YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD- 245
+ + ++ GM +L K V+RDL N +LD V++ADFG+ + IY DK
Sbjct: 98 KDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLAR-DIY-DKEYYS 155
Query: 246 ----TFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCD 291
T P +MA E ++ K+ D WSFG+LL+E M G P+ D
Sbjct: 156 VHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVD 207
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 59.3 bits (144), Expect = 1e-09
Identities = 74/327 (22%), Positives = 132/327 (40%), Gaps = 80/327 (24%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGT--DYYYAVKCL----KKDVVLEDDDVECTLIERKVLA 120
++L+K LG+G++G V A T + A+K + K ++ + L E K+L
Sbjct: 2 YELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVFSKKILAKR-----ALRELKLLR 56
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
H + L+ D + F + N L +LME DL I+
Sbjct: 57 HFRGHKNITCLY-----DMDIVFPGNF-NELYLY--------EELMEA----DLHQIIRS 98
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM-CKLQIY 239
+ + + +I+ G++++H +++RDLK N+L++ + ++I DFG+
Sbjct: 99 GQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSEN 158
Query: 240 LDKTTD---TFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
+ + T Y APEI+ + Y + +D WS G +L E+ + F G D
Sbjct: 159 PGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD---- 214
Query: 296 FWSICNERPRFPQFLSVEAKNILVHLL---DKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
V+ N ++ +L D++T R+GS + A Y R L
Sbjct: 215 ---------------YVDQLNQILQVLGTPDEETLSRIGSPK--------AQNYIRSL-- 249
Query: 353 QALEKRELEPPFRPRV----IEPFSSP 375
P P+ I P ++P
Sbjct: 250 ----------PNIPKKPFESIFPNANP 266
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 60.0 bits (145), Expect = 1e-09
Identities = 58/228 (25%), Positives = 103/228 (45%), Gaps = 27/228 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++L ++G GSFG V+ A T A+K + +D ++ ++ + + K
Sbjct: 68 YKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQYKNRELLIMKNLNHINIIFLKDY 127
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL---NGGDLMFHIQQSGR 183
Y F + + L VME+ IP + K M++ N +F +
Sbjct: 128 YYTECFKKNEKNIFLNVVMEF------IPQTVHK----YMKHYARNNHALPLFLV----- 172
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-VRIADFGMCKLQIYLDK 242
+ Y+ ++ + ++H K I +RDLK N+L+D H +++ DFG K + +
Sbjct: 173 ------KLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR 226
Query: 243 TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+ C + Y APE++ G Y +D WS G ++ EM +G FSG
Sbjct: 227 SVSYIC-SRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSG 273
|
Length = 440 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 58.9 bits (142), Expect = 1e-09
Identities = 65/247 (26%), Positives = 104/247 (42%), Gaps = 44/247 (17%)
Query: 69 LLKVLGKGSFGKVFLAELKGTDYYY--AVKCLKKDVV----LEDDDVECTLIERKVLALG 122
L K LG+G FG V +L D AVK +K + +ED + V
Sbjct: 3 LGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAICTRSEMED------FLSEAVCMKE 56
Query: 123 TKHPYLCHLF--CTFQTDSHLF----FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
HP + L C +S + ++ ++ GDL L D +YL L+
Sbjct: 57 FDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVK 116
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
+ +I SGM +L K ++RDL N +L+ +V +ADFG+ K
Sbjct: 117 ---------------FMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK- 160
Query: 237 QIYLDKTTDTF-----CGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289
+IY D + P ++A E + Y D WSFG+ ++E+ GQ+P+ G
Sbjct: 161 KIY---NGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPG 217
Query: 290 CDEDELF 296
+ E++
Sbjct: 218 VENSEIY 224
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 2e-09
Identities = 67/279 (24%), Positives = 111/279 (39%), Gaps = 78/279 (27%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVK----------CLKKDVVLEDDDVECTLI 114
+Q L +G+G++G V A K T A+K C + TL
Sbjct: 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPFEHQTFCQR------------TLR 52
Query: 115 ERKVLALGTKHPYLCHLF-----CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
E K+L KH + + +F++ + ++ V E + E DL + +
Sbjct: 53 EIKIL-RRFKHENIIGILDIIRPPSFESFNDVYIVQELM-------------ETDLYKLI 98
Query: 170 NGGDLMF-HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228
L HIQ ++ +I+ G++++H +++RDLK N+LL+ ++I
Sbjct: 99 KTQHLSNDHIQ-----------YFLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKI 147
Query: 229 ADFGMCKLQIYLDKTTD------TFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMH 281
DFG+ ++ D D + T Y APEI+ K Y + +D WS G +L EM
Sbjct: 148 CDFGLARIA---DPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEML 204
Query: 282 VGQSPFSGCD---------------EDELFWSICNERPR 305
+ F G D E I + R R
Sbjct: 205 SNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRAR 243
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 3e-09
Identities = 53/194 (27%), Positives = 79/194 (40%), Gaps = 50/194 (25%)
Query: 195 EIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG----- 249
+I+ G+++LH GI++RD+K N+L++ ++I DFG+ +++ D
Sbjct: 111 QILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVE-----EPDESKHMTQEV 165
Query: 250 -TPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVG------QSPFS---------GCDE 292
T Y APEI+ G + Y VD WS G + E+ QSP G
Sbjct: 166 VTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDLITDLLGTPS 225
Query: 293 DELFWSICNE-------RPRFPQFLSV----------EAKNILVHLLDKDTTKRLGSTQC 335
E S C P P L V EA ++L +L D KR+
Sbjct: 226 LEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI----- 280
Query: 336 NSGDDVVAHEYFRG 349
S D +AH Y
Sbjct: 281 -SAADALAHPYLDE 293
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 58.5 bits (141), Expect = 3e-09
Identities = 29/92 (31%), Positives = 50/92 (54%), Gaps = 5/92 (5%)
Query: 196 IVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF---CGTPD 252
++ +++LH+ I++RD+K +NI +++ G V + DFG + D + + GT
Sbjct: 191 VLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPV--DINANKYYGWAGTIA 248
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
APE++ Y VD WS GI+L+EM
Sbjct: 249 TNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 57.1 bits (138), Expect = 6e-09
Identities = 89/359 (24%), Positives = 141/359 (39%), Gaps = 78/359 (21%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+++ +V+GKGS+G V A T A+K + DV D L E K+L L +HP
Sbjct: 2 YKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKIN-DVFEHVSDATRILREIKLLRL-LRHP 59
Query: 127 YLCHLFCTFQTDSH-----LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+ + S ++ V E L DL + KA DL H Q
Sbjct: 60 DIVEIKHIMLPPSRREFKDIYVVFE-LMESDL--HQVIKANDDLTPE--------HHQ-- 106
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
F+ +++ ++++H + +RDLK NIL + + ++I DFG+ ++ + D
Sbjct: 107 ---------FFLYQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVA-FND 156
Query: 242 KTTDTF----CGTPDYMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGCD---- 291
T F T Y APE+ KY +D WS G + E+ G+ F G +
Sbjct: 157 TPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216
Query: 292 -----------EDELFWSICNE---------RPRFPQFLSVE-------AKNILVHLLDK 324
E + NE R + P S + A +L LL
Sbjct: 217 LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAF 276
Query: 325 DTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKD 383
D R + ++ +A YF+G L K E EP +P F +L+ +D
Sbjct: 277 DPKDR------PTAEEALADPYFKG-----LAKVEREPSAQPITKLEFEFERRRLTKED 324
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 57.6 bits (139), Expect = 6e-09
Identities = 34/105 (32%), Positives = 58/105 (55%), Gaps = 3/105 (2%)
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG-MCKLQ-IYLDKTTDTFCGT 250
A +++S + ++H +GI++RD+K +N+L++ + + DFG C + + GT
Sbjct: 266 ARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGT 325
Query: 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294
D APE++ G Y VD WS G++++E V S FS DE
Sbjct: 326 VDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDE 370
|
Length = 461 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 56.6 bits (136), Expect = 7e-09
Identities = 61/249 (24%), Positives = 101/249 (40%), Gaps = 44/249 (17%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGT-----DYYYAVKCLKKDVVLEDDDVECTLIER- 116
+L + ++ LG+ FGKV+ L GT A+K LK D E L E
Sbjct: 3 NLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLK-------DKAEGPLREEF 55
Query: 117 ---KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDL----------IPAGLTKAER 163
++ +HP + L + L + Y + DL G T ++
Sbjct: 56 KHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDK 115
Query: 164 DLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
+ L D HI +I +GM FL +V++DL N+L+ +
Sbjct: 116 TVKSTLEPADF-VHI--------------VTQIAAGMEFLSSHHVVHKDLATRNVLVFDK 160
Query: 224 GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM- 280
+V+I+D G+ + D K +M+PE I K++ D WS+G++L+E+
Sbjct: 161 LNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVF 220
Query: 281 HVGQSPFSG 289
G P+ G
Sbjct: 221 SYGLQPYCG 229
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 55.8 bits (135), Expect = 2e-08
Identities = 53/241 (21%), Positives = 90/241 (37%), Gaps = 52/241 (21%)
Query: 69 LLKVLGKGSFGK--VFLAELKGTDYYYAVKCLKKDVVLEDDDVEC-TLIERKVLALGTKH 125
LL ++GK V LA+ K T+ AVK + L+ E L+++++
Sbjct: 2 LLTLIGKCFEDLMIVHLAKHKPTNTLVAVK----KINLDSCSKEDLKLLQQEI------- 50
Query: 126 PYLCHLFC---------TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
+F DS L+ V LM Y + DL+
Sbjct: 51 -ITSRQLQHPNILPYVTSFIVDSELYVVSP------------------LMAYGSCEDLLK 91
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
G E F ++++ + ++H KG ++R +K +ILL +G V ++
Sbjct: 92 THFPEG-LPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVS 150
Query: 237 QIYLDKTTDTFCGTPDY-------MAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPF 287
I K P ++PE+++ YN+ D +S GI E+ G PF
Sbjct: 151 MIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPF 210
Query: 288 S 288
Sbjct: 211 K 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 3e-08
Identities = 60/237 (25%), Positives = 99/237 (41%), Gaps = 39/237 (16%)
Query: 73 LGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+G+G++G V+ A+ K D YA+K +E + + L KHP +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDDRDYALK------QIEGTGISMSACREIALLRELKHPNVIS 62
Query: 131 LFCTF--QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
L F D ++ + +Y AE DL + ++ + G
Sbjct: 63 LQKVFLSHADRKVWLLFDY-------------AEHDLWHIIKFHRASKANKKPVQLPRGM 109
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE----GHVRIADFGMCKL-------Q 237
+ +I+ G+ +LH +++RDLK NIL+ E G V+IAD G +L
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
LD TF Y APE++ G + Y + +D W+ G + E+ + F ED
Sbjct: 170 ADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 54.3 bits (130), Expect = 3e-08
Identities = 40/149 (26%), Positives = 68/149 (45%), Gaps = 21/149 (14%)
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARF----------YAAEIVSGMRFLHKKGIVYRDLK 214
+ME + GDL +++ E A EI GM +L+ V+RDL
Sbjct: 87 IMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANKFVHRDLA 146
Query: 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCV 268
N ++ + V+I DFGM + IY TD + +M+PE +K +
Sbjct: 147 ARNCMVAEDFTVKIGDFGMTR-DIY---ETDYYRKGGKGLLPVRWMSPESLKDGVFTTYS 202
Query: 269 DWWSFGILLYEMH-VGQSPFSGCDEDELF 296
D WSFG++L+E+ + + P+ G +++
Sbjct: 203 DVWSFGVVLWEIATLAEQPYQGMSNEQVL 231
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 55.6 bits (134), Expect = 4e-08
Identities = 63/253 (24%), Positives = 103/253 (40%), Gaps = 27/253 (10%)
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM----EYLNGGDLMF 176
L T P H F+ ++ L + + N L+ +G +A L+ EY+ G L
Sbjct: 11 LRTDAPEEEHQRARFRRETALCARLYHPNIVALLDSG--EAPPGLLFAVFEYVPGRTLRE 68
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGM 233
+ G G +++ + H +GIV+RDLK NI++ H ++ DFG+
Sbjct: 69 VLAADGALPAGETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGI 128
Query: 234 CKL--------QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS 285
L L +TT+ GTP Y APE ++G D +++G++ E GQ
Sbjct: 129 GTLLPGVRDADVATLTRTTE-VLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQR 187
Query: 286 PFSGCDEDELFWSICNERP-RFPQFL-SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343
G E+ + + P ++ +L L+KD +R S
Sbjct: 188 VVQGASVAEILYQQLSPVDVSLPPWIAGHPLGQVLRKALNKDPRQRAASAP-------AL 240
Query: 344 HEYFRGLDWQALE 356
E FR L+ AL
Sbjct: 241 AERFRALELCALV 253
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 5e-08
Identities = 51/225 (22%), Positives = 95/225 (42%), Gaps = 18/225 (8%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT--LIERKVLAL 121
L F+++ L G+FGK+F+ L+ ++ V + LI ++V A
Sbjct: 147 LAHFRVIDDLPAGAFGKIFICALRA---STEEAEARRGVNSTNQGKPKCERLIAKRVKAG 203
Query: 122 GTKHPYLCHLFCTFQTDSH--LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
L + +H + + E L K + DL ++
Sbjct: 204 SRAAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAF----D 259
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
R + R +++ + ++H K +++RD+KL+NI L+ +G + + DFG +
Sbjct: 260 WKDRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTA---MP 316
Query: 240 LDKTTDTF----CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280
+K + F GT +PEI+ G Y + D WS G++L +M
Sbjct: 317 FEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361
|
Length = 501 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 53.4 bits (128), Expect = 7e-08
Identities = 67/254 (26%), Positives = 109/254 (42%), Gaps = 38/254 (14%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYA---VKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
K +G G FGKV L E+ + Y A VK L+ +++ + +E +H
Sbjct: 1 KEIGNGWFGKVILGEVN-SGYTPAQVVVKELRVSASVQE---QMKFLEEAQPYRSLQHSN 56
Query: 128 L--CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
L C CT T VME+ GDL G ++ R +LM D
Sbjct: 57 LLQCLGQCTEVTP--YLLVMEFCPLGDL--KGYLRSCR-------KAELM-------TPD 98
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--T 243
+ A EI G+ LHK ++ DL L N LL + V+I D+G+ + D T
Sbjct: 99 PTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVT 158
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCV-------DWWSFGILLYEM-HVGQSPFSG-CDEDE 294
D ++APE++ + N V + WS G+ ++E+ +G P+ DE
Sbjct: 159 PDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQV 218
Query: 295 LFWSICNERPRFPQ 308
L +++ ++ + P+
Sbjct: 219 LTYTVREQQLKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 53.6 bits (129), Expect = 9e-08
Identities = 19/39 (48%), Positives = 28/39 (71%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
+ FDK FT E P LTP D+ ++ ++DQ++FQGFS+ N
Sbjct: 286 SAENFDKFFTREPPVLTPPDKLVIANIDQSEFQGFSFVN 324
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 52.8 bits (127), Expect = 1e-07
Identities = 20/38 (52%), Positives = 26/38 (68%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYT 487
DV FD FT E+P LTP D I+ ++DQ +F+GFSY
Sbjct: 281 DVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGFSYI 318
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|214529 smart00133, S_TK_X, Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 3e-07
Identities = 18/42 (42%), Positives = 21/42 (50%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
D FD FT E P LTPVD + + Q F+GFSY
Sbjct: 23 SPTDTSNFDPEFTEETPVLTPVDSPLSGGIQQEPFRGFSYVF 64
|
Length = 64 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 3e-07
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 39/237 (16%)
Query: 73 LGKGSFGKVFLAELK-GTDYY-YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130
+G+G++G V+ A+ K G D YA+K +E + + L KHP +
Sbjct: 9 VGRGTYGHVYKAKRKDGKDEKEYALK------QIEGTGISMSACREIALLRELKHPNVIA 62
Query: 131 LFCTF--QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
L F +D ++ + +Y AE DL + ++ +
Sbjct: 63 LQKVFLSHSDRKVWLLFDY-------------AEHDLWHIIKFHRASKANKKPMQLPRSM 109
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE----GHVRIADFGMCKL-------Q 237
+ +I+ G+ +LH +++RDLK NIL+ E G V+IAD G +L
Sbjct: 110 VKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPL 169
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
LD TF Y APE++ G + Y + +D W+ G + E+ + F ED
Sbjct: 170 ADLDPVVVTFW----YRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQED 222
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 3e-07
Identities = 52/251 (20%), Positives = 95/251 (37%), Gaps = 32/251 (12%)
Query: 71 KVLGKGSFGKVFLAEL-KGTDY-YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYL 128
+G G FGKV L E +G VK L+ ++ ++ HP +
Sbjct: 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASATPDEQL---LFLQEVQPYRELNHPNV 57
Query: 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
V+E+ GDL ++ R ++ + D++ +
Sbjct: 58 LQCLGQCIESIPYLLVLEFCPLGDL--KNYLRSNRGMVAQMAQKDVLQRM---------- 105
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDT 246
A E+ SG+ +LH+ ++ DL L N L + V+I D+G+ Q D T D
Sbjct: 106 ----ACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDC 161
Query: 247 FCGTPDYMAPEI-------IKGLKYNQCVDWWSFGILLYEM-HVGQSPFSG-CDEDELFW 297
++APE+ + + + WS G+ ++E+ P+ DE L
Sbjct: 162 HAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQ 221
Query: 298 SICNERPRFPQ 308
+ + + P+
Sbjct: 222 VVREQDIKLPK 232
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 5e-07
Identities = 19/39 (48%), Positives = 28/39 (71%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
DV FD+ FT E P LTPVD +++ ++Q +F+GFS+ N
Sbjct: 283 DVNNFDQDFTKEEPVLTPVDPAVIKQINQEEFRGFSFFN 321
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 48.9 bits (117), Expect = 3e-06
Identities = 17/42 (40%), Positives = 22/42 (52%), Gaps = 1/42 (2%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRT-ILESMDQTQFQGFSYT 487
DV FD+ FT+E P LTP +L +Q F+GF Y
Sbjct: 283 GPEDVSNFDEEFTSEAPVLTPPREPRLLTEEEQELFRGFDYV 324
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.4 bits (115), Expect = 5e-06
Identities = 58/241 (24%), Positives = 100/241 (41%), Gaps = 52/241 (21%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK-DVVLEDDDVECTLIERKVLALGTKH 125
F++L +LG+G+FGKV A + Y AVK ++ D +E +E+ A
Sbjct: 131 FKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPKYTRDAKIEIQFMEKVRQADPADR 190
Query: 126 PYLCHLFCTFQTDS-HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
L + FQ ++ H+ VM +Y G L+ I + G F
Sbjct: 191 FPLMKIQRYFQNETGHMCIVMP--------------------KY--GPCLLDWIMKHGPF 228
Query: 185 DEGRARFYAAEIV----SGMRFLHKK-GIVYRDLKLDNILLDYEG--------------- 224
+ A+I+ + + H + +++ DLK +NIL++
Sbjct: 229 SHR----HLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284
Query: 225 -HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283
VRI D G C + + + T Y +PE++ GL + D WS G ++YE++ G
Sbjct: 285 CRVRICDLGGCCDERH---SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTG 341
Query: 284 Q 284
+
Sbjct: 342 K 342
|
Length = 467 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 8e-06
Identities = 20/42 (47%), Positives = 26/42 (61%)
Query: 448 ALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 489
A D FDK F E+P L+ DR ++ SMDQ F+ FS+ NP
Sbjct: 275 ANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFENFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 18/40 (45%), Positives = 28/40 (70%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 489
D FD+ F +E+P L+ D+ +++SMDQ+ F GFS+ NP
Sbjct: 277 DYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGFSFINP 316
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 46.5 bits (110), Expect = 1e-05
Identities = 19/39 (48%), Positives = 28/39 (71%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
D + FDK FT P LTP D+ ++ ++DQ++F+GFSY N
Sbjct: 285 DAENFDKFFTRHPPVLTPPDQEVIMNLDQSEFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 1e-05
Identities = 27/103 (26%), Positives = 54/103 (52%), Gaps = 1/103 (0%)
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG 249
+++ +++ G++++H +++RDLK N+LL+ ++I DFG+ + +
Sbjct: 111 QYFLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVV 170
Query: 250 TPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
T Y APE++ +Y +D WS G + E+ + F G D
Sbjct: 171 TRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKD 213
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 46.0 bits (109), Expect = 2e-05
Identities = 17/38 (44%), Positives = 25/38 (65%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYT 487
DV FD F E P LTP++ ++L ++Q +F+ FSYT
Sbjct: 282 DVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRNFSYT 319
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 2e-05
Identities = 58/235 (24%), Positives = 100/235 (42%), Gaps = 38/235 (16%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
D + ++ ++LG G FG++ LK + A+ L+ D L E L
Sbjct: 3 DNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAE--AL 58
Query: 120 ALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
LG H + L + + V EY++ G L + L K E L+ G LM +
Sbjct: 59 TLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGAL-DSFLRKHEGQLV----AGQLMGML 113
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ SGM++L + G V++ L +L++ + +I+ F +LQ
Sbjct: 114 PG---------------LASGMKYLSEMGYVHKGLAAHKVLVNSDLVCKISGFR--RLQ- 155
Query: 239 YLDKTTDTFCGTPD-----YMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPF 287
DK+ + + APE I+ ++ D WSFGI+++E M G+ P+
Sbjct: 156 -EDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPY 209
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 2e-05
Identities = 20/44 (45%), Positives = 33/44 (75%), Gaps = 4/44 (9%)
Query: 195 EIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG----MC 234
++++G+R LH+ GIV+RD+K +N+L+ +G V+I DFG MC
Sbjct: 317 QVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMC 360
|
Length = 507 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 45.2 bits (107), Expect = 4e-05
Identities = 17/39 (43%), Positives = 24/39 (61%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
D+ FD FT E LTP D ++ +DQ++F+GF Y N
Sbjct: 291 DLDNFDPQFTDEPVQLTPDDPDVIARIDQSEFEGFEYIN 329
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 5e-05
Identities = 18/35 (51%), Positives = 25/35 (71%)
Query: 454 FDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
FDK FT +P LTP D+ ++ ++DQ F+GFSY N
Sbjct: 289 FDKFFTRGQPVLTPPDQLVIANIDQADFEGFSYVN 323
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 5e-04
Identities = 55/225 (24%), Positives = 94/225 (41%), Gaps = 43/225 (19%)
Query: 73 LGKGSFGKVFLAELKGTDYYYA---VKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLC 129
+G G FGKV L+E+ TD A VK LK + ++ + + L G + L
Sbjct: 3 IGNGWFGKVLLSEIY-TDTGVARVVVKELKANASSKEQN--------EFLQQGDPYRILQ 53
Query: 130 H---LFCTFQTDSHL--FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H L C Q + V EY GDL K+ ++ + +Q+
Sbjct: 54 HPNILQCLGQCVEAIPYLLVFEYCELGDL------KSYLSQEQWHRRNSQLLLLQR---- 103
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--K 242
A EI +G+ +HK ++ DL L N L + V++ D+G+ + D +
Sbjct: 104 -------MACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIE 156
Query: 243 TTDTFCGTPDYMAPEIIKGL-------KYNQCVDWWSFGILLYEM 280
T D C ++APE++ + + + W+ G+ L+E+
Sbjct: 157 TEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWEL 201
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 6e-04
Identities = 30/109 (27%), Positives = 47/109 (43%), Gaps = 7/109 (6%)
Query: 387 PIQMPQVLFQLHALDVKYFDKSFTAERPCLTPV-------DRTILESMDQTQFQGFSYTN 439
PI++P+ L + +K F ER P T S+D + T
Sbjct: 219 PIRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTP 278
Query: 440 PNATDFLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
P ++ FD FT+E LTP D +++ +DQ++F+GF Y N
Sbjct: 279 PFKPQITDDYGLENFDTQFTSEPVQLTPDDEDVIKRIDQSEFEGFEYIN 327
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 7e-04
Identities = 18/40 (45%), Positives = 23/40 (57%), Gaps = 1/40 (2%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 489
DV FD FT + P +P D T+ ES +Q F GF+Y P
Sbjct: 285 DVSQFDSKFTRQTPVDSPDDSTLSESANQI-FLGFTYVAP 323
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 7e-04
Identities = 41/179 (22%), Positives = 65/179 (36%), Gaps = 22/179 (12%)
Query: 166 MEYLNGGDLMFHIQQSGRFDEGRARFYAA-EIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
EY+ G L + + + A ++ S + +L K +V+ ++ NIL+
Sbjct: 79 EEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNILV---- 134
Query: 225 HVRIADFGMCKLQIYL-DKTTDTFCGTPDY-------MAPEIIKGL--KYNQCVDWWSFG 274
R I L D + + +APE I+ D WSFG
Sbjct: 135 -ARYGLNEGYVPFIKLSDPGIPITVLSREERVERIPWIAPECIRNGQASLTIAADKWSFG 193
Query: 275 ILLYEM-HVGQSPFSGCD--EDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRL 330
L E+ G+ P S E E F+ ++ R P E N++ D TKR
Sbjct: 194 TTLLEICSNGEEPLSTLSSSEKERFYQ---DQHRLPMPDCAELANLINQCWTYDPTKRP 249
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 38.9 bits (91), Expect = 0.002
Identities = 25/82 (30%), Positives = 39/82 (47%), Gaps = 13/82 (15%)
Query: 199 GMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEI 258
+R LH++ K NILL ++G +++ G + P +MAPE+
Sbjct: 29 ALRELHRQA------KSGNILLTWDGLLKL--DGSVAFK---TPEQSR--PDPYFMAPEV 75
Query: 259 IKGLKYNQCVDWWSFGILLYEM 280
I+G Y + D +S GI LYE
Sbjct: 76 IQGQSYTEKADIYSLGITLYEA 97
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 39.7 bits (92), Expect = 0.003
Identities = 17/35 (48%), Positives = 22/35 (62%)
Query: 454 FDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488
FD FT E LTP D I+ +DQ++F+GF Y N
Sbjct: 295 FDAQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYIN 329
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.003
Identities = 20/81 (24%), Positives = 38/81 (46%), Gaps = 4/81 (4%)
Query: 253 YMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310
Y + +++ + +Y D +S G++L+E+ G+ PF E++ I N+ L
Sbjct: 186 YFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTTKEIYDLIINKNNSLKLPL 245
Query: 311 S--VEAKNILVHLLDKDTTKR 329
+E K I+ D+ KR
Sbjct: 246 DCPLEIKCIVEACTSHDSIKR 266
|
Length = 283 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 39.8 bits (93), Expect = 0.004
Identities = 51/223 (22%), Positives = 90/223 (40%), Gaps = 50/223 (22%)
Query: 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLCH 130
V+ +G G + + + VK E +DV ++ ++ +G +HP +
Sbjct: 697 VISRGKKGASYKGKSIKNGMQFVVK--------EINDVN-SIPSSEIADMGKLQHPNIVK 747
Query: 131 LFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRAR 190
L +++ + + EY+ G ++L E L R R
Sbjct: 748 LIGLCRSEKGAYLIHEYIEG------------KNLSEVLRN------------LSWERRR 783
Query: 191 FYAAEIVSGMRFLH---KKGIVYRDLKLDNILLD--YEGHVRIADFGM-CKLQIYLDKTT 244
A I +RFLH +V +L + I++D E H+R++ G+ C T
Sbjct: 784 KIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLRLSLPGLLC---------T 834
Query: 245 DTFCGTPD-YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP 286
DT C Y+APE + + D + FG++L E+ G+SP
Sbjct: 835 DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 494 | |||
| KOG0694|consensus | 694 | 100.0 | ||
| KOG0598|consensus | 357 | 100.0 | ||
| KOG0696|consensus | 683 | 100.0 | ||
| KOG0616|consensus | 355 | 100.0 | ||
| KOG0605|consensus | 550 | 100.0 | ||
| KOG0690|consensus | 516 | 100.0 | ||
| KOG0695|consensus | 593 | 100.0 | ||
| KOG0592|consensus | 604 | 100.0 | ||
| KOG0610|consensus | 459 | 100.0 | ||
| KOG0612|consensus | 1317 | 100.0 | ||
| KOG0575|consensus | 592 | 100.0 | ||
| KOG0986|consensus | 591 | 100.0 | ||
| KOG0615|consensus | 475 | 100.0 | ||
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| KOG0614|consensus | 732 | 100.0 | ||
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0608|consensus | 1034 | 100.0 | ||
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| KOG0581|consensus | 364 | 100.0 | ||
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0588|consensus | 786 | 100.0 | ||
| KOG0595|consensus | 429 | 100.0 | ||
| KOG0583|consensus | 370 | 100.0 | ||
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0597|consensus | 808 | 100.0 | ||
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0580|consensus | 281 | 100.0 | ||
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0591|consensus | 375 | 100.0 | ||
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0033|consensus | 355 | 100.0 | ||
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0585|consensus | 576 | 100.0 | ||
| KOG0593|consensus | 396 | 100.0 | ||
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0611|consensus | 668 | 100.0 | ||
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| KOG0599|consensus | 411 | 100.0 | ||
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| KOG0661|consensus | 538 | 100.0 | ||
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| KOG0032|consensus | 382 | 100.0 | ||
| KOG0578|consensus | 550 | 100.0 | ||
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0198|consensus | 313 | 100.0 | ||
| KOG0600|consensus | 560 | 100.0 | ||
| KOG0663|consensus | 419 | 100.0 | ||
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG4717|consensus | 864 | 100.0 | ||
| KOG0659|consensus | 318 | 100.0 | ||
| KOG0582|consensus | 516 | 100.0 | ||
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0660|consensus | 359 | 100.0 | ||
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG0604|consensus | 400 | 100.0 | ||
| KOG0201|consensus | 467 | 100.0 | ||
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| KOG0594|consensus | 323 | 100.0 | ||
| KOG0607|consensus | 463 | 100.0 | ||
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0589|consensus | 426 | 100.0 | ||
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0192|consensus | 362 | 100.0 | ||
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| KOG0667|consensus | 586 | 100.0 | ||
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| KOG0658|consensus | 364 | 100.0 | ||
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG0586|consensus | 596 | 100.0 | ||
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0579|consensus | 1187 | 100.0 | ||
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| KOG4236|consensus | 888 | 100.0 | ||
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| KOG0983|consensus | 391 | 100.0 | ||
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| KOG0197|consensus | 468 | 100.0 | ||
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG4279|consensus | 1226 | 100.0 | ||
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0603|consensus | 612 | 100.0 | ||
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0574|consensus | 502 | 100.0 | ||
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0596|consensus | 677 | 100.0 | ||
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| KOG0671|consensus | 415 | 100.0 | ||
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| KOG4721|consensus | 904 | 100.0 | ||
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0662|consensus | 292 | 100.0 | ||
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| KOG0577|consensus | 948 | 100.0 | ||
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0193|consensus | 678 | 100.0 | ||
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| KOG1989|consensus | 738 | 100.0 | ||
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG4645|consensus | 1509 | 100.0 | ||
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0194|consensus | 474 | 100.0 | ||
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG1026|consensus | 774 | 100.0 | ||
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0584|consensus | 632 | 100.0 | ||
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0666|consensus | 438 | 100.0 | ||
| KOG1035|consensus | 1351 | 100.0 | ||
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1095|consensus | 1025 | 100.0 | ||
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG1006|consensus | 361 | 100.0 | ||
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG2345|consensus | 302 | 100.0 | ||
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| KOG0587|consensus | 953 | 100.0 | ||
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0669|consensus | 376 | 100.0 | ||
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG4250|consensus | 732 | 100.0 | ||
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 100.0 | |
| KOG1151|consensus | 775 | 100.0 | ||
| KOG4257|consensus | 974 | 100.0 | ||
| KOG1187|consensus | 361 | 100.0 | ||
| KOG0665|consensus | 369 | 100.0 | ||
| KOG1094|consensus | 807 | 100.0 | ||
| KOG4278|consensus | 1157 | 100.0 | ||
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| KOG0196|consensus | 996 | 100.0 | ||
| KOG0670|consensus | 752 | 100.0 | ||
| KOG1290|consensus | 590 | 100.0 | ||
| KOG0199|consensus | 1039 | 100.0 | ||
| KOG1152|consensus | 772 | 100.0 | ||
| KOG0984|consensus | 282 | 100.0 | ||
| KOG1027|consensus | 903 | 100.0 | ||
| KOG0668|consensus | 338 | 100.0 | ||
| KOG0664|consensus | 449 | 100.0 | ||
| KOG0606|consensus | 1205 | 100.0 | ||
| KOG0200|consensus | 609 | 100.0 | ||
| KOG0576|consensus | 829 | 100.0 | ||
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 100.0 | |
| KOG3653|consensus | 534 | 100.0 | ||
| KOG1025|consensus | 1177 | 100.0 | ||
| KOG2052|consensus | 513 | 99.97 | ||
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.97 | |
| KOG1167|consensus | 418 | 99.97 | ||
| KOG1345|consensus | 378 | 99.97 | ||
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG1024|consensus | 563 | 99.97 | ||
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.96 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.95 | |
| KOG0590|consensus | 601 | 99.95 | ||
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.95 | |
| KOG1165|consensus | 449 | 99.95 | ||
| KOG1164|consensus | 322 | 99.94 | ||
| KOG1163|consensus | 341 | 99.93 | ||
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.93 | |
| KOG0606|consensus | 1205 | 99.91 | ||
| KOG1240|consensus | 1431 | 99.89 | ||
| KOG4158|consensus | 598 | 99.89 | ||
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.89 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.89 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.88 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.88 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.88 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.84 | |
| KOG1166|consensus | 974 | 99.83 | ||
| KOG0195|consensus | 448 | 99.82 | ||
| KOG0590|consensus | 601 | 99.81 | ||
| smart00090 | 237 | RIO RIO-like kinase. | 99.8 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.78 | |
| KOG1033|consensus | 516 | 99.78 | ||
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.75 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.74 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.72 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.72 | |
| KOG1023|consensus | 484 | 99.67 | ||
| KOG0601|consensus | 524 | 99.67 | ||
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.65 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.64 | |
| KOG0601|consensus | 524 | 99.51 | ||
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 99.48 | |
| KOG1243|consensus | 690 | 99.47 | ||
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.44 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.37 | |
| KOG1266|consensus | 458 | 99.36 | ||
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.1 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 99.09 | |
| KOG3741|consensus | 655 | 99.08 | ||
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.05 | |
| KOG2137|consensus | 700 | 99.03 | ||
| KOG3087|consensus | 229 | 99.0 | ||
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.81 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.74 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 98.73 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 98.69 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.66 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.66 | |
| KOG0576|consensus | 829 | 98.46 | ||
| PRK09902 | 216 | hypothetical protein; Provisional | 98.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.36 | |
| KOG1035|consensus | 1351 | 98.35 | ||
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.31 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.29 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.27 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 98.2 | |
| PF00433 | 48 | Pkinase_C: Protein kinase C terminal domain; Inter | 98.11 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.1 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 98.09 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 97.96 | |
| KOG1235|consensus | 538 | 97.89 | ||
| KOG1826|consensus | 2724 | 97.88 | ||
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.84 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 97.76 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 97.68 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.66 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 97.62 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 97.58 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.54 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 97.53 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.42 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 97.33 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.31 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 97.14 | |
| KOG2270|consensus | 520 | 96.85 | ||
| TIGR01767 | 370 | MTRK 5-methylthioribose kinase. This enzyme is inv | 96.73 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 96.68 | |
| PLN02236 | 344 | choline kinase | 96.62 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 96.52 | |
| KOG0696|consensus | 683 | 96.52 | ||
| KOG2268|consensus | 465 | 96.5 | ||
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.42 | |
| PLN02756 | 418 | S-methyl-5-thioribose kinase | 96.35 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 96.08 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 96.02 | |
| smart00133 | 64 | S_TK_X Extension to Ser/Thr-type protein kinases. | 96.02 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.94 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 95.92 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 95.83 | |
| KOG0694|consensus | 694 | 95.83 | ||
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 95.79 | |
| PRK12396 | 409 | 5-methylribose kinase; Reviewed | 95.61 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 95.59 |
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-84 Score=659.76 Aligned_cols=332 Identities=52% Similarity=0.958 Sum_probs=316.1
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
..+.+++|.++++||+|+||+|++|..+.+++.||||+++|..+..+++++..+.|+.++....+||++++|+.+||+++
T Consensus 363 ~~~~l~~F~~l~vLGkGsFGkV~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~ 442 (694)
T KOG0694|consen 363 GPLTLDDFRLLAVLGRGSFGKVLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKE 442 (694)
T ss_pred CcccccceEEEEEeccCcCceEEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCC
Confidence 47889999999999999999999999999999999999999999999999999999999998778999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
++|+||||+. ||+ +.++++.+.|+|..+++|+++|++||.|||++||||||||.+|||
T Consensus 443 ~l~fvmey~~---------------------Ggd-m~~~~~~~~F~e~rarfyaAev~l~L~fLH~~~IIYRDlKLdNiL 500 (694)
T KOG0694|consen 443 HLFFVMEYVA---------------------GGD-LMHHIHTDVFSEPRARFYAAEVVLGLQFLHENGIIYRDLKLDNLL 500 (694)
T ss_pred eEEEEEEecC---------------------CCc-EEEEEecccccHHHHHHHHHHHHHHHHHHHhcCceeeecchhheE
Confidence 9999999999 555 446777789999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
||.+||+||+|||+||.....+..+.|+||||.|||||++.+..|+.++|||||||+|||||.|..||.|+++++++..|
T Consensus 501 LD~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI 580 (694)
T KOG0694|consen 501 LDTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSI 580 (694)
T ss_pred EcccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHH
Confidence 99999999999999999887888999999999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCccccc
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKL 379 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~ 379 (494)
++..+.+|.++|.++.+++++||.+||++|+|+.+ .++++|++||||+.|+|++|++++++|||+|++.
T Consensus 581 ~~d~~~yP~~ls~ea~~il~~ll~k~p~kRLG~~e-~d~~~i~~hpFFr~i~w~~L~~r~i~PPf~P~i~---------- 649 (694)
T KOG0694|consen 581 VNDEVRYPRFLSKEAIAIMRRLLRKNPEKRLGSGE-RDAEDIKKHPFFRSIDWDDLLNRRIKPPFVPTIK---------- 649 (694)
T ss_pred hcCCCCCCCcccHHHHHHHHHHhccCcccccCCCC-CCchhhhhCCccccCCHHHHhhccCCCCCCcccC----------
Confidence 99999999999999999999999999999999986 4899999999999999999999999999999876
Q ss_pred CCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccchhccccccccccCCc
Q psy8309 380 SSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDFLHALDVKYFDKSFT 459 (494)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~d~~f~ 459 (494)
+++|++|||.+||
T Consensus 650 -------------------------------------------------------------------~~~D~snFd~eFt 662 (694)
T KOG0694|consen 650 -------------------------------------------------------------------GPEDVSNFDEEFT 662 (694)
T ss_pred -------------------------------------------------------------------Chhhhcccchhhh
Confidence 2357888888899
Q ss_pred CCCCCCCCchhHHhhhccccccccccccCCCC
Q psy8309 460 AERPCLTPVDRTILESMDQTQFQGFSYTNPNA 491 (494)
Q Consensus 460 ~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~ 491 (494)
.+.|.|||.+..++..++|++|.||||+||.+
T Consensus 663 ~e~p~Lt~~~~~~l~~~~q~~F~~Fs~~~~~~ 694 (694)
T KOG0694|consen 663 SEKPALTPSDPRPLTEEEQEAFRDFSFVAEWC 694 (694)
T ss_pred cCCCccCCCCccccchhhHHHhcCccccCCCC
Confidence 99999999999999999999999999999975
|
|
| >KOG0598|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-82 Score=605.33 Aligned_cols=329 Identities=45% Similarity=0.868 Sum_probs=304.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+|+++++++|++.||+|+++|..+.....++++..|+.+|.. ++||+||++++.||+.++
T Consensus 21 ~~~~~dF~~lkviGkG~fGkV~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~-v~hPFiv~l~ysFQt~~k 99 (357)
T KOG0598|consen 21 MVGPDDFEILKVIGKGSFGKVFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSK-IKHPFIVKLIYSFQTEEK 99 (357)
T ss_pred cCChhheeeeeeeeccCCceEEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHh-CCCCcEeeeEEecccCCe
Confidence 4567899999999999999999999999999999999999999888899999999999995 899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|||+||+. ||+|+.++++++.|+|..+++|+++|++||.|||++||||||||||||||
T Consensus 100 LylVld~~~---------------------GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~gIiyRDlKPENILL 158 (357)
T KOG0598|consen 100 LYLVLDYLN---------------------GGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSKGIIYRDLKPENILL 158 (357)
T ss_pred EEEEEeccC---------------------CccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhCCeeeccCCHHHeee
Confidence 999999998 88899999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
|.+|||+|+|||||+.....+..+.++|||++|||||++.+.+|+.++|||||||++|||++|.+||.+.+..+++++|.
T Consensus 159 d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~~~~~~~I~ 238 (357)
T KOG0598|consen 159 DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDVKKMYDKIL 238 (357)
T ss_pred cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccHHHHHHHHh
Confidence 99999999999999987777888999999999999999999999999999999999999999999999999999999999
Q ss_pred hCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCccccc
Q psy8309 301 NER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKL 379 (494)
Q Consensus 301 ~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~ 379 (494)
.++ +..|..++.++++||++||.+||++|+|+. .++++|++||||++++|+++.++++.|||+|.+.
T Consensus 239 ~~k~~~~p~~ls~~ardll~~LL~rdp~~RLg~~--~d~~~ik~HpfF~~inW~~l~~k~l~PpF~P~~~---------- 306 (357)
T KOG0598|consen 239 KGKLPLPPGYLSEEARDLLKKLLKRDPRQRLGGP--GDAEEIKRHPFFKGINWEKLLAKKLSPPFKPNVT---------- 306 (357)
T ss_pred cCcCCCCCccCCHHHHHHHHHHhccCHHHhcCCC--CChHHhhcCcccccCCHHHHHhcCCCCCeecCCC----------
Confidence 998 555566999999999999999999999843 4899999999999999999999999999999998
Q ss_pred CCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCc--c-----ccCcccCCCccCeeeeCCC
Q psy8309 380 SSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDR--T-----ILESMDQTQFQGFSYTNPN 441 (494)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~--~-----~~~~~~~~~f~~f~~~~~~ 441 (494)
+..|+++||.+|+.+.+..++... . ......+..|.||+|.+++
T Consensus 307 ------------------~~~~~~~Fd~eft~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~gft~~~~s 357 (357)
T KOG0598|consen 307 ------------------GLEDTSNFDNEFTSYTVDYSPVDSSPDMSAFTAFSRTYNKIFPGFTYVASS 357 (357)
T ss_pred ------------------CccccccccHHHHhccccCCccccCcccccccccccccccccCCccccCCC
Confidence 889999999999998766665531 1 1222345679999998753
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-79 Score=586.31 Aligned_cols=335 Identities=56% Similarity=0.985 Sum_probs=320.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+...||.++.+||+|+||+|.+|..++|.+.||||+++|+.+.+.+.++..+.|+.+|+...+-|++++++.+|++-+.
T Consensus 345 ~i~~tDFnFl~VlGKGSFGKVlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDR 424 (683)
T KOG0696|consen 345 RIKATDFNFLMVLGKGSFGKVLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDR 424 (683)
T ss_pred ceeecccceEEEeccCccceeeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhh
Confidence 45678999999999999999999999999999999999999999999999999999999987889999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ ||+|+.++++-++|.|..+.+|+++|+.||-+||++|||+||||.+|||+
T Consensus 425 LyFVMEyvn---------------------GGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~kgIiYRDLKLDNvmL 483 (683)
T KOG0696|consen 425 LYFVMEYVN---------------------GGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVML 483 (683)
T ss_pred eeeEEEEec---------------------CchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhcCCeeeeeccccceEe
Confidence 999999999 77889999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|||||+|||+|+.....+..+.++||||.|+|||++..++|+..+||||+||+|||||.|++||.|.++.++++.|.
T Consensus 484 d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~elF~aI~ 563 (683)
T KOG0696|consen 484 DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQAIM 563 (683)
T ss_pred ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999998888899999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
.....+|..+|.++.++++++|.+.|.+|+|+.. .+..+|..||||+.|||++++.++++|||+|.+.
T Consensus 564 ehnvsyPKslSkEAv~ickg~ltK~P~kRLGcg~-~ge~di~~H~FFR~iDWek~E~~eiqPPfkPk~k----------- 631 (683)
T KOG0696|consen 564 EHNVSYPKSLSKEAVAICKGLLTKHPGKRLGCGP-EGERDIREHPFFRRIDWEKLERREIQPPFKPKIK----------- 631 (683)
T ss_pred HccCcCcccccHHHHHHHHHHhhcCCccccCCCC-ccccchhhCcchhhccHHHHhhccCCCCCCCccc-----------
Confidence 9999999999999999999999999999999976 3678999999999999999999999999999775
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccchhccccccccccCCcC
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDFLHALDVKYFDKSFTA 460 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~d~~f~~ 460 (494)
. ..+++|||+.||.
T Consensus 632 -----------------~-------------------------------------------------~r~~eNFD~~Ft~ 645 (683)
T KOG0696|consen 632 -----------------C-------------------------------------------------GRDAENFDKFFTR 645 (683)
T ss_pred -----------------c-------------------------------------------------CCchhhhhHHHhc
Confidence 0 1267899999999
Q ss_pred CCCCCCCchhHHhhhccccccccccccCCCCCCC
Q psy8309 461 ERPCLTPVDRTILESMDQTQFQGFSYTNPNATDP 494 (494)
Q Consensus 461 ~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 494 (494)
++|.|||+|+.++.++||++|.||||+||.|..|
T Consensus 646 ~~~~lTPpD~~v~~nldq~eF~gFsfvNpefv~~ 679 (683)
T KOG0696|consen 646 EPTDLTPPDKLVMMNLDQSEFEGFSFVNPEFVKP 679 (683)
T ss_pred CCCCCCCchHHHHhcCchhhcCceeeeChhhcCC
Confidence 9999999999999999999999999999999764
|
|
| >KOG0616|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-75 Score=542.50 Aligned_cols=293 Identities=45% Similarity=0.856 Sum_probs=280.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.+++|++++.||.|+||+|.+++++.+|..||+|++.+..+..-.++++...|+.+|. ...||+++++++.|.+.+++
T Consensus 41 ~~l~dfe~~~tlGtGSFGrV~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~-~v~~PFlv~l~~t~~d~~~l 119 (355)
T KOG0616|consen 41 YSLQDFERLKTLGTGSFGRVHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLK-AVSHPFLVKLYGTFKDNSNL 119 (355)
T ss_pred cchhhhhheeeeccCccceEEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHh-hccCceeEEEEEeeccCCeE
Confidence 67899999999999999999999999999999999999999999999999999999998 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||||||++ ||+|+.++++.++|+|..+++|++||++||+|||+++|+||||||||||||
T Consensus 120 ymvmeyv~---------------------GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~~iiYRDLKPENiLlD 178 (355)
T KOG0616|consen 120 YMVMEYVP---------------------GGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSLDIIYRDLKPENLLLD 178 (355)
T ss_pred EEEEeccC---------------------CccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhcCeeeccCChHHeeec
Confidence 99999999 888899999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+|++||+|||+|+.. ...+.+.||||+|+|||++..++|+.++|||||||++|||+.|.+||.+.++..++++|+.
T Consensus 179 ~~G~iKitDFGFAK~v---~~rT~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~~iY~KI~~ 255 (355)
T KOG0616|consen 179 QNGHIKITDFGFAKRV---SGRTWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPIQIYEKILE 255 (355)
T ss_pred cCCcEEEEeccceEEe---cCcEEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChHHHHHHHHh
Confidence 9999999999999963 3458899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc-cccCCCCCcccccC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP-RVIEPFSSPWIKLS 380 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p-~~~~~~~~~~~~~~ 380 (494)
+++.||..++.++++||++||+.|-.+|.|..+ ++.+||++||||++++|+++.+++++||+.| .+.
T Consensus 256 ~~v~fP~~fs~~~kdLl~~LL~vD~t~R~gnlk-nG~~dIk~H~wF~~v~W~~i~~r~ie~P~~pp~~~----------- 323 (355)
T KOG0616|consen 256 GKVKFPSYFSSDAKDLLKKLLQVDLTKRFGNLK-NGVEDIKNHPWFKGVDWEAILQRKIEPPFEPPNIH----------- 323 (355)
T ss_pred CcccCCcccCHHHHHHHHHHHhhhhHhhhcCcC-CCccccccCcccccccHHHHhhccccCCCCCcccc-----------
Confidence 999999999999999999999999999998765 5899999999999999999999999999999 333
Q ss_pred CCCCCCCccchhhhhhccccccCCCCcc
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKS 408 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~ 408 (494)
...|++|||..
T Consensus 324 -----------------~~gdtsnfd~y 334 (355)
T KOG0616|consen 324 -----------------GPGDTSNFDDY 334 (355)
T ss_pred -----------------CCccccccccc
Confidence 78999999974
|
|
| >KOG0605|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-75 Score=579.92 Aligned_cols=328 Identities=40% Similarity=0.730 Sum_probs=288.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+..++||+++++||+|+||.||+|+.+.||.+||||+++|.......++++++.|+.+|.. .++|+||+|++.||+.++
T Consensus 137 r~~~~DFe~Lk~IgkGAfGeVrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~-~ds~~vVKLyYsFQD~~~ 215 (550)
T KOG0605|consen 137 RLSLDDFELLKVIGKGAFGEVRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAE-VDSPWVVKLYYSFQDKEY 215 (550)
T ss_pred cCCcccchhheeeccccceeEEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhh-cCCCcEEEEEEEecCCCe
Confidence 5678999999999999999999999999999999999999999999999999999999996 899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+||||||++ ||++++.+.+.+.|+|+.+++|+++++.|++.||++|+|||||||+|+||
T Consensus 216 LYLiMEylP---------------------GGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~gyIHRDIKPdNlLi 274 (550)
T KOG0605|consen 216 LYLIMEYLP---------------------GGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQLGYIHRDIKPDNLLI 274 (550)
T ss_pred eEEEEEecC---------------------CccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHcCcccccCChhheee
Confidence 999999999 77888999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeec----------------------c--C-----C------------------cccccCCCCCc
Q psy8309 221 DYEGHVRIADFGMCKLQIY----------------------L--D-----K------------------TTDTFCGTPDY 253 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~----------------------~--~-----~------------------~~~~~~gt~~y 253 (494)
|..||+||+|||||+.... . . . ...+.+|||.|
T Consensus 275 D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDY 354 (550)
T KOG0605|consen 275 DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDY 354 (550)
T ss_pred cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccc
Confidence 9999999999999853110 0 0 0 02356899999
Q ss_pred cChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCCC
Q psy8309 254 MAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTKR 329 (494)
Q Consensus 254 ~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~R 329 (494)
||||++.+.+|+..+|||||||||||||.|.+||.+.++.+++.+|++++ +.+|. .++++|+|||.+||. ||++|
T Consensus 355 iAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~~~s~eA~DLI~rll~-d~~~R 433 (550)
T KOG0605|consen 355 IAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEVDLSDEAKDLITRLLC-DPENR 433 (550)
T ss_pred cchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcCcccHHHHHHHHHHhc-CHHHh
Confidence 99999999999999999999999999999999999999999999999987 66775 578999999999999 99999
Q ss_pred CCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccc
Q psy8309 330 LGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSF 409 (494)
Q Consensus 330 ~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~ 409 (494)
+|+ ++++||++||||++|+|+.|. +.+|||+|.+. ++.|++|||. |
T Consensus 434 LG~---~G~~EIK~HPfF~~v~W~~l~--~~~apfvP~v~----------------------------~~~DT~yFdd-F 479 (550)
T KOG0605|consen 434 LGS---KGAEEIKKHPFFKGVDWDHLR--EMPAPFVPQVN----------------------------SELDTQYFDD-F 479 (550)
T ss_pred cCc---ccHHHHhcCCccccCCcchhh--cCCCCCCCCCC----------------------------Cccccccccc-C
Confidence 985 489999999999999999996 45699999999 8999999994 6
Q ss_pred cCCCCCCCCCCcc----cc-------CcccCCCccCeeeeCCCccch
Q psy8309 410 TAERPCLTPVDRT----IL-------ESMDQTQFQGFSYTNPNATDF 445 (494)
Q Consensus 410 ~~~~~~~~~~~~~----~~-------~~~~~~~f~~f~~~~~~~~~~ 445 (494)
+++.......+.. -. ....+.+|.||+|.+-+....
T Consensus 480 ~e~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~FvgfTyk~~~~~~~ 526 (550)
T KOG0605|consen 480 PEEDSMTPTADKSGPSRKMLSMVDTNNSSKDINFVGFTYKNFDGLNK 526 (550)
T ss_pred cccccCcccccccccchhhhhcccccCCcccccccceeeeccccccc
Confidence 6544322211110 01 113456799999999776543
|
|
| >KOG0690|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-76 Score=550.76 Aligned_cols=336 Identities=47% Similarity=0.869 Sum_probs=316.3
Q ss_pred CCCCCCCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 55 TIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 55 ~~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
...+..++.+++|+.+++||+|.||+|.+|+.+.+++.||||+++|+.+..++++.+.+.|-.+|. ..+||++..|.+.
T Consensus 158 ~~~~~~kvTm~dFdfLKvLGkGTFGKVIL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~-~~~HPFLt~LKYs 236 (516)
T KOG0690|consen 158 EAKRKNKVTMEDFDFLKVLGKGTFGKVILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQ-NCRHPFLTSLKYS 236 (516)
T ss_pred cccccceeccchhhHHHHhcCCccceEEEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHH-hccCcHHHHhhhh
Confidence 445556788999999999999999999999999999999999999999999999999999999998 5799999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
|++.+++|+||||++ ||+|+.++.+...|+|..+++|.++|++||.|||+++||+||||
T Consensus 237 FQt~drlCFVMeyan---------------------GGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~~ivYRDlK 295 (516)
T KOG0690|consen 237 FQTQDRLCFVMEYAN---------------------GGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSRNIVYRDLK 295 (516)
T ss_pred hccCceEEEEEEEcc---------------------CceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhCCeeeeech
Confidence 999999999999998 77888999999999999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
.+|+|+|.+|||||+|||||+..+..+..+.++||||+|+|||++....|+.++|||.+||+||||++|++||+..+...
T Consensus 296 LENLlLDkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~k 375 (516)
T KOG0690|consen 296 LENLLLDKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHEK 375 (516)
T ss_pred hhhheeccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhccCcccccchhH
Confidence 99999999999999999999998888999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCC
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSS 374 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~ 374 (494)
++..|+-+.+.||..++++++.|+.++|.+||.+|+|... .++.||.+|+||.+++|+++..+++.|||+|.+.
T Consensus 376 LFeLIl~ed~kFPr~ls~eAktLLsGLL~kdP~kRLGgGp-dDakEi~~h~FF~~v~W~~~~~Kki~PPfKPqVt----- 449 (516)
T KOG0690|consen 376 LFELILMEDLKFPRTLSPEAKTLLSGLLKKDPKKRLGGGP-DDAKEIMRHRFFASVDWEATYRKKIEPPFKPQVT----- 449 (516)
T ss_pred HHHHHHhhhccCCccCCHHHHHHHHHHhhcChHhhcCCCc-hhHHHHHhhhhhccCCHHHHHHhccCCCCCCCcc-----
Confidence 9999999999999999999999999999999999999755 4889999999999999999999999999999998
Q ss_pred cccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCcccc----CcccCCCccCeeeeCCC
Q psy8309 375 PWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTIL----ESMDQTQFQGFSYTNPN 441 (494)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~----~~~~~~~f~~f~~~~~~ 441 (494)
++.|++|||.+||.++..++|+++... ....+..|..|+|.+..
T Consensus 450 -----------------------SetDTryFD~EFT~q~v~lTPP~r~~~~~~~~~e~~~~FpQFsy~~~~ 497 (516)
T KOG0690|consen 450 -----------------------SETDTRYFDEEFTSQPVTLTPPDRYGSTVDEDEERRPHFPQFSYSASM 497 (516)
T ss_pred -----------------------cccchhhhhhhhhcceeEecCCCCCCcccchhhhhccCCcceeeecch
Confidence 899999999999999999999876432 12345689999998764
|
|
| >KOG0695|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-74 Score=537.95 Aligned_cols=337 Identities=46% Similarity=0.875 Sum_probs=315.5
Q ss_pred CCCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 59 FRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 59 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.....+++|.++++||+|+|++|.+++++.|.+.||||+++|+.+..+..+.-...|+.+.....+||++|.|+.+|+++
T Consensus 244 ~~~l~l~df~ll~vigrgsyakvl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqte 323 (593)
T KOG0695|consen 244 SQGLGLQDFDLLRVIGRGSYAKVLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTE 323 (593)
T ss_pred ccccccccceeeeeecCcchhhhhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhccc
Confidence 34567899999999999999999999999999999999999988877778888888999998888999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+++|.||++ ||+|+.+++++.+|+|+.+++|.++|+.||.|||++|||+||||.+|+
T Consensus 324 srlffvieyv~---------------------ggdlmfhmqrqrklpeeharfys~ei~lal~flh~rgiiyrdlkldnv 382 (593)
T KOG0695|consen 324 SRLFFVIEYVN---------------------GGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHERGIIYRDLKLDNV 382 (593)
T ss_pred ceEEEEEEEec---------------------CcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhcCeeeeeccccce
Confidence 99999999999 777788999999999999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC--------C
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG--------C 290 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~--------~ 290 (494)
|+|..|++||+|+|+|+.....+..+.++||||.|+|||++++..|+..+|||+|||+|+||+.|+.||.- +
T Consensus 383 lldaeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmagrspfdivgm~n~d~n 462 (593)
T KOG0695|consen 383 LLDAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVGMDNPDMN 462 (593)
T ss_pred EEccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcCCCCcceecCCCcccc
Confidence 99999999999999999988889999999999999999999999999999999999999999999999962 2
Q ss_pred CHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccC
Q psy8309 291 DEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370 (494)
Q Consensus 291 ~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~ 370 (494)
.++-+++-|+..+..+|..+|..+..+++..|.+||.+|+|+....+..+++.|+||+.|||+.++++++.|||.|.+.
T Consensus 463 tedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~idwd~leqk~v~ppf~p~i~- 541 (593)
T KOG0695|consen 463 TEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRSIDWDLLEQKQVLPPFQPQIT- 541 (593)
T ss_pred hhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhhCCHHHHhhcccCCCCCCccc-
Confidence 3455677888999999999999999999999999999999998888999999999999999999999999999998775
Q ss_pred CCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccchhcccc
Q psy8309 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDFLHALD 450 (494)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~ 450 (494)
+ .++
T Consensus 542 ---------------------------~-------------------------------------------------d~~ 545 (593)
T KOG0695|consen 542 ---------------------------D-------------------------------------------------DYG 545 (593)
T ss_pred ---------------------------c-------------------------------------------------ccC
Confidence 1 136
Q ss_pred ccccccCCcCCCCCCCCchhHHhhhccccccccccccCCCCCC
Q psy8309 451 VKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATD 493 (494)
Q Consensus 451 ~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~~ 493 (494)
+.|||..||.|+|+|||+|.+++..|||+||+||+||||+.|+
T Consensus 546 l~~fd~qft~e~~qltpdd~d~i~ridqsefegfeyinpl~ms 588 (593)
T KOG0695|consen 546 LDNFDTQFTSEPVQLTPDDEDAIKRIDQSEFEGFEYINPLLMS 588 (593)
T ss_pred ccccccccccCCcccCCCCHHHHHhcchhhcCcceecchhhcc
Confidence 7788999999999999999999999999999999999999885
|
|
| >KOG0592|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-64 Score=501.48 Aligned_cols=271 Identities=38% Similarity=0.694 Sum_probs=253.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+....||.++++||.|+|++|++|+.+.+++.||||++.|..+..+..+..+.+|+.+|....+||.|++|+..|++...
T Consensus 69 kk~~~DF~Fg~~lGeGSYStV~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~s 148 (604)
T KOG0592|consen 69 KKTPNDFKFGKILGEGSYSTVVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEES 148 (604)
T ss_pred cCChhhcchhheeccccceeEEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccc
Confidence 56678999999999999999999999999999999999999888888999999999999976699999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|+||++ +|+|..++.+.|.|+|..+++|++||+.||+|||++||||||||||||||
T Consensus 149 LYFvLe~A~---------------------nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~~GIIHRDlKPENILL 207 (604)
T KOG0592|consen 149 LYFVLEYAP---------------------NGDLLDLIKKYGSFDETCARFYAAEILDALEYLHSNGIIHRDLKPENILL 207 (604)
T ss_pred eEEEEEecC---------------------CCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeE
Confidence 999999999 66667789999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC-------------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD-------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~-------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
|.+|++||+|||.|+...... ....+++||..|.+||+|.....+..+|+|+||||||.|+.|.+||
T Consensus 208 d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPF 287 (604)
T KOG0592|consen 208 DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPF 287 (604)
T ss_pred cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCC
Confidence 999999999999998643211 1125699999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcC
Q psy8309 288 SGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358 (494)
Q Consensus 288 ~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~ 358 (494)
.+.++.-++++|+.-.+.||..+++.++|||+++|..||.+|+ ++++|++||||.+|||+.|.+.
T Consensus 288 ra~NeyliFqkI~~l~y~fp~~fp~~a~dLv~KLLv~dp~~Rl------t~~qIk~HpFF~~Vdw~nlw~~ 352 (604)
T KOG0592|consen 288 RAANEYLIFQKIQALDYEFPEGFPEDARDLIKKLLVRDPSDRL------TSQQIKAHPFFEGVDWENLWQQ 352 (604)
T ss_pred ccccHHHHHHHHHHhcccCCCCCCHHHHHHHHHHHccCccccc------cHHHHhhCcccccCChhhhhhc
Confidence 9999999999999999999999999999999999999999999 5689999999999999998644
|
|
| >KOG0610|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-64 Score=483.27 Aligned_cols=283 Identities=40% Similarity=0.746 Sum_probs=255.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|++++.||.|.-|+||+|+.++++..+|||++.|..+...+...+...|+.||. .++||+++.||..|+++.+
T Consensus 73 ~l~l~~f~llk~LG~GdiG~VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~-~lDHPFlPTLYa~fet~~~ 151 (459)
T KOG0610|consen 73 SLGLRHFRLLKRLGCGDIGTVYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILS-LLDHPFLPTLYASFETDKY 151 (459)
T ss_pred ccCHHHHHHHHHcCCCCceeEEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHH-hcCCCccchhhheeeccce
Confidence 466789999999999999999999999999999999999998888888899999999998 5899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
.|+|||||+||+| ....++ .+.|++..+++|+++|+.||+|||-+||||||||||||
T Consensus 152 ~cl~meyCpGGdL---------------------~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLHmlGivYRDLKPENI 210 (459)
T KOG0610|consen 152 SCLVMEYCPGGDL---------------------HSLRQKQPGKRFSESAARFYAAEVLLALEYLHMLGIVYRDLKPENI 210 (459)
T ss_pred eEEEEecCCCccH---------------------HHHHhhCCCCccchhhHHHHHHHHHHHHHHHHhhceeeccCCccee
Confidence 9999999996555 444443 46899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeee----------------------------------c-c---------------------CC
Q psy8309 219 LLDYEGHVRIADFGMCKLQI----------------------------------Y-L---------------------DK 242 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~----------------------------------~-~---------------------~~ 242 (494)
||-++|||.|+||.|+.... . . +.
T Consensus 211 LvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~ 290 (459)
T KOG0610|consen 211 LVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGA 290 (459)
T ss_pred EEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccccccccccchhhhcCCCCc
Confidence 99999999999999874200 0 0 01
Q ss_pred cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHh
Q psy8309 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ--FLSVEAKNILVH 320 (494)
Q Consensus 243 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~ 320 (494)
.+.+++||-+|+|||+++|.+++.++|||+|||+|||||.|..||.|.+..+.+.+|+...+.||. .++..++|||++
T Consensus 291 RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~~~l~Fp~~~~vs~~akDLIr~ 370 (459)
T KOG0610|consen 291 RSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVGQPLKFPEEPEVSSAAKDLIRK 370 (459)
T ss_pred cccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhcCCCcCCCCCcchhHHHHHHHH
Confidence 235689999999999999999999999999999999999999999999999999999999999986 578999999999
Q ss_pred hccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 321 LLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 321 lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
||.+||.+|+|+.. ++.||++||||++++|.-+ +-..||++|...
T Consensus 371 LLvKdP~kRlg~~r--GA~eIK~HpFF~gVnWaLi--r~~~PP~iP~~~ 415 (459)
T KOG0610|consen 371 LLVKDPSKRLGSKR--GAAEIKRHPFFEGVNWALI--RCARPPEIPKPV 415 (459)
T ss_pred HhccChhhhhcccc--chHHhhcCccccCCChhhe--eccCCCcCCCcc
Confidence 99999999999864 8999999999999999944 677899999776
|
|
| >KOG0612|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-65 Score=540.72 Aligned_cols=323 Identities=37% Similarity=0.643 Sum_probs=279.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+...+||+++++||+|+||.|.+++++.|+++||||+++|...........+..|+.+|. ..+.+.|++|++.|+++.+
T Consensus 71 rl~~~DfeilKvIGrGaFGEV~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv-~~ns~Wiv~LhyAFQD~~~ 149 (1317)
T KOG0612|consen 71 RLKAEDFEILKVIGRGAFGEVALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMV-FGNSEWIVQLHYAFQDERY 149 (1317)
T ss_pred hCCHHhhHHHHHhcccccceeEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHH-cCCcHHHHHHHHHhcCccc
Confidence 456789999999999999999999999999999999999977777777888889999998 4679999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ ||+|...+.+.++++|+.++||+++|+.||.-||+.|+|||||||+||||
T Consensus 150 LYlVMdY~p---------------------GGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~mgyVHRDiKPDNvLl 208 (1317)
T KOG0612|consen 150 LYLVMDYMP---------------------GGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHSMGYVHRDIKPDNVLL 208 (1317)
T ss_pred eEEEEeccc---------------------CchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHhccceeccCCcceeEe
Confidence 999999999 66777788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeee-ccCCcccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 221 DYEGHVRIADFGMCKLQI-YLDKTTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~-~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
|..|||||+|||.|-... .+.....+.+|||.|++||++.. +.|+..+||||+||++|||+.|..||+..+-.+
T Consensus 209 d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 209 DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 999999999999886544 33344677899999999999963 459999999999999999999999999999999
Q ss_pred HHHHHHhC--CCCCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccC
Q psy8309 295 LFWSICNE--RPRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370 (494)
Q Consensus 295 ~~~~i~~~--~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~ 370 (494)
.|-+|++- .+.|| ..+|+++++||+++|. +|+.|+|- +|++||+.||||.+++|+.+ |...||++|.+.
T Consensus 289 TY~KIm~hk~~l~FP~~~~VSeeakdLI~~ll~-~~e~RLgr---ngiedik~HpFF~g~~W~~i--R~~~pP~vPevs- 361 (1317)
T KOG0612|consen 289 TYGKIMNHKESLSFPDETDVSEEAKDLIEALLC-DREVRLGR---NGIEDIKNHPFFEGIDWDNI--RESVPPVVPEVS- 361 (1317)
T ss_pred HHHHHhchhhhcCCCcccccCHHHHHHHHHHhc-Chhhhccc---ccHHHHHhCccccCCChhhh--hhcCCCCCCcCC-
Confidence 99999976 67888 4699999999999996 99999974 58999999999999999888 578999999998
Q ss_pred CCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCC-CCCCccccCcccCCCccCeeeeC
Q psy8309 371 PFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCL-TPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 371 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
++.|++|||-.-.....+. .|+.....-++++..|.||||+.
T Consensus 362 ---------------------------sd~DTsnFd~~~dd~~~~e~~p~~~~~~f~Gn~LPFIGfTy~~ 404 (1317)
T KOG0612|consen 362 ---------------------------SDDDTSNFDVDEDDLRDAETFPPRIPKAFSGNHLPFIGFTYTH 404 (1317)
T ss_pred ---------------------------CCCccccccccccccchhhccCCCCCCCCcCCcCCeeeeeecc
Confidence 8999999964321111111 11110011235788999999996
|
|
| >KOG0575|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-61 Score=483.62 Aligned_cols=256 Identities=32% Similarity=0.573 Sum_probs=244.1
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+|+..+.||+|||+.||.+++..+|+.||+|++.|..+......+....|+++.. .++|||||+++++|++.+++|||
T Consensus 18 ~~Y~~g~~LGkGgFA~cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr-~L~HpnIV~f~~~FEDs~nVYiv 96 (592)
T KOG0575|consen 18 KRYKRGRFLGKGGFARCYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHR-SLKHPNIVQFYHFFEDSNNVYIV 96 (592)
T ss_pred ceeeeeeeeccCcceEEEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHH-hcCCCcEEeeeeEeecCCceEEE
Confidence 57999999999999999999999999999999999998888888899999988887 68999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
+|+|.. ++|..++++.+.++|.+|++|+.||+.||.|||+++|||||||..|++|+++.
T Consensus 97 LELC~~---------------------~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~~IiHRDLKLGNlfL~~~~ 155 (592)
T KOG0575|consen 97 LELCHR---------------------GSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSLGIIHRDLKLGNLFLNENM 155 (592)
T ss_pred EEecCC---------------------ccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhcCceecccchhheeecCcC
Confidence 999994 45566777888999999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
+|||+|||||......+....++||||.|+|||++.+.+++..+||||+||+||.||+|+|||...+-.+++.+|....+
T Consensus 156 ~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y 235 (592)
T KOG0575|consen 156 NVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKETYNKIKLNEY 235 (592)
T ss_pred cEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHHHHHHHHhcCc
Confidence 99999999999877777888999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+|..+|.+|++||.+||+.||.+|| ++++|+.|+||+
T Consensus 236 ~~P~~ls~~A~dLI~~lL~~~P~~Rp------sl~~vL~h~Ff~ 273 (592)
T KOG0575|consen 236 SMPSHLSAEAKDLIRKLLRPNPSERP------SLDEVLDHPFFK 273 (592)
T ss_pred ccccccCHHHHHHHHHHhcCCcccCC------CHHHHhcCHhhh
Confidence 99999999999999999999999999 789999999994
|
|
| >KOG0986|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-61 Score=471.33 Aligned_cols=285 Identities=40% Similarity=0.685 Sum_probs=259.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....+.|..-++||+||||.|+.|+.+.||+.||+|.+.|+.+.......-.+.|+.+|. ..+.++||.+-+.|++.+.
T Consensus 181 pvt~n~F~~~RvlGkGGFGEV~acqvraTGKMYAcKkL~KKRiKkr~ge~maLnEk~iL~-kV~s~FiVslaYAfeTkd~ 259 (591)
T KOG0986|consen 181 PVTKNTFRVYRVLGKGGFGEVCACQVRATGKMYACKKLDKKRIKKRKGETMALNEKQILE-KVSSPFIVSLAYAFETKDA 259 (591)
T ss_pred hccccceeeeEEEecccccceeEEEEecchhhHHHHHHHHHHHHHhhhhHHhhHHHHHHH-HhccCcEEEEeeeecCCCc
Confidence 456788999999999999999999999999999999999887777766677889999998 4789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+++||..|+ ||+|..|+.+.+ .|+|.++++|+++|+.||++||+.+||||||||+||
T Consensus 260 LClVLtlMN---------------------GGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~~~iVYRDLKPeNI 318 (591)
T KOG0986|consen 260 LCLVLTLMN---------------------GGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHRRRIVYRDLKPENI 318 (591)
T ss_pred eEEEEEeec---------------------CCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHhcceeeccCChhhe
Confidence 999999999 666667777766 899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD----EDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~ 294 (494)
|+|+.|||+|+|+|||... ..+......+||.+|||||++.+..|+..+|||||||+||||+.|+.||.... .++
T Consensus 319 LLDd~GhvRISDLGLAvei-~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~KeKvk~eE 397 (591)
T KOG0986|consen 319 LLDDHGHVRISDLGLAVEI-PEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKEKVKREE 397 (591)
T ss_pred eeccCCCeEeeccceEEec-CCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhhhhhHHH
Confidence 9999999999999999864 34455555699999999999999999999999999999999999999997643 346
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+-+.+++....+|+.+|+++++|++.+|++||.+|+|+.. .+++++++||||+++||..|+.+.++|||+|...
T Consensus 398 vdrr~~~~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg-~ga~evk~HpfFk~lnw~rleagml~PPfiPdp~ 471 (591)
T KOG0986|consen 398 VDRRTLEDPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRG-EGAQEVKEHPFFKDLNWRRLEAGMLEPPFIPDPG 471 (591)
T ss_pred HHHHHhcchhhcccccCHHHHHHHHHHHccCHHHhccCCC-cCcchhhhCcccccCCHhHHhccCCCCCCCCCcc
Confidence 6677888888999999999999999999999999999976 4899999999999999999999999999999764
|
|
| >KOG0615|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-61 Score=465.03 Aligned_cols=260 Identities=30% Similarity=0.477 Sum_probs=231.8
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh----hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED----DDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~----~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
..+.|.+.+.||+|+||.|.+|..+.||+.||||++++...... ........|.++|. .++|||||+++++|+..
T Consensus 170 ~~d~yii~~~LGsGafg~Vkla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILk-kL~HP~IV~~~d~f~~~ 248 (475)
T KOG0615|consen 170 FNDYYIISKTLGSGAFGLVKLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILK-KLSHPNIVRIKDFFEVP 248 (475)
T ss_pred hcceeEeeeeecCCceeEEEEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHH-hcCCCCEEEEeeeeecC
Confidence 34678899999999999999999999999999999988655431 23334568899998 58999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+..||||||+. ||+|+..+..++.+.|...+.++.||+.||.|||++||+|||||||||
T Consensus 249 ds~YmVlE~v~---------------------GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRDiKPeNI 307 (475)
T KOG0615|consen 249 DSSYMVLEYVE---------------------GGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRDIKPENI 307 (475)
T ss_pred CceEEEEEEec---------------------CccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCcccccCCcceE
Confidence 99999999999 777888999999999999999999999999999999999999999999
Q ss_pred eeCCC---CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 219 LLDYE---GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK---YNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 219 Ll~~~---g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|+..+ -.+||+|||+|+.. .......++||||.|.|||++.+.+ |..++|+|||||+||-+|+|.+||.+...
T Consensus 308 Ll~~~~e~~llKItDFGlAK~~-g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~ 386 (475)
T KOG0615|consen 308 LLSNDAEDCLLKITDFGLAKVS-GEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYT 386 (475)
T ss_pred EeccCCcceEEEecccchhhcc-ccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCcccccC
Confidence 99876 67999999999974 3567789999999999999998776 34588999999999999999999988755
Q ss_pred HH-HHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 293 DE-LFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 293 ~~-~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
.. +.++|..+++.|- ..+|+++++||.+||..||++|| +++|+|+||||+.+.
T Consensus 387 ~~sl~eQI~~G~y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~------s~~eaL~hpW~~~~~ 444 (475)
T KOG0615|consen 387 DPSLKEQILKGRYAFGPLQWDRISEEALDLINWMLVVDPENRP------SADEALNHPWFKDAP 444 (475)
T ss_pred CccHHHHHhcCcccccChhhhhhhHHHHHHHHHhhEeCcccCc------CHHHHhcChhhhccc
Confidence 54 8999999988764 36899999999999999999999 689999999999765
|
|
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-59 Score=467.79 Aligned_cols=320 Identities=56% Similarity=1.039 Sum_probs=286.1
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||||++.+..............|..++....+||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~- 79 (320)
T cd05590 1 RVLGKGSFGKVMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVN- 79 (320)
T ss_pred CeeeeCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCC-
Confidence 4799999999999999999999999999876544555666777888888766689999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ivH~dlkp~NIli~~~~~~kL~D 139 (320)
T cd05590 80 --------------------GGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLAD 139 (320)
T ss_pred --------------------CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEee
Confidence 556666777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..|....+.+|..+
T Consensus 140 fG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (320)
T cd05590 140 FGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTWL 219 (320)
T ss_pred CCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 99987644344445567899999999999999999999999999999999999999999999999999999999999999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++++||.+||++||.+|+++.+..+.++++.||||++++|+.+..+.+.||+.|.+.
T Consensus 220 ~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~--------------------- 278 (320)
T cd05590 220 SQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKELDWEKLNRRQIEPPFRPRIK--------------------- 278 (320)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 99999999999999999999886656679999999999999999999999999999887
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
...|.++|+.++..+.+..++.....+...+++.|+||+|.+
T Consensus 279 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 320 (320)
T cd05590 279 -------SREDVSNFDPDFIKEDPVLTPIEESLLPMINQDEFRNFSYTA 320 (320)
T ss_pred -------CcchhhhcCcccccCCccCCCCcccccccccccCcCCCcccC
Confidence 677899999999888888787766656666788999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-59 Score=464.87 Aligned_cols=316 Identities=68% Similarity=1.207 Sum_probs=284.4
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||||++++..............|+.++....+||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~- 79 (316)
T cd05592 1 KVLGKGSFGKVMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLN- 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC-
Confidence 4799999999999999999999999999876544455566667787777766799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 --------------------gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dlkp~Nill~~~~~~kL~D 139 (316)
T cd05592 80 --------------------GGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIAD 139 (316)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHeEECCCCCEEEcc
Confidence 555566777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+....+.+|..+
T Consensus 140 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (316)
T cd05592 140 FGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRWI 219 (316)
T ss_pred CcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 99998644334445567899999999999999999999999999999999999999999999999999998888899999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++.+||.+||..||.+|+++ .++++.||||+.++|..+..+++.||+.|...
T Consensus 220 ~~~~~~ll~~~l~~~P~~R~~~-----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 273 (316)
T cd05592 220 SKEAKDCLSKLFERDPTKRLGV-----DGDIRQHPFFRGIDWERLEKREIPPPFKPKVK--------------------- 273 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCC-----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 9999999999999999999953 46899999999999999999999999988876
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 440 (494)
...+.++|+..|+......++.+.....+++|.+|.||.|+||
T Consensus 274 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05592 274 -------SPSDASNFDREFTNEKVRLSPVDKKLLASMDQEQFRGFSFTNP 316 (316)
T ss_pred -------CcchhhhcCcccccccccCCCccccccccccccccCCCcccCc
Confidence 5677899999999998888888888888999999999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >KOG0614|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-61 Score=474.41 Aligned_cols=296 Identities=36% Similarity=0.692 Sum_probs=279.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
...+.+++++..||-||||.|=+++.+.....+|+|+++|..+.+.++.+++..|+.+|.. ...|+||+||-.|.+..+
T Consensus 416 ~v~l~dl~~iaTLGvGgFGRVELV~~~~~~~~fAlKilkK~hIVdtkQqeHv~sEr~Im~~-~~s~fIvrLYrTfrd~ky 494 (732)
T KOG0614|consen 416 QVKLSDLKRIATLGVGGFGRVELVKVNSQKATFALKILKKKHIVDTKQQEHVFSERNIMME-CRSDFIVRLYRTFRDSKY 494 (732)
T ss_pred ccchhhhhhhhhcccCccceEEEEEecccchHHHHHHHhHhhccchhHHHHHHhHHHHHHh-cCchHHHHHHHHhccchh
Confidence 4567789999999999999999999888777799999999999999999999999999985 679999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|++||-|- ||++++.++..+.|++..+++|++.++.|++|||++|||||||||||+++
T Consensus 495 vYmLmEaCl---------------------GGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k~iIYRDLKPENllL 553 (732)
T KOG0614|consen 495 VYMLMEACL---------------------GGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRKGIIYRDLKPENLLL 553 (732)
T ss_pred hhhhHHhhc---------------------CchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhcCceeccCChhheee
Confidence 999999997 88889999999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|.+||.|||+|+. ...+..+.++||||+|.|||++.+++++.++|+||||+++||||+|.+||.+.++...|..|+
T Consensus 554 d~~Gy~KLVDFGFAKk-i~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmktYn~IL 632 (732)
T KOG0614|consen 554 DNRGYLKLVDFGFAKK-IGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMKTYNLIL 632 (732)
T ss_pred ccCCceEEeehhhHHH-hccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHHHHHHHH
Confidence 9999999999999996 455777889999999999999999999999999999999999999999999999999999999
Q ss_pred hC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccc
Q psy8309 301 NE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIK 378 (494)
Q Consensus 301 ~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~ 378 (494)
++ ...+|..++..+.+||++|...+|.+|+|.. .+++.||++|.||.++||+.|..+.++||++|.+.
T Consensus 633 kGid~i~~Pr~I~k~a~~Lik~LCr~~P~ERLG~~-~~gI~DIkkH~Wf~gfdweglr~~~L~pPi~~~va--------- 702 (732)
T KOG0614|consen 633 KGIDKIEFPRRITKTATDLIKKLCRDNPTERLGYQ-KGGINDIKKHRWFEGFDWEGLRSRTLPPPIIPSVA--------- 702 (732)
T ss_pred hhhhhhhcccccchhHHHHHHHHHhcCcHhhhccc-cCChHHHHhhhhhhcCChhhhhhccCCCCccccCC---------
Confidence 87 5789999999999999999999999999963 46999999999999999999999999999999998
Q ss_pred cCCCCCCCCccchhhhhhccccccCCCCcc
Q psy8309 379 LSSKDSAIPIQMPQVLFQLHALDVKYFDKS 408 (494)
Q Consensus 379 ~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~ 408 (494)
++.|++|||..
T Consensus 703 -------------------~ptD~s~Fd~~ 713 (732)
T KOG0614|consen 703 -------------------NPTDVSNFDNF 713 (732)
T ss_pred -------------------CcccchhccCC
Confidence 89999999973
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-58 Score=463.17 Aligned_cols=323 Identities=57% Similarity=1.005 Sum_probs=284.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++++.||+|+||.||+|+++.+++.||||++++..............|..++.....|++|+++++++++.+.+|+||
T Consensus 1 df~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05616 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVM 80 (323)
T ss_pred CceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEE
Confidence 68999999999999999999999999999999987655455555667778778776668999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++ ||+|...+...+.+++..+..++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 81 E~~~---------------------~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~Nill~~~~~ 139 (323)
T cd05616 81 EYVN---------------------GGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDSEGH 139 (323)
T ss_pred cCCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEecCCCHHHeEECCCCc
Confidence 9999 5555666777788999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 305 (494)
+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..|......
T Consensus 140 ~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~~~~~~i~~~~~~ 219 (323)
T cd05616 140 IKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVA 219 (323)
T ss_pred EEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999999975433344455678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCC
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSA 385 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~ 385 (494)
+|..++.++++||.+||++||.+|+++.. ...+++++|+||+.++|+.+..+.++||+.|...
T Consensus 220 ~p~~~s~~~~~li~~~l~~~p~~R~~~~~-~~~~~i~~h~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 282 (323)
T cd05616 220 YPKSMSKEAVAICKGLMTKHPGKRLGCGP-EGERDIKEHAFFRYIDWEKLERKEVQPPYKPKAC---------------- 282 (323)
T ss_pred CCCcCCHHHHHHHHHHcccCHHhcCCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC----------------
Confidence 99999999999999999999999998643 2578999999999999999999999999998754
Q ss_pred CCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 386 IPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
..|..+|+..|.+.++..+|.++..+...++..|+||+|+|
T Consensus 283 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05616 283 -------------GRDAENFDKFFTRHPPVLTPPDQEVIMNLDQSEFEGFSYVN 323 (323)
T ss_pred -------------CchhhhcCchhccCCccCCCCCccccccccccccCCCcccC
Confidence 35667888877776666677776666666778999999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-58 Score=462.24 Aligned_cols=324 Identities=59% Similarity=1.020 Sum_probs=287.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++++.||+|+||.||+|+++.+++.||||++.+.........+....|..++.....|++|+++++++.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (324)
T cd05587 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVM 80 (324)
T ss_pred CceEEEEEeeccCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEE
Confidence 68999999999999999999999999999999987655455566677788888875545667999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 81 E~~~---------------------~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~ 139 (324)
T cd05587 81 EYVN---------------------GGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSKGIIYRDLKLDNVMLDAEGH 139 (324)
T ss_pred cCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEEcCCCC
Confidence 9999 5566667777788999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 305 (494)
+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+++..+....+.
T Consensus 140 ~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 219 (324)
T cd05587 140 IKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219 (324)
T ss_pred EEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999999875433344455678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCC
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSA 385 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~ 385 (494)
+|..++.+++++|.+||.+||.+|+++.. ...+++++||||+.++|..+..+.+.+|+.|.+.
T Consensus 220 ~~~~~~~~~~~li~~~l~~~P~~R~~~~~-~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~---------------- 282 (324)
T cd05587 220 YPKSLSKEAVSICKGLLTKHPAKRLGCGP-TGERDIREHAFFRRIDWEKLERREIQPPFKPKVK---------------- 282 (324)
T ss_pred CCCCCCHHHHHHHHHHhhcCHHHcCCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCccCcCC----------------
Confidence 99999999999999999999999998643 2568999999999999999999999999988876
Q ss_pred CCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 386 IPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
...+.++|+..+.......+|.+...+.+.++..|++|+|+|
T Consensus 283 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05587 283 ------------GRRSAENFDKFFTREPPVLTPPDKLVIANIDQSEFQGFSFVN 324 (324)
T ss_pred ------------CcchhhhcCcccccCccccCCCCccccccccccccCCCcccC
Confidence 566788999888877777788887777788889999999975
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-58 Score=458.34 Aligned_cols=320 Identities=56% Similarity=1.032 Sum_probs=283.5
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||||++++..............|..++....+||||++++++|++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~- 79 (321)
T cd05591 1 KVLGKGSFGKVMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVN- 79 (321)
T ss_pred CccccCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCC-
Confidence 4699999999999999999999999999876555555666777888888766799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
|++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~Nill~~~~~~kL~D 139 (321)
T cd05591 80 --------------------GGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHGVIYRDLKLDNILLDAEGHCKLAD 139 (321)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCCEEEee
Confidence 555666677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|..+
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 219 (321)
T cd05591 140 FGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESILHDDVLYPVWL 219 (321)
T ss_pred cccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 99987644444445567899999999999999999999999999999999999999999999999999999998899999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCC-CChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCcc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQC-NSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQ 389 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~-~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (494)
+.++.+||.+||++||.+|+++... .+++++++||||.+++|..+..+.+.||+.|...
T Consensus 220 ~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 279 (321)
T cd05591 220 SKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKEIDWVLLEQRKIKPPFKPKIK-------------------- 279 (321)
T ss_pred CHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCCCCHHHHHhCCCCCCCCCCCC--------------------
Confidence 9999999999999999999976432 2689999999999999999999999999988775
Q ss_pred chhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 390 MPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 390 ~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
...+.++|+..++...+..+|..........|+.|.||++.|
T Consensus 280 --------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 321 (321)
T cd05591 280 --------TKRDVNNFDQDFTKEEPVLTPVDPAVIKQINQEEFRGFSFFN 321 (321)
T ss_pred --------CcchhhhcCCccccCccccCCCCccccccccccccCCCcccC
Confidence 456677888888887777777777777788899999999854
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-58 Score=457.20 Aligned_cols=318 Identities=62% Similarity=1.095 Sum_probs=285.1
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||+||+|+++.++..||||++++..............|..++....+||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~- 79 (318)
T cd05570 1 KVLGKGSFGKVLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVN- 79 (318)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCC-
Confidence 4799999999999999999999999999876554555566677788888765589999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
|++|..++.+.+.+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|
T Consensus 80 --------------------~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~~~kl~D 139 (318)
T cd05570 80 --------------------GGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHERGIIYRDLKLDNVLLDSEGHIKIAD 139 (318)
T ss_pred --------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEccCCCHHHeEECCCCcEEecc
Confidence 556666777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|+|||||++|+|++|..||.+.+..+.+..+....+.+|..+
T Consensus 140 fg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (318)
T cd05570 140 FGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRWL 219 (318)
T ss_pred cCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCcC
Confidence 99987543344445567899999999999999999999999999999999999999999999899999999888999999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++++||.+||..||.+||++.. ....+++.||||+.++|..+..+++.||+.|.+.
T Consensus 220 ~~~~~~li~~~l~~dP~~R~s~~~-~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 277 (318)
T cd05570 220 SKEAKSILKSFLTKNPEKRLGCLP-TGEQDIKGHPFFREIDWDKLERKEIKPPFKPKIK--------------------- 277 (318)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 999999999999999999997644 3459999999999999999999999999999887
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeee
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYT 438 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~ 438 (494)
...+.++|+..|....+..++.+...+.+.+|+.|+||+|.
T Consensus 278 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 278 -------GRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGFSYI 318 (318)
T ss_pred -------CcchhhhcCchhccCcccCCCCcccccccccccccCCCCCC
Confidence 56778999999998888889888888889999999999984
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-58 Score=458.23 Aligned_cols=318 Identities=47% Similarity=0.880 Sum_probs=276.7
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+|+.||||++++............+.|..++. .++||||++++++++..+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~- 78 (323)
T cd05571 1 KLLGKGTFGKVILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQ-NTRHPFLTALKYSFQTHDRLCFVMEYAN- 78 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCCEEEEEEcCCEEEEEEeCCC-
Confidence 47999999999999999999999999998765545555666777888887 5799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
|++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 79 --------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivHrDlkp~NIll~~~~~~kl~D 138 (323)
T cd05571 79 --------------------GGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITD 138 (323)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEee
Confidence 556666777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+...+...+..+...+|..+
T Consensus 139 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 218 (323)
T cd05571 139 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTL 218 (323)
T ss_pred CCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 99987544344445567899999999999999999999999999999999999999999999899999998899999999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
++++++||.+||.+||++||+... .+++++++||||.+++|..+..+.+.||+.|.+.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~-~~~~~ll~h~~f~~~~~~~~~~~~~~~~~~~~~~--------------------- 276 (323)
T cd05571 219 SPEAKSLLAGLLKKDPKQRLGGGP-EDAKEIMEHRFFASINWQDVVQKKLEPPFKPQVT--------------------- 276 (323)
T ss_pred CHHHHHHHHHHccCCHHHcCCCCC-CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 999999999999999999997644 3799999999999999999999999999988876
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccccC----cccCCCccCeeeeC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILE----SMDQTQFQGFSYTN 439 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~----~~~~~~f~~f~~~~ 439 (494)
...|+++|+.+++......+|..+.... ...+..|.+|+|..
T Consensus 277 -------~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05571 277 -------SETDTRYFDEEFTAQSITITPPDRYDSLGLLQLEERPHFPQFSYSA 322 (323)
T ss_pred -------CcchhhhcCcccccCCcccCCCCcccccccccccccccCCCCeeeC
Confidence 5677888988888776655555433211 12356799999975
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-57 Score=458.61 Aligned_cols=320 Identities=46% Similarity=0.890 Sum_probs=279.1
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||||++++..............|..++....+||||++++++|.+.+.+|+|||||+
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~- 79 (329)
T cd05588 1 RVIGRGSYAKVLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVS- 79 (329)
T ss_pred CeEeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCC-
Confidence 4799999999999999999999999999876544455556677888888766689999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 --------------------~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nili~~~~~~kL~D 139 (329)
T cd05588 80 --------------------GGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTD 139 (329)
T ss_pred --------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEECc
Confidence 556666777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------CHHHHHHHHHh
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC---------DEDELFWSICN 301 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---------~~~~~~~~i~~ 301 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||... ........+..
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (329)
T cd05588 140 YGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred CccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCCCCcccccccccccccchHHHHHHHHc
Confidence 999875433344556678999999999999999999999999999999999999999631 22345667778
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSS 381 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~ 381 (494)
....+|..++.++++||.+||..||.+|+++....+++++++||||+.++|..+..+++.||+.|.+.
T Consensus 220 ~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~~~~~~~~~~~~~~~~~~~~~------------ 287 (329)
T cd05588 220 KQIRIPRSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRNIDWDLLEQKQVLPPYKPNIE------------ 287 (329)
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHhCCCCCCccccCC------------
Confidence 88889999999999999999999999999875555799999999999999999999999999988776
Q ss_pred CCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 382 KDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
...+..+|+..|..+....+|.+...+..++|..|.||.|.|
T Consensus 288 ----------------~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~ 329 (329)
T cd05588 288 ----------------SDRDLDNFDPQFTDEPVQLTPDDPDVIARIDQSEFEGFEYIN 329 (329)
T ss_pred ----------------CcchhhhcCCccccCccccCCCCccccccccccccCCCcccC
Confidence 556778899888888877788777777788899999998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-57 Score=457.30 Aligned_cols=320 Identities=46% Similarity=0.903 Sum_probs=281.3
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||||++++..............|..++....+||+|+++++++++.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~- 79 (327)
T cd05617 1 RVIGRGSYAKVLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVN- 79 (327)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCC-
Confidence 4799999999999999999999999999886554555666677888888766689999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 --------------------~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nili~~~~~~kl~D 139 (327)
T cd05617 80 --------------------GGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERGIIYRDLKLDNVLLDADGHIKLTD 139 (327)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEEeCCCCEEEec
Confidence 555666677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-------CHHHHHHHHHhCC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC-------DEDELFWSICNER 303 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-------~~~~~~~~i~~~~ 303 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||... ........+....
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (327)
T cd05617 140 YGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP 219 (327)
T ss_pred cccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCCCCCCccCCCcccccHHHHHHHHHhCC
Confidence 999875433344456678999999999999999999999999999999999999999532 2344566677777
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCC
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKD 383 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~ 383 (494)
..+|..++..++++|.+||..||.+|+++....+.++++.||||+.++|+.+..+++.||+.|.+.
T Consensus 220 ~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~-------------- 285 (327)
T cd05617 220 IRIPRFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSIDWDLLEKKQVTPPFKPQIT-------------- 285 (327)
T ss_pred CCCCCCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCCCHHHHHhCCCCCCccCCCC--------------
Confidence 788999999999999999999999999886666899999999999999999999999999999887
Q ss_pred CCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 384 SAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
+..+.++|+..+..++...+|.+...+..+++..|.||.|.|
T Consensus 286 --------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 327 (327)
T cd05617 286 --------------DDYGLENFDTQFTSEPVQLTPDDEDVIKRIDQSEFEGFEYIN 327 (327)
T ss_pred --------------CCcchhhcCCccccCcccCCCCCccccccccccccCCCcCCC
Confidence 566788999888888777788888778888999999999875
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >KOG0608|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-58 Score=464.35 Aligned_cols=295 Identities=38% Similarity=0.690 Sum_probs=263.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+.+..-|..++.||-|+||.|.+++..+|...||+|.++|..+....++.+...|+.||+. .+.+.||+|++.|++++.
T Consensus 625 KMdKSmFvkik~iGvGAFGeV~Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAE-ADn~WVVrLyySFQDkdn 703 (1034)
T KOG0608|consen 625 KMDKSMFVKIKTIGVGAFGEVCLVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAE-ADNEWVVRLYYSFQDKDN 703 (1034)
T ss_pred hccccceEEEeeecccccceeEEEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhh-cCCcceEEEEEEeccCCc
Confidence 3455679999999999999999999999999999999999999999999999999999995 689999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ ||+++.++.+.+.|.|..+++|++++.+|+++.|..|+|||||||+||||
T Consensus 704 LYFVMdYIP---------------------GGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkmGFIHRDiKPDNILI 762 (1034)
T KOG0608|consen 704 LYFVMDYIP---------------------GGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILI 762 (1034)
T ss_pred eEEEEeccC---------------------CccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhccceecccCccceEE
Confidence 999999999 77788889999999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeee--------ccC----------------------------------CcccccCCCCCccChhh
Q psy8309 221 DYEGHVRIADFGMCKLQI--------YLD----------------------------------KTTDTFCGTPDYMAPEI 258 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~--------~~~----------------------------------~~~~~~~gt~~y~aPE~ 258 (494)
|.+|||||+|||||.-+. ..+ ......+||+.|+|||+
T Consensus 763 DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapev 842 (1034)
T KOG0608|consen 763 DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEV 842 (1034)
T ss_pred ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHH
Confidence 999999999999995310 000 01235689999999999
Q ss_pred hCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--ccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 259 IKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER--PRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 259 l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
|...+|+..+||||.|||||||+.|++||....+.+...+|.+++ +.+| ..+|.++.+||.+|.. +++.|+|.
T Consensus 843 l~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~~l~~~~~~~ls~e~~~li~kLc~-sad~RLGk-- 919 (1034)
T KOG0608|consen 843 LARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRNFLHIPYQGNLSKEALDLIQKLCC-SADSRLGK-- 919 (1034)
T ss_pred hcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhhccccccccccCHHHHHHHHHHhc-Chhhhhcc--
Confidence 999999999999999999999999999999999888888888764 3444 4799999999999874 89999986
Q ss_pred CCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccC
Q psy8309 335 CNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTA 411 (494)
Q Consensus 335 ~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~ 411 (494)
+++++|++||||++|||..| ++..+||+|.+. .+.|+||||+-..+
T Consensus 920 -ng~d~vKaHpfFkgIDfssl--Rkq~ApYIP~It----------------------------HptDTSNFdpvdpe 965 (1034)
T KOG0608|consen 920 -NGADQVKAHPFFKGIDFSSL--RKQRAPYIPRIT----------------------------HPTDTSNFDPVDPE 965 (1034)
T ss_pred -cchhhhhcCccccccchHhh--hhccCCcCcccc----------------------------CCCccccCCcCCcc
Confidence 47889999999999999997 456788999999 78999999985443
|
|
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-57 Score=454.10 Aligned_cols=316 Identities=63% Similarity=1.124 Sum_probs=281.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
+.||+|+||.||+|+++.+++.||||++++..............|+.++....+||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~- 79 (316)
T cd05619 1 KMLGKGSFGKVFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLN- 79 (316)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCC-
Confidence 4799999999999999999999999999876443444556667788888766799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++.....+++.++..++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 --------------------~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivHrdikp~Nil~~~~~~~kl~D 139 (316)
T cd05619 80 --------------------GGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDTDGHIKIAD 139 (316)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHEEECCCCCEEEcc
Confidence 555566677777899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+....+.+|..+
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (316)
T cd05619 140 FGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSIRMDNPCYPRWL 219 (316)
T ss_pred CCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Confidence 99987543333445567899999999999999999999999999999999999999999998888888888888888899
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++++||.+||..||.+|+++ .++++.||||+.++|..+..+.++||++|.+.
T Consensus 220 ~~~~~~li~~~l~~~P~~R~~~-----~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 273 (316)
T cd05619 220 TREAKDILVKLFVREPERRLGV-----KGDIRQHPFFREIDWSALEEREIEPPFKPKVK--------------------- 273 (316)
T ss_pred CHHHHHHHHHHhccCHhhcCCC-----hHHHHcCcccCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 9999999999999999999954 25899999999999999999999999999887
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 440 (494)
...+.++|+.++.+..+..+..+...+.+++|+.|+||++.+|
T Consensus 274 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05619 274 -------SANDCSNFDKEFLNEKPRLSVTDRMLINSMDQNMFENFSFINP 316 (316)
T ss_pred -------CccchhhcChhhhcCCcccCCCcccccccccccccCCCcccCc
Confidence 6788899999999888777777777788899999999999775
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-57 Score=454.31 Aligned_cols=323 Identities=57% Similarity=1.012 Sum_probs=282.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.++||+|+||.||+|+++.+++.||||++.+.........+....|..++....+|++|+++++++++.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~ 80 (323)
T cd05615 1 DFNFLMVLGKGSFGKVMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVM 80 (323)
T ss_pred CceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEE
Confidence 58899999999999999999999999999999987655455566667778888876667889999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++ ||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 81 Ey~~---------------------~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivHrDikp~Nill~~~~~ 139 (323)
T cd05615 81 EYVN---------------------GGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRGIIYRDLKLDNVMLDSEGH 139 (323)
T ss_pred cCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCCC
Confidence 9999 5566667777788999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 305 (494)
+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...+...|......
T Consensus 140 ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~~~~~~~i~~~~~~ 219 (323)
T cd05615 140 IKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSIMEHNVS 219 (323)
T ss_pred EEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Confidence 99999999875333333455678999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCC
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSA 385 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~ 385 (494)
+|..++.++++++.+||.+||.+|+++.+ ...+++++||||+.++|..+..+.+.+|+.|...
T Consensus 220 ~p~~~~~~~~~li~~~l~~~p~~R~~~~~-~~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~---------------- 282 (323)
T cd05615 220 YPKSLSKEAVSICKGLMTKHPSKRLGCGP-EGERDIREHAFFRRIDWDKLENREIQPPFKPKVC---------------- 282 (323)
T ss_pred CCccCCHHHHHHHHHHcccCHhhCCCCCC-CCHHHHhcCcccCCCCHHHHhcCCCCcCccCccC----------------
Confidence 99999999999999999999999998754 3678999999999999999999999999998764
Q ss_pred CCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 386 IPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
..+.++|+..++...+...+.....+...+...|+||+|.|
T Consensus 283 -------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 323 (323)
T cd05615 283 -------------GKGAENFDKFFTRGQPVLTPPDQLVIANIDQADFEGFSYVN 323 (323)
T ss_pred -------------CCchhhcCccccccCCCCCCCcccccccccccccCCCcccC
Confidence 23467888888776665555555556666667899999975
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-57 Score=453.55 Aligned_cols=316 Identities=62% Similarity=1.135 Sum_probs=278.2
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.++..||||++++..............|+.++....+||||+++++++++.+++|+||||+.
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~- 79 (316)
T cd05620 1 KVLGKGSFGKVLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLN- 79 (316)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCC-
Confidence 4799999999999999999999999999876444444556677788888766799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nil~~~~~~~kl~D 139 (316)
T cd05620 80 --------------------GGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIAD 139 (316)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEeCc
Confidence 555566677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..++...+....+.+|..+
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (316)
T cd05620 140 FGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRVDTPHYPRWI 219 (316)
T ss_pred cCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCCC
Confidence 99987533333445567899999999999999999999999999999999999999999999899999988888899999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++++||.+||..||.+|+++ .+++++||||++++|..+..+.+.+|+.|...
T Consensus 220 ~~~~~~li~~~l~~dP~~R~~~-----~~~~~~h~~f~~~~~~~~~~~~~~~~~~~~~~--------------------- 273 (316)
T cd05620 220 TKESKDILEKLFERDPTRRLGV-----VGNIRGHPFFKTINWTALEKRELDPPFKPKVK--------------------- 273 (316)
T ss_pred CHHHHHHHHHHccCCHHHcCCC-----hHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 9999999999999999999953 46899999999999999999999999988876
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 440 (494)
.+.+.++|+.++..+.+..+........+.++..|.||+|.+|
T Consensus 274 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 316 (316)
T cd05620 274 -------SPSDYSNFDREFLSEKPRLSYSDKNLIDSMDQSAFAGFSFINP 316 (316)
T ss_pred -------CcchhhhcCccccccCcccCCCcccccccccccCcCCCcccCC
Confidence 5667888888888777766666666667788999999999875
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-56 Score=450.17 Aligned_cols=321 Identities=49% Similarity=0.916 Sum_probs=277.4
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH--hcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA--LGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~--~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
|++++.||+|+||.||+|+++.+++.||||++++..............|..++. ..++||||+++++++.+.+.+|+|
T Consensus 1 y~i~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv 80 (324)
T cd05589 1 FRCLAVLGRGHFGKVLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFV 80 (324)
T ss_pred CeEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEE
Confidence 788999999999999999999999999999998765444455566666766653 246899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++||+| ...+. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 81 ~E~~~~~~L---------------------~~~~~-~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrdlkp~Nill~~~~ 138 (324)
T cd05589 81 MEYAAGGDL---------------------MMHIH-TDVFSEPRAVFYAACVVLGLQYLHENKIVYRDLKLDNLLLDTEG 138 (324)
T ss_pred EcCCCCCcH---------------------HHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC
Confidence 999995544 43443 35799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+....+
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~~~~~~~i~~~~~ 218 (324)
T cd05589 139 FVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEEVFDSIVNDEV 218 (324)
T ss_pred cEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Confidence 99999999987543334445567899999999999999999999999999999999999999999999999999999988
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCC
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDS 384 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~ 384 (494)
.+|..++.++.+||.+||..||.+||++.. .+++++++||||++++|..+..+.+.||+.|.+.
T Consensus 219 ~~p~~~~~~~~~li~~~L~~dP~~R~~~~~-~~~~~l~~~~~f~~~~~~~~~~~~~~~~~~~~~~--------------- 282 (324)
T cd05589 219 RYPRFLSREAISIMRRLLRRNPERRLGSGE-KDAEDVKKQPFFRDINWDDLLARKIKPPFVPTIK--------------- 282 (324)
T ss_pred CCCCCCCHHHHHHHHHHhhcCHhHcCCCCC-CCHHHHhhCCCcCCCCHHHHHhCCCCcCccCCCC---------------
Confidence 999999999999999999999999998755 3799999999999999999999999999998876
Q ss_pred CCCccchhhhhhccccccCCCCccccCCCCCCCCCCc-cccCcccCCCccCeeee
Q psy8309 385 AIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDR-TILESMDQTQFQGFSYT 438 (494)
Q Consensus 385 ~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~-~~~~~~~~~~f~~f~~~ 438 (494)
...|.++|+..++...+..+|... ..+....|..|.+|+|+
T Consensus 283 -------------~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 324 (324)
T cd05589 283 -------------GPEDVSNFDEEFTSEAPVLTPPREPRLLTEEEQELFRGFDYV 324 (324)
T ss_pred -------------CcchhhhcCccccccccccCCCccccccchhhhcccCCcccC
Confidence 566788888888877766665443 22345578999999885
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-56 Score=451.73 Aligned_cols=320 Identities=46% Similarity=0.892 Sum_probs=274.5
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||+|++++..............|..++....+||||+++++++.+.+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~- 79 (329)
T cd05618 1 RVIGRGSYAKVLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVN- 79 (329)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCC-
Confidence 4799999999999999999999999999876544455556677788887766799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ivH~Dikp~Nili~~~~~~kL~D 139 (329)
T cd05618 80 --------------------GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTD 139 (329)
T ss_pred --------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECCCCCEEEee
Confidence 555566677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---------CCHHHHHHHHHh
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG---------CDEDELFWSICN 301 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~---------~~~~~~~~~i~~ 301 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.. .....+...+..
T Consensus 140 fG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~ 219 (329)
T cd05618 140 YGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE 219 (329)
T ss_pred CCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCCCCCccCCCcCCcccccHHHHHHHHhc
Confidence 99987543334445567899999999999999999999999999999999999999952 122345566777
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSS 381 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~ 381 (494)
....+|..++.++++||.+||..||.+|+++....+++++++||||++++|..+..+++.||+.|.+.
T Consensus 220 ~~~~~p~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~~~~~~~~~~~~~~~~~~~~------------ 287 (329)
T cd05618 220 KQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDLMEQKQVVPPFKPNIS------------ 287 (329)
T ss_pred CCCCCCCCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCCCCHHHHHcCCCCcCccCCCC------------
Confidence 88889999999999999999999999999876555789999999999999999999999999999876
Q ss_pred CCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 382 KDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
...+..+|+..++.+....+|.+........+.+|.||.|.|
T Consensus 288 ----------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (329)
T cd05618 288 ----------------GEFGLDNFDAQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYIN 329 (329)
T ss_pred ----------------CcccchhcCcccccCCccCCCCcccccccccccccCCCcccC
Confidence 555667777777776666666665555556778899998865
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-56 Score=448.56 Aligned_cols=312 Identities=44% Similarity=0.856 Sum_probs=272.5
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||+|+||.||+|+++.+++.||+|++++..............|..++. .++||||+++++++.+.+.+|+||||++
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~~--- 76 (312)
T cd05585 1 IGKGSFGKVMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLA-QVNCPFIVPLKFSFQSPEKLYLVLAFIN--- 76 (312)
T ss_pred CCcCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCcEeceeeEEecCCeEEEEEcCCC---
Confidence 799999999999999999999999998765445556667778888887 5799999999999999999999999999
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecC
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFG 232 (494)
||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|.+||+|||
T Consensus 77 ------------------~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg 138 (312)
T cd05585 77 ------------------GGELFHHLQREGRFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFG 138 (312)
T ss_pred ------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeCCCCHHHeEECCCCcEEEEECc
Confidence 55666677777889999999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Q psy8309 233 MCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSV 312 (494)
Q Consensus 233 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 312 (494)
+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+......+|..+++
T Consensus 139 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (312)
T cd05585 139 LCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKILQEPLRFPDGFDR 218 (312)
T ss_pred ccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCCCCcCCCCHHHHHHHHHcCCCCCCCcCCH
Confidence 98754333344556789999999999999999999999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccchh
Q psy8309 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQ 392 (494)
Q Consensus 313 ~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 392 (494)
++++||.+||..||.+||+. .++.|++.||||+..+|..+..+.++|++.|.+.
T Consensus 219 ~~~~li~~~L~~dp~~R~~~---~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~~~~~----------------------- 272 (312)
T cd05585 219 DAKDLLIGLLSRDPTRRLGY---NGAQEIKNHPFFSQLSWKKLLMKGIQPPFKPAVS----------------------- 272 (312)
T ss_pred HHHHHHHHHcCCCHHHcCCC---CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC-----------------------
Confidence 99999999999999999976 3689999999999999999999999999988776
Q ss_pred hhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeee
Q psy8309 393 VLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSY 437 (494)
Q Consensus 393 ~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 437 (494)
...+.++|+.+++...+..+.....-.....|.+|.||+|
T Consensus 273 -----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (312)
T cd05585 273 -----SAIDTSNFDEEFTREKPIDSVVDDSHLSETVQQQFGGWSY 312 (312)
T ss_pred -----CccchhhcCccccccccccCCCccccccchhccccCCCCC
Confidence 5667888988888765544433332233445789999987
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >KOG0581|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-56 Score=426.90 Aligned_cols=257 Identities=31% Similarity=0.562 Sum_probs=231.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe-
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH- 140 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~- 140 (494)
+..++.+.+++||+|..|+||+|+|+.|++.||+|++... .+....+++.+|..++.. .+||+||++|+.|..+..
T Consensus 76 i~~~dle~~~~lG~G~gG~V~kv~Hk~t~~i~AlK~I~~~--~~~~~~~Qi~rEl~il~~-~~spyIV~~ygaF~~~~~~ 152 (364)
T KOG0581|consen 76 ISLSDLERLGVLGSGNGGTVYKVRHKPTGKIYALKVILLN--IDPALQKQILRELEILRS-CQSPYIVGFYGAFYSNGEE 152 (364)
T ss_pred cCHHHhhhhhhcccCCCcEEEEEEEcCCCeEEEEEeeccc--CCHHHHHHHHHHHHHHhh-CCCCCeeeEeEEEEeCCce
Confidence 4567899999999999999999999999999999999543 455666788999999996 599999999999999994
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NIL 219 (494)
++|+||||.|| +|...+...++++|.....++.+|+.||.|||+ ++||||||||.|||
T Consensus 153 isI~mEYMDgG---------------------SLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~~~~IIHRDIKPsNlL 211 (364)
T KOG0581|consen 153 ISICMEYMDGG---------------------SLDDILKRVGRIPEPVLGKIARAVLRGLSYLHEERKIIHRDIKPSNLL 211 (364)
T ss_pred EEeehhhcCCC---------------------CHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhccCeeeccCCHHHee
Confidence 99999999955 555566677899999999999999999999995 99999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC-----DEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-----~~~~ 294 (494)
|+..|.|||||||.++.... ....+++||..|||||.+.+..|+.++||||||+.++||++|+.||... +..+
T Consensus 212 vNskGeVKicDFGVS~~lvn--S~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~~~~~~~~~~ 289 (364)
T KOG0581|consen 212 VNSKGEVKICDFGVSGILVN--SIANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAIGRFPYPPPNPPYLDIFE 289 (364)
T ss_pred eccCCCEEeccccccHHhhh--hhcccccccccccChhhhcCCcCCcccceecccHHHHHHhhCCCCCCCcCCCCCCHHH
Confidence 99999999999999986543 3678999999999999999999999999999999999999999999874 6788
Q ss_pred HHHHHHhC-CCCCCcc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 295 LFWSICNE-RPRFPQF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
++..|+.+ .+.+|.. +|+++++||..||++||.+|+ +++++++|||++..
T Consensus 290 Ll~~Iv~~ppP~lP~~~fS~ef~~FV~~CL~Kdp~~R~------s~~qLl~Hpfi~~~ 341 (364)
T KOG0581|consen 290 LLCAIVDEPPPRLPEGEFSPEFRSFVSCCLRKDPSERP------SAKQLLQHPFIKKF 341 (364)
T ss_pred HHHHHhcCCCCCCCcccCCHHHHHHHHHHhcCCcccCC------CHHHHhcCHHHhhc
Confidence 99999985 5678886 999999999999999999999 68999999999753
|
|
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-56 Score=445.63 Aligned_cols=283 Identities=40% Similarity=0.804 Sum_probs=253.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|++.+.||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||+++++++.+++.
T Consensus 14 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~ 92 (329)
T PTZ00263 14 SWKLSDFEMGETLGTGSFGRVRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILM-ELSHPFIVNMMCSFQDENR 92 (329)
T ss_pred CCCchheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEcCCE
Confidence 456789999999999999999999999999999999998765444445566778888877 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+. |++|..++...+.+++..++.++.||+.||+|||++||+||||||+||||
T Consensus 93 ~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~NIll 151 (329)
T PTZ00263 93 VYFLLEFVV---------------------GGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDIIYRDLKPENLLL 151 (329)
T ss_pred EEEEEcCCC---------------------CChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEE
Confidence 999999999 55666677777889999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|.+||+|||+++.. .....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..|.
T Consensus 152 ~~~~~~kl~Dfg~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~ 228 (329)
T PTZ00263 152 DNKGHVKVTDFGFAKKV---PDRTFTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEKIL 228 (329)
T ss_pred CCCCCEEEeeccCceEc---CCCcceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCHHHHHHHHh
Confidence 99999999999998753 223345789999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+.+.+|..++.++++||.+||+.||.+|+++.. .++++++.||||++.+|+.+..+.+.+|..+.+.
T Consensus 229 ~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~-~~~~~ll~hp~f~~~~~~~~~~~~~~~~~~~~~~ 296 (329)
T PTZ00263 229 AGRLKFPNWFDGRARDLVKGLLQTDHTKRLGTLK-GGVADVKNHPYFHGANWDKLYARYYPAPIPVRVK 296 (329)
T ss_pred cCCcCCCCCCCHHHHHHHHHHhhcCHHHcCCCCC-CCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCC
Confidence 9999999999999999999999999999997644 3689999999999999999998888887766554
|
|
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-56 Score=444.70 Aligned_cols=319 Identities=46% Similarity=0.883 Sum_probs=272.4
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||++++++++..+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv~Ey~~- 78 (328)
T cd05593 1 KLLGKGTFGKVILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLK-NTRHPFLTSLKYSFQTKDRLCFVMEYVN- 78 (328)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCEEEEEEeCCC-
Confidence 47999999999999999999999999998765555556667777887776 5799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 79 --------------------~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~D 138 (328)
T cd05593 79 --------------------GGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITD 138 (328)
T ss_pred --------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHeEECCCCcEEEec
Confidence 555566677777899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+|..+
T Consensus 139 fG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 218 (328)
T cd05593 139 FGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEDIKFPRTL 218 (328)
T ss_pred CcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCCCCCCCCCHHHHHHHhccCCccCCCCC
Confidence 99987533333344567899999999999999999999999999999999999999999888888888888888999999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++++||.+||.+||.+|++... .++.++++|+||.+++|..+..+.+.||+.|.+.
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~-~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 276 (328)
T cd05593 219 SADAKSLLSGLLIKDPNKRLGGGP-DDAKEIMRHSFFTGVNWQDVYDKKLVPPFKPQVT--------------------- 276 (328)
T ss_pred CHHHHHHHHHHcCCCHHHcCCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC---------------------
Confidence 999999999999999999997543 3799999999999999999999999999998877
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCcc------ccCcccCCCccCeeeeCC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRT------ILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~------~~~~~~~~~f~~f~~~~~ 440 (494)
.+.+..+|+.+|+.+.....+.... ......+..|.+|+|...
T Consensus 277 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (328)
T cd05593 277 -------SETDTRYFDEEFTAQTITITPPEKYDEDGMDCMDNERRPHFPQFSYSAS 325 (328)
T ss_pred -------CcchhhhcCcccccCCcccCCccccccccccccccccccccCCceeeCC
Confidence 5566677887777765444333221 112233567899988764
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-55 Score=443.77 Aligned_cols=319 Identities=45% Similarity=0.775 Sum_probs=268.9
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||+||+|+++.+|+.||||++.+..............|+.++...++||||++++++++..+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~- 79 (325)
T cd05604 1 KVIGKGSFGKVLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVN- 79 (325)
T ss_pred CceeeCCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCC-
Confidence 4699999999999999999999999999876444444555666777666667899999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~givH~Dlkp~NIll~~~~~~kL~D 139 (325)
T cd05604 80 --------------------GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTD 139 (325)
T ss_pred --------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCCCEEEee
Confidence 555566677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+++..+......++...
T Consensus 140 fG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~~~~~~~~~~~~~~~~~~~ 219 (325)
T cd05604 140 FGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNILHKPLVLRPGA 219 (325)
T ss_pred cCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCCCCCCCCHHHHHHHHHcCCccCCCCC
Confidence 99987543334445567899999999999999999999999999999999999999999999999999998888888889
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
+.++.++|.+||.+||.+||++.. +++++++||||++++|..+..+.+++|+.|.+.
T Consensus 220 ~~~~~~ll~~ll~~~p~~R~~~~~--~~~~i~~h~~f~~~~~~~~~~~~~~~~~~~~~~--------------------- 276 (325)
T cd05604 220 SLTAWSILEELLEKDRQRRLGAKE--DFLEIQEHPFFESLSWTDLEQKKIPPPFNPNVE--------------------- 276 (325)
T ss_pred CHHHHHHHHHHhccCHHhcCCCCC--CHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC---------------------
Confidence 999999999999999999998754 689999999999999999999999999988776
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCC---ccccC---cccCCCccCeeeeCC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVD---RTILE---SMDQTQFQGFSYTNP 440 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~---~~~~~---~~~~~~f~~f~~~~~ 440 (494)
...|.++|+..++.+....+... ..... ......|.||+|..|
T Consensus 277 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 325 (325)
T cd05604 277 -------GPDDISNFDAVFTEETVPYSVCFSSDYSIVNASVLEADDAFVGFSYAPP 325 (325)
T ss_pred -------CcchhhhcCCccccCCcccCcccccccccccccccccccccCCCEecCC
Confidence 45567777776665443222110 11111 112567999999764
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-55 Score=442.53 Aligned_cols=284 Identities=36% Similarity=0.734 Sum_probs=254.8
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEeCCC-eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTD-YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.....++|++.+.||+|+||.||+|+++.++ ..||+|++.+..............|..++. .++||||+++++++.+.
T Consensus 25 ~~~~~~~y~~~~~ig~G~~g~Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~ 103 (340)
T PTZ00426 25 NKMKYEDFNFIRTLGTGSFGRVILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILN-YINHPFCVNLYGSFKDE 103 (340)
T ss_pred CCCChhhcEEEEEEeecCCeEEEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCCcceEEEEEeC
Confidence 3456789999999999999999999987665 689999998765544555666777888877 57999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|+||||+. ||+|..++...+.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 104 ~~~~lv~Ey~~---------------------~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NI 162 (340)
T PTZ00426 104 SYLYLVLEFVI---------------------GGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLNIVYRDLKPENL 162 (340)
T ss_pred CEEEEEEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHE
Confidence 99999999999 556666777778899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
|++.+|.+||+|||+++.. .....+.+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+....+..
T Consensus 163 Ll~~~~~ikL~DFG~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 239 (340)
T PTZ00426 163 LLDKDGFIKMTDFGFAKVV---DTRTYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQK 239 (340)
T ss_pred EECCCCCEEEecCCCCeec---CCCcceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999999998753 2234567899999999999999999999999999999999999999999999899999
Q ss_pred HHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 299 ICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 299 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+..+...+|..++++++++|++||+.||.+|++... .+++++++||||++++|..+..+.+.+|+.|...
T Consensus 240 i~~~~~~~p~~~~~~~~~li~~~l~~dp~~R~~~~~-~~~~~~~~hp~f~~~~~~~~~~~~~~~~~~p~~~ 309 (340)
T PTZ00426 240 ILEGIIYFPKFLDNNCKHLMKKLLSHDLTKRYGNLK-KGAQNVKEHPWFGNIDWVSLLHKNVEVPYKPKYK 309 (340)
T ss_pred HhcCCCCCCCCCCHHHHHHHHHHcccCHHHcCCCCC-CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC
Confidence 999988999999999999999999999999986543 3899999999999999999999999999999887
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-55 Score=441.37 Aligned_cols=276 Identities=47% Similarity=0.870 Sum_probs=248.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||+||+|+++.+++.||||++.+............+.|+..+...++||||+++++.+++.+.+|+||||++
T Consensus 1 ~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~- 79 (323)
T cd05575 1 KVIGKGSFGKVLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVN- 79 (323)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCC-
Confidence 4799999999999999999999999999876544444555666777766667899999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH~dikp~NIll~~~~~~kl~D 139 (323)
T cd05575 80 --------------------GGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILLDSQGHVVLTD 139 (323)
T ss_pred --------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHeEECCCCcEEEec
Confidence 555666777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+......++..+
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (323)
T cd05575 140 FGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDNILNKPLRLKPNI 219 (323)
T ss_pred cCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCCCCCCHHHHHHHHHcCCCCCCCCC
Confidence 99987544344445567899999999999999999999999999999999999999999999999999999888888889
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+.++.++|.+||++||.+||++.. ...+++.||||..++|..+..+.+.+|+.|.+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~--~~~~il~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (323)
T cd05575 220 SVSARHLLEGLLQKDRTKRLGAKD--DFLEIKNHVFFSSINWDDLVNKKITPPFNPNVS 276 (323)
T ss_pred CHHHHHHHHHHhhcCHHhCCCCCC--CHHHHHcCCCcCCCCHHHHhhccCCCCcCCCCC
Confidence 999999999999999999998753 678999999999999999999999999999876
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-55 Score=439.00 Aligned_cols=318 Identities=47% Similarity=0.887 Sum_probs=272.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+|..||+|++++..............|..++. .++||||++++++|...+.+|+||||++
T Consensus 1 ~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~i~~~~~~~~~~~~~~lv~E~~~- 78 (323)
T cd05595 1 KLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRLCFVMEYAN- 78 (323)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCEEEEEEeCCC-
Confidence 47999999999999999999999999998765444555566667777776 5799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 79 --------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D 138 (323)
T cd05595 79 --------------------GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITD 138 (323)
T ss_pred --------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEcCCCCEEecc
Confidence 555666677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+|..+
T Consensus 139 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~~~~~~~~~~p~~~ 218 (323)
T cd05595 139 FGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRTL 218 (323)
T ss_pred cHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 99987543333344567899999999999999999999999999999999999999999998899999988888999999
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQM 390 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~ 390 (494)
++++++||.+||..||.+|++... .++.++++|+||.+++|..+..+.+.||+.|...
T Consensus 219 ~~~~~~li~~~L~~dP~~R~~~~~-~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~--------------------- 276 (323)
T cd05595 219 SPEAKSLLAGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT--------------------- 276 (323)
T ss_pred CHHHHHHHHHHccCCHHHhCCCCC-CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC---------------------
Confidence 999999999999999999997644 3799999999999999999999999999988876
Q ss_pred hhhhhhccccccCCCCccccCCCCCCCCCCccc----cCcccCCCccCeeeeC
Q psy8309 391 PQVLFQLHALDVKYFDKSFTAERPCLTPVDRTI----LESMDQTQFQGFSYTN 439 (494)
Q Consensus 391 ~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~----~~~~~~~~f~~f~~~~ 439 (494)
.+.+.++|+.+++.......|.++.. .+...-..|.+|||..
T Consensus 277 -------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 322 (323)
T cd05595 277 -------SEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQRTHFPQFSYSA 322 (323)
T ss_pred -------ChhhhhhcCcccccCCccCCCCcccccccccccccccccCCCcccC
Confidence 56677888888887765555544321 1112224688888864
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-54 Score=440.56 Aligned_cols=273 Identities=35% Similarity=0.682 Sum_probs=235.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||+||+|+++.+++.||||++.+..............|..++. .++||||+++++.+++...+|+|
T Consensus 1 ~~y~~~~~LG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~~~~~~iv~~~~~~~~~~~~~lv 79 (363)
T cd05628 1 EDFESLKVIGRGAFGEVRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILV-EADSLWVVKMFYSFQDKLNLYLI 79 (363)
T ss_pred CCceEeEEEEeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHH-hCCCCCcceEEEEEecCCeEEEE
Confidence 47999999999999999999999999999999998765444455566677877777 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 80 ~E~~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~givHrDlKp~NILi~~~~ 138 (363)
T cd05628 80 MEFLP---------------------GGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGFIHRDIKPDNLLLDSKG 138 (363)
T ss_pred EcCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEecCCCHHHeEECCCC
Confidence 99999 566667777788999999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccC-----------------------------------CcccccCCCCCccChhhhCCCCCCCcch
Q psy8309 225 HVRIADFGMCKLQIYLD-----------------------------------KTTDTFCGTPDYMAPEIIKGLKYNQCVD 269 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~D 269 (494)
++||+|||+++...... ....+.+||+.|+|||++.+..|+.++|
T Consensus 139 ~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~D 218 (363)
T cd05628 139 HVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCD 218 (363)
T ss_pred CEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchh
Confidence 99999999986421100 0113468999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNE--RPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 270 iwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
||||||++|||++|.+||.+.+..+.+.+|... ...+|. .+++++++||.+|+. +|.+|++. .+++||++||
T Consensus 219 vwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~~-~~~~r~~r---~~~~ei~~hp 294 (363)
T cd05628 219 WWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPEVPISEKAKDLILRFCC-EWEHRIGA---PGVEEIKTNP 294 (363)
T ss_pred hhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCcCCCCHHHHHHHHHHcC-ChhhcCCC---CCHHHHhCCC
Confidence 999999999999999999999999999988864 345664 478999999999885 77877653 3799999999
Q ss_pred CcCCCChhHHhcCcCCCC
Q psy8309 346 YFRGLDWQALEKRELEPP 363 (494)
Q Consensus 346 ~f~~~~w~~l~~~~~~pp 363 (494)
||++++|+.+..+..++|
T Consensus 295 ~f~~~~~~~~~~~~~~~~ 312 (363)
T cd05628 295 FFEGVDWEHIRERPAAIP 312 (363)
T ss_pred CCCCCCHHHHHhCCCCCC
Confidence 999999999987755554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-55 Score=431.23 Aligned_cols=279 Identities=41% Similarity=0.775 Sum_probs=251.1
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv 79 (291)
T cd05612 1 DDLERIKTVGTGTFGRVHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLK-EVSHPFIIRLFWTEHDQRFLYML 79 (291)
T ss_pred CCceeeeeeecCCCeEEEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHH-hCCCCcHhhhHhhhccCCeEEEE
Confidence 47999999999999999999999999999999997654333344555667777776 58999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++ |++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 80 ~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~NIli~~~~ 138 (291)
T cd05612 80 MEYVP---------------------GGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEIVYRDLKPENILLDKEG 138 (291)
T ss_pred EeCCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCCC
Confidence 99999 556666777788899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..+..+.+
T Consensus 139 ~~kl~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~ 215 (291)
T cd05612 139 HIKLTDFGFAKKLR---DRTWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGKL 215 (291)
T ss_pred CEEEEecCcchhcc---CCcccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCc
Confidence 99999999987532 233456899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+|..++..+++||++||+.||.+|+++.. .+++|++.||||+.++|..+..++..||..|.+.
T Consensus 216 ~~~~~~~~~~~~li~~~l~~dp~~R~~~~~-~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~p~~~ 279 (291)
T cd05612 216 EFPRHLDLYAKDLIKKLLVVDRTRRLGNMK-NGADDVKNHRWFKSVDWDDVPQRKLKPPIVPKVS 279 (291)
T ss_pred CCCccCCHHHHHHHHHHcCCCHHHccCCcc-CCHHHHhcCccccCCCHHHHhcCCCCCCEeCCCC
Confidence 999999999999999999999999997644 3799999999999999999999999999999887
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-54 Score=436.35 Aligned_cols=276 Identities=45% Similarity=0.841 Sum_probs=245.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
+.||+|+||.||+|+++.+++.||+|++.+..............|+..+...++||||+++++++...+.+|+||||++
T Consensus 1 ~~lg~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~- 79 (325)
T cd05602 1 KVIGKGSFGKVLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN- 79 (325)
T ss_pred CeeeeCCCeEEEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCC-
Confidence 4799999999999999999999999999875443334444556666665557899999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
|++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|.+||+|
T Consensus 80 --------------------~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHrDlkp~Nili~~~~~~kl~D 139 (325)
T cd05602 80 --------------------GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTD 139 (325)
T ss_pred --------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHeEECCCCCEEEcc
Confidence 555666777778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+++..+......++..+
T Consensus 140 fG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (325)
T cd05602 140 FGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNI 219 (325)
T ss_pred CCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCHHHHHHHHHhCCcCCCCCC
Confidence 99987543334445667899999999999999999999999999999999999999999999999999988888888889
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+.+++++|.+||++||.+|+++.+ ...++++|+||..++|+.+..+++.||+.|.+.
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~--~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (325)
T cd05602 220 TNSARHLLEGLLQKDRTKRLGAKD--DFMEIKNHIFFSPINWDDLINKKITPPFNPNVS 276 (325)
T ss_pred CHHHHHHHHHHcccCHHHCCCCCC--CHHHHhcCcccCCCCHHHHHhCCCCcCcCCCCC
Confidence 999999999999999999998764 678999999999999999999999999888776
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0588|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-55 Score=446.17 Aligned_cols=260 Identities=32% Similarity=0.560 Sum_probs=240.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+.-|++++.||.|+-|.|.+|++..||+..|||++.+...........+.+|+.+|. .+.||||++++++|+++.++|
T Consensus 10 tiGpwkLgkTLG~Gstg~vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMk-Li~HpnVl~LydVwe~~~~ly 88 (786)
T KOG0588|consen 10 TIGPWKLGKTLGKGSTGCVRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMK-LIEHPNVLRLYDVWENKQHLY 88 (786)
T ss_pred cccceeccccccCCCCceehhhhcccccceeEEEeeccccccccccccchhhhhHHHH-HhcCCCeeeeeeeeccCceEE
Confidence 4557999999999999999999999999999999999875444555556667777776 689999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|+||++ ||+|+.++..+|+|+|.++..|+.||+.|+.|+|..+|+||||||||+|||.
T Consensus 89 lvlEyv~---------------------gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~~~icHRDLKpENlLLd~ 147 (786)
T KOG0588|consen 89 LVLEYVP---------------------GGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHAFNICHRDLKPENLLLDV 147 (786)
T ss_pred EEEEecC---------------------CchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhhhcceeccCCchhhhhhc
Confidence 9999999 7788889999999999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++|||+|||+|.. ...+....+.||+|.|.|||++.|..|+ .++||||.|||||.||+|++||.+++...++.++..
T Consensus 148 ~~nIKIADFGMAsL-e~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdNir~LLlKV~~ 226 (786)
T KOG0588|consen 148 KNNIKIADFGMASL-EVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDNIRVLLLKVQR 226 (786)
T ss_pred ccCEeeeccceeec-ccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 99999999999986 3456677889999999999999999984 899999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
+.+.+|..+|.+|++||.+||+.||++|+ +.+||++|||+.+..
T Consensus 227 G~f~MPs~Is~eaQdLLr~ml~VDp~~Ri------T~~eI~kHP~l~g~~ 270 (786)
T KOG0588|consen 227 GVFEMPSNISSEAQDLLRRMLDVDPSTRI------TTEEILKHPFLSGYT 270 (786)
T ss_pred CcccCCCcCCHHHHHHHHHHhccCccccc------cHHHHhhCchhhcCC
Confidence 99999999999999999999999999999 689999999998754
|
|
| >KOG0595|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-55 Score=423.38 Aligned_cols=257 Identities=35% Similarity=0.620 Sum_probs=232.2
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+.+|.+.+.||+|+||+||+|+++.++..||||.+.++.+ ....++....|..+|. .++|||||.++++.++++++|
T Consensus 8 ~~~~y~~~~~iG~GsfavVykg~h~~~~~~VAIK~i~~~~l-~~k~~e~L~~Ei~iLk-el~H~nIV~l~d~~~~~~~i~ 85 (429)
T KOG0595|consen 8 VVGDYELSREIGSGSFAVVYKGRHKKSGTEVAIKCIAKKKL-NKKLVELLLSEIKILK-ELKHPNIVRLLDCIEDDDFIY 85 (429)
T ss_pred ccccceehhhccCcceEEEEEeEeccCCceEEeeeehhhcc-CHHHHHHHHHHHHHHH-hcCCcceeeEEEEEecCCeEE
Confidence 35799999999999999999999999999999999988754 5667778889999998 588999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||||+ ||+|..++++.+.++|..++.++.||+.||++||+++||||||||+||||+.
T Consensus 86 lVMEyC~---------------------gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~~~~IiHRDLKPQNiLLs~ 144 (429)
T KOG0595|consen 86 LVMEYCN---------------------GGDLSDYIRRRGRLPEATARHFMQQLASALQFLHENNIIHRDLKPQNILLST 144 (429)
T ss_pred EEEEeCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCcceEEecc
Confidence 9999999 6777889999999999999999999999999999999999999999999987
Q ss_pred C------CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 223 E------GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 223 ~------g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
. -.+||+|||+|+.. ..+....+.||+|.|||||+++.+.|+.++|+||+|+|||+|++|++||...+..+++
T Consensus 145 ~~~~~~~~~LKIADFGfAR~L-~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~eL~ 223 (429)
T KOG0595|consen 145 TARNDTSPVLKIADFGFARFL-QPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKELL 223 (429)
T ss_pred CCCCCCCceEEecccchhhhC-CchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHHHH
Confidence 5 35899999999964 4566678999999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 297 WSICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 297 ~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..|..+.. .+|..++..+.+|+..+|..+|..|. +.++-+.|++...
T Consensus 224 ~~~~k~~~~~~~~~~~~s~~~~~Ll~~ll~~~~~~~~------~~~~~~~~~~l~~ 273 (429)
T KOG0595|consen 224 LYIKKGNEIVPVLPAELSNPLRELLISLLQRNPKDRI------SFEDFFDHPFLAA 273 (429)
T ss_pred HHHhccccccCchhhhccCchhhhhhHHHhcCccccC------chHHhhhhhhccc
Confidence 98877653 34567888899999999999999998 5677788888753
|
|
| >KOG0583|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-54 Score=438.56 Aligned_cols=261 Identities=34% Similarity=0.611 Sum_probs=235.9
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh--hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED--DDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~--~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
.....|.+.+.||+|+||+|++|.+..++..||||++.++..... ...+...+|..++.....||||+++++++.+..
T Consensus 14 ~~~g~y~~~~~lG~GsfgkV~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~ 93 (370)
T KOG0583|consen 14 LSIGKYELGRTLGSGSFGKVKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPT 93 (370)
T ss_pred cccCceeeeeeecCCCCeeEEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCC
Confidence 345689999999999999999999999999999998877533322 233445567777775444999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
++|+|||||. ||+|+.++.+.+++.|.+++.+++||+.|++|||++||+||||||||||
T Consensus 94 ~~~ivmEy~~---------------------gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~gi~HRDLK~ENil 152 (370)
T KOG0583|consen 94 KIYIVMEYCS---------------------GGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRGIVHRDLKPENIL 152 (370)
T ss_pred eEEEEEEecC---------------------CccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEE
Confidence 9999999998 6777888888999999999999999999999999999999999999999
Q ss_pred eCCC-CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 220 LDYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 220 l~~~-g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
++.+ +++||+|||++...........+.|||+.|+|||++.+.. |+ .++||||+||+||.|++|..||...+...++
T Consensus 153 ld~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~~~~l~ 232 (370)
T KOG0583|consen 153 LDGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSNVPNLY 232 (370)
T ss_pred ecCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCccHHHHH
Confidence 9999 9999999999986433456788999999999999999988 85 8999999999999999999999999999999
Q ss_pred HHHHhCCCCCCccC-CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 297 WSICNERPRFPQFL-SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 297 ~~i~~~~~~~p~~~-s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+|..+.+.+|..+ |.++++||.+||..||.+|+ ++.+|++||||+.
T Consensus 233 ~ki~~~~~~~p~~~~S~~~~~Li~~mL~~~P~~R~------t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 233 RKIRKGEFKIPSYLLSPEARSLIEKMLVPDPSTRI------TLLEILEHPWFQK 280 (370)
T ss_pred HHHhcCCccCCCCcCCHHHHHHHHHHcCCCcccCC------CHHHHhhChhhcc
Confidence 99999999999999 99999999999999999999 6899999999984
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-55 Score=439.23 Aligned_cols=274 Identities=42% Similarity=0.812 Sum_probs=242.4
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC--CCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT--KHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~--~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
||+|+||+||+|+++.+++.||||++.+..............|..++.... +||||+++++.+++.+.+|+||||+.
T Consensus 1 lG~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~- 79 (330)
T cd05586 1 IGKGTFGQVYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMS- 79 (330)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCC-
Confidence 799999999999999999999999998765444445555666777766544 89999999999999999999999998
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus 80 --------------------~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~ivHrDlkp~Nili~~~~~~kl~D 139 (330)
T cd05586 80 --------------------GGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCD 139 (330)
T ss_pred --------------------CChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEec
Confidence 556666777788999999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ- 308 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~- 308 (494)
||+++............+||+.|+|||++.+. .++.++|||||||++|+|++|..||.+.+..+++..|..+...+|.
T Consensus 140 fg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~ 219 (330)
T cd05586 140 FGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPKN 219 (330)
T ss_pred CCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCCHHHHHHHHHcCCCCCCCc
Confidence 99987543334445567899999999999764 5899999999999999999999999999999999999888888875
Q ss_pred cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 309 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+++++++||.+||..||.+||++.. +++++++||||++++|..+..+.+.||+.|...
T Consensus 220 ~~~~~~~~li~~~L~~~P~~R~~~~~--~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~ 278 (330)
T cd05586 220 VLSDEGRQFVKGLLNRNPQHRLGAHR--DAVELKEHPFFADIDWDLLSKKQITPPFKPIVD 278 (330)
T ss_pred cCCHHHHHHHHHHcCCCHHHCCCCCC--CHHHHhcCccccCCCHHHHHhCCCCCCccCCCC
Confidence 57999999999999999999998754 799999999999999999999999999988776
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-54 Score=432.11 Aligned_cols=276 Identities=44% Similarity=0.835 Sum_probs=245.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||+|++.+..............|+..+...++||||+++++++.+.+.+|+|||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~- 79 (321)
T cd05603 1 KVIGKGSFGKVLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVN- 79 (321)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCC-
Confidence 4799999999999999999999999999876444444455566676655557899999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
|++|..++.....+++..++.++.||+.||.|||++||+||||||+||||+.+|.+||+|
T Consensus 80 --------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~kl~D 139 (321)
T cd05603 80 --------------------GGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNIIYRDLKPENILLDSQGHVVLTD 139 (321)
T ss_pred --------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCCCEEEcc
Confidence 555566677778899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL 310 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~ 310 (494)
||+++............+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+...++..+......+|...
T Consensus 140 fg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~ 219 (321)
T cd05603 140 FGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGK 219 (321)
T ss_pred CCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCCHHHHHHHHhcCCCCCCCCC
Confidence 99987533333445567899999999999999999999999999999999999999999998899999998888899899
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+.++.++|.+||++||.+|+++.. ++.++++|+||..++|..+..+.+.||+.|...
T Consensus 220 ~~~~~~li~~~l~~~p~~R~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (321)
T cd05603 220 TVAACDLLVGLLHKDQRRRLGAKA--DFLEIKNHVFFSPINWDDLYHKRITPPYNPNVA 276 (321)
T ss_pred CHHHHHHHHHHccCCHhhcCCCCC--CHHHHhCCCCcCCCCHHHHhcCCCCCCcCCCCC
Confidence 999999999999999999998743 688999999999999999999999999888766
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-54 Score=431.00 Aligned_cols=319 Identities=41% Similarity=0.793 Sum_probs=270.7
Q ss_pred eeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 70 LKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
++.||+|+||.||+|++. .+++.||||++++..... .........|..++. .++||||++++++|..++.+|+||
T Consensus 1 ~~~lg~G~~g~V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv~ 79 (323)
T cd05584 1 LKVLGKGGYGKVFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILE-AVKHPFIVDLIYAFQTGGKLYLIL 79 (323)
T ss_pred CceeeecCCeEEEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHH-hCCCCchhceeeEEecCCeEEEEE
Confidence 368999999999999874 478899999998654322 223345567777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++ |++|..++.+.+.+.+..++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 80 e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~~ 138 (323)
T cd05584 80 EYLS---------------------GGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGIIYRDLKPENILLDAQGH 138 (323)
T ss_pred eCCC---------------------CchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCC
Confidence 9998 5566667777888999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 305 (494)
+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+....+..+..+...
T Consensus 139 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~~~~~~~~~~~~~~~ 218 (323)
T cd05584 139 VKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLN 218 (323)
T ss_pred EEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC
Confidence 99999999875443344455678999999999999999999999999999999999999999999988889999999999
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCC
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSA 385 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~ 385 (494)
+|..+++++++||.+||.+||++|+++.. .++++++.||||+..+|..+..+.+.||+.+...
T Consensus 219 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~-~~~~~l~~h~~~~~~~~~~~~~~~~~~~~~~~~~---------------- 281 (323)
T cd05584 219 LPPYLTPEARDLLKKLLKRNPSSRLGAGP-GDAAEVQSHPFFRHVNWDDLLARKVEPPFKPLLQ---------------- 281 (323)
T ss_pred CCCCCCHHHHHHHHHHcccCHhHcCCCCC-CCHHHHhcCCCcCCCCHHHHhcCCCCCCcCCCCC----------------
Confidence 99999999999999999999999997654 4799999999999999999999999888887665
Q ss_pred CCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCC
Q psy8309 386 IPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 386 ~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 440 (494)
...+.+.|+..++...+..++.+...... ....|.||+|..+
T Consensus 282 ------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~ 323 (323)
T cd05584 282 ------------SEEDVSQFDSKFTRQTPVDSPDDSTLSES-ANQIFLGFTYVAP 323 (323)
T ss_pred ------------CcchhhhcCchhcccccccCccccccccc-cccCcCCCeecCC
Confidence 45667778877777766655544333222 3467999999764
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-54 Score=431.61 Aligned_cols=297 Identities=48% Similarity=0.917 Sum_probs=258.9
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|+++.+++.||+|++++..............|..++. .++||||+++++++...+.+|+||||++
T Consensus 1 ~~lG~G~~g~V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~~~hp~i~~~~~~~~~~~~~~lv~E~~~- 78 (325)
T cd05594 1 KLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDRLCFVMEYAN- 78 (325)
T ss_pred CeeeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCCceEEEEEcCCEEEEEEeCCC-
Confidence 47999999999999999999999999998765444455566667777776 5799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeCCCCCEEEe
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~~~g~vkL~ 229 (494)
||+|..++...+.+++..++.++.||+.||.|||+ +||+||||||+|||++.+|.+||+
T Consensus 79 --------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ivHrDikp~NIll~~~~~~kL~ 138 (325)
T cd05594 79 --------------------GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKIT 138 (325)
T ss_pred --------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCCCCeEEECCCCCEEEe
Confidence 55556667777789999999999999999999997 799999999999999999999999
Q ss_pred ecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Q psy8309 230 DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQF 309 (494)
Q Consensus 230 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 309 (494)
|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+......+|..
T Consensus 139 Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~~~~~~~i~~~~~~~p~~ 218 (325)
T cd05594 139 DFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 218 (325)
T ss_pred cCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCCCCCCCCCHHHHHHHHhcCCCCCCCC
Confidence 99998754333344456789999999999999999999999999999999999999999999888888998888999999
Q ss_pred CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCcc
Q psy8309 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQ 389 (494)
Q Consensus 310 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~ 389 (494)
+++++.+||.+||++||.+|++... .++.++++|+||.++.|..+..+.+.||+.|...
T Consensus 219 ~~~~~~~li~~~L~~dP~~R~~~~~-~~~~~il~h~~~~~~~~~~~~~~~~~~~~~~~~~-------------------- 277 (325)
T cd05594 219 LSPEAKSLLSGLLKKDPKQRLGGGP-DDAKEIMQHKFFAGIVWQDVYEKKLVPPFKPQVT-------------------- 277 (325)
T ss_pred CCHHHHHHHHHHhhcCHHHhCCCCC-CCHHHHhcCCCcCCCCHHHHHhCCCCCCcCCcCC--------------------
Confidence 9999999999999999999996543 3789999999999999999999999999988776
Q ss_pred chhhhhhccccccCCCCccccCCCCCCCC
Q psy8309 390 MPQVLFQLHALDVKYFDKSFTAERPCLTP 418 (494)
Q Consensus 390 ~~~~~~~~~~~~~~~f~~~~~~~~~~~~~ 418 (494)
...+..+|+..++.......|
T Consensus 278 --------~~~~~~~~~~~~~~~~~~~~~ 298 (325)
T cd05594 278 --------SETDTRYFDEEFTAQMITITP 298 (325)
T ss_pred --------CcchhhhcCchhhcCccccCC
Confidence 566777888777765444333
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-53 Score=428.38 Aligned_cols=321 Identities=43% Similarity=0.804 Sum_probs=264.6
Q ss_pred CceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+|++++.||+|+||.||+|++. .+++.||+|++.+..... ....+....|..++....+||+|+++++++...+.+
T Consensus 1 ~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (332)
T cd05614 1 NFELLKVLGTGAYGKVFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKL 80 (332)
T ss_pred CceEEEEEeecCCEEEEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEE
Confidence 5899999999999999999874 478899999997653322 233455677888887655799999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ ||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 ~lv~e~~~---------------------~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivHrDlkp~Nili~ 139 (332)
T cd05614 81 HLILDYVS---------------------GGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLD 139 (332)
T ss_pred EEEEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHeEEC
Confidence 99999999 556666777778899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeecc-CCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC----CHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYL-DKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGC----DEDEL 295 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~-~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~~~~ 295 (494)
.+|.+||+|||+++..... .......+||+.|+|||++.+. .++.++|||||||++|||++|..||... .....
T Consensus 140 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~ 219 (332)
T cd05614 140 SEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEV 219 (332)
T ss_pred CCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCCCCCCCHHHH
Confidence 9999999999998753222 2233457899999999999875 4889999999999999999999999643 34455
Q ss_pred HHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCc
Q psy8309 296 FWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSP 375 (494)
Q Consensus 296 ~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~ 375 (494)
...+....+.+|..++.++++||.+||..||++||++.. .+++++++||||++++|..+...++.+|++|...
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~~~~~-~~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~~~~------ 292 (332)
T cd05614 220 SRRILKCDPPFPSFIGPEAQDLLHKLLRKDPKKRLGAGP-QGASEIKEHPFFKGLDWEALALRKVNPPFRPSIR------ 292 (332)
T ss_pred HHHHhcCCCCCCCCCCHHHHHHHHHHcCCCHHHcCCCCC-CCHHHHHcCCCcCCCCHHHHHhCCCCCCcCCCCC------
Confidence 666777788888899999999999999999999998754 3799999999999999999999999999998876
Q ss_pred ccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeC
Q psy8309 376 WIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 376 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~ 439 (494)
...+.++|..++....+..+|... ....+..|+||+|+.
T Consensus 293 ----------------------~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~ 331 (332)
T cd05614 293 ----------------------NELDVGNFAEEFTNLEPVYSPAGT---PPSGARVFQGYSFVA 331 (332)
T ss_pred ----------------------CcchhhhcCcccccCCcccCCCCC---CcccccccCCceecC
Confidence 556667776666555444443321 123456899999974
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0597|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-55 Score=436.05 Aligned_cols=256 Identities=33% Similarity=0.584 Sum_probs=240.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|.+.+.||+|+||+||+|+.|.|.+.||||++.|.. ..+.+......|.++++ .++|||||.++++|++..++++
T Consensus 1 me~yhv~e~iG~Gsfg~VYKgrrK~t~~~vAik~i~K~g-r~~k~l~~l~~ev~i~r-~lkHpniv~m~esfEt~~~~~v 78 (808)
T KOG0597|consen 1 MEQYHVYEMIGEGSFGRVYKGRRKYTIQVVAIKFIDKSG-RNEKELKNLRQEVRILR-SLKHPNIVEMLESFETSAHLWV 78 (808)
T ss_pred CcchhHHHHhcCCccceeeecccccceeEEEEEEehhcC-CchHHHHHHHHHHHHHH-hcCCcchhhHHHhhcccceEEE
Confidence 468999999999999999999999999999999998863 45667788889999998 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|.|||. | +|+..+...+.++|+.++.++.|++.||.|||+++|+|||+||.|||++..
T Consensus 79 Vte~a~---------------------g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~rilhrd~kPqniLl~~~ 136 (808)
T KOG0597|consen 79 VTEYAV---------------------G-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSNRILHRDMKPQNILLEKG 136 (808)
T ss_pred Eehhhh---------------------h-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhcCcccccCCcceeeecCC
Confidence 999996 4 889999999999999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
|++|+||||+|+..........++-|||.|||||++.++.|+..+|+||||||+|||++|++||......++...|....
T Consensus 137 ~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~si~~Lv~~I~~d~ 216 (808)
T KOG0597|consen 137 GTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVGQPPFYARSITQLVKSILKDP 216 (808)
T ss_pred CceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcCCCCchHHHHHHHHHHHhcCC
Confidence 99999999999976665555677889999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+.+|...|..+++||.++|.+||.+|+ ++.+++.|||.++
T Consensus 217 v~~p~~~S~~f~nfl~gLL~kdP~~Rl------tW~~Ll~HpF~k~ 256 (808)
T KOG0597|consen 217 VKPPSTASSSFVNFLQGLLIKDPAQRL------TWTDLLGHPFWKG 256 (808)
T ss_pred CCCcccccHHHHHHHHHHhhcChhhcc------cHHHHhcChHHhh
Confidence 999999999999999999999999999 7899999999875
|
|
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-53 Score=435.11 Aligned_cols=275 Identities=36% Similarity=0.647 Sum_probs=234.1
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++++.||+|+||+||+|+++.+++.||||++.+..............|..++. .++||||+++++++++.+++|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~l~~~~~~~~~~~lv~ 80 (381)
T cd05626 2 MFVKIKTLGIGAFGEVCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFVM 80 (381)
T ss_pred CceEEEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hcCCCCeeeeEEEEecCCEEEEEE
Confidence 6899999999999999999999999999999998765555566677788888887 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|||+ ||+|..++.+.+.+++..++.+++||+.||+|||++||+||||||+||||+.+|+
T Consensus 81 E~~~---------------------gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~givHrDlKp~Nili~~~~~ 139 (381)
T cd05626 81 DYIP---------------------GGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMGFIHRDIKPDNILIDLDGH 139 (381)
T ss_pred ecCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCcHHHEEECCCCC
Confidence 9999 5566667777788999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeecc-----------------------------------------------CCcccccCCCCCccChhh
Q psy8309 226 VRIADFGMCKLQIYL-----------------------------------------------DKTTDTFCGTPDYMAPEI 258 (494)
Q Consensus 226 vkL~DFGla~~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~ 258 (494)
+||+|||+++..... .....+.+||+.|+|||+
T Consensus 140 ~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 219 (381)
T cd05626 140 IKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEV 219 (381)
T ss_pred EEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccccccccccccccCCccccCHHH
Confidence 999999997531100 001234689999999999
Q ss_pred hCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHhhccC--CCCCCCCC
Q psy8309 259 IKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE--RPRFPQ--FLSVEAKNILVHLLDK--DTTKRLGS 332 (494)
Q Consensus 259 l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~--dP~~R~~~ 332 (494)
+.+..|+.++|||||||++|||++|.+||...+..+....+... ...+|. .+++++++||.+||.. ++..|+
T Consensus 220 ~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~dli~~ll~~~~~~~~R~-- 297 (381)
T cd05626 220 LLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPPQVKLSPEAVDLITKLCCSAEERLGRN-- 297 (381)
T ss_pred HcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCCCCCCCHHHHHHHHHHccCcccccCCC--
Confidence 99999999999999999999999999999988887777777643 344554 5899999999996654 444577
Q ss_pred CCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 333 TQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 333 ~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+++++++||||.+++|.... +...+|+.|.+.
T Consensus 298 ----~~~~~l~hp~f~~~~~~~~~-~~~~~~~~p~~~ 329 (381)
T cd05626 298 ----GADDIKAHPFFSEVDFSSDI-RTQPAPYVPKIS 329 (381)
T ss_pred ----CHHHHhcCcccCCCChhHHh-hcCCCCccCcCC
Confidence 68999999999999998865 356778888776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-53 Score=432.78 Aligned_cols=318 Identities=36% Similarity=0.685 Sum_probs=258.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||+||+|+++.+++.||||++.+..............|..++. .++||||++++++|++.+++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv 79 (364)
T cd05599 1 DDFESIKVIGRGAFGEVRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILA-EADNPWVVKLYYSFQDENYLYLI 79 (364)
T ss_pred CCceEEEEEEecCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceEEEEEcCCeEEEE
Confidence 47999999999999999999999999999999998764444455566677888887 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 80 ~E~~~---------------------~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~NIl~~~~~ 138 (364)
T cd05599 80 MEYLP---------------------GGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLLDAKG 138 (364)
T ss_pred ECCCC---------------------CcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeEECCCC
Confidence 99999 556666777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCC--------------------------------------cccccCCCCCccChhhhCCCCCCC
Q psy8309 225 HVRIADFGMCKLQIYLDK--------------------------------------TTDTFCGTPDYMAPEIIKGLKYNQ 266 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~--------------------------------------~~~~~~gt~~y~aPE~l~~~~~~~ 266 (494)
.+||+|||+++....... ...+.+||+.|+|||++.+..++.
T Consensus 139 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 218 (364)
T cd05599 139 HIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNK 218 (364)
T ss_pred CEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccccccccCccccCHHHHcCCCCCC
Confidence 999999999864221100 112357999999999999999999
Q ss_pred cchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 267 CVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 267 ~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
++|||||||++|||++|.+||.+.+..+.+..+.... ..+|. .+++++++||.+||. +|.+|++. .++++++
T Consensus 219 ~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~ll~-~p~~R~~~---~~~~~ll 294 (364)
T cd05599 219 ECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEVPLSPEAKDLIKRLCC-EAERRLGN---NGVNEIK 294 (364)
T ss_pred eeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-CHhhcCCC---CCHHHHh
Confidence 9999999999999999999999999888888887654 33443 479999999999996 99999964 2699999
Q ss_pred cCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCC--CCCCCC
Q psy8309 343 AHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERP--CLTPVD 420 (494)
Q Consensus 343 ~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~--~~~~~~ 420 (494)
.||||++++|+.+. ...+|+.|.+. ...|.++|+. |..... ..++..
T Consensus 295 ~h~~~~~~~~~~~~--~~~~~~~~~~~----------------------------~~~~~~~~~~-~~~~~~~~~~~~~~ 343 (364)
T cd05599 295 SHPFFKGVDWEHIR--ERPAPIIPELK----------------------------SITDTSNFDD-FEEIDLDVPTSPGP 343 (364)
T ss_pred cCCCcCCCCHHHHh--hcCCCCCCCCC----------------------------Cchhhhhccc-cccccccccCCCcc
Confidence 99999999999875 44677777665 4566777764 322221 111111
Q ss_pred ccccCcccCCCccCeeeeC
Q psy8309 421 RTILESMDQTQFQGFSYTN 439 (494)
Q Consensus 421 ~~~~~~~~~~~f~~f~~~~ 439 (494)
........+..|.||+|.+
T Consensus 344 ~~~~~~~~~~~~~~~~~~~ 362 (364)
T cd05599 344 PRGKIKSKDLAFIGYTYKR 362 (364)
T ss_pred ccccccccCCCCCCCeeeC
Confidence 1112234567899999975
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-53 Score=432.90 Aligned_cols=274 Identities=36% Similarity=0.713 Sum_probs=236.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++++..............|..++. .++||+|+++++.+++.+++|+|
T Consensus 1 ~~f~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~~~~~~lv 79 (360)
T cd05627 1 DDFESLKVIGRGAFGEVRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILV-EADGAWVVKMFYSFQDKRNLYLI 79 (360)
T ss_pred CCceEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999998755444555666777888776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+||||+.+|
T Consensus 80 ~E~~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~givHrDLkp~NIli~~~~ 138 (360)
T cd05627 80 MEFLP---------------------GGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLLLDAKG 138 (360)
T ss_pred EeCCC---------------------CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEccCCCHHHEEECCCC
Confidence 99999 556666777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccC-----------------------------------CcccccCCCCCccChhhhCCCCCCCcch
Q psy8309 225 HVRIADFGMCKLQIYLD-----------------------------------KTTDTFCGTPDYMAPEIIKGLKYNQCVD 269 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~-----------------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~D 269 (494)
++||+|||+++...... ....+.+||+.|+|||++.+..|+.++|
T Consensus 139 ~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~D 218 (360)
T cd05627 139 HVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCD 218 (360)
T ss_pred CEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCCCccccCHHHHcCCCCCCcce
Confidence 99999999986421100 0122468999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNE--RPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 270 iwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
||||||++|||++|.+||.+.+..+.+.++... ...+|. .+++++++||.+|+ .||.+|++. .+++|++.||
T Consensus 219 iwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~---~~~~ei~~hp 294 (360)
T cd05627 219 WWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPEVPISEKAKDLILRFC-TDSENRIGS---NGVEEIKSHP 294 (360)
T ss_pred eccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCCCCCCHHHHHHHHHhc-cChhhcCCC---CCHHHHhcCC
Confidence 999999999999999999999998888888864 344554 37899999999987 499999975 3689999999
Q ss_pred CcCCCChhHHhcCcCCCCC
Q psy8309 346 YFRGLDWQALEKRELEPPF 364 (494)
Q Consensus 346 ~f~~~~w~~l~~~~~~pp~ 364 (494)
||++++|..+..+...+|.
T Consensus 295 ~f~~~~~~~~~~~~~~~~~ 313 (360)
T cd05627 295 FFEGVDWGHIRERPAAIPI 313 (360)
T ss_pred CCCCCCHHHHhcCCCCCCc
Confidence 9999999999877655553
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-53 Score=435.78 Aligned_cols=277 Identities=38% Similarity=0.697 Sum_probs=237.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++++.||+|+||.||+|+++.+++.||||++.+..............|+.++. .++||||+++++.|++.+.+|+||
T Consensus 2 ~f~~~~~LG~G~~g~Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~-~~~h~~iv~~~~~~~~~~~~~lv~ 80 (382)
T cd05625 2 MFVKIKTLGIGAFGEVCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILA-EADNEWVVRLYYSFQDKDNLYFVM 80 (382)
T ss_pred CcEEEEEEEeCCCEEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH-hCCCCcCCeEEEEEEeCCEEEEEE
Confidence 6899999999999999999999999999999998765544556667778888887 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|||+ ||+|...+.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|+
T Consensus 81 E~~~---------------------gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ivHrDlKp~NILl~~~g~ 139 (382)
T cd05625 81 DYIP---------------------GGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNILIDRDGH 139 (382)
T ss_pred eCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEECCCCC
Confidence 9999 5555666777778999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeecc-----------------------------------------------CCcccccCCCCCccChhh
Q psy8309 226 VRIADFGMCKLQIYL-----------------------------------------------DKTTDTFCGTPDYMAPEI 258 (494)
Q Consensus 226 vkL~DFGla~~~~~~-----------------------------------------------~~~~~~~~gt~~y~aPE~ 258 (494)
+||+|||+|...... .....+.+||+.|+|||+
T Consensus 140 ~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~ 219 (382)
T cd05625 140 IKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEV 219 (382)
T ss_pred EEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhccccccccccccccCcccCCHHH
Confidence 999999997521100 001134689999999999
Q ss_pred hCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--ccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 259 IKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER--PRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 259 l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
+.+..|+.++|||||||++|||++|.+||.+.+..+...++.... ..+| ..++++++++|.+|+ .+|.+|++.
T Consensus 220 ~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~~li~~l~-~~p~~R~~~-- 296 (382)
T cd05625 220 LLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKLC-RGPEDRLGK-- 296 (382)
T ss_pred hcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCCcccCCHHHHHHHHHHc-cCHhHcCCC--
Confidence 999999999999999999999999999999988888877777643 3444 368999999999987 599999974
Q ss_pred CCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 335 CNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 335 ~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.++++++.||||++++|.... .+..+|+.|.+.
T Consensus 297 -~~~~ei~~hp~f~~~~~~~~~-~~~~~~~~~~~~ 329 (382)
T cd05625 297 -NGADEIKAHPFFKTIDFSSDL-RQQSAPYIPKIT 329 (382)
T ss_pred -CCHHHHhcCCCcCCcChHHHH-hcCCCCccCcCC
Confidence 368999999999999998865 456788888887
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >KOG0580|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-54 Score=391.57 Aligned_cols=261 Identities=32% Similarity=0.583 Sum_probs=238.7
Q ss_pred CCCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 59 FRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 59 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.+.+.+++|++++.||+|-||.||+|+.+.++..||+|++-|.++..........+|..+.. .++||||++++++|.+.
T Consensus 16 ~~~~~l~dfeigr~LgkgkFG~vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs-~L~hpnilrlY~~fhd~ 94 (281)
T KOG0580|consen 16 TKTWTLDDFEIGRPLGKGKFGNVYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQS-HLRHPNILRLYGYFHDS 94 (281)
T ss_pred ccccchhhccccccccCCccccEeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeec-ccCCccHHhhhhheecc
Confidence 45677899999999999999999999999999999999999987665555555666666665 68999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ--QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+||++||.. +|+++..++ ...+++|..+..|+.|++.||.|+|.++||||||||+
T Consensus 95 ~riyLilEya~---------------------~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h~k~VIhRdiKpe 153 (281)
T KOG0580|consen 95 KRIYLILEYAP---------------------RGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCHLKRVIHRDIKPE 153 (281)
T ss_pred ceeEEEEEecC---------------------CchHHHHHHhcccccccccchhHHHHHHHHHHHHhccCCcccCCCCHH
Confidence 99999999999 555666677 6678999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|+|++.+|.+||+|||.+... ......+.|||..|.+||++.+..++..+|+|++|++.||++.|.+||...+..+++
T Consensus 154 nlLlg~~~~lkiAdfGwsV~~--p~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~~etY 231 (281)
T KOG0580|consen 154 NLLLGSAGELKIADFGWSVHA--PSNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSHSETY 231 (281)
T ss_pred HhccCCCCCeeccCCCceeec--CCCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhhHHHH
Confidence 999999999999999998753 356677899999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 297 WSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 297 ~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
++|..-+..+|..++.+++|||.+||.++|.+|+ ...|++.|||...
T Consensus 232 krI~k~~~~~p~~is~~a~dlI~~ll~~~p~~r~------~l~~v~~hpwI~a 278 (281)
T KOG0580|consen 232 KRIRKVDLKFPSTISGGAADLISRLLVKNPIERL------ALTEVMDHPWIVA 278 (281)
T ss_pred HHHHHccccCCcccChhHHHHHHHHhccCccccc------cHHHHhhhHHHHh
Confidence 9999999999999999999999999999999998 6889999999753
|
|
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-53 Score=431.71 Aligned_cols=277 Identities=38% Similarity=0.723 Sum_probs=238.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||++++++|++.+++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~iv~~~~~~~~~~~~~lv 79 (377)
T cd05629 1 EDFHTVKVIGKGAFGEVRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLA-ESDSPWVVSLYYSFQDAQYLYLI 79 (377)
T ss_pred CCceEeEEEeecCCEEEEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCeeEEE
Confidence 47999999999999999999999999999999997754444455566777888877 58999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 80 ~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~givHrDlkp~NIll~~~~ 138 (377)
T cd05629 80 MEFLP---------------------GGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILIDRGG 138 (377)
T ss_pred EeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEECCCC
Confidence 99999 555666777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCC-----------------------------------------------cccccCCCCCccChh
Q psy8309 225 HVRIADFGMCKLQIYLDK-----------------------------------------------TTDTFCGTPDYMAPE 257 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~-----------------------------------------------~~~~~~gt~~y~aPE 257 (494)
.+||+|||+++....... ...+.+||+.|+|||
T Consensus 139 ~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE 218 (377)
T cd05629 139 HIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPE 218 (377)
T ss_pred CEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccccccccCCCccccCHH
Confidence 999999999853110000 011357999999999
Q ss_pred hhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--CCCCCc--cCCHHHHHHHHhhccCCCCCCCCCC
Q psy8309 258 IIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE--RPRFPQ--FLSVEAKNILVHLLDKDTTKRLGST 333 (494)
Q Consensus 258 ~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~--~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~ 333 (494)
++.+..|+.++|||||||++|||++|.+||.+.+..+.+..|... ...+|. .++.++++||.+||. +|.+|++.
T Consensus 219 ~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~s~~~~dli~~lL~-~~~~r~~r- 296 (377)
T cd05629 219 IFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPDDIHLSVEAEDLIRRLIT-NAENRLGR- 296 (377)
T ss_pred HHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCCCCCCCHHHHHHHHHHhc-CHhhcCCC-
Confidence 999999999999999999999999999999998888888888764 345554 579999999999997 89998753
Q ss_pred CCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 334 QCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 334 ~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.++.|++.||||++++|+.+ +.+.+|+.|.+.
T Consensus 297 --~~~~~~l~hp~~~~~~~~~~--~~~~~~~~~~~~ 328 (377)
T cd05629 297 --GGAHEIKSHPFFRGVDWDTI--RQIRAPFIPQLK 328 (377)
T ss_pred --CCHHHHhcCCCcCCCCHHHH--ccCCCCcccCCC
Confidence 37999999999999999998 577888888776
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-53 Score=429.52 Aligned_cols=275 Identities=41% Similarity=0.804 Sum_probs=239.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++++..............|..++. .++||||+++++++++.+++|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv 79 (350)
T cd05573 1 DDFEVIKVIGRGAFGEVWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILA-DADSPWIVKLYYSFQDEEHLYLV 79 (350)
T ss_pred CCceEEEEEEeCCcEEEEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHH-hcCCCCccchhhheecCCeEEEE
Confidence 47999999999999999999999999999999998765544455566777777777 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++ |++|..++...+.+++..++.++.||+.||+|||++||+||||||+||||+.+|
T Consensus 80 ~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giiH~Dlkp~NIll~~~~ 138 (350)
T cd05573 80 MEYMP---------------------GGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILIDADG 138 (350)
T ss_pred EcCCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEECCCC
Confidence 99999 555666677778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccC-----------------------------CcccccCCCCCccChhhhCCCCCCCcchHHHHHH
Q psy8309 225 HVRIADFGMCKLQIYLD-----------------------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGI 275 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGv 275 (494)
.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||
T Consensus 139 ~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~ 218 (350)
T cd05573 139 HIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGV 218 (350)
T ss_pred CEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCceeeEecch
Confidence 99999999987533222 1234567999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCCCcc--CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 276 LLYEMHVGQSPFSGCDEDELFWSICN--ERPRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 276 il~ell~G~~Pf~~~~~~~~~~~i~~--~~~~~p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
++|||++|..||.+.+..+.+.++.. ....+|.. +++++++||.+||. ||.+|++ +++++++||||++++
T Consensus 219 il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~~~~~~~~~~~li~~ll~-dp~~R~~-----s~~~ll~hp~~~~~~ 292 (350)
T cd05573 219 ILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPPDPPVSPEAIDLICRLLC-DPEDRLG-----SFEEIKSHPFFKGID 292 (350)
T ss_pred hhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCCCCCCCHHHHHHHHHHcc-ChhhcCC-----CHHHHhcCCCcCCCC
Confidence 99999999999999998888888887 44555543 59999999999997 9999994 389999999999999
Q ss_pred hhHHhcCcCCCCCccccc
Q psy8309 352 WQALEKRELEPPFRPRVI 369 (494)
Q Consensus 352 w~~l~~~~~~pp~~p~~~ 369 (494)
|+... +..||++|.+.
T Consensus 293 ~~~~~--~~~~~~~~~~~ 308 (350)
T cd05573 293 WENLR--ETKPPFVPELS 308 (350)
T ss_pred HHHHh--hCCCCcCCCCC
Confidence 99886 56678888766
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-52 Score=413.86 Aligned_cols=278 Identities=38% Similarity=0.654 Sum_probs=237.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++.+.||+|+||.||+|.++.+++.||||++.+..............|..++. .++|++|+++++++.+.+.+|+||
T Consensus 1 ~f~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05631 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILE-KVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCEEEEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHH-hcCCCcEEEEEEEEccCCeEEEEE
Confidence 3788999999999999999999999999999998764433334445667888877 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+++|+| ..++.. ...+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 e~~~~g~L---------------------~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nill~~~ 138 (285)
T cd05631 80 TIMNGGDL---------------------KFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDR 138 (285)
T ss_pred EecCCCcH---------------------HHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 99996554 333332 3468999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH----HHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED----ELFWSI 299 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~----~~~~~i 299 (494)
+.+||+|||++.... ........+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+.. .....+
T Consensus 139 ~~~kl~Dfg~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05631 139 GHIRISDLGLAVQIP-EGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRV 217 (285)
T ss_pred CCEEEeeCCCcEEcC-CCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCCcchhHHHHHHHh
Confidence 999999999987532 222334567999999999999999999999999999999999999999876542 333444
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccc
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPR 367 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~ 367 (494)
......++..++.++.+||.+||+.||.+||++.+. +++++++||||.+++|+.+.++.++||+.|.
T Consensus 218 ~~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~-~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05631 218 KEDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGN-GAAGVKQHPIFKNINFKRLEANMLEPPFCPD 284 (285)
T ss_pred hcccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCC-CHHHHhcCHhhcCCCHHHHHhCcCCcCCCCC
Confidence 455667788899999999999999999999987553 7999999999999999999999999999985
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=428.39 Aligned_cols=280 Identities=35% Similarity=0.640 Sum_probs=238.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|++.+.||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||+++++++.+.+.
T Consensus 39 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~-~~~h~~iv~~~~~~~~~~~ 117 (370)
T cd05596 39 RMKAEDFDVIKVIGRGAFGEVQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMA-HANSEWIVQLHYAFQDDKY 117 (370)
T ss_pred CCCHHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEecCCE
Confidence 345679999999999999999999999999999999998754434444445566777776 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+||+ |..++. ...+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus 118 ~~lv~Ey~~gg~---------------------L~~~l~-~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NILl 175 (370)
T cd05596 118 LYMVMEYMPGGD---------------------LVNLMS-NYDIPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (370)
T ss_pred EEEEEcCCCCCc---------------------HHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEEE
Confidence 999999999554 444443 3468999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCC----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGL----KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+.+|.+||+|||++....... ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+....
T Consensus 176 ~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~ 255 (370)
T cd05596 176 DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (370)
T ss_pred cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCHHHH
Confidence 999999999999987532221 123457899999999999754 388999999999999999999999999998888
Q ss_pred HHHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCC--CCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 296 FWSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTK--RLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 296 ~~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~--R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+.+|.... +.+|. .+|.++++||.+||+.+|.+ |+ +++|+++||||++.+|.....+...+|+.|...
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~r~~R~------s~~ell~h~~~~~~~~~~~~~~~~~~~~~p~~~ 329 (370)
T cd05596 256 YSKIMDHKNSLTFPDDIEISKQAKDLICAFLTDREVRLGRN------GVDEIKSHPFFKNDQWTFDNIRETVAPVVPELS 329 (370)
T ss_pred HHHHHcCCCcCCCCCcCCCCHHHHHHHHHHccChhhccCCC------CHHHHhcCcccCCCChhhHHhcCCCcCccCcCC
Confidence 88888653 45565 57999999999999988877 77 789999999999999988777888888888765
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >KOG0591|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-55 Score=404.59 Aligned_cols=251 Identities=28% Similarity=0.438 Sum_probs=222.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEE-EEEcCCe
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFC-TFQTDSH 140 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~-~~~~~~~ 140 (494)
..+.+|+++++||+|+||.||+|++..+|..+|.|.++-. ..+.........|..+|. +++|||||++++ .|..++.
T Consensus 16 ~~l~~y~Il~~IG~GsFg~vykv~~~~~g~l~a~K~i~f~-~md~k~rq~~v~Ei~lLk-QL~HpNIVqYy~~~f~~~~e 93 (375)
T KOG0591|consen 16 KTLADYQILKKIGRGSFGEVYKVQCLLDGKLVALKKIQFG-MMDAKARQDCVKEISLLK-QLNHPNIVQYYAHSFIEDNE 93 (375)
T ss_pred ccHHHHHHHHHHcCCcchheEEeeeccCcchhhhhhcchh-hccHHHHHHHHHHHHHHH-hcCCchHHHHHHHhhhccch
Confidence 3467999999999999999999999999999999999844 345556667788988887 689999999998 6666555
Q ss_pred -eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh--CC--CccccCCC
Q psy8309 141 -LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK--KG--IVYRDLKL 215 (494)
Q Consensus 141 -~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~--~g--ivHrDLKp 215 (494)
++||||||.+|||.. -...+.+....++|..++.|+.|++.||.++|. .. |+||||||
T Consensus 94 vlnivmE~c~~GDLsq-----------------mIk~~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKP 156 (375)
T KOG0591|consen 94 VLNIVMELCDAGDLSQ-----------------MIKHFKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKP 156 (375)
T ss_pred hhHHHHHhhcccCHHH-----------------HHHHHHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcc
Confidence 999999999887732 112233455689999999999999999999999 45 99999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
.||+|+.+|.|||+||||++........+.+++|||.||+||++.+.+|+.++|||||||++|||+.-++||+|.+-.++
T Consensus 157 aNIFl~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n~~~L 236 (375)
T KOG0591|consen 157 ANIFLTANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDNLLSL 236 (375)
T ss_pred hheEEcCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCcccccHHHH
Confidence 99999999999999999999877666778899999999999999999999999999999999999999999999999999
Q ss_pred HHHHHhCCCC-CC-ccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 296 FWSICNERPR-FP-QFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 296 ~~~i~~~~~~-~p-~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
..+|.++.++ +| ..+|.++..||..|+..||..||+
T Consensus 237 ~~KI~qgd~~~~p~~~YS~~l~~li~~ci~vd~~~RP~ 274 (375)
T KOG0591|consen 237 CKKIEQGDYPPLPDEHYSTDLRELINMCIAVDPEQRPD 274 (375)
T ss_pred HHHHHcCCCCCCcHHHhhhHHHHHHHHHccCCcccCCC
Confidence 9999999764 77 689999999999999999999995
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-53 Score=422.60 Aligned_cols=276 Identities=42% Similarity=0.787 Sum_probs=242.3
Q ss_pred eeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 70 LKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
++.||+|+||.||++++. .+|+.||+|++.+.... .........|..++. .++||||+++++++.+.+.+|+|||
T Consensus 1 l~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~e 78 (318)
T cd05582 1 LKVLGQGSFGKVFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILA-EVNHPFIVKLHYAFQTEGKLYLILD 78 (318)
T ss_pred CceeeeCCCEEEEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCEEEEEEc
Confidence 367999999999999863 57889999999875332 223344566777776 5799999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCE
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~v 226 (494)
|++ |++|..++.+...+++..++.++.||+.||.|||++||+||||||+|||++.+|.+
T Consensus 79 ~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~ 137 (318)
T cd05582 79 FLR---------------------GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHI 137 (318)
T ss_pred CCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHeEECCCCcE
Confidence 999 55566677777789999999999999999999999999999999999999999999
Q ss_pred EEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Q psy8309 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF 306 (494)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 306 (494)
||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|+.||.+.+..+.+..+......+
T Consensus 138 kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~i~~~~~~~ 217 (318)
T cd05582 138 KLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDRKETMTMILKAKLGM 217 (318)
T ss_pred EEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCHHHHHHHHHcCCCCC
Confidence 99999998764333344556789999999999999999999999999999999999999999999989999999888899
Q ss_pred CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 307 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
|..+++++++||.+||+.||.+||++.+. .+++++.|+||..++|..+..+++.||+.|...
T Consensus 218 p~~~~~~~~~li~~~l~~~P~~R~~a~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (318)
T cd05582 218 PQFLSPEAQSLLRALFKRNPANRLGAGPD-GVEEIKRHPFFSTIDWNKLYRREIKPPFKPAVG 279 (318)
T ss_pred CCCCCHHHHHHHHHHhhcCHhHcCCCCCC-CHHHHhCCCCcCCCCHHHHHhcCCCCCcCCCCC
Confidence 99999999999999999999999987542 589999999999999999999999998888665
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-52 Score=426.13 Aligned_cols=320 Identities=35% Similarity=0.643 Sum_probs=253.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
...++|++.+.||+|+||.||+|+++.+++.||+|++.+..............|..++. .++||||+++++++.+++.+
T Consensus 40 ~~~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~hp~iv~~~~~~~~~~~~ 118 (370)
T cd05621 40 MKAEDYDVVKVIGRGAFGEVQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFCAFQDDKYL 118 (370)
T ss_pred CCHHHCeEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEE
Confidence 44579999999999999999999999999999999998654434444445556666666 68999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||+|| +|..++.. ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 119 ~lv~Ey~~gg---------------------~L~~~l~~-~~~~~~~~~~~~~qil~aL~~LH~~~IvHrDLKp~NILl~ 176 (370)
T cd05621 119 YMVMEYMPGG---------------------DLVNLMSN-YDVPEKWAKFYTAEVVLALDAIHSMGLIHRDVKPDNMLLD 176 (370)
T ss_pred EEEEcCCCCC---------------------cHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEEC
Confidence 9999999954 44545543 4689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
.+|.+||+|||+|+....... ...+.+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+....+
T Consensus 177 ~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~~~~~ 256 (370)
T cd05621 177 KHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSLVGTY 256 (370)
T ss_pred CCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCHHHHH
Confidence 999999999999975322211 234678999999999997643 789999999999999999999999999988888
Q ss_pred HHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCC
Q psy8309 297 WSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPF 372 (494)
Q Consensus 297 ~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~ 372 (494)
.+|.... +.+|. .++..++++|..||. ++.+|++- .+++|+++||||+..+|.....+...+|+.|.+.
T Consensus 257 ~~i~~~~~~~~~p~~~~~s~~~~~li~~~L~-~~~~r~~R---~~~~e~l~hp~~~~~~~~~~~~~~~~~~~~p~~~--- 329 (370)
T cd05621 257 SKIMDHKNSLNFPEDVEISKHAKNLICAFLT-DREVRLGR---NGVEEIKQHPFFKNDQWNWDNIRETAAPVVPELS--- 329 (370)
T ss_pred HHHHhCCcccCCCCcccCCHHHHHHHHHHcc-CchhccCC---CCHHHHhcCcccCCCCcChHhcCCCCCCcCCCCC---
Confidence 8887643 55665 469999999999998 44444421 2789999999999988877666777888888776
Q ss_pred CCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCC-CCCCccccCcccCCCccCeeee
Q psy8309 373 SSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCL-TPVDRTILESMDQTQFQGFSYT 438 (494)
Q Consensus 373 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~-~~~~~~~~~~~~~~~f~~f~~~ 438 (494)
...|.++|+.......... .+...... ..+..|.||+|.
T Consensus 330 -------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~ 369 (370)
T cd05621 330 -------------------------SDIDSSNFDDIEDDKGDVETFPIPKAFV--GNQLPFIGFTYY 369 (370)
T ss_pred -------------------------CcchhhhcCCccccccccccCCCCcccc--ccccccCCCEec
Confidence 5666777764322222221 12222122 225789999985
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >KOG0033|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-54 Score=391.77 Aligned_cols=257 Identities=28% Similarity=0.497 Sum_probs=229.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
-+.|++-++||+|.|+.|+.|.++.||+.||+|++..+.+... ..+...+|..+.. .++|||||+|++.+.+....||
T Consensus 10 ~d~y~l~e~igkG~FSvVrRc~~~~tg~~fa~kiin~~k~~~~-~~e~l~rEarIC~-~LqHP~IvrL~~ti~~~~~~yl 87 (355)
T KOG0033|consen 10 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKLSAR-DFQKLEREARICR-KLQHPNIVRLHDSIQEESFHYL 87 (355)
T ss_pred chhhhHHHHHccCchHHHHHHHhccchHHHHHHHhhhhhhccc-cHHHHHHHHHHHH-hcCCCcEeehhhhhcccceeEE
Confidence 4689999999999999999999999999999999987655433 5556667777766 6899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|+|+|. |++|..-+-+...++|..+..+++||+.||.|+|.+||||||+||+|+|+.+.
T Consensus 88 vFe~m~---------------------G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~yCH~n~IvHRDvkP~nllLASK 146 (355)
T KOG0033|consen 88 VFDLVT---------------------GGELFEDIVAREFYSEADASHCIQQILEALAYCHSNGIVHRDLKPENLLLASK 146 (355)
T ss_pred EEeccc---------------------chHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHhcCceeccCChhheeeeec
Confidence 999999 55556566666778999999999999999999999999999999999999654
Q ss_pred ---CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 ---GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 ---g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.-+||+|||++.... .+.....++|||.|||||+++..+|+..+|||+.|||||-||.|.+||.+.+...+++.|.
T Consensus 147 ~~~A~vKL~~FGvAi~l~-~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~~rlye~I~ 225 (355)
T KOG0033|consen 147 AKGAAVKLADFGLAIEVN-DGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYEQIK 225 (355)
T ss_pred cCCCceeecccceEEEeC-CccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccHHHHHHHHh
Confidence 349999999998754 5566677899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 301 NERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 301 ~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+.+.+|. .+++++++||++||..||.+|+ ++.|+|+|||.++-
T Consensus 226 ~g~yd~~~~~w~~is~~Ak~LvrrML~~dP~kRI------ta~EAL~HpWi~~r 273 (355)
T KOG0033|consen 226 AGAYDYPSPEWDTVTPEAKSLIRRMLTVNPKKRI------TADEALKHPWICNR 273 (355)
T ss_pred ccccCCCCcccCcCCHHHHHHHHHHhccChhhhc------cHHHHhCCchhcch
Confidence 99988874 7899999999999999999999 68899999999863
|
|
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-51 Score=421.93 Aligned_cols=282 Identities=38% Similarity=0.661 Sum_probs=235.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|++.+.||+|+||.||+|+++.+++.||+|++.+..............|+.++. .++||||+++++.+.+.+.
T Consensus 39 ~~~~~~y~i~~~lG~G~fg~Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~-~~~hp~iv~~~~~~~~~~~ 117 (371)
T cd05622 39 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRY 117 (371)
T ss_pred CcchhhcEEEEEEeecCCeEEEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCE
Confidence 345689999999999999999999999999999999997654433444444556666666 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+||+ |..++.. ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 118 ~~lv~Ey~~gg~---------------------L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDLkp~NIll 175 (371)
T cd05622 118 LYMVMEYMPGGD---------------------LVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 175 (371)
T ss_pred EEEEEcCCCCCc---------------------HHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCEEeCCCCHHHEEE
Confidence 999999999554 4444443 468999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+.+|++||+|||+++...... ....+.+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+....
T Consensus 176 ~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 255 (371)
T cd05622 176 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 255 (371)
T ss_pred CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCHHHH
Confidence 999999999999997533221 1234678999999999997643 88999999999999999999999999998888
Q ss_pred HHHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 296 FWSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 296 ~~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+.+|.... ..+|. .++.++++||.+||. +|..|++. .+++||++|+||++.+|.....++..+|+.|.+.
T Consensus 256 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~-~~~~r~~r---~~~~ei~~h~~~~~~~~~~~~~~~~~~~~~~~~~ 329 (371)
T cd05622 256 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLT-DREVRLGR---NGVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 329 (371)
T ss_pred HHHHHcCCCcccCCCcCCCCHHHHHHHHHHcC-ChhhhcCC---CCHHHHhcCcccCCCChhHHhcCCCCCCCCCCCC
Confidence 88888653 44554 689999999999997 77776643 3789999999999977766666788888888765
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >KOG0585|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-52 Score=410.65 Aligned_cols=259 Identities=31% Similarity=0.527 Sum_probs=223.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-----------hhHHHHHHHHHHHHhcCCCCcee
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-----------DDVECTLIERKVLALGTKHPYLC 129 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----------~~~~~~~~e~~~l~~~~~hp~Iv 129 (494)
...+++|++++.||+|.||+|.+|++..+++.||||++.|...... ..++....|+.+|. .+.|||||
T Consensus 93 ~k~lNqy~l~~eiG~G~yGkVkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailK-kl~H~nVV 171 (576)
T KOG0585|consen 93 RKQLNQYELIKEIGSGQYGKVKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILK-KLHHPNVV 171 (576)
T ss_pred ceehhheehhhhhcCCccceEEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHH-hcCCcCee
Confidence 4467899999999999999999999999999999999987543321 23457788988888 58999999
Q ss_pred eEEEEEEcC--CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 130 HLFCTFQTD--SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR-FDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 130 ~l~~~~~~~--~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
+|+++..+. +++|||+|||..|.+.. ...... |++.+++.|+++++.||+|||.+
T Consensus 172 ~LiEvLDDP~s~~~YlVley~s~G~v~w----------------------~p~d~~els~~~Ar~ylrDvv~GLEYLH~Q 229 (576)
T KOG0585|consen 172 KLIEVLDDPESDKLYLVLEYCSKGEVKW----------------------CPPDKPELSEQQARKYLRDVVLGLEYLHYQ 229 (576)
T ss_pred EEEEeecCcccCceEEEEEeccCCcccc----------------------CCCCcccccHHHHHHHHHHHHHHHHHHHhc
Confidence 999998864 68999999999766521 122233 89999999999999999999999
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceeeeecc-----CCcccccCCCCCccChhhhCCCC----CCCcchHHHHHHHH
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL-----DKTTDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILL 277 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~-----~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil 277 (494)
|||||||||.|+||+.+|+|||+|||.+...... +......+|||.|+|||...+.. .+.+.||||+||+|
T Consensus 230 giiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTL 309 (576)
T KOG0585|consen 230 GIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTL 309 (576)
T ss_pred CeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhH
Confidence 9999999999999999999999999998753211 11233478999999999987632 46799999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 278 YEMHVGQSPFSGCDEDELFWSICNERPRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 278 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
|.|+.|+.||.+....+++.+|++..+.||.. +.++++|||.+||++||.+|+ ++.||+.|||..
T Consensus 310 YCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~pe~~e~~kDli~~lL~KdP~~Ri------~l~~ik~Hpwvt 376 (576)
T KOG0585|consen 310 YCLLFGQLPFFDDFELELFDKIVNDPLEFPENPEINEDLKDLIKRLLEKDPEQRI------TLPDIKLHPWVT 376 (576)
T ss_pred HHhhhccCCcccchHHHHHHHHhcCcccCCCcccccHHHHHHHHHHhhcChhhee------ehhhheecceec
Confidence 99999999999999999999999999999975 799999999999999999999 688999999974
|
|
| >KOG0593|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-53 Score=396.53 Aligned_cols=257 Identities=26% Similarity=0.463 Sum_probs=217.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
++.|+.+..+|+|+||+||+|+++.||+.||||.+.... .+..-.+.+++|+++|. +++|||+|.|+++|.....++|
T Consensus 1 MekYE~LgkvGEGSYGvV~KCrnk~TgqIVAIKkF~Ese-dd~~VkKIAlREIrmLK-qLkH~NLVnLiEVFrrkrklhL 78 (396)
T KOG0593|consen 1 MEKYEKLGKVGEGSYGVVMKCRNKDTGQIVAIKKFVESE-DDPVVKKIALREIRMLK-QLKHENLVNLIEVFRRKRKLHL 78 (396)
T ss_pred CcHHhhhhccccCcceEEEEeccCCcccEEEEEeeccCC-ccHHHHHHHHHHHHHHH-hcccchHHHHHHHHHhcceeEE
Confidence 468999999999999999999999999999999987542 12223355778888887 6899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|+|||+.. +...++. ...++++.++.|+.|++.|+.|+|++++||||||||||||+.
T Consensus 79 VFE~~dhT----------------------vL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~n~IHRDIKPENILit~ 136 (396)
T KOG0593|consen 79 VFEYCDHT----------------------VLHELERYPNGVPSELVKKYLYQLLKAIHFCHKNNCIHRDIKPENILITQ 136 (396)
T ss_pred EeeecchH----------------------HHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhcCeecccCChhheEEec
Confidence 99999732 1122332 356899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+|.+||||||+|+.....+.....++.|.+|.|||.+.| ..|+..+||||+||++.||++|.+.|+|.+.-+++..|..
T Consensus 137 ~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I~k 216 (396)
T KOG0593|consen 137 NGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLIRK 216 (396)
T ss_pred CCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHHHH
Confidence 999999999999987656666677899999999999988 7899999999999999999999999999987777665542
Q ss_pred --------------CCC-----CCC------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 --------------ERP-----RFP------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 --------------~~~-----~~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
..+ .+| +.++.-+.||+++||..||.+|++ -++++.|+||.++
T Consensus 217 tLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s------c~qll~H~yFd~~ 290 (396)
T KOG0593|consen 217 TLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS------CEQLLHHPYFDGF 290 (396)
T ss_pred HHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc------HHHHhcChHHHHH
Confidence 111 122 246778999999999999999995 5789999999553
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-52 Score=423.56 Aligned_cols=278 Identities=37% Similarity=0.705 Sum_probs=237.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||+++++.|++++.+|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~~lv 79 (376)
T cd05598 1 SMFVKIKTIGIGAFGEVCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILA-EADNEWVVKLYYSFQDKDNLYFV 79 (376)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999998754444445566777888877 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++.+|
T Consensus 80 ~E~~~---------------------~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~Nill~~~~ 138 (376)
T cd05598 80 MDYIP---------------------GGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGFIHRDIKPDNILIDRDG 138 (376)
T ss_pred EeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCCHHHEEECCCC
Confidence 99999 555666777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeecc-------------------------------------------CCcccccCCCCCccChhhhCC
Q psy8309 225 HVRIADFGMCKLQIYL-------------------------------------------DKTTDTFCGTPDYMAPEIIKG 261 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~-------------------------------------------~~~~~~~~gt~~y~aPE~l~~ 261 (494)
.+||+|||+|...... .......+||+.|+|||++.+
T Consensus 139 ~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 218 (376)
T cd05598 139 HIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218 (376)
T ss_pred CEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcC
Confidence 9999999997421000 001124689999999999999
Q ss_pred CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC--CCCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 262 LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER--PRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 262 ~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~--~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
..++.++|||||||++|||++|..||.+.+..+....+.... ..+| ..+++++.+||.+|+ .+|.+|++. .+
T Consensus 219 ~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~l~-~~p~~R~~~---~t 294 (376)
T cd05598 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQAKLSREASDLILRLC-CGAEDRLGK---NG 294 (376)
T ss_pred CCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCCCCCCCCHHHHHHHHHHh-cCHhhcCCC---CC
Confidence 999999999999999999999999999988888777776543 2333 368999999999987 599999964 26
Q ss_pred hhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 338 GDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 338 ~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
++++++||||++++|..+. +...+|+.|.+.
T Consensus 295 ~~ell~h~~~~~~~~~~~~-~~~~~~~~~~~~ 325 (376)
T cd05598 295 ADEIKAHPFFKGIDFASLI-RRQKAPYIPKIT 325 (376)
T ss_pred HHHHhCCCCcCCCCHHHHh-hcCCCCCCCcCC
Confidence 8999999999999999987 667788888776
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-51 Score=411.50 Aligned_cols=272 Identities=38% Similarity=0.709 Sum_probs=238.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++++..............|..++. .++||||++++++++..+.+|+|
T Consensus 1 ~~y~~~~~ig~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~iv~~~~~~~~~~~~~lv 79 (333)
T cd05600 1 KDFQILTQVGQGGYGQVFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILT-TTKSEWLVKLLYAFQDDEYLYLA 79 (333)
T ss_pred CCcEEEEEEeecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHH-hCCCCCCccEEEEEEcCCEEEEE
Confidence 37999999999999999999999999999999998765444445566777888877 46899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++ |++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++.+|
T Consensus 80 ~e~~~---------------------g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~~ 138 (333)
T cd05600 80 MEYVP---------------------GGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLIDASG 138 (333)
T ss_pred EeCCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC
Confidence 99999 556666777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
.+||+|||+++... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.....
T Consensus 139 ~~kL~Dfg~a~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~~ 215 (333)
T cd05600 139 HIKLTDFGLSKGIV---TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNETWENLKYWKE 215 (333)
T ss_pred CEEEEeCcCCcccc---cccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCCCCCCCHHHHHHHHHhccc
Confidence 99999999987532 234567899999999999999999999999999999999999999999988888877765432
Q ss_pred --CCCc------cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 305 --RFPQ------FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 305 --~~p~------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
..|. .++.++.+||.+||..+|.+|+ +++++++||||++++|..+. ...||+.|...
T Consensus 216 ~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~------s~~~ll~h~~~~~~~~~~~~--~~~~~~~~~~~ 280 (333)
T cd05600 216 TLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFG------SLEDIKNHPFFKEVDWNELR--ELKPPFVPELE 280 (333)
T ss_pred cccCCCCCccccccCHHHHHHHHHHhhChhhhcC------CHHHHHhCcccCCCCHHHHh--hCCCCCCCCCC
Confidence 2222 4589999999999999999998 68999999999999999886 77888888765
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-51 Score=402.18 Aligned_cols=271 Identities=39% Similarity=0.700 Sum_probs=232.6
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||+|+||+||+|.++.+++.||+|++.+.........+....|..++. .++||||+++++++.....+|+||||+++|+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~ 79 (280)
T cd05608 1 LGKGGFGEVSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILA-KVHSRFIVSLAYAFQTKTDLCLVMTIMNGGD 79 (280)
T ss_pred CCCCCceeEEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHH-hCCCCcEeeeeEEEcCCCeEEEEEeCCCCCC
Confidence 799999999999999999999999998754433444455667877777 5799999999999999999999999999666
Q ss_pred CccccchhhhhhhhhHhcCCchhHHh----hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEE
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHI----QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL 228 (494)
| ...+ .....+++..++.++.||+.||+|||++||+||||||+|||++.++.+||
T Consensus 80 L---------------------~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~~~~~~l 138 (280)
T cd05608 80 L---------------------RYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRI 138 (280)
T ss_pred H---------------------HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCCEEE
Confidence 5 2222 23457999999999999999999999999999999999999999999999
Q ss_pred eecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCC
Q psy8309 229 ADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSICNERP 304 (494)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~~ 304 (494)
+|||++..............||+.|+|||++.+..++.++|+|||||++|||++|+.||..... .+....+.....
T Consensus 139 ~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 218 (280)
T cd05608 139 SDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRILNDSV 218 (280)
T ss_pred eeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC
Confidence 9999987543333334456899999999999999999999999999999999999999986542 344455556666
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
.+|..++.++++++.+||+.||++|++.... +++++++||||++++|..+..+.++||+.|
T Consensus 219 ~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~-~~~~~l~h~~~~~~~~~~~~~~~~~~~~~~ 279 (280)
T cd05608 219 TYPDKFSPASKSFCEALLAKDPEKRLGFRDG-NCDGLRTHPLFRDLNWRQLEAGMLPPPFVP 279 (280)
T ss_pred CCcccCCHHHHHHHHHHhcCCHHHhcCCCCC-CHHHHhcChhhhcCCHhHHhhccCCCCCCC
Confidence 7788899999999999999999999987653 799999999999999999999999999887
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-51 Score=409.68 Aligned_cols=274 Identities=35% Similarity=0.651 Sum_probs=231.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+++.+++.||||++++..............|..++. ..+||||+++++++++.+.+|+|
T Consensus 1 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~-~~~~~~i~~~~~~~~~~~~~~lv 79 (330)
T cd05601 1 KDFDVKSLVGRGHFGEVQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILS-ISNSPWIPQLQYAFQDKDNLYLV 79 (330)
T ss_pred CCceEEEEEEeccCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCCcceeeEEecCCeEEEE
Confidence 47999999999999999999999999999999998764433444455556666665 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+++| +|..++.+. +.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~e~~~~~---------------------~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i~H~Dlkp~NIll~~~ 138 (330)
T cd05601 80 MEYQPGG---------------------DLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRT 138 (330)
T ss_pred ECCCCCC---------------------CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEcccCchHheEECCC
Confidence 9999954 455556554 689999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC-cccccCCCCCccChhhhC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIK------GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|.+||+|||++........ .....+||+.|+|||++. +..++.++|||||||++|||++|..||.+.+..+.+
T Consensus 139 ~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~~~~~ 218 (330)
T cd05601 139 GHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTY 218 (330)
T ss_pred CCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCCHHHHH
Confidence 9999999999975332221 223457999999999987 456889999999999999999999999998888888
Q ss_pred HHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 297 WSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 297 ~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+|.... ..+|. .++.++++||.+||. +|.+|| +++++++||||..++|..+.. ..||+.|.+.
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~li~~ll~-~p~~R~------t~~~l~~h~~~~~~~~~~~~~--~~~~~~~~~~ 286 (330)
T cd05601 219 NNIMNFQRFLKFPEDPKVSSDFLDLIQSLLC-GQKERL------GYEGLCCHPFFSKIDWNNIRN--SLPPFVPTLK 286 (330)
T ss_pred HHHHcCCCccCCCCCCCCCHHHHHHHHHHcc-ChhhCC------CHHHHhCCCCcCCCCHHHHhh--CCCCccCcCC
Confidence 8887643 34443 579999999999997 999999 678999999999999998863 5577777665
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-50 Score=406.31 Aligned_cols=277 Identities=38% Similarity=0.713 Sum_probs=230.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+..............|..++. ..+|++|+++++++++.+.+|+|
T Consensus 1 d~y~i~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~l~~~~~~~~~~~lv 79 (331)
T cd05624 1 DDFEIIKVIGRGAFGEVAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLV-NGDCQWITTLHYAFQDENYLYLV 79 (331)
T ss_pred CCceEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCEEEEE
Confidence 47999999999999999999999999999999998654333344444555666655 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||++| |+|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~Ey~~g---------------------g~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~~iiHrDlkp~Nill~~~ 138 (331)
T cd05624 80 MDYYVG---------------------GDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLLDMN 138 (331)
T ss_pred EeCCCC---------------------CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCchHHEEEcCC
Confidence 999994 455556655 4679999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 139 ~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~~~~~~ 218 (331)
T cd05624 139 GHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218 (331)
T ss_pred CCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCCHHHHHH
Confidence 9999999999875332221 2234679999999999976 468899999999999999999999999988888888
Q ss_pred HHHhCC--CCCCc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 298 SICNER--PRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 298 ~i~~~~--~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+|.... +.+|. .+++++++||.+||..++ +|++. .+++++++|+||++++|+.+. .+.+|+.|...
T Consensus 219 ~i~~~~~~~~~p~~~~~~~~~~~~li~~ll~~~~-~~~~~---~~~~~~~~h~~f~~~~~~~~~--~~~~~~~p~~~ 289 (331)
T cd05624 219 KIMNHEERFQFPSHITDVSEEAKDLIQRLICSRE-RRLGQ---NGIEDFKKHAFFEGIDWENIR--NLEAPYIPDVS 289 (331)
T ss_pred HHHcCCCcccCCCccccCCHHHHHHHHHHccCch-hhcCC---CCHHHHhcCCCcCCCCHHHHh--hCCCCccCCCC
Confidence 887643 34444 468999999999998654 55542 379999999999999999984 56778887655
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >KOG0611|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-52 Score=399.05 Aligned_cols=255 Identities=34% Similarity=0.613 Sum_probs=238.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..+|++.+.||+|+||+|-+|.....|+.||||.|+|+.+..+...-++.+|+.++. .++||||+++|++|++.+.+.|
T Consensus 52 kHRyE~~etLGkGTYGKVk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMS-sLNHPhII~IyEVFENkdKIvi 130 (668)
T KOG0611|consen 52 KHRYEITETLGKGTYGKVKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMS-SLNHPHIIQIYEVFENKDKIVI 130 (668)
T ss_pred hhHHHHHHHhcCCcccceeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHh-hcCCCceeehhhhhcCCceEEE
Confidence 458999999999999999999999999999999999999999999999999999998 6899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||.. ||+|.+++...+.|+|.+++.+++||++|+.|+|.++++|||||.+|||+|.+
T Consensus 131 vMEYaS---------------------~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHknrVvHRDLKLENILLD~N 189 (668)
T KOG0611|consen 131 VMEYAS---------------------GGELYDYISERGSLSEREARHFFRQIVSAVHYCHKNRVVHRDLKLENILLDQN 189 (668)
T ss_pred EEEecC---------------------CccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhccceecccchhheeecCC
Confidence 999998 77778899999999999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+++||+||||+... ..+....++||+|.|.+||++.|.+| ++.+|-|||||+||.|+.|..||.|.+...+..+|.++
T Consensus 190 ~NiKIADFGLSNly-~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dhk~lvrQIs~G 268 (668)
T KOG0611|consen 190 NNIKIADFGLSNLY-ADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDHKRLVRQISRG 268 (668)
T ss_pred CCeeeeccchhhhh-ccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhcccccCCchHHHHHHHhhcc
Confidence 99999999998753 34566789999999999999999998 58999999999999999999999999999999999999
Q ss_pred CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 303 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+.-|. -+.++.-||+.||..||++|. +++||-.|-|.+
T Consensus 269 aYrEP~-~PSdA~gLIRwmLmVNP~RRA------TieDiAsHWWvN 307 (668)
T KOG0611|consen 269 AYREPE-TPSDASGLIRWMLMVNPERRA------TIEDIASHWWVN 307 (668)
T ss_pred cccCCC-CCchHHHHHHHHHhcCcccch------hHHHHhhhheee
Confidence 887665 356788999999999999997 789999999974
|
|
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-50 Score=402.94 Aligned_cols=277 Identities=38% Similarity=0.712 Sum_probs=229.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+++++.+++.||+|++.+..............|..++. ..+|+||+++++.+++.+.+|+|
T Consensus 1 ~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv 79 (332)
T cd05623 1 EDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV-NGDNQWITTLHYAFQDENNLYLV 79 (332)
T ss_pred CCceEEEEEEeCCCeEEEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCEEEEE
Confidence 47999999999999999999999999999999997654333334444556666665 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+++ |+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~ey~~~---------------------g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~~iiHrDlkp~Nili~~~ 138 (332)
T cd05623 80 MDYYVG---------------------GDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMN 138 (332)
T ss_pred EeccCC---------------------CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCHHHEEECCC
Confidence 999994 455556655 4679999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC-cccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.+||+|||+++....... .....+||+.|+|||++. ...++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 139 ~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~~~~~~~ 218 (332)
T cd05623 139 GHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218 (332)
T ss_pred CCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 9999999999875322222 233468999999999986 3468899999999999999999999999999888888
Q ss_pred HHHhCC--CCCCc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 298 SICNER--PRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 298 ~i~~~~--~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+|.... ..+|. .+++++++||.+||..++ +|++. .+++|+++||||.+++|+.+. ...+|+.|...
T Consensus 219 ~i~~~~~~~~~p~~~~~~s~~~~~li~~ll~~~~-~r~~r---~~~~~~~~h~~f~~~~~~~~~--~~~~~~~~~~~ 289 (332)
T cd05623 219 KIMNHKERFQFPAQVTDVSEDAKDLIRRLICSRE-HRLGQ---NGIEDFKQHPFFTGIDWDNIR--NCEAPYIPEVS 289 (332)
T ss_pred HHhCCCccccCCCccccCCHHHHHHHHHHccChh-hhcCC---CCHHHHhCCCCcCCCCHHHHh--hCCCCccCCCC
Confidence 887654 33443 579999999999997644 44432 278999999999999999985 35666777654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0599|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-52 Score=382.36 Aligned_cols=259 Identities=29% Similarity=0.489 Sum_probs=233.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-----ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-----EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.+.|+-.++||+|..++|..|.++.+|..+|+|++...... .....+..+.|..+|.....||+|++++++|+++
T Consensus 16 y~~y~pkeilgrgvss~vrRci~k~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~ 95 (411)
T KOG0599|consen 16 YAKYEPKEILGRGVSSVVRRCIHKETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESD 95 (411)
T ss_pred HhhcChHHHhcccchhhhhhhhhcccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCc
Confidence 35677889999999999999999999999999998643221 1234566788999999889999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+++|+|.|+ .|+|++++.....++|.+++.+++|++.|++|||.++|||||||||||
T Consensus 96 sF~FlVFdl~p---------------------rGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~~IVHRDLKpENI 154 (411)
T KOG0599|consen 96 AFVFLVFDLMP---------------------RGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHARNIVHRDLKPENI 154 (411)
T ss_pred chhhhhhhhcc---------------------cchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHhhhhhcccChhhe
Confidence 99999999999 677788898999999999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK------GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|++++.++||+|||+++. ...+......||||.|+|||.+. ..+|+..+|+||+|||||.||.|.+||.....
T Consensus 155 Llddn~~i~isDFGFa~~-l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 155 LLDDNMNIKISDFGFACQ-LEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred eeccccceEEeccceeec-cCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 999999999999999986 45566677899999999999985 35799999999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 293 DELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 293 ~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.-++..|+.+++.|- ..+|.+++|||.+||+.||.+|+ +++|+|+||||..+
T Consensus 234 mlMLR~ImeGkyqF~speWadis~~~KdLIsrlLqVdp~~Ri------take~LaHpff~q~ 289 (411)
T KOG0599|consen 234 MLMLRMIMEGKYQFRSPEWADISATVKDLISRLLQVDPTKRI------TAKEALAHPFFIQI 289 (411)
T ss_pred HHHHHHHHhcccccCCcchhhccccHHHHHHHHHeeCchhcc------cHHHHhcChHHHHH
Confidence 999999999998874 36899999999999999999999 67899999999754
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=400.93 Aligned_cols=277 Identities=38% Similarity=0.716 Sum_probs=228.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+..............|..++. .++|+||++++++|.+++++|+|
T Consensus 1 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv 79 (331)
T cd05597 1 DDFEILKVIGRGAFGEVAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLV-NGDRRWITNLHYAFQDENNLYLV 79 (331)
T ss_pred CCceEEEEEEecCCeEEEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHH-hCCCCCCCceEEEEecCCeEEEE
Confidence 47999999999999999999999999999999998754444444555666777766 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||++| |+|..++.+ ...+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 ~e~~~g---------------------~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 138 (331)
T cd05597 80 MDYYVG---------------------GDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLGYVHRDIKPDNVLLDKN 138 (331)
T ss_pred EecCCC---------------------CcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEECCCCHHHEEECCC
Confidence 999994 455555654 4579999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|.+||+|||++........ .....+||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+..+.+.
T Consensus 139 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~~~~~~~ 218 (331)
T cd05597 139 GHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYG 218 (331)
T ss_pred CCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCCHHHHHH
Confidence 9999999999875332222 2233579999999999973 457889999999999999999999999988888888
Q ss_pred HHHhCC--CCCC---ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 298 SICNER--PRFP---QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 298 ~i~~~~--~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.|.... ..+| ..+++++++||++||.. |.+|++. .+++++++||||.+++|..+.. ..+|+.|...
T Consensus 219 ~i~~~~~~~~~~~~~~~~~~~~~~li~~ll~~-~~~r~~r---~~~~~~l~hp~~~~~~~~~~~~--~~~~~~~~~~ 289 (331)
T cd05597 219 KIMNHKEHFQFPPDVTDVSEEAKDLIRRLICS-PETRLGR---NGLQDFKDHPFFEGIDWDNIRN--STAPYVPEVS 289 (331)
T ss_pred HHHcCCCcccCCCccCCCCHHHHHHHHHHccC-cccccCC---CCHHHHhcCCCCCCCCHHHHhh--CCCCccCcCC
Confidence 887543 3333 34799999999999975 5555432 2789999999999999999864 4566777655
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >KOG0661|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-51 Score=403.53 Aligned_cols=257 Identities=29% Similarity=0.476 Sum_probs=219.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-e
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS-H 140 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~-~ 140 (494)
..+++|.+++.||.|+||.||+|+.+.++..||||.++++.. .. +.-..++|...|.+...|||||+|++++.+.+ .
T Consensus 7 ~~m~RY~~i~klGDGTfGsV~la~~~~~~~~VAIK~MK~Kf~-s~-ee~~nLREvksL~kln~hpniikL~Evi~d~~~~ 84 (538)
T KOG0661|consen 7 IFMDRYTVIRKLGDGTFGSVYLAKSKETGELVAIKKMKKKFY-SW-EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRI 84 (538)
T ss_pred hHHHHHHHHHHhcCCcceeEEEeeecCCCceeeHHHHHhhhc-cH-HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCce
Confidence 456799999999999999999999999999999999988643 22 22345778888885445999999999999988 9
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+|||||+ .+|.+.++ ++..|+|..++.|+.||+.||+|+|.+|+.||||||||||
T Consensus 85 L~fVfE~Md----------------------~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~GfFHRDlKPENiL 142 (538)
T KOG0661|consen 85 LYFVFEFMD----------------------CNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHGFFHRDLKPENIL 142 (538)
T ss_pred EeeeHHhhh----------------------hhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcCcccccCChhheE
Confidence 999999996 33444444 3567999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
+..+..|||+|||+|+.. ........++.|.+|+|||++.+ ..|+.++|+||+|||++|+++-++.|.|.++.+.+.+
T Consensus 143 i~~~~~iKiaDFGLARev-~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi~K 221 (538)
T KOG0661|consen 143 ISGNDVIKIADFGLAREV-RSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQIYK 221 (538)
T ss_pred ecccceeEeccccccccc-ccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHHHH
Confidence 999999999999999964 34445567889999999999865 5589999999999999999999999999999998888
Q ss_pred HHh--C-----------------CCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 299 ICN--E-----------------RPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 299 i~~--~-----------------~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
|+. + .+.+| ...+.++.+||.+||..||.+|| ++.++++||||+
T Consensus 222 Ic~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRp------TA~~al~~pffq 295 (538)
T KOG0661|consen 222 ICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRP------TASQALQHPFFQ 295 (538)
T ss_pred HHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCc------cHHHHhcCcccc
Confidence 873 1 12233 23789999999999999999999 578899999997
Q ss_pred C
Q psy8309 349 G 349 (494)
Q Consensus 349 ~ 349 (494)
.
T Consensus 296 ~ 296 (538)
T KOG0661|consen 296 V 296 (538)
T ss_pred c
Confidence 4
|
|
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=392.38 Aligned_cols=278 Identities=39% Similarity=0.655 Sum_probs=236.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++.++||+|+||.||+|.+..+++.||||++.+..............|..++. .++||||+++++.+.+.+.+|+||
T Consensus 1 ~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 79 (285)
T cd05605 1 TFRHYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHH-hcCCCCEeeeeeeecCCCeEEEEE
Confidence 4889999999999999999999999999999997654333333344566777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+.+|+| ..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 80 e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (285)
T cd05605 80 TLMNGGDL---------------------KFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERIVYRDLKPENILLDDY 138 (285)
T ss_pred eccCCCcH---------------------HHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCcEecCCCHHHEEECCC
Confidence 99995544 444433 2469999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH----HHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL----FWSI 299 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~~i 299 (494)
+.++|+|||++.... ........+||+.|+|||++.+..++.++||||+||++|||++|..||.+.+.... ...+
T Consensus 139 ~~~~l~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05605 139 GHIRISDLGLAVEIP-EGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRV 217 (285)
T ss_pred CCEEEeeCCCceecC-CCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCchhhHHHHHHHHh
Confidence 999999999987532 22233456899999999999998999999999999999999999999988665433 3334
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccc
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPR 367 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~ 367 (494)
......++..++..+++||.+||..||.+||++.. .++++++.||||...+|+.+.+++++||+.|.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05605 218 KEDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRG-EGAEEVKAHPFFRTANFKRLEAGMLEPPFCPD 284 (285)
T ss_pred hhcccccCcccCHHHHHHHHHHccCCHHHhcCCCC-CCHHHHhcCcCccCCCHHHHhhCCCCCCCCCC
Confidence 45556677789999999999999999999998754 38999999999999999999999999999884
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0032|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-50 Score=403.17 Aligned_cols=259 Identities=32% Similarity=0.550 Sum_probs=234.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
....|++.+.||+|.||.||+|+++.||+.||+|++.|.........+....|..+|.....|||||.++++|++...+|
T Consensus 33 ~~~~Y~l~~~lG~G~Fg~v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~ 112 (382)
T KOG0032|consen 33 IKEKYELGRELGRGQFGVVYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVY 112 (382)
T ss_pred ccccEEehhhhCCCCceEEEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEE
Confidence 44689999999999999999999999999999999999877666667788899999986445999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|||+|. ||+|+..+... .++|..+..++.||+.|+.|||+.||+||||||||+|+..
T Consensus 113 lvmEL~~---------------------GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gvvHrDlKpEN~L~~~ 170 (382)
T KOG0032|consen 113 LVMELCE---------------------GGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGVVHRDLKPENLLLAS 170 (382)
T ss_pred EEEEecC---------------------CchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCceeccCCHHHeeecc
Confidence 9999999 55666666655 4999999999999999999999999999999999999964
Q ss_pred C----CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 223 E----GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 223 ~----g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
. +.+|++|||++..... .......|||+.|+|||++.+..|+..+||||+||++|.|++|.+||.+.+..+.+.+
T Consensus 171 ~~~~~~~ik~~DFGla~~~~~-~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~~~~~ 249 (382)
T KOG0032|consen 171 KDEGSGRIKLIDFGLAKFIKP-GERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFEIFLA 249 (382)
T ss_pred ccCCCCcEEEeeCCCceEccC-CceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhHHHHH
Confidence 3 5799999999997544 6677889999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 299 ICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 299 i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
|..+.+.|+ +.++..+++||+.||..||.+|+ ++.++|+|||+++.
T Consensus 250 i~~~~~~f~~~~w~~is~~akd~i~~ll~~dp~~R~------ta~~~L~HpWi~~~ 299 (382)
T KOG0032|consen 250 ILRGDFDFTSEPWDDISESAKDFIRKLLEFDPRKRL------TAAQALQHPWIKSI 299 (382)
T ss_pred HHcCCCCCCCCCccccCHHHHHHHHHhcccCcccCC------CHHHHhcCccccCC
Confidence 999988776 36899999999999999999999 67889999998754
|
|
| >KOG0578|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-51 Score=407.61 Aligned_cols=252 Identities=32% Similarity=0.558 Sum_probs=223.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|.....||+|+-|.||.|+...+++.||||.+...... ..+-++.|..+|. ..+|+|||++++.|...+.+++|
T Consensus 273 ~~y~~~~kigqgaSG~vy~A~~~~~~~~VaiK~m~l~~Q~---~keLilnEi~Vm~-~~~H~NiVnfl~Sylv~deLWVV 348 (550)
T KOG0578|consen 273 SKYTDFKKIGQGATGGVYVARKISTKQEVAIKRMDLRKQP---KKELLLNEILVMR-DLHHPNIVNFLDSYLVGDELWVV 348 (550)
T ss_pred hhhcchhhhccccccceeeeeeccCCceEEEEEEEeccCC---chhhhHHHHHHHH-hccchHHHHHHHHhcccceeEEE
Confidence 4688889999999999999999999999999999875332 2344677777777 68999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++||+|.+ +.....++|.++..++++++.||+|||.+||+|||||.+|||++.+|
T Consensus 349 MEym~ggsLTD----------------------vVt~~~~~E~qIA~Icre~l~aL~fLH~~gIiHrDIKSDnILL~~~g 406 (550)
T KOG0578|consen 349 MEYMEGGSLTD----------------------VVTKTRMTEGQIAAICREILQGLKFLHARGIIHRDIKSDNILLTMDG 406 (550)
T ss_pred EeecCCCchhh----------------------hhhcccccHHHHHHHHHHHHHHHHHHHhcceeeeccccceeEeccCC
Confidence 99999776632 23345699999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-ER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~ 303 (494)
.+||+|||+|...........+.+|||+|||||++....|+.++||||||++++||+-|.+||...++...++.|.. +.
T Consensus 407 ~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~PlrAlyLIa~ng~ 486 (550)
T KOG0578|consen 407 SVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 486 (550)
T ss_pred cEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcCCCCccCCChHHHHHHHhhcCC
Confidence 99999999999766666677889999999999999999999999999999999999999999998888777777764 44
Q ss_pred C--CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 304 P--RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 304 ~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+ ..|..+|+++++||.+||+.|+.+|+ ++.|+|.||||+
T Consensus 487 P~lk~~~klS~~~kdFL~~cL~~dv~~Ra------sA~eLL~HpFl~ 527 (550)
T KOG0578|consen 487 PKLKNPEKLSPELKDFLDRCLVVDVEQRA------SAKELLEHPFLK 527 (550)
T ss_pred CCcCCccccCHHHHHHHHHHhhcchhcCC------CHHHHhcChhhh
Confidence 4 45789999999999999999999999 689999999995
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-49 Score=387.55 Aligned_cols=279 Identities=46% Similarity=0.870 Sum_probs=250.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|.+..+++.||+|++.+..............|..++. .++||||+++++++.+.+.+|+|
T Consensus 1 ~~y~~~~~ig~g~~~~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v 79 (290)
T cd05580 1 DDFEFIKTLGTGSFGRVMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQ-SIRHPFLVNLYGSFQDDSNLYLV 79 (290)
T ss_pred CceEEEEEeecCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHH-hCCCCCccceeeEEEcCCeEEEE
Confidence 47999999999999999999999999999999998765444445566777888777 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++ |++|..++...+.+++..+..++.||+.||.|||++||+||||+|.|||++.+|
T Consensus 80 ~e~~~---------------------~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i~H~dl~p~nili~~~~ 138 (290)
T cd05580 80 MEYVP---------------------GGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDG 138 (290)
T ss_pred EecCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECCCC
Confidence 99998 555666777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
.+||+|||+++.... .....+|++.|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+..+..
T Consensus 139 ~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 215 (290)
T cd05580 139 YIKITDFGFAKRVKG---RTYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKV 215 (290)
T ss_pred CEEEeeCCCccccCC---CCCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc
Confidence 999999999875322 24456799999999999988899999999999999999999999998888888888888888
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+|..++..++++|.+||..||.+|++... .+++|+++||||+.++|..+....+.+|+.|...
T Consensus 216 ~~~~~~~~~l~~li~~~l~~~p~~R~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 279 (290)
T cd05580 216 RFPSFFSPDAKDLIRNLLQVDLTKRLGNLK-NGVNDIKNHPWFAGIDWIALLQRKIEAPFIPKVK 279 (290)
T ss_pred cCCccCCHHHHHHHHHHccCCHHHccCccc-CCHHHHHcCcccccCCHHHHhhccCCCCccCCCC
Confidence 899999999999999999999999996543 4799999999999999999999999999998876
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG0198|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-50 Score=392.57 Aligned_cols=255 Identities=34% Similarity=0.550 Sum_probs=215.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC--ee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--HL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--~~ 141 (494)
..++...+.||+|+||.||++.++.+|..+|||.+.... ....+....|..+|.. ++|||||++++...... .+
T Consensus 16 ~~~~~~~~~lG~Gs~G~V~l~~~~~~g~~~AvK~v~~~~---~~~~~~l~~Ei~iL~~-l~~p~IV~~~G~~~~~~~~~~ 91 (313)
T KOG0198|consen 16 ISNWSKGKLLGRGSFGSVYLATNKKTGELMAVKSVELED---SPTSESLEREIRILSR-LNHPNIVQYYGSSSSRENDEY 91 (313)
T ss_pred cchhhhhccccCccceEEEEEEecCCCcceeeeeeeccc---chhHHHHHHHHHHHHh-CCCCCEEeeCCccccccCeee
Confidence 456888999999999999999999999999999987652 1225667788888884 67999999999755444 69
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++.|||++ ||+|...+.+.+ .|+|..++.|++||+.||+|||++|||||||||+||||
T Consensus 92 ~i~mEy~~---------------------~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g~vH~DiK~~NiLl 150 (313)
T KOG0198|consen 92 NIFMEYAP---------------------GGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKGIVHCDIKPANILL 150 (313)
T ss_pred EeeeeccC---------------------CCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCcccceEEE
Confidence 99999999 555566777766 79999999999999999999999999999999999999
Q ss_pred CC-CCCEEEeecCceeeeec---cCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHH
Q psy8309 221 DY-EGHVRIADFGMCKLQIY---LDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDE 294 (494)
Q Consensus 221 ~~-~g~vkL~DFGla~~~~~---~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~ 294 (494)
+. +|.+||+|||+++.... .........||+.|||||++... .-+.++|||||||++.||+||.+||.. ....+
T Consensus 151 ~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~~~~~~~ 230 (313)
T KOG0198|consen 151 DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSEFFEEAE 230 (313)
T ss_pred eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchhhcchHH
Confidence 99 79999999999886432 12234568899999999999962 233599999999999999999999987 45555
Q ss_pred HHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 295 LFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 295 ~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+..|... .+.+|..+|.++++||.+||.+||++|| +++++|.|||.+.
T Consensus 231 ~~~~ig~~~~~P~ip~~ls~~a~~Fl~~C~~~~p~~Rp------ta~eLL~hpf~~~ 281 (313)
T KOG0198|consen 231 ALLLIGREDSLPEIPDSLSDEAKDFLRKCFKRDPEKRP------TAEELLEHPFLKQ 281 (313)
T ss_pred HHHHHhccCCCCCCCcccCHHHHHHHHHHhhcCcccCc------CHHHHhhChhhhc
Confidence 55555544 3788999999999999999999999999 6899999999865
|
|
| >KOG0600|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-49 Score=391.81 Aligned_cols=258 Identities=27% Similarity=0.469 Sum_probs=220.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-- 138 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-- 138 (494)
....+.|+.++.||+|+||.||+|++..||+.||+|.+..+. .++.....+.+|+.+|. .++||||++|.+...+.
T Consensus 113 ~r~~~~feki~kIGeGTyg~VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr-~l~HpNIikL~eivt~~~~ 190 (560)
T KOG0600|consen 113 PRRADSFEKIEKIGEGTYGQVYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILR-RLDHPNIIKLEEIVTSKLS 190 (560)
T ss_pred ccchHHHHHHHHhcCcchhheeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHH-hcCCCcccceeeEEEecCC
Confidence 345678999999999999999999999999999999998763 34556677889999998 58999999999999877
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+|||+|||++ ||.-.+.. .-.|++.+++.|+.||+.||+|||++||+|||||..|
T Consensus 191 ~siYlVFeYMdh----------------------DL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~cH~~gvlHRDIK~SN 248 (560)
T KOG0600|consen 191 GSIYLVFEYMDH----------------------DLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYCHSRGVLHRDIKGSN 248 (560)
T ss_pred ceEEEEEecccc----------------------hhhhhhcCCCcccChHHHHHHHHHHHHHHHHHhhcCeeeccccccc
Confidence 689999999972 33333443 3489999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
||||.+|.+||+|||||+........ ....+-|.+|.|||.+.|. .|+.++|+||+||||.||++|++.|.|.++.+.
T Consensus 249 iLidn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQ 328 (560)
T KOG0600|consen 249 ILIDNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQ 328 (560)
T ss_pred eEEcCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHH
Confidence 99999999999999999964433322 4556789999999999985 599999999999999999999999999999988
Q ss_pred HHHHHh--CC--------CCCC-------------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 296 FWSICN--ER--------PRFP-------------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 296 ~~~i~~--~~--------~~~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
+.+|.+ +. ..+| ..++..+.+|+..||..||.+|. ++.++|.|+|
T Consensus 329 l~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR~------tA~~aL~sey 402 (560)
T KOG0600|consen 329 LHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKRG------TASSALQSEY 402 (560)
T ss_pred HHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCccccc------cHHHHhcCcc
Confidence 888763 11 1222 24788999999999999999998 6788999999
Q ss_pred cC
Q psy8309 347 FR 348 (494)
Q Consensus 347 f~ 348 (494)
|.
T Consensus 403 F~ 404 (560)
T KOG0600|consen 403 FT 404 (560)
T ss_pred cc
Confidence 94
|
|
| >KOG0663|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-49 Score=375.20 Aligned_cols=271 Identities=29% Similarity=0.444 Sum_probs=225.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DS 139 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~ 139 (494)
..+++|+.+..|++|+||.||+|+++.|++.||+|.++-+. .....--..++|+.+|. ..+|||||.+.++... -+
T Consensus 73 rsv~efe~lnrI~EGtyGiVYRakdk~t~eIVALKr~kmek-ek~GFPItsLREIniLl-~~~H~NIV~vkEVVvG~~~d 150 (419)
T KOG0663|consen 73 RSVEEFEKLNRIEEGTYGVVYRAKDKKTDEIVALKRLKMEK-EKEGFPITSLREINILL-KARHPNIVEVKEVVVGSNMD 150 (419)
T ss_pred ccHHHHHHHhhcccCcceeEEEeccCCcceeEEeeeccccc-ccCCCcchhHHHHHHHH-hcCCCCeeeeEEEEeccccc
Confidence 35789999999999999999999999999999999998654 22223335678998888 4689999999988874 46
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
.+|||||||+ .+|...+.+.+ +|...+++.++.|++.||+|||.+.|+||||||.|+
T Consensus 151 ~iy~VMe~~E----------------------hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilHRDLK~SNL 208 (419)
T KOG0663|consen 151 KIYIVMEYVE----------------------HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILHRDLKTSNL 208 (419)
T ss_pred eeeeeHHHHH----------------------hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEecccchhhe
Confidence 7999999996 34555555544 899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|++..|.+||+|||+|+.....-......+-|.+|.|||.+.+. .|+.++|+||+|||+.||+++++.|.|..+.+.+.
T Consensus 209 Lm~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~ 288 (419)
T KOG0663|consen 209 LLSHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD 288 (419)
T ss_pred eeccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence 99999999999999999766555556677889999999999875 59999999999999999999999999999888888
Q ss_pred HHHhC-------------------CCCCC------------cc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 298 SICNE-------------------RPRFP------------QF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 298 ~i~~~-------------------~~~~p------------~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
+|..- ...++ .. +++...+|+..+|..||.+|+ +++|.|+|.
T Consensus 289 ~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~------tA~~~L~h~ 362 (419)
T KOG0663|consen 289 KIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRI------TAEDGLKHE 362 (419)
T ss_pred HHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccc------cHHHhhccc
Confidence 77631 11111 11 679999999999999999999 678899999
Q ss_pred CcCCCChhHHhcCcCCCCCcccc
Q psy8309 346 YFRGLDWQALEKRELEPPFRPRV 368 (494)
Q Consensus 346 ~f~~~~w~~l~~~~~~pp~~p~~ 368 (494)
||.+.. ....|-+.|+.
T Consensus 363 ~F~e~P------~p~~P~~~Pt~ 379 (419)
T KOG0663|consen 363 YFRETP------LPIDPSMFPTW 379 (419)
T ss_pred ccccCC------CCCChhhcCCC
Confidence 998642 23445455544
|
|
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-48 Score=383.55 Aligned_cols=269 Identities=37% Similarity=0.651 Sum_probs=224.2
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||+|+||.||+|+.+.+|+.||+|++.+..............|..++. .++||||++++++++++.++|+||||++||+
T Consensus 1 lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~ 79 (277)
T cd05607 1 LGKGGFGEVCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILE-KVNSPFIVNLAYAFESKTHLCLVMSLMNGGD 79 (277)
T ss_pred CCCCCceEEEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHH-hcCCCcEEEEEEEEecCCeEEEEEecCCCCC
Confidence 799999999999999999999999997654433333344556777777 5799999999999999999999999999555
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
| ..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+|
T Consensus 80 L---------------------~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~Nili~~~~~~~l~D 138 (277)
T cd05607 80 L---------------------KYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSD 138 (277)
T ss_pred H---------------------HHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEEEccCChHhEEEcCCCCEEEee
Confidence 4 3344332 3588999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSICNERPRF 306 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~ 306 (494)
||++..... ........||+.|+|||++.+..++.++|+|||||++|||++|..||.+... .++...+......+
T Consensus 139 fg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 217 (277)
T cd05607 139 LGLAVELKD-GKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAKEELKRRTLEDEVKF 217 (277)
T ss_pred ceeeeecCC-CceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCCcchhhHHHHHHHhhcccccc
Confidence 999875322 2233346799999999999998999999999999999999999999976432 34444455444443
Q ss_pred C-ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 307 P-QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 307 p-~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+ ..++.++++||.+||++||.+||++.+ -.++++.|+||+.++|..+..+..+||++|
T Consensus 218 ~~~~~~~~~~~li~~~L~~~P~~R~~~~~--~~~~~~~h~~f~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05607 218 EHQNFTEESKDICRLFLAKKPEDRLGSRE--KNDDPRKHEFFKTINFPRLEAGLIPPPFVP 276 (277)
T ss_pred ccccCCHHHHHHHHHHhccCHhhCCCCcc--chhhhhcChhhcCCCHHHHhcCcCCCCCCC
Confidence 3 468999999999999999999998754 258899999999999999999999999877
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-48 Score=382.42 Aligned_cols=278 Identities=38% Similarity=0.673 Sum_probs=232.2
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++.++||+|+||.||+|.++.+++.||||.+.+..............|..++. .++|++|+.+++.+.+.+.+|+||
T Consensus 1 ~f~~~~~ig~G~~g~v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05630 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILE-KVNSRFVVSLAYAYETKDALCLVL 79 (285)
T ss_pred CceeeEEeecCCCeEEEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHH-hCCCCCeeeeeEEEecCCEEEEEE
Confidence 4788999999999999999999999999999997654433333445567877776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||++||+| ..++.. ...+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 80 e~~~g~~L---------------------~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~iiH~dikp~Nil~~~~ 138 (285)
T cd05630 80 TLMNGGDL---------------------KFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERIVYRDLKPENILLDDH 138 (285)
T ss_pred EecCCCcH---------------------HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHEEECCC
Confidence 99996554 334432 2358999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---HHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED---ELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---~~~~~i~ 300 (494)
+.++|+|||++.... ........+||+.|+|||++.+..++.++|+||+||++|+|++|.+||.+.... +....+.
T Consensus 139 ~~~~l~Dfg~~~~~~-~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~~~~~~~~~~~~~~ 217 (285)
T cd05630 139 GHIRISDLGLAVHVP-EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLV 217 (285)
T ss_pred CCEEEeeccceeecC-CCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCccchHHHHHhhh
Confidence 999999999987532 222233457999999999999999999999999999999999999999865431 2222222
Q ss_pred -hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccc
Q psy8309 301 -NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPR 367 (494)
Q Consensus 301 -~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~ 367 (494)
.....++..+++++++||.+||+.||.+|+++..+ +++|+++||||+.++|..+..++.+||++|.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~-~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05630 218 KEVQEEYSEKFSPDARSLCKMLLCKDPKERLGCQGG-GAREVKEHPLFKQINFKRLEAGMLEPPFKPD 284 (285)
T ss_pred hhhhhhcCccCCHHHHHHHHHHhhcCHHHccCCCCC-chHHHHcChhhhccCHHHHhcCCCCCCCCCC
Confidence 22334667789999999999999999999986543 6899999999999999999999999999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >KOG4717|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-50 Score=392.63 Aligned_cols=257 Identities=30% Similarity=0.502 Sum_probs=232.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
=|.+.+.||+|-|++|-+|+|.-||..||||++.|..+ ..-...+.+.|...+. ..+|||||+||++..+...+|||+
T Consensus 19 LYDLekTlG~GHFAVVKLArHVFTGekVAVKviDKTKl-D~~st~hlfqEVRCMK-LVQHpNiVRLYEViDTQTKlyLiL 96 (864)
T KOG4717|consen 19 LYDLEKTLGRGHFAVVKLARHVFTGEKVAVKVIDKTKL-DTLSTGHLFQEVRCMK-LVQHPNIVRLYEVIDTQTKLYLIL 96 (864)
T ss_pred eehhhhhhcCCceehhhhhhhhcccceeEEEEeccccc-chhhhhHHHHHHHHHH-HhcCcCeeeeeehhcccceEEEEE
Confidence 47888999999999999999999999999999998754 3445567778887777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC-CC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-YE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~-~~ 223 (494)
|+-. ||+|+.++.+ ...+.|+.++.|++||+.|+.|+|+..+||||||||||++- .-
T Consensus 97 ELGD---------------------~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCHqLHVVHRDLKPENVVFFEKl 155 (864)
T KOG4717|consen 97 ELGD---------------------GGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCHQLHVVHRDLKPENVVFFEKL 155 (864)
T ss_pred EecC---------------------CchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHhhhhhhcccCCcceeEEeeec
Confidence 9987 5566666554 46799999999999999999999999999999999999765 56
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
|-|||+|||++..+ ..+....+.||+..|-|||++.|..|+ +++||||||||||.|++|++||...+..+.+-.|+..
T Consensus 156 GlVKLTDFGFSNkf-~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSETLTmImDC 234 (864)
T KOG4717|consen 156 GLVKLTDFGFSNKF-QPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSETLTMIMDC 234 (864)
T ss_pred CceEeeeccccccC-CCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchhhhhhhhcc
Confidence 89999999998763 456677889999999999999999998 6899999999999999999999999999999999999
Q ss_pred CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 303 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
++.+|..+|.+++|||..||..||.+|. +++||..|+|++.+|-
T Consensus 235 KYtvPshvS~eCrdLI~sMLvRdPkkRA------slEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 235 KYTVPSHVSKECRDLIQSMLVRDPKKRA------SLEEIVSTSWLQAGDR 278 (864)
T ss_pred cccCchhhhHHHHHHHHHHHhcCchhhc------cHHHHhccccccCCCC
Confidence 9999999999999999999999999997 7999999999998863
|
|
| >KOG0659|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-49 Score=360.03 Aligned_cols=255 Identities=28% Similarity=0.466 Sum_probs=218.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+|..++.||+|+||.||+|++..||+.||||.++.... .+......++|++.|. .++|+||+.|+++|-..+.+.||
T Consensus 2 ~rY~~~~~lGEG~~gvVyka~d~~t~~~VAIKKIkl~~~-kdGi~~talREIK~Lq-el~h~nIi~LiD~F~~~~~l~lV 79 (318)
T KOG0659|consen 2 DRYEKLEKLGEGTYGVVYKARDTETGKRVAIKKIKLGNA-KDGINRTALREIKLLQ-ELKHPNIIELIDVFPHKSNLSLV 79 (318)
T ss_pred chhhhhhhhcCcceEEEEEEEecCCCcEEEEEEeecccc-ccCccHHHHHHHHHHH-HccCcchhhhhhhccCCCceEEE
Confidence 478889999999999999999999999999999987633 3334456788999988 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
+||++ .+|...++. ...|+..+++.|+.+++.||+|||++.|+||||||+|+||+.+
T Consensus 80 fEfm~----------------------tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~~~IlHRDlKPnNLLis~~ 137 (318)
T KOG0659|consen 80 FEFMP----------------------TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHSKWILHRDLKPNNLLISSD 137 (318)
T ss_pred EEecc----------------------ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHhhhhhcccCCccceEEcCC
Confidence 99996 344445544 3579999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
|.+||+|||+++............+-|.+|.|||.+.| ..|+..+|+||.|||+.||+.|.+-|.|.+.-+.+..|...
T Consensus 138 g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQL~~If~~ 217 (318)
T KOG0659|consen 138 GQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQLSKIFRA 217 (318)
T ss_pred CcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHHHHHHHHH
Confidence 99999999999986655554444578999999999987 45999999999999999999999999999988888777641
Q ss_pred --CC---------C---------CC--------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 303 --RP---------R---------FP--------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 303 --~~---------~---------~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+ . +| ...+.++.||+.+||..||.+|+ ++.++++|+||+.
T Consensus 218 LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Ri------ta~qaL~~~yf~~ 286 (318)
T KOG0659|consen 218 LGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRI------TASQALKHPYFKS 286 (318)
T ss_pred cCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcc------cHHHHhcchhhhc
Confidence 11 0 11 23578899999999999999999 5678999999974
|
|
| >KOG0582|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-48 Score=376.49 Aligned_cols=260 Identities=28% Similarity=0.509 Sum_probs=223.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
...++|++..+||.|.-++||+|+...++.+||||++..+... .....+..|...+. .++||||++++.+|..+..+
T Consensus 23 ~n~~~YeL~e~IG~G~sa~V~~A~c~p~~e~VAIK~inLEkc~--~~ld~l~kE~~~ms-l~~HPNIv~~~~sFvv~~~L 99 (516)
T KOG0582|consen 23 LNAKDYELQEVIGVGASAVVYLARCIPTNEVVAIKIINLEKCN--NDLDALRKEVQTMS-LIDHPNIVTYHCSFVVDSEL 99 (516)
T ss_pred CCccceeEEEEEeccceeEeeeeeecccCCEEEEEEeehhhhh--hhHHHHHHHHHHhh-hcCCCCcceEEEEEEeccee
Confidence 4567999999999999999999999999999999999876433 33667778888877 68999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
|+||.||.+|++. ..+... ..++|..+..++++++.||.|||.+|.||||||+.|||
T Consensus 100 WvVmpfMa~GS~l---------------------dIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G~IHRdvKAgnIL 158 (516)
T KOG0582|consen 100 WVVMPFMAGGSLL---------------------DIIKTYYPDGLEEASIATILREVLKALDYLHQNGHIHRDVKAGNIL 158 (516)
T ss_pred EEeehhhcCCcHH---------------------HHHHHHccccccHHHHHHHHHHHHHHHHHHHhcCceecccccccEE
Confidence 9999999976653 333322 34999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcc----cccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTT----DTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~----~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
|+.+|.|||+|||.+......+... .+++|||+|||||++.. .+|+.++||||||++..||.+|..||....+.
T Consensus 159 i~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 159 IDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred EcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 9999999999999876654433221 56799999999999754 57999999999999999999999999999888
Q ss_pred HHHHHHHhCCCCCC----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 294 ELFWSICNERPRFP----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 294 ~~~~~i~~~~~~~p----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
+++-.-+++.++.+ ..++..++.+|..||++||.+|| ++.++++|+||+...
T Consensus 239 kvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRp------tAskLlkh~FFk~~k 300 (516)
T KOG0582|consen 239 KVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRP------TASKLLKHAFFKKAK 300 (516)
T ss_pred HHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCC------CHHHHhccHHHhhcc
Confidence 88777777766533 24677899999999999999999 678999999998653
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=376.78 Aligned_cols=278 Identities=38% Similarity=0.651 Sum_probs=235.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|+..+.||+|+||+||+|.+..+++.||+|++.+..............|..++. .++|+||+.+++.+..++.+|+||
T Consensus 1 ~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~-~l~~~~i~~~~~~~~~~~~~~lv~ 79 (285)
T cd05632 1 TFRQYRVLGKGGFGEVCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILE-KVNSQFVVNLAYAYETKDALCLVL 79 (285)
T ss_pred CceEEEEEecCCCeEEEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHH-HcCCcCceeEEEEEecCCEEEEEE
Confidence 3788899999999999999999999999999997754433333445567777777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+.+|+| ..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 80 e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~iiH~dikp~Nili~~~ 138 (285)
T cd05632 80 TIMNGGDL---------------------KFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENTVYRDLKPENILLDDY 138 (285)
T ss_pred EeccCccH---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEECCC
Confidence 99995544 434433 3469999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH----HHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF----WSI 299 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----~~i 299 (494)
+.+||+|||++.... .........|++.|+|||++.+..++.++|+|||||++|+|++|..||.+....... ..+
T Consensus 139 ~~~kl~Dfg~~~~~~-~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~~~~~~~~~~~~~ 217 (285)
T cd05632 139 GHIRISDLGLAVKIP-EGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRV 217 (285)
T ss_pred CCEEEecCCcceecC-CCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence 999999999986532 222234567999999999999989999999999999999999999999877654333 333
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccc
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPR 367 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~ 367 (494)
......++..++.++.+|+..||..||.+||++.+. .+++++.|+||+.++|+.++.+++.||+.|.
T Consensus 218 ~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~-~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (285)
T cd05632 218 LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEE-GAGEVKRHPFFRNMNFKRLEAGMLDPPFVPD 284 (285)
T ss_pred hccccccCccCCHHHHHHHHHHccCCHhHcCCCccc-ChHHHHcChhhhcCCHHHHhcCcCCCCCCCC
Confidence 444556677889999999999999999999987553 6899999999999999999999999999885
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-47 Score=376.35 Aligned_cols=254 Identities=28% Similarity=0.484 Sum_probs=210.6
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|++++.||+|+||.||+|+++.++..||+|+++... ..........|..++. .++||||+++++++.+.+..|
T Consensus 3 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~ 79 (288)
T cd07871 3 KLETYVKLDKLGEGTYATVFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLK-NLKHANIVTLHDIIHTERCLT 79 (288)
T ss_pred ccccceEeeEEecCCCEEEEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEE
Confidence 3678999999999999999999999999999999997542 1222334567777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+.+ +|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 80 lv~e~~~~----------------------~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nil~~ 137 (288)
T cd07871 80 LVFEYLDS----------------------DLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLIN 137 (288)
T ss_pred EEEeCCCc----------------------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEEC
Confidence 99999962 444445443 3579999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.+|.+||+|||+++............+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+.+..+.
T Consensus 138 ~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~~~~~~~~~ 217 (288)
T cd07871 138 EKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELHLIF 217 (288)
T ss_pred CCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 9999999999998754333333445678999999999876 568999999999999999999999999887766655543
Q ss_pred hCC-------------------CCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 301 NER-------------------PRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 301 ~~~-------------------~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
... ..+| ..++.++++||.+||+.||.+|+ +++|+++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~------t~~~~l~hp~f 288 (288)
T cd07871 218 RLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRI------SAEAALRHSYF 288 (288)
T ss_pred HHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCC------CHHHHhcCCCC
Confidence 210 0111 24688999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-47 Score=379.72 Aligned_cols=258 Identities=26% Similarity=0.463 Sum_probs=207.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++.+.||+|+||.||+|+++.+++.||||++..... .........|..++. .++||||+++++++.+...+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 80 (303)
T cd07869 4 ADSYEKLEKLGEGSYATVYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTL 80 (303)
T ss_pred cccceEeeeEEecCCEEEEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHh-hCCCCCcCeEEEEEecCCeEEE
Confidence 4689999999999999999999999999999999975422 222234556777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+. ++|..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 81 v~e~~~----------------------~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 138 (303)
T cd07869 81 VFEYVH----------------------TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISD 138 (303)
T ss_pred EEECCC----------------------cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 999995 233333433 457899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELFWSIC 300 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~i~ 300 (494)
+|.+||+|||+++............+||+.|+|||++.+ ..++.++|||||||++|||++|..||.+... .+.+..+.
T Consensus 139 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 218 (303)
T cd07869 139 TGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQLERIF 218 (303)
T ss_pred CCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 999999999998753333333445678999999999876 4589999999999999999999999987533 33333322
Q ss_pred h--CCC---------C------------CC---------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 301 N--ERP---------R------------FP---------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 301 ~--~~~---------~------------~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
. +.+ . .| ..++.++++||.+||+.||.+|| +++|+++||||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~------s~~~~l~h~~f~ 292 (303)
T cd07869 219 LVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRL------SAQAALSHEYFS 292 (303)
T ss_pred HHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhcc------CHHHHhcCcccc
Confidence 1 000 0 01 02457899999999999999999 689999999999
Q ss_pred CCCh
Q psy8309 349 GLDW 352 (494)
Q Consensus 349 ~~~w 352 (494)
++.+
T Consensus 293 ~~~~ 296 (303)
T cd07869 293 DLPP 296 (303)
T ss_pred cCCh
Confidence 8864
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >KOG0660|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-48 Score=369.15 Aligned_cols=255 Identities=27% Similarity=0.450 Sum_probs=218.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-----CCe
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-----DSH 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-----~~~ 140 (494)
.|..++.||+|+||.|..|.++.+|+.||||.+... ....-..++.++|..+|. .++|+||+.+.+++.. -+.
T Consensus 23 ~y~~~~~iG~GAyGvVcsA~~~~t~~~VAIKKi~~~-F~~~~~akRtlRElklLr-~~~HeNIi~l~di~~p~~~~~f~D 100 (359)
T KOG0660|consen 23 YYVLIEPIGRGAYGVVCSAKDKRTGEKVAIKKILNP-FENQIDAKRTLRELKLLR-HLRHENIIGLLDIFRPPSRDKFND 100 (359)
T ss_pred eecccccccCcceeeEEEEEEcCCCCEeehhhhhhh-hhchHHHHHHHHHHHHHH-HhcCCCcceEEeecccccccccce
Confidence 455579999999999999999999999999998753 345567788999999998 4789999999999876 356
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|+|+| +.+|...++.+..|+++.+++++.||+.||.|+|+.||+||||||.|+|+
T Consensus 101 vYiV~elM----------------------etDL~~iik~~~~L~d~H~q~f~YQiLrgLKyiHSAnViHRDLKPsNll~ 158 (359)
T KOG0660|consen 101 VYLVFELM----------------------ETDLHQIIKSQQDLTDDHAQYFLYQILRGLKYIHSANVIHRDLKPSNLLL 158 (359)
T ss_pred eEEehhHH----------------------hhHHHHHHHcCccccHHHHHHHHHHHHHhcchhhcccccccccchhheee
Confidence 99999999 45777777777779999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeec--cCCcccccCCCCCccChhhhC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIY--LDKTTDTFCGTPDYMAPEIIK-GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.+..+||||||+|+.... .......++-|.+|.|||++. ...|+.++||||+|||+.||++|++.|.|.+..+.+.
T Consensus 159 n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 159 NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 9999999999999996432 233445678899999999975 4679999999999999999999999999998776666
Q ss_pred HHHhC-----------------------CCCCC--------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 298 SICNE-----------------------RPRFP--------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 298 ~i~~~-----------------------~~~~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.|+.- .+..| +..++.+.||+.+||..||.+|+ +++|+|+|||
T Consensus 239 lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~fdP~kRi------ta~eAL~hPY 312 (359)
T KOG0660|consen 239 LILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVFDPKKRI------TAEEALAHPY 312 (359)
T ss_pred HHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhccCccccC------CHHHHhcChh
Confidence 55421 11111 36799999999999999999999 7899999999
Q ss_pred cCCC
Q psy8309 347 FRGL 350 (494)
Q Consensus 347 f~~~ 350 (494)
+...
T Consensus 313 l~~~ 316 (359)
T KOG0660|consen 313 LAPY 316 (359)
T ss_pred hhhh
Confidence 9753
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-47 Score=373.64 Aligned_cols=254 Identities=27% Similarity=0.436 Sum_probs=209.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+++.+++.||||++..... ..........|..++. .++||||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 78 (287)
T cd07848 1 NKFEVLGVVGEGAYGVVLKCRHKETKEIVAIKKFKDSEE-NEEVKETTLRELKMLR-TLKQENIVELKEAFRRRGKLYLV 78 (287)
T ss_pred CCceEEEEecccCCEEEEEEEECCCCcEEEEEEEecccc-cccchhhHHHHHHHHH-hCCCccccchhhhEecCCEEEEE
Confidence 479999999999999999999999999999999976532 2333455667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++++. +.........+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 79 ~e~~~~~~---------------------l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nill~~~~ 137 (287)
T cd07848 79 FEYVEKNM---------------------LELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND 137 (287)
T ss_pred EecCCCCH---------------------HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcCCC
Confidence 99998443 333333446799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 225 HVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
.+||+|||++....... ......+||+.|+|||++.+..++.++|||||||++|||++|++||.+.+..+....+....
T Consensus 138 ~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~~~~~~~~~~~~~ 217 (287)
T cd07848 138 VLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTIQKVL 217 (287)
T ss_pred cEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhh
Confidence 99999999987532211 12234679999999999999899999999999999999999999999876554443332210
Q ss_pred -------------------CCC-------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 -------------------PRF-------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 -------------------~~~-------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..+ ...+|.++++||++||++||++|| +++++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~------s~~~~l~hp~f 287 (287)
T cd07848 218 GPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRY------LTEQCLNHPAF 287 (287)
T ss_pred CCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCC------CHHHHhcCCCC
Confidence 011 123688899999999999999999 67899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >KOG0604|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-48 Score=358.25 Aligned_cols=250 Identities=30% Similarity=0.500 Sum_probs=219.2
Q ss_pred CCCceEe-eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----C
Q psy8309 64 LEDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----D 138 (494)
Q Consensus 64 ~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~ 138 (494)
.+||.+- ++||-|--|+|..|.++.|++.+|+|++... ....+|.++......|||||+++++|++ .
T Consensus 60 tedY~is~qvLG~GinGkV~~C~~k~T~ekfALKvL~Ds--------~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~r 131 (400)
T KOG0604|consen 60 TEDYSISWQVLGAGINGKVVQCVHKRTQEKFALKVLLDS--------PKARREVELHWMASGHPHIVSIIDVYENSYQGR 131 (400)
T ss_pred hhhheehhhhhccccCCceEEEEeccchhhhHHHHHhcC--------HHHHhHhhhhhhhcCCCceEEeehhhhhhccCc
Confidence 4678775 5899999999999999999999999998643 2445666666666799999999999875 4
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+.+|||.|+ ||+|+..++..+. |+|.++..+++||..|+.|||+.+|.|||||||
T Consensus 132 kcLLiVmE~me---------------------GGeLfsriq~~g~~afTErea~eI~~qI~~Av~~lH~~nIAHRDlKpE 190 (400)
T KOG0604|consen 132 KCLLIVMECME---------------------GGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYLHSMNIAHRDLKPE 190 (400)
T ss_pred eeeEeeeeccc---------------------chHHHHHHHHcccccchHHHHHHHHHHHHHHHHHHHhcchhhccCChh
Confidence 57889999999 7788888888765 999999999999999999999999999999999
Q ss_pred ceeeCCC---CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-
Q psy8309 217 NILLDYE---GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE- 292 (494)
Q Consensus 217 NILl~~~---g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~- 292 (494)
|+|.+.. ..+||+|||+|+.. .......+.|-||.|.|||++..+.|+..+|+||+||++|-||+|.+||+....
T Consensus 191 NLLyt~t~~na~lKLtDfGFAK~t-~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 191 NLLYTTTSPNAPLKLTDFGFAKET-QEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred heeeecCCCCcceEeccccccccc-CCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 9999754 46999999999963 334556788999999999999999999999999999999999999999997653
Q ss_pred ---HHHHHHHHhCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 293 ---DELFWSICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 293 ---~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..+-.+|..+.+.||. .+|++++|+|+.||..+|.+|+ ++++++.|||..+
T Consensus 270 aispgMk~rI~~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRl------TI~~~m~hpwi~~ 327 (400)
T KOG0604|consen 270 AISPGMKRRIRTGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERL------TIEEVMDHPWINQ 327 (400)
T ss_pred cCChhHHhHhhccCccCCChhHhHHHHHHHHHHHHHhcCCchhhe------eHHHhhcCchhcc
Confidence 4567889999999994 6899999999999999999999 6889999999875
|
|
| >KOG0201|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-49 Score=385.68 Aligned_cols=255 Identities=29% Similarity=0.494 Sum_probs=226.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|..++.||+|+||.||+|.+..+++.||||++..+. .+++++.+..|..+|. .++++||.++|+.|..+..++++
T Consensus 13 ~~~~~~~~IgrGsfG~Vyk~~d~~t~k~vAiKii~Le~--~~deIediqqei~~Ls-~~~~~~it~yygsyl~g~~Lwii 89 (467)
T KOG0201|consen 13 LLYTKLELIGRGSFGEVYKAIDNKTKKVVAIKIIDLEE--AEDEIEDIQQEISVLS-QCDSPNITEYYGSYLKGTKLWII 89 (467)
T ss_pred cccccchhccccccceeeeeeeccccceEEEEEechhh--cchhhHHHHHHHHHHH-hcCcchHHhhhhheeecccHHHH
Confidence 46778899999999999999999999999999998763 4566777788888888 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||.||++ ...++....+.|..+..++++++.||.|||.++.+|||||+.|||+..+|
T Consensus 90 Mey~~gGsv---------------------~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~~kiHrDIKaanil~s~~g 148 (467)
T KOG0201|consen 90 MEYCGGGSV---------------------LDLLKSGNILDEFEIAVILREVLKGLDYLHSEKKIHRDIKAANILLSESG 148 (467)
T ss_pred HHHhcCcch---------------------hhhhccCCCCccceeeeehHHHHHHhhhhhhcceecccccccceeEeccC
Confidence 999996655 34455566679999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
.+||+|||++...........+++|||.|||||++++.+|+.++||||||++.+||++|.+|+....+...+..|-+..+
T Consensus 149 ~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmrvlflIpk~~P 228 (467)
T KOG0201|consen 149 DVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMRVLFLIPKSAP 228 (467)
T ss_pred cEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcCCCCCcccCcceEEEeccCCCC
Confidence 99999999998766666667899999999999999999999999999999999999999999999888666666655443
Q ss_pred -CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 305 -RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 305 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+...+|+.+++|+..||++||+.|| ++.++++|+|.+.
T Consensus 229 P~L~~~~S~~~kEFV~~CL~k~P~~Rp------sA~~LLKh~FIk~ 268 (467)
T KOG0201|consen 229 PRLDGDFSPPFKEFVEACLDKNPEFRP------SAKELLKHKFIKR 268 (467)
T ss_pred CccccccCHHHHHHHHHHhhcCcccCc------CHHHHhhhHHHHh
Confidence 44457899999999999999999999 6789999999986
|
|
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-46 Score=378.71 Aligned_cols=255 Identities=27% Similarity=0.445 Sum_probs=209.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
...++|++++.||+|+||.||+|+++.+++.||||++.... ..........|..++. .++|+||+++++++...+.+
T Consensus 71 ~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 147 (353)
T PLN00034 71 KSLSELERVNRIGSGAGGTVYKVIHRPTGRLYALKVIYGNH--EDTVRRQICREIEILR-DVNHPNVVKCHDMFDHNGEI 147 (353)
T ss_pred CCHHHHhhhhhccCCCCeEEEEEEECCCCCEEEEEEEecCC--cHHHHHHHHHHHHHHH-hCCCCCcceeeeEeccCCeE
Confidence 44678999999999999999999999999999999996542 2333455667777776 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||+.+|+|.. .....+..+..++.||+.||+|||++||+||||||+|||++
T Consensus 148 ~lv~e~~~~~~L~~-------------------------~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 202 (353)
T PLN00034 148 QVLLEFMDGGSLEG-------------------------THIADEQFLADVARQILSGIAYLHRRHIVHRDIKPSNLLIN 202 (353)
T ss_pred EEEEecCCCCcccc-------------------------cccCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 99999999777631 12356778889999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---H
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE---D 293 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~ 293 (494)
.++.+||+|||+++............+||+.|+|||++.. ..++.++|||||||++|||++|+.||..... .
T Consensus 203 ~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~ 282 (353)
T PLN00034 203 SAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGRQGDWA 282 (353)
T ss_pred CCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCCCCCccHH
Confidence 9999999999999864333333445689999999999843 2345789999999999999999999974332 2
Q ss_pred HHHHHHH-hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 294 ELFWSIC-NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 294 ~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.....+. ......+..++.++++||.+||..||++|| ++.|+++||||.+-
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp------t~~ell~hp~~~~~ 334 (353)
T PLN00034 283 SLMCAICMSQPPEAPATASREFRHFISCCLQREPAKRW------SAMQLLQHPFILRA 334 (353)
T ss_pred HHHHHHhccCCCCCCCccCHHHHHHHHHHccCChhhCc------CHHHHhcCcccccC
Confidence 2222332 334456678899999999999999999999 68999999999863
|
|
| >KOG0594|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-47 Score=364.02 Aligned_cols=257 Identities=28% Similarity=0.487 Sum_probs=216.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCc-eeeEEEEEEcCC---
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY-LCHLFCTFQTDS--- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~-Iv~l~~~~~~~~--- 139 (494)
+..|+.++.||+|+||+||+|+.+.+|+.||+|+++.+.- .+..-...++|+.++. .++|+| ||.|++++.+.+
T Consensus 10 ~~~~~~~eklGeGtyg~Vykar~~~~g~~VALKkirl~~~-~EG~P~taiREisllk-~L~~~~~iv~L~dv~~~~~~~~ 87 (323)
T KOG0594|consen 10 MFDYEKVEKLGEGTYGVVYKARSKRTGKFVALKKIRLEFE-EEGVPSTAIREISLLK-RLSHANHIVRLHDVIHTSNNHR 87 (323)
T ss_pred HHHHHHHHHhCCCCceEEEEEEEecCCCEEEEEEEecccc-ccCCCchhhHHHHHHH-HhCCCcceEEEEeeeeeccccc
Confidence 5678889999999999999999999999999999986532 1233345678888887 589999 999999999887
Q ss_pred ---eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC----CCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 140 ---HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG----RFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 140 ---~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~----~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
.+|+|+||+. .+|..++.... .++...++.++.||+.||+|||++||+|||
T Consensus 88 ~~~~l~lvfe~~d----------------------~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~~~IlHRD 145 (323)
T KOG0594|consen 88 GIGKLYLVFEFLD----------------------RDLKKYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHSHGILHRD 145 (323)
T ss_pred ccceEEEEEEeec----------------------ccHHHHHHhccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 8999999996 34444444433 577789999999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
|||+||||+.+|.+||+|||+|+............++|.+|.|||++.+. .|+..+||||+|||++||+++++.|.+..
T Consensus 146 LKPQNlLi~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~s 225 (323)
T KOG0594|consen 146 LKPQNLLISSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDS 225 (323)
T ss_pred CCcceEEECCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999998654444445667899999999999987 69999999999999999999999999999
Q ss_pred HHHHHHHHHhC------------------CCCCC------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhh
Q psy8309 292 EDELFWSICNE------------------RPRFP------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDV 341 (494)
Q Consensus 292 ~~~~~~~i~~~------------------~~~~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei 341 (494)
+.++...|..- +..+| +..++++.+++.+||+.+|.+|+ +++.+
T Consensus 226 e~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y~p~~R~------Sa~~a 299 (323)
T KOG0594|consen 226 EIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQYDPAKRI------SAKGA 299 (323)
T ss_pred HHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhccCcccCc------CHHHH
Confidence 88888777531 11122 12345899999999999999999 67899
Q ss_pred hcCCCcCCC
Q psy8309 342 VAHEYFRGL 350 (494)
Q Consensus 342 l~h~~f~~~ 350 (494)
+.||||..+
T Consensus 300 l~h~yf~~~ 308 (323)
T KOG0594|consen 300 LTHPYFSEL 308 (323)
T ss_pred hcChhhccc
Confidence 999999877
|
|
| >KOG0607|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-48 Score=360.80 Aligned_cols=252 Identities=32% Similarity=0.517 Sum_probs=221.6
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.|--|....+|..||||++.|. ......++++|.+++.....|+||++|+++|+++...|||||.|.
T Consensus 84 e~LGeGAyasVqtcv~i~t~~EYAVKiidKq---~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~- 159 (463)
T KOG0607|consen 84 ELLGEGAYASVQTCVSIQTGKEYAVKIIDKQ---PGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMR- 159 (463)
T ss_pred HHhcCccceeeeeeeeeccchhhhhhhhhcC---CchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEeccc-
Confidence 5899999999999999999999999999886 345567789999999988899999999999999999999999998
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC---EE
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VR 227 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~---vk 227 (494)
||.|..++++...|+|.++..++++|+.||.|||.+||.||||||||||.....+ ||
T Consensus 160 --------------------GGplLshI~~~~~F~E~EAs~vvkdia~aLdFlH~kgIAHRDlKPENiLC~~pn~vsPvK 219 (463)
T KOG0607|consen 160 --------------------GGPLLSHIQKRKHFNEREASRVVKDIASALDFLHTKGIAHRDLKPENILCESPNKVSPVK 219 (463)
T ss_pred --------------------CchHHHHHHHhhhccHHHHHHHHHHHHHHHHHHhhcCcccccCCccceeecCCCCcCcee
Confidence 7778889999999999999999999999999999999999999999999977655 79
Q ss_pred EeecCceeeeecc-------CCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC----
Q psy8309 228 IADFGMCKLQIYL-------DKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD---- 291 (494)
Q Consensus 228 L~DFGla~~~~~~-------~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---- 291 (494)
||||.|..-.... .....+.||+.+|||||++. ...|+.++|.||||||||-||.|.+||.|.=
T Consensus 220 iCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dC 299 (463)
T KOG0607|consen 220 ICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADC 299 (463)
T ss_pred eeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcC
Confidence 9999986431111 12234679999999999973 3459999999999999999999999997632
Q ss_pred -----------HHHHHHHHHhCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 292 -----------EDELFWSICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 292 -----------~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
.+.++..|..+.+.||+ .+|.+++|||..||.+|+.+|+ ++..+++|||++.+.-
T Consensus 300 GWdrGe~Cr~CQ~~LFesIQEGkYeFPdkdWahIS~eakdlisnLlvrda~~rl------sa~~vlnhPw~~~~~~ 369 (463)
T KOG0607|consen 300 GWDRGEVCRVCQNKLFESIQEGKYEFPDKDWAHISSEAKDLISNLLVRDAKQRL------SAAQVLNHPWVQRCAP 369 (463)
T ss_pred CccCCCccHHHHHHHHHHHhccCCcCChhhhHHhhHHHHHHHHHHHhccHHhhh------hhhhccCCccccccch
Confidence 35788899999999996 6899999999999999999999 5677999999987743
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-46 Score=365.61 Aligned_cols=271 Identities=37% Similarity=0.687 Sum_probs=220.7
Q ss_pred EeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH--hcCCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA--LGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~--~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
+||+|+||.||+|.+..+++.||+|++.+..............|..++. ....||+|+.+++.+...+..|+||||++
T Consensus 1 ~lg~G~~g~Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~ 80 (279)
T cd05633 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMN 80 (279)
T ss_pred CcccCCCeEEEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCC
Confidence 4899999999999999999999999997754332222222333333322 23579999999999999999999999999
Q ss_pred CCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEe
Q psy8309 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 150 ~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~ 229 (494)
|++|..++...+.+++..+..++.||+.||+|||++||+||||||+|||++.++.++|+
T Consensus 81 ---------------------~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dikp~Nil~~~~~~~~l~ 139 (279)
T cd05633 81 ---------------------GGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 139 (279)
T ss_pred ---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCCCCCCHHHEEECCCCCEEEc
Confidence 45555567777789999999999999999999999999999999999999999999999
Q ss_pred ecCceeeeeccCCcccccCCCCCccChhhhC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhCCCC
Q psy8309 230 DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD---EDELFWSICNERPR 305 (494)
Q Consensus 230 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~~~~ 305 (494)
|||++.... ........||+.|+|||.+. +..++.++|+||+||++|+|++|..||.... ..............
T Consensus 140 dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~ 217 (279)
T cd05633 140 DLGLACDFS--KKKPHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTVNVE 217 (279)
T ss_pred cCCcceecc--ccCccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCCCcCHHHHHHHhhcCCcC
Confidence 999986432 22233457999999999986 4668999999999999999999999997543 22222333344566
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+|..++.+++++|.+||..||.+|+++... ++.|+++||||++++|......+..+|.+|
T Consensus 218 ~~~~~~~~~~~li~~~l~~~p~~R~~~~~~-~~~~~~~h~~~~~~~~~~~~~~~~~~~~~~ 277 (279)
T cd05633 218 LPDSFSPELKSLLEGLLQRDVSKRLGCLGR-GAQEVKEHVFFKGIDWQQVYLQKYPPPLIP 277 (279)
T ss_pred CccccCHHHHHHHHHHhcCCHHHhcCCCCC-CHHHHHhCccccCCCHhHHhcCCCCCCCCC
Confidence 778899999999999999999999976543 799999999999999999887777777655
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0589|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-47 Score=381.82 Aligned_cols=256 Identities=29% Similarity=0.526 Sum_probs=231.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe-eE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH-LF 142 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~-~~ 142 (494)
+++|+.++++|+|+||.+++++++..++.|++|.+.-.... .........|..++.+ +.|||||.+.+.|..++. ++
T Consensus 3 m~~Ye~~~~iG~GafG~a~lvrhk~~~~~~vlK~I~l~~~t-~~~r~~A~~E~~lis~-~~hP~iv~y~ds~~~~~~~l~ 80 (426)
T KOG0589|consen 3 MDNYEVLRQVGRGAFGSALLVRHKSDDKLYVLKKINLEKLT-EPERRSAIQEMDLLSK-LLHPNIVEYKDSFEEDGQLLC 80 (426)
T ss_pred cchhhhhhhcCccccchhhhhhhccCCceEEEEEEeccccC-chhhHHHHHHHHHHHh-ccCCCeeeeccchhcCCceEE
Confidence 57899999999999999999999999999999999876443 3344467888888885 899999999999999888 99
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|||+||+||+| ...+.. ...|+|+.+..|+.||+.|+.|||+++|+|||||+.||++
T Consensus 81 Ivm~Y~eGg~l---------------------~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~~~iLHRDlK~~Nifl 139 (426)
T KOG0589|consen 81 IVMEYCEGGDL---------------------AQLIKEQKGVLFPEERILKWFVQILLAVNYLHENRVLHRDLKCANIFL 139 (426)
T ss_pred EEEeecCCCCH---------------------HHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhhhhhcccchhhhhhc
Confidence 99999996655 333332 2479999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.++.|||+|||+|+..........+.+|||.||+||++.+.+|+.++|||||||++|||++-+++|.+.+...+..+|.
T Consensus 140 tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~aF~a~~m~~Li~ki~ 219 (426)
T KOG0589|consen 140 TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPAFKASNMSELILKIN 219 (426)
T ss_pred cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccccCccchHHHHHHHh
Confidence 99999999999999986665557889999999999999999999999999999999999999999999999999999999
Q ss_pred hCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 301 NER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 301 ~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+. .++|...+.+++.||+.||.++|..|| ++.+++.+|...
T Consensus 220 ~~~~~Plp~~ys~el~~lv~~~l~~~P~~RP------sa~~LL~~P~l~ 262 (426)
T KOG0589|consen 220 RGLYSPLPSMYSSELRSLVKSMLRKNPEHRP------SALELLRRPHLL 262 (426)
T ss_pred hccCCCCCccccHHHHHHHHHHhhcCCccCC------CHHHHhhChhhh
Confidence 887 677889999999999999999999999 689999998775
|
|
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=367.88 Aligned_cols=278 Identities=36% Similarity=0.734 Sum_probs=235.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|.++.+++.||+|.+.+..............|..++. .++||||+++++.+..++++|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv 79 (305)
T cd05609 1 EDFETIKLISNGAYGAVYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILT-FAENPFVVSMFCSFETKRHLCMV 79 (305)
T ss_pred CCceEeeEeecCCCeeEEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEecCCEEEEE
Confidence 47999999999999999999999999999999997754333344455667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++ |++|..++...+.+++..+..++.|++.||.|||++|++||||||+||+++.+|
T Consensus 80 ~e~~~---------------------g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~NIll~~~~ 138 (305)
T cd05609 80 MEYVE---------------------GGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMG 138 (305)
T ss_pred EecCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHEEECCCC
Confidence 99999 555566777778899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccC---------------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 225 HVRIADFGMCKLQIYLD---------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~---------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
.+||+|||+++...... .......|+..|+|||.+.+..++.++|+|||||++|||++|..||.+
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~ 218 (305)
T cd05609 139 HIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFG 218 (305)
T ss_pred CEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99999999986311000 011234688899999999988999999999999999999999999999
Q ss_pred CCHHHHHHHHHhCCCCCCc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 290 CDEDELFWSICNERPRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 290 ~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
.+..++...+.......|. .++.+++++|.+||..||.+||++ .++.++++||||...+|..+... ...+.|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~---~~~~~ll~~~~~~~~~~~~~~~~--~~~~~~ 293 (305)
T cd05609 219 DTPEELFGQVISDDIEWPEGDEALPADAQDLISRLLRQNPLERLGT---GGAFEVKQHRFFLGLDWNGLLRQ--KAEFIP 293 (305)
T ss_pred CCHHHHHHHHHhcccCCCCccccCCHHHHHHHHHHhccChhhccCc---cCHHHHHhCccccCCCHHHHhhc--CCCCCC
Confidence 8888888888776555443 578999999999999999999976 36899999999999999997644 335666
Q ss_pred ccc
Q psy8309 367 RVI 369 (494)
Q Consensus 367 ~~~ 369 (494)
...
T Consensus 294 ~~~ 296 (305)
T cd05609 294 QLE 296 (305)
T ss_pred CCC
Confidence 654
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >KOG0192|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-46 Score=375.40 Aligned_cols=249 Identities=29% Similarity=0.505 Sum_probs=213.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS- 139 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~- 139 (494)
.++..++.+.+.||+|+||+||+|.++++.. ||||++......... .+.+..|..+|. .++|||||+++|++.+..
T Consensus 37 ~i~~~~l~~~~~iG~G~~g~V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E~~il~-~l~HpNIV~f~G~~~~~~~ 113 (362)
T KOG0192|consen 37 EIDPDELPIEEVLGSGSFGTVYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRREASLLS-RLRHPNIVQFYGACTSPPG 113 (362)
T ss_pred ecChHHhhhhhhcccCCceeEEEEEeCCcee-EEEEEecchhcChHH-HHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCC
Confidence 4556677888889999999999999987643 899999876543333 667888888888 589999999999999888
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCC-CccccCCCC
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKG-IVYRDLKLD 216 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~g-ivHrDLKp~ 216 (494)
.++|||||+++| +|..++.. .+.++...+..++.||+.||+|||+++ ||||||||+
T Consensus 114 ~~~iVtEy~~~G---------------------sL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~~iIHrDLK~~ 172 (362)
T KOG0192|consen 114 SLCIVTEYMPGG---------------------SLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEGPIIHRDLKSD 172 (362)
T ss_pred ceEEEEEeCCCC---------------------cHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCeeecccChh
Confidence 799999999955 45555655 678999999999999999999999999 999999999
Q ss_pred ceeeCCCC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 217 NILLDYEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK--GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
|||++.++ ++||+|||+++.............||+.|||||++. +..|+.++|||||||+||||+||..||.+....
T Consensus 173 NiLv~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~~ 252 (362)
T KOG0192|consen 173 NILVDLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAPV 252 (362)
T ss_pred hEEEcCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCHH
Confidence 99999998 999999999986443323344478999999999999 568999999999999999999999999998886
Q ss_pred HHHHHHHh--CCCCCCccCCHHHHHHHHhhccCCCCCCCCCC
Q psy8309 294 ELFWSICN--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGST 333 (494)
Q Consensus 294 ~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 333 (494)
.....+.. .++.+|...++.+..||.+||..||.+||+..
T Consensus 253 ~~~~~v~~~~~Rp~~p~~~~~~l~~l~~~CW~~dp~~RP~f~ 294 (362)
T KOG0192|consen 253 QVASAVVVGGLRPPIPKECPPHLSSLMERCWLVDPSRRPSFL 294 (362)
T ss_pred HHHHHHHhcCCCCCCCccCCHHHHHHHHHhCCCCCCcCCCHH
Confidence 66666653 46778888999999999999999999999653
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-46 Score=365.79 Aligned_cols=270 Identities=43% Similarity=0.713 Sum_probs=228.8
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||+|+||+||+|.++.+++.||+|++.+..............|..++. .++||||+++++++...+..|+||||+++
T Consensus 1 lg~g~~g~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-- 77 (277)
T cd05577 1 LGKGGFGEVCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILE-KVSSRFIVSLAYAFETKDDLCLVMTLMNG-- 77 (277)
T ss_pred CCCCCceeEEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHH-hCCCCCEeeeeeEEecCCeEEEEEecCCC--
Confidence 699999999999999999999999997654333333444566777776 57899999999999999999999999994
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
++|..++.+.. .+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|
T Consensus 78 -------------------~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~Nil~~~~~~~~l~d 138 (277)
T cd05577 78 -------------------GDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISD 138 (277)
T ss_pred -------------------CcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCCCEEEcc
Confidence 45555555544 799999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH----HHHHHHHHhCCCCC
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSICNERPRF 306 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----~~~~~~i~~~~~~~ 306 (494)
||++..... ........|+..|+|||++.+..++.++|+|||||++|+|++|+.||..... ..+...+......+
T Consensus 139 fg~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 217 (277)
T cd05577 139 LGLAVELKG-GKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRKEKVEKEELKRRTLEMAVEY 217 (277)
T ss_pred Ccchhhhcc-CCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCcccccHHHHHhccccccccC
Confidence 998864322 2333445688999999999988899999999999999999999999987543 33444444455667
Q ss_pred CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 307 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
|..++++++++|.+||+.||.+||+..+. ++++++.||||+.++|..+.+....|||.|
T Consensus 218 ~~~~~~~~~~li~~~l~~~p~~R~~~~~~-~~~~ll~h~~~~~~~~~~~~~~~~~~~~~~ 276 (277)
T cd05577 218 PDKFSPEAKDLCEALLQKDPEKRLGCRGG-SADEVREHPLFKDLNWRRLEAGMLEPPFIP 276 (277)
T ss_pred CccCCHHHHHHHHHHccCChhHccCCCcc-cHHHHHhChhhhcCChhhhhcCCCCCCCCC
Confidence 77889999999999999999999988663 799999999999999999999888888876
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-46 Score=363.54 Aligned_cols=271 Identities=37% Similarity=0.683 Sum_probs=224.3
Q ss_pred EeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH--hcCCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA--LGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~--~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
+||+|+||.||+|++..+++.||||++.+..............|..++. ....||+|+++++.+...+.+|+||||+.
T Consensus 1 ~ig~g~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~ 80 (278)
T cd05606 1 IIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMN 80 (278)
T ss_pred CcccCCCeEEEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCC
Confidence 4899999999999999999999999998754332222222233333222 23589999999999999999999999999
Q ss_pred CCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEe
Q psy8309 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 150 ~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~ 229 (494)
|++|..++...+.+++..++.++.|++.||+|||+++|+||||||+||+++.++.+||+
T Consensus 81 ---------------------g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~nili~~~~~~kl~ 139 (278)
T cd05606 81 ---------------------GGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRIS 139 (278)
T ss_pred ---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHEEECCCCCEEEc
Confidence 44555566677789999999999999999999999999999999999999999999999
Q ss_pred ecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHHhCCCC
Q psy8309 230 DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGC---DEDELFWSICNERPR 305 (494)
Q Consensus 230 DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~---~~~~~~~~i~~~~~~ 305 (494)
|||++.... .......+|+..|+|||++.+ ..++.++|+||+||++|||++|..||.+. ........+....+.
T Consensus 140 dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~ 217 (278)
T cd05606 140 DLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE 217 (278)
T ss_pred cCcCccccC--ccCCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccchHHHHHHhhccCCC
Confidence 999987432 223345689999999999975 46899999999999999999999999876 444444455556677
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+|..++.++.++|.+||..+|.+|+.+.. .+++++++||||++++|..+..++.+|+..|
T Consensus 218 ~~~~~s~~~~~li~~~l~~~p~~R~~~~~-~~~~~ll~~~~~~~~~~~~~~~~~~~~~~~~ 277 (278)
T cd05606 218 LPDSFSPELRSLLEGLLQRDVNRRLGCLG-RGAQEVKEHPFFRSLDWQMVFLQKYPPPLIP 277 (278)
T ss_pred CCCcCCHHHHHHHHHHhhcCHHhccCCCC-CCHHHHHhCccccCCCchHhhhcccCCCCCC
Confidence 88888999999999999999999997644 3899999999999999999988887777665
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-45 Score=387.91 Aligned_cols=251 Identities=26% Similarity=0.390 Sum_probs=200.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH-----hcCCCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-----LGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~-----~~~~hp~Iv~l~~~~~~~ 138 (494)
..+|+++++||+|+||+||+|.+..+++.||||++++... .......|..++. ...+|.+|++++++|...
T Consensus 128 ~~~y~i~~~lG~G~fg~V~~a~~~~~~~~vAvK~i~~~~~----~~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~ 203 (467)
T PTZ00284 128 TQRFKILSLLGEGTFGKVVEAWDRKRKEYCAVKIVRNVPK----YTRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE 203 (467)
T ss_pred CCcEEEEEEEEeccCEEEEEEEEcCCCeEEEEEEEecchh----hHHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC
Confidence 3689999999999999999999999999999999965311 1111222333332 123567799999999865
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCC
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLD 216 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~ 216 (494)
.++|+|||++ |++|..++.+.+.+++..++.++.||+.||+|||+ .|||||||||+
T Consensus 204 ~~~~~iv~~~~----------------------g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~~gIiHrDlKP~ 261 (467)
T PTZ00284 204 TGHMCIVMPKY----------------------GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPE 261 (467)
T ss_pred CceEEEEEecc----------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCeecCCCCHH
Confidence 5799999987 55666677777889999999999999999999998 59999999999
Q ss_pred ceeeCCCC----------------CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHH
Q psy8309 217 NILLDYEG----------------HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280 (494)
Q Consensus 217 NILl~~~g----------------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~el 280 (494)
|||++.++ .+||+|||++.. ........+||+.|+|||++.+..|+.++|||||||++|||
T Consensus 262 NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~---~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~el 338 (467)
T PTZ00284 262 NILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD---ERHSRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYEL 338 (467)
T ss_pred HEEEecCCcccccccccccCCCCceEEECCCCcccc---CccccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHH
Confidence 99998776 499999998763 22334567899999999999999999999999999999999
Q ss_pred HhCCCCCCCCCHHHHHHHHHhCCCCCCc------------------------------------------cCCHHHHHHH
Q psy8309 281 HVGQSPFSGCDEDELFWSICNERPRFPQ------------------------------------------FLSVEAKNIL 318 (494)
Q Consensus 281 l~G~~Pf~~~~~~~~~~~i~~~~~~~p~------------------------------------------~~s~~~~~li 318 (494)
++|++||.+.+..+.+..|......+|. ..++.+.|||
T Consensus 339 ltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli 418 (467)
T PTZ00284 339 YTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPVREVIRDDLLCDLI 418 (467)
T ss_pred HhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccchhhhhchHHHHHHH
Confidence 9999999987765554443321111110 1135678999
Q ss_pred HhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 319 VHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 319 ~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+||.+||.+|| +++|+++||||..
T Consensus 419 ~~mL~~dP~~R~------ta~e~L~Hp~~~~ 443 (467)
T PTZ00284 419 YGLLHYDRQKRL------NARQMTTHPYVLK 443 (467)
T ss_pred HHhCCcChhhCC------CHHHHhcCccccc
Confidence 999999999999 6899999999975
|
|
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-46 Score=374.16 Aligned_cols=257 Identities=25% Similarity=0.409 Sum_probs=207.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----Ce
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-----SH 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-----~~ 140 (494)
+|++.+.||+|+||.||+|+++.++..||||++.... ...........|..++. .++||||+++++++... ..
T Consensus 1 ry~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~~~ 78 (338)
T cd07859 1 RYKIQEVIGKGSYGVVCSAIDTHTGEKVAIKKINDVF-EHVSDATRILREIKLLR-LLRHPDIVEIKHIMLPPSRREFKD 78 (338)
T ss_pred CeEEEEEEeecCCeEEEEEEECCCCCEEEEEEechhh-ccchhHHHHHHHHHHHH-hCCCCCEeeecceEeccCCCCCce
Confidence 5899999999999999999999999999999987532 12233345677888877 57999999999988643 35
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||. ++|...+.....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~lv~e~~~----------------------~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIll 136 (338)
T cd07859 79 IYVVFELME----------------------SDLHQVIKANDDLTPEHHQFFLYQLLRALKYIHTANVFHRDLKPKNILA 136 (338)
T ss_pred EEEEEecCC----------------------CCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEE
Confidence 899999994 3455666677789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+.+|.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|++||.+.+....
T Consensus 137 ~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~~~~~ 216 (338)
T cd07859 137 NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQ 216 (338)
T ss_pred CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCChHHH
Confidence 9999999999999875322111 1234679999999999876 6789999999999999999999999987665433
Q ss_pred HHHHHh--------------------------CCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICN--------------------------ERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~--------------------------~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
...+.. .....+ ..+++++.++|.+||..||++|| +++|+++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~e~l~h 290 (338)
T cd07859 217 LDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFPNADPLALRLLERLLAFDPKDRP------TAEEALAD 290 (338)
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcCCCChHHHHHHHHHcCcCcccCC------CHHHHhcC
Confidence 222110 000000 24678899999999999999999 68999999
Q ss_pred CCcCCCCh
Q psy8309 345 EYFRGLDW 352 (494)
Q Consensus 345 ~~f~~~~w 352 (494)
|||+++..
T Consensus 291 p~f~~~~~ 298 (338)
T cd07859 291 PYFKGLAK 298 (338)
T ss_pred chhhhcCc
Confidence 99987643
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-46 Score=386.33 Aligned_cols=257 Identities=25% Similarity=0.381 Sum_probs=205.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC----
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD---- 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~---- 138 (494)
...+|+++++||+|+||.||+|.+..+++.||||++.+... ....|..++. .++|||||+++++|...
T Consensus 64 ~~~~y~~~~~LG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~-------~~~~Ei~il~-~l~h~niv~l~~~~~~~~~~~ 135 (440)
T PTZ00036 64 PNKSYKLGNIIGNGSFGVVYEAICIDTSEKVAIKKVLQDPQ-------YKNRELLIMK-NLNHINIIFLKDYYYTECFKK 135 (440)
T ss_pred cCCeEEEeEEEEeCCCEEEEEEEECCCCCEEEEEEEecCcc-------hHHHHHHHHH-hcCCCCCcceeeeEeeccccc
Confidence 34689999999999999999999999999999998865321 1234666666 57999999999887532
Q ss_pred ----CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 139 ----SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 139 ----~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
..+++||||+++ +|. ++ +..+......+++..++.++.||+.||.|||++||+|||||
T Consensus 136 ~~~~~~l~lvmE~~~~-~l~------------~~-----~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~~~IiHrDLK 197 (440)
T PTZ00036 136 NEKNIFLNVVMEFIPQ-TVH------------KY-----MKHYARNNHALPLFLVKLYSYQLCRALAYIHSKFICHRDLK 197 (440)
T ss_pred CCCceEEEEEEecCCc-cHH------------HH-----HHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCcC
Confidence 257899999973 221 10 11123345689999999999999999999999999999999
Q ss_pred CCceeeCCCC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 215 LDNILLDYEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 215 p~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|+||||+.++ .+||+|||+|+... ........+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+.+.
T Consensus 198 p~NILl~~~~~~vkL~DFGla~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 198 PQNLLIDPNTHTLKLCDFGSAKNLL-AGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred HHHEEEcCCCCceeeeccccchhcc-CCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999765 69999999998533 23334456899999999998764 699999999999999999999999998877
Q ss_pred HHHHHHHHhC-----------------CC------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE-----------------RP------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~-----------------~~------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+.+..+... .. .+|...++++++||.+||++||.+|| ++.|+++
T Consensus 277 ~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~~R~------ta~e~l~ 350 (440)
T PTZ00036 277 VDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPLKRL------NPIEALA 350 (440)
T ss_pred HHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChhHCc------CHHHHhC
Confidence 6655555321 01 13445788999999999999999999 6899999
Q ss_pred CCCcCCCCh
Q psy8309 344 HEYFRGLDW 352 (494)
Q Consensus 344 h~~f~~~~w 352 (494)
||||.++.+
T Consensus 351 hp~f~~~~~ 359 (440)
T PTZ00036 351 DPFFDDLRD 359 (440)
T ss_pred ChhHHhhhc
Confidence 999987644
|
|
| >KOG0667|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-46 Score=383.14 Aligned_cols=252 Identities=30% Similarity=0.469 Sum_probs=210.1
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-----CceeeEEEEEEcCCe
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-----PYLCHLFCTFQTDSH 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-----p~Iv~l~~~~~~~~~ 140 (494)
+|+++++||+|+||+|.+|.+..|++.||||+++.. .....+...|..+|....+| -|+|+++++|...+|
T Consensus 187 rY~V~e~LGkGtFGQVvk~~d~~T~e~VAIKIiKN~----k~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~H 262 (586)
T KOG0667|consen 187 RYEVLEVLGKGSFGQVVKAYDHKTGEIVAIKIIKNK----KRFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNH 262 (586)
T ss_pred EEEEEEEecccccceeEEEEecCCCcEEEEEeeccC----hHHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccc
Confidence 678999999999999999999999999999999865 34556677788888754433 389999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|||+|.+. .+|+|+++. .+...|+...++.++.||+.||.+||++||||+|||||||||
T Consensus 263 lciVfELL~-------------~NLYellK~-------n~f~Glsl~~ir~~~~Qil~~L~~L~~l~IIHcDLKPENILL 322 (586)
T KOG0667|consen 263 LCIVFELLS-------------TNLYELLKN-------NKFRGLSLPLVRKFAQQILTALLFLHELGIIHCDLKPENILL 322 (586)
T ss_pred eeeeehhhh-------------hhHHHHHHh-------cCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCChhheee
Confidence 999999985 455554431 123469999999999999999999999999999999999999
Q ss_pred CCCC--CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 221 DYEG--HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g--~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
...+ .|||+|||.|... .....+++.+..|+|||+|.|.+|+.+.||||||||++||++|.+.|.|.++.+++..
T Consensus 323 ~~~~r~~vKVIDFGSSc~~---~q~vytYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl~~ 399 (586)
T KOG0667|consen 323 KDPKRSRIKVIDFGSSCFE---SQRVYTYIQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQLAR 399 (586)
T ss_pred ccCCcCceeEEeccccccc---CCcceeeeeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHHHH
Confidence 7654 5999999999853 3344488999999999999999999999999999999999999999999999888876
Q ss_pred HHhC--------------------C--------------------------------CCCCc-----------cCCHHHH
Q psy8309 299 ICNE--------------------R--------------------------------PRFPQ-----------FLSVEAK 315 (494)
Q Consensus 299 i~~~--------------------~--------------------------------~~~p~-----------~~s~~~~ 315 (494)
|+.- . ...|. .-...+.
T Consensus 400 I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~P~~~~~l~~~~~~~~~~~F~ 479 (586)
T KOG0667|consen 400 IIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRGPPGSRSLESGLPKADDKLFI 479 (586)
T ss_pred HHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccCCCCCcccchhcccccHHHHH
Confidence 6520 0 00110 0123578
Q ss_pred HHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 316 NILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 316 ~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
|||++||+.||.+|+ ++.++++||||.+.
T Consensus 480 dflk~~L~~dP~~R~------tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 480 DFLKRCLEWDPAERI------TPAQALNHPFLTGT 508 (586)
T ss_pred HHHHHHhccCchhcC------CHHHHhcCcccccc
Confidence 999999999999999 67889999999864
|
|
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=367.32 Aligned_cols=278 Identities=41% Similarity=0.775 Sum_probs=234.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|.+..+++.||||.+.+..............|..++. .++||||+++++.+......|+|
T Consensus 1 ~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv 79 (316)
T cd05574 1 KHFKKIKLLGKGDVGRVFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILA-TLDHPFLPTLYASFQTETYLCLV 79 (316)
T ss_pred CceEEeeeecCCccEEEEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHH-hCCCCCchhheeeeecCCEEEEE
Confidence 47999999999999999999999999999999998765444345556677777776 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||+.|++ |..++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.
T Consensus 80 ~e~~~~~~---------------------L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nili~~ 138 (316)
T cd05574 80 MDYCPGGE---------------------LFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLLGIVYRDLKPENILLHE 138 (316)
T ss_pred EEecCCCC---------------------HHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHCCeeccCCChHHeEEcC
Confidence 99999554 4444443 257999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccC-----------------------------CcccccCCCCCccChhhhCCCCCCCcchHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLD-----------------------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSF 273 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~-----------------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSl 273 (494)
+|.++|+|||++....... .......||..|+|||++.+..++.++|||||
T Consensus 139 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~sl 218 (316)
T cd05574 139 SGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTL 218 (316)
T ss_pred CCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHH
Confidence 9999999999876422111 11224578999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc--CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 274 GILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 274 Gvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
|+++|+|++|..||.+.+..+.+..+......++.. ++.+++++|.+||..||++||++.. ++++++.||||++++
T Consensus 219 G~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~--~~~~ll~~~~~~~~~ 296 (316)
T cd05574 219 GILLYEMLYGTTPFKGSNRDETFSNILKKEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKR--GAAEIKQHPFFRGVN 296 (316)
T ss_pred HHHHHHHhhCCCCCCCCchHHHHHHHhcCCccCCCccccCHHHHHHHHHHccCCHhHCCCchh--hHHHHHcCchhhcCC
Confidence 999999999999999998888888888777766654 6999999999999999999996432 489999999999999
Q ss_pred hhHHhcCcCCCCCcccc
Q psy8309 352 WQALEKRELEPPFRPRV 368 (494)
Q Consensus 352 w~~l~~~~~~pp~~p~~ 368 (494)
|..+.. ..||..|..
T Consensus 297 ~~~~~~--~~~~~~~~~ 311 (316)
T cd05574 297 WALIRH--TTPPIIPRP 311 (316)
T ss_pred hhhccc--CCCCCCCCc
Confidence 998865 445555543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >KOG0658|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-46 Score=360.81 Aligned_cols=252 Identities=29% Similarity=0.508 Sum_probs=208.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--C---e
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--S---H 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~---~ 140 (494)
.|.-.+++|.|+||.||.|+...+++.||||.+-.+.-. .-+|..+|. .++|||||+|..+|... . +
T Consensus 25 ~~~~~~liG~GsFg~Vyq~~~~e~~~~vAIKKv~~d~r~-------knrEl~im~-~l~HpNIV~L~~~f~~~~~~d~~~ 96 (364)
T KOG0658|consen 25 SYEAVRLIGSGSFGVVYQAKLRETEEEVAIKKVLQDKRY-------KNRELQIMR-KLDHPNIVRLLYFFSSSTESDEVY 96 (364)
T ss_pred EEEeeEEEeecccceEEEEEEcCCCceeEEEEecCCCCc-------CcHHHHHHH-hcCCcCeeeEEEEEEecCCCchhH
Confidence 588899999999999999999999999999988654221 224566666 68999999999998743 2 5
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+.+||||++ .+|.++++ .+...+..++...++.|+.||+.||.|||+.||+||||||.|||+
T Consensus 97 lnlVleymP-------------~tL~~~~r-----~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~~~IcHRDIKPqNlLv 158 (364)
T KOG0658|consen 97 LNLVLEYMP-------------ETLYRVIR-----HYTRANQRMPLLEIKLYTYQLFRGLAYLHSHGICHRDIKPQNLLV 158 (364)
T ss_pred HHHHHHhch-------------HHHHHHHH-----HHhhcCCCCceeeeHHHHHHHHHHHHHHHhcCcccCCCChheEEE
Confidence 678999997 44444432 233456789999999999999999999999999999999999999
Q ss_pred CCC-CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 221 DYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~-g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
|.+ |.+||||||.|+.... +....++..|..|+|||.+.| ..|+.+.||||.||++.||+.|++.|.|.+..+++..
T Consensus 159 D~~tg~LKicDFGSAK~L~~-~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQL~e 237 (364)
T KOG0658|consen 159 DPDTGVLKICDFGSAKVLVK-GEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQLVE 237 (364)
T ss_pred cCCCCeEEeccCCcceeecc-CCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHHHHH
Confidence 976 8999999999997544 455567788999999999987 4699999999999999999999999999988777766
Q ss_pred HHh------------CC-----CCC------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 299 ICN------------ER-----PRF------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 299 i~~------------~~-----~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
|.+ .. ..+ ....++++.+|+.++|..+|.+|. ++.|++.||||..
T Consensus 238 Iik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R~------~~~~~l~h~fFde 311 (364)
T KOG0658|consen 238 IIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKRL------SALEALAHPFFDE 311 (364)
T ss_pred HHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhcC------CHHHHhcchhhHH
Confidence 652 01 112 235789999999999999999998 6789999999975
Q ss_pred C
Q psy8309 350 L 350 (494)
Q Consensus 350 ~ 350 (494)
+
T Consensus 312 l 312 (364)
T KOG0658|consen 312 L 312 (364)
T ss_pred h
Confidence 4
|
|
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-45 Score=369.67 Aligned_cols=257 Identities=26% Similarity=0.470 Sum_probs=215.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++++.||+|+||.||+|+++.++..||+|++.... ..........|..++. .++||||+++++++..++.++
T Consensus 3 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 79 (331)
T cd06649 3 KDDDFERISELGAGNGGVVTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEIS 79 (331)
T ss_pred CcccceEEEeecCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEE
Confidence 4579999999999999999999999999999999997642 2334456777888877 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NILl~ 221 (494)
+||||++ |++|..++.....+++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus 80 lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~ivH~dlkp~Nil~~ 138 (331)
T cd06649 80 ICMEHMD---------------------GGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVN 138 (331)
T ss_pred EEeecCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEcCCCChhhEEEc
Confidence 9999999 455556677777899999999999999999999986 699999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH--
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI-- 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-- 299 (494)
.+|.+||+|||++.... .......+||+.|+|||++.+..++.++|||||||++|||++|+.||...+..++...+
T Consensus 139 ~~~~~kl~Dfg~~~~~~--~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~~~~~~~~~~ 216 (331)
T cd06649 139 SRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPPDAKELEAIFGR 216 (331)
T ss_pred CCCcEEEccCccccccc--ccccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhcc
Confidence 99999999999987532 23344568999999999999999999999999999999999999999876654433221
Q ss_pred --------------------------------------------HhC-CCCCC-ccCCHHHHHHHHhhccCCCCCCCCCC
Q psy8309 300 --------------------------------------------CNE-RPRFP-QFLSVEAKNILVHLLDKDTTKRLGST 333 (494)
Q Consensus 300 --------------------------------------------~~~-~~~~p-~~~s~~~~~li~~lL~~dP~~R~~~~ 333 (494)
... .+..+ ..+++++++||.+||.+||++||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~~P~~Rp--- 293 (331)
T cd06649 217 PVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQEFVNKCLIKNPAERA--- 293 (331)
T ss_pred cccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHHHHHHHccCCcccCC---
Confidence 111 11112 24688999999999999999999
Q ss_pred CCCChhhhhcCCCcCCCC
Q psy8309 334 QCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 334 ~~~~~~eil~h~~f~~~~ 351 (494)
+++|+++||||+...
T Consensus 294 ---t~~ell~h~~~~~~~ 308 (331)
T cd06649 294 ---DLKMLMNHTFIKRSE 308 (331)
T ss_pred ---CHHHHhcChHHhhcc
Confidence 689999999997643
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-45 Score=379.34 Aligned_cols=251 Identities=22% Similarity=0.350 Sum_probs=204.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+...+|++++.||+|+||.||+|+++.+++.||||..... ....|..++. .++||||++++++|......
T Consensus 89 ~~~~~y~~~~~lg~G~~g~V~~~~d~~~~~~vaiK~~~~~---------~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~ 158 (391)
T PHA03212 89 IEKAGFSILETFTPGAEGFAFACIDNKTCEHVVIKAGQRG---------GTATEAHILR-AINHPSIIQLKGTFTYNKFT 158 (391)
T ss_pred cccCCcEEEEEEcCCCCeEEEEEEECCCCCEEEEechhhh---------hhHHHHHHHH-hCCCCCCCCEeEEEEECCee
Confidence 3456899999999999999999999999999999975432 3456777777 58999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
++|||++. ++|..++.....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 159 ~lv~e~~~----------------------~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvHrDiKP~NIll~ 216 (391)
T PHA03212 159 CLILPRYK----------------------TDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIHRDIKAENIFIN 216 (391)
T ss_pred EEEEecCC----------------------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHhEEEc
Confidence 99999984 35555666677899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeec-cCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------HH
Q psy8309 222 YEGHVRIADFGMCKLQIY-LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-------ED 293 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-------~~ 293 (494)
.+|.+||+|||+++.... ........+||+.|+|||++.+..|+.++|||||||++|||++|..||...+ ..
T Consensus 217 ~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~~~~~~~~~~~ 296 (391)
T PHA03212 217 HPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSD 296 (391)
T ss_pred CCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCcccccccCchh
Confidence 999999999999864221 1123345689999999999999999999999999999999999998875422 11
Q ss_pred HHHHHHHh--------------------------CCCCCC---------ccCCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 294 ELFWSICN--------------------------ERPRFP---------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 294 ~~~~~i~~--------------------------~~~~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
..+..+.. .....| ..++.++.+||.+||+.||.+|| ++
T Consensus 297 ~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~dP~~Rp------ta 370 (391)
T PHA03212 297 RQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAFDAHHRP------SA 370 (391)
T ss_pred HHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcCChhhCC------CH
Confidence 11111111 000001 12467899999999999999999 68
Q ss_pred hhhhcCCCcCCC
Q psy8309 339 DDVVAHEYFRGL 350 (494)
Q Consensus 339 ~eil~h~~f~~~ 350 (494)
+|+++||||+.+
T Consensus 371 ~elL~hp~f~~~ 382 (391)
T PHA03212 371 EALLDFAAFQDI 382 (391)
T ss_pred HHHhcChhhccC
Confidence 999999999764
|
|
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-45 Score=356.67 Aligned_cols=255 Identities=38% Similarity=0.745 Sum_probs=220.3
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
+.||+|+||.||+|.++.+++.||||++.+..............|..++....+|+||+++++++...+.+|+||||++
T Consensus 2 ~~l~~g~~~~v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~- 80 (260)
T cd05611 2 KPISKGAFGSVYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLN- 80 (260)
T ss_pred ccCCcCCCeeEEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccC-
Confidence 5799999999999999999999999999765433333444455666666666799999999999999999999999999
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEee
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~D 230 (494)
|++|..++...+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.+||+|
T Consensus 81 --------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~d 140 (260)
T cd05611 81 --------------------GGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLIDQTGHLKLTD 140 (260)
T ss_pred --------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCCcEEEee
Confidence 455555666677899999999999999999999999999999999999999999999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC---
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP--- 307 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--- 307 (494)
||+++.... .....|++.|+|||.+.+..++.++||||||+++|+|++|..||...+....+..+......++
T Consensus 141 fg~~~~~~~----~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 216 (260)
T cd05611 141 FGLSRNGLE----NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILSRRINWPEEV 216 (260)
T ss_pred cccceeccc----cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccCCCCcc
Confidence 999875322 3456789999999999988899999999999999999999999999888888877776654433
Q ss_pred -ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 308 -QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 308 -~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
..++.++.++|.+||+.||++||++. +++|++.||||++++|+
T Consensus 217 ~~~~~~~~~~~i~~~l~~~p~~R~~~~---~~~~~l~~~~~~~~~~~ 260 (260)
T cd05611 217 KEFCSPEAVDLINRLLCMDPAKRLGAN---GYQEIKSHPFFKSINWD 260 (260)
T ss_pred cccCCHHHHHHHHHHccCCHHHccCCC---cHHHHHcChHhhcCCCC
Confidence 35789999999999999999999873 68999999999999995
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=361.58 Aligned_cols=253 Identities=26% Similarity=0.417 Sum_probs=204.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeC-CCeEEEeeeeccccccChhhHHHHHHHHHHHHh--cCCCCceeeEEEEEE-----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKG-TDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLFCTFQ----- 136 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~--~~~hp~Iv~l~~~~~----- 136 (494)
++|++++.||+|+||.||+|++.. ++..||||+++..... .........|..++.. .++||||+++++++.
T Consensus 1 ~~Y~~~~~lg~G~~g~Vy~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~ 79 (290)
T cd07862 1 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 79 (290)
T ss_pred CCcceeeEeccCCCeEEEEEEEcCCCCeEEEEEEEecccCC-CCchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCC
Confidence 379999999999999999999854 4688999998764322 2222334456555543 247999999999885
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
....+++||||+. | +|..++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 80 ~~~~~~lv~e~~~-~---------------------~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~iiH~dlk 137 (290)
T cd07862 80 RETKLTLVFEHVD-Q---------------------DLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 137 (290)
T ss_pred CCCcEEEEEccCC-C---------------------CHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCC
Confidence 3457999999996 2 33334433 2458999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
|+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+..+
T Consensus 138 p~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~ 216 (290)
T cd07862 138 PQNILVTSSGQIKLADFGLARIYSF-QMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 216 (290)
T ss_pred HHHEEEcCCCCEEEccccceEeccC-CcccccccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCHHH
Confidence 9999999999999999999975322 233456679999999999999899999999999999999999999999988877
Q ss_pred HHHHHHhCCC-----C----------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 295 LFWSICNERP-----R----------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 295 ~~~~i~~~~~-----~----------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.+..|..... . +...+++.+++||.+||+.||++|| ++.|+++||||
T Consensus 217 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------s~~~~l~hp~f 290 (290)
T cd07862 217 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI------SAYSALSHPYF 290 (290)
T ss_pred HHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcC------CHHHHhcCCCC
Confidence 7777653210 0 1124678899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-45 Score=365.42 Aligned_cols=257 Identities=27% Similarity=0.493 Sum_probs=210.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|.+++.||+|+||.||+|+++.++..||+|+++.... .........|..++. .++||||+++++++..++..|
T Consensus 4 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 80 (309)
T cd07872 4 KMETYIKLEKLGEGTYATVFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLK-DLKHANIVTLHDIVHTDKSLT 80 (309)
T ss_pred CCCceEEEEEecccCCEEEEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHH-hCCCCCcceEEEEEeeCCeEE
Confidence 35789999999999999999999999999999999975422 222234556777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 81 lv~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~dlkp~Nill~ 138 (309)
T cd07872 81 LVFEYLDK----------------------DLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLIN 138 (309)
T ss_pred EEEeCCCC----------------------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 99999962 33334433 34589999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.++.+||+|||+++............+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+..+....+.
T Consensus 139 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~ 218 (309)
T cd07872 139 ERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIF 218 (309)
T ss_pred CCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 9999999999998754333333345678999999999875 458999999999999999999999999877665554443
Q ss_pred hC-------------------CCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 301 NE-------------------RPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 301 ~~-------------------~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.. ...+| ..++.++++||.+||..||.+|+ +++|++.||||+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~------t~~e~l~h~~~~~~ 292 (309)
T cd07872 219 RLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRI------SAEEAMKHAYFRSL 292 (309)
T ss_pred HHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCC------CHHHHhcChhhhhc
Confidence 21 01111 24688999999999999999999 68999999999864
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG0586|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-46 Score=374.16 Aligned_cols=259 Identities=34% Similarity=0.561 Sum_probs=238.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
.....|.+.+.||+|.|++|.+|++..|+..||||++.|...... ......+|.+++. .++|||||+++.+.++...+
T Consensus 53 ~~vg~y~i~~tig~g~f~~V~La~~~~t~~~VaiK~idkt~ln~~-~~~k~~rev~imk-~l~HPnIvkl~~v~~t~~~l 130 (596)
T KOG0586|consen 53 NSVGLYVIIKTIGKGNFAKVKLARHILTGTEVAIKIIDKTQLNPS-KRQKLGREVDIMK-SLNHPNIVKLFSVIETEATL 130 (596)
T ss_pred ccccceeeeeeeccceeEEEEeeEecCCCceEEEEEehhcccChH-HHHHHHHHHHHHH-hcCCcceeeeeeeeeeccee
Confidence 345689999999999999999999999999999999998765433 3345788888887 68999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||+. ||+++.++.+.++..+..++.++.|++.|++|||+++|||||||++||||+
T Consensus 131 ylV~eya~---------------------~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~ivHrdLk~eNilL~ 189 (596)
T KOG0586|consen 131 YLVMEYAS---------------------GGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNIVHRDLKAENILLD 189 (596)
T ss_pred EEEEEecc---------------------CchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcceeccccchhhcccc
Confidence 99999998 778888999999999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.+.++||+|||++.... .+....++||++.|.|||++.+..|+ ..+|+||+|++||-|+.|.+||.+.+..++....+
T Consensus 190 ~~mnikIaDfgfS~~~~-~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~lk~Lr~rvl 268 (596)
T KOG0586|consen 190 ENMNIKIADFGFSTFFD-YGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQNLKELRPRVL 268 (596)
T ss_pred cccceeeeccccceeec-ccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeecccccCCcccccccchhe
Confidence 99999999999998754 56677899999999999999998874 89999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+++.+|-.++.++++||+++|..+|.+|+ +.++|++|.|....
T Consensus 269 ~gk~rIp~~ms~dce~lLrk~lvl~Pskr~------~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 269 RGKYRIPFYMSCDCEDLLRKFLVLNPSKRG------PCDQIMKDRWRNDL 312 (596)
T ss_pred eeeecccceeechhHHHHHHhhccCccccC------CHHHhhhhcccchh
Confidence 999999999999999999999999999999 57889999998754
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-45 Score=384.76 Aligned_cols=259 Identities=26% Similarity=0.448 Sum_probs=219.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCC-CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGT-DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~-~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..|.+.+.||+|+||.||+|....+ +..||+|.+... ..........|..++. .++|||||+++++|+..+++||
T Consensus 67 ~~y~~~~~lg~G~~g~vy~a~~~~~~~~~vv~K~~~~~---~~~~~~~~~~E~~~l~-~l~Hpniv~~~~~~~~~~~~~l 142 (478)
T PTZ00267 67 HMYVLTTLVGRNPTTAAFVATRGSDPKEKVVAKFVMLN---DERQAAYARSELHCLA-ACDHFGIVKHFDDFKSDDKLLL 142 (478)
T ss_pred eeEEEEEEEEeCCCcEEEEEEEcCCCCeEEEEEEcccC---CHHHHHHHHHHHHHHH-hCCCCCEeEEEEEEEECCEEEE
Confidence 4599999999999999999998877 788999977543 2334445566777776 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||++||+|.+ .+...+.....+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 143 v~E~~~gg~L~~-----------------~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~~~ 205 (478)
T PTZ00267 143 IMEYGSGGDLNK-----------------QIKQRLKEHLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPT 205 (478)
T ss_pred EEECCCCCCHHH-----------------HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEECCcCHHhEEECCC
Confidence 999999776621 111223345679999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 224 GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+.+||+|||+++...... ....+.+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+++..+..
T Consensus 206 ~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~~~~~~~~~~~ 285 (478)
T PTZ00267 206 GIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLY 285 (478)
T ss_pred CcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999999999998532211 124567899999999999999999999999999999999999999999988888888876
Q ss_pred CCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+.. .+|..++.++++||.+||.+||++|| ++++++.|+|++.+
T Consensus 286 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------s~~~~l~~~~~~~~ 329 (478)
T PTZ00267 286 GKYDPFPCPVSSGMKALLDPLLSKNPALRP------TTQQLLHTEFLKYV 329 (478)
T ss_pred CCCCCCCccCCHHHHHHHHHHhccChhhCc------CHHHHHhCHHHHHH
Confidence 654 46778999999999999999999999 67899999999754
|
|
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-45 Score=374.04 Aligned_cols=257 Identities=25% Similarity=0.346 Sum_probs=212.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-----e
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS-----H 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~-----~ 140 (494)
+|++++.||+|+||.||+|++..+++.||||++.+.. ...........|..++. .++||||+++++++...+ .
T Consensus 1 ~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~~ 78 (372)
T cd07853 1 DVEPDRPIGYGAFGVVWSVTDPRDGKRVALKKMPNVF-QNLVSCKRVFRELKMLC-FFKHDNVLSALDILQPPHIDPFEE 78 (372)
T ss_pred CCcccceeeeCCCEEEEEEEECCCCCEEEEEeccccc-cchHHHHHHHHHHHHHH-hCCCCCcCCHhheecCCCccccce
Confidence 5889999999999999999999999999999986532 22234456677888777 579999999999998877 8
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+. ++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 79 ~~lv~e~~~----------------------~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dlkp~Nili 136 (372)
T cd07853 79 IYVVTELMQ----------------------SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLLV 136 (372)
T ss_pred EEEEeeccc----------------------cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHHEEE
Confidence 999999985 3455566667789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
+.++.+||+|||+++...... ......+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.+..
T Consensus 137 ~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~ 216 (372)
T cd07853 137 NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPIQQLDL 216 (372)
T ss_pred CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHHHHHHH
Confidence 999999999999997532221 122345689999999999874 489999999999999999999999998877665554
Q ss_pred HHh-----------------------CCC---------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 299 ICN-----------------------ERP---------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 299 i~~-----------------------~~~---------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
|.. ... .+....++++.+||.+||+.||.+|| +++|+++|||
T Consensus 217 i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~------t~~e~l~hp~ 290 (372)
T cd07853 217 ITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPDKRI------SAADALAHPY 290 (372)
T ss_pred HHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChhhCc------CHHHHhcCHh
Confidence 432 111 12234688999999999999999999 6899999999
Q ss_pred cCCCCh
Q psy8309 347 FRGLDW 352 (494)
Q Consensus 347 f~~~~w 352 (494)
|++..+
T Consensus 291 ~~~~~~ 296 (372)
T cd07853 291 LDEGRL 296 (372)
T ss_pred hCCCcc
Confidence 987643
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-45 Score=370.11 Aligned_cols=253 Identities=28% Similarity=0.466 Sum_probs=205.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++++.||+|+||.||+|+++.++..||||++.+.. ...........|..++. .++||||+++++++....
T Consensus 20 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~ 97 (359)
T cd07876 20 LKRYQQLKPIGSGAQGIVCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLK-CVNHKNIISLLNVFTPQKSLEE 97 (359)
T ss_pred hhceEEEEEeecCCCEEEEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCCccc
Confidence 578999999999999999999999999999999997652 22334455667777776 579999999999987543
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+||||+.++ +...+. ..+++..+..++.||+.||.|||++||+||||||+|
T Consensus 98 ~~~~~lv~e~~~~~----------------------l~~~~~--~~~~~~~~~~~~~qi~~~L~~LH~~~ivHrDlkp~N 153 (359)
T cd07876 98 FQDVYLVMELMDAN----------------------LCQVIH--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 153 (359)
T ss_pred cceeEEEEeCCCcC----------------------HHHHHh--ccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHH
Confidence 579999999632 222222 358899999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.+|.+||+|||+++... .........||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 154 Il~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~~~~~~~ 232 (359)
T cd07876 154 IVVKSDCTLKILDFGLARTAC-TNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWN 232 (359)
T ss_pred EEECCCCCEEEecCCCccccc-cCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999987532 2223345679999999999999999999999999999999999999998876544333
Q ss_pred HHHh----------------------CCCCC--------------------CccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 SICN----------------------ERPRF--------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ~i~~----------------------~~~~~--------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
.+.. ..+.+ +...++++++||.+||..||.+||
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~----- 307 (359)
T cd07876 233 KVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLLSKMLVIDPDKRI----- 307 (359)
T ss_pred HHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHHHHHhccCcccCC-----
Confidence 2221 11111 112467899999999999999999
Q ss_pred CChhhhhcCCCcCC
Q psy8309 336 NSGDDVVAHEYFRG 349 (494)
Q Consensus 336 ~~~~eil~h~~f~~ 349 (494)
+++|+++||||..
T Consensus 308 -t~~e~l~hp~~~~ 320 (359)
T cd07876 308 -SVDEALRHPYITV 320 (359)
T ss_pred -CHHHHhcCchhhh
Confidence 6899999999974
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-45 Score=384.84 Aligned_cols=259 Identities=28% Similarity=0.459 Sum_probs=219.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC---
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--- 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--- 139 (494)
..++|++.+.||+|+||+||+|++..+++.||||++..... ..........|..++. .++|+||++++..+....
T Consensus 30 ~~~rY~i~~~LG~G~fG~Vy~a~~~~~g~~vAvK~i~~~~~-~~~~~~~~~~Ei~~l~-~~~h~~iv~~~~~~~~~~~~~ 107 (496)
T PTZ00283 30 QAKKYWISRVLGSGATGTVLCAKRVSDGEPFAVKVVDMEGM-SEADKNRAQAEVCCLL-NCDFFSIVKCHEDFAKKDPRN 107 (496)
T ss_pred cCCCEEEEEEEecCCCEEEEEEEEcCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHh-cCCCCcEEEeecceecccccC
Confidence 34699999999999999999999999999999999976533 3344455667777766 579999999998876432
Q ss_pred -----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy8309 140 -----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVY 210 (494)
Q Consensus 140 -----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givH 210 (494)
.+++||||+++|+| ..++. ....+++..+..++.||+.||.|||++||+|
T Consensus 108 ~~~~~~i~lV~Ey~~~gsL---------------------~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~~~IiH 166 (496)
T PTZ00283 108 PENVLMIALVLDYANAGDL---------------------RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHSKHMIH 166 (496)
T ss_pred cccceEEEEEEeCCCCCcH---------------------HHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 37899999996665 33332 3457999999999999999999999999999
Q ss_pred ccCCCCceeeCCCCCEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 211 RDLKLDNILLDYEGHVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 211 rDLKp~NILl~~~g~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
|||||+|||++.++.+||+|||+++..... .....+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.
T Consensus 167 rDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~ 246 (496)
T PTZ00283 167 RDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFD 246 (496)
T ss_pred CCCCHHHEEEeCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCC
Confidence 999999999999999999999998753221 223456789999999999999999999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 289 GCDEDELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+.+..+.+..+..+.. .+|..+++++++||.+||..||.+|| ++.++++|||++..
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~RP------s~~ell~~p~~~~~ 303 (496)
T PTZ00283 247 GENMEEVMHKTLAGRYDPLPPSISPEMQEIVTALLSSDPKRRP------SSSKLLNMPICKLF 303 (496)
T ss_pred CCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccChhhCc------CHHHHHhCHHHHHh
Confidence 9988888888876544 46788999999999999999999999 67899999998754
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-45 Score=370.58 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=206.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++++.||+|+||.||+|.++.+++.||||++.+.. ...........|..++. .++||||+++++++...
T Consensus 23 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~ii~~~~~~~~~~~~~~ 100 (364)
T cd07875 23 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEE 100 (364)
T ss_pred hcceeEEEEeecCCCeEEEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHH-hcCCCCccccceeecccccccc
Confidence 578999999999999999999999999999999997642 22333445666777766 57999999999988643
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+|+||||+.+ .+...+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 101 ~~~~~lv~e~~~~----------------------~l~~~~~--~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp~N 156 (364)
T cd07875 101 FQDVYIVMELMDA----------------------NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 156 (364)
T ss_pred cCeEEEEEeCCCC----------------------CHHHHHH--hcCCHHHHHHHHHHHHHHHHHHhhCCeecCCCCHHH
Confidence 357999999963 2333332 347889999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 157 Ill~~~~~~kL~DfG~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~ 235 (364)
T cd07875 157 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 235 (364)
T ss_pred EEECCCCcEEEEeCCCccccC-CCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999997532 2223345689999999999999999999999999999999999999999888766665
Q ss_pred HHHhC----------------------CCCC--------------------CccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 SICNE----------------------RPRF--------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ~i~~~----------------------~~~~--------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
++... .+.+ ....+.++++||.+||..||.+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~R~----- 310 (364)
T cd07875 236 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI----- 310 (364)
T ss_pred HHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHHHHhcCcCcccCC-----
Confidence 55431 1110 011356789999999999999999
Q ss_pred CChhhhhcCCCcCC
Q psy8309 336 NSGDDVVAHEYFRG 349 (494)
Q Consensus 336 ~~~~eil~h~~f~~ 349 (494)
+++++++||||..
T Consensus 311 -t~~e~L~hp~~~~ 323 (364)
T cd07875 311 -SVDEALQHPYINV 323 (364)
T ss_pred -CHHHHhcCccccc
Confidence 6899999999973
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-44 Score=369.08 Aligned_cols=256 Identities=23% Similarity=0.329 Sum_probs=208.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
..+|++++.||+|+||.||+|...+ ++..||+|.+.+.. ....|..++. .++||||++++++|.....+
T Consensus 91 ~~~y~i~~~Lg~G~~g~Vy~~~~~~~~~~~~v~vK~~~~~~--------~~~~E~~il~-~l~h~~iv~~~~~~~~~~~~ 161 (392)
T PHA03207 91 RMQYNILSSLTPGSEGEVFVCTKHGDEQRKKVIVKAVTGGK--------TPGREIDILK-TISHRAIINLIHAYRWKSTV 161 (392)
T ss_pred cCceEEEEeecCCCCeEEEEEEEcCCccceeEEEEeccccc--------cHHHHHHHHH-hcCCCCccceeeeEeeCCEE
Confidence 3579999999999999999998654 56789999886531 2235777776 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||++. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 162 ~lv~e~~~----------------------~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHrDlkp~Nill~ 219 (392)
T PHA03207 162 CMVMPKYK----------------------CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHRDVKTENIFLD 219 (392)
T ss_pred EEEehhcC----------------------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEc
Confidence 99999984 35556666677899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE---DELF 296 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~ 296 (494)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++|..||.+... ...+
T Consensus 220 ~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~~~~~~~~l 299 (392)
T PHA03207 220 EPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQL 299 (392)
T ss_pred CCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCCCCcHHHH
Confidence 999999999999875322211 22356799999999999999999999999999999999999999976542 1222
Q ss_pred HHHHhC----C-------------------------CCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 297 WSICNE----R-------------------------PRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 297 ~~i~~~----~-------------------------~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
..|... . ...| ..++.++++||.+||..||.+|| ++.|++
T Consensus 300 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~Rp------sa~e~l 373 (392)
T PHA03207 300 RSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFRP------SAQDIL 373 (392)
T ss_pred HHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhCC------CHHHHh
Confidence 222210 0 1111 13467899999999999999999 689999
Q ss_pred cCCCcCCCChhHHh
Q psy8309 343 AHEYFRGLDWQALE 356 (494)
Q Consensus 343 ~h~~f~~~~w~~l~ 356 (494)
.||||....|+.+.
T Consensus 374 ~~p~f~~~~~~~~~ 387 (392)
T PHA03207 374 SLPLFTKEPINLLN 387 (392)
T ss_pred hCchhhccchhhhc
Confidence 99999998888774
|
|
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=355.85 Aligned_cols=252 Identities=25% Similarity=0.383 Sum_probs=202.6
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh--cCCCCceeeEEEEEEc-----C
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLFCTFQT-----D 138 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~--~~~hp~Iv~l~~~~~~-----~ 138 (494)
+|++++.||+|+||.||+|+++.+++.||+|+++..... .........|..++.. .++||||+++++++.. .
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~ 79 (288)
T cd07863 1 QYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVQTNE-DGLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRE 79 (288)
T ss_pred CceEeeEEeecCCeEEEEEEECCCCcEEEEEEeccCcCC-CCCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCC
Confidence 589999999999999999999999999999999764221 2222233445555442 3479999999998864 3
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+++||||+.+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+
T Consensus 80 ~~~~lv~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dikp~ 137 (288)
T cd07863 80 TKVTLVFEHVDQ----------------------DLRTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPE 137 (288)
T ss_pred ceEEEEEccccc----------------------CHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 468999999962 344444432 35899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|||++.++.+||+|||+++... .........||+.|+|||++.+..++.++|||||||++|+|++|.+||.+......+
T Consensus 138 Nili~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~~~~~ 216 (288)
T cd07863 138 NILVTSGGQVKLADFGLARIYS-CQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQL 216 (288)
T ss_pred HEEECCCCCEEECccCcccccc-CcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCHHHHH
Confidence 9999999999999999987532 222334567899999999999999999999999999999999999999888776666
Q ss_pred HHHHhCC-----------CC----------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 297 WSICNER-----------PR----------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 297 ~~i~~~~-----------~~----------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.++.... .. +...++.++++||.+||+.||.+|| ++.|++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~~~l~hp~f 288 (288)
T cd07863 217 GKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRI------SAFRALQHPFF 288 (288)
T ss_pred HHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCC------CHHHHhcCCCC
Confidence 5554310 00 1124678899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >KOG0579|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=376.89 Aligned_cols=259 Identities=27% Similarity=0.510 Sum_probs=228.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|+|+..||.|+||+||+|..+.++-.-|.|+|..+ .....+..+.|+.+|+. ++||+||+|++.|..++.++|+
T Consensus 32 d~WeIiGELGDGAFGKVyKA~nket~~lAAaKvIetk---seEELEDylVEIeILa~-CdHP~ivkLl~ayy~enkLwil 107 (1187)
T KOG0579|consen 32 DHWEIIGELGDGAFGKVYKAVNKETKLLAAAKVIETK---SEEELEDYLVEIEILAE-CDHPVIVKLLSAYYFENKLWIL 107 (1187)
T ss_pred HHHHHHhhhcCccchhhhhhhcccchhhhhhhhhccc---chhHHhhhhhhhhhhhc-CCChHHHHHHHHHhccCceEEE
Confidence 4678999999999999999999999988889998643 56677888999999994 6899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
.|||.||-... ..+.-...|+|.+++.++.|++.||.|||+++|||||||..|||++.+|
T Consensus 108 iEFC~GGAVDa--------------------imlEL~r~LtE~QIqvvc~q~ldALn~LHs~~iIHRDLKAGNiL~TldG 167 (1187)
T KOG0579|consen 108 IEFCGGGAVDA--------------------IMLELGRVLTEDQIQVVCYQVLDALNWLHSQNIIHRDLKAGNILLTLDG 167 (1187)
T ss_pred EeecCCchHhH--------------------HHHHhccccchHHHHHHHHHHHHHHHHHhhcchhhhhccccceEEEecC
Confidence 99999764411 1233456899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
.|+|+|||.+...........+++|||+|||||++. ..+|++++||||||++|.||..+.+|....++...+-+|
T Consensus 168 dirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpMRVllKi 247 (1187)
T KOG0579|consen 168 DIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI 247 (1187)
T ss_pred cEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchHHHHHHH
Confidence 999999999876655556678899999999999974 568999999999999999999999999999999999999
Q ss_pred HhCCCC---CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 300 CNERPR---FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 300 ~~~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.+..++ -|..++..+.|||++||.+||..|| ++.++++||||.+++-.
T Consensus 248 aKSePPTLlqPS~Ws~~F~DfLk~cL~Knp~~Rp------~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 248 AKSEPPTLLQPSHWSRSFSDFLKRCLVKNPRNRP------PAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred hhcCCCcccCcchhhhHHHHHHHHHHhcCCccCC------CHHHHhhCcccccCCcc
Confidence 877553 3678999999999999999999999 57889999999977543
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=349.97 Aligned_cols=257 Identities=40% Similarity=0.783 Sum_probs=223.6
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||.|+||.||+|+++.+++.||+|++.+..............|..++. .++||||+++++.+.++..+|+||||++
T Consensus 1 lg~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~--- 76 (262)
T cd05572 1 LGVGGFGRVELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILE-ECNHPFIVKLYRTFKDKKYIYMLMEYCL--- 76 (262)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHH-hCCCCCEeeeeeeEEcCCccEEEEecCC---
Confidence 799999999999999999999999998765444445566777777776 5799999999999999999999999998
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecC
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFG 232 (494)
|++|..++.+...+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 77 ------------------~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~h~dl~~~nilv~~~~~~~l~df~ 138 (262)
T cd05572 77 ------------------GGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFG 138 (262)
T ss_pred ------------------CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEEcCCCCEEEeeCC
Confidence 55566677777779999999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHHH--hCCCCCCc
Q psy8309 233 MCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD--EDELFWSIC--NERPRFPQ 308 (494)
Q Consensus 233 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i~--~~~~~~p~ 308 (494)
+++..... ......+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.... ..+.+.++. ...+.+|.
T Consensus 139 ~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 217 (262)
T cd05572 139 FAKKLKSG-QKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDPMEIYNDILKGNGKLEFPN 217 (262)
T ss_pred cccccCcc-cccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCCCCc
Confidence 98754322 23345678999999999998889999999999999999999999998776 667777777 45677788
Q ss_pred cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 309 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
..+.+++++|.+||..||.+|++..+ ..++|+++||||++.+|+
T Consensus 218 ~~~~~~~~~i~~~l~~~p~~R~~~~~-~~~~~l~~~~~~~~~~~~ 261 (262)
T cd05572 218 YIDKAAKDLIKQLLRRNPEERLGNLK-GGIKDIKKHKWFNGFDWE 261 (262)
T ss_pred ccCHHHHHHHHHHccCChhhCcCCcc-cCHHHHhcChhhhCCCCC
Confidence 88999999999999999999997544 268999999999999996
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-44 Score=352.69 Aligned_cols=279 Identities=42% Similarity=0.794 Sum_probs=232.7
Q ss_pred CceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+|++.+.||.|+||.||+|+.. .+|..||+|++++..... ....+....|..++....+|++|+++++.|+.+..+
T Consensus 1 ~y~~~~~lg~G~~g~v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~ 80 (290)
T cd05613 1 NFELLKVLGTGAYGKVFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKL 80 (290)
T ss_pred CceeeeeeccCCcceEEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeE
Confidence 4889999999999999999875 478899999997643322 223345566777777555799999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ |++|..++.....+++..+..++.||+.||.|||++|++||||+|+|||++
T Consensus 81 ~lv~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nil~~ 139 (290)
T cd05613 81 HLILDYIN---------------------GGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLD 139 (290)
T ss_pred EEEEecCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEC
Confidence 99999999 555666777777899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCC----HHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGCD----EDE 294 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~ 294 (494)
.++.+||+|||++....... ......+|+..|+|||.+.+. .++.++|+||||+++|+|++|..||.... ..+
T Consensus 140 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~ 219 (290)
T cd05613 140 SNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQAE 219 (290)
T ss_pred CCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCcCCccccHHH
Confidence 99999999999987532211 122356799999999998753 47889999999999999999999997432 344
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+...+......+|..++..+.+++.+||..||.+|+++.. .++++++.||||..++|+.+..+..++|+.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~~p~~R~~~~~-~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~ 290 (290)
T cd05613 220 ISRRILKSEPPYPQEMSALAKDIIQRLLMKDPKKRLGCGP-SDADEIKKHPFFQKINWDDLAAKKVPAPFKP 290 (290)
T ss_pred HHHHhhccCCCCCccCCHHHHHHHHHHhcCCHHHhcCCCC-CCHHHHHcCcccccCCHHHHhhccCCCCCCC
Confidence 5556666677788889999999999999999999997653 4899999999999999999988888887764
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-44 Score=362.27 Aligned_cols=256 Identities=29% Similarity=0.512 Sum_probs=212.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||+|+++.++..+|+|++.... ..........|..++. .++||||++++++|.+.+++|
T Consensus 3 ~~~~y~~~~~lg~g~~g~V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 79 (333)
T cd06650 3 KDDDFEKISELGAGNGGVVFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEIS 79 (333)
T ss_pred chhhhheeccccCCCCEEEEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHH-HCCCCcccceeEEEEECCEEE
Confidence 3578999999999999999999999999999999987642 2334455677888887 578999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NILl~ 221 (494)
+||||++ |++|..++...+.+++..+..++.||+.||.|||++ +|+||||||+|||++
T Consensus 80 lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~ivH~dlkp~Nili~ 138 (333)
T cd06650 80 ICMEHMD---------------------GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 138 (333)
T ss_pred EEEecCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcCCEEecCCChhhEEEc
Confidence 9999999 555566677777899999999999999999999985 799999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH---
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS--- 298 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--- 298 (494)
.+|.+||+|||++.... .......+||+.|+|||++.+..++.++|||||||++|||++|..||......++...
T Consensus 139 ~~~~~kL~Dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 216 (333)
T cd06650 139 SRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGC 216 (333)
T ss_pred CCCCEEEeeCCcchhhh--hhccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcchhHHHHHhcC
Confidence 99999999999986432 2233456799999999999998999999999999999999999999986554333211
Q ss_pred -----------------------------------------HHhC-CCCCCc-cCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 299 -----------------------------------------ICNE-RPRFPQ-FLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 299 -----------------------------------------i~~~-~~~~p~-~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
+.+. .+.++. .++.++++||.+||++||++||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~P~~Rp----- 291 (333)
T cd06650 217 PVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFVNKCLIKNPAERA----- 291 (333)
T ss_pred cccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHHHHhccCCcccCc-----
Confidence 1111 111221 3678999999999999999999
Q ss_pred CChhhhhcCCCcCCC
Q psy8309 336 NSGDDVVAHEYFRGL 350 (494)
Q Consensus 336 ~~~~eil~h~~f~~~ 350 (494)
++.|++.|+||+..
T Consensus 292 -t~~ell~h~~~~~~ 305 (333)
T cd06650 292 -DLKQLMVHAFIKRS 305 (333)
T ss_pred -CHHHHhhCHHHhcC
Confidence 68999999999753
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-44 Score=355.37 Aligned_cols=258 Identities=27% Similarity=0.488 Sum_probs=210.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|++++.||+|+||.||+|+++.++..||+|.+..... .........|..++. .++||||+++++++...+.+|
T Consensus 4 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~nI~~~~~~~~~~~~~~ 80 (301)
T cd07873 4 KLETYIKLDKLGEGTYATVYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLK-DLKHANIVTLHDIIHTEKSLT 80 (301)
T ss_pred cccceEEeeEeccCcCEEEEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHH-hcCCCCcceEEEEEecCCeEE
Confidence 36789999999999999999999999999999999875421 222334556777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+.+ +|...+.. ...+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 81 lv~e~~~~----------------------~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~H~dlkp~Nil~~ 138 (301)
T cd07873 81 LVFEYLDK----------------------DLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLIN 138 (301)
T ss_pred EEEecccc----------------------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHHHEEEC
Confidence 99999962 33334433 35689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.++.+||+|||++..............+++.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+....+.
T Consensus 139 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~~~~~~~~~ 218 (301)
T cd07873 139 ERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLHFIF 218 (301)
T ss_pred CCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999987533222333345679999999998764 58899999999999999999999999887665554433
Q ss_pred hC-------------------CCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 301 NE-------------------RPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 301 ~~-------------------~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.. ...+| ..+++++++||.+||..||.+|| +++|++.||||+.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~------t~~eil~h~~f~~~ 292 (301)
T cd07873 219 RILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRI------SAEEAMKHPYFHCL 292 (301)
T ss_pred HHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCc------CHHHHhcCcccccc
Confidence 21 01112 24688999999999999999999 68999999999865
Q ss_pred C
Q psy8309 351 D 351 (494)
Q Consensus 351 ~ 351 (494)
.
T Consensus 293 ~ 293 (301)
T cd07873 293 G 293 (301)
T ss_pred c
Confidence 3
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=352.38 Aligned_cols=277 Identities=43% Similarity=0.831 Sum_probs=231.4
Q ss_pred CceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+|++.+.||+|+||.||+|+.. .++..||||++++..... .........|..++....+||+|+++++.+.....+
T Consensus 1 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~ 80 (288)
T cd05583 1 NFELLRVLGTGAYGKVFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKL 80 (288)
T ss_pred CceEEEEeccCCCceEEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEE
Confidence 4889999999999999999864 457789999997643322 223345667777777555799999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||+.+ ++|..++.....+++..++.++.|++.||.|||+.|++||||||.||+++
T Consensus 81 ~lv~e~~~~---------------------~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~~~H~dl~p~nil~~ 139 (288)
T cd05583 81 HLILDYVNG---------------------GELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLD 139 (288)
T ss_pred EEEEecCCC---------------------CcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHeEEC
Confidence 999999994 45555666667899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCC----HHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCD----EDE 294 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~----~~~ 294 (494)
.++.++|+|||+++....... .....+|+..|+|||.+.+.. ++.++|+||||+++|||++|..||...+ ..+
T Consensus 140 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~ 219 (288)
T cd05583 140 SEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSE 219 (288)
T ss_pred CCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCcccCcccchHHH
Confidence 999999999999875332221 223457899999999987755 7889999999999999999999996432 344
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
....+.......|..++.+++++|.+||+.||++||++. ++.++++||||+.++|+.+.++++.|||.|
T Consensus 220 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~t~~---~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~ 288 (288)
T cd05583 220 ISRRILKSKPPFPKTMSAEARDFIQKLLEKDPKKRLGAN---GADEIKNHPFFQGIDWDDLAAKRIPAPFKP 288 (288)
T ss_pred HHHHHHccCCCCCcccCHHHHHHHHHHhcCCHhhccCcc---hHHHHhcCcccccCCHHHHhhhccCCCCCC
Confidence 555666667777888999999999999999999999863 689999999999999999999999999865
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-44 Score=365.09 Aligned_cols=253 Identities=28% Similarity=0.449 Sum_probs=204.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++++.||+|+||.||+|.+..+++.||||++.+.. ...........|..++. .++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~ 93 (355)
T cd07874 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKSLEE 93 (355)
T ss_pred hhceeEEEEeeecCCEEEEEEEecCCCceEEEEEeCCcc-cChHHHHHHHHHHHHHH-HhCCCchhceeeeeeccccccc
Confidence 578999999999999999999999999999999997642 22334455666776666 57999999999998754
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+|+||||+.+ .+...+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~~lv~e~~~~----------------------~l~~~~~--~~l~~~~~~~~~~qi~~aL~~LH~~givHrDikp~N 149 (355)
T cd07874 94 FQDVYLVMELMDA----------------------NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_pred cceeEEEhhhhcc----------------------cHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHH
Confidence 357999999963 2222332 358899999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+..+.+.
T Consensus 150 ill~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 228 (355)
T cd07874 150 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_pred EEECCCCCEEEeeCcccccCC-CccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999997532 2223345689999999999999999999999999999999999999999877554443
Q ss_pred HHHhC----------------------CCC--------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 SICNE----------------------RPR--------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ~i~~~----------------------~~~--------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
.+... .+. .+...+.++++||.+||..||.+||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp----- 303 (355)
T cd07874 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----- 303 (355)
T ss_pred HHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHHHHHHhcCCchhcC-----
Confidence 32210 000 1122457889999999999999999
Q ss_pred CChhhhhcCCCcCC
Q psy8309 336 NSGDDVVAHEYFRG 349 (494)
Q Consensus 336 ~~~~eil~h~~f~~ 349 (494)
+++|+++||||..
T Consensus 304 -s~~ell~hp~~~~ 316 (355)
T cd07874 304 -SVDEALQHPYINV 316 (355)
T ss_pred -CHHHHhcCcchhc
Confidence 6899999999963
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-44 Score=388.10 Aligned_cols=150 Identities=39% Similarity=0.733 Sum_probs=134.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||.||+|++..+++.||||++++..............|..++. .++||||+++++++....++||
T Consensus 3 ~~~y~i~~~LG~G~fg~Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~~l 81 (669)
T cd05610 3 IEEFVIVKPISRGAFGKVYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALA-LSKSPFIVHLYYSLQSANNVYL 81 (669)
T ss_pred cCCEEEEEEEecCCCeEEEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHH-hcCCCCcCeEEEEEEECCEEEE
Confidence 578999999999999999999999999999999998765555555566777777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+. |++|..++...+.+++..++.|+.||+.||.|||.+|||||||||+||||+.+
T Consensus 82 VmEy~~---------------------g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gIiHrDLKP~NILl~~~ 140 (669)
T cd05610 82 VMEYLI---------------------GGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLISNE 140 (669)
T ss_pred EEeCCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCccHHHEEEcCC
Confidence 999998 55556667667789999999999999999999999999999999999999999
Q ss_pred CCEEEeecCcee
Q psy8309 224 GHVRIADFGMCK 235 (494)
Q Consensus 224 g~vkL~DFGla~ 235 (494)
|++||+|||+++
T Consensus 141 g~vkL~DFGls~ 152 (669)
T cd05610 141 GHIKLTDFGLSK 152 (669)
T ss_pred CCEEEEeCCCCc
Confidence 999999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=343.64 Aligned_cols=255 Identities=29% Similarity=0.501 Sum_probs=216.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC--hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+.|++.+.||+|++|.||+|.+..+++.||||++....... .........|..++. .++||||+++++++++.+.+|
T Consensus 2 ~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 80 (263)
T cd06625 2 TNWRRGKLLGQGAFGRVYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLK-NLQHERIVQYYGCLRDDETLS 80 (263)
T ss_pred CcccccceecCCCceEEEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHH-hCCCCCeeeeEEEEccCCeEE
Confidence 46899999999999999999999999999999987543221 123345566777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|+||++ |++|...+...+.+++..++.++.||+.||.|||+.||+||||+|+||+++.
T Consensus 81 ~v~e~~~---------------------~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nilv~~ 139 (263)
T cd06625 81 IFMEYMP---------------------GGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANILRDS 139 (263)
T ss_pred EEEEECC---------------------CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 9999999 4455556666778999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
++.++|+|||+++........ .....|+..|+|||++.+..++.++|+|||||++|||++|+.||...+..+...++
T Consensus 140 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~ 219 (263)
T cd06625 140 AGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIFKI 219 (263)
T ss_pred CCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccchHHHHHHH
Confidence 999999999998753221111 13457889999999999989999999999999999999999999887666655555
Q ss_pred HhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 300 CNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 300 ~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
... ...+|..++.++.++|.+||..+|.+|| ++.++++|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~ll~~~~~ 263 (263)
T cd06625 220 ATQPTNPQLPSHVSPDARNFLRRTFVENAKKRP------SAEELLRHFFV 263 (263)
T ss_pred hccCCCCCCCccCCHHHHHHHHHHhhcCcccCC------CHHHHhhCCCC
Confidence 443 4557778999999999999999999999 68999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >KOG4236|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-45 Score=364.49 Aligned_cols=256 Identities=32% Similarity=0.540 Sum_probs=223.9
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|.||+||-|+++.+|+.||||+|.|.....+. ......|..+|. .+.||.||.+-..|++.+.+++|||.+.
T Consensus 570 evLGSGQFG~VYgg~hRktGrdVAvKvIdKlrFp~kq-esqlR~EVaILq-~l~HPGiV~le~M~ET~ervFVVMEKl~- 646 (888)
T KOG4236|consen 570 EVLGSGQFGTVYGGKHRKTGRDVAVKVIDKLRFPTKQ-ESQLRNEVAILQ-NLHHPGIVNLECMFETPERVFVVMEKLH- 646 (888)
T ss_pred hhccCCcceeeecceecccCceeeeeeeecccCCCch-HHHHHHHHHHHH-hcCCCCeeEEEEeecCCceEEEEehhhc-
Confidence 7999999999999999999999999999987654443 366778888887 6899999999999999999999999996
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC---CE
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG---HV 226 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g---~v 226 (494)
|.-|...+ ...++|+|...++++.||+.||.|||.+||+|+||||||||+.+.. ++
T Consensus 647 --------------------GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH~knIvHCDLKPENVLLas~~~FPQv 706 (888)
T KOG4236|consen 647 --------------------GDMLEMILSSEKGRLPERITKFLVTQILVALRYLHFKNIVHCDLKPENVLLASASPFPQV 706 (888)
T ss_pred --------------------chHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhhhcceeeccCCchheeeccCCCCCce
Confidence 33333333 3568999999999999999999999999999999999999997653 69
Q ss_pred EEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCC
Q psy8309 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF 306 (494)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~ 306 (494)
||||||+|+. +.......+.+|||.|+|||++++++|....|+||+|||+|--|.|..||..+ +++-.+|.+..+.+
T Consensus 707 KlCDFGfARi-IgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEd--EdIndQIQNAaFMy 783 (888)
T KOG4236|consen 707 KLCDFGFARI-IGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNED--EDINDQIQNAAFMY 783 (888)
T ss_pred eeccccceee-cchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEecccccCCCc--cchhHHhhcccccc
Confidence 9999999996 44556677889999999999999999999999999999999999999999643 45677888888888
Q ss_pred Cc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC-ChhHHhcC
Q psy8309 307 PQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL-DWQALEKR 358 (494)
Q Consensus 307 p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~-~w~~l~~~ 358 (494)
|. .+++++.|||..+|+..-.+|. +++..+.|||+++. .|.+|+..
T Consensus 784 Pp~PW~eis~~AidlIn~LLqVkm~kRy------svdk~lsh~Wlq~yq~w~DLRel 834 (888)
T KOG4236|consen 784 PPNPWSEISPEAIDLINNLLQVKMRKRY------SVDKSLSHPWLQDYQTWLDLREL 834 (888)
T ss_pred CCCchhhcCHHHHHHHHHHHHHHHHHhc------chHhhccchhhhcchHHHHHHHH
Confidence 74 5899999999999999999999 67888999999987 49888643
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-43 Score=340.35 Aligned_cols=253 Identities=26% Similarity=0.480 Sum_probs=214.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-CCeeEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-DSHLFFV 144 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-~~~~~lv 144 (494)
+|++++.||+|++|.||+|+++.+++.||+|.+..... ..........|..++. .++|+|++++++.+.. +..+|+|
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~lv 78 (257)
T cd08223 1 AYCFVRVVGKGSYGEVSLVRHRTDGKQYVIKKLNLRNA-SRRERKAAEQEAQLLS-QLKHPNIVAYRESWEGEDGLLYIV 78 (257)
T ss_pred CceEEEEecCCCCeEEEEEEEcCCCcEEEEEEEehhhc-CHHHHHHHHHHHHHHH-hCCCCCeeeeeeeecCCCCEEEEE
Confidence 58999999999999999999999999999999976432 2233445566666665 5799999999998875 4578999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||++++ +|..++.. ...+++.+++.++.||+.||.+||++||+||||||+||+++.
T Consensus 79 ~e~~~~~---------------------~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i~H~di~p~nil~~~ 137 (257)
T cd08223 79 MGFCEGG---------------------DLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTR 137 (257)
T ss_pred ecccCCC---------------------cHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCchhEEEec
Confidence 9999954 44444443 346899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
++.++|+|||+++.............|++.|+|||++.+..++.++|+|||||++|+|++|..||.+.+.......+..+
T Consensus 138 ~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (257)
T cd08223 138 TNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKDMNSLVYRIIEG 217 (257)
T ss_pred CCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHHhc
Confidence 99999999999986543333445667999999999999999999999999999999999999999988877777776665
Q ss_pred CC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 RP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.. ..+..+++++.++|.+||+.||.+|| ++.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~~l~~~~~ 257 (257)
T cd08223 218 KLPPMPKDYSPELGELIATMLSKRPEKRP------SVKSILRQPYI 257 (257)
T ss_pred CCCCCccccCHHHHHHHHHHhccCcccCC------CHHHHhcCCCC
Confidence 43 55677899999999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-44 Score=349.54 Aligned_cols=252 Identities=35% Similarity=0.598 Sum_probs=210.8
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
|++++.||+|+||+||+|++..+++.||+|++....... ........|..++.. ++||||+++++++.....+++|||
T Consensus 1 y~~~~~lg~G~~g~v~~~~~~~~~~~~~~K~~~~~~~~~-~~~~~~~~e~~~~~~-l~~~~i~~~~~~~~~~~~~~~v~~ 78 (260)
T PF00069_consen 1 YRLVKKLGSGGFGTVYKAKNKKNGQKVAVKIIDKSEIEE-EEREENIREIKILRR-LRHPNIVQILDVFQDDNYLYIVME 78 (260)
T ss_dssp EEEEEEEEEESSEEEEEEEETTTTEEEEEEEEESTTHHH-HHHHHHHHHHHHHHH-HTBTTBCHEEEEEEESSEEEEEEE
T ss_pred CEEeEEEEeCCCEEEEEEEECCCCeEEEEEEeccccccc-cccchhhhhhhcccc-cccccccccccccccccccccccc
Confidence 789999999999999999999999999999998763322 222233457777774 599999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCE
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~v 226 (494)
++. +++|..++...+.+++..+..++.||+.||.+||++||+||||||+||+++.++.+
T Consensus 79 ~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H~dikp~NIl~~~~~~~ 137 (260)
T PF00069_consen 79 YCP---------------------GGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVHRDIKPENILLDENGEV 137 (260)
T ss_dssp EET---------------------TEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEESSBSGGGEEESTTSEE
T ss_pred ccc---------------------cccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 998 55666677778899999999999999999999999999999999999999999999
Q ss_pred EEeecCceeeeeccCCcccccCCCCCccChhhhC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhC
Q psy8309 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD---EDELFWSICNE 302 (494)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~ 302 (494)
+|+|||.+.............+||+.|+|||++. +..++.++||||||+++|+|++|..||...+ ......+....
T Consensus 138 ~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~~~~~~~~~~~~~~~~ 217 (260)
T PF00069_consen 138 KLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLPFEESNSDDQLEIIEKILKR 217 (260)
T ss_dssp EESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTSSHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccchhhhhhhhhcccc
Confidence 9999999875323344455678999999999998 8889999999999999999999999999873 33334333332
Q ss_pred CCCC----CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 RPRF----PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~~~~----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.... ....+.++.++|.+||+.||++|| +++++++||||
T Consensus 218 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~------~~~~l~~~~~~ 260 (260)
T PF00069_consen 218 PLPSSSQQSREKSEELRDLIKKMLSKDPEQRP------SAEELLKHPWF 260 (260)
T ss_dssp HHHHHTTSHTTSHHHHHHHHHHHSSSSGGGST------THHHHHTSGGG
T ss_pred cccccccccchhHHHHHHHHHHHccCChhHCc------CHHHHhcCCCC
Confidence 2111 112248999999999999999999 68999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=363.33 Aligned_cols=249 Identities=27% Similarity=0.409 Sum_probs=198.0
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
...+|++++.||+|+||.||+|++..++..||+|+..+.. ...|..++. .++||||+++++++......|
T Consensus 64 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~valK~~~~~~---------~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 133 (357)
T PHA03209 64 ASLGYTVIKTLTPGSEGRVFVATKPGQPDPVVLKIGQKGT---------TLIEAMLLQ-NVNHPSVIRMKDTLVSGAITC 133 (357)
T ss_pred hhcCcEEEEEecCCCCeEEEEEEECCCCceEEEEeCCccc---------cHHHHHHHH-hCCCCCCcChhheEEeCCeeE
Confidence 3457999999999999999999999999999999865432 234666666 589999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+|||++. ++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 134 lv~e~~~----------------------~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~Nill~ 191 (357)
T PHA03209 134 MVLPHYS----------------------SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFIN 191 (357)
T ss_pred EEEEccC----------------------CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEC
Confidence 9999995 23334443 346799999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCC-CCCCCCCHH-------
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ-SPFSGCDED------- 293 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~-~Pf~~~~~~------- 293 (494)
.++.+||+|||+++... .........||+.|+|||++.+..|+.++|||||||++|||+++. ++|......
T Consensus 192 ~~~~~kl~DfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f~~~~~~~~~~~~~ 270 (357)
T PHA03209 192 DVDQVCIGDLGAAQFPV-VAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEEYVKS 270 (357)
T ss_pred CCCCEEEecCccccccc-cCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccccCCCCcHHHHHHH
Confidence 99999999999987422 223334567999999999999999999999999999999999854 444432110
Q ss_pred --HHHHHHHhC----CCCCC------------------------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 294 --ELFWSICNE----RPRFP------------------------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 294 --~~~~~i~~~----~~~~p------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
..+..+... ...+| ..++.++.+||.+||+.||.+|| +
T Consensus 271 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~Rp------t 344 (357)
T PHA03209 271 CHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTFDAAMRP------S 344 (357)
T ss_pred HHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcCCcccCc------C
Confidence 111111110 01111 13567788999999999999999 6
Q ss_pred hhhhhcCCCcCCC
Q psy8309 338 GDDVVAHEYFRGL 350 (494)
Q Consensus 338 ~~eil~h~~f~~~ 350 (494)
++|+++||||+++
T Consensus 345 a~e~l~hp~f~~~ 357 (357)
T PHA03209 345 AEEILNYPMFAQL 357 (357)
T ss_pred HHHHhcCchhccC
Confidence 8999999999864
|
|
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-46 Score=380.56 Aligned_cols=311 Identities=39% Similarity=0.713 Sum_probs=277.0
Q ss_pred EeccCCceEEEEEEE---eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 72 VLGKGSFGKVFLAEL---KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~---~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
++|.|+||.|++++. .+.+..||+|++++......... +...|+.++....+||++|++++.|+++..+|+++++.
T Consensus 1 vlg~g~~gkvfLvrk~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~ 79 (612)
T KOG0603|consen 1 VLGQGSYGKVFLVRKAGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFL 79 (612)
T ss_pred CCCcCCCcchHHHHHhccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhc
Confidence 479999999999865 34577899999998766655555 77889999987777999999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEE
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL 228 (494)
. ||+++.++.+...+.+...++|.++++.|++++|+.||+|||+|++||+++.+|++++
T Consensus 80 r---------------------gg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyrd~k~enilld~~Ghi~~ 138 (612)
T KOG0603|consen 80 R---------------------GGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYRDYKLENVLLLLEGHIKL 138 (612)
T ss_pred c---------------------cchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHhcccccceeecccCcccc
Confidence 8 6777888888899999999999999999999999999999999999999999999999
Q ss_pred eecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc
Q psy8309 229 ADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ 308 (494)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~ 308 (494)
.|||+++........ |||..|||||++. ++..++||||+|++++||++|..||.+ ++...|....+.+|.
T Consensus 139 tdfglske~v~~~~~----cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~----~~~~~Il~~~~~~p~ 208 (612)
T KOG0603|consen 139 TDFGLSKEAVKEKIA----CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG----DTMKRILKAELEMPR 208 (612)
T ss_pred CCchhhhHhHhhhhc----ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch----HHHHHHhhhccCCch
Confidence 999999864433222 9999999999999 788999999999999999999999988 788899999999999
Q ss_pred cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCc
Q psy8309 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPI 388 (494)
Q Consensus 309 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~ 388 (494)
.++.++++++..++.++|.+|+++.. .+++||++|+||..++|..+..++.+|||+|.+.
T Consensus 209 ~l~~~a~~~~~~l~~r~p~nrLg~~~-~~~~eik~h~f~~~i~~~~l~~r~~~~~fkp~~~------------------- 268 (612)
T KOG0603|consen 209 ELSAEARSLFRQLFKRNPENRLGAGP-DGVDEIKQHEFFQSIDWNELEARSRPPPFKPGSI------------------- 268 (612)
T ss_pred hhhHHHHHHHHHHHhhCHHHHhccCc-chhHHHhccchheeeeHhhHhhcCCCCCCCCccc-------------------
Confidence 99999999999999999999998753 3799999999999999999999999999999998
Q ss_pred cchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccch
Q psy8309 389 QMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDF 445 (494)
Q Consensus 389 ~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 445 (494)
.+.|+.+||++|+.+.|..+|.-... ..++..|.||+|+.+.....
T Consensus 269 ---------~e~~~~~fd~eft~~~P~dsp~~~~~--~s~~~if~g~sfva~~il~~ 314 (612)
T KOG0603|consen 269 ---------TERDVAQFDPEFTSQVPADSPLLSAS--GSDHTIFSGPSFVAPGVLED 314 (612)
T ss_pred ---------chhhhhhcCchhccCCcccCCCCCCC--ccccchhcCCCccChHHhhc
Confidence 78999999999999998877654322 23457899999999987544
|
|
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-43 Score=349.78 Aligned_cols=261 Identities=28% Similarity=0.514 Sum_probs=218.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|++++.||+|+||.||+|++..+++.||+|++... ..........|..++. .++||||+++++.+..++.+|+|
T Consensus 12 ~~y~i~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 87 (292)
T cd06644 12 EVWEIIGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYMVEIEILA-TCNHPYIVKLLGAFYWDGKLWIM 87 (292)
T ss_pred hhhhhhheecCCCCeEEEEEEECCCCceEEEEEeccC---CHHHHHHHHHHHHHHH-hCCCCcEeeeEEEEEeCCeEEEE
Confidence 5699999999999999999999999999999998754 3334555666777776 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+++++ |...+. ....+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 88 ~e~~~~~~---------------------l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nili~~~ 146 (292)
T cd06644 88 IEFCPGGA---------------------VDAIMLELDRGLTEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLD 146 (292)
T ss_pred EecCCCCc---------------------HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhcCCeeecCCCcceEEEcCC
Confidence 99999554 433333 34578999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
|.+||+|||++..............|++.|+|||++. ...++.++|||||||++|||++|.+||...+..+...+
T Consensus 147 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~ 226 (292)
T cd06644 147 GDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLK 226 (292)
T ss_pred CCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCccccHHHHHHH
Confidence 9999999999875333223334567899999999985 34578899999999999999999999988777666666
Q ss_pred HHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHh
Q psy8309 299 ICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALE 356 (494)
Q Consensus 299 i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~ 356 (494)
+..... ..+..++.++.++|.+||..||++|| +++++++||||..++|....
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~~~~~~~~~~ 281 (292)
T cd06644 227 IAKSEPPTLSQPSKWSMEFRDFLKTALDKHPETRP------SAAQLLEHPFVSSVTSNRPL 281 (292)
T ss_pred HhcCCCccCCCCcccCHHHHHHHHHHhcCCcccCc------CHHHHhcCccccccccchhH
Confidence 654432 23557889999999999999999999 68999999999999887643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=345.68 Aligned_cols=255 Identities=42% Similarity=0.810 Sum_probs=222.0
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||.|+||.||+|++..+++.||+|++.+..............|..++. .++||||+++++.+......|+||||+.
T Consensus 1 lg~g~~~~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~e~~~--- 76 (265)
T cd05579 1 ISKGAYGRVFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILS-QAQSPYVVKLYYSFQGKKNLYLVMEYLP--- 76 (265)
T ss_pred CCCCCceEEEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHH-hCCCcchhHHHHheecCcEEEEEEecCC---
Confidence 699999999999999999999999998764434445566677777776 5789999999999999999999999998
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecC
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFG 232 (494)
|++|...+.+.+.+++..+..++.||+.||.|||++|++||||+|+||+++.++.++|+|||
T Consensus 77 ------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~di~~~nil~~~~~~~~l~dfg 138 (265)
T cd05579 77 ------------------GGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFG 138 (265)
T ss_pred ------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCeecCCCCHHHeEEcCCCCEEEEecc
Confidence 44555566666789999999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCC--------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 233 MCKLQIYLDK--------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 233 la~~~~~~~~--------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
++........ .....+++..|+|||.+.+..++.++|+||||+++|+|++|..||......+....+..+..
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~ 218 (265)
T cd05579 139 LSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETPEEIFQNILNGKI 218 (265)
T ss_pred cchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCc
Confidence 9875332211 23345788999999999988899999999999999999999999999988888888888777
Q ss_pred CCCccC--CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 305 RFPQFL--SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 305 ~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
.+|... +..+.++|.+||+.+|.+||++ .++.++++||||++++|
T Consensus 219 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~---~~~~~~l~~~~~~~~~~ 265 (265)
T cd05579 219 EWPEDVEVSDEAIDLISKLLVPDPEKRLGA---KSIEEIKNHPFFKGIDW 265 (265)
T ss_pred CCCccccCCHHHHHHHHHHhcCCHhhcCCC---ccHHHHhcCccccCCCC
Confidence 777665 9999999999999999999976 35699999999999998
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-43 Score=358.16 Aligned_cols=273 Identities=27% Similarity=0.364 Sum_probs=203.9
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|++.+.||+|+||.||+|.+. .++..||||+++... ..........|..++....+||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (338)
T cd05102 4 FPRDRLRLGKVLGHGAFGKVVEASAFGIDKKSSCNTVAVKMLKEGA--TASEHKALMSELKILIHIGNHLNVVNLLGACT 81 (338)
T ss_pred cchhHceeeeEeccCCcceEEEEEEeccCCcccchhhheecccccc--chHHHHHHHHHHHHHHHhccCcceeeEEeEec
Confidence 44578999999999999999999853 345679999987542 23344567788888886558999999999887
Q ss_pred cC-CeeEEEEEecCCCCCccccchhhhhh-------------h---hh------HhcCCc---hhHH-------------
Q psy8309 137 TD-SHLFFVMEYLNGGDLIPAGLTKAERD-------------L---ME------YLNGGD---LMFH------------- 177 (494)
Q Consensus 137 ~~-~~~~lv~E~~~~g~L~~~~~~~~~~~-------------l---~~------~~~gg~---L~~~------------- 177 (494)
.. ..+|+||||+++|+|.+.+....... + .+ ....+. +...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (338)
T cd05102 82 KPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQ 161 (338)
T ss_pred CCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccch
Confidence 64 46899999999999854332211000 0 00 000000 0000
Q ss_pred ---hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCC
Q psy8309 178 ---IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPD 252 (494)
Q Consensus 178 ---l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~ 252 (494)
-.....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++...... .......+++.
T Consensus 162 ~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~ 241 (338)
T cd05102 162 ETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLK 241 (338)
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCcc
Confidence 0012358899999999999999999999999999999999999999999999999987532111 11223456788
Q ss_pred ccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH-HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCC
Q psy8309 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF-WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKR 329 (494)
Q Consensus 253 y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~-~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R 329 (494)
|+|||++.+..++.++|||||||++|||++ |..||.+....+.+ ..+..+ ....|..+++++.+||.+||..||.+|
T Consensus 242 y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~R 321 (338)
T cd05102 242 WMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQRLKDGTRMRAPENATPEIYRIMLACWQGDPKER 321 (338)
T ss_pred ccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHccCChhhC
Confidence 999999999999999999999999999997 99999886544433 333333 345577889999999999999999999
Q ss_pred CCCCCCCChhhhh
Q psy8309 330 LGSTQCNSGDDVV 342 (494)
Q Consensus 330 ~~~~~~~~~~eil 342 (494)
|+ +.|++
T Consensus 322 Ps------~~el~ 328 (338)
T cd05102 322 PT------FSALV 328 (338)
T ss_pred cC------HHHHH
Confidence 94 55665
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-44 Score=360.55 Aligned_cols=253 Identities=28% Similarity=0.467 Sum_probs=205.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++++.||+|+||.||+|.+..+++.||||++.+... ..........|..++. .++||||++++++|...
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07878 14 PERYQNLTPVGSGAYGSVCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLK-HMKHENVIGLLDVFTPATSIEN 91 (343)
T ss_pred hhhhhhheecccCCCeEEEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHH-hcCCCchhhhhhhhcccccccc
Confidence 3689999999999999999999999999999999976421 2223345567777777 57999999999988643
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+|++||++ |++|...+ ..+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~~~~~~~~~~~----------------------~~~l~~~~-~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrdikp~N 148 (343)
T cd07878 92 FNEVYLVTNLM----------------------GADLNNIV-KCQKLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSN 148 (343)
T ss_pred cCcEEEEeecC----------------------CCCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecccCChhh
Confidence 4579999987 33444333 34579999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
||++.++.+||+|||+++.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+
T Consensus 149 il~~~~~~~kl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 225 (343)
T cd07878 149 VAVNEDCELRILDFGLARQA---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQL 225 (343)
T ss_pred EEECCCCCEEEcCCccceec---CCCcCCccccccccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999998753 223445689999999999977 56899999999999999999999999887765554
Q ss_pred HHHHhCC-----------------------CCCC--------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNER-----------------------PRFP--------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~~-----------------------~~~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+.... ..+| ...++.+.+||.+||..||.+|| ++.|++.||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R~------s~~ell~hp 299 (343)
T cd07878 226 KRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKRI------SASEALAHP 299 (343)
T ss_pred HHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhCC------CHHHHhcCc
Confidence 4443210 0111 23567789999999999999999 689999999
Q ss_pred CcCCC
Q psy8309 346 YFRGL 350 (494)
Q Consensus 346 ~f~~~ 350 (494)
||...
T Consensus 300 ~~~~~ 304 (343)
T cd07878 300 YFSQY 304 (343)
T ss_pred chhcc
Confidence 99754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-43 Score=344.92 Aligned_cols=253 Identities=28% Similarity=0.463 Sum_probs=210.2
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||+|++..+++.||+|+++... .........|..++. .++||||+++++.+...+.+|
T Consensus 7 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~~~-~l~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06645 7 PQEDFELIQRIGSGTYGDVYKARNVNTGELAAIKVIKLEP---GEDFAVVQQEIIMMK-DCKHSNIVAYFGSYLRRDKLW 82 (267)
T ss_pred cHHHHHHHHHhCCCCCeEEEEEEEcCCCcEEEEEEEecCc---hhHHHHHHHHHHHHH-hCCCCCeeeEEEEEEeCCEEE
Confidence 3468999999999999999999999999999999987542 223334455666665 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ +++|..++...+.+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 83 lv~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nili~~ 141 (267)
T cd06645 83 ICMEFCG---------------------GGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred EEEeccC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECC
Confidence 9999999 5555666777788999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
++.++|+|||++..............||+.|+|||++. ...++.++|+|||||++|+|++|..||...........+
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~~~~~~~~~ 221 (267)
T cd06645 142 NGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred CCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcCCCCcccccchhhHHhh
Confidence 99999999999875433333344568999999999984 456889999999999999999999999776655444444
Q ss_pred HhCCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 300 CNERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 300 ~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.......+ ..++..+.++|.+||..+|++|| ++++++.|||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------~~~~ll~~~~ 267 (267)
T cd06645 222 TKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRP------TAEKLLQHPF 267 (267)
T ss_pred hccCCCCCcccccCCCCHHHHHHHHHHccCCchhCc------CHHHHhcCCC
Confidence 33332221 24678999999999999999999 6899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >KOG0983|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-44 Score=329.23 Aligned_cols=260 Identities=29% Similarity=0.495 Sum_probs=220.3
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
...++++.+.+..||.|+-|+|++++++.+|...|||.+.+. .+..+..++++...++....++|+||+.+++|..+.
T Consensus 87 ~~~dindl~~l~dlGsGtcG~V~k~~~rs~~~iiAVK~M~rt--~Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~ 164 (391)
T KOG0983|consen 87 YQADINDLENLGDLGSGTCGQVWKMRFRSTGHIIAVKQMRRT--GNKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNT 164 (391)
T ss_pred cccChHHhhhHHhhcCCCccceEEEEEcccceEEEEEeeccc--CCHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCc
Confidence 356778999999999999999999999999999999999876 456677788888888877777999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchh-HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM-FHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDN 217 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~-~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~N 217 (494)
.+++.||.|.. -+. ....-.++++|..+-.+..-++.||.||.++ ||+|||+||.|
T Consensus 165 dV~IcMelMs~----------------------C~ekLlkrik~piPE~ilGk~tva~v~AL~YLKeKH~viHRDvKPSN 222 (391)
T KOG0983|consen 165 DVFICMELMST----------------------CAEKLLKRIKGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSN 222 (391)
T ss_pred hHHHHHHHHHH----------------------HHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHHHhcceeecccCccc
Confidence 99999998751 111 1223356799999999999999999999875 89999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGC-DED 293 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~ 293 (494)
||+|..|+|||||||++-..... .......|-+.|||||.+.- ..|+.++||||||++++||.||..||.+. ..-
T Consensus 223 ILlDe~GniKlCDFGIsGrlvdS-kAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~tdF 301 (391)
T KOG0983|consen 223 ILLDERGNIKLCDFGISGRLVDS-KAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCKTDF 301 (391)
T ss_pred eEEccCCCEEeecccccceeecc-cccccccCCccccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCCccH
Confidence 99999999999999998765433 33344568999999999863 46999999999999999999999999985 456
Q ss_pred HHHHHHHhCCCC-CC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 294 ELFWSICNERPR-FP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 294 ~~~~~i~~~~~~-~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+++-+|++..++ +| ..+|+.+++|+..||++|+.+|| ...++++|||....
T Consensus 302 e~ltkvln~ePP~L~~~~gFSp~F~~fv~~CL~kd~r~RP------~Y~~Ll~h~Fi~~y 355 (391)
T KOG0983|consen 302 EVLTKVLNEEPPLLPGHMGFSPDFQSFVKDCLTKDHRKRP------KYNKLLEHPFIKRY 355 (391)
T ss_pred HHHHHHHhcCCCCCCcccCcCHHHHHHHHHHhhcCcccCc------chHHHhcCcceeec
Confidence 788888876553 33 25899999999999999999999 56889999999754
|
|
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=345.32 Aligned_cols=257 Identities=28% Similarity=0.518 Sum_probs=217.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||.|+||.||+|++..++..||+|++... ..........|..++. .++||||+++++.+.....+|+|
T Consensus 5 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (280)
T cd06611 5 DIWEIIGELGDGAFGKVYKAQHKETGLFAAAKIIQIE---SEEELEDFMVEIDILS-ECKHPNIVGLYEAYFYENKLWIL 80 (280)
T ss_pred hHHHHHHHhcCCCCceEEEEEEcCCCcEEEEEEEeeC---CHHHHHHHHHHHHHHH-hCCCCceeEEEEEEecCCeEEEE
Confidence 5799999999999999999999989999999998643 3344556667777777 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+++| +|..++.. ...+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 81 ~e~~~~~---------------------~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~nili~~~ 139 (280)
T cd06611 81 IEFCDGG---------------------ALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLD 139 (280)
T ss_pred eeccCCC---------------------cHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEECCC
Confidence 9999954 44445544 3579999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
+.++|+|||++..............||+.|+|||++. ...++.++|+|||||++|+|++|.+||.+.+..+...+
T Consensus 140 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~~~~~~~ 219 (280)
T cd06611 140 GDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNPMRVLLK 219 (280)
T ss_pred CCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCHHHHHHH
Confidence 9999999998865433333344567999999999985 34577899999999999999999999998887777777
Q ss_pred HHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 299 ICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 299 i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
+..... ..|..++.++.++|.+||..+|.+|| +++++++|+||.+..+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~~~~~~~~~~ 270 (280)
T cd06611 220 ILKSEPPTLDQPSKWSSSFNDFLKSCLVKDPDDRP------TAAELLKHPFVSDQSD 270 (280)
T ss_pred HhcCCCCCcCCcccCCHHHHHHHHHHhccChhhCc------CHHHHhcChhhcccch
Confidence 765532 34567899999999999999999999 6899999999987643
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=348.68 Aligned_cols=253 Identities=28% Similarity=0.485 Sum_probs=211.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|++..++..||+|.+... ...........|..++. .++||||+++++++.+++.+|+|
T Consensus 1 ~~~~~~~~lg~G~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 77 (308)
T cd06615 1 DDFEKLGELGAGNGGVVTKVLHRPSGLIMARKLIHLE--IKPAIRNQIIRELKVLH-ECNSPYIVGFYGAFYSDGEISIC 77 (308)
T ss_pred CCceEEeeccCCCCeEEEEEEEcCCCeEEEEEEeccc--cCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCEEEEE
Confidence 4799999999999999999999999999999998754 12334455677888887 47999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~~~ 223 (494)
|||++ |++|..++.+.+.+++..++.++.||+.||.|||+ ++++||||||+|||++.+
T Consensus 78 ~ey~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dl~p~nil~~~~ 136 (308)
T cd06615 78 MEHMD---------------------GGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKHKIMHRDVKPSNILVNSR 136 (308)
T ss_pred eeccC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEEECCCChHHEEEecC
Confidence 99999 55566677777889999999999999999999997 599999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh--
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-- 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-- 301 (494)
+.+||+|||++.... .......+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+..
T Consensus 137 ~~~~l~dfg~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~ 214 (308)
T cd06615 137 GEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMFGRPV 214 (308)
T ss_pred CcEEEccCCCccccc--ccccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcchhhHHHhhcCcc
Confidence 999999999986432 2234557899999999999988899999999999999999999999976554333222211
Q ss_pred -----------------------------------CCCCCCc-cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 302 -----------------------------------ERPRFPQ-FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 302 -----------------------------------~~~~~p~-~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+..|. .++.++++||.+||..||++|| ++.+++.||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~ll~~~ 288 (308)
T cd06615 215 SEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNPKERA------DLKELTKHP 288 (308)
T ss_pred ccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCChhhCc------CHHHHhcCh
Confidence 1112221 3688999999999999999999 689999999
Q ss_pred CcCC
Q psy8309 346 YFRG 349 (494)
Q Consensus 346 ~f~~ 349 (494)
||.+
T Consensus 289 ~~~~ 292 (308)
T cd06615 289 FIKR 292 (308)
T ss_pred hhhh
Confidence 9975
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=342.48 Aligned_cols=255 Identities=39% Similarity=0.726 Sum_probs=220.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||.|+||.||+|++..++..||+|++.+..............|..++. .++||||+++++.+.+...+|+|+
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 79 (258)
T cd05578 1 HFELLRVIGKGAFGKVCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQ-ELNHPFLVNLWYSFQDEENMYLVV 79 (258)
T ss_pred CceEEEEeccCCCceEEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHH-hCCCCChHHHHHhhcCCCeEEEEE
Confidence 4899999999999999999999999999999998765544456667777887777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||+. |++|..++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.
T Consensus 80 e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~~~ 138 (258)
T cd05578 80 DLLL---------------------GGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGH 138 (258)
T ss_pred eCCC---------------------CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeEEcCCCC
Confidence 9999 5555666766678999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---HHHHHHHHHhC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD---EDELFWSICNE 302 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~~~~~~~i~~~ 302 (494)
++|+|||++..... ........|+..|+|||++.+..++.++|+||||+++|+|++|..||...+ ...+...+...
T Consensus 139 ~~l~d~~~~~~~~~-~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (258)
T cd05578 139 VHITDFNIATKVTP-DTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQIRAKQETA 217 (258)
T ss_pred EEEeecccccccCC-CccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCccHHHHHHHHhccc
Confidence 99999999875322 223345678999999999999889999999999999999999999998776 34444444446
Q ss_pred CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
...+|..++.++.++|.+||..||.+|+++. ++|+++||||
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~----~~~l~~~~~~ 258 (258)
T cd05578 218 DVLYPATWSTEAIDAINKLLERDPQKRLGDN----LKDLKNHPYF 258 (258)
T ss_pred cccCcccCcHHHHHHHHHHccCChhHcCCcc----HHHHhcCCCC
Confidence 6778888999999999999999999999541 5999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-43 Score=343.15 Aligned_cols=252 Identities=27% Similarity=0.446 Sum_probs=203.2
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++++.||+|+||.||+|+++.++..||||+++.... ..........|..++. .++||||+++++++.+++.+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~ 78 (285)
T cd07861 1 DYTKIEKIGEGTYGVVYKGRNKKTGQIVAMKKIRLESE-EEGVPSTAIREISLLK-ELQHPNIVCLQDVLMQESRLYLIF 78 (285)
T ss_pred CceEeeEecccCceEEEEEEECCCCcEEEEEEeccccc-cCCchHHHHHHHHHHH-hcCCCCEeeeEEEEeeCCeEEEEE
Confidence 58999999999999999999999999999999875422 2223345566777776 578999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ---QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||+. |+| ..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 e~~~-~~l---------------------~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~ 136 (285)
T cd07861 79 EFLS-MDL---------------------KKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDN 136 (285)
T ss_pred ecCC-CCH---------------------HHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCCeeecCCCHHHEEEcC
Confidence 9997 233 22332 2357899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+|.+||+|||++..............|++.|+|||++.+. .++.++|+|||||++|+|++|++||.+.........+..
T Consensus 137 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~~~~~~~~~~~ 216 (285)
T cd07861 137 KGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFRIFR 216 (285)
T ss_pred CCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 9999999999987533222223344678999999998764 578999999999999999999999987765433332211
Q ss_pred C------------------CC-----------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 E------------------RP-----------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 ~------------------~~-----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. .. .....+++++++||.+||+.||.+|| ++++++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp------t~~~ll~~~~~ 285 (285)
T cd07861 217 ILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRI------SAKKALNHPYF 285 (285)
T ss_pred HhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCC------CHHHHhcCCCC
Confidence 0 00 01234789999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=335.12 Aligned_cols=253 Identities=30% Similarity=0.495 Sum_probs=217.9
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|..+.+++.||+|.+..... ..........|..++. .++||||+++++++.+.+..|+||
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08529 1 DFEILNKIGKGSFGVVFKVVRKADKRVYAMKQIDLSKM-NRREREEAIDEARVLA-KLDSSYIIRYYESFLDKGKLNIVM 78 (256)
T ss_pred CceEeEEecCCCCeEEEEEEEcCCCcEEEEEEeehhhC-CHHHHHHHHHHHHHHH-hcCCCCeehheeeeccCCEEEEEE
Confidence 58899999999999999999999999999999876432 2344556667777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||++|++| ..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++.+
T Consensus 79 e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~h~dl~~~nili~~~ 137 (256)
T cd08529 79 EYAENGDL---------------------HKLLKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAY 137 (256)
T ss_pred EeCCCCcH---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEEeCC
Confidence 99995544 444444 3578999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
+.++|+|||+++............+|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+.
T Consensus 138 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (256)
T cd08529 138 DNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALILKIIRGV 217 (256)
T ss_pred CCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998864433333455679999999999999999999999999999999999999999888877777777654
Q ss_pred -CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 -PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..++..++.+++++|.+||+.+|++|| ++.+++.|||+
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~Rp------~~~~ll~~~~~ 256 (256)
T cd08529 218 FPPVSQMYSQQLAQLIDQCLTKDYRQRP------DTFQLLRNPSL 256 (256)
T ss_pred CCCCccccCHHHHHHHHHHccCCcccCc------CHHHHhhCCCC
Confidence 345557899999999999999999999 67899999984
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-43 Score=343.68 Aligned_cols=253 Identities=28% Similarity=0.500 Sum_probs=212.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
-|++.+.||+|+||.||+|++..++..+|+|.+... ..........|..++. .++||||+++++.+...+..|+||
T Consensus 6 ~~~i~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~-~l~h~~ii~~~~~~~~~~~~~~v~ 81 (282)
T cd06643 6 FWEIIGELGDGAFGKVYKAQNKETGVLAAAKVIDTK---SEEELEDYMVEIDILA-SCDHPNIVKLLDAFYYENNLWILI 81 (282)
T ss_pred HHHHHhhcccCCCeEEEEEEECCCCeEEEEEEeCCC---CHHHHHHHHHHHHHHH-HCCCCCeeeEEEEEeeCCEEEEEE
Confidence 368899999999999999999999999999998653 2334455667777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||+++|+ |...+.+ ...+++..+..++.||+.||.|||+.||+||||||+|||++.++
T Consensus 82 e~~~~~~---------------------l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~~i~H~dlkp~nili~~~~ 140 (282)
T cd06643 82 EFCAGGA---------------------VDAVMLELERPLTEPQIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDG 140 (282)
T ss_pred EecCCCc---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccEEEccCC
Confidence 9999554 4444433 45799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
.+||+|||++..............||+.|+|||++. +..++.++|||||||++|||++|.+||...+..+....+
T Consensus 141 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~ 220 (282)
T cd06643 141 DIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKI 220 (282)
T ss_pred CEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCHHHHHHHH
Confidence 999999999875433333344567999999999984 455788999999999999999999999988777766666
Q ss_pred HhCC---CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 300 CNER---PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 300 ~~~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.... ...|..++.++++||.+||..||.+|| +++++++||||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~~~ 267 (282)
T cd06643 221 AKSEPPTLAQPSRWSSEFKDFLKKCLEKNVDARW------TTTQLLQHPFVTV 267 (282)
T ss_pred hhcCCCCCCCccccCHHHHHHHHHHccCChhhCc------CHHHHhcCCCEec
Confidence 5443 234567899999999999999999999 6899999999974
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=342.50 Aligned_cols=250 Identities=26% Similarity=0.472 Sum_probs=207.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|+++++||+|+||.||+|++..+++.||||++.+.. ..........|..++. .++||||+++++.+...+..++|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 77 (279)
T cd06619 1 QDIQYQEILGHGNGGTVYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILY-KCDSPYIIGFYGAFFVENRISIC 77 (279)
T ss_pred CcchheeeeccCCCeEEEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHH-hCCCCCeeeEEEEEEECCEEEEE
Confidence 47899999999999999999999999999999997642 2333445667877776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+++|+|. . ...+++..+..++.||+.||.|||++||+|+||||+|||++.++
T Consensus 78 ~e~~~~~~l~---------------------~----~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nill~~~~ 132 (279)
T cd06619 78 TEFMDGGSLD---------------------V----YRKIPEHVLGRIAVAVVKGLTYLWSLKILHRDVKPSNMLVNTRG 132 (279)
T ss_pred EecCCCCChH---------------------H----hhcCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCCHHHEEECCCC
Confidence 9999976551 1 13578889999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-------HHHHH
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-------DELFW 297 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-------~~~~~ 297 (494)
.++|+|||++.... .......+||+.|+|||++.+..++.++|+|||||++|+|++|..||..... .+...
T Consensus 133 ~~~l~dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~ 210 (279)
T cd06619 133 QVKLCDFGVSTQLV--NSIAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQ 210 (279)
T ss_pred CEEEeeCCcceecc--cccccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCCCchhhcccccccchHHHHH
Confidence 99999999987532 2334456899999999999999999999999999999999999999965321 22233
Q ss_pred HHHhCC-CCCC-ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 298 SICNER-PRFP-QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 298 ~i~~~~-~~~p-~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+.... ...+ ...+++++++|.+||..||.+|| +++|++.||||...
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------~~~eil~~~~~~~~ 259 (279)
T cd06619 211 CIVDEDPPVLPVGQFSEKFVHFITQCMRKQPKERP------APENLMDHPFIVQY 259 (279)
T ss_pred HHhccCCCCCCCCcCCHHHHHHHHHHhhCChhhCC------CHHHHhcCcccccc
Confidence 333322 2222 35789999999999999999999 68999999999765
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=338.69 Aligned_cols=254 Identities=28% Similarity=0.514 Sum_probs=213.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh------hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED------DDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~------~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
.|.+.+.||+|+||.||+|.+..+++.||+|.+........ ...+....|..++. .++||||+++++++...+
T Consensus 1 ~~~~~~~ig~g~~~~v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 79 (267)
T cd06628 1 KWIKGALIGSGSFGSVYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLK-ELQHENIVQYLGSSLDAD 79 (267)
T ss_pred CccccceeecCCCeEEEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEeCC
Confidence 36788999999999999999999999999999876432211 12344556667676 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
..++||||++ +++|..++...+.+++..++.++.||+.||+|||++|++||||+|+||+
T Consensus 80 ~~~lv~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~ivH~di~p~nil 138 (267)
T cd06628 80 HLNIFLEYVP---------------------GGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL 138 (267)
T ss_pred ccEEEEEecC---------------------CCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCcccccCCHHHEE
Confidence 9999999998 4555566777778999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
++.++.++|+|||+++...... .......|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..
T Consensus 139 ~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~ 218 (267)
T cd06628 139 VDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQL 218 (267)
T ss_pred EcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCccHH
Confidence 9999999999999987543111 1122456899999999999989999999999999999999999999887665
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..+.++... .+.+|..++.+++++|.+||+.||.+|| +++++++||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~ 267 (267)
T cd06628 219 QAIFKIGENASPEIPSNISSEAIDFLEKTFEIDHNKRP------TAAELLKHPFL 267 (267)
T ss_pred HHHHHHhccCCCcCCcccCHHHHHHHHHHccCCchhCc------CHHHHhhCCCC
Confidence 555555443 4567778999999999999999999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >KOG0197|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-44 Score=357.20 Aligned_cols=244 Identities=29% Similarity=0.469 Sum_probs=208.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..+.+.+++.||+|.||.|++|.++++.+ ||+|.++.... ..+..+.|..+|. .++|++||++++++..+..
T Consensus 202 ei~r~~l~l~~~LG~G~FG~V~~g~~~~~~~-vavk~ik~~~m----~~~~f~~Ea~iMk-~L~H~~lV~l~gV~~~~~p 275 (468)
T KOG0197|consen 202 EIPREELKLIRELGSGQFGEVWLGKWNGSTK-VAVKTIKEGSM----SPEAFLREAQIMK-KLRHEKLVKLYGVCTKQEP 275 (468)
T ss_pred eecHHHHHHHHHhcCCccceEEEEEEcCCCc-ccceEEecccc----ChhHHHHHHHHHH-hCcccCeEEEEEEEecCCc
Confidence 3445678889999999999999999987744 89999986533 2234567888888 6899999999999999899
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|||||||+.|+| ..+++. ...+...+...++.||+.||+||+++++|||||...||
T Consensus 276 iyIVtE~m~~GsL---------------------l~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~IHRDLAARNi 334 (468)
T KOG0197|consen 276 IYIVTEYMPKGSL---------------------LDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNYIHRDLAARNI 334 (468)
T ss_pred eEEEEEecccCcH---------------------HHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCccchhhhhhhe
Confidence 9999999995544 445554 56789999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCccccc--CCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTF--CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~--~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
||++++.|||+|||||+. ...+...... --...|.|||.+....++.++|||||||+||||+| |+.||.+.+..+.
T Consensus 335 LV~~~~~vKIsDFGLAr~-~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G~~py~~msn~ev 413 (468)
T KOG0197|consen 335 LVDEDLVVKISDFGLARL-IGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYGRVPYPGMSNEEV 413 (468)
T ss_pred eeccCceEEEcccccccc-cCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccCCCCCCCCCHHHH
Confidence 999999999999999994 2222222111 12357999999999999999999999999999998 9999999999999
Q ss_pred HHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 296 FWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 296 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+..+..+ +.+-|..+++++-+++..||..+|++||+.
T Consensus 414 ~~~le~GyRlp~P~~CP~~vY~lM~~CW~~~P~~RPtF 451 (468)
T KOG0197|consen 414 LELLERGYRLPRPEGCPDEVYELMKSCWHEDPEDRPTF 451 (468)
T ss_pred HHHHhccCcCCCCCCCCHHHHHHHHHHhhCCcccCCCH
Confidence 9999876 667788999999999999999999999975
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=340.71 Aligned_cols=253 Identities=28% Similarity=0.427 Sum_probs=208.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
...+|++.+.||+|+||.||+|+.+.+++.||+|++.... .........|..++. .++||||+++++++...+.+|
T Consensus 7 ~~~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~---~~~~~~~~~e~~~l~-~~~h~~ii~~~~~~~~~~~~~ 82 (267)
T cd06646 7 PQHDYELIQRVGSGTYGDVYKARNLHTGELAAVKIIKLEP---GDDFSLIQQEIFMVK-ECKHCNIVAYFGSYLSREKLW 82 (267)
T ss_pred chhhcchhheeecCCCeEEEEEEECCCCeEEEEEEEecCc---cchHHHHHHHHHHHH-hcCCCCeeeeeEEEEeCCEEE
Confidence 3468999999999999999999999999999999997542 223344556766666 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ +++|..++...+.+++..+..++.|++.||.|||++||+||||||+||+++.
T Consensus 83 iv~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nill~~ 141 (267)
T cd06646 83 ICMEYCG---------------------GGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTD 141 (267)
T ss_pred EEEeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECC
Confidence 9999998 4555566666778999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
++.+||+|||++..............|++.|+|||.+. ...++.++|+|||||++|||++|..||...+..+....+
T Consensus 142 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~~~~~~~~ 221 (267)
T cd06646 142 NGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHPMRALFLM 221 (267)
T ss_pred CCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccchhhhheee
Confidence 99999999999876433223334567999999999985 345788999999999999999999999766554443333
Q ss_pred HhCCCCC-----CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 300 CNERPRF-----PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 300 ~~~~~~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
....... +..++.++.+||++||..+|++|| ++++|++|+|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------~~~~il~~l~ 267 (267)
T cd06646 222 SKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRP------TAERLLTHLF 267 (267)
T ss_pred ecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCc------CHHHHhcCCC
Confidence 3322221 234689999999999999999999 6889999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=341.12 Aligned_cols=247 Identities=28% Similarity=0.545 Sum_probs=203.6
Q ss_pred CCceEeeEe--ccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 65 EDFQLLKVL--GKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 65 ~~y~~~~~L--G~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
++|++.+.+ |+|+||.||+++++.++..||+|++.+..... . |........+||||+++++.|...+.+|
T Consensus 14 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~k~~~~~~~~~---~-----e~~~~~~~~~h~~iv~~~~~~~~~~~~~ 85 (267)
T PHA03390 14 KNCEIVKKLKLIDGKFGKVSVLKHKPTQKLFVQKIIKAKNFNA---I-----EPMVHQLMKDNPNFIKLYYSVTTLKGHV 85 (267)
T ss_pred HhhccccceeecCCCceEEEEEEEcCCCcEEEEEEEehhhcch---h-----hHHHHHHhhcCCCEEEEEEEEecCCeeE
Confidence 456666665 99999999999999999999999987653211 1 1111211237999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ |++|..++...+.+++.+++.++.||+.||.|||+.|++||||||+||+++.
T Consensus 86 iv~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 144 (267)
T PHA03390 86 LIMDYIK---------------------DGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYDR 144 (267)
T ss_pred EEEEcCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEeC
Confidence 9999999 5556666777778999999999999999999999999999999999999999
Q ss_pred CC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH----HH
Q psy8309 223 EG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL----FW 297 (494)
Q Consensus 223 ~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~----~~ 297 (494)
++ .++|+|||+++... ......|+..|+|||++.+..++.++|||||||++|+|++|..||........ +.
T Consensus 145 ~~~~~~l~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 145 AKDRIYLCDYGLCKIIG----TPSCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred CCCeEEEecCccceecC----CCccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 98 99999999987532 22345789999999999999999999999999999999999999986543322 22
Q ss_pred HHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 298 SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 298 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.........++.+++.+++||.+||+.||.+|++ +++++++||||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~-----~~~~~l~h~~~~~ 267 (267)
T PHA03390 221 KRQQKKLPFIKNVSKNANDFVQSMLKYNINYRLT-----NYNEIIKHPFLKI 267 (267)
T ss_pred HhhcccCCcccccCHHHHHHHHHHhccChhhCCc-----hHHHHhcCCcccC
Confidence 2223444566689999999999999999999994 3699999999973
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-43 Score=343.39 Aligned_cols=249 Identities=17% Similarity=0.204 Sum_probs=207.7
Q ss_pred CCCCCCceEe--eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-
Q psy8309 61 KYDLEDFQLL--KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT- 137 (494)
Q Consensus 61 ~~~~~~y~~~--~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~- 137 (494)
.++.++++.. ..||+|++|.||+|+. +|+.||||++++.........+....|..++. .++||||+++++++.+
T Consensus 14 ~i~~~~i~~~~~~~i~~g~~~~v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~nIv~~~g~~~~~ 90 (283)
T PHA02988 14 CIESDDIDKYTSVLIKENDQNSIYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLR-RIDSNNILKIYGFIIDI 90 (283)
T ss_pred ecCHHHcCCCCCeEEeeCCceEEEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHH-hcCCCCEEEEeeeEEec
Confidence 3444555555 6899999999999987 57889999998754333334566678888887 5799999999999877
Q ss_pred ---CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccC
Q psy8309 138 ---DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDL 213 (494)
Q Consensus 138 ---~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDL 213 (494)
...+++||||++ ||+|..++...+.+++..+..++.|++.||.|||+. +++||||
T Consensus 91 ~~~~~~~~lv~Ey~~---------------------~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~Hrdl 149 (283)
T PHA02988 91 VDDLPRLSLILEYCT---------------------RGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNL 149 (283)
T ss_pred ccCCCceEEEEEeCC---------------------CCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhcCCCCCCcC
Confidence 457899999999 455556677777899999999999999999999984 9999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
||+|||++.+|.+||+|||+++... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+.+
T Consensus 150 kp~nill~~~~~~kl~dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~ 226 (283)
T PHA02988 150 TSVSFLVTENYKLKIICHGLEKILS---SPPFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLT 226 (283)
T ss_pred ChhhEEECCCCcEEEcccchHhhhc---cccccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCC
Confidence 9999999999999999999987532 22234578999999999976 689999999999999999999999999988
Q ss_pred HHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 292 EDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 292 ~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
..+++..+... .+.+|...++++++||.+||+.||.+|| +++|++
T Consensus 227 ~~~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp------s~~ell 273 (283)
T PHA02988 227 TKEIYDLIINKNNSLKLPLDCPLEIKCIVEACTSHDSIKRP------NIKEIL 273 (283)
T ss_pred HHHHHHHHHhcCCCCCCCCcCcHHHHHHHHHHhcCCcccCc------CHHHHH
Confidence 88888887654 4556667899999999999999999999 456665
|
|
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=340.92 Aligned_cols=254 Identities=27% Similarity=0.424 Sum_probs=207.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+++.+++.||+|++.+... ..........|..++. .++||||+++++++.....+|+|
T Consensus 1 ~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~v 78 (286)
T cd07847 1 EKYEKLSKIGEGSYGVVFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLK-QLKHPNLVNLIEVFRRKRKLHLV 78 (286)
T ss_pred CceeeeeeecccCCeEEEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHH-hCCCCCEeeeeeEEeeCCEEEEE
Confidence 479999999999999999999999999999999875421 1122234456777776 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+++ +.+.........+++..++.++.||+.||+|||++||+||||||+||+++.+|
T Consensus 79 ~e~~~~---------------------~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H~dl~p~nil~~~~~ 137 (286)
T cd07847 79 FEYCDH---------------------TVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQG 137 (286)
T ss_pred EeccCc---------------------cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCChhhEEEcCCC
Confidence 999984 44444455556799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
.+||+|||++..............++..|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+....
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~ 217 (286)
T cd07847 138 QIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIRKTL 217 (286)
T ss_pred cEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHh
Confidence 9999999998864333323345568899999999876 458899999999999999999999998876654443332100
Q ss_pred -------------------CCCC------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 -------------------PRFP------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 -------------------~~~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
...| ..++..+.+||.+||..||++|| ++.|++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~eil~~~~f 286 (286)
T cd07847 218 GDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERL------SCEELLEHPYF 286 (286)
T ss_pred CCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccC------CHHHHhcCCCC
Confidence 0011 24688899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-43 Score=350.85 Aligned_cols=253 Identities=26% Similarity=0.395 Sum_probs=188.3
Q ss_pred eeEeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CCeeEEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DSHLFFVM 145 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~~~~lv~ 145 (494)
.+.||+|+||.||+|+++. +++.||+|.+..... ......|..++. .++||||++++++|.. ...+|+||
T Consensus 6 ~~~lG~G~~g~Vy~~~~~~~~~~~~~aiK~~~~~~~-----~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07868 6 GCKVGRGTYGHVYKAKRKDGKDDRDYALKQIEGTGI-----SMSACREIALLR-ELKHPNVISLQKVFLSHADRKVWLLF 79 (317)
T ss_pred ccccccCCCeEEEEEEEccCCCCceEEEEEECCCCC-----cHHHHHHHHHHH-hcCCCCCcceeeeEecCCCcEEEEEE
Confidence 4689999999999999764 678899999875421 223456777777 5799999999999864 56789999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee----C
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----D 221 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl----~ 221 (494)
||+.+ +| .+++..............+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 80 e~~~~-~l------------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~ 146 (317)
T cd07868 80 DYAEH-DL------------WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 146 (317)
T ss_pred eccCC-CH------------HHHHHhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCC
Confidence 99863 32 1111100000011122368999999999999999999999999999999999999 4
Q ss_pred CCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH-----
Q psy8309 222 YEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDE----- 292 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~----- 292 (494)
.++.+||+|||+++...... ......+||+.|+|||++.+. .|+.++|||||||++|||++|.+||.+...
T Consensus 147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~ 226 (317)
T cd07868 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226 (317)
T ss_pred CcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCccccccc
Confidence 56789999999997532211 123456899999999999874 589999999999999999999999975432
Q ss_pred ----HHHHHHHHhCC-----------CCC---------------------------CccCCHHHHHHHHhhccCCCCCCC
Q psy8309 293 ----DELFWSICNER-----------PRF---------------------------PQFLSVEAKNILVHLLDKDTTKRL 330 (494)
Q Consensus 293 ----~~~~~~i~~~~-----------~~~---------------------------p~~~s~~~~~li~~lL~~dP~~R~ 330 (494)
...+..+.... ..+ ....+.++.+||.+||+.||.+|+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ 306 (317)
T cd07868 227 NPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRI 306 (317)
T ss_pred ccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHHhcCCCCChHHHHHHHHHhccCcccCC
Confidence 11222221100 000 012356789999999999999999
Q ss_pred CCCCCCChhhhhcCCCc
Q psy8309 331 GSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 331 ~~~~~~~~~eil~h~~f 347 (494)
+++|+++||||
T Consensus 307 ------t~~e~l~hp~f 317 (317)
T cd07868 307 ------TSEQAMQDPYF 317 (317)
T ss_pred ------CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-43 Score=343.46 Aligned_cols=262 Identities=23% Similarity=0.387 Sum_probs=208.1
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|+++.+|+.||||++++... .........|...+.+..+||||+++++++..++.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv 78 (283)
T cd06617 1 DDLEVIEELGRGAYGVVDKMRHVPTGTIMAVKRIRATVN--SQEQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWIC 78 (283)
T ss_pred CCceEEEEecccCCeEEEEEEEcCCCcEEEEEEEecCCC--cHHHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEE
Confidence 479999999999999999999999999999999976522 222334555666655568999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NILl~~~ 223 (494)
|||++ |+|. + -+.........+++..++.++.||+.||+|||++ +++||||||+|||++.+
T Consensus 79 ~e~~~-~~l~------------~-----~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~i~h~dlkp~nil~~~~ 140 (283)
T cd06617 79 MEVMD-TSLD------------K-----FYKKVYDKGLTIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVLINRN 140 (283)
T ss_pred hhhhc-ccHH------------H-----HHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEECCC
Confidence 99996 3331 1 1111222345799999999999999999999998 99999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC----CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG----LKYNQCVDWWSFGILLYEMHVGQSPFSGC-DEDELFWS 298 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~----~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~ 298 (494)
+.+||+|||++..... ........|+..|+|||++.+ ..++.++|+|||||++|+|++|..||... ...+.+..
T Consensus 141 ~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~ 219 (283)
T cd06617 141 GQVKLCDFGISGYLVD-SVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQQLKQ 219 (283)
T ss_pred CCEEEeeccccccccc-ccccccccCCccccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCccccCHHHHHH
Confidence 9999999999875321 222233568999999999865 45789999999999999999999999753 22333334
Q ss_pred HHh-CCCCCC-ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 299 ICN-ERPRFP-QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 299 i~~-~~~~~p-~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
+.. ..+.+| ..++.+++++|.+||..+|.+|| +++++++||||....+.
T Consensus 220 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 220 VVEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERP------NYPELLQHPFFELHLSK 270 (283)
T ss_pred HHhcCCCCCCccccCHHHHHHHHHHccCChhhCc------CHHHHhcCchhhhcccc
Confidence 333 334444 35789999999999999999999 67999999999875543
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=382.93 Aligned_cols=260 Identities=25% Similarity=0.471 Sum_probs=211.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DS 139 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~ 139 (494)
..+++|++++.||+|+||.||+|+++.++..||+|++..... .......+..|..++. .++|||||+++++|.. ..
T Consensus 10 ~~l~~YeIl~kLG~GgFGtVYLAkdk~tg~~vAlKvIk~~~l-~e~~~~~~~~EI~IL~-~L~HPNIVrl~d~f~de~~~ 87 (1021)
T PTZ00266 10 SRLNEYEVIKKIGNGRFGEVFLVKHKRTQEFFCWKAISYRGL-KEREKSQLVIEVNVMR-ELKHKNIVRYIDRFLNKANQ 87 (1021)
T ss_pred cccCCEEEEEEEecCCCeEEEEEEECCCCeEEEEEEEecccc-CHHHHHHHHHHHHHHH-HcCCCCcCeEEEEEEecCCC
Confidence 446799999999999999999999999999999999976533 3344556777888877 5899999999999864 45
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhC-------CC
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKK-------GI 208 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~-------gi 208 (494)
.+|||||||.+|+| ..++. ..+.+++..++.|+.||+.||.|||+. +|
T Consensus 88 ~lyIVMEY~~gGSL---------------------~~lL~k~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~I 146 (1021)
T PTZ00266 88 KLYILMEFCDAGDL---------------------SRNIQKCYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERV 146 (1021)
T ss_pred EEEEEEeCCCCCcH---------------------HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCc
Confidence 79999999996655 33333 246799999999999999999999985 49
Q ss_pred ccccCCCCceeeCC-----------------CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC--CCCCCcch
Q psy8309 209 VYRDLKLDNILLDY-----------------EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG--LKYNQCVD 269 (494)
Q Consensus 209 vHrDLKp~NILl~~-----------------~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~~D 269 (494)
|||||||+||||+. .+.+||+|||++.... ........+||+.|+|||++.+ ..++.++|
T Consensus 147 VHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~-~~s~~~s~vGTp~YmAPEvL~ge~~~~s~KSD 225 (1021)
T PTZ00266 147 LHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIG-IESMAHSCVGTPYYWSPELLLHETKSYDDKSD 225 (1021)
T ss_pred eeccCcHHHeEeecCccccccccccccccCCCCceEEccCCcccccc-ccccccccCCCccccCHHHHhccCCCCCchhH
Confidence 99999999999964 2358999999987532 2233445689999999999965 45889999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC-ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP-QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 270 iwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p-~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
|||||||||||++|..||...+....+..++...+.+| ...+.++.+||..||..+|.+|| ++.+++.|+|++
T Consensus 226 VWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lpi~~~S~eL~dLI~~~L~~dPeeRP------Sa~QlL~h~~ik 299 (1021)
T PTZ00266 226 MWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLPIKGKSKELNILIKNLLNLSAKERP------SALQCLGYQIIK 299 (1021)
T ss_pred HHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCCcCCCCHHHHHHHHHHhcCChhHCc------CHHHHhccHHHh
Confidence 99999999999999999987655444444444444444 45789999999999999999999 678999999998
Q ss_pred CCC
Q psy8309 349 GLD 351 (494)
Q Consensus 349 ~~~ 351 (494)
.+.
T Consensus 300 ~i~ 302 (1021)
T PTZ00266 300 NVG 302 (1021)
T ss_pred hcC
Confidence 764
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-42 Score=339.25 Aligned_cols=252 Identities=25% Similarity=0.425 Sum_probs=206.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD------ 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~------ 138 (494)
+.|++.+.||+|+||.||+|+.+.+++.||+|++.... ........|..++....+||||+++++++...
T Consensus 6 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 81 (272)
T cd06637 6 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMD 81 (272)
T ss_pred hhhhHHHheeecCCeEEEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCC
Confidence 46888999999999999999999999999999987542 22345567777777555899999999998753
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+|+||||+.+|+ |..++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 82 ~~~~iv~e~~~~~~---------------------L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivh~dl~~~ 140 (272)
T cd06637 82 DQLWLVMEFCGAGS---------------------VTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQ 140 (272)
T ss_pred cEEEEEEEcCCCCc---------------------HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHH
Confidence 46899999999554 4444443 246899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
||+++.++.++|+|||++..............|++.|+|||++. +..|+.++|||||||++|||++|..||....
T Consensus 141 nili~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 141 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred HEEECCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 99999999999999999875433333445678999999999986 3468889999999999999999999998766
Q ss_pred HHHHHHHHHhCCC--CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 292 EDELFWSICNERP--RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 292 ~~~~~~~i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.......+..... ..+..++.++++||.+||..||.+|| +++++++||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~il~~~~~ 272 (272)
T cd06637 221 PMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP------TTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHhcCCCCCCCCCCcCHHHHHHHHHHcCCChhhCC------CHHHHhhCCCC
Confidence 5555544443221 12346789999999999999999999 68999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-43 Score=345.05 Aligned_cols=252 Identities=26% Similarity=0.449 Sum_probs=202.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|+++.+|+.||+|.++.... ..........|..++. .++||||+++++++.+...+|+|+
T Consensus 1 ~y~~~~~l~~g~~~~vy~~~~~~~g~~~~~k~~~~~~~-~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 78 (284)
T cd07839 1 KYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLK-ELKHKNIVRLYDVLHSDKKLTLVF 78 (284)
T ss_pred CceeEEEecccCCeEEEEEEECCCCcEEEEEEeecccc-cccCccchhHHHHHHH-hcCCCCeeeHHHHhccCCceEEEE
Confidence 48899999999999999999999999999999976422 2222334556777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||+.+ +|..++. ..+.+++..++.++.||+.||.|||++||+||||||+||+++.++
T Consensus 79 e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dl~~~nil~~~~~ 136 (284)
T cd07839 79 EYCDQ----------------------DLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNG 136 (284)
T ss_pred ecCCC----------------------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEEcCCC
Confidence 99962 3333443 356799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHhC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPF-SGCDEDELFWSICNE 302 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf-~~~~~~~~~~~i~~~ 302 (494)
.+||+|||+++.............+++.|+|||++.+. .++.++|||||||++|+|++|..|| .+.+..+.+..+...
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (284)
T cd07839 137 ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 216 (284)
T ss_pred cEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcCCCCHHHHHHHHHHH
Confidence 99999999987533222223345688999999998774 4789999999999999999988775 555555544444211
Q ss_pred --------------C------CC---------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 --------------R------PR---------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 --------------~------~~---------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. .. ....+++++++||.+||..||.+|| ++++++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------t~~~il~h~~f 284 (284)
T cd07839 217 LGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRI------SAEEALQHPYF 284 (284)
T ss_pred hCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcC------CHHHHhcCCCC
Confidence 0 00 1124789999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-43 Score=350.62 Aligned_cols=255 Identities=21% Similarity=0.337 Sum_probs=201.2
Q ss_pred eEeeEeccC--CceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 68 QLLKVLGKG--SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 68 ~~~~~LG~G--~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+++++||+| +||+||+++++.+|+.||||++..... ..........|..++. .++||||++++++|..++.+|+||
T Consensus 1 ~~~~~ig~G~~~~~~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~-~l~hpniv~~~~~~~~~~~~~lv~ 78 (327)
T cd08227 1 ELLTVIGRGFEDLMTVNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSK-LFNHPNIVPYRATFIADNELWVVT 78 (327)
T ss_pred ChhhhccccccceEEEEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEEECCEEEEEE
Confidence 357899999 789999999999999999999976532 2233344555666665 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+++|+| ..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 79 e~~~~~~l---------------------~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiH~dlkp~Nil~~~~ 137 (327)
T cd08227 79 SFMAYGSA---------------------KDLICTHFMDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVD 137 (327)
T ss_pred eccCCCcH---------------------HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCChhhEEEecC
Confidence 99995554 444433 2458999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
+.++++|||.+........ .....+++..|+|||++.+ ..|+.++|||||||++|||++|..||.......
T Consensus 138 ~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~ 217 (327)
T cd08227 138 GKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPATQ 217 (327)
T ss_pred CcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCcchhH
Confidence 9999999986543221111 1223457788999999976 468999999999999999999999998765444
Q ss_pred HHHHHHhCCCC----------------------------------------------CCccCCHHHHHHHHhhccCCCCC
Q psy8309 295 LFWSICNERPR----------------------------------------------FPQFLSVEAKNILVHLLDKDTTK 328 (494)
Q Consensus 295 ~~~~i~~~~~~----------------------------------------------~p~~~s~~~~~li~~lL~~dP~~ 328 (494)
.......+... +...+++++++||.+||+.||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~ 297 (327)
T cd08227 218 MLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYNRTFSPHFHHFVEQCLQRNPDA 297 (327)
T ss_pred HHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccccccCHHHHHHHHHHHhhCchh
Confidence 33333222110 11235778999999999999999
Q ss_pred CCCCCCCCChhhhhcCCCcCCCC
Q psy8309 329 RLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 329 R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
|| +++++++||||+.+.
T Consensus 298 Rp------t~~ell~~p~f~~~~ 314 (327)
T cd08227 298 RP------SASTLLNHSFFKQIK 314 (327)
T ss_pred cC------CHHHHhcChhhhhcc
Confidence 99 679999999998763
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG4279|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=364.56 Aligned_cols=249 Identities=31% Similarity=0.544 Sum_probs=213.6
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
-+||+|+||+||.|+++.|....|||.+... .... ..-+.|+..|.+.+.|.|||+++|++..++++-|.||-++|
T Consensus 581 vVLGKGTYG~VYA~RD~~tqvrIaIKEIpek---dsr~-~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPG 656 (1226)
T KOG4279|consen 581 VVLGKGTYGTVYAARDMDTQVRIAIKEIPEK---DSRE-VQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPG 656 (1226)
T ss_pred EEeecCceeEEEeeccccceeEEEeeecccc---cchh-hccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCC
Confidence 3899999999999999999999999998653 1222 34456667777789999999999999999999999999996
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhh-hcCCC--CHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC-CCCE
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRF--DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY-EGHV 226 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l--~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~-~g~v 226 (494)
|+| ...++ +.|++ .|..+.+|.+||+.||.|||++.|||||||-+||||+. .|.+
T Consensus 657 GSL---------------------SsLLrskWGPlKDNEstm~fYtkQILeGLkYLHen~IVHRDIKGDNVLvNTySGvl 715 (1226)
T KOG4279|consen 657 GSL---------------------SSLLRSKWGPLKDNESTMNFYTKQILEGLKYLHENKIVHRDIKGDNVLVNTYSGVL 715 (1226)
T ss_pred CcH---------------------HHHHHhccCCCccchhHHHHHHHHHHHHhhhhhhcceeeccccCCcEEEeeccceE
Confidence 665 33444 34677 88999999999999999999999999999999999964 6899
Q ss_pred EEeecCceeeeeccCCcccccCCCCCccChhhhCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH--HHh
Q psy8309 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGC-DEDELFWS--ICN 301 (494)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~--i~~ 301 (494)
||+|||-++.......-+.++.||..|||||++-.+ +|+.++|||||||++.||.||++||... ++...+.+ +.+
T Consensus 716 KISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~ElgspqAAMFkVGmyK 795 (1226)
T KOG4279|consen 716 KISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELGSPQAAMFKVGMYK 795 (1226)
T ss_pred EecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecCChhHhhhhhccee
Confidence 999999999877777788899999999999999754 5999999999999999999999999754 34333333 245
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
..+++|..+|.++++||.+|+..||..|| ++.++|..||++.-
T Consensus 796 vHP~iPeelsaeak~FilrcFepd~~~R~------sA~~LL~DpFlq~~ 838 (1226)
T KOG4279|consen 796 VHPPIPEELSAEAKNFILRCFEPDPCDRP------SAKDLLQDPFLQHN 838 (1226)
T ss_pred cCCCCcHHHHHHHHHHHHHHcCCCcccCc------cHHHhccCcccccC
Confidence 67889999999999999999999999999 67889999999753
|
|
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=338.55 Aligned_cols=255 Identities=33% Similarity=0.569 Sum_probs=217.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||.|+||.||+|++..++..||+|++.... ..........|..++. .++|+||+++++++.+...+|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v 77 (274)
T cd06609 1 ELFTLLECIGKGSFGEVYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLS-QCRSPYITKYYGSFLKGSKLWII 77 (274)
T ss_pred ChhhhhhhhcCCCCeEEEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHH-HcCCCCeeeeeEEEEECCeEEEE
Confidence 47889999999999999999999999999999997642 2333445566777766 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
+||+++++ |..++... .+++..++.++.||+.||.|||++|++||||+|+||+++.+|
T Consensus 78 ~e~~~~~~---------------------L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (274)
T cd06609 78 MEYCGGGS---------------------CLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEG 135 (274)
T ss_pred EEeeCCCc---------------------HHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEEECCCC
Confidence 99999554 44445443 889999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER- 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~- 303 (494)
.++|+|||+++.............|++.|+|||.+.+..++.++|||||||++|+|++|.+||...+.......+....
T Consensus 136 ~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~~ 215 (274)
T cd06609 136 DVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNP 215 (274)
T ss_pred CEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCCCcccCchHHHHHHhhhcCC
Confidence 9999999999865433334455678999999999999889999999999999999999999998877766666665543
Q ss_pred CCCCcc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 304 PRFPQF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 304 ~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+.++.. ++.++.++|.+||..+|.+|| +++++++||||...
T Consensus 216 ~~~~~~~~~~~~~~~l~~~l~~~p~~Rp------t~~~il~~~~~~~~ 257 (274)
T cd06609 216 PSLEGNKFSKPFKDFVSLCLNKDPKERP------SAKELLKHKFIKKA 257 (274)
T ss_pred CCCcccccCHHHHHHHHHHhhCChhhCc------CHHHHhhChhhcCC
Confidence 344444 889999999999999999999 68999999999864
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-43 Score=341.47 Aligned_cols=259 Identities=38% Similarity=0.681 Sum_probs=225.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC-CCceeeEEEEEEcCCeeEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK-HPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~l~~~~~~~~~~~l 143 (494)
++|++.+.||+|+||.||+|+.+.+++.||+|++.+..............|..++.. +. ||||+++++++...+.+|+
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~-l~~~~~i~~~~~~~~~~~~~~l 79 (280)
T cd05581 1 DDFKFGKIIGEGSFSTVVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTR-LNGHPGIIKLYYTFQDEENLYF 79 (280)
T ss_pred CCceEeeeecCCCceEEEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHh-cccCCCchhHHHHhcCCceEEE
Confidence 479999999999999999999999999999999987654444445566677777764 55 9999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||++. +++|...+.+.+.+++..++.++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 80 v~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~~~~H~dl~~~ni~i~~~ 138 (280)
T cd05581 80 VLEYAP---------------------NGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKD 138 (280)
T ss_pred EEcCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHeEECCC
Confidence 999998 55556667777789999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC--------------------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLD--------------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~--------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G 283 (494)
|.++|+|||++....... .......|+..|+|||++.+..++.++|+||||+++|+|++|
T Consensus 139 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g 218 (280)
T cd05581 139 MHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTG 218 (280)
T ss_pred CCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhC
Confidence 999999999987532221 223345688999999999988899999999999999999999
Q ss_pred CCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 284 QSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 284 ~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..||...+....+..+......+|..+++.+.+||.+||+.+|.+||++.+ +.+++++||||
T Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~--~~~~ll~~~~~ 280 (280)
T cd05581 219 KPPFRGSNEYLTFQKILKLEYSFPPNFPPDAKDLIEKLLVLDPQDRLGVNE--GYDELKAHPFF 280 (280)
T ss_pred CCCCCCccHHHHHHHHHhcCCCCCCccCHHHHHHHHHHhcCCHhhCCCccc--CHHHHhcCCCC
Confidence 999998888788888888888889999999999999999999999996533 34999999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=333.08 Aligned_cols=248 Identities=31% Similarity=0.581 Sum_probs=211.9
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+++++.+++.||+|.++... .....+....|..++. .++||||+++++.+.+.+.+|+||
T Consensus 1 ~y~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 77 (255)
T cd08219 1 QYNVLRVVGEGSFGRALLVQHVNSDQKYAMKEIRLPK--SSSAVEDSRKEAVLLA-KMKHPNIVAFKESFEADGHLYIVM 77 (255)
T ss_pred CceEEEEeeccCCeEEEEEEEcCCCceEEEEEEEcCc--chHHHHHHHHHHHHHH-hCCCCCcceEEEEEEECCEEEEEE
Confidence 5899999999999999999999999999999986542 2334455666777766 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+++|+| ..++.. ...+++..+..++.||+.||.|||++||+|+||||+||+++.+
T Consensus 78 e~~~~~~l---------------------~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dl~p~nili~~~ 136 (255)
T cd08219 78 EYCDGGDL---------------------MQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQN 136 (255)
T ss_pred eeCCCCcH---------------------HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEECCC
Confidence 99995544 444432 3468999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
+.++|+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||...+.......+..+.
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~~~~~~~~ 216 (255)
T cd08219 137 GKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNLILKVCQGS 216 (255)
T ss_pred CcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhhccCCCCCCCHHHHHHHHhcCC
Confidence 99999999998764433333445679999999999999899999999999999999999999999888887777776654
Q ss_pred C-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 304 P-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 304 ~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
. .+|..++.++++||.+||+.||.+|| ++.+++.
T Consensus 217 ~~~~~~~~~~~~~~li~~~l~~~P~~Rp------~~~~il~ 251 (255)
T cd08219 217 YKPLPSHYSYELRSLIKQMFKRNPRSRP------SATTILS 251 (255)
T ss_pred CCCCCcccCHHHHHHHHHHHhCCcccCC------CHHHHhh
Confidence 3 46678899999999999999999999 5677764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=343.35 Aligned_cols=258 Identities=28% Similarity=0.439 Sum_probs=208.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--Ce
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SH 140 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~ 140 (494)
.+++|++.+.||+|+||.||+|.++.++..||+|+++..... .........|..++. .++|+||+++++++... +.
T Consensus 5 ~~~~y~~~~~ig~g~~~~v~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~ 82 (309)
T cd07845 5 SVTEFEKLNRIGEGTYGIVYRARDTTSGEIVALKKVRMDNER-DGIPISSLREITLLL-NLRHPNIVELKEVVVGKHLDS 82 (309)
T ss_pred cccceeEeeeeeecCCEEEEEEEECCCCcEEEEEEEEeccCC-CCCcchhhHHHHHHH-hCCCCCCcceEEEEecCCCCe
Confidence 467999999999999999999999999999999998754321 222223456777776 57999999999999765 57
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 83 ~~lv~e~~~~----------------------~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil 140 (309)
T cd07845 83 IFLVMEYCEQ----------------------DLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLL 140 (309)
T ss_pred EEEEEecCCC----------------------CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 8999999962 23333332 367899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
++.++.+||+|||++..............+++.|+|||++.+ ..++.++|+|||||++|||++|.+||.+.+..+.+..
T Consensus 141 ~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~~~~~~~ 220 (309)
T cd07845 141 LTDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDL 220 (309)
T ss_pred ECCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999999999999998864332223333456889999999875 5689999999999999999999999999888777776
Q ss_pred HHhC-------------------CCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 299 ICNE-------------------RPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 299 i~~~-------------------~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+... ...++ ..+++++.+||.+||..||++|| ++++++.||||+
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~------t~~~il~h~~f~ 294 (309)
T cd07845 221 IIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRA------TAEEALESSYFK 294 (309)
T ss_pred HHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCc------CHHHHhcChhhc
Confidence 6541 11111 12588999999999999999999 688999999997
Q ss_pred CC
Q psy8309 349 GL 350 (494)
Q Consensus 349 ~~ 350 (494)
+.
T Consensus 295 ~~ 296 (309)
T cd07845 295 EK 296 (309)
T ss_pred cC
Confidence 53
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-42 Score=341.11 Aligned_cols=253 Identities=29% Similarity=0.491 Sum_probs=211.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+|++.+.||+|+||.||+|+++.++..||+|.+..... ........|..++. .+.||||+++++.+....+.|+|
T Consensus 20 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~v~ik~~~~~~~---~~~~~~~~e~~~l~-~~~h~~v~~~~~~~~~~~~~~lv 95 (296)
T cd06654 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVV 95 (296)
T ss_pred cceeeEEEecCCCCeEEEEEEECCCCcEEEEEEEecCCc---chHHHHHHHHHHHH-hCCCCCEeeEEEEEEeCCEEEEe
Confidence 589999999999999999999999999999999876432 23345566777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+++|+ |..++. ...+++.++..++.||+.||.|||++||+||||||+|||++.++
T Consensus 96 ~e~~~~~~---------------------L~~~~~-~~~~~~~~~~~i~~ql~~aL~~LH~~gi~H~dLkp~Nill~~~~ 153 (296)
T cd06654 96 MEYLAGGS---------------------LTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153 (296)
T ss_pred ecccCCCC---------------------HHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcCCC
Confidence 99999554 444443 34689999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-ER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~ 303 (494)
.+||+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+.. ..
T Consensus 154 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~~~~~~~~~~~~~ 233 (296)
T cd06654 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (296)
T ss_pred CEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCHHHhHHHHhcCCC
Confidence 99999999987533222233445799999999999998899999999999999999999999988776544333332 22
Q ss_pred --CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 304 --PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 304 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
...|..++..+.+||.+||..||.+|| +++|++.|+||..
T Consensus 234 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~eil~~~~~~~ 275 (296)
T cd06654 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRG------SAKELLQHQFLKI 275 (296)
T ss_pred CCCCCccccCHHHHHHHHHHCcCCcccCc------CHHHHhhChhhhc
Confidence 234567889999999999999999999 6899999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >KOG0603|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-44 Score=362.57 Aligned_cols=245 Identities=36% Similarity=0.565 Sum_probs=209.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++...||.|+|+.|-.|.+..+++.+|+|++.+.... ...|..++....+||||+++++.+.+..+.|
T Consensus 320 ~~~~y~~~~~~~~gs~s~~~~~~~~~t~~~~~vkii~~~~~~-------~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~ 392 (612)
T KOG0603|consen 320 FTESYEFREELGEGSFSAVKYCESSPTDQEPAVKIISKRADD-------NQDEIPISLLVRDHPNIVKSHDVYEDGKEIY 392 (612)
T ss_pred cchhhccccccCCCCccceeeeeccccccchhheeccccccc-------cccccchhhhhcCCCcceeecceecCCceee
Confidence 357899999999999999999999999999999999876221 1234445555679999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee-C
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL-D 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl-~ 221 (494)
+|||.+. |+.+...+.....+. .++..|++||+.|+.|||++|||||||||+|||+ +
T Consensus 393 ~v~e~l~---------------------g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvvhRDLkp~NIL~~~ 450 (612)
T KOG0603|consen 393 LVMELLD---------------------GGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVVHRDLKPGNILLDG 450 (612)
T ss_pred eeehhcc---------------------ccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCeeecCCChhheeecC
Confidence 9999998 555566666665555 7888999999999999999999999999999999 6
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i~ 300 (494)
..|+++|+|||.++... ....+.|-|..|.|||++...+|+.++||||||++||+||+|+.||...... ++...|.
T Consensus 451 ~~g~lrltyFG~a~~~~---~~~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~~ei~~~i~ 527 (612)
T KOG0603|consen 451 SAGHLRLTYFGFWSELE---RSCDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAGIEIHTRIQ 527 (612)
T ss_pred CCCcEEEEEechhhhCc---hhhcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCchHHHHHhhc
Confidence 99999999999987532 2244567789999999999999999999999999999999999999876554 5665655
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.+. +...+|.++++||++||+.||.+|| ++++++.||||
T Consensus 528 ~~~--~s~~vS~~AKdLl~~LL~~dP~~Rl------~~~~i~~h~w~ 566 (612)
T KOG0603|consen 528 MPK--FSECVSDEAKDLLQQLLQVDPALRL------GADEIGAHPWF 566 (612)
T ss_pred CCc--cccccCHHHHHHHHHhccCChhhCc------ChhhhccCcch
Confidence 443 3488999999999999999999999 67889999999
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=332.72 Aligned_cols=253 Identities=27% Similarity=0.488 Sum_probs=216.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+++...+++.||+|.+..... ..........|..++. .++||||+++++++...++.|+||
T Consensus 1 ~y~~~~~lg~g~~g~~~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08218 1 KYVKVKKIGEGSFGKAILVKSKEDGKQYVIKEINISKM-SPKEREESRKEVAVLS-NMKHPNIVQYQESFEENGNLYIVM 78 (256)
T ss_pred CceEEEEeccCCceEEEEEEEcCCCCEEEEEEEEhHhC-ChHHHHHHHHHHHHHH-hCCCCCeeeeEeeecCCCeEEEEE
Confidence 58999999999999999999999999999999876432 2334455667777776 589999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+.+++ |...+... ..+++..+..++.||+.||.|||++|++|+||+|+|||++.+
T Consensus 79 e~~~~~~---------------------l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~l~~~nil~~~~ 137 (256)
T cd08218 79 DYCEGGD---------------------LYKKINAQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKD 137 (256)
T ss_pred ecCCCCc---------------------HHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEEcCC
Confidence 9999554 44444432 368899999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
+.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..||...+..+....+..+.
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08218 138 GTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGS 217 (256)
T ss_pred CCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCCHHHHHHHHhcCC
Confidence 99999999998754332222334568999999999999899999999999999999999999999888888887777654
Q ss_pred C-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 P-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 ~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. ..|..++.++.++|.+||+.+|.+|| +++++++||||
T Consensus 218 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~vl~~~~~ 256 (256)
T cd08218 218 YPPVSSHYSYDLRNLVSQLFKRNPRDRP------SVNSILEKNFI 256 (256)
T ss_pred CCCCcccCCHHHHHHHHHHhhCChhhCc------CHHHHhhCcCC
Confidence 3 46778899999999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-42 Score=338.60 Aligned_cols=271 Identities=23% Similarity=0.302 Sum_probs=211.0
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
...++|++.+.||+|+||.||+|..+. .+..||+|.+.... ..........|..++. .++||||+++++++.
T Consensus 3 ~~~~~~~i~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~ 79 (288)
T cd05061 3 VSREKITLLRELGQGSFGMVYEGNARDIIKGEAETRVAVKTVNESA--SLRERIEFLNEASVMK-GFTCHHVVRLLGVVS 79 (288)
T ss_pred ccHHHceeeeeecCCCCcEEEEEEEeccCCCCcceEEEEEECCCcC--CHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEc
Confidence 345789999999999999999997653 35579999886542 2222334556666665 578999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+.+..|+||||+.+|+|.+.+... +.. .........++...+..++.||+.||.|||++||+||||||+
T Consensus 80 ~~~~~~lv~e~~~~g~L~~~l~~~----------~~~-~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dikp~ 148 (288)
T cd05061 80 KGQPTLVVMELMAHGDLKSYLRSL----------RPE-AENNPGRPPPTLQEMIQMAAEIADGMAYLNAKKFVHRDLAAR 148 (288)
T ss_pred CCCCcEEEEeCCCCCCHHHHHHHh----------ccc-cccCCCCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCCChh
Confidence 999999999999977663211000 000 000001234567788999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.++|+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..
T Consensus 149 nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l~el~~~~~~p~~~~~~~ 228 (288)
T cd05061 149 NCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNE 228 (288)
T ss_pred eEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999874322111 1222345778999999999899999999999999999998 89999988888
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc------CCCcCCCCh
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA------HEYFRGLDW 352 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~------h~~f~~~~w 352 (494)
+....+..+ ....+...++++++++.+||+.||.+||+ +.++++ ||||++++|
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~ll~~l~~~~~~~~~~~~~ 288 (288)
T cd05061 229 QVLKFVMDGGYLDQPDNCPERVTDLMRMCWQFNPKMRPT------FLEIVNLLKDDLHPSFPEVSF 288 (288)
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCcC------HHHHHHHHHhhcCCCCCCCCC
Confidence 877777654 34566778899999999999999999995 455554 999999998
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=341.01 Aligned_cols=254 Identities=29% Similarity=0.483 Sum_probs=213.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+|++.+.||.|+||.||+|.+..+++.||+|.+.... .........|..++. .++||||+++++++...+.+|+|
T Consensus 19 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 94 (296)
T cd06655 19 KKYTRYEKIGQGASGTVFTAIDVATGQEVAIKQINLQK---QPKKELIINEILVMK-ELKNPNIVNFLDSFLVGDELFVV 94 (296)
T ss_pred ceEEEEEEEecCCCeEEEEEEEcCCCcEEEEEEEeccc---CchHHHHHHHHHHHH-hcCCCceeeeeeeEecCceEEEE
Confidence 57999999999999999999999999999999987542 223345566766666 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
+||+++|+| ..++. ...+++.++..++.||+.||+|||++|++||||||+||+++.++
T Consensus 95 ~e~~~~~~L---------------------~~~~~-~~~l~~~~~~~i~~~l~~al~~LH~~~i~H~dL~p~Nili~~~~ 152 (296)
T cd06655 95 MEYLAGGSL---------------------TDVVT-ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDG 152 (296)
T ss_pred EEecCCCcH---------------------HHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 999995544 44443 34689999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-- 302 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-- 302 (494)
.+||+|||++.............+|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 153 ~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~~~~~~~~~~~~~ 232 (296)
T cd06655 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (296)
T ss_pred CEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 999999999875433333334567999999999999988999999999999999999999999988776555444432
Q ss_pred -CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 -RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
....|..++..+++||.+||..||.+|| ++.+++.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------t~~~il~~~~~~~~ 275 (296)
T cd06655 233 PELQNPEKLSPIFRDFLNRCLEMDVEKRG------SAKELLQHPFLKLA 275 (296)
T ss_pred cccCCcccCCHHHHHHHHHHhhcChhhCC------CHHHHhhChHhhhc
Confidence 2234567899999999999999999999 68999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=340.19 Aligned_cols=257 Identities=28% Similarity=0.438 Sum_probs=206.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE-----cC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ-----TD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~-----~~ 138 (494)
.++|++++.||+|+||.||+|+++.+++.||+|++.... ........|..++....+||||+++++++. ..
T Consensus 17 ~~~~~~~~~lg~g~~~~vy~~~~~~~~~~~~ik~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 92 (286)
T cd06638 17 SDTWEIIETIGKGTYGKVFKVLNKKNGSKAAVKILDPIH----DIDEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNG 92 (286)
T ss_pred ccceeeeeeeccCCCcEEEEEEECCCCceeEEEeecccc----chHHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCC
Confidence 568999999999999999999999999999999886431 112344567777765447999999999873 45
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|+||||++||+|.+ -+...+.....+++..++.++.||+.||.|||+++|+||||||+||
T Consensus 93 ~~~~lv~e~~~~~~L~~-----------------~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 155 (286)
T cd06638 93 DQLWLVLELCNGGSVTD-----------------LVKGFLKRGERMEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNI 155 (286)
T ss_pred CeEEEEEeecCCCCHHH-----------------HHHHhhccCccccHHHHHHHHHHHHHHHHHHHhCCccccCCCHHhE
Confidence 67999999999776621 0111223345789999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
+++.++.+||+|||+++.............|++.|+|||++.. ..++.++|||||||++|||++|..||...+..
T Consensus 156 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~~ 235 (286)
T cd06638 156 LLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHPM 235 (286)
T ss_pred EECCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCchh
Confidence 9999999999999998754333333345679999999999853 45889999999999999999999999877665
Q ss_pred HHHHHHHhCC---CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 294 ELFWSICNER---PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 294 ~~~~~i~~~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.....+.... ...|..++.++++||.+||+.||.+|| ++.|+++|+||
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~ell~~~~~ 286 (286)
T cd06638 236 RALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRP------TVSDLLQHVFI 286 (286)
T ss_pred HHHhhccccCCCcccCCCCcCHHHHHHHHHHccCCcccCC------CHHHHhhcccC
Confidence 5444433221 223456788999999999999999999 68999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=335.11 Aligned_cols=255 Identities=28% Similarity=0.494 Sum_probs=211.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CCe
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--EDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DSH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~~ 140 (494)
.+|+..+.||+|+||.||+|.+..++..||+|++...... ..........|..++. .++||||+++++++.+ ...
T Consensus 2 ~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 80 (266)
T cd06651 2 INWRRGKLLGQGAFGRVYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLK-NLQHERIVQYYGCLRDRAEKT 80 (266)
T ss_pred CCccccceecCCCCEEEEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHH-HcCCCCeeeEEEEEEcCCCCE
Confidence 4789999999999999999999999999999998754321 2234455666777776 5799999999999876 367
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++++|||++ +++|...+...+.+++..++.++.||+.||+|||++||+||||||+||++
T Consensus 81 ~~l~~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~~i~H~~l~p~nil~ 139 (266)
T cd06651 81 LTIFMEYMP---------------------GGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILR 139 (266)
T ss_pred EEEEEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEE
Confidence 899999998 44555566666789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeecc---CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYL---DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.++.+||+|||+++..... ........|+..|+|||.+.+..++.++|+|||||++|||++|..||...+..+...
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~~~~~~~ 219 (266)
T cd06651 140 DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYEAMAAIF 219 (266)
T ss_pred CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccchHHHHH
Confidence 99999999999998743211 111233568999999999999899999999999999999999999998776555554
Q ss_pred HHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 298 SICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 298 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+... .+.+|..+++.++++| +||..+|++|| +++||++||||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~li-~~~~~~p~~Rp------~~~eil~hp~~~ 265 (266)
T cd06651 220 KIATQPTNPQLPSHISEHARDFL-GCIFVEARHRP------SAEELLRHPFAQ 265 (266)
T ss_pred HHhcCCCCCCCchhcCHHHHHHH-HHhcCChhhCc------CHHHHhcCcccc
Confidence 44332 4566778899999999 57778999999 689999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-42 Score=333.55 Aligned_cols=251 Identities=29% Similarity=0.470 Sum_probs=211.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||.|+||.||+|++..+++.+|+|++.... .........|..++. .++||||+++++++.....+|++
T Consensus 3 ~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~---~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l~ 78 (262)
T cd06613 3 EDYELIQRIGSGTYGDVYKARDIATGELVAIKVIKLEP---GDDFEIIQQEISMLK-ECRHPNIVAYFGSYLRRDKLWIV 78 (262)
T ss_pred cceEEEEEecCCCceEEEEeEecCCCCEEEEEEEEcCc---hhhHHHHHHHHHHHH-hCCCCChhceEEEEEeCCEEEEE
Confidence 68999999999999999999999999999999997642 224455667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+.++ .|..++... ..+++..+..++.|++.||.|||++||+||||||+||+++.+
T Consensus 79 ~e~~~~~---------------------~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~i~h~dl~p~ni~i~~~ 137 (262)
T cd06613 79 MEYCGGG---------------------SLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTED 137 (262)
T ss_pred EeCCCCC---------------------cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCceecCCChhhEEECCC
Confidence 9999854 444455554 689999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+||+|||++.............+|+..|+|||.+.+. .++.++|+|||||++|+|++|.+||.+.+.......+.
T Consensus 138 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~~~~~~~~~~ 217 (262)
T cd06613 138 GDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLHPMRALFLIS 217 (262)
T ss_pred CCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 999999999987533322233456789999999999877 88999999999999999999999998877666555555
Q ss_pred hCCCC-----CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 301 NERPR-----FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 301 ~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
..... .+..++.+++++|.+||..+|.+|| ++.+|+.|+|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~il~~~~ 262 (262)
T cd06613 218 KSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRP------TATKLLQHPF 262 (262)
T ss_pred hccCCCccccchhhhhHHHHHHHHHHcCCChhhCC------CHHHHhcCCC
Confidence 44222 2334678899999999999999999 6899999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-42 Score=334.65 Aligned_cols=253 Identities=27% Similarity=0.475 Sum_probs=211.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc---ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL---EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~---~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+|++.+.||+|+||.||+|.. .+++.+|||.+...... ..........|..++. .++|+||+++++++.+.+..|
T Consensus 1 ~~~~~~~ig~g~~~~v~~~~~-~~~~~~avk~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 78 (265)
T cd06631 1 EWTKGEVLGKGAYGTVYCGLT-NQGQLIAVKQVELDTSNVLAAEKEYEKLQEEVDLLK-SLKHVNIVQYLGTCLDDNTIS 78 (265)
T ss_pred CccccceEeccCCeEEEEEEE-cCCCeEEEEEeecCccchhhHHHHHHHHHHHHHHHH-hcCCCCEeeEeeEeecCCeEE
Confidence 578899999999999999975 57888999998754221 1223345666777776 578999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ |++|..++.+.+.+++..+..++.||+.||+|||++||+|+||+|+||+++.
T Consensus 79 lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~~ 137 (265)
T cd06631 79 IFMEFVP---------------------GGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMP 137 (265)
T ss_pred EEEecCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHhEEECC
Confidence 9999999 5555667777778999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeec------cCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIY------LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~------~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
++.++|+|||++..... .........|+..|+|||++.+..++.++|+|||||++|+|++|..||...+.....
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~ 217 (265)
T cd06631 138 NGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAM 217 (265)
T ss_pred CCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHhCCCccccCChHHHH
Confidence 99999999998864211 111223457899999999999999999999999999999999999999877665555
Q ss_pred HHHHhC---CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 297 WSICNE---RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 297 ~~i~~~---~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..+... .+.++..++.++.++|.+||..+|.+|| ++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp------~~~~~l~~~~~ 265 (265)
T cd06631 218 FYIGAHRGLMPRLPDSFSAAAIDFVTSCLTRDQHERP------SALQLLRHDFL 265 (265)
T ss_pred HHhhhccCCCCCCCCCCCHHHHHHHHHHhcCCcccCC------CHHHHhcCCCC
Confidence 444433 2456678899999999999999999999 67999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-42 Score=339.07 Aligned_cols=258 Identities=28% Similarity=0.428 Sum_probs=208.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++.+.||+|+||.||+|..+.+++.||+|++.... ........|..++....+||||+++++++...
T Consensus 21 ~~~y~~~~~l~~g~~~~vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~ 96 (291)
T cd06639 21 TDTWEIIETIGKGTYGKVYKVTNKKDGSLAAVKILDPIS----DVDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVG 96 (291)
T ss_pred CCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEecccc----cHHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCC
Confidence 468999999999999999999999999999999986532 12234455666666545899999999998754
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|+||||++||+|.+. + .........+++..++.++.||+.||+|||++||+||||||+||
T Consensus 97 ~~~~lv~ey~~~~sL~~~------------~-----~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~dlkp~ni 159 (291)
T cd06639 97 GQLWLVLELCNGGSVTEL------------V-----KGLLICGQRLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNI 159 (291)
T ss_pred CeeEEEEEECCCCcHHHH------------H-----HHhhhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHE
Confidence 368999999996665210 0 01122345789999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
+++.++.+||+|||++.............+|+..|+|||++... .++.++|||||||++|||++|++||...+..
T Consensus 160 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~~ 239 (291)
T cd06639 160 LLTTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPV 239 (291)
T ss_pred EEcCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcHH
Confidence 99999999999999987533322233456789999999998643 3689999999999999999999999888776
Q ss_pred HHHHHHHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 294 ELFWSICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 294 ~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+....+..... ..+..++.++++||.+||..+|++|| ++.||+.||||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~il~~~~~~ 291 (291)
T cd06639 240 KTLFKIPRNPPPTLLHPEKWCRSFNHFISQCLIKDFEARP------SVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHhcCCCCCCCcccccCHHHHHHHHHHhhcChhhCc------CHHHHhcCcccC
Confidence 66666654422 23556778999999999999999999 689999999984
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-42 Score=332.98 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=211.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--Ce
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~ 140 (494)
++|++.+.||+|+||.||+|.+..++..||||++...... ..........|..++. .+.||||+++++++.+. ..
T Consensus 2 ~~~~~~~~l~~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~ 80 (265)
T cd06652 2 TNWRLGKLLGQGAFGRVYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLK-NLLHERIVQYYGCLRDPMERT 80 (265)
T ss_pred CcceEeeEEecCCceEEEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHH-hcCCCCeeeEEeEeccCCCce
Confidence 5899999999999999999999999999999998643211 2234456667777776 57999999999998763 57
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ |++|..++.+.+.+++..+..++.||+.||+|||++||+|+||||+||++
T Consensus 81 ~~~v~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~nil~ 139 (265)
T cd06652 81 LSIFMEHMP---------------------GGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSNMIVHRDIKGANILR 139 (265)
T ss_pred EEEEEEecC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEe
Confidence 899999999 45556667666788999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeecc---CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYL---DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.++.++|+|||++...... ........|+..|+|||++.+..++.++|+|||||++|||++|+.||..........
T Consensus 140 ~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~ 219 (265)
T cd06652 140 DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIF 219 (265)
T ss_pred cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCccchHHHHH
Confidence 99999999999998743211 112334568999999999998889999999999999999999999998776555555
Q ss_pred HHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 298 SICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 298 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+... .+..|..++..+.++|.+||. +|++|| +++|++.|||++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~i~~~l~-~p~~Rp------~~~~il~~~~~~ 265 (265)
T cd06652 220 KIATQPTNPVLPPHVSDHCRDFLKRIFV-EAKLRP------SADELLRHTFVH 265 (265)
T ss_pred HHhcCCCCCCCchhhCHHHHHHHHHHhc-ChhhCC------CHHHHhcCcccC
Confidence 54433 345667789999999999995 999999 689999999974
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-42 Score=354.75 Aligned_cols=270 Identities=28% Similarity=0.389 Sum_probs=205.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCC-----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|++..++ ..||||+++... ..........|..++....+|+|||++++++
T Consensus 34 ~~~~~~~~~~~~LG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~il~~l~~h~nIv~~~~~~ 111 (374)
T cd05106 34 EFPRDNLQFGKTLGAGAFGKVVEATAFGLGKEDNVLRVAVKMLKASA--HTDEREALMSELKILSHLGQHKNIVNLLGAC 111 (374)
T ss_pred cccHHHceehheecCCCcccEEEEEEecCCcccccceeEEEeccCCC--CHHHHHHHHHHHHHHHhhccCCceeeEeeEe
Confidence 345678999999999999999999875443 479999997642 2334456777888887544899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhh-------------Hhc--------------------------------
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLME-------------YLN-------------------------------- 170 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~-------------~~~-------------------------------- 170 (494)
.....+|+|||||++|+|.+.+.......... +..
T Consensus 112 ~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 191 (374)
T cd05106 112 THGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSS 191 (374)
T ss_pred cCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccchhcccccccccccccccccccccCCccccc
Confidence 99999999999999999865432211100000 000
Q ss_pred --CCchhH--HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cc
Q psy8309 171 --GGDLMF--HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TT 244 (494)
Q Consensus 171 --gg~L~~--~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~ 244 (494)
+..... ......++++.+++.++.||+.||.|||++||+||||||+|||++.++.+||+|||+++....... ..
T Consensus 192 ~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~ 271 (374)
T cd05106 192 SQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVK 271 (374)
T ss_pred cccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeec
Confidence 000000 001124689999999999999999999999999999999999999999999999999875322111 11
Q ss_pred cccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHhh
Q psy8309 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE--RPRFPQFLSVEAKNILVHL 321 (494)
Q Consensus 245 ~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~l 321 (494)
....+++.|||||++.+..++.++|||||||++|||++ |..||........+..+... .+..|..++++++++|.+|
T Consensus 272 ~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~c 351 (374)
T cd05106 272 GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILVNSKFYKMVKRGYQMSRPDFAPPEIYSIMKMC 351 (374)
T ss_pred cCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccccHHHHHHHHcccCccCCCCCCHHHHHHHHHH
Confidence 22335678999999999899999999999999999997 99999887655555444443 3445667899999999999
Q ss_pred ccCCCCCCCCC
Q psy8309 322 LDKDTTKRLGS 332 (494)
Q Consensus 322 L~~dP~~R~~~ 332 (494)
|+.||.+||++
T Consensus 352 l~~dp~~RPs~ 362 (374)
T cd05106 352 WNLEPTERPTF 362 (374)
T ss_pred cCCChhhCcCH
Confidence 99999999943
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-42 Score=360.18 Aligned_cols=248 Identities=22% Similarity=0.321 Sum_probs=198.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
...|.+.+.||+|+||.||+|.+..+++.||||..... ....|..++. .++|||||++++++...+..|+
T Consensus 168 ~~gy~i~~~Lg~G~~G~Vy~a~~~~~~~~vavK~~~~~---------~~~~E~~iL~-~L~HpnIv~l~~~~~~~~~~~l 237 (461)
T PHA03211 168 GLGFAIHRALTPGSEGCVFESSHPDYPQRVVVKAGWYA---------SSVHEARLLR-RLSHPAVLALLDVRVVGGLTCL 237 (461)
T ss_pred cCCeEEEEEEccCCCeEEEEEEECCCCCEEEEeccccc---------CHHHHHHHHH-HCCCCCCCcEEEEEEECCEEEE
Confidence 34799999999999999999999999999999964321 2346777777 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||++. | +|..++.. ...+++..++.++.||+.||.|||++||+||||||+||||+.
T Consensus 238 v~e~~~-~---------------------~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDLKP~NILl~~ 295 (461)
T PHA03211 238 VLPKYR-S---------------------DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNG 295 (461)
T ss_pred EEEccC-C---------------------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEECcCCHHHEEECC
Confidence 999985 2 33344433 357999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--------H
Q psy8309 223 EGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD--------E 292 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--------~ 292 (494)
++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||+||||++|..|+.... .
T Consensus 296 ~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~~~~~~~~~~~~ 375 (461)
T PHA03211 296 PEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFSASRGDERRPYD 375 (461)
T ss_pred CCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcCCCcccCCcccccCCcH
Confidence 99999999999875322111 1234679999999999999999999999999999999999876553221 2
Q ss_pred HHHHHHHHhCCC---CCC-------------------------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 293 DELFWSICNERP---RFP-------------------------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 293 ~~~~~~i~~~~~---~~p-------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
..+...|..... .+| ..++.++++||.+||+.||.+|| ++
T Consensus 376 ~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~DP~~RP------sa 449 (461)
T PHA03211 376 AQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRALTFDGARRP------SA 449 (461)
T ss_pred HHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHcccChhhCc------CH
Confidence 223332222111 111 02456899999999999999999 68
Q ss_pred hhhhcCCCcCC
Q psy8309 339 DDVVAHEYFRG 349 (494)
Q Consensus 339 ~eil~h~~f~~ 349 (494)
.|+|+||||+.
T Consensus 450 ~elL~hp~f~~ 460 (461)
T PHA03211 450 AELLRLPLFQS 460 (461)
T ss_pred HHHhhCcccCC
Confidence 99999999964
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-42 Score=341.71 Aligned_cols=254 Identities=28% Similarity=0.482 Sum_probs=211.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+|++++.||+|+||.||+|.+..+++.||||.+..... ...+....|..++. .++||||+++++++...+..|+|
T Consensus 19 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~lv 94 (297)
T cd06656 19 KKYTRFEKIGQGASGTVYTAIDIATGQEVAIKQMNLQQQ---PKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVV 94 (297)
T ss_pred hhceeeeeeccCCCeEEEEEEECCCCCEEEEEEEecCcc---chHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCEEEEe
Confidence 689999999999999999999999999999999875422 23344556666665 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+++|+ |..++. ...+++.++..++.|++.||.|||+.||+||||||+|||++.+|
T Consensus 95 ~e~~~~~~---------------------L~~~~~-~~~~~~~~~~~~~~~l~~~L~~LH~~~i~H~dL~p~Nili~~~~ 152 (297)
T cd06656 95 MEYLAGGS---------------------LTDVVT-ETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDG 152 (297)
T ss_pred ecccCCCC---------------------HHHHHH-hCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCC
Confidence 99999554 444443 35689999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-ER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~ 303 (494)
.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+.......+.. +.
T Consensus 153 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~~~~~~~~~~~~~ 232 (297)
T cd06656 153 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGT 232 (297)
T ss_pred CEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcchheeeeccCCC
Confidence 99999999987533322233456789999999999998999999999999999999999999987665443333322 22
Q ss_pred --CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 304 --PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 304 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
...|..++..+++||.+||..||.+|| ++++++.||||+..
T Consensus 233 ~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~~~~~~~~ 275 (297)
T cd06656 233 PELQNPERLSAVFRDFLNRCLEMDVDRRG------SAKELLQHPFLKLA 275 (297)
T ss_pred CCCCCccccCHHHHHHHHHHccCChhhCc------CHHHHhcCchhccc
Confidence 234567889999999999999999999 68999999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=339.83 Aligned_cols=254 Identities=28% Similarity=0.439 Sum_probs=207.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|.++.+++.||+|++.+.... ....+....|..++. .++||||+++++++...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 78 (286)
T cd07846 1 EKYENLGLVGEGSYGMVMKCKHKETGQIVAIKKFLESEDD-KMVKKIAMREIRMLK-QLRHENLVNLIEVFRRKKRLYLV 78 (286)
T ss_pred CceeEeeeeccCCCeEEEEEEECCCCCEEEEEeHhhccCc-chhhHHHHHHHHHHH-hcCCcchhhHHHhcccCCeEEEE
Confidence 4799999999999999999999999999999998764322 223344556777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++++ .+.........+++..++.++.||+.||.|||++||+||||+|+||+++.++
T Consensus 79 ~e~~~~~---------------------~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~h~~l~p~ni~~~~~~ 137 (286)
T cd07846 79 FEFVDHT---------------------VLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSG 137 (286)
T ss_pred EecCCcc---------------------HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEECCCC
Confidence 9999844 3444444455689999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
.++|+|||++..............|+..|+|||++.+ ..++.++|||||||++|||++|.+||.+....+....+....
T Consensus 138 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~ 217 (286)
T cd07846 138 VVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKCL 217 (286)
T ss_pred cEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCCCCCCCchHHHHHHHHHHh
Confidence 9999999998764333333345678999999999876 447889999999999999999999998776554443333100
Q ss_pred -------------------CCC------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 -------------------PRF------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 -------------------~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
... ++.++..+++||.+||..+|.+|| ++.++++|+||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------~~~~il~~~~~ 286 (286)
T cd07846 218 GNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRP------SSSQLLHHEFF 286 (286)
T ss_pred CCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccch------hHHHHhcCCCC
Confidence 001 235688999999999999999999 67899999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=337.70 Aligned_cols=266 Identities=25% Similarity=0.375 Sum_probs=210.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCC-----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|++++.||+|+||.||+|.....+ ..||+|.++... ..........|..++. .++||||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~v~~K~~~~~~--~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~ 78 (283)
T cd05048 2 IPLSAVRFLEELGEGAFGKVYKGELTGPNERLSATSVAIKTLKENA--EPKVQQEFRQEAELMS-DLQHPNIVCLLGVCT 78 (283)
T ss_pred CChHHcchhhcccCccCCcEEEEEEecCCCCcceeeEEEEecccCC--CHHHHHHHHHHHHHHH-hcCCcccceEEEEEc
Confidence 45678999999999999999999987655 679999987542 2233344566777776 579999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHH---hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH---IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~---l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
.....|++|||+++|+|.+.+..... ..+.... ......+++..+..++.||+.||.|||++|++||||
T Consensus 79 ~~~~~~~~~e~~~~~~L~~~l~~~~~--------~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~al~~lH~~~i~H~dl 150 (283)
T cd05048 79 KEQPTCMLFEYLAHGDLHEFLVRNSP--------HSDVGAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDL 150 (283)
T ss_pred CCCceEEEEecCCCCcHHHHHHhcCC--------CcccccccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeecccc
Confidence 99999999999997766321110000 0000000 001156889999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~ 290 (494)
||+||+++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 151 kp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv~slG~il~el~~~g~~p~~~~ 230 (283)
T cd05048 151 AARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGF 230 (283)
T ss_pred ccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999987532211 12334567889999999998899999999999999999998 99999998
Q ss_pred CHHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 291 DEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 291 ~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..++...|.... ...|..++.++.+|+.+||+.||.+|| ++.||++|
T Consensus 231 ~~~~~~~~i~~~~~~~~~~~~~~~~~~l~~~c~~~~p~~Rp------~~~~i~~~ 279 (283)
T cd05048 231 SNQEVIEMIRSRQLLPCPEDCPARVYALMIECWNEIPARRP------RFKDIHTR 279 (283)
T ss_pred CHHHHHHHHHcCCcCCCcccCCHHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 8888888877654 345678999999999999999999999 56777653
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-41 Score=327.93 Aligned_cols=253 Identities=30% Similarity=0.494 Sum_probs=218.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|+.+++||.|+||.||.++...++..+++|.+..... ..........|..++. .++|+||+++++++.+.+.++++|
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~~~ 78 (256)
T cd08221 1 HYIPIRVLGKGAFGEATLYRRTEDDSLVVWKEVNLTRL-SEKERRDALNEIVILS-LLQHPNIIAYYNHFMDDNTLLIEM 78 (256)
T ss_pred CceEeeEecccCCceEEEEEEcCCCcEEEEEEEeeccc-chhHHHHHHHHHHHHH-hCCCCCeeEEEeEEecCCeEEEEE
Confidence 58999999999999999999999999999999875432 2334455677888777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||++|+ |..++... ..+++..+..++.|++.||.|||+.|++||||+|+||+++.+
T Consensus 79 e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~ni~~~~~ 137 (256)
T cd08221 79 EYANGGT---------------------LYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKA 137 (256)
T ss_pred EecCCCc---------------------HHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChHhEEEeCC
Confidence 9999554 44445443 568999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
+.+||+|||++..............|++.|+|||.+.+..++.++|+||||+++|||++|..||...+..+....+..+.
T Consensus 138 ~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~~~~~~~~~~~~ 217 (256)
T cd08221 138 GLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGN 217 (256)
T ss_pred CCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999998864333333445679999999999998889999999999999999999999999988888888887664
Q ss_pred CC-CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 PR-FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 ~~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.. .+..++.++.++|.+||..+|.+|| +++++++|+|+
T Consensus 218 ~~~~~~~~~~~~~~~i~~~l~~~p~~R~------s~~~ll~~~~l 256 (256)
T cd08221 218 YTPVVSVYSSELISLVHSLLQQDPEKRP------TADEVLDQPLL 256 (256)
T ss_pred CCCCccccCHHHHHHHHHHcccCcccCC------CHHHHhhCcCC
Confidence 43 3456899999999999999999999 68999999985
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=332.49 Aligned_cols=253 Identities=29% Similarity=0.532 Sum_probs=212.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||.|+||+||+|....++..+|+|++.+..... .......|..++. .++|+||+++++.+...+..|+|
T Consensus 1 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv 77 (267)
T cd06610 1 DDYELIEVIGVGATAVVYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMS-QCNHPNVVKYYTSFVVGDELWLV 77 (267)
T ss_pred CcceeeeeecCCCCeEEEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHH-hcCCCCEEEEEEEEeeCCEEEEE
Confidence 47999999999999999999999899999999997643222 4455667777766 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||++++++ |...+... ..+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 78 ~e~~~~~~---------------------l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~~i~h~~l~p~ni~~~ 136 (267)
T cd06610 78 MPYLSGGS---------------------LLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLG 136 (267)
T ss_pred EeccCCCc---------------------HHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHhEEEc
Confidence 99999554 44455442 4689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCc----ccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
.++.++|+|||++......... ....+|+..|+|||++... .++.++|+|||||++|+|++|..||...+..+.+
T Consensus 137 ~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~~~~~ 216 (267)
T cd06610 137 EDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPPMKVL 216 (267)
T ss_pred CCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccChhhhH
Confidence 9999999999998754322221 2445799999999999876 7899999999999999999999999887776666
Q ss_pred HHHHhCCC-CCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 297 WSICNERP-RFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 297 ~~i~~~~~-~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.++..... .++ ..++.+++++|.+||..||.+|| ++++++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~ll~~p~~ 267 (267)
T cd06610 217 MLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRP------TAEELLKHKFF 267 (267)
T ss_pred HHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCc------CHHHHhhCCCC
Confidence 66655432 222 25688999999999999999999 68999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-42 Score=340.20 Aligned_cols=254 Identities=26% Similarity=0.495 Sum_probs=211.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|++..++..||+|.++.. ...........|..++. .++||||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv 77 (286)
T cd06622 1 DEIEVLDELGKGNYGSVYKVLHRPTGVTMAMKEIRLE--LDESKFNQIIMELDILH-KAVSPYIVDFYGAFFIEGAVYMC 77 (286)
T ss_pred ChhhhhhhhcccCCeEEEEEEEcCCCcEEEEEEeecc--cCHHHHHHHHHHHHHHH-hcCCCcHHhhhhheecCCeEEEE
Confidence 4789999999999999999999999999999998753 23334456777888887 47999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceee
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ---SGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILL 220 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl 220 (494)
|||+++++ |..++.. ...+++..+..++.||+.||.|||+ +||+||||||+||++
T Consensus 78 ~e~~~~~~---------------------l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~ 136 (286)
T cd06622 78 MEYMDAGS---------------------LDKLYAGGVATEGIPEDVLRRITYAVVKGLKFLKEEHNIIHRDVKPTNVLV 136 (286)
T ss_pred EeecCCCC---------------------HHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhcCCEeeCCCCHHHEEE
Confidence 99999554 4444443 2478999999999999999999997 599999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC------CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL------KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
+.++.+||+|||++.... .......+|++.|+|||.+.+. .++.++|+|||||++|+|++|..||.......
T Consensus 137 ~~~~~~~l~dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~ 214 (286)
T cd06622 137 NGNGQVKLCDFGVSGNLV--ASLAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPETYAN 214 (286)
T ss_pred CCCCCEEEeecCCccccc--CCccccCCCccCccCcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcchhh
Confidence 999999999999986432 2334456789999999998653 35889999999999999999999997765544
Q ss_pred HHH---HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 295 LFW---SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 295 ~~~---~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
... .+... .+.+|..++.++.+||.+||..+|.+|| ++++++.||||...
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~l~~~~~~~~~ 268 (286)
T cd06622 215 IFAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRP------TYAQLLEHPWLVKY 268 (286)
T ss_pred HHHHHHHHhhcCCCCCCcccCHHHHHHHHHHcccCcccCC------CHHHHhcChhhhhc
Confidence 433 33333 3456777999999999999999999999 68999999999653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-42 Score=335.64 Aligned_cols=249 Identities=27% Similarity=0.463 Sum_probs=202.4
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--CeeEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SHLFFV 144 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~~~lv 144 (494)
|++++.||+|+||.||+|.++.+++.||+|++++... .........|..++....+|+||+++++++.+. +.+++|
T Consensus 1 y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv 78 (282)
T cd07831 1 YKILGKIGEGTFSEVLKAQSRKTGKYYAIKCMKKHFK--SLEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALV 78 (282)
T ss_pred CceEeeccccccceEEEEEEcCCCcEEEEEEehhccC--CchhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEE
Confidence 6789999999999999999999999999999876421 122223456777777555799999999999988 899999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+.+ ++...+.. ...+++..++.++.||+.||+|||++|++||||||+||+++.
T Consensus 79 ~e~~~~----------------------~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~p~ni~l~~- 135 (282)
T cd07831 79 FELMDM----------------------NLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILIKD- 135 (282)
T ss_pred EecCCc----------------------cHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEcC-
Confidence 999962 33334443 357899999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+.+||+|||+++.... ........+++.|+|||.+.. ..++.++|||||||++|||++|.+||.+.+..+....+...
T Consensus 136 ~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~~~~~~~~~~~~ 214 (282)
T cd07831 136 DILKLADFGSCRGIYS-KPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIAKIHDV 214 (282)
T ss_pred CCeEEEeccccccccc-CCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCCHHHHHHHHHHH
Confidence 9999999999875322 222334568999999998754 55789999999999999999999999988776655544321
Q ss_pred ------------------CCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 ------------------RPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ------------------~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
...+| ..++.++++||.+||.++|.+|| ++++++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------~~~~~l~~~~~ 282 (282)
T cd07831 215 LGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERI------TAKQALRHPYF 282 (282)
T ss_pred cCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCccccc------CHHHHhhCCCC
Confidence 11122 24689999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=333.36 Aligned_cols=247 Identities=21% Similarity=0.338 Sum_probs=203.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
++..+|++.+.||+|+||.||+|.++ ..+..||+|.++... ..........|..++. .++||||+++++++...
T Consensus 2 i~~~~~~~~~~ig~G~fg~V~~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~ 78 (266)
T cd05064 2 LDNKSIKIERILGTGRFGELCRGCLKLPSKRELPVAIHTLRAGC--SDKQRRGFLAEALTLG-QFDHSNIVRLEGVITRG 78 (266)
T ss_pred CchHHeEEeeeecccCCCeEEEEEEecCCCceeeEEEEecCCCC--CHHHHHHHHHHHHHHh-cCCCCCcCeEEEEEecC
Confidence 34568999999999999999999875 446689999997642 2333445667777776 57999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+.+|+||||+++| +|..++.. .+.+++..++.++.||+.||+|||++|++||||||+|
T Consensus 79 ~~~~lv~e~~~~~---------------------~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~iiH~dikp~n 137 (266)
T cd05064 79 NTMMIVTEYMSNG---------------------ALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMGYVHKGLAAHK 137 (266)
T ss_pred CCcEEEEEeCCCC---------------------cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeeccccHhh
Confidence 9999999999955 44445544 3578999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
||++.++.+||+|||.+....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+..++
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~~~~ 217 (266)
T cd05064 138 VLVNSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDV 217 (266)
T ss_pred EEEcCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHH
Confidence 999999999999999876421111 11122345678999999999999999999999999999775 9999999888887
Q ss_pred HHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 296 FWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 296 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
...+..+ ....|..++..+.+++.+||..+|.+||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~RP~~ 255 (266)
T cd05064 218 IKAVEDGFRLPAPRNCPNLLHQLMLDCWQKERGERPRF 255 (266)
T ss_pred HHHHHCCCCCCCCCCCCHHHHHHHHHHcCCCchhCCCH
Confidence 7777654 345567889999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=336.18 Aligned_cols=252 Identities=26% Similarity=0.449 Sum_probs=206.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------D 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------~ 138 (494)
..|++.+.||.|+||.||+|+++.+++.||+|++... .........|..++....+||||+++++++.. .
T Consensus 16 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~a~K~~~~~----~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~ 91 (282)
T cd06636 16 GIFELVEVVGNGTYGQVYKGRHVKTGQLAAIKVMDVT----EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHD 91 (282)
T ss_pred hhhhhheeeccCCCeEEEEEEEcCCCcEEEEEEEecC----hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCC
Confidence 5899999999999999999999999999999998653 22334556677777765589999999999853 5
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+|++|||+.+|+| ..++.. ...+++..++.++.||+.||.|||++||+||||||+
T Consensus 92 ~~~~iv~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~ivH~dl~~~ 150 (282)
T cd06636 92 DQLWLVMEFCGAGSV---------------------TDLVKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQ 150 (282)
T ss_pred CEEEEEEEeCCCCcH---------------------HHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHH
Confidence 689999999996655 333332 345889999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
||+++.++.++|+|||++.............+|++.|+|||++. +..++.++|+|||||++|||++|..||....
T Consensus 151 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~ 230 (282)
T cd06636 151 NVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMH 230 (282)
T ss_pred HEEECCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccC
Confidence 99999999999999999875332223344567999999999986 3468889999999999999999999998776
Q ss_pred HHHHHHHHHhCCC-C-CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 292 EDELFWSICNERP-R-FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 292 ~~~~~~~i~~~~~-~-~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..+....+..... . .+..++.++.+||.+||..||.+|| +++||++||||
T Consensus 231 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------~~~ell~~~~~ 282 (282)
T cd06636 231 PMRALFLIPRNPPPKLKSKKWSKKFIDFIEGCLVKNYLSRP------STEQLLKHPFI 282 (282)
T ss_pred HHhhhhhHhhCCCCCCcccccCHHHHHHHHHHhCCChhhCc------CHHHHhcCCCC
Confidence 5554444443322 1 1235789999999999999999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-42 Score=331.09 Aligned_cols=250 Identities=29% Similarity=0.474 Sum_probs=211.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+.+.++..||+|.+..... ......|..++. .++||||+++++.+.+...+|++
T Consensus 3 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~l~ 76 (256)
T cd06612 3 EVFDILEKLGEGSYGSVYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILK-QCDSPYIVKYYGSYFKNTDLWIV 76 (256)
T ss_pred ccchhhhhhcCCCCeEEEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHH-hCCCCcEeeeeeeeecCCcEEEE
Confidence 689999999999999999999999899999999875421 455667777776 46999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
+||+.+++ |..++.. ...+++..++.++.||+.||.|||+.||+||||+|+||+++.+
T Consensus 77 ~e~~~~~~---------------------L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~ni~~~~~ 135 (256)
T cd06612 77 MEYCGAGS---------------------VSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEE 135 (256)
T ss_pred EecCCCCc---------------------HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcceEEECCC
Confidence 99999554 4444543 4578999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE- 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~- 302 (494)
+.++|+|||++..............|+..|+|||++.+..++.++|||||||++|+|++|+.||...........+...
T Consensus 136 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 215 (256)
T cd06612 136 GQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHPMRAIFMIPNKP 215 (256)
T ss_pred CcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcchhhhhhhhccCC
Confidence 9999999999875433332334556899999999999999999999999999999999999999877665544444332
Q ss_pred --CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 --RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
....+..++.++.++|.+||+.||.+|| ++.|++.||||
T Consensus 216 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp------s~~~il~~~~~ 256 (256)
T cd06612 216 PPTLSDPEKWSPEFNDFVKKCLVKDPEERP------SAIQLLQHPFI 256 (256)
T ss_pred CCCCCchhhcCHHHHHHHHHHHhcChhhCc------CHHHHhcCCCC
Confidence 2234456789999999999999999999 68999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-42 Score=334.65 Aligned_cols=255 Identities=26% Similarity=0.470 Sum_probs=211.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC---hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE---DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+|+..+.||+|+||.||+|+...+++.||+|++....... .........|..++. .++|+||+++++++.+.+.++
T Consensus 1 ~~~~~~~lg~g~~~~v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 79 (268)
T cd06630 1 EWLKGQQLGTGAFSSCYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMA-RLNHPHIIRMLGATCEDSHFN 79 (268)
T ss_pred CccccceecCcCceEEEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHH-HcCCCceehhhceeccCCeEE
Confidence 4788899999999999999999999999999997543211 223456667777777 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ |++|...+.+.+.+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus 80 ~v~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i~H~~i~~~nil~~~ 138 (268)
T cd06630 80 LFVEWMA---------------------GGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDS 138 (268)
T ss_pred EEEeccC---------------------CCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcC
Confidence 9999999 4455556666778999999999999999999999999999999999999988
Q ss_pred CC-CEEEeecCceeeeeccC----CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 223 EG-HVRIADFGMCKLQIYLD----KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 223 ~g-~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
++ .+||+|||++....... ......+||..|+|||++.+..++.++|+|||||++|+|++|..||...+......
T Consensus 139 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 218 (268)
T cd06630 139 TGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLA 218 (268)
T ss_pred CCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCCCcchHH
Confidence 76 59999999987533221 11234578999999999998899999999999999999999999997544322222
Q ss_pred ---HHH--hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 298 ---SIC--NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 298 ---~i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+. .....+|..++++++++|.+||..+|.+|| ++.++++||||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~------~~~~ll~~~~~~ 268 (268)
T cd06630 219 LIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRP------PSRELLKHPVFR 268 (268)
T ss_pred HHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCc------CHHHHhcCcccC
Confidence 222 234566778899999999999999999999 679999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-42 Score=337.10 Aligned_cols=255 Identities=29% Similarity=0.464 Sum_probs=204.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH---- 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~---- 140 (494)
++|++.+.||+|+||.||+|.+..+++.||||++..... ..........|..++....+||||+++++++.....
T Consensus 1 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~lK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~ 79 (295)
T cd07837 1 DAYEKLEKIGEGTYGKVYKARDKNTGKLVALKKTRLEMD-EEGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKP 79 (295)
T ss_pred CCceEeeEecccCCeEEEEEEECCCCcEEEEEeehhhcc-ccCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCc
Confidence 479999999999999999999999999999999876422 222334566788888755578999999999987766
Q ss_pred -eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 141 -LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-----SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 141 -~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
.|+||||+++ +| ..++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 80 ~~~lv~e~~~~-~l---------------------~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i~H~dl~ 137 (295)
T cd07837 80 SLYLVFEYLDS-DL---------------------KKFMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLK 137 (295)
T ss_pred eEEEEeeccCc-CH---------------------HHHHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCC
Confidence 8999999973 33 333322 2468999999999999999999999999999999
Q ss_pred CCceeeCC-CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 215 LDNILLDY-EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 215 p~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|+||+++. ++.+||+|||+++.............+++.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+.
T Consensus 138 ~~nil~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~~ 217 (295)
T cd07837 138 PQNLLVDKQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSE 217 (295)
T ss_pred hHHEEEecCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 99999998 889999999998754322222233467899999999865 4579999999999999999999999998776
Q ss_pred HHHHHHHHhCC--C---------------CCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 293 DELFWSICNER--P---------------RFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 293 ~~~~~~i~~~~--~---------------~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+...++.... + .++ ..++.++.+||.+||..||.+|| +++|++.|
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~R~------~~~eil~~ 291 (295)
T cd07837 218 LQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRI------SAKAALTH 291 (295)
T ss_pred HHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChhhcC------CHHHHhcC
Confidence 66555443210 0 001 24789999999999999999999 68999999
Q ss_pred CCcC
Q psy8309 345 EYFR 348 (494)
Q Consensus 345 ~~f~ 348 (494)
|||+
T Consensus 292 ~~~~ 295 (295)
T cd07837 292 PYFD 295 (295)
T ss_pred CCcC
Confidence 9985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-42 Score=334.71 Aligned_cols=255 Identities=31% Similarity=0.518 Sum_probs=216.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|+.++.||.|+||.||+|.++.++..||||++.... ..........|..++. .+.||||+++++.+.+....|+|
T Consensus 4 ~~y~~~~~lg~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06640 4 ELFTKLERIGKGSFGEVFKGIDNRTQQVVAIKIIDLEE--AEDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKGTKLWII 80 (277)
T ss_pred HhhhhhhhcccCCCeEEEEEEEccCCEEEEEEEEeccc--cHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCEEEEE
Confidence 36788899999999999999999999999999987542 2334456667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+.||+ |..++. .+.+++..+..++.|++.||+|||+++++|+||+|+||+++.++
T Consensus 81 ~e~~~~~~---------------------L~~~i~-~~~l~~~~~~~~~~~l~~~l~~lh~~~ivH~dl~p~Nil~~~~~ 138 (277)
T cd06640 81 MEYLGGGS---------------------ALDLLR-AGPFDEFQIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQG 138 (277)
T ss_pred EecCCCCc---------------------HHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccCcCCChhhEEEcCCC
Confidence 99999554 444554 35789999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-R 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~ 303 (494)
.++|+|||++..............|+..|+|||++.+..++.++|+|||||++|||++|.+||...+.......+... .
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 218 (277)
T cd06640 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLFLIPKNNP 218 (277)
T ss_pred CEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCCCCCCCcChHhHhhhhhcCCC
Confidence 999999999875433333334457899999999999989999999999999999999999999988777666655433 3
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+.++..++..+.++|.+||..+|++|| ++++++.|+||...
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~~~~ 259 (277)
T cd06640 219 PTLTGEFSKPFKEFIDACLNKDPSFRP------TAKELLKHKFIVKN 259 (277)
T ss_pred CCCchhhhHHHHHHHHHHcccCcccCc------CHHHHHhChHhhhc
Confidence 445567889999999999999999999 68999999999754
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-42 Score=347.01 Aligned_cols=252 Identities=29% Similarity=0.475 Sum_probs=204.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
..+|++++.||+|+||.||+|++..+++.||||++.+.. ...........|..++. .++||||++++++|...
T Consensus 15 ~~~y~~~~~lg~g~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 92 (353)
T cd07850 15 LKRYQNLKPIGSGAQGIVCAAYDTVTGQNVAIKKLSRPF-QNVTHAKRAYRELVLMK-LVNHKNIIGLLNVFTPQKSLEE 92 (353)
T ss_pred hcceEEEEEeccCCCEEEEEEEECCCCCEEEEEecCccc-cChhHHHHHHHHHHHHH-hcCCCCCcceeeeeccCCCccc
Confidence 468999999999999999999999999999999987542 22333445567777776 57999999999998754
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.++|+||||+.+ +|...+.. .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 93 ~~~~~lv~e~~~~----------------------~l~~~~~~--~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (353)
T cd07850 93 FQDVYLVMELMDA----------------------NLCQVIQM--DLDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 148 (353)
T ss_pred cCcEEEEEeccCC----------------------CHHHHHhh--cCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHH
Confidence 357999999952 33333333 28999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.+|.+||+|||+++... .........||+.|+|||++.+..++.++|||||||++|+|++|+.||.+.+....+.
T Consensus 149 il~~~~~~~kL~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~~~~~~~ 227 (353)
T cd07850 149 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWN 227 (353)
T ss_pred EEECCCCCEEEccCccceeCC-CCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCCHHHHHH
Confidence 999999999999999997532 2222345678999999999999999999999999999999999999998877655444
Q ss_pred HHHhC----------------------CCC--------------C-------CccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 298 SICNE----------------------RPR--------------F-------PQFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 298 ~i~~~----------------------~~~--------------~-------p~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
++... .+. + +...+.++++||.+||+.||.+||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~---- 303 (353)
T cd07850 228 KIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDLLSKMLVIDPEKRI---- 303 (353)
T ss_pred HHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHHHHHHcCCChhhCc----
Confidence 44321 000 0 112466789999999999999999
Q ss_pred CCChhhhhcCCCcC
Q psy8309 335 CNSGDDVVAHEYFR 348 (494)
Q Consensus 335 ~~~~~eil~h~~f~ 348 (494)
+++|++.||||+
T Consensus 304 --t~~eiL~~~~~~ 315 (353)
T cd07850 304 --SVDDALQHPYIN 315 (353)
T ss_pred --CHHHHhcChhHh
Confidence 689999999997
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >KOG0574|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=339.12 Aligned_cols=253 Identities=27% Similarity=0.458 Sum_probs=219.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+-|.++..||+|+||.||+|.|+.+|.++|||.+.-+ ...+.++.|+.++. +++.|++|++|+.|-....+++|
T Consensus 33 EVFDi~~KLGEGSYGSV~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQ-QC~S~yVVKYYGSYFK~sDLWIV 106 (502)
T KOG0574|consen 33 EVFDIVGKLGEGSYGSVHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQ-QCKSKYVVKYYGSYFKHSDLWIV 106 (502)
T ss_pred HHHHHHHHhcCCcchHHHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHH-HcCCchhhhhhhhhccCCceEee
Confidence 4688999999999999999999999999999988643 45667888988887 58999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||..|+. ...++ ++..|+|.++..+++..+.||+|||...-||||||..|||++.+
T Consensus 107 MEYCGAGSi---------------------SDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~~KIHRDIKAGNILLNT~ 165 (502)
T KOG0574|consen 107 MEYCGAGSI---------------------SDIMRARRKPLSEQEISAVLRDTLKGLQYLHDLKKIHRDIKAGNILLNTD 165 (502)
T ss_pred hhhcCCCcH---------------------HHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHHHHHHhhcccccEEEccc
Confidence 999986654 33333 45689999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
|+.||+|||.+-.....-....+..|||.|||||++..-+|+..+||||||++..||.-|++||....+...+..|-...
T Consensus 166 G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMRAIFMIPT~P 245 (502)
T KOG0574|consen 166 GIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMRAIFMIPTKP 245 (502)
T ss_pred chhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccceeEeccCCC
Confidence 99999999998765444455678899999999999999999999999999999999999999998877765555554332
Q ss_pred C---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 304 P---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 304 ~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+ .-|..+|.++.|||+.||.++|++|- ++-.+++|+|.++-
T Consensus 246 PPTF~KPE~WS~~F~DFi~~CLiK~PE~R~------TA~~L~~H~FiknA 289 (502)
T KOG0574|consen 246 PPTFKKPEEWSSEFNDFIRSCLIKKPEERK------TALRLCEHTFIKNA 289 (502)
T ss_pred CCCCCChHhhhhHHHHHHHHHhcCCHHHHH------HHHHHhhhhhhcCC
Confidence 2 23567899999999999999999997 57789999999853
|
|
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=337.26 Aligned_cols=265 Identities=24% Similarity=0.309 Sum_probs=198.2
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC----------------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG----------------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~----------------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp 126 (494)
..++|++.+.||+|+||.||+|.+.. ++..||||++.... ..........|..++. .++||
T Consensus 3 ~~~~~~~~~~lg~G~fg~V~~~~~~~~~~~~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~ 79 (304)
T cd05096 3 PRGHLLFKEKLGEGQFGEVHLCEVVNPQDLPTLQFPFNVRKGRPLLVAVKILRPDA--NKNARNDFLKEVKILS-RLKDP 79 (304)
T ss_pred chhhCeeeeEecccCCeEEEEEEeccCcccccccccccccCCcceEEEEEEecCCC--CHHHHHHHHHHHHHHh-hcCCC
Confidence 34689999999999999999998542 44579999987642 2334445667877777 57999
Q ss_pred ceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 127 ~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
||+++++++.+.+.+|+||||+.+|+|.+.+........... .-...........+++..+..++.||+.||.|||++
T Consensus 80 niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~ 157 (304)
T cd05096 80 NIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEEN--GNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSL 157 (304)
T ss_pred CeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccc--cccccccccccccccHHHHHHHHHHHHHHHHHHHHC
Confidence 999999999999999999999998877432110000000000 000000011123578889999999999999999999
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh--
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-- 282 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-- 282 (494)
||+||||||+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++
T Consensus 158 ~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~ 237 (304)
T cd05096 158 NFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLC 237 (304)
T ss_pred CccccCcchhheEEcCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHcc
Confidence 999999999999999999999999999875322111 1234456889999999998899999999999999999986
Q ss_pred CCCCCCCCCHHHHHHHHHh--------CCCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 283 GQSPFSGCDEDELFWSICN--------ERPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 283 G~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
|..||.+.+..+....+.. .....|..++..+.+||.+||..||.+||++
T Consensus 238 ~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~ 295 (304)
T cd05096 238 KEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSF 295 (304)
T ss_pred CCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCH
Confidence 6788988776665554421 1123355678999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-41 Score=328.44 Aligned_cols=257 Identities=33% Similarity=0.566 Sum_probs=218.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|++|.||+|+++.+++.||||++..... .........|...+. .++|+||+++++++...+.+|+|
T Consensus 1 ~~~~~~~~i~~g~~~~v~~~~~~~~~~~~~vk~~~~~~~--~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~lv 77 (264)
T cd06623 1 SDLERVKVLGQGSSGVVYKVRHKPTGKIYALKKIHVDGD--EEFRKQLLRELKTLR-SCESPYVVKCYGAFYKEGEISIV 77 (264)
T ss_pred CcceeeeeeeecCCeEEEEEEEcCCCcEEEEEEeccCcc--hHHHHHHHHHHHHHH-hcCCCCeeeEEEEEccCCeEEEE
Confidence 478999999999999999999999999999999876532 133455667777776 46899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~~~ 223 (494)
|||++ |++|..++.....+++..+..++.||+.||.|||+ +|++||||+|+||+++.+
T Consensus 78 ~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~~~H~~l~~~ni~~~~~ 136 (264)
T cd06623 78 LEYMD---------------------GGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSK 136 (264)
T ss_pred EEecC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCCCccCCCCHHHEEECCC
Confidence 99999 45555666666889999999999999999999999 999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC---DEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---~~~~~~~~i~ 300 (494)
+.++|+|||++..............|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+....+.
T Consensus 137 ~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~~ 216 (264)
T cd06623 137 GEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAIC 216 (264)
T ss_pred CCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCCCCCccccccCHHHHHHHHh
Confidence 9999999999886443333333567899999999999989999999999999999999999999876 4455555555
Q ss_pred hC-CCCCCcc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 301 NE-RPRFPQF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 301 ~~-~~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
.. .+.++.. ++..+.++|.+||..+|++|| ++.+++.||||+.++
T Consensus 217 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~------~~~~ll~~~~~~~~~ 263 (264)
T cd06623 217 DGPPPSLPAEEFSPEFRDFISACLQKDPKKRP------SAAELLQHPFIKKAD 263 (264)
T ss_pred cCCCCCCCcccCCHHHHHHHHHHccCChhhCC------CHHHHHhCHHHHhcc
Confidence 43 3445555 899999999999999999999 689999999998653
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-42 Score=335.95 Aligned_cols=252 Identities=29% Similarity=0.484 Sum_probs=204.1
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++++.||.|+||.||+|+++.++..||||.+..+.. ..........|..++. .++||||+++++++.+.+..|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~ 78 (284)
T cd07860 1 NFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYLVF 78 (284)
T ss_pred CceeeeeecCCCceEEEEEEECCCCCEEEEEEcccccc-ccccchHHHHHHHHHH-hcCCCCCcchhhhcccCCcEEEEe
Confidence 48899999999999999999999999999999875432 2223345667777777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+. ++ |..++.. ...+++..++.++.||+.||+|||++|++||||+|+||+++.+
T Consensus 79 e~~~-~~---------------------l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i~H~~l~p~nill~~~ 136 (284)
T cd07860 79 EFLH-QD---------------------LKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTE 136 (284)
T ss_pred eccc-cC---------------------HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCC
Confidence 9995 23 3333322 3578999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+.+||+|||++..............+++.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+...++...
T Consensus 137 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~~~~~~~~~~~~ 216 (284)
T cd07860 137 GAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 216 (284)
T ss_pred CCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHHH
Confidence 9999999999875332222333456789999999987644 688999999999999999999999887665444433321
Q ss_pred C------------------CCC-----------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 R------------------PRF-----------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~------------------~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. ..+ ...++++++++|.+||+.||.+|| +++++++||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~~l~~~~f 284 (284)
T cd07860 217 LGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRI------SAKAALAHPFF 284 (284)
T ss_pred hCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCC------CHHHHhcCCCC
Confidence 0 011 134788999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=327.78 Aligned_cols=253 Identities=28% Similarity=0.462 Sum_probs=214.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CCeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DSHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~~~~l 143 (494)
+|++++.||.|+||.||+|.+..++..||+|++..... ..........|..++. .++||||+++++.+.. ...+|+
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~ 78 (265)
T cd08217 1 DYEVLETIGKGSFGTVRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILR-ELKHPNIVRYYDRIIDRSNQTLYI 78 (265)
T ss_pred CceeeeeeccCCCeEEEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHH-hcCCCccceeeeeeecCCCCEEEE
Confidence 58999999999999999999999999999999976533 3334455666777776 5799999999998764 457899
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHH-----hCCCccccCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLH-----KKGIVYRDLK 214 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH-----~~givHrDLK 214 (494)
+|||+++++| ..++. ....+++..++.++.||+.||.||| +.+|+|||||
T Consensus 79 ~~e~~~~~~L---------------------~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~~~i~h~dl~ 137 (265)
T cd08217 79 VMEYCEGGDL---------------------AQLIQKCKKERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLK 137 (265)
T ss_pred EehhccCCCH---------------------HHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhcCccccCcceecCCC
Confidence 9999996655 33333 2467999999999999999999999 8999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
|+||+++.++.+||+|||++..............|++.|+|||++.+..++.++|+||||+++|+|++|..||...+..+
T Consensus 138 p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~ 217 (265)
T cd08217 138 PANIFLDANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARNQLQ 217 (265)
T ss_pred HHHEEEecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcCHHH
Confidence 99999999999999999998864333322445679999999999999889999999999999999999999999888777
Q ss_pred HHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 295 LFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 295 ~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
+...+..... .+|..++.++.+++.+||..+|.+|| ++++|++|||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp------~~~~il~~~~~ 265 (265)
T cd08217 218 LASKIKEGKFRRIPYRYSSELNEVIKSMLNVDPDKRP------STEELLQLPLI 265 (265)
T ss_pred HHHHHhcCCCCCCccccCHHHHHHHHHHccCCcccCC------CHHHHhhCCCC
Confidence 7777776543 46778899999999999999999999 68999999995
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-41 Score=334.73 Aligned_cols=253 Identities=26% Similarity=0.482 Sum_probs=201.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++.+.||+|+||.||+|..+.+++.||||.+..... .........|..++. .++||||+++++++.+.+..|+
T Consensus 4 ~~~y~~~~~lg~g~~~~vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~l 80 (291)
T cd07844 4 LETYKKLDKLGEGSYATVYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLK-DLKHANIVTLHDIIHTKKTLTL 80 (291)
T ss_pred ccceeEEEEEeecCCeEEEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHh-hCCCcceeeEEEEEecCCeEEE
Confidence 5789999999999999999999998999999999875421 112233456777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+.+ +|..++.. .+.+++..++.++.||+.||.|||++||+||||||+||+++.
T Consensus 81 v~e~~~~----------------------~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~dl~p~nil~~~ 138 (291)
T cd07844 81 VFEYLDT----------------------DLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISE 138 (291)
T ss_pred EEecCCC----------------------CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccCCHHHEEEcC
Confidence 9999962 44444443 347899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFWSIC 300 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~i~ 300 (494)
+|.+||+|||+++.............++..|+|||++.+ ..++.++||||+||++|+|++|..||.+.. ..+....+.
T Consensus 139 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~~~~~~~~~~~ 218 (291)
T cd07844 139 RGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQLHKIF 218 (291)
T ss_pred CCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCccHHHHHHHHH
Confidence 999999999998743222222233457889999999876 458999999999999999999999997665 333332221
Q ss_pred hC-------------------CCCC-----------CccCC--HHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 301 NE-------------------RPRF-----------PQFLS--VEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 301 ~~-------------------~~~~-----------p~~~s--~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.. ...+ ...++ .++.++|.+||+.+|.+|| ++++++.||||
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rp------s~~e~l~~~~f 291 (291)
T cd07844 219 RVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRI------SAAEAMKHPYF 291 (291)
T ss_pred HhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCccccc------CHHHHhcCCCC
Confidence 10 0000 01234 8899999999999999999 67899999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=350.13 Aligned_cols=275 Identities=28% Similarity=0.370 Sum_probs=207.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEE-----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|+. ..++..||||+++... ..........|..++....+||||+++++++
T Consensus 31 ~~~~~~~~~~~~LG~G~fG~V~~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~Ei~il~~l~~HpnIv~l~~~~ 108 (375)
T cd05104 31 EFPRNRLSFGKTLGAGAFGKVVEATAYGLFKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHINIVNLLGAC 108 (375)
T ss_pred ccchHHeehhheecCCccceEEEEEEeccccCccceeEEEEeccCCc--CcHHHHHHHHHHHHHHHhcCCcceeeeeeee
Confidence 44566899999999999999999974 3467789999997542 2234456677888887544899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhh---------------------------hhhhhH--------------------
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAE---------------------------RDLMEY-------------------- 168 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~---------------------------~~l~~~-------------------- 168 (494)
...+..|+|||||+||+|.+.+..... .++.++
T Consensus 109 ~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 188 (375)
T cd05104 109 TVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRS 188 (375)
T ss_pred ccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccc
Confidence 999999999999999999654332110 001111
Q ss_pred ------hcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC
Q psy8309 169 ------LNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241 (494)
Q Consensus 169 ------~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 241 (494)
..+..+...+. ....+++..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......
T Consensus 189 ~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~ 268 (375)
T cd05104 189 VRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDS 268 (375)
T ss_pred cccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCchhhEEEECCCcEEEecCccceeccCcc
Confidence 01111111111 22468999999999999999999999999999999999999999999999999987532211
Q ss_pred C--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh-C-CCCCCccCCHHHHH
Q psy8309 242 K--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICN-E-RPRFPQFLSVEAKN 316 (494)
Q Consensus 242 ~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~-~-~~~~p~~~s~~~~~ 316 (494)
. ......++..|+|||++.+..++.++|||||||++|||++ |..||.+......+.++.. + ....|...+.++++
T Consensus 269 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 348 (375)
T cd05104 269 NYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPGMPVDSKFYKMIKEGYRMLSPECAPSEMYD 348 (375)
T ss_pred cccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCCCchHHHHHHHHhCccCCCCCCCCHHHHH
Confidence 1 1122345678999999999999999999999999999998 9999987654444333333 3 23446677899999
Q ss_pred HHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 317 ILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 317 li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
||.+||..||++|| ++.||++
T Consensus 349 li~~cl~~dP~~RP------s~~eil~ 369 (375)
T cd05104 349 IMKSCWDADPLKRP------TFKQIVQ 369 (375)
T ss_pred HHHHHccCChhHCc------CHHHHHH
Confidence 99999999999999 4666664
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=334.25 Aligned_cols=254 Identities=27% Similarity=0.466 Sum_probs=210.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|.++.+++.||||+++.... ..........|..++. .++|+||+++++++...+.+|+|
T Consensus 1 ~~y~~~~~i~~g~~~~v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~iv 78 (288)
T cd07833 1 NKYEVLGVVGEGAYGVVLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLR-QLRHENIVNLKEAFRRKGRLYLV 78 (288)
T ss_pred CceeEEEEecccCCeeEEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHH-hcCCCCeeehhheEEECCEEEEE
Confidence 379999999999999999999999999999999876432 2333455667777777 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+.+ +.+.....+...+++..+..++.||+.||.|||++|++||||+|+||+++.++
T Consensus 79 ~e~~~~---------------------~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~ni~~~~~~ 137 (288)
T cd07833 79 FEYVER---------------------TLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESG 137 (288)
T ss_pred EecCCC---------------------CHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeEECCCC
Confidence 999984 33344445556799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 225 HVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
.+||+|||++........ .....+|+..|+|||++.+. .++.++|+||||+++|+|++|.+||.+.+..+....+...
T Consensus 138 ~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~ 217 (288)
T cd07833 138 VLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKC 217 (288)
T ss_pred CEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 999999999875433222 33456789999999999888 8999999999999999999999999877655444333210
Q ss_pred C--------------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 R--------------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~--------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
- ..++..++.++++||++||..+|++|| +++++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~~~~f 288 (288)
T cd07833 218 LGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERL------TCDELLQHPYF 288 (288)
T ss_pred hCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhcc------cHHHHhcCCCC
Confidence 0 012334589999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=360.42 Aligned_cols=268 Identities=21% Similarity=0.332 Sum_probs=195.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCC-eEEEee--------------eeccccccChhhHHHHHHHHHHHHhcCCCCce
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTD-YYYAVK--------------CLKKDVVLEDDDVECTLIERKVLALGTKHPYL 128 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~-~~~AiK--------------~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I 128 (494)
.++|++++.||+|+||+||+|..+... ...++| ++.+..............|..++. .++||||
T Consensus 147 ~~~Y~ii~~LG~G~fG~Vyl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~Ei~il~-~l~HpnI 225 (501)
T PHA03210 147 LAHFRVIDDLPAGAFGKIFICALRASTEEAEARRGVNSTNQGKPKCERLIAKRVKAGSRAAIQLENEILALG-RLNHENI 225 (501)
T ss_pred hhccEEEeEecCCCCcceEEEEEeccchhhhhhhccccccccchhhhhhHhHHhhcchHHHHHHHHHHHHHH-hCCCCCc
Confidence 468999999999999999999875432 222222 111111112223344567777776 5799999
Q ss_pred eeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 129 v~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
|++++++...+..|+|+|++.+ + +.+++.++.+ ..........++.++.||+.||+|||++||
T Consensus 226 v~l~~~~~~~~~~~lv~e~~~~-~------------l~~~l~~~~~----~~~~~~~~~~~~~i~~ql~~aL~yLH~~gI 288 (501)
T PHA03210 226 LKIEEILRSEANTYMITQKYDF-D------------LYSFMYDEAF----DWKDRPLLKQTRAIMKQLLCAVEYIHDKKL 288 (501)
T ss_pred CcEeEEEEECCeeEEEEecccc-C------------HHHHHhhccc----cccccccHHHHHHHHHHHHHHHHHHHhCCe
Confidence 9999999999999999999852 2 2333322221 112234567788999999999999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCC-
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP- 286 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~P- 286 (494)
|||||||+||||+.+|.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++|..+
T Consensus 289 iHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~~~~~p 368 (501)
T PHA03210 289 IHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCP 368 (501)
T ss_pred ecCCCCHHHEEECCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHHHCCCCC
Confidence 999999999999999999999999997543221 223356899999999999999999999999999999999998754
Q ss_pred CCCC--CHHHHHHHHHhC----CCCCC----------------------------ccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 287 FSGC--DEDELFWSICNE----RPRFP----------------------------QFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 287 f~~~--~~~~~~~~i~~~----~~~~p----------------------------~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
|... +....+.++... ...+| ..++.++.++|.+||..||.+||
T Consensus 369 ~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~DP~~Rp-- 446 (501)
T PHA03210 369 IGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFDWHLRP-- 446 (501)
T ss_pred ccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccCcccCc--
Confidence 4322 222222222210 00011 13566788899999999999999
Q ss_pred CCCCChhhhhcCCCcCCCChhHH
Q psy8309 333 TQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 333 ~~~~~~~eil~h~~f~~~~w~~l 355 (494)
++.|++.||||.+..++.+
T Consensus 447 ----sa~elL~hp~f~~~~~~~~ 465 (501)
T PHA03210 447 ----GAAELLALPLFSAEEEEEI 465 (501)
T ss_pred ----CHHHHhhChhhhcCCchHH
Confidence 6899999999998776654
|
|
| >KOG0596|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-42 Score=343.54 Aligned_cols=257 Identities=25% Similarity=0.387 Sum_probs=206.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.-..|++++.||+||-++||++...+.+ .||+|.+... ..+...+.....|...|.+.-.|.+||+|+++-..++++
T Consensus 358 Vkg~~Yeilk~iG~GGSSkV~kV~~s~~~-iyalkkv~~~-~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~l 435 (677)
T KOG0596|consen 358 VKGREYEILKQIGSGGSSKVFKVLNSDKQ-IYALKKVVLL-EADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYL 435 (677)
T ss_pred ECcchhhHHHhhcCCCcceeeeeecCCCc-chhhhHHHHh-hcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceE
Confidence 34568999999999999999999865544 5677666543 235566778889999999888999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCH-HHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE-GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e-~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
||||||- ..+|...+++.....+ -.+++|..||++|+.++|++||||.||||.|+|+
T Consensus 436 YmvmE~G----------------------d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~IH~~gIVHSDLKPANFLl 493 (677)
T KOG0596|consen 436 YMVMECG----------------------DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKTIHQHGIVHSDLKPANFLL 493 (677)
T ss_pred EEEeecc----------------------cccHHHHHHhccCCCchHHHHHHHHHHHHHHHHHHHhceeecCCCcccEEE
Confidence 9999985 3566777776654433 5899999999999999999999999999999998
Q ss_pred CCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCC-----------CCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLK-----------YNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~-----------~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
- .|.+||+|||+|+...... ....+.|||+.||+||.+.... .+.++||||||||||+|+.|++||
T Consensus 494 V-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf 572 (677)
T KOG0596|consen 494 V-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPF 572 (677)
T ss_pred E-eeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCch
Confidence 4 6999999999998532211 1245679999999999996543 457899999999999999999999
Q ss_pred CCCC-HHHHHHHHHhC--CCCCCccCCHH-HHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 288 SGCD-EDELFWSICNE--RPRFPQFLSVE-AKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 288 ~~~~-~~~~~~~i~~~--~~~~p~~~s~~-~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.... ...-+..|... .++||..-+.. +.++++.||..||.+|| ++.|+|+|||...
T Consensus 573 ~~~~n~~aKl~aI~~P~~~Iefp~~~~~~~li~~mK~CL~rdPkkR~------si~eLLqhpFl~~ 632 (677)
T KOG0596|consen 573 GQIINQIAKLHAITDPNHEIEFPDIPENDELIDVMKCCLARDPKKRW------SIPELLQHPFLQI 632 (677)
T ss_pred HHHHHHHHHHHhhcCCCccccccCCCCchHHHHHHHHHHhcCcccCC------CcHHHhcCccccc
Confidence 7542 33334445543 34677655444 99999999999999999 6789999999864
|
|
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=331.17 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=208.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++.+.||+|+||.||+|+++.+++.||+|++..... .......|..++....+|+||+++++++....
T Consensus 5 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~ 80 (275)
T cd06608 5 TGIFELVEVIGEGTYGKVYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGN 80 (275)
T ss_pred hhheeheeeecCCCCeEEEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCc
Confidence 4689999999999999999999999999999999875421 23456677777775558999999999997644
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
.+|+||||+++++| ...+. ....+++..++.++.||+.||.|||++|++||||
T Consensus 81 ~~~~~lv~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H~~l 139 (275)
T cd06608 81 DDQLWLVMELCGGGSV---------------------TDLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHENKVIHRDI 139 (275)
T ss_pred ceEEEEEEEcCCCCcH---------------------HHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 58999999996655 22222 2457999999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
+|+||+++.++.+||+|||++..............|++.|+|||++.. ..++.++|+|||||++|+|++|.+||.
T Consensus 140 ~p~ni~~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 219 (275)
T cd06608 140 KGQNILLTKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219 (275)
T ss_pred CHHHEEEccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCcc
Confidence 999999999999999999998754333333455679999999999864 347789999999999999999999998
Q ss_pred CCCHHHHHHHHHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 289 GCDEDELFWSICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..........+..... ..+..++.++++||.+||..||.+|| +++++++|||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------t~~~ll~~~~~ 275 (275)
T cd06608 220 DMHPMRALFKIPRNPPPTLKSPENWSKKFNDFISECLIKNYEQRP------FMEELLEHPFI 275 (275)
T ss_pred ccchHHHHHHhhccCCCCCCchhhcCHHHHHHHHHHhhcChhhCc------CHHHHhcCCCC
Confidence 7766665556554422 22334788999999999999999999 68999999995
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=337.87 Aligned_cols=270 Identities=24% Similarity=0.337 Sum_probs=206.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeE--EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY--YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~--~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.+..++|++.+.||+|+||.||+|+++.++.. +|+|.++.. ...........|..++....+||||+++++++...
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~a~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~ 80 (303)
T cd05088 3 VLEWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 80 (303)
T ss_pred ccchhhceeeeeecCCCCceEEEEEEccCCceeeEEEEEeccc--CCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCC
Confidence 35678999999999999999999998877754 466665532 23334455667877777555899999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|+||||+++|+|.+.+........ .............+++..++.++.||+.||+|||++||+||||||+||
T Consensus 81 ~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Ni 155 (303)
T cd05088 81 GYLYLAIEYAPHGNLLDFLRKSRVLET-----DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 155 (303)
T ss_pred CCceEEEEeCCCCcHHHHHHhcccccc-----cccccccccccCcCCHHHHHHHHHHHHHHHHHHHhCCccccccchheE
Confidence 999999999997766321110000000 000000001123689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
|++.++.+||+|||+++.... ........++..|+|||.+.+..++.++|||||||++|||++ |.+||.+.+..+...
T Consensus 156 li~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~ 234 (303)
T cd05088 156 LVGENYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 234 (303)
T ss_pred EecCCCcEEeCccccCcccch-hhhcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCChHHHHH
Confidence 999999999999999863211 111122234678999999998889999999999999999998 999999888777777
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+... ....|..++.++.+||.+||..+|.+|| ++++++.+
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~ 276 (303)
T cd05088 235 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP------SFAQILVS 276 (303)
T ss_pred HHhcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 66554 3445667889999999999999999999 56777765
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-42 Score=337.73 Aligned_cols=264 Identities=24% Similarity=0.391 Sum_probs=210.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|+..+.||+|+||.||++++..+++.||||.+.+... .........|..++....+||||+++++++..+...++
T Consensus 3 ~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~ 80 (288)
T cd06616 3 AEDLKDLGEIGRGAFGTVNKMLHKPSGTIMAVKRIRSTVD--EKEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWI 80 (288)
T ss_pred HHHhHHHHHhCCCCceEEEEEEECCCCCEEEEEEehhccC--hHHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEE
Confidence 4678889999999999999999999999999999876432 23444566777777765569999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHH--hhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCceee
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH--IQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILL 220 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~--l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NILl 220 (494)
+|||+.. +| .++... ....+.+++..+..++.|++.||+|||+. ||+||||||+|||+
T Consensus 81 ~~e~~~~-~l------------------~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil~ 141 (288)
T cd06616 81 CMELMDI-SL------------------DKFYKYVYEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNILL 141 (288)
T ss_pred EEecccC-CH------------------HHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhcCCeeccCCCHHHEEE
Confidence 9999862 21 122212 12346799999999999999999999975 99999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF 296 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~ 296 (494)
+.++.+||+|||++..... ........|++.|+|||++.+. .++.++|||||||++|||++|.+||..... .+..
T Consensus 142 ~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~ 220 (288)
T cd06616 142 DRNGNIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQL 220 (288)
T ss_pred ccCCcEEEeecchhHHhcc-CCccccccCccCccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhcchHHHHH
Confidence 9999999999999864322 2222345689999999999876 689999999999999999999999976542 2222
Q ss_pred HHHHhCC-CCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 297 WSICNER-PRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 297 ~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
..+..+. +.++ ..++.++.+||.+||.+||.+|| ++++|++||||+...|.+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~i~~~~~~~~~~~~~~ 278 (288)
T cd06616 221 TQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRP------KYKELLEHPFIKDYEERNV 278 (288)
T ss_pred hhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCc------CHHHHhcChhhhchhhcch
Confidence 3333222 2222 24789999999999999999999 6899999999998776654
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=333.66 Aligned_cols=254 Identities=27% Similarity=0.464 Sum_probs=200.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|.+++.||+|+||.||+|.++.++..||||++..... .........|..++. .++|+||+++++++......|+
T Consensus 4 ~~~y~~~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~l 80 (291)
T cd07870 4 ATSYLNLEKLGEGSYATVYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLK-GLKHANIVLLHDIIHTKETLTF 80 (291)
T ss_pred cceeEEEEEEEecCCEEEEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHH-hcCCCCEeEEEEEEecCCeEEE
Confidence 3689999999999999999999999999999999976422 222234456777766 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+. ++| +.........+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 81 v~e~~~-~~l--------------------~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dlkp~Nil~~~~ 139 (291)
T cd07870 81 VFEYMH-TDL--------------------AQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYL 139 (291)
T ss_pred EEeccc-CCH--------------------HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChHHEEEcCC
Confidence 999995 222 11222334568889999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHh
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELFWSICN 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~i~~ 301 (494)
+.+||+|||+++............++++.|+|||.+.+. .++.++|+|||||++|||++|..||.+.+. .+.+..+..
T Consensus 140 ~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~ 219 (291)
T cd07870 140 GELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQLEKIWT 219 (291)
T ss_pred CcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCchhHHHHHHHHHH
Confidence 999999999987533323333445689999999998764 588999999999999999999999986543 222222211
Q ss_pred C--------------CCC---------CCc---------cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 E--------------RPR---------FPQ---------FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 ~--------------~~~---------~p~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. .+. .+. ..+.++.++|.+||..||.+|| +++|++.||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~------t~~~~l~h~~~ 291 (291)
T cd07870 220 VLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRI------SAQDALLHPYF 291 (291)
T ss_pred HcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCc------CHHHHhcCCCC
Confidence 0 000 000 1257899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=336.99 Aligned_cols=256 Identities=27% Similarity=0.388 Sum_probs=208.2
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC--hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+|++.+.||+|+||.||+|.++.+++.||||.++...... .........|..++. .++|+||+++++++.+.+.+|+
T Consensus 1 ~y~~~~~lg~g~~~~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l 79 (298)
T cd07841 1 RYEKGKKLGEGTYAVVYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQ-ELKHPNIIGLLDVFGHKSNINL 79 (298)
T ss_pred CceeeeeeeeccccEEEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHh-hcCCCCChhhhheeecCCEEEE
Confidence 4889999999999999999999999999999998654321 122233455666666 5789999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+ +|+| ..++.... .+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 80 v~e~~-~~~L---------------------~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dl~p~nill~~ 137 (298)
T cd07841 80 VFEFM-ETDL---------------------EKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIAS 137 (298)
T ss_pred EEccc-CCCH---------------------HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecCCChhhEEEcC
Confidence 99999 5544 34454444 7999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+|.++|+|||+++.............+++.|+|||.+.+ ..++.++|+|||||++|||++|.+||.+.+..+.+.++..
T Consensus 138 ~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~~~~~~~~~~ 217 (298)
T cd07841 138 DGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFE 217 (298)
T ss_pred CCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCccHHHHHHHHH
Confidence 999999999998764333333334467889999999865 4578999999999999999999999988776665555542
Q ss_pred CC-----------------------CC-----CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ER-----------------------PR-----FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~-----------------------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.. .. .....+.++.+||.+||.+||.+|| ++.|++.|+||++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------s~~e~l~~~~~~~~ 288 (298)
T cd07841 218 ALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRI------TARQALEHPYFSND 288 (298)
T ss_pred HcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCc------CHHHHhhCccccCC
Confidence 10 00 1134578899999999999999999 68999999999863
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-41 Score=325.95 Aligned_cols=253 Identities=30% Similarity=0.531 Sum_probs=213.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+|+..+.||+|+||+||+|..+.++..||+|++...... ..........|..++. .++|+||+++++++.+...+|+
T Consensus 1 ~~~~~~~ig~g~~~~vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~l 79 (258)
T cd06632 1 RWRKGELLGSGSFGSVYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLS-KLQHPNIVQYLGTEREEDNLYI 79 (258)
T ss_pred CccccceeeecCCceEEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHH-hcCCCCchheeeeEecCCeEEE
Confidence 477789999999999999999988999999998754321 1234455667777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|+||++ |++|..++.+.+.+++..+..++.||+.||.|||++||+|+||+|+||+++.+
T Consensus 80 v~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~~~ni~~~~~ 138 (258)
T cd06632 80 FLELVP---------------------GGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTN 138 (258)
T ss_pred EEEecC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 999999 44555566667779999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN- 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~- 301 (494)
+.+||+|||++...... .......|++.|+|||.+.... ++.++|+|||||++|+|++|..||......+....+..
T Consensus 139 ~~~kl~d~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~ 217 (258)
T cd06632 139 GVVKLADFGMAKQVVEF-SFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRS 217 (258)
T ss_pred CCEEEccCccceecccc-ccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCcHHHHHHHHHhc
Confidence 99999999998753322 2334567999999999998776 89999999999999999999999987765555555443
Q ss_pred -CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 -ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 -~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
....+|..++++++++|.+||..+|.+|| ++++++.|||+
T Consensus 218 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~~l~~~~~ 258 (258)
T cd06632 218 KELPPIPDHLSDEAKDFILKCLQRDPSLRP------TAAELLEHPFV 258 (258)
T ss_pred ccCCCcCCCcCHHHHHHHHHHhhcCcccCc------CHHHHhcCCCC
Confidence 34456778899999999999999999999 68999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-41 Score=326.88 Aligned_cols=250 Identities=50% Similarity=0.920 Sum_probs=220.6
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||+|+||.||+|.+..+++.||+|++.+..............|..++. .++||||+++++.++.+...|+||||++
T Consensus 1 lg~G~~~~v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v~e~~~--- 76 (250)
T cd05123 1 LGKGSFGKVLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILS-RINHPFIVKLHYAFQTEEKLYLVLEYAP--- 76 (250)
T ss_pred CCCCCceEEEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHH-HcCCCcHHHHHHHeecCCeeEEEEecCC---
Confidence 799999999999999899999999998775544556667777877776 5789999999999999999999999998
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecC
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFG 232 (494)
+++|..++.....+++..+..++.||+.||.|||++|++|+||+|+||+++.++.++|+|||
T Consensus 77 ------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~ 138 (250)
T cd05123 77 ------------------GGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFG 138 (250)
T ss_pred ------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcceEEEcCCCcEEEeecC
Confidence 45556667777789999999999999999999999999999999999999999999999999
Q ss_pred ceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCH
Q psy8309 233 MCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSV 312 (494)
Q Consensus 233 la~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~ 312 (494)
++..............|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+..+....+......+|..++.
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~ 218 (250)
T cd05123 139 LAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEFLSP 218 (250)
T ss_pred cceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCCCCCH
Confidence 98764333234456678999999999998889999999999999999999999999888888888888888889999999
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 313 ~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
++.++|++||..||.+||++.. ++++++||||
T Consensus 219 ~l~~~i~~~l~~~p~~R~~~~~---~~~l~~~~~f 250 (250)
T cd05123 219 EARDLISGLLQKDPTKRLGSGG---AEEIKAHPFF 250 (250)
T ss_pred HHHHHHHHHhcCCHhhCCCccc---HHHHHhCCCC
Confidence 9999999999999999996521 4899999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-41 Score=336.06 Aligned_cols=254 Identities=29% Similarity=0.458 Sum_probs=207.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--Cee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SHL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~~ 141 (494)
.++|++.+.||.|+||.||+|+++.+++.+|+|.++..... .........|..++. .++||||+++++++... ..+
T Consensus 4 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~~~~~ 81 (293)
T cd07843 4 VDEYEKLNRIEEGTYGVVYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILL-KLQHPNIVTVKEVVVGSNLDKI 81 (293)
T ss_pred hhhhhhhhhhcCCCCeEEEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHH-hcCCCCEEEEEEEEEecCCCcE
Confidence 46899999999999999999999999999999999765322 222234456777776 57899999999999887 899
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+||||+.+ +|...+... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 82 ~lv~e~~~~----------------------~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dl~p~nili 139 (293)
T cd07843 82 YMVMEYVEH----------------------DLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLL 139 (293)
T ss_pred EEEehhcCc----------------------CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 999999962 344444433 368999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
+.+|.+||+|||++..............+++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||.+....+.+.++
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~~~~~~~~~ 219 (293)
T cd07843 140 NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQLNKI 219 (293)
T ss_pred CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHH
Confidence 9999999999999886443323334456889999999987644 689999999999999999999999987766555544
Q ss_pred HhC-------------------------------CCCCCcc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 300 CNE-------------------------------RPRFPQF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 300 ~~~-------------------------------~~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
... ...++.. +++.+++||++||..||++|| ++.|++.|+||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------t~~ell~~~~f 293 (293)
T cd07843 220 FKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRI------SAEDALKHPYF 293 (293)
T ss_pred HHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccC------CHHHHhcCCCC
Confidence 321 0123333 688999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=334.32 Aligned_cols=258 Identities=26% Similarity=0.441 Sum_probs=206.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++.+.||+|++|.||+|+++.+++.||||.+..... ..........|..++. .++||||+++++++.+..+.|+
T Consensus 1 ~~~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 78 (294)
T PLN00009 1 MDQYEKVEKIGEGTYGVVYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLK-EMQHGNIVRLQDVVHSEKRLYL 78 (294)
T ss_pred CCceEEEEEecCCCCEEEEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHH-hccCCCEeeEEEEEecCCeEEE
Confidence 3689999999999999999999999999999999876432 2223344566777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||||+++ ++..++.... .+++..++.++.||+.||+|||++||+||||+|+||+++
T Consensus 79 v~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dl~p~nill~ 136 (294)
T PLN00009 79 VFEYLDL----------------------DLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLID 136 (294)
T ss_pred EEecccc----------------------cHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCcceEEEE
Confidence 9999952 3333443322 368889999999999999999999999999999999998
Q ss_pred C-CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 222 Y-EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
. ++.+||+|||++..............|++.|+|||.+.+. .++.++|||||||++|+|++|.+||...+..+...++
T Consensus 137 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~~~~~~~~~ 216 (294)
T PLN00009 137 RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDELFKI 216 (294)
T ss_pred CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 5 4579999999987532222223345678999999998764 5789999999999999999999999887766655554
Q ss_pred HhC--C-------------------CC--------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 300 CNE--R-------------------PR--------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 300 ~~~--~-------------------~~--------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
... . +. ....++++++++|.+||+.+|++|| ++++++.||||+++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp------s~~~~l~~~~~~~~ 290 (294)
T PLN00009 217 FRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRI------TARAALEHEYFKDL 290 (294)
T ss_pred HHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCc------CHHHHhcCchHhHH
Confidence 321 0 00 1134688999999999999999999 68999999999875
Q ss_pred C
Q psy8309 351 D 351 (494)
Q Consensus 351 ~ 351 (494)
+
T Consensus 291 ~ 291 (294)
T PLN00009 291 G 291 (294)
T ss_pred h
Confidence 3
|
|
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-42 Score=340.66 Aligned_cols=253 Identities=25% Similarity=0.391 Sum_probs=186.9
Q ss_pred eeEeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE--cCCeeEEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ--TDSHLFFVM 145 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~--~~~~~~lv~ 145 (494)
...||+|+||.||+|+.+. ++..||+|.+..... ......|..++. .++||||+++++++. .+..+|+||
T Consensus 6 g~~lG~G~~g~Vy~~~~~~~~~~~~~a~k~~~~~~~-----~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~lv~ 79 (317)
T cd07867 6 GCKVGRGTYGHVYKAKRKDGKDEKEYALKQIEGTGI-----SMSACREIALLR-ELKHPNVIALQKVFLSHSDRKVWLLF 79 (317)
T ss_pred ceEeccCCCeeEEEEEecCCCccceEEEEEecCCCC-----cHHHHHHHHHHH-hCCCCCeeeEEEEEeccCCCeEEEEE
Confidence 3689999999999999764 567899999875421 223456777776 579999999999985 456889999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee----C
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----D 221 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl----~ 221 (494)
||+.+ +| .+++..............+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 80 e~~~~-~l------------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~ 146 (317)
T cd07867 80 DYAEH-DL------------WHIIKFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGP 146 (317)
T ss_pred eeeCC-cH------------HHHHHhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHhCCEEcCCCCHHHEEEccCCC
Confidence 99873 22 1111110000011122358999999999999999999999999999999999999 5
Q ss_pred CCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH----
Q psy8309 222 YEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDED---- 293 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~---- 293 (494)
.++.+||+|||+++...... ......+||+.|+|||++.+. .++.++|||||||++|||++|.+||......
T Consensus 147 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~ 226 (317)
T cd07867 147 ERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTS 226 (317)
T ss_pred CCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccccccccc
Confidence 67899999999997532211 123346789999999999774 5899999999999999999999999754321
Q ss_pred -----HHHHHHHh--------------CCCC------------------------CCccCCHHHHHHHHhhccCCCCCCC
Q psy8309 294 -----ELFWSICN--------------ERPR------------------------FPQFLSVEAKNILVHLLDKDTTKRL 330 (494)
Q Consensus 294 -----~~~~~i~~--------------~~~~------------------------~p~~~s~~~~~li~~lL~~dP~~R~ 330 (494)
.....+.. .... .....+..+.+||.+||+.||.+||
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~ 306 (317)
T cd07867 227 NPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRI 306 (317)
T ss_pred ccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhhcccCCCChHHHHHHHHHhccCccccc
Confidence 11111110 0000 0112356788999999999999999
Q ss_pred CCCCCCChhhhhcCCCc
Q psy8309 331 GSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 331 ~~~~~~~~~eil~h~~f 347 (494)
+++|+++||||
T Consensus 307 ------t~~e~l~hp~f 317 (317)
T cd07867 307 ------TSEQALQDPYF 317 (317)
T ss_pred ------CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >KOG0671|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-43 Score=334.02 Aligned_cols=254 Identities=27% Similarity=0.442 Sum_probs=208.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-C----ceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-P----YLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-p----~Iv~l~~~~~ 136 (494)
....+|++++.+|+|+||+|..|.+..++..||||+++.- ....+..+.|..+|.+...+ | -+|++.++|.
T Consensus 86 ~l~~Ry~i~~~lGeGtFGkV~ec~D~~~~~~vAlKIik~V----~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFd 161 (415)
T KOG0671|consen 86 ILTNRYEIVDLLGEGTFGKVVECWDRETKEHVALKIIKNV----DKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFD 161 (415)
T ss_pred ccccceehhhhhcCCcccceEEEeecCCCceehHHHHHHH----HHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhh
Confidence 3457899999999999999999999999999999999742 23445667788888754332 2 4788889999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
-.++.|||+|.+ |.+++.++..++ +++...++.++.||+.+++|||+++++|.|||
T Consensus 162 yrghiCivfell----------------------G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv~fLh~~kl~HTDLK 219 (415)
T KOG0671|consen 162 YRGHICIVFELL----------------------GLSTFDFLKENNYIPFPIDHIRHMGYQLLESVAFLHDLKLTHTDLK 219 (415)
T ss_pred ccCceEEEEecc----------------------ChhHHHHhccCCccccchHHHHHHHHHHHHHHHHHHhcceeecCCC
Confidence 999999999988 666777777654 68999999999999999999999999999999
Q ss_pred CCceeeCC--------------------CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHH
Q psy8309 215 LDNILLDY--------------------EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFG 274 (494)
Q Consensus 215 p~NILl~~--------------------~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlG 274 (494)
|||||+.+ +-.|||+|||.|... .....+.+.|..|.|||++.+.+++.++||||+|
T Consensus 220 PENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~---~e~hs~iVsTRHYRAPEViLgLGwS~pCDvWSiG 296 (415)
T KOG0671|consen 220 PENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFD---HEHHSTIVSTRHYRAPEVILGLGWSQPCDVWSIG 296 (415)
T ss_pred hheEEEeccceEEEeccCCccceeccCCCcceEEEecCCccee---ccCcceeeeccccCCchheeccCcCCccCceeee
Confidence 99999943 235899999998753 3334678899999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHH---HHHHHHhC------------------CCCCCcc------------------------
Q psy8309 275 ILLYEMHVGQSPFSGCDEDE---LFWSICNE------------------RPRFPQF------------------------ 309 (494)
Q Consensus 275 vil~ell~G~~Pf~~~~~~~---~~~~i~~~------------------~~~~p~~------------------------ 309 (494)
|||+|+++|...|+..+..| +++.|+.. .+.+|..
T Consensus 297 CIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~~ckpl~~~~~~~d 376 (415)
T KOG0671|consen 297 CILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFEPCKPLKKYMLQDD 376 (415)
T ss_pred eEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhcCCccHHHHhccCc
Confidence 99999999999999877555 55555531 1122210
Q ss_pred -CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 310 -LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 310 -~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
-..++.|||++||..||.+|+ ++.|++.||||+..
T Consensus 377 ~e~~~LfDLl~~mL~fDP~~Ri------Tl~EAL~HpFF~~~ 412 (415)
T KOG0671|consen 377 LEHVQLFDLLRRMLEFDPARRI------TLREALSHPFFARL 412 (415)
T ss_pred HHHhHHHHHHHHHHccCccccc------cHHHHhcCHHhhcC
Confidence 123578999999999999999 68999999999854
|
|
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=324.16 Aligned_cols=252 Identities=29% Similarity=0.479 Sum_probs=214.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|....+++.||||.+..... ..........|..++. .++||||+++++.+...+.+++||
T Consensus 1 ~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~ 78 (256)
T cd08220 1 KYEKIRVVGRGAFGIVHLCRRKADQKLVIIKQIPVEQM-TKDERLAAQNECQVLK-LLSHPNIIEYYENFLEDKALMIVM 78 (256)
T ss_pred CceEEEEecccCceEEEEEEEcCCCcEEEEEEEecccc-ccHHHHHHHHHHHHHh-hCCCCchhheeeeEecCCEEEEEE
Confidence 58999999999999999999999999999999976533 3334556667777777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+++++ |..++... ..+++..+..++.|++.||+|||++||+||||||+||+++.+
T Consensus 79 e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~h~dl~~~nil~~~~ 137 (256)
T cd08220 79 EYAPGGT---------------------LAEYIQKRCNSLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKH 137 (256)
T ss_pred ecCCCCC---------------------HHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 9999554 44455442 358999999999999999999999999999999999999865
Q ss_pred C-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 G-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+ .+||+|||++.... .........|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+.......+...
T Consensus 138 ~~~~~l~d~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~ 216 (256)
T cd08220 138 KMVVKIGDFGISKILS-SKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSG 216 (256)
T ss_pred CCEEEEccCCCceecC-CCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCchHHHHHHHHhc
Confidence 5 57999999987532 223334567899999999999988999999999999999999999999988877777776654
Q ss_pred -CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 -RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
...++..++.+++++|.+||..||.+|| +++|+++||||
T Consensus 217 ~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~ll~~p~~ 256 (256)
T cd08220 217 TFAPISDRYSPDLRQLILSMLNLDPSKRP------QLSQIMAQPIC 256 (256)
T ss_pred CCCCCCCCcCHHHHHHHHHHccCChhhCC------CHHHHhhCCCC
Confidence 3456778999999999999999999999 68999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=333.92 Aligned_cols=255 Identities=28% Similarity=0.464 Sum_probs=212.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++++.||+|+||+||+|++..+++.||+|++.... ..........|..++. .++||||+++++.+...+.+|
T Consensus 3 ~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~ 79 (284)
T cd06620 3 RNEDLETISDLGAGNGGSVSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMH-ECRSPYIVSFYGAFLNENNIC 79 (284)
T ss_pred cHHHHHHHHHcCCCCCeEEEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHH-HcCCCCcceEeeeEecCCEEE
Confidence 3568999999999999999999999999999999987542 2233455667777776 479999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~ 221 (494)
+||||+++ ++|...+...+.+++..++.++.|++.||.|||+ +|++||||||+||+++
T Consensus 80 lv~e~~~~---------------------~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~~i~H~dl~p~nil~~ 138 (284)
T cd06620 80 MCMEFMDC---------------------GSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVHRIMHRDIKPSNILVN 138 (284)
T ss_pred EEEecCCC---------------------CCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhcCeeccCCCHHHEEEC
Confidence 99999994 4555566666789999999999999999999997 6999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--------
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-------- 293 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-------- 293 (494)
.++.++|+|||++.... .......+|+..|+|||++.+..++.++|+|||||++|+|++|..||......
T Consensus 139 ~~~~~~l~d~gl~~~~~--~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~~~~~~~~~~ 216 (284)
T cd06620 139 SRGQIKLCDFGVSGELI--NSIADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNIDDDGQDDPM 216 (284)
T ss_pred CCCcEEEccCCcccchh--hhccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCCCCCcccchhhhhhhhhh
Confidence 99999999999986432 22334568999999999998889999999999999999999999999865432
Q ss_pred ---HHHHHHHhC-CCCCCcc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 294 ---ELFWSICNE-RPRFPQF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 294 ---~~~~~i~~~-~~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+....+... .+.++.. ++.++.+||.+||..||.+|| +++|+++|+||..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------t~~e~~~~~~~~~ 271 (284)
T cd06620 217 GILDLLQQIVQEPPPRLPSSDFPEDLRDFVDACLLKDPTERP------TPQQLCAMPPFIQ 271 (284)
T ss_pred HHHHHHHHHhhccCCCCCchhcCHHHHHHHHHHhcCCcccCc------CHHHHhcCccccc
Confidence 233344333 2333333 788999999999999999999 6899999999953
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=327.35 Aligned_cols=252 Identities=31% Similarity=0.507 Sum_probs=204.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.+.....||+|+||.||+|++..++..||+|.+... .....+....|..++. .++|+||+++++++...+..|+|
T Consensus 8 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 83 (268)
T cd06624 8 DENGERVVLGKGTYGIVYAARDLSTQVRIAIKEIPER---DSRYVQPLHEEIALHS-YLKHRNIVQYLGSDSENGFFKIF 83 (268)
T ss_pred ccCCceEEEecCCceEEEEeEecCCCcEEEEEEecCC---CHHHHHHHHHHHHHHH-hcCCCCeeeeeeeeccCCEEEEE
Confidence 3444557899999999999999999999999988754 2234455667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCC--CHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRF--DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l--~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||+++++ |..++... ..+ ++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 84 ~e~~~~~~---------------------L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~h~dl~p~nil~~ 142 (268)
T cd06624 84 MEQVPGGS---------------------LSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVN 142 (268)
T ss_pred EecCCCCC---------------------HHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEc
Confidence 99999554 44455443 445 8889999999999999999999999999999999998
Q ss_pred C-CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHH
Q psy8309 222 Y-EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFW 297 (494)
Q Consensus 222 ~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~ 297 (494)
. ++.++|+|||++..............|++.|+|||.+.+.. ++.++|+||||+++|+|++|.+||...... ....
T Consensus 143 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~~~~~~~~~ 222 (268)
T cd06624 143 TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIELGEPQAAMF 222 (268)
T ss_pred CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccccChhhhHh
Confidence 6 67999999999875332233334456899999999987643 889999999999999999999999764322 2222
Q ss_pred H--HHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 298 S--ICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 298 ~--i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. .....+.+|..+++++++|+.+||..+|.+|| ++.+++.||||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~ll~~~~~ 268 (268)
T cd06624 223 KVGMFKIHPEIPESLSAEAKNFILRCFEPDPDKRA------SAHDLLQDPFL 268 (268)
T ss_pred hhhhhccCCCCCcccCHHHHHHHHHHcCCCchhCC------CHHHHHhCCCC
Confidence 2 22344567888999999999999999999999 68999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.4e-42 Score=338.54 Aligned_cols=253 Identities=26% Similarity=0.462 Sum_probs=210.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|.....||+|+||.||++.+..++..||||.+... .....+....|..++. .++||||+++++.+...++.|+|
T Consensus 22 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~ii~~~~~~~~~~~~~lv 97 (292)
T cd06658 22 EYLDSFIKIGEGSTGIVCIATEKHTGKQVAVKKMDLR---KQQRRELLFNEVVIMR-DYHHENVVDMYNSYLVGDELWVV 97 (292)
T ss_pred HHHhhhhcccCCCCeEEEEEEECCCCCEEEEEEEecc---hHHHHHHHHHHHHHHH-hCCCCcHHHHHHheecCCeEEEE
Confidence 3455567899999999999999999999999998653 2233445666777666 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+++++ |..++ ..+.+++..+..++.||+.||.|||++||+||||||+||+++.++
T Consensus 98 ~e~~~~~~---------------------L~~~~-~~~~l~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nill~~~~ 155 (292)
T cd06658 98 MEFLEGGA---------------------LTDIV-THTRMNEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDG 155 (292)
T ss_pred EeCCCCCc---------------------HHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecCCCHHHEEEcCCC
Confidence 99999554 44444 335689999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER- 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~- 303 (494)
.++|+|||++.............+|++.|+|||.+.+..++.++|+||||+++|||++|..||.+.+....+..+....
T Consensus 156 ~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06658 156 RIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRIRDNLP 235 (292)
T ss_pred CEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCC
Confidence 9999999998653322333345679999999999999899999999999999999999999999877766665554432
Q ss_pred --CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 304 --PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 304 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
......++..++++|.+||..||.+|| +++++++||||+.
T Consensus 236 ~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~il~~~~~~~ 277 (292)
T cd06658 236 PRVKDSHKVSSVLRGFLDLMLVREPSQRA------TAQELLQHPFLKL 277 (292)
T ss_pred CccccccccCHHHHHHHHHHccCChhHCc------CHHHHhhChhhhc
Confidence 222235789999999999999999999 6899999999975
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=330.90 Aligned_cols=251 Identities=25% Similarity=0.469 Sum_probs=205.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++++.||.|++|.||+|+++.++..||||+++.... .........|..++. .++||||+++++++.+.+..|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 77 (284)
T cd07836 1 NFKQLEKLGEGTYATVYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMK-ELKHENIVRLHDVIHTENKLMLVF 77 (284)
T ss_pred CceEeeeeccCCceEEEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHH-hhcCCCEeeeeeeEeeCCcEEEEE
Confidence 58999999999999999999999999999999976532 223345566777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh---cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ---SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~---~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||+.+ + |..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.
T Consensus 78 e~~~~-~---------------------l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~h~dl~p~ni~~~~ 135 (284)
T cd07836 78 EYMDK-D---------------------LKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINK 135 (284)
T ss_pred ecCCc-c---------------------HHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEECC
Confidence 99973 2 3333332 246899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
++.++|+|||++..............+|+.|+|||++.+. .++.++|+|||||++|+|++|..||.+.+..+....+..
T Consensus 136 ~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~ 215 (284)
T cd07836 136 RGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFR 215 (284)
T ss_pred CCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHH
Confidence 9999999999987533222223345688999999998664 578999999999999999999999998876665555432
Q ss_pred CC------------------CCC-----------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 ER------------------PRF-----------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 ~~------------------~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.. ..+ ...++.+++++|.+||+.||.+|| ++.++++||||
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~------~~~~~l~~~~f 284 (284)
T cd07836 216 IMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRI------SAHDALQHPWF 284 (284)
T ss_pred HhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCC------CHHHHhcCCCC
Confidence 10 011 124578899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-42 Score=336.51 Aligned_cols=257 Identities=30% Similarity=0.497 Sum_probs=214.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|+..+.||+|+||.||+|.+..++..||+|++.... ..........|..++. .++||||+++++.+...+..|+|
T Consensus 4 ~~y~~~~~l~~g~~~~vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 80 (277)
T cd06642 4 ELFTKLERIGKGSFGEVYKGIDNRTKEVVAIKIIDLEE--AEDEIEDIQQEITVLS-QCDSPYITRYYGSYLKGTKLWII 80 (277)
T ss_pred HHHHHHHHhcCCCCeeEEEEEEcCCCeEEEEEEecccc--chHHHHHHHHHHHHHH-cCCCCccHhhhcccccCCceEEE
Confidence 35778899999999999999999999999999987542 2234455667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||+++|+ |..++. .+.+++..++.++.||+.||.|||++|++|+||+|+||+++.++
T Consensus 81 ~e~~~~~~---------------------L~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~ivH~dl~p~ni~i~~~~ 138 (277)
T cd06642 81 MEYLGGGS---------------------ALDLLK-PGPLEETYIATILREILKGLDYLHSERKIHRDIKAANVLLSEQG 138 (277)
T ss_pred EEccCCCc---------------------HHHHhh-cCCCCHHHHHHHHHHHHHHHHHHhcCCeeccCCChheEEEeCCC
Confidence 99999554 444443 35789999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-C
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-R 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~ 303 (494)
.++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|||++|..||...........+... .
T Consensus 139 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~~~~~~~~~~~~~ 218 (277)
T cd06642 139 DVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSP 218 (277)
T ss_pred CEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCCCCCcccchhhHHhhhhcCCC
Confidence 999999999875433222334457899999999999989999999999999999999999999877666655555433 3
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
+.++..++.++.++|.+||..+|.+|| ++.++++||||....+
T Consensus 219 ~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~~~~~~ 261 (277)
T cd06642 219 PTLEGQYSKPFKEFVEACLNKDPRFRP------TAKELLKHKFITRYTK 261 (277)
T ss_pred CCCCcccCHHHHHHHHHHccCCcccCc------CHHHHHHhHHHHHHhh
Confidence 344556789999999999999999999 6899999999976544
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=328.38 Aligned_cols=254 Identities=29% Similarity=0.512 Sum_probs=207.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-------hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-------DDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-------~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+|.+.+.||.|+||.||+|....+++.||+|.++...... ....+....|..++. .++||||+++++++...
T Consensus 2 ~~~~~~~lg~g~~~~vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~ 80 (272)
T cd06629 2 KWVKGELIGKGTYGRVYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLK-DLDHLNIVQYLGFETTE 80 (272)
T ss_pred ceeecceecccCceEEEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHH-hcCCCCcceEEEEeccC
Confidence 4788899999999999999999999999999886432111 112334556767666 57999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+++||||+++ ++|..++...+.+++..++.++.||+.||.|||++|++||||+|+||
T Consensus 81 ~~~~lv~e~~~~---------------------~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~~~ni 139 (272)
T cd06629 81 EYLSIFLEYVPG---------------------GSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNL 139 (272)
T ss_pred CceEEEEecCCC---------------------CcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeeecCCChhhE
Confidence 999999999994 45555666667899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
+++.++.++|+|||+++..... ........|+..|+|||.+.+.. ++.++|+||||+++|+|++|..||...+..+
T Consensus 140 l~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~ 219 (272)
T cd06629 140 LVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIA 219 (272)
T ss_pred EEcCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCcchHH
Confidence 9999999999999998753211 11123456899999999988754 8899999999999999999999998766555
Q ss_pred HHHHHHhC--CCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 295 LFWSICNE--RPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 295 ~~~~i~~~--~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
....+... ...++. .++.+++++|.+||..+|.+|| +++++++||||
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~~~~~ 272 (272)
T cd06629 220 AMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRP------TARELLQHPFI 272 (272)
T ss_pred HHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCC------CHHHHhhCCCC
Confidence 44444332 233333 4689999999999999999999 68999999996
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=330.72 Aligned_cols=253 Identities=30% Similarity=0.510 Sum_probs=211.8
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|.++.+++.||+|.+.+.. ..........|..++. .+.||||+++++.+...+.+|+|
T Consensus 1 ~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv 77 (265)
T cd06605 1 DDLEYLGELGAGNSGVVSKVLHRPTGKIMAVKTIRLEI--NEAIQKQILRELDILH-KCNSPYIVGFYGAFYNNGDISIC 77 (265)
T ss_pred CcchHHHHhcCCCCeEEEEEEEcCCCcEEEEEEEeccc--ChHHHHHHHHHHHHHH-HCCCCchhhhheeeecCCEEEEE
Confidence 47889999999999999999999999999999997652 2234455667777777 46799999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLDY 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~~ 222 (494)
+||+.++ +|...+... ..+++..+..++.||+.||+|||+ .|++||||||+||+++.
T Consensus 78 ~e~~~~~---------------------~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~i~H~dl~~~ni~~~~ 136 (265)
T cd06605 78 MEYMDGG---------------------SLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNS 136 (265)
T ss_pred EEecCCC---------------------cHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCCCCeecCCCCHHHEEECC
Confidence 9999854 445555554 789999999999999999999999 99999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC-----DEDELFW 297 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-----~~~~~~~ 297 (494)
+|.++|+|||++..... .......|+..|+|||.+.+..++.++|+||||+++|+|++|..||... ...+...
T Consensus 137 ~~~~~l~d~g~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 214 (265)
T cd06605 137 RGQIKLCDFGVSGQLVN--SLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPENDPPDGIFELLQ 214 (265)
T ss_pred CCCEEEeecccchhhHH--HHhhcccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCccccccccHHHHHH
Confidence 99999999999864322 1222377999999999999999999999999999999999999999754 2334444
Q ss_pred HHHhC-CCCCCcc-CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 298 SICNE-RPRFPQF-LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 298 ~i~~~-~~~~p~~-~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+... .+..+.. ++.+++++|.+||..||.+|| ++.+++.||||+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~ll~~~~~~~ 262 (265)
T cd06605 215 YIVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERP------SYKELLEHPFIKK 262 (265)
T ss_pred HHhcCCCCCCChhhcCHHHHHHHHHHcCCCchhCc------CHHHHhhCchhhc
Confidence 44443 3344544 899999999999999999999 6899999999964
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-41 Score=330.37 Aligned_cols=253 Identities=28% Similarity=0.484 Sum_probs=212.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|...+.||+|++|.||+|.++.+++.+|+|++... ..........|..++. .++||||+++++++...+..|+|+
T Consensus 20 ~~~~~~~lg~g~~g~v~~~~~~~~~~~~~iK~~~~~---~~~~~~~~~~e~~~l~-~~~h~~vv~~~~~~~~~~~~~~v~ 95 (285)
T cd06648 20 YLDNFVKIGEGSTGIVCIATDKSTGRQVAVKKMDLR---KQQRRELLFNEVVIMR-DYQHPNIVEMYSSYLVGDELWVVM 95 (285)
T ss_pred hhhcceEeccCCCeEEEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHH-HcCCCChheEEEEEEcCCeEEEEE
Confidence 455668999999999999999999999999988643 2223344566777666 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||+.|+ +|..++.. +.+++..+..++.||+.||+|||++||+||||+|+||+++.++.
T Consensus 96 e~~~~~---------------------~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i~H~dl~p~Nil~~~~~~ 153 (285)
T cd06648 96 EFLEGG---------------------ALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGR 153 (285)
T ss_pred eccCCC---------------------CHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChhhEEEcCCCc
Confidence 999954 44445555 67899999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~ 305 (494)
++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+......
T Consensus 154 ~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~~~~~~~~~~~~~~~ 233 (285)
T cd06648 154 VKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRIRDNLPP 233 (285)
T ss_pred EEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHHhcCCC
Confidence 99999998764332222334467999999999999988999999999999999999999999988877777777655322
Q ss_pred C---CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 306 F---PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 306 ~---p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
. +..++..+.+||.+||..+|.+|| ++.++++|+||+..
T Consensus 234 ~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~il~~~~~~~~ 275 (285)
T cd06648 234 KLKNLHKVSPRLRSFLDRMLVRDPAQRA------TAAELLNHPFLAKA 275 (285)
T ss_pred CCcccccCCHHHHHHHHHHcccChhhCc------CHHHHccCcccccC
Confidence 2 234789999999999999999999 67899999999753
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=342.62 Aligned_cols=256 Identities=24% Similarity=0.398 Sum_probs=208.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-----S 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-----~ 139 (494)
.+|.+++.||+|+||+||+|++..++..||||.+.+... ..........|..++. .++||||+++++++... .
T Consensus 5 ~~y~~~~~lg~G~~~~vy~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~ni~~~~~~~~~~~~~~~~ 82 (337)
T cd07858 5 TKYVPIKPIGRGAYGIVCSAKNSETNEKVAIKKIANAFD-NRIDAKRTLREIKLLR-HLDHENVIAIKDIMPPPHREAFN 82 (337)
T ss_pred cceeEEEEeccCCCeEEEEEEecCCCCeEEEEEeccccc-ccchhHHHHHHHHHHH-hcCCCCccchHHheecccccccC
Confidence 479999999999999999999999999999999876422 2233445567777776 57999999999988654 3
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+|+||+. ++|...+...+.+++..++.++.||+.||.|||++|++||||||+||+
T Consensus 83 ~~~lv~e~~~----------------------~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i~H~dlkp~Nil 140 (337)
T cd07858 83 DVYIVYELMD----------------------TDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIHSANVLHRDLKPSNLL 140 (337)
T ss_pred cEEEEEeCCC----------------------CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEE
Confidence 5899999994 345566777788999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
++.++.+||+|||+++.............|+..|+|||.+.+ ..++.++|+|||||++|+|++|++||.+.+....+..
T Consensus 141 ~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~ 220 (337)
T cd07858 141 LNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKL 220 (337)
T ss_pred EcCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCCChHHHHHH
Confidence 999999999999998754333233445678999999999865 4689999999999999999999999987665433332
Q ss_pred HHhC----------------------------CC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 299 ICNE----------------------------RP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 299 i~~~----------------------------~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
+... .. ...+.+++++++||.+||+.+|++|| +++++++||||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------s~~ell~h~~~ 294 (337)
T cd07858 221 ITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKRI------TVEEALAHPYL 294 (337)
T ss_pred HHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhcc------CHHHHHcCcch
Confidence 2210 00 01235789999999999999999999 68999999999
Q ss_pred CCC
Q psy8309 348 RGL 350 (494)
Q Consensus 348 ~~~ 350 (494)
+.+
T Consensus 295 ~~~ 297 (337)
T cd07858 295 ASL 297 (337)
T ss_pred hhh
Confidence 754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=329.33 Aligned_cols=255 Identities=29% Similarity=0.528 Sum_probs=209.9
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC--CCCceeeEEEEEEcCCeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT--KHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~--~hp~Iv~l~~~~~~~~~~~l 143 (494)
.|++++.||+|+||.||+|.+..+++.||+|+++... ..........|..++.... .||||+++++++......|+
T Consensus 2 ~y~~~~~l~~g~~g~v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~l 79 (277)
T cd06917 2 LYQRLELIGRGAYGAVYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWI 79 (277)
T ss_pred hhhhhhheeccCCceEEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEE
Confidence 5788999999999999999999999999999987642 2334445566766666432 49999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||++|++ |..++.. +.+++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 80 v~e~~~~~~---------------------L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~p~ni~i~~~ 137 (277)
T cd06917 80 IMEYAEGGS---------------------VRTLMKA-GPIAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNT 137 (277)
T ss_pred EEecCCCCc---------------------HHHHHHc-cCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcCHHHEEEcCC
Confidence 999999554 4444433 478999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+.++|+|||++..............|+..|+|||.+.+ ..++.++|+|||||++|+|++|..||.+.+.......+...
T Consensus 138 ~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~~~~~~~~~~~ 217 (277)
T cd06917 138 GNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKS 217 (277)
T ss_pred CCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCChhhhhhccccC
Confidence 99999999998764433333445679999999999875 45789999999999999999999999887765554444332
Q ss_pred -CCCCCc-cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 -RPRFPQ-FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 -~~~~p~-~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+.++. .++.++.++|.+||..||.+|| ++.+++.|+||+..
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~------~~~~il~~~~~~~~ 261 (277)
T cd06917 218 KPPRLEDNGYSKLLREFVAACLDEEPKERL------SAEELLKSKWIKAH 261 (277)
T ss_pred CCCCCCcccCCHHHHHHHHHHcCCCcccCc------CHHHHhhChHhhcc
Confidence 223333 3788999999999999999999 68999999999764
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-41 Score=328.91 Aligned_cols=253 Identities=30% Similarity=0.524 Sum_probs=213.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
-|++++.||+|+||.||+|.++.++..||||++..... .........|..++. .++||||+++++++..+...|+||
T Consensus 5 ~~~~~~~ig~G~~~~vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 81 (277)
T cd06641 5 LFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKDTKLWIIM 81 (277)
T ss_pred hhhhheeEeecCCeEEEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHH-hcCCCCEeEEEEEEEeCCeEEEEE
Confidence 47788999999999999999999999999999865422 233445566777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||+.+|+| ..++. .+.+++..+..++.|++.||.|||++|++|+||||+||+++.++.
T Consensus 82 e~~~~~~l---------------------~~~i~-~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~Ni~i~~~~~ 139 (277)
T cd06641 82 EYLGGGSA---------------------LDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGE 139 (277)
T ss_pred EeCCCCcH---------------------HHHHh-cCCCCHHHHHHHHHHHHHHHHHHccCCeecCCCCHHhEEECCCCC
Confidence 99995544 44443 357899999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-CC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-RP 304 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-~~ 304 (494)
++|+|||++..............|+..|+|||.+.+..++.++|+|||||++|+|++|..||...+.......+... .+
T Consensus 140 ~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 219 (277)
T cd06641 140 VKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVLFLIPKNNPP 219 (277)
T ss_pred EEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCCCCCccchHHHHHHHhcCCCC
Confidence 99999999875433222334467899999999999888999999999999999999999999887776666666544 33
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.++..++.++.++|.+||..+|.+|| ++.++++||||..
T Consensus 220 ~~~~~~~~~~~~~i~~~l~~~p~~Rp------~~~~~l~~~~~~~ 258 (277)
T cd06641 220 TLEGNYSKPLKEFVEACLNKEPSFRP------TAKELLKHKFIVR 258 (277)
T ss_pred CCCcccCHHHHHHHHHHccCChhhCc------CHHHHHhCHHHhh
Confidence 45667899999999999999999999 6899999999975
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=334.35 Aligned_cols=255 Identities=25% Similarity=0.410 Sum_probs=200.2
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC---
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--- 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--- 139 (494)
.+++|++++.||+|+||.||+|+++.+++.||||++..... ..........|..++. .++||||+++++++....
T Consensus 10 ~~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~aik~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 87 (310)
T cd07865 10 EVSKYEKLAKIGQGTFGEVFKARHKKTKQIVALKKVLMENE-KEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPY 87 (310)
T ss_pred hhhheEEEEEeecCCCEEEEEEEECCCCcEEEEEEEeccCC-cCCchhHHHHHHHHHH-hCCCCCccceEEEEecccccc
Confidence 35689999999999999999999999999999999865422 1222233456777666 579999999999987654
Q ss_pred -----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 140 -----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 140 -----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
..|+||||+. +++...+... ..+++.+++.++.||+.||+|||++|++||||
T Consensus 88 ~~~~~~~~lv~e~~~----------------------~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dl 145 (310)
T cd07865 88 NRYKGSFYLVFEFCE----------------------HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHRNKILHRDM 145 (310)
T ss_pred cCCCceEEEEEcCCC----------------------cCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeccCC
Confidence 4599999995 2333344333 47899999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
||+||+++.++.+||+|||++........ ......++..|+|||.+.+. .++.++|+||||+++|||++|.+||.
T Consensus 146 ~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~ 225 (310)
T cd07865 146 KAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQ 225 (310)
T ss_pred CHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCC
Confidence 99999999999999999999875322211 12244678899999998764 47899999999999999999999998
Q ss_pred CCCHHHHHHHHHhC--C-----------------CCCCc-------------cCCHHHHHHHHhhccCCCCCCCCCCCCC
Q psy8309 289 GCDEDELFWSICNE--R-----------------PRFPQ-------------FLSVEAKNILVHLLDKDTTKRLGSTQCN 336 (494)
Q Consensus 289 ~~~~~~~~~~i~~~--~-----------------~~~p~-------------~~s~~~~~li~~lL~~dP~~R~~~~~~~ 336 (494)
+.+.......+..- . ..+|. ..+..+++||.+||..||.+||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~P~~R~------ 299 (310)
T cd07865 226 GNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRI------ 299 (310)
T ss_pred CCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCChhhcc------
Confidence 87765443332220 0 01111 1357788999999999999999
Q ss_pred ChhhhhcCCCc
Q psy8309 337 SGDDVVAHEYF 347 (494)
Q Consensus 337 ~~~eil~h~~f 347 (494)
++++++.||||
T Consensus 300 t~~e~l~h~~f 310 (310)
T cd07865 300 DADTALNHDFF 310 (310)
T ss_pred CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=330.70 Aligned_cols=262 Identities=28% Similarity=0.422 Sum_probs=209.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
..++|.+.+.||+|+||.||+|+... ++..||||++++.. ..........|..++. .++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~ 79 (280)
T cd05049 3 QRDTIVLKRELGEGAFGKVFLGECYHLEPENDKELVAVKTLKETA--SNDARKDFEREAELLT-NFQHENIVKFYGVCTE 79 (280)
T ss_pred ChHHhhHHhhccccCCceEeeeeeccccCcCCcceEEEEeecccC--CHHHHHHHHHHHHHHH-hcCCCCchheeeEEec
Confidence 35689999999999999999998753 46789999987542 2223456677877777 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHH---hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH---IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~---l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
....|+||||+++|+|.+.+... +...... ......+++..+..++.||+.||.|||++|++|||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~i~~~----------~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~h~dlk 149 (280)
T cd05049 80 GDPPIMVFEYMEHGDLNKFLRSH----------GPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLA 149 (280)
T ss_pred CCCeEEEEecCCCCCHHHHHHhc----------CCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhhCCeeccccc
Confidence 99999999999977663221110 1111111 1223468999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|+||+++.++.+||+|||+++...... .......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 150 p~nili~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~ 229 (280)
T cd05049 150 TRNCLVGYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLS 229 (280)
T ss_pred cceEEEcCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999999999987532211 11233456789999999999999999999999999999998 999999888
Q ss_pred HHHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+....+..+.. ..+..++.+++++|.+||..||.+|| +++|+++
T Consensus 230 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~eil~ 276 (280)
T cd05049 230 NEEVIECITQGRLLQRPRTCPSEVYDIMLGCWKRDPQQRI------NIKDIHE 276 (280)
T ss_pred HHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCC------CHHHHHH
Confidence 8888888876654 34567899999999999999999999 4666653
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=320.65 Aligned_cols=253 Identities=27% Similarity=0.543 Sum_probs=218.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|++|.||+|+++.+++.||+|.+.+... ..........|..++. .++|||++++++++.+.+..|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~ 78 (254)
T cd06627 1 NYQLGDLIGRGAFGVVYKGLNLETGDFVAIKQISLEKI-KEEALKSIMQEIDLLK-NLKHPNIVKYIGSIETSDSLYIIL 78 (254)
T ss_pred CceeeeEEcccCCeEEEEEEEcCCCcEEEEEEeccccc-CHHHHHHHHHHHHHHH-hCCCCCccEEEEEEEeCCEEEEEE
Confidence 58899999999999999999999999999999987643 2345556677777777 578999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++ +++|...+...+.+++..+..++.|++.||.|||++||+||||||+||+++.++.
T Consensus 79 e~~~---------------------~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~~~~~ 137 (254)
T cd06627 79 EYAE---------------------NGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGV 137 (254)
T ss_pred ecCC---------------------CCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCHHHEEECCCCC
Confidence 9998 4455566666688999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hCCC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-NERP 304 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-~~~~ 304 (494)
++|+|||++..............|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+......++. ....
T Consensus 138 ~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~ 217 (254)
T cd06627 138 VKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIVQDDHP 217 (254)
T ss_pred EEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhccCCC
Confidence 999999999864433333345678999999999988889999999999999999999999998776655555544 4455
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.+|..++.+++++|.+||..+|++|| ++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~i~~~l~~~p~~R~------~~~~~l~~~~~ 254 (254)
T cd06627 218 PLPEGISPELKDFLMQCFQKDPNLRP------TAKQLLKHPWI 254 (254)
T ss_pred CCCCCCCHHHHHHHHHHHhCChhhCc------CHHHHhcCCCC
Confidence 67788999999999999999999999 68999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >KOG4721|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-43 Score=348.77 Aligned_cols=239 Identities=29% Similarity=0.474 Sum_probs=205.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+...-++-||.|+.|.||+|+.+. +.||||.++.- ++. +++-|. .++||||+.+.++|.....+|||
T Consensus 124 e~IsELeWlGSGaQGAVF~Grl~n--etVAVKKV~el---kET-------dIKHLR-kLkH~NII~FkGVCtqsPcyCIi 190 (904)
T KOG4721|consen 124 EEISELEWLGSGAQGAVFLGRLHN--ETVAVKKVREL---KET-------DIKHLR-KLKHPNIITFKGVCTQSPCYCII 190 (904)
T ss_pred HHhhhhhhhccCcccceeeeeccC--ceehhHHHhhh---hhh-------hHHHHH-hccCcceeeEeeeecCCceeEEe
Confidence 344456789999999999998754 55999987531 222 233344 58999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||. .|.|...++....++......|..+|+.||.|||.+.|||||||.-||||+.+.
T Consensus 191 MEfCa---------------------~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRDLKSPNiLIs~~d 249 (904)
T KOG4721|consen 191 MEFCA---------------------QGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRDLKSPNILISYDD 249 (904)
T ss_pred eeccc---------------------cccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhccCCCceEeeccc
Confidence 99999 566677788888999999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER- 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~- 303 (494)
.|||+|||-++.... .....+++||..|||||+|++++.+.++|||||||+|||||||..||...+...+++-+-...
T Consensus 250 ~VKIsDFGTS~e~~~-~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVdssAIIwGVGsNsL 328 (904)
T KOG4721|consen 250 VVKISDFGTSKELSD-KSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDSSAIIWGVGSNSL 328 (904)
T ss_pred eEEeccccchHhhhh-hhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccchheeEEeccCCcc
Confidence 999999999986433 355678999999999999999999999999999999999999999999988888877665554
Q ss_pred -CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 304 -PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 304 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..|..+++.++-||++||...|.+|| +..+|+.|
T Consensus 329 ~LpvPstcP~GfklL~Kqcw~sKpRNRP------SFrqil~H 364 (904)
T KOG4721|consen 329 HLPVPSTCPDGFKLLLKQCWNSKPRNRP------SFRQILLH 364 (904)
T ss_pred cccCcccCchHHHHHHHHHHhcCCCCCc------cHHHHHHH
Confidence 456789999999999999999999999 45666666
|
|
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-41 Score=330.56 Aligned_cols=256 Identities=27% Similarity=0.398 Sum_probs=204.0
Q ss_pred CCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
...+|.+.+.||+|+||.||+|... .++..||+|.+.+. ..........|..++. .++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~G~~~~v~~~~~~~~~~~~~~~~~~ik~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~ 78 (288)
T cd05093 3 KRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLT-NLQHEHIVKFYGVCVE 78 (288)
T ss_pred chHHeeeccccCCcCCeeEEeeEeccCCCCCcceEEEEEecCCc---CHHHHHHHHHHHHHHH-hCCCCCcceEEEEEec
Confidence 4568999999999999999999853 34567999988753 2334455667777776 5789999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCc--hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD--LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~--L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+.+|+||||+++|+|.+.+... +.. ....-.+...+++..+..++.||+.||+|||++|++||||||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~----------~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~lH~~~i~H~dlkp 148 (288)
T cd05093 79 GDPLIMVFEYMKHGDLNKFLRAH----------GPDAVLMAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 148 (288)
T ss_pred CCccEEEEEcCCCCCHHHHHHHc----------CCccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccCc
Confidence 99999999999977663211000 000 000001223599999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+.
T Consensus 149 ~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 149 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred ceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999874321111 1223345788999999999999999999999999999998 9999999888
Q ss_pred HHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 293 DELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 293 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+....+..+. ...+..++.++.+|+.+||+.||.+||++
T Consensus 229 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 269 (288)
T cd05093 229 NEVIECITQGRVLQRPRTCPKEVYDLMLGCWQREPHMRLNI 269 (288)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 88888887765 34566789999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=329.76 Aligned_cols=253 Identities=31% Similarity=0.476 Sum_probs=206.9
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|.+..++..||||++..... ..........|..++. .++||||+++++++.....+|+||
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~vK~~~~~~~-~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~ 78 (286)
T cd07832 1 RYKILGRIGEGAHGIVFKAKDRETGETVALKKVALRRL-EGGIPNQALREIKALQ-ACQHPYVVKLLDVFPHGSGFVLVM 78 (286)
T ss_pred CceEEeecccCCCcEEEEEEECCCCceEEEEEEEcccc-cchhhHHHHHHHHHHH-hCCCCCCcceeeEEecCCeeEEEe
Confidence 58999999999999999999999999999999976532 2233455667777776 568999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||+ +++| ..++. ....+++.+++.++.||+.||+|||++|++|+||||+||+++.++
T Consensus 79 e~~-~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~~~~~~ 136 (286)
T cd07832 79 EYM-PSDL---------------------SEVLRDEERPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADG 136 (286)
T ss_pred ccc-CCCH---------------------HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCHHHEEEcCCC
Confidence 999 6665 23332 235699999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 225 HVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
.++|+|||++........ ......|+..|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..+...
T Consensus 137 ~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~ 216 (286)
T cd07832 137 VLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRT 216 (286)
T ss_pred cEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCCHHHHHHHHHHH
Confidence 999999999875432221 23345789999999998754 4689999999999999999999999887766655554421
Q ss_pred C-------------------CCC-----------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 303 R-------------------PRF-----------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 303 ~-------------------~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
- ..+ ....+.++.+||.+||..||.+|| ++++++.||||.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------~~~~~l~h~~~~ 286 (286)
T cd07832 217 LGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRL------SAAEALRHPYFT 286 (286)
T ss_pred cCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCC------CHHHHhhCcCcC
Confidence 0 001 124578999999999999999999 678999999983
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-41 Score=325.64 Aligned_cols=251 Identities=27% Similarity=0.387 Sum_probs=205.8
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+.+.+++.||||.+................|..++. .++||||+++++++.+.+..|+|
T Consensus 2 ~~~~i~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08228 2 ANFQIEKKIGRGQFSEVYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLK-QLNHPNVIKYLDSFIEDNELNIV 80 (267)
T ss_pred cceeeeeeeccCCCeeEEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHH-hCCCcceeeeeeeEEECCeEEEE
Confidence 58999999999999999999999999999999987644444444555667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|||+++|+| ...+. ....+++..+..++.||+.||.|||++|++||||||+|||+
T Consensus 81 ~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~~~nil~ 139 (267)
T cd08228 81 LELADAGDL---------------------SQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred EEecCCCcH---------------------HHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCHHHEEE
Confidence 999996655 22222 23468999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD--EDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~ 298 (494)
+.++.++|+|||++..............|++.|+|||.+.+..++.++|+||||+++|||++|..||.... .......
T Consensus 140 ~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08228 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQK 219 (267)
T ss_pred cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCccccccHHHHHHH
Confidence 99999999999998754332222345678999999999999899999999999999999999999997653 2344444
Q ss_pred HHhCC-CCC-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 299 ICNER-PRF-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 299 i~~~~-~~~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+.... +.. +..++..++++|.+||..+|.+|| ++.++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------~~~~vl~ 260 (267)
T cd08228 220 IEQCDYPPLPTEHYSEKLRELVSMCIYPDPDQRP------DIGYVHQ 260 (267)
T ss_pred HhcCCCCCCChhhcCHHHHHHHHHHCCCCcccCc------CHHHHHH
Confidence 44322 222 235788999999999999999999 5667764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-41 Score=323.86 Aligned_cols=253 Identities=32% Similarity=0.540 Sum_probs=211.1
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|....+++.||+|+++.... ..........|..++. .++|+||+++++.+.+.+.+++|+
T Consensus 1 ~y~~~~~lg~G~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~lv~ 78 (264)
T cd06626 1 RWQRGNKIGGGTFGKVYTAVNLDTGELMAVKEIRIQDN-DPKTIKEIADEMKVLE-LLKHPNLVKYYGVEVHREKVYIFM 78 (264)
T ss_pred CceeeeEeecCCCcEEEEEEECCCCcEEEEEEEECccc-chHHHHHHHHHHHHHH-hCCCCChhheeeeEecCCEEEEEE
Confidence 58899999999999999999999999999999976533 2345667777887777 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||+++ ++|...+.....+++..++.++.||+.||.|||++||+||||+|+||+++.++.
T Consensus 79 e~~~~---------------------~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~ 137 (264)
T cd06626 79 EYCSG---------------------GTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGV 137 (264)
T ss_pred ecCCC---------------------CcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCCCC
Confidence 99994 455556666667899999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCc----ccccCCCCCccChhhhCCCC---CCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q psy8309 226 VRIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEIIKGLK---YNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFW 297 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~ 297 (494)
+||+|||++......... .....|++.|+|||++.+.. ++.++||||||+++|+|++|..||...+ ......
T Consensus 138 ~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~~~~~~~~~ 217 (264)
T cd06626 138 IKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNEFQIMF 217 (264)
T ss_pred EEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCCcchHHHHH
Confidence 999999998753322221 12357889999999998766 8899999999999999999999997653 333333
Q ss_pred HHHh-CCCCCCccC--CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 298 SICN-ERPRFPQFL--SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 298 ~i~~-~~~~~p~~~--s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.+.. ..+.+|... +..+.++|.+||+.+|.+|| ++.|++.|||+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~------~~~~i~~~~~~ 264 (264)
T cd06626 218 HVGAGHKPPIPDSLQLSPEGKDFLDRCLESDPKKRP------TASELLQHPFV 264 (264)
T ss_pred HHhcCCCCCCCcccccCHHHHHHHHHHccCCcccCC------CHHHHhcCCCC
Confidence 3333 234556544 89999999999999999999 67899999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-41 Score=328.87 Aligned_cols=270 Identities=23% Similarity=0.333 Sum_probs=207.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+.+++|++.+.||+|+||+||+|... .++..||+|.+... ...........|..++. .++||||+++++++..
T Consensus 2 ~~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~ 78 (283)
T cd05090 2 LPLSAVRFMEELGECAFGKIYKGHLYLPGMDHAQLVAIKTLKDI--NNPQQWGEFQQEASLMA-ELHHPNIVCLLGVVTQ 78 (283)
T ss_pred CChhhceeeeeccccCCcceEEEEEecCCCCCcceEEEEeccCC--CCHHHHHHHHHHHHHHh-hCCCCCeeeEEEEEec
Confidence 34678999999999999999999863 35578999998753 22333445666777776 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
....|+||||+++|+|.+.+....... ..+......-.....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 79 ~~~~~lv~e~~~~~~L~~~l~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~dlkp~n 154 (283)
T cd05090 79 EQPVCMLFEYLNQGDLHEFLIMRSPHS----DVGCSSDEDGTVKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARN 154 (283)
T ss_pred CCceEEEEEcCCCCcHHHHHHhcCCCC----ccccccccccccccccCHHHHHHHHHHHHHHHHHHHhcCeehhccccce
Confidence 999999999999777643211000000 0000000000112357889999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
||++.++.+||+|||+++...... .......++..|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 155 ili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~ 234 (283)
T cd05090 155 ILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQE 234 (283)
T ss_pred EEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 999999999999999987532211 12334456778999999998899999999999999999998 999999887777
Q ss_pred HHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 295 LFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 295 ~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+...+.... +..|..++++++++|.+||+.||.+|| ++++|+++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------~~~~i~~~ 279 (283)
T cd05090 235 VIEMVRKRQLLPCSEDCPPRMYSLMTECWQEGPSRRP------RFKDIHTR 279 (283)
T ss_pred HHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc------CHHHHHHH
Confidence 766665543 455677899999999999999999999 45666643
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=365.43 Aligned_cols=258 Identities=24% Similarity=0.368 Sum_probs=200.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++.++||+|+||.||+|++..+++.||||++................|..++. .++||||+++++++.+.+..|+
T Consensus 1 igrYeIi~~LGkGgfG~VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs-~L~HPNIVkl~~v~~d~~~lyL 79 (932)
T PRK13184 1 MQRYDIIRLIGKGGMGEVYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAA-DLIHPGIVPVYSICSDGDPVYY 79 (932)
T ss_pred CCCeEEEEEEecCCCEEEEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHH-hCCCcCcCeEEEEEeeCCEEEE
Confidence 368999999999999999999999999999999998654333334456677877776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||++||+|.+.+... .....+. -.....++...+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 80 VMEY~eGGSL~~lL~s~--------~~~~~l~--e~~~~~lsv~~iL~I~~QIa~AL~yLHs~GIIHRDLKPeNILLd~d 149 (932)
T PRK13184 80 TMPYIEGYTLKSLLKSV--------WQKESLS--KELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLF 149 (932)
T ss_pred EEEcCCCCCHHHHHHHh--------hhccccc--hhhhcccCHHHHHHHHHHHHHHHHHHHHCCccccCCchheEEEcCC
Confidence 99999977763211100 0000000 0112345677888999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC------------------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCC
Q psy8309 224 GHVRIADFGMCKLQIYLD------------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS 285 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~------------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~ 285 (494)
|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..
T Consensus 150 g~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~ 229 (932)
T PRK13184 150 GEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSF 229 (932)
T ss_pred CCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCC
Confidence 999999999997541110 11223579999999999999999999999999999999999999
Q ss_pred CCCCCCHHHHHHHHH-hCCCCC--CccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 286 PFSGCDEDELFWSIC-NERPRF--PQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 286 Pf~~~~~~~~~~~i~-~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
||...+..+...... .....+ ...+++.+.+++.+||..||++|+++
T Consensus 230 PF~~~~~~ki~~~~~i~~P~~~~p~~~iP~~L~~LI~rcL~~DP~kR~ss 279 (932)
T PRK13184 230 PYRRKKGRKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYSS 279 (932)
T ss_pred CCCCcchhhhhhhhhccChhhccccccCCHHHHHHHHHHccCChhhCcCH
Confidence 998765544333221 111111 13578999999999999999999953
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=323.72 Aligned_cols=253 Identities=30% Similarity=0.542 Sum_probs=212.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|..+.++..||+|.+..... ..........|..++. .++|+||+++++.+......|+|+
T Consensus 1 ~~~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~-~~~h~~i~~~~~~~~~~~~~~lv~ 78 (257)
T cd08225 1 RYEIIKKIGEGSFGKIYLAKAKSDSEHCVIKEIDLTKM-PVKEKEASKKEVILLA-KMKHPNIVTFFASFQENGRLFIVM 78 (257)
T ss_pred CceEEEEecCCCcceEEEEEEcCCCceEEEEEeeHhhc-cchhhHHHHHHHHHHH-hCCCCChhhhhheeccCCeEEEEE
Confidence 58899999999999999999999999999999876432 2233345567777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+++++| ..++... ..+++..+..++.||+.||.|||+++++|+||||+||+++.+
T Consensus 79 e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~H~dl~~~nil~~~~ 137 (257)
T cd08225 79 EYCDGGDL---------------------MKRINRQRGVLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKN 137 (257)
T ss_pred ecCCCCcH---------------------HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEcCC
Confidence 99995544 4444332 357999999999999999999999999999999999999988
Q ss_pred CC-EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GH-VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~-vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+. +||+|||.+..............|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+....+...
T Consensus 138 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 217 (257)
T cd08225 138 GMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQG 217 (257)
T ss_pred CCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHhcc
Confidence 65 69999999875433222334456899999999999888999999999999999999999999988877777666654
Q ss_pred CC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 RP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.. ..+..++.+++++|.+||..+|++|| +++|+++||||
T Consensus 218 ~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp------t~~~ll~~~~~ 257 (257)
T cd08225 218 YFAPISPNFSRDLRSLISQLFKVSPRDRP------SITSILKRPFL 257 (257)
T ss_pred cCCCCCCCCCHHHHHHHHHHhccChhhCc------CHHHHhhCCCC
Confidence 33 34556889999999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=335.37 Aligned_cols=257 Identities=26% Similarity=0.429 Sum_probs=200.4
Q ss_pred CceEeeEeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--Cee
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SHL 141 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~~ 141 (494)
.|++.+.||+|+||.||+|..+. ++..||||++.+..............|..++. .++||||+++++++.+. ..+
T Consensus 1 ~y~~~~~ig~g~~g~v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 79 (316)
T cd07842 1 KYEIEGCIGRGTYGRVYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLR-ELKHENVVSLVEVFLEHADKSV 79 (316)
T ss_pred CceEEEEeccCCcEEEEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHH-hcCCCCccceEEEEeCCCCceE
Confidence 48899999999999999999988 89999999998753222333445566777776 57999999999999988 889
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+||||+.+ +|. . .+..+... ...+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 80 ~lv~e~~~~-~l~------------~-----~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~h~dlkp~Nil~ 141 (316)
T cd07842 80 YLLFDYAEH-DLW------------Q-----IIKFHRQAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILV 141 (316)
T ss_pred EEEEeCCCc-CHH------------H-----HHHhhccCCCcCcCHHHHHHHHHHHHHHHHHHHhCCEeeCCCCHHHEEE
Confidence 999999973 221 0 01111111 2378999999999999999999999999999999999999
Q ss_pred CC----CCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 221 DY----EGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 221 ~~----~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
+. +|.+||+|||+++....... .....++|+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+.
T Consensus 142 ~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~ 221 (316)
T cd07842 142 MGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREA 221 (316)
T ss_pred cCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCcc
Confidence 99 89999999999875322211 23345789999999998764 589999999999999999999999986543
Q ss_pred HH---------HHHHHH--------------------------hCCCCCC-----------ccCCHHHHHHHHhhccCCC
Q psy8309 293 DE---------LFWSIC--------------------------NERPRFP-----------QFLSVEAKNILVHLLDKDT 326 (494)
Q Consensus 293 ~~---------~~~~i~--------------------------~~~~~~p-----------~~~s~~~~~li~~lL~~dP 326 (494)
.. .+..+. .....++ ...+.++.++|.+||..||
T Consensus 222 ~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P 301 (316)
T cd07842 222 KIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGFDLLRKLLEYDP 301 (316)
T ss_pred cccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccCCCHHHHHHHHHHhcCCc
Confidence 21 111110 0011111 1467789999999999999
Q ss_pred CCCCCCCCCCChhhhhcCCCc
Q psy8309 327 TKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 327 ~~R~~~~~~~~~~eil~h~~f 347 (494)
++|| +++|++.||||
T Consensus 302 ~~Rp------s~~eil~~~~f 316 (316)
T cd07842 302 TKRI------TAEEALEHPYF 316 (316)
T ss_pred ccCc------CHHHHhcCCCC
Confidence 9999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=334.67 Aligned_cols=252 Identities=25% Similarity=0.462 Sum_probs=210.1
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|+....||+|+||.||+|.+..+++.||||++..... ........|..++. .++||||+++++.+...+..|+||
T Consensus 22 ~~~~~~~ig~g~~g~v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~iv~ 97 (297)
T cd06659 22 LLENYIKIGEGSTGIVCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMR-DYQHQNVVEMYKSYLVGEELWVLM 97 (297)
T ss_pred hHHhhhhcCCCCceeEEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHH-hCCCCchhhhhhheeeCCeEEEEE
Confidence 45556689999999999999999999999999865422 22344566766666 578999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||+++++| ...+ ....+++..++.++.||+.||.|||++||+||||||+||+++.++.
T Consensus 98 e~~~~~~L---------------------~~~~-~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dl~p~Nill~~~~~ 155 (297)
T cd06659 98 EFLQGGAL---------------------TDIV-SQTRLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGR 155 (297)
T ss_pred ecCCCCCH---------------------HHHH-hhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHeEEccCCc
Confidence 99995544 3333 3356899999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP- 304 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~- 304 (494)
+||+|||++.............+|++.|+|||++.+..++.++|+|||||++|||++|..||...+..+....+.....
T Consensus 156 ~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~ 235 (297)
T cd06659 156 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP 235 (297)
T ss_pred EEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhccCCC
Confidence 9999999986433222233456799999999999998999999999999999999999999988877776666654322
Q ss_pred --CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 305 --RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 305 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..+..++.++.++|.+||+.+|.+|| ++++++.|+||..
T Consensus 236 ~~~~~~~~~~~l~~~i~~~l~~~P~~Rp------s~~~ll~~~~~~~ 276 (297)
T cd06659 236 KLKNAHKISPVLRDFLERMLTREPQERA------TAQELLDHPFLLQ 276 (297)
T ss_pred CccccCCCCHHHHHHHHHHhcCCcccCc------CHHHHhhChhhcc
Confidence 22346789999999999999999999 6899999999964
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=340.38 Aligned_cols=256 Identities=23% Similarity=0.365 Sum_probs=207.8
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----CCe
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----DSH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~~~ 140 (494)
++|++.+.||+|+||.||+|..+.++..||+|++.+... ..........|..++. .++||||++++++|.. ...
T Consensus 5 ~~y~~~~~lg~g~~g~v~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 82 (334)
T cd07855 5 SRYKPIENIGSGAYGVVCSAIDTRSGKKVAIKKIPHAFD-VPTLAKRTLRELKILR-HFKHDNIIAIRDILRPPGADFKD 82 (334)
T ss_pred hceeeeeeeecCCCeEEEEEEEcCCCCEEEEEEeccccc-cccchHHHHHHHHHHH-hcCCCCccCHHHhccccCCCCce
Confidence 589999999999999999999999999999999976432 2233455667777776 5789999999998863 357
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 83 ~~lv~e~~~----------------------~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~Nil~ 140 (334)
T cd07855 83 VYVVMDLME----------------------SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIHSANVIHRDLKPSNLLV 140 (334)
T ss_pred EEEEEehhh----------------------hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 899999995 3455566667779999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+.+|.+||+|||+++....... .....+|+..|+|||++.+ ..++.++|||||||++|||++|++||.+.+....
T Consensus 141 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~~~~~ 220 (334)
T cd07855 141 NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220 (334)
T ss_pred cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCChHHH
Confidence 9999999999999875432221 1234578999999999866 4689999999999999999999999988765443
Q ss_pred HHHHHhC--------------------------CCCC-----CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICNE--------------------------RPRF-----PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~~--------------------------~~~~-----p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..+... .... ...++.+++++|++||+.+|.+|| ++.+++.|
T Consensus 221 ~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~~l~~ 294 (334)
T cd07855 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFDPEERI------TVEQALQH 294 (334)
T ss_pred HHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCChhhCc------CHHHHHhC
Confidence 3322210 0111 134689999999999999999999 67899999
Q ss_pred CCcCCC
Q psy8309 345 EYFRGL 350 (494)
Q Consensus 345 ~~f~~~ 350 (494)
|||++.
T Consensus 295 ~~~~~~ 300 (334)
T cd07855 295 PFLAQY 300 (334)
T ss_pred hhhhhc
Confidence 999753
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=324.05 Aligned_cols=245 Identities=26% Similarity=0.394 Sum_probs=205.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+...+|++.+.||+|+||.||+|..+.++..||+|++.++ .........|..++. .++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~K~~~~~----~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 77 (263)
T cd05052 3 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPPF 77 (263)
T ss_pred CchHHeEEeeecCCcccceEEEEEEecCCceEEEEEecCC----chHHHHHHHHHHHHH-hCCCCChhheEEEEcCCCCc
Confidence 3456899999999999999999999999999999998754 223445667877777 47999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
++||||+++|+| ..++.. ...+++..++.++.|++.||+|||++|++||||||+|||
T Consensus 78 ~lv~e~~~~~~L---------------------~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~nil 136 (263)
T cd05052 78 YIITEFMTYGNL---------------------LDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL 136 (263)
T ss_pred EEEEEeCCCCcH---------------------HHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEE
Confidence 999999995554 444443 246889999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||++......... .....+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 137 ~~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~~~~~ 216 (263)
T cd05052 137 VGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYE 216 (263)
T ss_pred EcCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHHHHHH
Confidence 999999999999998753221111 112234668999999999999999999999999999998 999999988888877
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+... .+..|..++.++.++|.+||..||++||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 252 (263)
T cd05052 217 LLEKGYRMERPEGCPPKVYELMRACWQWNPSDRPSF 252 (263)
T ss_pred HHHCCCCCCCCCCCCHHHHHHHHHHccCCcccCCCH
Confidence 77654 556678899999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-41 Score=338.52 Aligned_cols=254 Identities=25% Similarity=0.410 Sum_probs=201.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-----S 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-----~ 139 (494)
++|++.+.||+|+||.||+|+++.+++.||||++... ...........|..++. .++||||+++++++... .
T Consensus 5 ~~y~i~~~lg~G~~g~vy~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 81 (336)
T cd07849 5 PRYQNLSYIGEGAYGMVCSATHKPTGVKVAIKKISPF--EHQTFCQRTLREIKILR-RFKHENIIGILDIIRPPSFESFN 81 (336)
T ss_pred cceEEEEEEEecCCeEEEEEEEcCCCCeEEEEEeccc--ccchhHHHHHHHHHHHH-hCCCCCcCchhheeecccccccc
Confidence 5899999999999999999999999999999998642 12233445566777776 57899999999886644 3
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+|+||+. +++...+ ....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 82 ~~~lv~e~~~----------------------~~l~~~~-~~~~l~~~~~~~i~~ql~~aL~~LH~~~ivH~dlkp~Nil 138 (336)
T cd07849 82 DVYIVQELME----------------------TDLYKLI-KTQHLSNDHIQYFLYQILRGLKYIHSANVLHRDLKPSNLL 138 (336)
T ss_pred eEEEEehhcc----------------------cCHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEE
Confidence 5899999995 2333333 3457999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
++.++.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|++||.+.+....
T Consensus 139 l~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~~~~~~ 218 (336)
T cd07849 139 LNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQ 218 (336)
T ss_pred ECCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999875322111 1234578999999998765 5689999999999999999999999987654433
Q ss_pred HHHHHh---------------C-----------CCC-----CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICN---------------E-----------RPR-----FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~---------------~-----------~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
...+.. . ... .....+.++.+||.+||+.||.+|| ++.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp------t~~e~l~h 292 (336)
T cd07849 219 LNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNPHKRI------TVEEALAH 292 (336)
T ss_pred HHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCChhhCc------CHHHHhcC
Confidence 322211 0 000 0124678899999999999999999 68999999
Q ss_pred CCcCCC
Q psy8309 345 EYFRGL 350 (494)
Q Consensus 345 ~~f~~~ 350 (494)
|||+..
T Consensus 293 p~~~~~ 298 (336)
T cd07849 293 PYLEQY 298 (336)
T ss_pred cccccc
Confidence 999854
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=331.91 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=209.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|++.+.||+|+||.||+|+...+++.||+|++................|..++. .++||||+++++++.+.+..|+|
T Consensus 15 ~~y~~~~~lg~g~~g~vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~-~l~h~niv~~~~~~~~~~~~~lv 93 (307)
T cd06607 15 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-QLRHPNTIEYKGCYLREHTAWLV 93 (307)
T ss_pred hhhhhheeecCCCCeEEEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEEeCCeEEEE
Confidence 46999999999999999999999999999999987553333444456677877777 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+.| + +...+ .....+++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 94 ~e~~~g-~---------------------l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~i~H~dl~p~nIl~~~~ 151 (307)
T cd06607 94 MEYCLG-S---------------------ASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEP 151 (307)
T ss_pred HHhhCC-C---------------------HHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEECCC
Confidence 999963 2 22222 234578999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.++|+|||++... .......|++.|+|||++. ...++.++||||||+++|||++|.+||.+.+.......+.
T Consensus 152 ~~~kL~dfg~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~~~~~~~~~~ 227 (307)
T cd06607 152 GTVKLADFGSASLV----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (307)
T ss_pred CCEEEeecCcceec----CCCCCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCccHHHHHHHHh
Confidence 99999999998752 2233567899999999984 3568899999999999999999999998887766555554
Q ss_pred hC-CCCC-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NE-RPRF-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~-~~~~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.. .+.+ +..++.+++++|.+||..||.+|| ++.+|+.|+||..
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~~~ 272 (307)
T cd06607 228 QNDSPTLSSNDWSDYFRNFVDSCLQKIPQDRP------SSEELLKHRFVLR 272 (307)
T ss_pred cCCCCCCCchhhCHHHHHHHHHHhcCChhhCc------CHHHHhcChhhcc
Confidence 33 2333 235788999999999999999999 6899999999974
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=322.36 Aligned_cols=254 Identities=27% Similarity=0.479 Sum_probs=211.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccc--cChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--Ce
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV--LEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~ 140 (494)
.+|++.+.||+|+||.||+|+++.+++.||+|++..... ...........|..++. .++||||+++++++.+. ..
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~-~l~h~~i~~~~~~~~~~~~~~ 80 (264)
T cd06653 2 VNWRLGKLLGRGAFGEVYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLK-NLRHDRIVQYYGCLRDPEEKK 80 (264)
T ss_pred CceeeeeeEccCCCeEEEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHH-HcCCCCcceEEEEEEcCCCCE
Confidence 579999999999999999999999999999999864321 12234455667777777 57999999999998764 56
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+++||||++ |++|...+...+.+++..++.++.||+.||.|||++|++||||||+||++
T Consensus 81 ~~~v~e~~~---------------------~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~H~dl~p~ni~i 139 (264)
T cd06653 81 LSIFVEYMP---------------------GGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILR 139 (264)
T ss_pred EEEEEEeCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEE
Confidence 899999998 45555566666789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeecc---CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYL---DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~---~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.++.++|+|||+++..... ........|+..|+|||.+.+..++.++|+|||||++|+|++|++||......+...
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 219 (264)
T cd06653 140 DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEYEAMAAIF 219 (264)
T ss_pred cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCccCHHHHHH
Confidence 99999999999998753211 111234578999999999999889999999999999999999999998876666555
Q ss_pred HHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 298 SICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 298 ~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
++... .+.+|..++++++++|.+||. +|.+|| ++.+++.|||.
T Consensus 220 ~~~~~~~~~~~p~~~~~~~~~~i~~~l~-~~~~r~------~~~~~~~~~~~ 264 (264)
T cd06653 220 KIATQPTKPMLPDGVSDACRDFLKQIFV-EEKRRP------TAEFLLRHPFV 264 (264)
T ss_pred HHHcCCCCCCCCcccCHHHHHHHHHHhc-CcccCc------cHHHHhcCCCC
Confidence 55533 356788999999999999998 579999 67899999983
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=326.79 Aligned_cols=258 Identities=32% Similarity=0.485 Sum_probs=207.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--CeeE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SHLF 142 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~~~ 142 (494)
++|+..+.||.|++|.||+|.+..+++.||+|.+.... ..........|..++. .++||||++++++|.+. +.+|
T Consensus 1 ~~~~~~~~lg~g~~~~v~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 77 (287)
T cd06621 1 EKIVELSRLGEGAGGSVTKCRLKNTGMIFALKTITTDP--NPDLQKQILRELEINK-SCKSPYIVKYYGAFLDESSSSIG 77 (287)
T ss_pred CceEEEEEeccCCceEEEEEEECCCCeEEEEEEEecCC--chHHHHHHHHHHHHHH-hCCCCCeeeeeeEEEccCCCeEE
Confidence 47899999999999999999999999999999987542 2233455677877776 57999999999988653 4789
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||+++|+|.+. +.........+++..+..++.||+.||.|||+.|++|+||+|+||+++.
T Consensus 78 lv~e~~~~~~L~~~-----------------l~~~~~~~~~l~~~~~~~i~~~i~~~L~~lH~~~i~H~dl~~~nil~~~ 140 (287)
T cd06621 78 IAMEYCEGGSLDSI-----------------YKKVKKRGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTR 140 (287)
T ss_pred EEEEecCCCCHHHH-----------------HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEec
Confidence 99999997665210 1111223456899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-----CHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC-----DEDELFW 297 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-----~~~~~~~ 297 (494)
++.++|+|||++.... ........++..|+|||.+.+..++.++|+|||||++|+|++|..||... ...+...
T Consensus 141 ~~~~~l~dfg~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (287)
T cd06621 141 KGQVKLCDFGVSGELV--NSLAGTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPEGEPPLGPIELLS 218 (287)
T ss_pred CCeEEEeecccccccc--ccccccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcccCCCCChHHHHH
Confidence 9999999999986432 12223456889999999999999999999999999999999999999865 2344444
Q ss_pred HHHhCC-CCCCc------cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 298 SICNER-PRFPQ------FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 298 ~i~~~~-~~~p~------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+.... +.++. .+++++.+||.+||..+|.+|| ++.|++.|+||+..
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~eil~~~~~~~~ 272 (287)
T cd06621 219 YIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRP------TPWDMLEHPWIKAQ 272 (287)
T ss_pred HHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCC------CHHHHHhCcccccc
Confidence 444422 22221 3467899999999999999999 68999999999754
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=319.47 Aligned_cols=253 Identities=32% Similarity=0.558 Sum_probs=217.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|.+..++..||+|++..... ..........|..++. .++|||++++++.+......++|+
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~~~~~~~~~~~~~~~~lv~ 78 (258)
T cd08215 1 KYEIIKQIGKGSFGKVYLVRRKSDGKLYVLKEIDLSNM-SEKEREDALNEVKILK-KLNHPNIIKYYESFEEKGKLCIVM 78 (258)
T ss_pred CceEEeeeccCCCeEEEEEEEcCCCcEEEEEEeecccC-ChHHHHHHHHHHHHHH-hcCCCChhheEEEEecCCEEEEEE
Confidence 58899999999999999999999999999999976532 2334455667777776 578999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||+++++| ..++.. ...+++..+..++.||+.||.|||++|++|+||+|+||+++
T Consensus 79 e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~~H~dl~~~nil~~ 137 (258)
T cd08215 79 EYADGGDL---------------------SQKIKKQKKEGKPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLT 137 (258)
T ss_pred EecCCCcH---------------------HHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecccCChHHeEEc
Confidence 99995544 444443 36899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.++|+|||++.............+|++.|+|||.+.+..++.++|+||+|+++|+|++|..||...+..++...+..
T Consensus 138 ~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 217 (258)
T cd08215 138 SNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILK 217 (258)
T ss_pred CCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCcHHHHHHHHhc
Confidence 99999999999987643333234556799999999999998999999999999999999999999998887777777665
Q ss_pred C-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 E-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 ~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. ...+|..++.++.++|.+||..+|.+|| ++.++++||||
T Consensus 218 ~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp------~~~~ll~~~~~ 258 (258)
T cd08215 218 GQYPPIPSQYSSELRNLVSSLLQKDPEERP------SIAQILQSPFI 258 (258)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHhcCCCC
Confidence 4 3455668899999999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >KOG0662|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-42 Score=297.52 Aligned_cols=257 Identities=26% Similarity=0.495 Sum_probs=213.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+|..++.||+|+||+||+|+.+.+++.||+|.++.+.. .+.--...++|+-++. .++|.|||+++++...+..+-+|
T Consensus 2 ~~ydkmekigegtygtvfkarn~~t~eivalkrvrlddd-degvpssalreicllk-elkhknivrl~dvlhsdkkltlv 79 (292)
T KOG0662|consen 2 QKYDKMEKIGEGTYGTVFKARNRETHEIVALKRVRLDDD-DEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTLV 79 (292)
T ss_pred cchHHHHhhcCCcceeeEecccCCccceEEEEEEeccCC-CCCCcHHHHHHHHHHH-HhhhcceeehhhhhccCceeEEe
Confidence 467778899999999999999999999999999986532 2333456778887776 58999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
+|||. ++|..|.. .-++.++.+.++.++.|++.||.++|+++++||||||.|+||+.+|
T Consensus 80 fe~cd-------------qdlkkyfd--------slng~~d~~~~rsfmlqllrgl~fchshnvlhrdlkpqnllin~ng 138 (292)
T KOG0662|consen 80 FEFCD-------------QDLKKYFD--------SLNGDLDPEIVRSFMLQLLRGLGFCHSHNVLHRDLKPQNLLINRNG 138 (292)
T ss_pred HHHhh-------------HHHHHHHH--------hcCCcCCHHHHHHHHHHHHhhhhhhhhhhhhhccCCcceEEeccCC
Confidence 99996 33333322 2357899999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~ 302 (494)
.+||+|||+++.....-.-....+-|.+|.+|.++.|.. |+...|+||.|||+.|+.. |++.|.|.+..+.+.+|...
T Consensus 139 elkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanagrplfpg~dvddqlkrif~~ 218 (292)
T KOG0662|consen 139 ELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFRL 218 (292)
T ss_pred cEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHHHHHHHHH
Confidence 999999999986433333334456799999999998754 8999999999999999996 99999999998888887631
Q ss_pred --C------------------CCCC---------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 --R------------------PRFP---------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 --~------------------~~~p---------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
. +.+| +.++...+||++++|.-+|.+|+ +++++++||||.+.
T Consensus 219 lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qri------saeaalqhpyf~d~ 289 (292)
T KOG0662|consen 219 LGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRI------SAEAALQHPYFSDF 289 (292)
T ss_pred hCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCccccc------CHHHHhcCcccccc
Confidence 0 1112 23456789999999999999999 68999999999864
|
|
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-40 Score=322.88 Aligned_cols=252 Identities=25% Similarity=0.382 Sum_probs=206.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
+.++|++.+.||+|+||.||+|..+.+ ...||||+++... ..........|..++. .++||||+++++++...+
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 78 (266)
T cd05033 2 DPSYVTIEKVIGGGEFGEVCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMG-QFDHPNIIRLEGVVTKSR 78 (266)
T ss_pred ChHHceeeeEecCCccceEEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHH-hCCCCCcceEeEEEecCC
Confidence 356899999999999999999998654 4579999987542 2333445566777776 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..|+||||+++|+ |..++.. .+.+++..+..++.|++.||.|||++||+||||||+||
T Consensus 79 ~~~iv~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~di~p~ni 137 (266)
T cd05033 79 PVMIITEYMENGS---------------------LDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEMNYVHRDLAARNI 137 (266)
T ss_pred ceEEEEEcCCCCC---------------------HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceE
Confidence 9999999999554 4445543 35789999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
|++.++.++|+|||+++........ .....+++.|+|||.+.+..++.++||||||+++|+|++ |..||......+.
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~~~~~ 217 (266)
T cd05033 138 LVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDV 217 (266)
T ss_pred EEcCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCCHHHH
Confidence 9999999999999998864311111 122345678999999999999999999999999999998 9999988887777
Q ss_pred HHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
...+... ....+...+..+.+|+.+||+.+|++|| ++++++++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp------~~~ei~~~ 261 (266)
T cd05033 218 IKAVEDGYRLPPPMDCPSALYQLMLDCWQKDRNERP------TFSQIVST 261 (266)
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc------CHHHHHHH
Confidence 7777654 3455667899999999999999999999 56666643
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >KOG0577|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=346.36 Aligned_cols=251 Identities=25% Similarity=0.403 Sum_probs=216.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
-|.-++.||.|+||.||.|++..+...||||.+....-.....-..++.|...|. .+.|||+|.+.++|..+.-.+|||
T Consensus 27 lf~dLrEIGHGSFGAVYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~-~l~HPntieYkgCyLre~TaWLVM 105 (948)
T KOG0577|consen 27 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLR-QLRHPNTIEYKGCYLREHTAWLVM 105 (948)
T ss_pred HHHHHHHhcCCccceeEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHH-hccCCCcccccceeeccchHHHHH
Confidence 4777899999999999999999999999999997643333334456788988888 689999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||-|. -.+.+. ...++.|.++..++.+.+.||.|||+++.||||||..|||+++.|
T Consensus 106 EYClGS----------------------AsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS~~~IHRDiKAGNILLse~g 163 (948)
T KOG0577|consen 106 EYCLGS----------------------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNRIHRDIKAGNILLSEPG 163 (948)
T ss_pred HHHhcc----------------------HHHHHHHHhccchHHHHHHHHHHHHHHHHHHHHhhHHhhhccccceEecCCC
Confidence 999632 122222 346799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.|||+|||.+.. .....+++|||+|||||+|.. +.|+-++|||||||+..||.-.++|+..++....+..|..
T Consensus 164 ~VKLaDFGSAsi----~~PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMSALYHIAQ 239 (948)
T KOG0577|consen 164 LVKLADFGSASI----MAPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 239 (948)
T ss_pred eeeeccccchhh----cCchhcccCCccccchhHheeccccccCCccceeeccchhhhhhhcCCCccCchHHHHHHHHHh
Confidence 999999998864 455778999999999999864 5699999999999999999999999999998888888875
Q ss_pred C-CCCCCc-cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 E-RPRFPQ-FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~-~~~~p~-~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
. .+.++. .+|..+++|+..||++-|..|| +.+++++|+|...
T Consensus 240 NesPtLqs~eWS~~F~~Fvd~CLqKipqeRp------tse~ll~H~fv~R 283 (948)
T KOG0577|consen 240 NESPTLQSNEWSDYFRNFVDSCLQKIPQERP------TSEELLKHRFVLR 283 (948)
T ss_pred cCCCCCCCchhHHHHHHHHHHHHhhCcccCC------cHHHHhhcchhcc
Confidence 4 455553 6899999999999999999999 5789999999853
|
|
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=324.44 Aligned_cols=262 Identities=24% Similarity=0.316 Sum_probs=208.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC-----CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT-----DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~-----~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|++.+.||+|+||.||+|..+.. +..||+|.+.... ..........|..++. .++||||+++++++.
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~ 79 (277)
T cd05032 3 LPREKITLIRELGQGSFGMVYEGLAKGVVKGEPETRVAIKTVNENA--SMRERIEFLNEASVMK-EFNCHHVVRLLGVVS 79 (277)
T ss_pred cchHHeeEEeEecCCCCceEEEEEEeccCCCCcceeEEEEecCCcc--CHHHHHHHHHHHHHHH-hCCCCceeEEEEEEc
Confidence 4567999999999999999999998754 3789999986542 2233445666777776 579999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
.....|+||||+++|+|.+.+... ............+++..+..++.||+.||.|||++||+||||||+
T Consensus 80 ~~~~~~~v~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di~p~ 148 (277)
T cd05032 80 TGQPTLVVMELMAKGDLKSYLRSR-----------RPEAENNPGLGPPTLQKFIQMAAEIADGMAYLAAKKFVHRDLAAR 148 (277)
T ss_pred CCCCcEEEEecCCCCCHHHHHHhc-----------ccchhhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccChh
Confidence 999999999999977663211000 000000112345788899999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++...... .......+|..|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..
T Consensus 149 nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 228 (277)
T cd05032 149 NCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNE 228 (277)
T ss_pred eEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHHHHhhccCCCCCccCCHH
Confidence 9999999999999999987532221 12234457889999999998889999999999999999998 99999988888
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+....+... .+.+|..++.++.++|.+||..+|++|| ++.+++.
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~l~~ 273 (277)
T cd05032 229 EVLKFVIDGGHLDLPENCPDKLLELMRMCWQYNPKMRP------TFLEIVS 273 (277)
T ss_pred HHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCC------CHHHHHH
Confidence 877777654 4566778899999999999999999999 4566653
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=332.71 Aligned_cols=252 Identities=24% Similarity=0.368 Sum_probs=201.0
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeE----EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYY----YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~----~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+...+|++.+.||+|+||.||+|++..++.. ||||+++.. ...........|..++. .++||||+++++++..
T Consensus 4 ~~~~~f~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~-~l~h~niv~~~g~~~~ 80 (316)
T cd05108 4 LKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMA-SVDNPHVCRLLGICLT 80 (316)
T ss_pred cchhhceeeeeeecCCCceEEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEcC
Confidence 4567899999999999999999998766654 899998643 22333445666766666 6799999999999876
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
. ..++|+||+++|+| ..++.. ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 81 ~-~~~~v~e~~~~g~l---------------------~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iiH~dlkp~ 138 (316)
T cd05108 81 S-TVQLITQLMPFGCL---------------------LDYVREHKDNIGSQYLLNWCVQIAKGMNYLEERRLVHRDLAAR 138 (316)
T ss_pred C-CceeeeecCCCCCH---------------------HHHHHhccccCCHHHHHHHHHHHHHHHHHHHhcCeeccccchh
Confidence 4 57899999995544 444544 346889999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 139 Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~~~ 218 (316)
T cd05108 139 NVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 218 (316)
T ss_pred heEecCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999999854322211 122334678999999999999999999999999999997 99999887766
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
++...+... .+..|...+.++.+++.+||..||.+|| ++.+++.+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------s~~~l~~~ 264 (316)
T cd05108 219 EISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP------KFRELIIE 264 (316)
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 654433332 3344567889999999999999999999 56777765
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-41 Score=338.12 Aligned_cols=255 Identities=27% Similarity=0.400 Sum_probs=213.1
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-----e
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS-----H 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~-----~ 140 (494)
+|++.+.||+|+||.||+|++..++..||||++.+.. ...........|..++. .++||||+++++++.... .
T Consensus 1 ~y~i~~~ig~g~~~~v~~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~~ 78 (330)
T cd07834 1 RYELLKPIGSGAYGVVCSAVDKRTGRKVAIKKISNVF-DDLIDAKRILREIKLLR-HLRHENIIGLLDILRPPSPEDFND 78 (330)
T ss_pred CceeeeeecCCCCeEEEEEEeCCCCcEEEEEeecccc-ccchhhhhHHHHHHHHH-hcCCcchhhhhhhhcccCcccccc
Confidence 5899999999999999999999999999999997642 12334455667777776 578999999999998875 8
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+. ++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 79 ~~lv~e~~~----------------------~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~LH~~gi~H~dlkp~nili 136 (330)
T cd07834 79 VYIVTELME----------------------TDLHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV 136 (330)
T ss_pred eEEEecchh----------------------hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE
Confidence 999999995 2455566666789999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
+.++.++|+|||++....... .......||+.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+..+.+
T Consensus 137 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~~~~~ 216 (330)
T cd07834 137 NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYIDQL 216 (330)
T ss_pred cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCHHHHH
Confidence 999999999999998643332 123445689999999999887 7999999999999999999999999988877766
Q ss_pred HHHHhCCCC-------------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNERPR-------------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~~~~-------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+...... ....++.++.+||.+||+++|.+|| ++++++.||
T Consensus 217 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~ll~~~ 290 (330)
T cd07834 217 NLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVFDPKKRI------TADEALAHP 290 (330)
T ss_pred HHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccCChhhCC------CHHHHHhCc
Confidence 665542110 1123688999999999999999999 689999999
Q ss_pred CcCCC
Q psy8309 346 YFRGL 350 (494)
Q Consensus 346 ~f~~~ 350 (494)
||+++
T Consensus 291 ~~~~~ 295 (330)
T cd07834 291 YLAQL 295 (330)
T ss_pred cHHhh
Confidence 99864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-41 Score=331.27 Aligned_cols=255 Identities=30% Similarity=0.505 Sum_probs=211.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..+|++.+.||+|+||.||+|....++..||+|.+.... .........|..++. .++||||+++++.+...+..|+
T Consensus 18 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~-~l~hp~i~~~~~~~~~~~~~~l 93 (293)
T cd06647 18 KKKYTRFEKIGQGASGTVYTAIDVATGQEVAIKQMNLQQ---QPKKELIINEILVMR-ENKHPNIVNYLDSYLVGDELWV 93 (293)
T ss_pred hhhceeeeEecCCCCeEEEEEEEcCCCCEEEEEEecccc---chHHHHHHHHHHHHh-hcCCCCeeehhheeeeCCcEEE
Confidence 368999999999999999999998899999999986432 223345566776666 5789999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|+||+++|+| ..++.+ ..+++..+..++.||+.||.|||++|++||||||+||+++.+
T Consensus 94 v~e~~~~~~L---------------------~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~H~dL~p~Nili~~~ 151 (293)
T cd06647 94 VMEYLAGGSL---------------------TDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 151 (293)
T ss_pred EEecCCCCcH---------------------HHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEeeccCCHHHEEEcCC
Confidence 9999995544 444433 468899999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH-hC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-NE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~-~~ 302 (494)
+.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||...+..+....+. .+
T Consensus 152 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~~~~~~~~~~~~ 231 (293)
T cd06647 152 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNG 231 (293)
T ss_pred CCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCChhhheeehhcCC
Confidence 99999999998754333333345578999999999998889999999999999999999999998776654433332 22
Q ss_pred CCC--CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 RPR--FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 ~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+. .+..++..++++|.+||..+|.+|| ++++++.|+||+..
T Consensus 232 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------~~~~il~h~~~~~~ 275 (293)
T cd06647 232 TPELQNPEKLSAIFRDFLNRCLEMDVEKRG------SAKELLQHPFLKIA 275 (293)
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhhCc------CHHHHhcCHHHhcC
Confidence 222 2346788999999999999999999 68999999999754
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-41 Score=328.35 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=203.7
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
|++.+.||.|++|.||+|.++.+|..||||++..... ..........|..++. .++||||+++++++.+.+..|+|||
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~E~~~l~-~l~~~~iv~~~~~~~~~~~~~iv~e 78 (283)
T cd07835 1 YQKVEKIGEGTYGVVYKARDKLTGEIVALKKIRLETE-DEGVPSTAIREISLLK-ELNHPNIVRLLDVVHSENKLYLVFE 78 (283)
T ss_pred CchheEecCCCCeEEEEEEEcCCCCEEEEEEeecccc-cccchhHHHHHHHHHH-hcCCCCccCHhheeccCCeEEEEEe
Confidence 6788999999999999999999999999999976532 2223345566777776 5789999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|++ + +|..++.... .+++..+..++.||+.||+|||++|++||||+|+||+++.++
T Consensus 79 ~~~-~---------------------~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~~H~dl~p~nil~~~~~ 136 (283)
T cd07835 79 FLD-L---------------------DLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREG 136 (283)
T ss_pred ccC-c---------------------CHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCHHHEEEcCCC
Confidence 985 2 3444444443 789999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
.++|+|||++..............+++.|+|||++.+. .++.++|+|||||++|+|++|.+||.+.+......++....
T Consensus 137 ~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (283)
T cd07835 137 ALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIFRTL 216 (283)
T ss_pred cEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHh
Confidence 99999999987532222222334678999999988764 57899999999999999999999998877655444433210
Q ss_pred ---------------------C--------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 ---------------------P--------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 ---------------------~--------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. .....++.++.++|.+||+.||.+|| +++|++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~il~~~~~ 283 (283)
T cd07835 217 GTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRI------SAKAALQHPYF 283 (283)
T ss_pred CCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCc------CHHHHhcCCCC
Confidence 0 11235778999999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-40 Score=320.74 Aligned_cols=248 Identities=24% Similarity=0.423 Sum_probs=204.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+.++|++.+.||+|+||.||+|+.+.. ..+|+|.+.+... .......|..++. .++||||+++++++...+.+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~a~K~~~~~~~----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05114 2 NPSELTFMKELGSGQFGVVHLGKWRAQ-IKVAIKAINEGAM----SEEDFIEEAKVMM-KLSHPKLVQLYGVCTQQKPLY 75 (256)
T ss_pred CHHHcEEeeEecCCcCceEEEEEeccC-ceEEEEecccCCc----cHHHHHHHHHHHH-HCCCCCceeEEEEEccCCCEE
Confidence 456899999999999999999987654 4699998865422 1234566777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+++|+| ..++.. .+.+++..++.++.||+.||+|||++||+||||||+||+++
T Consensus 76 iv~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~ni~i~ 134 (256)
T cd05114 76 IVTEFMENGCL---------------------LNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVS 134 (256)
T ss_pred EEEEcCCCCcH---------------------HHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcceEEEc
Confidence 99999995554 444443 35689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
.++.+||+|||+++........ .....++..|+|||++.+..++.++|+||||+++|||++ |+.||...+..+....+
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~p~~~~~~~~~~~~i 214 (256)
T cd05114 135 STGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214 (256)
T ss_pred CCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHH
Confidence 9999999999998753221111 112235668999999998899999999999999999999 99999998888888888
Q ss_pred HhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 300 CNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 300 ~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+. +..|...+.++.+++.+||..+|.+|| ++++++.
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp------s~~~l~~ 253 (256)
T cd05114 215 SRGFRLYRPKLASMTVYEVMYSCWHEKPEGRP------TFAELLR 253 (256)
T ss_pred HCCCCCCCCCCCCHHHHHHHHHHccCCcccCc------CHHHHHH
Confidence 7653 445667889999999999999999999 4566653
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=324.41 Aligned_cols=251 Identities=22% Similarity=0.307 Sum_probs=203.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
..++|++.+.||+|+||.||+|.+++ ++..||||++.... ..........|..++. .++||||+++++++..
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~~~~~~~~~~~aik~~~~~~--~~~~~~~~~~e~~~l~-~l~~~~iv~~~~~~~~ 80 (277)
T cd05062 4 AREKITMSRELGQGSFGMVYEGIAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK-EFNCHHVVRLLGVVSQ 80 (277)
T ss_pred cHHHceeeeeeccccCCeEEEEEeccCCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEcC
Confidence 35689999999999999999998753 35679999986532 2223344566777766 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----------cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----------SGRFDEGRARFYAAEIVSGMRFLHKKG 207 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~yLH~~g 207 (494)
....++||||+++|+|. .++.. ...++...+..++.|++.||.|||++|
T Consensus 81 ~~~~~lv~e~~~~~~L~---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 139 (277)
T cd05062 81 GQPTLVIMELMTRGDLK---------------------SYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAYLNANK 139 (277)
T ss_pred CCCeEEEEecCCCCCHH---------------------HHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 99999999999976653 22222 124677889999999999999999999
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CC
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQ 284 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~ 284 (494)
++||||||+|||++.++.++|+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |.
T Consensus 140 ~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~ 219 (277)
T cd05062 140 FVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAE 219 (277)
T ss_pred cccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHHHHHHcCCC
Confidence 99999999999999999999999999874321111 1122356788999999999899999999999999999998 79
Q ss_pred CCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 285 SPFSGCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 285 ~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.||.+.+..+....+.... ..++..++..++++|.+||+.||.+|| ++.|++.
T Consensus 220 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~e~l~ 273 (277)
T cd05062 220 QPYQGMSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP------SFLEIIS 273 (277)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 9999888887777766554 456778899999999999999999999 5666664
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-41 Score=324.92 Aligned_cols=245 Identities=27% Similarity=0.424 Sum_probs=202.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+.+.++..||||.+.+..............|..++. .++||||+++++++..++..+++
T Consensus 2 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~~~~~~~v 80 (267)
T cd08229 2 ANFRIEKKIGRGQFSEVYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNELNIV 80 (267)
T ss_pred chhhhhhhhcccCCeEEEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHH-HccCCchhhhhheeEeCCeEEEE
Confidence 57999999999999999999999999999999987654444445556677777777 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|||+++++| ..++. ....+++..++.++.||+.||.|||++|++|+||||+||++
T Consensus 81 ~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili 139 (267)
T cd08229 81 LELADAGDL---------------------SRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFI 139 (267)
T ss_pred EEecCCCCH---------------------HHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 999996655 33332 24568999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH--HHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE--DELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~--~~~~~~ 298 (494)
+.++.++|+|||++.............+|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+... .+....
T Consensus 140 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08229 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCcccccchHHHHhhh
Confidence 999999999999987543333333456799999999999998999999999999999999999999976543 344444
Q ss_pred HHhCC-CCC-CccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 299 ICNER-PRF-PQFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 299 i~~~~-~~~-p~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
+.... +.. +..++.+++++|.+||..||.+||+
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt 254 (267)
T cd08229 220 IEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRPD 254 (267)
T ss_pred hhcCCCCCCCcccccHHHHHHHHHhcCCCcccCCC
Confidence 44332 222 2468899999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-40 Score=327.87 Aligned_cols=268 Identities=22% Similarity=0.316 Sum_probs=208.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC-----CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT-----DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~-----~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
++..+|++.+.||+|+||.||+|....+ +..||||+++... .....+....|..++. .++||||+++++++.
T Consensus 2 i~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~ 78 (283)
T cd05091 2 INLSTVRFMEELGEDRFGKVYKGHLFGTAPGEQTQAVAIKTLKDKA--EGPLREEFKHEAMMRS-RLQHPNIVCLLGVVT 78 (283)
T ss_pred CCHHHHHHHHHhCCCCCCeEEEEEEecCCCCCceeEEEEEEccCCC--CHHHHHHHHHHHHHHh-cCCCCCcCeEEEEEc
Confidence 3456899999999999999999987653 5789999997542 2222334455655555 689999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
....+++++||+.+++|.+.+...... ...+...........+++..+..++.||+.||.|||++||+||||||+
T Consensus 79 ~~~~~~~~~e~~~~~~l~~~l~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~~gi~H~dlkp~ 153 (283)
T cd05091 79 KEQPLSMIFSYCSHSDLHEFLVMRSPH-----SDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATR 153 (283)
T ss_pred CCCceEEEEEcCCCCcHHHHHHhcCCC-----ccccccccccccccccCHHHHHHHHHHHHHHHHHHHHcCccccccchh
Confidence 999999999999987764321100000 000111111122346889999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 154 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 154 NVLVFDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred heEecCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999875322111 1233456789999999998889999999999999999998 99999998888
Q ss_pred HHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+....+..... .+|..++.++.+|+.+||+.+|.+|| ++++|+.
T Consensus 234 ~~~~~i~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP------~~~~i~~ 278 (283)
T cd05091 234 DVIEMIRNRQVLPCPDDCPAWVYTLMLECWNEFPSRRP------RFKDIHS 278 (283)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHhCCCcccCC------CHHHHHH
Confidence 88888877653 45778999999999999999999999 4666664
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=324.38 Aligned_cols=251 Identities=24% Similarity=0.392 Sum_probs=205.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.++|++.+.||+|+||.||+|.+.. ++..||+|.+... ...........|..++. .++|+||+++++++.+.
T Consensus 5 ~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~v~ik~~~~~--~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~ 81 (277)
T cd05036 5 RDSITLLRALGHGAFGEVYEGLYRGRDGDAVELQVAVKTLPES--CSEQDESDFLMEALIMS-KFNHQNIVRLIGVSFER 81 (277)
T ss_pred HHHcEeeeECCCCCCCcEEEEEEecCCCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEccC
Confidence 4689999999999999999999987 7788999988643 22333345667777776 57999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-------GRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
+..|+||||+.||+| ..++... ..+++..+..++.||+.||+|||++|++||
T Consensus 82 ~~~~lv~e~~~g~~L---------------------~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~ 140 (277)
T cd05036 82 LPRFILLELMAGGDL---------------------KSFLRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEENHFIHR 140 (277)
T ss_pred CCcEEEEecCCCCCH---------------------HHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeec
Confidence 999999999996655 3333332 258999999999999999999999999999
Q ss_pred cCCCCceeeCCCC---CEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCC
Q psy8309 212 DLKLDNILLDYEG---HVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQS 285 (494)
Q Consensus 212 DLKp~NILl~~~g---~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~ 285 (494)
||||+|||++.++ .+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..
T Consensus 141 dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~ 220 (277)
T cd05036 141 DIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYM 220 (277)
T ss_pred ccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCC
Confidence 9999999998765 599999999875321111 1112234568999999998899999999999999999997 999
Q ss_pred CCCCCCHHHHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 286 PFSGCDEDELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 286 Pf~~~~~~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
||.+.+..+....+.. ....+|..++..+.+++.+||..+|++|| ++.++++|
T Consensus 221 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp------s~~~vl~~ 274 (277)
T cd05036 221 PYPGRTNQEVMEFVTGGGRLDPPKGCPGPVYRIMTDCWQHTPEDRP------NFATILER 274 (277)
T ss_pred CCCCCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCc------CHHHHHHH
Confidence 9998887777766654 34566778899999999999999999999 57788765
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=341.70 Aligned_cols=270 Identities=26% Similarity=0.366 Sum_probs=207.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCC-----CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGT-----DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~-----~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++++.||+|+||.||+|.+... +..||||+++.. ......+..+.|..++.....||||+++++++
T Consensus 33 ~~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~--~~~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~ 110 (400)
T cd05105 33 EFPRDGLVLGRILGSGAFGKVVEGTAYGLSRSQPVMKVAVKMLKPT--ARSSEKQALMSELKIMTHLGPHLNIVNLLGAC 110 (400)
T ss_pred eccccceehhheecCCCCceEEEEEEcccCCCCCceEEEEEecCCC--CChHHHHHHHHHHHHHHhcCCCCCeeeEEEEE
Confidence 34567899999999999999999987543 346999999754 23334456778888888544599999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhh-------------------------------------------------
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLM------------------------------------------------- 166 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~------------------------------------------------- 166 (494)
.+...+|||||||++|+|.+.+.........
T Consensus 111 ~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (400)
T cd05105 111 TKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPADESTRSYVILSFENKGDYMDMKQADTTQYVP 190 (400)
T ss_pred ccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCcccccccchhhhhhcccccccccccccccccch
Confidence 9999999999999999996543322110000
Q ss_pred ------------------------hHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 167 ------------------------EYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 167 ------------------------~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
.-..++.+...+.. ...+++..+..++.||+.||.|||++||+||||||+|||+
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill 270 (400)
T cd05105 191 MLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLLSFTYQVARGMEFLASKNCVHRDLAARNVLL 270 (400)
T ss_pred hhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEE
Confidence 00011223333332 2468999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH-
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF- 296 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~- 296 (494)
+.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.........
T Consensus 271 ~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~ 350 (400)
T cd05105 271 AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFY 350 (400)
T ss_pred eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHH
Confidence 9999999999999875322111 2233457789999999999899999999999999999997 99999876544443
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..+..+ .+..+..++.+++++|.+||..||++||++
T Consensus 351 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RPt~ 387 (400)
T cd05105 351 NKIKSGYRMAKPDHATQEVYDIMVKCWNSEPEKRPSF 387 (400)
T ss_pred HHHhcCCCCCCCccCCHHHHHHHHHHCccCHhHCcCH
Confidence 333333 345567889999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.3e-41 Score=337.38 Aligned_cols=274 Identities=27% Similarity=0.341 Sum_probs=204.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
..++|+++++||+|+||.||+|...+ +++.||+|+++... ..........|..++....+|+||+++++++..
T Consensus 5 ~~~~~~i~~~lG~G~fg~Vy~a~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~ 82 (337)
T cd05054 5 PRDRLKLGKPLGRGAFGKVIQASAFGIEKSASCRTVAVKMLKEGA--TASEYKALMTELKILIHIGHHLNVVNLLGACTK 82 (337)
T ss_pred CHHHhhhhcccccCcCceEEeccccccccccccceeeeeeccCCC--CHHHHHHHHHHHHHHHhhccCcchhheeeeEec
Confidence 34589999999999999999997543 45789999987532 233445566788877754489999999998765
Q ss_pred -CCeeEEEEEecCCCCCccccchhhhhhhhhHh---------------------------------cCC-------chhH
Q psy8309 138 -DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL---------------------------------NGG-------DLMF 176 (494)
Q Consensus 138 -~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~---------------------------------~gg-------~L~~ 176 (494)
+..++++|||+++|+|.+.+............ .+. ....
T Consensus 83 ~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 162 (337)
T cd05054 83 PGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEG 162 (337)
T ss_pred CCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccccccccCCccccccccccccCcchhhcccchhh
Confidence 46789999999999885433211100000000 000 0000
Q ss_pred HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCcc
Q psy8309 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYM 254 (494)
Q Consensus 177 ~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~ 254 (494)
.......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++....... ......++..|+
T Consensus 163 ~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~ 242 (337)
T cd05054 163 DELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWM 242 (337)
T ss_pred hHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCcccc
Confidence 011124789999999999999999999999999999999999999999999999999875322111 123345677899
Q ss_pred ChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 255 APEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 255 aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
|||++.+..++.++|||||||++|||++ |..||.+....+.+...... ....|...++++.+++.+||+.+|++||
T Consensus 243 aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~cl~~~p~~RP- 321 (337)
T cd05054 243 APESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCRRLKEGTRMRAPEYATPEIYSIMLDCWHNNPEDRP- 321 (337)
T ss_pred CcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHHHHhccCCCCCCccCCHHHHHHHHHHccCChhhCc-
Confidence 9999999999999999999999999998 99999876554444333322 3345667899999999999999999999
Q ss_pred CCCCCChhhhhcC
Q psy8309 332 STQCNSGDDVVAH 344 (494)
Q Consensus 332 ~~~~~~~~eil~h 344 (494)
+++|+++|
T Consensus 322 -----s~~ell~~ 329 (337)
T cd05054 322 -----TFSELVEI 329 (337)
T ss_pred -----CHHHHHHH
Confidence 56777754
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-40 Score=327.80 Aligned_cols=265 Identities=23% Similarity=0.323 Sum_probs=203.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCe--EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDY--YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~--~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
++|++.++||+|+||.||+|..+.++. .+|+|.++.. ......+....|..++....+||||+++++++...+.+|
T Consensus 2 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~ik~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~ 79 (297)
T cd05089 2 EDIKFEDVIGEGNFGQVIRAMIKKDGLKMNAAIKMLKEF--ASENDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLY 79 (297)
T ss_pred ccceeeeeecCCCcceEEEEEecCCCCcceeEEEEcccc--CCHHHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcce
Confidence 589999999999999999999887764 4688877632 223334556677777775558999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||+++|+|.+.+.......... ...........+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 80 lv~e~~~~~~L~~~l~~~~~~~~~~-----~~~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~ 154 (297)
T cd05089 80 IAIEYAPYGNLLDFLRKSRVLETDP-----AFAKEHGTASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGE 154 (297)
T ss_pred EEEEecCCCcHHHHHHhcccccccc-----ccccccCccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECC
Confidence 9999999776633211100000000 00000011236899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~ 301 (494)
++.+||+|||++..... ........++..|+|||++.+..++.++|||||||++|||++ |..||.+....+....+..
T Consensus 155 ~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~ 233 (297)
T cd05089 155 NLASKIADFGLSRGEEV-YVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQ 233 (297)
T ss_pred CCeEEECCcCCCccccc-eeccCCCCcCccccCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhc
Confidence 99999999999863211 111111223557999999999899999999999999999997 9999999888888877765
Q ss_pred C-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 302 E-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 302 ~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+ .+..|..++.++++||.+||..+|.+|| +++++++
T Consensus 234 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~i~~ 270 (297)
T cd05089 234 GYRMEKPRNCDDEVYELMRQCWRDRPYERP------PFAQISV 270 (297)
T ss_pred CCCCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 4 3456677899999999999999999999 4566654
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=329.51 Aligned_cols=267 Identities=26% Similarity=0.349 Sum_probs=204.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCC-------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGT-------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~-------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.++|.+.+.||+|+||.||+|++... ...||+|+++... ..........|..++....+||||+++++++.
T Consensus 17 ~~~~~i~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (307)
T cd05098 17 RDRLVLGKPLGEGCFGQVVMAEAIGLDKEKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACT 94 (307)
T ss_pred hHHeEEeeeeccCCCeeEEEeEEeccCCcccCccceEEEEeccCCC--ChHHHHHHHHHHHHHHHhcCCCCEeeEEEEEe
Confidence 47899999999999999999987542 3469999997642 23344556677777775458999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+.+|+||||+++|+|.+.+..........+ ..........++..++..++.||+.||+|||++|++||||||+
T Consensus 95 ~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~-----~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~ 169 (307)
T cd05098 95 QDGPLYVIVEYASKGNLREYLRARRPPGMEYC-----YNPTQVPEEQLSFKDLVSCAYQVARGMEYLASKKCIHRDLAAR 169 (307)
T ss_pred cCCceEEEEecCCCCcHHHHHHhcCCcccccc-----cccccCccccCCHHHHHHHHHHHHHHHHHHHHCCcccccccHH
Confidence 99999999999997665322111000000000 0000011235888999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++........ .....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+....
T Consensus 170 Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~~~g~~p~~~~~~~ 249 (307)
T cd05098 170 NVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 249 (307)
T ss_pred heEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHHHHHHHHHHHHcCCCCCCCcCCHH
Confidence 999999999999999998753221111 112234578999999999899999999999999999998 99999988887
Q ss_pred HHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
++...+.... ...|..++.++++||.+||..+|.+|| ++.++++
T Consensus 250 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~evl~ 294 (307)
T cd05098 250 ELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP------TFKQLVE 294 (307)
T ss_pred HHHHHHHcCCCCCCCCcCCHHHHHHHHHHcccChhhCc------CHHHHHH
Confidence 7777766553 466778899999999999999999999 4566654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=319.07 Aligned_cols=238 Identities=25% Similarity=0.385 Sum_probs=195.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
+.||+|+||.||+|+++.+++.||+|.+.+. ...........|..++. .++||||+++++++.....+|+||||+++
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~a~k~~~~~--~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 77 (252)
T cd05084 1 ERIGRGNFGEVFSGRLRADNTPVAVKSCRET--LPPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQPIYIVMELVQG 77 (252)
T ss_pred CccCcccCccEEEEEEecCCceEEEEecCcc--CCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEcCCCCeEEEEeeccC
Confidence 4699999999999999999999999988653 22334455677777776 57999999999999999999999999995
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEe
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~ 229 (494)
+ +|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.++.+||+
T Consensus 78 ~---------------------~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~dl~p~nil~~~~~~~kl~ 136 (252)
T cd05084 78 G---------------------DFLTFLRTEGPRLKVKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKIS 136 (252)
T ss_pred C---------------------cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchheEEEcCCCcEEEC
Confidence 4 445555543 468999999999999999999999999999999999999999999999
Q ss_pred ecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC
Q psy8309 230 DFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-RPR 305 (494)
Q Consensus 230 DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~ 305 (494)
|||++......... .....++..|+|||.+.+..++.++|||||||++|||++ |.+||...........+... ...
T Consensus 137 dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~ 216 (252)
T cd05084 137 DFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQGVRLP 216 (252)
T ss_pred ccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCHHHHHHHHHcCCCCC
Confidence 99998742211000 011122457999999999899999999999999999997 99999877776666655543 445
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+|..++..+.+|+.+||..+|++||++
T Consensus 217 ~~~~~~~~~~~li~~~l~~~p~~Rps~ 243 (252)
T cd05084 217 CPELCPDAVYRLMERCWEYDPGQRPSF 243 (252)
T ss_pred CcccCCHHHHHHHHHHcCCChhhCcCH
Confidence 667789999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG0193|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=339.92 Aligned_cols=247 Identities=26% Similarity=0.381 Sum_probs=206.2
Q ss_pred CCCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 59 FRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 59 ~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
...+..++..++..||+|.||+||+|++.++ ||||+++-+.. .....+.+..|..+++ ..+|.||+-+.|++...
T Consensus 386 ~WeIp~~ev~l~~rIGsGsFGtV~Rg~whGd---VAVK~Lnv~~p-t~~qlqaFKnEVa~lk-kTRH~NIlLFMG~~~~p 460 (678)
T KOG0193|consen 386 EWEIPPEEVLLGERIGSGSFGTVYRGRWHGD---VAVKLLNVDDP-TPEQLQAFKNEVAVLK-KTRHENILLFMGACMNP 460 (678)
T ss_pred ccccCHHHhhccceeccccccceeecccccc---eEEEEEecCCC-CHHHHHHHHHHHHHHh-hcchhhheeeehhhcCC
Confidence 3455567888999999999999999999877 99999987654 3447788888988887 57999999999999888
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.. .||..+|+ |.+|..++.- ..+|.....+.|++||++||.|||.++|||||||..|
T Consensus 461 ~~-AIiTqwCe---------------------GsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLHAK~IIHrDLKSnN 518 (678)
T KOG0193|consen 461 PL-AIITQWCE---------------------GSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLHAKNIIHRDLKSNN 518 (678)
T ss_pred ce-eeeehhcc---------------------CchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhhhhhhhhhhccccc
Confidence 77 99999999 4455555543 3579999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeee--ccCCcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQI--YLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~--~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|++.+++.|||+||||+..-. ..+.......|...|||||+++. .+|+..+|||||||++|||++|..||...+.
T Consensus 519 IFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPysi~~~ 598 (678)
T KOG0193|consen 519 IFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYSIQNR 598 (678)
T ss_pred eEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcCCCCh
Confidence 999999999999999985422 22333445568889999999974 4699999999999999999999999997777
Q ss_pred HHHHHHHHhCCC--C---CCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 293 DELFWSICNERP--R---FPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 293 ~~~~~~i~~~~~--~---~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+.+++.+-.+.. . .-...+.++++|+..||.+++++||..
T Consensus 599 dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F 643 (678)
T KOG0193|consen 599 DQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLF 643 (678)
T ss_pred hheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccH
Confidence 777777766522 2 123567799999999999999999954
|
|
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=315.58 Aligned_cols=253 Identities=34% Similarity=0.596 Sum_probs=215.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--CeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~~~l 143 (494)
+|++.+.||+|++|.||+|.+..+++.|++|++...... .........|..++. .++||||+++++.+... ..+++
T Consensus 1 ~~~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~l 78 (260)
T cd06606 1 EWTRGELLGRGSFGSVYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILS-SLQHPNIVRYYGSERDEEKNTLNI 78 (260)
T ss_pred CceeeeEeeecCceEEEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHH-HcCCCCEeeEEEEEecCCCCeEEE
Confidence 588899999999999999999999999999999765322 344556667777776 57899999999999988 89999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|+||++ +++|..++.+...+++..+..++.|++.||.|||++|++|+||+|+||+++.+
T Consensus 79 v~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~h~dl~p~ni~i~~~ 137 (260)
T cd06606 79 FLEYVS---------------------GGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSD 137 (260)
T ss_pred EEEecC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEcCC
Confidence 999998 44555666666689999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~i~ 300 (494)
+.++|+|||.+........ ......++..|+|||.+.+..++.++|+||||+++|+|++|..||...+ .......+.
T Consensus 138 ~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 217 (260)
T cd06606 138 GVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIG 217 (260)
T ss_pred CCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHHhcc
Confidence 9999999999876433322 1345678999999999998889999999999999999999999998765 344444444
Q ss_pred h--CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 301 N--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 301 ~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
. ....+|..++.+++++|.+||+.||.+|| ++.+++.||||
T Consensus 218 ~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp------~~~~ll~~~~~ 260 (260)
T cd06606 218 SSGEPPEIPEHLSEEAKDFLRKCLRRDPKKRP------TADELLQHPFL 260 (260)
T ss_pred ccCCCcCCCcccCHHHHHHHHHhCcCChhhCC------CHHHHhhCCCC
Confidence 2 44567788899999999999999999999 68999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG1989|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=354.71 Aligned_cols=245 Identities=25% Similarity=0.416 Sum_probs=202.9
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE-EEc---
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT-FQT--- 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~-~~~--- 137 (494)
+.-.++++.++|.+|||+.||+|+....|..||+|.+--. ++...+.+..|+.+|.++..|+|||.+++. ...
T Consensus 34 Vg~~~v~V~~vLAEGGFa~VYla~~~~~~~~~AlKrm~~~---de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~ 110 (738)
T KOG1989|consen 34 VGSHRVTVEKVLAEGGFAQVYLAQDVKGGKKYALKRMYVN---DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSS 110 (738)
T ss_pred ECCEEEEEEEEEccCCcEEEEEEEecCCCceeeeeeeecC---CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccC
Confidence 3445788999999999999999999998888999988543 667778889999999987789999999993 221
Q ss_pred ---CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCC--Ccc
Q psy8309 138 ---DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ--QSGRFDEGRARFYAAEIVSGMRFLHKKG--IVY 210 (494)
Q Consensus 138 ---~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivH 210 (494)
.-.++|+||||.||.| .+++. ...+|+|.++..|+.|++.|+.+||... |||
T Consensus 111 ~~~~~EvllLmEyC~gg~L---------------------vd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~~~pPiIH 169 (738)
T KOG1989|consen 111 NNGVWEVLLLMEYCKGGSL---------------------VDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHYLKPPIIH 169 (738)
T ss_pred CCceeEEEeehhhccCCcH---------------------HHHHHHHHhccCChHHHHHHHHHHHHHHHHHhcCCCccch
Confidence 1247889999996554 33443 2345999999999999999999999998 999
Q ss_pred ccCCCCceeeCCCCCEEEeecCceeeeeccCCccc---------ccCCCCCccChhhh---CCCCCCCcchHHHHHHHHH
Q psy8309 211 RDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD---------TFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLY 278 (494)
Q Consensus 211 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~---------~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvil~ 278 (494)
||||-|||||+.+|+.||||||.+........... ...-|+.|+|||++ .+.+.+.++|||||||+||
T Consensus 170 RDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLY 249 (738)
T KOG1989|consen 170 RDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLY 249 (738)
T ss_pred hhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHH
Confidence 99999999999999999999998764322221111 12369999999997 5788999999999999999
Q ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCc--cCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 279 EMHVGQSPFSGCDEDELFWSICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 279 ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
-|+....||+.... ..|+++++.||. .++..+++||+.||+.||.+||.+.|
T Consensus 250 kLCy~t~PFe~sg~----laIlng~Y~~P~~p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 250 KLCYFTTPFEESGK----LAILNGNYSFPPFPNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred HHHHhCCCcCcCcc----eeEEeccccCCCCccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 99999999987633 268899999986 68999999999999999999996544
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=334.26 Aligned_cols=253 Identities=28% Similarity=0.465 Sum_probs=206.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++++.||+|+||.||+|.+..++..||||++.+.. ...........|..++. .++||||+++++++....
T Consensus 14 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07880 14 PDRYRDLKQVGSGAYGTVCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLK-HMKHENVIGLLDVFTPDLSLDR 91 (343)
T ss_pred ccceEEEEEeeecCCeEEEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHH-hcCCCCccceeeeecCCccccc
Confidence 357999999999999999999999999999999986542 22233345667777776 579999999999998654
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+||||+ ++ +|..++. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~~~~~lv~e~~-~~---------------------~l~~~~~-~~~l~~~~~~~i~~qi~~al~~LH~~gi~H~dlkp~N 148 (343)
T cd07880 92 FHDFYLVMPFM-GT---------------------DLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGN 148 (343)
T ss_pred cceEEEEEecC-CC---------------------CHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHH
Confidence 458999998 33 3433333 4579999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|+++.++.++|+|||++... ........+++.|+|||.+.+ ..++.++|+|||||++|+|++|.+||.+.+....+
T Consensus 149 ill~~~~~~kl~dfg~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~ 225 (343)
T cd07880 149 LAVNEDCELKILDFGLARQT---DSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQL 225 (343)
T ss_pred EEEcCCCCEEEeeccccccc---ccCccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998742 222334578999999999876 45889999999999999999999999887765555
Q ss_pred HHHHhCCCC-------------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNERPR-------------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~~~~-------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+...... +...++.++.++|.+||..||.+|| ++.+++.||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~------t~~~~l~~~ 299 (343)
T cd07880 226 MEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESRI------TAAEALAHP 299 (343)
T ss_pred HHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhCC------CHHHHhcCc
Confidence 544331111 1135788899999999999999999 678999999
Q ss_pred CcCCC
Q psy8309 346 YFRGL 350 (494)
Q Consensus 346 ~f~~~ 350 (494)
||+..
T Consensus 300 ~~~~~ 304 (343)
T cd07880 300 YFEEF 304 (343)
T ss_pred cHhhh
Confidence 99864
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=318.65 Aligned_cols=246 Identities=29% Similarity=0.425 Sum_probs=204.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|....+++.||+|.++...............|..++. .++|++|+++++++...+..++|
T Consensus 2 ~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~-~~~~~~i~~~~~~~~~~~~~~lv 80 (267)
T cd08224 2 GNFKIEKKIGKGQFSVVYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLK-QLDHPNVIKYLASFIENNELNIV 80 (267)
T ss_pred CceeeeeeeccCCceEEEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHH-hCCCCCeeeeeeeeecCCeEEEE
Confidence 58999999999999999999999999999999997644444444566777887777 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|||+++|+| ..++. ....+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 81 ~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~dl~p~nil~ 139 (267)
T cd08224 81 LELADAGDL---------------------SRMIKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFI 139 (267)
T ss_pred EecCCCCCH---------------------HHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHHHhCCEecCCcChhhEEE
Confidence 999996655 33332 23568999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--HHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD--EDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~ 298 (494)
+.+|.++|+|||++..............|++.|+|||.+.+..++.++|+|||||++|+|++|..||.... ..+....
T Consensus 140 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 219 (267)
T cd08224 140 TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKK 219 (267)
T ss_pred CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccCCccHHHHHhh
Confidence 99999999999998754333333445678999999999999999999999999999999999999996543 3344444
Q ss_pred HHhCC-CCCCc-cCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 299 ICNER-PRFPQ-FLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 299 i~~~~-~~~p~-~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+..+. ...|. .++.++.++|.+||..+|.+||++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~i~~cl~~~p~~Rp~~ 255 (267)
T cd08224 220 IEKCDYPPLPADHYSEELRDLVSRCINPDPEKRPDI 255 (267)
T ss_pred hhcCCCCCCChhhcCHHHHHHHHHHcCCCcccCCCH
Confidence 44432 23444 688899999999999999999943
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=326.47 Aligned_cols=271 Identities=27% Similarity=0.368 Sum_probs=210.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCC-----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|..+... ..+|+|++.... ..........|..++....+||||+++++++
T Consensus 8 ~~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 85 (293)
T cd05053 8 ELPRDRLTLGKPLGEGAFGQVVKAEAVGLDNPNETSTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGVC 85 (293)
T ss_pred ccCHhHeEEeeEecccccccEEEEEEecCCCCCCceeEEEEEccCCC--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 345678999999999999999999987543 789999987642 2334455677887777544899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
...+.+|++|||+++|+|...+..... ..+ ...+.......+.+++..+..++.||+.||.|||++||+||||||
T Consensus 86 ~~~~~~~li~e~~~~~~L~~~l~~~~~--~~~---~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp 160 (293)
T cd05053 86 TQEGPLYVVVEYAAHGNLRDFLRARRP--PGE---YASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAA 160 (293)
T ss_pred cCCCCeEEEEEeCCCCcHHHHHHhcCC--Ccc---ccccccccccccccCHHHHHHHHHHHHHHHHHHHHCCccccccce
Confidence 999999999999997776322110000 000 000001112345789999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 161 ~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 240 (293)
T cd05053 161 RNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIPV 240 (293)
T ss_pred eeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCcccceeehhhHHHHHhcCCCCCCCCCCH
Confidence 999999999999999999875322111 1122235678999999999899999999999999999997 9999998888
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+.+..+... .+..|...+.++.+|+.+||..||.+|| +++|++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~eil~~ 287 (293)
T cd05053 241 EELFKLLKEGYRMEKPQNCTQELYHLMRDCWHEVPSQRP------TFKQLVED 287 (293)
T ss_pred HHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccCcccCc------CHHHHHHH
Confidence 7777776654 3456677899999999999999999999 56777653
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=318.44 Aligned_cols=244 Identities=30% Similarity=0.482 Sum_probs=206.9
Q ss_pred eEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEe
Q psy8309 71 KVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEY 147 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 147 (494)
+.||+|+||.||+|..... +..||+|++..... .........|..++. .++|+||+++++++.+...+++||||
T Consensus 1 ~~ig~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~~--~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~lv~e~ 77 (262)
T cd00192 1 KKLGEGAFGEVYKGKLKGKDGKTTEVAVKTLKEDAS--EEERKDFLKEARVMK-KLGHPNVVRLLGVCTEEEPLYLVLEY 77 (262)
T ss_pred CccccCCceEEEEEEEecCCCCCceEEeEeeccccc--hhHHHHHHHHHHHHh-hcCCCChheeeeeecCCCceEEEEEe
Confidence 4699999999999999865 88899999976532 224556667777777 46799999999999999999999999
Q ss_pred cCCCCCccccchhhhhhhhhHhcCCchhHHhhhc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 148 LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---------GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 148 ~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~---------~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+++| +|..++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 78 ~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~ni 136 (262)
T cd00192 78 MEGG---------------------DLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNC 136 (262)
T ss_pred ccCC---------------------cHHHHHhhccccccccccccCCHHHHHHHHHHHHHHHHHHHcCCcccCccCcceE
Confidence 9954 445555553 7899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
+++.++.+||+|||.+....... .......+++.|+|||.+.+..++.++|+|||||++|||++ |..||......+.
T Consensus 137 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~ 216 (262)
T cd00192 137 LVGEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEV 216 (262)
T ss_pred EECCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999987643322 22344568899999999998899999999999999999999 6999999988888
Q ss_pred HHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
...+..+ ....|..++.++.++|.+||..+|.+|| +++++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~l~~~ 260 (262)
T cd00192 217 LEYLRKGYRLPKPEYCPDELYELMLSCWQLDPEDRP------TFSELVER 260 (262)
T ss_pred HHHHHcCCCCCCCccCChHHHHHHHHHccCCcccCc------CHHHHHHh
Confidence 8887754 4566778899999999999999999999 56777754
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=321.95 Aligned_cols=251 Identities=25% Similarity=0.389 Sum_probs=202.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCe----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDY----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+..++|++++.||+|+||+||+|++..++. .||+|+++... ..........|..++. .++||||+++++++..
T Consensus 4 l~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~ 80 (279)
T cd05109 4 LKETELKKVKVLGSGAFGTVYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMA-GVGSPYVCRLLGICLT 80 (279)
T ss_pred cchhheeeeeecCCCCCceEEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHH-hcCCCCCceEEEEEcC
Confidence 456799999999999999999999887766 48999986542 2333445566666666 5799999999999875
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
...++++||+++| +|...+.. .+.+++..+..++.||+.||+|||++||+||||||+
T Consensus 81 -~~~~l~~~~~~~g---------------------~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iiH~dlkp~ 138 (279)
T cd05109 81 -STVQLVTQLMPYG---------------------CLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEEVRLVHRDLAAR 138 (279)
T ss_pred -CCcEEEEEcCCCC---------------------CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccccc
Confidence 4578999999954 44445544 457999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|||||||++|||++ |..||......
T Consensus 139 Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~ 218 (279)
T cd05109 139 NVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIPAR 218 (279)
T ss_pred eEEEcCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 999999999999999998754322111 112234678999999999999999999999999999998 99999887776
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+...+... .+..+...+.++.++|.+||..||++|| ++.+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------~~~~l~~ 263 (279)
T cd05109 219 EIPDLLEKGERLPQPPICTIDVYMIMVKCWMIDSECRP------RFRELVD 263 (279)
T ss_pred HHHHHHHCCCcCCCCccCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 666655543 3455667899999999999999999999 5666663
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=319.84 Aligned_cols=237 Identities=27% Similarity=0.363 Sum_probs=196.4
Q ss_pred EeccCCceEEEEEEE--eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 72 VLGKGSFGKVFLAEL--KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~--~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
.||+|+||.||+|.. +.++..||+|+++... ...........|..++. .++||||++++++++ .+..++||||++
T Consensus 2 ~lg~G~~g~v~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~-~~~~~lv~e~~~ 78 (257)
T cd05116 2 ELGSGNFGTVKKGMYKMKKSEKTVAVKILKNDN-NDPALKDELLREANVMQ-QLDNPYIVRMIGICE-AESWMLVMELAE 78 (257)
T ss_pred cCCCcCCcceEEeEEecCCCceEEEEEEccCCC-CcHHHHHHHHHHHHHHH-hCCCCCcceEEEEEc-CCCcEEEEecCC
Confidence 689999999999965 4567889999987542 23334455667777776 579999999999875 456799999998
Q ss_pred CCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEe
Q psy8309 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 150 ~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~ 229 (494)
+ ++|..++.....+++..+..++.||+.||+|||++||+||||||.|||++.++.+||+
T Consensus 79 ~---------------------~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~nill~~~~~~kl~ 137 (257)
T cd05116 79 L---------------------GPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKIS 137 (257)
T ss_pred C---------------------CcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccchhhEEEcCCCeEEEC
Confidence 4 4555566666789999999999999999999999999999999999999999999999
Q ss_pred ecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CC
Q psy8309 230 DFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-RP 304 (494)
Q Consensus 230 DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~ 304 (494)
|||+++........ .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..++...+.++ .+
T Consensus 138 Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~i~~~~~~ 217 (257)
T cd05116 138 DFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMIESGERM 217 (257)
T ss_pred CCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHCCCCC
Confidence 99998753222111 122334679999999988889999999999999999998 99999988888888777764 35
Q ss_pred CCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 305 RFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 305 ~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..|..++++++++|.+||+.||.+||++
T Consensus 218 ~~~~~~~~~l~~li~~~~~~~p~~Rp~~ 245 (257)
T cd05116 218 ECPQRCPPEMYDLMKLCWTYGVDERPGF 245 (257)
T ss_pred CCCCCCCHHHHHHHHHHhccCchhCcCH
Confidence 6778899999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=325.58 Aligned_cols=258 Identities=30% Similarity=0.505 Sum_probs=216.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.+.|++.+.||+|+||.||+|.+..++..||+|++..... .......|..++. .++|+||+++++.+......|+
T Consensus 18 ~~~~~~~~~l~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 92 (286)
T cd06614 18 RELYKNLEKIGEGASGEVYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMK-DCKHPNIVDYYDSYLVGDELWV 92 (286)
T ss_pred cccchHhHhccCCCCeEEEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHH-HCCCCCeeEEEEEEEECCEEEE
Confidence 3468889999999999999999998899999999975422 3445566777666 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|+||+++ ++|..++.... .+++..+..++.||+.||.|||++||+|+||+|+||+++.
T Consensus 93 v~e~~~~---------------------~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi~H~dl~p~ni~i~~ 151 (286)
T cd06614 93 VMEYMDG---------------------GSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSK 151 (286)
T ss_pred EEeccCC---------------------CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCChhhEEEcC
Confidence 9999984 45555666555 8999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+|.++|+|||++..............|++.|+|||++.+..++.++|+|||||++|+|++|..||...+.......+...
T Consensus 152 ~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~~~~~~~~~~~ 231 (286)
T cd06614 152 DGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPPLRALFLITTK 231 (286)
T ss_pred CCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhc
Confidence 99999999998764332222334556889999999999988999999999999999999999999887776666555543
Q ss_pred CC-CC--CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 303 RP-RF--PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 303 ~~-~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.. .. +..++.+++++|.+||+.+|.+|| ++.+++.|+||+...|.
T Consensus 232 ~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~il~~~~~~~~~~~ 279 (286)
T cd06614 232 GIPPLKNPEKWSPEFKDFLNKCLVKDPEKRP------SAEELLQHPFLKKACPK 279 (286)
T ss_pred CCCCCcchhhCCHHHHHHHHHHhccChhhCc------CHHHHhhChHhhccCch
Confidence 22 22 234789999999999999999999 68999999999986543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >KOG4645|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-43 Score=376.67 Aligned_cols=255 Identities=31% Similarity=0.536 Sum_probs=215.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+++....||.|.||.||-|.+..||...|||.++-.... .........|..++. .++|||+|+++++-...+.+||.|
T Consensus 1236 rWqrg~~Ig~G~fG~VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE-~lnHpNlV~YyGVEvHRekv~IFM 1313 (1509)
T KOG4645|consen 1236 RWQRGNFIGGGTFGKVYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLE-GLNHPNLVRYYGVEVHREKVYIFM 1313 (1509)
T ss_pred eeccccccCCcceeeeEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHH-hccCccccccCceeecHHHHHHHH
Confidence 456677899999999999999999999999999765333 344455667777777 689999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|||.+|+| ...++..+..+|...+.|..|++.|+.|||++|||||||||+||+++.+|.
T Consensus 1314 EyC~~GsL---------------------a~ll~~gri~dE~vt~vyt~qll~gla~LH~~gIVHRDIK~aNI~Ld~~g~ 1372 (1509)
T KOG4645|consen 1314 EYCEGGSL---------------------ASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHGIVHRDIKPANILLDFNGL 1372 (1509)
T ss_pred HHhccCcH---------------------HHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcCceecCCCccceeeecCCc
Confidence 99995555 455666677889999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccC----CcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q psy8309 226 VRIADFGMCKLQIYLD----KTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFW 297 (494)
Q Consensus 226 vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~ 297 (494)
+|++|||.|....... .......|||.|||||++.+ .+...+.|||||||++.||+||+.||...+ .-.++.
T Consensus 1373 iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne~aIMy 1452 (1509)
T KOG4645|consen 1373 IKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNEWAIMY 1452 (1509)
T ss_pred EEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceEEEeecCCCchhhccchhHHHh
Confidence 9999999987643221 12346789999999999975 568899999999999999999999997654 334444
Q ss_pred HHH-hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 298 SIC-NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 298 ~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+. ...+.+|..+|.+.++||.+||+.||++|+ ++.++++|.|-+.
T Consensus 1453 ~V~~gh~Pq~P~~ls~~g~dFle~Cl~~dP~~Rw------~~~qlle~~f~~~ 1499 (1509)
T KOG4645|consen 1453 HVAAGHKPQIPERLSSEGRDFLEHCLEQDPKMRW------TASQLLEHAFGKS 1499 (1509)
T ss_pred HHhccCCCCCchhhhHhHHHHHHHHHhcCchhhh------HHHHHHHhhcccc
Confidence 544 447899999999999999999999999998 5678999999764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=322.02 Aligned_cols=243 Identities=26% Similarity=0.371 Sum_probs=203.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..+|++++.||.|+||.||+|..+. +..+|+|++.... .........|..++. .++||||+++++++.+.+..|+
T Consensus 5 ~~~y~~~~~ig~g~~~~vy~~~~~~-~~~~~~k~~~~~~---~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 79 (261)
T cd05148 5 REEFTLERKLGSGYFGEVWEGLWKN-RVRVAIKILKSDD---LLKQQDFQKEVQALK-RLRHKHLISLFAVCSVGEPVYI 79 (261)
T ss_pred HHHHHHhhhhccCCCccEEEeEecC-CCcEEEEeccccc---hhhHHHHHHHHHHHh-cCCCcchhheeeeEecCCCeEE
Confidence 4589999999999999999999988 7889999987652 222344556777766 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||||+++|+ |..++.. ...+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 80 v~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~h~dl~~~nilv~ 138 (261)
T cd05148 80 ITELMEKGS---------------------LLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVG 138 (261)
T ss_pred EEeecccCC---------------------HHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccCcceEEEc
Confidence 999999554 4445543 34689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~ 300 (494)
.++.+||+|||++..............++..|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+.+..+.
T Consensus 139 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~~~~~~~~~ 218 (261)
T cd05148 139 EDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQIT 218 (261)
T ss_pred CCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHH
Confidence 9999999999998753222222223346778999999998899999999999999999998 899999888888887777
Q ss_pred hC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 301 NE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 301 ~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.. ....|..+++++.++|.+||..||.+||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rpt~ 251 (261)
T cd05148 219 AGYRMPCPAKCPQEIYKIMLECWAAEPEDRPSF 251 (261)
T ss_pred hCCcCCCCCCCCHHHHHHHHHHcCCCchhCcCH
Confidence 54 445567889999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-40 Score=325.22 Aligned_cols=250 Identities=26% Similarity=0.389 Sum_probs=203.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCC----------------eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD----------------YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~----------------~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp 126 (494)
...+|++++.||+|+||.||+|.+..++ ..||+|++.... ..........|..++. .++||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~-~l~~~ 79 (296)
T cd05051 3 PRQPLNFVEKLGEGQFGEVHLCEADGLQDFSEKAFAENDNADAPVLVAVKVLRPDA--SDNAREDFLKEVKILS-RLSDP 79 (296)
T ss_pred chhhCcccccccCCCCccEEEEEeccCCcccccccccccccCCceeEEEEEecCcc--CHHHHHHHHHHHHHHH-hcCCC
Confidence 4568999999999999999999876543 458999987652 2344556677888887 57999
Q ss_pred ceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-----------CCCHHHHHHHHHH
Q psy8309 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-----------RFDEGRARFYAAE 195 (494)
Q Consensus 127 ~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-----------~l~e~~~~~~~~q 195 (494)
||+++++++..+...++|||++.+++| ..++.... .+++..++.++.|
T Consensus 80 ~i~~~~~~~~~~~~~~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 138 (296)
T cd05051 80 NIARLLGVCTVDPPLCMIMEYMENGDL---------------------NQFLQKHVAETSGLACNSKSLSFSTLLYMATQ 138 (296)
T ss_pred CEeEEEEEEecCCCcEEEEecCCCCCH---------------------HHHHHhcccccccccccCCCCCHHHHHHHHHH
Confidence 999999999999999999999996655 33333332 6899999999999
Q ss_pred HHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHH
Q psy8309 196 IVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSF 273 (494)
Q Consensus 196 i~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSl 273 (494)
|+.||.|||++||+||||||+||+++.++.++|+|||+++...... .......+++.|+|||.+.+..++.++|||||
T Consensus 139 i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~sl 218 (296)
T cd05051 139 IASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAF 218 (296)
T ss_pred HHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhh
Confidence 9999999999999999999999999999999999999987532211 12334557789999999998889999999999
Q ss_pred HHHHHHHHh--CCCCCCCCCHHHHHHHHHhC--------CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 274 GILLYEMHV--GQSPFSGCDEDELFWSICNE--------RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 274 Gvil~ell~--G~~Pf~~~~~~~~~~~i~~~--------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
||++|||++ |..||...+..+.+..+... ....|..++.++.++|.+||+.||.+|| ++.+|+
T Consensus 219 G~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp------t~~el~ 291 (296)
T cd05051 219 GVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRP------TFREIH 291 (296)
T ss_pred HHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCC------CHHHHH
Confidence 999999998 78899887777766665432 1223456789999999999999999999 456664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=319.25 Aligned_cols=247 Identities=23% Similarity=0.435 Sum_probs=202.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..+|++.+.||+|+||.||+|+++. +..+|+|++.+... .......|..++. .++||||+++++++...+..|+
T Consensus 3 ~~~~~~~~~lg~G~~~~v~~~~~~~-~~~~~iK~~~~~~~----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l 76 (256)
T cd05059 3 PSELTFLKELGSGQFGVVHLGKWRG-KIDVAIKMIREGAM----SEDDFIEEAKVMM-KLSHPNLVQLYGVCTKQRPIFI 76 (256)
T ss_pred hHHcchhhhhccCCCceEEEeEecC-CccEEEEEeccCCC----CHHHHHHHHHHHH-hCCCCCEEEEEEEEcCCCceEE
Confidence 4579999999999999999998864 55799999875432 1223456777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||++|+ +|..++.. .+.+++..+..++.||+.||.|||++||+||||||+||+++.
T Consensus 77 v~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~ni~i~~ 135 (256)
T cd05059 77 VTEYMANG---------------------CLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGE 135 (256)
T ss_pred EEecCCCC---------------------CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcccccccHhhEEECC
Confidence 99999954 44555544 347899999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~ 300 (494)
+|.+||+|||+++........ .....++..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..+....+.
T Consensus 136 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~~ 215 (256)
T cd05059 136 DNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESVS 215 (256)
T ss_pred CCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCHHHHHHHHH
Confidence 999999999998753221111 111123457999999999999999999999999999999 899999888777777776
Q ss_pred hC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 301 NE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 301 ~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.. .+..|...+.++.+++.+||..+|++|| +++|+++
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------t~~~~l~ 253 (256)
T cd05059 216 AGYRLYRPKLAPTEVYTIMYSCWHEKPEDRP------AFKKLLS 253 (256)
T ss_pred cCCcCCCCCCCCHHHHHHHHHHhcCChhhCc------CHHHHHH
Confidence 54 4456677899999999999999999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-40 Score=334.48 Aligned_cols=255 Identities=28% Similarity=0.481 Sum_probs=205.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS----- 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~----- 139 (494)
.+|.+.+.||+|+||.||+|+++.+++.||||++.+... ..........|..++. .++||||+++++++....
T Consensus 15 ~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 92 (342)
T cd07879 15 ERYTSLKQVGSGAYGSVCSAIDKRTGEKVAIKKLSRPFQ-SEIFAKRAYRELTLLK-HMQHENVIGLLDVFTSAVSGDEF 92 (342)
T ss_pred cceEEEEEeeecCCeEEEEEEeCCCCcEEEEEEecCccc-cccchhHHHHHHHHHH-hcCCCCccchhheecccccCCCC
Confidence 589999999999999999999999999999999976422 2223345667777776 579999999999987653
Q ss_pred -eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 -HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 -~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
.+|+||||+.+ ++.... ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 93 ~~~~lv~e~~~~----------------------~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH~~~i~H~dlkp~NI 148 (342)
T cd07879 93 QDFYLVMPYMQT----------------------DLQKIM--GHPLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNL 148 (342)
T ss_pred ceEEEEeccccc----------------------CHHHHH--cCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 46999999851 222222 24689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|++.+|.+||+|||+++.. ........||+.|+|||++.+ ..++.++|||||||++|||++|+.||.+.+....+.
T Consensus 149 ll~~~~~~kL~dfg~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~~~~~~~ 225 (342)
T cd07879 149 AVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 225 (342)
T ss_pred EECCCCCEEEeeCCCCcCC---CCCCCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998742 222334578999999999876 468999999999999999999999999877655554
Q ss_pred HHHhC-----------------------CCCCC--------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 298 SICNE-----------------------RPRFP--------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 298 ~i~~~-----------------------~~~~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.+... .+.++ ...+.++.+||.+||+.||.+|| ++++++.|||
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~------~~~e~l~h~~ 299 (342)
T cd07879 226 QILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL------TATEALEHPY 299 (342)
T ss_pred HHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc------CHHHHhcCcc
Confidence 44321 01111 24678899999999999999999 6899999999
Q ss_pred cCCCChhH
Q psy8309 347 FRGLDWQA 354 (494)
Q Consensus 347 f~~~~w~~ 354 (494)
|+.+.+..
T Consensus 300 f~~~~~~~ 307 (342)
T cd07879 300 FDSFRDAD 307 (342)
T ss_pred hhhccccc
Confidence 99876533
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-40 Score=320.64 Aligned_cols=248 Identities=23% Similarity=0.363 Sum_probs=202.5
Q ss_pred ceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe---
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH--- 140 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~--- 140 (494)
|++++.||+|+||.||+|....+ +..||||.++... ...........|...+. .++||||+++++++.....
T Consensus 1 ~~~~~~lg~G~~g~v~~~~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 78 (273)
T cd05035 1 LKLGKILGEGEFGSVMEGQLSQDDGSQLKVAVKTMKLDI-HTYSEIEEFLSEAACMK-DFDHPNVMKLIGVCFEASSLQK 78 (273)
T ss_pred CccccccCcCCCceEEEEEEecCCCCcceEEEEEeccCc-CCHHHHHHHHHHHHHHH-hCCCCCeeeEEeeeccCCcccc
Confidence 57889999999999999987653 4789999987542 23344556777877776 5799999999998766554
Q ss_pred ---eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 141 ---LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ------QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 141 ---~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~------~~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
.++||||+++|+|. ..+. ....+++..+..++.||+.||.|||++||+||
T Consensus 79 ~~~~~~v~e~~~~~~l~---------------------~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL~~lH~~~i~H~ 137 (273)
T cd05035 79 IPKPMVILPFMKHGDLH---------------------SFLLYSRLGGLPEKLPLQTLLKFMVDIALGMEYLSNRNFIHR 137 (273)
T ss_pred CcccEEEEeccCCCCHH---------------------HHHHHhhccCCcccCCHHHHHHHHHHHHHHHHHHHhCCeecc
Confidence 79999999977662 2221 12468999999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFS 288 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~ 288 (494)
||||+||++++++.+||+|||+++........ .....++..|+|||.+.+..++.++|||||||++|||++ |.+||.
T Consensus 138 dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~il~el~~~g~~p~~ 217 (273)
T cd05035 138 DLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYP 217 (273)
T ss_pred ccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHHHHHHHHhCCCCCCC
Confidence 99999999999999999999998854322211 122345678999999998899999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 289 GCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 289 ~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+.+..+.+..+..+ ....|..++.++.++|.+||..||.+|| ++.|+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~e~~~ 267 (273)
T cd05035 218 GVENHEIYDYLRHGNRLKQPEDCLDELYDLMYSCWRADPKDRP------TFTKLRE 267 (273)
T ss_pred CCCHHHHHHHHHcCCCCCCCcCCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 88888887777654 4556778999999999999999999999 5666664
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=328.18 Aligned_cols=269 Identities=26% Similarity=0.367 Sum_probs=206.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC-------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG-------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
+..++|.+.+.||+|+||.||+|++.. ....||+|+++... ..........|..++....+||||++++++
T Consensus 9 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (314)
T cd05099 9 FPRDRLVLGKPLGEGCFGQVVRAEAYGIDKSRPDQTVTVAVKMLKDNA--TDKDLADLISEMELMKLIGKHKNIINLLGV 86 (314)
T ss_pred ccHHHeeeeeeecCCCcccEEEeeecccCCccCCcceEEEEEecCCCC--ChHHHHHHHHHHHHHHhccCCCCeeeEEEE
Confidence 345789999999999999999998642 34569999987542 234455667788887754479999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
+...+.+|+||||+++|+|.+.+....... ..+ ...........+++..+..++.||+.||.|||++||+|||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~-~~~----~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi~H~dlk 161 (314)
T cd05099 87 CTQEGPLYVIVEYAAKGNLREFLRARRPPG-PDY----TFDITKVPEEQLSFKDLVSCAYQVARGMEYLESRRCIHRDLA 161 (314)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCCc-ccc----cccccCCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecccc
Confidence 999999999999999777633211100000 000 000001122468899999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+..
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 162 ARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred ceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhhHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999999999999753221111 112234568999999999899999999999999999999 999999988
Q ss_pred HHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+.+..+.... ...|..++.+++++|.+||..||.+||+ +.++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps------~~~ll~ 288 (314)
T cd05099 242 VEELFKLLREGHRMDKPSNCTHELYMLMRECWHAVPTQRPT------FKQLVE 288 (314)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCcC------HHHHHH
Confidence 888887776653 4567778999999999999999999994 556553
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-40 Score=334.05 Aligned_cols=253 Identities=25% Similarity=0.416 Sum_probs=201.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD------ 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~------ 138 (494)
.+|++.+.||.|+||.||+|.++.++..||+|++.... ....+....|..++. .++||||+++++++...
T Consensus 5 ~~y~~~~~Lg~g~~g~vy~~~~~~~~~~v~iK~i~~~~---~~~~~~~~~Ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 80 (342)
T cd07854 5 SRYMDLRPLGCGSNGLVFSAVDSDCDKRVAVKKIVLTD---PQSVKHALREIKIIR-RLDHDNIVKVYEVLGPSGSDLTE 80 (342)
T ss_pred cceEEEEEecCCCCEEEEEEEECCCCcEEEEEEEecCC---CchHHHHHHHHHHHH-hcCCCcchhhHhhhccccccccc
Confidence 58999999999999999999999999999999986543 234455667777777 57999999999776654
Q ss_pred --------CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy8309 139 --------SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVY 210 (494)
Q Consensus 139 --------~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givH 210 (494)
..+|+||||+. + +|...+. .+.+++..++.++.||+.||.|||++||+|
T Consensus 81 ~~~~~~~~~~~~lv~e~~~-~---------------------~L~~~~~-~~~l~~~~~~~~~~qi~~aL~~LH~~givH 137 (342)
T cd07854 81 DVGSLTELNSVYIVQEYME-T---------------------DLANVLE-QGPLSEEHARLFMYQLLRGLKYIHSANVLH 137 (342)
T ss_pred ccccccccceEEEEeeccc-c---------------------cHHHHHH-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 36899999996 2 3333333 357899999999999999999999999999
Q ss_pred ccCCCCceeeCC-CCCEEEeecCceeeeecc---CCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCC
Q psy8309 211 RDLKLDNILLDY-EGHVRIADFGMCKLQIYL---DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQS 285 (494)
Q Consensus 211 rDLKp~NILl~~-~g~vkL~DFGla~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~ 285 (494)
|||||+||+++. ++.+||+|||+++..... .......+|+..|+|||++.+ ..++.++|+|||||++|+|++|..
T Consensus 138 ~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~ 217 (342)
T cd07854 138 RDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKP 217 (342)
T ss_pred CCCCHHHEEEcCCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCC
Confidence 999999999985 557899999998753211 111223468899999998754 568899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCC-------------------------CC-----CCccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 286 PFSGCDEDELFWSICNER-------------------------PR-----FPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 286 Pf~~~~~~~~~~~i~~~~-------------------------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
||.+.+..+....+.... .. +...++.++++||.+||..||.+||
T Consensus 218 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~----- 292 (342)
T cd07854 218 LFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDFLEQILTFNPMDRL----- 292 (342)
T ss_pred CCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHHHHHHhCCCchhcc-----
Confidence 998877655554443211 00 1135788999999999999999999
Q ss_pred CChhhhhcCCCcCCC
Q psy8309 336 NSGDDVVAHEYFRGL 350 (494)
Q Consensus 336 ~~~~eil~h~~f~~~ 350 (494)
++.+++.||||+.+
T Consensus 293 -t~~ell~h~~~~~~ 306 (342)
T cd07854 293 -TAEEALMHPYMSCY 306 (342)
T ss_pred -CHHHHhCCCccccc
Confidence 68999999999864
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=333.00 Aligned_cols=257 Identities=29% Similarity=0.387 Sum_probs=206.9
Q ss_pred CCce-EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChh-----------hHHHHHHHHHHHHhcCCCCceeeEE
Q psy8309 65 EDFQ-LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-----------DVECTLIERKVLALGTKHPYLCHLF 132 (494)
Q Consensus 65 ~~y~-~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~-----------~~~~~~~e~~~l~~~~~hp~Iv~l~ 132 (494)
++|. +.+.||+|+||.||+|+++.+++.||||++......... .......|..++. .++||||++++
T Consensus 8 ~ry~~~~~~ig~G~~g~vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~ 86 (335)
T PTZ00024 8 ERYIQKGAHLGEGTYGKVEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMN-EIKHENIMGLV 86 (335)
T ss_pred cchhhhhhcccCCCceeEEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHH-hCCCcceeeee
Confidence 3565 457899999999999999999999999998764322211 0113456777776 57999999999
Q ss_pred EEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 133 ~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
+++...+..|+||||+. ++|...+.....+++..+..++.||+.||+|||++||+|||
T Consensus 87 ~~~~~~~~~~lv~e~~~----------------------~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 87 DVYVEGDFINLVMDIMA----------------------SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred EEEecCCcEEEEEeccc----------------------cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 99999999999999995 24555666677899999999999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeec--------------cCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHH
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIY--------------LDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILL 277 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~--------------~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil 277 (494)
|+|+||+++.++.++|+|||++..... .........+++.|+|||.+.+. .++.++|+|||||++
T Consensus 145 l~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l 224 (335)
T PTZ00024 145 LSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIF 224 (335)
T ss_pred ccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHH
Confidence 999999999999999999999875320 11112234578899999998764 478999999999999
Q ss_pred HHHHhCCCCCCCCCHHHHHHHHHhCC--C---CC-----------------------CccCCHHHHHHHHhhccCCCCCC
Q psy8309 278 YEMHVGQSPFSGCDEDELFWSICNER--P---RF-----------------------PQFLSVEAKNILVHLLDKDTTKR 329 (494)
Q Consensus 278 ~ell~G~~Pf~~~~~~~~~~~i~~~~--~---~~-----------------------p~~~s~~~~~li~~lL~~dP~~R 329 (494)
|||++|.+||.+.+..+.+..+.... + .+ ....+.++.++|.+||..+|.+|
T Consensus 225 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 304 (335)
T PTZ00024 225 AELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLER 304 (335)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCchhc
Confidence 99999999999888777666554310 0 00 12357889999999999999999
Q ss_pred CCCCCCCChhhhhcCCCcCCC
Q psy8309 330 LGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 330 ~~~~~~~~~~eil~h~~f~~~ 350 (494)
| +++|++.||||+.-
T Consensus 305 ~------s~~~~l~~~~~~~~ 319 (335)
T PTZ00024 305 I------SAKEALKHEYFKSD 319 (335)
T ss_pred c------CHHHHhcCcccCCC
Confidence 9 68999999999853
|
|
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=320.64 Aligned_cols=253 Identities=23% Similarity=0.327 Sum_probs=200.8
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCe--EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC------
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDY--YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD------ 138 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~--~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~------ 138 (494)
|.+.+.||+|+||.||+|+...++. .||+|.++... ......+....|..++. .++||||+++++.+...
T Consensus 1 ~~i~~~ig~G~~g~V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 78 (272)
T cd05075 1 LALGKTLGEGEFGSVMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMK-EFDHPNVMRLIGVCLQTVESEGY 78 (272)
T ss_pred CccccccCcccCceEEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEccCCcccCC
Confidence 3567899999999999999887765 58999987642 23444566677877777 57999999999876432
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
...+++|||+.+|+|.+... ...+. ....+++..+..++.||+.||.|||++||+||||||+|
T Consensus 79 ~~~~~v~e~~~~~~l~~~~~----------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 142 (272)
T cd05075 79 PSPVVILPFMKHGDLHSFLL----------------YSRLGDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARN 142 (272)
T ss_pred CCcEEEEEeCCCCcHHHHHH----------------HhcccCCcccCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhh
Confidence 35789999999776632100 00011 22358999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
||++.++.+||+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+....+
T Consensus 143 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~ 222 (272)
T cd05075 143 CMLNENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSE 222 (272)
T ss_pred eEEcCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCCHHH
Confidence 9999999999999999875322111 1223346778999999999999999999999999999999 899999888888
Q ss_pred HHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 LFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+...+.++. +..+..++..++++|.+||..||.+|| +++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~l~~ 266 (272)
T cd05075 223 IYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRP------SFETLRC 266 (272)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc------CHHHHHH
Confidence 777777653 355677899999999999999999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=325.70 Aligned_cols=253 Identities=26% Similarity=0.409 Sum_probs=209.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
-|...+.||+|+||.||+|++..++..||||++................|..++. .++|||++++++++.+....|+||
T Consensus 22 ~~~~~~~lg~g~~g~v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~ 100 (313)
T cd06633 22 IFVGLHEIGHGSFGAVYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQ-QLKHPNTIEYKGCYLKEHTAWLVM 100 (313)
T ss_pred HhhcceeeccCCCeEEEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEEEEEE
Confidence 3667788999999999999999999999999997654434444556667777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||+.+ + +...+. ....+++..+..++.||+.||.|||++||+||||+|+||+++.++
T Consensus 101 e~~~~-~---------------------l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~gi~H~dl~p~nili~~~~ 158 (313)
T cd06633 101 EYCLG-S---------------------ASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPG 158 (313)
T ss_pred ecCCC-C---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChhhEEECCCC
Confidence 99962 2 222332 345789999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+||+|||++... .......|+..|+|||++. +..++.++|+|||||++|+|++|.+||...+.......+..
T Consensus 159 ~~kL~dfg~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~~~~~~~~~~~ 234 (313)
T cd06633 159 QVKLADFGSASKS----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQ 234 (313)
T ss_pred CEEEeecCCCccc----CCCCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHh
Confidence 9999999988642 2234567999999999984 45688999999999999999999999988776666655554
Q ss_pred CC-CCC-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 302 ER-PRF-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 302 ~~-~~~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
.. +.. ...++..+++||.+||+.+|.+|| ++.+++.||||+..+
T Consensus 235 ~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp------~~~~~l~~~~~~~~~ 280 (313)
T cd06633 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQERP------ASAELLRHDFVRRDR 280 (313)
T ss_pred cCCCCCCccccCHHHHHHHHHHccCChhhCc------CHHHHhcCcccCCCc
Confidence 32 222 235778899999999999999999 689999999998643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=322.14 Aligned_cols=257 Identities=28% Similarity=0.462 Sum_probs=209.9
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+|.+.+.||+|+||.||+|++..++..+++|+++.-... ..........|..++. .++||||+++++++.+....++
T Consensus 1 ~y~i~~~ig~g~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 79 (260)
T cd08222 1 RYILQQRLGKGSFGTVYLVKDKKAVAEERLKVLKEIPVGELNPNETVQANQEAQLLS-KLDHPAIVKFHASFLERDAFCI 79 (260)
T ss_pred CceeeeeecCCCCceEEEEEecCCCCcceEEEeccccccccCcchHHHHHHHHHHHH-hCCCCcHHHHHHHHhcCCceEE
Confidence 588999999999999999999888777778877643221 1223334455666665 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+++++|.+ .+.........+++..++.++.|++.||.|||++|++|+||||+||+++.
T Consensus 80 v~e~~~~~~l~~-----------------~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~~l~~~nili~~- 141 (260)
T cd08222 80 ITEYCEGRDLDC-----------------KLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLKAKNIFLKN- 141 (260)
T ss_pred EEEeCCCCCHHH-----------------HHHHHhhcccccCHHHHHHHHHHHHHHHHHHHHcCccccCCChhheEeec-
Confidence 999999666521 11111223467999999999999999999999999999999999999974
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE- 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~- 302 (494)
+.++|+|||+++.............|++.|+|||.+.+..++.++|+||||+++|+|++|..||.+.+..+....+..+
T Consensus 142 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 221 (260)
T cd08222 142 NLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRIVEGP 221 (260)
T ss_pred CCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHcCC
Confidence 6799999999876443333444567899999999999888999999999999999999999999887776666666554
Q ss_pred CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.+.++..++.++.++|.+||..||.+|| +++|++.||||
T Consensus 222 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~il~~~~~ 260 (260)
T cd08222 222 TPSLPETYSRQLNSIMQSMLNKDPSLRP------SAAEILRNPFI 260 (260)
T ss_pred CCCCcchhcHHHHHHHHHHhcCChhhCc------CHHHHhhCCCC
Confidence 3455677899999999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=319.09 Aligned_cols=234 Identities=29% Similarity=0.447 Sum_probs=193.9
Q ss_pred CCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCCCcc
Q psy8309 76 GSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIP 155 (494)
Q Consensus 76 G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~ 155 (494)
|.||.||+|+++.+++.||+|.+.+... ...|+..+. ...||||+++++++++.+..|+||||++
T Consensus 4 g~~~~v~~~~~~~~~~~~~~K~i~~~~~--------~~~~~~~~~-~~~~~~i~~~~~~~~~~~~~~lv~e~~~------ 68 (237)
T cd05576 4 GVIDKVLLVMDTRTQQTFILKGLRKSSE--------YSRERLTII-PHCVPNMVCLHKYIVSEDSVFLVLQHAE------ 68 (237)
T ss_pred cccceEEEEEEccCCcEEEEEeecchhh--------hhhHHHHHH-hcCCCceeehhhheecCCeEEEEEecCC------
Confidence 8999999999999999999999976521 112222232 3469999999999999999999999999
Q ss_pred ccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 156 AGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 156 ~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
|++|..++.+...+++..+..++.||+.||+|||++||+||||||+||+++.++.++|+|||++.
T Consensus 69 ---------------~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~ 133 (237)
T cd05576 69 ---------------GGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDLNPNNILLDDRGHIQLTYFSRWS 133 (237)
T ss_pred ---------------CCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHEEEcCCCCEEEecccchh
Confidence 45555666666779999999999999999999999999999999999999999999999999876
Q ss_pred eeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHH
Q psy8309 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAK 315 (494)
Q Consensus 236 ~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~ 315 (494)
... .......++..|+|||.+.+..++.++|+||+||++|||++|..||...... .. ......+|..+++.++
T Consensus 134 ~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~~~-~~---~~~~~~~~~~~~~~~~ 206 (237)
T cd05576 134 EVE---DSCDGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHPSG-IN---THTTLNIPEWVSEEAR 206 (237)
T ss_pred ccc---cccccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCchh-cc---cccccCCcccCCHHHH
Confidence 422 2233456778899999998888999999999999999999999988643211 00 1123457788999999
Q ss_pred HHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 316 NILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 316 ~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
+||.+||+.||.+|+++... +++++++||||
T Consensus 207 ~li~~~l~~dp~~R~~~~~~-~~~~~~~h~~~ 237 (237)
T cd05576 207 SLLQQLLQFNPTERLGAGVA-GVEDIKSHPFF 237 (237)
T ss_pred HHHHHHccCCHHHhcCCCcc-chHHHHcCCCC
Confidence 99999999999999987553 68999999998
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=326.11 Aligned_cols=258 Identities=30% Similarity=0.489 Sum_probs=207.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|+++.+++.||||++++... .........|..++.....||||+++++++.+...
T Consensus 11 ~~~~~~~~~~~~lg~g~~~~v~~~~~~~~~~~~avK~~~~~~~--~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~ 88 (296)
T cd06618 11 PADLNDLENLGEIGSGTCGQVYKMRFKKTGHVMAVKQMRRTGN--KEENKRILMDLDVVLKSHDCPYIVKCYGYFITDSD 88 (296)
T ss_pred cCCcchheeeeEeeccCCeEEEEEEECCCCeEEEEEEEeccCC--hHHHHHHHHHHHHHHhccCCCchHhhheeeecCCe
Confidence 4567899999999999999999999999999999999976422 22334455566666655679999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NI 218 (494)
+|+||||+.+ .+...+.. .+.+++..+..++.||+.||.|||+ +||+||||+|+||
T Consensus 89 ~~~v~e~~~~----------------------~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~~i~H~dl~p~ni 146 (296)
T cd06618 89 VFICMELMST----------------------CLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKHGVIHRDVKPSNI 146 (296)
T ss_pred EEEEeeccCc----------------------CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhCCEecCCCcHHHE
Confidence 9999999852 22222222 4578999999999999999999997 5999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCH-H
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPFSGCDE-D 293 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~ 293 (494)
+++.++.+||+|||++..... ........|++.|+|||.+.+.. ++.++||||||+++|+|++|+.||..... .
T Consensus 147 ll~~~~~~kL~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 225 (296)
T cd06618 147 LLDASGNVKLCDFGISGRLVD-SKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKNCKTEF 225 (296)
T ss_pred EEcCCCCEEECccccchhccC-CCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCcchhHH
Confidence 999999999999999864322 22223346888999999997654 88999999999999999999999976433 3
Q ss_pred HHHHHHHhCC-CCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 294 ELFWSICNER-PRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 294 ~~~~~i~~~~-~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+.+..+.... ..++. .++.++++||.+||..||.+|| ++++++.|+||..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------~~~~il~~~~~~~ 278 (296)
T cd06618 226 EVLTKILQEEPPSLPPNEGFSPDFCSFVDLCLTKDHRKRP------KYRELLQHPFIRR 278 (296)
T ss_pred HHHHHHhcCCCCCCCCCCCCCHHHHHHHHHHccCChhhCC------CHHHHhcChhhhc
Confidence 4455555443 23332 4789999999999999999999 6799999999974
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-40 Score=326.23 Aligned_cols=253 Identities=27% Similarity=0.413 Sum_probs=204.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEE-----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|.. ..++..||||++++.. .....+....|..++....+||||+++++++
T Consensus 31 ~~~~~~~~~~~~ig~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 108 (302)
T cd05055 31 EFPRNNLSFGKTLGAGAFGKVVEATAYGLSKSDAVMKVAVKMLKPTA--HSSEREALMSELKIMSHLGNHENIVNLLGAC 108 (302)
T ss_pred cccHHHeEEcceeeccCCeeEEEEEEecCCCCCceeEEEEEecCccC--ChHHHHHHHHHHHHHHhccCCCCcceEEEEE
Confidence 45567999999999999999999975 3345689999987542 2334456677888887544899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
...+.+|+||||+.+|+ |..++... ..+++.++..++.||+.||+|||++||+||||
T Consensus 109 ~~~~~~~lv~e~~~~~~---------------------L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ivH~dl 167 (302)
T cd05055 109 TIGGPILVITEYCCYGD---------------------LLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDL 167 (302)
T ss_pred ecCCceEEEEEcCCCCc---------------------HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeehhhh
Confidence 99999999999999554 44455433 23899999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~ 290 (494)
||+|||++.++.++|+|||+++....... ......+++.|+|||.+.+..++.++|||||||++|||++ |..||.+.
T Consensus 168 kp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g~~p~~~~ 247 (302)
T cd05055 168 AARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSNPYPGM 247 (302)
T ss_pred ccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCCCCCcCCC
Confidence 99999999999999999999875322211 1223346788999999999899999999999999999998 99999887
Q ss_pred CHHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 291 DEDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 291 ~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
...+.+.++... ....+...+.++.+|+.+||.++|++||+ +++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt------~~ell 295 (302)
T cd05055 248 PVDSKFYKLIKEGYRMAQPEHAPAEIYDIMKTCWDADPLKRPT------FKQIV 295 (302)
T ss_pred CchHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCchhCcC------HHHHH
Confidence 766555444433 23345678999999999999999999994 56665
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=322.37 Aligned_cols=261 Identities=28% Similarity=0.376 Sum_probs=205.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+...+|++.++||+|+||.||+|+.. .++..+|+|.+... ..........|..++. .++|+||+++++++.
T Consensus 2 ~~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~---~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~ 77 (280)
T cd05092 2 IKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLT-VLQHQHIVRFYGVCT 77 (280)
T ss_pred CChHhceeccccCCccCCeEEEeEEecCCCCCCceEEEEEecCcC---CHHHHHHHHHHHHHHh-cCCCCCCceEEEEEe
Confidence 34568999999999999999999753 35678999988653 2334456667777776 579999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhH----HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF----HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~----~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
.....++||||+++|+|.+.+... +..+.. .......+++..+..++.||+.||+|||++||+|||
T Consensus 78 ~~~~~~lv~e~~~~~~L~~~i~~~----------~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~~i~H~d 147 (280)
T cd05092 78 EGRPLLMVFEYMRHGDLNRFLRSH----------GPDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRD 147 (280)
T ss_pred cCCceEEEEecCCCCCHHHHHHhc----------CcchhhhcccccCCccccCHHHHHHHHHHHHHHHHHHHHCCeeccc
Confidence 999999999999977763321110 000000 001123589999999999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~ 289 (494)
|||+|||++.++.+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||..
T Consensus 148 lkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~ 227 (280)
T cd05092 148 LATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIFTYGKQPWYQ 227 (280)
T ss_pred ccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCcc
Confidence 99999999999999999999987532111 11223345788999999999999999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 290 CDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 290 ~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
....+....+..+ ....|..+++.+.+||.+||+.||.+|| +++||+
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp------~~~~l~ 275 (280)
T cd05092 228 LSNTEAIECITQGRELERPRTCPPEVYAIMQGCWQREPQQRM------VIKDIH 275 (280)
T ss_pred CCHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCChhhCC------CHHHHH
Confidence 8777777777654 3455677899999999999999999999 456665
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-40 Score=327.69 Aligned_cols=252 Identities=26% Similarity=0.405 Sum_probs=211.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|+..+.||+|+||.||+|++..++..||+|++.+..............|..++. .++|||++++++++.+....|+|
T Consensus 25 ~~f~~~~~lg~G~~~~v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv 103 (317)
T cd06635 25 KLFTDLREIGHGSFGAVYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQ-RIKHPNSIEYKGCYLREHTAWLV 103 (317)
T ss_pred hhhhhhheeccCCCeEEEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHH-hCCCCCEEEEEEEEeeCCeEEEE
Confidence 45888999999999999999999999999999997654334444556777887777 57899999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+.| +| ...+ .....+++..+..++.||+.||.|||++||+||||+|+||+++.+
T Consensus 104 ~e~~~g-~l---------------------~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~i~H~dL~p~Nil~~~~ 161 (317)
T cd06635 104 MEYCLG-SA---------------------SDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEP 161 (317)
T ss_pred EeCCCC-CH---------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcccEEECCC
Confidence 999963 32 2222 234578999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+||+|||++... .......|++.|+|||.+. +..++.++|||||||++|||++|.+||...+.......+.
T Consensus 162 ~~~kl~dfg~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~~~~~~~~~ 237 (317)
T cd06635 162 GQVKLADFGSASIA----SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 237 (317)
T ss_pred CCEEEecCCCcccc----CCcccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHH
Confidence 99999999988642 2234567899999999984 4568899999999999999999999998887777666666
Q ss_pred hCCC-CC-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERP-RF-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~-~~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.... .. +..++..+++||.+||+.+|.+|| ++.++++|+|+..
T Consensus 238 ~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~il~~~~~~~ 282 (317)
T cd06635 238 QNESPTLQSNEWSDYFRNFVDSCLQKIPQDRP------TSEELLKHMFVLR 282 (317)
T ss_pred hccCCCCCCccccHHHHHHHHHHccCCcccCc------CHHHHHhChhhhc
Confidence 5432 22 346788999999999999999999 6899999999853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.9e-40 Score=322.35 Aligned_cols=251 Identities=27% Similarity=0.443 Sum_probs=203.3
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh--cCCCCceeeEEEEEEcCCe----
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLFCTFQTDSH---- 140 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~--~~~hp~Iv~l~~~~~~~~~---- 140 (494)
|++.+.||+|+||.||+|+++.++..||||+++.... ..........|..++.. .++||||+++++++...+.
T Consensus 1 y~~~~~l~~g~~~~v~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~ 79 (287)
T cd07838 1 YEELAEIGEGAYGTVYKARDLNTGRFVALKKVRVPLS-EEGIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDREL 79 (287)
T ss_pred CeEEEEecccCceEEEEEEECCCCCEEEEEEeccccc-cchhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCc
Confidence 6889999999999999999998899999999975432 22222334455555442 3479999999999998877
Q ss_pred -eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 141 -LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 141 -~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+|++|||+.+ +|..++... ..+++..++.++.||+.||.|||++|++|+||+|+|
T Consensus 80 ~~~l~~e~~~~----------------------~l~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~~~i~h~~l~~~n 137 (287)
T cd07838 80 KLTLVFEHVDQ----------------------DLATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQN 137 (287)
T ss_pred eeEEEehhccc----------------------CHHHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhh
Confidence 9999999962 333444432 358999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|+++.++.+||+|||++..... ........+++.|+|||++.+..++.++|+|||||++|||++|.+||.+.+..+.+.
T Consensus 138 ili~~~~~~~l~dfg~~~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~~~~~~ 216 (287)
T cd07838 138 ILVTSDGQVKIADFGLARIYSF-EMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLD 216 (287)
T ss_pred EEEccCCCEEEeccCcceeccC-CcccccccccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCChHHHHH
Confidence 9999999999999999875322 222334568899999999999999999999999999999999999999888777776
Q ss_pred HHHhCC-----CC-----------CC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 298 SICNER-----PR-----------FP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 298 ~i~~~~-----~~-----------~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
++.... .. ++ ..+++.+.++|.+||+.||.+|| ++++++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------~~~~il~~~~~ 287 (287)
T cd07838 217 KIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRI------SAFEALQHPYF 287 (287)
T ss_pred HHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCC------CHHHHhcCcCC
Confidence 665311 00 00 13567889999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-40 Score=317.23 Aligned_cols=244 Identities=25% Similarity=0.404 Sum_probs=200.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++++.||+|+||.||+|.... +..||+|.+.... ...+....|..++. .++|+||+++++.+...+..
T Consensus 3 ~~~~~~~~~~~lg~g~~g~v~~~~~~~-~~~v~iK~~~~~~----~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05072 3 IPRESIKLVKKLGAGQFGEVWMGYYNN-STKVAVKTLKPGT----MSVQAFLEEANLMK-TLQHDKLVRLYAVVTKEEPI 76 (261)
T ss_pred CchHHeEEeeecCCcCCceEEEEEecC-CceEEEEEccCCc----hhHHHHHHHHHHHH-hCCCCCeeeEEEEEcCCCCc
Confidence 456799999999999999999998654 4569999886532 22345667777776 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
|+||||+++|+| ..++.. ...+++..+..++.||+.||+|||++|++||||||+||+
T Consensus 77 ~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil 135 (261)
T cd05072 77 YIITEYMAKGSL---------------------LDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVL 135 (261)
T ss_pred EEEEecCCCCcH---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhEE
Confidence 999999995554 444433 356888999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.++|+|||++........ ......++..|+|||.+.+..++.++|||||||++|+|++ |..||.+....+...
T Consensus 136 i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05072 136 VSESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMS 215 (261)
T ss_pred ecCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCHHHHHH
Confidence 99999999999999975322111 1122345678999999998889999999999999999998 999999888777777
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+... ....+..++.++.+++.+||..+|++||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 251 (261)
T cd05072 216 ALQRGYRMPRMENCPDELYDIMKTCWKEKAEERPTF 251 (261)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHccCCcccCcCH
Confidence 77654 233345688999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=333.96 Aligned_cols=251 Identities=19% Similarity=0.322 Sum_probs=196.2
Q ss_pred eEeccC--CceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 71 KVLGKG--SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 71 ~~LG~G--~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
..||+| +||+||+|++..+++.||||++..... .....+....|..++. .++||||++++++|+..+.+|+||||+
T Consensus 4 ~~ig~g~~~~~~v~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~~~~~~~v~e~~ 81 (328)
T cd08226 4 VEIGRGFCNLTSVYLARHTPTGTLVTVRITDLENC-TEEHLKALQNEVVLSH-FFRHPNIMTSWTVFTTGSWLWVISPFM 81 (328)
T ss_pred HHhCCcccCceeEEEEEEcCCCcEEEEEEeccccC-CHHHHHHHHHHHHHHH-hCCCCCcceEeeeEecCCceEEEEecc
Confidence 456777 999999999999999999999876432 2233445555665554 579999999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCE
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~v 226 (494)
.+|+| ...+.+. ..+++..++.++.||+.||+|||++||+||||||+|||++.++.+
T Consensus 82 ~~~~l---------------------~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivHrDlkp~Nill~~~~~~ 140 (328)
T cd08226 82 AYGSA---------------------NSLLKTYFPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLV 140 (328)
T ss_pred cCCCH---------------------HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEeCCCcE
Confidence 95544 4444432 358999999999999999999999999999999999999999999
Q ss_pred EEeecCceeeeeccCCc-------ccccCCCCCccChhhhCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 227 RIADFGMCKLQIYLDKT-------TDTFCGTPDYMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 227 kL~DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+++|||.+......... .....++..|+|||++.+. .++.++|||||||++|||++|.+||.+....+...
T Consensus 141 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~~~~~~~ 220 (328)
T cd08226 141 SLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQMLL 220 (328)
T ss_pred EEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcChHHHHH
Confidence 99999864321111111 1112356679999999763 57899999999999999999999998876555544
Q ss_pred HHHhCCCC-----------------------------------------------CCccCCHHHHHHHHhhccCCCCCCC
Q psy8309 298 SICNERPR-----------------------------------------------FPQFLSVEAKNILVHLLDKDTTKRL 330 (494)
Q Consensus 298 ~i~~~~~~-----------------------------------------------~p~~~s~~~~~li~~lL~~dP~~R~ 330 (494)
.+...... .+..+++++++||++||+.||++||
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp 300 (328)
T cd08226 221 QKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPSSKTFSPAFQNLVELCLQQDPEKRP 300 (328)
T ss_pred HHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchhhhhhhHHHHHHHHHHccCCcccCC
Confidence 44332111 1123567899999999999999999
Q ss_pred CCCCCCChhhhhcCCCcCCC
Q psy8309 331 GSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 331 ~~~~~~~~~eil~h~~f~~~ 350 (494)
+++|+++|+||+.+
T Consensus 301 ------ta~e~l~~~~~~~~ 314 (328)
T cd08226 301 ------SASSLLSHAFFKQV 314 (328)
T ss_pred ------CHHHHhhCHHHHHH
Confidence 68999999999754
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-40 Score=329.93 Aligned_cols=255 Identities=25% Similarity=0.360 Sum_probs=203.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCC--CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----CC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGT--DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----DS 139 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~--~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~~ 139 (494)
+|++.+.||+|+||.||+|++..+ +..||||++.... ...........|..++....+||||+++++.+.. ..
T Consensus 1 ~y~~~~~lg~G~~g~vy~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~ 79 (332)
T cd07857 1 RYELIKELGQGAYGIVCSARNAETSEEETVAIKKITNVF-SKKILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFN 79 (332)
T ss_pred CceEEEEccccCCeEEEEEEeCCCCcCceEEEEEecccc-ccchhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCC
Confidence 488999999999999999999988 8899999987532 1222344566787777755579999999987543 25
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+++||+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 80 ~~~~~~e~~~----------------------~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givH~dlkp~Nil 137 (332)
T cd07857 80 ELYLYEELME----------------------ADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHSANVLHRDLKPGNLL 137 (332)
T ss_pred cEEEEEeccc----------------------CCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHeE
Confidence 6889999884 355666666778999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC----CcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD----KTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
++.++.+||+|||+++...... ......+||+.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+...
T Consensus 138 i~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~~~~ 217 (332)
T cd07857 138 VNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVD 217 (332)
T ss_pred EcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCCHHH
Confidence 9999999999999987532211 11234579999999998765 568999999999999999999999998876544
Q ss_pred HHHHHHhC----------------------------CCCCC---ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 LFWSICNE----------------------------RPRFP---QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~~~~i~~~----------------------------~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+..+... ...++ ...+.++++||.+||+.||.+|| ++++++.
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------t~~~ll~ 291 (332)
T cd07857 218 QLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDPTKRI------SVEEALE 291 (332)
T ss_pred HHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCcccCC------CHHHHhc
Confidence 44333211 01111 23578999999999999999999 6899999
Q ss_pred CCCcCC
Q psy8309 344 HEYFRG 349 (494)
Q Consensus 344 h~~f~~ 349 (494)
||||+.
T Consensus 292 ~~~~~~ 297 (332)
T cd07857 292 HPYLAI 297 (332)
T ss_pred Chhhhh
Confidence 999964
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=332.70 Aligned_cols=252 Identities=28% Similarity=0.454 Sum_probs=202.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++.+.||+|+||.||+|.+..+++.||+|++.+... .....+....|..++. .++||||+++++++...
T Consensus 16 ~~~y~~~~~lg~G~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~-~l~h~~iv~~~~~~~~~~~~~~ 93 (345)
T cd07877 16 PERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLEE 93 (345)
T ss_pred cCceEEEEEeeecCCeEEEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHH-HcCCCcccceeeeeeecccccc
Confidence 3689999999999999999999999999999999976421 2223345566777776 57999999999988643
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
...|++++++ |++|...+. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 94 ~~~~~lv~~~~----------------------~~~L~~~~~-~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 150 (345)
T cd07877 94 FNDVYLVTHLM----------------------GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSN 150 (345)
T ss_pred cccEEEEehhc----------------------ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCChHH
Confidence 3478888876 344443333 3469999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|+++.+|.+||+|||+++.. ........||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+.....
T Consensus 151 Ill~~~~~~kl~dfg~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~~~~~~ 227 (345)
T cd07877 151 LAVNEDCELKILDFGLARHT---DDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQL 227 (345)
T ss_pred EEEcCCCCEEEecccccccc---cccccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999998752 223345678999999999876 56889999999999999999999999877665544
Q ss_pred HHHHhCC-----------------------CCCC--------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNER-----------------------PRFP--------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~~-----------------------~~~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+.... ...| ...++++++||.+||..||.+|+ ++.+++.||
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~------t~~e~l~h~ 301 (345)
T cd07877 228 KLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI------TAAQALAHA 301 (345)
T ss_pred HHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhcC------CHHHHhcCh
Confidence 4432210 0111 13578899999999999999999 678999999
Q ss_pred CcCC
Q psy8309 346 YFRG 349 (494)
Q Consensus 346 ~f~~ 349 (494)
||+.
T Consensus 302 ~f~~ 305 (345)
T cd07877 302 YFAQ 305 (345)
T ss_pred hhhh
Confidence 9975
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=316.46 Aligned_cols=248 Identities=24% Similarity=0.426 Sum_probs=203.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+.++|++++.||+|+||.||+|+.... ..+|||.+..... .......|..++. .++||||+++++++.....+|
T Consensus 2 ~~~~~~~~~~lg~G~~~~vy~~~~~~~-~~~aik~~~~~~~----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 75 (256)
T cd05113 2 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSM----SEDEFIEEAKVMM-KLSHEKLVQLYGVCTKQRPIY 75 (256)
T ss_pred ChHHeEEeeEecCcccceEEEEEecCC-CcEEEEEcCCCcc----cHHHHHHHHHHHh-cCCCCCeeeEEEEEccCCCcE
Confidence 456899999999999999999987653 4599999875422 1234566777766 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+.+| +|..++... ..+++..+..++.||+.||.|||++|++||||||+||+++
T Consensus 76 lv~e~~~~~---------------------~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~nili~ 134 (256)
T cd05113 76 IVTEYMSNG---------------------CLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVD 134 (256)
T ss_pred EEEEcCCCC---------------------cHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEEc
Confidence 999999854 445555543 4689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
.++.+||+|||+++........ .....++..|+|||.+.+..++.++|+|||||++|+|++ |..||...+..+....+
T Consensus 135 ~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05113 135 DQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKV 214 (256)
T ss_pred CCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHH
Confidence 9999999999998753221111 112234567999999998889999999999999999998 99999988887777777
Q ss_pred HhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 300 CNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 300 ~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+.. ..+...+..+++++.+||..||.+|| ++.+|+.
T Consensus 215 ~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------~~~~ll~ 253 (256)
T cd05113 215 SQGLRLYRPHLASEKVYAIMYSCWHEKAEERP------TFQQLLS 253 (256)
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcCCCcccCC------CHHHHHH
Confidence 76533 34566789999999999999999999 5667764
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=322.40 Aligned_cols=256 Identities=29% Similarity=0.413 Sum_probs=202.0
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
...+|.+.+.||+|+||.||+|+... ++..+|+|.+.... .........|..++. .++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~ 78 (291)
T cd05094 3 KRRDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPT---LAARKDFQREAELLT-NLQHEHIVKFYGVCGD 78 (291)
T ss_pred chHHeEEeeeecccCCCeEEEeEeeccCCCCcceeeEEEecCCcc---HHHHHHHHHHHHHHh-cCCCCCcceEEEEEcc
Confidence 35689999999999999999998643 45668899886532 222344556777776 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhH-----HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-----HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~-----~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
.+..++||||+++|+|.+.+... +..... .....+.+++..++.++.||+.||+|||++||+|||
T Consensus 79 ~~~~~lv~e~~~~~~L~~~i~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i~H~d 148 (291)
T cd05094 79 GDPLIMVFEYMKHGDLNKFLRAH----------GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRD 148 (291)
T ss_pred CCceEEEEecCCCCcHHHHHHhc----------CcccccccccccccCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 99999999999977663211100 000000 001224589999999999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~ 289 (494)
|||+|||++.++.++|+|||+++...... .......|++.|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 149 lkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 228 (291)
T cd05094 149 LATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQ 228 (291)
T ss_pred cCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCC
Confidence 99999999999999999999987532211 11233457889999999999999999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 290 CDEDELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 290 ~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+..+....+..+.. ..+...+.++.+++.+||..||.+||++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~ 272 (291)
T cd05094 229 LSNTEVIECITQGRVLERPRVCPKEVYDIMLGCWQREPQQRLNI 272 (291)
T ss_pred CCHHHHHHHHhCCCCCCCCccCCHHHHHHHHHHcccChhhCcCH
Confidence 888887777766543 3456778999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-40 Score=318.50 Aligned_cols=246 Identities=25% Similarity=0.376 Sum_probs=200.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCC---eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD---YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
+..+|++.+.||+|+||.||+|+++.++ ..+|+|.++... ..........|..++. .++||||+++++++.+.+
T Consensus 2 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 78 (267)
T cd05066 2 DASCIKIEKVIGAGEFGEVCSGRLKLPGKREIPVAIKTLKAGY--TEKQRRDFLSEASIMG-QFDHPNIIHLEGVVTKSK 78 (267)
T ss_pred CHHHeEeeeeecccCCCceEEEEEecCCCCceEEEEEECCCCC--CHHHHHHHHHHHHHHH-hCCCCCcceEEEEEecCC
Confidence 3468999999999999999999987544 379999987542 2334455667777776 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..|+||||+++|+ |..++... +.+++.++..++.||+.||.|||++|++||||||+||
T Consensus 79 ~~~lv~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~h~dlkp~ni 137 (267)
T cd05066 79 PVMIVTEYMENGS---------------------LDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNI 137 (267)
T ss_pred ccEEEEEcCCCCC---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEeehhhchhcE
Confidence 9999999999554 44455443 4689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcc---cccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTT---DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~---~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
|++.++.++|+|||++.......... ....++..|+|||.+.+..++.++|+|||||++||+++ |..||.+.+..+
T Consensus 138 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~~p~~~~~~~~ 217 (267)
T cd05066 138 LVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQD 217 (267)
T ss_pred EECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCCCCcccCCHHH
Confidence 99999999999999987532221111 11223568999999999899999999999999999886 999999888777
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
....+... .+..+..+++.+++++.+||+++|.+||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 256 (267)
T cd05066 218 VIKAIEEGYRLPAPMDCPAALHQLMLDCWQKDRNERPKF 256 (267)
T ss_pred HHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCchhCCCH
Confidence 77777654 234445678999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-40 Score=324.97 Aligned_cols=251 Identities=27% Similarity=0.478 Sum_probs=207.7
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
|+....||+|+||.||++..+.++..||||.+... ..........|..++. .++|+||+++++.+...++.|+|||
T Consensus 22 ~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e 97 (292)
T cd06657 22 LDNFIKIGEGSTGIVCIATVKSSGKLVAVKKMDLR---KQQRRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVVME 97 (292)
T ss_pred hhhHHHcCCCCCeEEEEEEEcCCCeEEEEEEeccc---chhHHHHHHHHHHHHH-hcCCcchhheeeEEEeCCEEEEEEe
Confidence 44457899999999999999999999999988543 2223344566776666 5789999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCE
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~v 226 (494)
|+++++| ...+ ..+.+++..++.++.||+.||+|||++|++||||+|+||+++.++.+
T Consensus 98 ~~~~~~L---------------------~~~~-~~~~~~~~~~~~~~~ql~~~l~~lH~~givH~dl~p~Nilv~~~~~~ 155 (292)
T cd06657 98 FLEGGAL---------------------TDIV-THTRMNEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRV 155 (292)
T ss_pred cCCCCcH---------------------HHHH-hcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCCE
Confidence 9995544 3333 34568999999999999999999999999999999999999999999
Q ss_pred EEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC--
Q psy8309 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP-- 304 (494)
Q Consensus 227 kL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-- 304 (494)
+|+|||++.............+|++.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..+....+....+
T Consensus 156 ~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~~~~~~~~~~~~~~~~ 235 (292)
T cd06657 156 KLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLPPK 235 (292)
T ss_pred EEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhhCCcc
Confidence 999999886533222233456789999999999888899999999999999999999999998777666555543322
Q ss_pred -CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 305 -RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 305 -~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.....++.++.++|.+||..||.+|| ++.+++.||||..
T Consensus 236 ~~~~~~~~~~l~~li~~~l~~~P~~R~------~~~~ll~~~~~~~ 275 (292)
T cd06657 236 LKNLHKVSPSLKGFLDRLLVRDPAQRA------TAAELLKHPFLAK 275 (292)
T ss_pred cCCcccCCHHHHHHHHHHHhCCcccCc------CHHHHhcChHHhc
Confidence 22345789999999999999999999 6789999999974
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=315.05 Aligned_cols=251 Identities=32% Similarity=0.492 Sum_probs=214.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|+||.||+|+++.+++.||+|.+.+... ..........|..++. .++|+||+++++++.+....|+||
T Consensus 1 ~y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~ 78 (256)
T cd08530 1 DFKVLKKLGKGSYGSVYKVKRLSDNQFYALKEVDLGSM-SQKEREDAVNEIRILA-SVNHPNIISYKEAFLDGNKLCIVM 78 (256)
T ss_pred CceEeeeecCCCceeEEEEEECCCCCEEEEEEEehhhc-cHHHHHHHHHHHHHHH-hCCCCCchhhhhhhccCCEEEEEe
Confidence 58999999999999999999999999999999976533 2333445566777776 578999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||+++++| ..++.. ...+++..+..++.||+.||.|||++|++||||+|+||+++
T Consensus 79 e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lh~~~i~h~~l~~~ni~~~ 137 (256)
T cd08530 79 EYAPFGDL---------------------SKAISKRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLV 137 (256)
T ss_pred hhcCCCCH---------------------HHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCcccCCCCcceEEEe
Confidence 99995554 333333 35789999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.+||+|||++...... ......|++.|+|||.+.+..++.++|+||||+++|+|++|+.||...+..+....+..
T Consensus 138 ~~~~~kl~d~g~~~~~~~~--~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~~~~~~~~~~ 215 (256)
T cd08530 138 ANDLVKIGDLGISKVLKKN--MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQR 215 (256)
T ss_pred cCCcEEEeeccchhhhccC--CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 9999999999998754322 33445689999999999999999999999999999999999999999888777777665
Q ss_pred CC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 ER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 ~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.. ...+..++.+++++|.+||..+|.+|| ++.++++||+.
T Consensus 216 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~~l~~p~~ 256 (256)
T cd08530 216 GKYPPIPPIYSQDLQNFIRSMLQVKPKLRP------NCDKILASPAV 256 (256)
T ss_pred CCCCCCchhhCHHHHHHHHHHcCCCcccCC------CHHHHhcCCCC
Confidence 54 345567899999999999999999999 68999999973
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=310.93 Aligned_cols=249 Identities=31% Similarity=0.562 Sum_probs=208.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+|++.+.||+|++|.||+|....+++.|++|++..... ........|..++. .++|++|+++++.+......++++
T Consensus 1 ~y~~~~~l~~g~~~~v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~l~~ 76 (253)
T cd05122 1 LFEILEKIGKGGFGEVYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILK-KCKHPNIVKYYGSYLKKDELWIVM 76 (253)
T ss_pred CceeeeeeccCCceEEEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEEEE
Confidence 58899999999999999999998999999999976532 34455667777766 578999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||+++++ |...+... ..+++..+..++.|++.||.|||++|++||||+|+||+++.++
T Consensus 77 e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i~h~dl~p~ni~i~~~~ 135 (253)
T cd05122 77 EFCSGGS---------------------LKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDG 135 (253)
T ss_pred ecCCCCc---------------------HHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCEecCCCCHHHEEEccCC
Confidence 9998554 44445444 5799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh-CC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-ER 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~-~~ 303 (494)
.++|+|||.+........ .....|+..|+|||.+.+..++.++|+||||+++|+|++|..||...+.......+.. ..
T Consensus 136 ~~~l~d~~~~~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~ 214 (253)
T cd05122 136 EVKLIDFGLSAQLSDTKA-RNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPPYSELPPMKALFKIATNGP 214 (253)
T ss_pred eEEEeecccccccccccc-ccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHHhcCC
Confidence 999999999875332221 4566789999999999988899999999999999999999999988755544444432 22
Q ss_pred CCCCcc--CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 304 PRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 304 ~~~p~~--~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
..++.. ++.++.++|.+||+.||.+|| ++.+++.|||
T Consensus 215 ~~~~~~~~~~~~~~~~i~~~l~~~p~~R~------t~~~~l~~~~ 253 (253)
T cd05122 215 PGLRNPEKWSDEFKDFLKKCLQKNPEKRP------TAEQLLKHPF 253 (253)
T ss_pred CCcCcccccCHHHHHHHHHHccCChhhCC------CHHHHhcCCC
Confidence 333333 489999999999999999999 6899999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-40 Score=326.70 Aligned_cols=254 Identities=30% Similarity=0.475 Sum_probs=200.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
+++|++.+.||+|+||.||+|+++.+++.||||++...... .........|..++. .++||||+++++++...
T Consensus 7 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 84 (311)
T cd07866 7 LRDYEILGKLGEGTFGEVYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILK-KLKHPNVVPLIDMAVERPDKSK 84 (311)
T ss_pred cccEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHH-hcCCCCccchhhheeccccccc
Confidence 57999999999999999999999999999999998764322 222233456777766 57999999999887543
Q ss_pred ---CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 139 ---SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 139 ---~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
..+|+||||+.+ ++...+. ....+++..++.++.||+.||.|||++||+|||||
T Consensus 85 ~~~~~~~lv~~~~~~----------------------~l~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~~~i~H~dl~ 142 (311)
T cd07866 85 RKRGSVYMVTPYMDH----------------------DLSGLLENPSVKLTESQIKCYMLQLLEGINYLHENHILHRDIK 142 (311)
T ss_pred ccCceEEEEEecCCc----------------------CHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCC
Confidence 357999999862 2333333 34579999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCC-----------cccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHh
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDK-----------TTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHV 282 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~-----------~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~ 282 (494)
|+|||++.++.++|+|||++........ ......|++.|+|||.+.+. .++.++|||||||++|||++
T Consensus 143 p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~ 222 (311)
T cd07866 143 AANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFT 222 (311)
T ss_pred HHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHh
Confidence 9999999999999999999875322111 11234678899999998654 58999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCC--C---------------------CCC-------ccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 283 GQSPFSGCDEDELFWSICNER--P---------------------RFP-------QFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 283 G~~Pf~~~~~~~~~~~i~~~~--~---------------------~~p-------~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
|++||.+.+.......+.... + ..+ ..+++++.++|.+||..||.+||
T Consensus 223 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~-- 300 (311)
T cd07866 223 RRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLDLLSKLLSLDPYKRL-- 300 (311)
T ss_pred CCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHHHHHHHcccCcccCc--
Confidence 999999887766555543210 0 001 13457889999999999999999
Q ss_pred CCCCChhhhhcCCCc
Q psy8309 333 TQCNSGDDVVAHEYF 347 (494)
Q Consensus 333 ~~~~~~~eil~h~~f 347 (494)
++.|++.||||
T Consensus 301 ----t~~ell~~~~f 311 (311)
T cd07866 301 ----TASDALEHPYF 311 (311)
T ss_pred ----CHHHHhcCCCC
Confidence 68999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >KOG0194|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=338.14 Aligned_cols=249 Identities=26% Similarity=0.407 Sum_probs=214.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCe---E-EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDY---Y-YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~-~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+..++..+.+.||+|+||.||+|+.+..+. . ||||..+.+.......+...+.|.+++. .++|||||+++|+..
T Consensus 153 el~H~~v~l~kkLGeGaFGeV~~G~l~~~~~~~~~~VAvK~~k~~~~~~~~~~~e~m~EArvMr-~l~H~NVVr~yGVa~ 231 (474)
T KOG0194|consen 153 ELSHSDIELGKKLGEGAFGEVFKGKLKLKNGFKVVPVAVKTTKGSSELTKEQIKEFMKEARVMR-QLNHPNVVRFYGVAV 231 (474)
T ss_pred EEeccCccccceeecccccEEEEEEEEecCCceeeeeEEEeecccccccHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEc
Confidence 4455677788999999999999999876422 3 8999998655566778888999999998 499999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
....+|+|||+|+ ||+|..++++.+ .++..+...++.+.+.||+|||++++|||||..
T Consensus 232 ~~~Pl~ivmEl~~---------------------gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh~k~~IHRDIAA 290 (474)
T KOG0194|consen 232 LEEPLMLVMELCN---------------------GGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLHSKNCIHRDIAA 290 (474)
T ss_pred CCCccEEEEEecC---------------------CCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHHHCCCcchhHhH
Confidence 9999999999999 566677888877 599999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccC-CCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFC-GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~-gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
+|||++.++.+||+|||+++.... .......+ -...|+|||.+....|+.++||||+||++||+++ |..||.+....
T Consensus 291 RNcL~~~~~~vKISDFGLs~~~~~-~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 291 RNCLYSKKGVVKISDFGLSRAGSQ-YVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred HHheecCCCeEEeCccccccCCcc-eeeccccccCcceecChhhhccCccccccchhheeeeEEeeeccCCCCCCCCCHH
Confidence 999999999999999999885321 11111122 3468999999999999999999999999999998 89999999999
Q ss_pred HHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 294 ELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 294 ~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
++..+|... +...|...+.++..++.+||..||++|+++
T Consensus 370 ~v~~kI~~~~~r~~~~~~~p~~~~~~~~~c~~~~p~~R~tm 410 (474)
T KOG0194|consen 370 EVKAKIVKNGYRMPIPSKTPKELAKVMKQCWKKDPEDRPTM 410 (474)
T ss_pred HHHHHHHhcCccCCCCCCCHHHHHHHHHHhccCChhhccCH
Confidence 999999554 345667888999999999999999999964
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=315.04 Aligned_cols=239 Identities=26% Similarity=0.457 Sum_probs=198.0
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE-EcCCe
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF-QTDSH 140 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~-~~~~~ 140 (494)
++..+|++.+.||+|+||.||+|... +..||+|.++... .......|..++. .++|++|+++++++ ...+.
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~--~~~~~~k~~~~~~-----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~ 74 (256)
T cd05082 3 LNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKGG 74 (256)
T ss_pred ccHHhCeeeeeecccCCCeEEEEEEc--CCcEEEEEeCCCc-----hHHHHHHHHHHHH-hCCCCCeeeEEEEEEcCCCc
Confidence 45679999999999999999999765 5669999986432 2344566777776 57999999999875 45678
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
.|+||||+++|+ |..++...+ .+++..+..++.||+.||+|||++||+||||||+||
T Consensus 75 ~~lv~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ni 133 (256)
T cd05082 75 LYIVTEYMAKGS---------------------LVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEANNFVHRDLAARNV 133 (256)
T ss_pred eEEEEECCCCCc---------------------HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccccchheE
Confidence 999999999554 444454432 488999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
+++.++.+||+|||+++.... ......++..|+|||++.+..++.++|||||||++|||++ |..||...+..+...
T Consensus 134 l~~~~~~~kl~dfg~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g~~p~~~~~~~~~~~ 210 (256)
T cd05082 134 LVSEDNVAKVSDFGLTKEASS---TQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVP 210 (256)
T ss_pred EEcCCCcEEecCCccceeccc---cCCCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 999999999999999875322 2233455678999999999899999999999999999997 999999888877777
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+..+ ....++.+++.++++|.+||..+|++||++
T Consensus 211 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 246 (256)
T cd05082 211 RVEKGYKMDAPDGCPPVVYDVMKQCWHLDAATRPSF 246 (256)
T ss_pred HHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 77654 345567889999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-40 Score=332.16 Aligned_cols=256 Identities=28% Similarity=0.477 Sum_probs=204.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC-CCCceeeEEEEEEcC--Ce
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTD--SH 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~l~~~~~~~--~~ 140 (494)
.++|++.+.||+|+||.||+|.+..++..||||.+.+.. ...........|..++. .+ +||||+++++++... ..
T Consensus 6 ~~~y~~~~~lg~g~~~~v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~-~l~~h~ni~~~~~~~~~~~~~~ 83 (337)
T cd07852 6 LRKYEILQKLGKGAYGIVWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQ-ELGDHPNIVKLLNVIKAENDKD 83 (337)
T ss_pred hhHHHHhHhhcCCCCeeEEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHH-HhcCCCCccceeeeeccCCCce
Confidence 468999999999999999999999999999999986532 22233344556777776 46 999999999998754 46
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+. ++|..++... .+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 84 ~~lv~e~~~----------------------~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~~~i~H~dl~p~nill 140 (337)
T cd07852 84 IYLVFEYME----------------------TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHSGNVIHRDLKPSNILL 140 (337)
T ss_pred EEEEecccc----------------------cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEE
Confidence 899999996 2344444443 78889999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC-----CcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD-----KTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~-----~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
+.+|.+||+|||+++...... .......||+.|+|||++.+ ..++.++|+|||||++|+|++|++||.+....+
T Consensus 141 ~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~~~~ 220 (337)
T cd07852 141 NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLN 220 (337)
T ss_pred cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCChHH
Confidence 999999999999987533222 12234578999999998765 458899999999999999999999998766554
Q ss_pred HHHHHHhCCC-------------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 LFWSICNERP-------------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~~~~i~~~~~-------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
....+..... .....++.++.++|.+||+.||.+|| ++.++++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~P~~Rp------s~~~il~ 294 (337)
T cd07852 221 QLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFNPNKRL------TAEEALE 294 (337)
T ss_pred HHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCCccccc------CHHHHhh
Confidence 4433322110 01123688999999999999999999 6899999
Q ss_pred CCCcCCC
Q psy8309 344 HEYFRGL 350 (494)
Q Consensus 344 h~~f~~~ 350 (494)
||||+.+
T Consensus 295 ~~~~~~~ 301 (337)
T cd07852 295 HPYVAQF 301 (337)
T ss_pred Chhhhhh
Confidence 9999875
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=314.25 Aligned_cols=242 Identities=27% Similarity=0.410 Sum_probs=199.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++.+.||+|+||.||+|.+.. ++.||||.++.... .......|..++. .++||||+++++++...+.+
T Consensus 3 ~~~~~~~~~~~lg~g~~~~v~~~~~~~-~~~v~iK~~~~~~~----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05068 3 IDRTSIQLLRKLGAGQFGEVWEGLWNN-TTPVAVKTLKPGTM----DPKDFLAEAQIMK-KLRHPKLIQLYAVCTLEEPI 76 (261)
T ss_pred cchhheeeEEEecccCCccEEEEEecC-CeEEEEEeeCCCcc----cHHHHHHHHHHHH-HCCCCCccceeEEEecCCCe
Confidence 345689999999999999999999765 46799999875432 2334556777776 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
|+||||+++++ |..++... ..+++..+..++.||+.||.|||++||+||||||+||+
T Consensus 77 ~lv~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil 135 (261)
T cd05068 77 YIVTELMKYGS---------------------LLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVL 135 (261)
T ss_pred eeeeecccCCc---------------------HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCCcceEE
Confidence 99999998554 44455443 36899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCC---CCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCG---TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
++.++.+||+|||+++.... .......| +..|+|||.+.+..++.++|+|||||++|||++ |+.||.+.+...+
T Consensus 136 ~~~~~~~~l~dfg~~~~~~~--~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~ 213 (261)
T cd05068 136 VGENNICKVADFGLARVIKE--DIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEV 213 (261)
T ss_pred EcCCCCEEECCcceEEEccC--CcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCHHHH
Confidence 99999999999999876431 11111223 457999999999899999999999999999999 9999999888777
Q ss_pred HHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 296 FWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 296 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
...+... ....+..++..+.+++.+||..+|.+||++
T Consensus 214 ~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~ 251 (261)
T cd05068 214 LQQVDQGYRMPCPPGCPKELYDIMLDCWKEDPDDRPTF 251 (261)
T ss_pred HHHHHcCCCCCCCCcCCHHHHHHHHHHhhcCcccCCCH
Confidence 7777654 334566789999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=313.37 Aligned_cols=244 Identities=27% Similarity=0.451 Sum_probs=204.6
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||+|... ++.||||.++.... .......|..++. .++|+||+++++++.+.+..|
T Consensus 4 ~~~~~~~~~~ig~g~~g~v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 76 (256)
T cd05039 4 NSKELKLGATIGKGEFGDVMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMT-TLRHPNLVQLLGVVLQGNPLY 76 (256)
T ss_pred ChhhccceeeeecCCCceEEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHH-hcCCcceeeeEEEEcCCCCeE
Confidence 4578999999999999999999865 67799999976522 4456677777777 578999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+||||+++| +|..++.... .+++..++.++.|++.||.|||++||+||||||+||++
T Consensus 77 ~v~e~~~~~---------------------~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~Nili 135 (256)
T cd05039 77 IVTEYMAKG---------------------SLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLV 135 (256)
T ss_pred EEEEecCCC---------------------cHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCccchhcccceEEE
Confidence 999999954 4445555444 68999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
+.+|.+||+|||+++.... ......++..|+|||.+.+..++.++|+||||+++|||++ |..||......++...+
T Consensus 136 ~~~~~~~l~d~g~~~~~~~---~~~~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~~ 212 (256)
T cd05039 136 SEDLVAKVSDFGLAKEASQ---GQDSGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPHV 212 (256)
T ss_pred eCCCCEEEccccccccccc---ccccCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHH
Confidence 9999999999999875421 1113345668999999998889999999999999999997 99999988877776666
Q ss_pred HhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 300 CNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 300 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
... ....|..+++++.++|.+||..+|++|| +++|+++
T Consensus 213 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~l~~ 251 (256)
T cd05039 213 EKGYRMEAPEGCPPEVYKVMKDCWELDPAKRP------TFKQLRE 251 (256)
T ss_pred hcCCCCCCccCCCHHHHHHHHHHhccChhhCc------CHHHHHH
Confidence 544 4456677899999999999999999999 4566653
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-40 Score=332.23 Aligned_cols=252 Identities=27% Similarity=0.432 Sum_probs=206.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe---
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH--- 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~--- 140 (494)
.++|++.+.||+|+||.||+|++..++..||||++.... ...........|..++. .++||||+++++++...+.
T Consensus 14 ~~~y~~~~~ig~g~~g~vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 91 (343)
T cd07851 14 PDRYQNLSPVGSGAYGQVCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLK-HMDHENVIGLLDVFTPASSLED 91 (343)
T ss_pred cCceEEEEEeccCCceEEEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHH-hccCCCHHHHHHHhhccccccc
Confidence 458999999999999999999999999999999987542 22233345566777776 5799999999988876654
Q ss_pred ---eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 141 ---LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 141 ---~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+|+|+||+ |++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 92 ~~~~~lv~e~~----------------------~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~LH~~gi~H~dlkp~N 148 (343)
T cd07851 92 FQDVYLVTHLM----------------------GADLNNIVKC-QKLSDDHIQFLVYQILRGLKYIHSAGIIHRDLKPSN 148 (343)
T ss_pred cccEEEEEecC----------------------CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHH
Confidence 99999998 3344444433 579999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|+++.+|.++|+|||++.... .......+|..|+|||.+.+ ..++.++|||||||++|+|++|+.||.+.+..+.+
T Consensus 149 ill~~~~~~kL~dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~~~~~~ 225 (343)
T cd07851 149 IAVNEDCELKILDFGLARHTD---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQL 225 (343)
T ss_pred eEECCCCCEEEcccccccccc---ccccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 999999999999999987532 22345678999999999865 46889999999999999999999999887776665
Q ss_pred HHHHhCCCC-------------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNERPR-------------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~~~~-------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+...... ....++.++.+||.+||..||.+|| ++.+|+.||
T Consensus 226 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~Rp------t~~ell~h~ 299 (343)
T cd07851 226 KRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDKRI------TAAEALAHP 299 (343)
T ss_pred HHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhhCC------CHHHHhcCC
Confidence 555432100 0123589999999999999999999 689999999
Q ss_pred CcCC
Q psy8309 346 YFRG 349 (494)
Q Consensus 346 ~f~~ 349 (494)
||+.
T Consensus 300 ~~~~ 303 (343)
T cd07851 300 YLAE 303 (343)
T ss_pred Cccc
Confidence 9985
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-39 Score=317.58 Aligned_cols=251 Identities=24% Similarity=0.340 Sum_probs=198.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeE----EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYY----YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~----~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+..++|++++.||+|+||.||+|....++.. +|+|.+... ...........|...+. .+.||||+++++++.
T Consensus 4 ~~~~~~~~~~~lg~G~~~~vy~~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~~~~~l~-~l~h~~iv~~~~~~~- 79 (279)
T cd05111 4 LKETELRKLKLLGSGVFGTVHKGIWIPEGDSIKIPVAIKTIQDR--SGRQTFQEITDHMLAMG-SLDHAYIVRLLGICP- 79 (279)
T ss_pred CCHhhceeccccCccCCcceEEEEEcCCCCceeeEEEEeecccc--cchHHHHHHHHHHHHHh-cCCCCCcceEEEEEC-
Confidence 4567999999999999999999999877764 566665432 11222233444444554 579999999999875
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
....++++||+++|+ |..++.. .+.+++..+..++.||+.||.|||++|++||||||+
T Consensus 80 ~~~~~~i~e~~~~gs---------------------L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiH~dlkp~ 138 (279)
T cd05111 80 GASLQLVTQLSPLGS---------------------LLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRMVHRNLAAR 138 (279)
T ss_pred CCccEEEEEeCCCCc---------------------HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCEeccccCcc
Confidence 456789999999554 4455544 457899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++....... ......|+..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 139 nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~~~ 218 (279)
T cd05111 139 NILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAGMRPH 218 (279)
T ss_pred eEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 99999999999999999975322211 1233457788999999998899999999999999999998 99999988777
Q ss_pred HHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+....+..+. +..|...+.++.+++.+||..||++|| ++.|+++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp------s~~el~~ 263 (279)
T cd05111 219 EVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENVRP------TFKELAN 263 (279)
T ss_pred HHHHHHHCCCcCCCCCCCCHHHHHHHHHHcCCCcccCc------CHHHHHH
Confidence 6655555443 344556788999999999999999999 4566654
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-40 Score=320.45 Aligned_cols=251 Identities=31% Similarity=0.502 Sum_probs=206.7
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
|++.+.||+|+||.||+|+...+++.||+|++.... ...........|..++. .++|+||+++++++.+...+|+|||
T Consensus 1 y~~~~~ig~g~~~~vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~~~~~~v~e 78 (282)
T cd07829 1 YEKLEKLGEGTYGVVYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLK-ELKHPNIVKLLDVIHTERKLYLVFE 78 (282)
T ss_pred CeeehcccccCcceEEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHH-hcCCCCHHHHHhhhhcCCceEEEec
Confidence 677889999999999999999999999999998753 22333345566777776 5689999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|+. ++|..++.+. ..+++..+..++.||+.||.|||++||+||||+|+||+++.++.
T Consensus 79 ~~~----------------------~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~~l~~~ni~~~~~~~ 136 (282)
T cd07829 79 YCD----------------------MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGV 136 (282)
T ss_pred CcC----------------------cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChheEEEcCCCC
Confidence 996 2445555554 57999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-- 302 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-- 302 (494)
++|+|||+++.............++..|+|||.+.+. .++.++|+|||||++|||++|.+||.+.+..+.+.++...
T Consensus 137 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~ 216 (282)
T cd07829 137 LKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQILG 216 (282)
T ss_pred EEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHHHhC
Confidence 9999999987643333233345578899999999776 7899999999999999999999999887766555544320
Q ss_pred ----------------CCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 ----------------RPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ----------------~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
...++ ..++.++.++|.+||..||.+|| ++++++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp------~~~~~l~~p~~ 282 (282)
T cd07829 217 TPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRI------SAKEALKHPYF 282 (282)
T ss_pred CCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCC------CHHHHhhCcCC
Confidence 11111 13478899999999999999999 68999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=323.19 Aligned_cols=255 Identities=25% Similarity=0.423 Sum_probs=202.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC---
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--- 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--- 139 (494)
..++|++.+.||+|+||.||+|.++.+++.||||+++.... ..........|..++. .++||||+++++++.+..
T Consensus 5 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~-~l~h~~i~~~~~~~~~~~~~~ 82 (302)
T cd07864 5 CVDKFDIIGQIGEGTYGQVYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILR-QLNHRNIVNLKEIVTDKQDAL 82 (302)
T ss_pred hhhhhheeeeecccCCEEEEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHH-hCCCCCeeeeeheecCcchhh
Confidence 45789999999999999999999999999999999976422 1222234455666666 579999999999987655
Q ss_pred -------eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 140 -------HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 140 -------~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
.+|+|+||+++ ++...+.. ...+++..++.++.||+.||.|||++||+||
T Consensus 83 ~~~~~~~~~~lv~e~~~~----------------------~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~i~H~ 140 (302)
T cd07864 83 DFKKDKGAFYLVFEYMDH----------------------DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHR 140 (302)
T ss_pred hccccCCcEEEEEcccCc----------------------cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 89999999973 22233333 3478999999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
||||+||+++.++.+||+|||++........ ......++..|+|||.+.+ ..++.++|||||||++|||++|++||..
T Consensus 141 dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~ 220 (302)
T cd07864 141 DIKCSNILLNNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQA 220 (302)
T ss_pred CCCHHHEEECCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999875332221 1222356889999999865 3578999999999999999999999987
Q ss_pred CCHHHHHHHHHhC---CC--C-------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 290 CDEDELFWSICNE---RP--R-------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 290 ~~~~~~~~~i~~~---~~--~-------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
.+..+.+..+... .. . ....++..+.++|.+||..||.+|| +++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------~~~ 294 (302)
T cd07864 221 NQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTLDPSKRC------TAE 294 (302)
T ss_pred CChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccCChhhCC------CHH
Confidence 7765555444321 10 0 0124688999999999999999999 689
Q ss_pred hhhcCCCc
Q psy8309 340 DVVAHEYF 347 (494)
Q Consensus 340 eil~h~~f 347 (494)
+++.||||
T Consensus 295 ~il~~~~~ 302 (302)
T cd07864 295 EALNSPWL 302 (302)
T ss_pred HHhcCCCC
Confidence 99999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=335.27 Aligned_cols=275 Identities=24% Similarity=0.336 Sum_probs=210.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|.+.+.||+|+||.||+|++. .+++.||||+++... ..........|..++.....||||+++++++
T Consensus 33 ~~~~~~~~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~~vavK~l~~~~--~~~~~~~~~~E~~~l~~l~~H~niv~~~~~~ 110 (401)
T cd05107 33 EMPRDNLVLGRTLGSGAFGRVVEATAHGLSHSQSTMKVAVKMLKSTA--RSSEKQALMSELKIMSHLGPHLNIVNLLGAC 110 (401)
T ss_pred eecHHHeehhhhccCCCceeEEEEEEcCCCCCCCceEEEEEecCCCC--ChhHHHHHHHHHHHHHhcCCCCCeEEEEEEE
Confidence 345568999999999999999999964 345689999997642 2333446778888888543499999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhh----------hHh------------------------------------
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLM----------EYL------------------------------------ 169 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~----------~~~------------------------------------ 169 (494)
...+.+|+|||||.+|+|.+.+......... +.+
T Consensus 111 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 190 (401)
T cd05107 111 TKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPLSQRKSHVSLGSESDGGYMDMSKDESADYV 190 (401)
T ss_pred ccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccccccccchhhhhccCccccccCCccccCcc
Confidence 9999999999999999996544322110000 000
Q ss_pred -------------------------------cCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 170 -------------------------------NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 170 -------------------------------~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..............+++..+..++.||+.||+|||++||+||||||+||
T Consensus 191 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~Ni 270 (401)
T cd05107 191 PMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDLVGFSYQVANGMEFLASKNCVHRDLAARNV 270 (401)
T ss_pred chhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceE
Confidence 0000011112334688889999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
|++.++.+||+|||+++....... .....+|++.|+|||.+.+..++.++|||||||++|||++ |..||......+.
T Consensus 271 Ll~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~ 350 (401)
T cd05107 271 LICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQ 350 (401)
T ss_pred EEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHH
Confidence 999999999999999875322111 1233467889999999999899999999999999999998 8999987665555
Q ss_pred HHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 296 FWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 296 ~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
....... .+..|..++.++.+||.+||..+|.+|| +++||+.
T Consensus 351 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP------s~~ell~ 394 (401)
T cd05107 351 FYNAIKRGYRMAKPAHASDEIYEIMQKCWEEKFEIRP------DFSQLVH 394 (401)
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc------CHHHHHH
Confidence 4444333 3456778899999999999999999999 5667664
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=313.01 Aligned_cols=237 Identities=25% Similarity=0.318 Sum_probs=195.0
Q ss_pred eEeccCCceEEEEEEEeCCC---eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEe
Q psy8309 71 KVLGKGSFGKVFLAELKGTD---YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEY 147 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 147 (494)
++||+|+||.||+|.+..++ ..||+|.+...... ........|..++. .++||||+++++++. .+..++||||
T Consensus 1 ~~ig~G~~g~v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~~~~~~v~e~ 76 (257)
T cd05060 1 KELGHGNFGSVVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMA-QLDHPCIVRLIGVCK-GEPLMLVMEL 76 (257)
T ss_pred CccCccCceeEEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHH-hcCCCCeeeEEEEEc-CCceEEEEEe
Confidence 47999999999999876654 78999999865332 33445667777776 579999999999876 4568999999
Q ss_pred cCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEE
Q psy8309 148 LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227 (494)
Q Consensus 148 ~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vk 227 (494)
++ +++|..++.....+++..+..++.||+.||+|||.+|++||||||+|||++.++.+|
T Consensus 77 ~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i~H~di~p~nili~~~~~~k 135 (257)
T cd05060 77 AP---------------------LGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAK 135 (257)
T ss_pred CC---------------------CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCeeccCcccceEEEcCCCcEE
Confidence 98 445566676667899999999999999999999999999999999999999999999
Q ss_pred EeecCceeeeeccCCccc---ccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCC
Q psy8309 228 IADFGMCKLQIYLDKTTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 228 L~DFGla~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
|+|||+++.......... ...++..|+|||.+.+..++.++|||||||++|||++ |.+||...+..+....+....
T Consensus 136 l~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~~~~~~~~~~~~ 215 (257)
T cd05060 136 ISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGE 215 (257)
T ss_pred eccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCC
Confidence 999999875432222111 1123467999999999899999999999999999998 999998888777777766543
Q ss_pred -CCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 304 -PRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 304 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
...|..++..++++|.+||..+|.+||++
T Consensus 216 ~~~~~~~~~~~l~~li~~cl~~~p~~Rp~~ 245 (257)
T cd05060 216 RLPRPEECPQEIYSIMLSCWKYRPEDRPTF 245 (257)
T ss_pred cCCCCCCCCHHHHHHHHHHhcCChhhCcCH
Confidence 35667789999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=314.10 Aligned_cols=250 Identities=24% Similarity=0.342 Sum_probs=203.6
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
..++|+..+.||+|+||.||+|+.+.++. .+|||.+.... ..........|..++. .++||||+++++++...+
T Consensus 3 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 79 (268)
T cd05063 3 HPSHITKQKVIGAGEFGEVFRGILKMPGRKEVAVAIKTLKPGY--TEKQRQDFLSEASIMG-QFSHHNIIRLEGVVTKFK 79 (268)
T ss_pred ChHHceEeeEecCCCCccEEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHh-cCCCCCeeEEEEEEccCC
Confidence 34689999999999999999999876554 79999986542 2333445667777766 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..|+||||+++|+ |..++.. .+.+++..+..++.|++.||+|||++|++||||||+||
T Consensus 80 ~~~lv~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dlkp~Ni 138 (268)
T cd05063 80 PAMIITEYMENGA---------------------LDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNI 138 (268)
T ss_pred CcEEEEEcCCCCC---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccccchhhE
Confidence 9999999999544 4445544 35789999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCccc---ccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~---~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
+++.++.+||+|||++........... ....++.|+|||++.+..++.++|||||||++|||++ |..||...+..+
T Consensus 139 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~~p~~~~~~~~ 218 (268)
T cd05063 139 LVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHE 218 (268)
T ss_pred EEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCCCCCCcCCHHH
Confidence 999999999999999875332211111 1123457999999998899999999999999999997 999999888878
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
....|... ....+..++.++.+++.+||..+|.+|| +.++|+
T Consensus 219 ~~~~i~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp------~~~~i~ 261 (268)
T cd05063 219 VMKAINDGFRLPAPMDCPSAVYQLMLQCWQQDRARRP------RFVDIV 261 (268)
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCcccCc------CHHHHH
Confidence 87777654 2334456789999999999999999999 456665
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=322.38 Aligned_cols=268 Identities=25% Similarity=0.383 Sum_probs=207.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC-------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG-------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFC 133 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~ 133 (494)
.+..++|++.+.||+|+||.||+|++.. ++..||+|++... ...........|..++....+||||+++++
T Consensus 11 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~i~~~~~ 88 (304)
T cd05101 11 EFSRDKLTLGKPLGEGCFGQVVMAEALGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 88 (304)
T ss_pred cccHHHeeecceeeccCCceEEEEEEeccCCCCCCcceeEEeeecccc--cchHHHHHHHHHHHHHHhhccCCCchheeE
Confidence 3456799999999999999999998532 3457999998754 223344566778777774448999999999
Q ss_pred EEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHh--hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 134 TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI--QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 134 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l--~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
++......|+||||+++|+|.+.+...... +......+ .....++...+..++.||+.||.|||++||+||
T Consensus 89 ~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~givH~ 161 (304)
T cd05101 89 ACTQDGPLYVIVEYASKGNLREYLRARRPP-------GMEYSYDIARVPDEQMTFKDLVSCTYQVARGMEYLASQKCIHR 161 (304)
T ss_pred EEecCCceEEEEecCCCCcHHHHHHhcCCc-------ccccccccccCCcccccHHHHHHHHHHHHHHHHHHHHCCeeec
Confidence 999999999999999977663221110000 00000000 112357888999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFS 288 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~ 288 (494)
||||+|||++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|+|++ |..||.
T Consensus 162 dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~ 241 (304)
T cd05101 162 DLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYP 241 (304)
T ss_pred ccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhHHHHHHHHHHHHcCCCCCcc
Confidence 9999999999999999999999875432221 1223346778999999999899999999999999999998 899999
Q ss_pred CCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 289 GCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+.+..++...+.... ...|..++.++++||.+||..+|.+|| ++.|+++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------s~~e~l~ 291 (304)
T cd05101 242 GIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAIPSHRP------TFKQLVE 291 (304)
T ss_pred cCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcccChhhCC------CHHHHHH
Confidence 988888888776543 345667899999999999999999999 4666664
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=314.26 Aligned_cols=236 Identities=25% Similarity=0.327 Sum_probs=192.2
Q ss_pred EeccCCceEEEEEEEe--CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 72 VLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~~--~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
.||+|+||.||+|..+ .++..||+|++.... .....+....|..++. .++||||++++++++ ....++||||++
T Consensus 2 ~ig~G~~g~v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~ii~~~~~~~-~~~~~lv~e~~~ 77 (257)
T cd05115 2 ELGSGNFGCVKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMH-QLDNPYIVRMIGVCE-AEALMLVMEMAS 77 (257)
T ss_pred ccCCCCcccEEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHH-hcCCCCeEEEEEEEc-CCCeEEEEEeCC
Confidence 4899999999999875 445679999987542 2333455667877777 579999999999886 457899999999
Q ss_pred CCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEE
Q psy8309 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228 (494)
Q Consensus 150 ~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL 228 (494)
+|+| ..++.. ...+++..++.++.||+.||.|||++|++||||||+|||++.++.+||
T Consensus 78 ~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~nil~~~~~~~kl 136 (257)
T cd05115 78 GGPL---------------------NKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKI 136 (257)
T ss_pred CCCH---------------------HHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcCeeecccchheEEEcCCCcEEe
Confidence 5544 444443 457899999999999999999999999999999999999999999999
Q ss_pred eecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q psy8309 229 ADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-R 303 (494)
Q Consensus 229 ~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~ 303 (494)
+|||+++........ .....+++.|+|||++.+..++.++|+|||||++|||++ |..||.+....+....+..+ .
T Consensus 137 ~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~ 216 (257)
T cd05115 137 SDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKGPEVMSFIEQGKR 216 (257)
T ss_pred ccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCHHHHHHHHHCCCC
Confidence 999998743222111 111223578999999998889999999999999999996 99999988887777766654 4
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+.+|...++++.++|.+||..||++||+.
T Consensus 217 ~~~~~~~~~~l~~li~~c~~~~~~~Rp~~ 245 (257)
T cd05115 217 LDCPAECPPEMYALMKDCWIYKWEDRPNF 245 (257)
T ss_pred CCCCCCCCHHHHHHHHHHcCCChhhCcCH
Confidence 56677889999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG1026|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=345.19 Aligned_cols=262 Identities=27% Similarity=0.398 Sum_probs=215.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+...+.+..+.||+|+||+||+|+.- .....||||.++.. ........+.+|..++. .++|||||+|+|++
T Consensus 482 ~i~r~~i~~~~eLGegaFGkVf~a~~~~l~p~~~~~lVAVK~LKd~--a~~~~~~dF~REaeLla-~l~H~nIVrLlGVC 558 (774)
T KOG1026|consen 482 EIPRSDIVFKEELGEGAFGKVFLAEAYGLLPGQDEQLVAVKALKDK--AENQARQDFRREAELLA-ELQHPNIVRLLGVC 558 (774)
T ss_pred EechhheeehhhhcCchhhhhhhhhccCCCCCccceehhHhhhccc--ccHHHHHHHHHHHHHHH-hccCCCeEEEEEEE
Confidence 455678889999999999999999864 34567999999875 23335566778888887 68999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
..++.+|||+|||..|||...+.......-.. +.|.+ ....|+..+...++.||+.||+||-++.+|||||..
T Consensus 559 ~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~-~~g~~------~~~~L~~~q~L~iA~QIAaGM~YLs~~~FVHRDLAT 631 (774)
T KOG1026|consen 559 REGDPLCMVFEYMDHGDLHEFLRARSPKADKL-ASGQD------TPPPLSTSQFLHIATQIAAGMEYLSSHHFVHRDLAT 631 (774)
T ss_pred ccCCeeEEEEEecccccHHHHHHhhCCccccc-cCCCC------CCCCCCHHHHHHHHHHHHHHHHHHHhCcccccchhh
Confidence 99999999999999999865433322111100 01111 145699999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccc---cCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDT---FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~---~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
.|+||.++..|||+||||++.. +....... ..-..+|||||.|....|+.++||||+||+|||+++ |..||++..
T Consensus 632 RNCLVge~l~VKIsDfGLsRdi-YssDYYk~~~~t~lPIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glS 710 (774)
T KOG1026|consen 632 RNCLVGENLVVKISDFGLSRDI-YSSDYYKVRGNTLLPIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLS 710 (774)
T ss_pred hhceeccceEEEecccccchhh-hhhhhhcccCCceeeeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccc
Confidence 9999999999999999999863 22222111 112468999999999999999999999999999998 999999999
Q ss_pred HHHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCC
Q psy8309 292 EDELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGST 333 (494)
Q Consensus 292 ~~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 333 (494)
.++.++.|.+++. .-|...+.++.+|+..||..+|.+||+..
T Consensus 711 n~EVIe~i~~g~lL~~Pe~CP~~vY~LM~~CW~~~P~~RPsF~ 753 (774)
T KOG1026|consen 711 NQEVIECIRAGQLLSCPENCPTEVYSLMLECWNENPKRRPSFK 753 (774)
T ss_pred hHHHHHHHHcCCcccCCCCCCHHHHHHHHHHhhcCcccCCCHH
Confidence 9999999998865 55789999999999999999999999654
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=330.03 Aligned_cols=275 Identities=26% Similarity=0.365 Sum_probs=204.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|++.+.||+|+||.||+|++. .+++.||||+++... ..........|..++....+||||+++++++.
T Consensus 4 ~~~~~~~~~~~lG~G~fg~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~ 81 (343)
T cd05103 4 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 81 (343)
T ss_pred cchhHhcccccccCCccceEEEEeeccCCccccceeEEEEEeccCC--ChHHHHHHHHHHHHHHhccCCccHhhhcceee
Confidence 34568999999999999999999853 457889999997542 23345567788888886558999999999876
Q ss_pred c-CCeeEEEEEecCCCCCccccchhhhhhh---------hhHhcC-CchhHH----------------------------
Q psy8309 137 T-DSHLFFVMEYLNGGDLIPAGLTKAERDL---------MEYLNG-GDLMFH---------------------------- 177 (494)
Q Consensus 137 ~-~~~~~lv~E~~~~g~L~~~~~~~~~~~l---------~~~~~g-g~L~~~---------------------------- 177 (494)
. ...+++|||||++|+|.+.+........ .....+ +.+...
T Consensus 82 ~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (343)
T cd05103 82 KPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDISEDLKRRLDSITSSQSSASSGFVEEKSLSDV 161 (343)
T ss_pred cCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchhhhhhhhccccccccccccccccCCCccccc
Confidence 5 4568999999999998543322100000 000000 000000
Q ss_pred --------hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCC--ccccc
Q psy8309 178 --------IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTF 247 (494)
Q Consensus 178 --------l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~ 247 (494)
......+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||++........ .....
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~ 241 (343)
T cd05103 162 EEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDA 241 (343)
T ss_pred hhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCC
Confidence 00123578899999999999999999999999999999999999999999999999875322111 12233
Q ss_pred CCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH-HHHHHHhC-CCCCCccCCHHHHHHHHhhccC
Q psy8309 248 CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE-LFWSICNE-RPRFPQFLSVEAKNILVHLLDK 324 (494)
Q Consensus 248 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~ 324 (494)
.+++.|+|||++.+..++.++|||||||++|+|++ |..||.+..... ....+..+ ....|...++++.+++.+||..
T Consensus 242 ~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~cl~~ 321 (343)
T cd05103 242 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 321 (343)
T ss_pred CCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCccccHHHHHHHhccCCCCCCCCCCHHHHHHHHHHccC
Confidence 45678999999999899999999999999999997 999998765433 33333332 3455677889999999999999
Q ss_pred CCCCCCCCCCCCChhhhhcC
Q psy8309 325 DTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 325 dP~~R~~~~~~~~~~eil~h 344 (494)
||.+|| ++.||++|
T Consensus 322 ~p~~Rp------s~~eil~~ 335 (343)
T cd05103 322 EPSQRP------TFSELVEH 335 (343)
T ss_pred ChhhCc------CHHHHHHH
Confidence 999999 57788765
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-39 Score=323.06 Aligned_cols=252 Identities=25% Similarity=0.393 Sum_probs=208.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|+..+.||+|+||.||+|+++.++..+|||.+................|..++. .++|+|++++++++......|+|
T Consensus 15 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 93 (308)
T cd06634 15 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLV 93 (308)
T ss_pred HHHHHHHheeeCCCEEEEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHH-hCCCCCcccEEEEEEcCCeeEEE
Confidence 46888899999999999999999999999999987543333344455667777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+. |+| ...+ .....+++..+..++.||+.||.|||++|++||||||+|||++.+
T Consensus 94 ~e~~~-~~l---------------------~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~H~dl~p~nil~~~~ 151 (308)
T cd06634 94 MEYCL-GSA---------------------SDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 151 (308)
T ss_pred EEccC-CCH---------------------HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHhEEECCC
Confidence 99996 232 2222 234568999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.++|+|||++.... ......|++.|+|||.+. ...++.++|||||||++|+|++|..||...+..+....+.
T Consensus 152 ~~~kl~dfg~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~ 227 (308)
T cd06634 152 GLVKLGDFGSASIMA----PANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 227 (308)
T ss_pred CcEEECCcccceeec----CcccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCccccHHHHHHHHh
Confidence 999999999987532 233467899999999985 3457889999999999999999999998876665555555
Q ss_pred hCC-CCC-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NER-PRF-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~-~~~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
... +.. +..++..+++||.+||..+|.+|| +++++++|+|+..
T Consensus 228 ~~~~~~~~~~~~~~~~~~li~~cl~~~P~~Rp------~~~~ll~~~~~~~ 272 (308)
T cd06634 228 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRP------TSEVLLKHRFVLR 272 (308)
T ss_pred hcCCCCcCcccccHHHHHHHHHHhhCCcccCC------CHHHHhhCccccc
Confidence 433 222 346889999999999999999999 6899999999975
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=313.05 Aligned_cols=242 Identities=27% Similarity=0.425 Sum_probs=198.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|+++++||+|+||.||+|..+. ++.||+|.+.+... .......|..++. .++||||+++++++. .+..|
T Consensus 4 ~~~~~~~~~~ig~G~~g~v~~~~~~~-~~~~a~K~~~~~~~----~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~ 76 (260)
T cd05067 4 PRETLKLVKKLGAGQFGEVWMGYYNG-HTKVAIKSLKQGSM----SPEAFLAEANLMK-QLQHPRLVRLYAVVT-QEPIY 76 (260)
T ss_pred chHHceeeeeeccCccceEEeeecCC-CceEEEEEecCCCC----cHHHHHHHHHHHH-hcCCcCeeeEEEEEc-cCCcE
Confidence 35689999999999999999998654 56799999876432 2334566777776 579999999999874 56799
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++|||+.+|+| ..++.. ...+++.++..++.||+.||+|||++|++||||||+||++
T Consensus 77 ~v~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i~H~dl~p~ni~i 135 (260)
T cd05067 77 IITEYMENGSL---------------------VDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILV 135 (260)
T ss_pred EEEEcCCCCCH---------------------HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccccHHhEEE
Confidence 99999995554 444433 3468999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
+.++.++|+|||++........ ......++..|+|||++.+..++.++|+||||+++|||++ |++||.+.+..+....
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05067 136 SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQN 215 (260)
T ss_pred cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCChHHHHHH
Confidence 9999999999999875331111 1223446778999999999899999999999999999998 9999998887777776
Q ss_pred HHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 299 ICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 299 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+... ....+...+.++.++|.+||..+|++||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05067 216 LERGYRMPRPDNCPEELYELMRLCWKEKPEERPTF 250 (260)
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHccCChhhCCCH
Confidence 6544 345567788999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=318.45 Aligned_cols=266 Identities=27% Similarity=0.364 Sum_probs=203.6
Q ss_pred CceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+|++.+.||+|+||.||+|.... ....+|+|.+.+.. ..........|..++. .++||||+++++.+...+.
T Consensus 1 ~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 77 (290)
T cd05045 1 NLVLGKTLGEGEFGKVVKATAFRLKGRAGYTTVAVKMLKENA--SSSELRDLLSEFNLLK-QVNHPHVIKLYGACSQDGP 77 (290)
T ss_pred CccccccccCcCCcceEEEEEecCCCCCcceeEEEEecCCCC--CHHHHHHHHHHHHHHh-hCCCCCEeeEEEEEecCCC
Confidence 57889999999999999998753 23568999887542 2234456677877776 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCc-----hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD-----LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~-----L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.|+||||+.+|+|.+.+..... ...-..+.+ ..........+++..+..++.||+.||+|||++||+||||||
T Consensus 78 ~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp 155 (290)
T cd05045 78 LLLIVEYAKYGSLRSFLRESRK--VGPSYLGSDGNRNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAA 155 (290)
T ss_pred cEEEEEecCCCCHHHHHHhcCC--ccccccccccccccccccCccccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhh
Confidence 9999999998877432111000 000000000 000112234688999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++||||||+++|||++ |..||.+...
T Consensus 156 ~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 156 RNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred heEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999999999999875322111 1223356778999999999899999999999999999998 9999998888
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
.++...+... ....|..++.++.++|..||+.+|.+||+ +.+++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~cl~~~P~~Rp~------~~~i~ 280 (290)
T cd05045 236 ERLFNLLKTGYRMERPENCSEEMYNLMLTCWKQEPDKRPT------FADIS 280 (290)
T ss_pred HHHHHHHhCCCCCCCCCCCCHHHHHHHHHHccCCcccCCC------HHHHH
Confidence 7776665543 34456788999999999999999999994 55655
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG0584|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=337.56 Aligned_cols=250 Identities=25% Similarity=0.459 Sum_probs=212.4
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe--eEEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH--LFFV 144 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~--~~lv 144 (494)
+...+||+|+|-+||+|.+..+|..||--.++...+. .....++...|..+|. .++|||||+++.+|.+... +.+|
T Consensus 43 k~~evLGrGafKtVYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLK-sL~H~NIirfy~SW~d~~n~~in~i 121 (632)
T KOG0584|consen 43 KFDEVLGRGAFKTVYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLK-SLKHPNIIRFYDSWVDTDNKTINFI 121 (632)
T ss_pred ehhhhcccccceeeeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHc-cCCCCceeeeeeheecCCCceeeee
Confidence 4557899999999999999999998885554433333 3344566666776666 7999999999999998766 8889
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCCceeeCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDNILLDY 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLKp~NILl~~ 222 (494)
+|++. +|+|+.++.+.++++...++.|++||+.||.|||++. |||||||.+||+|+.
T Consensus 122 TEL~T---------------------SGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs~~PPIIHRDLKCDNIFinG 180 (632)
T KOG0584|consen 122 TELFT---------------------SGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHSQDPPIIHRDLKCDNIFVNG 180 (632)
T ss_pred eeccc---------------------CCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhcCCCCccccccccceEEEcC
Confidence 99998 6777889999999999999999999999999999995 999999999999975
Q ss_pred -CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHH
Q psy8309 223 -EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFWSIC 300 (494)
Q Consensus 223 -~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~ 300 (494)
.|.|||+|+|||... ........+|||+|||||+.. ..|+..+||||||.+|.||+|+..||.. .++..+|.++.
T Consensus 181 ~~G~VKIGDLGLAtl~--r~s~aksvIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~AQIYKKV~ 257 (632)
T KOG0584|consen 181 NLGEVKIGDLGLATLL--RKSHAKSVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPAQIYKKVT 257 (632)
T ss_pred CcCceeecchhHHHHh--hccccceeccCccccChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHHHHHHHHH
Confidence 489999999999853 334455689999999999998 6999999999999999999999999964 57888899988
Q ss_pred hCCCC--CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPR--FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+..+ |...-.+++++||.+||.. ...|+ ++.|+|+||||..
T Consensus 258 SGiKP~sl~kV~dPevr~fIekCl~~-~~~R~------sa~eLL~d~Ff~~ 301 (632)
T KOG0584|consen 258 SGIKPAALSKVKDPEVREFIEKCLAT-KSERL------SAKELLKDPFFDE 301 (632)
T ss_pred cCCCHHHhhccCCHHHHHHHHHHhcC-chhcc------CHHHHhhChhhcc
Confidence 87542 2334479999999999998 99999 6899999999975
|
|
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-39 Score=313.35 Aligned_cols=242 Identities=26% Similarity=0.402 Sum_probs=197.6
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||+|++..++ .||+|++++... .......|..++. .++||||+++++.+. ....|
T Consensus 4 ~~~~~~~~~~lg~g~~~~v~~~~~~~~~-~valK~~~~~~~----~~~~~~~E~~~l~-~l~~~~i~~~~~~~~-~~~~~ 76 (262)
T cd05071 4 PRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMK-KLRHEKLVQLYAVVS-EEPIY 76 (262)
T ss_pred ChHHeeEeeecCCCCCCcEEEEEecCCc-eEEEEecccCcc----CHHHHHHHHHHHH-hCCCCCcceEEEEEC-CCCcE
Confidence 3468999999999999999999887765 499999976422 1234566777776 578999999999875 45689
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+||||+++|+| ..++.. ...+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 77 lv~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~Nill 135 (262)
T cd05071 77 IVTEYMSKGSL---------------------LDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV 135 (262)
T ss_pred EEEEcCCCCcH---------------------HHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCccccccCcccEEE
Confidence 99999995544 444543 2457899999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
+.++.++|+|||++........ ......++..|+|||++.+..++.++|+|||||++|||++ |.+||.+....++...
T Consensus 136 ~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~~~~~~~ 215 (262)
T cd05071 136 GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 215 (262)
T ss_pred cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCChHHHHHH
Confidence 9999999999999875322211 1123346678999999998899999999999999999999 8999998888777777
Q ss_pred HHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 299 ICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 299 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+... ....+..++..+.++|.+||++||++||++
T Consensus 216 ~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp~~ 250 (262)
T cd05071 216 VERGYRMPCPPECPESLHDLMCQCWRKEPEERPTF 250 (262)
T ss_pred HhcCCCCCCccccCHHHHHHHHHHccCCcccCCCH
Confidence 7654 234456789999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=325.87 Aligned_cols=270 Identities=26% Similarity=0.359 Sum_probs=207.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC-------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT-------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~-------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
+...+|++++.||+|+||.||+|++... +..||+|+++.. ...........|..++....+||||++++++
T Consensus 9 ~~~~~~~i~~~ig~G~~g~v~~~~~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~ 86 (334)
T cd05100 9 LSRTRLTLGKPLGEGCFGQVVMAEAIGIDKDKPNKPVTVAVKMLKDD--ATDKDLSDLVSEMEMMKMIGKHKNIINLLGA 86 (334)
T ss_pred cCHhHeeecceeccccCCcEEEEEEeccCCccCCcceeEEEEEcccc--cCHHHHHHHHHHHHHHHhhcCCCCeeeeeEE
Confidence 3445899999999999999999986532 236899988753 2333455677788887754489999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
+...+.+|++|||+++|+|.+.+.......+ . ..+.........++...+..++.||+.||.|||++||+|||||
T Consensus 87 ~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~-~----~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~~givH~dlk 161 (334)
T cd05100 87 CTQDGPLYVLVEYASKGNLREYLRARRPPGM-D----YSFDTCKLPEEQLTFKDLVSCAYQVARGMEYLASQKCIHRDLA 161 (334)
T ss_pred EccCCceEEEEecCCCCcHHHHHHhcCCccc-c----cccccccCccccCCHHHHHHHHHHHHHHHHHHHHCCeeccccc
Confidence 9999999999999997776432111000000 0 0000000122357888899999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|+|||++.++.+||+|||+++........ .....++..|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 162 p~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 241 (334)
T cd05100 162 ARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPGIP 241 (334)
T ss_pred cceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhhHHHHHHHHHHHhcCCCCCCCCC
Confidence 99999999999999999998753221111 122234568999999999999999999999999999998 999999988
Q ss_pred HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 292 EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 292 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..+....+... ....|...+.++.+||.+||..+|.+|| ++.|++++
T Consensus 242 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp------s~~ell~~ 289 (334)
T cd05100 242 VEELFKLLKEGHRMDKPANCTHELYMIMRECWHAVPSQRP------TFKQLVED 289 (334)
T ss_pred HHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHcccChhhCc------CHHHHHHH
Confidence 88888777664 3456677899999999999999999999 56777764
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=319.29 Aligned_cols=251 Identities=29% Similarity=0.475 Sum_probs=205.7
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
|++.+.||+|++|.||+|.+..+++.+|+|.+..... ..........|..++. .++|+||+++++++...+.+|+|||
T Consensus 1 y~~~~~i~~g~~~~v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e 78 (283)
T cd05118 1 YQKLGKIGEGTYGVVYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLK-ELNHPNIIKLLDVFRHKGDLYLVFE 78 (283)
T ss_pred CccceeeecCCCceEEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHH-HhcCCCcchHHHhhccCCCEEEEEe
Confidence 6778999999999999999999999999999876532 2233445556767776 4689999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|+.+ ++...+.. .+.+++..+..++.||+.||.|||++||+|+||||+||+++.++.
T Consensus 79 ~~~~----------------------~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dl~p~nili~~~~~ 136 (283)
T cd05118 79 FMDT----------------------DLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGV 136 (283)
T ss_pred ccCC----------------------CHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCeeecCcCHHHEEECCCCc
Confidence 9962 33444444 368999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER- 303 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~- 303 (494)
++|+|||.+..............++..|+|||.+.+. .++.++|+||||+++|+|++|+.||.+.+..+.+..+...-
T Consensus 137 ~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~~~~~~~~~~~~~ 216 (283)
T cd05118 137 LKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLG 216 (283)
T ss_pred EEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcC
Confidence 9999999987543322223335688899999999876 78999999999999999999999998887766555543210
Q ss_pred ------------------CCC-----------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 304 ------------------PRF-----------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 304 ------------------~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
..+ ...++.+++++|.+||..||.+|| ++.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp------~~~~ll~~~~~ 283 (283)
T cd05118 217 TPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRI------TAEQALAHPYF 283 (283)
T ss_pred CCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCc------CHHHHhhCCCC
Confidence 001 124678999999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=312.52 Aligned_cols=242 Identities=27% Similarity=0.432 Sum_probs=198.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++++.||+|+||.||+|.... +..+|+|.+..... .......|..++. .++|++|+++++++. ....|
T Consensus 4 ~~~~~~~~~~ig~g~~~~v~~~~~~~-~~~~~~k~~~~~~~----~~~~~~~E~~~l~-~l~~~~i~~~~~~~~-~~~~~ 76 (260)
T cd05070 4 PRESLQLIKKLGNGQFGEVWMGTWNG-NTKVAVKTLKPGTM----SPESFLEEAQIMK-KLRHDKLVQLYAVVS-EEPIY 76 (260)
T ss_pred chHHhhhhheeccccCceEEEEEecC-CceeEEEEecCCCC----CHHHHHHHHHHHH-hcCCCceEEEEeEEC-CCCcE
Confidence 45689999999999999999998764 45699999876432 1234566777776 579999999999875 45689
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++|||+++|+ |..++.. ...+++..++.++.||+.||.|||++||+||||||+||++
T Consensus 77 lv~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~di~p~Nili 135 (260)
T cd05070 77 IVTEYMSKGS---------------------LLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILV 135 (260)
T ss_pred EEEEecCCCc---------------------HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccceEEE
Confidence 9999999554 4444443 2458999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
+.++.++|+|||++........ ......++..|+|||.+.+..++.++|+||||+++|+|++ |.+||.+.+..+....
T Consensus 136 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~~~~~~~ 215 (260)
T cd05070 136 GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQ 215 (260)
T ss_pred eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHH
Confidence 9999999999999875322111 1122335668999999998889999999999999999999 9999998888887777
Q ss_pred HHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 299 ICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 299 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+... .+..+...+.++++|+.+||.++|.+||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~ 250 (260)
T cd05070 216 VERGYRMPCPQDCPISLHELMLQCWKKDPEERPTF 250 (260)
T ss_pred HHcCCCCCCCCcCCHHHHHHHHHHcccCcccCcCH
Confidence 7654 445677789999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-39 Score=311.42 Aligned_cols=244 Identities=27% Similarity=0.421 Sum_probs=201.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++.+.||+|+||.||+|..++ +..||||.+..... .......|..++. .++||||+++++++.....+
T Consensus 3 ~~~~~~~i~~~ig~g~~~~v~~~~~~~-~~~~~vK~~~~~~~----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 76 (261)
T cd05034 3 IPRESLKLERKLGAGQFGEVWMGTWNG-TTKVAVKTLKPGTM----SPEAFLQEAQIMK-KLRHDKLVQLYAVCSEEEPI 76 (261)
T ss_pred cchhheeeeeeeccCcceEEEEEEEcC-CceEEEEEecCCcc----CHHHHHHHHHHHh-hCCCCCEeeeeeeeecCCce
Confidence 456799999999999999999999764 46699999875432 2344566777776 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
++||||+++++ |..++... ..+++..+..++.||+.||.|||++|++||||||+||+
T Consensus 77 ~~v~e~~~~~~---------------------L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~i~h~di~p~nil 135 (261)
T cd05034 77 YIVTEYMSKGS---------------------LLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNIL 135 (261)
T ss_pred EEEEeccCCCC---------------------HHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcchheEE
Confidence 99999999554 44455443 36899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||++....... .......++..|+|||.+.+..++.++|+|||||++|+|++ |+.||.+.+......
T Consensus 136 i~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~ 215 (261)
T cd05034 136 VGENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLE 215 (261)
T ss_pred EcCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999987532111 11112234578999999999899999999999999999998 999999888888888
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+... ....|...+.++.+++.+||..+|.+||++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~ 251 (261)
T cd05034 216 QVERGYRMPRPPNCPEELYDLMLQCWDKDPEERPTF 251 (261)
T ss_pred HHHcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 77654 345566779999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=317.15 Aligned_cols=251 Identities=29% Similarity=0.510 Sum_probs=204.1
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--CeeEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--SHLFFV 144 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--~~~~lv 144 (494)
|++.+.||+|+||.||+|+...+++.||+|++.... ...........|..++. .++|||++++++++... +..|+|
T Consensus 1 y~~~~~l~~g~~~~vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~~lv 78 (287)
T cd07840 1 YEKIAQIGEGTYGQVYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQ-KLRHPNIVRLKEIVTSKGKGSIYMV 78 (287)
T ss_pred CeeeEEeccCCCeEEEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHH-hccCCCeeeheeeEecCCCCcEEEE
Confidence 688999999999999999999999999999998763 22333445566777776 57899999999999988 899999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+++ +|...+... ..+++..++.++.||+.||+|||++|++|+||||+||+++.+
T Consensus 79 ~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~~~h~dl~p~nil~~~~ 136 (287)
T cd07840 79 FEYMDH----------------------DLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINND 136 (287)
T ss_pred eccccc----------------------cHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEEcCC
Confidence 999962 333344333 579999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 224 GHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+.+||+|||++........ ......++..|+|||.+.+ ..++.++||||||+++|||++|..||...+.......+..
T Consensus 137 ~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~~~~~~~~~~ 216 (287)
T cd07840 137 GVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFE 216 (287)
T ss_pred CCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 9999999999875433221 1223457889999998765 4588999999999999999999999998877666555543
Q ss_pred CCC-----------------------C--------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 302 ERP-----------------------R--------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 302 ~~~-----------------------~--------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
... . +...++.++.++|.+||..+|.+|| ++.+++.||||
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp------~~~~~l~~~~~ 287 (287)
T cd07840 217 LCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI------SADQALQHEYF 287 (287)
T ss_pred HhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc------CHHHHhhCcCC
Confidence 100 0 0111388999999999999999999 67999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=318.10 Aligned_cols=266 Identities=24% Similarity=0.342 Sum_probs=203.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
..++|++++.||+|+||.||+|.+.. ++..||||++.... ..........|..++. .++||||+++++++..
T Consensus 3 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~ei~~l~-~l~h~~iv~~~~~~~~ 79 (288)
T cd05050 3 PRNNIEYVRDIGQGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA-EFDHPNIVKLLGVCAV 79 (288)
T ss_pred ChHhceecccccccccccEEEEEEcccCCCCcceeEEEEecCCCc--CHHHHHHHHHHHHHHH-hcCCCchheEEEEEcC
Confidence 45789999999999999999998753 67789999987542 2233345666777776 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhc--CCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN--GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~--gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
...+|+||||+++|+|.+.+....... ..... .............+++..+..++.||+.||.|||++|++||||||
T Consensus 80 ~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p 158 (288)
T cd05050 80 GKPMCLLFEYMAYGDLNEFLRHRSPRA-QCSLSHSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLAT 158 (288)
T ss_pred CCccEEEEecCCCCCHHHHHHHcCccc-cccccccccccccccccccccCHHHHHHHHHHHHHHHHHHHhCCeecccccH
Confidence 999999999999877633211100000 00000 000000111123588999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+||+++.++.++|+|||++....... .......++..|+|||.+.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 159 ~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~ 238 (288)
T cd05050 159 RNCLVGENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAH 238 (288)
T ss_pred hheEecCCCceEECccccceecccCccccccCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999999999987432211 11222345678999999999899999999999999999997 8899998888
Q ss_pred HHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 293 DELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 293 ~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.+....+..+.. ..|..++.++.+||.+||+.||.+||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~ 279 (288)
T cd05050 239 EEVIYYVRDGNVLSCPDNCPLELYNLMRLCWSKLPSDRPSF 279 (288)
T ss_pred HHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcccCcccCCCH
Confidence 888877776543 3466789999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=323.89 Aligned_cols=283 Identities=29% Similarity=0.435 Sum_probs=216.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-CCeeE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-DSHLF 142 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-~~~~~ 142 (494)
.++|++++.||+|+||.||+|.++.+++.||||++.+... ..........|..++. .++||||++++++|.. ....|
T Consensus 9 ~~~y~~~~~ig~g~~g~v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~ 86 (328)
T cd07856 9 TNRYVDLQPVGMGAFGLVCSARDQLTGQNVAIKKIMKPFS-TPVLAKRTYRELKLLK-HLRHENIISLSDIFISPLEDIY 86 (328)
T ss_pred ccceEEEEeecccCCeEEEEEEECCCCCEEEEEEeccccc-ccchhHHHHHHHHHHH-hcCCCCeeeEeeeEecCCCcEE
Confidence 3589999999999999999999999999999999876422 2233445567777776 5799999999999876 56899
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||+. ++|...+. ...+++..+..++.||+.||.|||++||+||||+|.|||++.
T Consensus 87 lv~e~~~----------------------~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~iiH~dl~p~Nili~~ 143 (328)
T cd07856 87 FVTELLG----------------------TDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINE 143 (328)
T ss_pred EEeehhc----------------------cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCHHHEeECC
Confidence 9999983 23333333 356889999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
++.++|+|||++... ........+++.|+|||.+.+ ..++.++|||||||++|+|++|.+||.+.+.......+.+
T Consensus 144 ~~~~~l~dfg~~~~~---~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~~~~~~~~~~~ 220 (328)
T cd07856 144 NCDLKICDFGLARIQ---DPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITD 220 (328)
T ss_pred CCCEEeCcccccccc---CCCcCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999998742 223345678999999999765 5689999999999999999999999987765332221111
Q ss_pred --------------------------CCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 --------------------------ERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 --------------------------~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.....| ..++.+++++|.+||+.+|++|| ++++++.||||...
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~------t~~ell~~~~~~~~ 294 (328)
T cd07856 221 LLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRI------SAAEALAHPYLAPY 294 (328)
T ss_pred HhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCC------CHHHHhcCCccccc
Confidence 001111 34688999999999999999999 68999999999642
Q ss_pred ChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccchhhh
Q psy8309 351 DWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVL 394 (494)
Q Consensus 351 ~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 394 (494)
. .|+..|... .-+.++..+..+|+....++
T Consensus 295 ~---------~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~ 324 (328)
T cd07856 295 H---------DPTDEPVAE-----EKFDWSFNDADLPVDTWKVM 324 (328)
T ss_pred c---------CCccccCch-----hhcCCchhcccCCHHHHHHH
Confidence 1 222223222 23345556666666655443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=315.05 Aligned_cols=259 Identities=24% Similarity=0.339 Sum_probs=197.3
Q ss_pred eEeccCCceEEEEEEEeCCCe--EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 71 KVLGKGSFGKVFLAELKGTDY--YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~--~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
++||+|+||.||+|+.+.++. .+|+|.++.. ...........|..++....+||||+++++++...+.+|+||||+
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~ 78 (270)
T cd05047 1 DVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYA 78 (270)
T ss_pred CcCCCCCCceEEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeC
Confidence 369999999999999988775 4688887643 233344566678888775448999999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEE
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL 228 (494)
++|+|.+.+........ .............+++..++.++.||+.||+|||++|++||||||+|||++.++.+||
T Consensus 79 ~~~~L~~~i~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl 153 (270)
T cd05047 79 PHGNLLDFLRKSRVLET-----DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKI 153 (270)
T ss_pred CCCcHHHHHHhcccccc-----ccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEE
Confidence 97766322111000000 0000000011235889999999999999999999999999999999999999999999
Q ss_pred eecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC
Q psy8309 229 ADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-RPRF 306 (494)
Q Consensus 229 ~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 306 (494)
+|||++..... ........++..|+|||++.+..++.++|+|||||++|||++ |..||.+.+..+....+... ....
T Consensus 154 ~dfgl~~~~~~-~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~ 232 (270)
T cd05047 154 ADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEK 232 (270)
T ss_pred CCCCCccccch-hhhccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCC
Confidence 99999863211 111112234667999999999899999999999999999997 99999988887777777654 3455
Q ss_pred CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 307 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+..++.++.+|+.+||..||.+|| +++++++
T Consensus 233 ~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~ 263 (270)
T cd05047 233 PLNCDDEVYDLMRQCWREKPYERP------SFAQILV 263 (270)
T ss_pred CCcCCHHHHHHHHHHcccChhhCC------CHHHHHH
Confidence 667889999999999999999999 4566653
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=324.02 Aligned_cols=250 Identities=22% Similarity=0.339 Sum_probs=196.4
Q ss_pred EeccC--CceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 72 VLGKG--SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 72 ~LG~G--~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
+||+| ++|.||.++.+.+++.||||+++... ...........|..++. .++||||++++++|.+.+..|++|||++
T Consensus 5 ~i~~~~~~~~~v~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~-~l~h~~i~~~~~~~~~~~~~~~~~e~~~ 82 (314)
T cd08216 5 LIGKCFEDLMIVHLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSR-QLQHPNILPYVTSFIVDSELYVVSPLMA 82 (314)
T ss_pred hhhHhhcCCceEEEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHH-hcCCcchhhhhheeecCCeEEEEEeccC
Confidence 44444 55667777777799999999998652 23345567778887777 5789999999999999999999999999
Q ss_pred CCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEE
Q psy8309 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227 (494)
Q Consensus 150 ~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vk 227 (494)
+|+| ..++.. ...+++..++.++.||+.||+|||++||+||||||+||+++.+|.+|
T Consensus 83 ~~~l---------------------~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH~~~ivH~dlk~~Nili~~~~~~k 141 (314)
T cd08216 83 YGSC---------------------EDLLKTHFPEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVV 141 (314)
T ss_pred CCCH---------------------HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCcceEEEecCCceE
Confidence 5544 444443 24689999999999999999999999999999999999999999999
Q ss_pred EeecCceeeeeccCC-------cccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 228 IADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 228 L~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
|+|||.+........ ......++..|+|||++.+ ..|+.++|+||+||++|||++|..||...........
T Consensus 142 l~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~~~~~~~~ 221 (314)
T cd08216 142 LSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMPATQMLLE 221 (314)
T ss_pred EecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 999998865332221 1234467889999999976 4688999999999999999999999987654433322
Q ss_pred HHhCC----------------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 299 ICNER----------------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 299 i~~~~----------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
...+. ...+..++.++.+||.+||..||++|| +++++++|
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp------t~~~ll~~ 295 (314)
T cd08216 222 KVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFVELCLQRDPESRP------SASQLLNH 295 (314)
T ss_pred HHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHHHHHhhcCCCcCc------CHHHHhcC
Confidence 11111 011123457899999999999999999 68999999
Q ss_pred CCcCCC
Q psy8309 345 EYFRGL 350 (494)
Q Consensus 345 ~~f~~~ 350 (494)
|||+.+
T Consensus 296 p~~~~~ 301 (314)
T cd08216 296 SFFKQC 301 (314)
T ss_pred chHhhh
Confidence 999865
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=313.04 Aligned_cols=251 Identities=24% Similarity=0.395 Sum_probs=204.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
...+|++.+.||+|+||.||+|+.+.+++ .||||++++. ...........|..++. .++||||+++++++.+..
T Consensus 2 ~~~~~~~~~~lg~g~~g~vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~~~ 78 (269)
T cd05065 2 DVSCVKIEEVIGAGEFGEVCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMG-QFDHPNIIHLEGVVTKSR 78 (269)
T ss_pred ChHHeEEEeEecCCCCCeEEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHH-hCCCcCcceEEEEECCCC
Confidence 35689999999999999999999887664 5999998754 23444556677777776 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..++||||+++|+| ..++.. .+.+++..++.++.|++.||.|||++|++||||||+||
T Consensus 79 ~~~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~~g~~H~dl~p~ni 137 (269)
T cd05065 79 PVMIITEFMENGAL---------------------DSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNI 137 (269)
T ss_pred ceEEEEecCCCCcH---------------------HHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccChheE
Confidence 99999999995544 444443 35689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCc---ccccC--CCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKT---TDTFC--GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~---~~~~~--gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
|++.++.+||+|||++......... ..... ++..|+|||.+.+..++.++|||||||++|||++ |..||...+.
T Consensus 138 li~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~~ 217 (269)
T cd05065 138 LVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSN 217 (269)
T ss_pred EEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCCH
Confidence 9999999999999998643221111 11111 2457999999999999999999999999999886 9999998888
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+....+... ....+..++.++.+++.+||..+|.+|| ++++|+.
T Consensus 218 ~~~~~~i~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~i~~ 263 (269)
T cd05065 218 QDVINAIEQDYRLPPPMDCPTALHQLMLDCWQKDRNARP------KFGQIVS 263 (269)
T ss_pred HHHHHHHHcCCcCCCcccCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 7777777543 3344567889999999999999999999 4566654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-39 Score=314.30 Aligned_cols=250 Identities=22% Similarity=0.359 Sum_probs=205.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.++|++++.||+|+||.||+|+.+. +.+.||+|.+.... ..........|..++. .++||||+++++++.+.
T Consensus 4 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~ 80 (275)
T cd05046 4 RSNLQEITTLGRGEFGEVFLAKAKGIEEEGGETLVLVKALQKTK--DENLQSEFRRELDMFR-KLSHKNVVRLLGLCREA 80 (275)
T ss_pred hHhceeeeeecccceeEEEEEEeccCCcCCCcceEEEEccCCcc--chHHHHHHHHHHHHHH-hcCCcceeeeEEEECCC
Confidence 4689999999999999999999764 34679999886532 2224456677888877 47999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC---------CCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG---------RFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~---------~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
+..|+||||+++|+ |..++.... .+++..+..++.||+.||.|||++||+
T Consensus 81 ~~~~lv~e~~~~~~---------------------L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~i~ 139 (275)
T cd05046 81 EPHYMILEYTDLGD---------------------LKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFV 139 (275)
T ss_pred CcceEEEEecCCCc---------------------HHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHHhhhcCcc
Confidence 99999999999554 444554443 689999999999999999999999999
Q ss_pred cccCCCCceeeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy8309 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPF 287 (494)
Q Consensus 210 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf 287 (494)
||||||+|||++.++.++|+|||+++...... .......++..|+|||.+.+..++.++||||||+++|+|++ |..||
T Consensus 140 H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~~~~~p~ 219 (275)
T cd05046 140 HRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQGELPF 219 (275)
T ss_pred cCcCccceEEEeCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCc
Confidence 99999999999999999999999986422111 11233456788999999998889999999999999999998 89999
Q ss_pred CCCCHHHHHHHHHhCCCC--CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 288 SGCDEDELFWSICNERPR--FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 288 ~~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
...........+..+... .+..++..+.++|.+||..+|.+|| ++.+++.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~i~~~l~~~p~~Rp------~~~~~l~ 271 (275)
T cd05046 220 YGLSDEEVLNRLQAGKLELPVPEGCPSRLYKLMTRCWAVNPKDRP------SFSELVS 271 (275)
T ss_pred cccchHHHHHHHHcCCcCCCCCCCCCHHHHHHHHHHcCCCcccCC------CHHHHHH
Confidence 887777777777755543 3557889999999999999999999 5677765
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-39 Score=318.96 Aligned_cols=262 Identities=25% Similarity=0.350 Sum_probs=199.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCC--------------eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCce
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD--------------YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYL 128 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~--------------~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I 128 (494)
...+|++.+.||+|+||.||+|++..++ ..||||.++.. ...........|..++. .++||||
T Consensus 3 ~~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~ei~~l~-~l~h~~i 79 (295)
T cd05097 3 PRQQLRLKEKLGEGQFGEVHLCEAEGLAEFLGEGAPEFDGQPVLVAVKMLRAD--VTKTARNDFLKEIKIMS-RLKNPNI 79 (295)
T ss_pred chHhCeehhccCCCCCceEEecccccchhhccccCcccCCCceEEEEEecCCC--CCHHHHHHHHHHHHHHH-hCCCCCc
Confidence 3468999999999999999999876432 35899998754 22334445667877777 5899999
Q ss_pred eeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 129 v~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
+++++++...+..|+||||+.+++|.+.+.... .............+++..+..++.||+.||.|||++|+
T Consensus 80 ~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~~~i 150 (295)
T cd05097 80 IRLLGVCVSDDPLCMITEYMENGDLNQFLSQRE---------IESTFTHANNIPSVSIANLLYMAVQIASGMKYLASLNF 150 (295)
T ss_pred CeEEEEEcCCCccEEEEecCCCCcHHHHHHhcc---------ccccccccccCCcccHHHHHHHHHHHHHHHHHHHhcCe
Confidence 999999999999999999999777633110000 00000111112347888999999999999999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh--CC
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV--GQ 284 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~--G~ 284 (494)
+||||||+|||++.++.+||+|||++........ ......+++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 151 ~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~~l~el~~~~~~ 230 (295)
T cd05097 151 VHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKE 230 (295)
T ss_pred eccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHHHHHHHHHcCCC
Confidence 9999999999999999999999999875322111 1223345778999999998899999999999999999988 77
Q ss_pred CCCCCCCHHHHHHHHHh-----CC---CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 285 SPFSGCDEDELFWSICN-----ER---PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 285 ~Pf~~~~~~~~~~~i~~-----~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
.||...+..+....+.. .. ...+..+++.+++||.+||..||.+|| ++++|+
T Consensus 231 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RP------s~~~i~ 290 (295)
T cd05097 231 QPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRP------TFNKIH 290 (295)
T ss_pred CCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCc------CHHHHH
Confidence 89988776666555432 11 223456789999999999999999999 456664
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-39 Score=313.35 Aligned_cols=248 Identities=28% Similarity=0.453 Sum_probs=203.6
Q ss_pred CceEeeEeccCCceEEEEEEEeC-CCeEEEeeeeccccc-------cChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKG-TDYYYAVKCLKKDVV-------LEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~-------~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+|++.+.||+|+||.||+|+++. +++.+|+|.+..... ...........|..++....+||||+++++++..
T Consensus 1 ~y~~~~~ig~G~~~~v~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~ 80 (269)
T cd08528 1 EYAVLEHLGSGAFGCVYKVRKKNNGQNLLALKEINVHNPAFGKDKRERDKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLE 80 (269)
T ss_pred CchhhhhhcCCCCceEEEEEEcCCCCceeeeeEeeccccccccccccchHHHHHHHHHHHHHhhcCCCCCeeeEEeeEcc
Confidence 48889999999999999999988 788899999864321 1233445566777777767899999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~ 216 (494)
++..++||||++|++|.+. +.........+++..++.++.|++.||.|||+ .|++||||+|+
T Consensus 81 ~~~~~lv~e~~~~~~l~~~-----------------l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~i~H~dl~~~ 143 (269)
T cd08528 81 NDRLYIVMDLIEGAPLGEH-----------------FNSLKEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPN 143 (269)
T ss_pred CCeEEEEEecCCCCcHHHH-----------------HHHHHhccCCCCHHHHHHHHHHHHHHHHHhccCCceeecCCCHH
Confidence 9999999999997766221 11112234578999999999999999999996 78999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|||++.++.+||+|||++....... ......|+..|+|||.+.+..++.++|+||||+++|+|++|.+||...+.....
T Consensus 144 nil~~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~~~~~~ 222 (269)
T cd08528 144 NIMLGEDDKVTITDFGLAKQKQPES-KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLA 222 (269)
T ss_pred HEEECCCCcEEEecccceeeccccc-ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccCHHHHH
Confidence 9999999999999999987533222 334567899999999999988999999999999999999999999888777777
Q ss_pred HHHHhCCCC-CC-ccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 297 WSICNERPR-FP-QFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 297 ~~i~~~~~~-~p-~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
..+...... .+ ..+++++.++|.+||+.||.+||+
T Consensus 223 ~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp~ 259 (269)
T cd08528 223 TKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPD 259 (269)
T ss_pred HHHhhccCCcCCcccCCHHHHHHHHHHCCCCCccCCC
Confidence 676655432 22 257899999999999999999994
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.81 Aligned_cols=248 Identities=23% Similarity=0.390 Sum_probs=203.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+..+|++.+.||+|+||.||+|.+.. +..+|+|.+.+.... ......|..++. .++||+|+++++++......|
T Consensus 2 ~~~~~~~~~~ig~g~~g~v~~~~~~~-~~~~~~k~~~~~~~~----~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~ 75 (256)
T cd05112 2 HPSELTLVQEIGSGQFGLVWLGYWLE-KRKVAIKTIREGAMS----EEDFIEEAQVMM-KLSHPKLVQLYGVCTERSPIC 75 (256)
T ss_pred ChhHeEEEeeecCcccceEEEEEEeC-CCeEEEEECCCCCCC----HHHHHHHHHHHH-hCCCCCeeeEEEEEccCCceE
Confidence 35689999999999999999998764 567999998754321 233556777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+.+|+ |..++.. .+.+++..++.++.|++.||+|||++|++||||||+||+++
T Consensus 76 ~v~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~h~dl~p~ni~i~ 134 (256)
T cd05112 76 LVFEFMEHGC---------------------LSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVG 134 (256)
T ss_pred EEEEcCCCCc---------------------HHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCccccccccceEEEc
Confidence 9999999554 4445544 35689999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
.++.+||+|||++........ ......++..|+|||.+.+..++.++|+|||||++|||++ |..||......++...+
T Consensus 135 ~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 214 (256)
T cd05112 135 ENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETI 214 (256)
T ss_pred CCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHH
Confidence 999999999999875322111 1112235678999999998899999999999999999998 99999988888888777
Q ss_pred HhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 300 CNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 300 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+ ....|...+.++.+|+.+||..+|.+|| +++++++
T Consensus 215 ~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp------~~~~~l~ 253 (256)
T cd05112 215 NAGFRLYKPRLASQSVYELMQHCWKERPEDRP------SFSLLLH 253 (256)
T ss_pred hCCCCCCCCCCCCHHHHHHHHHHcccChhhCC------CHHHHHH
Confidence 654 3344667899999999999999999999 5667764
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=312.39 Aligned_cols=246 Identities=24% Similarity=0.347 Sum_probs=202.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCe----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDY----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+...+|++++.||+|+||.||+|..+.++. .||+|.+.+... .........|..++. .++||||+++++++..
T Consensus 4 ~~~~~~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~~aik~~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~ 80 (279)
T cd05057 4 LKETELEKIKVLGSGAFGTVYKGVWIPEGEKVKIPVAIKVLREETS--PKANKEILDEAYVMA-SVDHPHVVRLLGICLS 80 (279)
T ss_pred cCHHHcEEcceecCCCCccEEEEEEecCCCCcceEEEEEeccCCCC--HHHHHHHHHHHHHHH-hCCCCCcceEEEEEec
Confidence 456789999999999999999999877664 589998876532 333445666777776 5799999999999987
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
...++||||+++|+ |..++.. ...+++..+..++.||+.||+|||++||+||||||+
T Consensus 81 -~~~~~v~e~~~~g~---------------------L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~di~p~ 138 (279)
T cd05057 81 -SQVQLITQLMPLGC---------------------LLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKRLVHRDLAAR 138 (279)
T ss_pred -CceEEEEecCCCCc---------------------HHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCEEecccCcc
Confidence 78999999999554 4445554 356899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcc--cccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTT--DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~--~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++......... ....++..|+|||.+....++.++|+|||||++|||++ |..||.+....
T Consensus 139 nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 218 (279)
T cd05057 139 NVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAV 218 (279)
T ss_pred eEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCCCCCCCCHH
Confidence 9999999999999999987533211111 11223568999999998899999999999999999998 99999998888
Q ss_pred HHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 294 ELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 294 ~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
++...+..+. ...|...+.++.+++.+||..||.+||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~p~~Rp~~ 258 (279)
T cd05057 219 EIPDLLEKGERLPQPPICTIDVYMVLVKCWMIDAESRPTF 258 (279)
T ss_pred HHHHHHhCCCCCCCCCCCCHHHHHHHHHHcCCChhhCCCH
Confidence 8777777553 45566788999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=315.00 Aligned_cols=245 Identities=31% Similarity=0.497 Sum_probs=199.1
Q ss_pred eEeeEeccCCceEEEEEEEe----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELK----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
++.+.||.|+||.||+|..+ ..+..|+||+++.. ...........|...+.. ++||||+++++++...+.+++
T Consensus 2 ~~~~~ig~G~fg~v~~~~~~~~~~~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~-l~h~ni~~~~g~~~~~~~~~l 78 (259)
T PF07714_consen 2 KLIKQIGEGSFGKVYRAEWKQKDNDKNQPVAVKILKPS--SSEEEEEEFLNEIQILRK-LRHPNIVKLYGFCIENEPLFL 78 (259)
T ss_dssp EEEEEEEEESSEEEEEEEEESTTTSSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHT-HSBTTBE-EEEEEESSSSEEE
T ss_pred EEeeEEccCCCcEEEEEEEEcccCCCCEEEEEEEeccc--cccccceeeeeccccccc-ccccccccccccccccccccc
Confidence 57789999999999999998 45678999999542 234446677788888874 599999999999998888999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|||||+ +|+|..++... ..+++..+..++.||+.||.|||+++++|+||++.|||++
T Consensus 79 v~e~~~---------------------~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~~~iiH~~l~~~nill~ 137 (259)
T PF07714_consen 79 VMEYCP---------------------GGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHSNNIIHGNLSPSNILLD 137 (259)
T ss_dssp EEE--T---------------------TEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEEE
T ss_pred cccccc---------------------ccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999 45556666665 6899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
.++.+||+|||++....... .......+...|+|||.+.+..++.++||||||+++|||++ |..||...+..++...
T Consensus 138 ~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~~~~~~~ 217 (259)
T PF07714_consen 138 SNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEILTLGKFPFSDYDNEEIIEK 217 (259)
T ss_dssp TTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHHHTTSSGTTTTSCHHHHHHH
T ss_pred cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 99999999999987631111 11223446778999999998889999999999999999999 7899999888888888
Q ss_pred HHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 299 ICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 299 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
+..+ ....|..++..+.++|..||..||.+|| ++++|+
T Consensus 218 ~~~~~~~~~~~~~~~~~~~li~~C~~~~p~~RP------s~~~i~ 256 (259)
T PF07714_consen 218 LKQGQRLPIPDNCPKDIYSLIQQCWSHDPEKRP------SFQEIL 256 (259)
T ss_dssp HHTTEETTSBTTSBHHHHHHHHHHT-SSGGGS--------HHHHH
T ss_pred ccccccceeccchhHHHHHHHHHHcCCChhhCc------CHHHHH
Confidence 8654 3456678999999999999999999999 566665
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-38 Score=308.83 Aligned_cols=241 Identities=26% Similarity=0.391 Sum_probs=196.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++.+.||+|+||.||+|....++ .+|+|.+..... .......|..++. .++||||+++++++. .+..|+
T Consensus 5 ~~~~~~~~~ig~g~~~~v~~~~~~~~~-~~~lK~~~~~~~----~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~~~ 77 (260)
T cd05069 5 RESLRLDVKLGQGCFGEVWMGTWNGTT-KVAIKTLKPGTM----MPEAFLQEAQIMK-KLRHDKLVPLYAVVS-EEPIYI 77 (260)
T ss_pred hHHeeeeeeecCcCCCeEEEEEEcCCc-eEEEEEcccCCc----cHHHHHHHHHHHH-hCCCCCeeeEEEEEc-CCCcEE
Confidence 467999999999999999999887665 489998865422 2234556777776 579999999998875 467899
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
||||+.+|+| ..++... ..+++..+..++.||+.||.|||++||+||||||+||+++
T Consensus 78 v~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i~H~dl~~~Nill~ 136 (260)
T cd05069 78 VTEFMGKGSL---------------------LDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVG 136 (260)
T ss_pred EEEcCCCCCH---------------------HHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccCcceEEEc
Confidence 9999995544 4444432 3578999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
.++.++|+|||++........ ......++..|+|||.+.+..++.++|+|||||++|||++ |.+||.+....+....+
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~ 216 (260)
T cd05069 137 DNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQV 216 (260)
T ss_pred CCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHH
Confidence 999999999999875322111 1122345678999999998899999999999999999999 99999998887777777
Q ss_pred HhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 300 CNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 300 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
... ....+..++..+++++.+||.+||.+||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~ 250 (260)
T cd05069 217 ERGYRMPCPQGCPESLHELMKLCWKKDPDERPTF 250 (260)
T ss_pred HcCCCCCCCcccCHHHHHHHHHHccCCcccCcCH
Confidence 654 345567789999999999999999999943
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-39 Score=316.59 Aligned_cols=256 Identities=24% Similarity=0.345 Sum_probs=194.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC----------------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCc
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG----------------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~----------------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~ 127 (494)
.++|++.+.||+|+||.||+|++.. ++..||+|++.... ..........|..++. .++|+|
T Consensus 4 ~~~~~~~~~lg~G~~g~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~a~K~~~~~~--~~~~~~~~~~E~~~l~-~l~~~~ 80 (296)
T cd05095 4 RKRLTFKEKLGEGQFGEVHLCEAEGMEKFMDKDFSLDVSGNQPVLVAVKMLREDA--NKNARNDFLKEIKIMS-RLKDPN 80 (296)
T ss_pred hhhceeeeeccCCCCCeEEecccccccccccccccccCCCCceeEEEEEeccccC--CHHHHHHHHHHHHHHH-hCCCCC
Confidence 4579999999999999999986543 34568999987542 2333455667777776 579999
Q ss_pred eeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy8309 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG 207 (494)
Q Consensus 128 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g 207 (494)
|+++++++...+.+|+||||+.+|+|.+.+... ..... ........+++..+..++.||+.||+|||++|
T Consensus 81 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~-~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 150 (296)
T cd05095 81 IIRLLAVCITSDPLCMITEYMENGDLNQFLSRH---------EPQEA-AEKADVVTISYSTLIFMATQIASGMKYLSSLN 150 (296)
T ss_pred cceEEEEEecCCccEEEEEeCCCCcHHHHHHhc---------Ccccc-cccccccccCHHHHHHHHHHHHHHHHHHHHCC
Confidence 999999999999999999999977663211000 00000 00111235788899999999999999999999
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh--C
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV--G 283 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~--G 283 (494)
|+||||||+|||++.++.++|+|||+++...... .......+++.|+|||++.+..++.++|+|||||++|||++ |
T Consensus 151 i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~l~el~~~~~ 230 (296)
T cd05095 151 FVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCK 230 (296)
T ss_pred eecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHHHHHHHHhCC
Confidence 9999999999999999999999999987432211 11223345678999999988899999999999999999998 7
Q ss_pred CCCCCCCCHHHHHHHHHh--------CCCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 284 QSPFSGCDEDELFWSICN--------ERPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 284 ~~Pf~~~~~~~~~~~i~~--------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..||...+..+....... .....|..+++.+.+|+.+||+.||.+||++
T Consensus 231 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~ 287 (296)
T cd05095 231 EQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSF 287 (296)
T ss_pred CCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCH
Confidence 899987766665543321 1123345678999999999999999999954
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=314.77 Aligned_cols=237 Identities=21% Similarity=0.318 Sum_probs=189.7
Q ss_pred eEeccCCceEEEEEEEeCCCe-------EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 71 KVLGKGSFGKVFLAELKGTDY-------YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~-------~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+.||+|+||.||+|.++.++. .||+|.+.+.. ....+....|..++. .++||||+++++++......++
T Consensus 1 ~~lg~G~~~~Vy~~~~~~~~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~-~~~h~~iv~~~~~~~~~~~~~l 76 (258)
T cd05078 1 ESLGQGTFTKIFKGIRREVGDYGELHKTEVLLKVLDKSH---RNYSESFFEAASMMS-QLSHKHLVLNYGVCVCGDESIM 76 (258)
T ss_pred CCCCcccchhheeeeecccccccccccchhhHHhhcchh---HHHHHHHHHHHHHHH-hCCCCChhheeeEEEeCCCcEE
Confidence 369999999999999866543 38888875431 223334455655555 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+++ |+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.
T Consensus 77 v~e~~~~---------------------g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiH~dlkp~nili~~ 135 (258)
T cd05078 77 VQEYVKF---------------------GSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIR 135 (258)
T ss_pred EEecCCC---------------------CcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEec
Confidence 9999994 4455556543 36899999999999999999999999999999999999987
Q ss_pred CCC--------EEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhC-CCCCCCCCH
Q psy8309 223 EGH--------VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVG-QSPFSGCDE 292 (494)
Q Consensus 223 ~g~--------vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~~ 292 (494)
++. ++++|||++... .......|++.|+|||++.+ ..++.++|||||||++|||++| .+||...+.
T Consensus 136 ~~~~~~~~~~~~~l~d~g~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 136 EEDRKTGNPPFIKLSDPGISITV----LPKEILLERIPWVPPECIENPQNLSLAADKWSFGTTLWEIFSGGDKPLSALDS 211 (258)
T ss_pred ccccccCCCceEEeccccccccc----CCchhccccCCccCchhccCCCCCCchhhHHHHHHHHHHHHcCCCCChhhccH
Confidence 765 699999987642 22334678999999999987 4589999999999999999998 577766655
Q ss_pred HHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.... .+......+|...+.++.+||.+||+.||++|| ++++|++
T Consensus 212 ~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~ 255 (258)
T cd05078 212 QKKL-QFYEDRHQLPAPKWTELANLINQCMDYEPDFRP------SFRAIIR 255 (258)
T ss_pred HHHH-HHHHccccCCCCCcHHHHHHHHHHhccChhhCC------CHHHHHH
Confidence 4433 344556677888889999999999999999999 5677764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=315.01 Aligned_cols=249 Identities=32% Similarity=0.504 Sum_probs=199.9
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC-CCceeeEEEEEEcCCeeEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK-HPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
|++.+.||+|+||.||+|+...+++.||||.+.+.... ........|...+.. +. ||||+++++++..++..|+||
T Consensus 1 y~~~~~ig~g~~g~v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~-~~~h~~i~~~~~~~~~~~~~~lv~ 77 (283)
T cd07830 1 YKVIKQLGDGTFGSVYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRK-LNEHPNIVKLKEVFRENDELYFVF 77 (283)
T ss_pred CeeheeeccCCceEEEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHh-ccCCCCchhHHHHhhcCCcEEEEE
Confidence 67889999999999999999999999999998764321 111223446666664 55 999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||+ +|+| ...+... ..+++..+..++.||+.||.|||++|++|+||+|+||+++.+
T Consensus 78 e~~-~~~l---------------------~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~i~H~dl~~~ni~i~~~ 135 (283)
T cd07830 78 EYM-EGNL---------------------YQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGP 135 (283)
T ss_pred ecC-CCCH---------------------HHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCC
Confidence 999 4444 3334433 378999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+.++|+|||++..... ........|+..|+|||++.+ ..++.++|+||||+++|||++|.+||...+..+.+.++...
T Consensus 136 ~~~~l~d~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~~~~~~~~~~~~ 214 (283)
T cd07830 136 EVVKIADFGLAREIRS-RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLYKICSV 214 (283)
T ss_pred CCEEEeecccceeccC-CCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCChHHHHHHHHHh
Confidence 9999999999875322 222334678999999998854 45889999999999999999999999887766555444321
Q ss_pred C-------------------CCC-----------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 303 R-------------------PRF-----------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 303 ~-------------------~~~-----------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
- ..+ ....+.++++||.+||..||.+|| +++|++.||||
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------t~~ei~~~~~~ 283 (283)
T cd07830 215 LGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRP------TASQALQHPYF 283 (283)
T ss_pred cCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCC------CHHHHhhCCCC
Confidence 0 000 112368899999999999999999 68999999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=307.55 Aligned_cols=247 Identities=30% Similarity=0.469 Sum_probs=204.6
Q ss_pred ceEeeEeccCCceEEEEEEEeCCC----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTD----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+++.+.||.|+||.||+|++..++ ..||+|+++... ..........|..++.. ++|+||+++++++.+.+..|
T Consensus 1 ~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~-l~~~~i~~~~~~~~~~~~~~ 77 (258)
T smart00219 1 LTLGKKLGEGAFGEVYKGTLKGLSGEKEVEVAVKTLKEDA--DEQQIEEFLREARIMRK-LDHPNIVKLLGVCTEEEPLM 77 (258)
T ss_pred CcccceeccCCCcceEEEEecCCCCCCCceEEEEEccCCC--ChHHHHHHHHHHHHHHh-cCCCchheEEEEEcCCCeeE
Confidence 457789999999999999998766 889999996542 22245566777777774 69999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++|||++++ +|..++..... +++..+..++.||+.||.|||++|++||||||+||++
T Consensus 78 ~i~e~~~~~---------------------~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~~~h~dl~~~nil~ 136 (258)
T smart00219 78 IVMEYMEGG---------------------DLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLV 136 (258)
T ss_pred EEEeccCCC---------------------CHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCCeeecccccceEEE
Confidence 999999954 44445544333 8999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCccc-ccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTD-TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~-~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
+.++.++|+|||+++.......... ...+++.|+|||.+.+..++.++|+||||+++|+|++ |.+||...+...+...
T Consensus 137 ~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~~~~~~~~~ 216 (258)
T smart00219 137 GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGMSNEEVLEY 216 (258)
T ss_pred ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999999875432211111 1236789999999988889999999999999999998 8999998888888877
Q ss_pred HHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 299 ICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 299 i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+.... ...+..++.++.+++.+||..||.+|| ++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp------t~~~ll~ 256 (258)
T smart00219 217 LKKGYRLPKPENCPPEIYKLMLQCWAEDPEDRP------TFSELVE 256 (258)
T ss_pred HhcCCCCCCCCcCCHHHHHHHHHHCcCChhhCc------CHHHHHh
Confidence 76553 345667899999999999999999999 4666654
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=307.38 Aligned_cols=242 Identities=26% Similarity=0.399 Sum_probs=198.8
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|.+.. ++.||+|++..... .........|..++. .++||||+++++++.+....|+||||+.+
T Consensus 1 ~~lg~g~~g~v~~~~~~~-~~~v~~K~~~~~~~--~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~~~~~~~v~e~~~~ 76 (251)
T cd05041 1 EKIGKGNFGDVYKGVLKG-NTEVAVKTCRSTLP--PDLKRKFLQEAEILK-QYDHPNIVKLIGVCVQKQPIYIVMELVPG 76 (251)
T ss_pred CccccCCCceEEEEEEeC-CCcEEEEeccccCC--HHHHHHHHHHHHHHH-hCCCCCeEEEEEEEecCCCeEEEEEcCCC
Confidence 469999999999999888 88999999876532 234455667777776 57999999999999999999999999984
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEe
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~ 229 (494)
++|..++.. ...+++..+..++.|++.||.|||++|++||||||+|||++.++.+||+
T Consensus 77 ---------------------~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~i~h~di~p~nili~~~~~~~l~ 135 (251)
T cd05041 77 ---------------------GSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKIS 135 (251)
T ss_pred ---------------------CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCEehhhcCcceEEEcCCCcEEEe
Confidence 445555544 3468899999999999999999999999999999999999999999999
Q ss_pred ecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCC
Q psy8309 230 DFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-RPR 305 (494)
Q Consensus 230 DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~ 305 (494)
|||+++........ .....++..|+|||.+.+..++.++|+|||||++|||++ |..||...........+... .+.
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~ 215 (251)
T cd05041 136 DFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMP 215 (251)
T ss_pred eccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCCHHHHHHHHhcCCCCC
Confidence 99998743211111 112234567999999998899999999999999999998 89999888777766666543 345
Q ss_pred CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 306 ~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.|..++.++.++|.+||..+|.+|| +++|++.
T Consensus 216 ~~~~~~~~~~~li~~~l~~~p~~Rp------~~~ell~ 247 (251)
T cd05041 216 APQLCPEEIYRLMLQCWAYDPENRP------SFSEIYN 247 (251)
T ss_pred CCccCCHHHHHHHHHHhccChhhCc------CHHHHHH
Confidence 6678899999999999999999999 5667664
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=305.99 Aligned_cols=242 Identities=26% Similarity=0.395 Sum_probs=196.8
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
++||+|+||.||+|... ++..||+|++.... ..........|..++. .++||||+++++++...+..++||||+++
T Consensus 1 ~~ig~g~~g~vy~~~~~-~~~~~a~K~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~e~~~~ 76 (250)
T cd05085 1 ELLGKGNFGEVFKGTLK-DKTPVAVKTCKEDL--PQELKIKFLSEARILK-QYDHPNIVKLIGVCTQRQPIYIVMELVPG 76 (250)
T ss_pred CccCCCCCceEEEEEec-CCcEEEEEecCCcC--CHHHHHHHHHHHHHHH-hCCCCCcCeEEEEEecCCccEEEEECCCC
Confidence 47999999999999865 57789999987542 2233345667777776 57999999999999999999999999995
Q ss_pred CCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEe
Q psy8309 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229 (494)
Q Consensus 151 g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~ 229 (494)
|+| ..++.. ...+++..+..++.||+.||.|||++|++||||||+||+++.++.+||+
T Consensus 77 ~~L---------------------~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~H~dl~p~nili~~~~~~~l~ 135 (250)
T cd05085 77 GDF---------------------LSFLRKKKDELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKIS 135 (250)
T ss_pred CcH---------------------HHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccChheEEEcCCCeEEEC
Confidence 544 444443 3468899999999999999999999999999999999999999999999
Q ss_pred ecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCC
Q psy8309 230 DFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-RPRF 306 (494)
Q Consensus 230 DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~ 306 (494)
|||++......... .....+++.|+|||++.+..++.++||||||+++|+|++ |..||.+.........+... ....
T Consensus 136 d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~ 215 (250)
T cd05085 136 DFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQAREQVEKGYRMSC 215 (250)
T ss_pred CCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCCHHHHHHHHHcCCCCCC
Confidence 99998642211111 112234678999999998889999999999999999998 99999988877776666554 3456
Q ss_pred CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 307 p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+..++.++.+++.+||..+|++|| +++|+++
T Consensus 216 ~~~~~~~~~~li~~~l~~~p~~Rp------~~~~l~~ 246 (250)
T cd05085 216 PQKCPDDVYKVMQRCWDYKPENRP------KFSELQK 246 (250)
T ss_pred CCCCCHHHHHHHHHHcccCcccCC------CHHHHHH
Confidence 677899999999999999999999 4566653
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=307.37 Aligned_cols=241 Identities=29% Similarity=0.444 Sum_probs=198.1
Q ss_pred eEeccCCceEEEEEEEeC-CC--eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEe
Q psy8309 71 KVLGKGSFGKVFLAELKG-TD--YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEY 147 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~-~~--~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 147 (494)
++||+|++|.||+|.+.. .+ ..||||++...... ........|..++. .++||||+++++.+.. ..+++||||
T Consensus 1 ~~ig~g~~~~v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~-~~~~~v~e~ 76 (257)
T cd05040 1 KKLGDGSFGVVRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMH-SLDHENLIRLYGVVLT-HPLMMVTEL 76 (257)
T ss_pred CcCCccCcccEEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHh-hcCCCCccceeEEEcC-CeEEEEEEe
Confidence 468999999999999865 33 36999999876432 45556677777776 5799999999999988 899999999
Q ss_pred cCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 148 LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 148 ~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
+++|+ |...+... ..+++..++.++.||+.||+|||++|++||||||+||+++.++.
T Consensus 77 ~~~~~---------------------L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~H~di~p~nil~~~~~~ 135 (257)
T cd05040 77 APLGS---------------------LLDRLRKDALGHFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDK 135 (257)
T ss_pred cCCCc---------------------HHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhCCccccccCcccEEEecCCE
Confidence 99554 44455443 36899999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHh
Q psy8309 226 VRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~ 301 (494)
+||+|||+++....... ......++..|+|||.+.+..++.++|+|||||++|||++ |..||...+..+....+..
T Consensus 136 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~ 215 (257)
T cd05040 136 VKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQILKKIDK 215 (257)
T ss_pred EEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHh
Confidence 99999999875432111 1123457789999999999999999999999999999998 9999988888777777664
Q ss_pred C--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 302 E--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 302 ~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
. ....|..++..+.+++.+||..+|++|| ++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~~~ 252 (257)
T cd05040 216 EGERLERPEACPQDIYNVMLQCWAHNPADRP------TFAALR 252 (257)
T ss_pred cCCcCCCCccCCHHHHHHHHHHCCCCcccCC------CHHHHH
Confidence 3 3344567889999999999999999999 456655
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=311.50 Aligned_cols=247 Identities=25% Similarity=0.371 Sum_probs=200.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+..++|++.++||+|+||.||+|.+.. ++..||+|.+... ...........|..++. .++||||+++++++..
T Consensus 3 ~~~~~~~~~~~i~~g~~g~V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~-~l~h~ni~~~~~~~~~ 79 (280)
T cd05043 3 ISRDRVTLSDLLQEGTFGRIFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLY-GLSHQNILPILHVCIE 79 (280)
T ss_pred cchhheEEeeeecccCCceEEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEec
Confidence 345789999999999999999999876 3578999988643 23445566777877776 5799999999998665
Q ss_pred -CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--------cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 138 -DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--------SGRFDEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 138 -~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--------~~~l~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
....++++||+.+|+| ..++.. ...+++..+..++.||+.||+|||++|+
T Consensus 80 ~~~~~~~~~~~~~~~~L---------------------~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~~~i 138 (280)
T cd05043 80 DGEPPFVLYPYMNWGNL---------------------KLFLQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHKRGV 138 (280)
T ss_pred CCCCCEEEEEcCCCCcH---------------------HHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 5788999999996655 223322 1468999999999999999999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCC
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQS 285 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~ 285 (494)
+||||||+|||++.++.+||+|||+++....... ......++..|+|||++.+..++.++|||||||++||+++ |.+
T Consensus 139 ~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 218 (280)
T cd05043 139 IHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQT 218 (280)
T ss_pred eecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCC
Confidence 9999999999999999999999999875322111 1122346778999999999899999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 286 PFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 286 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
||...+..++...+..+ .+..+..+++++.+++.+||..||++||++
T Consensus 219 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 266 (280)
T cd05043 219 PYVEIDPFEMAAYLKDGYRLAQPINCPDELFAVMACCWALDPEERPSF 266 (280)
T ss_pred CcCcCCHHHHHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhhCCCH
Confidence 99988877776665544 233455678999999999999999999953
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=314.43 Aligned_cols=249 Identities=14% Similarity=0.170 Sum_probs=185.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccC--hhhHH------HHHHHHHHHHhcCCCCceeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLE--DDDVE------CTLIERKVLALGTKHPYLCHLF 132 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~--~~~~~------~~~~e~~~l~~~~~hp~Iv~l~ 132 (494)
-.+|++.++||+|+||.||+|++..+ +..+|+|+........ +.... ....+...+ ..+.|++|++++
T Consensus 11 ~~~y~i~~~LG~G~fG~Vy~~~~~~~~~~~~~~~~k~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~-~~~~h~~i~~~~ 89 (294)
T PHA02882 11 GKEWKIDKLIGCGGFGCVYETQCASDHCINNQAVAKIENLENETIVMETLVYNNIYDIDKIALWKNI-HNIDHLGIPKYY 89 (294)
T ss_pred CCceEEeeEEecCCCceEEEEEEcCCcccccceEEEeccccCCchhhHHHHHHhhhhHHHHHHHHHh-ccCCCCCCCcEE
Confidence 46899999999999999999999887 6677887654321110 00000 011111122 246899999999
Q ss_pred EEEEcCC----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 133 CTFQTDS----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 133 ~~~~~~~----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
++..... ..+++||++. ..+...+.....+++..++.++.||+.||+|||++||
T Consensus 90 ~~~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 147 (294)
T PHA02882 90 GCGSFKRCRMYYRFILLEKLV----------------------ENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGI 147 (294)
T ss_pred EeeeEecCCceEEEEEEehhc----------------------cCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 8765543 3467777663 2333344444457888999999999999999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHH
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell 281 (494)
+||||||+|||++.++.++|+|||+|+...... .......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 148 iHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 148 SHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred ecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999999999999999997643211 1123457999999999999999999999999999999999
Q ss_pred hCCCCCCCCCH-H--------HHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 282 VGQSPFSGCDE-D--------ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 282 ~G~~Pf~~~~~-~--------~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
+|.+||.+... . +....+..+...+ ...++++.+++..||..+|.+|| +.++++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~rp------~~~~l~ 290 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKI-KNANKFIYDFIECVTKLSYEEKP------DYDALI 290 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhcc-CCCCHHHHHHHHHHHhCCCCCCC------CHHHHH
Confidence 99999987632 2 2233444444433 34689999999999999999999 456655
|
|
| >KOG0666|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=309.28 Aligned_cols=262 Identities=27% Similarity=0.469 Sum_probs=199.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCe----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDY----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT- 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~- 137 (494)
.+..|+++..||+|+||.||+|..+.++. .||||.++.+.. ....-....+|..++. .++||||+.|..+|.+
T Consensus 22 ~l~~ye~ig~Ig~GTYG~VykA~~~~~n~kr~k~yAiKkfk~~kd-~tGiS~SAcREiaL~R-El~h~nvi~Lv~Vfl~~ 99 (438)
T KOG0666|consen 22 DLFEYEGIGKIGRGTYGKVYKAVRKNTNDKRTKEYAIKKFKGEKD-GTGISMSACREIALLR-ELKHPNVISLVKVFLSH 99 (438)
T ss_pred HHHHhhccceecccccceeeEeeeccCCcccchhhHHHHHhccCC-CCCcCHHHHHHHHHHH-HhcCCcchhHHHHHhcc
Confidence 45689999999999999999996655432 699999976532 1122234566766665 6899999999999988
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+..++|++||.+. +|.+.+. +..-.....++...++.++.||+.|+.|||++-|+||||||.|
T Consensus 100 d~~v~l~fdYAEh-------------DL~~II~----fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~NWvlHRDLKPaN 162 (438)
T KOG0666|consen 100 DKKVWLLFDYAEH-------------DLWHIIK----FHRASKAKQLPRSMVKSILWQILDGVHYLHSNWVLHRDLKPAN 162 (438)
T ss_pred CceEEEEehhhhh-------------hHHHHHH----HhccchhccCCHHHHHHHHHHHHhhhHHHhhhheeeccCCcce
Confidence 7899999999972 2222211 0001122468999999999999999999999999999999999
Q ss_pred eeeCCC----CCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 218 ILLDYE----GHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 218 ILl~~~----g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
|||..+ |.|||+|||+++.....-. .....+-|.+|.|||.+.|. .|+.++|+||+|||+.|||+-.+.|.+
T Consensus 163 IlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIfaElLtl~PlF~g 242 (438)
T KOG0666|consen 163 ILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIFAELLTLEPLFKG 242 (438)
T ss_pred EEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHHHHHHccCccccc
Confidence 999888 8999999999986432222 23445679999999999885 599999999999999999999999976
Q ss_pred CCH---------HHHHHHHHh--CCC---------CCCc--------------------------cCCHHHHHHHHhhcc
Q psy8309 290 CDE---------DELFWSICN--ERP---------RFPQ--------------------------FLSVEAKNILVHLLD 323 (494)
Q Consensus 290 ~~~---------~~~~~~i~~--~~~---------~~p~--------------------------~~s~~~~~li~~lL~ 323 (494)
... .+.+.+|.+ +.+ .+|. .-++.+.+|+.+||+
T Consensus 243 ~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k~~~a~~LL~klL~ 322 (438)
T KOG0666|consen 243 REEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVKDPSALDLLQKLLT 322 (438)
T ss_pred hhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCCCchHHHHHHHHhc
Confidence 542 233344432 100 1121 125568999999999
Q ss_pred CCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 324 KDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 324 ~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.||.+|+ +++++++|+||..
T Consensus 323 yDP~kRI------ta~qAleh~yF~~ 342 (438)
T KOG0666|consen 323 YDPIKRI------TAEQALEHPYFTE 342 (438)
T ss_pred cCchhhc------cHHHHhccccccc
Confidence 9999999 5688999999974
|
|
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=349.96 Aligned_cols=273 Identities=29% Similarity=0.415 Sum_probs=205.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..||+.+++||+||||.||+|+++-+|+.||||.|.... .......+++|...|+ .++|||||+++..|.+...-.-
T Consensus 478 ~~DFEEL~lLGkGGFG~VvkVRNKlDGr~YAIKKIpl~~--s~~~~skI~rEVk~LA-rLnHpNVVRYysAWVEs~~~~~ 554 (1351)
T KOG1035|consen 478 LNDFEELELLGKGGFGSVVKVRNKLDGREYAIKKIPLKA--SDKLYSKILREVKLLA-RLNHPNVVRYYSAWVESTAELT 554 (1351)
T ss_pred hhhhHHHHHhcCCCCceEEEEeecccchhhhhhhccCch--HHHHHHHHHHHHHHHh-hcCCcceeeeehhhhccCCccc
Confidence 579999999999999999999999999999999998763 4556677888999998 5899999999987754322111
Q ss_pred EEEec------------------------C-------------CCCCccc----------------------c-------
Q psy8309 144 VMEYL------------------------N-------------GGDLIPA----------------------G------- 157 (494)
Q Consensus 144 v~E~~------------------------~-------------~g~L~~~----------------------~------- 157 (494)
++|-+ . .++.... +
T Consensus 555 ~~ei~~~~~~~~sQs~s~~~~~~~~~q~t~~p~~~~~~~~~~~~dd~sss~~~~~~~~~~~~d~e~~d~dedg~~~S~tS 634 (1351)
T KOG1035|consen 555 VLEIVASDSESRSQSASKYNGVDIRYQPTSSPSLTLSELDSEDEDDKSSSYTTRKASYESSTDEENDDSDEDGRNLSNTS 634 (1351)
T ss_pred cccccccchhhhcccCCCcccceeeeccCCCcccCcchhhccccCccccccccccccccccCCccccccccccccccccc
Confidence 11100 0 0000000 0
Q ss_pred -------------------chh-------------hhhhhhhHhcCCchhHHhhhcCCC-CHHHHHHHHHHHHHHHHHHH
Q psy8309 158 -------------------LTK-------------AERDLMEYLNGGDLMFHIQQSGRF-DEGRARFYAAEIVSGMRFLH 204 (494)
Q Consensus 158 -------------------~~~-------------~~~~l~~~~~gg~L~~~l~~~~~l-~e~~~~~~~~qi~~aL~yLH 204 (494)
.+. ...--|+||....+.+.+..+... ....++.+++||+.||.|+|
T Consensus 635 ~~e~~~~~d~~~ess~s~~~~~n~~e~~~~~q~~~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH 714 (1351)
T KOG1035|consen 635 DSEGSVILDDTSESSESIPKTENSSEPMVPVQKPLILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIH 714 (1351)
T ss_pred ccCCccccCcchhhhhhccccCCccccccccccceEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHH
Confidence 000 000126777776677666666554 57889999999999999999
Q ss_pred hCCCccccCCCCceeeCCCCCEEEeecCceeeee------------------ccCCcccccCCCCCccChhhhCCCC---
Q psy8309 205 KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI------------------YLDKTTDTFCGTPDYMAPEIIKGLK--- 263 (494)
Q Consensus 205 ~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~------------------~~~~~~~~~~gt~~y~aPE~l~~~~--- 263 (494)
++|||||||||.||+++++++|||+|||+++... .......+.+||.-|+|||++.+..
T Consensus 715 ~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~ 794 (1351)
T KOG1035|consen 715 DQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNK 794 (1351)
T ss_pred hCceeeccCCcceeEEcCCCCeeecccccchhhhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhccccccc
Confidence 9999999999999999999999999999997511 0111345678999999999997655
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcc----CCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 264 YNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFWSICNERPRFPQF----LSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 264 ~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~----~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
|+.++|+||||||++||+. ||.. +....++.++..+..++|.. --+..+.+|+.||+.||++|| ++
T Consensus 795 Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~iL~~LR~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRP------tA 865 (1351)
T KOG1035|consen 795 YNSKIDMYSLGIVLFEMLY---PFGTSMERASILTNLRKGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRP------TA 865 (1351)
T ss_pred ccchhhhHHHHHHHHHHhc---cCCchHHHHHHHHhcccCCCCCCcccccccchHHHHHHHHHhcCCCccCC------CH
Confidence 9999999999999999984 5754 34455666666666665522 235577899999999999999 67
Q ss_pred hhhhcCCCcC
Q psy8309 339 DDVVAHEYFR 348 (494)
Q Consensus 339 ~eil~h~~f~ 348 (494)
.|+|++.||-
T Consensus 866 ~eLL~s~llp 875 (1351)
T KOG1035|consen 866 TELLNSELLP 875 (1351)
T ss_pred HHHhhccCCC
Confidence 8999999996
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=316.54 Aligned_cols=251 Identities=24% Similarity=0.350 Sum_probs=198.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCe----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDY----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+..++|+..+.||+|+||.||+|.+..++. .||+|.+.... ..........|..++. .++||||+++++++..
T Consensus 4 ~~~~~~~~~~~lg~G~~g~vy~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~-~l~h~niv~~~~~~~~ 80 (303)
T cd05110 4 LKETELKRVKVLGSGAFGTVYKGIWVPEGETVKIPVAIKILNETT--GPKANVEFMDEALIMA-SMDHPHLVRLLGVCLS 80 (303)
T ss_pred cchhhceeccccccCCCccEEEEEEecCCCcceeeEEEEeccccC--CHHHHHHHHHHHHHHH-hCCCCCcccEEEEEcC
Confidence 456789999999999999999999887775 46888876532 2222334556666665 5799999999999875
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
. ..++++||+++|+| ..++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 81 ~-~~~~v~e~~~~g~l---------------------~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~dikp~ 138 (303)
T cd05110 81 P-TIQLVTQLMPHGCL---------------------LDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLVHRDLAAR 138 (303)
T ss_pred C-CceeeehhcCCCCH---------------------HHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCeeccccccc
Confidence 4 56799999995544 4444443 46899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++ |..||.+....
T Consensus 139 Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p~~~~~~~ 218 (303)
T cd05110 139 NVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDGIPTR 218 (303)
T ss_pred eeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999875322211 1223345778999999999999999999999999999997 99999887766
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+....+..+ .+..+...+..+.+++.+||..+|++|| +++++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~li~~c~~~~p~~Rp------~~~~l~~ 263 (303)
T cd05110 219 EIPDLLEKGERLPQPPICTIDVYMVMVKCWMIDADSRP------KFKELAA 263 (303)
T ss_pred HHHHHHHCCCCCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 555444433 3344566789999999999999999999 4566655
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >KOG1095|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-39 Score=347.71 Aligned_cols=252 Identities=27% Similarity=0.434 Sum_probs=213.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCe-----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDY-----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+.....++.+.||+|+||.||.|...+... .||||.+++. ....++..++.|..+|. ..+|||||+++|++-
T Consensus 689 v~~~~v~l~~~lG~G~FG~VY~g~~~~~~~~~~~~~vaiK~l~~~--~~~~~~~~Fl~Ea~~m~-~f~HpNiv~liGv~l 765 (1025)
T KOG1095|consen 689 VPRKNVTLLRVLGKGAFGEVYEGTYSDVPGSVSPIQVAVKSLKRL--SSEQEVSDFLKEALLMS-KFDHPNIVSLIGVCL 765 (1025)
T ss_pred CChhheEeeeeeccccccceEEEEEecCCCCccceEEEEEecccc--CCHHHHHHHHHHHHHHh-cCCCcceeeEEEeec
Confidence 445678899999999999999999875433 3899988764 56677778888888877 689999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-------GRFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
+....+|++|||+ ||+|..++++. ..++..+...++.||+.|++||+++++|
T Consensus 766 ~~~~~~i~leyM~---------------------gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G~~YLe~~~fv 824 (1025)
T KOG1095|consen 766 DSGPPLILLEYME---------------------GGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKGMNYLESKHFV 824 (1025)
T ss_pred CCCCcEEEehhcc---------------------cCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhhhHHHHhCCCc
Confidence 9999999999999 55556666654 4688999999999999999999999999
Q ss_pred cccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCC--CCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCC
Q psy8309 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG--TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSP 286 (494)
Q Consensus 210 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~P 286 (494)
||||...|+||+....|||+|||+|+.....+.....-.+ ...|||||.+....++.++|||||||+|||+++ |..|
T Consensus 825 HRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFGVllWEifslG~~P 904 (1025)
T KOG1095|consen 825 HRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFGVLLWEIFSLGATP 904 (1025)
T ss_pred CcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhHHHHHHHHhCCCCC
Confidence 9999999999999999999999999943222222222122 248999999999999999999999999999998 9999
Q ss_pred CCCCCHHHHHHHH-HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 287 FSGCDEDELFWSI-CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 287 f~~~~~~~~~~~i-~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
|.+.+..+++.-. ..+++..|.++++.+.++|..||+.+|++|| +...|++
T Consensus 905 Y~~~~n~~v~~~~~~ggRL~~P~~CP~~ly~lM~~CW~~~pe~RP------~F~~i~~ 956 (1025)
T KOG1095|consen 905 YPSRSNFEVLLDVLEGGRLDPPSYCPEKLYQLMLQCWKHDPEDRP------SFRTIVE 956 (1025)
T ss_pred CCCcchHHHHHHHHhCCccCCCCCCChHHHHHHHHHccCChhhCc------cHHHHHh
Confidence 9999988888744 4568888999999999999999999999999 4556665
|
|
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=308.41 Aligned_cols=244 Identities=24% Similarity=0.361 Sum_probs=198.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
...+|.+.+.||+|+||.||+|.+... ...||||...... .....+....|..++. .++||||+++++++.+ .
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~v~ik~~~~~~--~~~~~~~~~~e~~~l~-~~~h~~i~~~~~~~~~-~ 79 (270)
T cd05056 4 QREDITLGRCIGEGQFGDVYQGVYMSPENEKIAVAVKTCKNCT--SPSVREKFLQEAYIMR-QFDHPHIVKLIGVITE-N 79 (270)
T ss_pred chhhceeeeeeCCccceeEEEEEEecCCCCCcceEEEecCCcC--CHHHHHHHHHHHHHHH-hCCCCchhceeEEEcC-C
Confidence 346799999999999999999987654 4468999886542 2334455666777766 5789999999998875 5
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..|+||||+++| +|..++.+. ..+++..+..++.||+.||+|||++|++||||||+||
T Consensus 80 ~~~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~H~dl~p~ni 138 (270)
T cd05056 80 PVWIVMELAPLG---------------------ELRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNV 138 (270)
T ss_pred CcEEEEEcCCCC---------------------cHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccChheE
Confidence 678999999954 445555543 3589999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
|++.++.+||+|||+++........ .....+++.|+|||.+.+..++.++|+|||||++|||++ |..||.+.+..+..
T Consensus 139 li~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~ 218 (270)
T cd05056 139 LVSSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPFQGVKNNDVI 218 (270)
T ss_pred EEecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCCCCCCCCHHHHH
Confidence 9999999999999998753322111 112234568999999998899999999999999999996 99999988877777
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
..+..+ .+..|..++.+++++|.+||..+|.+||+
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt 254 (270)
T cd05056 219 GRIENGERLPMPPNCPPTLYSLMTKCWAYDPSKRPR 254 (270)
T ss_pred HHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCcC
Confidence 776654 45667788999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >KOG1006|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-41 Score=307.42 Aligned_cols=267 Identities=25% Similarity=0.402 Sum_probs=217.3
Q ss_pred CCCCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 58 RFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 58 ~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+...+..++.+-+..||.|+||+|++-.++.+|+..|||.++... .+.+..+.+.|.....+..++||||+++|..-.
T Consensus 57 ~~~~F~~~~Lqdlg~iG~G~fG~V~KM~hk~sg~~mAVKrIr~~n--~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~ 134 (361)
T KOG1006|consen 57 HLHTFTSDNLQDLGEIGNGAFGTVNKMLHKPSGKLMAVKRIRSNN--IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFS 134 (361)
T ss_pred cccccccchHHHHHHhcCCcchhhhhhhcCccCcEEEEEEeeecc--chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhc
Confidence 344667778888899999999999999999999999999998653 345666788888887778899999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~ 216 (494)
++..++.||+|. .++-.+. ...+..++..++|..+-.+....+.||.||... .|||||+||.
T Consensus 135 EGdcWiCMELMd-------------~SlDklY----k~vy~vq~~~ipE~Ilg~ItvatV~AL~yLK~~lkiIHRDvKPS 197 (361)
T KOG1006|consen 135 EGDCWICMELMD-------------ISLDKLY----KRVYSVQKSRIPENILGHITVATVDALDYLKEELKIIHRDVKPS 197 (361)
T ss_pred CCceeeeHHHHh-------------hhHHHHH----HHHHHHHhccCcHhhhhheeeeehhHHHHHHHHhhhhhccCChh
Confidence 999999999986 1111110 011334567899999999999999999999865 8999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC--CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK--GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-ED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~ 293 (494)
|||++..|.|||||||+|-... .......-.|-..|||||.+. +.+|+.++|+||||++|||+.||..||.+-+ ..
T Consensus 198 NILldr~G~vKLCDFGIcGqLv-~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~svf 276 (361)
T KOG1006|consen 198 NILLDRHGDVKLCDFGICGQLV-DSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDSVF 276 (361)
T ss_pred heEEecCCCEeeecccchHhHH-HHHHhhhccCCccccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHHHH
Confidence 9999999999999999986432 222233446888999999995 4579999999999999999999999998754 44
Q ss_pred HHHHHHHhCCCCC---Cc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 294 ELFWSICNERPRF---PQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 294 ~~~~~i~~~~~~~---p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+.+..++.+.++. +. .++..++.+|.-||.+|-..|| ..++++++||++..
T Consensus 277 eql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rp------ky~~Lk~~~fyr~y 333 (361)
T KOG1006|consen 277 EQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRP------KYDDLKKFPFYRMY 333 (361)
T ss_pred HHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCc------chhhhhcCchhhhh
Confidence 5566667776543 22 3789999999999999999999 57899999999743
|
|
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=304.76 Aligned_cols=242 Identities=26% Similarity=0.406 Sum_probs=197.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++.+.||+|+||.||+|.... +..+|+|.+... .........|..++. .++|+||+++++.+.. ...
T Consensus 3 ~~~~~~~~~~~lg~g~~~~vy~~~~~~-~~~~~iK~~~~~----~~~~~~~~~e~~~l~-~l~~~~i~~~~~~~~~-~~~ 75 (260)
T cd05073 3 IPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPG----SMSVEAFLAEANVMK-TLQHDKLVKLHAVVTK-EPI 75 (260)
T ss_pred ccccceeEEeEecCccceEEEEEEecC-CccEEEEecCCC----hhHHHHHHHHHHHHH-hcCCCCcceEEEEEcC-CCe
Confidence 346789999999999999999998654 445999988753 223345666777776 5799999999999988 788
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
|++|||+++|+ |..++.. ...+++..+..++.||+.||.|||++|++||||||+||+
T Consensus 76 ~~v~e~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ni~ 134 (260)
T cd05073 76 YIITEFMAKGS---------------------LLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANIL 134 (260)
T ss_pred EEEEEeCCCCc---------------------HHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEE
Confidence 99999999554 4444543 345788899999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||++........ ......++..|+|||++.+..++.++|+|||||++|+|++ |.+||.+.+...+..
T Consensus 135 i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~~~~~~ 214 (260)
T cd05073 135 VSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIR 214 (260)
T ss_pred EcCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 99999999999999875322111 1122345678999999998889999999999999999998 999999888777777
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
.+... ....+...+.++.+++.+||..+|++||+
T Consensus 215 ~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~ 249 (260)
T cd05073 215 ALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT 249 (260)
T ss_pred HHhCCCCCCCcccCCHHHHHHHHHHcccCcccCcC
Confidence 66654 23445678899999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=305.86 Aligned_cols=243 Identities=25% Similarity=0.375 Sum_probs=191.6
Q ss_pred eEeccCCceEEEEEEEeC---CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE-cCCeeEEEEE
Q psy8309 71 KVLGKGSFGKVFLAELKG---TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ-TDSHLFFVME 146 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~-~~~~~~lv~E 146 (494)
+.||+|+||.||+|.... .+..||||.+... ...........|..++. .++||||+++++++. .++..|+|||
T Consensus 1 ~~lg~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~lv~e 77 (262)
T cd05058 1 RVIGKGHFGCVYHGTLIDSDGQKIHCAVKSLNRI--TDLEEVEQFLKEGIIMK-DFSHPNVLSLLGICLPSEGSPLVVLP 77 (262)
T ss_pred CcccccCCceEEEEEEecCCCceEEEEEEecCcc--CCHHHHHHHHHHHHHHc-cCCCCCcceEEEEeecCCCCcEEEEe
Confidence 468999999999998754 3457999988542 22334455666777665 589999999999765 4567899999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|+.+|+ |..++... ..+++..+..++.||+.||.|||++||+||||||+|||++.++.
T Consensus 78 ~~~~~~---------------------L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlk~~nili~~~~~ 136 (262)
T cd05058 78 YMKHGD---------------------LRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFT 136 (262)
T ss_pred cCCCCC---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccccCcceEEEcCCCc
Confidence 999554 44455443 45677888899999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccC----CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHH
Q psy8309 226 VRIADFGMCKLQIYLD----KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 226 vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~ 300 (494)
+||+|||+++...... .......+++.|+|||.+.+..++.++|||||||++|||++ |.+||...+..++...+.
T Consensus 137 ~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~~~~~~~~~ 216 (262)
T cd05058 137 VKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLL 216 (262)
T ss_pred EEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHh
Confidence 9999999987432111 11123346778999999998899999999999999999999 677888877777776666
Q ss_pred hCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 301 NER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 301 ~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+. +..+..++..+.+++.+||..+|++|| ++.++++
T Consensus 217 ~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------~~~~il~ 254 (262)
T cd05058 217 QGRRLLQPEYCPDPLYEVMLSCWHPKPEMRP------TFSELVS 254 (262)
T ss_pred cCCCCCCCCcCCHHHHHHHHHHcCCChhhCC------CHHHHHH
Confidence 543 445667889999999999999999999 4566654
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=310.70 Aligned_cols=246 Identities=25% Similarity=0.352 Sum_probs=189.9
Q ss_pred Cc-eEeeEeccCCceEEEEEEE----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--
Q psy8309 66 DF-QLLKVLGKGSFGKVFLAEL----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-- 138 (494)
Q Consensus 66 ~y-~~~~~LG~G~fG~V~~~~~----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-- 138 (494)
+| ++++.||+|+||+||++.. ..++..||+|+++... ..........|..++. .++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 80 (283)
T cd05080 4 RYLKKIRVLGEGHFGKVSLYCYDPANDGTGEMVAVKTLKREC--GQQNTSGWKKEINILK-TLYHENIVKYKGCCSEQGG 80 (283)
T ss_pred hhceeceecccCCCcEEEEeeEccccCCCCceEEEEEecccc--ChHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCC
Confidence 44 8999999999999988753 3567889999987542 2223345566777776 57999999999987653
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+|+||||+++|+ |..++.. ..+++.+++.++.||+.||.|||++||+||||||+||
T Consensus 81 ~~~~lv~e~~~~~~---------------------l~~~~~~-~~l~~~~~~~i~~~l~~~l~~lH~~~i~H~dlkp~Ni 138 (283)
T cd05080 81 KGLQLIMEYVPLGS---------------------LRDYLPK-HKLNLAQLLLFAQQICEGMAYLHSQHYIHRDLAARNV 138 (283)
T ss_pred ceEEEEecCCCCCC---------------------HHHHHHH-cCCCHHHHHHHHHHHHHHHHHHHHCCeeccccChheE
Confidence 46899999999554 4444443 4699999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH--
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-- 293 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-- 293 (494)
|++.++.+||+|||+++....... ......++..|+|||.+.+..++.++|||||||++|||++|..||......
T Consensus 139 li~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~~~ 218 (283)
T cd05080 139 LLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYELLTHCDSKQSPPKKFE 218 (283)
T ss_pred EEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHHHhCCCCCCCCcchhh
Confidence 999999999999999875322111 112234567799999999889999999999999999999999998643211
Q ss_pred HH------------HHHHHh--CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 294 EL------------FWSICN--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 294 ~~------------~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
+. ...... .....|..++.++++++.+||..||++||+ +++++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rps------~~~i~ 275 (283)
T cd05080 219 EMIGPKQGQMTVVRLIELLERGMRLPCPKNCPQEVYILMKNCWETEAKFRPT------FRSLI 275 (283)
T ss_pred hhhcccccccchhhhhhhhhcCCCCCCCCCCCHHHHHHHHHHhccChhhCCC------HHHHH
Confidence 00 111111 122345678899999999999999999994 55555
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=308.16 Aligned_cols=238 Identities=19% Similarity=0.277 Sum_probs=184.6
Q ss_pred eEeccCCceEEEEEEEeCC------------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 71 KVLGKGSFGKVFLAELKGT------------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~------------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+.||+|+||.||+|+.... ...+|+|++... ..........|..++. .++||||+++++++..+
T Consensus 1 ~~lg~G~~~~vy~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~---~~~~~~~~~~~~~~l~-~l~hp~iv~~~~~~~~~ 76 (262)
T cd05077 1 EHLGRGTRTQIYAGILNYKDDDEDDGYSYEKEIKVILKVLDPS---HRDISLAFFETASMMR-QVSHKHIVLLYGVCVRD 76 (262)
T ss_pred CccccCCcceEeeeecccCCCccccccchhhceeEEEeecChh---hhhHHHHHHHHHHHHH-hCCCCCEeeEEEEEecC
Confidence 3689999999999985322 235788887653 1222233444445554 67999999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
...++||||+++|+ |..++.. .+.+++..+..++.||+.||+|||++||+||||||+|
T Consensus 77 ~~~~lv~e~~~~~~---------------------l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~N 135 (262)
T cd05077 77 VENIMVEEFVEFGP---------------------LDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDKDLVHGNVCTKN 135 (262)
T ss_pred CCCEEEEecccCCC---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhCCeECCCCCccc
Confidence 99999999999554 4444443 4579999999999999999999999999999999999
Q ss_pred eeeCCCCC-------EEEeecCceeeeeccCCcccccCCCCCccChhhhC-CCCCCCcchHHHHHHHHHHHH-hCCCCCC
Q psy8309 218 ILLDYEGH-------VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-GLKYNQCVDWWSFGILLYEMH-VGQSPFS 288 (494)
Q Consensus 218 ILl~~~g~-------vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell-~G~~Pf~ 288 (494)
||++.++. ++++|||++.... ......|+..|+|||.+. +..++.++|||||||++|||+ .|..||.
T Consensus 136 ill~~~~~~~~~~~~~~l~d~g~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~ 211 (262)
T cd05077 136 ILLAREGIDGECGPFIKLSDPGIPITVL----SRQECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWEICYNGEIPLK 211 (262)
T ss_pred EEEecCCccCCCCceeEeCCCCCCcccc----CcccccccccccChhhhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCC
Confidence 99987764 8999999886422 223456889999999987 567899999999999999998 5899998
Q ss_pred CCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 289 GCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.....+.. .+...........+.++++||.+||+.||.+|| +..+|+.+
T Consensus 212 ~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp------~~~~il~~ 260 (262)
T cd05077 212 DKTLAEKE-RFYEGQCMLVTPSCKELADLMTHCMNYDPNQRP------FFRAIMRD 260 (262)
T ss_pred CcchhHHH-HHHhcCccCCCCChHHHHHHHHHHcCCChhhCc------CHHHHHHh
Confidence 76554433 233333344444578899999999999999999 56777654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >KOG2345|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-40 Score=300.24 Aligned_cols=256 Identities=23% Similarity=0.313 Sum_probs=201.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC---
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD--- 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~--- 138 (494)
++-++|.+.+.||+|||+.||+++...++..||+|.+.-. ..+..+..++|..... ..+||||++++++...+
T Consensus 18 In~~Ryri~~~LgeGGfsfv~LV~~~s~~~~YAlKkI~c~---~~~~~e~~~rEid~~r-kf~s~~vl~l~dh~l~~~~D 93 (302)
T KOG2345|consen 18 INNKRYRIQRLLGEGGFSFVDLVKGLSTGHLYALKKILCH---SQEDIEEALREIDNHR-KFNSPNVLRLVDHQLREEKD 93 (302)
T ss_pred EcCceEEEeeeecCCCceeeeeecccCcccchhhheeecc---chHHHHHHHHHHHHHH-hhCCcchHHHHHHHHHhhcc
Confidence 3456899999999999999999999999999999998754 3456777888888877 58999999998775433
Q ss_pred --CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCC
Q psy8309 139 --SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLK 214 (494)
Q Consensus 139 --~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLK 214 (494)
...||++.|...|+|.+. +.....+...++|.++..|+.+|+.||++||+.. ++|||||
T Consensus 94 ~~~~~yll~Pyy~~Gsl~d~-----------------i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~~~yAH~DiK 156 (302)
T KOG2345|consen 94 GKHEAYLLLPYYKRGSLLDE-----------------IERLKIKGNFVSEAQILWIFLGICRGLEALHEKEPPYAHRDIK 156 (302)
T ss_pred CceeEEEEeehhccccHHHH-----------------HHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccCCcccccCCC
Confidence 349999999997776321 1111223347999999999999999999999998 9999999
Q ss_pred CCceeeCCCCCEEEeecCceeeee---ccCCc------ccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHh
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQI---YLDKT------TDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHV 282 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~---~~~~~------~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~ 282 (494)
|.|||+...+.++|.|||.+.... ..... -..-..|..|.|||.+.- ...+.++|||||||+||+|+.
T Consensus 157 P~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf 236 (302)
T KOG2345|consen 157 PANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMF 236 (302)
T ss_pred cceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHH
Confidence 999999999999999999875421 11100 012236889999999864 446789999999999999999
Q ss_pred CCCCCCCCC--HHHHHHHHHhCCCCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 283 GQSPFSGCD--EDELFWSICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 283 G~~Pf~~~~--~~~~~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
|..||.-.- ...+...+.++++.+|. .+|+.+.+||+.||+.||.+|| ++.+++.+
T Consensus 237 ~~sPfe~~~~~GgSlaLAv~n~q~s~P~~~~yse~l~~lik~mlqvdP~qRP------~i~~ll~~ 296 (302)
T KOG2345|consen 237 GESPFERIYQQGGSLALAVQNAQISIPNSSRYSEALHQLIKSMLQVDPNQRP------TIPELLSK 296 (302)
T ss_pred cCCcchHHhhcCCeEEEeeeccccccCCCCCccHHHHHHHHHHhcCCcccCC------CHHHHHHH
Confidence 999996321 11223345666777774 4899999999999999999999 45666643
|
|
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=308.39 Aligned_cols=242 Identities=24% Similarity=0.405 Sum_probs=196.0
Q ss_pred eEeccCCceEEEEEEEeCCC------eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 71 KVLGKGSFGKVFLAELKGTD------YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~------~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.||+|+||.||+|+.+... ..||||.+.+.. ..........|..++. .++||||+++++++......|+|
T Consensus 1 ~~lg~g~~g~vy~~~~~~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~v 77 (269)
T cd05044 1 NFLGSGAFGEVYEGTATDILGPGSGPIRVAVKTLRKGA--TDQEKKEFLKEAHLMS-NFNHPNIVKLLGVCLLNEPQYII 77 (269)
T ss_pred CccccccceeEEeeeecccccCcccceeehhhhhhccc--chhhHHHHHHHHHHHH-hcCCCCeeeEeeeecCCCCeEEE
Confidence 36999999999999987544 679999986542 1233445566777776 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-------QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-------~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
|||+++|+| ..++. ....+++..+..++.||+.||.|||+++++|+||||+|
T Consensus 78 ~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~H~dl~p~n 136 (269)
T cd05044 78 MELMEGGDL---------------------LSYLRDARVERFGPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARN 136 (269)
T ss_pred EeccCCCcH---------------------HHHHHHhhhcccCCccccHHHHHHHHHHHHHHHHHHHhCCcccCCCChhe
Confidence 999996655 33332 22357889999999999999999999999999999999
Q ss_pred eeeCCCC-----CEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy8309 218 ILLDYEG-----HVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289 (494)
Q Consensus 218 ILl~~~g-----~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~ 289 (494)
|+++.++ .++|+|||+++...... .......++..|+|||.+.+..++.++|||||||++|||++ |..||..
T Consensus 137 il~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~ 216 (269)
T cd05044 137 CLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPA 216 (269)
T ss_pred EEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcc
Confidence 9999887 89999999987432111 11223346788999999999899999999999999999998 9999988
Q ss_pred CCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 290 CDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 290 ~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
.+..+....+..+ .+..+..++..+.++|.+||..+|.+|| ++++++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------~~~~i~ 264 (269)
T cd05044 217 LNNQEVLQHVTAGGRLQKPENCPDKIYQLMTNCWAQDPSERP------TFDRIQ 264 (269)
T ss_pred cCHHHHHHHHhcCCccCCcccchHHHHHHHHHHcCCCcccCC------CHHHHH
Confidence 8777777666543 4566778899999999999999999999 455554
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=304.99 Aligned_cols=236 Identities=26% Similarity=0.446 Sum_probs=194.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||++.. +++.||+|.++... .......|..++. .++||||+++++++..+ ..|
T Consensus 4 ~~~~~~~~~~lg~g~~g~v~~~~~--~~~~~~iK~~~~~~-----~~~~~~~e~~~l~-~~~~~~i~~~~~~~~~~-~~~ 74 (254)
T cd05083 4 NLQKLTLGEIIGEGEFGAVLQGEY--TGQKVAVKNIKCDV-----TAQAFLEETAVMT-KLHHKNLVRLLGVILHN-GLY 74 (254)
T ss_pred cHHHceeeeeeccCCCCceEeccc--CCCceEEEeecCcc-----hHHHHHHHHHHHH-hCCCCCcCeEEEEEcCC-CcE
Confidence 356899999999999999999864 66779999986531 2245566777776 57999999999998764 579
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+||||+.+|+ |..++... ..+++..+..++.||+.||.|||++|++||||||+||++
T Consensus 75 ~v~e~~~~~~---------------------L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~H~dl~p~nili 133 (254)
T cd05083 75 IVMELMSKGN---------------------LVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKKLVHRDLAARNILV 133 (254)
T ss_pred EEEECCCCCC---------------------HHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccccCcceEEE
Confidence 9999999554 44455433 358899999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
+.++.+||+|||+++.... .......+..|+|||.+.+..++.++|+|||||++|||++ |.+||...+..+....+
T Consensus 134 ~~~~~~kl~Dfg~~~~~~~---~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~~ 210 (254)
T cd05083 134 SEDGVAKVSDFGLARVGSM---GVDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPYPKMSLKEVKECV 210 (254)
T ss_pred cCCCcEEECCCccceeccc---cCCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCCCCccCCHHHHHHHH
Confidence 9999999999999875221 1222334678999999998899999999999999999997 99999988887777776
Q ss_pred HhC-CCCCCccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 300 CNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 300 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
..+ .+..+..++.++.+++.+||..+|.+||+
T Consensus 211 ~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~ 243 (254)
T cd05083 211 EKGYRMEPPEGCPADVYVLMTSCWETEPKKRPS 243 (254)
T ss_pred hCCCCCCCCCcCCHHHHHHHHHHcCCChhhCcC
Confidence 654 23445678999999999999999999994
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=310.08 Aligned_cols=237 Identities=21% Similarity=0.316 Sum_probs=185.8
Q ss_pred EeccCCceEEEEEEEeCC------------------------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCc
Q psy8309 72 VLGKGSFGKVFLAELKGT------------------------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~~~~------------------------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~ 127 (494)
.||+|+||.||+|....+ ...||+|++.... .........|..++. .++|||
T Consensus 2 ~lG~G~~~~vy~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~---~~~~~~~~~~~~~~~-~l~h~n 77 (274)
T cd05076 2 HLGQGTRTNIYDGRLRVEGGGEPEEDEMEDEDPLVEGNNNGRELRVVLKVLDPSH---RDIALAFFETASLMS-QVSHIH 77 (274)
T ss_pred CcCcccccceecceeEeccCCCCcccccccccccccccCCCeeeeEEEEecChHH---HHHHHHHHHHHHHHh-cCCCCC
Confidence 599999999999975322 2358888886431 222334444555554 689999
Q ss_pred eeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 128 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
|+++++++......|+||||+++|+ |...+.. .+.+++..+..++.||+.||+|||++
T Consensus 78 iv~~~~~~~~~~~~~lv~ey~~~g~---------------------L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 136 (274)
T cd05076 78 LAFVHGVCVRGSENIMVEEFVEHGP---------------------LDVCLRKEKGRVPVAWKITVAQQLASALSYLEDK 136 (274)
T ss_pred eeeEEEEEEeCCceEEEEecCCCCc---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcC
Confidence 9999999999999999999999554 4445543 46789999999999999999999999
Q ss_pred CCccccCCCCceeeCCCC-------CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHH
Q psy8309 207 GIVYRDLKLDNILLDYEG-------HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLY 278 (494)
Q Consensus 207 givHrDLKp~NILl~~~g-------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ 278 (494)
||+||||||+|||++..+ .+||+|||++.... ......++..|+|||.+.+ ..++.++|+|||||++|
T Consensus 137 ~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~----~~~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~ 212 (274)
T cd05076 137 NLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTAL----SREERVERIPWIAPECVPGGNSLSTAADKWSFGTTLL 212 (274)
T ss_pred CccCCCCCcccEEEeccCcccCccceeeecCCccccccc----cccccccCCcccCchhhcCCCCCCcHHHHHHHHHHHH
Confidence 999999999999998654 48999999876422 1223457889999999875 56899999999999999
Q ss_pred HHH-hCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 279 EMH-VGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 279 ell-~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
||+ +|..||.+....+... +......+|...++++.++|.+||+.+|.+|| ++++|+++
T Consensus 213 el~~~g~~p~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------s~~~il~~ 272 (274)
T cd05076 213 EICFDGEVPLKERTPSEKER-FYEKKHRLPEPSCKELATLISQCLTYEPTQRP------SFRTILRD 272 (274)
T ss_pred HHHhCCCCCccccChHHHHH-HHHhccCCCCCCChHHHHHHHHHcccChhhCc------CHHHHHHh
Confidence 995 6999998876655433 33444556666778999999999999999999 56777753
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-38 Score=306.83 Aligned_cols=237 Identities=22% Similarity=0.327 Sum_probs=182.4
Q ss_pred eEeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 71 KVLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
+.||+|+||.||+|.... ....+|+|.+.... ..........|..++. .++||||+++++.+.....+|+||||+
T Consensus 1 ~~lg~G~fg~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~-~l~h~nii~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05042 1 DEIGNGWFGKVLLGEAHRGMSKARVVVKELRASA--TPDEQLLFLQEVQPYR-ELNHPNVLQCLGQCIESIPYLLVLEFC 77 (269)
T ss_pred CcCCccCCceEEEEEEecCCCCeEEEEeecCccC--ChHHHHHHHHHHHHHH-hCCCCCcceEEEEECCCCceEEEEEeC
Confidence 369999999999997543 34568888775432 2233344556766665 579999999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhhc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-----GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-----~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
++|+| ..++... ..+++..+..++.||+.||+|||++||+||||||+|||++.+
T Consensus 78 ~~g~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nill~~~ 136 (269)
T cd05042 78 PLGDL---------------------KNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTAD 136 (269)
T ss_pred CCCcH---------------------HHHHHhccccccccccHHHHHHHHHHHHHHHHHHHhcCEecccccHhheEecCC
Confidence 96554 3444332 235678889999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 224 GHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKG-------LKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
+.+||+|||++........ ......+++.|+|||++.. ..++.++|||||||++|||++ |..||......
T Consensus 137 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~ 216 (269)
T cd05042 137 LSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDE 216 (269)
T ss_pred CcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHHHHHHHHhCCCCCCCcCCHH
Confidence 9999999999864222111 1233456778999999753 357889999999999999999 88999887766
Q ss_pred HHHHHHHhC-CC-----CCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 294 ELFWSICNE-RP-----RFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 294 ~~~~~i~~~-~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+....+... .. .++..++....+++..|+ .||++||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~ 260 (269)
T cd05042 217 QVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTA 260 (269)
T ss_pred HHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCH
Confidence 666555433 22 234468899999999999 599999954
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=310.10 Aligned_cols=249 Identities=25% Similarity=0.338 Sum_probs=194.6
Q ss_pred CCceEeeEeccCCceEEEEEEE----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAEL----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-- 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-- 138 (494)
.-|++++.||+|+||.||+|+. +.++..||+|.++... ..........|..++. .++||||+++++++...
T Consensus 4 ~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 80 (284)
T cd05079 4 RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILR-NLYHENIVKYKGICTEDGG 80 (284)
T ss_pred hhhhhceecCCCCceeEEEEEEccCCCCccceEEEEEcCccc--cHHHHHHHHHHHHHHH-hCCCCCeeeeeeEEecCCC
Confidence 3578999999999999999985 4568889999987542 2334455667777776 57999999999998875
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
...++||||++|| +|..++.+. ..+++..+..++.||+.||+|||++||+||||||+|
T Consensus 81 ~~~~lv~e~~~g~---------------------~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH~~gi~H~dlkp~N 139 (284)
T cd05079 81 NGIKLIMEFLPSG---------------------SLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARN 139 (284)
T ss_pred CceEEEEEccCCC---------------------CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccchhe
Confidence 5789999999954 445555443 368999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD--- 291 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~--- 291 (494)
|+++.++.++|+|||++........ ......|+..|+|||++.+..++.++|||||||++|||++|..|+....
T Consensus 140 il~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ellt~~~~~~~~~~~~ 219 (284)
T cd05079 140 VLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLF 219 (284)
T ss_pred EEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhhhhhcCCCCCccccchh
Confidence 9999999999999999875322111 1234567788999999998899999999999999999999877653211
Q ss_pred ------------HHHHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 ------------EDELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ------------~~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.......+.. .....+..++.++.+||.+||+.||.+|| +++++++
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~il~ 278 (284)
T cd05079 220 LKMIGPTHGQMTVTRLVRVLEEGKRLPRPPNCPEEVYQLMRKCWEFQPSKRT------TFQNLIE 278 (284)
T ss_pred hhhcccccccccHHHHHHHHHcCccCCCCCCCCHHHHHHHHHHccCCcccCc------CHHHHHH
Confidence 0111111111 22344567899999999999999999999 5667764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >KOG0587|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-39 Score=334.93 Aligned_cols=256 Identities=27% Similarity=0.488 Sum_probs=219.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-----CC
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-----DS 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-----~~ 139 (494)
+.|++.++||.|.+|+||+++++.+++..|+|++.... +.-+.+..|..++.....|||++.++++|.- ++
T Consensus 19 d~~ei~evig~Gtygkv~k~k~~~~~~~aa~kI~~~~~----d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~D 94 (953)
T KOG0587|consen 19 DIFEIIEVIGNGTYGKVYKGRHVKTGQLAAIKIMDPTE----DEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGD 94 (953)
T ss_pred CccEEEEEEeeccceeEEEEeeeecCceeeeEeecCCc----cccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCC
Confidence 57999999999999999999999999999999987542 2334556788888888899999999999873 56
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.++||||||.||+..| ..+ -+. ..++.|..+..+++.++.||.+||.+.++|||||-.|||
T Consensus 95 qLWLVMEfC~gGSVTD------------LVK------n~~-g~rl~E~~IaYI~re~lrgl~HLH~nkviHRDikG~NiL 155 (953)
T KOG0587|consen 95 QLWLVMEFCGGGSVTD------------LVK------NTK-GNRLKEEWIAYILREILRGLAHLHNNKVIHRDIKGQNVL 155 (953)
T ss_pred eEEEEeeccCCccHHH------------HHh------hhc-ccchhhHHHHHHHHHHHHHHHHHhhcceeeecccCceEE
Confidence 8999999999776522 111 111 568999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
++.+|.|||+|||++...........+.+|||.|||||++... .|+..+|+||||++..||.-|.+|+-+..+..
T Consensus 156 LT~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 156 LTENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred EeccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 9999999999999999877777788899999999999999643 48889999999999999999999999988877
Q ss_pred HHHHHHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 295 LFWSICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 295 ~~~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+..|-...+ .-|...+.++.++|..||.+|-.+|| ...+++.|||...
T Consensus 236 aLF~IpRNPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP------~~~~ll~hpFi~e 287 (953)
T KOG0587|consen 236 ALFLIPRNPPPKLKRPKKWSKKFNDFISTCLVKDYEQRP------STEELLKHPFITE 287 (953)
T ss_pred hhccCCCCCCccccchhhHHHHHHHHHHHHHhhccccCc------chhhhccCCcccc
Confidence 7766655432 23567899999999999999999999 5788999999974
|
|
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=305.37 Aligned_cols=241 Identities=24% Similarity=0.343 Sum_probs=185.1
Q ss_pred eEeccCCceEEEEEEEe--CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 71 KVLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~--~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
+.||+|+||.||+|... .++..+|+|.++... ..........|..++. .++||||+++++++.+...+|+||||+
T Consensus 1 ~~lg~G~~g~Vy~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (269)
T cd05087 1 KEIGNGWFGKVILGEVNSGYTPAQVVVKELRVSA--SVQEQMKFLEEAQPYR-SLQHSNLLQCLGQCTEVTPYLLVMEFC 77 (269)
T ss_pred CcccccCCceEEEEEEcCCCCceEEEEEecCCCC--ChHHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCCcEEEEECC
Confidence 46999999999999864 355679999886542 1223335566777666 579999999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhh-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-----SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-----~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
++|+| ..++.. ...+++..++.++.||+.||+|||++|++||||||+||+++.+
T Consensus 78 ~~g~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dlkp~nil~~~~ 136 (269)
T cd05087 78 PLGDL---------------------KGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTAD 136 (269)
T ss_pred CCCcH---------------------HHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCEeccccCcceEEEcCC
Confidence 96655 333332 1245677888999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCC-------CCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 224 GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGL-------KYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~-------~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
+++||+|||+++...... ......+|++.|+|||++.+. .++.++|||||||++|||++ |..||......
T Consensus 137 ~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~g~~p~~~~~~~ 216 (269)
T cd05087 137 LTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDE 216 (269)
T ss_pred CcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHHHHHHHHhCCCCCCCCCChH
Confidence 999999999986422111 112345678899999998643 35789999999999999996 99999877665
Q ss_pred HHHHHHH-hCCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 294 ELFWSIC-NERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 294 ~~~~~i~-~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
+...... .....++ ...++.+.+++..|+ .+|.+||+ ++||.
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt------~~~l~ 264 (269)
T cd05087 217 QVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPS------AEEVH 264 (269)
T ss_pred HHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCC------HHHHH
Confidence 5544333 2222222 346889999999999 68999994 56655
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-38 Score=307.05 Aligned_cols=249 Identities=27% Similarity=0.368 Sum_probs=192.5
Q ss_pred CCCceEeeEeccCCceEEEEEEE----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAEL----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-- 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-- 137 (494)
-.+|++++.||+|+||.||+|.. ..++..||||.+... ..........|..++. .++||||+++++++..
T Consensus 3 ~~~~~~~~~lg~g~~g~v~~~~~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~ 78 (284)
T cd05081 3 ERHLKFIQQLGKGNFGSVELCRYDPLQDNTGEVVAVKKLQHS---TAEHLRDFEREIEILK-SLQHDNIVKYKGVCYSAG 78 (284)
T ss_pred cccceeeeeccCCCCceEEEEEecCCcCCCCcEEEEEEeccC---CHHHHHHHHHHHHHHH-hCCCCCeeEEEEEEccCC
Confidence 35899999999999999999984 456888999998654 2334455667877777 5799999999998654
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
...+++||||+++| +|..++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 79 ~~~~~lv~e~~~~~---------------------~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH~~~i~H~dlkp~ 137 (284)
T cd05081 79 RRNLRLVMEYLPYG---------------------SLRDYLQKHRERLDHRKLLLYASQICKGMEYLGSKRYVHRDLATR 137 (284)
T ss_pred CCceEEEEEecCCC---------------------CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCceeccCCHh
Confidence 35789999999954 445555443 46899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
||+++.++.+||+|||++......... .....++..|+|||++.+..++.++|||||||++|||++|..|+......
T Consensus 138 nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~~~~~~~~~~~ 217 (284)
T cd05081 138 NILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAE 217 (284)
T ss_pred hEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHHHHhhcCCcCCCcchh
Confidence 999999999999999998753221111 11122345699999999989999999999999999999988776433211
Q ss_pred H---------------HHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 E---------------LFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~---------------~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
. .+..++.. .+..+..++.++.+||.+||..+|++|| +++||++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp------t~~ei~~ 278 (284)
T cd05081 218 FMRMMGNDKQGQMIVYHLIELLKNNGRLPAPPGCPAEIYAIMKECWNNDPSQRP------SFSELAL 278 (284)
T ss_pred hhhhcccccccccchHHHHHHHhcCCcCCCCCCCCHHHHHHHHHHccCChhhCC------CHHHHHH
Confidence 0 01122222 2334567889999999999999999999 5666654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-38 Score=338.14 Aligned_cols=276 Identities=21% Similarity=0.259 Sum_probs=187.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCC----CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE--
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGT----DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT-- 134 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~----~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~-- 134 (494)
.+..++|++.+.||+|+||.||+|++..+ +..||||.+.... ..+....++ +.. ..+.+++.+...
T Consensus 128 ~~~~~~y~l~~~LG~G~FG~VYka~~~~~~~~~~~~vAvK~~~~~~-----~~e~~~~e~-l~~--~~~~~~~~~~~~~~ 199 (566)
T PLN03225 128 SFKKDDFVLGKKLGEGAFGVVYKASLVNKQSKKEGKYVLKKATEYG-----AVEIWMNER-VRR--ACPNSCADFVYGFL 199 (566)
T ss_pred CCccCCeEEeEEEeeCCCeEEEEEEEcCCccccCcEEEEEEecccc-----hhHHHHHHH-HHh--hchhhHHHHHHhhh
Confidence 45678999999999999999999999988 8999999876431 111112221 111 112222222211
Q ss_pred ----EEcCCeeEEEEEecCCCCCccccchhh-hhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 135 ----FQTDSHLFFVMEYLNGGDLIPAGLTKA-ERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 135 ----~~~~~~~~lv~E~~~~g~L~~~~~~~~-~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
......+++||||+.+|+|.+.+.... ...+.+++.++ + ..+.......+..++.++.||+.||+|||++||+
T Consensus 200 ~~~~~~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~-~-~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIi 277 (566)
T PLN03225 200 EPVSSKKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGK-V-QDLPKGLERENKIIQTIMRQILFALDGLHSTGIV 277 (566)
T ss_pred cccccccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccc-h-hhccccchhhHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 245678999999999998865433221 22344444332 1 1111222344567788999999999999999999
Q ss_pred cccCCCCceeeCC-CCCEEEeecCceeeeec-cCCcccccCCCCCccChhhhCCC----------------------CCC
Q psy8309 210 YRDLKLDNILLDY-EGHVRIADFGMCKLQIY-LDKTTDTFCGTPDYMAPEIIKGL----------------------KYN 265 (494)
Q Consensus 210 HrDLKp~NILl~~-~g~vkL~DFGla~~~~~-~~~~~~~~~gt~~y~aPE~l~~~----------------------~~~ 265 (494)
||||||+|||++. ++.+||+|||+++.... .......++||+.|+|||++... .++
T Consensus 278 HRDLKP~NILl~~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~ 357 (566)
T PLN03225 278 HRDVKPQNIIFSEGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLP 357 (566)
T ss_pred eCcCCHHHEEEeCCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCC
Confidence 9999999999986 58999999999975322 12234567899999999976432 244
Q ss_pred CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH-HhCCC---------------------CCCccCCHHHHHHHHhhcc
Q psy8309 266 QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI-CNERP---------------------RFPQFLSVEAKNILVHLLD 323 (494)
Q Consensus 266 ~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i-~~~~~---------------------~~p~~~s~~~~~li~~lL~ 323 (494)
.++|||||||+||||+++..|+.. ....+..+ ..... ...+.....+++||.+||+
T Consensus 358 ~k~DVwSlGviL~el~~~~~~~~~--~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~ 435 (566)
T PLN03225 358 DRFDIYSAGLIFLQMAFPNLRSDS--NLIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMR 435 (566)
T ss_pred CCcccHHHHHHHHHHHhCcCCCch--HHHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHcc
Confidence 567999999999999997766542 21122111 11110 0111123456699999999
Q ss_pred CCCCCCCCCCCCCChhhhhcCCCcCCCChhH
Q psy8309 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 324 ~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~ 354 (494)
+||.+|| +++++++||||++..|..
T Consensus 436 ~dP~kR~------ta~e~L~Hpff~~~~~~~ 460 (566)
T PLN03225 436 FKGRQRI------SAKAALAHPYFDREGLLG 460 (566)
T ss_pred CCcccCC------CHHHHhCCcCcCCCCccc
Confidence 9999999 689999999999877643
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=303.64 Aligned_cols=253 Identities=26% Similarity=0.369 Sum_probs=198.3
Q ss_pred ceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 67 FQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
|++.++||+|+||.||+|..+ .++..||||++..+. ......+....|..++. .++||||+++++++....
T Consensus 1 ~~~~~~ig~g~~g~v~~~~~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 78 (273)
T cd05074 1 FTLGRMLGKGEFGSVREAQLKSEDGSFQKVAVKMLKADI-FSSSDIEEFLREAACMK-EFDHPNVIKLIGVSLRSRAKGR 78 (273)
T ss_pred CcchhcccCCCCCCEEeeEeeccCCCceEEEEEEecccc-CChHHHHHHHHHHHHHh-cCCCCCcceEEEEEccCCCCCc
Confidence 677899999999999999865 357889999997653 23334556677887776 579999999999886532
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..++++||+.+|+|.+.... .... ....+++..++.++.||+.||+|||++||+||||||+
T Consensus 79 ~~~~~~~~~~~~~~~l~~~~~~----------------~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~ 142 (273)
T cd05074 79 LPIPMVILPFMKHGDLHTFLLM----------------SRIGEEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAAR 142 (273)
T ss_pred ccceEEEEecCCCCcHHHHHHH----------------hcccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCEeecccchh
Confidence 24788999997665221000 0001 1125788999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
||+++.++.+||+|||+++....... ......+++.|++||.+.+..++.++|||||||++|||++ |.+||.+.+..
T Consensus 143 nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~~ 222 (273)
T cd05074 143 NCMLNENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENS 222 (273)
T ss_pred hEEEcCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCHH
Confidence 99999999999999999875322111 1223345678999999999899999999999999999999 99999988887
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+....+... ....+...+..+.+++.+||..+|.+|| ++.+++.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~l~~~p~~Rp------s~~~~~~ 267 (273)
T cd05074 223 EIYNYLIKGNRLKQPPDCLEDVYELMCQCWSPEPKCRP------SFQHLRD 267 (273)
T ss_pred HHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 777776654 3445567889999999999999999999 4566654
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=301.41 Aligned_cols=235 Identities=22% Similarity=0.296 Sum_probs=186.2
Q ss_pred eEeccCCceEEEEEEEeCCC----------eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 71 KVLGKGSFGKVFLAELKGTD----------YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~----------~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+.||+|+||.||+|.+..++ ..+++|++.... ........|..++. .++||||+++++++.. ..
T Consensus 1 ~~lg~G~~~~v~~~~~~~~~~~~~~~~~~~~~v~~k~~~~~~----~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~-~~ 74 (259)
T cd05037 1 EHLGQGTFTNIYKGVLRVQSDLDIVGPGQEVSVVLKVLGSDH----RDSLAFFETASLMS-QLSHKHLVKLYGVCVR-DE 74 (259)
T ss_pred CcccccccceEEEEEEeccCCccccCCccceeeeeeccccch----hhHHHHHHHHHHHH-cCCCcchhheeeEEec-CC
Confidence 46999999999999998777 347777765432 11344556666665 6799999999999988 78
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.++||||+++ ++|..++.... .+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 75 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~H~dlkp~Nil 133 (259)
T cd05037 75 NIMVEEYVKF---------------------GPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLVHGNVCGKNIL 133 (259)
T ss_pred cEEEEEcCCC---------------------CcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeecccCccceEE
Confidence 8999999994 45555666554 7899999999999999999999999999999999999
Q ss_pred eCCCC-------CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC--CCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy8309 220 LDYEG-------HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL--KYNQCVDWWSFGILLYEMHV-GQSPFSG 289 (494)
Q Consensus 220 l~~~g-------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~ell~-G~~Pf~~ 289 (494)
++.++ .+||+|||++..... .....++..|+|||++.+. .++.++|+|||||++|||++ |..||..
T Consensus 134 l~~~~~~~~~~~~~kl~Dfg~a~~~~~----~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~~~~~~p~~~ 209 (259)
T cd05037 134 VARYGLNEGYVPFIKLSDPGIPITVLS----REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLST 209 (259)
T ss_pred EecCccccCCceeEEeCCCCccccccc----ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHHhCCCCCccc
Confidence 99888 899999999875322 3345678889999999876 78999999999999999999 6888877
Q ss_pred CCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 290 CDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 290 ~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+..+...... .....|......+.++|.+||..+|.+|| ++.++++
T Consensus 210 ~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~~il~ 256 (259)
T cd05037 210 LSSSEKERFYQ-DQHRLPMPDCAELANLINQCWTYDPTKRP------SFRAILR 256 (259)
T ss_pred CCchhHHHHHh-cCCCCCCCCchHHHHHHHHHhccChhhCC------CHHHHHH
Confidence 65443333222 22333333458999999999999999999 4566653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-37 Score=302.24 Aligned_cols=241 Identities=23% Similarity=0.352 Sum_probs=185.4
Q ss_pred eEeccCCceEEEEEEEeCCC--eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 71 KVLGKGSFGKVFLAELKGTD--YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~--~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
+.||+|+||.||+|+....+ ..+++|.+.... ..........|..++. .++||||+++++.+.+....|+||||+
T Consensus 1 ~~lg~G~~g~v~~~~~~~~~~~~~~~~k~~~~~~--~~~~~~~~~~e~~~~~-~l~h~~iv~~~~~~~~~~~~~lv~e~~ 77 (268)
T cd05086 1 QEIGNGWFGKVLLSEIYTDTGVARVVVKELKANA--SSKEQNEFLQQGDPYR-ILQHPNILQCLGQCVEAIPYLLVFEYC 77 (268)
T ss_pred CcCCCCcCceEEEEEEEcCCCcceEEEEEecCCC--ChHHHHHHHHHHHHHh-ccCCcchhheEEEecCCCccEEEEecC
Confidence 36999999999999765432 345666655431 2233455666766666 579999999999999999999999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS----GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
++|+| ..++.+. ..+++..++.++.||+.||+|||+++|+||||||+|||++.++
T Consensus 78 ~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~i~H~dikp~nil~~~~~ 136 (268)
T cd05086 78 ELGDL---------------------KSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDL 136 (268)
T ss_pred CCCcH---------------------HHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHHCCeeccCCccceEEEcCCc
Confidence 95544 4444432 3467778889999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccC--CcccccCCCCCccChhhhCC-------CCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 225 HVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKG-------LKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
.+||+|||++....... ......+|+..|+|||++.. ..++.++|||||||++|||++ |..||...+..+
T Consensus 137 ~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~~l~el~~~~~~p~~~~~~~~ 216 (268)
T cd05086 137 TVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDRE 216 (268)
T ss_pred cEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999976321111 12335678999999999853 245789999999999999997 678998877777
Q ss_pred HHHHHHhCC------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 295 LFWSICNER------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 295 ~~~~i~~~~------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
.+..+..+. +.++..+++.+.+++..|| .+|.+||+ +++|+
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~------~~~i~ 263 (268)
T cd05086 217 VLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRAT------AEEVH 263 (268)
T ss_pred HHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCC------HHHHH
Confidence 777655432 2334467899999999999 68999994 56654
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >KOG0669|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=298.98 Aligned_cols=255 Identities=25% Similarity=0.422 Sum_probs=204.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
...|+-+..||+|.||.||+|+.+.+++.||+|++--+. .....-...++|..+|. .++|+|++.+++.+.+
T Consensus 16 ~~~yek~~kigqGtfgeVFkAr~~n~~kkvalkkvlmen-eKeGfpitalreikiL~-~lkHenv~nliEic~tk~Tp~~ 93 (376)
T KOG0669|consen 16 VSKYEKLAKIGQGTFGEVFKARSKNTGKKVALKKVLMEN-EKEGFPITALREIKILQ-LLKHENVVNLIEICRTKATPTN 93 (376)
T ss_pred chHHHHHHhcCCchHHHHHHHhhcCccchhHHHHHHHhc-cccCCcHHHHHHHHHHH-HhcchhHHHHHHHHhhccCCcc
Confidence 457888899999999999999999999999998763221 12233345678888888 5899999999877653
Q ss_pred --CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 138 --DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 138 --~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
...+|+|+++|+. +|.-.+... .+++..+++.++.+++.||.|+|.+.|+|||+|
T Consensus 94 r~r~t~ylVf~~ceh----------------------DLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr~kilHRDmK 151 (376)
T KOG0669|consen 94 RDRATFYLVFDFCEH----------------------DLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHRNKILHRDMK 151 (376)
T ss_pred cccceeeeeHHHhhh----------------------hHHHHhcCccccccHHHHHHHHHHHHHHHHHHHHhhHHhhccc
Confidence 2348999999972 333344443 689999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCc----ccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
|+|+||+.+|.+||+|||+++........ ....+-|.+|++||.+.| ..|+.+.|+|..|||+.||.+|.+-+.+
T Consensus 152 aaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqg 231 (376)
T KOG0669|consen 152 AANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQG 231 (376)
T ss_pred HhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccC
Confidence 99999999999999999999764332221 223456999999999987 4699999999999999999999999999
Q ss_pred CCHHHHHHHHHh--CC--------------------CCCCc-------------cCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 290 CDEDELFWSICN--ER--------------------PRFPQ-------------FLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 290 ~~~~~~~~~i~~--~~--------------------~~~p~-------------~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
+.+...+..|.. +. .++|. .-++++.||+.+||..||.+|+
T Consensus 232 nteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~---- 307 (376)
T KOG0669|consen 232 NTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRI---- 307 (376)
T ss_pred ChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHHHhccCcccCc----
Confidence 988776665531 10 01121 1256899999999999999999
Q ss_pred CCChhhhhcCCCcC
Q psy8309 335 CNSGDDVVAHEYFR 348 (494)
Q Consensus 335 ~~~~~eil~h~~f~ 348 (494)
++++++.|.||.
T Consensus 308 --~ad~alnh~~F~ 319 (376)
T KOG0669|consen 308 --DADQALNHDFFW 319 (376)
T ss_pred --chHhhhchhhhh
Confidence 678999999995
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=301.65 Aligned_cols=250 Identities=25% Similarity=0.345 Sum_probs=195.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEe----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELK----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-- 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-- 137 (494)
..+|++.+.||+|+||.||+|+.. .++..||||++.+.... ........|..++. .+.||||+++++++..
T Consensus 3 ~~~~~~~~~ig~g~~~~v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~-~l~~~~i~~~~~~~~~~~ 79 (284)
T cd05038 3 KRHLKFIKQLGEGHFGKVELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILR-TLDHENIVKYKGVCEKPG 79 (284)
T ss_pred hhhchhheeeccCCCeeEEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHH-hCCCCChheEEeeeecCC
Confidence 457899999999999999999865 34788999999765321 23455667777776 5799999999999887
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
....++||||+++| +|..++.... .+++..+..++.||+.||+|||++||+||||||+
T Consensus 80 ~~~~~lv~e~~~~~---------------------~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i~H~dl~p~ 138 (284)
T cd05038 80 GRSLRLIMEYLPSG---------------------SLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQRYIHRDLAAR 138 (284)
T ss_pred CCceEEEEecCCCC---------------------CHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 66899999999954 4444554433 6899999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
||+++.++.++|+|||++......... .....++..|+|||.+.+..++.++|+|||||++|||++|..||......
T Consensus 139 nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~~~~ 218 (284)
T cd05038 139 NILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSPPAE 218 (284)
T ss_pred hEEEcCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccccch
Confidence 999999999999999998753311111 11223456799999999889999999999999999999999998654221
Q ss_pred H--------------HHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 E--------------LFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~--------------~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
. ....++.. ....+..++.++.+|+.+||..+|.+||+ +.||++
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt------~~ei~~ 278 (284)
T cd05038 219 FLRMIGIAQGQMIVTRLLELLKEGERLPRPPSCPDEVYDLMKLCWEAEPQDRPS------FADLIL 278 (284)
T ss_pred hccccccccccccHHHHHHHHHcCCcCCCCccCCHHHHHHHHHHhccChhhCCC------HHHHHH
Confidence 1 11222222 23334567889999999999999999994 566653
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG4250|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=324.02 Aligned_cols=241 Identities=32% Similarity=0.486 Sum_probs=194.3
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC------
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS------ 139 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~------ 139 (494)
-+..-+.||+||||.||+++++.+|+.||||.+++.. ....++....|.+++.+ ++|||||+++++-++..
T Consensus 14 ~W~~~e~LG~Ga~g~V~rgrnketG~~vAvK~~~~~~--~~r~~e~~~~EieilkK-Lnh~NIVk~f~iee~~~~~~~~~ 90 (732)
T KOG4250|consen 14 LWEMDERLGKGAFGNVYRGRNKETGRLVAVKTFNKES--SLRPRERWCREIEILKK-LNHPNIVKLFDIEETKFLGLVTR 90 (732)
T ss_pred ceeehhhhcCCccceeeeecccccccchhHHhhhhhc--ccchHHHHHHHHHHHHH-cCchhhhhhcccCCccccCcccc
Confidence 3556688999999999999999999999999998764 45566778899999984 77999999998876544
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ---QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
.-.+|||||.||+| ...++ +...|+|.+...++.+++.||.|||++|||||||||+
T Consensus 91 ~~vlvmEyC~gGsL---------------------~~~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrEn~IvHRDlKP~ 149 (732)
T KOG4250|consen 91 LPVLVMEYCSGGSL---------------------RKVLNSPENAYGLPESEFLDLLSDLVSALRHLRENGIVHRDLKPG 149 (732)
T ss_pred cceEEEeecCCCcH---------------------HHHhcCcccccCCCHHHHHHHHHHHHHHHHHHHHcCceeccCCCC
Confidence 45799999995554 44554 3457999999999999999999999999999999999
Q ss_pred ceeeC--CCCC--EEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC-
Q psy8309 217 NILLD--YEGH--VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGC- 290 (494)
Q Consensus 217 NILl~--~~g~--vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~- 290 (494)
||++- .+|. -||+|||.|+.. ..+....+++||+.|++||+..+ +.|+..+|.|||||++|+++||..||...
T Consensus 150 NIvl~~Gedgq~IyKLtDfG~Arel-~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~ 228 (732)
T KOG4250|consen 150 NIVLQIGEDGQSIYKLTDFGAAREL-DDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFG 228 (732)
T ss_pred cEEEeecCCCceEEeeecccccccC-CCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCC
Confidence 99884 3344 599999999964 44556778999999999999985 78999999999999999999999999642
Q ss_pred ---CHHHHHHHHHhCC---------------------CCCCccCCHHH----HHHHHhhccCCCCCCCC
Q psy8309 291 ---DEDELFWSICNER---------------------PRFPQFLSVEA----KNILVHLLDKDTTKRLG 331 (494)
Q Consensus 291 ---~~~~~~~~i~~~~---------------------~~~p~~~s~~~----~~li~~lL~~dP~~R~~ 331 (494)
+..++.+.+...+ +++|..++..+ -..|..+|..+|.+|.+
T Consensus 229 ~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~~~~~~ 297 (732)
T KOG4250|consen 229 GPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNPRKRGH 297 (732)
T ss_pred CccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhHHHhCC
Confidence 2334555554221 23344555543 45677889999999984
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-37 Score=319.51 Aligned_cols=281 Identities=22% Similarity=0.286 Sum_probs=196.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe----------------CCCeEEEeeeeccccccCh-----------hhHHHHH
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK----------------GTDYYYAVKCLKKDVVLED-----------DDVECTL 113 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~----------------~~~~~~AiK~~~k~~~~~~-----------~~~~~~~ 113 (494)
++..++|++.++||+|+||.||+|... ..++.||||.+........ ...+...
T Consensus 141 r~~~d~F~i~~~LG~GgFG~VYkG~~~~~~~~~v~~~~~~~~~~~~r~VAVK~l~~~~~~~~~~fl~e~~~~~~~~e~~~ 220 (507)
T PLN03224 141 RWSSDDFQLRDKLGGGNFGITFEGLRLQADDQGVTQRSKLTAEQKKRRVVLKRVNMDRQGVRQDFLKTGTLAKGSAETGM 220 (507)
T ss_pred CccccCceEeeEeecCCCeEEEEEEecccccchhhhhccccccccCceEEEEEecccchhhHHHHHhhhhhhhcccchhH
Confidence 456789999999999999999999752 2346799999864321100 0112223
Q ss_pred HHHHHHHhcCCCC-----ceeeEEEEEEc--------CCeeEEEEEecCCCCCccccchh---hhhhhhhHhcCCchhHH
Q psy8309 114 IERKVLALGTKHP-----YLCHLFCTFQT--------DSHLFFVMEYLNGGDLIPAGLTK---AERDLMEYLNGGDLMFH 177 (494)
Q Consensus 114 ~e~~~l~~~~~hp-----~Iv~l~~~~~~--------~~~~~lv~E~~~~g~L~~~~~~~---~~~~l~~~~~gg~L~~~ 177 (494)
.|..++.. ++|. ++++++++|.. .+..+|||||+++|+|.+.+... ....+.+|+.++.....
T Consensus 221 vE~~~l~~-l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~ 299 (507)
T PLN03224 221 VEAYMCAK-IKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPD 299 (507)
T ss_pred HHHHHHHH-hhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhh
Confidence 34444442 3444 34667776643 35689999999999996644321 12345555554443333
Q ss_pred hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccc--cCCCCCccC
Q psy8309 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT--FCGTPDYMA 255 (494)
Q Consensus 178 l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~--~~gt~~y~a 255 (494)
......+++..++.++.||+.||.|||+++|+||||||+|||++.++.+||+|||+++.... ...... ..+|+.|+|
T Consensus 300 ~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~-~~~~~~~~g~~tp~Y~a 378 (507)
T PLN03224 300 NMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCT-GINFNPLYGMLDPRYSP 378 (507)
T ss_pred hcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCcccccc-CCccCccccCCCcceeC
Confidence 33345678889999999999999999999999999999999999999999999999864322 111222 235899999
Q ss_pred hhhhCCCC--------------------CC--CcchHHHHHHHHHHHHhCCC-CCCCCCH-----------HHHHHHHHh
Q psy8309 256 PEIIKGLK--------------------YN--QCVDWWSFGILLYEMHVGQS-PFSGCDE-----------DELFWSICN 301 (494)
Q Consensus 256 PE~l~~~~--------------------~~--~~~DiwSlGvil~ell~G~~-Pf~~~~~-----------~~~~~~i~~ 301 (494)
||++.... |+ ...|+||+||++|+|++|.. ||.+... ...+..+..
T Consensus 379 PE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~~~~ 458 (507)
T PLN03224 379 PEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRMYKG 458 (507)
T ss_pred hhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHhhcc
Confidence 99986432 22 24799999999999999886 7754211 111122223
Q ss_pred CCCCCC--ccCCHHHHHHHHhhccCCC---CCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 ERPRFP--QFLSVEAKNILVHLLDKDT---TKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~~~~~p--~~~s~~~~~li~~lL~~dP---~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..+.++ +..+++++|||.+||.++| .+|+ +++|+|+||||..
T Consensus 459 ~~~~~~~~d~~s~~~~dLi~~LL~~~~~~~~~Rl------Sa~eaL~Hp~f~~ 505 (507)
T PLN03224 459 QKYDFSLLDRNKEAGWDLACKLITKRDQANRGRL------SVGQALSHRFFLP 505 (507)
T ss_pred cCCCcccccccChHHHHHHHHHhccCCCCcccCC------CHHHHhCCCCcCC
Confidence 344443 4678999999999999876 6798 7899999999953
|
|
| >KOG1151|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-38 Score=308.37 Aligned_cols=256 Identities=28% Similarity=0.432 Sum_probs=211.1
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc----ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-CC
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL----EDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-DS 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~----~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-~~ 139 (494)
++|-++.+||+|||+.||+|-+....++||+|+-...... ......+..+|..+.. .++||.||++|++|.- .+
T Consensus 463 ~RYLlLhLLGrGGFSEVyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHK-eLDHpRIVKlYDyfslDtd 541 (775)
T KOG1151|consen 463 DRYLLLHLLGRGGFSEVYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHK-ELDHPRIVKLYDYFSLDTD 541 (775)
T ss_pred HHHHHHHHhccccHHHHHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhh-ccCcceeeeeeeeeeeccc
Confidence 4688899999999999999999999999999986433222 2345567788888876 6899999999999974 56
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--CCccccCCCCc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK--GIVYRDLKLDN 217 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~--givHrDLKp~N 217 (494)
.+|-|+|||+ |.+|..++.+...++|.+++.|+.||+.||.||.+. -|||-||||.|
T Consensus 542 sFCTVLEYce---------------------GNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpPIIHYDLKPgN 600 (775)
T KOG1151|consen 542 SFCTVLEYCE---------------------GNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPPIIHYDLKPGN 600 (775)
T ss_pred cceeeeeecC---------------------CCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCCeeeeccCCcc
Confidence 7889999999 677778899999999999999999999999999987 59999999999
Q ss_pred eeeC---CCCCEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCC----CCCCcchHHHHHHHHHHHHhC
Q psy8309 218 ILLD---YEGHVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGL----KYNQCVDWWSFGILLYEMHVG 283 (494)
Q Consensus 218 ILl~---~~g~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~----~~~~~~DiwSlGvil~ell~G 283 (494)
||+- .-|.|||+||||++++..... .+....||.+|++||.+.-. ..+.++||||+|||+|.++.|
T Consensus 601 ILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYG 680 (775)
T KOG1151|consen 601 ILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYG 680 (775)
T ss_pred EEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhcc
Confidence 9994 357899999999997543222 24567899999999987432 367899999999999999999
Q ss_pred CCCCCCCC-HHHHHH--HHHhC-CCCCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 284 QSPFSGCD-EDELFW--SICNE-RPRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 284 ~~Pf~~~~-~~~~~~--~i~~~-~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+-||..+. ..++++ .|++. ...|| +.++.++++||++||+.--+.|. ++.++-.||||.
T Consensus 681 rKPFGhnqsQQdILqeNTIlkAtEVqFP~KPvVsseAkaFIRRCLaYRKeDR~------DV~qLA~dpyll 745 (775)
T KOG1151|consen 681 RKPFGHNQSQQDILQENTILKATEVQFPPKPVVSSEAKAFIRRCLAYRKEDRI------DVQQLACDPYLL 745 (775)
T ss_pred CCCCCCchhHHHHHhhhchhcceeccCCCCCccCHHHHHHHHHHHHhhhhhhh------hHHHHccCcccc
Confidence 99997653 333332 24433 45666 47999999999999999999998 788999999985
|
|
| >KOG4257|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-37 Score=310.66 Aligned_cols=248 Identities=25% Similarity=0.370 Sum_probs=208.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+..+...+.+.||.|.||.||.|.+.. ..--||||.-+.+. ..+..+.++.|..++. ..+|||||+|+|++.+
T Consensus 386 l~Re~Itl~r~iG~GqFGdVy~gvYt~~~kge~iaVAvKtCK~d~--t~d~tekflqEa~iMr-nfdHphIikLIGv~~e 462 (974)
T KOG4257|consen 386 LRRELITLKRLIGEGQFGDVYKGVYTDPEKGERIAVAVKTCKTDC--TPDDTEKFLQEASIMR-NFDHPHIIKLIGVCVE 462 (974)
T ss_pred eehhhccHHHhhcCCcccceeeeEecccccCcceeeeeehhccCC--ChhhHHHHHHHHHHHH-hCCCcchhheeeeeec
Confidence 334556667899999999999998743 34458999988753 3445677888887777 6899999999999864
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
...+||||+++ -|+|..+++.+ ..|+......|+.||+.||.|||+.++|||||...
T Consensus 463 -~P~WivmEL~~---------------------~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLeSkrfVHRDIAaR 520 (974)
T KOG4257|consen 463 -QPMWIVMELAP---------------------LGELREYLQQNKDSLPLRTLTLYCYQICTALAYLESKRFVHRDIAAR 520 (974)
T ss_pred -cceeEEEeccc---------------------chhHHHHHHhccccchHHHHHHHHHHHHHHHHHHHhhchhhhhhhhh
Confidence 57899999999 66777777765 57999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCccccc-CCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTF-CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
|||+.+...|||+|||+++..........+. .-...|||||.+.-..++.++|||-|||+|||++. |..||.+-...+
T Consensus 521 NiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEIl~lGvkPfqgvkNsD 600 (974)
T KOG4257|consen 521 NILVSSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEILSLGVKPFQGVKNSD 600 (974)
T ss_pred heeecCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHHHHhcCCccccccccc
Confidence 9999999999999999999754433333331 12458999999999999999999999999999997 999999988888
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
.+-.|.++ +++.|+.+++.+..|+.+||..+|.+||...+
T Consensus 601 VI~~iEnGeRlP~P~nCPp~LYslmskcWayeP~kRPrfte 641 (974)
T KOG4257|consen 601 VIGHIENGERLPCPPNCPPALYSLMSKCWAYEPSKRPRFTE 641 (974)
T ss_pred eEEEecCCCCCCCCCCCChHHHHHHHHHhccCcccCCcHHH
Confidence 77777765 68889999999999999999999999997643
|
|
| >KOG1187|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=305.85 Aligned_cols=242 Identities=28% Similarity=0.386 Sum_probs=187.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-eeEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS-HLFF 143 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~-~~~l 143 (494)
++|.-..+||+|+||.||+|...+. ..||||.+....... ...+..|..++. .++|||+|+|+|+|.+.+ ..+|
T Consensus 75 ~~Fs~~~~ig~Ggfg~VYkG~l~~~-~~vAVK~~~~~~~~~---~~eF~~Ei~~ls-~l~H~Nlv~LlGyC~e~~~~~~L 149 (361)
T KOG1187|consen 75 NNFSESNLIGEGGFGTVYKGVLSDG-TVVAVKRLSSNSGQG---EREFLNEVEILS-RLRHPNLVKLLGYCLEGGEHRLL 149 (361)
T ss_pred hCCchhcceecCCCeEEEEEEECCC-CEEEEEEecCCCCcc---hhHHHHHHHHHh-cCCCcCcccEEEEEecCCceEEE
Confidence 5788889999999999999997665 779999876542211 334788888888 578999999999999998 5999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC---CccccCCCCce
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKG---IVYRDLKLDNI 218 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~g---ivHrDLKp~NI 218 (494)
|+|||++|+|. .++.... .+++.....|+.+++.||+|||... ||||||||.||
T Consensus 150 VYEym~nGsL~---------------------d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNI 208 (361)
T KOG1187|consen 150 VYEYMPNGSLE---------------------DHLHGKKGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNI 208 (361)
T ss_pred EEEccCCCCHH---------------------HHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHe
Confidence 99999977663 3443332 7899999999999999999999864 99999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCccccc-CCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC---H--
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTF-CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD---E-- 292 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~-~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~---~-- 292 (494)
|||.+...||+|||+|+..........+. .||..|+|||.+.....+.++|||||||+|.||++|+.|..... .
T Consensus 209 LLD~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~ 288 (361)
T KOG1187|consen 209 LLDEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELS 288 (361)
T ss_pred eECCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCccccc
Confidence 99999999999999997533212222222 79999999999998899999999999999999999998887432 1
Q ss_pred -HHHHHHHH-hC------CCCCC-ccCC--HH---HHHHHHhhccCCCCCCCCC
Q psy8309 293 -DELFWSIC-NE------RPRFP-QFLS--VE---AKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 293 -~~~~~~i~-~~------~~~~p-~~~s--~~---~~~li~~lL~~dP~~R~~~ 332 (494)
.+...... ++ .+.+. ...+ .+ +..+..+|++.+|..||..
T Consensus 289 l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m 342 (361)
T KOG1187|consen 289 LVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTM 342 (361)
T ss_pred HHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCH
Confidence 11111111 11 11222 2222 22 4567789999999999965
|
|
| >KOG0665|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=291.32 Aligned_cols=262 Identities=28% Similarity=0.461 Sum_probs=210.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD------ 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~------ 138 (494)
.+|.-++.+|.|+- .|..|-+.-+++.||+|.+... ........+..+|..++. .++|+||++++.+|.-.
T Consensus 17 ~Ry~nL~p~~~g~~-~v~~a~D~v~~~~v~ikk~~~p-f~n~~~akra~rel~l~~-~v~~~nii~l~n~ftP~~~l~~~ 93 (369)
T KOG0665|consen 17 KRYVNLKPIGSGAQ-IVVAAFDQVLGRPVAIKKLSRP-FQNQTHAKRAYRELKLMK-CVNHKNIISLLNVFTPQKTLEEF 93 (369)
T ss_pred eeeeeecccCCCCc-eEEecchhhccCceehhhhcCc-cccCccchhhhhhhhhhh-hhcccceeeeeeccCccccHHHH
Confidence 47888999999998 7888888888999999998776 444556677778887776 68999999999998744
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+|+|||+|. .+|...+. -.++-..++++..|++.|++|||+.||+||||||+||
T Consensus 94 ~e~y~v~e~m~----------------------~nl~~vi~--~elDH~tis~i~yq~~~~ik~lhs~~IihRdLkPsni 149 (369)
T KOG0665|consen 94 QEVYLVMELMD----------------------ANLCQVIL--MELDHETISYILYQMLCGIKHLHSAGIIHRDLKPSNI 149 (369)
T ss_pred HhHHHHHHhhh----------------------hHHHHHHH--HhcchHHHHHHHHHHHHHHHHHHhcceeecccCcccc
Confidence 35799999996 23333333 3567788999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
++..++.+||.|||+++.... .-....++.|..|.|||++.+.+|...+||||+||++.||++|+..|.|.+.-+.+.+
T Consensus 150 vv~~~~~lKi~dfg~ar~e~~-~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gEli~~~Vlf~g~d~idQ~~k 228 (369)
T KOG0665|consen 150 VVNSDCTLKILDFGLARTEDT-DFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGELILGTVLFPGKDHIDQWNK 228 (369)
T ss_pred eecchhheeeccchhhcccCc-ccccCchhheeeccCchheeccCCcccchhhhhhhHHHHHhhceEEecCchHHHHHHH
Confidence 999999999999999986322 2345667899999999999999999999999999999999999999999887666555
Q ss_pred HHhC----------------------C-----C----CCCc-----------cCCHHHHHHHHhhccCCCCCCCCCCCCC
Q psy8309 299 ICNE----------------------R-----P----RFPQ-----------FLSVEAKNILVHLLDKDTTKRLGSTQCN 336 (494)
Q Consensus 299 i~~~----------------------~-----~----~~p~-----------~~s~~~~~li~~lL~~dP~~R~~~~~~~ 336 (494)
|... . . .||+ .-+..+++|+.+||..||++|+
T Consensus 229 i~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardll~~MLvi~pe~Ri------ 302 (369)
T KOG0665|consen 229 IIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDLLSKMLVIDPEKRI------ 302 (369)
T ss_pred HHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHHHHHhhccChhhcc------
Confidence 5421 0 0 1221 1134589999999999999999
Q ss_pred ChhhhhcCCCcCCCChhHHhcCcCCCCC
Q psy8309 337 SGDDVVAHEYFRGLDWQALEKRELEPPF 364 (494)
Q Consensus 337 ~~~eil~h~~f~~~~w~~l~~~~~~pp~ 364 (494)
+++++|.||||+ -| ....+++.|.
T Consensus 303 sv~daL~HPY~~--vw--~~~~ev~ap~ 326 (369)
T KOG0665|consen 303 SVDDALRHPYIK--VW--YDPDEVEAPP 326 (369)
T ss_pred cHHHHhcCCeee--ee--cccccccCCC
Confidence 789999999998 46 2233444443
|
|
| >KOG1094|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-36 Score=299.62 Aligned_cols=247 Identities=26% Similarity=0.383 Sum_probs=202.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
++..+...+.+.||+|-||.|.+|+-.. +..||||.++... ..+....+..|+++|. .++|||||+|+++|..++.
T Consensus 534 EfPRs~L~~~ekiGeGqFGEVhLCeveg-~lkVAVK~Lr~~a--~~~~r~~F~kEIkiLs-qLkhPNIveLvGVC~~DeP 609 (807)
T KOG1094|consen 534 EFPRSRLRFKEKIGEGQFGEVHLCEVEG-PLKVAVKILRPDA--TKNARNDFLKEIKILS-RLKHPNIVELLGVCVQDDP 609 (807)
T ss_pred hcchhheehhhhhcCcccceeEEEEecC-ceEEEEeecCccc--chhHHHHHHHHHHHHh-ccCCCCeeEEEeeeecCCc
Confidence 4555678889999999999999998765 6789999998753 3445567889999998 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+++||||+++|+ |..++... ..+.......++.||+.||+||.+.++|||||.+.||
T Consensus 610 icmI~EYmEnGD---------------------LnqFl~aheapt~~t~~~vsi~tqiasgmaYLes~nfVHrd~a~rNc 668 (807)
T KOG1094|consen 610 LCMITEYMENGD---------------------LNQFLSAHELPTAETAPGVSICTQIASGMAYLESLNFVHRDLATRNC 668 (807)
T ss_pred hHHHHHHHhcCc---------------------HHHHHHhccCcccccchhHHHHHHHHHHHHHHHhhchhhccccccce
Confidence 999999999555 45555554 2234556667999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh--CCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV--GQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~--G~~Pf~~~~~~~ 294 (494)
|++.++++||+|||+++..-..+.. ....+-...|||+|.+.-..++.++|+|++|+++||+++ ...||.....++
T Consensus 669 Lv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE~~~~C~e~Py~~lt~e~ 748 (807)
T KOG1094|consen 669 LVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEVFMLCREQPYSQLTDEQ 748 (807)
T ss_pred eecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHHHHHHHhhCchhhhhHHH
Confidence 9999999999999999853222211 223455679999999999999999999999999999875 789998887777
Q ss_pred HHHHHHh---C-----CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 295 LFWSICN---E-----RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 295 ~~~~i~~---~-----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..++... . -+..|.-++.++..||.+||..+-.+||+.
T Consensus 749 vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsF 794 (807)
T KOG1094|consen 749 VVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSF 794 (807)
T ss_pred HHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCH
Confidence 6665432 1 134567789999999999999999999953
|
|
| >KOG4278|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-36 Score=302.59 Aligned_cols=244 Identities=26% Similarity=0.411 Sum_probs=208.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.++..+..+...||-|.||.||.|.++...-.||||.++.+ .-.++.++.|..++. .++|||+|+|+++|..+..
T Consensus 263 EmeRtdItMkhKLGGGQYGeVYeGvWKkyslTvAVKtLKED----tMeveEFLkEAAvMK-eikHpNLVqLLGVCT~EpP 337 (1157)
T KOG4278|consen 263 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTHEPP 337 (1157)
T ss_pred hccchheeeeeccCCCcccceeeeeeeccceeeehhhhhhc----chhHHHHHHHHHHHH-hhcCccHHHHhhhhccCCC
Confidence 33445777888999999999999999998888999999765 346788899999988 5899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|||+|||..| +|..+++.. ..++.-....++.||.+||+||..+++|||||...|+
T Consensus 338 FYIiTEfM~yG---------------------NLLdYLRecnr~ev~avvLlyMAtQIsSaMeYLEkknFIHRDLAARNC 396 (1157)
T KOG4278|consen 338 FYIITEFMCYG---------------------NLLDYLRECNRSEVPAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 396 (1157)
T ss_pred eEEEEecccCc---------------------cHHHHHHHhchhhcchhHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhc
Confidence 99999999954 444455543 3466677888999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCC---CCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCG---TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
|+.++..||++||||++.+...... .-.| ...|.|||-+....++.++|||+|||+|||+.| |..||.|.+...
T Consensus 397 LVgEnhiVKvADFGLsRlMtgDTYT--AHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGidlSq 474 (1157)
T KOG4278|consen 397 LVGENHIVKVADFGLSRLMTGDTYT--AHAGAKFPIKWTAPESLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 474 (1157)
T ss_pred cccccceEEeeccchhhhhcCCcee--cccCccCcccccCcccccccccccchhhHHHHHHHHHHHhcCCCCCCCccHHH
Confidence 9999999999999999964332222 2223 458999999999999999999999999999998 999999999988
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
.|..+.++ +..-|..+++.+..|++.||+.+|..||+.
T Consensus 475 VY~LLEkgyRM~~PeGCPpkVYeLMraCW~WsPsDRPsF 513 (1157)
T KOG4278|consen 475 VYGLLEKGYRMDGPEGCPPKVYELMRACWNWSPSDRPSF 513 (1157)
T ss_pred HHHHHhccccccCCCCCCHHHHHHHHHHhcCCcccCccH
Confidence 88776655 456689999999999999999999999965
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-35 Score=278.96 Aligned_cols=240 Identities=44% Similarity=0.770 Sum_probs=201.7
Q ss_pred CceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCCCccc
Q psy8309 77 SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPA 156 (494)
Q Consensus 77 ~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~ 156 (494)
+||.||+|+...+++.+|+|++........ ......|...+. .++|+||+++++.+......++++||+.++
T Consensus 1 ~~g~v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~----- 72 (244)
T smart00220 1 SFGKVYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILK-KLKHPNIVRLYDVFEDEDKLYLVMEYCDGG----- 72 (244)
T ss_pred CceEEEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHH-hCCCCcHHHHHhheeeCCEEEEEEeCCCCC-----
Confidence 689999999999999999999976533221 456667777776 469999999999999999999999999844
Q ss_pred cchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 157 GLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 157 ~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+|..++.....+++..+..++.+++.+|.|||+.|++|+||+|.||+++.++.++|+|||.+..
T Consensus 73 ----------------~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~ 136 (244)
T smart00220 73 ----------------DLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIHRDLKPENILLDEDGHVKLADFGLARQ 136 (244)
T ss_pred ----------------CHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeecCCcCHHHeEECCCCcEEEccccceee
Confidence 4455555555589999999999999999999999999999999999999999999999999876
Q ss_pred eeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCCcc---CCH
Q psy8309 237 QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFWSICNERPRFPQF---LSV 312 (494)
Q Consensus 237 ~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~p~~---~s~ 312 (494)
... ........|+..|+|||.+.+..++.++|+||||+++|+|++|..||.. .+.......+.......... ++.
T Consensus 137 ~~~-~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 215 (244)
T smart00220 137 LDP-GGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFPGDDQLLELFKKIGKPKPPFPPPEWKISP 215 (244)
T ss_pred ecc-ccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCCCCccccccCCH
Confidence 332 2234556789999999999988899999999999999999999999988 55556666555554444332 889
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 313 ~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
++.+++.+||..+|++|| ++.++++||||
T Consensus 216 ~~~~~i~~~l~~~p~~Rp------~~~~~~~~~~~ 244 (244)
T smart00220 216 EAKDLIRKLLVKDPEKRL------TAEEALQHPFF 244 (244)
T ss_pred HHHHHHHHHccCCchhcc------CHHHHhhCCCC
Confidence 999999999999999999 68999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >KOG0196|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=313.40 Aligned_cols=254 Identities=24% Similarity=0.378 Sum_probs=217.5
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+.++.....|.++||.|.||.|++|+.+..++ .||||.++-. ..+.+...++.|..||- +.+||||++|.++..
T Consensus 624 kEId~s~i~Ie~VIGaGEFGEVc~GrLk~pgkre~~VAIKTLK~G--ytekqrrdFL~EAsIMG-QFdHPNIIrLEGVVT 700 (996)
T KOG0196|consen 624 KEIDPSCVKIEKVIGAGEFGEVCSGRLKLPGKREITVAIKTLKAG--YTEKQRRDFLSEASIMG-QFDHPNIIRLEGVVT 700 (996)
T ss_pred hhcChhheEEEEEEecccccceecccccCCCCcceeEEEeeeccC--ccHHHHhhhhhhhhhcc-cCCCCcEEEEEEEEe
Confidence 35677889999999999999999999987664 6999999764 45566677888998887 689999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
....+.||.|||++|+| ..+++ +.+.|+..+...+++-|+.||.||-++|+|||||..
T Consensus 701 ks~PvMIiTEyMENGsL---------------------DsFLR~~DGqftviQLVgMLrGIAsGMkYLsdm~YVHRDLAA 759 (996)
T KOG0196|consen 701 KSKPVMIITEYMENGSL---------------------DSFLRQNDGQFTVIQLVGMLRGIASGMKYLSDMNYVHRDLAA 759 (996)
T ss_pred cCceeEEEhhhhhCCcH---------------------HHHHhhcCCceEeehHHHHHHHHHHHhHHHhhcCchhhhhhh
Confidence 99999999999997766 33444 347899999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccCC---CCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG---TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g---t~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
.||||+.+-.+|++||||++..........+..| ..+|.|||.|....++.++||||+||+|||.++ |..||-...
T Consensus 760 RNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWEVmSyGERPYWdmS 839 (996)
T KOG0196|consen 760 RNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 839 (996)
T ss_pred hheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEEecccCCCcccccc
Confidence 9999999999999999999965333323222222 358999999999999999999999999999886 999999999
Q ss_pred HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.++.+..|..+ +++-|-.++..+..|+..||++|-.+||. ..+|..
T Consensus 840 NQdVIkaIe~gyRLPpPmDCP~aL~qLMldCWqkdR~~RP~------F~qiV~ 886 (996)
T KOG0196|consen 840 NQDVIKAIEQGYRLPPPMDCPAALYQLMLDCWQKDRNRRPK------FAQIVS 886 (996)
T ss_pred hHHHHHHHHhccCCCCCCCCcHHHHHHHHHHHHHHhhcCCC------HHHHHH
Confidence 99999999876 55666789999999999999999999994 455554
|
|
| >KOG0670|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-37 Score=303.82 Aligned_cols=252 Identities=25% Similarity=0.410 Sum_probs=202.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC-----CCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-----KHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~-----~hp~Iv~l~~~~~~~ 138 (494)
-..|.+....|+|-|+.|..|.+...|..||||+|....+. ...-+.|..+|.+.. .--++++|+-.|...
T Consensus 431 D~RY~V~~~~GkGvFs~Vvra~D~~r~~~vAiKIIRnNE~M----~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk 506 (752)
T KOG0670|consen 431 DSRYEVQGYTGKGVFSTVVRARDQARGQEVAIKIIRNNEVM----HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK 506 (752)
T ss_pred cceeEEEeccccceeeeeeeccccCCCCeeEEEEeecchHH----hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc
Confidence 45799999999999999999999988999999999876443 334456777776432 224789999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
+|+|||+|-+. .+|...+.+. ..|....++.|+.|+..||..|...||+|.||||
T Consensus 507 nHLClVFE~Ls----------------------lNLRevLKKyG~nvGL~ikaVRsYaqQLflALklLK~c~vlHaDIKP 564 (752)
T KOG0670|consen 507 NHLCLVFEPLS----------------------LNLREVLKKYGRNVGLHIKAVRSYAQQLFLALKLLKKCGVLHADIKP 564 (752)
T ss_pred ceeEEEehhhh----------------------chHHHHHHHhCcccceeehHHHHHHHHHHHHHHHHHhcCeeecccCc
Confidence 99999999874 2333344443 4688899999999999999999999999999999
Q ss_pred CceeeCCCC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 216 DNILLDYEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 216 ~NILl~~~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
+|||++... .+||||||.|.... ......+.-+..|.|||++.|..|+...|+||+||+||||+||+..|.|.+...
T Consensus 565 DNiLVNE~k~iLKLCDfGSA~~~~--eneitPYLVSRFYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 565 DNILVNESKNILKLCDFGSASFAS--ENEITPYLVSRFYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred cceEeccCcceeeeccCccccccc--cccccHHHHHHhccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 999998765 47999999886532 222233445678999999999999999999999999999999999999998888
Q ss_pred HHHHHHhCCCCCCc-----------------------------------------------------cC-------CHHH
Q psy8309 295 LFWSICNERPRFPQ-----------------------------------------------------FL-------SVEA 314 (494)
Q Consensus 295 ~~~~i~~~~~~~p~-----------------------------------------------------~~-------s~~~ 314 (494)
++...+.-.-.||. .+ -..+
T Consensus 643 MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s~l~~~q~~~deq~~~~~~~ 722 (752)
T KOG0670|consen 643 MLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGSELIAVQRLPDEQPKIVQQL 722 (752)
T ss_pred HHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHHHHhccCCCCchhHHHHHHH
Confidence 87655543333320 01 1258
Q ss_pred HHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 315 KNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 315 ~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
++||.+||..||++|+ ++.++|+||||..
T Consensus 723 rdLLdkml~LdP~KRi------t~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 723 RDLLDKMLILDPEKRI------TVNQALKHPFITE 751 (752)
T ss_pred HHHHHHHhccChhhcC------CHHHHhcCCcccC
Confidence 8999999999999999 6788999999963
|
|
| >KOG1290|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-35 Score=286.83 Aligned_cols=133 Identities=28% Similarity=0.440 Sum_probs=112.9
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC-------CCCceeeEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-------KHPYLCHLFCT 134 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~-------~hp~Iv~l~~~ 134 (494)
+.-.+|.+.+.||-|-|++||+|.+..+.+.||+|+.+... ...+..+.|+.+|.... +..+||+|++.
T Consensus 75 F~~gRY~v~rKLGWGHFSTVWLawDtq~~r~VAlKVvKSAq----hYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~ 150 (590)
T KOG1290|consen 75 FNGGRYHVQRKLGWGHFSTVWLAWDTQNKRYVALKVVKSAQ----HYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDH 150 (590)
T ss_pred ccCceEEEEEeccccccceeEEEeeccCCeEEEEEEEehhh----HHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeecc
Confidence 44479999999999999999999999999999999998653 35566778888876532 22479999999
Q ss_pred EEc----CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-C
Q psy8309 135 FQT----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKK-G 207 (494)
Q Consensus 135 ~~~----~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~-g 207 (494)
|.. ..|+|||+|++ |..|..++... ..++...++.|++||+.||.|||.. |
T Consensus 151 FkhsGpNG~HVCMVfEvL----------------------GdnLLklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~ecg 208 (590)
T KOG1290|consen 151 FKHSGPNGQHVCMVFEVL----------------------GDNLLKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRECG 208 (590)
T ss_pred ceecCCCCcEEEEEehhh----------------------hhHHHHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHhcC
Confidence 984 56899999998 66777777654 5799999999999999999999976 9
Q ss_pred CccccCCCCceee
Q psy8309 208 IVYRDLKLDNILL 220 (494)
Q Consensus 208 ivHrDLKp~NILl 220 (494)
|||.||||||||+
T Consensus 209 IIHTDlKPENvLl 221 (590)
T KOG1290|consen 209 IIHTDLKPENVLL 221 (590)
T ss_pred ccccCCCcceeee
Confidence 9999999999999
|
|
| >KOG0199|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-36 Score=303.93 Aligned_cols=246 Identities=26% Similarity=0.404 Sum_probs=207.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++..+.++||+|+||.|+.|.++.. -..||||+++...... ....++.|..+|. .++|||+++||++..+
T Consensus 107 Ipee~i~l~e~LG~GsFgvV~rg~Wt~psgk~V~VAVKclr~d~l~~--~mddflrEas~M~-~L~H~hliRLyGvVl~- 182 (1039)
T KOG0199|consen 107 IPEEQIKLYELLGEGSFGVVKRGTWTQPSGKHVNVAVKCLRDDSLNA--IMDDFLREASHML-KLQHPHLIRLYGVVLD- 182 (1039)
T ss_pred ccHHHHHHHHHhcCcceeeEeeccccCCCCcEEeEEEEeccCCccch--hHHHHHHHHHHHH-hccCcceeEEeeeecc-
Confidence 4456788899999999999999998643 2358999998764432 5567888988888 5899999999999987
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+.||||+++.|+| ...+.+ ...|.......|+.||+.||.||..+++|||||...
T Consensus 183 qp~mMV~ELaplGSL---------------------ldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskrlvHRDLAAR 241 (1039)
T KOG0199|consen 183 QPAMMVFELAPLGSL---------------------LDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKRLVHRDLAAR 241 (1039)
T ss_pred chhhHHhhhcccchH---------------------HHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhhhhhhhhhhh
Confidence 788999999996555 444443 467888999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCC----CCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG----TPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g----t~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|||+-....||||||||.+.....+. .+.+.+ ...|+|||.|+...++.++|+|++||+||||++ |..||.|..
T Consensus 242 NlllasprtVKI~DFGLmRaLg~ned-~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMFtyGEePW~G~~ 320 (1039)
T KOG0199|consen 242 NLLLASPRTVKICDFGLMRALGENED-MYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMFTYGEEPWVGCR 320 (1039)
T ss_pred hheecccceeeeecccceeccCCCCc-ceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhhccCCCCCCCCC
Confidence 99999999999999999986433222 222222 347999999999999999999999999999998 999999999
Q ss_pred HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCC
Q psy8309 292 EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGST 333 (494)
Q Consensus 292 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~ 333 (494)
...++++|-.+ ++.-|+.+++++.++++.||..+|++||+..
T Consensus 321 g~qIL~~iD~~erLpRPk~csedIY~imk~cWah~paDRptFs 363 (1039)
T KOG0199|consen 321 GIQILKNIDAGERLPRPKYCSEDIYQIMKNCWAHNPADRPTFS 363 (1039)
T ss_pred HHHHHHhccccccCCCCCCChHHHHHHHHHhccCCccccccHH
Confidence 99999888743 5667889999999999999999999999753
|
|
| >KOG1152|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=302.72 Aligned_cols=205 Identities=34% Similarity=0.572 Sum_probs=181.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHH-----HHHHHHHHHHhc--CCCCceeeEEEEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVE-----CTLIERKVLALG--TKHPYLCHLFCTF 135 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~-----~~~~e~~~l~~~--~~hp~Iv~l~~~~ 135 (494)
...+|..++.||.|+||.|++|.++.....|+||.|.|+.+..+..++ .+-.|+.+|+.. ..|+||++++++|
T Consensus 559 k~s~yttlq~lG~GAyGkV~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfF 638 (772)
T KOG1152|consen 559 KFSDYTTLQPLGEGAYGKVNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFF 638 (772)
T ss_pred ccccceeeeeccccccceEEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhhee
Confidence 346899999999999999999999999999999999998776554433 345688888742 2499999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
++++++||+||--. . |.+|+.++..+..++|.+++.+++||+.|+++||+.||||||||-
T Consensus 639 Eddd~yyl~te~hg--~------------------gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~ivhrdikd 698 (772)
T KOG1152|consen 639 EDDDYYYLETEVHG--E------------------GIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGIVHRDIKD 698 (772)
T ss_pred ecCCeeEEEecCCC--C------------------CcchhhhhhccCccchHHHHHHHHHHHhccccccccCceeccccc
Confidence 99999999999643 1 778999999999999999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
||+.++.+|.+||+|||.+.. .......+++||..|.|||++.|..| +..-|||+||++||.++....||+.
T Consensus 699 envivd~~g~~klidfgsaa~--~ksgpfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 699 ENVIVDSNGFVKLIDFGSAAY--TKSGPFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred ccEEEecCCeEEEeeccchhh--hcCCCcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 999999999999999998864 34556778999999999999999887 6889999999999999999999974
|
|
| >KOG0984|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-35 Score=263.11 Aligned_cols=219 Identities=25% Similarity=0.464 Sum_probs=183.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++..-+..||+|+||.|-+.++..+|...|+|.++-. .+.+...+.++|..+......+|++|.+++.+.....++
T Consensus 44 ~ad~L~~i~elGrGayG~vekmrh~~sg~imAvKri~~t--vn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvw 121 (282)
T KOG0984|consen 44 PADDLVGIEELGRGAYGVVEKMRHIQSGTIMAVKRIRAT--VNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVW 121 (282)
T ss_pred chhhhhhhhhhcCCccchhhheeeccCCeEEEEeeehhh--cChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEE
Confidence 345777788999999999999999999999999999764 456667788899999888889999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NILl~ 221 (494)
+.||.|. .++..+. ...+.+.+.++|..+-.++.-++.||.|||++ .+||||+||.||||+
T Consensus 122 IcME~M~-------------tSldkfy-----~~v~~~g~~ipE~vlGkIa~Svv~al~~L~~kL~vIHRDvKPsNiLIn 183 (282)
T KOG0984|consen 122 ICMELMD-------------TSLDKFY-----RKVLKKGGTIPEDVLGKIAVSVVHALEFLHSKLSVIHRDVKPSNILIN 183 (282)
T ss_pred EeHHHhh-------------hhHHHHH-----HHHHhcCCcCchHHhhHhHHHHHHHHHHHHHHhhhhhccCCcceEEEc
Confidence 9999986 1221111 12355678899999999999999999999987 899999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccc-cCCCCCccChhhhC----CCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDT-FCGTPDYMAPEIIK----GLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDEL 295 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~-~~gt~~y~aPE~l~----~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~ 295 (494)
.+|+||+||||++-... +.-..+ -.|-..|||||.+. ..+|+.++||||||+++.||.+++.||.. .++-++
T Consensus 184 ~~GqVKiCDFGIsG~L~--dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w~tpF~q 261 (282)
T KOG0984|consen 184 YDGQVKICDFGISGYLV--DSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESWGTPFQQ 261 (282)
T ss_pred cCCcEEEcccccceeeh--hhhHHHHhcCCCccCChhhcCcccCcccceeehhhhhhhhhhhhhhhccccccccCCHHHH
Confidence 99999999999987532 222222 45778899999985 34799999999999999999999999975 477788
Q ss_pred HHHHHhCC
Q psy8309 296 FWSICNER 303 (494)
Q Consensus 296 ~~~i~~~~ 303 (494)
+.+++...
T Consensus 262 LkqvVeep 269 (282)
T KOG0984|consen 262 LKQVVEEP 269 (282)
T ss_pred HHHHhcCC
Confidence 88887654
|
|
| >KOG1027|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-36 Score=309.79 Aligned_cols=248 Identities=27% Similarity=0.377 Sum_probs=195.4
Q ss_pred eEeeEeccCCceE-EEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 68 QLLKVLGKGSFGK-VFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 68 ~~~~~LG~G~fG~-V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
.-.+++|.|+-|+ ||+|... |+.||||.+-.+ ....+.+|...|....+|||||++++.-++..++||.+|
T Consensus 512 ~~~eilG~Gs~Gt~Vf~G~ye--~R~VAVKrll~e------~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalE 583 (903)
T KOG1027|consen 512 SPKEILGYGSNGTVVFRGVYE--GREVAVKRLLEE------FFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALE 583 (903)
T ss_pred ccHHHcccCCCCcEEEEEeeC--CceehHHHHhhH------hHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEeh
Confidence 3346899999985 8899864 568999987543 334677899999888899999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC---C
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY---E 223 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~---~ 223 (494)
.|. .+|.+|+... .... .. ......+..+.|++.||++||+.+||||||||.||||+. +
T Consensus 584 LC~-------------~sL~dlie~~-~~d~-~~---~~~i~~~~~l~q~~~GlaHLHsl~iVHRDLkPQNILI~~~~~~ 645 (903)
T KOG1027|consen 584 LCA-------------CSLQDLIESS-GLDV-EM---QSDIDPISVLSQIASGLAHLHSLKIVHRDLKPQNILISVPSAD 645 (903)
T ss_pred Hhh-------------hhHHHHHhcc-ccch-hh---cccccHHHHHHHHHHHHHHHHhcccccccCCCceEEEEccCCC
Confidence 997 4555555432 1111 11 111456778999999999999999999999999999986 3
Q ss_pred C--CEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 224 G--HVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 224 g--~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
| .++|+|||+|+....... ...+..||-+|+|||++....-+.++||+||||++|..++ |.+||...- +.-.
T Consensus 646 ~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltgG~HpFGd~~--~R~~ 723 (903)
T KOG1027|consen 646 GTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTGGSHPFGDSL--ERQA 723 (903)
T ss_pred cceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecCCccCCCchH--Hhhh
Confidence 4 589999999997543222 2445679999999999999888999999999999999998 599997543 3445
Q ss_pred HHHhCCCCCCc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 298 SICNERPRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 298 ~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+|+.+...+-. ....+++|||.+||..+|..|| ++.+++.||||.+
T Consensus 724 NIl~~~~~L~~L~~~~d~eA~dLI~~ml~~dP~~RP------sa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 724 NILTGNYTLVHLEPLPDCEAKDLISRMLNPDPQLRP------SATDVLNHPLFWD 772 (903)
T ss_pred hhhcCccceeeeccCchHHHHHHHHHhcCCCcccCC------CHHHHhCCCccCC
Confidence 78877655422 1222899999999999999999 6789999999964
|
|
| >KOG0668|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-36 Score=267.71 Aligned_cols=251 Identities=24% Similarity=0.433 Sum_probs=201.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC--e
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--H 140 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--~ 140 (494)
..++|++.+.+|+|-|+.||.|....+++.++||+++.- ....+.+|..+|.....||||++|+++..+.. -
T Consensus 36 ~~ddYeivrk~GRGKYSEVFeg~~~~~~eK~ViKiLKPV------kkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~Skt 109 (338)
T KOG0668|consen 36 NQDDYEIVRKVGRGKYSEVFEGINITNNEKCVIKILKPV------KKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKT 109 (338)
T ss_pred ccchHHHHHHHcCccHhhHhcccccCCCceEEEeeechH------HHHHHHHHHHHHHhccCCCCeeehhhhhcCccccC
Confidence 467999999999999999999999999999999998642 22457789999987778999999999988753 4
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
..||+||+++.+. . .--..|+.-+++.|+.|++.||.|+|++||+|||+||.|++|
T Consensus 110 paLiFE~v~n~Df---------------------k---~ly~tl~d~dIryY~~elLkALdyCHS~GImHRDVKPhNvmI 165 (338)
T KOG0668|consen 110 PSLIFEYVNNTDF---------------------K---QLYPTLTDYDIRYYIYELLKALDYCHSMGIMHRDVKPHNVMI 165 (338)
T ss_pred chhHhhhhccccH---------------------H---HHhhhhchhhHHHHHHHHHHHHhHHHhcCcccccCCcceeee
Confidence 6788999885432 1 223467888999999999999999999999999999999999
Q ss_pred CCC-CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHH
Q psy8309 221 DYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPF-SGCDEDELFW 297 (494)
Q Consensus 221 ~~~-g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf-~~~~~~~~~~ 297 (494)
|.. ..++|+|+|+|.... .+...+..+.+..|..||.+.. +.|+...|+|||||++..|+..+-|| .|.+..+.+-
T Consensus 166 dh~~rkLrlIDWGLAEFYH-p~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~dN~DQLV 244 (338)
T KOG0668|consen 166 DHELRKLRLIDWGLAEFYH-PGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 244 (338)
T ss_pred chhhceeeeeecchHhhcC-CCceeeeeeehhhcCCchheeechhccccHHHHHHHHHHHHHHhccCcccCCCCCHHHHH
Confidence 865 469999999998633 3444556678899999999875 45899999999999999999988886 4555444433
Q ss_pred HHHh-------------CCCCCC------------------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhh
Q psy8309 298 SICN-------------ERPRFP------------------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDD 340 (494)
Q Consensus 298 ~i~~-------------~~~~~p------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~e 340 (494)
+|.. -...++ .-.++++.|||.++|..|-.+|+ +++|
T Consensus 245 kIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDlldklLrYDHqeRl------TakE 318 (338)
T KOG0668|consen 245 KIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDLLDKLLRYDHQERL------TAKE 318 (338)
T ss_pred HHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHHHHHHHhhcccccc------chHH
Confidence 3321 011111 12579999999999999999999 6789
Q ss_pred hhcCCCcCCC
Q psy8309 341 VVAHEYFRGL 350 (494)
Q Consensus 341 il~h~~f~~~ 350 (494)
++.||||..+
T Consensus 319 am~HpyF~~~ 328 (338)
T KOG0668|consen 319 AMAHPYFAPV 328 (338)
T ss_pred HhcCchHHHH
Confidence 9999999754
|
|
| >KOG0664|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-36 Score=279.67 Aligned_cols=284 Identities=25% Similarity=0.391 Sum_probs=219.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS----- 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~----- 139 (494)
.|.+--+.||.|+||+||.+.+..+|+.||+|.+..- ..+-...++.++|..+|. ..+|.|++..++..+-..
T Consensus 53 ~Di~PDRPIGYGAFGVVWsVTDPRdgrrvalkK~pnv-fq~L~s~krvFre~kmLc-fFkHdNVLSaLDILQPph~dfFq 130 (449)
T KOG0664|consen 53 QDIQPDRPIGYGAFGVVWSVTDPRSGKRVALKKMPNV-FQNLASCKRVFREIKMLS-SFRHDNVLSLLDILQPANPSFFQ 130 (449)
T ss_pred ccCCCCCcccccceeEEEeccCCCCccchhHhhcchH-HHHHHHHHHHHHHHHHHH-hhccccHHHHHHhcCCCCchHHH
Confidence 3555668999999999999999999999999988642 222334567788888887 579999999988877543
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+++|+| ..+|...+.....++.+.++-++.||+.||+|||+.||+||||||.|+|
T Consensus 131 EiYV~TELm----------------------QSDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLHsA~ILHRDIKPGNLL 188 (449)
T KOG0664|consen 131 ELYVLTELM----------------------QSDLHKIIVSPQALTPDHVKVFVYQILRGLKYLHTANILHRDIKPGNLL 188 (449)
T ss_pred HHHHHHHHH----------------------HhhhhheeccCCCCCcchhhhhHHHHHhhhHHHhhcchhhccCCCccEE
Confidence 367777776 3566667777789999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
++++..+||||||+++........ ....+-|.+|.|||++.|. .|+.++||||+|||+.||+..+..|...++-+.++
T Consensus 189 VNSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~ 268 (449)
T KOG0664|consen 189 VNSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ 268 (449)
T ss_pred eccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH
Confidence 999999999999999974433222 2334568899999999985 49999999999999999999999999888766665
Q ss_pred HHHh-----------------------CCCCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 298 SICN-----------------------ERPRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 298 ~i~~-----------------------~~~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.|.. +..+-| ..-..++.+++..+|..||.+|. +..+.+.
T Consensus 269 lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d~dkri------s~~~A~~ 342 (449)
T KOG0664|consen 269 MIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFDPDKRI------SVEEALQ 342 (449)
T ss_pred HHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCCCcccc------cHhhhcc
Confidence 5531 112222 12345788999999999999998 6788999
Q ss_pred CCCcCCCChh-------------HHhcCcCCCCCcccccCCCCCcccc
Q psy8309 344 HEYFRGLDWQ-------------ALEKRELEPPFRPRVIEPFSSPWIK 378 (494)
Q Consensus 344 h~~f~~~~w~-------------~l~~~~~~pp~~p~~~~~~~~~~~~ 378 (494)
|++....... ....+...+-+-|...+++...|-+
T Consensus 343 ~~~~~e~R~r~~sCmC~~~~tt~~~~~r~f~~~~~P~~~~pFd~~~e~ 390 (449)
T KOG0664|consen 343 HRYLEEGRLRFHSCMCSCCYTKPNMPSRLFAQDLDPRHESPFDPKWEK 390 (449)
T ss_pred cccccccceeeeeeeEeeeccCCCcchhhhccccCcccCCCcChhHHH
Confidence 9998654321 1122344555556666555555544
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=312.40 Aligned_cols=240 Identities=34% Similarity=0.671 Sum_probs=197.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.-.+|+.++.|..|+||.||+++|+.+.+.+|+| ++|+.+.- +.++. ....|++|
T Consensus 81 ~e~df~~IklisngAygavylvrh~~trqrfa~k-iNkq~lil----------Rnilt-~a~npfvv------------- 135 (1205)
T KOG0606|consen 81 SESDFNTIKLISNGAYGAVYLVRHKETRQRFAMK-INKQNLIL----------RNILT-FAGNPFVV------------- 135 (1205)
T ss_pred CccccceeEeeccCCCCceeeeeccccccchhhc-ccccchhh----------hcccc-ccCCccee-------------
Confidence 4579999999999999999999999999999995 44432211 11222 34566665
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|| -...+..-+.++.+. +.|++|||+.||+|||+||+|.||+.
T Consensus 136 --------gD---------------------c~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllIT~ 178 (1205)
T KOG0606|consen 136 --------GD---------------------CATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLITS 178 (1205)
T ss_pred --------ch---------------------hhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCcceeee
Confidence 11 112344445665544 88999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCC---------------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 223 EGHVRIADFGMCKLQIYLDK---------------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~---------------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
-|++|++|||+++....... .....||||+|+|||++..++|+..+|||++|+|+||.+.|..||
T Consensus 179 mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpf 258 (1205)
T KOG0606|consen 179 MGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPF 258 (1205)
T ss_pred cccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeec
Confidence 99999999999986432111 124569999999999999999999999999999999999999999
Q ss_pred CCCCHHHHHHHHHhCCCCCCc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCC
Q psy8309 288 SGCDEDELFWSICNERPRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPF 364 (494)
Q Consensus 288 ~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~ 364 (494)
.++++++++...+.....+|. -+.++++++|.+||+.+|..|++.. ++-++++|+||+.+||..|..+ +.+|
T Consensus 259 fGdtpeelfg~visd~i~wpE~dea~p~Ea~dli~~LL~qnp~~Rlgt~---ga~evk~h~ff~~LDw~~llRq--kaef 333 (1205)
T KOG0606|consen 259 FGDTPEELFGQVISDDIEWPEEDEALPPEAQDLIEQLLRQNPLCRLGTG---GALEVKQHGFFQLLDWKSLLRQ--KAEF 333 (1205)
T ss_pred cCCCHHHHHhhhhhhhccccccCcCCCHHHHHHHHHHHHhChHhhcccc---hhhhhhhccceeecccchhhhh--hccc
Confidence 999999999999998888885 4789999999999999999999873 7899999999999999988766 4568
Q ss_pred ccccc
Q psy8309 365 RPRVI 369 (494)
Q Consensus 365 ~p~~~ 369 (494)
+|.+.
T Consensus 334 vpql~ 338 (1205)
T KOG0606|consen 334 VPQLE 338 (1205)
T ss_pred ccccc
Confidence 88877
|
|
| >KOG0200|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-33 Score=303.35 Aligned_cols=265 Identities=29% Similarity=0.430 Sum_probs=207.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC-------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG-------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFC 133 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~ 133 (494)
.+..++..+.+.||+|+||.|++|..+. ....||||.++... ...+......|..++.....|+||+.+++
T Consensus 292 e~~~~~l~~~~~lg~g~fG~v~~~~~~~~~~~~~~~~~~VaVK~~k~~~--~~~~~~~~~~El~~m~~~g~H~niv~llG 369 (609)
T KOG0200|consen 292 EIPRENLKLGKYLGEGAFGQVVKALLFGLSKALLSIYVTVAVKMLKENA--SSSEKKDLMSELNVLKELGKHPNIVNLLG 369 (609)
T ss_pred eechhhccccceeecccccceEeEEEeecccccccceEEEEEEeccccc--CcHHHHHHHHHHHHHHHhcCCcchhhhee
Confidence 3444566778899999999999997541 14569999998653 33667778899999998889999999999
Q ss_pred EEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 134 TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 134 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
++...+.+++|+|||..|+|...+.........+ ..+ .... ..++..+...++.||+.|++||++.++|||
T Consensus 370 ~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~--~~~-----~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~~~~vHR 442 (609)
T KOG0200|consen 370 ACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESID--GSG-----VFPNERDALTTKDLLSFAYQIANGMEYLASVPCVHR 442 (609)
T ss_pred eeccCCceEEEEEeccCCcHHHHHHhcccccccc--ccC-----CCccccCCcCHHHHHHHHHHHHHHHHHHhhCCccch
Confidence 9999999999999999877643222221000000 000 0001 248999999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCCcc-cccCCC--CCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT-DTFCGT--PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPF 287 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~-~~~~gt--~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf 287 (494)
||...|||+..+..+||+|||+|+......... ..-.|+ ..|||||.+....|+.++||||+||+|||+++ |..||
T Consensus 443 DLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PY 522 (609)
T KOG0200|consen 443 DLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPY 522 (609)
T ss_pred hhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCC
Confidence 999999999999999999999998533222221 222232 35999999999999999999999999999998 99999
Q ss_pred CCCC-HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 288 SGCD-EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 288 ~~~~-~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
.+.. ..+++..+..+ +..-|...+++..++++.||..+|++||+..+
T Consensus 523 p~~~~~~~l~~~l~~G~r~~~P~~c~~eiY~iM~~CW~~~p~~RP~F~~ 571 (609)
T KOG0200|consen 523 PGIPPTEELLEFLKEGNRMEQPEHCSDEIYDLMKSCWNADPEDRPTFSE 571 (609)
T ss_pred CCCCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhCCCcccCCCHHH
Confidence 9865 66666656655 56788999999999999999999999997644
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-35 Score=299.36 Aligned_cols=255 Identities=29% Similarity=0.467 Sum_probs=216.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|+++..+|.|+||.||+++++.+++..|+|+++.. ..+.+.....|+.++. ..+|||||.+++.+-..+.+++
T Consensus 14 ~ddyellqrvgsgTygdvyKaRd~~s~elaavkvVkLe---p~dd~~~iqqei~~~~-dc~h~nivay~gsylr~dklwi 89 (829)
T KOG0576|consen 14 QDDYELLQRVGSGTYGDVYKARDKRSGELAAVKVVKLE---PGDDFSGIQQEIGMLR-DCRHPNIVAYFGSYLRRDKLWI 89 (829)
T ss_pred ccchhheeeecCCcccchhhhcccccCchhhheeeecc---CCccccccccceeeee-cCCCcChHHHHhhhhhhcCcEE
Confidence 46999999999999999999999999999999999865 3344444555665555 6799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
.||||.||+|. ....-.+.++|.++.+..++.+.||+|||+.|=+|||||-.|||+++.
T Consensus 90 cMEycgggslQ---------------------diy~~TgplselqiayvcRetl~gl~ylhs~gk~hRdiKGanilltd~ 148 (829)
T KOG0576|consen 90 CMEYCGGGSLQ---------------------DIYHVTGPLSELQIAYVCRETLQGLKYLHSQGKIHRDIKGANILLTDE 148 (829)
T ss_pred EEEecCCCccc---------------------ceeeecccchhHHHHHHHhhhhccchhhhcCCcccccccccceeeccc
Confidence 99999966663 334456899999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhh---CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
|.+||+|||.+......-....++.|||+|||||+- +..+|...+|+|++|+...|+---++|-....+......+.
T Consensus 149 gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpmr~l~LmT 228 (829)
T KOG0576|consen 149 GDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPMRALFLMT 228 (829)
T ss_pred CceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhhhhcCCcccccchHHHHHHhh
Confidence 999999999987544444556789999999999985 46689999999999999999988888877666666666665
Q ss_pred hCCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+..+.-| ...++.+-+|++.+|.++|++||+ ++-++.|||...
T Consensus 229 kS~~qpp~lkDk~kws~~fh~fvK~altknpKkRpt------aeklL~h~fvs~ 276 (829)
T KOG0576|consen 229 KSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPT------AEKLLQHPFVSQ 276 (829)
T ss_pred ccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCC------hhhheeceeecc
Confidence 5555444 357899999999999999999995 556788999864
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-33 Score=322.78 Aligned_cols=235 Identities=22% Similarity=0.317 Sum_probs=178.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|...++||+|+||.||+|+.+.++..||||.+....... ..|..++. .++|||||++++++.+.+..|+||
T Consensus 691 ~~~~~~~ig~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~-------~~~~~~l~-~l~HpnIv~~~~~~~~~~~~~lv~ 762 (968)
T PLN00113 691 SLKEENVISRGKKGASYKGKSIKNGMQFVVKEINDVNSIP-------SSEIADMG-KLQHPNIVKLIGLCRSEKGAYLIH 762 (968)
T ss_pred hCCcccEEccCCCeeEEEEEECCCCcEEEEEEccCCcccc-------HHHHHHHh-hCCCCCcceEEEEEEcCCCCEEEE
Confidence 4566789999999999999999999999999986532111 12344454 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH---hCCCccccCCCCceeeCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH---KKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH---~~givHrDLKp~NILl~~ 222 (494)
||+++|+| ..++. .+++..+..++.||+.||+||| +.+|+||||||+||+++.
T Consensus 763 Ey~~~g~L---------------------~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~ 818 (968)
T PLN00113 763 EYIEGKNL---------------------SEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG 818 (968)
T ss_pred eCCCCCcH---------------------HHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECC
Confidence 99995554 44443 3788899999999999999999 669999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-----HHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-----DELFW 297 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-----~~~~~ 297 (494)
++..++. ||...... ......||+.|+|||++.+..|+.++|||||||++|||++|+.||..... .+...
T Consensus 819 ~~~~~~~-~~~~~~~~----~~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~~~~~~~~~~~~~ 893 (968)
T PLN00113 819 KDEPHLR-LSLPGLLC----TDTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPADAEFGVHGSIVEWAR 893 (968)
T ss_pred CCceEEE-eccccccc----cCCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCCcccCCCCcHHHHHH
Confidence 9888876 66554321 12234689999999999999999999999999999999999999953211 11111
Q ss_pred HHHhC-------CC------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 298 SICNE-------RP------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 298 ~i~~~-------~~------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..... .+ ..+.....++.+++.+||+.||++||+ +.|+++
T Consensus 894 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt------~~evl~ 946 (968)
T PLN00113 894 YCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPC------ANDVLK 946 (968)
T ss_pred HhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcC------HHHHHH
Confidence 11000 01 111112235778999999999999994 566653
|
|
| >KOG3653|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-32 Score=270.69 Aligned_cols=241 Identities=26% Similarity=0.415 Sum_probs=188.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-cCCCCceeeEEEEEEcCC-
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQTDS- 139 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-~~~hp~Iv~l~~~~~~~~- 139 (494)
..+...+++++||+|.||.||+|+... +.||||++... +.+....|+.+... .++|+||+++++.-....
T Consensus 207 ~~l~pl~l~eli~~Grfg~V~KaqL~~--~~VAVKifp~~------~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~ 278 (534)
T KOG3653|consen 207 LELDPLQLLELIGRGRFGCVWKAQLDN--RLVAVKIFPEQ------EKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA 278 (534)
T ss_pred ccCCchhhHHHhhcCccceeehhhccC--ceeEEEecCHH------HHHHHHhHHHHHhccCccchhHHHhhchhccCCc
Confidence 346678889999999999999998765 78999998643 45567778887764 469999999998876555
Q ss_pred ---eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---------C
Q psy8309 140 ---HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK---------G 207 (494)
Q Consensus 140 ---~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~---------g 207 (494)
.++||+||.+.|+| ..++.. ..++......++.-|+.||+|||+- .
T Consensus 279 ~~~eywLVt~fh~kGsL---------------------~dyL~~-ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~ 336 (534)
T KOG3653|consen 279 DRMEYWLVTEFHPKGSL---------------------CDYLKA-NTISWNSLCRIAESMARGLAHLHEELPRGDHHKPP 336 (534)
T ss_pred cccceeEEeeeccCCcH---------------------HHHHHh-ccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCc
Confidence 78999999996654 334443 4689999999999999999999962 5
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCC-CC-----CcchHHHHHHHHHH
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLK-YN-----QCVDWWSFGILLYE 279 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~-~~-----~~~DiwSlGvil~e 279 (494)
|+|||||..||||..|+++.|+|||||........ .+...+||.+|||||++.+.- .. .+.||||+|.+|||
T Consensus 337 IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWE 416 (534)
T KOG3653|consen 337 IAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWE 416 (534)
T ss_pred cccccccccceEEccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999987543222 233478999999999997632 22 47999999999999
Q ss_pred HHhCCC------------CCC-----CCCHHHHHHHHH--hCCCCCCccC-----CHHHHHHHHhhccCCCCCCCCC
Q psy8309 280 MHVGQS------------PFS-----GCDEDELFWSIC--NERPRFPQFL-----SVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 280 ll~G~~------------Pf~-----~~~~~~~~~~i~--~~~~~~p~~~-----s~~~~~li~~lL~~dP~~R~~~ 332 (494)
|++... ||. ....+++...++ +.++.+|+.+ -.-+++.|..||+.||+.|+++
T Consensus 417 i~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~~l~et~EeCWDhDaeARLTA 493 (534)
T KOG3653|consen 417 IASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMAVLCETIEECWDHDAEARLTA 493 (534)
T ss_pred HHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHHHHHHHHHHHcCCchhhhhhh
Confidence 997432 332 122345555554 3567777643 3457899999999999999987
|
|
| >KOG1025|consensus | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=285.97 Aligned_cols=244 Identities=25% Similarity=0.351 Sum_probs=200.6
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCe----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDY----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
..+..++||+|+||+||+|.+-..|+ +||||++..... ......++.|..+|. .++|||+++|++++.... +
T Consensus 697 elkk~kvLGsgAfGtV~kGiw~Pege~vKipVaiKvl~~~t~--~~~s~e~LdeAl~ma-sldHpnl~RLLgvc~~s~-~ 772 (1177)
T KOG1025|consen 697 ELKKDKVLGSGAFGTVYKGIWIPEGENVKIPVAIKVLIEFTS--PKASIELLDEALRMA-SLDHPNLLRLLGVCMLST-L 772 (1177)
T ss_pred hhhhhceeccccceeEEeeeEecCCceecceeEEEEeeccCC--chhhHHHHHHHHHHh-cCCCchHHHHhhhcccch-H
Confidence 45567899999999999999865554 588888866432 223345667777776 689999999999998776 7
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
-||++|+++| .|..+++. ++.+..+....|..||+.||.|||++++|||||...||||
T Consensus 773 qlvtq~mP~G---------------------~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~qrlVHrdLaaRNVLV 831 (1177)
T KOG1025|consen 773 QLVTQLMPLG---------------------CLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEEQRLVHRDLAARNVLV 831 (1177)
T ss_pred HHHHHhcccc---------------------hHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHhcchhhhhhhhhheee
Confidence 8889999855 44455553 4688999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccC--CCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFC--GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~--gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
..-.++||+|||+++.....+....... -.+.|||-|.+....|+.++||||+||++||++| |..|+.+...+++-.
T Consensus 832 ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWElmTFGa~Py~gi~~~eI~d 911 (1177)
T KOG1025|consen 832 KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWELMTFGAKPYDGIPAEEIPD 911 (1177)
T ss_pred cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHHHhcCCCccCCCCHHHhhH
Confidence 9999999999999987544333322222 2468999999999999999999999999999998 999999998888776
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
.+..+ ++.-|+..+.++.-++.+||..|+..||++.+
T Consensus 912 lle~geRLsqPpiCtiDVy~~mvkCwmid~~~rp~fke 949 (1177)
T KOG1025|consen 912 LLEKGERLSQPPICTIDVYMVMVKCWMIDADSRPTFKE 949 (1177)
T ss_pred HHhccccCCCCCCccHHHHHHHHHHhccCcccCccHHH
Confidence 66543 56778899999999999999999999997643
|
|
| >KOG2052|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=261.05 Aligned_cols=238 Identities=26% Similarity=0.405 Sum_probs=181.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-cCCCCceeeEEEEEEcC----C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQTD----S 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-~~~hp~Iv~l~~~~~~~----~ 139 (494)
.+..+.+.||+|-||.||+|++++. .||||++... +...-++|.++... .++|+||+.+++.-..+ .
T Consensus 211 rqI~L~e~IGkGRyGEVwrG~wrGe--~VAVKiF~sr------dE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~T 282 (513)
T KOG2052|consen 211 RQIVLQEIIGKGRFGEVWRGRWRGE--DVAVKIFSSR------DERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWT 282 (513)
T ss_pred heeEEEEEecCccccceeeccccCC--ceEEEEeccc------chhhhhhHHHHHHHHHhccchhhhhhhccccCCCceE
Confidence 4789999999999999999999865 4999999642 22344566666543 35899999999876543 3
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK--------GIVYR 211 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~--------givHr 211 (494)
.++||.+|-+.|+| ++++.+ ..++.+.+..++.-+++||+|||.. .|.||
T Consensus 283 QLwLvTdYHe~GSL---------------------~DyL~r-~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHR 340 (513)
T KOG2052|consen 283 QLWLVTDYHEHGSL---------------------YDYLNR-NTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHR 340 (513)
T ss_pred EEEEeeecccCCcH---------------------HHHHhh-ccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhcc
Confidence 69999999996554 456655 6788999999999999999999953 49999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeecc----CCcccccCCCCCccChhhhCCCC------CCCcchHHHHHHHHHHHH
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYL----DKTTDTFCGTPDYMAPEIIKGLK------YNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~----~~~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~ell 281 (494)
|||..||||..+|.+.|+|+|||...... +...+..+||.+|||||++...- --..+||||||.++||++
T Consensus 341 DlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEia 420 (513)
T KOG2052|consen 341 DLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIA 420 (513)
T ss_pred ccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHH
Confidence 99999999999999999999999764332 22356789999999999986421 225799999999999998
Q ss_pred h-----C-----CCCCCCCC-----HHHHHHHHHh--CCCCCCccCC--H---HHHHHHHhhccCCCCCCCCC
Q psy8309 282 V-----G-----QSPFSGCD-----EDELFWSICN--ERPRFPQFLS--V---EAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 282 ~-----G-----~~Pf~~~~-----~~~~~~~i~~--~~~~~p~~~s--~---~~~~li~~lL~~dP~~R~~~ 332 (494)
. | ++||++.- .+++..-++- -++.+|.... + .+..|++.||..||.-|+++
T Consensus 421 rRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~m~klMkeCW~~Np~aRltA 493 (513)
T KOG2052|consen 421 RRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRVMAKLMKECWYANPAARLTA 493 (513)
T ss_pred HHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHHHHHHHHHhhcCCchhhhHH
Confidence 5 2 58887532 2344333332 3456664332 2 35568999999999999965
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.9e-30 Score=242.58 Aligned_cols=215 Identities=41% Similarity=0.655 Sum_probs=179.5
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
|.+.+.||.|++|.||+|.+..+++.+|||.+...... ........|...+. .++|+|++++++++......++++|
T Consensus 1 ~~~~~~i~~g~~~~v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~-~~~~~~i~~~~~~~~~~~~~~~v~e 77 (225)
T smart00221 1 YELGKKLGEGAFGKVYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILK-KLKHPNIVKLYGVFEDPEPLYLVME 77 (225)
T ss_pred CceeeEeecCCCeEEEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHH-hCCCCChhhheeeeecCCceEEEEe
Confidence 57789999999999999999998999999999865322 24456666777776 4699999999999999999999999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCC-CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR-FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~-l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
++.++ +|...+..... +++..+..++.+++.+|.+||+++++|+||+|.||+++.++.
T Consensus 78 ~~~~~---------------------~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h~di~~~ni~v~~~~~ 136 (225)
T smart00221 78 YCEGG---------------------DLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGIVHRDLKPENILLGMDGL 136 (225)
T ss_pred ccCCC---------------------CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCC
Confidence 99844 45555655555 899999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccC-CcccccCCCCCccChhhh-CCCCCCCcchHHHHHHHHHHHHhCCCCCCC--CCHHHHHHHHHh
Q psy8309 226 VRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSG--CDEDELFWSICN 301 (494)
Q Consensus 226 vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGvil~ell~G~~Pf~~--~~~~~~~~~i~~ 301 (494)
++|+|||++....... .......++..|++||.+ ....++.++|+|+||+++|+|++|+.||.+ .+...+.+.|..
T Consensus 137 ~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~~~~~~~~~~~~~~~ 216 (225)
T smart00221 137 VKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSGEGEFTSLLSDVWSF 216 (225)
T ss_pred EEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccccchhHHHHHHHHhc
Confidence 9999999987643221 123456788999999999 667788899999999999999999999988 444577777777
Q ss_pred CCCC
Q psy8309 302 ERPR 305 (494)
Q Consensus 302 ~~~~ 305 (494)
+.+.
T Consensus 217 ~~~~ 220 (225)
T smart00221 217 GVPL 220 (225)
T ss_pred CCcc
Confidence 7643
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1167|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=263.77 Aligned_cols=252 Identities=22% Similarity=0.367 Sum_probs=195.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC---CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG---TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.|..++.||.|+|++||++.... .++.||+|.+.... ...++..|..+|.....+.||+++.+++..++.
T Consensus 35 ~~~~~~v~kigeGsFssv~~a~~~~~~~~~~~valk~i~~ts-----~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~ 109 (418)
T KOG1167|consen 35 SNAYKVVNKIGEGSFSSVYKATDIEQDTKRRYVALKAIYRTS-----SPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQ 109 (418)
T ss_pred hhhhhhhccccccchhhhhhhhHhhhccccceEeeeeccccc-----CchHHHHHHHHHHHhccchhhhcchhhhccCCe
Confidence 4679999999999999999998876 78899999886542 334578888999888899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+.+||||+++-+- ..+ ...++..+++.|++.++.||.++|.+|||||||||.|+|.
T Consensus 110 v~ivlp~~~H~~f---------------------~~l---~~~l~~~~i~~Yl~~ll~Al~~~h~~GIvHRDiKpsNFL~ 165 (418)
T KOG1167|consen 110 VAIVLPYFEHDRF---------------------RDL---YRSLSLAEIRWYLRNLLKALAHLHKNGIVHRDIKPSNFLY 165 (418)
T ss_pred eEEEecccCccCH---------------------HHH---HhcCCHHHHHHHHHHHHHHhhhhhccCccccCCCcccccc
Confidence 9999999984322 111 1246788999999999999999999999999999999999
Q ss_pred CC-CCCEEEeecCceeeee-----------------c-cCC--------------------------cccccCCCCCccC
Q psy8309 221 DY-EGHVRIADFGMCKLQI-----------------Y-LDK--------------------------TTDTFCGTPDYMA 255 (494)
Q Consensus 221 ~~-~g~vkL~DFGla~~~~-----------------~-~~~--------------------------~~~~~~gt~~y~a 255 (494)
+. .+.-.|+|||++.... . .+. ......||++|.|
T Consensus 166 n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRa 245 (418)
T KOG1167|consen 166 NRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRA 245 (418)
T ss_pred ccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCc
Confidence 85 4778999999986100 0 000 0112459999999
Q ss_pred hhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHHHH--------------hCC----------------
Q psy8309 256 PEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFWSIC--------------NER---------------- 303 (494)
Q Consensus 256 PE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~i~--------------~~~---------------- 303 (494)
||++.+. ..+.++||||.|||+.-++++..||.... .-..+..|. .+.
T Consensus 246 PEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~~l~~ksn~~~~~e~~ 325 (418)
T KOG1167|consen 246 PEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRILLWQKSNIPTIPELR 325 (418)
T ss_pred hHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCceeeeccccccccHHHH
Confidence 9998764 47889999999999999999999985321 111110000 000
Q ss_pred -----C----------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 304 -----P----------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 304 -----~----------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+ ...+..+..+.+|+.+||+.||.+|+ +++|+|+||||...
T Consensus 326 ~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRi------tAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 326 VNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRI------TAEDALKHPFFDEA 387 (418)
T ss_pred hchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcc------cHHHHhcCcCCcch
Confidence 0 00123456899999999999999999 68999999999854
|
|
| >KOG1345|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=246.73 Aligned_cols=237 Identities=26% Similarity=0.435 Sum_probs=180.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEE-EEEEcCCeeE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF-CTFQTDSHLF 142 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~-~~~~~~~~~~ 142 (494)
.+.|.+.+.||+|.||.+.+|+|++++..+++|.+.+.... .....+|-..-.....|.||+.-| ..|++.+.++
T Consensus 23 ~d~y~I~k~lgeG~FgkIlL~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~Yv 98 (378)
T KOG1345|consen 23 EDVYTINKQLGEGRFGKILLAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYV 98 (378)
T ss_pred hhhhhHHHHhcccceeeEEeeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEE
Confidence 45799999999999999999999999999999999876432 233444444333345789999766 4589999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
++|||++-|+|. .-+.. ..+.|.-.+.+++|+++||+|+|++++||||||.+||||-.
T Consensus 99 F~qE~aP~gdL~---------------------snv~~-~GigE~~~K~v~~ql~SAi~fMHsknlVHRdlK~eNiLif~ 156 (378)
T KOG1345|consen 99 FVQEFAPRGDLR---------------------SNVEA-AGIGEANTKKVFAQLLSAIEFMHSKNLVHRDLKAENILIFD 156 (378)
T ss_pred EeeccCccchhh---------------------hhcCc-ccccHHHHHHHHHHHHHHHHHhhccchhhcccccceEEEec
Confidence 999999977663 22222 45788999999999999999999999999999999999943
Q ss_pred C--CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-----CCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HH
Q psy8309 223 E--GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DE 294 (494)
Q Consensus 223 ~--g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~ 294 (494)
. -.|||||||+.+.. +..-...--+..|.+||+.... ...+.+|+|.||+++|.+|+|.+||..... ..
T Consensus 157 ~df~rvKlcDFG~t~k~---g~tV~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~ 233 (378)
T KOG1345|consen 157 ADFYRVKLCDFGLTRKV---GTTVKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDK 233 (378)
T ss_pred CCccEEEeeeccccccc---CceehhhhhhcccCCcHHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCc
Confidence 2 36999999998642 2222223345678999986432 246789999999999999999999974321 12
Q ss_pred HHHHHH----hCCCCCCc---cCCHHHHHHHHhhccCCCCCC
Q psy8309 295 LFWSIC----NERPRFPQ---FLSVEAKNILVHLLDKDTTKR 329 (494)
Q Consensus 295 ~~~~i~----~~~~~~p~---~~s~~~~~li~~lL~~dP~~R 329 (494)
-+++-. ...+..|+ -+++.+..+.++-|..++++|
T Consensus 234 ~Y~~~~~w~~rk~~~~P~~F~~fs~~a~r~Fkk~lt~~~~dr 275 (378)
T KOG1345|consen 234 PYWEWEQWLKRKNPALPKKFNPFSEKALRLFKKSLTPRFKDR 275 (378)
T ss_pred hHHHHHHHhcccCccCchhhcccCHHHHHHHHHhcCCccccc
Confidence 222222 22345554 579999999999999999999
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.5e-29 Score=234.57 Aligned_cols=212 Identities=39% Similarity=0.679 Sum_probs=179.6
Q ss_pred eccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCC
Q psy8309 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152 (494)
Q Consensus 73 LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~ 152 (494)
||+|++|.||+|....+++.+++|++....... .......|...+. .+.|++|+++++++......++++|++.|
T Consensus 1 l~~g~~~~v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~-~l~~~~i~~~~~~~~~~~~~~~~~e~~~~-- 75 (215)
T cd00180 1 LGEGGFGTVYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILK-KLNHPNIVKLYGVFEDENHLYLVMEYCEG-- 75 (215)
T ss_pred CCcCCceEEEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHH-hcCCCCeeeEeeeeecCCeEEEEEecCCC--
Confidence 689999999999998889999999997653211 3455667777776 57899999999999999999999999984
Q ss_pred CccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC-CCCEEEee
Q psy8309 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY-EGHVRIAD 230 (494)
Q Consensus 153 L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~-~g~vkL~D 230 (494)
++|..++... ..+++..+..++.+++.+|.+||++|++|+||+|.||+++. ++.++|+|
T Consensus 76 -------------------~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~H~dl~~~ni~~~~~~~~~~l~d 136 (215)
T cd00180 76 -------------------GSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLAD 136 (215)
T ss_pred -------------------CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHhhEEEeCCCCcEEEec
Confidence 4445555544 57899999999999999999999999999999999999999 89999999
Q ss_pred cCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcc
Q psy8309 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQF 309 (494)
Q Consensus 231 FGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~ 309 (494)
||.+..............+...|++||.+... .++.+.|+|+||+++++|
T Consensus 137 ~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l----------------------------- 187 (215)
T cd00180 137 FGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL----------------------------- 187 (215)
T ss_pred CCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH-----------------------------
Confidence 99987543222123445688999999999887 889999999999999999
Q ss_pred CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 310 ~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+.+++.+||..||.+|| +++++++|+
T Consensus 188 --~~~~~~l~~~l~~~p~~R~------~~~~l~~~~ 215 (215)
T cd00180 188 --PELKDLIRKMLQKDPEKRP------SAKEILEHL 215 (215)
T ss_pred --HHHHHHHHHHhhCCcccCc------CHHHHhhCC
Confidence 7889999999999999999 578888764
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1024|consensus | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-29 Score=242.27 Aligned_cols=246 Identities=22% Similarity=0.301 Sum_probs=195.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCC-----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
...++++..++-+|+||+||.|.++..+ +.|-+|.++.. ...-++...+.|..++. ...|||+..+.++..+
T Consensus 282 ~r~Rv~l~~llqEGtFGri~~gI~~eEdt~n~~q~v~vKTvk~~--AS~iQv~~~L~es~lly-~~sH~nll~V~~V~ie 358 (563)
T KOG1024|consen 282 QRCRVRLSCLLQEGTFGRIYRGIWREEDTYNDCQEVLVKTVKQH--ASQIQVNLLLQESMLLY-GASHPNLLSVLGVSIE 358 (563)
T ss_pred hhhheechhhhhcCchhheeeeeecccCCcchHHHHHHHHHHhc--ccHHHHHHHHHHHHHHh-cCcCCCccceeEEEee
Confidence 3457888889999999999999766443 23557776543 23445556666665555 6789999999988765
Q ss_pred C-CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 138 D-SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ--------QSGRFDEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 138 ~-~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~--------~~~~l~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
+ ..-++++.++.-| +|..++. ....++..+...++.|++.|++|||++||
T Consensus 359 ~~~~P~V~y~~~~~g---------------------NLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~am~hlh~~~V 417 (563)
T KOG1024|consen 359 DYATPFVLYPATGVG---------------------NLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAMAMEHLHNHGV 417 (563)
T ss_pred ccCcceEEEeccCcc---------------------hHHHHHHHhccCCCccccchhHHHHHHHHHHHHHHHHHHHhcCc
Confidence 4 4456666776644 4444444 12357778889999999999999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCC
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQS 285 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~ 285 (494)
||.||...|++||+.-.|||+|=.+++.....+.. .........||+||.+.+..|+.++|+|||||+||||+| |+.
T Consensus 418 iHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsfGVllWELmtlg~~ 497 (563)
T KOG1024|consen 418 IHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSFGVLLWELMTLGKL 497 (563)
T ss_pred ccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHHHHHHHHHHhcCCC
Confidence 99999999999999999999999999875433322 122223568999999999999999999999999999998 999
Q ss_pred CCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 286 PFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 286 Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
||...++.|+..-+..+ +..-|-++++++..++.-||..+|++||+.
T Consensus 498 PyaeIDPfEm~~ylkdGyRlaQP~NCPDeLf~vMacCWallpeeRPsf 545 (563)
T KOG1024|consen 498 PYAEIDPFEMEHYLKDGYRLAQPFNCPDELFTVMACCWALLPEERPSF 545 (563)
T ss_pred CccccCHHHHHHHHhccceecCCCCCcHHHHHHHHHHHhcCcccCCCH
Confidence 99999999999888876 456677899999999999999999999965
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-30 Score=290.07 Aligned_cols=194 Identities=16% Similarity=0.166 Sum_probs=142.6
Q ss_pred CceeeEEEEE-------EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHH
Q psy8309 126 PYLCHLFCTF-------QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIV 197 (494)
Q Consensus 126 p~Iv~l~~~~-------~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~ 197 (494)
+||++++++| .....++++||++ +++|..++.. ...+++.+++.++.||+
T Consensus 33 ~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~----------------------~~~L~~~l~~~~~~~~~~~~~~i~~qi~ 90 (793)
T PLN00181 33 DYVRSLLGSHKEGNLDGLDDDSIVRALECE----------------------DVSLRQWLDNPDRSVDAFECFHVFRQIV 90 (793)
T ss_pred HHHHHhhcccCCccccccccchhhhhhccC----------------------CccHHHHHhcccccccHHHHHHHHHHHH
Confidence 5777777777 2334577788877 4466666654 35699999999999999
Q ss_pred HHHHHHHhCCCccccCCCCceeeCCCC-------------------CEEEeecCceeeeeccC----------------C
Q psy8309 198 SGMRFLHKKGIVYRDLKLDNILLDYEG-------------------HVRIADFGMCKLQIYLD----------------K 242 (494)
Q Consensus 198 ~aL~yLH~~givHrDLKp~NILl~~~g-------------------~vkL~DFGla~~~~~~~----------------~ 242 (494)
.||.|||++||+||||||+||||+..| .+||+|||+++...... .
T Consensus 91 ~al~~lH~~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~ 170 (793)
T PLN00181 91 EIVNAAHSQGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPM 170 (793)
T ss_pred HHHHHHHhCCeeeccCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcc
Confidence 999999999999999999999996544 45555666554211000 0
Q ss_pred cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-CCCccCCHHHHHHHHhh
Q psy8309 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP-RFPQFLSVEAKNILVHL 321 (494)
Q Consensus 243 ~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~-~~p~~~s~~~~~li~~l 321 (494)
.....+||+.|||||++.+..|+.++|||||||+||||++|.+|+.... .....+..... ..+..-...+.+++.+|
T Consensus 171 ~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 248 (793)
T PLN00181 171 KQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVLPPQILLNWPKEASFCLWL 248 (793)
T ss_pred cccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhcChhhhhcCHHHHHHHHHh
Confidence 0112468999999999999999999999999999999999999876432 22222222111 11111245678999999
Q ss_pred ccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 322 LDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 322 L~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
|.++|.+|| ++.|+++||||..
T Consensus 249 L~~~P~~Rp------s~~eil~h~~~~~ 270 (793)
T PLN00181 249 LHPEPSCRP------SMSELLQSEFINE 270 (793)
T ss_pred CCCChhhCc------ChHHHhhchhhhh
Confidence 999999999 6789999999975
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=223.42 Aligned_cols=158 Identities=22% Similarity=0.308 Sum_probs=127.3
Q ss_pred CchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCC
Q psy8309 172 GDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250 (494)
Q Consensus 172 g~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 250 (494)
|+|...+.. ...+++.+++.++.||+.||.|||+++ ||+|||++.++.+|+ ||+++.... ....||
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~-----~~~~g~ 67 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTP-----EQSRVD 67 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeecc-----ccCCCc
Confidence 345556665 456999999999999999999999999 999999999999999 999875322 123689
Q ss_pred CCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH-HHHHHHHHhCCCCC-------CccCCH--HHHHHHHh
Q psy8309 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELFWSICNERPRF-------PQFLSV--EAKNILVH 320 (494)
Q Consensus 251 ~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~-~~~~~~i~~~~~~~-------p~~~s~--~~~~li~~ 320 (494)
+.|||||++.+..|+.++|||||||++|||++|..||..... ...+..+....... +..++. +++++|.+
T Consensus 68 ~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 147 (176)
T smart00750 68 PYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFMRV 147 (176)
T ss_pred ccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHHHH
Confidence 999999999999999999999999999999999999976543 23333433322111 223444 69999999
Q ss_pred hccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 321 LLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 321 lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
||..||.+|| ++.++++|+|+.
T Consensus 148 cl~~~p~~Rp------~~~~ll~~~~~~ 169 (176)
T smart00750 148 CASRLPQRRE------AANHYLAHCRAL 169 (176)
T ss_pred HHhccccccc------CHHHHHHHHHHH
Confidence 9999999999 678999999874
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-29 Score=269.81 Aligned_cols=256 Identities=25% Similarity=0.449 Sum_probs=198.2
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccc--cccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKD--VVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~--~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
....++|.|++|.|+.+......+.++.|..... ...........+.++......+.|||++.....+++....+-+|
T Consensus 321 ~~~~~~g~ga~g~~~~~~~~~~~~~~~~~~~r~~~~~~~s~~~~~~~i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~m 400 (601)
T KOG0590|consen 321 KPGRVLGSGAYGSVRIAKRRSDLKSFPEKEFRVRVKPTESERKYNYNITSEFCIGSSLSHPNIIETLDIVQEIDGILQSM 400 (601)
T ss_pred CccceeeecccCceEEEEecCCCccchhhhhhcccCCcccHHHHhhhhhhheeecccccCCchhhhHHHHhhcccchhhh
Confidence 4678999999999988888776666777655421 11111111121333444445689999988777777666666669
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|||+ + +|+..+...+.+...++..++.|++.||.|||+.||.||||||+|+|++.+|.
T Consensus 401 E~~~---------------------~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~GiahrdlK~enll~~~~g~ 458 (601)
T KOG0590|consen 401 EYCP---------------------Y-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDLKLENLLVTENGI 458 (601)
T ss_pred hccc---------------------H-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccCccccEEEecCCc
Confidence 9998 5 66777777788999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCC----cccccCCCCCccChhhhCCCCCCC-cchHHHHHHHHHHHHhCCCCCCCCCHHHHH-H--
Q psy8309 226 VRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKGLKYNQ-CVDWWSFGILLYEMHVGQSPFSGCDEDELF-W-- 297 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~-~~DiwSlGvil~ell~G~~Pf~~~~~~~~~-~-- 297 (494)
+||+|||.+........ ....++|+..|+|||++.+..|+. .+||||.|++++.|++|+.||......+.. .
T Consensus 459 lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~~~~~ 538 (601)
T KOG0590|consen 459 LKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNSFKTN 538 (601)
T ss_pred eEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccchhhh
Confidence 99999999876544333 356789999999999999999985 799999999999999999999755433221 1
Q ss_pred ------HHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 298 ------SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 298 ------~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
++..+...+-..++.+.+.+|.+||+.||.+|. ++++|++.+||+.++
T Consensus 539 ~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~------ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 539 NYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRI------TIEQILNDEWIRSIE 592 (601)
T ss_pred ccccccccccChHHHHHhchhhHHHHHHHHccCChhhee------cHHHHhhChHhhhcc
Confidence 111111222245788999999999999999998 789999999999874
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.95 E-value=6e-26 Score=223.89 Aligned_cols=251 Identities=38% Similarity=0.627 Sum_probs=198.5
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCC-ceeeEEEEEEcCCeeEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP-YLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp-~Iv~l~~~~~~~~~~~lv~ 145 (494)
|.+.+.||.|+||.||++.+. ..+|+|.+.+..............|..++.. +.|+ +|+++.+.+......++++
T Consensus 2 ~~~~~~l~~g~~~~v~~~~~~---~~~~~k~~~~~~~~~~~~~~~~~~e~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~ 77 (384)
T COG0515 2 YRILRKLGEGSFGEVYLARDR---KLVALKVLAKKLESKSKEVERFLREIQILAS-LNHPPNIVKLYDFFQDEGSLYLVM 77 (384)
T ss_pred ceeEEeecCCCCeEEEEEEec---cEEEEEeechhhccchhHHHHHHHHHHHHHH-ccCCcceeeEEEEEecCCEEEEEE
Confidence 788999999999999999988 6689999987644333345667777777774 5666 8999999998888899999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG---RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+++.++++ ...+.... .+++..+..++.|++.++.|+|+.|++||||||+||+++.
T Consensus 78 ~~~~~~~l---------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~~~~~hrd~kp~nil~~~ 136 (384)
T COG0515 78 EYVDGGSL---------------------EDLLKKIGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDR 136 (384)
T ss_pred ecCCCCcH---------------------HHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeecC
Confidence 99995544 43444443 7999999999999999999999999999999999999999
Q ss_pred CC-CEEEeecCceeeeeccCC------cccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 223 EG-HVRIADFGMCKLQIYLDK------TTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 223 ~g-~vkL~DFGla~~~~~~~~------~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
.+ .++++|||+++....... .....+||..|+|||.+.+ ..+....|+||+|++++++++|..||.....
T Consensus 137 ~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~g~~~~~~~~~~~p~~~~~~ 216 (384)
T COG0515 137 DGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKN 216 (384)
T ss_pred CCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 98 799999999874332221 3467789999999999988 5789999999999999999999999887763
Q ss_pred ----HHHHHHHHhCCCC-CCccC--------CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 293 ----DELFWSICNERPR-FPQFL--------SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 293 ----~~~~~~i~~~~~~-~p~~~--------s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
......+...... ..... ...+.+++..++..+|..|.++ .+...++|..
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~------~~~~~~~~~~ 279 (384)
T COG0515 217 SSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSS------SSDLSHDLLA 279 (384)
T ss_pred cccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCH------HHHhhchHhh
Confidence 4555555444332 22111 1578999999999999999953 4445554443
|
|
| >KOG1165|consensus | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-26 Score=219.69 Aligned_cols=211 Identities=23% Similarity=0.333 Sum_probs=174.6
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++++.||+|+||..++|+..-+++.||||.-..+. .+-....|-.........++|.+.+++-+...+-.|||
T Consensus 29 hyrVGkKIGeGsFG~lf~G~Nl~nne~VAIKfEPrkS-----~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVi 103 (449)
T KOG1165|consen 29 HYRVGKKIGEGSFGVLFLGKNLYNNEPVAIKFEPRKS-----EAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVI 103 (449)
T ss_pred cceeccccccCcceeeecccccccCceEEEEeccccC-----CcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhh
Confidence 7999999999999999999999999999999875442 22344455555555568899999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|++ |.+|.+...-. .+|+...+..++.|++.-++|+|++.+|+|||||+|+||...|
T Consensus 104 dLL----------------------GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k~LIYRDIKPdNFLIGrp~ 161 (449)
T KOG1165|consen 104 DLL----------------------GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEKDLIYRDIKPDNFLIGRPG 161 (449)
T ss_pred hhh----------------------CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhcceeecccCccceeecCCC
Confidence 987 44444444433 4799999999999999999999999999999999999997655
Q ss_pred -----CEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---
Q psy8309 225 -----HVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG--- 289 (494)
Q Consensus 225 -----~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~--- 289 (494)
.|.|+|||+|+....... ...+..||..||+-....|...+.+.|+-|||.+++.+|.|.+||.|
T Consensus 162 ~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 162 TKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred CCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 389999999986443221 24567899999999999999999999999999999999999999986
Q ss_pred CCHHHHHHHHHhCC
Q psy8309 290 CDEDELFWSICNER 303 (494)
Q Consensus 290 ~~~~~~~~~i~~~~ 303 (494)
.+..+-+++|-..+
T Consensus 242 ~tnK~kYeKIGe~K 255 (449)
T KOG1165|consen 242 DTNKEKYEKIGETK 255 (449)
T ss_pred cchHHHHHHhcccc
Confidence 45667777776543
|
|
| >KOG1164|consensus | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.4e-25 Score=223.03 Aligned_cols=240 Identities=24% Similarity=0.288 Sum_probs=182.6
Q ss_pred CceEeeEeccCCceEEEEEEEeCCC-eEEEeeeeccccccChhhHHHHHHHHHHHHhcC---CCCceeeEEEEE-EcCCe
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTD-YYYAVKCLKKDVVLEDDDVECTLIERKVLALGT---KHPYLCHLFCTF-QTDSH 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~---~hp~Iv~l~~~~-~~~~~ 140 (494)
.|.+.+.||+|+||.||+|.+..++ ..+|+|+.......... ....|..++.... ..+++..+++.. ....+
T Consensus 19 ~~~i~~~iG~G~fG~V~~v~~~~~~~~~~a~K~e~~~~~~~~~---~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~ 95 (322)
T KOG1164|consen 19 RYKLGKKIGEGGFGAVYLVSDKSEKNKEYAKKLEKKELGSKPS---VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDF 95 (322)
T ss_pred ceEEeeeccccCCceEEEEEecCCCCeeEEEEEEEecccCCCc---cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCce
Confidence 8999999999999999999988774 67999988764222111 3445666665433 346899999999 58889
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
-|+||+.+ |.+|...... .+.|+...+..++.|++.+|++||+.|++||||||.|+
T Consensus 96 ~~iVM~l~----------------------G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~~G~iHRDiKp~N~ 153 (322)
T KOG1164|consen 96 NFIVMSLL----------------------GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHSKGFIHRDIKPENF 153 (322)
T ss_pred eEEEEecc----------------------CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHhcCcccCCcCHHHe
Confidence 99999987 6666665533 36899999999999999999999999999999999999
Q ss_pred eeCCC-----CCEEEeecCcee--eeeccCC-------c-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC
Q psy8309 219 LLDYE-----GHVRIADFGMCK--LQIYLDK-------T-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283 (494)
Q Consensus 219 Ll~~~-----g~vkL~DFGla~--~~~~~~~-------~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G 283 (494)
++... ..+.|.|||+++ ....... . ...+.||..|+++.+..+...+.+.|+||++.++.||+.|
T Consensus 154 ~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g 233 (322)
T KOG1164|consen 154 VVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKG 233 (322)
T ss_pred eecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcC
Confidence 99865 359999999998 3211111 1 2345699999999999999999999999999999999999
Q ss_pred CCCCCCCCHHHHHHHH---HhCCCC--CCccCCHHHHHHHHhhccCCCCCCC
Q psy8309 284 QSPFSGCDEDELFWSI---CNERPR--FPQFLSVEAKNILVHLLDKDTTKRL 330 (494)
Q Consensus 284 ~~Pf~~~~~~~~~~~i---~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~ 330 (494)
.+||.+........++ ...... +....+.++..+...+-..+...+|
T Consensus 234 ~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~P 285 (322)
T KOG1164|consen 234 SLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKP 285 (322)
T ss_pred CCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCC
Confidence 9999775532222222 211111 2334556777777777767777777
|
|
| >KOG1163|consensus | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.5e-26 Score=205.10 Aligned_cols=242 Identities=21% Similarity=0.264 Sum_probs=189.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+....|.+++.||+|+||.+|+|....+|..||||+-....-. .....|..+.........|..+..++.+..+-
T Consensus 12 iv~gky~lvrkiGsGSFGdIy~~~~i~~ge~VAiK~Es~~a~h-----pqL~yEskvY~iL~~g~GiP~i~~y~~e~~yn 86 (341)
T KOG1163|consen 12 IVGGKYKLVRKIGSGSFGDIYLGISITSGEEVAIKLESSKAKH-----PQLLYESKVYRILQGGVGIPHIRHYGTEKDYN 86 (341)
T ss_pred eeccceEEEEeecCCchhheeeeeeccCCceEEEEeecccCCC-----cchhHHHHHHHHhccCCCCchhhhhccccccc
Confidence 3456899999999999999999999999999999987654221 13445666655444567888888889999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
.+|||++ |.+|.....- ...|+...+.-++-|++.-++|+|.+++|||||||+|+|.
T Consensus 87 vlVMdLL----------------------GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~fiHRDIKPdNFLM 144 (341)
T KOG1163|consen 87 VLVMDLL----------------------GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNFIHRDIKPDNFLM 144 (341)
T ss_pred eeeeecc----------------------CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhccccccCCccceee
Confidence 9999988 4444444432 3578999999999999999999999999999999999999
Q ss_pred CCCC---CEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 221 DYEG---HVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 221 ~~~g---~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
.-+- .+.|+|||+|+...... .......||..|.+-....+...+.+.|+-|+|.+|..+..|.+||.+.
T Consensus 145 Glgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQgl 224 (341)
T KOG1163|consen 145 GLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGL 224 (341)
T ss_pred ccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCccccc
Confidence 7554 47899999998643221 1234567999999999999888999999999999999999999999975
Q ss_pred C---HHHHHHHHHhCCCCCC-----ccCCHHHHHHHHhhccCCCCCCC
Q psy8309 291 D---EDELFWSICNERPRFP-----QFLSVEAKNILVHLLDKDTTKRL 330 (494)
Q Consensus 291 ~---~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~ 330 (494)
. ...-+++|.+.+...| ..++.|+.-.|.-|-..--++-|
T Consensus 225 ka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~P 272 (341)
T KOG1163|consen 225 KAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKP 272 (341)
T ss_pred chhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCC
Confidence 4 4556777887766655 46778877777766544444433
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-25 Score=225.33 Aligned_cols=166 Identities=19% Similarity=0.164 Sum_probs=125.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-CCeEEEeeeeccccc--cChhhHHHHHHHHHHHHhcCCCCceee-EEEEEEcC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-TDYYYAVKCLKKDVV--LEDDDVECTLIERKVLALGTKHPYLCH-LFCTFQTD 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~--~~~~~~~~~~~e~~~l~~~~~hp~Iv~-l~~~~~~~ 138 (494)
-.++|.+.++||+|+||+||+|+++. ++..||||++..... ...........|..++. .++|+||+. +++.
T Consensus 16 ~~~~Y~~~~~IG~G~fg~Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~-~L~h~~iv~~l~~~---- 90 (365)
T PRK09188 16 LSARFVETAVLKRDVFSTVERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALK-TVRGIGVVPQLLAT---- 90 (365)
T ss_pred ccCCceEccEEeecCcEEEEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHH-hccCCCCCcEEEEc----
Confidence 35689999999999999999999876 678889998753311 12223455778888887 578999985 4432
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC-CCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL-KLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL-Kp~N 217 (494)
+..|+|||||+|++| .. ... .. ...++.|++.||.|||++||+|||| ||+|
T Consensus 91 ~~~~LVmE~~~G~~L---------------------~~-~~~---~~---~~~~~~~i~~aL~~lH~~gIiHrDL~KP~N 142 (365)
T PRK09188 91 GKDGLVRGWTEGVPL---------------------HL-ARP---HG---DPAWFRSAHRALRDLHRAGITHNDLAKPQN 142 (365)
T ss_pred CCcEEEEEccCCCCH---------------------HH-hCc---cc---hHHHHHHHHHHHHHHHHCCCeeCCCCCcce
Confidence 468999999996655 21 110 01 1457899999999999999999999 9999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC--------cccccCCCCCccChhhhCC
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK--------TTDTFCGTPDYMAPEIIKG 261 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~--------~~~~~~gt~~y~aPE~l~~ 261 (494)
||++.++.+||+|||+|+....... ...+.+|++.|+|||.+.-
T Consensus 143 ILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~ 194 (365)
T PRK09188 143 WLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTP 194 (365)
T ss_pred EEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCCh
Confidence 9999999999999999985432211 1135678999999999864
|
|
| >KOG0606|consensus | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=237.96 Aligned_cols=282 Identities=30% Similarity=0.514 Sum_probs=237.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....+++.+.+-+-+|++|.++.+....+|...++|+..+.........+....+..++. ...+|.++.....|.....
T Consensus 800 rsS~d~~~i~~p~qS~sp~ss~p~~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i-~p~~P~v~~~~~s~~~rsP 878 (1205)
T KOG0606|consen 800 RSSPDGFEITKPSQSGSPSSSFPASPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILI-TPRSPAVVRSFPSFPCRSP 878 (1205)
T ss_pred cCCCccceecccccCCCCcccccCCccccccccchhhhccchhhccccccccCCccCccc-cCCCCceecccCCCCCCCC
Confidence 356788999999999999999999999999888888887665555555566666666554 3467888887777777889
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++||++|+. |+++...+++.+..+++-++.++..++.+++|||...++|||++|.|+|+
T Consensus 879 ~~L~~~~~~---------------------~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~ 937 (1205)
T KOG0606|consen 879 LPLVGHYLN---------------------GGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI 937 (1205)
T ss_pred cchhhHHhc---------------------cCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh
Confidence 999999998 55666678888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCcee-eeec-----c-------------------------CCcccccCCCCCccChhhhCCCCCCCcch
Q psy8309 221 DYEGHVRIADFGMCK-LQIY-----L-------------------------DKTTDTFCGTPDYMAPEIIKGLKYNQCVD 269 (494)
Q Consensus 221 ~~~g~vkL~DFGla~-~~~~-----~-------------------------~~~~~~~~gt~~y~aPE~l~~~~~~~~~D 269 (494)
..+|+.+++|||... .... . ........||+.|.+||.+.+...+.++|
T Consensus 938 ~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad 1017 (1205)
T KOG0606|consen 938 AYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAAD 1017 (1205)
T ss_pred cccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcch
Confidence 999999999998432 2100 0 01123467999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 270 iwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
||++|++++|.++|.+||....+...+++|.+....+|. ..+.++++++..+|..+|.+|.++. .+-++..|+|
T Consensus 1018 ~~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~---~~~e~k~~~~ 1094 (1205)
T KOG0606|consen 1018 WWSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPWPEGPEEGSYEAQDLINRLLTEEPTQRLGAK---GAAEVKGHPF 1094 (1205)
T ss_pred hhhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCCCCCccccChhhhhhhhhhhccCchhccCcc---cccccccCCc
Confidence 999999999999999999999999999999999888774 5799999999999999999999874 5779999999
Q ss_pred cCCCChhHHhcCcCCCCCccccc
Q psy8309 347 FRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 347 f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
|++++|+.|..+. .+|+|...
T Consensus 1095 ~~~~~~~~l~~q~--~~~~p~~~ 1115 (1205)
T KOG0606|consen 1095 FQDVDWENLALQK--AEFVPQPE 1115 (1205)
T ss_pred cCCCCcccccccc--CccCCCCC
Confidence 9999999996554 34566655
|
|
| >KOG1240|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=3.3e-24 Score=228.99 Aligned_cols=237 Identities=23% Similarity=0.301 Sum_probs=180.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccc-ccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV-VLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+|...+.||++-|=+|.+|++.. |. |+||++-+.. ...-....+.+.|++.. .++|||++.+.-+-.++...|||
T Consensus 24 e~~~~~~LGstRFlKv~r~k~~e-G~-vVvKVFvk~~p~~sL~~~~qrL~~ik~~--l~~~pn~lPfqk~~~t~kAAylv 99 (1431)
T KOG1240|consen 24 ECHYVENLGSTRFLKVARAKDRE-GL-VVVKVFVKQDPTISLRPFKQRLEEIKFA--LMKAPNCLPFQKVLVTDKAAYLV 99 (1431)
T ss_pred ceeeecccCchhhhhhhhccCCC-ce-EEEEEEeccCCCCCchHHHHHHHHHHHH--hhcCCcccchHHHHHhhHHHHHH
Confidence 78999999999999999998754 43 8999986643 33334455555555532 47999999998887788888888
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
-+|+. .+|.+++..+.-+.+.+.+.|+.||+.||.-+|..||+|+|||.|||||++-.
T Consensus 100 Rqyvk----------------------hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVcHGDIKsENILiTSWN 157 (1431)
T KOG1240|consen 100 RQYVK----------------------HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVCHGDIKSENILITSWN 157 (1431)
T ss_pred HHHHh----------------------hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCccccccccceEEEeeec
Confidence 88874 46677788888888999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCc-------ccccCCCCCccChhhhCCCC-----------CCCcchHHHHHHHHHHHHh-CCC
Q psy8309 225 HVRIADFGMCKLQIYLDKT-------TDTFCGTPDYMAPEIIKGLK-----------YNQCVDWWSFGILLYEMHV-GQS 285 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~-------~~~~~gt~~y~aPE~l~~~~-----------~~~~~DiwSlGvil~ell~-G~~ 285 (494)
.+.|+||..-|.-.-.... ..+...-..|+|||.+.... .+++.||||+||+++||++ |++
T Consensus 158 W~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~P 237 (1431)
T KOG1240|consen 158 WLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRP 237 (1431)
T ss_pred hhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCC
Confidence 9999999876531111111 11122234799999975421 5678999999999999998 899
Q ss_pred CCCC-----------CCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 286 PFSG-----------CDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 286 Pf~~-----------~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
||.- .+.+..+++| -+...++||..|++.||.+|+ ++++.|+.
T Consensus 238 lF~LSQL~aYr~~~~~~~e~~Le~I----------ed~~~Rnlil~Mi~rdPs~Rl------SAedyL~~ 291 (1431)
T KOG1240|consen 238 LFTLSQLLAYRSGNADDPEQLLEKI----------EDVSLRNLILSMIQRDPSKRL------SAEDYLQK 291 (1431)
T ss_pred cccHHHHHhHhccCccCHHHHHHhC----------cCccHHHHHHHHHccCchhcc------CHHHHHHh
Confidence 9941 1122222222 144789999999999999999 56777764
|
|
| >KOG4158|consensus | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.1e-23 Score=198.99 Aligned_cols=204 Identities=28% Similarity=0.431 Sum_probs=146.4
Q ss_pred CCCCceeeEEEEEEcC---------------------------CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchh
Q psy8309 123 TKHPYLCHLFCTFQTD---------------------------SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175 (494)
Q Consensus 123 ~~hp~Iv~l~~~~~~~---------------------------~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~ 175 (494)
.+|||||++...|.+. ..+|+||.-.. .+|.+|+..
T Consensus 273 a~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~-------------~tLr~yl~~---- 335 (598)
T KOG4158|consen 273 AKHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYR-------------QTLREYLWT---- 335 (598)
T ss_pred CCCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcch-------------hhHHHHHhc----
Confidence 4799999999888643 22577776554 445555432
Q ss_pred HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC--CCC--CEEEeecCceeeeec------cCCccc
Q psy8309 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD--YEG--HVRIADFGMCKLQIY------LDKTTD 245 (494)
Q Consensus 176 ~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~--~~g--~vkL~DFGla~~~~~------~~~~~~ 245 (494)
...+....+-+++|++.|+.|||++||.|||||.+||||. .|+ .+.|+|||.|-.... .....-
T Consensus 336 ------~~~s~r~~~~~laQlLEav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~V 409 (598)
T KOG4158|consen 336 ------RHRSYRTGRVILAQLLEAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEV 409 (598)
T ss_pred ------CCCchHHHHHHHHHHHHHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccc
Confidence 2355667788999999999999999999999999999984 333 479999997743111 111122
Q ss_pred ccCCCCCccChhhhCCCC------CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH--HHhCCCCCCccCCHHHHHH
Q psy8309 246 TFCGTPDYMAPEIIKGLK------YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS--ICNERPRFPQFLSVEAKNI 317 (494)
Q Consensus 246 ~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~--i~~~~~~~p~~~s~~~~~l 317 (494)
..-|...-||||+....+ --.++|.|+.|.+.||++....||++..+..+--. -...-+.+|+.+++.+++|
T Consensus 410 d~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLPalp~~vpp~~rql 489 (598)
T KOG4158|consen 410 DLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLPALPSRVPPVARQL 489 (598)
T ss_pred cCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCCCCcccCChHHHHH
Confidence 345778899999986532 12479999999999999999999998443211111 1123467788999999999
Q ss_pred HHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 318 LVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 318 i~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
+..+|+.||++|++..- +..+++-..|.--+|
T Consensus 490 V~~lL~r~pskRvsp~i---AANvl~LsLw~~~~~ 521 (598)
T KOG4158|consen 490 VFDLLKRDPSKRVSPNI---AANVLNLSLWRMGED 521 (598)
T ss_pred HHHHhcCCccccCCccH---HHhHHHHHHhcCchH
Confidence 99999999999997632 455666555554444
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.4e-23 Score=189.86 Aligned_cols=141 Identities=18% Similarity=0.167 Sum_probs=102.1
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhh-----------------------HHHHHHHHHHHHhcCCCC
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-----------------------VECTLIERKVLALGTKHP 126 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~-----------------------~~~~~~e~~~l~~~~~hp 126 (494)
...||+|+||.||+|.+. +|+.||||+++......... ......|...+.. +.++
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vAvKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~ 79 (190)
T cd05147 2 NGCISTGKEANVYHATTA-NGEERAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKSNPRKMVRTWAEKEMRNLKR-LVTA 79 (190)
T ss_pred CCccccccceEEEEEECC-CCCEEEEEEEEecccccccHHHhhcCCchhhccccCCCHHHHHHHHHHHHHHHHHH-HHHC
Confidence 467999999999999987 89999999997653211110 0122336566553 4455
Q ss_pred ceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHH-Hh
Q psy8309 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFL-HK 205 (494)
Q Consensus 127 ~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yL-H~ 205 (494)
++....... .. ..+|||||++|+++ .......+.+++..+..++.||+.+|.+| |+
T Consensus 80 ~v~~p~~~~-~~-~~~iVmE~i~g~~l---------------------~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~ 136 (190)
T cd05147 80 GIPCPEPIL-LK-SHVLVMEFIGDDGW---------------------AAPRLKDAPLSESKARELYLQVIQIMRILYQD 136 (190)
T ss_pred CCCCCcEEE-ec-CCEEEEEEeCCCCC---------------------cchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 543222221 12 23899999986543 22222346789999999999999999999 79
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.||+||||||+|||++ ++.++|+|||+|..
T Consensus 137 ~giiHrDlkP~NIli~-~~~v~LiDFG~a~~ 166 (190)
T cd05147 137 CRLVHADLSEYNLLYH-DGKLYIIDVSQSVE 166 (190)
T ss_pred CCcccCCCCHHHEEEE-CCcEEEEEcccccc
Confidence 9999999999999998 58899999999863
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.89 E-value=3e-23 Score=200.04 Aligned_cols=238 Identities=21% Similarity=0.236 Sum_probs=141.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC---------CCceeeEEEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK---------HPYLCHLFCTFQ 136 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~---------hp~Iv~l~~~~~ 136 (494)
.+...+.||.|++|.||.+.+..|++.+|||+..-.........+....|......... |-.++-.++...
T Consensus 13 ~l~~~~~i~~g~~~~v~~v~d~~t~~~~avkvf~~~~~~~~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~ 92 (288)
T PF14531_consen 13 TLVRGRIIGKGGFSIVFEVTDVETGEEFAVKVFLLPADASANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLR 92 (288)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEEESSTTHTTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEE
T ss_pred EEEEccccccCCceEEEEEEEccCCceEEEEEEecccccchHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEE
Confidence 46678899999999999999999999999999865542233344444333322221111 212222222221
Q ss_pred ---------cCC--------eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCC---CHHHH-HHHHHH
Q psy8309 137 ---------TDS--------HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF---DEGRA-RFYAAE 195 (494)
Q Consensus 137 ---------~~~--------~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l---~e~~~-~~~~~q 195 (494)
... +.+++|.-+. +||. .+. ..+...... ....+ ..+..|
T Consensus 93 i~~~~~~~~~~~~~~~~~v~n~~~l~P~~~-~dL~---------~~~---------~~l~~~~~~~~~l~~~arl~lT~Q 153 (288)
T PF14531_consen 93 IPGKPPFFERGPGQSIYWVLNRFLLMPRAQ-GDLQ---------DLV---------EALFSRAQTHSPLAFAARLSLTVQ 153 (288)
T ss_dssp ETTS-SEEEECETTEEEEEESEEEEEE--S-EEHH---------HHH---------HHHHHHTTTSHHHHHHHHHHHHHH
T ss_pred EcCCCcceecCCCCccceeehhhhccchhh-hcHH---------HHH---------HHHhhcccccchhHHHHHHHHHHH
Confidence 111 2355566553 2221 111 112222111 11223 345589
Q ss_pred HHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC--------CCCCCc
Q psy8309 196 IVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG--------LKYNQC 267 (494)
Q Consensus 196 i~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~ 267 (494)
++..+++||.+|++|+||||+|++++.+|.+.|+||+..... +........+..|.+||.... ..++.+
T Consensus 154 ~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~---g~~~~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~ 230 (288)
T PF14531_consen 154 MIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLVRA---GTRYRCSEFPVAFTPPELESCAGQFGQNNAPYTFA 230 (288)
T ss_dssp HHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEEET---TEEEEGGGS-TTTS-HHHHHHHTSCHHSEEEE-HH
T ss_pred HHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHeec---CceeeccCCCcccCChhhhhhhcccCcccceeeec
Confidence 999999999999999999999999999999999999976541 222221345678999998743 247889
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCC
Q psy8309 268 VDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKR 329 (494)
Q Consensus 268 ~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R 329 (494)
.|.|+||+++|.|.+|..||........... ....-..+++..+.||.++|+.||.+|
T Consensus 231 ~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~----~f~~C~~~Pe~v~~LI~~lL~~~~~~R 288 (288)
T PF14531_consen 231 TDAWQLGITLYSLWCGRLPFGLSSPEADPEW----DFSRCRDMPEPVQFLIRGLLQRNPEDR 288 (288)
T ss_dssp HHHHHHHHHHHHHHHSS-STCCCGGGSTSGG----GGTTSS---HHHHHHHHHHT-SSGGGS
T ss_pred cCHHHHHHHHHHHHHccCCCCCCCccccccc----cchhcCCcCHHHHHHHHHHccCCcccC
Confidence 9999999999999999999986543221111 111112678999999999999999988
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=8.4e-23 Score=191.41 Aligned_cols=175 Identities=18% Similarity=0.165 Sum_probs=127.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHH------HHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC------TLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~------~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
+-..+|+++++||.|+||.||++.. ++..+|||++.......+..... ...|...+. .+.||+|..+..++
T Consensus 28 ~l~~~y~~~~~l~~~~f~~v~l~~~--~~~~~iiKvf~~~~~~~~~~~~~f~~g~~~e~Ea~~l~-rL~~~GI~~~~d~~ 104 (232)
T PRK10359 28 FLSYNIKTIKVFRNIDDTKVSLIDT--DYGKYILKVFAPKVKRTERFLKSFVKGDYYENLIVQTD-RVRSEGLASLNDFY 104 (232)
T ss_pred HhhCceEEEEEecCCCceEEEEEec--CCCcEEEEEechhcCchHHHHHhhhhhHHHHHHHHHHH-HHHHCCCCcceEee
Confidence 3457899999999999999999765 35569999997654333333333 235555666 46899999998886
Q ss_pred EcC--------CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy8309 136 QTD--------SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG 207 (494)
Q Consensus 136 ~~~--------~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g 207 (494)
... ...+|||||++|.+|. .. ..+++. ...+|+.+|..||++|
T Consensus 105 ~~~~~~~~~~~~~~~lvmEyi~G~tL~---------------------~~----~~~~~~----~~~~i~~~l~~lH~~g 155 (232)
T PRK10359 105 LLAERKTLRYAHTYIMLIEYIEGVELN---------------------DM----PEISED----VKAKIKASIESLHQHG 155 (232)
T ss_pred eecccccccccCCeEEEEEEECCccHH---------------------Hh----hhccHH----HHHHHHHHHHHHHHcC
Confidence 643 3589999999965542 22 122332 4569999999999999
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHH
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell 281 (494)
++||||||.||+++.+| ++|+|||.+.... .... ....+....|+.++|+||||+++.-+.
T Consensus 156 i~H~Dikp~Nili~~~g-i~liDfg~~~~~~--e~~a----------~d~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 156 MVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA--QRKA----------KDRIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred CccCCCChHHEEEeCCC-EEEEECCCccccc--chhh----------HHHHHHHhHhcccccccceeEeehHHH
Confidence 99999999999999999 9999999876421 1111 111455556888999999999876553
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.88 E-value=5.2e-22 Score=182.31 Aligned_cols=190 Identities=16% Similarity=0.131 Sum_probs=136.9
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhh-HHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~-~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
.+...|++|+||+|+++.. .+..++.+.+.-........ ...+..|..+|....+|++|++++++ +..|++||
T Consensus 5 ~~~~~l~~~~f~~v~~~~~--~~~k~~~~~l~~~~~~~~~~~~~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvme 78 (218)
T PRK12274 5 AVNEPLKSDTFGRILLVRG--GERKFVRRDLSAAPWWLRGVAWWLARREALALRQLDGLPRTPRLLHW----DGRHLDRS 78 (218)
T ss_pred ccceeecCCCcceEEEeec--CCceeeecccccchhhhhhHHHHHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEe
Confidence 3568899999999998765 45556766665432211111 12356788888865467889999886 45799999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC-CCCceeeCCCCC
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL-KLDNILLDYEGH 225 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL-Kp~NILl~~~g~ 225 (494)
|+.|.+| ..... .. ...++.|++.+|.++|++||+|||| ||+|||++.+|.
T Consensus 79 yI~G~~L---------------------~~~~~------~~-~~~~~~qi~~~L~~lH~~GIvHrDL~kp~NILv~~~g~ 130 (218)
T PRK12274 79 YLAGAAM---------------------YQRPP------RG-DLAYFRAARRLLQQLHRCGVAHNDLAKEANWLVQEDGS 130 (218)
T ss_pred eecCccH---------------------Hhhhh------hh-hHHHHHHHHHHHHHHHHCcCccCCCCCcceEEEcCCCC
Confidence 9996554 21111 11 1347789999999999999999999 799999999999
Q ss_pred EEEeecCceeeeeccCCc-------------ccccCCCCCccChhhhCCC-CCC-CcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 226 VRIADFGMCKLQIYLDKT-------------TDTFCGTPDYMAPEIIKGL-KYN-QCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~-------------~~~~~gt~~y~aPE~l~~~-~~~-~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
++|+|||++......... ..-..+++.|++|+...-. ..+ .+.+|++.|+-+|.++||..|+.++
T Consensus 131 i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~~~~~~~~~~~~~~~ 210 (218)
T PRK12274 131 PAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKPVYRFVTRRVLHWED 210 (218)
T ss_pred EEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcchHHHHHhccCCcccc
Confidence 999999999853222210 0112368899999976543 233 6789999999999999999988765
Q ss_pred C
Q psy8309 291 D 291 (494)
Q Consensus 291 ~ 291 (494)
+
T Consensus 211 ~ 211 (218)
T PRK12274 211 N 211 (218)
T ss_pred C
Confidence 4
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.5e-22 Score=184.07 Aligned_cols=141 Identities=21% Similarity=0.139 Sum_probs=104.8
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChh---------------------h--HHHHHHHHHHHHhcCCCC
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD---------------------D--VECTLIERKVLALGTKHP 126 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~---------------------~--~~~~~~e~~~l~~~~~hp 126 (494)
.+.||+|+||.||+|++. +|+.||||+++........ . ......|...+. .+.|+
T Consensus 2 ~~~ig~G~~~~Vy~a~~~-~g~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~ 79 (190)
T cd05145 2 NGCISTGKEANVYHARTG-DGEELAVKIYKTSTLSFKDRDKYIEGDPRFRSRYSKSNPRKLVFAWAEKEFRNLK-RLYEA 79 (190)
T ss_pred CceeecCCCcEEEEEEcC-CCCEEEEEEEEcCcceEeeHHHHhcCCcccccccccCCHHHHHHHHHHHHHHHHH-HHHhC
Confidence 578999999999999987 8999999999865221000 0 111234555555 35677
Q ss_pred ceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q psy8309 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK- 205 (494)
Q Consensus 127 ~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~- 205 (494)
+|.....+... ..||||||++|+++ .........+++..+..++.|++.+|.+||+
T Consensus 80 ~i~~p~~~~~~--~~~lVmE~~~g~~~---------------------~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~ 136 (190)
T cd05145 80 GVPVPEPILLK--KNVLVMEFIGDDGS---------------------PAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE 136 (190)
T ss_pred CCCCceEEEec--CCEEEEEEecCCCc---------------------hhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh
Confidence 76443333322 24899999986533 1122234567889999999999999999999
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+||+||||||+|||++ ++.++|+|||++..
T Consensus 137 ~givHrDlkP~NIll~-~~~~~liDFG~a~~ 166 (190)
T cd05145 137 AGLVHGDLSEYNILYH-DGKPYIIDVSQAVE 166 (190)
T ss_pred CCEecCCCChhhEEEE-CCCEEEEEccccee
Confidence 9999999999999998 89999999999875
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.3e-20 Score=174.16 Aligned_cols=137 Identities=18% Similarity=0.132 Sum_probs=103.0
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC----CCCceeeEEEEEEcCC---ee
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT----KHPYLCHLFCTFQTDS---HL 141 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~----~hp~Iv~l~~~~~~~~---~~ 141 (494)
-.+.||+|+||.||. +..++.. +||++..... .......+|..++.... .||||++++++++++. .+
T Consensus 6 ~~~~LG~G~~~~Vy~--hp~~~~k-~IKv~~~~~~---~~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v 79 (210)
T PRK10345 6 EQSPLGTGRHRKCYA--HPEDAQR-CIKIVYHRGD---GGDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYV 79 (210)
T ss_pred CcceecCCCceEEEE--CCCCcCe-EEEEEecccc---chHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEE
Confidence 357899999999995 6666654 6888865422 23345677888777432 6899999999999874 44
Q ss_pred E-EEEEe--cCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHH-HHHHhCCCccccCCCCc
Q psy8309 142 F-FVMEY--LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGM-RFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 142 ~-lv~E~--~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL-~yLH~~givHrDLKp~N 217 (494)
+ +|||| +. +++|..++.+ +.+++. ..++.|++.++ +|||+++|+||||||+|
T Consensus 80 ~~~I~e~~G~~---------------------~~tL~~~l~~-~~~~e~--~~~~~~~L~~l~~yLh~~~IvhrDlKp~N 135 (210)
T PRK10345 80 YDVIADFDGKP---------------------SITLTEFAEQ-CRYEED--VAQLRQLLKKLKRYLLDNRIVTMELKPQN 135 (210)
T ss_pred EEEEecCCCCc---------------------chhHHHHHHc-ccccHh--HHHHHHHHHHHHHHHHHCCEeecCCCHHH
Confidence 4 78999 33 4566667755 356666 35688888888 99999999999999999
Q ss_pred eeeCCC----CCEEEeecCcee
Q psy8309 218 ILLDYE----GHVRIADFGMCK 235 (494)
Q Consensus 218 ILl~~~----g~vkL~DFGla~ 235 (494)
||++.. +.++|+||+.++
T Consensus 136 ILl~~~~~~~~~~~LiDg~G~~ 157 (210)
T PRK10345 136 ILCQRISESEVIPVVCDNIGES 157 (210)
T ss_pred EEEeccCCCCCcEEEEECCCCc
Confidence 999743 379999955443
|
|
| >KOG1166|consensus | Back alignment and domain information |
|---|
Probab=99.83 E-value=2.3e-20 Score=203.45 Aligned_cols=197 Identities=23% Similarity=0.279 Sum_probs=154.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..+.|.|.+.||+|+||+||+|.+.. |+.||+|+-+.....+ -.+-..+++|.-+. --+.|..+...+.-.+.-+
T Consensus 696 ~~~~~~I~~e~G~g~y~~vy~a~~~~-~~~~alK~e~P~~~WE-fYI~~q~~~RLk~~---~~~~~~~~~~a~~~~~~S~ 770 (974)
T KOG1166|consen 696 GGEKFCISKEIGEGSYGSVYVATHSN-GKLVALKVEKPPNPWE-FYICLQVMERLKPQ---MLPSIMHISSAHVFQNASV 770 (974)
T ss_pred cceeEEEEeeeccccceEEEEeecCC-CcEEEEEeecCCCcee-eeehHHHHHhhchh---hhcchHHHHHHHccCCcce
Confidence 44689999999999999999999887 9999999987653322 12222222222211 1345666666666677888
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||+||.+.|+| ...+...+.+++..+.+++.|++..+++||..+|||+||||+|+||..
T Consensus 771 lv~ey~~~Gtl---------------------ld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~ 829 (974)
T KOG1166|consen 771 LVSEYSPYGTL---------------------LDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRR 829 (974)
T ss_pred eeeeccccccH---------------------HHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeec
Confidence 99999995554 445667788999999999999999999999999999999999999943
Q ss_pred -------CCCEEEeecCceeeeec--cCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCC
Q psy8309 223 -------EGHVRIADFGMCKLQIY--LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS 285 (494)
Q Consensus 223 -------~g~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~ 285 (494)
.--++|+|||.+-.+.. .+......++|-.+-.+|+..|..+++.+|.|.|+.++|-||.|+.
T Consensus 830 ~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y 901 (974)
T KOG1166|consen 830 EICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKY 901 (974)
T ss_pred ccCCCCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHH
Confidence 23599999998764322 2224456788999999999999999999999999999999999973
|
|
| >KOG0195|consensus | Back alignment and domain information |
|---|
Probab=99.82 E-value=2.2e-20 Score=172.63 Aligned_cols=245 Identities=22% Similarity=0.314 Sum_probs=186.9
Q ss_pred CCCCCCCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 56 ~~~~~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
..++..+++.+..++..|.+.-.|..|+|+..++. +++|+++-...... .-+.+-.|.-.|. ...||||+.+++.+
T Consensus 181 lsr~~gid~~~lnl~tkl~e~hsgelwrgrwqgnd--ivakil~vr~~t~r-isrdfneefp~lr-ifshpnilpvlgac 256 (448)
T KOG0195|consen 181 LSRYTGIDVSSLNLITKLAESHSGELWRGRWQGND--IVAKILNVREVTAR-ISRDFNEEFPALR-IFSHPNILPVLGAC 256 (448)
T ss_pred cccccCcchhhhhhhhhhccCCCcccccccccCcc--hhhhhhhhhhcchh-hcchhhhhCccee-eecCCchhhhhhhc
Confidence 34566778888899999999999999999987765 67787764332211 1111222222332 46899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCC--Cccc
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKG--IVYR 211 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHr 211 (494)
....++.++..||+.|+| +..+... -..+..++..++.+|+.|+.|||+.. |---
T Consensus 257 nsppnlv~isq~mp~gsl---------------------ynvlhe~t~vvvd~sqav~faldiargmaflhslep~ipr~ 315 (448)
T KOG0195|consen 257 NSPPNLVIISQYMPFGSL---------------------YNVLHEQTSVVVDHSQAVRFALDIARGMAFLHSLEPMIPRF 315 (448)
T ss_pred cCCCCceEeeeeccchHH---------------------HHHHhcCccEEEecchHHHHHHHHHhhHHHHhhcchhhhhh
Confidence 999999999999996655 3333332 24677889999999999999999984 4445
Q ss_pred cCCCCceeeCCCCCEEEe--ecCceeeeeccCCcccccCCCCCccChhhhCCCCCC---CcchHHHHHHHHHHHHhCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIA--DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN---QCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~---~~~DiwSlGvil~ell~G~~P 286 (494)
-|....++||++-+.+|. |--++. +. ......|.||+||.+...+-+ .++|+|||+++||||-|...|
T Consensus 316 ~lns~hvmidedltarismad~kfsf---qe----~gr~y~pawmspealqrkped~n~raadmwsfaillwel~trevp 388 (448)
T KOG0195|consen 316 YLNSKHVMIDEDLTARISMADTKFSF---QE----VGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAILLWELNTREVP 388 (448)
T ss_pred hcccceEEecchhhhheecccceeee---ec----cccccCcccCCHHHHhcCchhcchhhhhHHHHHHHHHHhhccccc
Confidence 688889999998877664 332221 11 122347899999999887644 689999999999999999999
Q ss_pred CCCCCHHHHHHHHHh--CCCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 287 FSGCDEDELFWSICN--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 287 f~~~~~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
|..-.+.+.--+|.- -++.+|+.++.....|++-|+..||.+||..
T Consensus 389 fadlspmecgmkialeglrv~ippgis~hm~klm~icmnedpgkrpkf 436 (448)
T KOG0195|consen 389 FADLSPMECGMKIALEGLRVHIPPGISRHMNKLMNICMNEDPGKRPKF 436 (448)
T ss_pred cccCCchhhhhhhhhccccccCCCCccHHHHHHHHHHhcCCCCcCCCc
Confidence 999888887777754 3678899999999999999999999999954
|
|
| >KOG0590|consensus | Back alignment and domain information |
|---|
Probab=99.81 E-value=2.1e-21 Score=207.40 Aligned_cols=258 Identities=26% Similarity=0.393 Sum_probs=199.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEe-CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELK-GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
...|.+.+.||+|+|+.|-++... .+...+|+|.+.... .......++..|..+-....+|+|++.+++........+
T Consensus 19 ~~~~~~~~~ig~gs~~~~~~~~~~~~~~~~~a~~~~s~~~-~~~~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~ 97 (601)
T KOG0590|consen 19 NSQYKLSRSIGKGSFSSSALASNSRDPESSSATKPISIPP-KSEDSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYL 97 (601)
T ss_pred cccccccccccccccchhhhhhhcCCCcceeeccCCCCCC-CccchhhhcCccccccccccccccccccCCccCCCcccc
Confidence 346788888999999999988764 445567777776543 223344444445555443345999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHh-hhcC-CCCHHHHHHHHHHHHHHHHHHH-hCCCccccCCCCcee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSG-RFDEGRARFYAAEIVSGMRFLH-KKGIVYRDLKLDNIL 219 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~-~l~e~~~~~~~~qi~~aL~yLH-~~givHrDLKp~NIL 219 (494)
++++|..||++. ..+ .... ..+...+.+++.|+..++.|+| ..++.||||||+|.+
T Consensus 98 ~~~~~s~g~~~f---------------------~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 98 LSLSYSDGGSLF---------------------SKISHPDSTGTSSSSASRYLPQLNSGLSYLHPENGVTHRDIKPSNSL 156 (601)
T ss_pred cccCcccccccc---------------------cccccCCccCCCCcchhhhhhhhccCccccCcccccccCCCCCccch
Confidence 999998866654 333 3333 6778889999999999999999 999999999999999
Q ss_pred eCCCC-CEEEeecCceeeeec-cC--CcccccCC-CCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 220 LDYEG-HVRIADFGMCKLQIY-LD--KTTDTFCG-TPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 220 l~~~g-~vkL~DFGla~~~~~-~~--~~~~~~~g-t~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
++..+ .++++|||+|..... .+ ......|| ++.|+|||...+. ..+...|+||+|+++.-+++|..|+......
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99999 999999999976443 11 22345689 9999999999985 4578899999999999999999999765433
Q ss_pred HHH-HHHHhC----CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 294 ELF-WSICNE----RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 294 ~~~-~~i~~~----~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
... ...... .......++..+.+++.++|..+|..|. +.+++..++|+..
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~------s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 237 DGRYSSWKSNKGRFTQLPWNSISDQAHDLLHKILKENPSNRL------SIEELKLDNWLSS 291 (601)
T ss_pred cccceeecccccccccCccccCChhhhhcccccccCCchhcc------ccccccccccccc
Confidence 211 111111 1333457889999999999999999998 6788999999987
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.80 E-value=2.2e-19 Score=171.52 Aligned_cols=144 Identities=22% Similarity=0.160 Sum_probs=105.8
Q ss_pred CceEeeEeccCCceEEEEEE-EeCCCeEEEeeeeccccccCh-----------------h----hHHHHHHHHHHHHhcC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAE-LKGTDYYYAVKCLKKDVVLED-----------------D----DVECTLIERKVLALGT 123 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~-~~~~~~~~AiK~~~k~~~~~~-----------------~----~~~~~~~e~~~l~~~~ 123 (494)
.|.+.+.||+|+||.||+|. +..+|+.||||+++....... . .......|...+.. +
T Consensus 29 ~~~i~~~Lg~G~~g~Vy~a~~~~~~g~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~L~~-L 107 (237)
T smart00090 29 LSAIGGCISTGKEANVYHALDFDGSGKERAVKIYRTGTLEFKRRDRYVDGDFRFKYRKINPRKLVRLWAEKEFRNLQR-L 107 (237)
T ss_pred hHHhCCeeccCcceeEEEEEecCCCCcEEEEEEEEcCcceecchhhhcccchhhccCCCCHHHHHHHHHHHHHHHHHH-H
Confidence 57889999999999999998 677899999999975421100 0 01123456666654 3
Q ss_pred CC--CceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHH
Q psy8309 124 KH--PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMR 201 (494)
Q Consensus 124 ~h--p~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ 201 (494)
.+ ..+.++++. ...|+||||+.|++|.. .......+.+.++..++.||+.+|.
T Consensus 108 ~~~~i~~p~~~~~----~~~~lV~E~~~g~~L~~---------------------~~~~~~~~~~~~~~~i~~qi~~~l~ 162 (237)
T smart00090 108 YEAGVPVPKPIAW----RRNVLVMEFIGGDGLPA---------------------PRLKDVEPEEEEEFELYDDILEEMR 162 (237)
T ss_pred HhcCCCCCeeeEe----cCceEEEEEecCCcccc---------------------cccccCCcchHHHHHHHHHHHHHHH
Confidence 33 233444432 23589999999665521 2222345666778899999999999
Q ss_pred HHHhCC-CccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 202 FLHKKG-IVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 202 yLH~~g-ivHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+||++| |+||||||+||+++ ++.++|+|||.+..
T Consensus 163 ~LH~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~ 197 (237)
T smart00090 163 KLYKEGELVHGDLSEYNILVH-DGKVVIIDVSQSVE 197 (237)
T ss_pred HHHhcCCEEeCCCChhhEEEE-CCCEEEEEChhhhc
Confidence 999999 99999999999999 88999999998763
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.78 E-value=2.3e-18 Score=161.82 Aligned_cols=138 Identities=22% Similarity=0.324 Sum_probs=104.6
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-----hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-----DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++.||+|++|.||+|.. .+..+++|+......... ........|..++. .+.|++|+....++...+..++|
T Consensus 1 ~~~l~~G~~~~vy~~~~--~~~~~~vK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~~~lv 77 (211)
T PRK14879 1 MKLIKRGAEAEIYLGDF--LGIKAVIKWRIPKRYRHPELDERIRRERTRREARIMS-RARKAGVNVPAVYFVDPENFIIV 77 (211)
T ss_pred CcccccCceEEEEEEee--CCCceEEEEeCCcCCcChHHHHHHHHHHHHHHHHHHH-HHHHCCCCCCeEEEEeCCCCEEE
Confidence 36799999999999987 555689998654322111 11233556666665 45788887766677777889999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
|||++|++| ...+.... . ....++.+|+.+|.+||+.|++|||++|.|||++ ++
T Consensus 78 ~e~~~G~~L---------------------~~~~~~~~---~-~~~~i~~~i~~~l~~lH~~~i~H~Dl~p~Nil~~-~~ 131 (211)
T PRK14879 78 MEYIEGEPL---------------------KDLINSNG---M-EELELSREIGRLVGKLHSAGIIHGDLTTSNMILS-GG 131 (211)
T ss_pred EEEeCCcCH---------------------HHHHHhcc---H-HHHHHHHHHHHHHHHHHhCCcccCCCCcccEEEE-CC
Confidence 999995554 33443322 1 7788999999999999999999999999999999 88
Q ss_pred CEEEeecCceee
Q psy8309 225 HVRIADFGMCKL 236 (494)
Q Consensus 225 ~vkL~DFGla~~ 236 (494)
.++|+|||++..
T Consensus 132 ~~~liDf~~a~~ 143 (211)
T PRK14879 132 KIYLIDFGLAEF 143 (211)
T ss_pred CEEEEECCcccC
Confidence 999999998864
|
|
| >KOG1033|consensus | Back alignment and domain information |
|---|
Probab=99.78 E-value=1e-19 Score=183.00 Aligned_cols=174 Identities=25% Similarity=0.348 Sum_probs=128.8
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.++||.|++|. ...|..++... ...+...+..++.|++.|++| +|.+|||+||
T Consensus 329 ~~lyI~Mn~c~---------------------~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp 384 (516)
T KOG1033|consen 329 VYLYIQMNLCE---------------------KETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKP 384 (516)
T ss_pred cchhhhhhhhh---------------------hhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccc
Confidence 35888999988 34444555433 245667888999999999999 9999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccC------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLD------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFS 288 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~ 288 (494)
.||.+..++.+||+|||+........ ......+||..||+||.|.+..|+.++||||||+||+||+. -..+|+
T Consensus 385 ~nif~~~d~q~kIgDFgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~f~T~~e 464 (516)
T KOG1033|consen 385 SNIFFSDDDQLKIGDFGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQFSTQFE 464 (516)
T ss_pred cccccccchhhhhhhhhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHHhccHHH
Confidence 99999999999999999976543322 12345679999999999999999999999999999999997 344442
Q ss_pred CCCHHHHHHHHHhCCCC--CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 289 GCDEDELFWSICNERPR--FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
. ...+..|..+.++ +-.. -++..+|+.+||...|.+||. +.+.--|.|
T Consensus 465 r---~~t~~d~r~g~ip~~~~~d-~p~e~~ll~~lls~~p~~RP~------~~~~~~~~~ 514 (516)
T KOG1033|consen 465 R---IATLTDIRDGIIPPEFLQD-YPEEYTLLQQLLSPSPEERPS------AIEVALHEF 514 (516)
T ss_pred H---HHhhhhhhcCCCChHHhhc-CcHHHHHHHHhcCCCcccCch------HHHHhhhhh
Confidence 2 2223334344332 1111 245569999999999999993 344445544
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.75 E-value=9.8e-18 Score=156.04 Aligned_cols=133 Identities=23% Similarity=0.258 Sum_probs=96.8
Q ss_pred EeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-----hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEE
Q psy8309 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-----DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
.||+|+||.||+|.. ++..+++|+......... ........|..++.. +.|+++.....++...+..++|||
T Consensus 1 ~ig~G~~~~vy~~~~--~~~~~viK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~i~~p~~~~~~~~~~~lv~e 77 (199)
T TIGR03724 1 LIAKGAEAIIYLGDF--LGLKAVIKERVPKSYRHPELDERIRRERTRNEARLLSR-ARKAGVNTPVVYDVDPDNKTIVME 77 (199)
T ss_pred CCCCCceEEEEEeec--CCccEEEEEecCCcCcCchHHHHHHHHHHHHHHHHHHH-HHHCCCCCCEEEEEECCCCEEEEE
Confidence 489999999999985 456789998654322111 122445567777763 556655444444456667899999
Q ss_pred ecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCE
Q psy8309 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226 (494)
Q Consensus 147 ~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~v 226 (494)
|++|++| ...+..... .++.||+.+|.+||+.|++|||++|.||+++ ++.+
T Consensus 78 ~~~g~~l---------------------~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H~Dl~~~Nil~~-~~~~ 128 (199)
T TIGR03724 78 YIEGKPL---------------------KDVIEEGND-------ELLREIGRLVGKLHKAGIVHGDLTTSNIIVR-DDKL 128 (199)
T ss_pred EECCccH---------------------HHHHhhcHH-------HHHHHHHHHHHHHHHCCeecCCCCcceEEEE-CCcE
Confidence 9996554 333322111 6899999999999999999999999999999 8999
Q ss_pred EEeecCceee
Q psy8309 227 RIADFGMCKL 236 (494)
Q Consensus 227 kL~DFGla~~ 236 (494)
+++|||+++.
T Consensus 129 ~liDfg~a~~ 138 (199)
T TIGR03724 129 YLIDFGLGKY 138 (199)
T ss_pred EEEECCCCcC
Confidence 9999998864
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.74 E-value=9.9e-18 Score=156.06 Aligned_cols=137 Identities=22% Similarity=0.112 Sum_probs=99.0
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh------h-------------hHHHHHHHHHHHHhcCCCC-
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED------D-------------DVECTLIERKVLALGTKHP- 126 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~------~-------------~~~~~~~e~~~l~~~~~hp- 126 (494)
|.+.+.||+|+||.||+|... +|+.||||++........ + .......|..++.. +.|+
T Consensus 17 ~~~~~~i~~G~~g~Vy~~~~~-~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l~~~~ 94 (198)
T cd05144 17 ESLGNQIGVGKESDVYLALDP-DGNPVALKFHRLGRTSFRKVKRKRDYLGDRKHASWLYLSRLAAQKEFAALKA-LYEEG 94 (198)
T ss_pred hhcCCccccCcceEEEEEEcC-CCCEEEEEEEecccchhhhhcchHHHHhccccchhHHHhHHHHHHHHHHHHH-HHHcC
Confidence 777899999999999999875 788999999765321000 0 01123345555543 3455
Q ss_pred -ceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8309 127 -YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK 205 (494)
Q Consensus 127 -~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~ 205 (494)
.++..++ ....++||||++|++|.. ... ......++.+|+.++.++|+
T Consensus 95 i~v~~~~~----~~~~~lv~e~~~g~~L~~---------------------~~~------~~~~~~~~~~i~~~l~~lh~ 143 (198)
T cd05144 95 FPVPKPID----WNRHAVVMEYIDGVELYR---------------------VRV------LEDPEEVLDEILEEIVKAYK 143 (198)
T ss_pred CCCCceee----cCCceEEEEEeCCcchhh---------------------ccc------cccHHHHHHHHHHHHHHHHH
Confidence 3444443 245689999999766521 111 13456788999999999999
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.||+||||||+||+++.++.++|+|||++..
T Consensus 144 ~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~ 174 (198)
T cd05144 144 HGIIHGDLSEFNILVDDDEKIYIIDWPQMVS 174 (198)
T ss_pred CCCCcCCCCcccEEEcCCCcEEEEECCcccc
Confidence 9999999999999999999999999999854
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=2.3e-17 Score=151.86 Aligned_cols=139 Identities=22% Similarity=0.142 Sum_probs=94.4
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHH---------------------HHHHHHHHHhcCCC-Cc
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC---------------------TLIERKVLALGTKH-PY 127 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~---------------------~~~e~~~l~~~~~h-p~ 127 (494)
.+.||+|+||+||+|.+. +++.||||+++............ ...|...+.....+ -.
T Consensus 2 ~~~lg~G~~g~Vy~a~~~-~~~~vavKv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~~ 80 (187)
T cd05119 2 GGPIGTGKEADVYLALDG-DGEPVAVKIYRTGRTSFKKRKRYRTGDYRFGRKKSNWRYLSRLWAEKEFRNLKRLYEAGVP 80 (187)
T ss_pred CcccccccceeEEEEECC-CCCEEEEEEEecCccchhhhhhhhHHHHHhccCCcchhhhhhHHHHHHHHHHHHHHHcCCC
Confidence 568999999999999876 78899999987642211111110 01222222221111 22
Q ss_pred eeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q psy8309 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-K 206 (494)
Q Consensus 128 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~ 206 (494)
+.+.++. ...++||||++|+.+.. ..+.... . ..+++.++.+++.++.++|. +
T Consensus 81 ~~~~~~~----~~~~lv~e~~~g~~~~~----------------~~l~~~~-----~-~~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 81 VPKPIDL----NRHVLVMEFIGGDGIPA----------------PRLKDVR-----L-LEDPEELYDQILELMRKLYREA 134 (187)
T ss_pred CCceEec----CCCEEEEEEeCCCCccC----------------hhhhhhh-----h-cccHHHHHHHHHHHHHHHhhcc
Confidence 4444443 24689999999765421 1111111 0 16678899999999999999 9
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
||+||||||+||+++ ++.++|+|||.+..
T Consensus 135 ~ivH~Dl~p~Nili~-~~~~~liDfg~a~~ 163 (187)
T cd05119 135 GLVHGDLSEYNILVD-DGKVYIIDVPQAVE 163 (187)
T ss_pred CcCcCCCChhhEEEE-CCcEEEEECccccc
Confidence 999999999999999 99999999999864
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.72 E-value=3.9e-17 Score=174.72 Aligned_cols=138 Identities=22% Similarity=0.218 Sum_probs=104.8
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-----hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-----DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.|...+.||+|+||.||+|...... +++|+........ ....+....|..++. .++|++|+....++.+...
T Consensus 334 ~~~~~~~iG~G~~g~Vy~~~~~~~~--~v~k~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~~~~i~~p~~~~~~~~~ 410 (535)
T PRK09605 334 RKIPDHLIGKGAEADIKKGEYLGRD--AVIKERVPKGYRHPELDERLRTERTRAEARLLS-EARRAGVPTPVIYDVDPEE 410 (535)
T ss_pred ccCccceeccCCcEEEEEEeecCcc--ceeEEEecccccchhHHHHHHHHHHHHHHHHHH-hhcccCCCeeEEEEEeCCC
Confidence 4466789999999999999876554 4444432211111 112345667877777 5789999888777777778
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
.++||||++|++| ...+. ....++.||+.+|.+||++||+||||||+|||+
T Consensus 411 ~~lv~E~~~g~~L---------------------~~~l~--------~~~~~~~~i~~~L~~lH~~giiHrDlkp~NILl 461 (535)
T PRK09605 411 KTIVMEYIGGKDL---------------------KDVLE--------GNPELVRKVGEIVAKLHKAGIVHGDLTTSNFIV 461 (535)
T ss_pred CEEEEEecCCCcH---------------------HHHHH--------HHHHHHHHHHHHHHHHHhCCCccCCCChHHEEE
Confidence 8999999995554 33332 346789999999999999999999999999999
Q ss_pred CCCCCEEEeecCceee
Q psy8309 221 DYEGHVRIADFGMCKL 236 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~ 236 (494)
.++.++|+|||+++.
T Consensus 462 -~~~~~~liDFGla~~ 476 (535)
T PRK09605 462 -RDDRLYLIDFGLGKY 476 (535)
T ss_pred -ECCcEEEEeCccccc
Confidence 688999999999874
|
|
| >KOG1023|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=3.5e-16 Score=160.45 Aligned_cols=193 Identities=23% Similarity=0.333 Sum_probs=148.1
Q ss_pred cCCCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHH
Q psy8309 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGM 200 (494)
Q Consensus 122 ~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL 200 (494)
.+.|.|+.++++...+....++|.+||..|+|.+ .+.. ...++.--...++++|+.||
T Consensus 3 ~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D---------------------~i~~~~~~~d~~F~~s~~rdi~~Gl 61 (484)
T KOG1023|consen 3 QLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLD---------------------ILSNEDIKLDYFFILSFIRDISKGL 61 (484)
T ss_pred ccchhhhhhheeeEecCCceEEEEeeecCccHHh---------------------HHhccccCccHHHHHHHHHHHHHHH
Confidence 4689999999999999999999999999766643 3333 34567777788999999999
Q ss_pred HHHHhCCC-ccccCCCCceeeCCCCCEEEeecCceeeeec--cCCcccccCCCCCccChhhhCCCC-------CCCcchH
Q psy8309 201 RFLHKKGI-VYRDLKLDNILLDYEGHVRIADFGMCKLQIY--LDKTTDTFCGTPDYMAPEIIKGLK-------YNQCVDW 270 (494)
Q Consensus 201 ~yLH~~gi-vHrDLKp~NILl~~~g~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~-------~~~~~Di 270 (494)
+|||.-.| .|+.|+..|++++..-.+||+|||+...... .........-..-|.|||.+++.. -+.+.|+
T Consensus 62 ~ylh~s~i~~hg~l~s~nClvd~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdi 141 (484)
T KOG1023|consen 62 AYLHNSPIGYHGALKSSNCLVDSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDI 141 (484)
T ss_pred HHHhcCcceeeeeeccccceeeeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCe
Confidence 99999866 9999999999999999999999999765321 001111112334699999998742 3567999
Q ss_pred HHHHHHHHHHHhCCCCCCCC----CHHHHHHHHHh-CCCCC-Cc-----cCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 271 WSFGILLYEMHVGQSPFSGC----DEDELFWSICN-ERPRF-PQ-----FLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 271 wSlGvil~ell~G~~Pf~~~----~~~~~~~~i~~-~~~~~-p~-----~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
||+|++++|+++...||... ++.++...+.+ +...+ |. .+.+++..++..||..+|.+||+..+.
T Consensus 142 Ys~~ii~~ei~~r~~~~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i 217 (484)
T KOG1023|consen 142 YSFGIIMYEILFRSGPFDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQI 217 (484)
T ss_pred ehHHHHHHHHHhccCccccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHH
Confidence 99999999999999999752 33466666666 32212 21 345579999999999999999976543
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.67 E-value=2.4e-16 Score=161.73 Aligned_cols=257 Identities=20% Similarity=0.143 Sum_probs=191.9
Q ss_pred CCCCceEeeEecc--CCceEEEEEEE--eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 63 DLEDFQLLKVLGK--GSFGKVFLAEL--KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~--G~fG~V~~~~~--~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
....+.+.+.+|. |.+|.||.+.. ..++..+|+|.-+... .....-....+|....+....|++.++.+..++..
T Consensus 112 ~~~~~~~~~~~g~~~g~~~s~~~~~~~~~~s~~~~a~k~s~~p~-s~p~~~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~ 190 (524)
T KOG0601|consen 112 FDQRFPISSRTGSLPGSKGSVFKSRCTNSESPHKFAVKKSKIPF-SPPLDSKRKLREFLSHHKIDSHENPVRDSPAWEGS 190 (524)
T ss_pred hhhhcccccccccCCCCCceeecccCCcccCCcccccccccCCC-CCccccccccchhhcccccCccccccccCcccccC
Confidence 3456778899999 99999999998 8888999999744321 11122223344444444456799999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHH----HHHHHHhCCCccccC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVS----GMRFLHKKGIVYRDL 213 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~----aL~yLH~~givHrDL 213 (494)
+.+|+-+|+|. ..+..+..... .+++..++.+..+... ||.++|+.+++|-|+
T Consensus 191 ~~lfiqtE~~~----------------------~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs~~~~~~~~ 248 (524)
T KOG0601|consen 191 GILFIQTELCG----------------------ESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHSNNIVHDDL 248 (524)
T ss_pred Ccceeeecccc----------------------chhHHhhhcccccCCchhhhhHHhhhhhcccccccccCCCccccccc
Confidence 99999999994 34444444443 4888999999999999 999999999999999
Q ss_pred CCCceeeCCC-CCEEEeecCceeeeeccCCcc-----cccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 214 KLDNILLDYE-GHVRIADFGMCKLQIYLDKTT-----DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 214 Kp~NILl~~~-g~vkL~DFGla~~~~~~~~~~-----~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
||+||++..+ ..++++|||+........-.. ....|...|++||.+.+ -++...|+++||.++.+..+|..++
T Consensus 249 kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~ 327 (524)
T KOG0601|consen 249 KPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLP 327 (524)
T ss_pred chhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccc
Confidence 9999999999 889999999987533222111 22257888999999887 7889999999999999999987766
Q ss_pred CCC--CHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 288 SGC--DEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 288 ~~~--~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
... +.-..+.++. -..++-...+.++...+..+++.+|..|+ +.+++++|.+....
T Consensus 328 ~~g~~~~W~~~r~~~-ip~e~~~~~s~~l~~~~~~~~d~~~~~~~------~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 328 SVGKNSSWSQLRQGY-IPLEFCEGGSSSLRSVTSQMLDEDPRLRL------TAQILTALNVIHSK 385 (524)
T ss_pred cCCCCCCcccccccc-CchhhhcCcchhhhhHHHHhcCcchhhhh------HHHHHhccccccch
Confidence 433 2111111111 11223345677778899999999999998 57889999998743
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.65 E-value=5.5e-16 Score=136.38 Aligned_cols=133 Identities=21% Similarity=0.220 Sum_probs=104.4
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-CceeeEEEEEEcCCeeEEEEEe
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-PYLCHLFCTFQTDSHLFFVMEY 147 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-p~Iv~l~~~~~~~~~~~lv~E~ 147 (494)
+++.||+|.++.||++...+ ..+++|+..+... ......|...+.....+ .++++++.++...+..|++|||
T Consensus 2 ~~~~i~~g~~~~v~~~~~~~--~~~~iK~~~~~~~-----~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~ 74 (155)
T cd05120 2 SIKLLKGGLTNRVYLLGTKD--EDYVLKINPSREK-----GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEW 74 (155)
T ss_pred cceecccccccceEEEEecC--CeEEEEecCCCCc-----hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEe
Confidence 45789999999999999755 5699999866422 23344555555532223 6888999988888899999999
Q ss_pred cCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC---CCccccCCCCceeeCCCC
Q psy8309 148 LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK---GIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 148 ~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~---givHrDLKp~NILl~~~g 224 (494)
+.|+.+.. . +......++.+++.+|.+||.. +++|+||+|+||+++..+
T Consensus 75 ~~g~~~~~---------------------~-------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~ 126 (155)
T cd05120 75 IEGETLDE---------------------V-------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGK 126 (155)
T ss_pred cCCeeccc---------------------C-------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCc
Confidence 98665421 1 4456677899999999999985 799999999999999989
Q ss_pred CEEEeecCceee
Q psy8309 225 HVRIADFGMCKL 236 (494)
Q Consensus 225 ~vkL~DFGla~~ 236 (494)
.++++|||.+..
T Consensus 127 ~~~l~Df~~~~~ 138 (155)
T cd05120 127 ILGIIDWEYAGY 138 (155)
T ss_pred EEEEEecccccC
Confidence 999999998763
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.8e-15 Score=143.45 Aligned_cols=138 Identities=20% Similarity=0.281 Sum_probs=96.4
Q ss_pred eEec-cCCceEEEEEEEeCCCeEEEeeeecccccc----C------hhhHHHHHHHHHHHHhcCCCCce--eeEEEEEEc
Q psy8309 71 KVLG-KGSFGKVFLAELKGTDYYYAVKCLKKDVVL----E------DDDVECTLIERKVLALGTKHPYL--CHLFCTFQT 137 (494)
Q Consensus 71 ~~LG-~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~----~------~~~~~~~~~e~~~l~~~~~hp~I--v~l~~~~~~ 137 (494)
.+|| .||.|+||.+... +..++||.+.+..+. . .........|..++. .+.|++| +..+++...
T Consensus 37 ~~lg~~~g~gtv~~v~~~--~~~~vlk~~~r~~~i~kv~~~~~~~~~~~~~r~~rE~~ll~-~L~~~gi~vP~pl~~~~~ 113 (239)
T PRK01723 37 RVVGSAKGRGTTWFVQTP--GVNWVLRHYRRGGLIGKLSKDRYLFTGLERTRAFAEFRLLA-QLYEAGLPVPRPIAARVV 113 (239)
T ss_pred ceeecCCCCccEEEEEeC--CceEEEEEeeEcchHHhhhhhcccccchhhhHHHHHHHHHH-HHHhCCCCCceeEeeeee
Confidence 4677 7888888888764 556899988643221 1 112234566777766 4566664 666666443
Q ss_pred CC-e---eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 138 DS-H---LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 138 ~~-~---~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
.. . .++|||+++|+ .+|...+.. ..+++.. +.||+.+|.+||++||+||||
T Consensus 114 ~~~~~~~~~lV~e~l~G~--------------------~~L~~~l~~-~~l~~~~----~~~i~~~l~~lH~~GI~HrDl 168 (239)
T PRK01723 114 RHGLFYRADILIERIEGA--------------------RDLVALLQE-APLSEEQ----WQAIGQLIARFHDAGVYHADL 168 (239)
T ss_pred ecCcceeeeEEEEecCCC--------------------CCHHHHHhc-CCCCHHH----HHHHHHHHHHHHHCCCCCCCC
Confidence 22 2 35999999852 234334332 3455543 578999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceee
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~ 236 (494)
||+|||++.++.++|+|||.+..
T Consensus 169 kp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 169 NAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred CchhEEEcCCCCEEEEECCCccc
Confidence 99999999999999999998764
|
|
| >KOG0601|consensus | Back alignment and domain information |
|---|
Probab=99.51 E-value=1.2e-14 Score=149.29 Aligned_cols=252 Identities=20% Similarity=0.240 Sum_probs=185.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe-CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK-GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....+|..+..||.|.|+.|+.+..+ .++..|++|.+.+.......++ ..+.|..+......|.+++.++..|....+
T Consensus 262 ~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~l~~~~~di-~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~ 340 (524)
T KOG0601|consen 262 CKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNGLATFASDI-FSLGEVILEAILGSHLPSVGKNSSWSQLRQ 340 (524)
T ss_pred eecCCcceeEEccCCccccceeeeecCCCCceEeChhhhccccchHhhh-cchhhhhHhhHhhcccccCCCCCCcccccc
Confidence 34568999999999999999998866 6788899999887644333332 344555555555679999999999988899
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
.|+-.|||+++++. ........+.+...+....|++.|+.++|+..++|+|+||+||++
T Consensus 341 ~~ip~e~~~~~s~~---------------------l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~~d~~psni~i 399 (524)
T KOG0601|consen 341 GYIPLEFCEGGSSS---------------------LRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVHLDVKPSNILI 399 (524)
T ss_pred ccCchhhhcCcchh---------------------hhhHHHHhcCcchhhhhHHHHHhccccccchhhhcccccccceee
Confidence 99999999976652 222333457888899999999999999999999999999999999
Q ss_pred CCC-CCEEEeecCceeeeeccCCcccccCCCCCcc--ChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 DYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYM--APEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~-g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~--aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
..+ +..++.|||..... ........++-.+. +++......+..+.|++|||..+.|.++|.+.-.... ...
T Consensus 400 ~~~~~~~~~~~~~~~t~~---~~~~~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls~~~~---~~~ 473 (524)
T KOG0601|consen 400 SNDGFFSKLGDFGCWTRL---AFSSGVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLSESGV---QSL 473 (524)
T ss_pred ccchhhhhcccccccccc---ceecccccccccccccchhhccccccccccccccccccccccccCcccCcccc---cce
Confidence 886 77899999987531 11222233333444 5555566778999999999999999999875332211 223
Q ss_pred HHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 298 SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 298 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.|..+..........++..+.+.++..++..|+. +.++..|.-|
T Consensus 474 ~i~~~~~p~~~~~~~~~q~~~kv~~~~~~~~~~l------~~~l~~~~~~ 517 (524)
T KOG0601|consen 474 TIRSGDTPNLPGLKLQLQVLLKVMINPDRKRRPS------AVELSLHSEF 517 (524)
T ss_pred eeecccccCCCchHHhhhhhhhhhcCCccccchh------hhhhcccchh
Confidence 4445544444445588999999999999999984 4455555544
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=99.48 E-value=4.4e-14 Score=148.51 Aligned_cols=146 Identities=20% Similarity=0.279 Sum_probs=92.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC---------------------------h----hhHHHHH
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE---------------------------D----DDVECTL 113 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---------------------------~----~~~~~~~ 113 (494)
.+|+. +.||+|++|+||+|+.+.+|+.||||++++..... . ...+...
T Consensus 120 ~~fd~-~PlasaSiaQVh~A~l~~~G~~VAVKV~rP~i~~~I~~Dl~~l~~~a~~l~~~~~~~~~l~~~~~v~e~~~~l~ 198 (537)
T PRK04750 120 DDFDI-KPLASASIAQVHFARLKDNGREVVVKVLRPDILPVIDADLALMYRLARWVERLLPDGRRLKPREVVAEFEKTLH 198 (537)
T ss_pred HhcCh-hhhcCCCccEEEEEEECCCCCEEEEEEeCcchHHHHHHHHHHHHHHHHHHHHhCcccccCCHHHHHHHHHHHHH
Confidence 35666 78999999999999999889999999997542100 0 0011122
Q ss_pred HHHHHHHh---------cCCCCceeeEEEEEEc-CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-
Q psy8309 114 IERKVLAL---------GTKHPYLCHLFCTFQT-DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG- 182 (494)
Q Consensus 114 ~e~~~l~~---------~~~hp~Iv~l~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~- 182 (494)
.|...... ...+...+.+-.++.+ ....+|||||+.|+.+.+. ..+...+
T Consensus 199 ~ElD~~~Ea~N~~~~~~~f~~~~~v~VP~v~~d~st~~VLvmE~i~G~~l~d~-------------------~~l~~~g~ 259 (537)
T PRK04750 199 DELDLMREAANASQLRRNFEDSDMLYVPEVYWDYCSETVMVMERMYGIPVSDV-------------------AALRAAGT 259 (537)
T ss_pred HhhCHHHHHHHHHHHHHHccCCCCeecceeecccCCCceEEEeeecCccHHhH-------------------HHHHhcCC
Confidence 22222211 1122222322222222 3456799999997766320 0122222
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC----CEEEeecCceeee
Q psy8309 183 ---RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG----HVRIADFGMCKLQ 237 (494)
Q Consensus 183 ---~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g----~vkL~DFGla~~~ 237 (494)
.+.+..+..++.||+ ..|++|+|+||.||+++.+| .++++|||++...
T Consensus 260 d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~llDFGivg~l 314 (537)
T PRK04750 260 DMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIALDFGIVGSL 314 (537)
T ss_pred CHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEEecceEEEC
Confidence 244555666666664 58999999999999999988 9999999998753
|
|
| >KOG1243|consensus | Back alignment and domain information |
|---|
Probab=99.47 E-value=7.8e-13 Score=137.29 Aligned_cols=169 Identities=17% Similarity=0.236 Sum_probs=121.1
Q ss_pred EEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhh
Q psy8309 83 LAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAE 162 (494)
Q Consensus 83 ~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~ 162 (494)
.|..+.++.+|.|.+.+...- .......+-...|+ .++||||++++..++.++.+|||+|-+.
T Consensus 30 ~~t~k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lK-tlRHP~Il~yL~t~e~~~~~ylvTErV~------------- 92 (690)
T KOG1243|consen 30 DGTRKADGGPVSVFVYKRSNG---EVTELAKRAVKRLK-TLRHPNILSYLDTTEEEGTLYLVTERVR------------- 92 (690)
T ss_pred ccceeccCCceEEEEEeCCCc---hhhHHHHHHHHHhh-hccCchhhhhhhhhcccCceEEEeeccc-------------
Confidence 466677888888888876422 22222333333344 5799999999999999999999999885
Q ss_pred hhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC
Q psy8309 163 RDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH-KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241 (494)
Q Consensus 163 ~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH-~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~ 241 (494)
.|-..+.+. ....+..-+.||+.||.||| +.+++|++|....|+|+..|..||++|-++.......
T Consensus 93 ----------Pl~~~lk~l---~~~~v~~Gl~qIl~AL~FL~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~ 159 (690)
T KOG1243|consen 93 ----------PLETVLKEL---GKEEVCLGLFQILAALSFLNDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFN 159 (690)
T ss_pred ----------cHHHHHHHh---HHHHHHHHHHHHHHHHHHHhccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCC
Confidence 222233333 36677788999999999998 5689999999999999999999999999875422222
Q ss_pred CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC
Q psy8309 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283 (494)
Q Consensus 242 ~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G 283 (494)
.......---.|..|+.+.... -..|.|-|||+++|++.|
T Consensus 160 ~~~~~~~~~~s~~~P~~~~~s~--~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 160 APAKSLYLIESFDDPEEIDPSE--WSIDSWGLGCLIEELFNG 199 (690)
T ss_pred cccccchhhhcccChhhcCccc--cchhhhhHHHHHHHHhCc
Confidence 1111111222356666554333 357999999999999998
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.44 E-value=1.2e-12 Score=135.88 Aligned_cols=143 Identities=20% Similarity=0.242 Sum_probs=89.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccC---h------------------------h---hH-H------HHH
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE---D------------------------D---DV-E------CTL 113 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---~------------------------~---~~-~------~~~ 113 (494)
+.||.|++|+||+|+.+ +|+.||||+.+...... + . +. . ...
T Consensus 123 ~plasaSigQVh~A~l~-~G~~VaVKv~rp~i~~~i~~Dl~~l~~~~~~~~~~~~~~~~~~~~~~~~e~~~~l~~Eldf~ 201 (437)
T TIGR01982 123 KPLAAASIAQVHRARLV-DGKEVAVKVLRPGIEKTIAADIALLYRLARIVERLSPDSRRLRPTEVVKEFEKTLRRELDLR 201 (437)
T ss_pred cceeeeehhheEEEEec-CCCEEEEEeeCCCcHHHHHHHHHHHHHHHHHHHHhCccccccCHHHHHHHHHHHHHHHHCHH
Confidence 67999999999999875 67889999986532100 0 0 00 0 011
Q ss_pred HHHHHHHh---cC-CCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHH
Q psy8309 114 IERKVLAL---GT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189 (494)
Q Consensus 114 ~e~~~l~~---~~-~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~ 189 (494)
.|...+.. .. ++++|.-..-+....+..+|||||++|++|.+.. .... ..++ .
T Consensus 202 ~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~-------------------~~~~-~~~~---~ 258 (437)
T TIGR01982 202 REAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIA-------------------ALDE-AGLD---R 258 (437)
T ss_pred HHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHH-------------------HHHh-cCCC---H
Confidence 12221111 12 3444332222222344579999999987764310 0001 1111 2
Q ss_pred HHHHHHHHH-HHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeee
Q psy8309 190 RFYAAEIVS-GMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237 (494)
Q Consensus 190 ~~~~~qi~~-aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~ 237 (494)
..++.+++. .+..+|..|++|+|+||.||+++.+|.++|+|||++...
T Consensus 259 ~~ia~~~~~~~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l 307 (437)
T TIGR01982 259 KALAENLARSFLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRL 307 (437)
T ss_pred HHHHHHHHHHHHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeEC
Confidence 335555555 468899999999999999999999999999999998753
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.1e-12 Score=116.15 Aligned_cols=140 Identities=16% Similarity=0.131 Sum_probs=94.0
Q ss_pred eEeccCCceEEEEEEEeC------CCeEEEeeeeccccc--------c-----------ChhhHHH----HHHHHHHHHh
Q psy8309 71 KVLGKGSFGKVFLAELKG------TDYYYAVKCLKKDVV--------L-----------EDDDVEC----TLIERKVLAL 121 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~k~~~--------~-----------~~~~~~~----~~~e~~~l~~ 121 (494)
..||.|--+.||.|.... .+..+|||+.+-... . ....... ...|...|.+
T Consensus 3 g~i~~GKEa~V~~~~~~~~~~~~~~~~~~avKi~r~~~~~Fk~~~~y~~~~~rf~~~~~k~~~~~~~~~wa~kE~r~L~r 82 (197)
T cd05146 3 GCISTGKESVVLHANGGSNETEQVIPTECAIKVFKTTLNEFKNRDKYIKDDYRFKDRFSKLNPRKIIRMWAEKEMHNLKR 82 (197)
T ss_pred CccccCcceEEEEEecCcccccccCCceEEEEEEeccceeEcChhhhccCCcccccCcCCCCHHHHHHHHHHHHHHHHHH
Confidence 579999999999997543 346899999752210 0 0011111 2255555554
Q ss_pred cCC-CCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHH
Q psy8309 122 GTK-HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGM 200 (494)
Q Consensus 122 ~~~-hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL 200 (494)
... .-.+.+.+++ ..-+|||||+.++.+. ...-+...+++.++..+..+++.+|
T Consensus 83 l~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~---------------------~~~Lkd~~~~~~~~~~i~~~i~~~l 137 (197)
T cd05146 83 MQKAGIPCPEVVVL----KKHVLVMSFIGDDQVP---------------------APKLKDAKLNDEEMKNAYYQVLSMM 137 (197)
T ss_pred HHHcCCCCCeEEEe----cCCEEEEEEcCCCCcc---------------------chhhhccccCHHHHHHHHHHHHHHH
Confidence 222 1344555543 4678999999754331 1111223455667778889999999
Q ss_pred HHH-HhCCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 201 RFL-HKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 201 ~yL-H~~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
..| |+.||||+||++.|||++ +|.+.|+|||.+..
T Consensus 138 ~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~ 173 (197)
T cd05146 138 KQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVE 173 (197)
T ss_pred HHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCcee
Confidence 999 899999999999999996 57899999998764
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.37 E-value=2.7e-12 Score=115.93 Aligned_cols=128 Identities=19% Similarity=0.229 Sum_probs=88.4
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
++.|+.|.++.||+++.. +..|++|+....... ......|..++....+...+.+++.... ...++||||++
T Consensus 3 ~~~l~~G~~~~vy~~~~~--~~~~~lK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~P~~~~~~~--~~~~lv~e~i~ 74 (170)
T cd05151 3 ISPLKGGMTNKNYRVEVA--NKKYVVRIPGNGTEL----LINRENEAENSKLAAEAGIGPKLYYFDP--ETGVLITEFIE 74 (170)
T ss_pred eeecCCcccCceEEEEEC--CeEEEEEeCCCCccc----ccCHHHHHHHHHHHHHhCCCCceEEEeC--CCCeEEEEecC
Confidence 467899999999999864 667999997654210 1122344455543222223445555443 34589999999
Q ss_pred CCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC-----ccccCCCCceeeCCCC
Q psy8309 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGI-----VYRDLKLDNILLDYEG 224 (494)
Q Consensus 150 ~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~gi-----vHrDLKp~NILl~~~g 224 (494)
|.++.. . ......++.+++.+|..||..++ +|+|++|.||+++ ++
T Consensus 75 G~~l~~---------------------~--------~~~~~~~~~~l~~~l~~LH~~~~~~~~~~HgD~~~~Nil~~-~~ 124 (170)
T cd05151 75 GSELLT---------------------E--------DFSDPENLEKIAKLLKKLHSSPLPDLVPCHNDLLPGNFLLD-DG 124 (170)
T ss_pred CCcccc---------------------c--------cccCHHHHHHHHHHHHHHhCCCCCCceeecCCCCcCcEEEE-CC
Confidence 766521 0 01113457899999999999985 9999999999999 77
Q ss_pred CEEEeecCcee
Q psy8309 225 HVRIADFGMCK 235 (494)
Q Consensus 225 ~vkL~DFGla~ 235 (494)
.++|+|||.+.
T Consensus 125 ~~~liDf~~a~ 135 (170)
T cd05151 125 RLWLIDWEYAG 135 (170)
T ss_pred eEEEEeccccc
Confidence 89999999875
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >KOG1266|consensus | Back alignment and domain information |
|---|
Probab=99.36 E-value=1e-13 Score=132.12 Aligned_cols=203 Identities=16% Similarity=0.233 Sum_probs=142.3
Q ss_pred CCCCceeeEEEEEEcCC-----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHH
Q psy8309 123 TKHPYLCHLFCTFQTDS-----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYA 193 (494)
Q Consensus 123 ~~hp~Iv~l~~~~~~~~-----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~ 193 (494)
+-|.|||+++.++.+.. ...++.||+..|+| ..+++ ....+.....++|+
T Consensus 124 lvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~---------------------~~fLkrt~~~~~a~~~~~wkkw~ 182 (458)
T KOG1266|consen 124 LVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSL---------------------KQFLKRTKKNQKALFQKAWKKWC 182 (458)
T ss_pred HHHHHHHHHHHhhcccccccccceEEEEecccchhH---------------------HHHHHHHHHhhhhhhHHHHHHHH
Confidence 46999999999887644 48899999996554 33333 33568888999999
Q ss_pred HHHHHHHHHHHhCC--CccccCCCCceeeCCCCCEEEeecCceeeee----ccCCcccccCCCCCccChhhhCCCCCCCc
Q psy8309 194 AEIVSGMRFLHKKG--IVYRDLKLDNILLDYEGHVRIADFGMCKLQI----YLDKTTDTFCGTPDYMAPEIIKGLKYNQC 267 (494)
Q Consensus 194 ~qi~~aL~yLH~~g--ivHrDLKp~NILl~~~g~vkL~DFGla~~~~----~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 267 (494)
-||+.||.|||+.. |+|+++..+-|++..+|-||++--.-..... ........-.|-++|.|||.=.-...+-+
T Consensus 183 tqIlsal~yLhs~~PpiihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a 262 (458)
T KOG1266|consen 183 TQILSALSYLHSCDPPIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGA 262 (458)
T ss_pred HHHHhhhhhhhccCCccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccc
Confidence 99999999999984 9999999999999999988875322111000 00011222346788999998776677789
Q ss_pred chHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 268 VDWWSFGILLYEMHVGQSP-FSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 268 ~DiwSlGvil~ell~G~~P-f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
+|||++|....||..|..- =.+....+.-..|.+...-.. ..--+++|.+||+-.|..|| ++.+++.||-
T Consensus 263 ~dIy~fgmcAlemailEiq~tnseS~~~~ee~ia~~i~~le---n~lqr~~i~kcl~~eP~~rp------~ar~llfHpl 333 (458)
T KOG1266|consen 263 SDIYKFGMCALEMAILEIQSTNSESKVEVEENIANVIIGLE---NGLQRGSITKCLEGEPNGRP------DARLLLFHPL 333 (458)
T ss_pred hhhhhhhHHHHHHHHheeccCCCcceeehhhhhhhheeecc---CccccCcCcccccCCCCCCc------chhhhhcCce
Confidence 9999999999999987753 333322222223332221111 12235789999999999999 6788999998
Q ss_pred cCCCChhHH
Q psy8309 347 FRGLDWQAL 355 (494)
Q Consensus 347 f~~~~w~~l 355 (494)
.-.+.-.++
T Consensus 334 lfeVhslkl 342 (458)
T KOG1266|consen 334 LFEVHSLKL 342 (458)
T ss_pred eeecchHHH
Confidence 766654443
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.10 E-value=1.1e-09 Score=97.83 Aligned_cols=134 Identities=23% Similarity=0.234 Sum_probs=89.8
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-----hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-----DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
..|++|+-+.++.+...+ ..+++|.=.++..... -..++...|..++... .--.|.--.-++.+.....|+|
T Consensus 2 ~~i~~GAEa~i~~~~~~g--~~av~K~Ri~K~YR~p~LD~klrr~Rt~~Earil~~a-~~~GV~~P~v~dvD~~~~~I~m 78 (204)
T COG3642 2 DLIKQGAEAIIYLTDFLG--LPAVVKERIPKRYRHPELDEKLRRERTRREARILAKA-REAGVPVPIVYDVDPDNGLIVM 78 (204)
T ss_pred chhhCCcceeEEeeeccC--cceEEEeecCcccCChHHHHHHHHHHHHHHHHHHHHH-HHcCCCCCeEEEEcCCCCEEEE
Confidence 468899999999996643 2366665433322222 1234566777777642 2223333333455677788999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++ |..|...+... ...++..+-.-+.-||..||||+||.+.||++...+
T Consensus 79 e~I~---------------------G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givHGDLTtsNiIl~~~~- 129 (204)
T COG3642 79 EYIE---------------------GELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVHGDLTTSNIILSGGR- 129 (204)
T ss_pred EEeC---------------------ChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeecCCCccceEEEeCCc-
Confidence 9998 33444444433 134566677778889999999999999999997654
Q ss_pred EEEeecCceee
Q psy8309 226 VRIADFGMCKL 236 (494)
Q Consensus 226 vkL~DFGla~~ 236 (494)
+.++||||+..
T Consensus 130 i~~IDfGLg~~ 140 (204)
T COG3642 130 IYFIDFGLGEF 140 (204)
T ss_pred EEEEECCcccc
Confidence 99999999874
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=99.09 E-value=7e-10 Score=104.47 Aligned_cols=84 Identities=17% Similarity=0.150 Sum_probs=57.0
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC-CCceeeEEEEEEcC---CeeEEEEE
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK-HPYLCHLFCTFQTD---SHLFFVME 146 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~l~~~~~~~---~~~~lv~E 146 (494)
+.||.|..+.||++...+ |+.|++|+....... ........|..++..... +..+.+++.+.... +..++|||
T Consensus 4 ~~l~~G~~n~~~~v~~~~-g~~~ilK~~~~~~~~--~~~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e 80 (223)
T cd05154 4 RQLSGGQSNLTYLLTAGG-GRRLVLRRPPPGALL--PSAHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVME 80 (223)
T ss_pred eecCCCccceEEEEEecC-CcceEEEeCCCcccC--cccccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEE
Confidence 678999999999998754 567999998654321 122344566666654222 23466677766554 36789999
Q ss_pred ecCCCCCcccc
Q psy8309 147 YLNGGDLIPAG 157 (494)
Q Consensus 147 ~~~~g~L~~~~ 157 (494)
|++|+++....
T Consensus 81 ~i~G~~l~~~~ 91 (223)
T cd05154 81 RVDGRVLRDRL 91 (223)
T ss_pred EeCCEecCCCC
Confidence 99999886644
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >KOG3741|consensus | Back alignment and domain information |
|---|
Probab=99.08 E-value=3.6e-09 Score=107.21 Aligned_cols=225 Identities=19% Similarity=0.205 Sum_probs=149.6
Q ss_pred eEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----CCeeEEEEEecCC-CCC
Q psy8309 79 GKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----DSHLFFVMEYLNG-GDL 153 (494)
Q Consensus 79 G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~~~~~lv~E~~~~-g~L 153 (494)
.+.|+|..+.+|..|++|.++........... .+.| +. +++.|+|||++.++|.+ +..+++|++|.++ ++|
T Consensus 290 ~Ttyk~~s~~DG~~YvLkRlhg~r~~~~nk~t-~lve--~w-kkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL 365 (655)
T KOG3741|consen 290 ITTYKATSNVDGNAYVLKRLHGDRDQSTNKDT-SLVE--AW-KKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTL 365 (655)
T ss_pred ceeEeeeeccCCceeeeeeeccccccCcccch-HHHH--HH-HHhccCceeehhhhhhhhccCcceEEEEEecCCCCchH
Confidence 57899999999999999999544332221111 1112 22 25789999999999984 4568999999984 333
Q ss_pred ccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCc
Q psy8309 154 IPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233 (494)
Q Consensus 154 ~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGl 233 (494)
.+..+...... ...-..+..++...+|..+|.|+.||..||.++|+.|+..+-|.|.+||++.+..|+|...|.
T Consensus 366 ~d~~F~~~~~t------~~~n~~~~~~~~~~~e~~lW~y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i 439 (655)
T KOG3741|consen 366 YDLYFANPPFT------KRTNSFYPSQNLKAPEEVLWSYISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGI 439 (655)
T ss_pred HHHHccCCccc------cccccccccCCCCchHHHHHHHHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccc
Confidence 22111111000 000112334556789999999999999999999999999999999999999888899887776
Q ss_pred eeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHH-HHHHHhCCCCCCccCC
Q psy8309 234 CKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP-FSGCDEDEL-FWSICNERPRFPQFLS 311 (494)
Q Consensus 234 a~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~P-f~~~~~~~~-~~~i~~~~~~~p~~~s 311 (494)
...... +. + |.+. --.+-|.=.||.++..|.||..- +......+. ...| -..+|
T Consensus 440 ~Dvl~~-d~------~-------~~le---~~Qq~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I-------~~~yS 495 (655)
T KOG3741|consen 440 MDVLQE-DP------T-------EPLE---SQQQNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRI-------TTTYS 495 (655)
T ss_pred eeeecC-CC------C-------cchh---HHhhhhHHHHHHHHHHHhhcccccccccchHHHHHHHh-------hhhhh
Confidence 554221 11 1 1111 12357999999999999999643 222222222 2222 24578
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 312 VEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 312 ~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+++++|.-+...++..| ++.+++.|
T Consensus 496 ~D~rn~v~yl~s~~~~~k-------sI~~llp~ 521 (655)
T KOG3741|consen 496 TDLRNVVEYLESLNFREK-------SIQDLLPM 521 (655)
T ss_pred HHHHHHHHHHHhcCcccc-------cHHHHHHH
Confidence 999999999998888742 45666643
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.05 E-value=4.5e-09 Score=104.03 Aligned_cols=240 Identities=16% Similarity=0.190 Sum_probs=155.7
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE------EcC-Cee
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF------QTD-SHL 141 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~------~~~-~~~ 141 (494)
..+.||+|+-+.+|-.-.-.+ .+.|+..+.... ........|...-.||-+-.=+.+= -+. ..+
T Consensus 15 ~gr~LgqGgea~ly~l~e~~d---~VAKIYh~Pppa------~~aqk~a~la~~p~~p~~~~rvaWPqa~L~G~~~~~~i 85 (637)
T COG4248 15 PGRPLGQGGEADLYTLGEVRD---QVAKIYHAPPPA------AQAQKVAELAATPDAPLLNYRVAWPQATLHGGRRGKVI 85 (637)
T ss_pred CCccccCCccceeeecchhhc---hhheeecCCCch------HHHHHHHHhccCCCCcchhhhhcccHHHhhCCCcccee
Confidence 357899999999997654333 356887664221 1112233444445666543211111 112 236
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
.++|..++|..- +..++ .-.+..+......+.-+...++.|+.|...||..|.+-+|+.++|+|+.
T Consensus 86 GflmP~v~g~~p-----------I~~~y---~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVs 151 (637)
T COG4248 86 GFLMPKVSGKEP-----------IHMIY---SPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVS 151 (637)
T ss_pred EEecccCCCccc-----------hhhhc---CchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeee
Confidence 788888875421 11110 0111222334577888999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCH---
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVG-QSPFSGCDE--- 292 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~~--- 292 (494)
+++.|.|.|=..-.. ...+......+|.++|.+||.-. +.+-+...|.|.||++++++|.| +.||.|...
T Consensus 152 d~~~V~LVdsDsfqi-~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ 230 (637)
T COG4248 152 DDSKVVLVDSDSFQI-NANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISD 230 (637)
T ss_pred cCceEEEEcccceee-ccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCC
Confidence 999999998554332 12344455678999999999865 44567889999999999999985 999976321
Q ss_pred --HHHHHHHHhCCCC---------------CC-ccCCHHHHHHHHhhccCC--CCCCCCC
Q psy8309 293 --DELFWSICNERPR---------------FP-QFLSVEAKNILVHLLDKD--TTKRLGS 332 (494)
Q Consensus 293 --~~~~~~i~~~~~~---------------~p-~~~s~~~~~li~~lL~~d--P~~R~~~ 332 (494)
.-.-..|..+.+. +| .-++++++.|..+|++.. +.-||++
T Consensus 231 ap~p~E~~Ia~g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a 290 (637)
T COG4248 231 APNPLETDIAHGRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTA 290 (637)
T ss_pred CCCcchhhhhcceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCH
Confidence 1111133332211 11 247899999999999643 4578875
|
|
| >KOG2137|consensus | Back alignment and domain information |
|---|
Probab=99.03 E-value=1.2e-10 Score=121.80 Aligned_cols=159 Identities=21% Similarity=0.319 Sum_probs=120.4
Q ss_pred HHHHHHHHHHHhC-CCccccCCCCceeeCCCCCEEEeecCceeeeeccCCc---------ccccCCCCCccChhhhCCCC
Q psy8309 194 AEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT---------TDTFCGTPDYMAPEIIKGLK 263 (494)
Q Consensus 194 ~qi~~aL~yLH~~-givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~---------~~~~~gt~~y~aPE~l~~~~ 263 (494)
.+++.||.|+|.. ++||++|.|++|.++.+|..||+.|+.+......... .....-...|.|||.+.+..
T Consensus 106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~ 185 (700)
T KOG2137|consen 106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT 185 (700)
T ss_pred hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence 4455999999987 8999999999999999999999999987542221110 11122456899999999988
Q ss_pred CCCcchHHHHHHHHHHHH-hCCCCCCCCCHHHHHHHHHh----CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 264 YNQCVDWWSFGILLYEMH-VGQSPFSGCDEDELFWSICN----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 264 ~~~~~DiwSlGvil~ell-~G~~Pf~~~~~~~~~~~i~~----~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
.+.++|++||||++|-+. .|+.-+.+.+....+..-.. +...++..++.++++=|.++|..++..|| ++
T Consensus 186 ~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~~~~~~~~s~~~p~el~~~l~k~l~~~~~~rp------~~ 259 (700)
T KOG2137|consen 186 NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLLNAGAFGYSNNLPSELRESLKKLLNGDSAVRP------TL 259 (700)
T ss_pred ccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhcccccccccccccCcHHHHHHHHHHhcCCcccCc------ch
Confidence 899999999999999999 56666655543322222111 12344567899999999999999999999 57
Q ss_pred hhhhcCCCcCCCChhHHhcC
Q psy8309 339 DDVVAHEYFRGLDWQALEKR 358 (494)
Q Consensus 339 ~eil~h~~f~~~~w~~l~~~ 358 (494)
.+++.-+||.+.--..|...
T Consensus 260 ~~l~~~~ff~D~~~~aLrfL 279 (700)
T KOG2137|consen 260 DLLLSIPFFSDPGLKALRFL 279 (700)
T ss_pred hhhhcccccCCchhhhhhhc
Confidence 88999999998766666443
|
|
| >KOG3087|consensus | Back alignment and domain information |
|---|
Probab=99.00 E-value=2.3e-09 Score=95.23 Aligned_cols=145 Identities=19% Similarity=0.168 Sum_probs=96.5
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeecccc-----ccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV-----VLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.+..|-+|+-+.|+.+... |+.+.||.--.+. +...-...+...|...|.++ .--.|.--.-+|.+...-.|
T Consensus 11 ~l~likQGAEArv~~~~~~--Ge~~iIK~Rf~K~YRHP~LD~kLtr~Rt~~Ear~l~k~-~~~GI~~P~l~~~D~~~~~i 87 (229)
T KOG3087|consen 11 SLELIKQGAEARVPRGSFS--GEAAIIKERFSKRYRHPALDQKLTRKRTKQEARLLAKC-RALGIPAPRLIFIDTYGGQI 87 (229)
T ss_pred cceeeeccceeeEeeeccC--CceeEEeecccccccchHHHHHHHHHHHHHHHHHHHHH-HHhCCCCceEEEEecCCCeE
Confidence 5788999999999999764 5556777532221 11222334566777777642 22233333335666777789
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-C-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-G-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+|||++|-. .+..++... . .........++.+|-..+.-||.++|||+||..+||++.
T Consensus 88 ~ME~~~g~~--------------------~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~ndiiHGDLTTSNill~ 147 (229)
T KOG3087|consen 88 YMEFIDGAS--------------------TVKDFILSTMEDESEDEGLAELARRIGELIGKLHDNDIIHGDLTTSNILLR 147 (229)
T ss_pred EEEeccchh--------------------HHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhhCCeecccccccceEEe
Confidence 999998522 233333322 2 222233367889999999999999999999999999998
Q ss_pred CCCC---EEEeecCceee
Q psy8309 222 YEGH---VRIADFGMCKL 236 (494)
Q Consensus 222 ~~g~---vkL~DFGla~~ 236 (494)
.+|. +.|+|||++..
T Consensus 148 ~~~~~~~~~lIdfgls~~ 165 (229)
T KOG3087|consen 148 SDGNQITPILIDFGLSSV 165 (229)
T ss_pred cCCCcCceEEEeecchhc
Confidence 7764 58999999864
|
|
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.81 E-value=2.4e-07 Score=89.86 Aligned_cols=77 Identities=19% Similarity=0.199 Sum_probs=60.8
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
...+||||++++- .+|...+.. ....++.....++.+|+..+.-||..||+|+||++.
T Consensus 108 ~~s~LVte~l~~~--------------------~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~~Gi~HgDL~~~ 167 (268)
T PRK15123 108 RTSFIITEDLAPT--------------------ISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHAAGINHRDCYIC 167 (268)
T ss_pred ceeEEEEeeCCCC--------------------ccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCcCccCCCChh
Confidence 3578999999842 133333332 234567778889999999999999999999999999
Q ss_pred ceeeCC-------CCCEEEeecCcee
Q psy8309 217 NILLDY-------EGHVRIADFGMCK 235 (494)
Q Consensus 217 NILl~~-------~g~vkL~DFGla~ 235 (494)
|||++. ++.+.|+||+.+.
T Consensus 168 NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 168 HFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred hEEEeccccCCCCCceEEEEECCccc
Confidence 999975 4679999999875
|
|
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.74 E-value=5.6e-08 Score=89.10 Aligned_cols=128 Identities=26% Similarity=0.161 Sum_probs=75.0
Q ss_pred EEEEEEEeCCCeEEEeeeecccccc---------------------Ch--hhHHHHHHHHHHHHhcCCC-CceeeEEEEE
Q psy8309 80 KVFLAELKGTDYYYAVKCLKKDVVL---------------------ED--DDVECTLIERKVLALGTKH-PYLCHLFCTF 135 (494)
Q Consensus 80 ~V~~~~~~~~~~~~AiK~~~k~~~~---------------------~~--~~~~~~~~e~~~l~~~~~h-p~Iv~l~~~~ 135 (494)
.||.|.. ..|..+|||+.+..... .. -.......|...|...... -++.+.+.+-
T Consensus 1 ~Vy~~~~-~~~~~~a~K~~r~~~~~Fk~~~~y~~~~~r~~~~~~~~~~~~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~ 79 (188)
T PF01163_consen 1 DVYHAID-PDGEEVAVKIYRTGRTSFKRRKKYRDYDYRFKKYRHKSSWRYLIREWAKKEFRNLKRLYEAGVPVPKPYDYN 79 (188)
T ss_dssp EEEEEEE-CTTEEEEEEEE-S---SS-HHHHHTTTSTTSTTC--G--CHHHHHHHHHHHHHHHHHCCCTT-SS--EEEEE
T ss_pred CEEEEEC-CCCCEEEEEEeccCceEEEEeeeeecccchhcccccccCHHHHHHHHHHHHHHHHHHHHHCCccCCcEEEEe
Confidence 3888876 45667999987532110 00 1123456677777754332 2456666442
Q ss_pred EcCCeeEEEEEecC--CCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHH-HHhCCCcccc
Q psy8309 136 QTDSHLFFVMEYLN--GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRF-LHKKGIVYRD 212 (494)
Q Consensus 136 ~~~~~~~lv~E~~~--~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~y-LH~~givHrD 212 (494)
.-+|||||+. |..+ ..+.. ..++......++.+++..+.. +|..||+|+|
T Consensus 80 ----~~~ivME~I~~~G~~~----------------------~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~~givHGD 132 (188)
T PF01163_consen 80 ----RNVIVMEYIGEDGVPL----------------------PRLKD-VDLSPEEPKELLEEILEEIIKMLHKAGIVHGD 132 (188)
T ss_dssp ----TTEEEEE--EETTEEG----------------------GCHHH-CGGGGSTHHHHHHHHHHHHHHHHHCTTEEESS
T ss_pred ----CCEEEEEecCCCccch----------------------hhHHh-ccccchhHHHHHHHHHHHHHHHHHhcCceecC
Confidence 3479999997 3222 11111 112244556678888886555 5799999999
Q ss_pred CCCCceeeCCCCCEEEeecCceee
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~ 236 (494)
|.+.|||++.+ .+.|+|||.+..
T Consensus 133 Ls~~NIlv~~~-~~~iIDf~qav~ 155 (188)
T PF01163_consen 133 LSEYNILVDDG-KVYIIDFGQAVD 155 (188)
T ss_dssp -STTSEEEETT-CEEE--GTTEEE
T ss_pred CChhhEEeecc-eEEEEecCccee
Confidence 99999999876 999999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.73 E-value=3.5e-09 Score=74.22 Aligned_cols=44 Identities=45% Similarity=0.684 Sum_probs=35.4
Q ss_pred ccccccccccCCcCCCCCCCCc-hhHHhhhccccccccccccCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPV-DRTILESMDQTQFQGFSYTNPN 490 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~-~~~~~~~~~~~~f~~f~~~~~~ 490 (494)
++.|++|||++||.++|.++|+ +...+.+..|..|.||||++|+
T Consensus 4 ~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~s 48 (48)
T PF00433_consen 4 SETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNPS 48 (48)
T ss_dssp STT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETCT
T ss_pred chhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCCC
Confidence 6789999999999999999996 8888888888889999999974
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=98.69 E-value=1.5e-08 Score=75.80 Aligned_cols=63 Identities=48% Similarity=0.920 Sum_probs=51.2
Q ss_pred CCCChhHHhcCcCCCCCcccccCCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcc
Q psy8309 348 RGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESM 427 (494)
Q Consensus 348 ~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~ 427 (494)
++|+|++|.+++++|||+|.+. +..|+++||.+|+.+.+..++.........
T Consensus 1 ~~idW~~l~~r~~~pP~~P~~~----------------------------~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~ 52 (64)
T smart00133 1 RGIDWDKLENKEIEPPFVPKIK----------------------------SPTDTSNFDDEFTEETPVLTPVDSPASGGS 52 (64)
T ss_pred CCCCHHHHHhCCCCCCcccccC----------------------------CccHHhHcCCcCCCCCCCCCCCCccccccc
Confidence 4799999999999999999887 788999999989988877776654333333
Q ss_pred cCCCccCeeee
Q psy8309 428 DQTQFQGFSYT 438 (494)
Q Consensus 428 ~~~~f~~f~~~ 438 (494)
.+..|.||+|.
T Consensus 53 ~~~~F~gfsy~ 63 (64)
T smart00133 53 QQEPFRGFSYV 63 (64)
T ss_pred cccccCCCccc
Confidence 35789999996
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.66 E-value=6.1e-07 Score=83.94 Aligned_cols=77 Identities=26% Similarity=0.348 Sum_probs=64.4
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
..+||+|++++. .+|...+.....++......++.+++..+.-||.+||+|+|+++.|||
T Consensus 91 ~s~lite~l~~~--------------------~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~~gi~H~Dl~~~NIL 150 (206)
T PF06293_consen 91 RSYLITEALPGA--------------------QDLRDLLQQWEQLDPSQRRELLRALARLIAKLHDAGIYHGDLNPSNIL 150 (206)
T ss_pred eEEEEEEeCCCc--------------------ccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHHCcCCCCCCCcccEE
Confidence 458999999842 345555555444777788899999999999999999999999999999
Q ss_pred eCCCC---CEEEeecCceee
Q psy8309 220 LDYEG---HVRIADFGMCKL 236 (494)
Q Consensus 220 l~~~g---~vkL~DFGla~~ 236 (494)
++.++ .+.|+||+.++.
T Consensus 151 v~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 151 VDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred EeCCCCceeEEEEcchhcee
Confidence 99887 899999998764
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=1.5e-07 Score=89.16 Aligned_cols=137 Identities=21% Similarity=0.123 Sum_probs=92.7
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccc-----------------ccChhh--HHHHHHHHHHHHhcCCC-C
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV-----------------VLEDDD--VECTLIERKVLALGTKH-P 126 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~-----------------~~~~~~--~~~~~~e~~~l~~~~~h-p 126 (494)
..+...||-|--|.||.|... .|..+|||.=+-.. ....-. .....+|-.+|...-.+ -
T Consensus 93 e~iG~~IGvGKEsdVY~~~~~-~g~~~~vKfHR~GrtsFrkvk~~R~y~~~~~h~sWl~~sRl~A~rEf~~L~~L~~~G~ 171 (304)
T COG0478 93 EAIGTKIGVGKESDVYVAIDP-KGRKVAVKFHRLGRTSFRKVKRNRDYLADKEHGSWLYVSRLAAEREFEALQRLYPEGV 171 (304)
T ss_pred HhhccccccCccceEEEEECC-CCCEEEEEEeecCchhhhhhcchhhhhccccCcchhhhHHHHHHHHHHHHHHhhhcCC
Confidence 346689999999999999875 56779999732110 001111 22344555566532222 1
Q ss_pred ceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 127 ~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
.|.+.++ -+...+|||+++|-.|.. -+++.+.+..++..|+.-+.-+-..
T Consensus 172 ~VP~P~~----~nRHaVvMe~ieG~eL~~--------------------------~r~~~en~~~il~~il~~~~~~~~~ 221 (304)
T COG0478 172 KVPKPIA----WNRHAVVMEYIEGVELYR--------------------------LRLDVENPDEILDKILEEVRKAYRR 221 (304)
T ss_pred CCCCccc----cccceeeeehcccceeec--------------------------ccCcccCHHHHHHHHHHHHHHHHHc
Confidence 3444443 356789999999655421 1223455566777788777777799
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCce
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMC 234 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla 234 (494)
||||+|+.+-|||++.+|.+.++||--+
T Consensus 222 GiVHGDlSefNIlV~~dg~~~vIDwPQ~ 249 (304)
T COG0478 222 GIVHGDLSEFNILVTEDGDIVVIDWPQA 249 (304)
T ss_pred CccccCCchheEEEecCCCEEEEeCccc
Confidence 9999999999999999999999999754
|
|
| >KOG0576|consensus | Back alignment and domain information |
|---|
Probab=98.46 E-value=2.7e-08 Score=103.31 Aligned_cols=187 Identities=19% Similarity=0.205 Sum_probs=136.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCc-eeeEEEEEEcCCeeEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY-LCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~-Iv~l~~~~~~~~~~~lv 144 (494)
-+....-+++|+++++++.+...+.... .+.+... .....++++|. +.+||| .+..++.++.+.+..++
T Consensus 243 ws~~fh~fvK~altknpKkRptaeklL~-h~fvs~~--------l~~rl~~eLLd-K~n~P~~~v~~~~d~~~E~~~~i~ 312 (829)
T KOG0576|consen 243 WSEFFHNFVKGALTKNPKKRPTAEKLLQ-HPFVSQT--------LSRRLAIELLD-KVNNPNPVVRYLEDYDGEDYLWIP 312 (829)
T ss_pred chHHHHHHHHHHhcCCCccCCChhhhee-ceeeccc--------hhhHHHHHHHH-HccCCCCcccccccCCcccccchh
Confidence 4566678899999999998876665443 5555332 33445666776 579999 78888888889999999
Q ss_pred EEecCCC-CCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGG-DLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g-~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|+++.+| +-.. ... ...-.+.+-+.....+.-+.+|++||+.-=+||| |||..+
T Consensus 313 ~~i~s~~rs~~~-~~~-------------------~se~~~~~~~~~~~~r~et~~l~~l~~~~~~~~d----~~l~s~- 367 (829)
T KOG0576|consen 313 MRICSTGRSSAL-EMT-------------------VSEIALEQYQFAYPLRKETRPLAELHSSYKVHRD----NILGSE- 367 (829)
T ss_pred hhhhcCCccccc-cCC-------------------hhhHhhhhhhhhhhhhhhcccccccccccccCcc----cccccc-
Confidence 9999876 1110 000 0111233334445566667889999998789999 887754
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
+..|++||+...... ......+..+|+.++|||++....+....|.|++|+--.+|.-|.+|-.
T Consensus 368 ~~~~~~~~~v~~~L~-~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 368 EEVKLLDFAVPPQLT-RTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred cccccccccCCcccC-cccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCCCC
Confidence 789999999876432 2224677889999999999999999999999999987778877877754
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.43 E-value=7.3e-06 Score=75.86 Aligned_cols=140 Identities=12% Similarity=0.055 Sum_probs=91.7
Q ss_pred ccCCceEEEEEEEeCCCeEEEeeeecccc---ccChhhHHHHHHHHHHHHhc--CCCCceeeEEEEEEc----CCeeEEE
Q psy8309 74 GKGSFGKVFLAELKGTDYYYAVKCLKKDV---VLEDDDVECTLIERKVLALG--TKHPYLCHLFCTFQT----DSHLFFV 144 (494)
Q Consensus 74 G~G~fG~V~~~~~~~~~~~~AiK~~~k~~---~~~~~~~~~~~~e~~~l~~~--~~hp~Iv~l~~~~~~----~~~~~lv 144 (494)
|+||.+-|+.....+. .|=+|.-.... .....-...+..|...|... ..-| +.+....-.. .-..+||
T Consensus 27 ~rgG~SgV~r~~~~g~--~~ylKrq~nhl~~s~r~P~g~ptf~rE~~~L~~L~~~GvP-VP~pvf~~~~k~~~~~rA~LV 103 (216)
T PRK09902 27 RRNGMSGVQCVERNGK--KLYVKRMTHHLFHSVRYPFGRPTIVREVAVIKELERAGVI-VPKIVFGEAVKIEGEWRALLV 103 (216)
T ss_pred CCCCcceEEEEEeCCc--EEEEEeccCcccccccCCCCchHHHHHHHHHHHHHHcCCC-CCccceeeeeccCCceEEEEE
Confidence 6789999998776544 46777654110 11011223455555555431 2223 4444422222 1246899
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|-+.| -.+|...+... .+.++.....++.+|+.++.-||+.|+.|+|+-+.|||++.
T Consensus 104 Te~L~g--------------------~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~~Gv~Hgdly~khIll~~ 163 (216)
T PRK09902 104 TEDMAG--------------------FISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHSVNRQHGCCYVRHIYVKT 163 (216)
T ss_pred EEeCCC--------------------CccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHHCCCcCCCCCHhheeecC
Confidence 998763 23454444432 35577777899999999999999999999999999999997
Q ss_pred CCC--EEEeecCceee
Q psy8309 223 EGH--VRIADFGMCKL 236 (494)
Q Consensus 223 ~g~--vkL~DFGla~~ 236 (494)
+|. |+++||--++.
T Consensus 164 ~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 164 EGKAEAGFLDLEKSRR 179 (216)
T ss_pred CCCeeEEEEEhhccch
Confidence 787 99999986653
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.36 E-value=6.2e-06 Score=76.61 Aligned_cols=142 Identities=23% Similarity=0.290 Sum_probs=87.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhh---------HHHHHHHHHHHHh-cCCCC---ce
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD---------VECTLIERKVLAL-GTKHP---YL 128 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~---------~~~~~~e~~~l~~-~~~hp---~I 128 (494)
+...+|.+.+++-......|.+..- .|+.|++|..+......+.. ....+.....+.. ....+ .+
T Consensus 28 i~~~~~~~~kv~k~~~r~~ValIei--~~~kyIlK~pr~~~~r~er~~~sf~kg~~~~~l~~~~~~i~~~g~~~~~~~yl 105 (229)
T PF06176_consen 28 ILDNNYKIIKVFKNTKRNYVALIEI--DGKKYILKEPREENRRPERRFKSFFKGSEYSRLINNTDKIRNEGFTEPADPYL 105 (229)
T ss_pred HHhCCceEEEeecCCCccEEEEEEE--CCcEEEEeccchhhhhHHHHHHHHhccHHHHHHHHHHHHHHHcCcccccccee
Confidence 3446889999998888888877764 34669999876542222211 1112222222211 12222 22
Q ss_pred eeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 129 v~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
+.-.-.+.-....+|+|||++|..|.+ . ..+++ .++..|+.++.-||+.|+
T Consensus 106 ~~ekk~~~~~~~~~ll~EYIeG~~l~d---------------------~----~~i~e----~~~~ki~~~ikqlH~~G~ 156 (229)
T PF06176_consen 106 AAEKKIFRYTSSYVLLMEYIEGVELND---------------------I----EDIDE----DLAEKIVEAIKQLHKHGF 156 (229)
T ss_pred eeeeeeccceeEEEEEEEEecCeeccc---------------------c----hhcCH----HHHHHHHHHHHHHHHcCC
Confidence 222222222345678999999765532 1 11222 245667788999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
+|+|..|.|++++.+ .++++||+..+
T Consensus 157 ~HGD~hpgNFlv~~~-~i~iID~~~k~ 182 (229)
T PF06176_consen 157 YHGDPHPGNFLVSNN-GIRIIDTQGKR 182 (229)
T ss_pred ccCCCCcCcEEEECC-cEEEEECcccc
Confidence 999999999999855 49999998654
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG1035|consensus | Back alignment and domain information |
|---|
Probab=98.35 E-value=2.6e-06 Score=94.39 Aligned_cols=207 Identities=22% Similarity=0.237 Sum_probs=141.9
Q ss_pred hHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHH
Q psy8309 108 DVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187 (494)
Q Consensus 108 ~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~ 187 (494)
.+.....|...+. ...|+|++.++.+-.......+++ .-+.+++.+.++...++..+.++..
T Consensus 225 ~i~~~E~e~~~l~-k~~~~n~~~~~~~~le~~~~g~~~-----------------~v~~~~~s~~~~~~~~q~v~~i~~~ 286 (1351)
T KOG1035|consen 225 EIQTTEIELESLS-KIAHDNLGGYFVYGLERLFRGIVL-----------------DVLQEICSKVELRSLLQSVGSIPLE 286 (1351)
T ss_pred HHHHHHHHHHHHH-hhccccccceeEEeehhhcchHHH-----------------HHHHhhcCccchHHHHhhccccCHH
Confidence 3334444555555 578999998887654432222222 1234556688888899999999999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCccccCCCC---ceeeCCCCCEEEe--ecCceeeeeccCCcccccCCCCCccChhhhCCC
Q psy8309 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLD---NILLDYEGHVRIA--DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL 262 (494)
Q Consensus 188 ~~~~~~~qi~~aL~yLH~~givHrDLKp~---NILl~~~g~vkL~--DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~ 262 (494)
.++.+..+++.||.|+|+....|.-|... +-..+..+.+.++ ||+.++.... ........-+..|.|+|.....
T Consensus 287 ~~r~~~~~~~~GL~~~h~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d-~~~~~~~~~~~~~~~~e~~~~~ 365 (1351)
T KOG1035|consen 287 TLRILHQKLLEGLAYLHSLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPD-NEKSFSDLLAEIRNADEDLKEN 365 (1351)
T ss_pred HHHHHHHHHhhhHHHHHHhccceeEEecccccccccCccceeecchhhhcccccCCC-cccchhhcCccccccccccccc
Confidence 99999999999999999996666655554 4444566677776 8887765322 2223334456678889988877
Q ss_pred CCCCc--chHHHHHHHHHHHHhCCCCCC-CCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 263 KYNQC--VDWWSFGILLYEMHVGQSPFS-GCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 263 ~~~~~--~DiwSlGvil~ell~G~~Pf~-~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
.+..+ .|+|++|.+...+..|..+-. .... ..++ +.....+..+++.+|+..++++|+ ++.
T Consensus 366 ~~~~~r~~dL~~lgll~~~~~~~~~i~~~~~~~----~~~l------~~~~~~~~~d~~~~~~~~~~~~Rl------~~~ 429 (1351)
T KOG1035|consen 366 TAKKSRLTDLWCLGLLLLQLSQGEDISEKSAVP----VSLL------DVLSTSELLDALPKCLDEDSEERL------SAL 429 (1351)
T ss_pred cchhhhhhHHHHHHHHHhhhhhcCcccccccch----hhhh------ccccchhhhhhhhhhcchhhhhcc------chh
Confidence 66654 699999999999988764421 1111 1111 111122778899999999999999 568
Q ss_pred hhhcCCCcCC
Q psy8309 340 DVVAHEYFRG 349 (494)
Q Consensus 340 eil~h~~f~~ 349 (494)
+++.|+|.+-
T Consensus 430 ~ll~~~f~~~ 439 (1351)
T KOG1035|consen 430 ELLTHPFLRF 439 (1351)
T ss_pred hhhhchhccc
Confidence 8999999864
|
|
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.31 E-value=8.8e-06 Score=77.21 Aligned_cols=73 Identities=16% Similarity=0.113 Sum_probs=48.7
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCC-ceeeEEEEEEcCCeeEEEEEecC
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP-YLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp-~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
..||+|..+.||+.. +..+++|...... .......|..++....... -+.+.+++....+...+|||+++
T Consensus 7 ~~i~~G~t~~~y~~~----~~~~VlR~~~~~~-----~~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~ 77 (226)
T TIGR02172 7 TQTGEGGNGESYTHK----TGKWMLKLYNPGF-----DKETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIV 77 (226)
T ss_pred eeecCCCCcceeEec----CCCEEEEeCCCCC-----CHHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecC
Confidence 678999999999842 3357888876431 1223456666665422222 24566777777788899999999
Q ss_pred CCC
Q psy8309 150 GGD 152 (494)
Q Consensus 150 ~g~ 152 (494)
|.+
T Consensus 78 G~~ 80 (226)
T TIGR02172 78 GKR 80 (226)
T ss_pred Ccc
Confidence 874
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.29 E-value=1e-06 Score=82.60 Aligned_cols=139 Identities=23% Similarity=0.227 Sum_probs=87.1
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-------------------hhHHH--HHHHHHHHHhc-CCCCce
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-------------------DDVEC--TLIERKVLALG-TKHPYL 128 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-------------------~~~~~--~~~e~~~l~~~-~~hp~I 128 (494)
..|..|--+.||+|.. .++..+|+|+.+-....-. ..... ...|..-|.+. -.+=.+
T Consensus 54 g~istGKEA~Vy~a~~-~~~~~~avKiyr~~t~~fk~~~~Yi~gd~Rf~~~~~~rr~lv~~W~~kEf~NL~R~~eAGVrv 132 (268)
T COG1718 54 GCISTGKEANVYLAET-GDGRYVAVKIYRTSTSEFKRIRRYIQGDPRFRNSRSNRRKLVFAWARKEFRNLKRAYEAGVRV 132 (268)
T ss_pred eeecCCcceEEEeecc-CCCceEEEEEEehhhhhhhhHHHHHhcChhhhcCCCCHHHHHHHHHHHHHHHHHHHHHcCCCC
Confidence 3677777888999875 4567899999864322111 11111 11222222211 122333
Q ss_pred eeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q psy8309 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KG 207 (494)
Q Consensus 129 v~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~g 207 (494)
.+-+.+. +-.|||||+..... -.-.+. .-.+...++..+..+++..+.-|-. .|
T Consensus 133 P~Pi~~~----~nVLvMEfIg~~g~--------------------pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~a~ 187 (268)
T COG1718 133 PEPIAFR----NNVLVMEFIGDDGL--------------------PAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKEAG 187 (268)
T ss_pred CCceeec----CCeEEEEeccCCCC--------------------CCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHhcC
Confidence 3444333 34799999963211 001111 1234444788889999999998887 89
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+||+||..=|||+. +|.+.|+|||-|..
T Consensus 188 LVHgDLSEyNiL~~-~~~p~iID~~QaV~ 215 (268)
T COG1718 188 LVHGDLSEYNILVH-DGEPYIIDVSQAVT 215 (268)
T ss_pred cccccchhhheEEE-CCeEEEEECccccc
Confidence 99999999999999 89999999997653
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.27 E-value=7.6e-06 Score=86.15 Aligned_cols=143 Identities=18% Similarity=0.212 Sum_probs=85.1
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccC--------------------h----------hhH-HHHH------
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--------------------D----------DDV-ECTL------ 113 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--------------------~----------~~~-~~~~------ 113 (494)
+.|+.++-|+||.|+.+. |+.||||+.+...... . ++. +...
T Consensus 131 ~PiAsASIaQVH~A~L~s-G~~VAVKVqrPgi~~~i~~DL~il~~~a~~~~~~~~~~~~l~~~~vv~e~~~~l~~ElDy~ 209 (517)
T COG0661 131 EPIASASIAQVHRAVLKS-GEEVAVKVQRPGIRERIEADLKLLRRLARLIKRLPPGGRRLDLVEVVDEFEKRLREELDYR 209 (517)
T ss_pred CchhhhhHhhheeEEecC-CCEEEEEecCCChHHHHHHHHHHHHHHHHHHHHcCCccccCChHHHHHHHHHHHHHHhCHH
Confidence 679999999999999876 8889999976431100 0 000 0111
Q ss_pred HHHHHHH---h-cCCCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHH
Q psy8309 114 IERKVLA---L-GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRA 189 (494)
Q Consensus 114 ~e~~~l~---~-~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~ 189 (494)
.|..-+. . .-+.++|.--.=+++-.+.-.|+|||+.|--+.+. ..+.. ..++...+
T Consensus 210 ~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~-------------------~~l~~-~g~d~k~i 269 (517)
T COG0661 210 REAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDI-------------------AALKS-AGIDRKEL 269 (517)
T ss_pred HHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccH-------------------HHHHh-cCCCHHHH
Confidence 1111111 1 11345443333333445667899999996554321 11222 33443332
Q ss_pred HHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 190 ~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
...+.++. +..+-..|+.|.|..|.||+++.+|.+.+.|||+...
T Consensus 270 a~~~~~~f--~~q~~~dgffHaDpHpGNi~v~~~g~i~~lDfGi~g~ 314 (517)
T COG0661 270 AELLVRAF--LRQLLRDGFFHADPHPGNILVRSDGRIVLLDFGIVGR 314 (517)
T ss_pred HHHHHHHH--HHHHHhcCccccCCCccceEEecCCcEEEEcCcceec
Confidence 22222221 3344458999999999999999999999999998764
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=98.20 E-value=2.7e-05 Score=73.58 Aligned_cols=79 Identities=20% Similarity=0.254 Sum_probs=49.4
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-CceeeEEEEEE---cCCeeEEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-PYLCHLFCTFQ---TDSHLFFVM 145 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-p~Iv~l~~~~~---~~~~~~lv~ 145 (494)
++.|+.|..+.||++.... + .|++|+.... ........|..++.....+ .-+.+++.... .....+++|
T Consensus 2 i~~l~~G~~n~~~~v~~~~-~-~~vlK~~~~~-----~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~ 74 (239)
T PF01636_consen 2 IRPLSGGFSNRVYRVTTDD-G-RYVLKFYRPP-----DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLM 74 (239)
T ss_dssp EEEEEESSSSEEEEEEETT-S-EEEEEEESSH-----HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEE
T ss_pred CccCCCCCeeeEEEEEECC-c-EEEEEEeCCC-----CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEE
Confidence 5789999999999998766 4 6999987543 2233344454444322122 13455555332 334579999
Q ss_pred EecCCCCCcc
Q psy8309 146 EYLNGGDLIP 155 (494)
Q Consensus 146 E~~~~g~L~~ 155 (494)
++++|..+..
T Consensus 75 ~~i~g~~~~~ 84 (239)
T PF01636_consen 75 EYIPGRPLDD 84 (239)
T ss_dssp EEESSEEHHH
T ss_pred EEeccccccc
Confidence 9999877754
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >PF00433 Pkinase_C: Protein kinase C terminal domain; InterPro: IPR017892 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.11 E-value=1.1e-06 Score=61.47 Aligned_cols=44 Identities=45% Similarity=0.684 Sum_probs=31.5
Q ss_pred cccccCCCCccccCCCCCCCCC-CccccCcccCCCccCeeeeCCC
Q psy8309 398 HALDVKYFDKSFTAERPCLTPV-DRTILESMDQTQFQGFSYTNPN 441 (494)
Q Consensus 398 ~~~~~~~f~~~~~~~~~~~~~~-~~~~~~~~~~~~f~~f~~~~~~ 441 (494)
++.|++|||++|+++.+.+++. ....+....|..|.||+|++++
T Consensus 4 ~~~DtsnFD~eFt~~~~~~t~~~~~~~~~~~~~~~F~GFTy~~~s 48 (48)
T PF00433_consen 4 SETDTSNFDPEFTEEPPVDTPPSDPSPLSSSMQENFQGFTYVNPS 48 (48)
T ss_dssp STT-GTTSCHHHHTSSSSS--S--HHHHCTSSGGGGTT-CEETCT
T ss_pred chhhhhhcCcccccCCCCCCCcccCCcccccccCcCCCCeecCCC
Confidence 6889999999999999998885 4444455556679999999874
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This domain is found in a large variety of protein kinases with different functions and dependencies. Protein kinase C, for example, is a calcium-activated, phospholipid-dependent serine- and threonine-specific enzyme. It is activated by diacylglycerol which, in turn, phosphorylates a range of cellular proteins. This domain is most often found associated with IPR000719 from INTERPRO.; GO: 0004674 protein serine/threonine kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3E8D_A 1MRV_A 3E88_A 1GZO_A 1GZK_A 2JDO_A 2JDR_A 1MRY_A 1GZN_A 1O6L_A .... |
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.10 E-value=6.5e-05 Score=69.49 Aligned_cols=136 Identities=18% Similarity=0.235 Sum_probs=88.5
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-------------ChhhHHHHHHHHHH---H--HhcCCCCceeeE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-------------EDDDVECTLIERKV---L--ALGTKHPYLCHL 131 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-------------~~~~~~~~~~e~~~---l--~~~~~hp~Iv~l 131 (494)
...||+|+.=.||.--+.. ..+||++...... ..........|... + .....+.+|.++
T Consensus 6 ~~~i~~G~~R~cy~HP~dp---~~cIKV~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~ 82 (199)
T PF10707_consen 6 SDLIAQGGERDCYQHPDDP---NLCIKVMRPDRGERRRPFKRWLKRLRPKSRYRQNRRELRYYKQLSLRRGVDWSHIPRF 82 (199)
T ss_pred CcccccCCCceEEECCCCC---CeEEEEEccccccccccchhHHHhhcccchhHHHHHHHHHHHHHhhccCCcccccccE
Confidence 4579999999998643332 2689999876400 00111222223222 2 223458899999
Q ss_pred EEEEEcCCeeEEEEEecCC--CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 132 FCTFQTDSHLFFVMEYLNG--GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 132 ~~~~~~~~~~~lv~E~~~~--g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
+|+.+++.-+.+|+|.+.+ |.+ +.+|..++. .+.+++ . +...+-.-..||-+++|+
T Consensus 83 ~G~veT~~G~Glv~e~I~d~dG~~-----------------s~TL~~~l~-~~~~~~-~---~~~~L~~f~~~l~~~~Iv 140 (199)
T PF10707_consen 83 YGFVETNLGLGLVVELIRDADGNI-----------------SPTLEDYLK-EGGLTE-E---LRQALDEFKRYLLDHHIV 140 (199)
T ss_pred eEEEecCCceEEEEEEEECCCCCc-----------------CccHHHHHH-cCCccH-H---HHHHHHHHHHHHHHcCCe
Confidence 9999999999999999864 333 345555553 334555 2 233344455788999999
Q ss_pred cccCCCCceeeCCCC----CEEEee
Q psy8309 210 YRDLKLDNILLDYEG----HVRIAD 230 (494)
Q Consensus 210 HrDLKp~NILl~~~g----~vkL~D 230 (494)
.+||+|.||++...+ .+.|+|
T Consensus 141 ~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 141 IRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred ecCCCcccEEEEecCCCceEEEEEe
Confidence 999999999996433 467776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=98.09 E-value=0.00017 Score=66.29 Aligned_cols=129 Identities=22% Similarity=0.279 Sum_probs=84.2
Q ss_pred CCceEeeEeccCCc-eEEEEEEEeCCCeEEEeeeeccccccCh------------------hhHHHHHHHHHHHHh--cC
Q psy8309 65 EDFQLLKVLGKGSF-GKVFLAELKGTDYYYAVKCLKKDVVLED------------------DDVECTLIERKVLAL--GT 123 (494)
Q Consensus 65 ~~y~~~~~LG~G~f-G~V~~~~~~~~~~~~AiK~~~k~~~~~~------------------~~~~~~~~e~~~l~~--~~ 123 (494)
.+++.++.||.|+- |.||+++.. |+.||+|+++.-..... ....-...|.....+ ..
T Consensus 37 ~~I~flefLg~g~~~~~V~kv~I~--g~~YALKlf~~~~~~~~~~~~~~~~~~~~~~~~~~~y~~PF~~ECRAfgRLke~ 114 (207)
T PF13095_consen 37 DDIEFLEFLGHGSHDGYVFKVEID--GRIYALKLFRFWDYTEPDYTRERFAGHETSLSTPAHYADPFNCECRAFGRLKEA 114 (207)
T ss_pred CcEeeeeecCCCCceeEEEEEEEC--CeEEEEEEeeccccCCCccccccccccccccchhhhhcChHHHHHHhhHHHHhc
Confidence 69999999999999 999999864 55899999432100000 011122334443322 23
Q ss_pred CCCce--eeEEEEEEcC------------------CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCC
Q psy8309 124 KHPYL--CHLFCTFQTD------------------SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183 (494)
Q Consensus 124 ~hp~I--v~l~~~~~~~------------------~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~ 183 (494)
.+..+ |++++++.-. ....||.||++... .
T Consensus 115 ~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~------------------------------~ 164 (207)
T PF13095_consen 115 GREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP------------------------------P 164 (207)
T ss_pred cccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc------------------------------c
Confidence 45556 8999887322 12356777765211 1
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCce
Q psy8309 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234 (494)
Q Consensus 184 l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla 234 (494)
+.. .-+.+|..-|..+|..||+-+|+++.|.. .=||+|||.+
T Consensus 165 ~~~----~~~~~~~~dl~~~~k~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 165 LQI----RDIPQMLRDLKILHKLGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred cch----hHHHHHHHHHHHHHHCCeeeccCcccccc-----CCEEEecccC
Confidence 222 23567888889999999999999999986 2389999853
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=97.96 E-value=7.5e-05 Score=71.61 Aligned_cols=76 Identities=11% Similarity=-0.047 Sum_probs=49.1
Q ss_pred EeccCCc-eEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCC
Q psy8309 72 VLGKGSF-GKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150 (494)
Q Consensus 72 ~LG~G~f-G~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~ 150 (494)
.|-.|.. +.||++...+ ..+.||+..... ......|..++...-.+--+.+++++....+..++|||+++|
T Consensus 5 ~~~~g~~~~~v~~~~~~~--~~~~vk~~~~~~------~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G 76 (244)
T cd05150 5 RVTEGQSGATVYRLDGKN--PGLYLKIAPSGP------TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPG 76 (244)
T ss_pred ecCCCCCcCeEEEEcCCC--CcEEEEecCCCc------ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCC
Confidence 3445555 7899987543 458888876432 122344555554333344466778877777778999999998
Q ss_pred CCCcc
Q psy8309 151 GDLIP 155 (494)
Q Consensus 151 g~L~~ 155 (494)
..|..
T Consensus 77 ~~l~~ 81 (244)
T cd05150 77 VPAAA 81 (244)
T ss_pred ccHhH
Confidence 87753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG1235|consensus | Back alignment and domain information |
|---|
Probab=97.89 E-value=7.7e-05 Score=78.47 Aligned_cols=141 Identities=18% Similarity=0.176 Sum_probs=83.4
Q ss_pred eEeccCCceEEEEEEEeCCCeEEEeeeeccccccC--h-------------------------hh-HHHHHHHHHHH---
Q psy8309 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--D-------------------------DD-VECTLIERKVL--- 119 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~-------------------------~~-~~~~~~e~~~l--- 119 (494)
+.||.-+.|+|++|+.+. |+.||||+-+...-.. . ++ .+....|...+
T Consensus 167 ~piaaASlaQVhrA~L~~-G~~VaVKVQ~P~l~~~~~~Dl~~~~~~~~~l~k~~p~~~~~~lvdE~~~~L~~ELDF~~EA 245 (538)
T KOG1235|consen 167 EPIAAASLAQVHRARLKN-GEDVAVKVQHPGLEKLIMLDLRNLRLLAKVLQKFFPDFDLVWLVDEIAKSLPQELDFTKEA 245 (538)
T ss_pred chhhhcchhheEEEEecC-CCEEEEEecCcChHHHHHHHHHHHHHHHHHHHHhCcCCchhhHHHHHHhhhHhhcchHHHH
Confidence 679999999999999887 8889999965421100 0 00 00111111111
Q ss_pred ------HhcCCCCc------eeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHH
Q psy8309 120 ------ALGTKHPY------LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187 (494)
Q Consensus 120 ------~~~~~hp~------Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~ 187 (494)
+....|-+ |.+++..+ ...-.|+||||+|.-+.+ + ..+.+. .++..
T Consensus 246 ~Nae~~~~~f~~~~~~~~V~VP~Vy~~~--st~RVLtME~~~G~~i~D------------------l-~~i~~~-gi~~~ 303 (538)
T KOG1235|consen 246 KNAERFRENFKDFSLLTYVLVPKVYWDL--STKRVLTMEYVDGIKIND------------------L-DAIDKR-GISPH 303 (538)
T ss_pred HhHHHHHHHHHhcccccceeCCeehhhc--CcceEEEEEecCCccCCC------------------H-HHHHHc-CCCHH
Confidence 11223333 33333222 345689999999876643 1 223332 34444
Q ss_pred HHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC----CCCEEEeecCceee
Q psy8309 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY----EGHVRIADFGMCKL 236 (494)
Q Consensus 188 ~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~----~g~vkL~DFGla~~ 236 (494)
.+...+.++.. +-|=..|++|.|-.|.||++.. ++.+.+.|||+...
T Consensus 304 ~i~~~l~~~~~--~qIf~~GffHaDPHPGNilv~~~~~~~~~ivllDhGl~~~ 354 (538)
T KOG1235|consen 304 DILNKLVEAYL--EQIFKTGFFHADPHPGNILVRPNPEGDEEIVLLDHGLYAV 354 (538)
T ss_pred HHHHHHHHHHH--HHHHhcCCccCCCCCCcEEEecCCCCCccEEEEccccccc
Confidence 43333333222 2233468999999999999984 56799999999874
|
|
| >KOG1826|consensus | Back alignment and domain information |
|---|
Probab=97.88 E-value=1e-06 Score=99.36 Aligned_cols=201 Identities=16% Similarity=0.065 Sum_probs=132.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--EDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DS 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~ 139 (494)
+.++++.--+|.|.+++--.-+.+..+ +.+|+.+.-... .+...+-.+.|+..+. ...|+++.....-... ..
T Consensus 1228 ~e~~EV~l~i~~~~~~R~k~Lr~kid~--Fk~~I~ke~d~e~LsePlkemll~e~de~~-~~~h~~~~~~p~rI~ps~s~ 1304 (2724)
T KOG1826|consen 1228 MEHSEVNLGISNHFHFRNKWLRSKIDW--FKFSIYKEYDFENLSEPLKEMLLSERDELR-EAKHYLTEVDPLRIPPSEST 1304 (2724)
T ss_pred hhhhheeeecccceeeccchHhhhhce--eEEEeehhhhHHHHhhHHHHhhhhhhhhhh-hhhceeeecccccCCCCCCh
Confidence 456666666777766654333333333 556665432111 1112222333433333 3478887755433332 33
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhC-----CCcc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----SGRFDEGRARFYAAEIVSGMRFLHKK-----GIVY 210 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yLH~~-----givH 210 (494)
..|.+++||.+ |.++..+.+ ...+.+.-+.....+.+.+..-+|++ -.+|
T Consensus 1305 ee~~r~~~~~~---------------------g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~~~ls~tnlg~T~v~ 1363 (2724)
T KOG1826|consen 1305 EEYIRSLYVEF---------------------GKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRNVILSLTNLGNTNVS 1363 (2724)
T ss_pred HHHHHHHHHHH---------------------hHHHHHHHhccccCCcchhchHHHHHHHHHhccchhhhcccCCccchh
Confidence 45677777774 444444433 23455555555555557887777765 2799
Q ss_pred ccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 211 RDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 211 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
++||+-|.+|..+..+|++++|+.+.........+..++++.|++|++...-.++.++|+|..|+.+|++..|..+|.
T Consensus 1364 ~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1364 KSLKFTLPMIVTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred hhhhhhccceecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 999999999999999999999999854444445667788999999999999999999999999999999999988874
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.84 E-value=0.00024 Score=80.19 Aligned_cols=85 Identities=21% Similarity=0.368 Sum_probs=55.4
Q ss_pred EeeEeccCCceEEEEEEEeCCC--eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCce--eeEEEEEEcC---Cee
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTD--YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYL--CHLFCTFQTD---SHL 141 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~--~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I--v~l~~~~~~~---~~~ 141 (494)
-++.|+.|.++.+|+......+ ..+++|+........ .......|..++.....|++| .+++.++.+. +..
T Consensus 42 ~v~~l~gG~sn~ty~l~~~~~~~~~~~VLR~~p~~~~~~--~~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~ 119 (822)
T PLN02876 42 KVSQFGHGQSNPTFLLEVGNGGSVKRYVLRKKPPGKLLQ--SAHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTA 119 (822)
T ss_pred eEEEeCCCCcCceEEEEECCCCcceeEEEEeCCCCccCc--cHHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCc
Confidence 3677899999999998765432 357777765432211 123455677777643335554 6777777654 467
Q ss_pred EEEEEecCCCCCcc
Q psy8309 142 FFVMEYLNGGDLIP 155 (494)
Q Consensus 142 ~lv~E~~~~g~L~~ 155 (494)
|+||||++|..+.+
T Consensus 120 flVME~v~G~~~~~ 133 (822)
T PLN02876 120 FYIMEYLEGRIFVD 133 (822)
T ss_pred eEEEEecCCcccCC
Confidence 89999999866543
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.76 E-value=0.00029 Score=67.09 Aligned_cols=77 Identities=22% Similarity=0.224 Sum_probs=45.6
Q ss_pred eeEeccCCceEEEEEEEeC-CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 70 LKVLGKGSFGKVFLAELKG-TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
++.|..|-...||++.... .++.|++|+....... .+ ....|..++.....+...+++++.+.. .+||||+
T Consensus 3 i~~l~gG~tN~~~~v~~~~~~~~~~vlR~~~~~~~~---~~-d~~~E~~~~~~l~~~gl~P~v~~~~~~----~~l~e~i 74 (235)
T cd05157 3 FKRFTGGITNKLVKVSNKEDNQDAVLVRVYGNKTEL---II-DRERELRIHKLLSKHGLAPKLYATFQN----GLIYEFI 74 (235)
T ss_pred EEEcCCcccceEEEEEcCCCCCCeEEEEEccCCccc---ee-cHHHHHHHHHHHHhCCCCCeEEEEeCC----cEEEEee
Confidence 4678888899999997543 3456889977543111 11 112344444432233334555554432 3799999
Q ss_pred CCCCCc
Q psy8309 149 NGGDLI 154 (494)
Q Consensus 149 ~~g~L~ 154 (494)
+|-++.
T Consensus 75 ~G~~l~ 80 (235)
T cd05157 75 PGRTLE 80 (235)
T ss_pred CCCcCC
Confidence 997774
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=97.68 E-value=0.00037 Score=71.40 Aligned_cols=81 Identities=20% Similarity=0.181 Sum_probs=53.4
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--C--hhhHHHHHHHHHHHHhcCC--CCceeeEEEEEEcCCeeEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--E--DDDVECTLIERKVLALGTK--HPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~--~~~~~~~~~e~~~l~~~~~--hp~Iv~l~~~~~~~~~~~l 143 (494)
.+.||.|.++.||++...+.++.++||.-...... . .-..++...|...|..... ...+++++.+ +.+..++
T Consensus 31 ~~elggGn~N~VyrV~~~~g~~svIVKqa~p~~r~~g~~wpl~~eR~~~Eae~L~~l~~~~p~~VPkV~~~--D~~~~~l 108 (401)
T PRK09550 31 AREIGDGNLNLVFRVSDTEGGKSVIVKQALPYVRVVGESWPLTLDRARIEAEALKIQAKYVPDLVPKVYHY--DEELAVT 108 (401)
T ss_pred eeEcCCCceEEEEEEEeCCCCeEEEEEecCcccccccccccccHHHHHHHHHHHHHHHhhCCCCCCeEEEE--CCCCCEE
Confidence 46899999999999998654457999985421110 1 1234556667766664322 2456777766 4466889
Q ss_pred EEEecCCCC
Q psy8309 144 VMEYLNGGD 152 (494)
Q Consensus 144 v~E~~~~g~ 152 (494)
|||++++..
T Consensus 109 VME~L~~~~ 117 (401)
T PRK09550 109 VMEDLSDHK 117 (401)
T ss_pred EEecCCCcc
Confidence 999998754
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.66 E-value=0.00034 Score=62.53 Aligned_cols=130 Identities=24% Similarity=0.251 Sum_probs=84.0
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCce-eeEEEEEEcCCeeEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYL-CHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~I-v~l~~~~~~~~~~~lv~ 145 (494)
.+..+.||+|.+|.||+|..++. .+|+|+-+.+ ........|.++|.. ++-.++ .+++.+-. .++.|
T Consensus 24 ~~v~~~L~KG~~s~Vyl~~~~~~--~~a~Kvrr~d-----s~r~~l~kEakiLei-l~g~~~~p~vy~yg~----~~i~m 91 (201)
T COG2112 24 LRVEKELAKGTTSVVYLGEWRGG--EVALKVRRRD-----SPRRNLEKEAKILEI-LAGEGVTPEVYFYGE----DFIRM 91 (201)
T ss_pred hhhhhhhhcccccEEEEeeccCc--eEEEEEecCC-----cchhhHHHHHHHHHH-hhhcCCCceEEEech----hhhhh
Confidence 34567899999999999987654 6899987654 233455667777764 333344 34444432 33459
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC-CCceeeCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK-LDNILLDYEG 224 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK-p~NILl~~~g 224 (494)
||+.|-.| ....... + +.-+..++.+---|-..||-|..|. |..++|..++
T Consensus 92 e~i~G~~L---------------------~~~~~~~---~----rk~l~~vlE~a~~LD~~GI~H~El~~~~k~vlv~~~ 143 (201)
T COG2112 92 EYIDGRPL---------------------GKLEIGG---D----RKHLLRVLEKAYKLDRLGIEHGELSRPWKNVLVNDR 143 (201)
T ss_pred hhhcCcch---------------------hhhhhcc---c----HHHHHHHHHHHHHHHHhccchhhhcCCceeEEecCC
Confidence 99985433 2221110 1 2233455566556777899999995 7767777777
Q ss_pred CEEEeecCceee
Q psy8309 225 HVRIADFGMCKL 236 (494)
Q Consensus 225 ~vkL~DFGla~~ 236 (494)
.+.|+||..|..
T Consensus 144 ~~~iIDFd~At~ 155 (201)
T COG2112 144 DVYIIDFDSATF 155 (201)
T ss_pred cEEEEEccchhh
Confidence 999999998763
|
|
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=97.62 E-value=0.0012 Score=65.61 Aligned_cols=162 Identities=17% Similarity=0.162 Sum_probs=82.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh----cCCCCceeeEEE---EE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL----GTKHPYLCHLFC---TF 135 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~----~~~hp~Iv~l~~---~~ 135 (494)
++.....++.++.|.-..||++.. .++ .|++|+..... .... ...|..++.. ....|-++.-.. +.
T Consensus 20 ~~~~~~~i~~~~~G~~n~~y~v~t-~~~-~~vLK~~~~~~--~~~~---i~~e~~~l~~L~~~g~pvp~~i~t~~g~~~~ 92 (307)
T TIGR00938 20 DLGELLSLKGIAEGVENSNYLLTT-DVG-RYILTLYEKRV--KAEE---LPFFLALTTHLAARGLPVPKPVKSRDGRQLS 92 (307)
T ss_pred CCCCceeccccCCccccceEEEEe-CCC-cEEEEEecCCC--CHHH---HHHHHHHHHHHHHCCCCCCccccCCCCCeeh
Confidence 444555677888888899999864 334 48889875421 1112 2222333221 122333332110 11
Q ss_pred EcCCeeEEEEEecCCCCCccccch------hhhhhhhhHhcCCc--------hhHHh---hhc----CCCCHHHHHHHHH
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLT------KAERDLMEYLNGGD--------LMFHI---QQS----GRFDEGRARFYAA 194 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~------~~~~~l~~~~~gg~--------L~~~l---~~~----~~l~e~~~~~~~~ 194 (494)
...+..++++||++|..+...... .....+.....+.. +..+. ... ..+... ...
T Consensus 93 ~~~g~~~~l~e~i~G~~~~~~~~~~~~~~G~~LA~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~l~~~----~~~ 168 (307)
T TIGR00938 93 TLAGKPACLVEFLQGLSVGRPTAMHCRPVGEVLAWMHLAGAHFPENRKNSLRLEAWHILAEKCFEAAPQLEAH----MGA 168 (307)
T ss_pred hcCCeEEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHhhhccCCCCCCCCCChHHHHHHHHhhhhcccccCHH----HHH
Confidence 234667899999998766421100 00011111111100 00000 000 011111 112
Q ss_pred HHHHHHHHHHh-------CCCccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 195 EIVSGMRFLHK-------KGIVYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 195 qi~~aL~yLH~-------~givHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
.+...++++.. .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus 169 ~l~~~~~~l~~~~~~~~~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 169 ELDKELDYLDKFWPRDLPRGVIHADLFPDNVLFDGDSVKGVIDFYFAC 216 (307)
T ss_pred HHHHHHHHHHhhhhhcCCCccCCCCCCcCcEEEECCceEEEeeccccc
Confidence 23334555532 689999999999999988877899999875
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=97.58 E-value=0.0026 Score=63.55 Aligned_cols=31 Identities=26% Similarity=0.369 Sum_probs=26.2
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.|+||+|+.|.|||++.+..+-|+||+.+..
T Consensus 187 ~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 4899999999999998665568999998753
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.54 E-value=0.0013 Score=64.83 Aligned_cols=157 Identities=14% Similarity=0.100 Sum_probs=80.9
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc--CCCCceeeEEE------EEEc
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG--TKHPYLCHLFC------TFQT 137 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~--~~hp~Iv~l~~------~~~~ 137 (494)
+..-++.|..|.-..+|++...+ ..+++|+.... .. .....|..++... ..-| +.+++. +...
T Consensus 15 ~~~~i~~i~~G~~n~~y~v~~~~--~~~vLr~~~~~---~~---~~~~~e~~~l~~L~~~g~~-vp~~i~~~~g~~~~~~ 85 (296)
T cd05153 15 ELLSFEGISAGIENTNYFVTTDS--GRYVLTLFEKV---SA---EELPFFLALLDHLAERGLP-VPRPIADRDGEYLSEL 85 (296)
T ss_pred chhheecccCccccceEEEEeCC--CcEEEEEcCCC---Ch---HhccHHHHHHHHHHHCCCC-CCccccCCCCcEeeee
Confidence 33446778888889999986433 35889987641 11 1222333333221 1112 334332 2233
Q ss_pred CCeeEEEEEecCCCCCcccc---chhh---hhhhhhHhcCCch-------hHHhhh-----cCCCCHHHHHHHHHHHHHH
Q psy8309 138 DSHLFFVMEYLNGGDLIPAG---LTKA---ERDLMEYLNGGDL-------MFHIQQ-----SGRFDEGRARFYAAEIVSG 199 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~---~~~~---~~~l~~~~~gg~L-------~~~l~~-----~~~l~e~~~~~~~~qi~~a 199 (494)
.+..++|+++++|..+.... ...- ...+.....+... ..+... ...+... ....+..+
T Consensus 86 ~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~----~~~~~~~~ 161 (296)
T cd05153 86 AGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLAAQSFPGERNNLRGLAWIRELGKDLLPLLSAE----DRALLADE 161 (296)
T ss_pred CCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHHhccCCccCCCcCCcHHHHHHHHHhccccCHH----HHHHHHHH
Confidence 55678999999998764310 0000 0111111111000 000000 0001111 11222334
Q ss_pred HHHHHh-------CCCccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 200 MRFLHK-------KGIVYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 200 L~yLH~-------~givHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
+.++.. .+++|+|+.|.|||++.++.+.|+||+.+.
T Consensus 162 ~~~l~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~ 204 (296)
T cd05153 162 LARQDAFDPSDLPRGVIHADLFRDNVLFDGDELSGVIDFYFAC 204 (296)
T ss_pred HHHHHhhhhhcCCCcCCccCcCcccEEEeCCceEEEeehhhhc
Confidence 444443 479999999999999987777899999775
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=97.53 E-value=0.00037 Score=67.38 Aligned_cols=29 Identities=14% Similarity=0.285 Sum_probs=25.9
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.++|+|+.|.|||++.++ +.|+||..+..
T Consensus 147 ~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 589999999999999877 78999998764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.42 E-value=0.00075 Score=64.37 Aligned_cols=31 Identities=23% Similarity=0.232 Sum_probs=25.8
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.+++|+|+.|.|||++.++..-|+||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 3589999999999998665567999998753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=97.33 E-value=0.0019 Score=64.08 Aligned_cols=78 Identities=14% Similarity=0.077 Sum_probs=45.8
Q ss_pred eeEeccCCceEEEEEEEeC------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 70 LKVLGKGSFGKVFLAELKG------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
++.|..|--..||++.... +++.|++|+...... .......|..++.....+--..++++++.. .+
T Consensus 3 i~~l~gGltN~~y~v~~~~~~~~~~~~~~~vlRi~~~~~~----~~~~r~~E~~~~~~l~~~g~~P~~~~~~~~----~~ 74 (302)
T cd05156 3 VSKISGGLTNAVYKVSLPDEDALSDEPRKVLLRVYGQSVE----LLIDRERELVVFARLSERNLGPKLYGIFPN----GR 74 (302)
T ss_pred EEEecCcccceeEEEEcCCcccccCCCCeEEEEEecCCCc----ceechHHHHHHHHHHHhCCCCCceEEEeCC----Cc
Confidence 4566777778999987643 256799999765321 111233444444432222234556666542 36
Q ss_pred EEEecCCCCCcc
Q psy8309 144 VMEYLNGGDLIP 155 (494)
Q Consensus 144 v~E~~~~g~L~~ 155 (494)
|+||++|..+..
T Consensus 75 v~e~i~G~~l~~ 86 (302)
T cd05156 75 IEEFIPSRTLTT 86 (302)
T ss_pred hhheeCCCcCCH
Confidence 899999987753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0011 Score=61.03 Aligned_cols=100 Identities=18% Similarity=0.177 Sum_probs=72.9
Q ss_pred HHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHH
Q psy8309 115 ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAA 194 (494)
Q Consensus 115 e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~ 194 (494)
|-.++...-..+++++++|++- -++|.||...+++... ...+.+-..-++.....++.
T Consensus 9 E~lll~~l~~~~~~pk~lG~CG----~~~v~E~~~~~~~~~~------------------~~~l~~~~~~~w~~R~~iA~ 66 (188)
T PF12260_consen 9 EPLLLQLLQGSEPFPKLLGSCG----RFYVVEYVGAGSLYGI------------------YRPLSQFLQSPWEQRAKIAL 66 (188)
T ss_pred HHHHHHHcCCCCCCCCeeeECC----CEEEEEeecCcccccc------------------ccccccccccCHHHHHHHHH
Confidence 3334443223369999999983 3568899986655210 00122223467888999999
Q ss_pred HHHHHHHHHHh---CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 195 EIVSGMRFLHK---KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 195 qi~~aL~yLH~---~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+++..+++|+. ..+.-.|++|+|+-++++|++|++|...+..
T Consensus 67 ~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~ 111 (188)
T PF12260_consen 67 QLLELLEELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFV 111 (188)
T ss_pred HHHHHHHHHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcch
Confidence 99999999998 4588899999999999999999999987643
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.14 E-value=0.0081 Score=59.47 Aligned_cols=81 Identities=6% Similarity=0.011 Sum_probs=51.8
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC--CceeeEEEEEEc---CCeeE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH--PYLCHLFCTFQT---DSHLF 142 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h--p~Iv~l~~~~~~---~~~~~ 142 (494)
.-.+.||.|..+.||.....+ + .+.+|..+.. . .......|...|....++ -.+.++++++.. .+..+
T Consensus 17 ~~~~~i~~G~~~~vy~~~~~~-~-~~~~k~~~~~--~---~~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~ 89 (297)
T PRK10593 17 SRVECISEQPYAALWALYDSQ-G-NPMPLMARSF--S---TPGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDV 89 (297)
T ss_pred heeeecCCccceeEEEEEcCC-C-CEEEEEeccc--c---cchHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeE
Confidence 345789999999999986433 3 3677774321 0 112345566665533232 356677776654 46789
Q ss_pred EEEEecCCCCCcc
Q psy8309 143 FVMEYLNGGDLIP 155 (494)
Q Consensus 143 lv~E~~~~g~L~~ 155 (494)
||||+++|+++.+
T Consensus 90 LVmE~i~G~~~~~ 102 (297)
T PRK10593 90 LLLERLRGVSVEA 102 (297)
T ss_pred EEEeccCCEecCC
Confidence 9999999987753
|
|
| >KOG2270|consensus | Back alignment and domain information |
|---|
Probab=96.85 E-value=0.014 Score=58.21 Aligned_cols=136 Identities=23% Similarity=0.242 Sum_probs=86.9
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC---------------------hhhHHHHHHHHHH--HH----hc
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE---------------------DDDVECTLIERKV--LA----LG 122 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---------------------~~~~~~~~~e~~~--l~----~~ 122 (494)
-..|..|--+-||.|... +|..+|||+++-..+.- ....-....|+.+ |. ..
T Consensus 149 nGCiSTGKEANVYHat~~-dG~~~AIKIYKTSILvFKDRdRYV~GEfRFRhgyck~NPRKMVk~WAEKE~RNLkRl~~aG 227 (520)
T KOG2270|consen 149 NGCISTGKEANVYHATEE-DGSEFAIKIYKTSILVFKDRDRYVSGEFRFRHGYCKHNPRKMVKTWAEKEMRNLKRLNNAG 227 (520)
T ss_pred ccccccCccceeEeeecC-CCceEEEEEEeeeEEEEechhhhccceeeeecccccCCcHHHHHHHHHHHHHHHHHHHhcC
Confidence 346777888899998754 56679999987433211 1111122333322 22 12
Q ss_pred CCCCceeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHH
Q psy8309 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRF 202 (494)
Q Consensus 123 ~~hp~Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~y 202 (494)
+.+|--+-|. ...|||+|+.+- |.. .-.-+...++...+..+-.|++.-|.-
T Consensus 228 IP~PePIlLk-------~hVLVM~FlGrd--------------------gw~-aPkLKd~~ls~~ka~~~Y~~~v~~MR~ 279 (520)
T KOG2270|consen 228 IPCPEPILLK-------NHVLVMEFLGRD--------------------GWA-APKLKDASLSTSKARELYQQCVRIMRR 279 (520)
T ss_pred CCCCCceeee-------cceEeeeeccCC--------------------CCc-CcccccccCChHHHHHHHHHHHHHHHH
Confidence 3333333222 346999999521 111 112233467788899999999988887
Q ss_pred HHh-CCCccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 203 LHK-KGIVYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 203 LH~-~givHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
|.+ .++||.||.-=|+|+. +|.+.|+|.+-+.
T Consensus 280 lY~~c~LVHADLSEfN~Lyh-dG~lyiIDVSQSV 312 (520)
T KOG2270|consen 280 LYQKCRLVHADLSEFNLLYH-DGKLYIIDVSQSV 312 (520)
T ss_pred HHHHhceeccchhhhhheEE-CCEEEEEEccccc
Confidence 765 5999999999999994 7899999998654
|
|
| >TIGR01767 MTRK 5-methylthioribose kinase | Back alignment and domain information |
|---|
Probab=96.73 E-value=0.013 Score=59.03 Aligned_cols=78 Identities=22% Similarity=0.137 Sum_probs=48.3
Q ss_pred EeccCCceEEEEEEEeCCCeEEEeeeecccccc----ChhhHHHHHHHHHHHHhcCC-CC-ceeeEEEEEEcCCeeEEEE
Q psy8309 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL----EDDDVECTLIERKVLALGTK-HP-YLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 72 ~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~----~~~~~~~~~~e~~~l~~~~~-hp-~Iv~l~~~~~~~~~~~lv~ 145 (494)
.||-|.-..||++.....++.++||.-..-... -.-...+...|...|..... .| .+++++.+ +.....+||
T Consensus 2 EigdGnlN~VfrV~~~~g~~svIVKQAlp~vRv~g~~wpl~~~R~~~E~~~L~~~~~~~P~~vP~vy~~--D~e~~~~vM 79 (370)
T TIGR01767 2 EVGDGNLNLVFHVYDQEGDRAAIVKQALPYVRVVGESWPLTLDRARIESSALIRQGEHVPHLVPRIFHF--DTEMAVTVM 79 (370)
T ss_pred cCCCCceEEEEEEEcCCCCeeEEEEEcCHHHhhcCCCCCCCccHHHHHHHHHHHhhccCccccCeEEEE--ccccceehH
Confidence 579999999999997544457899975421111 12234556677777654322 23 44555433 455667999
Q ss_pred EecCCC
Q psy8309 146 EYLNGG 151 (494)
Q Consensus 146 E~~~~g 151 (494)
|+++..
T Consensus 80 EdL~~~ 85 (370)
T TIGR01767 80 EDLSHH 85 (370)
T ss_pred hhCccc
Confidence 999753
|
This enzyme is involved in the methionine salvage pathway in certain bacteria. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=96.68 E-value=0.046 Score=54.22 Aligned_cols=29 Identities=34% Similarity=0.640 Sum_probs=25.8
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
.+++|+|+.+.||+++. +.+.|+||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 57999999999999987 778999999765
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=96.62 E-value=0.013 Score=59.37 Aligned_cols=81 Identities=17% Similarity=0.117 Sum_probs=46.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeC----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKG----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
+...+ +.|-.|-...+|++.... +++.|++|+..... ...+. ...|..++.....+.--.++++.+...
T Consensus 37 ~~~~i-~~l~gGlTN~~y~v~~~~~~~~~~~~~v~Ri~g~~t---~~~id-R~~E~~~~~~l~~~gl~P~~~~~~~~g-- 109 (344)
T PLN02236 37 EALQV-IPLKGAMTNEVFQIKWPTKEGNLGRKVLVRIYGEGV---ELFFD-RDDEIRTFECMSRHGQGPRLLGRFPNG-- 109 (344)
T ss_pred CcEEE-EEcCCcccceeEEEEeCCCCCCCCCeEEEEEccCCC---Ceeec-hHHHHHHHHHHHHcCCCCceEEEECCc--
Confidence 34444 455558888999987532 24678999876532 11111 234555554333333344566666432
Q ss_pred eEEEEEecCCCCCc
Q psy8309 141 LFFVMEYLNGGDLI 154 (494)
Q Consensus 141 ~~lv~E~~~~g~L~ 154 (494)
.|.||++|.+|.
T Consensus 110 --~v~efi~g~~l~ 121 (344)
T PLN02236 110 --RVEEFIHARTLS 121 (344)
T ss_pred --eEEEeeCCCCCC
Confidence 589999887764
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.032 Score=55.35 Aligned_cols=166 Identities=15% Similarity=0.168 Sum_probs=84.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-CceeeEEEEEEcCC--eeE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-PYLCHLFCTFQTDS--HLF 142 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-p~Iv~l~~~~~~~~--~~~ 142 (494)
...+++.+-.|.--.+|..... ++.++++ ... .............|..++.....- --+...++.+.++. ..|
T Consensus 26 ~~~~v~~~~~G~sn~t~~~~~~--~~~~vlR-~P~-~~~~~~~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf 101 (321)
T COG3173 26 GLLIVEEISGGWSNDTFRLGDT--GQKYVLR-KPP-RGDPVESAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPF 101 (321)
T ss_pred CCceeeeccCCcccceEEEecC--CceEEEe-cCC-ccccchhhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCce
Confidence 3445555544444445554433 6678888 332 112223334445555666543321 12234455555554 669
Q ss_pred EEEEecCCCCCccccchhhhh------hhhhHhc---CCchhHHhhhcC---CCCHHHHHHHHHHH--------------
Q psy8309 143 FVMEYLNGGDLIPAGLTKAER------DLMEYLN---GGDLMFHIQQSG---RFDEGRARFYAAEI-------------- 196 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~------~l~~~~~---gg~L~~~l~~~~---~l~e~~~~~~~~qi-------------- 196 (494)
.||+|++|..+.+........ .+.+.+. ..+ ..-....+ .....++..+..+.
T Consensus 102 ~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~id-a~~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~ 180 (321)
T COG3173 102 YVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSID-AAGLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLA 180 (321)
T ss_pred EEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCC-CcCCCCCCccCccccchhhHHHHHHHHHHHhccCCCchH
Confidence 999999986654322221111 1211111 111 00000000 11122223333333
Q ss_pred HHHHHHHHhC--------CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 197 VSGMRFLHKK--------GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 197 ~~aL~yLH~~--------givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
..-..+|+.+ .++|+|+.+.||+|+..+-+-|.||+++..
T Consensus 181 ~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii~~~~~~gVlDwe~~~l 228 (321)
T COG3173 181 DRLIKWLEANRPPWAGPPVLVHGDYRPGNLIIDPGRPTGVLDWELATL 228 (321)
T ss_pred HHHHHHHHhcCCCcCCCceeeeCCcccCCEEEeCCCeeEEEecccccc
Confidence 1224555543 489999999999999999999999999875
|
|
| >KOG0696|consensus | Back alignment and domain information |
|---|
Probab=96.52 E-value=0.00078 Score=67.14 Aligned_cols=43 Identities=42% Similarity=0.753 Sum_probs=39.7
Q ss_pred cCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccc
Q psy8309 402 VKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATD 444 (494)
Q Consensus 402 ~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~ 444 (494)
++|||..||++++.++|.+..++.+++|..|.||+|+||.+..
T Consensus 636 ~eNFD~~Ft~~~~~lTPpD~~v~~nldq~eF~gFsfvNpefv~ 678 (683)
T KOG0696|consen 636 AENFDKFFTREPTDLTPPDKLVMMNLDQSEFEGFSFVNPEFVK 678 (683)
T ss_pred hhhhhHHHhcCCCCCCCchHHHHhcCchhhcCceeeeChhhcC
Confidence 4799999999999999999999999999999999999998753
|
|
| >KOG2268|consensus | Back alignment and domain information |
|---|
Probab=96.50 E-value=0.0043 Score=60.78 Aligned_cols=136 Identities=12% Similarity=0.084 Sum_probs=84.1
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccc-----------------cChhhH--HHHHHHHHHHHhcCCCCc
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV-----------------LEDDDV--ECTLIERKVLALGTKHPY 127 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-----------------~~~~~~--~~~~~e~~~l~~~~~hp~ 127 (494)
+.++..||-|--+-||.+-+. .|..+++|.=+.... ..+-.. -....|...|...-.|-+
T Consensus 94 ~svGnqIGVGKESDIY~v~d~-~G~~~~lK~HRLGRtSFR~Vk~kRDY~r~r~~~sWlyLSRlaa~kEfafmkaL~e~gf 172 (465)
T KOG2268|consen 94 ESVGNQIGVGKESDIYVVADE-EGNPLILKLHRLGRTSFRNVKNKRDYLRKRKSGSWLYLSRLAATKEFAFMKALYERGF 172 (465)
T ss_pred hhhccccccccccceEEEecC-CCCchhHHHHhhhhhhHHHhhhhhhhHhcCCccchhhhHHHHHHHHHHHHHHHHHcCC
Confidence 456789999999999999764 466688886321110 001111 122334444443223333
Q ss_pred ee-eEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 128 LC-HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 128 Iv-~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
=| +.+ +.+..++|||++.|-.|... .. ...+..+...+..-+--|-.+
T Consensus 173 pVPkpi----D~~RH~Vvmelv~g~Pl~~v-------------------------~~--v~d~~~ly~~lm~~Iv~la~~ 221 (465)
T KOG2268|consen 173 PVPKPI----DHNRHCVVMELVDGYPLRQV-------------------------RH--VEDPPTLYDDLMGLIVRLANH 221 (465)
T ss_pred CCCCcc----cccceeeHHHhhcccceeee-------------------------ee--cCChHHHHHHHHHHHHHHHHc
Confidence 22 222 34567899999985544211 00 111223444555556778899
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCce
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMC 234 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla 234 (494)
|+||+|..-=||+|+.++.++++||--+
T Consensus 222 GlIHgDFNEFNimv~dd~~i~vIDFPQm 249 (465)
T KOG2268|consen 222 GLIHGDFNEFNIMVKDDDKIVVIDFPQM 249 (465)
T ss_pred CceecccchheeEEecCCCEEEeechHh
Confidence 9999999999999999999999999744
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.42 E-value=0.029 Score=56.42 Aligned_cols=83 Identities=16% Similarity=0.242 Sum_probs=46.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
..++.++..+.| |--..+|++...+. +..|++|+..... ...+ ....|..++.....+.--.++++++.. +
T Consensus 13 ~~~~i~i~~l~g-GlTN~~~~v~~~~~~~~~~~~v~Ri~g~~t---~~~I-dR~~E~~il~~l~~~gl~P~~l~~~~~-G 86 (330)
T PLN02421 13 DDSDFSVERISG-GITNLLLKVSVKEENGNEVSVTVRLFGPNT---DYVI-DRERELQAIKYLSAAGFGAKLLGVFGN-G 86 (330)
T ss_pred CcCceEEEEeCC-cccceEEEEEecCCCCCCceEEEEEecCCc---CeEe-chHHHHHHHHHHHhcCCCCceeEEeCC-c
Confidence 344566655444 77788999875442 2368899875431 1111 123344444432233333566666632 2
Q ss_pred eeEEEEEecCCCCCc
Q psy8309 140 HLFFVMEYLNGGDLI 154 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~ 154 (494)
+|.+|++|-+|.
T Consensus 87 ---~i~~fi~g~~l~ 98 (330)
T PLN02421 87 ---MIQSFINARTLT 98 (330)
T ss_pred ---EeehhhcCCCCC
Confidence 589999877663
|
|
| >PLN02756 S-methyl-5-thioribose kinase | Back alignment and domain information |
|---|
Probab=96.35 E-value=0.052 Score=55.69 Aligned_cols=78 Identities=14% Similarity=0.136 Sum_probs=50.0
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh----hhHHHHHHHHHHHHhcCC--CCceeeEEEEEEcCCeeE
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED----DDVECTLIERKVLALGTK--HPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~----~~~~~~~~e~~~l~~~~~--hp~Iv~l~~~~~~~~~~~ 142 (494)
..+.||.|.-..||++... +..|+||.-........ ....+...|...|....+ ...+.+++.+.. +..+
T Consensus 36 ~~~eiggGn~N~VyrV~~~--~~svVVKqa~p~~r~vga~wpl~~~R~~~Ea~aL~~~~~~~p~~VPkVy~~de--d~~v 111 (418)
T PLN02756 36 KIKEVGDGNLNFVYIVVSS--SGSFVIKQALPYIRCIGESWPMTKERAYFEATALREHGRLCPDHVPEVYHFDR--TMAL 111 (418)
T ss_pred eEEEcCCCceeeEEEEEcC--CccEEEEeCCccccCCCccccCCccHHHHHHHHHHHhhhcCCCCCCeEEEECC--CCCE
Confidence 3678999999999998863 34588997652211111 134455556656553222 246777777765 4567
Q ss_pred EEEEecCC
Q psy8309 143 FVMEYLNG 150 (494)
Q Consensus 143 lv~E~~~~ 150 (494)
++||++++
T Consensus 112 lvME~L~~ 119 (418)
T PLN02756 112 IGMRYLEP 119 (418)
T ss_pred EEEeecCC
Confidence 88999987
|
|
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=96.08 E-value=0.095 Score=52.11 Aligned_cols=30 Identities=20% Similarity=0.215 Sum_probs=27.7
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+++|+|+.+.|||++.++.+.++||..+..
T Consensus 197 ~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 799999999999999999999999998764
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.07 Score=52.23 Aligned_cols=30 Identities=27% Similarity=0.405 Sum_probs=25.4
Q ss_pred CCccccCCCCceeeCCCCC-EEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGH-VRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~-vkL~DFGla~~ 236 (494)
.++|+|+.|.|||++.++. +-|+||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 4899999999999997565 46999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >smart00133 S_TK_X Extension to Ser/Thr-type protein kinases | Back alignment and domain information |
|---|
Probab=96.02 E-value=0.0032 Score=46.65 Aligned_cols=42 Identities=43% Similarity=0.673 Sum_probs=34.6
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhccccccccccccC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTN 488 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~ 488 (494)
+..|++|||..|+.+.+..++......+...+..|.||+|++
T Consensus 23 ~~~d~s~fd~~~~~~~~~~s~~~~~~~~~~~~~~F~gfsy~~ 64 (64)
T smart00133 23 SPTDTSNFDDEFTEETPVLTPVDSPASGGSQQEPFRGFSYVF 64 (64)
T ss_pred CccHHhHcCCcCCCCCCCCCCCCccccccccccccCCCcccC
Confidence 567899999999999998888776555555578999999974
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.94 E-value=0.062 Score=55.07 Aligned_cols=83 Identities=14% Similarity=0.160 Sum_probs=46.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCC-CeE-----EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGT-DYY-----YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~-~~~-----~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
..++.++. .|..|--+.+|++..... +.. |.+++... .....-....|..++.....+-.-.++++.|.
T Consensus 49 ~~~~i~i~-~l~gGLTN~l~~v~~~~~~~~~~~~k~Vl~R~~g~----~~~l~IdR~~E~~i~~~Ls~~glgP~l~~~f~ 123 (383)
T PTZ00384 49 NPEFIEIK-KMNNGITNQVYQATLVDGDKDRYPIKSVCIKKSST----YNSLVIDNDLQYNIAKLLGDNNFGPKIIGRFG 123 (383)
T ss_pred CcccEEEE-EeCCcccceEEEEEecCCCCCccccceEEEEeccC----CCceEeccHHHHHHHHHHHhCCCCCeEEEecC
Confidence 33455554 454588899999975433 122 33333211 11111122345555554445555667777775
Q ss_pred cCCeeEEEEEecCCCCCc
Q psy8309 137 TDSHLFFVMEYLNGGDLI 154 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~ 154 (494)
. ++|.||++|-+|.
T Consensus 124 ~----g~l~efIeGr~l~ 137 (383)
T PTZ00384 124 D----FTIQEWVEGNTMG 137 (383)
T ss_pred C----EEEEEEeccccCC
Confidence 3 6999999988774
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=95.92 E-value=0.0036 Score=62.44 Aligned_cols=41 Identities=49% Similarity=0.904 Sum_probs=38.1
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhcccccccccccc
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYT 487 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~ 487 (494)
...+.+||+..|..++|.++|.+..++++++|++|+||+|+
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 318 (318)
T cd05570 278 GRFDVSNFDDEFTKEKPVLTPPDEAIIRNIDQEEFRGFSYI 318 (318)
T ss_pred CcchhhhcCchhccCcccCCCCcccccccccccccCCCCCC
Confidence 44678999999999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.22 Score=49.90 Aligned_cols=28 Identities=18% Similarity=0.125 Sum_probs=24.0
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCcee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCK 235 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~ 235 (494)
.++||+|+.+.|||++ + .+.|+||+-|.
T Consensus 196 ~~liHgD~h~~NvL~~-d-~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILWR-D-GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhcccc-C-CcEEEeCCCCC
Confidence 4799999999999995 4 57899999775
|
|
| >KOG0694|consensus | Back alignment and domain information |
|---|
Probab=95.83 E-value=0.0028 Score=67.08 Aligned_cols=41 Identities=41% Similarity=0.689 Sum_probs=37.9
Q ss_pred ccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCC
Q psy8309 401 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441 (494)
Q Consensus 401 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 441 (494)
|++|||.+||.+.+.++|.++..+...+|+.|.||+|+++.
T Consensus 653 D~snFd~eFt~e~p~Lt~~~~~~l~~~~q~~F~~Fs~~~~~ 693 (694)
T KOG0694|consen 653 DVSNFDEEFTSEKPALTPSDPRPLTEEEQEAFRDFSFVAEW 693 (694)
T ss_pred hhcccchhhhcCCCccCCCCccccchhhHHHhcCccccCCC
Confidence 57999999999999999988888889999999999999875
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=95.79 E-value=0.024 Score=53.02 Aligned_cols=31 Identities=29% Similarity=0.470 Sum_probs=22.3
Q ss_pred CCCccccCCCCceee-CCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILL-DYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl-~~~g~vkL~DFGla~~ 236 (494)
..++|+||.|.|||+ +.++.++|+||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 358999999999999 8899999999998864
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >PRK12396 5-methylribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=95.61 E-value=0.073 Score=54.35 Aligned_cols=79 Identities=22% Similarity=0.203 Sum_probs=50.8
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC---hhhHHHHHHHHHHHHhcCC-CC-ceeeEEEEEEcCCeeEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE---DDDVECTLIERKVLALGTK-HP-YLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~---~~~~~~~~~e~~~l~~~~~-hp-~Iv~l~~~~~~~~~~~lv 144 (494)
.+.||-|.-..||++.....++.++||.-..-.... .-...+...|...|....+ .| .+++++.+ +.....+|
T Consensus 34 ~~eigdGnlN~VfrV~~~~~~~svIVKQAlp~vRv~~swpL~~~R~~~E~~aL~~~~~~~P~~VP~vy~~--D~e~~~~v 111 (409)
T PRK12396 34 CKEIGDGNLNYVFRVWDEQKNISVIVKQAGDTARISDEFKLSTNRIRIESDVLQLEEELAPGLVPKVYLF--DSVMNCCV 111 (409)
T ss_pred eeEcCCCceEEEEEEeeCCCCceEEEEeccHhhccCCCCCCChHHHHHHHHHHHHHHhhCCCcCCeEEEE--CcHHhhHH
Confidence 678999999999999974334568898753211111 2345666777777764322 23 45555543 55667789
Q ss_pred EEecCC
Q psy8309 145 MEYLNG 150 (494)
Q Consensus 145 ~E~~~~ 150 (494)
||+++.
T Consensus 112 MEdL~~ 117 (409)
T PRK12396 112 MEDLSD 117 (409)
T ss_pred HHhCcc
Confidence 999974
|
|
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=95.59 E-value=0.15 Score=50.05 Aligned_cols=77 Identities=16% Similarity=0.150 Sum_probs=42.7
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc--CCCCceeeEEEEEEcCCeeEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG--TKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~--~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.+-.+.||.|....+|... .+++.|.||+-.... .. ....|..-|... ..--.+++.+.+....+.-|||
T Consensus 19 i~~~~~v~GG~i~~a~~~~--~~~~~~FvK~~~~~~---~~---~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLl 90 (288)
T PF03881_consen 19 ITSIEPVSGGDINEAYRLD--TDGGSYFVKVNSESG---RD---MFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLL 90 (288)
T ss_dssp --EEEEE--SSSSEEEEEE--TTS-EEEEEEEEGGG---CC---HHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEE
T ss_pred eeeeEecCCCChhheEEEE--CCCccEEEEecChhh---HH---HHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEE
Confidence 3446789999999999887 667779999876321 11 222333333322 2445677888888877788999
Q ss_pred EEecCCC
Q psy8309 145 MEYLNGG 151 (494)
Q Consensus 145 ~E~~~~g 151 (494)
|||++.+
T Consensus 91 le~l~~~ 97 (288)
T PF03881_consen 91 LEFLEMG 97 (288)
T ss_dssp EE-----
T ss_pred EEeecCC
Confidence 9999876
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
No homologous structure with e-value below 0.005
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 540 bits (1393), Expect = 0.0
Identities = 183/396 (46%), Positives = 237/396 (59%), Gaps = 51/396 (12%)
Query: 46 SQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE 105
+ ++ + L DF L VLGKGSFGKV L+E KGTD YAVK LKKDVV++
Sbjct: 1 TTNTVSKFDNNGNRDRMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQ 60
Query: 106 DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL 165
DDDVECT++E++VLAL K P+L L FQT L+FVMEY+NGGDL
Sbjct: 61 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDL------------ 108
Query: 166 MEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225
M+HIQQ GRF E A FYAAEI G+ FL KGI+YRDLKLDN++LD EGH
Sbjct: 109 ---------MYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGH 159
Query: 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS 285
++IADFGMCK I+ TT TFCGTPDY+APEII Y + VDWW+FG+LLYEM GQ+
Sbjct: 160 IKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 219
Query: 286 PFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345
PF G DEDELF SI +P+ +S EA I L+ K KRLG D+ H
Sbjct: 220 PFEGEDEDELFQSIMEHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGP-EGERDIKEHA 278
Query: 346 YFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYF 405
+FR +DW+ LE++E++PP++P+ + + F
Sbjct: 279 FFRYIDWEKLERKEIQPPYKPKA-----------------------------CGRNAENF 309
Query: 406 DKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441
D+ FT P LTP D+ ++ ++DQ++F+GFS+ N
Sbjct: 310 DRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSE 345
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 2e-12
Identities = 17/49 (34%), Positives = 29/49 (59%)
Query: 446 LHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDP 494
+ + FD+ FT P LTP D+ ++ ++DQ++F+GFS+ N P
Sbjct: 301 ACGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKP 349
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 539 bits (1391), Expect = 0.0
Identities = 197/387 (50%), Positives = 251/387 (64%), Gaps = 54/387 (13%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
K +EDF L K+LGKGSFGKVFLAE K T+ ++A+K LKKDVVL DDDVECT++E++VL
Sbjct: 12 IKLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVL 71
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+L +HP+L H+FCTFQT +LFFVMEYLNGGDL M+HIQ
Sbjct: 72 SLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDL---------------------MYHIQ 110
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+FD RA FYAAEI+ G++FLH KGIVYRDLKLDNILLD +GH++IADFGMCK +
Sbjct: 111 SCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENML 170
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
D T+TFCGTPDY+APEI+ G KYN VDWWSFG+LLYEM +GQSPF G DE+ELF SI
Sbjct: 171 GDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI 230
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRE 359
+ P +P++L EAK++LV L ++ KRLG D+ H FR ++W+ LE++E
Sbjct: 231 RMDNPFYPRWLEKEAKDLLVKLFVREPEKRLGV-----RGDIRQHPLFREINWEELERKE 285
Query: 360 LEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPV 419
++PPFRP+V D FDK F E+P L+
Sbjct: 286 IDPPFRPKVK----------------------------SPFDCSNFDKEFLNEKPRLSFA 317
Query: 420 DRTILESMDQTQFQGFSYTNPNATDFL 446
DR ++ SMDQ F+ FS+ NP +
Sbjct: 318 DRALINSMDQNMFRNFSFMNPGMERLI 344
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 68.8 bits (169), Expect = 7e-13
Identities = 19/44 (43%), Positives = 25/44 (56%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 490
D FDK F E+P L+ DR ++ SMDQ F+ FS+ NP
Sbjct: 296 SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPG 339
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 539 bits (1390), Expect = 0.0
Identities = 178/397 (44%), Positives = 237/397 (59%), Gaps = 49/397 (12%)
Query: 45 QSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL 104
+ + + + +++F+ ++VLGKGSFGKV LA +K T YAVK LKKDV+L
Sbjct: 3 KESSKEGNGIGVNSSNRLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVIL 62
Query: 105 EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERD 164
+DDDVECT+ E+++L+L HP+L LFC FQT LFFVME++NGGDL
Sbjct: 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDL----------- 111
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224
MFHIQ+S RFDE RARFYAAEI+S + FLH KGI+YRDLKLDN+LLD+EG
Sbjct: 112 ----------MFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEG 161
Query: 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQ 284
H ++ADFGMCK I TT TFCGTPDY+APEI++ + Y VDWW+ G+LLYEM G
Sbjct: 162 HCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGH 221
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
+PF +ED+LF +I N+ +P +L +A IL + K+ T RLGS ++ H
Sbjct: 222 APFEAENEDDLFEAILNDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRH 281
Query: 345 EYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKY 404
+F+ +DW L R++EPPFRPR+ DV
Sbjct: 282 PFFKEIDWAQLNHRQIEPPFRPRIK----------------------------SREDVSN 313
Query: 405 FDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441
FD F E P LTP+D L ++Q +F+ F Y +P
Sbjct: 314 FDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPE 350
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 68.4 bits (168), Expect = 1e-12
Identities = 17/44 (38%), Positives = 23/44 (52%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 490
DV FD F E P LTP+D L ++Q +F+ F Y +P
Sbjct: 307 SREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPE 350
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = 0.0
Identities = 154/390 (39%), Positives = 221/390 (56%), Gaps = 58/390 (14%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
L+DF LL+V+G+GS+ KV L LK TD YA+K +KK++V +D+D++ E+ V
Sbjct: 4 DPLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVF 63
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+ HP+L L FQT+S LFFV+EY+NGGDL MFH+Q
Sbjct: 64 EQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL---------------------MFHMQ 102
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ + E ARFY+AEI + +LH++GI+YRDLKLDN+LLD EGH+++ D+GMCK +
Sbjct: 103 RQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLR 162
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS---------GC 290
TT TFCGTP+Y+APEI++G Y VDWW+ G+L++EM G+SPF
Sbjct: 163 PGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQN 222
Query: 291 DEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
ED LF I ++ R P+ LSV+A ++L L+KD +RLG D+ H +FR +
Sbjct: 223 TEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNV 282
Query: 351 DWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFT 410
DW +E++++ PPF+P + + FD FT
Sbjct: 283 DWDMMEQKQVVPPFKPNIS----------------------------GEFGLDNFDSQFT 314
Query: 411 AERPCLTPVDRTILESMDQTQFQGFSYTNP 440
E LTP D I+ +DQ++F+GF Y NP
Sbjct: 315 NEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 67.6 bits (166), Expect = 1e-12
Identities = 18/43 (41%), Positives = 24/43 (55%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 489
+ FD FT E LTP D I+ +DQ++F+GF Y NP
Sbjct: 302 GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINP 344
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 529 bits (1365), Expect = 0.0
Identities = 154/410 (37%), Positives = 226/410 (55%), Gaps = 58/410 (14%)
Query: 41 SRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK 100
S + + + + L+DF LL+V+G+GS+ KV L LK TD YA++ +KK
Sbjct: 28 SGIEEEKEAMNTRESGKASSSLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKK 87
Query: 101 DVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTK 160
++V +D+D++ E+ V + HP+L L FQT+S LFFV+EY+NGGDL
Sbjct: 88 ELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDL------- 140
Query: 161 AERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220
MFH+Q+ + E ARFY+AEI + +LH++GI+YRDLKLDN+LL
Sbjct: 141 --------------MFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186
Query: 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280
D EGH+++ D+GMCK + TT TFCGTP+Y+APEI++G Y VDWW+ G+L++EM
Sbjct: 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEM 246
Query: 281 HVGQSPFS---------GCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLG 331
G+SPF ED LF I ++ R P+ LSV+A ++L L+KD +RLG
Sbjct: 247 MAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLG 306
Query: 332 STQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMP 391
D+ H +FR +DW +E++++ PPF+P +
Sbjct: 307 CHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS---------------------- 344
Query: 392 QVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441
+ FD FT E LTP D I+ +DQ++F+GF Y NP
Sbjct: 345 ------GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 388
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 2e-12
Identities = 18/44 (40%), Positives = 24/44 (54%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 490
+ FD FT E LTP D I+ +DQ++F+GF Y NP
Sbjct: 345 GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 388
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 524 bits (1351), Expect = 0.0
Identities = 145/420 (34%), Positives = 213/420 (50%), Gaps = 61/420 (14%)
Query: 30 ESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGT 89
E + + Q N+ P++ DF LKV+GKGSFGKV LA K
Sbjct: 7 EPELMNANPAPPPAPSQQINLGPSSN----PHAKPSDFHFLKVIGKGSFGKVLLARHKAE 62
Query: 90 DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149
+ +YAVK L+K +L+ + + + ER VL KHP+L L +FQT L+FV++Y+N
Sbjct: 63 EVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYIN 122
Query: 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209
GG+L +H+Q+ F E RARFYAAEI S + +LH IV
Sbjct: 123 GGEL---------------------FYHLQRERCFLEPRARFYAAEIASALGYLHSLNIV 161
Query: 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVD 269
YRDLK +NILLD +GH+ + DFG+CK I + TT TFCGTP+Y+APE++ Y++ VD
Sbjct: 162 YRDLKPENILLDSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVD 221
Query: 270 WWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKR 329
WW G +LYEM G PF + E++ +I N+ + ++ A+++L LL KD TKR
Sbjct: 222 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPNITNSARHLLEGLLQKDRTKR 281
Query: 330 LGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQ 389
LG+ + ++ +H +F ++W L +++ PPF P V
Sbjct: 282 LGAK--DDFMEIKSHVFFSLINWDDLINKKITPPFNPNVS-------------------- 319
Query: 390 MPQVLFQLHALDVKYFDKSFTAE----RPCLTPVDRTILESMDQTQ--FQGFSYTNPNAT 443
D+++FD FT E P + S+ + F GFSY P +
Sbjct: 320 --------GPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTDS 371
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-08
Identities = 14/52 (26%), Positives = 21/52 (40%), Gaps = 6/52 (11%)
Query: 447 HALDVKYFDKSFTAE----RPCLTPVDRTILESMDQTQ--FQGFSYTNPNAT 492
D+++FD FT E P + S+ + F GFSY P +
Sbjct: 320 GPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTDS 371
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 517 bits (1333), Expect = 0.0
Identities = 151/386 (39%), Positives = 214/386 (55%), Gaps = 58/386 (15%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
K + DF LK+LGKG+FGKV L K T YYA+K L+K+V++ D+V T+ E +VL
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
T+HP+L L FQT L FVMEY NGG+L FH+ +
Sbjct: 61 N-TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---------------------FFHLSR 98
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
F E RARFY AEIVS + +LH + +VYRD+KL+N++LD +GH++I DFG+CK I
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
T TFCGTP+Y+APE+++ Y + VDWW G+++YEM G+ PF D + LF I
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
E RFP+ LS EAK++L LL KD +RLG + +V+ H +F ++WQ + +++L
Sbjct: 219 MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVVQKKL 277
Query: 361 EPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVD 420
PPF+P+V +D +YFD FTA+ +TP D
Sbjct: 278 LPPFKPQVT----------------------------SEVDTRYFDDEFTAQSITITPPD 309
Query: 421 R-------TILESMDQTQFQGFSYTN 439
R + + +Q F+ F Y
Sbjct: 310 RYDSLGLLELDQREEQEMFEDFDYIA 335
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 56.5 bits (137), Expect = 7e-09
Identities = 15/49 (30%), Positives = 23/49 (46%), Gaps = 7/49 (14%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDR-------TILESMDQTQFQGFSYTN 488
+D +YFD FTA+ +TP DR + + +Q F+ F Y
Sbjct: 287 SEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 528 bits (1362), Expect = 0.0
Identities = 187/429 (43%), Positives = 246/429 (57%), Gaps = 51/429 (11%)
Query: 13 PPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKV 72
P ++ + + Q Q + ++ I+ + L DF L V
Sbjct: 289 VPVPPEGSEGNEELRQKFERAKIGQGTKAPEEKTANTISKFDNNGNRDRMKLTDFNFLMV 348
Query: 73 LGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
LGKGSFGKV L+E KGTD YAVK LKKDVV++DDDVECT++E++VLAL K P+L L
Sbjct: 349 LGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLH 408
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
FQT L+FVMEY+NGGDL M+HIQQ GRF E A FY
Sbjct: 409 SCFQTMDRLYFVMEYVNGGDL---------------------MYHIQQVGRFKEPHAVFY 447
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
AAEI G+ FL KGI+YRDLKLDN++LD EGH++IADFGMCK I+ TT TFCGTPD
Sbjct: 448 AAEIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGVTTKTFCGTPD 507
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSV 312
Y+APEII Y + VDWW+FG+LLYEM GQ+PF G DEDELF SI +P+ +S
Sbjct: 508 YIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKSMSK 567
Query: 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPF 372
EA I L+ K KRLG D+ H +FR +DW+ LE++E++PP++P+
Sbjct: 568 EAVAICKGLMTKHPGKRLGCGP-EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKA---- 622
Query: 373 SSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQF 432
+ + FD+ FT P LTP D+ ++ ++DQ++F
Sbjct: 623 -------------------------SGRNAENFDRFFTRHPPVLTPPDQEVIRNIDQSEF 657
Query: 433 QGFSYTNPN 441
+GFS+ N
Sbjct: 658 EGFSFVNSE 666
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 68.1 bits (166), Expect = 3e-12
Identities = 17/45 (37%), Positives = 29/45 (64%)
Query: 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDP 494
+ + FD+ FT P LTP D+ ++ ++DQ++F+GFS+ N P
Sbjct: 626 NAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKP 670
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 483 bits (1246), Expect = e-171
Identities = 130/367 (35%), Positives = 191/367 (52%), Gaps = 55/367 (14%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAE---LKGTDYYYAVKCLKKDVVLED-DDVECTLIE 115
K E F+LL+VLGKG +GKVF T +A+K LKK +++ + D T E
Sbjct: 12 EKIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAE 71
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
R +L KHP++ L FQT L+ ++EYL+GG+L
Sbjct: 72 RNILEE-VKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---------------------F 109
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+++ G F E A FY AEI + LH+KGI+YRDLK +NI+L+++GHV++ DFG+CK
Sbjct: 110 MQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
I+ T TFCGT +YMAPEI+ +N+ VDWWS G L+Y+M G PF+G + +
Sbjct: 170 ESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKT 229
Query: 296 FWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355
I + P +L+ EA+++L LL ++ RLG+ +V AH +FR ++W+ L
Sbjct: 230 IDKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGP-GDAGEVQAHPFFRHINWEEL 288
Query: 356 EKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPC 415
R++EPPF+P + DV FD FT + P
Sbjct: 289 LARKVEPPFKPLLQ----------------------------SEEDVSQFDSKFTRQTPV 320
Query: 416 LTPVDRT 422
+P D T
Sbjct: 321 DSPDDST 327
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 477 bits (1229), Expect = e-168
Identities = 127/361 (35%), Positives = 179/361 (49%), Gaps = 55/361 (15%)
Query: 57 PRFRKYDLEDFQLLKVLGKGSFGKVFLAE---LKGTDYYYAVKCLKKDVVLEDDDVECTL 113
K D F+LLKVLG+GSFGKVFL + YA+K LKK + D V T
Sbjct: 16 EGHEKADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVRDRVR-TK 74
Query: 114 IERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
+ER +L HP++ L FQT+ L+ ++++L GGDL
Sbjct: 75 MERDILVE-VNHPFIVKLHYAFQTEGKLYLILDFLRGGDL-------------------- 113
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
+ + F E +FY AE+ + LH GI+YRDLK +NILLD EGH+++ DFG+
Sbjct: 114 -FTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGL 172
Query: 234 CKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
K I +K +FCGT +YMAPE++ + Q DWWSFG+L++EM G PF G D
Sbjct: 173 SKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232
Query: 294 ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
E I + PQFLS EA+++L L ++ RLG+ + +++ H +F +DW
Sbjct: 233 ETMTMILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGP-DGVEEIKRHSFFSTIDWN 291
Query: 354 ALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAER 413
L +RE+ PPF+P D YFD FTA+
Sbjct: 292 KLYRREIHPPFKPATG----------------------------RPEDTFYFDPEFTAKT 323
Query: 414 P 414
P
Sbjct: 324 P 324
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 468 bits (1207), Expect = e-163
Identities = 148/389 (38%), Positives = 214/389 (55%), Gaps = 52/389 (13%)
Query: 25 DNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLA 84
D + +++ S S S A + + + +F+ LK+LGKG+FGKV L
Sbjct: 108 DGLKKQAAAEMDFRSGSPSDNSGAEEMEVSLAKPKHRVTMNEFEYLKLLGKGTFGKVILV 167
Query: 85 ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144
+ K T YYA+K LKK+V++ D+V TL E +VL ++HP+L L +FQT L FV
Sbjct: 168 KEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQN-SRHPFLTALKYSFQTHDRLCFV 226
Query: 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH 204
MEY NGG+L FH+ + F E RARFY AEIVS + +LH
Sbjct: 227 MEYANGGEL---------------------FFHLSRERVFSEDRARFYGAEIVSALDYLH 265
Query: 205 -KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK 263
+K +VYRDLKL+N++LD +GH++I DFG+CK I T TFCGTP+Y+APE+++
Sbjct: 266 SEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDND 325
Query: 264 YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLD 323
Y + VDWW G+++YEM G+ PF D ++LF I E RFP+ L EAK++L LL
Sbjct: 326 YGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRTLGPEAKSLLSGLLK 385
Query: 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKD 383
KD +RLG +++ H +F G+ WQ + +++L PPF+P+V
Sbjct: 386 KDPKQRLGGGS-EDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVTSE------------ 432
Query: 384 SAIPIQMPQVLFQLHALDVKYFDKSFTAE 412
D +YFD+ FTA+
Sbjct: 433 ----------------TDTRYFDEEFTAQ 445
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 459 bits (1183), Expect = e-161
Identities = 121/363 (33%), Positives = 186/363 (51%), Gaps = 33/363 (9%)
Query: 17 LSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKG 76
+ + +G + + + + A K +E+F+LLKVLG G
Sbjct: 6 HHHEEEGGSSGGAAGTSADGGDGGEQLLTVKHELRTANLTGHAEKVGIENFELLKVLGTG 65
Query: 77 SFGKVFLAE---LKGTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLF 132
++GKVFL T YA+K LKK +++ E T ER+VL + P+L L
Sbjct: 66 AYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLH 125
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
FQT++ L +++Y+NGG+L H+ Q RF E + Y
Sbjct: 126 YAFQTETKLHLILDYINGGEL---------------------FTHLSQRERFTEHEVQIY 164
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTP 251
EIV + LHK GI+YRD+KL+NILLD GHV + DFG+ K + + + FCGT
Sbjct: 165 VGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 252 DYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDED----ELFWSICNERPR 305
+YMAP+I++G +++ VDWWS G+L+YE+ G SPF+ E E+ I P
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
+PQ +S AK+++ LL KD KRLG D++ H +F+ ++W L +++ PF+
Sbjct: 285 YPQEMSALAKDLIQRLLMKDPKKRLGCGP-RDADEIKEHLFFQKINWDDLAAKKVPAPFK 343
Query: 366 PRV 368
P +
Sbjct: 344 PVI 346
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 462 bits (1191), Expect = e-159
Identities = 120/443 (27%), Positives = 181/443 (40%), Gaps = 92/443 (20%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
+ + F +VLG+G FG+VF ++K T YA K L K + + + ++E+K+L
Sbjct: 180 QPMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKIL 239
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI- 178
A ++ L F+T + L VM +NGGD+ +HI
Sbjct: 240 AK-VHSRFIVSLAYAFETKTDLCLVMTIMNGGDI---------------------RYHIY 277
Query: 179 ---QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ + F E RA FY A+IVSG+ LH++ I+YRDLK +N+LLD +G+VRI+D G+
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAV 337
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE--- 292
T + GTP +MAPE++ G +Y+ VD+++ G+ LYEM + PF E
Sbjct: 338 ELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVE 397
Query: 293 -DELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
EL + + +P S +K+ LL KD KRLG S D + H FR +
Sbjct: 398 NKELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRD-GSCDGLRTHPLFRDIS 456
Query: 352 WQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTA 411
W+ LE L PPF P ++ + DV F
Sbjct: 457 WRQLEAGMLTPPFVPDSRTVYAK-----------------------NIQDVGAFS----- 488
Query: 412 ERPCLTPVDRTILESMDQTQFQGFSYTNPNATDFLHALDVKYFDKSFTAERPCLTPVDRT 471
V E D FQ F+
Sbjct: 489 ------TVKGVAFEKADTEFFQEFASGTCP---------------------------IPW 515
Query: 472 ILESMDQTQFQGFSYTNPNATDP 494
E ++ F + P+ D
Sbjct: 516 QEEMIETGVFGDLNVWRPDGVDH 538
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 461 bits (1187), Expect = e-158
Identities = 118/402 (29%), Positives = 178/402 (44%), Gaps = 64/402 (15%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
+ F+ +VLGKG FG+V +++ T YA K L+K + + L E+++L
Sbjct: 179 QPVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQIL 238
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
++ L ++T L V+ +NGGDL FHI
Sbjct: 239 EK-VNSRFVVSLAYAYETKDALCLVLTLMNGGDL---------------------KFHIY 276
Query: 180 QSGR--FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
G+ F E RA FYAAEI G+ LH++ IVYRDLK +NILLD GH+RI+D G+
Sbjct: 277 HMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLAV-H 335
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE----D 293
+ +T GT YMAPE++K +Y DWW+ G LLYEM GQSPF + +
Sbjct: 336 VPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKRE 395
Query: 294 ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
E+ + + + S +A+++ LL KD +RLG S +V H F+ L+++
Sbjct: 396 EVERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG-GSAREVKEHPLFKKLNFK 454
Query: 354 ALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAER 413
L LEPPF+P + DV ++ T +
Sbjct: 455 RLGAGMLEPPFKPDPQAI--------------------------YCKDVLDIEQFSTVKG 488
Query: 414 PCLTPVDRTILESMDQTQFQGFSYTNPNATDFLHALDVKYFD 455
L P DQ +Q F+ + ++ + F
Sbjct: 489 VELEP--------TDQDFYQKFATGSVPIPWQNEMVETECFQ 522
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 42.5 bits (100), Expect = 3e-04
Identities = 9/44 (20%), Positives = 16/44 (36%), Gaps = 8/44 (18%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 490
+ DV ++ T + L P DQ +Q F+ +
Sbjct: 473 YCKDVLDIEQFSTVKGVELEP--------TDQDFYQKFATGSVP 508
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 441 bits (1138), Expect = e-154
Identities = 131/375 (34%), Positives = 193/375 (51%), Gaps = 58/375 (15%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
KY L+DFQ+L+ LG GSFG+V L + YYA+K LKK++V+ VE T ER +L+
Sbjct: 2 KYSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS 61
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+ HP++ ++ TFQ +F +M+Y+ GG+L +++
Sbjct: 62 I-VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL---------------------FSLLRK 99
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
S RF A+FYAAE+ + +LH K I+YRDLK +NILLD GH++I DFG K Y+
Sbjct: 100 SQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---YV 156
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
T T CGTPDY+APE++ YN+ +DWWSFGIL+YEM G +PF + + + I
Sbjct: 157 PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKIL 216
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
N RFP F + + K++L L+ +D ++RLG+ Q N +DV H +F+ + W+ L R +
Sbjct: 217 NAELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ-NGTEDVKNHPWFKEVVWEKLLSRNI 275
Query: 361 EPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVD 420
E P+ P + D FDK + E
Sbjct: 276 ETPYEPPI-----------QQGQG----------------DTSQFDK-YPEEDINYGVQ- 306
Query: 421 RTILESMDQTQFQGF 435
E F+ F
Sbjct: 307 ---GEDPYADLFRDF 318
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 439 bits (1130), Expect = e-148
Identities = 114/393 (29%), Positives = 170/393 (43%), Gaps = 62/393 (15%)
Query: 55 TIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI 114
+ + DF + +++G+G FG+V+ T YA+KCL K + L
Sbjct: 179 NVELNIHLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALN 238
Query: 115 ERKVLAL--GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGG 172
ER +L+L P++ + F T L F+++ +NGGDL
Sbjct: 239 ERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL------------------- 279
Query: 173 DLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232
+H+ Q G F E RFYAAEI+ G+ +H + +VYRDLK NILLD GHVRI+D G
Sbjct: 280 --HYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLG 337
Query: 233 MCKLQIYLDKTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGC- 290
+ K GT YMAPE++ KG+ Y+ DW+S G +L+++ G SPF
Sbjct: 338 LACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395
Query: 291 --DEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
D+ E+ P S E +++L LL +D +RLG +V +FR
Sbjct: 396 TKDKHEIDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG-RGAQEVKESPFFR 454
Query: 349 GLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKS 408
LDWQ + ++ PP P E ++ A D+ FD+
Sbjct: 455 SLDWQMVFLQKYPPPLIPPRGEVNAA-----------------------DAFDIGSFDEE 491
Query: 409 FTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441
T L DQ ++ F T
Sbjct: 492 DTKGIKLLDS---------DQELYRNFPLTISE 515
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 424 bits (1091), Expect = e-147
Identities = 122/410 (29%), Positives = 199/410 (48%), Gaps = 61/410 (14%)
Query: 26 NGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAE 85
N ++ ++++ + P L+ F +K LG GSFG+V L +
Sbjct: 2 NAAAAKKGSEQESVKEFLAKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVK 61
Query: 86 LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145
K + +YA+K L K V++ +E TL E+++L P+L L +F+ +S+L+ VM
Sbjct: 62 HKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQA-VNFPFLVKLEFSFKDNSNLYMVM 120
Query: 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK 205
EY+ GG++ H+++ GRF E ARFYAA+IV +LH
Sbjct: 121 EYVAGGEM---------------------FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS 159
Query: 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN 265
++YRDLK +N+L+D +G++++ DFG K + T T CGTP+ +APEII YN
Sbjct: 160 LDLIYRDLKPENLLIDQQGYIQVTDFGFAK---RVKGRTWTLCGTPEALAPEIILSKGYN 216
Query: 266 QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKD 325
+ VDWW+ G+L+YEM G PF +++ I + + RFP S + K++L +LL D
Sbjct: 217 KAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVD 276
Query: 326 TTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSA 385
TKR G+ + N +D+ H++F DW A+ +R++E PF P+
Sbjct: 277 LTKRFGNLK-NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK---------------- 319
Query: 386 IPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGF 435
D FD + E ++ ++ +F F
Sbjct: 320 ------------GPGDTSNFDD-YEEEEIRVSINEK------CGKEFTEF 350
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 417 bits (1075), Expect = e-144
Identities = 119/413 (28%), Positives = 179/413 (43%), Gaps = 76/413 (18%)
Query: 52 PATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC 111
P + + +DF++LKV+G+G+F +V + ++K T YA+K + K +L+ +V C
Sbjct: 48 PIVVRLKEVRLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSC 107
Query: 112 TLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNG 171
ER VL G ++ L FQ +++L+ VMEY GGDL
Sbjct: 108 FREERDVLVNG-DRRWITQLHFAFQDENYLYLVMEYYVGGDL------------------ 148
Query: 172 GDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
+ + + G R ARFY AEIV + +H+ G V+RD+K DNILLD GH+R+AD
Sbjct: 149 ---LTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLAD 205
Query: 231 FGMCK-LQIYLDKTTDTFCGTPDYMAPEIIKGL-------KYNQCVDWWSFGILLYEMHV 282
FG C L+ + GTPDY++PEI++ + Y DWW+ G+ YEM
Sbjct: 206 FGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFY 265
Query: 283 GQSPFSGCDEDELFWSICNER-----PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNS 337
GQ+PF E + I + + P + + EA++ + LL RLG
Sbjct: 266 GQTPFYADSTAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLL-CPPETRLG---RGG 321
Query: 338 GDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQL 397
D H +F GLDW L R+ PPF P
Sbjct: 322 AGDFRTHPFFFGLDWDGL--RDSVPPFTPDF----EGA---------------------- 353
Query: 398 HALDVKYFDKSFTAERPCLTPVDRTILESMD------QTQFQGFSYTNPNATD 444
D FD ++ T+ + + F G+SY+ D
Sbjct: 354 --TDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRD 404
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 48.6 bits (116), Expect = 3e-06
Identities = 10/53 (18%), Positives = 17/53 (32%), Gaps = 6/53 (11%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMD------QTQFQGFSYTNPNATD 493
A D FD ++ T+ + + F G+SY+ D
Sbjct: 352 GATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCMALRD 404
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 414 bits (1065), Expect = e-143
Identities = 99/365 (27%), Positives = 159/365 (43%), Gaps = 66/365 (18%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
+ + F++L+ +GKGSFGKV + + T YA+K + K +E ++V E +++
Sbjct: 10 EDVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIM 69
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
G +HP+L +L+ +FQ + +F V++ L GGDL +H+Q
Sbjct: 70 Q-GLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDL---------------------RYHLQ 107
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
Q+ F E + + E+V + +L + I++RD+K DNILLD GHV I DF + +
Sbjct: 108 QNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAA-MLP 166
Query: 240 LDKTTDTFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLYEMHVGQSPF---SGCDED 293
+ T GT YMAPE+ KG Y+ VDWWS G+ YE+ G+ P+ S
Sbjct: 167 RETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSK 226
Query: 294 ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
E+ + +P S E ++L LL+ + +R DV Y ++W
Sbjct: 227 EIVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFSQLS-----DVQNFPYMNDINWD 281
Query: 354 ALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAER 413
A+ ++ L P F P D +F E
Sbjct: 282 AVFQKRLIPGFIPNK--------------------------------GRLNCDPTFELEE 309
Query: 414 PCLTP 418
L
Sbjct: 310 MILES 314
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 412 bits (1061), Expect = e-141
Identities = 123/404 (30%), Positives = 184/404 (45%), Gaps = 69/404 (17%)
Query: 52 PATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC 111
P T+ + + EDF++LKV+G+G+FG+V + +LK D +A+K L K +L+ + C
Sbjct: 61 PFTSKVKQMRLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETAC 120
Query: 112 TLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNG 171
ER VL G ++ L FQ D++L+ VM+Y GGDL
Sbjct: 121 FREERDVLVNG-DSKWITTLHYAFQDDNNLYLVMDYYVGGDL------------------ 161
Query: 172 GDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
+ + + R E ARFY AE+V + +H+ V+RD+K DNIL+D GH+R+AD
Sbjct: 162 ---LTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLAD 218
Query: 231 FGMCKLQI-YLDKTTDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEMHVGQ 284
FG C + + GTPDY++PEI++ + +Y DWWS G+ +YEM G+
Sbjct: 219 FGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGE 278
Query: 285 SPFSGCDEDELFWSICNER-----PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339
+PF E + I N + P +S AK+++ L+ RLG N +
Sbjct: 279 TPFYAESLVETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLI-CSREHRLGQ---NGIE 334
Query: 340 DVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHA 399
D H +F G+DW + R E P+ P V SSP
Sbjct: 335 DFKKHPFFSGIDWDNI--RNCEAPYIPEV----SSP------------------------ 364
Query: 400 LDVKYFDKSFTAERPCLT-PVDRTILESMDQTQFQGFSYTNPNA 442
D FD + T P S F GF+YT+
Sbjct: 365 TDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCV 408
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 9e-06
Identities = 11/45 (24%), Positives = 14/45 (31%), Gaps = 1/45 (2%)
Query: 448 ALDVKYFDKSFTAERPCLT-PVDRTILESMDQTQFQGFSYTNPNA 491
D FD + T P S F GF+YT+
Sbjct: 364 PTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCV 408
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 404 bits (1041), Expect = e-140
Identities = 103/327 (31%), Positives = 165/327 (50%), Gaps = 25/327 (7%)
Query: 41 SRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK 100
+ ++ A P+ RK EDF+ K+LG+GSF V LA T YA+K L+K
Sbjct: 6 AEPRPGAGSLQHAQPPPQPRKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEK 65
Query: 101 DVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTK 160
+++++ V ER V++ HP+ L+ TFQ D L+F + Y G+L
Sbjct: 66 RHIIKENKVPYVTRERDVMSR-LDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL------- 117
Query: 161 AERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220
+ +I++ G FDE RFY AEIVS + +LH KGI++RDLK +NILL
Sbjct: 118 --------------LKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILL 163
Query: 221 DYEGHVRIADFGMCKL--QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLY 278
+ + H++I DFG K+ ++F GT Y++PE++ + D W+ G ++Y
Sbjct: 164 NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIY 223
Query: 279 EMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338
++ G PF +E +F I FP+ +A++++ LL D TKRLG +
Sbjct: 224 QLVAGLPPFRAGNEYLIFQKIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGY 283
Query: 339 DDVVAHEYFRGLDWQALEKRELEPPFR 365
+ AH +F + W+ L ++ P
Sbjct: 284 GPLKAHPFFESVTWENLHQQTP-PKLT 309
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 407 bits (1047), Expect = e-139
Identities = 116/400 (29%), Positives = 173/400 (43%), Gaps = 65/400 (16%)
Query: 52 PATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC 111
R + ED++++KV+G+G+FG+V L K T YA+K L K +++ D
Sbjct: 56 DTINKIRDLRMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAF 115
Query: 112 TLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNG 171
ER ++A P++ LF FQ D +L+ VMEY+ GGDL
Sbjct: 116 FWEERDIMAFA-NSPWVVQLFYAFQDDRYLYMVMEYMPGGDL------------------ 156
Query: 172 GDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADF 231
++ + E ARFY AE+V + +H G ++RD+K DN+LLD GH+++ADF
Sbjct: 157 ----VNLMSNYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADF 212
Query: 232 GMCK-LQIYLDKTTDTFCGTPDYMAPEIIKG----LKYNQCVDWWSFGILLYEMHVGQSP 286
G C + DT GTPDY++PE++K Y + DWWS G+ LYEM VG +P
Sbjct: 213 GTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTP 272
Query: 287 FSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342
F + I N + +S EAKN++ L D RLG N +++
Sbjct: 273 FYADSLVGTYSKIMNHKNSLTFPDDNDISKEAKNLICAFL-TDREVRLGR---NGVEEIK 328
Query: 343 AHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDV 402
H +F+ W R+ P P + SS +D
Sbjct: 329 RHLFFKNDQWAWETLRDTVAPVVPDL----SSD------------------------IDT 360
Query: 403 KYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNA 442
FD + T Q F GF+Y +
Sbjct: 361 SNFDDLEEDKGEEETFPIPKAFVGN-QLPFVGFTYYSNRR 399
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 44.7 bits (106), Expect = 4e-05
Identities = 9/45 (20%), Positives = 13/45 (28%), Gaps = 1/45 (2%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNA 491
+D FD + T Q F GF+Y +
Sbjct: 356 SDIDTSNFDDLEEDKGEEETFPIPKAFVGN-QLPFVGFTYYSNRR 399
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 300 bits (770), Expect = 1e-99
Identities = 85/309 (27%), Positives = 145/309 (46%), Gaps = 36/309 (11%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
RK+ ++DF + + LGKG FG V+LA K + A+K L K + ++ E ++
Sbjct: 9 RKFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQ 68
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+ +HP + ++ F ++ ++E+ G+L +Q
Sbjct: 69 SH-LRHPNILRMYNYFHDRKRIYLMLEFAPRGEL---------------------YKELQ 106
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ GRFDE R+ + E+ + + H++ +++RD+K +N+L+ Y+G ++IADFG
Sbjct: 107 KHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAP- 165
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
T CGT DY+ PE+I+G +++ VD W G+L YE VG PF E I
Sbjct: 166 -SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRI 224
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRE 359
N +FP FLS +K+++ LL +RL V+ H + + R
Sbjct: 225 VNVDLKFPPFLSDGSKDLISKLLRYHPPQRLPL------KGVMEHPWVK------ANSRR 272
Query: 360 LEPPFRPRV 368
+ PP
Sbjct: 273 VLPPVYQST 281
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 293 bits (753), Expect = 4e-97
Identities = 81/305 (26%), Positives = 143/305 (46%), Gaps = 32/305 (10%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
R++ LEDF++ + LGKG FG V+LA K + + A+K L K + + E ++
Sbjct: 4 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 63
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HI 178
+ +HP + L+ F + ++ ++EY G + + +
Sbjct: 64 SH-LRHPNILRLYGYFHDATRVYLILEYAPLGTV----------------------YREL 100
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
Q+ +FDE R Y E+ + + + H K +++RD+K +N+LL G ++IADFG
Sbjct: 101 QKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP 160
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
CGT DY+ PE+I+G +++ VD WS G+L YE VG+ PF E +
Sbjct: 161 --SSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKR 218
Query: 299 ICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358
I FP F++ A++++ LL + ++R +V+ H + + +
Sbjct: 219 ISRVEFTFPDFVTEGARDLISRLLKHNPSQRPML------REVLEHPWITANSSKPSNCQ 272
Query: 359 ELEPP 363
E
Sbjct: 273 NKESA 277
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 266 bits (681), Expect = 6e-86
Identities = 80/330 (24%), Positives = 124/330 (37%), Gaps = 36/330 (10%)
Query: 22 LSLDNGQGESSHHSKQCRHS-RSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGK 80
L +N +S H + R S R S+ +P R + + FQ L LG GS+G+
Sbjct: 13 LGTENLYFQSMHQLQPRRVSFRGEASETLQSPGYDPSRPESFFQQSFQRLSRLGHGSYGE 72
Query: 81 VFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140
VF K YAVK D L E +HP L ++
Sbjct: 73 VFKVRSKEDGRLYAVKRSMSPF-RGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGI 131
Query: 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSG 199
L+ E G L H + G E + Y + +
Sbjct: 132 LYLQTELC----------------------GPSLQQHCEAWGASLPEAQVWGYLRDTLLA 169
Query: 200 MRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII 259
+ LH +G+V+ D+K NI L G ++ DFG+ ++ + G P YMAPE++
Sbjct: 170 LAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLV-ELGTAGAGEVQEGDPRYMAPELL 228
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQS-PFSGCDEDELFWSICNERPRFPQFLSVEAKNIL 318
+G Y D +S G+ + E+ P G +L P F LS E +++L
Sbjct: 229 QG-SYGTAADVFSLGLTILEVACNMELPHGGEGWQQLRQGYL--PPEFTAGLSSELRSVL 285
Query: 319 VHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
V +L+ D R + ++A R
Sbjct: 286 VMMLEPDPKLRATAEA------LLALPVLR 309
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 258 bits (661), Expect = 2e-82
Identities = 71/354 (20%), Positives = 136/354 (38%), Gaps = 61/354 (17%)
Query: 45 QSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL 104
+ +N+ + + + D+++++ L +G F K+ L E +YA+K +K ++
Sbjct: 11 SNYSNLIYLNKYVKEKDKYINDYRIIRTLNQGKFNKIILCEKDNK--FYALKKYEKSLLE 68
Query: 105 EDDDVECTLI--------------ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150
+ D + E +++ K+ Y ++ + EY+
Sbjct: 69 KKRDFTKSNNDKISIKSKYDDFKNELQIITD-IKNEYCLTCEGIITNYDEVYIIYEYMEN 127
Query: 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH-KKGIV 209
+ +++ + + + +++ ++H +K I
Sbjct: 128 DSI------------LKFDEYFF-VLDKNYTCFIPIQVIKCIIKSVLNSFSYIHNEKNIC 174
Query: 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII--KGLKYNQC 267
+RD+K NIL+D G V+++DFG + + DK GT ++M PE +
Sbjct: 175 HRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGTYEFMPPEFFSNESSYNGAK 232
Query: 268 VDWWSFGILLYEMHVGQSPFSG-CDEDELFWSICNERPRFP------------------- 307
VD WS GI LY M PFS ELF +I + +P
Sbjct: 233 VDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSN 292
Query: 308 QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELE 361
FLS E + L L K+ +R+ S +D + HE+ + + L + E
Sbjct: 293 NFLSNEDIDFLKLFLRKNPAERITS------EDALKHEWLADTNIEDLREFSKE 340
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 236 bits (605), Expect = 2e-74
Identities = 77/324 (23%), Positives = 136/324 (41%), Gaps = 30/324 (9%)
Query: 27 GQGESSHHSKQCRHSRSSQSQANITPATTIPRF--RKYDLEDFQLLKVLGKGSFGKVFLA 84
G + + + A PA IP + + LGKG F K F
Sbjct: 1 GPAPADPGKAGVPGVAAPGAPAAAPPAKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEI 60
Query: 85 ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144
T +A K + K ++L+ E +E + H ++ F+ + +F V
Sbjct: 61 SDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRS-LAHQHVVGFHGFFEDNDFVFVV 119
Query: 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH 204
+E L +E ++ E AR+Y +IV G ++LH
Sbjct: 120 LELCRRRSL------------LEL---------HKRRKALTEPEARYYLRQIVLGCQYLH 158
Query: 205 KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY 264
+ +++RDLKL N+ L+ + V+I DFG+ Y + CGTP+Y+APE++ +
Sbjct: 159 RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGH 218
Query: 265 NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDK 324
+ VD WS G ++Y + VG+ PF E + I P+ ++ A +++ +L
Sbjct: 219 SFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKHINPVAASLIQKMLQT 278
Query: 325 DTTKRLGSTQCNSGDDVVAHEYFR 348
D T R + ++++ E+F
Sbjct: 279 DPTARP------TINELLNDEFFT 296
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 233 bits (596), Expect = 1e-73
Identities = 83/294 (28%), Positives = 138/294 (46%), Gaps = 27/294 (9%)
Query: 55 TIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI 114
++ +EDF++ +LGKGSF V+ AE T A+K + K + + V+
Sbjct: 1 SLATCIGEKIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQN 60
Query: 115 ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDL 174
E K+ KHP + L+ F+ ++++ V+E + G++ YL
Sbjct: 61 EVKIHCQ-LKHPSILELYNYFEDSNYVYLVLEMCHNGEM------------NRYL----- 102
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
+ F E AR + +I++GM +LH GI++RDL L N+LL +++IADFG+
Sbjct: 103 ---KNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA 159
Query: 235 KLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
+ T CGTP+Y++PEI + D WS G + Y + +G+ PF
Sbjct: 160 TQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKN 219
Query: 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+ P FLS+EAK+++ LL ++ RL S V+ H +
Sbjct: 220 TLNKVVLADYEMPSFLSIEAKDLIHQLLRRNPADRL------SLSSVLDHPFMS 267
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 232 bits (595), Expect = 2e-73
Identities = 74/298 (24%), Positives = 130/298 (43%), Gaps = 30/298 (10%)
Query: 53 ATTIPRF--RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVE 110
A IP + + LGKG F K F T +A K + K ++L+ E
Sbjct: 1 AKEIPEVLVDPRSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQRE 60
Query: 111 CTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
+E + H ++ F+ + +F V+E L +E
Sbjct: 61 KMSMEISIHRS-LAHQHVVGFHGFFEDNDFVFVVLELCRRRSL------------LEL-- 105
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
++ E AR+Y +IV G ++LH+ +++RDLKL N+ L+ + V+I D
Sbjct: 106 -------HKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGD 158
Query: 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290
FG+ Y + CGTP+Y+APE++ ++ VD WS G ++Y + VG+ PF
Sbjct: 159 FGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETS 218
Query: 291 DEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
E + I P+ ++ A +++ +L D T R + ++++ E+F
Sbjct: 219 CLKETYLRIKKNEYSIPKHINPVAASLIQKMLQTDPTARP------TINELLNDEFFT 270
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 227 bits (581), Expect = 4e-71
Identities = 73/330 (22%), Positives = 124/330 (37%), Gaps = 65/330 (19%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
DF+ + VLG+G+FG+V A YYA+K ++ ++ + L E +LA
Sbjct: 5 ASDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLAS-L 59
Query: 124 KHPYLCHLFCTFQ-------------TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
H Y+ + + S LF MEY G L DL+
Sbjct: 60 NHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTL---------YDLIH--- 107
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
++ +I+ + ++H +GI++RDLK NI +D +V+I D
Sbjct: 108 --------SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGD 159
Query: 231 FGMCKL--------------QIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGI 275
FG+ K + GT Y+A E++ G YN+ +D +S GI
Sbjct: 160 FGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219
Query: 276 LLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFL----SVEAKNILVHLLDKDTTKRLG 331
+ +EM +G + + + + FP K I+ L+D D KR
Sbjct: 220 IFFEMIYP--FSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP- 276
Query: 332 STQCNSGDDVVAHEYFRGLDWQALEKRELE 361
++ + + K L+
Sbjct: 277 -----GARTLLNSGWLPVKHQDEVIKEALK 301
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 221 bits (564), Expect = 5e-68
Identities = 77/327 (23%), Positives = 138/327 (42%), Gaps = 34/327 (10%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+E + L+ +G+GSFGK L + Y +K + + + E + E VLA
Sbjct: 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISR-MSSKEREESRREVAVLA-N 79
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KHP + +F+ + L+ VM+Y GGDL + +N Q+
Sbjct: 80 MKHPNIVQYRESFEENGSLYIVMDYCEGGDL------------FKRINA-------QKGV 120
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
F E + + +I ++ +H + I++RD+K NI L +G V++ DFG+ ++ L+
Sbjct: 121 LFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARV---LNS 177
Query: 243 TTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
T + GTP Y++PEI + YN D W+ G +LYE+ + F L I
Sbjct: 178 TVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKI 237
Query: 300 CNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358
+ P S + ++++ L ++ R S + ++ + + L +
Sbjct: 238 ISGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP------SVNSILEKGFIAKRIEKFLSPQ 291
Query: 359 ELEPPFRPRVIEPFSSPWIKLSSKDSA 385
+ F + F S I S
Sbjct: 292 LIAEEFCLKTFSKFGSQPIPAKRPASG 318
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 219 bits (560), Expect = 1e-67
Identities = 90/304 (29%), Positives = 147/304 (48%), Gaps = 35/304 (11%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-K 124
+++LLK +GKG+F KV LA T A+K + K + + + R+V +
Sbjct: 16 NYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL---NPTSLQKLFREVRIMKILN 72
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGR 183
HP + LF +T+ L+ +MEY +GG++ F ++ GR
Sbjct: 73 HPNIVKLFEVIETEKTLYLIMEYASGGEV----------------------FDYLVAHGR 110
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
E AR +IVS +++ H+K IV+RDLK +N+LLD + +++IADFG +
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFT-VGGK 169
Query: 244 TDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302
D FCG P Y APE+ +G KY+ VD WS G++LY + G PF G + EL +
Sbjct: 170 LDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRG 229
Query: 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEP 362
+ R P ++S + +N+L L + KR + + ++ + + K +EP
Sbjct: 230 KYRIPFYMSTDCENLLKRFLVLNPIKRG------TLEQIMKDRWINAGHEEDELKPFVEP 283
Query: 363 PFRP 366
Sbjct: 284 ELDI 287
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 218 bits (556), Expect = 4e-67
Identities = 79/351 (22%), Positives = 142/351 (40%), Gaps = 41/351 (11%)
Query: 43 SSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV 102
+ + + + + + LG G+FG V+ A K + VK +KK+
Sbjct: 2 ALEEPPKAVELEGLAACEGEYSQKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEK 61
Query: 103 VLEDDDVECTL---IERKVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGL 158
VLED +E + ++ L +H + + F+ VME
Sbjct: 62 VLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEK----------- 110
Query: 159 TKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218
+ +G DL I + R DE A + ++VS + +L K I++RD+K +NI
Sbjct: 111 ---------HGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENI 161
Query: 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILL 277
++ + +++ DFG + K TFCGT +Y APE++ G Y ++ WS G+ L
Sbjct: 162 VIAEDFTIKLIDFGSAAY-LERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220
Query: 278 YEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNS 337
Y + ++PF C+ +E P +S E +++ LL +R +
Sbjct: 221 YTLVFEENPF--CELEE----TVEAAIHPPYLVSKELMSLVSGLLQPVPERRT------T 268
Query: 338 GDDVVAHEYFR-GLDWQALEKRELEPPFRP--RVIEPFSSPWIKLSSKDSA 385
+ +V + ++ E+ +P V+ S S D A
Sbjct: 269 LEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLEMGNRSLSDVA 319
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 215 bits (551), Expect = 4e-67
Identities = 91/285 (31%), Positives = 142/285 (49%), Gaps = 34/285 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKH 125
+ L LG G+FGKV + E + T + AVK L + + D V I+R++ L +H
Sbjct: 13 YVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVG--KIKREIQNLKLFRH 70
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGRF 184
P++ L+ T + F VMEY++GG+L F +I + GR
Sbjct: 71 PHIIKLYQVISTPTDFFMVMEYVSGGEL----------------------FDYICKHGRV 108
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
+E AR +I+S + + H+ +V+RDLK +N+LLD + +IADFG+ + +
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS-DGEFL 167
Query: 245 DTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T CG+P+Y APE+I G Y VD WS G++LY + G PF LF I
Sbjct: 168 RTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGV 227
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
P++L+ +L+H+L D KR + D+ HE+F+
Sbjct: 228 FYIPEYLNRSVATLLMHMLQVDPLKRA------TIKDIREHEWFK 266
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 216 bits (553), Expect = 6e-67
Identities = 80/352 (22%), Positives = 129/352 (36%), Gaps = 51/352 (14%)
Query: 32 SHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDY 91
S +K + + P +++L +LGKG FG VF
Sbjct: 1 SMLTKPLQGPPAPPGTPTPPPGGKDREAF---EAEYRLGPLLGKGGFGTVFAGHRLTDRL 57
Query: 92 YYAVKCLKKDVVLEDDDVE-CTLIER-----KVLALGTKHPYLCHLFCTFQTDSHLFFVM 145
A+K + ++ VL + + G HP + L F+T V+
Sbjct: 58 QVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVL 117
Query: 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK 205
E L DL +I + G EG +R + ++V+ ++ H
Sbjct: 118 ERP--------------------LPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHS 157
Query: 206 KGIVYRDLKLDNILLDYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY 264
+G+V+RD+K +NIL+D G ++ DFG L D+ F GT Y PE I +Y
Sbjct: 158 RGVVHRDIKDENILIDLRRGCAKLIDFGSGAL--LHDEPYTDFDGTRVYSPPEWISRHQY 215
Query: 265 N-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLD 323
+ WS GILLY+M G PF E I FP +S + ++ L
Sbjct: 216 HALPATVWSLGILLYDMVCGDIPFERDQE------ILEAELHFPAHVSPDCCALIRRCLA 269
Query: 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSP 375
+ R S ++++ + + E L P P +
Sbjct: 270 PKPSSRP------SLEEILLDPWMQ----TPAEDVPLNPSKGGP--APLAWS 309
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 214 bits (547), Expect = 7e-66
Identities = 75/332 (22%), Positives = 134/332 (40%), Gaps = 42/332 (12%)
Query: 26 NGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYD--LEDFQLLKVLGKGSFGKVFL 83
HHS S + N AT + ++ + +Q+ +LG G FG V+
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMAPCNDLHATKLAPGKEKEPLESQYQVGPLLGSGGFGSVYS 61
Query: 84 AELKGTDYYYAVKCLKKDVVLEDDDVEC-TLIERKVLAL---GTKHPYLCHLFCTFQTDS 139
+ A+K ++KD + + ++ T + +V+ L + + L F+
Sbjct: 62 GIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPD 121
Query: 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSG 199
++E DL I + G E AR + +++
Sbjct: 122 SFVLILERPEPV--------------------QDLFDFITERGALQEELARSFFWQVLEA 161
Query: 200 MRFLHKKGIVYRDLKLDNILLDYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEI 258
+R H G+++RD+K +NIL+D G +++ DFG L D F GT Y PE
Sbjct: 162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGAL--LKDTVYTDFDGTRVYSPPEW 219
Query: 259 IKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNI 317
I+ +Y+ + WS GILLY+M G PF +E I + F Q +S E +++
Sbjct: 220 IRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------IIRGQVFFRQRVSSECQHL 273
Query: 318 LVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349
+ L + R + +++ H + +
Sbjct: 274 IRWCLALRPSDRP------TFEEIQNHPWMQD 299
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 212 bits (543), Expect = 2e-65
Identities = 84/340 (24%), Positives = 139/340 (40%), Gaps = 49/340 (14%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
+ + +LG+GS+GKV T AVK LKK + + E +++++ L +H
Sbjct: 7 YLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEAN-VKKEIQLLRRLRH 65
Query: 126 PYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+ L + ++ VMEY G + E M R
Sbjct: 66 KNVIQLVDVLYNEEKQKMYMVMEYCVCG-------------MQE-------MLDSVPEKR 105
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QIYLD 241
F +A Y +++ G+ +LH +GIV++D+K N+LL G ++I+ G+ + D
Sbjct: 106 FPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAAD 165
Query: 242 KTTDTFCGTPDYMAPEIIKGLK-YN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
T T G+P + PEI GL ++ VD WS G+ LY + G PF G + +LF +I
Sbjct: 166 DTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENI 225
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRE 359
P ++L +L+ + KR S + H +F +++
Sbjct: 226 GKGSYAIPGDCGPPLSDLLKGMLEYEPAKRF------SIRQIRQHSWF---------RKK 270
Query: 360 LEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHA 399
P P I P KD + + L LH
Sbjct: 271 HPPAEAPVPIPPSPDT------KDRWRSMTVVPYLEDLHG 304
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 212 bits (541), Expect = 3e-65
Identities = 73/311 (23%), Positives = 126/311 (40%), Gaps = 57/311 (18%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT--- 123
+ L +GKGS+G V LA + + YYA+K L K ++ R
Sbjct: 15 YTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCI 74
Query: 124 -------------------KHPYLCHLFC--TFQTDSHLFFVMEYLNGGDLIPAGLTKAE 162
HP + L + HL+ V E +N G +
Sbjct: 75 QPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPV--------- 125
Query: 163 RDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222
+ E +ARFY +++ G+ +LH + I++RD+K N+L+
Sbjct: 126 -------------MEVPTLKPLSEDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGE 172
Query: 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK--YN-QCVDWWSFGILLYE 279
+GH++IADFG+ D GTP +MAPE + + ++ + +D W+ G+ LY
Sbjct: 173 DGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYC 232
Query: 280 MHVGQSPFSGCDEDELFWSICNERPRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNS 337
GQ PF L I ++ FP ++ + K+++ +LDK+ R+
Sbjct: 233 FVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI------V 286
Query: 338 GDDVVAHEYFR 348
++ H +
Sbjct: 287 VPEIKLHPWVT 297
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-65
Identities = 73/330 (22%), Positives = 141/330 (42%), Gaps = 36/330 (10%)
Query: 38 CRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKC 97
H SS + ++ + + + L +G+GS+G V +A T A+K
Sbjct: 3 HHHHHSSGRENLYFQGGSLLELQ----KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKI 58
Query: 98 LKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDL--- 153
+ K+ + + + + I+ +V + HP + L+ ++ + ++ VME +GG L
Sbjct: 59 MNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDK 118
Query: 154 ----------------IPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIV 197
+ + E +NG F E +I
Sbjct: 119 LNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIF 178
Query: 198 SGMRFLHKKGIVYRDLKLDNILL--DYEGHVRIADFGMCKLQIYLDKTTD----TFCGTP 251
S + +LH +GI +RD+K +N L + +++ DFG+ K L+ T GTP
Sbjct: 179 SALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTP 238
Query: 252 DYMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP-- 307
++APE++ Y D WS G+LL+ + +G PF G ++ + + N++ F
Sbjct: 239 YFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENP 298
Query: 308 --QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
LS A+++L +LL+++ +R + +
Sbjct: 299 NYNVLSPLARDLLSNLLNRNVDERFDAMRA 328
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-64
Identities = 73/327 (22%), Positives = 128/327 (39%), Gaps = 50/327 (15%)
Query: 40 HSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLK 99
H S ++ + + +LK +G G KVF L YA+K +
Sbjct: 3 HHHHHSSGVDLGTENLYFQSMSVKGRIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVN 61
Query: 100 KDVVLEDDDVECTLIERKVL-ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGL 158
+ ++ ++ E L L + L+ TD +++ VME
Sbjct: 62 LEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC----------- 109
Query: 159 TKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218
DL +++ D + Y ++ + +H+ GIV+ DLK N
Sbjct: 110 -----------GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANF 158
Query: 219 LLDYEGHVRIADFGMCKLQIYLDKTT---DTFCGTPDYMAPEIIKG-----------LKY 264
L+ +G +++ DFG+ Q+ D T+ D+ GT +YM PE IK K
Sbjct: 159 LIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKI 216
Query: 265 NQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSICN--ERPRFPQFLSVEAKNILVHL 321
+ D WS G +LY M G++PF +I + FP + +++L
Sbjct: 217 SPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCC 276
Query: 322 LDKDTTKRLGSTQCNSGDDVVAHEYFR 348
L +D +R+ S +++AH Y +
Sbjct: 277 LKRDPKQRI------SIPELLAHPYVQ 297
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 211 bits (539), Expect = 2e-64
Identities = 83/284 (29%), Positives = 138/284 (48%), Gaps = 33/284 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
+ + + LG+GSFGKV LA T A+K + + ++ + D +ER++ L +H
Sbjct: 11 YIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHM--RVEREISYLKLLRH 68
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
P++ L+ T + + V+EY GG+L +I + R
Sbjct: 69 PHIIKLYDVITTPTDIVMVIEYA----------------------GGELFDYIVEKKRMT 106
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
E R + +I+ + + H+ IV+RDLK +N+LLD +V+IADFG+ +
Sbjct: 107 EDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIM-TDGNFLK 165
Query: 246 TFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304
T CG+P+Y APE+I G Y VD WS GI+LY M VG+ PF LF + +
Sbjct: 166 TSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVY 225
Query: 305 RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
P FLS A++++ ++ D +R+ + ++ +F
Sbjct: 226 VMPDFLSPGAQSLIRRMIVADPMQRI------TIQEIRRDPWFN 263
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 208 bits (530), Expect = 4e-63
Identities = 78/363 (21%), Positives = 138/363 (38%), Gaps = 51/363 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-LGT 123
+ +LK +G G KVF L YA+K + + ++ ++ E L L
Sbjct: 9 RIYSILKQIGSGGSSKVFQV-LNEKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQ 66
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+ L+ TD +++ VME DL +++
Sbjct: 67 HSDKIIRLYDYEITDQYIYMVMEC----------------------GNIDLNSWLKKKKS 104
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
D + Y ++ + +H+ GIV+ DLK N L+ +G +++ DFG+ Q+ D T
Sbjct: 105 IDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTT 162
Query: 244 T---DTFCGTPDYMAPEIIKG-----------LKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+ D+ GT +YM PE IK K + D WS G +LY M G++PF
Sbjct: 163 SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 222
Query: 290 CDED-ELFWSICN--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346
+I + FP + +++L L +D +R+ S +++AH Y
Sbjct: 223 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI------SIPELLAHPY 276
Query: 347 FRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLH-ALDVKYF 405
+ + + V+ S +A + + H + K F
Sbjct: 277 VQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSILKAAKTLYEHYSGGESHNSSSSKTF 336
Query: 406 DKS 408
+K
Sbjct: 337 EKK 339
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 208 bits (532), Expect = 7e-63
Identities = 73/339 (21%), Positives = 133/339 (39%), Gaps = 50/339 (14%)
Query: 28 QGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELK 87
+ ++ +Q S + + +++ + +LK +G G KVF L
Sbjct: 19 ETAAAKFERQHMDSPDLGTDDDDKASSSANECISVKGRIYSILKQIGSGGSSKVFQV-LN 77
Query: 88 GTDYYYAVKCLKKDVVLEDDDVECTLIERKVL-ALGTKHPYLCHLFCTFQTDSHLFFVME 146
YA+K + + ++ ++ E L L + L+ TD +++ VME
Sbjct: 78 EKKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME 136
Query: 147 YLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK 206
DL +++ D + Y ++ + +H+
Sbjct: 137 C----------------------GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQH 174
Query: 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT---DTFCGTPDYMAPEIIKG-- 261
GIV+ DLK N L+ +G +++ DFG+ Q+ D T+ D+ G +YM PE IK
Sbjct: 175 GIVHSDLKPANFLIV-DGMLKLIDFGIAN-QMQPDTTSVVKDSQVGAVNYMPPEAIKDMS 232
Query: 262 ---------LKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSI--CNERPRFPQF 309
K + D WS G +LY M G++PF +I N FP
Sbjct: 233 SSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFPDI 292
Query: 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+ +++L L +D +R+ S +++AH Y +
Sbjct: 293 PEKDLQDVLKCCLKRDPKQRI------SIPELLAHPYVQ 325
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-62
Identities = 94/285 (32%), Positives = 146/285 (51%), Gaps = 34/285 (11%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KH 125
+ L LG G+FGKV + + + T + AVK L + + D V I R++ L +H
Sbjct: 18 YILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVG--KIRREIQNLKLFRH 75
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGRF 184
P++ L+ T S +F VMEY++GG+L F +I ++GR
Sbjct: 76 PHIIKLYQVISTPSDIFMVMEYVSGGEL----------------------FDYICKNGRL 113
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
DE +R +I+SG+ + H+ +V+RDLK +N+LLD + +IADFG+ + +
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMM-SDGEFL 172
Query: 245 DTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T CG+P+Y APE+I G Y VD WS G++LY + G PF LF IC+
Sbjct: 173 RTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGI 232
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
PQ+L+ ++L H+L D KR + D+ HE+F+
Sbjct: 233 FYTPQYLNPSVISLLKHMLQVDPMKRA------TIKDIREHEWFK 271
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 211 bits (538), Expect = 1e-62
Identities = 88/346 (25%), Positives = 156/346 (45%), Gaps = 42/346 (12%)
Query: 33 HHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY 92
HH R + Q TP I + + E +Q +K LG G++G+V L K T
Sbjct: 5 HHHSSGRENLYFQGDLQATPGMFITSKKGHLSEMYQRVKKLGSGAYGEVLLCRDKVTHVE 64
Query: 93 YAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGG 151
A+K ++K V + + + +V L HP + L+ F+ + + VME GG
Sbjct: 65 RAIKIIRKTSVSTSSN---SKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGG 121
Query: 152 DLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211
+L + I +F+E A +++SG+ +LHK IV+R
Sbjct: 122 ELF-------DE--------------IIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHR 160
Query: 212 DLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCV 268
DLK +N+LL + + ++I DFG+ + K GT Y+APE+++ KY++
Sbjct: 161 DLKPENLLLESKEKDALIKIVDFGLSAV-FENQKKMKERLGTAYYIAPEVLRK-KYDEKC 218
Query: 269 DWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDK 324
D WS G++L+ + G PF G + E+ + + F + +S AK+++ +L
Sbjct: 219 DVWSIGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWKNVSEGAKDLIKQMLQF 278
Query: 325 DTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
D+ +R+ S + H + + + ++ +E P IE
Sbjct: 279 DSQRRI------SAQQALEHPWIKE--MCSKKESGIELPSLANAIE 316
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 210 bits (536), Expect = 2e-62
Identities = 91/336 (27%), Positives = 151/336 (44%), Gaps = 42/336 (12%)
Query: 43 SSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV 102
S + TP + + ++ +VLGKGSFG+V L + K T AVK + K
Sbjct: 4 SMMDHLHATPGMFVQHSTAIFSDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQ 63
Query: 103 VLEDDDVECTLIERKVL-ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKA 161
V + D E L E ++L L HP + L+ F+ + + V E GG+L
Sbjct: 64 VKQKTDKESLLREVQLLKQLD--HPNIMKLYEFFEDKGYFYLVGEVYTGGELF------- 114
Query: 162 ERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL- 220
+ I RF E A +++SG+ ++HK IV+RDLK +N+LL
Sbjct: 115 DE--------------IISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLE 160
Query: 221 --DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLY 278
+ ++RI DFG+ K GT Y+APE++ G Y++ D WS G++LY
Sbjct: 161 SKSKDANIRIIDFGLSTH-FEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILY 218
Query: 279 EMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQ 334
+ G PF+G +E ++ + + F + +S AK+++ +L + R+
Sbjct: 219 ILLSGCPPFNGANEYDILKKVEKGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI---- 274
Query: 335 CNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
S D + HE+ + E+ ++ P I
Sbjct: 275 --SARDALDHEWIQT---YTKEQISVDVPSLDNAIL 305
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 204 bits (521), Expect = 4e-62
Identities = 68/316 (21%), Positives = 111/316 (35%), Gaps = 69/316 (21%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE--RKVLALG 122
+ L +LG+G+ VF K T +A+K L DV+ E +K+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL---- 64
Query: 123 TKHPYLCHLFCTFQ--TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
H + LF + T H +ME+ G L L
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL------------YTVLE------EPSN 105
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----DYEGHVRIADFGMCKL 236
+ E ++V GM L + GIV+R++K NI+ D + ++ DFG +
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR- 164
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGL--------KYNQCVDWWSFGILLYEMHVGQSPF- 287
++ D+ + GT +Y+ P++ + KY VD WS G+ Y G PF
Sbjct: 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 288 ---SGCDEDELFWSICNERP-------------------------RFPQFLSVEAKNILV 319
E+ + I +P + L V +L
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 320 HLLDKDTTKRLGSTQC 335
++L+ D K G Q
Sbjct: 285 NILEADQEKCWGFDQF 300
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 205 bits (523), Expect = 2e-61
Identities = 68/316 (21%), Positives = 111/316 (35%), Gaps = 69/316 (21%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE--RKVLALG 122
+ L +LG+G+ VF K T +A+K L DV+ E +K+
Sbjct: 9 HLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISFLRPVDVQMREFEVLKKL---- 64
Query: 123 TKHPYLCHLFCTFQ--TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
H + LF + T H +ME+ G L L
Sbjct: 65 -NHKNIVKLFAIEEETTTRHKVLIMEFCPCGSL------------YTVLE------EPSN 105
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----DYEGHVRIADFGMCKL 236
+ E ++V GM L + GIV+R++K NI+ D + ++ DFG +
Sbjct: 106 AYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAAR- 164
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGL--------KYNQCVDWWSFGILLYEMHVGQSPF- 287
++ D+ + GT +Y+ P++ + KY VD WS G+ Y G PF
Sbjct: 165 ELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFR 224
Query: 288 ---SGCDEDELFWSICNERP-------------------------RFPQFLSVEAKNILV 319
E+ + I +P + L V +L
Sbjct: 225 PFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLA 284
Query: 320 HLLDKDTTKRLGSTQC 335
++L+ D K G Q
Sbjct: 285 NILEADQEKCWGFDQF 300
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 2e-61
Identities = 73/296 (24%), Positives = 127/296 (42%), Gaps = 39/296 (13%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
ED+++L +G GS+G+ K K L + + + + + E +L
Sbjct: 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLR-EL 62
Query: 124 KHPYLCHLFCTFQ--TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
KHP + + T++ L+ VMEY GGDL + ++
Sbjct: 63 KHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL------------ASVIT-----KGTKER 105
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKG-----IVYRDLKLDNILLDYEGHVRIADFGMCKL 236
DE ++ ++ H++ +++RDLK N+ LD + +V++ DFG+ ++
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165
Query: 237 QIYLDKTTD---TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
L+ T TF GTP YM+PE + + YN+ D WS G LLYE+ PF+ +
Sbjct: 166 ---LNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 222
Query: 294 ELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
EL I + R P S E I+ +L+ R S ++++ +
Sbjct: 223 ELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP------SVEEILENPLIL 272
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 203 bits (519), Expect = 2e-61
Identities = 80/297 (26%), Positives = 138/297 (46%), Gaps = 46/297 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D + + +K +G G+FG L K T AVK +++ ++++ ++R+++
Sbjct: 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAIDEN------VQREIINHR 71
Query: 123 T-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQ 180
+ +HP + T +HL +MEY +GG+L + I
Sbjct: 72 SLRHPNIVRFKEVILTPTHLAIIMEYASGGEL----------------------YERICN 109
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD--YEGHVRIADFGMCKLQI 238
+GRF E ARF+ +++SG+ + H I +RDLKL+N LLD ++I DFG K +
Sbjct: 110 AGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSV 169
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELF- 296
L + GTP Y+APE++ +Y+ + D WS G+ LY M VG PF +E +
Sbjct: 170 -LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYR 228
Query: 297 ---WSICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
I + + P +S E +++ + D R+ S ++ H +F
Sbjct: 229 KTIQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI------SIPEIKTHSWFL 279
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 204 bits (520), Expect = 3e-61
Identities = 50/350 (14%), Positives = 90/350 (25%), Gaps = 36/350 (10%)
Query: 26 NGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAE 85
+S + + S S S N + VLG+ A
Sbjct: 34 ANVRTTSEYMQSAADSLVSTSLWNTGQPFRVESELGERPRTLVRGTVLGQEDPYAYLEAT 93
Query: 86 LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLFCTFQTDSHLFF 143
+ T + V + ++ E L L G K+ + F L
Sbjct: 94 DQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVK 153
Query: 144 VMEYLNGGDLIPAGLTKAERD---LMEYLN------GGDLMFHIQQSGRFDEGRARFYAA 194
+ + L + G L+ H
Sbjct: 154 DPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTL 213
Query: 195 EIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYM 254
+++ + LH G+V+ L+ +I+LD G V + F D + +
Sbjct: 214 QVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLV----RDGARVVSSVSRGFE 269
Query: 255 APEIIK-----------GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
PE+ D W+ G+++Y + P + I
Sbjct: 270 PPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFRSC 329
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
PQ + +L L RL Q + + L +
Sbjct: 330 KNIPQ----PVRALLEGFLRYPKEDRLLPLQ------AMETPEYEQLRTE 369
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 3e-61
Identities = 71/304 (23%), Positives = 118/304 (38%), Gaps = 44/304 (14%)
Query: 54 TTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTL 113
T RF DF+ ++++G G FG+VF A+ + Y +K +K + E
Sbjct: 4 TVDKRF----GMDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAE 52
Query: 114 IERKVLA-LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL---MEYL 169
E K LA L H + H + + + + L ME+
Sbjct: 53 REVKALAKL--DHVNIVHYNGCWDGFDY--------DPETSSKNSSRSKTKCLFIQMEFC 102
Query: 170 NGGDLMFHI--QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227
+ G L I ++ + D+ A +I G+ ++H K ++ RDLK NI L V+
Sbjct: 103 DKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVK 162
Query: 228 IADFGMCKLQIYLDKTTD--TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQ 284
I DFG+ L GT YM+PE I Y + VD ++ G++L E+ HV
Sbjct: 163 IGDFGLVTS---LKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCD 219
Query: 285 SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
+ F + + F + + K +L LL K R + +++
Sbjct: 220 TAF---ETSKFFTDLR--DGIISDIFDKKEKTLLQKLLSKKPEDRP------NTSEILRT 268
Query: 345 EYFR 348
Sbjct: 269 LTVW 272
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 206 bits (525), Expect = 7e-61
Identities = 83/347 (23%), Positives = 146/347 (42%), Gaps = 55/347 (15%)
Query: 32 SHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDY 91
HH + Q E + ++ +LGKGSFG+V + + T
Sbjct: 2 HHHHHHSSGRENLYFQGTFA-------------ERYNIVCMLGKGSFGEVLKCKDRITQQ 48
Query: 92 YYAVKCLKKDVVLEDDDVECTLIERKVL-ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150
YAVK + K ++ D L E ++L L HP + LF + S + V E G
Sbjct: 49 EYAVKVINKAS-AKNKDTSTILREVELLKKLD--HPNIMKLFEILEDSSSFYIVGELYTG 105
Query: 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVY 210
G+L + I + RF E A ++ SG+ ++HK IV+
Sbjct: 106 GELF-------DE--------------IIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 211 RDLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQC 267
RDLK +NILL + + ++I DFG+ + GT Y+APE+++G Y++
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLST-CFQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202
Query: 268 VDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLD 323
D WS G++LY + G PF G +E ++ + + F + +S +AK+++ +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIE 370
+ R+ + + H + + + + + P +
Sbjct: 263 FHPSLRI------TATQCLEHPWIQK--YSSETPTISDLPSLESAMT 301
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 1e-60
Identities = 66/309 (21%), Positives = 143/309 (46%), Gaps = 47/309 (15%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+ED+ L++ LG+G++G+V LA + T+ AVK + ++ + I++++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICINKM 61
Query: 124 -KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQS 181
H + + + + + +EY +GG+L F I+
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGEL----------------------FDRIEPD 99
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QIY 239
E A+ + ++++G+ +LH GI +RD+K +N+LLD +++I+DFG+ +
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDED-ELFW 297
++ + CGT Y+APE++K +++ + VD WS GI+L M G+ P+ + + +
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
Query: 298 SICNERPRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR-GLDWQA 354
++ + + +L +L ++ + R+ + D+ ++ L
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI------TIPDIKKDRWYNKPL---- 269
Query: 355 LEKRELEPP 363
K+ + P
Sbjct: 270 --KKGAKRP 276
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 199 bits (507), Expect = 3e-60
Identities = 75/302 (24%), Positives = 123/302 (40%), Gaps = 36/302 (11%)
Query: 43 SSQSQANITPATTI--------PRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYA 94
QSQ P P L +F++ K +G+G F +V+ A A
Sbjct: 2 DEQSQGMQGPPVPQFQPQKALRPDMGYNTLANFRIEKKIGRGQFSEVYRAACLLDGVPVA 61
Query: 95 VKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLI 154
+K ++ +++ + E +L HP + + +F D+ L V+E + GDL
Sbjct: 62 LKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNELNIVLELADAGDL- 119
Query: 155 PAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214
+ + K + +Q E Y ++ S + +H + +++RD+K
Sbjct: 120 -SRMIKHFK---------------KQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIK 163
Query: 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTD---TFCGTPDYMAPEIIKGLKYNQCVDWW 271
N+ + G V++ D G+ + T + GTP YM+PE I YN D W
Sbjct: 164 PANVFITATGVVKLGDLGLGRF---FSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIW 220
Query: 272 SFGILLYEMHVGQSPFSGCDED--ELFWSICNER-PRFPQ-FLSVEAKNILVHLLDKDTT 327
S G LLYEM QSPF G + L I P P S E + ++ ++ D
Sbjct: 221 SLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPE 280
Query: 328 KR 329
KR
Sbjct: 281 KR 282
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 203 bits (517), Expect = 2e-59
Identities = 81/334 (24%), Positives = 146/334 (43%), Gaps = 47/334 (14%)
Query: 33 HHSKQCRHSRSSQSQANITPATTIPRFRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDY 91
HH I P + + ++ + + + ++ LG G++G+V L + K
Sbjct: 4 HHHHSSGRENLYFQGIAINPGMYVRK-KEGKIGESYFKVRKLGSGAYGEVLLCKEKNGHS 62
Query: 92 YYAVKCLKKDVVLEDDDVECTL--------IERKVLALGT-KHPYLCHLFCTFQTDSHLF 142
A+K +KK + + I ++ L + HP + LF F+ + +
Sbjct: 63 EKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFY 122
Query: 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRF 202
V E+ GG+L E+ I +FDE A +I+SG+ +
Sbjct: 123 LVTEFYEGGELF-------EQ--------------IINRHKFDECDAANIMKQILSGICY 161
Query: 203 LHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII 259
LHK IV+RD+K +NILL + +++I DFG+ D GT Y+APE++
Sbjct: 162 LHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSF-FSKDYKLRDRLGTAYYIAPEVL 220
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAK 315
K KYN+ D WS G+++Y + G PF G ++ ++ + + F + +S EAK
Sbjct: 221 KK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDWKNISDEAK 279
Query: 316 NILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349
++ +L D KR + ++ + + +
Sbjct: 280 ELIKLMLTYDYNKRC------TAEEALNSRWIKK 307
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 3e-59
Identities = 63/293 (21%), Positives = 138/293 (47%), Gaps = 40/293 (13%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+ED+ L++ LG+G++G+V LA + T+ AVK + ++ + I++++
Sbjct: 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRAVDCPE----NIKKEICINKM 61
Query: 124 -KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQS 181
H + + + + + +EY +GG+L F I+
Sbjct: 62 LNHENVVKFYGHRREGNIQYLFLEYCSGGEL----------------------FDRIEPD 99
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QIY 239
E A+ + ++++G+ +LH GI +RD+K +N+LLD +++I+DFG+ +
Sbjct: 100 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNN 159
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDED-ELFW 297
++ + CGT Y+APE++K +++ + VD WS GI+L M G+ P+ + + +
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYS 219
Query: 298 SICNERPRFPQF--LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
++ + + +L +L ++ + R+ + D+ ++
Sbjct: 220 DWKEKKTYLNPWKKIDSAPLALLHKILVENPSARI------TIPDIKKDRWYN 266
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 196 bits (500), Expect = 4e-59
Identities = 84/286 (29%), Positives = 139/286 (48%), Gaps = 37/286 (12%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK 117
+ ++ F ++VLG G+F +VFL + + T +A+KC+KK D +E E
Sbjct: 2 MQTTNIRKTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPAFRDSSLE---NEIA 58
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF- 176
VL KH + L +++ +H + VM+ ++GG+L F
Sbjct: 59 VL-KKIKHENIVTLEDIYESTTHYYLVMQLVSGGEL----------------------FD 95
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGM 233
I + G + E A +++S +++LH+ GIV+RDLK +N+L + + I DFG+
Sbjct: 96 RILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGL 155
Query: 234 CKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
K + + T CGTP Y+APE++ Y++ VD WS G++ Y + G PF E
Sbjct: 156 SK--MEQNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETES 213
Query: 294 ELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+LF I F +S AK+ + HLL+KD +R +
Sbjct: 214 KLFEKIKEGYYEFESPFWDDISESAKDFICHLLEKDPNERYTCEKA 259
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 197 bits (503), Expect = 7e-59
Identities = 76/347 (21%), Positives = 135/347 (38%), Gaps = 41/347 (11%)
Query: 7 SSDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYD--L 64
R L ++ N E+ + + ++ P +P +
Sbjct: 34 REQRRAFIRSLRDDPSQSANLLAEAKKLNDAQPKGTENLYFQSMGPEDELPDWAAAKEFY 93
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKD-----VVLEDDDVECTLIERKVL 119
+ + V+G+G V + T + +AVK ++ ++ E T E +L
Sbjct: 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHIL 153
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-I 178
HP++ L ++++ S +F V + + G+L F +
Sbjct: 154 RQVAGHPHIITLIDSYESSSFMFLVFDLMRKGEL----------------------FDYL 191
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ E R ++ + FLH IV+RDLK +NILLD +R++DFG +
Sbjct: 192 TEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSC-HL 250
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGL------KYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292
+ CGTP Y+APEI+K Y + VD W+ G++L+ + G PF +
Sbjct: 251 EPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQ 310
Query: 293 DELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+ I + +F S K+++ LL D RL + Q
Sbjct: 311 ILMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQA 357
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 194 bits (496), Expect = 9e-59
Identities = 74/310 (23%), Positives = 132/310 (42%), Gaps = 43/310 (13%)
Query: 33 HHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY 92
HH + Q I + F + LG G+FG V L E + +
Sbjct: 3 HHHHHSSGRENLYFQGTID-------------DLFIFKRKLGSGAFGDVHLVEERSSGLE 49
Query: 93 YAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGG 151
+K + KD + IE ++ L + HP + +F F+ +++ VME GG
Sbjct: 50 RVIKTINKDRSQVPME----QIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGG 105
Query: 152 DLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211
+L+ ER ++ + EG ++++ + + H + +V++
Sbjct: 106 ELL-------ER----------IVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHK 148
Query: 212 DLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCV 268
DLK +NIL ++I DFG+ +L D+ + GT YMAPE+ K
Sbjct: 149 DLKPENILFQDTSPHSPIKIIDFGLAEL-FKSDEHSTNAAGTALYMAPEVFKR-DVTFKC 206
Query: 269 DWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF---PQFLSVEAKNILVHLLDKD 325
D WS G+++Y + G PF+G +E+ + P + + L+ +A ++L +L KD
Sbjct: 207 DIWSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVECRPLTPQAVDLLKQMLTKD 266
Query: 326 TTKRLGSTQC 335
+R + Q
Sbjct: 267 PERRPSAAQV 276
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 193 bits (494), Expect = 2e-58
Identities = 84/312 (26%), Positives = 139/312 (44%), Gaps = 47/312 (15%)
Query: 32 SHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDY 91
HH + Q E + ++ +LGKGSFG+V + + T
Sbjct: 2 HHHHHHSSGRENLYFQGTFA-------------ERYNIVCMLGKGSFGEVLKCKDRITQQ 48
Query: 92 YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGG 151
YAVK + K ++ D L E ++L HP + LF + S + V E GG
Sbjct: 49 EYAVKVINKAS-AKNKDTSTILREVELL-KKLDHPNIMKLFEILEDSSSFYIVGELYTGG 106
Query: 152 DLIPAGLTKAERDLMEYLNGGDLMFH-IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVY 210
+L F I + RF E A ++ SG+ ++HK IV+
Sbjct: 107 EL----------------------FDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVH 144
Query: 211 RDLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQC 267
RDLK +NILL + + ++I DFG+ + GT Y+APE+++G Y++
Sbjct: 145 RDLKPENILLESKEKDCDIKIIDFGLSTC-FQQNTKMKDRIGTAYYIAPEVLRG-TYDEK 202
Query: 268 VDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLD 323
D WS G++LY + G PF G +E ++ + + F + +S +AK+++ +L
Sbjct: 203 CDVWSAGVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQWRTISDDAKDLIRKMLT 262
Query: 324 KDTTKRLGSTQC 335
+ R+ +TQC
Sbjct: 263 FHPSLRITATQC 274
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 3e-58
Identities = 72/279 (25%), Positives = 128/279 (45%), Gaps = 33/279 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+++ + + LGKG+F V K T +A K + L D + E ++ +
Sbjct: 6 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKK-LSARDFQKLEREARICRK-LQ 63
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-IQQSGR 183
HP + L + Q +S + V + + GG+L F I
Sbjct: 64 HPNIVRLHDSIQEESFHYLVFDLVTGGEL----------------------FEDIVAREF 101
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQIYL 240
+ E A +I+ + + H GIV+R+LK +N+LL V++ADFG+ ++
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAI-EVND 160
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
+ F GTP Y++PE++K Y++ VD W+ G++LY + VG PF D+ L+ I
Sbjct: 161 SEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 220
Query: 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+P ++ EAK+++ +L + KR+ + Q
Sbjct: 221 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQA 259
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 8e-58
Identities = 75/282 (26%), Positives = 130/282 (46%), Gaps = 37/282 (13%)
Query: 63 DLEDF-QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
D+ + L +G+GS+G+V +A KGT A K + K V +DV+ E +++
Sbjct: 6 DINQYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMKS 62
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-IQQ 180
HP + L+ TF+ ++ ++ VME GG+L F +
Sbjct: 63 -LDHPNIIRLYETFEDNTDIYLVMELCTGGEL----------------------FERVVH 99
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQ 237
F E A +++S + + HK + +RDLK +N L + +++ DFG+
Sbjct: 100 KRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAAR- 158
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
K T GTP Y++P++++G Y D WS G+++Y + G PFS + E+
Sbjct: 159 FKPGKMMRTKVGTPYYVSPQVLEG-LYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVML 217
Query: 298 SICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
I FP +S +A++++ LL K +R+ S Q
Sbjct: 218 KIREGTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQA 259
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 193 bits (492), Expect = 1e-57
Identities = 95/366 (25%), Positives = 144/366 (39%), Gaps = 81/366 (22%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
YDL+ K LG+GSF K ++ +AVK + K + + + E L
Sbjct: 9 HYDLDLKD--KPLGEGSFSICRKCVHKKSNQAFAVKIISKRME---ANTQ---KEITALK 60
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQ 179
L HP + L F H F VME LNGG+L F I+
Sbjct: 61 LCEGHPNIVKLHEVFHDQLHTFLVMELLNGGEL----------------------FERIK 98
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIADFGMCKL 236
+ F E A + ++VS + +H G+V+RDLK +N+L E ++I DFG +L
Sbjct: 99 KKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARL 158
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED--- 293
+ ++ T C T Y APE++ Y++ D WS G++LY M GQ PF D
Sbjct: 159 KPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTC 218
Query: 294 ----ELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345
E+ I F + +S EAK+++ LL D KRL + +
Sbjct: 219 TSAVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL------KMSGLRYN- 271
Query: 346 YFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYF 405
W++ S+ S+ P+ P +L A
Sbjct: 272 -----------------------------EWLQDGSQLSSNPLMTPDILGSSGAAVHTCV 302
Query: 406 DKSFTA 411
+F A
Sbjct: 303 KATFHA 308
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 1e-57
Identities = 76/309 (24%), Positives = 130/309 (42%), Gaps = 46/309 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK------DVVLEDDDVECTLIERKV 118
E+++ ++LG+G V K T YAVK + + E TL E +
Sbjct: 17 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 76
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH- 177
L + HP + L T++T++ F V + + G+L F
Sbjct: 77 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL----------------------FDY 114
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
+ + E R ++ + LHK IV+RDLK +NILLD + ++++ DFG Q
Sbjct: 115 LTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-Q 173
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGL------KYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
+ + CGTP Y+APEII+ Y + VD WS G+++Y + G PF
Sbjct: 174 LDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233
Query: 292 EDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
+ + I + +F S K+++ L KR + ++ +AH +F
Sbjct: 234 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY------TAEEALAHPFF 287
Query: 348 RGLDWQALE 356
+ + +
Sbjct: 288 QQYVVEEVR 296
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 194 bits (493), Expect = 2e-57
Identities = 47/325 (14%), Positives = 91/325 (28%), Gaps = 49/325 (15%)
Query: 24 LDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFL 83
L S + + I P T + + + +LG+G+F +V+
Sbjct: 31 LSGLSKPVSSYPNTFEWQCKLPA---IKPKTEF----QLGSKLVYVHHLLGEGAFAQVYE 83
Query: 84 AELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138
A + +K K E + L + +
Sbjct: 84 ATQGDLNDAKNKQKFVLKVQKPANPWE---FYIGTQLMERL-KPSMQHMFMKFYSAHLFQ 139
Query: 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVS 198
+ V E + G L + +N ++ +G +A ++
Sbjct: 140 NGSVLVGELYSYGTL------------LNAIN----LYKNTPEKVMPQGLVISFAMRMLY 183
Query: 199 GMRFLHKKGIVYRDLKLDNILL-----------DYEGHVRIADFGMCKLQIYLDKTT--D 245
+ +H I++ D+K DN +L D + + D G K T
Sbjct: 184 MIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFT 243
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR 305
C T + E++ +N +D++ +Y M G + E R
Sbjct: 244 AKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE--CKPEGLFRR 301
Query: 306 FPQFLSVEAKNILVHLLDKDTTKRL 330
P +L+ L
Sbjct: 302 LPH--LDMWNEFFHVMLNIPDCHHL 324
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 193 bits (491), Expect = 9e-57
Identities = 44/320 (13%), Positives = 82/320 (25%), Gaps = 28/320 (8%)
Query: 71 KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYL 128
VLG+ A + T + V + ++ E L L G K+
Sbjct: 84 TVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQ 143
Query: 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERD---LMEYLNG------GDLMFHIQ 179
+ F L + + L + L+ H
Sbjct: 144 AKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSS 203
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQI 238
+++ + LH G+V+ L+ +I+LD G V + F
Sbjct: 204 THKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA 263
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLK-----YNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
P+ A ++ + D W+ G+ +Y + P +
Sbjct: 264 SAVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAAL 323
Query: 294 ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
I PQ + +L L RL Q + + L +
Sbjct: 324 GGSEWIFRSCKNIPQ----PVRALLEGFLRYPKEDRLLPLQ------AMETPEYEQLRTE 373
Query: 354 -ALEKRELEPPFRPRVIEPF 372
+ + P
Sbjct: 374 LSAALPLYQTDGEPTREGGA 393
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-56
Identities = 73/305 (23%), Positives = 133/305 (43%), Gaps = 33/305 (10%)
Query: 39 RHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCL 98
+ + Q + + +++ + + LGKG+F V K T +A K +
Sbjct: 3 HMASMTGGQQMGRGSEFMMNASTKFSDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKII 62
Query: 99 KKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGL 158
L D + E ++ +HP + L + Q +S + V + + GG+L
Sbjct: 63 NTKK-LSARDFQKLEREARICRK-LQHPNIVRLHDSIQEESFHYLVFDLVTGGEL----- 115
Query: 159 TKAERDLMEYLNGGDLMFH-IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217
F I + E A +I+ + + H GIV+R+LK +N
Sbjct: 116 -----------------FEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPEN 158
Query: 218 ILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFG 274
+LL V++ADFG+ ++ + F GTP Y++PE++K Y++ VD W+ G
Sbjct: 159 LLLASKAKGAAVKLADFGLAI-EVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACG 217
Query: 275 ILLYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRL 330
++LY + VG PF D+ L+ I +P ++ EAK+++ +L + KR+
Sbjct: 218 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI 277
Query: 331 GSTQC 335
+ Q
Sbjct: 278 TADQA 282
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-56
Identities = 78/290 (26%), Positives = 124/290 (42%), Gaps = 37/290 (12%)
Query: 59 FRKYDLEDF-QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT-LIER 116
F++ +EDF + + LG G F V K T YA K +KK IER
Sbjct: 5 FKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIER 64
Query: 117 KVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+V L H + L ++ + + ++E ++GG+L
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGEL---------------------- 102
Query: 176 F-HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----DYEGHVRIAD 230
F + Q E A + +I+ G+ +LH K I + DLK +NI+L H+++ D
Sbjct: 103 FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLID 162
Query: 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290
FG+ +I GTP+++APEI+ D WS G++ Y + G SPF G
Sbjct: 163 FGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 221
Query: 291 DEDELFWSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+ E +I + + F S AK+ + LL K+T KRL +
Sbjct: 222 TKQETLANITSVSYDFDEEFFSH-TSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 3e-56
Identities = 82/313 (26%), Positives = 120/313 (38%), Gaps = 39/313 (12%)
Query: 33 HHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY 92
HH S N+ + Y L K LG+G F V K T
Sbjct: 2 HHHHH-HSSGVDLGTENLYFQSMENFNNFYILTS----KELGRGKFAVVRQCISKSTGQE 56
Query: 93 YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGD 152
YA K LKK D L E VL L P + +L ++ S + ++EY GG+
Sbjct: 57 YAAKFLKKRR-RGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGE 115
Query: 153 L---IPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209
+ + + E +I+ G+ +LH+ IV
Sbjct: 116 IFSLCLP----------------------ELAEMVSENDVIRLIKQILEGVYYLHQNNIV 153
Query: 210 YRDLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQ 266
+ DLK NILL G ++I DFGM + +I GTP+Y+APEI+
Sbjct: 154 HLDLKPQNILLSSIYPLGDIKIVDFGMSR-KIGHACELREIMGTPEYLAPEILNYDPITT 212
Query: 267 CVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLL 322
D W+ GI+ Y + SPF G D E + +I + +S A + + LL
Sbjct: 213 ATDMWNIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLL 272
Query: 323 DKDTTKRLGSTQC 335
K+ KR + C
Sbjct: 273 VKNPEKRPTAEIC 285
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 3e-56
Identities = 57/287 (19%), Positives = 102/287 (35%), Gaps = 46/287 (16%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+F L+ +G G FG VF + YA+K KK + D + L E A+
Sbjct: 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPL-AGSVDEQNALREVYAHAVLG 68
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H ++ F + D H+ EY NGG L D + + +
Sbjct: 69 QHSHVVRYFSAWAEDDHMLIQNEYCNGGSL---------ADAISE--------NYRIMSY 111
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH------------------ 225
F E + ++ G+R++H +V+ D+K NI +
Sbjct: 112 FKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKV 171
Query: 226 -VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVG 283
+I D G + G ++A E+++ + D ++ + +
Sbjct: 172 MFKIGDLGHVTRI----SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGA 227
Query: 284 QSPFSGCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKR 329
+ + + I R PR PQ LS E +L ++ D +R
Sbjct: 228 EPLPR---NGDQWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERR 271
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 196 bits (499), Expect = 9e-56
Identities = 71/326 (21%), Positives = 119/326 (36%), Gaps = 57/326 (17%)
Query: 57 PRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIER 116
P +++ + LG G FG V + T A+K ++++ ++ +
Sbjct: 6 PSLPTQTCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQELSPKNRER----WCL 61
Query: 117 KVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
++ + HP + L L L MEY GGDL
Sbjct: 62 EIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPL----LA-----------MEYCEGGDLR 106
Query: 176 FHIQQSGR---FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIA 229
++ Q EG R ++I S +R+LH+ I++RDLK +NI+L +I
Sbjct: 107 KYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKII 166
Query: 230 DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
D G K ++ + F GT Y+APE+++ KY VD+WSFG L +E G PF
Sbjct: 167 DLGYAK-ELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLP 225
Query: 290 CDEDELF--------------WSICNERPRFPQFLSV----------EAKNILVHLLDKD 325
+ + + +F L + + L +L
Sbjct: 226 NWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWH 285
Query: 326 TTKRLGSTQCNSGDDVVAHEYFRGLD 351
+R + F+ LD
Sbjct: 286 QRQR------GTDPQNPNVGCFQALD 305
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 187 bits (477), Expect = 1e-55
Identities = 70/320 (21%), Positives = 116/320 (36%), Gaps = 48/320 (15%)
Query: 30 ESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGT 89
SSHH H SS + + D + + ++ LG+G F V L E
Sbjct: 2 GSSHHH----HHHSSGRENLYFQGHMV----IIDNKHYLFIQKLGEGGFSYVDLVEGLHD 53
Query: 90 DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS----HLFFVM 145
++YA LK+ + E D E E + L HP + L + + ++
Sbjct: 54 GHFYA---LKRILCHEQQDREEAQREADMHRL-FNHPNILRLVAYCLRERGAKHEAWLLL 109
Query: 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK 205
+ G L + +E + E + + I G+ +H
Sbjct: 110 PFFKRGTLW---------NEIER--------LKDKGNFLTEDQILWLLLGICRGLEAIHA 152
Query: 206 KGIVYRDLKLDNILLDYEGHVRIADFG-MCKLQIYLDKTTD--------TFCGTPDYMAP 256
KG +RDLK NILL EG + D G M + I+++ + T Y AP
Sbjct: 153 KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAP 212
Query: 257 EIIKGLKY---NQCVDWWSFGILLYEMHVGQSPFSGCDE-DELFWSICNERPRFPQF--L 310
E+ + ++ D WS G +LY M G+ P+ + + + PQ
Sbjct: 213 ELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQSPRH 272
Query: 311 SVEAKNILVHLLDKDTTKRL 330
S +L ++ D +R
Sbjct: 273 SSALWQLLNSMMTVDPHQRP 292
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 1e-55
Identities = 81/293 (27%), Positives = 127/293 (43%), Gaps = 37/293 (12%)
Query: 56 IPRFRKYDLEDF-QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC-TL 113
+ F++ +EDF + + LG G F V K T YA K +KK C
Sbjct: 2 METFKQQKVEDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREE 61
Query: 114 IERKVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGG 172
IER+V L HP + L ++ + + ++E ++GG+L
Sbjct: 62 IEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGEL------------------- 102
Query: 173 DLMF-HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----DYEGHVR 227
F + Q E A + +I+ G+ +LH K I + DLK +NI+L H++
Sbjct: 103 ---FDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIK 159
Query: 228 IADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
+ DFG+ +I GTP+++APEI+ D WS G++ Y + G SPF
Sbjct: 160 LIDFGLAH-EIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPF 218
Query: 288 SGCDEDELFWSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
G + E +I + F Q S AK+ + LL K+T KRL +
Sbjct: 219 LGDTKQETLANITAVSYDFDEEFFSQ-TSELAKDFIRKLLVKETRKRLTIQEA 270
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-55
Identities = 69/307 (22%), Positives = 119/307 (38%), Gaps = 42/307 (13%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L DF+ ++ LG+G FG VF A+ K D YA+K ++ L + ++ + R+V AL
Sbjct: 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIR----LPNRELAREKVMREVKALAK 59
Query: 124 -KHPYLCHLFCTFQTDSHLFFVMEYLNGGDL-IPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+HP + F + + + L I M+ +L +
Sbjct: 60 LEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYI----------QMQLCRKENLKDWMNGR 109
Query: 182 GR---FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-- 236
+ +I + FLH KG+++RDLK NI + V++ DFG+
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169
Query: 237 ----------QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP 286
+ GT YM+PE I G Y+ VD +S G++L+E+ P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---P 226
Query: 287 FS-GCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
FS + + N + P ++ +L +R +++ +
Sbjct: 227 FSTQMERVRTLTDVRNLKFPPLFTQKYPCEYVMVQDMLSPSPMERP------EAINIIEN 280
Query: 345 EYFRGLD 351
F LD
Sbjct: 281 AVFEDLD 287
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 2e-55
Identities = 74/287 (25%), Positives = 120/287 (41%), Gaps = 39/287 (13%)
Query: 63 DLEDF-QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD---DVECTLIERKV 118
+ED ++ + LG G F V KGT YA K +KK + E E +
Sbjct: 2 MVEDHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNI 61
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH- 177
L +HP + L F+ + + ++E ++GG+L F
Sbjct: 62 LRE-IRHPNIITLHDIFENKTDVVLILELVSGGEL----------------------FDF 98
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGH-VRIADFGM 233
+ + E A + +I+ G+ +LH K I + DLK +NI+L + +++ DFG+
Sbjct: 99 LAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGI 158
Query: 234 CKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
I GTP+++APEI+ D WS G++ Y + G SPF G +
Sbjct: 159 AHK-IEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217
Query: 294 ELFWSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
E +I + F S AK+ + LL KD +R+ Q
Sbjct: 218 ETLTNISAVNYDFDEEYFSN-TSELAKDFIRRLLVKDPKRRMTIAQS 263
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-55
Identities = 92/328 (28%), Positives = 148/328 (45%), Gaps = 41/328 (12%)
Query: 19 NNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDF-QLLKVLGKGS 77
++ +D G S + ++ A++ P I + L DF ++ LG+G+
Sbjct: 6 HHSSGVDLGTENLYFQSMSSVTASAAPGTASLVPDYWIDGSNRDALSDFFEVESELGRGA 65
Query: 78 FGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQ 136
V+ + KGT YA+K LKK V + + ++ L HP + L F+
Sbjct: 66 TSIVYRCKQKGTQKPYALKVLKKTVDKKI-------VRTEIGVLLRLSHPNIIKLKEIFE 118
Query: 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGRFDEGRARFYAAE 195
T + + V+E + GG+L F I + G + E A +
Sbjct: 119 TPTEISLVLELVTGGEL----------------------FDRIVEKGYYSERDAADAVKQ 156
Query: 196 IVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD 252
I+ + +LH+ GIV+RDLK +N+L + ++IADFG+ K+ + T CGTP
Sbjct: 157 ILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKI-VEHQVLMKTVCGTPG 215
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFWSICNERPRFP---- 307
Y APEI++G Y VD WS GI+ Y + G PF + +F I N F
Sbjct: 216 YCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW 275
Query: 308 QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+S+ AK+++ L+ D KRL + Q
Sbjct: 276 DEVSLNAKDLVRKLIVLDPKKRLTTFQA 303
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 185 bits (473), Expect = 8e-55
Identities = 82/372 (22%), Positives = 141/372 (37%), Gaps = 77/372 (20%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ +++ + +G GS+ K T+ +AVK + K +++E +L +
Sbjct: 22 DGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRDPTEEIE-------ILLRYGQ 74
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGR 183
HP + L + +++ V E + GG+L I +
Sbjct: 75 HPNIITLKDVYDDGKYVYVVTELMKGGEL----------------------LDKILRQKF 112
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL-DYEGH---VRIADFGMCKLQIY 239
F E A I + +LH +G+V+RDLK NIL D G+ +RI DFG K
Sbjct: 113 FSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRA 172
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED---ELF 296
+ T C T +++APE+++ Y+ D WS G+LLY M G +PF+ +D E+
Sbjct: 173 ENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232
Query: 297 WSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
I + + +S AK+++ +L D +RL + V+ H
Sbjct: 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL------TAALVLRH-------- 278
Query: 353 QALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAE 412
PWI + + + + +
Sbjct: 279 ----------------------PWIVHWDQLPQYQLNRQDAPHLVKGAMAATYSALNRNQ 316
Query: 413 RPCLTPVDRTIL 424
P L PV R+ L
Sbjct: 317 SPVLEPVGRSTL 328
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 185 bits (472), Expect = 9e-55
Identities = 75/290 (25%), Positives = 122/290 (42%), Gaps = 37/290 (12%)
Query: 59 FRKYDLEDF-QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC-TLIER 116
FR+ +++D+ + LG G F V K T YA K +KK IER
Sbjct: 4 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 63
Query: 117 KVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+V L +HP + L ++ + + ++E + GG+L
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---------------------- 101
Query: 176 FH-IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL----DYEGHVRIAD 230
F + + E A + +I++G+ +LH I + DLK +NI+L + ++I D
Sbjct: 102 FDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIID 161
Query: 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290
FG+ +I GTP+++APEI+ D WS G++ Y + G SPF G
Sbjct: 162 FGLAH-KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGD 220
Query: 291 DEDELFWSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+ E ++ E F S AK+ + LL KD KR+
Sbjct: 221 TKQETLANVSAVNYEFEDEYFSN-TSALAKDFIRRLLVKDPKKRMTIQDS 269
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 187 bits (478), Expect = 2e-54
Identities = 71/279 (25%), Positives = 124/279 (44%), Gaps = 32/279 (11%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E++QL + LGKG+F V YA + L D + E ++ L K
Sbjct: 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKK-LSARDHQKLEREARICRL-LK 68
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-IQQSGR 183
HP + L + + H + + + + GG+L F I
Sbjct: 69 HPNIVRLHDSISEEGHHYLIFDLVTGGEL----------------------FEDIVAREY 106
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQIYL 240
+ E A +I+ + H+ G+V+R+LK +N+LL V++ADFG+
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
+ F GTP Y++PE+++ Y + VD W+ G++LY + VG PF D+ L+ I
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226
Query: 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
FP ++ EAK+++ +L + +KR+ + +
Sbjct: 227 AGAYDFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEA 265
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 186 bits (474), Expect = 5e-54
Identities = 71/286 (24%), Positives = 131/286 (45%), Gaps = 38/286 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT---LIERKVLAL 121
+++ + K LG G+ G+V LA + T A++ + K E +E ++ L
Sbjct: 135 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEIL 194
Query: 122 GT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP + + F + + + V+E + GG+L + +
Sbjct: 195 KKLNHPCIIKIKNFFDAEDY-YIVLELMEGGEL------------FDK---------VVG 232
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQ 237
+ R E + Y +++ +++LH+ GI++RDLK +N+LL + + ++I DFG K+
Sbjct: 233 NKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKI- 291
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSG-CDED 293
+ T CGTP Y+APE++ + YN+ VD WS G++L+ G PFS +
Sbjct: 292 LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQV 351
Query: 294 ELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
L I + + F +S +A +++ LL D R + +
Sbjct: 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 397
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 183 bits (467), Expect = 9e-54
Identities = 69/303 (22%), Positives = 124/303 (40%), Gaps = 30/303 (9%)
Query: 41 SRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK 100
S + A F ++L +V+GKG F V + T +AVK +
Sbjct: 4 GISGGGGGILDMADDDVLFEDV----YELCEVIGKGPFSVVRRCINRETGQQFAVKIVDV 59
Query: 101 DVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLT 159
+ ++R+ KHP++ L T+ +D L+ V E+++G DL
Sbjct: 60 AKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLC----- 114
Query: 160 KAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219
++ + E A Y +I+ +R+ H I++RD+K +L
Sbjct: 115 --FE----------IVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVL 162
Query: 220 L---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGIL 276
L + V++ FG+ GTP +MAPE++K Y + VD W G++
Sbjct: 163 LASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVI 222
Query: 277 LYEMHVGQSPFSGCDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGS 332
L+ + G PF G ++ LF I + + +S AK+++ +L D +R+
Sbjct: 223 LFILLSGCLPFYG-TKERLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITV 281
Query: 333 TQC 335
+
Sbjct: 282 YEA 284
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 9e-54
Identities = 72/329 (21%), Positives = 128/329 (38%), Gaps = 49/329 (14%)
Query: 27 GQGESSHHSKQCRHSRSSQSQANI---------TPATTIPRFRKYDLED-FQLLKVLGKG 76
G HH + R + ++ + D + +L+ LG G
Sbjct: 3 GSHHHHHHGSKVRGKYDGPKINDYDKFYEDIWKKYVPQPVEVKQGSVYDYYDILEELGSG 62
Query: 77 SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTF 135
+FG V K T + K + L+ V+ ++ + HP L +L F
Sbjct: 63 AFGVVHRCVEKATGRVFVAKFINTPYPLDKYTVK-----NEISIMNQLHHPKLINLHDAF 117
Query: 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH--IQQSGRFDEGRARFYA 193
+ + ++E+L+GG+L F + + E Y
Sbjct: 118 EDKYEMVLILEFLSGGEL----------------------FDRIAAEDYKMSEAEVINYM 155
Query: 194 AEIVSGMRFLHKKGIVYRDLKLDNILL--DYEGHVRIADFGMCKLQIYLDKTTDTFCGTP 251
+ G++ +H+ IV+ D+K +NI+ V+I DFG+ ++ D+ T
Sbjct: 156 RQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPDEIVKVTTATA 214
Query: 252 DYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN-----ERPRF 306
++ APEI+ D W+ G+L Y + G SPF+G D+ E ++ + F
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF 274
Query: 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+S EAK+ + +LL K+ KRL
Sbjct: 275 SS-VSPEAKDFIKNLLQKEPRKRLTVHDA 302
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 183 bits (466), Expect = 2e-53
Identities = 78/345 (22%), Positives = 142/345 (41%), Gaps = 43/345 (12%)
Query: 6 FSSDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRF---RKY 62
+ R N + + + + + + + PA R ++
Sbjct: 24 MKNSGDQDSRSGHNEAKEVWSNADLTERMPVKSKRTSALAVDIPAPPAPFDHRIVTAKQG 83
Query: 63 DLEDF---QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
+ F ++LG G FG+V E T A K +K + + ++V+ E V+
Sbjct: 84 AVNSFYTVSKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRGMKDKEEVK---NEISVM 140
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-- 177
H L L+ F++ + + VMEY++GG+L F
Sbjct: 141 NQ-LDHANLIQLYDAFESKNDIVLVMEYVDGGEL----------------------FDRI 177
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL--DYEGHVRIADFGMCK 235
I +S E + +I G+R +H+ I++ DLK +NIL ++I DFG+ +
Sbjct: 178 IDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLAR 237
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
+ + GTP+++APE++ + D WS G++ Y + G SPF G ++ E
Sbjct: 238 -RYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAET 296
Query: 296 FWSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+I E F +S EAK + LL K+ + R+ +++
Sbjct: 297 LNNILACRWDLEDEEFQD-ISEEAKEFISKLLIKEKSWRISASEA 340
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 181 bits (462), Expect = 2e-53
Identities = 72/288 (25%), Positives = 129/288 (44%), Gaps = 42/288 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIER-----KVL 119
+++ + K LG G+ G+V LA + T A+K + K E ++L
Sbjct: 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEIL 69
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-I 178
HP + + F + + + V+E + GG+L F +
Sbjct: 70 KK-LNHPCIIKIKNFFDAEDY-YIVLELMEGGEL----------------------FDKV 105
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCK 235
+ R E + Y +++ +++LH+ GI++RDLK +N+LL + + ++I DFG K
Sbjct: 106 VGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSK 165
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSG-CD 291
+ + T CGTP Y+APE++ + YN+ VD WS G++L+ G PFS
Sbjct: 166 I-LGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224
Query: 292 EDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+ L I + + F +S +A +++ LL D R + +
Sbjct: 225 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEA 272
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 4e-53
Identities = 64/336 (19%), Positives = 125/336 (37%), Gaps = 38/336 (11%)
Query: 10 TSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLED-FQ 68
R +D + + + + D +
Sbjct: 101 LIPGDERKRRRGYDVDEQGKIVRGKGTVSSNYDNYVFDIWKQYYPQPVEIKHDHVLDHYD 160
Query: 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPY 127
+ + LG G+FG V + T +A K + + + V +++ + +HP
Sbjct: 161 IHEELGTGAFGVVHRVTERATGNNFAAKFVMTPHESDKETVR-----KEIQTMSVLRHPT 215
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH--IQQSGRFD 185
L +L F+ D+ + + E+++GG+L F + +
Sbjct: 216 LVNLHDAFEDDNEMVMIYEFMSGGEL----------------------FEKVADEHNKMS 253
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL--DYEGHVRIADFGMCKLQIYLDKT 243
E A Y ++ G+ +H+ V+ DLK +NI+ +++ DFG+ + ++
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPKQS 312
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
GT ++ APE+ +G D WS G+L Y + G SPF G ++DE ++ +
Sbjct: 313 VKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSCD 372
Query: 304 PRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+S + K+ + LL D R+ Q
Sbjct: 373 WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQA 408
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 181 bits (460), Expect = 5e-53
Identities = 78/331 (23%), Positives = 124/331 (37%), Gaps = 42/331 (12%)
Query: 8 SDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDF 67
S +S L++ + +G + + + + P R ++
Sbjct: 4 SVSSGQAHSLASLAKTWSSGSAKLQRLGPETEDNEGVLLTEKLKPVDYEYR---EEVHWM 60
Query: 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
+G+GSFG+V + K T + AVK V LE VE E A G P
Sbjct: 61 THQPRVGRGSFGEVHRMKDKQTGFQCAVK----KVRLEVFRVE----ELVACA-GLSSPR 111
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ L+ + + ME L GG L G L+ +Q G E
Sbjct: 112 IVPLYGAVREGPWVNIFMELLEGGSL------------------GQLI---KQMGCLPED 150
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG-HVRIADFGMCK-----LQIYLD 241
RA +Y + + G+ +LH + I++ D+K DN+LL +G + DFG
Sbjct: 151 RALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301
T D GT +MAPE++ G + VD WS ++ M G P++ L I +
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270
Query: 302 E---RPRFPQFLSVEAKNILVHLLDKDTTKR 329
E P + + L K+ R
Sbjct: 271 EPPPIREIPPSCAPLTAQAIQEGLRKEPVHR 301
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 180 bits (459), Expect = 6e-53
Identities = 57/284 (20%), Positives = 118/284 (41%), Gaps = 41/284 (14%)
Query: 63 DLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
+L + + + + LG+G FG V + Y K +K + +++++ L
Sbjct: 2 ELYEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKGTDQVL------VKKEISIL 55
Query: 122 GT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH--I 178
+H + HL +F++ L + E+++G D+ F
Sbjct: 56 NIARHRNILHLHESFESMEELVMIFEFISGLDI----------------------FERIN 93
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL--DYEGHVRIADFGMCKL 236
+ +E Y ++ ++FLH I + D++ +NI+ ++I +FG +
Sbjct: 94 TSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR- 152
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
Q+ P+Y APE+ + + D WS G L+Y + G +PF ++
Sbjct: 153 QLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQII 212
Query: 297 WSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+I N + F + +S+EA + + LL K+ R+ +++
Sbjct: 213 ENIMNAEYTFDEEAFKE-ISIEAMDFVDRLLVKERKSRMTASEA 255
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 180 bits (458), Expect = 2e-52
Identities = 42/311 (13%), Positives = 81/311 (26%), Gaps = 34/311 (10%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
+L++ L G VFL +A+K ++E L E A
Sbjct: 63 KLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELE-RLHEATFAAARLLG 121
Query: 126 PYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERD------LMEYLNG------GD 173
+ + + + + LM +
Sbjct: 122 ESPEEARDRRRL-LLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFST 180
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
L F G A+++ L KG+V+ DN+ + +G + + D
Sbjct: 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSA 240
Query: 234 CKLQIYLDKTTDTFCGTPDYMAPEII--KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
+ Y E + + ++ W G+ +Y + PF
Sbjct: 241 LW---KVGTRGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVT 297
Query: 292 E--DELFWSICNERPRFPQF-------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342
+ P L K ++ L+ D +RL + +
Sbjct: 298 PGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL------LPLEAM 351
Query: 343 AHEYFRGLDWQ 353
F L +
Sbjct: 352 ETPEFLQLQNE 362
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 178 bits (454), Expect = 3e-52
Identities = 87/329 (26%), Positives = 135/329 (41%), Gaps = 71/329 (21%)
Query: 57 PRFR-KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
RF Y L++ VLG+G+ +V T YAVK ++K V E
Sbjct: 8 GRFEDVYQLQE----DVLGEGAHARVQTCINLITSQEYAVKIIEKQPGHIRSRVF---RE 60
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
++L H + L F+ + + V E + GG +
Sbjct: 61 VEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSI---------------------- 98
Query: 176 F-HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIADF 231
HI + F+E A ++ S + FLH KGI +RDLK +NIL ++ V+I DF
Sbjct: 99 LSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDF 158
Query: 232 G---MCKLQIYLDKTTD----TFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYE 279
KL + T CG+ +YMAPE+++ Y++ D WS G++LY
Sbjct: 159 DLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYI 218
Query: 280 MHVGQSPFSG---------------CDEDELFWSICNERPRFP----QFLSVEAKNILVH 320
+ G PF G ++ LF SI + FP +S AK+++
Sbjct: 219 LLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISK 278
Query: 321 LLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349
LL +D +RL S V+ H + +G
Sbjct: 279 LLVRDAKQRL------SAAQVLQHPWVQG 301
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 4e-52
Identities = 83/270 (30%), Positives = 125/270 (46%), Gaps = 34/270 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
E F L+ +GKGSFG+VF T A+K + LE+ + E I++++ L
Sbjct: 22 ELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIID----LEEAEDEIEDIQQEITVLSQC 77
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
PY+ + ++ D+ L+ +MEYL GG DL+E G
Sbjct: 78 DSPYVTKYYGSYLKDTKLWIIMEYLGGGSA---------LDLLE-------------PGP 115
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDK 242
DE + EI+ G+ +LH + ++RD+K N+LL G V++ADFG+ +L K
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK 175
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED---ELFWSI 299
TF GTP +MAPE+IK Y+ D WS GI E+ G+ P + LF
Sbjct: 176 RN-TFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPH--SELHPMKVLFLIP 232
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKR 329
N P S K + L+K+ + R
Sbjct: 233 KNNPPTLEGNYSKPLKEFVEACLNKEPSFR 262
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 1e-51
Identities = 92/426 (21%), Positives = 154/426 (36%), Gaps = 89/426 (20%)
Query: 7 SSDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLED 66
+S +PP H Q Q + + + ++D
Sbjct: 4 NSQGQSPPVPFPAPAPPPQPPTPALPHPPAQ-PPPPPPQQFPQFHVKSGLQIKKNAIIDD 62
Query: 67 FQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH 125
+++ +VLG G GKV K T +A+K L D E ++ ++
Sbjct: 63 YKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWRASQC 114
Query: 126 PYLCHLFCTFQT----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQ 180
P++ + ++ L VME L+GG+L F IQ
Sbjct: 115 PHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----------------------FSRIQD 152
Query: 181 SG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIADFGMCK 235
G F E A I +++LH I +RD+K +N+L + +++ DFG K
Sbjct: 153 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 212
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG----CD 291
+ + T C TP Y+APE++ KY++ D WS G+++Y + G PF
Sbjct: 213 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 271
Query: 292 EDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
+ I + FP +S E K ++ +LL + T+R+ + + + H
Sbjct: 272 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM------TITEFMNH--- 322
Query: 348 RGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVL--FQLHALDVKYF 405
PWI S+K P+ +VL + DVK
Sbjct: 323 ---------------------------PWIMQSTKVPQTPLHTSRVLKEDKERWEDVKEE 355
Query: 406 DKSFTA 411
S A
Sbjct: 356 MTSALA 361
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 175 bits (446), Expect = 3e-51
Identities = 76/306 (24%), Positives = 130/306 (42%), Gaps = 34/306 (11%)
Query: 33 HHSKQCRHSRSSQSQANITPATTIPRFRKY--DLEDFQLLKVLGKGSFGKVFLAELKGTD 90
HH S D + + +G GSFG V AE G+D
Sbjct: 3 HHHHHHPMSDYDIPTTENLYFQGAMDGDDMDIPWCDLNIKEKIGAGSFGTVHRAEWHGSD 62
Query: 91 YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYL 148
AVK L + + V L E ++ +HP + T +L V EYL
Sbjct: 63 V--AVKILMEQD-FHAERVNEFLREVAIMK-RLRHPNIVLFMGAVT--QPPNLSIVTEYL 116
Query: 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR-FDEGRARFYAAEIVSGMRFLHKKG 207
+ G L L+ H + DE R A ++ GM +LH +
Sbjct: 117 SRGSL---------YRLL----------HKSGAREQLDERRRLSMAYDVAKGMNYLHNRN 157
Query: 208 --IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN 265
IV+R+LK N+L+D + V++ DFG+ +L+ ++ + GTP++MAPE+++ N
Sbjct: 158 PPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSN 217
Query: 266 QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC--NERPRFPQFLSVEAKNILVHLLD 323
+ D +SFG++L+E+ Q P+ + ++ ++ +R P+ L+ + I+
Sbjct: 218 EKSDVYSFGVILWELATLQQPWGNLNPAQVVAAVGFKCKRLEIPRNLNPQVAAIIEGCWT 277
Query: 324 KDTTKR 329
+ KR
Sbjct: 278 NEPWKR 283
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 173 bits (440), Expect = 2e-50
Identities = 76/284 (26%), Positives = 128/284 (45%), Gaps = 38/284 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
+D++L +V+G G+ V A A+K + LE + +++ A+
Sbjct: 15 DDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRIN----LEKCQTSMDELLKEIQAMSQC 70
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
HP + + +F L+ VM+ L+GG + D+++++ +SG
Sbjct: 71 HHPNIVSYYTSFVVKDELWLVMKLLSGGSV---------LDIIKHIVAKGE----HKSGV 117
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDK 242
DE E++ G+ +LHK G ++RD+K NILL +G V+IADFG+ L D
Sbjct: 118 LDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDI 177
Query: 243 TT----DTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDE--- 294
T TF GTP +MAPE+++ ++ Y+ D WSFGI E+ G +P+
Sbjct: 178 TRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPY--HKYPPMKV 235
Query: 295 LFWSICNERPRFPQF---------LSVEAKNILVHLLDKDTTKR 329
L ++ N+ P + ++ L KD KR
Sbjct: 236 LMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKR 279
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 174 bits (442), Expect = 3e-50
Identities = 89/396 (22%), Positives = 139/396 (35%), Gaps = 86/396 (21%)
Query: 32 SHHSKQCRHSRSSQSQANITPATTIPRFRK-YDLEDFQLLKVLGKGSFGKVFLAELKGTD 90
+HH H S P Y L +VLG G GKV + T
Sbjct: 2 AHHH---HHHSSGLEVLFQGPEPKKYAVTDDYQLSK----QVLGLGVNGKVLECFHRRTG 54
Query: 91 YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNG 150
A+K L E + P++ + ++ H + +
Sbjct: 55 QKCALKLLYD--------SPKARQEVDHHWQASGGPHIVCILDVYENMHHGKRCL-LI-- 103
Query: 151 GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGI 208
+ME + GG+L IQ+ G F E A +I + ++FLH I
Sbjct: 104 --------------IMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNI 149
Query: 209 VYRDLKLDNILLDYEGH---VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN 265
+RD+K +N+L + +++ DFG K T C TP Y+APE++ KY+
Sbjct: 150 AHRDVKPENLLYTSKEKDAVLKLTDFGFAK--ETTQNALQTPCYTPYYVAPEVLGPEKYD 207
Query: 266 QCVDWWSFGILLYEMHVGQSPFSGCDE----DELFWSICNERPRFP----QFLSVEAKNI 317
+ D WS G+++Y + G PF + I + FP +S +AK +
Sbjct: 208 KSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQL 267
Query: 318 LVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWI 377
+ LL D T+RL + + H PWI
Sbjct: 268 IRLLLKTDPTERL------TITQFMNH------------------------------PWI 291
Query: 378 KLSSKDSAIPIQMPQVLFQL--HALDVKYFDKSFTA 411
S P+ +VL + H +VK S A
Sbjct: 292 NQSMVVPQTPLHTARVLQEDKDHWDEVKEEMTSALA 327
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 5e-50
Identities = 77/296 (26%), Positives = 122/296 (41%), Gaps = 36/296 (12%)
Query: 44 SQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV 103
S + Y+ ++ VLGKG++G V+ A+K +
Sbjct: 1 SMRSTEEGDCESDLLEYDYEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIK-----EI 55
Query: 104 LEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAE 162
E D + ++ KH + +F + + ME + GG L
Sbjct: 56 PERDSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSL--------- 106
Query: 163 RDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD- 221
L+ G + +E FY +I+ G+++LH IV+RD+K DN+L++
Sbjct: 107 SALLRSKWG---------PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINT 157
Query: 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYE 279
Y G ++I+DFG K ++ T+TF GT YMAPEII Y + D WS G + E
Sbjct: 158 YSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIE 217
Query: 280 MHVGQSPFSGCDEDELFWSIC------NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
M G+ PF E + P P+ +S EAK ++ + D KR
Sbjct: 218 MATGKPPFYELGEP---QAAMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKR 270
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 1e-49
Identities = 70/340 (20%), Positives = 123/340 (36%), Gaps = 65/340 (19%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L DF+ ++ +G+G FG VF A+ K D YA+K + + + E + E K LA
Sbjct: 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIK--RIRLPNRELAREKVMREVKALA-KL 61
Query: 124 KHPYLCHLFCTFQTDSH---------LFFVMEYLNGGDLIPAGLTKAERD---------- 164
+HP + F + ++ E + P+ +
Sbjct: 62 EHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTK 121
Query: 165 -----------------LMEYLNGGDLMFHIQQSGRF---DEGRARFYAAEIVSGMRFLH 204
M+ +L + + + G +I + FLH
Sbjct: 122 NTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLH 181
Query: 205 KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF------------CGTPD 252
KG+++RDLK NI + V++ DFG+ ++ GT
Sbjct: 182 SKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKL 241
Query: 253 YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELFWSICNER-PRFPQFL 310
YM+PE I G Y+ VD +S G++L+E+ FS E + + N + P
Sbjct: 242 YMSPEQIHGNNYSHKVDIFSLGLILFELLY---SFSTQMERVRIITDVRNLKFPLLFTQK 298
Query: 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
+ ++ +L T+R D++ + F L
Sbjct: 299 YPQEHMMVQDMLSPSPTERP------EATDIIENAIFENL 332
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 173 bits (441), Expect = 3e-49
Identities = 72/326 (22%), Positives = 117/326 (35%), Gaps = 62/326 (19%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
IP F + K+LG GS G V AVK + D + L+E
Sbjct: 6 IPNFEQSLKNLVVSEKILGYGSSGTVVFQG-SFQGRPVAVKRMLID------FCDIALME 58
Query: 116 RKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
K+L HP + +C+ TD L+ +E N +L + + +
Sbjct: 59 IKLLTESDDHPNVIRYYCSETTDRFLYIALELCNL-------------NLQDLVESKN-- 103
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---------- 225
+ E +I SG+ LH I++RDLK NIL+
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 226 ---VRIADFGMCKL----QIYLDKTTDTFCGTPDYMAPEIIKGL-------KYNQCVDWW 271
+ I+DFG+CK Q + GT + APE+++ + + +D +
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 272 SFGILLYEM-HVGQSPFSGCDEDELFWSICNERPRFPQF-------LSVEAKNILVHLLD 323
S G + Y + G+ PF E +I + L EA +++ ++D
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRES--NIIRGIFSLDEMKCLHDRSLIAEATDLISQMID 281
Query: 324 KDTTKRLGSTQCNSGDDVVAHEYFRG 349
D KR + V+ H F
Sbjct: 282 HDPLKRP------TAMKVLRHPLFWP 301
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 1e-48
Identities = 75/273 (27%), Positives = 122/273 (44%), Gaps = 39/273 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ + + +G+G+ G V+ A T A++ + + + E + E V+ K
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMN---LQQQPKKELIINEILVMR-ENK 75
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+P + + ++ L+ VMEYL GG L D++
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSL---------TDVV-------------TETCM 113
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDKT 243
DEG+ E + + FLH +++RD+K DNILL +G V++ DFG C ++ K
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE-----LFWS 298
+ T GTP +MAPE++ Y VD WS GI+ EM G+ P+ +E L+
Sbjct: 174 S-TMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYL----NENPLRALYLI 228
Query: 299 ICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
N P P+ LS ++ L L+ D KR
Sbjct: 229 ATNGTPELQNPEKLSAIFRDFLNRCLEMDVEKR 261
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 168 bits (427), Expect = 2e-48
Identities = 64/276 (23%), Positives = 119/276 (43%), Gaps = 42/276 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D ++ ++ +V+G+G+FG V A+ + D A+K ++ + + VE + R
Sbjct: 6 DYKEIEVEEVVGRGAFGVVCKAKWRAKDV--AIKQIESESERKAFIVELRQLSR------ 57
Query: 123 TKHPYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP + L C + + VMEY GG L +++ +
Sbjct: 58 VNHPNIVKLYGACL----NPVCLVMEYAEGGSL------------------YNVLHGAEP 95
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHK---KGIVYRDLKLDNILLDYEG-HVRIADFGMCKL 236
+ A + + G+ +LH K +++RDLK N+LL G ++I DFG
Sbjct: 96 LPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACD 155
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL- 295
G+ +MAPE+ +G Y++ D +S+GI+L+E+ + PF
Sbjct: 156 I---QTHMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFR 212
Query: 296 -FWSIC-NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
W++ RP + L ++++ KD ++R
Sbjct: 213 IMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQR 248
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 168 bits (428), Expect = 2e-48
Identities = 66/273 (24%), Positives = 121/273 (44%), Gaps = 39/273 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+G+GS G V LA K + AVK + + + E E ++ +
Sbjct: 45 LLLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMD---LRKQQRRELLFNEVVIMR-DYQ 100
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H + ++ ++ L+ +ME+L GG L D++ R
Sbjct: 101 HFNVVEMYKSYLVGEELWVLMEFLQGGAL---------TDIV-------------SQVRL 138
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDKT 243
+E + ++ + +LH +G+++RD+K D+ILL +G V+++DFG C ++ + K
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPKR 198
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE-----LFWS 298
+ GTP +MAPE+I Y VD WS GI++ EM G+ P+ + +
Sbjct: 199 K-SLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYF----SDSPVQAMKRL 253
Query: 299 ICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
+ P+ +S ++ L +L +D +R
Sbjct: 254 RDSPPPKLKNSHKVSPVLRDFLERMLVRDPQER 286
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 4e-48
Identities = 82/278 (29%), Positives = 133/278 (47%), Gaps = 42/278 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E ++++ LG G+FGKV+ A+ K T A K ++ ++++E ++E ++LA
Sbjct: 19 EVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILA-TCD 74
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HPY+ L + D L+ ++E+ GG + +M L+ G
Sbjct: 75 HPYIVKLLGAYYHDGKLWIMIEFCPGGAV---------DAIMLELDRG-----------L 114
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDKT 243
E + + +++ + FLH K I++RDLK N+L+ EG +R+ADFG+ K L K
Sbjct: 115 TEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTLQK- 173
Query: 244 TDTFCGTPDYMAPEII-----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE---- 294
D+F GTP +MAPE++ K Y+ D WS GI L EM + P +
Sbjct: 174 RDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH----ELNPMR 229
Query: 295 -LFWSICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
L ++ P P SVE ++ L LDK+ R
Sbjct: 230 VLLKIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETR 267
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 2e-47
Identities = 67/324 (20%), Positives = 111/324 (34%), Gaps = 52/324 (16%)
Query: 41 SRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK 100
S S Q + T++ K F VLG G+ G + + + AVK +
Sbjct: 3 SSPSLEQDDGDEETSVVIVGKIS---FCPKDVLGHGAEGTIVYRGMF-DNRDVAVKRILP 58
Query: 101 DVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTK 160
+ E ++L +HP + FCT + + +E
Sbjct: 59 E------CFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCAA---------- 102
Query: 161 AERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220
L EY+ Q+ + SG+ LH IV+RDLK NIL+
Sbjct: 103 ---TLQEYV--------EQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILI 151
Query: 221 DYEGH-----VRIADFGMCKL---QIYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVD 269
I+DFG+CK + GT ++APE++ VD
Sbjct: 152 SMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211
Query: 270 WWSFGILLYEM-HVGQSPFSGCDEDELFWSICN---ERPRFPQFLSVEAKNILVHLLDKD 325
+S G + Y + G PF + + + + + V A+ ++ ++ D
Sbjct: 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMD 271
Query: 326 TTKRLGSTQCNSGDDVVAHEYFRG 349
KR S V+ H +F
Sbjct: 272 PQKRP------SAKHVLKHPFFWS 289
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 163 bits (416), Expect = 3e-47
Identities = 55/280 (19%), Positives = 104/280 (37%), Gaps = 45/280 (16%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK----DVVLEDDDVECTLIERKV 118
D + L L + G+++ +G D VK LK D + EC +
Sbjct: 8 DFKQLNFLTKLNENHSGELWKGRWQGNDI--VVKVLKVRDWSTRKSRDFNEECPRLRI-- 63
Query: 119 LALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
HP + + C H + ++ G L +++
Sbjct: 64 ----FSHPNVLPVLGACQSPPAPHPTLITHWMPYGSL---------YNVL---------- 100
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLH--KKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
H + D+ +A +A ++ GM FLH + I L ++++D + RI+ +
Sbjct: 101 HEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVK 160
Query: 235 KLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQC---VDWWSFGILLYEMHVGQSPFSGCD 291
+ P ++APE ++ + D WSF +LL+E+ + PF+
Sbjct: 161 FS-----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215
Query: 292 EDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKR 329
E+ + E RP P +S ++ +++D KR
Sbjct: 216 NMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKR 255
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 4e-47
Identities = 77/274 (28%), Positives = 124/274 (45%), Gaps = 41/274 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
E F +L+ LG+GS+G V+ A K T A+K + +E D E I +++ +
Sbjct: 29 EVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVP----VESDLQE---IIKEISIMQQC 81
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
P++ + ++ ++ L+ VMEY G + D++ N
Sbjct: 82 DSPHVVKYYGSYFKNTDLWIVMEYCGAGSV---------SDIIRLRNK-----------T 121
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC-KLQIYLDK 242
E + G+ +LH ++RD+K NILL+ EGH ++ADFG+ +L + K
Sbjct: 122 LTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMAK 181
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE-----LFW 297
T GTP +MAPE+I+ + YN D WS GI EM G+ P++ D +F
Sbjct: 182 RN-TVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYA----DIHPMRAIFM 236
Query: 298 SICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
N P F P+ S + + L K +R
Sbjct: 237 IPTNPPPTFRKPELWSDNFTDFVKQCLVKSPEQR 270
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-47
Identities = 74/283 (26%), Positives = 122/283 (43%), Gaps = 46/283 (16%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
F+L++++G G++G+V+ T A+K + + D+ E E +L +
Sbjct: 24 GIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMD----VTGDEEEEIKQEINMLKKYSH 79
Query: 125 HPYLCHLFCTF------QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
H + + F D L+ VME+ G + DL++ G
Sbjct: 80 HRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSV---------TDLIKNTKGN------ 124
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
E + EI+ G+ LH+ +++RD+K N+LL V++ DFG+
Sbjct: 125 ----TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQ-- 178
Query: 239 YLDKTT---DTFCGTPDYMAPEIIKGLK-----YNQCVDWWSFGILLYEMHVGQSPFSGC 290
LD+T +TF GTP +MAPE+I + Y+ D WS GI EM G P C
Sbjct: 179 -LDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL--C 235
Query: 291 DED---ELFWSICNERPRF-PQFLSVEAKNILVHLLDKDTTKR 329
D LF N PR + S + ++ + L K+ ++R
Sbjct: 236 DMHPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQR 278
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 163 bits (415), Expect = 2e-46
Identities = 72/320 (22%), Positives = 113/320 (35%), Gaps = 48/320 (15%)
Query: 30 ESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLED-------------FQLLKVLGKG 76
HH + + Q + P R D F L+ +G G
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMDPMPAGGRAGSLKDPDVAELFFKDDPEKLFSDLREIGHG 65
Query: 77 SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136
SFG V+ A A+K + ++ + + E + L +HP +
Sbjct: 66 SFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYL 124
Query: 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEI 196
+ + VMEY G DL+E E
Sbjct: 125 REHTAWLVMEYCLGSAS----------DLLEVHKK-----------PLQEVEIAAVTHGA 163
Query: 197 VSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAP 256
+ G+ +LH +++RD+K NILL G V++ DFG + + +F GTP +MAP
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASI---MAPAN-SFVGTPYWMAP 219
Query: 257 EIIKGLK---YNQCVDWWSFGILLYEMHVGQSPFSGCDED---ELFWSICNERPRF-PQF 309
E+I + Y+ VD WS GI E+ + P + + L+ NE P
Sbjct: 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPL--FNMNAMSALYHIAQNESPALQSGH 277
Query: 310 LSVEAKNILVHLLDKDTTKR 329
S +N + L K R
Sbjct: 278 WSEYFRNFVDSCLQKIPQDR 297
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 162 bits (411), Expect = 7e-46
Identities = 60/290 (20%), Positives = 110/290 (37%), Gaps = 51/290 (17%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++ +VL +G F V+ A+ G+ YA LK+ + E++ + E + + HP
Sbjct: 30 LRVRRVLAEGGFAFVYEAQDVGSGREYA---LKRLLSNEEEKNRAIIQEVCFMKKLSGHP 86
Query: 127 YLCHLFCTF-------QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+ T F ++ L G L+ + + ++
Sbjct: 87 NIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLV------------------EFLKKME 128
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDNILLDYEGHVRIADFG-MCKL 236
G + ++ +H++ I++RDLK++N+LL +G +++ DFG +
Sbjct: 129 SRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTI 188
Query: 237 QIYLDKTTD-----------TFCGTPDYMAPEII---KGLKYNQCVDWWSFGILLYEMHV 282
Y D + T TP Y PEII + D W+ G +LY +
Sbjct: 189 SHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCF 248
Query: 283 GQSPFSGCDEDELFWSICNERPRFPQFL--SVEAKNILVHLLDKDTTKRL 330
Q PF ED I N + P +++ +L + +RL
Sbjct: 249 RQHPF----EDGAKLRIVNGKYSIPPHDTQYTVFHSLIRAMLQVNPEERL 294
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 1e-45
Identities = 70/285 (24%), Positives = 117/285 (41%), Gaps = 49/285 (17%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE--RKVLA 120
D + L +++G G FGKV+ A G + AVK + D D+D+ T+ ++
Sbjct: 5 DFAELTLEEIIGIGGFGKVYRAFWIGDEV--AVKAARHD---PDEDISQTIENVRQEAKL 59
Query: 121 LGT-KHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
KHP + L C + +L VME+ GG L
Sbjct: 60 FAMLKHPNIIALRGVCL--KEPNLCLVMEFARGGPL----------------------NR 95
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKG---IVYRDLKLDNILLDYEGH--------V 226
+ R +A +I GM +LH + I++RDLK NIL+ + +
Sbjct: 96 VLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKIL 155
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP 286
+I DFG+ + K + G +MAPE+I+ +++ D WS+G+LL+E+ G+ P
Sbjct: 156 KITDFGLAREWHRTTKMS--AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVP 213
Query: 287 FSGCDEDELFWSIC--NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
F G D + + + P ++ + D R
Sbjct: 214 FRGIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSR 258
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (405), Expect = 2e-45
Identities = 59/279 (21%), Positives = 106/279 (37%), Gaps = 33/279 (11%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
+ +D + + LG+G++G V + AVK + + + + L++ +
Sbjct: 3 EVKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRI--RATVNSQEQKRLLMDLDISM 60
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
P+ + + ++ ME ++ L K I +
Sbjct: 61 RTVDCPFTVTFYGALFREGDVWICMELMDT------SLDK------------FYKQVIDK 102
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKG-IVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
E A IV + LH K +++RD+K N+L++ G V++ DFG+ Y
Sbjct: 103 GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISG---Y 159
Query: 240 LDKTT--DTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPFSGCDE- 292
L D G YMAPE I Y+ D WS GI + E+ + + P+
Sbjct: 160 LVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTP 219
Query: 293 -DELFWSICNERPRFP-QFLSVEAKNILVHLLDKDTTKR 329
+L + P+ P S E + L K++ +R
Sbjct: 220 FQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKER 258
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 3e-45
Identities = 62/308 (20%), Positives = 117/308 (37%), Gaps = 45/308 (14%)
Query: 34 HSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY 93
+ + + + + RF K+D +G+GSF V+ T
Sbjct: 2 EERNQQQDDIEELETKAVGMSNDGRFLKFD-------IEIGRGSFKTVYKGLDTETTVEV 54
Query: 94 AVKCLKKDVVLEDDDVECTLIERKVLALGT-KHP----YLCHLFCTFQTDSHLFFVMEYL 148
A L+ + + + + + L +HP + T + + V E +
Sbjct: 55 AWCELQDRKLTKSERQR---FKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELM 111
Query: 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG- 207
G L + +++ R + +I+ G++FLH +
Sbjct: 112 TSGTL---------KTY------------LKRFKVMKIKVLRSWCRQILKGLQFLHTRTP 150
Query: 208 -IVYRDLKLDNILLDYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN 265
I++RDLK DNI + G V+I D G+ + GTP++MAPE+ + KY+
Sbjct: 151 PIIHRDLKCDNIFITGPTGSVKIGDLGLAT--LKRASFAKAVIGTPEFMAPEMYEE-KYD 207
Query: 266 QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER---PRFPQFLSVEAKNILVHLL 322
+ VD ++FG+ + EM + P+S C + F + E K I+ +
Sbjct: 208 ESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEGCI 267
Query: 323 DKDTTKRL 330
++ +R
Sbjct: 268 RQNKDERY 275
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 159 bits (404), Expect = 5e-45
Identities = 66/286 (23%), Positives = 116/286 (40%), Gaps = 48/286 (16%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL- 121
E ++ +++GKG FG+V+ G A++ + + D++ + +R+V+A
Sbjct: 31 PFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIE---RDNEDQLKAFKREVMAYR 84
Query: 122 GTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
T+H + C + HL + G L +
Sbjct: 85 QTRHENVVLFMGACM--SPPHLAIITSLCKGRTL------------YSVVRD-------- 122
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
D + R A EIV GM +LH KGI+++DLK N+ D G V I DFG+ +
Sbjct: 123 AKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGV 181
Query: 240 LDKTTDT-----FCGTPDYMAPEIIKGLK---------YNQCVDWWSFGILLYEMHVGQS 285
L G ++APEII+ L +++ D ++ G + YE+H +
Sbjct: 182 LQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241
Query: 286 PFSGCDEDELFWSI-CNERPRFPQF-LSVEAKNILVHLLDKDTTKR 329
PF + + W + +P Q + E +IL+ + +R
Sbjct: 242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEER 287
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 157 bits (400), Expect = 8e-45
Identities = 59/285 (20%), Positives = 102/285 (35%), Gaps = 45/285 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE--RKVLA 120
+ + K +GKG FG V L A+K L + ++ E R+V
Sbjct: 17 ADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFI 76
Query: 121 LGT-KHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
+ HP + L+ + VME++ GDL +
Sbjct: 77 MSNLNHPNIVKLYGLMH----NPPRMVMEFVPCGDL---------YHRLL---------- 113
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDNILLDYEG-----HVRIAD 230
++ +I G+ ++ + IV+RDL+ NI L ++AD
Sbjct: 114 -DKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVAD 172
Query: 231 FGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFS 288
FG+ + + G +MAPE I Y + D +SF ++LY + G+ PF
Sbjct: 173 FGLSQQS---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFD 229
Query: 289 GCDEDELFWSIC----NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
++ + RP P+ +N++ D KR
Sbjct: 230 EYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKR 274
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 158 bits (401), Expect = 1e-44
Identities = 72/281 (25%), Positives = 114/281 (40%), Gaps = 38/281 (13%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
+ ++ D + L +G G+ G+V+ + T + AVK + ++ + L++ V+
Sbjct: 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQM--RRSGNKEENKRILMDLDVVL 78
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
PY+ F TF T++ +F ME + +
Sbjct: 79 KSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEK---------------------LKKRM 117
Query: 181 SGRFDEGRARFYAAEIVSGMRFLH-KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
G E IV + +L K G+++RD+K NILLD G +++ DFG+
Sbjct: 118 QGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISG---R 174
Query: 240 LDKTT--DTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292
L D G YMAPE I Y+ D WS GI L E+ GQ P+ C
Sbjct: 175 LVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT 234
Query: 293 D-ELFWSICNER-PRFP--QFLSVEAKNILVHLLDKDTTKR 329
D E+ + E P P S + ++ + L KD KR
Sbjct: 235 DFEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKR 275
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 159 bits (403), Expect = 2e-44
Identities = 66/263 (25%), Positives = 113/263 (42%), Gaps = 33/263 (12%)
Query: 58 RFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIER- 116
+ + +DF+ + LG G+ G VF K + A K + LE I R
Sbjct: 26 KVGELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKL----IHLEIKPAIRNQIIRE 81
Query: 117 -KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+VL PY+ + F +D + ME+++GG L ++
Sbjct: 82 LQVLH-ECNSPYIVGFYGAFYSDGEISICMEHMDGGSL---------DQVL--------- 122
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG-IVYRDLKLDNILLDYEGHVRIADFGMC 234
+++GR E + ++ G+ +L +K I++RD+K NIL++ G +++ DFG+
Sbjct: 123 ---KKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179
Query: 235 KLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
L + ++F GT YM+PE ++G Y+ D WS G+ L EM VG+ P D
Sbjct: 180 G---QLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAK 236
Query: 294 ELFWSICNERPRFPQFLSVEAKN 316
EL + +
Sbjct: 237 ELELMFGCQVEGDAAETPPRPRT 259
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 154 bits (392), Expect = 3e-43
Identities = 66/281 (23%), Positives = 115/281 (40%), Gaps = 33/281 (11%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
+ ED + L +G+G++G V K + AVK + +++ + + L++ V+
Sbjct: 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRI--RSTVDEKEQKQLLMDLDVVM 75
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+ PY+ + + + ME ++ K + + L+
Sbjct: 76 RSSDCPYIVQFYGALFREGDCWICMELMSTS------FDKFYKYVYSVLDD--------- 120
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKG-IVYRDLKLDNILLDYEGHVRIADFGMC-KLQI 238
E V + L + I++RD+K NILLD G++++ DFG+ +L
Sbjct: 121 --VIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVD 178
Query: 239 YLDKTTDTFCGTPDYMAPEIIKG----LKYNQCVDWWSFGILLYEMHVGQSPFSGCD--E 292
+ KT G YMAPE I Y+ D WS GI LYE+ G+ P+ +
Sbjct: 179 SIAKT--RDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVF 236
Query: 293 DELFWSICNERPRFPQFL----SVEAKNILVHLLDKDTTKR 329
D+L + + P+ S N + L KD +KR
Sbjct: 237 DQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKR 277
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 4e-43
Identities = 65/280 (23%), Positives = 110/280 (39%), Gaps = 41/280 (14%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ + +G GSFG V+ + G AVK L ++ E VL
Sbjct: 22 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTA-PTPQQLQAFKNEVGVLR-K 76
Query: 123 TKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
T+H + T L V ++ G L +L+
Sbjct: 77 TRHVNILLFMGYST---APQLAIVTQWCEGSSL------------YHHLH--------AS 113
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL--QI 238
+F+ + A + GM +LH K I++RDLK +NI L + V+I DFG+ +
Sbjct: 114 ETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRW 173
Query: 239 YLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDE 294
+ G+ +MAPE+I+ Y+ D ++FGI+LYE+ GQ P+S + D+
Sbjct: 174 SGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 233
Query: 295 LFWSICN-----ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
+ + + + K ++ L K +R
Sbjct: 234 IIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDER 273
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 151 bits (382), Expect = 3e-41
Identities = 53/269 (19%), Positives = 98/269 (36%), Gaps = 44/269 (16%)
Query: 32 SHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKG--SFGKVFLAELKGT 89
+HH + Q ++ P + ++LL V+GKG V LA K T
Sbjct: 2 AHHHHHHMENLYFQGMSSFLP----------EGGCYELLTVIGKGFEDLMTVNLARYKPT 51
Query: 90 DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149
Y V+ + + ++ V E V L HP + TF D+ L+ V ++
Sbjct: 52 GEYVTVRRINLEAC-SNEMVTFLQGELHVSKL-FNHPNIVPYRATFIADNELWVVTSFMA 109
Query: 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209
G +DL+ +E + ++ + ++H G V
Sbjct: 110 YGSA---------KDLICT----------HFMDGMNELAIAYILQGVLKALDYIHHMGYV 150
Query: 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIY--------LDKTTDTFCGTPDYMAPEIIK- 260
+R +K +IL+ +G V ++ L + + +++PE+++
Sbjct: 151 HRSVKASHILISVDGKVYLSGLRSN-LSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQ 209
Query: 261 -GLKYNQCVDWWSFGILLYEMHVGQSPFS 288
Y+ D +S GI E+ G PF
Sbjct: 210 NLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 9e-41
Identities = 63/243 (25%), Positives = 98/243 (40%), Gaps = 42/243 (17%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D +VLGKG FG+ + T +K L + +++ L E KV+
Sbjct: 8 RPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIR---FDEETQRTFLKEVKVMRC- 63
Query: 123 TKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+HP + D L F+ EY+ GG L +
Sbjct: 64 LEHPNVLKFIGVLY--KDKRLNFITEYIKGGTL------------RGIIK--------SM 101
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM------- 233
++ + +A +I SGM +LH I++RDL N L+ +V +ADFG+
Sbjct: 102 DSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDE 161
Query: 234 -------CKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP 286
L+ K T G P +MAPE+I G Y++ VD +SFGI+L E+ +
Sbjct: 162 KTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221
Query: 287 FSG 289
Sbjct: 222 DPD 224
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 145 bits (369), Expect = 3e-40
Identities = 74/351 (21%), Positives = 125/351 (35%), Gaps = 107/351 (30%)
Query: 63 DLEDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
++D+++ +VLG G GKV K T +A+K L D E ++
Sbjct: 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKML--------QDCPKARREVELHWR 66
Query: 122 GTKHPYLCHLFCTFQT----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
++ P++ + ++ L VME L+GG+L F
Sbjct: 67 ASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL----------------------FS 104
Query: 178 -IQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIADF 231
IQ G F E A I +++LH I +RD+K +N+L + +++ DF
Sbjct: 105 RIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDF 164
Query: 232 GMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-- 289
G A E KY++ D WS G+++Y + G PF
Sbjct: 165 G---------------------FAKETTGE-KYDKSCDMWSLGVIMYILLCGYPPFYSNH 202
Query: 290 --CDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343
+ I + FP +S E K ++ +LL + T+R+ + + +
Sbjct: 203 GLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM------TITEFMN 256
Query: 344 HEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVL 394
H PWI S+K P+ +VL
Sbjct: 257 H------------------------------PWIMQSTKVPQTPLHTSRVL 277
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 4e-37
Identities = 61/313 (19%), Positives = 104/313 (33%), Gaps = 75/313 (23%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
L + +GKG FG+V+ + +G + AVK + + E ++
Sbjct: 40 IARTIVLQESIGKGRFGEVWRGKWRGEEV--AVK------IFSSREERSWFREAEIYQTV 91
Query: 123 T-KHPYLCHLF--CTFQTDS--HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
+H + + L+ V +Y G L F
Sbjct: 92 MLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSL----------------------FD 129
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLH--------KKGIVYRDLKLDNILLDYEGHVRIA 229
A SG+ LH K I +RDLK NIL+ G IA
Sbjct: 130 YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIA 189
Query: 230 DFGMCKLQIYLDKTTDTF----CGTPDYMAPEIIKG------LKYNQCVDWWSFGILLYE 279
D G+ T D GT YMAPE++ + + D ++ G++ +E
Sbjct: 190 DLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWE 249
Query: 280 MHVGQSPFSGCDEDELFWS---------------ICNE--RPRFP-QFLSVEAKNILVHL 321
+ S ++ +L + +C + RP P ++ S EA ++ +
Sbjct: 250 IARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKI 309
Query: 322 L----DKDTTKRL 330
+ + RL
Sbjct: 310 MRECWYANGAARL 322
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 137 bits (346), Expect = 1e-36
Identities = 67/313 (21%), Positives = 110/313 (35%), Gaps = 75/313 (23%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL- 121
+ Q++K +GKG +G+V++ + +G AVK V + E ++
Sbjct: 35 IAKQIQMVKQIGKGRYGEVWMGKWRGEKV--AVK------VFFTTEEASWFRETEIYQTV 86
Query: 122 GTKHPYLCHLF--CT--FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
+H + + + L+ + +Y G L +
Sbjct: 87 LMRHENILGFIAADIKGTGSWTQLYLITDYHENGSL----------------------YD 124
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLH--------KKGIVYRDLKLDNILLDYEGHVRIA 229
+S D A VSG+ LH K I +RDLK NIL+ G IA
Sbjct: 125 YLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIA 184
Query: 230 DFGMCKLQIYLDKTTD----TFCGTPDYMAPEIIKG------LKYNQCVDWWSFGILLYE 279
D G+ I D T GT YM PE++ + D +SFG++L+E
Sbjct: 185 DLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWE 244
Query: 280 MHVGQSPFSGCDEDELFWS---------------ICNE--RPRFPQ-FLSVEAKNILVHL 321
+ +E +L + +C + RP FP + S E + L
Sbjct: 245 VARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKL 304
Query: 322 L----DKDTTKRL 330
+ + RL
Sbjct: 305 MTECWAHNPASRL 317
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 3e-36
Identities = 65/311 (20%), Positives = 106/311 (34%), Gaps = 75/311 (24%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GT 123
D LL+ +GKG +G+V+ +G + AVK + D + E ++
Sbjct: 8 RDITLLECVGKGRYGEVWRGSWQGENV--AVK------IFSSRDEKSWFRETELYNTVML 59
Query: 124 KHPYLCHLF--CTFQTDSH--LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+H + S L+ + Y G L +
Sbjct: 60 RHENILGFIASDMTSRHSSTQLWLITHYHEMGSL----------------------YDYL 97
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLH--------KKGIVYRDLKLDNILLDYEGHVRIADF 231
Q D I SG+ LH K I +RDLK NIL+ G IAD
Sbjct: 98 QLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADL 157
Query: 232 GMCKLQIYLDKTTDTF----CGTPDYMAPEIIKG------LKYNQCVDWWSFGILLYEMH 281
G+ + D GT YMAPE++ + VD W+FG++L+E+
Sbjct: 158 GLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVA 217
Query: 282 VGQSPFSGCDEDELFWS---------------IC--NERPRFP-QFLSVEAKNILVHLL- 322
++ + + +C +RP P ++ S L L+
Sbjct: 218 RRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMK 277
Query: 323 ---DKDTTKRL 330
++ + RL
Sbjct: 278 ECWYQNPSARL 288
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 128 bits (325), Expect = 1e-33
Identities = 76/369 (20%), Positives = 141/369 (38%), Gaps = 85/369 (23%)
Query: 41 SRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKK 100
+ + T F+ +E ++ L ++G+GS+G V K T A+K +
Sbjct: 3 HHHHHHSSGVDLGTENLYFQS--MEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLE 60
Query: 101 DVVLEDDDVECTLI-ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLT 159
+D V+ + E K+L +H L +L + + V E++
Sbjct: 61 S--DDDKMVKKIAMREIKLL-KQLRHENLVNLLEVCKKKKRWYLVFEFV----------- 106
Query: 160 KAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219
+ +++ L D + Y +I++G+ F H I++RD+K +NIL
Sbjct: 107 --DHTILDDLE--------LFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENIL 156
Query: 220 LDYEGHVRIADFGM-----CKLQIYLDKTTDTFCGTPD-----YMAPEIIKGLK-YNQCV 268
+ G V++ DFG ++Y + Y APE++ G Y + V
Sbjct: 157 VSQSGVVKLCDFGFARTLAAPGEVY----------DDEVATRWYRAPELLVGDVKYGKAV 206
Query: 269 DWWSFGILLYEMHVGQSPFSG-CDEDELF-------------WSICNERP-----RFPQF 309
D W+ G L+ EM +G+ F G D D+L+ + N+ P R P+
Sbjct: 207 DVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEI 266
Query: 310 ------------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357
LS ++ L D KR +++ H++F+ +
Sbjct: 267 KEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP------FCAELLHHDFFQMDGFAERFS 320
Query: 358 RELEPPFRP 366
+EL+ +
Sbjct: 321 QELQLKVQK 329
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 128 bits (322), Expect = 3e-33
Identities = 59/280 (21%), Positives = 103/280 (36%), Gaps = 56/280 (20%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
DL++ +LL+++G+G +G V+ L AVK V + + + E+ + +
Sbjct: 11 DLDNLKLLELIGRGRYGAVYKGSLDERPV--AVK------VFSFANRQNFINEKNIYRVP 62
Query: 123 T-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL-MEYLNGGDLMFHIQQ 180
+H + GD + E L MEY G L ++
Sbjct: 63 LMEHDNIARFI-----------------VGDERVTADGRMEYLLVMEYYPNGSLXKYLSL 105
Query: 181 SGRFDEGRARFYAAEIVSGMRFLH---------KKGIVYRDLKLDNILLDYEGHVRIADF 231
R A + G+ +LH K I +RDL N+L+ +G I+DF
Sbjct: 106 HTSDWVSSCRL-AHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDF 164
Query: 232 GM--------CKLQIYLDKTTDTFCGTPDYMAPEIIKGL-------KYNQCVDWWSFGIL 276
G+ D + GT YMAPE+++G + VD ++ G++
Sbjct: 165 GLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLI 224
Query: 277 LYEM---HVGQSPFSGCDEDEL-FWSICNERPRFPQFLSV 312
+E+ P E ++ F + P F +
Sbjct: 225 YWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVL 264
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 4e-33
Identities = 67/289 (23%), Positives = 100/289 (34%), Gaps = 61/289 (21%)
Query: 40 HSRSSQSQANITPATTIPRF-RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----A 94
H + P + + ++ LG+G FGKV L T+ A
Sbjct: 5 HHHHHHHHGALEVLFQGPGDPTVFHKRYLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVA 64
Query: 95 VKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGD 152
VK LK D E +L H ++ C + L VMEY+ G
Sbjct: 65 VKALKADA--GPQHRSGWKQEIDILR-TLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGS 121
Query: 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212
L +YL + +A +I GM +LH + ++RD
Sbjct: 122 LR------------DYL----------PRHSIGLAQLLLFAQQICEGMAYLHAQHYIHRD 159
Query: 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEII 259
L N+LLD + V+I DFG+ K + +Y APE +
Sbjct: 160 LAARNVLLDNDRLVKIGDFGLAKA-VPEGH---------EYYRVREDGDSPVFWYAPECL 209
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ 308
K K+ D WSFG+ LYE+ + CD + + E Q
Sbjct: 210 KEYKFYYASDVWSFGVTLYEL------LTHCDSSQSPPTKFLELIGIAQ 252
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 1e-32
Identities = 71/302 (23%), Positives = 122/302 (40%), Gaps = 49/302 (16%)
Query: 15 RRLSNNKLSLDNGQGESS------HHSKQ-----CRHSRSSQSQANITPATTIPRFRKYD 63
S+ KL + + ++ HHS + + T P + K++
Sbjct: 157 NTASDGKLYVSSESRFNTLAELVHHHSTVADGLITTLHYPAPKRNKPTIYGVSPNYDKWE 216
Query: 64 L--EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
+ D + LG G +G+V+ K AVK LK+D + ++ ++ E V+
Sbjct: 217 MERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK----EAAVMK- 271
Query: 122 GTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL-NGGDLMFHI 178
KHP L L CT + + + E++ G+L+ +YL
Sbjct: 272 EIKHPNLVQLLGVCT--REPPFYIITEFMTYGNLL------------DYLRECNRQEVSA 317
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-- 236
A +I S M +L KK ++R+L N L+ V++ADFG+ +L
Sbjct: 318 VVLLYM--------ATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMT 369
Query: 237 -QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDE 294
Y F + APE + K++ D W+FG+LL+E G SP+ G D +
Sbjct: 370 GDTYTAHAGAKF--PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQ 427
Query: 295 LF 296
++
Sbjct: 428 VY 429
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 125 bits (317), Expect = 1e-32
Identities = 76/369 (20%), Positives = 140/369 (37%), Gaps = 92/369 (24%)
Query: 31 SSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTD 90
+ HH + + P ++ ++ + LG+G++G+V+ A T+
Sbjct: 2 AHHHHHHMGTLEAQTQGPGSMSVSAAPSATS--IDRYRRITKLGEGTYGEVYKAIDTVTN 59
Query: 91 YYYAVKCLKKDVVLEDDDVECTLI-ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLN 149
A+K ++ + E++ V T I E +L +H + L + L + EY
Sbjct: 60 ETVAIKRIRLE--HEEEGVPGTAIREVSLL-KELQHRNIIELKSVIHHNHRLHLIFEYA- 115
Query: 150 GGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209
E DL +Y++ ++ + + ++++G+ F H + +
Sbjct: 116 ------------ENDLKKYMD---------KNPDVSMRVIKSFLYQLINGVNFCHSRRCL 154
Query: 210 YRDLKLDNILLDY-----EGHVRIADFGMCKLQIYLDKTTDTFCGTPD-----------Y 253
+RDLK N+LL ++I DFG+ + G P Y
Sbjct: 155 HRDLKPQNLLLSVSDASETPVLKIGDFGLAR-----------AFGIPIRQFTHEIITLWY 203
Query: 254 MAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF--WSIC---NE---- 302
PEI+ G + Y+ VD WS + EM + F G E D+LF + + ++
Sbjct: 204 RPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWP 263
Query: 303 --------RPRFPQF------------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342
+ FP+F L E ++L +L+ D KR+ S + +
Sbjct: 264 GVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI------SAKNAL 317
Query: 343 AHEYFRGLD 351
H YF D
Sbjct: 318 EHPYFSHND 326
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 124 bits (315), Expect = 2e-32
Identities = 67/344 (19%), Positives = 123/344 (35%), Gaps = 85/344 (24%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLALG 122
+E ++ + +G+GS+G VF + T A+K + +D ++ + E ++L
Sbjct: 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLES--EDDPVIKKIALREIRML-KQ 58
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KHP L +L F+ L V EY + ++ L +
Sbjct: 59 LKHPNLVNLLEVFRRKRRLHLVFEYC-------------DHTVLHEL--------DRYQR 97
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
E + + + + F HK ++RD+K +NIL+ +++ DFG +
Sbjct: 98 GVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFAR------- 150
Query: 243 TTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSG- 289
P Y +PE++ G Y VD W+ G + E+ G + G
Sbjct: 151 ---LL-TGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGK 206
Query: 290 CDEDELF-------------WSICNERPRFPQF-----------------LSVEAKNILV 319
D D+L+ + + F +S A +L
Sbjct: 207 SDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLK 266
Query: 320 HLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363
L D T+RL + + ++ H YF + +E + P
Sbjct: 267 GCLHMDPTERL------TCEQLLHHPYFENIREIEDLAKEHDKP 304
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 2e-32
Identities = 62/230 (26%), Positives = 100/230 (43%), Gaps = 35/230 (15%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIER------KVLA 120
++++ LG G V+LAE + A+K + + + ++R
Sbjct: 13 YKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIP--PREKE---ETLKRFEREVHNSSQ 67
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
L H + + + D + VMEY+ G L + I+
Sbjct: 68 L--SHQNIVSMIDVDEEDDCYYLVMEYIEGPTL---------SEY------------IES 104
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
G A + +I+ G++ H IV+RD+K NIL+D ++I DFG+ K
Sbjct: 105 HGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSET 164
Query: 241 DKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
T T+ GT Y +PE KG ++C D +S GI+LYEM VG+ PF+G
Sbjct: 165 SLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNG 214
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-32
Identities = 65/263 (24%), Positives = 104/263 (39%), Gaps = 39/263 (14%)
Query: 30 ESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGT 89
HH + + Q + A +++ + L+ LGKG+FG V +
Sbjct: 6 HHHHHDYDIPTTENLYFQGAMGSAFEDRDPTQFEERHLKFLQQLGKGNFGSVEMCRYDPL 65
Query: 90 DYYY----AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFF 143
AVK L+ D E E ++L +H + C +L
Sbjct: 66 QDNTGEVVAVKKLQHSTEEHLRDFER---EIEILK-SLQHDNIVKYKGVCYSAGRRNLKL 121
Query: 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFL 203
+MEYL G L +YL + R D + Y ++I GM +L
Sbjct: 122 IMEYLPYGSLR------------DYL--------QKHKERIDHIKLLQYTSQICKGMEYL 161
Query: 204 HKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPE 257
K ++RDL NIL++ E V+I DFG+ K L + + + + APE
Sbjct: 162 GTKRYIHRDLATRNILVENENRVKIGDFGLTK---VLPQDKEYYKVKEPGESPIFWYAPE 218
Query: 258 IIKGLKYNQCVDWWSFGILLYEM 280
+ K++ D WSFG++LYE+
Sbjct: 219 SLTESKFSVASDVWSFGVVLYEL 241
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-32
Identities = 63/265 (23%), Positives = 102/265 (38%), Gaps = 50/265 (18%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVEC 111
+ + ++ LG+G FGKV L AVK LK + + +
Sbjct: 18 FEK------RFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIAD 69
Query: 112 TLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
E ++L H + CT + + +ME+L G L EYL
Sbjct: 70 LKKEIEILR-NLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLK------------EYL 116
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229
+ + + YA +I GM +L + V+RDL N+L++ E V+I
Sbjct: 117 PKNK--------NKINLKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIG 168
Query: 230 DFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283
DFG+ K I DK + + D + APE + K+ D WSFG+ L+E+
Sbjct: 169 DFGLTKA-IETDK--EYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL--- 222
Query: 284 QSPFSGCDEDELFWSICNERPRFPQ 308
+ CD D ++ +
Sbjct: 223 ---LTYCDSDSSPMALFLKMIGPTH 244
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-32
Identities = 75/330 (22%), Positives = 137/330 (41%), Gaps = 84/330 (25%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLALG 122
+E + L+ +G+G++G V+ A+ +A+K ++ + ED+ + T I E +L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLE--KEDEGIPSTTIREISIL-KE 56
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KH + L+ T L V E+L ++DL + L+ G
Sbjct: 57 LKHSNIVKLYDVIHTKKRLVLVFEHL-------------DQDLKKLLD--------VCEG 95
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+ A+ + ++++G+ + H + +++RDLK N+L++ EG ++IADFG+ +
Sbjct: 96 GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLAR------- 148
Query: 243 TTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGC 290
G P Y AP+++ G K Y+ +D WS G + EM G F G
Sbjct: 149 ----AFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGV 204
Query: 291 DE-DELF--WSIC---NE------------RPRFPQF-----------LSVEAKNILVHL 321
E D+L + I N P F + L ++L +
Sbjct: 205 SEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKM 264
Query: 322 LDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
L D +R+ + + H YF+ +
Sbjct: 265 LKLDPNQRI------TAKQALEHAYFKENN 288
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 5e-32
Identities = 67/267 (25%), Positives = 98/267 (36%), Gaps = 47/267 (17%)
Query: 40 HSRSSQSQANITP-ATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----A 94
H +Q T + + LGKG+FG V L A
Sbjct: 3 HHHHHHAQLYACQDPTIFEE------RHLKYISQLGKGNFGSVELCRYDPLGDNTGALVA 56
Query: 95 VKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGD 152
VK L+ + D E ++L ++ L VMEYL G
Sbjct: 57 VKQLQHSGPDQQRDF---QREIQILK-ALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGC 112
Query: 153 LIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212
L ++L + R D R Y+++I GM +L + V+RD
Sbjct: 113 LR------------DFL--------QRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRD 152
Query: 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQ 266
L NIL++ E HV+IADFG+ KL L D + + APE + +++
Sbjct: 153 LAARNILVESEAHVKIADFGLAKL---LPLDKDYYVVREPGQSPIFWYAPESLSDNIFSR 209
Query: 267 CVDWWSFGILLYE-MHVGQSPFSGCDE 292
D WSFG++LYE S E
Sbjct: 210 QSDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 8e-32
Identities = 64/313 (20%), Positives = 105/313 (33%), Gaps = 75/313 (23%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
QLL+V +G FG V+ A+L AVK + D + E +V +L
Sbjct: 22 QSMPLQLLEVKARGRFGCVWKAQLLNEYV--AVK------IFPIQDKQSWQNEYEVYSLP 73
Query: 123 T-KHPYLCHL--FCTFQTDSH--LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
KH + T L+ + + G L ++L +
Sbjct: 74 GMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSL------------SDFLKANVV--- 118
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLH----------KKGIVYRDLKLDNILLDYEGHVR 227
A + G+ +LH K I +RD+K N+LL
Sbjct: 119 -------SWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTAC 171
Query: 228 IADFGMCKLQIYLDKTTDT--FCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEM 280
IADFG+ DT GT YMAPE+++G +D ++ G++L+E+
Sbjct: 172 IADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231
Query: 281 HVGQSPFSGCDED------ELFWS----------ICNE--RPRFPQ-FLSVEAKNILVHL 321
+ G ++ E + ++ RP + +L
Sbjct: 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCET 291
Query: 322 L----DKDTTKRL 330
+ D D RL
Sbjct: 292 IEECWDHDAEARL 304
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 1e-31
Identities = 61/237 (25%), Positives = 94/237 (39%), Gaps = 45/237 (18%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVEC 111
+ L+ LGKG+FG V + AVK L+ D
Sbjct: 7 FEE------RHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDF-- 58
Query: 112 TLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
E ++L +H + C +L +MEYL G L +YL
Sbjct: 59 -EREIEILK-SLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLR------------DYL 104
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229
+ R D + Y ++I GM +L K ++RDL NIL++ E V+I
Sbjct: 105 --------QKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIG 156
Query: 230 DFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYEM 280
DFG+ K+ L + + F + APE + K++ D WSFG++LYE+
Sbjct: 157 DFGLTKV---LPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 210
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 122 bits (308), Expect = 2e-31
Identities = 82/350 (23%), Positives = 144/350 (41%), Gaps = 87/350 (24%)
Query: 45 QSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL 104
+ + + +E +Q L+ +G+G++G V+ A+ A+K ++ D
Sbjct: 3 HHHHHSSGRENLYFQGL--MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLD--A 57
Query: 105 EDDDVECTLI-ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAER 163
ED+ + T I E +L HP + L ++ L V E++ E+
Sbjct: 58 EDEGIPSTAIREISLL-KELHHPNIVSLIDVIHSERCLTLVFEFM-------------EK 103
Query: 164 DLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
DL + L+ + + + + Y +++ G+ H+ I++RDLK N+L++ +
Sbjct: 104 DLKKVLD--------ENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSD 155
Query: 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWW 271
G +++ADFG+ + G P Y AP+++ G K Y+ VD W
Sbjct: 156 GALKLADFGLAR-----------AFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIW 204
Query: 272 SFGILLYEMHVGQSPFSG-CDEDELF--WSIC---NER-------------PRFPQF--- 309
S G + EM G+ F G D+D+L +SI N R F F
Sbjct: 205 SIGCIFAEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKK 264
Query: 310 --------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
E ++L ++L D KR+ S D + H YF+ LD
Sbjct: 265 PWSSIIPGFCQEGIDLLSNMLCFDPNKRI------SARDAMNHPYFKDLD 308
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 124 bits (313), Expect = 3e-31
Identities = 68/298 (22%), Positives = 120/298 (40%), Gaps = 50/298 (16%)
Query: 16 RLSNNKLSLDNGQGESS------HHSKQ----CRHSRSSQSQANITPATTIPRFRKY--D 63
+KLS+D + H++ C + A + +
Sbjct: 132 MYHASKLSIDEEVYFENLMQLVEHYTTDADGLCTRLIKPKVMEGTVAAQDEFYRSGWALN 191
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+++ +LL+ +GKG FG V L + +G AVKC+K D + L E V+
Sbjct: 192 MKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQA-----FLAEASVMT-QL 243
Query: 124 KHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL-NGGDLMFHIQQ 180
+H L L + L+ V EY+ G L+ +YL + G +
Sbjct: 244 RHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSLV------------DYLRSRGRSVLGGDC 290
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
+F + ++ M +L V+RDL N+L+ + +++DFG+ K +
Sbjct: 291 LLKF--------SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EASS 341
Query: 241 DKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
+ T P + APE ++ K++ D WSFGILL+E G+ P+ ++
Sbjct: 342 TQDTGKL---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 3e-31
Identities = 70/330 (21%), Positives = 138/330 (41%), Gaps = 84/330 (25%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLALG 122
++ ++ L+ +G+G++G VF A+ + T A+K ++ D +D+ V + + E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLD--DDDEGVPSSALREICLL-KE 57
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KH + L +D L V E+ ++DL +Y + +G
Sbjct: 58 LKHKNIVRLHDVLHSDKKLTLVFEFC-------------DQDLKKYFD--------SCNG 96
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
D + + +++ G+ F H + +++RDLK N+L++ G +++A+FG+ +
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLAR------- 149
Query: 243 TTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP-FSG 289
G P Y P+++ G K Y+ +D WS G + E+ P F G
Sbjct: 150 ----AFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205
Query: 290 CDE-DELF--WSIC---NER--------------PRFPQ---------FLSVEAKNILVH 320
D D+L + + E P +P L+ +++L +
Sbjct: 206 NDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQN 265
Query: 321 LLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
LL + +R+ S ++ + H YF
Sbjct: 266 LLKCNPVQRI------SAEEALQHPYFSDF 289
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 121 bits (307), Expect = 3e-31
Identities = 75/332 (22%), Positives = 134/332 (40%), Gaps = 87/332 (26%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLI-ERKVLAL 121
+E + L LG+G++ V+ + K TD A LK+ + LE ++ CT I E +L
Sbjct: 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVA---LKE-IRLEHEEGAPCTAIREVSLL-K 55
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
KH + L T+ L V EYL ++DL +YL+
Sbjct: 56 DLKHANIVTLHDIIHTEKSLTLVFEYL-------------DKDLKQYLD--------DCG 94
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+ + + +++ G+ + H++ +++RDLK N+L++ G +++ADFG+ +
Sbjct: 95 NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLAR------ 148
Query: 242 KTTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSG 289
P Y P+I+ G Y+ +D W G + YEM G+ F G
Sbjct: 149 -----AKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPG 203
Query: 290 -CDEDELF--WSIC---NER-------------PRFPQF-----------LSVEAKNILV 319
E++L + I E +P++ L + ++L
Sbjct: 204 STVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLT 263
Query: 320 HLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
LL + R+ S +D + H +F L
Sbjct: 264 KLLQFEGRNRI------SAEDAMKHPFFLSLG 289
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 4e-31
Identities = 74/347 (21%), Positives = 131/347 (37%), Gaps = 86/347 (24%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLI-ERKVLALG 122
F+ L+ LG G++ V+ K T Y A+K +K L+ ++ T I E ++
Sbjct: 5 SQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVK----LDSEEGTPSTAIREISLM-KE 59
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KH + L+ T++ L V E++ + DL +Y+ D
Sbjct: 60 LKHENIVRLYDVIHTENKLTLVFEFM-------------DNDLKKYM---DSRTVGNTPR 103
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+ +++ +++ G+ F H+ I++RDLK N+L++ G +++ DFG+ +
Sbjct: 104 GLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLAR------- 156
Query: 243 TTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGC 290
G P Y AP+++ G + Y+ +D WS G +L EM G+ F G
Sbjct: 157 ----AFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGT 212
Query: 291 DE-DELF--WSIC---NE------------RPRFPQF----------------LSVEAKN 316
++ ++L + I NE P Q L +
Sbjct: 213 NDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMD 272
Query: 317 ILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363
L LL + RL S + H +F A
Sbjct: 273 FLHGLLQLNPDMRL------SAKQALHHPWFAEYYHHASMGGSRSHH 313
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 1e-30
Identities = 61/239 (25%), Positives = 106/239 (44%), Gaps = 38/239 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
++++ +LL+ +GKG FG V L + +G AVKC+K D + L E V+
Sbjct: 19 NMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKNDATAQA-----FLAEASVMT-Q 70
Query: 123 TKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL-NGGDLMFHIQ 179
+H L L + L+ V EY+ G L ++YL + G +
Sbjct: 71 LRHSNLVQLLGVIV-EEKGGLYIVTEYMAKGSL------------VDYLRSRGRSVLGGD 117
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+F + ++ M +L V+RDL N+L+ + +++DFG+ K +
Sbjct: 118 CLLKF--------SLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK-EAS 168
Query: 240 LDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
+ T P + APE ++ K++ D WSFGILL+E G+ P+ ++
Sbjct: 169 STQDTGKL---PVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 121 bits (306), Expect = 1e-30
Identities = 60/237 (25%), Positives = 100/237 (42%), Gaps = 34/237 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
ED L + +G+G+FG+VF L+ + AVK ++ + D L E ++L
Sbjct: 114 EDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRETLP--PDLKAKFLQEARILK-QYS 170
Query: 125 HPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP + L CT ++ VME + GGD + +L ++
Sbjct: 171 HPNIVRLIGVCT--QKQPIYIVMELVQGGDFL------------TFLRTEGARLRVKTLL 216
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+ + +GM +L K ++RDL N L+ + ++I+DFGM +
Sbjct: 217 QM--------VGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSRE-EADGV 267
Query: 243 TTDTFCGTPDY----MAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDE 294
+ G APE + +Y+ D WSFGILL+E +G SP+ +
Sbjct: 268 YAAS-GGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQ 323
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 2e-30
Identities = 70/262 (26%), Positives = 104/262 (39%), Gaps = 39/262 (14%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECT 112
I +D +LL+ LG GSFG V E AVKCLK DV+ + + ++
Sbjct: 15 IGE------KDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDF 68
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
+ E + H L L+ + V E G L ++ L
Sbjct: 69 IREVNAMH-SLDHRNLIRLYGVVL---TPPMKMVTELAPLGSL------------LDRLR 112
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
G F G YA ++ GM +L K ++RDL N+LL V+I D
Sbjct: 113 KHQ--------GHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGD 164
Query: 231 FGMCKLQIYLDKTTDTFCGT--P-DYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSP 286
FG+ + D P + APE +K ++ D W FG+ L+EM GQ P
Sbjct: 165 FGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEP 224
Query: 287 FSGCDEDELFWSICNERPRFPQ 308
+ G + ++ I E R P+
Sbjct: 225 WIGLNGSQILHKIDKEGERLPR 246
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-30
Identities = 71/301 (23%), Positives = 121/301 (40%), Gaps = 52/301 (17%)
Query: 15 RRLSNNKLSLDNGQGESS------HHSKQ----CRHSRSSQSQANITPATTIPRFRKYDL 64
R+L + + + +S ++SK C + + +
Sbjct: 124 RKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPR 183
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E +L LG+G FG+V++ GT A+K LK + + L E +V+ +
Sbjct: 184 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA----FLQEAQVMK-KLR 237
Query: 125 HPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL--NGGDLMFHIQQ 180
H L L+ + + ++ V EY++ G L+ ++L G + Q
Sbjct: 238 HEKLVQLYAVVS---EEPIYIVTEYMSKGSLL------------DFLKGETGKYLRLPQL 282
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---Q 237
AA+I SGM ++ + V+RDL+ NIL+ ++ADFG+ +L
Sbjct: 283 VD---------MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 333
Query: 238 IYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDEL 295
Y + F P + APE ++ D WSFGILL E G+ P+ G E+
Sbjct: 334 EYTARQGAKF---PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 390
Query: 296 F 296
Sbjct: 391 L 391
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-30
Identities = 65/306 (21%), Positives = 112/306 (36%), Gaps = 79/306 (25%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVEC 111
+ +F+ +KVLG G+FG V+ A+K L++ +
Sbjct: 12 LKE------TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKE 63
Query: 112 TLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
L E V+A +P++C L C S + + + + G L ++Y+
Sbjct: 64 ILDEAYVMA-SVDNPHVCRLLGICL---TSTVQLITQLMPFGCL------------LDYV 107
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229
+ + +I GM +L + +V+RDL N+L+ HV+I
Sbjct: 108 R--------EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKIT 159
Query: 230 DFGMCKLQIYLDKTTDTFCGT--P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQS 285
DFG+ KL + ++ G P +MA E I Y D WS+G+ ++E M G
Sbjct: 160 DFGLAKL-LGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSK 218
Query: 286 PFSGCDEDELFWSI----------------------C-----NERPRFPQFLSVEAKNIL 318
P+ G E+ + C + RP+F + L
Sbjct: 219 PYDGIPASEISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRPKFRE---------L 269
Query: 319 VHLLDK 324
+ K
Sbjct: 270 IIEFSK 275
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 118 bits (299), Expect = 3e-30
Identities = 59/270 (21%), Positives = 96/270 (35%), Gaps = 43/270 (15%)
Query: 29 GESSHHSKQCRHSRSSQSQANITPATTI-PRFRKYDLEDFQLLKVLGKGSFGKVFLAELK 87
G S HH S + T + +F Y +L +++G+G G V+ AE
Sbjct: 2 GSSHHHHHHSSGLVPRGSHMDGTAESREGTQFGPY-----RLRRLVGRGGMGDVYEAEDT 56
Query: 88 GTDYYYAVKCLKKDVVLEDDDVECTLIER----KVLALGTKHPYLCHLFCTFQTDSHLFF 143
+ A+K + + L D R A + P++ + + D L+
Sbjct: 57 VRERIVALKLMSET--LSSDP---VFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYV 111
Query: 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFL 203
M +NG DL + +++ G RA +I S +
Sbjct: 112 DMRLINGVDL---------AAM------------LRRQGPLAPPRAVAIVRQIGSALDAA 150
Query: 204 HKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEII 259
H G +RD+K +NIL+ + + DFG+ GT YMAPE
Sbjct: 151 HAAGATHRDVKPENILVSADDFAYLVDFGIASA---TTDEKLTQLGNTVGTLYYMAPERF 207
Query: 260 KGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
D ++ +LYE G P+ G
Sbjct: 208 SESHATYRADIYALTCVLYECLTGSPPYQG 237
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 123 bits (309), Expect = 5e-30
Identities = 58/276 (21%), Positives = 100/276 (36%), Gaps = 52/276 (18%)
Query: 67 FQLLKVLGKGSFGKVFLAE---LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+++ + G G ++LA + G +K L + + + ER+ LA
Sbjct: 82 YEVKGCIAHGGLGWIYLALDRNVNGRPV--VLKGLVHS--GDAEAQAMAMAERQFLA-EV 136
Query: 124 KHPYLCHLF-----CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
HP + +F D + VMEY+ G L +
Sbjct: 137 VHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSL---------KRSKG----------- 176
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ A Y EI+ + +LH G+VY DLK +NI+L E +++ D G
Sbjct: 177 ---QKLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLT-EEQLKLIDLGAVS--- 229
Query: 239 YLDKTTDT--FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
+ GTP + APEI++ D ++ G L + + +G D L
Sbjct: 230 ---RINSFGYLYGTPGFQAPEIVRTGPTVAT-DIYTVGRTLAALTLDLPTRNGRYVDGL- 284
Query: 297 WSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332
+ P + S +L +D D +R +
Sbjct: 285 ---PEDDPVLKTYDSYGR--LLRRAIDPDPRQRFTT 315
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-30
Identities = 72/270 (26%), Positives = 106/270 (39%), Gaps = 66/270 (24%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
PR + +L K LG+G+FG+V A+ G D AVK LK+ +
Sbjct: 24 FPR------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHR 75
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDL----------IPAGL 158
+ E K+L H + +L CT + L ++E+ G+L
Sbjct: 76 ALMSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 134
Query: 159 TKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218
E ++L L+ Y+ ++ GM FL + ++RDL NI
Sbjct: 135 VAPEDLYKDFLTLEHLI---------------CYSFQVAKGMEFLASRKCIHRDLAARNI 179
Query: 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYN 265
LL + V+I DFG+ + IY D MAPE I Y
Sbjct: 180 LLSEKNVVKICDFGLARD-IYKD----------PDYVRKGDARLPLKWMAPETIFDRVYT 228
Query: 266 QCVDWWSFGILLYE-MHVGQSPFSGCDEDE 294
D WSFG+LL+E +G SP+ G DE
Sbjct: 229 IQSDVWSFGVLLWEIFSLGASPYPGVKIDE 258
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 7e-30
Identities = 71/301 (23%), Positives = 121/301 (40%), Gaps = 52/301 (17%)
Query: 15 RRLSNNKLSLDNGQGESS------HHSKQ----CRHSRSSQSQANITPATTIPRFRKYDL 64
R+L + + + +S ++SK C + + +
Sbjct: 207 RKLDSGGFYITSRTQFNSLQQLVAYYSKHADGLCHRLTTVCPTSKPQTQGLAKDAWEIPR 266
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E +L LG+G FG+V++ GT A+K LK + + L E +V+ +
Sbjct: 267 ESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTMSPEA----FLQEAQVMK-KLR 320
Query: 125 HPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL--NGGDLMFHIQQ 180
H L L+ + + ++ V EY++ G L+ ++L G + Q
Sbjct: 321 HEKLVQLYAVVS---EEPIYIVTEYMSKGSLL------------DFLKGETGKYLRLPQL 365
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---Q 237
AA+I SGM ++ + V+RDL+ NIL+ ++ADFG+ +L
Sbjct: 366 VD---------MAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDN 416
Query: 238 IYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDEL 295
Y + F P + APE ++ D WSFGILL E G+ P+ G E+
Sbjct: 417 EYTARQGAKF---PIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREV 473
Query: 296 F 296
Sbjct: 474 L 474
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 1e-29
Identities = 75/348 (21%), Positives = 132/348 (37%), Gaps = 88/348 (25%)
Query: 65 EDFQLLKVLGKGSFGKVFLA-ELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLAL- 121
+ ++ + +G+G++GKVF A +LK + A+K ++ ++ + + I E VL
Sbjct: 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQ--TGEEGMPLSTIREVAVLRHL 68
Query: 122 -GTKHPYLCHLFCTFQT-----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+HP + LF ++ L V E++ ++DL YL+
Sbjct: 69 ETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHV-------------DQDLTTYLDK---- 111
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ +++ G+ FLH +V+RDLK NIL+ G +++ADFG+ +
Sbjct: 112 ---VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLAR 168
Query: 236 LQIYLDKTTDTFCGTPD----------YMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS 285
Y APE++ Y VD WS G + EM +
Sbjct: 169 -----------IYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 217
Query: 286 PFSGCDE-DELF--WSIC---NE----------RPRFPQF-----------LSVEAKNIL 318
F G + D+L + E R F + K++L
Sbjct: 218 LFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 319 VHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
+ L + KR+ S ++H YF+ L+ K L+ P
Sbjct: 278 LKCLTFNPAKRI------SAYSALSHPYFQDLE---RCKENLDSHLPP 316
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 1e-29
Identities = 83/330 (25%), Positives = 130/330 (39%), Gaps = 81/330 (24%)
Query: 15 RRLSNNKLSLD-----NGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDL----- 64
+ + NG G HH H + N+ + +Y+L
Sbjct: 7 HHHHDYDIPTTENLYFNGMGYYHHHHH---HDYDIPTTENLYFQGMLAGVSEYELPEDPR 63
Query: 65 -----EDFQLLKVLGKGSFGKVFLAELKGTDYYY-------AVKCLKKDVVLEDDDVECT 112
+ L K LG+G+FG+V LAE G D AVK LK D + D+
Sbjct: 64 WELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDL 121
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDL----------IPAGLTK 160
+ E +++ + KH + +L CT D L+ ++EY + G+L
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACT--QDGPLYVIVEYASKGNLREYLQARRPPGLEYSYN 179
Query: 161 AERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220
+ E L+ DL+ A ++ GM +L K ++RDL N+L+
Sbjct: 180 PSHNPEEQLSSKDLVS---------------CAYQVARGMEYLASKKCIHRDLAARNVLV 224
Query: 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQC 267
+ ++IADFG+ + I+ DY MAPE + Y
Sbjct: 225 TEDNVMKIADFGLARD-IHHI----------DYYKKTTNGRLPVKWMAPEALFDRIYTHQ 273
Query: 268 VDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
D WSFG+LL+E +G SP+ G +ELF
Sbjct: 274 SDVWSFGVLLWEIFTLGGSPYPGVPVEELF 303
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 65/251 (25%), Positives = 111/251 (44%), Gaps = 36/251 (14%)
Query: 51 TPATTIPRFRKY--DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD 108
P+T + + D +D LK LG G FG V + +G Y A+K +K+ + ED+
Sbjct: 8 APSTAGLGYGSWEIDPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDE- 65
Query: 109 VECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM 166
+ E KV+ H L L+ CT +F + EY+ G L +
Sbjct: 66 ---FIEEAKVMM-NLSHEKLVQLYGVCT--KQRPIFIITEYMANGCL------------L 107
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
YL F QQ ++ M +L K ++RDL N L++ +G V
Sbjct: 108 NYLREMRHRFQTQQLLEM--------CKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVV 159
Query: 227 RIADFGMCKLQIYLDKTTDTFCGT-P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVG 283
+++DFG+ + + D+ T + P + PE++ K++ D W+FG+L++E +G
Sbjct: 160 KVSDFGLSRY-VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218
Query: 284 QSPFSGCDEDE 294
+ P+ E
Sbjct: 219 KMPYERFTNSE 229
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-29
Identities = 66/250 (26%), Positives = 108/250 (43%), Gaps = 40/250 (16%)
Query: 57 PRFRKY--DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI 114
P + K+ + D + LG G +G+V+ K AVK LK+D + ++ ++
Sbjct: 3 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTMEVEEFLK---- 58
Query: 115 ERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL-NG 171
E V+ KHP L L CT + + + E++ G+L ++YL
Sbjct: 59 EAAVMK-EIKHPNLVQLLGVCT--REPPFYIITEFMTYGNL------------LDYLREC 103
Query: 172 GDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADF 231
A +I S M +L KK ++RDL N L+ V++ADF
Sbjct: 104 NRQEVSAVVLLYM--------ATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADF 155
Query: 232 GMCKL---QIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSP 286
G+ +L Y F P + APE + K++ D W+FG+LL+E G SP
Sbjct: 156 GLSRLMTGDTYTAHAGAKF---PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSP 212
Query: 287 FSGCDEDELF 296
+ G D +++
Sbjct: 213 YPGIDLSQVY 222
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 117 bits (295), Expect = 2e-29
Identities = 72/328 (21%), Positives = 123/328 (37%), Gaps = 83/328 (25%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD-VECTLI-ERKVLAL 121
+ ++ L LG+G F V+ A K T+ A+K +K E D + T + E K+L
Sbjct: 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLL-Q 67
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
HP + L F S++ V +++ E DL + S
Sbjct: 68 ELSHPNIIGLLDAFGHKSNISLVFDFM-------------ETDLEVIIK--------DNS 106
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+ Y + G+ +LH+ I++RDLK +N+LLD G +++ADFG+ K
Sbjct: 107 LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAK------ 160
Query: 242 KTTDTFCGTPD-----------YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSG 289
G+P+ Y APE++ G + Y VD W+ G +L E+ + G
Sbjct: 161 -----SFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPG 215
Query: 290 -CDEDELF----------------------------WSICNERPRFPQFLSVEAKNILVH 320
D D+L + F + +++
Sbjct: 216 DSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSA-AGDDLLDLIQG 274
Query: 321 LLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
L + R+ +TQ + +YF
Sbjct: 275 LFLFNPCARITATQA------LKMKYFS 296
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 4e-29
Identities = 66/270 (24%), Positives = 114/270 (42%), Gaps = 37/270 (13%)
Query: 40 HSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY--AVKC 97
H ++ + T + D + V+G+G+FG+V A +K A+K
Sbjct: 6 HHHHGKNNPDPTIYPVLDW------NDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKR 59
Query: 98 LKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIP 155
+K+ DD E +VL HP + +L C +L+ +EY G+L
Sbjct: 60 MKEYAS--KDDHRDFAGELEVLCKLGHHPNIINLLGACE--HRGYLYLAIEYAPHGNL-- 113
Query: 156 AGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARF-------YAAEIVSGMRFLHKKGI 208
+++L ++ + + +AA++ GM +L +K
Sbjct: 114 ----------LDFLRKSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQF 163
Query: 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQC 267
++RDL NIL+ +IADFG+ + Q K T P +MA E + Y
Sbjct: 164 IHRDLAARNILVGENYVAKIADFGLSRGQEVYVKKTMGR--LPVRWMAIESLNYSVYTTN 221
Query: 268 VDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
D WS+G+LL+E + +G +P+ G EL+
Sbjct: 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 66/246 (26%), Positives = 106/246 (43%), Gaps = 40/246 (16%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
+ R E+ LLK LG G FG V L + KG Y AVK +K+ + ED+ E
Sbjct: 5 LKR------EEITLLKELGSGQFGVVKLGKWKGQ-YDVAVKMIKEGSMSEDE----FFQE 53
Query: 116 RKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
+ + HP L + C+ + ++ V EY++ G L + YL
Sbjct: 54 AQTMM-KLSHPKLVKFYGVCS--KEYPIYIVTEYISNGCL------------LNYLRSHG 98
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
Q ++ GM FL ++RDL N L+D + V+++DFGM
Sbjct: 99 KGLEPSQLLEM--------CYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGM 150
Query: 234 CKLQIYLDKTTDTFCGT-P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGC 290
+ + D+ + P + APE+ KY+ D W+FGIL++E +G+ P+
Sbjct: 151 TRY-VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLY 209
Query: 291 DEDELF 296
E+
Sbjct: 210 TNSEVV 215
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 115 bits (291), Expect = 5e-29
Identities = 75/297 (25%), Positives = 117/297 (39%), Gaps = 65/297 (21%)
Query: 35 SKQCRHSRSSQSQANITPATTIPRFRK--YDLEDFQLLKVLGKGSFGKVFLAELKGTDYY 92
S H S +P K + + L K LG+G+FG+V +AE G D
Sbjct: 3 SSHHHHHHSQDPMLAGVSEYELPEDPKWEFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKD 62
Query: 93 Y-------AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFF 143
AVK LK D + D+ + E +++ + KH + +L CT D L+
Sbjct: 63 KPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACT--QDGPLYV 118
Query: 144 VMEYLNGGDL----------IPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYA 193
++EY + G+L R E + DL+
Sbjct: 119 IVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDLV---------------SCT 163
Query: 194 AEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY 253
++ GM +L + ++RDL N+L+ ++IADFG+ + I DY
Sbjct: 164 YQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARD-INNI----------DY 212
Query: 254 -------------MAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
MAPE + Y D WSFG+L++E +G SP+ G +ELF
Sbjct: 213 YKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELF 269
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 5e-29
Identities = 55/239 (23%), Positives = 99/239 (41%), Gaps = 38/239 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D + ++ +G G FG V L D A+K +++ + E+D + E +V+
Sbjct: 6 DPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEED----FIEEAEVMM-K 59
Query: 123 TKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
HP L L+ C + + V E++ G L +YL +F +
Sbjct: 60 LSHPKLVQLYGVCL--EQAPICLVTEFMEHGCL------------SDYLRTQRGLFAAET 105
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---Q 237
++ GM +L + +++RDL N L+ ++++DFGM +
Sbjct: 106 LLGM--------CLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDD 157
Query: 238 IYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDE 294
Y T F P + +PE+ +Y+ D WSFG+L++E G+ P+ E
Sbjct: 158 QYTSSTGTKF---PVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 213
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 7e-29
Identities = 76/318 (23%), Positives = 124/318 (38%), Gaps = 71/318 (22%)
Query: 20 NKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATT------IPRFRKY--DLEDFQLLK 71
++++ S + + + S TP +P K+ + L K
Sbjct: 28 RQVTVSAESSSSMNSNTPLVRITTRLSSTADTPMLAGVSEYELPEDPKWEFPRDKLTLGK 87
Query: 72 VLGKGSFGKVFLAELKGTDYYY-------AVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
LG+G FG+V +AE G D AVK LK D + D+ + E +++ + K
Sbjct: 88 PLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGK 145
Query: 125 HPYLCHLF--CTFQTDSHLFFVMEYLNGGDL----------IPAGLTKAERDLMEYLNGG 172
H + +L CT D L+ ++EY + G+L R E +
Sbjct: 146 HKNIINLLGACT--QDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFK 203
Query: 173 DLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFG 232
DL+ ++ GM +L + ++RDL N+L+ ++IADFG
Sbjct: 204 DLV---------------SCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFG 248
Query: 233 MCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYE 279
+ + I DY MAPE + Y D WSFG+L++E
Sbjct: 249 LARD-INNI----------DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWE 297
Query: 280 -MHVGQSPFSGCDEDELF 296
+G SP+ G +ELF
Sbjct: 298 IFTLGGSPYPGIPVEELF 315
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 115 bits (289), Expect = 9e-29
Identities = 63/272 (23%), Positives = 102/272 (37%), Gaps = 40/272 (14%)
Query: 33 HHSKQ----CRHSRSSQSQANITPATTIPRFRK-YDLEDFQLLKVLGKGSFGKVFLAELK 87
HH + Q P + +F KV+G G FG+V+ LK
Sbjct: 7 HHHHDYDIPTTENLYFQGAMGSDPNQAVLKFTTEIHPSCVTRQKVIGAGEFGEVYKGMLK 66
Query: 88 GTDYYY----AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHL 141
+ A+K LK + L E ++ H + L + +
Sbjct: 67 TSSGKKEVPVAIKTLKAGYT--EKQRVDFLGEAGIMG-QFSHHNIIRLEGVIS--KYKPM 121
Query: 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMR 201
+ EY+ G L ++L D G F + I +GM+
Sbjct: 122 MIITEYMENGAL------------DKFLREKD--------GEFSVLQLVGMLRGIAAGMK 161
Query: 202 FLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT--P-DYMAPEI 258
+L V+RDL NIL++ +++DFG+ ++ + T T G P + APE
Sbjct: 162 YLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEA 221
Query: 259 IKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
I K+ D WSFGI+++E M G+ P+
Sbjct: 222 ISYRKFTSASDVWSFGIVMWEVMTYGERPYWE 253
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 1e-28
Identities = 67/335 (20%), Positives = 118/335 (35%), Gaps = 85/335 (25%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLAL- 121
++ + +G G++G V+ A + ++ A+K ++ + + + R+V L
Sbjct: 8 TSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTV-REVALLR 66
Query: 122 ---GTKHPYLCHLFCTFQTDSH-----LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
+HP + L T + V E++ ++DL YL+
Sbjct: 67 RLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHV-------------DQDLRTYLDK-- 111
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
+ + + G+ FLH IV+RDLK +NIL+ G V++ADFG+
Sbjct: 112 -----APPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGL 166
Query: 234 CKLQIYLDKTTDTFCGTPD----------YMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283
+ Y APE++ Y VD WS G + EM
Sbjct: 167 AR-----------IYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRR 215
Query: 284 QSPFSGCDE-DELF--WSIC---NE----------RPRFPQF-----------LSVEAKN 316
+ F G E D+L + + E R FP +
Sbjct: 216 KPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQ 275
Query: 317 ILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351
+L+ +L + KR+ S + H Y +
Sbjct: 276 LLLEMLTFNPHKRI------SAFRALQHSYLHKDE 304
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 2e-28
Identities = 71/262 (27%), Positives = 95/262 (36%), Gaps = 49/262 (18%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
PR K LG G+FGKV A G AVK LK + E
Sbjct: 20 FPR------NRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTERE 71
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLT--KAERDLM 166
+ E KVL+ H + +L CT + EY GDL L + +RD
Sbjct: 72 ALMSELKVLSYLGNHMNIVNLLGACT--IGGPTLVITEYCCYGDL----LNFLRRKRDSF 125
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
+ D ++ ++ GM FL K ++RDL NILL +
Sbjct: 126 ICSKTSPAIME-DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSF 273
+I DFG+ + I D MAPE I Y D WS+
Sbjct: 185 KICDFGLAR-DIKND----------SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSY 233
Query: 274 GILLYE-MHVGQSPFSGCDEDE 294
GI L+E +G SP+ G D
Sbjct: 234 GIFLWELFSLGSSPYPGMPVDS 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-28
Identities = 67/250 (26%), Positives = 107/250 (42%), Gaps = 48/250 (19%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIE 115
+PR E +L++ LG G FG+V++ G AVK LK+ + D L E
Sbjct: 10 VPR------ETLKLVERLGAGQFGEVWMGYYNGH-TKVAVKSLKQGSMSPDA----FLAE 58
Query: 116 RKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL--NG 171
++ +H L L+ T ++ + EY+ G L +++L
Sbjct: 59 ANLMK-QLQHQRLVRLYAVVT---QEPIYIITEYMENGSL------------VDFLKTPS 102
Query: 172 GDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADF 231
G + + AA+I GM F+ ++ ++RDL+ NIL+ +IADF
Sbjct: 103 GIKLTINKLLD---------MAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADF 153
Query: 232 GMCKL---QIYLDKTTDTFCGTP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSP 286
G+ +L Y + F P + APE I + D WSFGILL E + G+ P
Sbjct: 154 GLARLIEDNEYTAREGAKF---PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIP 210
Query: 287 FSGCDEDELF 296
+ G E+
Sbjct: 211 YPGMTNPEVI 220
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 3e-28
Identities = 65/264 (24%), Positives = 109/264 (41%), Gaps = 57/264 (21%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECT 112
IP + F L ++LGKG FG V A+LK D + AVK LK D+ + D+E
Sbjct: 20 IPE------QQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADI-IASSDIEEF 72
Query: 113 LIERKVLALGTKHPYLCHLF--CT----FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM 166
L E + HP++ L ++ ++ GDL
Sbjct: 73 LREAACMK-EFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDL------------H 119
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARF-------YAAEIVSGMRFLHKKGIVYRDLKLDNIL 219
+L + R E + +I GM +L + ++RDL N +
Sbjct: 120 AFL----------LASRIGENPFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCM 169
Query: 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSF 273
L + V +ADFG+ + +IY + D + ++A E + Y D W+F
Sbjct: 170 LAEDMTVCVADFGLSR-KIY---SGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAF 225
Query: 274 GILLYE-MHVGQSPFSGCDEDELF 296
G+ ++E M GQ+P++G + E++
Sbjct: 226 GVTMWEIMTRGQTPYAGIENAEIY 249
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 5e-28
Identities = 62/236 (26%), Positives = 101/236 (42%), Gaps = 41/236 (17%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIER------KVLA 120
++L ++LG G +V LA AVK L+ D L D + R A
Sbjct: 14 YELGEILGFGGMSEVHLARDLRDHRDVAVKVLRAD--LARDP---SFYLRFRREAQNAAA 68
Query: 121 LGTKHPYLCHLFCTFQTD----SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
L HP + ++ T + + + VMEY++G L RD+
Sbjct: 69 L--NHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTL---------RDI----------- 106
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
+ G RA A+ + F H+ GI++RD+K NI++ V++ DFG+ +
Sbjct: 107 -VHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARA 165
Query: 237 QIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+ T GT Y++PE +G + D +S G +LYE+ G+ PF+G
Sbjct: 166 IADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 221
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 6e-28
Identities = 68/290 (23%), Positives = 105/290 (36%), Gaps = 57/290 (19%)
Query: 31 SSHHSKQCRHSRSSQSQANITPATTIPRFRKY--DLEDFQLLKVLGKGSFGKVFLAELKG 88
SSHH H S + D L K+LG+G FG V LK
Sbjct: 3 SSHH-----HHHHSSGLVPRGSEELQNKLEDVVIDRNLLILGKILGEGEFGSVMEGNLKQ 57
Query: 89 TDYYY---AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTF---QTDSH 140
D AVK +K D + + E L E + HP + L C Q
Sbjct: 58 EDGTSLKVAVKTMKLDNSSQREIEEF-LSEAACMK-DFSHPNVIRLLGVCIEMSSQGIPK 115
Query: 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARF-------YA 193
++ ++ G DL YL R + G +
Sbjct: 116 PMVILPFMKYG------------DLHTYL----------LYSRLETGPKHIPLQTLLKFM 153
Query: 194 AEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD- 252
+I GM +L + ++RDL N +L + V +ADFG+ K +IY + D +
Sbjct: 154 VDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK-KIY---SGDYYRQGRIA 209
Query: 253 -----YMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
++A E + Y D W+FG+ ++E G +P+ G E++
Sbjct: 210 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNHEMY 259
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 66/262 (25%), Positives = 102/262 (38%), Gaps = 53/262 (20%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
PR + Q K LG G+FGKV A G AVK LK D+ E
Sbjct: 43 FPR------NNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKE 94
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLT--KAERDLM 166
+ E K+++ +H + +L CT + + EY GDL L + + ++
Sbjct: 95 ALMSELKIMSHLGQHENIVNLLGACT--HGGPVLVITEYCCYGDL----LNFLRRKSRVL 148
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
E + + +++++ GM FL K ++RD+ N+LL
Sbjct: 149 ETDPAFAIANSTASTRDLLH-----FSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVA 203
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSF 273
+I DFG+ + I D MAPE I Y D WS+
Sbjct: 204 KIGDFGLAR-DIMND----------SNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSY 252
Query: 274 GILLYE-MHVGQSPFSGCDEDE 294
GILL+E +G +P+ G +
Sbjct: 253 GILLWEIFSLGLNPYPGILVNS 274
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-28
Identities = 59/245 (24%), Positives = 101/245 (41%), Gaps = 37/245 (15%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVECTLIERKVLA 120
+F+ +KVLG G+FG V+ A+K L++ + L E V+A
Sbjct: 15 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREAT--SPKANKEILDEAYVMA 72
Query: 121 LGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
+P++C L C S + + + + G L ++Y+
Sbjct: 73 -SVDNPHVCRLLGICL---TSTVQLITQLMPFGCL------------LDYVR-------- 108
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ + +I GM +L + +V+RDL N+L+ HV+I DFG+ KL +
Sbjct: 109 EHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKL-L 167
Query: 239 YLDKTTDTFCGT--P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDE 294
++ G P +MA E I Y D WS+G+ ++E M G P+ G E
Sbjct: 168 GAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227
Query: 295 LFWSI 299
+ +
Sbjct: 228 ISSIL 232
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 9e-28
Identities = 57/252 (22%), Positives = 92/252 (36%), Gaps = 61/252 (24%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECT 112
I R ED L ++LG+G FG+V+ AVK KKD D+ E
Sbjct: 9 IAR------EDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKF 60
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
+ E ++ HP++ L + + +ME G+L YL
Sbjct: 61 MSEAVIMK-NLDHPHIVKLIGIIE---EEPTWIIMELYPYGEL------------GHYLE 104
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
Y+ +I M +L V+RD+ + NIL+ V++ D
Sbjct: 105 RNK--------NSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGD 156
Query: 231 FGMCKLQIYLDKTTDTFCGTPDY------------MAPEIIKGLKYNQCVDWWSFGILLY 278
FG+ + I + DY M+PE I ++ D W F + ++
Sbjct: 157 FGLSRY-IEDE----------DYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMW 205
Query: 279 EMH-VGQSPFSG 289
E+ G+ PF
Sbjct: 206 EILSFGKQPFFW 217
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 112 bits (282), Expect = 1e-27
Identities = 74/297 (24%), Positives = 110/297 (37%), Gaps = 66/297 (22%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVE 110
PR + +L K LG+G+FG+V A+ G D AVK LK+ +
Sbjct: 19 FPR------DRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGATHSEHRAL 72
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDL------------IPA 156
+ E K+L H + +L CT + L ++E+ G+L
Sbjct: 73 --MSELKILIHIGHHLNVVNLLGACT-KPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYK 129
Query: 157 GLTKAERDLMEYLN--------GGDLMFHIQQSGRFDEGRARFY---------------- 192
R +Y+ D + Q S +
Sbjct: 130 TKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDF 189
Query: 193 ---------AAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
+ ++ GM FL + ++RDL NILL + V+I DFG+ + IY D
Sbjct: 190 LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLAR-DIYKDPD 248
Query: 244 TDTFCGTP---DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
+MAPE I Y D WSFG+LL+E +G SP+ G DE F
Sbjct: 249 YVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEF 305
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 1e-27
Identities = 70/269 (26%), Positives = 109/269 (40%), Gaps = 54/269 (20%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
PR ++ L K LG+G FGKV A AVK LK++ ++
Sbjct: 20 FPR------KNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKENA--SPSELR 71
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLT--KAERDLM 166
L E VL HP++ L+ C+ D L ++EY G L + R +
Sbjct: 72 DLLSEFNVLKQ-VNHPHVIKLYGACS--QDGPLLLIVEYAKYGSL----RGFLRESRKVG 124
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARF-----YAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221
G + DE +A +I GM++L + +V+RDL NIL+
Sbjct: 125 PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA 184
Query: 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCV 268
++I+DFG+ + +Y + D MA E + Y
Sbjct: 185 EGRKMKISDFGLSRD-VYEE----------DSYVKRSQGRIPVKWMAIESLFDHIYTTQS 233
Query: 269 DWWSFGILLYEMH-VGQSPFSGCDEDELF 296
D WSFG+LL+E+ +G +P+ G + LF
Sbjct: 234 DVWSFGVLLWEIVTLGGNPYPGIPPERLF 262
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 1e-27
Identities = 57/254 (22%), Positives = 93/254 (36%), Gaps = 43/254 (16%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVEC 111
+ + LKVLG G FG V +K ++ +
Sbjct: 10 FKE------TELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQA 61
Query: 112 TLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
+ H ++ L C S L V +YL G L ++++
Sbjct: 62 VTDHMLAIG-SLDHAHIVRLLGLCP---GSSLQLVTQYLPLGSL------------LDHV 105
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229
Q G + +I GM +L + G+V+R+L N+LL V++A
Sbjct: 106 R--------QHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVA 157
Query: 230 DFGMCKLQIYLDKTTDTFCGT--P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQS 285
DFG+ L + D + P +MA E I KY D WS+G+ ++E M G
Sbjct: 158 DFGVADL-LPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAE 216
Query: 286 PFSGCDEDELFWSI 299
P++G E+ +
Sbjct: 217 PYAGLRLAEVPDLL 230
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 2e-27
Identities = 57/252 (22%), Positives = 98/252 (38%), Gaps = 40/252 (15%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECT 112
IP + +V+GKG FG V+ E A+K L + E VE
Sbjct: 16 IPH----ERVVTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAF 69
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
L E ++ G HP + L + ++ Y+ GDL ++++
Sbjct: 70 LREGLLMR-GLNHPNVLALIGIML-PPEGLPHVLLPYMCHGDL------------LQFIR 115
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
++ F ++ GM +L ++ V+RDL N +LD V++AD
Sbjct: 116 SPQRNPTVKDLISF--------GLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVAD 167
Query: 231 FGMCKLQIYLDKTTDTFCGTPD-----YMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQ 284
FG+ + I + + A E ++ ++ D WSFG+LL+E + G
Sbjct: 168 FGLARD-ILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGA 226
Query: 285 SPFSGCDEDELF 296
P+ D +L
Sbjct: 227 PPYRHIDPFDLT 238
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 2e-27
Identities = 64/256 (25%), Positives = 100/256 (39%), Gaps = 41/256 (16%)
Query: 52 PATTIPRFRK-YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDD 107
P T+ F K D + + KV+G G FG+V LK A+K LK +
Sbjct: 31 PTQTVHEFAKELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVGYT--EK 88
Query: 108 DVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL 165
L E ++ HP + L T + V EY+ G L
Sbjct: 89 QRRDFLGEASIMG-QFDHPNIIRLEGVVT--KSKPVMIVTEYMENGSL------------ 133
Query: 166 MEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225
+L D +F + I SGM++L G V+RDL NIL++
Sbjct: 134 DSFLRKHD--------AQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLV 185
Query: 226 VRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYE 279
+++DFG+ + L+ + T + +PE I K+ D WS+GI+L+E
Sbjct: 186 CKVSDFGLGR---VLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242
Query: 280 -MHVGQSPFSGCDEDE 294
M G+ P+ +
Sbjct: 243 VMSYGERPYWEMSNQD 258
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 3e-27
Identities = 57/256 (22%), Positives = 96/256 (37%), Gaps = 41/256 (16%)
Query: 52 PATTIPRFRK-YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDD 107
P F + + + K++G G G+V L+ A+K LK +
Sbjct: 35 PGRAGRSFTREIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAGYT--ER 92
Query: 108 DVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDL 165
L E ++ HP + L T V EY+ G L
Sbjct: 93 QRRDFLSEASIMG-QFDHPNIIRLEGVVT--RGRLAMIVTEYMENGSL------------ 137
Query: 166 MEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225
+L D G+F + + +GMR+L G V+RDL N+L+D
Sbjct: 138 DTFLRTHD--------GQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLV 189
Query: 226 VRIADFGMCKLQIYLDKTTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYE 279
+++DFG+ + L+ D T + APE I ++ D WSFG++++E
Sbjct: 190 CKVSDFGLSR---VLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246
Query: 280 -MHVGQSPFSGCDEDE 294
+ G+ P+ +
Sbjct: 247 VLAYGERPYWNMTNRD 262
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 3e-27
Identities = 71/298 (23%), Positives = 115/298 (38%), Gaps = 61/298 (20%)
Query: 15 RRLSNNKLSLDNGQGESS------HHSKQ-----CRHSRSSQSQANITPATT----IPRF 59
R L N + S+ H+ K + S S P IPR
Sbjct: 129 RTLDNGGFYISPRSTFSTLQELVDHYKKGNDGLCQKLSVPCMSSKPQKPWEKDAWEIPR- 187
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
E +L K LG G FG+V++A AVK +K + + + E V+
Sbjct: 188 -----ESLKLEKKLGAGQFGEVWMATYNKH-TKVAVKTMKPGSMSVEAFLA----EANVM 237
Query: 120 ALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL--NGGDLM 175
+H L L T ++ + E++ G L+ ++L + G
Sbjct: 238 K-TLQHDKLVKLHAVVT---KEPIYIITEFMAKGSLL------------DFLKSDEGSKQ 281
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
+ ++A+I GM F+ ++ ++RDL+ NIL+ +IADFG+ +
Sbjct: 282 PLPKLID---------FSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLAR 332
Query: 236 L---QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
+ Y + F + APE I + D WSFGILL E + G+ P+ G
Sbjct: 333 VIEDNEYTAREGAKFPIK--WTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPG 388
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 3e-27
Identities = 64/311 (20%), Positives = 115/311 (36%), Gaps = 44/311 (14%)
Query: 3 RKYFSSDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANI-------TPATT 55
R + S R + +L + +++ + R S S+ + T
Sbjct: 319 RLVNGATQSFIIRPQKEGERALPSIPKLANNEKQGVRSHTVSVSETDDYAEIIDEEDTYT 378
Query: 56 IPRFRKY--DLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVE 110
+P R Y E +L + +G+G FG V + A+K K D E
Sbjct: 379 MPSTRDYEIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVRE 436
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY 168
L E + HP++ L T ++ ++ +ME G+L +
Sbjct: 437 KFLQEALTMR-QFDHPHIVKLIGVIT---ENPVWIIMELCTLGEL------------RSF 480
Query: 169 LNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228
L D YA ++ + + +L K V+RD+ N+L+ V++
Sbjct: 481 LQVRK--------FSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKL 532
Query: 229 ADFGMCKLQIYLDKTTDTFCG-TP-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQS 285
DFG+ + + G P +MAPE I ++ D W FG+ ++E + G
Sbjct: 533 GDFGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVK 591
Query: 286 PFSGCDEDELF 296
PF G +++
Sbjct: 592 PFQGVKNNDVI 602
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-27
Identities = 55/242 (22%), Positives = 90/242 (37%), Gaps = 41/242 (16%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECT 112
I R E +L + +G+G FG V + A+K K D E
Sbjct: 12 IQR------ERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCT--SDSVREKF 63
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
L E + HP++ L T ++ +ME G+L +L
Sbjct: 64 LQEALTMR-QFDHPHIVKLIGVITENP---VWIIMELCTLGEL------------RSFLQ 107
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
D YA ++ + + +L K V+RD+ N+L+ V++ D
Sbjct: 108 VRK--------YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGD 159
Query: 231 FGMCKLQIYLDKTTDTFCGT-P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPF 287
FG+ + + G P +MAPE I ++ D W FG+ ++E + G PF
Sbjct: 160 FGLSRY-MEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPF 218
Query: 288 SG 289
G
Sbjct: 219 QG 220
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 6e-27
Identities = 62/267 (23%), Positives = 102/267 (38%), Gaps = 56/267 (20%)
Query: 58 RFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVECT 112
+ ++ L + ++ LG+ FGKV+ L G A+K LK E E
Sbjct: 2 KLKEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEF 59
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL- 169
E + A +HP + L T D L + Y + G DL E+L
Sbjct: 60 RHEAMLRARL-QHPNVVCLLGVVT--KDQPLSMIFSYCSHG------------DLHEFLV 104
Query: 170 -NGGDLMFHIQQSGRFDEGRARF-----YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
R + A+I +GM +L +V++DL N+L+ +
Sbjct: 105 MRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDK 164
Query: 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDW 270
+V+I+D G+ + +Y DY MAPE I K++ D
Sbjct: 165 LNVKISDLGLFRE-VYAA----------DYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDI 213
Query: 271 WSFGILLYE-MHVGQSPFSGCDEDELF 296
WS+G++L+E G P+ G ++
Sbjct: 214 WSYGVVLWEVFSYGLQPYCGYSNQDVV 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 7e-27
Identities = 62/246 (25%), Positives = 95/246 (38%), Gaps = 55/246 (22%)
Query: 63 DLEDFQLL-KVLGKGSFGKVFLAELKGTDYYY--AVKCLKKDVVLEDDDVECTLIERKVL 119
D + L K LG G+FG V + AVK LK + + + L E V+
Sbjct: 14 DRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVM 72
Query: 120 ALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
+PY+ + C VME G L +YL
Sbjct: 73 Q-QLDNPYIVRMIGICE---AESWMLVMEMAELGPL------------NKYL-------- 108
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
QQ+ + ++ GM++L + V+RDL N+LL + + +I+DFG+ K
Sbjct: 109 -QQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA- 166
Query: 238 IYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYE-MHVG 283
+ D +Y APE I K++ D WSFG+L++E G
Sbjct: 167 LRAD---------ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYG 217
Query: 284 QSPFSG 289
Q P+ G
Sbjct: 218 QKPYRG 223
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 110 bits (276), Expect = 7e-27
Identities = 69/262 (26%), Positives = 107/262 (40%), Gaps = 44/262 (16%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
PR E+ + KVLG G+FGKV A G AVK LK+ + + E
Sbjct: 42 FPR------ENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSERE 93
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY 168
+ E K++ H + +L CT ++ + EY GDL+ +K E+ +
Sbjct: 94 ALMSELKMMTQLGSHENIVNLLGACT--LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDE 151
Query: 169 LNGGDLMFHIQQSGRFDEGRARF--YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
+ + ++ +A ++ GM FL K V+RDL N+L+ + V
Sbjct: 152 IEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVV 211
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSF 273
+I DFG+ + I D MAPE + Y D WS+
Sbjct: 212 KICDFGLAR-DIMSD----------SNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSY 260
Query: 274 GILLYE-MHVGQSPFSGCDEDE 294
GILL+E +G +P+ G D
Sbjct: 261 GILLWEIFSLGVNPYPGIPVDA 282
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 7e-27
Identities = 71/269 (26%), Positives = 103/269 (38%), Gaps = 63/269 (23%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
I R D L + LG+G+FGKVFLAE AVK LK + D
Sbjct: 12 IKR------RDIVLKRELGEGAFGKVFLAECYNLSPTKDKMLVAVKALKDPTLAARKDF- 64
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY 168
E ++L +H ++ + C L V EY+ GDL ++
Sbjct: 65 --QREAELLT-NLQHEHIVKFYGVCG--DGDPLIMVFEYMKHGDL------------NKF 107
Query: 169 LNGGDLMFHIQQSGRFDEGRARFY-------AAEIVSGMRFLHKKGIVYRDLKLDNILLD 221
L I G+ + + A++I SGM +L + V+RDL N L+
Sbjct: 108 LRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG 167
Query: 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCV 268
V+I DFGM + +Y DY M PE I K+
Sbjct: 168 ANLLVKIGDFGMSRD-VYST----------DYYRVGGHTMLPIRWMPPESIMYRKFTTES 216
Query: 269 DWWSFGILLYE-MHVGQSPFSGCDEDELF 296
D WSFG++L+E G+ P+ E+
Sbjct: 217 DVWSFGVILWEIFTYGKQPWFQLSNTEVI 245
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 1e-26
Identities = 59/241 (24%), Positives = 101/241 (41%), Gaps = 38/241 (15%)
Query: 68 QLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+V+G+G FG V+ L D AVK L + + +V L E ++
Sbjct: 28 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMK-DFS 84
Query: 125 HPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP + L C +++ V+ Y+ GDL ++ ++
Sbjct: 85 HPNVLSLLGICL-RSEGSPLVVLPYMKHGDL------------RNFIRNETHNPTVKDLI 131
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
F ++ GM++L K V+RDL N +LD + V++ADFG+ + +Y DK
Sbjct: 132 GF--------GLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARD-MY-DK 181
Query: 243 TTDTFCGTPD------YMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDEL 295
+ +MA E ++ K+ D WSFG+LL+E M G P+ + ++
Sbjct: 182 EYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDI 241
Query: 296 F 296
Sbjct: 242 T 242
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 1e-26
Identities = 65/315 (20%), Positives = 117/315 (37%), Gaps = 46/315 (14%)
Query: 3 RKYFSSDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATT------I 56
R+ + PR + +S + K + Q + + +
Sbjct: 17 RRASVAAGILVPRGSPGLDGICSIEELSTSLYKKAGSENLYFQGANTVHIDLSALNPELV 76
Query: 57 PRFRKYDLE----DFQLLKVLGKGSFGKVFLAELKGTDYYY---AVKCLKKDVVLEDDDV 109
+ + +V+G+G FG V+ L D AVK L + + +V
Sbjct: 77 QAVQHVVIGPSSLIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEV 134
Query: 110 ECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLME 167
L E ++ HP + L C +++ V+ Y+ GDL
Sbjct: 135 SQFLTEGIIMK-DFSHPNVLSLLGICL-RSEGSPLVVLPYMKHGDL------------RN 180
Query: 168 YLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227
++ ++ F ++ GM+FL K V+RDL N +LD + V+
Sbjct: 181 FIRNETHNPTVKDLIGF--------GLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVK 232
Query: 228 IADFGMCKLQIYLDKTTDTFCGTPD-----YMAPEIIKGLKYNQCVDWWSFGILLYE-MH 281
+ADFG+ + +Y + T +MA E ++ K+ D WSFG+LL+E M
Sbjct: 233 VADFGLARD-MYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 291
Query: 282 VGQSPFSGCDEDELF 296
G P+ + ++
Sbjct: 292 RGAPPYPDVNTFDIT 306
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 59/263 (22%), Positives = 97/263 (36%), Gaps = 56/263 (21%)
Query: 56 IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVE 110
+ R E + + LG+GSFG V+ KG A+K + + +
Sbjct: 22 VAR------EKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERI 73
Query: 111 CTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY 168
L E V+ ++ L + +ME + GDL Y
Sbjct: 74 EFLNEASVMK-EFNCHHVVRLLGVVS--QGQPTLVIMELMTRGDL------------KSY 118
Query: 169 L-NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227
L + M + + A EI GM +L+ V+RDL N ++ + V+
Sbjct: 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVK 178
Query: 228 IADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFG 274
I DFGM + IY DY M+PE +K + D WSFG
Sbjct: 179 IGDFGMTR-DIYET----------DYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 227
Query: 275 ILLYE-MHVGQSPFSGCDEDELF 296
++L+E + + P+ G +++
Sbjct: 228 VVLWEIATLAEQPYQGLSNEQVL 250
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 2e-26
Identities = 73/301 (24%), Positives = 103/301 (34%), Gaps = 59/301 (19%)
Query: 23 SLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVF 82
++ +G S K + D L LG+G+FGKVF
Sbjct: 2 AMGSGSSLSPTEGKGSGLQGHIIENPQYFSDACVHHI---KRRDIVLKWELGEGAFGKVF 58
Query: 83 LAELKGTDYYY-----AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTF 135
LAE AVK LK+ D E ++L +H ++ F CT
Sbjct: 59 LAECHNLLPEQDKMLVAVKALKEASESARQDF---QREAELLT-MLQHQHIVRFFGVCT- 113
Query: 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL------NGGDLMFHIQQSGRFDEGRA 189
L V EY+ G DL +L G G+
Sbjct: 114 -EGRPLLMVFEYMRHG------------DLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQL 160
Query: 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG 249
A+++ +GM +L V+RDL N L+ V+I DFGM + IY
Sbjct: 161 LAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSR-DIYST-------- 211
Query: 250 TPDY-------------MAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDEL 295
DY M PE I K+ D WSFG++L+E G+ P+ E
Sbjct: 212 --DYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEA 269
Query: 296 F 296
Sbjct: 270 I 270
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 3e-26
Identities = 51/262 (19%), Positives = 84/262 (32%), Gaps = 63/262 (24%)
Query: 59 FRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-------AVKCLKKDVVLEDDDVEC 111
F K ED + LG+G+F K+F + Y +K L K +
Sbjct: 2 FHKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKAHRNYSESF-- 59
Query: 112 TLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
+++ H +L + C V E++ G L YL
Sbjct: 60 -FEAASMMS-KLSHKHLVLNYGVCV--CGDENILVQEFVKFGSL------------DTYL 103
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---- 225
+I A ++ + M FL + +++ ++ NILL E
Sbjct: 104 KKNKNCINILWKLEV--------AKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTG 155
Query: 226 ----VRIADFGMCKLQIYLDKTTDTFCGTPDY-------MAPEIIK-GLKYNQCVDWWSF 273
++++D G+ + D + PE I+ N D WSF
Sbjct: 156 NPPFIKLSDPGISIT-VLPK----------DILQERIPWVPPECIENPKNLNLATDKWSF 204
Query: 274 GILLYE-MHVGQSPFSGCDEDE 294
G L+E G P S D
Sbjct: 205 GTTLWEICSGGDKPLSALDSQR 226
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 109 bits (274), Expect = 4e-26
Identities = 65/262 (24%), Positives = 105/262 (40%), Gaps = 36/262 (13%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-LGTKH 125
+++LKV+GKGSFG+V A + A+K ++ E E ++L L +
Sbjct: 99 YEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRN----EKRFHRQAAEEIRILEHLRKQD 154
Query: 126 P----YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM-FHIQQ 180
+ H+ F +H+ E L +L E + F +
Sbjct: 155 KDNTMNVIHMLENFTFRNHICMTFELL-------------SMNLYELIKKNKFQGFSLPL 201
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH--VRIADFGMCKLQI 238
R +A I+ + LHK I++ DLK +NILL +G +++ DFG
Sbjct: 202 --------VRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSS---C 250
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
Y + T+ + Y APE+I G +Y +D WS G +L E+ G G DE +
Sbjct: 251 YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLAC 310
Query: 299 ICNERPRFPQFLSVEAKNILVH 320
+ Q L +K
Sbjct: 311 MIELLGMPSQKLLDASKRAKNF 332
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 1e-25
Identities = 60/263 (22%), Positives = 102/263 (38%), Gaps = 48/263 (18%)
Query: 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKDVVLEDDDVECTLIER 116
Y + + ++ +G+G+FG+VF A G Y AVK LK++ D E
Sbjct: 44 YPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREA 101
Query: 117 KVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLT--KAERDLMEYLNGG 172
++A +P + L C + + EY+ GDL ++
Sbjct: 102 ALMA-EFDNPNIVKLLGVCA--VGKPMCLLFEYMAYGDL----NEFLRSMSPHTVCSLSH 154
Query: 173 DLMFHIQQSGRFDEGRARF-----YAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVR 227
+ + A ++ +GM +L ++ V+RDL N L+ V+
Sbjct: 155 SDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVK 214
Query: 228 IADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLKYNQCVDWWSFG 274
IADFG+ + IY DY M PE I +Y D W++G
Sbjct: 215 IADFGLSR-NIYSA----------DYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYG 263
Query: 275 ILLYEMH-VGQSPFSGCDEDELF 296
++L+E+ G P+ G +E+
Sbjct: 264 VVLWEIFSYGLQPYYGMAHEEVI 286
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 1e-25
Identities = 59/243 (24%), Positives = 98/243 (40%), Gaps = 41/243 (16%)
Query: 56 IPRFRKYDLEDFQLLKV-LGKGSFGKVFLAELKGTDYYY--AVKCLKKDVVLEDDDVECT 112
+ R ++ + + LG G+FG V + A+K LK+ E D E
Sbjct: 6 LKR------DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEM 57
Query: 113 LIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
+ E +++ +PY+ L C + L VME GG L ++L
Sbjct: 58 MREAQIMH-QLDNPYIVRLIGVCQAEA---LMLVMEMAGGGPL------------HKFLV 101
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIAD 230
G + ++ GM++L +K V+RDL N+LL + +I+D
Sbjct: 102 GKREEIPVSNVAEL--------LHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISD 153
Query: 231 FGMCKLQIYLDKTTDTFCGT--P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSP 286
FG+ K D P + APE I K++ D WS+G+ ++E + GQ P
Sbjct: 154 FGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKP 213
Query: 287 FSG 289
+
Sbjct: 214 YKK 216
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 3e-25
Identities = 59/274 (21%), Positives = 99/274 (36%), Gaps = 54/274 (19%)
Query: 47 QANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY-----AVKCLKKD 101
++I ++ ++ L++ LG G+FG+V+ ++ G AVK L +
Sbjct: 12 YCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV 71
Query: 102 VVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLT 159
+ D L+E +++ H + Q+ F +ME + GGDL
Sbjct: 72 CS--EQDELDFLMEALIIS-KFNHQNIVRCIGVSL-QSLP-RFILMELMAGGDL------ 120
Query: 160 KAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219
+L + Q A +I G ++L + ++RD+ N L
Sbjct: 121 ------KSFLR--ETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCL 172
Query: 220 LDYEGH---VRIADFGMCKLQIYLDKTTDTFCGTPDY-------------MAPEIIKGLK 263
L G +I DFGM + IY Y M PE
Sbjct: 173 LTCPGPGRVAKIGDFGMAR-DIYRA----------SYYRKGGCAMLPVKWMPPEAFMEGI 221
Query: 264 YNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
+ D WSFG+LL+E +G P+ E+
Sbjct: 222 FTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 255
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 4e-25
Identities = 61/291 (20%), Positives = 103/291 (35%), Gaps = 61/291 (20%)
Query: 37 QCRHSRSSQSQANITPATT-------IPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGT 89
+ R+S + P I ++ ++ L++ LG G+FG+V+ ++ G
Sbjct: 36 KLSKLRTSTIMTDYNPNYCFAGKTSSISDLKEVPRKNITLIRGLGHGAFGEVYEGQVSGM 95
Query: 90 DYYY-----AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF--CTFQTDSHLF 142
AVK L + + D L+E +++ H + Q+ F
Sbjct: 96 PNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIISK-FNHQNIVRCIGVSL-QSLP-RF 150
Query: 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRF 202
++E + GGDL +L + Q A +I G ++
Sbjct: 151 ILLELMAGGDL------------KSFLR--ETRPRPSQPSSLAMLDLLHVARDIACGCQY 196
Query: 203 LHKKGIVYRDLKLDNILLDYEGH---VRIADFGMCKLQIYLDKTTDTFCGTPDY------ 253
L + ++RD+ N LL G +I DFGM + IY Y
Sbjct: 197 LEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR-DIYRA----------GYYRKGGC 245
Query: 254 -------MAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSGCDEDELF 296
M PE + D WSFG+LL+E +G P+ E+
Sbjct: 246 AMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVL 296
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 6e-25
Identities = 51/252 (20%), Positives = 99/252 (39%), Gaps = 52/252 (20%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL------- 119
+ L++ LG G F V+LA+ + + A+K ++ D E E K+L
Sbjct: 21 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGD----KVYTEAAEDEIKLLQRVNDAD 76
Query: 120 -----ALGTKHPYLCHLFCTFQ----TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN 170
++G H + L F H+ V E L G +L L++
Sbjct: 77 NTKEDSMGANH--ILKLLDHFNHKGPNGVHVVMVFEVL-GENL---------LALIKKYE 124
Query: 171 GGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYEGH---- 225
+ + +++ G+ ++H++ GI++ D+K +N+L++
Sbjct: 125 HR----------GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENL 174
Query: 226 --VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283
++IAD G + D+ T +Y +PE++ G + D WS L++E+ G
Sbjct: 175 IQIKIADLGNA---CWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITG 231
Query: 284 QSPFSGCDEDEL 295
F +
Sbjct: 232 DFLFEPDEGHSY 243
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 104 bits (262), Expect = 1e-24
Identities = 84/363 (23%), Positives = 140/363 (38%), Gaps = 76/363 (20%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+ KV+G GSFG VF A+L +D A +KK VL+D E +++ + KHP
Sbjct: 42 YTNCKVIGNGSFGVVFQAKLVESDEV-A---IKK--VLQDK--RFKNRELQIMRI-VKHP 92
Query: 127 YLCHLFCTFQTDSH------LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+ L F ++ L V+EY+ + + +
Sbjct: 93 NVVDLKAFFYSNGDKKDEVFLNLVLEYV-------------PETVYRASR-----HYAKL 134
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE-GHVRIADFGMCKLQIY 239
+ Y +++ + ++H GI +RD+K N+LLD G +++ DFG K+ I
Sbjct: 135 KQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA 194
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF- 296
+ C + Y APE+I G Y +D WS G ++ E+ GQ F G D+L
Sbjct: 195 GEPNVSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 297 ------------WSICN---ERPRFPQF------------LSVEAKNILVHLLDKDTTKR 329
N +FPQ +A +++ LL+ + R
Sbjct: 254 IIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSAR 313
Query: 330 LGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQ 389
L + + + H +F L E P + F+ +LS + I
Sbjct: 314 L------TAIEALCHPFFDELR-----TGEARMPNGRELPPLFNWTKEELSVRPDLISRL 362
Query: 390 MPQ 392
+PQ
Sbjct: 363 VPQ 365
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 2e-24
Identities = 61/288 (21%), Positives = 107/288 (37%), Gaps = 35/288 (12%)
Query: 11 STPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLL 70
L+++ + + + S + S P + ++ +
Sbjct: 281 QRRIDTLNSDGYTPEPARITSPDKPRPMPMDTSVFESPFSDPEELKDKKLFLKRDNLLIA 340
Query: 71 K-VLGKGSFGKVFLAELKGTDYYY--AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
LG G+FG V + A+K LK+ E D E + E +++ +PY
Sbjct: 341 DIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMH-QLDNPY 397
Query: 128 LCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185
+ L C + L VME GG L ++L G +
Sbjct: 398 IVRLIGVCQAEA---LMLVMEMAGGGPL------------HKFLVGKREEIPVSNVAEL- 441
Query: 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTD 245
++ GM++L +K V+R+L N+LL + +I+DFG+ K D
Sbjct: 442 -------LHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 246 TFCGT--P-DYMAPEIIKGLKYNQCVDWWSFGILLYE-MHVGQSPFSG 289
P + APE I K++ D WS+G+ ++E + GQ P+
Sbjct: 495 ARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKK 542
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 4e-24
Identities = 70/354 (19%), Positives = 120/354 (33%), Gaps = 72/354 (20%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
F +++ +G G+FG+V L + YYAVK ++ IE +L
Sbjct: 37 FLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRN----IKKYTRSAKIEADILKKIQNDD 92
Query: 127 ---YLC-HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
F H+ + E L G L +++ FHI+
Sbjct: 93 INNNNIVKYHGKFMYYDHMCLIFEPL-GPSL---------YEIIT--RNNYNGFHIED-- 138
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH----------------- 225
+ Y EI+ + +L K + + DLK +NILLD
Sbjct: 139 ------IKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQ 192
Query: 226 --------VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILL 277
+++ DFG + + T Y APE+I L ++ D WSFG +L
Sbjct: 193 IYRTKSTGIKLIDFGCA---TFKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVL 249
Query: 278 YEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRL------- 330
E++ G F + E + + P+ + EA +L
Sbjct: 250 AELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENAS 309
Query: 331 ------GSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIK 378
+C ++ HE F + L +++P RP E +++
Sbjct: 310 SINSIKHVKKCLPLYKIIKHELFCDFLYSIL---QIDPTLRPSPAELLKHKFLE 360
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 102 bits (256), Expect = 6e-24
Identities = 64/253 (25%), Positives = 109/253 (43%), Gaps = 36/253 (14%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-LGTKH 125
+++ ++GKGSFG+V A + + A+K +K + + IE ++L +
Sbjct: 56 YEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKN----KKAFLNQAQIEVRLLELMNKHD 111
Query: 126 P----YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
Y+ HL F +HL V E L+ N DL+ +
Sbjct: 112 TEMKYYIVHLKRHFMFRNHLCLVFEMLS-------------------YNLYDLLRNTNFR 152
Query: 182 GRFDEGRARFYAAEIVSGMRFLH--KKGIVYRDLKLDNILLDYEGH--VRIADFGMCKLQ 237
G R +A ++ + + FL + I++ DLK +NILL ++I DFG
Sbjct: 153 G-VSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS--- 208
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
L + + + Y +PE++ G+ Y+ +D WS G +L EMH G+ FSG +E +
Sbjct: 209 CQLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQMN 268
Query: 298 SICNERPRFPQFL 310
I P +
Sbjct: 269 KIVEVLGIPPAHI 281
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 101 bits (255), Expect = 6e-24
Identities = 64/334 (19%), Positives = 130/334 (38%), Gaps = 80/334 (23%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI-ERKVLAL 121
++ ++ L +G+G+FG+VF A + T A+K + + E + T + E K+L
Sbjct: 15 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN--EKEGFPITALREIKIL-Q 71
Query: 122 GTKHPYLCHLFCTFQTDSH--------LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
KH + +L +T + ++ V ++ E DL L+
Sbjct: 72 LLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFC-------------EHDLAGLLS--- 115
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM 233
+F + +++G+ ++H+ I++RD+K N+L+ +G +++ADFG+
Sbjct: 116 -----NVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGL 170
Query: 234 CKL-QIYLDKTTDTFCGTPD-----YMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP 286
+ + + + + T Y PE++ G + Y +D W G ++ EM
Sbjct: 171 ARAFSLAKNSQPNRY--TNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 228
Query: 287 FSGCDE-DELF--WSIC---NE-------------------------RPRFPQF-LSVEA 314
G E +L +C + R + A
Sbjct: 229 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 288
Query: 315 KNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+++ LL D +R+ DD + H++F
Sbjct: 289 LDLIDKLLVLDPAQRI------DSDDALNHDFFW 316
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 101 bits (254), Expect = 7e-24
Identities = 65/345 (18%), Positives = 116/345 (33%), Gaps = 60/345 (17%)
Query: 67 FQLLKVLGKGSFGKVFLA-ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-LGTK 124
++++ LG+G+FGKV + A+K ++ E +E VL + K
Sbjct: 21 YEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRN----VGKYREAARLEINVLKKIKEK 76
Query: 125 HP---YLC-HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
+LC + F H+ E L G + + ++ + +
Sbjct: 77 DKENKFLCVLMSDWFNFHGHMCIAFELL-GKNT---------FEFLK--ENNFQPYPLPH 124
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH--------------- 225
R A ++ +RFLH+ + + DLK +NIL
Sbjct: 125 --------VRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSV 176
Query: 226 ----VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH 281
+R+ADFG + + T T Y PE+I L + Q D WS G +L+E +
Sbjct: 177 KNTSIRVADFGSA---TFDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 282 VGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVH------LLDKDTTKRLGSTQC 335
G + F + E + P + + + + R C
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 336 NSGDDVVAHEYFRGLDWQALEKR--ELEPPFRPRVIEPFSSPWIK 378
+ + + L +R E +P R + E P+
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFA 338
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 100 bits (252), Expect = 1e-23
Identities = 80/346 (23%), Positives = 130/346 (37%), Gaps = 60/346 (17%)
Query: 67 FQLLKVLGKGSFGKVFLA-ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-LGTK 124
++++ LG+G+FGKV + K + AVK +K D E E +VL L T
Sbjct: 16 YEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKN----VDRYCEAARSEIQVLEHLNTT 71
Query: 125 HP---YLC-HLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
P + C + F+ H+ V E L G D ++ G L F +
Sbjct: 72 DPNSTFRCVQMLEWFEHHGHICIVFELL-GLST---------YDFIK--ENGFLPFRLDH 119
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH--------------- 225
R A +I + FLH + + DLK +NIL +
Sbjct: 120 --------IRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTL 171
Query: 226 ----VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH 281
+++ DFG Y D+ T T Y APE+I L ++Q D WS G +L E +
Sbjct: 172 INPDIKVVDFGSA---TYDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 282 VGQSPFSGCDEDELFWSICNERPRFPQFL---SVEAKNILVHLLDKDTTKRLGSTQCNSG 338
+G + F D E + P+ + + + K LD D G +
Sbjct: 229 LGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRAC 288
Query: 339 DD----VVAHEYFRGLDWQALEKR-ELEPPFRPRVIEPFSSPWIKL 379
+++ + + ++K E +P R + E P+ L
Sbjct: 289 KPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL 334
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 98.1 bits (245), Expect = 9e-23
Identities = 68/329 (20%), Positives = 124/329 (37%), Gaps = 79/329 (24%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+D+QL++ LG+G + +VF A + VK LK + E K+L
Sbjct: 36 DDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRG 89
Query: 125 HPYLCHLFCTFQTDSH--LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
P + L + V E++N D + L + L + I+
Sbjct: 90 GPNIITLADIVKDPVSRTPALVFEHVNNTDF---------KQLYQTLT----DYDIR--- 133
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE-GHVRIADFGMCKLQIYLD 241
FY EI+ + + H GI++RD+K N+++D+E +R+ D+G+ +
Sbjct: 134 --------FYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ 185
Query: 242 KTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP-FSGCDEDELFWSI 299
+ + + PE++ + Y+ +D WS G +L M + P F G D + I
Sbjct: 186 EYNV-RVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 244
Query: 300 CN-----------------------------ERPRFPQFLSVEAKNIL----VHLLDK-- 324
R R+ +F+ E ++++ + LDK
Sbjct: 245 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 304
Query: 325 --DTTKRLGSTQCNSGDDVVAHEYFRGLD 351
D RL + + + H YF +
Sbjct: 305 RYDHQSRL------TAREAMEHPYFYTVV 327
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 98.7 bits (246), Expect = 1e-22
Identities = 64/249 (25%), Positives = 105/249 (42%), Gaps = 32/249 (12%)
Query: 58 RFRKYDLEDFQLLKVLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIE 115
R R DL +++ KV G+G++G V+ A+ K D YA LK+ +E + +
Sbjct: 15 RERVEDLFEYEGCKV-GRGTYGHVYKAKRKDGKDDKDYA---LKQ---IEGTGISMSACR 67
Query: 116 RKVLALGTKHPYLCHLF--CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGD 173
L KHP + L D ++ + +Y E DL +
Sbjct: 68 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-------------EHDLWHIIKFHR 114
Query: 174 LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE----GHVRIA 229
++ + G + +I+ G+ +LH +++RDLK NIL+ E G V+IA
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174
Query: 230 DFGMCKL-QIYLDKTTDTFCG--TPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQS 285
D G +L L D T Y APE++ G + Y + +D W+ G + E+ +
Sbjct: 175 DMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEP 234
Query: 286 PFSGCDEDE 294
F ED
Sbjct: 235 IFHCRQEDI 243
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 1e-22
Identities = 42/288 (14%), Positives = 74/288 (25%), Gaps = 66/288 (22%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++LL G + + A D A+ + VL DD ++ TL L+ P
Sbjct: 33 YRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS-RIDKP 91
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ + T + V E++ GG L +++ +
Sbjct: 92 GVARVLDVVHTRAGGLVVAEWIRGGSL---------QEVAD--------------TSPSP 128
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDT 246
A + + H+ G+ + + +G V +A
Sbjct: 129 VGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA-------------- 174
Query: 247 FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE---- 302
M N D G LY + V + P +
Sbjct: 175 ------TMPDA-------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDTAGQ 221
Query: 303 -------RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343
P +S + + D R ST N A
Sbjct: 222 PIEPADIDRDIPFQIS----AVAARSVQGDGGIRSASTLLNLMQQATA 265
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 98.6 bits (246), Expect = 2e-22
Identities = 81/373 (21%), Positives = 136/373 (36%), Gaps = 71/373 (19%)
Query: 15 RRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLG 74
R ++ S Q S+ S + + S+ AT + + KV+G
Sbjct: 5 PRTTSFAESCKPVQQPSAFGSMKVSRDKDG-SKVTTVVATPGQGPDRPQEVSYTDTKVIG 63
Query: 75 KGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134
GSFG V+ A+L + A +KK VL+D E +++ H + L
Sbjct: 64 NGSFGVVYQAKLCDSGELVA---IKK--VLQDK--RFKNRELQIMRK-LDHCNIVRLRYF 115
Query: 135 FQT------DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
F + + +L V++Y+ + + +
Sbjct: 116 FYSSGEKKDEVYLNLVLDYV-------------PETVYRVAR-----HYSRAKQTLPVIY 157
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE-GHVRIADFGMCKLQIYLDKTTDTF 247
+ Y ++ + ++H GI +RD+K N+LLD + +++ DFG K + +
Sbjct: 158 VKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYI 217
Query: 248 CGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDE-DELF--------- 296
C + Y APE+I G Y +D WS G +L E+ +GQ F G D+L
Sbjct: 218 C-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVEIIKVLGTP 276
Query: 297 ----WSICNE---RPRFPQF------------LSVEAKNILVHLLDKDTTKRLGSTQCNS 337
N +FPQ EA + LL+ T RL +
Sbjct: 277 TREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL------T 330
Query: 338 GDDVVAHEYFRGL 350
+ AH +F L
Sbjct: 331 PLEACAHSFFDEL 343
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 96.7 bits (241), Expect = 5e-22
Identities = 69/338 (20%), Positives = 118/338 (34%), Gaps = 68/338 (20%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ + L K LG GSFG V + +A+K K VL+D E ++ +
Sbjct: 7 KKYSLGKTLGTGSFGIVCEVFDIESGKRFALK--K---VLQDPRY--KNRELDIMKV-LD 58
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKA--------------ERDL---ME 167
H + L F T G + L ME
Sbjct: 59 HVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIME 118
Query: 168 YLNGGDL---MFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
Y+ L + +SG Y ++ + F+H GI +RD+K N+L++ +
Sbjct: 119 YV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSK 177
Query: 224 -GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMH 281
+++ DFG K I + + C + Y APE++ G +Y +D WS G + E+
Sbjct: 178 DNTLKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPELMLGATEYTPSIDLWSIGCVFGELI 236
Query: 282 VGQSPFSGCDE---------------DELFWSICNERPR--------------FPQFLSV 312
+G+ FSG E + P+
Sbjct: 237 LGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPS 296
Query: 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
A ++L +L + R+ + + +AH +F L
Sbjct: 297 LAIDLLEQILRYEPDLRI------NPYEAMAHPFFDHL 328
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 93.9 bits (234), Expect = 4e-21
Identities = 74/360 (20%), Positives = 134/360 (37%), Gaps = 89/360 (24%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
DFQL +LG+G++G V A K T A+K K + + TL E K+L
Sbjct: 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIK--KIEPFDKPLFALRTLREIKILKH-F 66
Query: 124 KHP---YLCHLFC--TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM-FH 177
KH + ++ +F+ + ++ + E + + DL ++ L H
Sbjct: 67 KHENIITIFNIQRPDSFENFNEVYIIQELM-------------QTDLHRVISTQMLSDDH 113
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
IQ ++ + + ++ LH +++RDLK N+L++ +++ DFG+ ++
Sbjct: 114 IQ-----------YFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARII 162
Query: 238 IYLDKTTDTFCGTPDYM----------APEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP 286
G M APE++ Y++ +D WS G +L E+ + +
Sbjct: 163 DESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPI 222
Query: 287 FSGCD----------------EDELFWSICNERPR-----------------FPQFLSVE 313
F G D D I + R R FP+ ++ +
Sbjct: 223 FPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPR-VNPK 281
Query: 314 AKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFS 373
++L +L D KR+ + + + H Y Q EP P F
Sbjct: 282 GIDLLQRMLVFDPAKRI------TAKEALEHPYL-----QTYHDPNDEPEGEPIPPSFFE 330
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 92.0 bits (229), Expect = 2e-20
Identities = 77/351 (21%), Positives = 130/351 (37%), Gaps = 79/351 (22%)
Query: 46 SQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE 105
S ++ A + +++ FQ+ ++ G+G+FG V L + K T A +KK V++
Sbjct: 4 SMMSLNAAAAADERSRKEMDRFQVERMAGQGTFGTVQLGKEKSTGMSVA---IKK--VIQ 58
Query: 106 DD-DVECTLIERKVLALGTKHP---YLCHLFCTFQ----TDSHLFFVMEYLNGGDLIPAG 157
D L + LA+ HP L F T D +L VMEY+ P
Sbjct: 59 DPRFRNRELQIMQDLAV-LHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV------PDT 111
Query: 158 LTKAERDLMEYLNGGDLM--FHIQQSGRFDEGRARFYAAEIVSGMRFLHKK--GIVYRDL 213
L + R+ Y I+ + +++ + LH + +RD+
Sbjct: 112 LHRCCRN---YYRRQVAPPPILIK-----------VFLFQLIRSIGCLHLPSVNVCHRDI 157
Query: 214 KLDNILLDYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWW 271
K N+L++ G +++ DFG K + C + Y APE+I G + Y VD W
Sbjct: 158 KPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYIC-SRYYRAPELIFGNQHYTTAVDIW 216
Query: 272 SFGILLYEMHVGQSPFSGCDE---------------DELFWSICNERPR--FPQF----- 309
S G + EM +G+ F G + E+ +
Sbjct: 217 SVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPW 276
Query: 310 ----------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
+ EA ++L LL +R+ + + H YF L
Sbjct: 277 SNVFSDHSLKDAKEAYDLLSALLQYLPEERM------KPYEALCHPYFDEL 321
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 90.3 bits (225), Expect = 3e-20
Identities = 65/255 (25%), Positives = 101/255 (39%), Gaps = 47/255 (18%)
Query: 72 VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD------DVECTLIERKVLALGTKH 125
+G+G FG V+ + T AVK L V + + D E ++ + +H
Sbjct: 38 KMGEGGFGVVYKGYVNNTTV--AVKKLAAMVDITTEELKQQFDQEIKVMAK------CQH 89
Query: 126 PYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
L L F + L V Y+ G L L L +H+ R
Sbjct: 90 ENLVELLGFSS--DGDDLCLVYVYMPNGSL--------LDRLSCLDGTPPLSWHM----R 135
Query: 184 FD--EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
+G A G+ FLH+ ++RD+K NILLD +I+DFG+ +
Sbjct: 136 CKIAQGAAN--------GINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFA 187
Query: 242 KT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL---- 295
+T T GT YMAPE ++G + D +SFG++L E+ G E +L
Sbjct: 188 QTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDI 246
Query: 296 FWSICNERPRFPQFL 310
I +E ++
Sbjct: 247 KEEIEDEEKTIEDYI 261
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 88.5 bits (220), Expect = 2e-19
Identities = 76/328 (23%), Positives = 126/328 (38%), Gaps = 84/328 (25%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-DVECTLIERKVLALGTKH 125
+Q L +G G++G V A T AVK L + + + T E ++L KH
Sbjct: 31 YQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSR--PFQSIIHAKRTYRELRLLKH-MKH 87
Query: 126 P---YLCHLFC---TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
L +F + + + ++ V LM DL +I
Sbjct: 88 ENVIGLLDVFTPARSLEEFNDVYLVTH------------------LMGA----DL-NNIV 124
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ + + +F +I+ G++++H I++RDLK N+ ++ + ++I DFG
Sbjct: 125 KCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFG------- 177
Query: 240 LDKTTDTF----CGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCD--- 291
L + T T Y APEI+ YNQ VD WS G ++ E+ G++ F G D
Sbjct: 178 LARHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHID 237
Query: 292 ------------EDELFWSICNERPR-----------------FPQFLSVEAKNILVHLL 322
EL I +E R F + A ++L +L
Sbjct: 238 QLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGA-NPLAVDLLEKML 296
Query: 323 DKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
D+ KR+ + +AH YF
Sbjct: 297 VLDSDKRI------TAAQALAHAYFAQY 318
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 88.1 bits (219), Expect = 3e-19
Identities = 71/347 (20%), Positives = 131/347 (37%), Gaps = 85/347 (24%)
Query: 52 PATTIPRFRKYDL--------EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV 103
F K D+ + + +G G++G V A K + A+K L +
Sbjct: 3 SLIRKKGFYKQDVNKTAWELPKTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSR--P 60
Query: 104 LED-DDVECTLIERKVLALGTKHP---YLCHLFC---TFQTDSHLFFVMEYLNGGDLIPA 156
+ + E +L +H L +F + + + VM
Sbjct: 61 FQSEIFAKRAYRELLLLKH-MQHENVIGLLDVFTPASSLRNFYDFYLVMP---------- 109
Query: 157 GLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216
M+ DL + +F E + ++ +++ G++++H G+V+RDLK
Sbjct: 110 --------FMQT----DLQKIMGL--KFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPG 155
Query: 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGI 275
N+ ++ + ++I DFG+ + + T + T Y APE+I YNQ VD WS G
Sbjct: 156 NLAVNEDCELKILDFGLAR--HADAEMTG-YVVTRWYRAPEVILSWMHYNQTVDIWSVGC 212
Query: 276 LLYEMHVGQSPFSGCD---------------EDELFWSICNERPR--------------- 305
++ EM G++ F G D E + ++ +
Sbjct: 213 IMAEMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFT 272
Query: 306 --FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
FP+ S +A ++L +L+ D KRL + + H +F
Sbjct: 273 QLFPRA-SPQAADLLEKMLELDVDKRL------TAAQALTHPFFEPF 312
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 89.1 bits (221), Expect = 3e-19
Identities = 70/302 (23%), Positives = 120/302 (39%), Gaps = 53/302 (17%)
Query: 5 YFSSDTSTPPRRLSNNKLSLDNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDL 64
+F S P + + Q + S+ +K S+S +F ++
Sbjct: 4 HFLYYCSEPTLDVKIAFCQGFDKQVDVSYIAKHYNMSKSKVD----------NQFYSVEV 53
Query: 65 --------EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-DVECTLIE 115
+ +Q LK +G G+ G V A D A+K L + ++ + E
Sbjct: 54 GDSTFTVLKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSR--PFQNQTHAKRAYRE 111
Query: 116 RKVLALGTKHP---YLCHLFC---TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
++ H L ++F T + ++ VME LM+
Sbjct: 112 LVLMKC-VNHKNIISLLNVFTPQKTLEEFQDVYLVME------------------LMDA- 151
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIA 229
+L IQ D R + +++ G++ LH GI++RDLK NI++ + ++I
Sbjct: 152 ---NLCQVIQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKIL 206
Query: 230 DFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
DFG+ + T + T Y APE+I G+ Y + VD WS G ++ EM + F G
Sbjct: 207 DFGLARTAGTSFMMTP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 290 CD 291
D
Sbjct: 266 RD 267
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 85.5 bits (212), Expect = 2e-18
Identities = 73/347 (21%), Positives = 130/347 (37%), Gaps = 84/347 (24%)
Query: 52 PATTIPRFRKYDL--------EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV 103
P F + ++ ++ L+ +G G++G V A T A+K L +
Sbjct: 4 PPPARSGFYRQEVTKTAWEVRAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYR--P 61
Query: 104 LED-DDVECTLIERKVLALGTKHP---YLCHLFCTFQTDSH---LFFVMEYLNGGDLIPA 156
+ + E ++L +H L +F +T + VM
Sbjct: 62 FQSELFAKRAYRELRLLKH-MRHENVIGLLDVFTPDETLDDFTDFYLVMP---------- 110
Query: 157 GLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216
M DL + + + E R +F +++ G+R++H GI++RDLK
Sbjct: 111 --------FMGT----DL-GKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPG 157
Query: 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGI 275
N+ ++ + ++I DFG+ + + T + T Y APE+I Y Q VD WS G
Sbjct: 158 NLAVNEDCELKILDFGLAR--QADSEMTG-YVVTRWYRAPEVILNWMRYTQTVDIWSVGC 214
Query: 276 LLYEMHVGQSPFSGCD---------------EDELFWSICNERPR--------------- 305
++ EM G++ F G D E + ++ +
Sbjct: 215 IMAEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFA 274
Query: 306 --FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
S A N+L +L D +R+ + + +AH YF L
Sbjct: 275 SILTNA-SPLAVNLLEKMLVLDAEQRV------TAGEALAHPYFESL 314
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 85.4 bits (212), Expect = 2e-18
Identities = 72/353 (20%), Positives = 127/353 (35%), Gaps = 75/353 (21%)
Query: 40 HSRSSQSQANITPATTIPRFRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCL 98
H A + R + +D+ + L +G+G++G V A A+K
Sbjct: 1 HHHHHHMAAAAAAGPEMVRGQVFDVGPRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIK-- 58
Query: 99 KKDVVLEDDDVECTLIERKVLALGTKHP---YLCHLFC--TFQTDSHLFFVMEYLNGGDL 153
K + TL E K+L +H + + T + ++ V +
Sbjct: 59 KISPFEHQTYCQRTLREIKILLR-FRHENIIGINDIIRAPTIEQMKDVYIVQD------- 110
Query: 154 IPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213
LME DL + + ++ ++ +I+ G++++H +++RDL
Sbjct: 111 -----------LMET----DL-YKLLKTQHLSNDHICYFLYQILRGLKYIHSANVLHRDL 154
Query: 214 KLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG---TPDYMAPEIIKGLK-YNQCVD 269
K N+LL+ ++I DFG+ ++ T T Y APEI+ K Y + +D
Sbjct: 155 KPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSID 214
Query: 270 WWSFGILLYEMHVGQSPFSGCD---------------EDELFWSICNERPR--------- 305
WS G +L EM + F G E I N + R
Sbjct: 215 IWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHK 274
Query: 306 --------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
FP +A ++L +L + KR+ + +AH Y
Sbjct: 275 NKVPWNRLFPN-ADSKALDLLDKMLTFNPHKRI------EVEQALAHPYLEQY 320
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 83.9 bits (208), Expect = 7e-18
Identities = 63/338 (18%), Positives = 114/338 (33%), Gaps = 88/338 (26%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
+ + + + GS+G V + A+K + D ++ L
Sbjct: 22 SPYTVQRFISSGSYGAVCAG-VDSEGIPVAIK---RVFNTVSDGRTVNILSDSFLCKRVL 77
Query: 124 ---------KHP---YLCHLFCTFQTDS--HLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
HP L +F F+ + L+ V E + DL + +
Sbjct: 78 REIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM-------------RTDLAQVI 124
Query: 170 NGGDLMF---HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
+ ++ HIQ ++ I+ G+ LH+ G+V+RDL NILL +
Sbjct: 125 HDQRIVISPQHIQ-----------YFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDI 173
Query: 227 RIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQS 285
I DF + + T + Y APE++ K + + VD WS G ++ EM ++
Sbjct: 174 TICDFNLAREDTADANKTH-YVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKA 232
Query: 286 PFSGCD---------------EDELFWSICNERPR------------------FPQFLSV 312
F G + E + R P
Sbjct: 233 LFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTA-DP 291
Query: 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
A +++ +L+ + +R+ S + + H YF L
Sbjct: 292 VALDLIAKMLEFNPQRRI------STEQALRHPYFESL 323
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 8e-18
Identities = 68/239 (28%), Positives = 98/239 (41%), Gaps = 49/239 (20%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELK-GTDYYYAVKCLKKDVVLEDDD---VECTLIERKVLA 120
++F +LG+G FGKV+ L GT AVK LK++ + E +I
Sbjct: 30 DNFSNKNILGRGGFGKVYKGRLADGTLV--AVKRLKEERTQGGELQFQTEVEMISM---- 83
Query: 121 LGTKHPYLCHL--FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM--- 175
H L L FC T + V Y+ G + L E +
Sbjct: 84 --AVHRNLLRLRGFCM--TPTERLLVYPYMANGSV--------ASCLRERPESQPPLDWP 131
Query: 176 --FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG---IVYRDLKLDNILLDYEGHVRIAD 230
I G AR G+ +LH I++RD+K NILLD E + D
Sbjct: 132 KRQRIAL------GSAR--------GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGD 177
Query: 231 FGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287
FG+ KL Y D TT GT ++APE + K ++ D + +G++L E+ GQ F
Sbjct: 178 FGLAKLMDYKDTHVTTA-VRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAF 235
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 84.0 bits (208), Expect = 9e-18
Identities = 61/234 (26%), Positives = 99/234 (42%), Gaps = 33/234 (14%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L+ +Q LK +G G+ G V A + A+K L + E ++
Sbjct: 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKL-SRPFQNQTHAKRAYRELVLMKC-V 81
Query: 124 KHP---YLCHLFC---TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
H L ++F + + ++ VME LM+ +L
Sbjct: 82 NHKNIIGLLNVFTPQKSLEEFQDVYIVME------------------LMDA----NLCQV 119
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
IQ D R + +++ G++ LH GI++RDLK NI++ + ++I DFG+ +
Sbjct: 120 IQM--ELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTA 177
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
T + T Y APE+I G+ Y + VD WS G ++ EM G F G D
Sbjct: 178 GTSFMMTP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 230
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 83.0 bits (206), Expect = 9e-18
Identities = 67/265 (25%), Positives = 116/265 (43%), Gaps = 45/265 (16%)
Query: 39 RHSRSSQSQANITPATTIPRFRKY-----DLE----DFQLLKVLGKGSFGKVFLAELK-G 88
++S+++ S + ++ + F Y DLE +F ++G G FGKV+ L+ G
Sbjct: 4 KYSKATNSINDALSSSYLVPFESYRVPLVDLEEATNNFDHKFLIGHGVFGKVYKGVLRDG 63
Query: 89 TDYYYAVKCLKKDVV--LEDDDVECTLIERKVLALGTKHPYLCHL--FCTFQTDSHLFFV 144
A+K + +E+ + E + +HP+L L FC + + +
Sbjct: 64 AKV--ALKRRTPESSQGIEEFETEIETLSF------CRHPHLVSLIGFC--DERNEMILI 113
Query: 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD-EGRARFYAAEIVSGMRFL 203
+Y+ G+L +L G DL + E R G+ +L
Sbjct: 114 YKYMENGNL------------KRHLYGSDL-----PTMSMSWEQRLEI-CIGAARGLHYL 155
Query: 204 HKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKG 261
H + I++RD+K NILLD +I DFG+ K LD+T + GT Y+ PE
Sbjct: 156 HTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIK 215
Query: 262 LKYNQCVDWWSFGILLYEMHVGQSP 286
+ + D +SFG++L+E+ +S
Sbjct: 216 GRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 81.9 bits (203), Expect = 2e-17
Identities = 69/344 (20%), Positives = 122/344 (35%), Gaps = 98/344 (28%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-DVECTLIERKVL--- 119
+ LK LG G G VF A D A+K K +VL D V+ L E K++
Sbjct: 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIK--K--IVLTDPQSVKHALREIKIIRRL 65
Query: 120 ----------ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
LG L + + ++ V E ME
Sbjct: 66 DHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQE------------------YMET- 106
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG-HVRI 228
DL ++ + G E AR + +++ G++++H +++RDLK N+ ++ E ++I
Sbjct: 107 ---DL-ANVLEQGPLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKI 162
Query: 229 ADFGMCKLQIYLDKTTDTFCGTPDYM----------APEIIKGLK-YNQCVDWWSFGILL 277
DFG L + D ++ +P ++ Y + +D W+ G +
Sbjct: 163 GDFG-------LARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIF 215
Query: 278 YEMHVGQSPFSGCD---------------EDELFWSICNE----------RPR------F 306
EM G++ F+G +E + + P
Sbjct: 216 AEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL 275
Query: 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
P +S EA + L +L RL + ++ ++H Y
Sbjct: 276 PG-ISREAVDFLEQILTFSPMDRL------TAEEALSHPYMSIY 312
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 81.2 bits (201), Expect = 3e-17
Identities = 49/239 (20%), Positives = 90/239 (37%), Gaps = 46/239 (19%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI--ERKVLALGTK 124
+++ + +G+GSFG +F + A+K E + + E + L
Sbjct: 12 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKF-------EPRRSDAPQLRDEYRTYKLLAG 64
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+ +++ Q H V++ L G L DL++ +F
Sbjct: 65 CTGIPNVYYFGQEGLHNVLVIDLL-GPSL---------EDLLDLCGR-----------KF 103
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-----VRIADFGMCKLQIY 239
A ++++ ++ +H+K +VYRD+K DN L+ + + DFGM K Y
Sbjct: 104 SVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK--FY 161
Query: 240 LDKTTDT---------FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
D T GT YM+ G + ++ D + G + G P+ G
Sbjct: 162 RDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQG 220
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 79.0 bits (195), Expect = 4e-16
Identities = 79/382 (20%), Positives = 142/382 (37%), Gaps = 110/382 (28%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-DVECTLIERKVLALG 122
L ++L+K LGKG++G V+ + + T AVK + ++ D + T E +L
Sbjct: 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFD--AFQNSTDAQRTFREIMILTEL 65
Query: 123 TKHPYLCHLFCTFQTDS--HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM-FHIQ 179
+ H + +L + D+ ++ V +Y+ E DL + L H Q
Sbjct: 66 SGHENIVNLLNVLRADNDRDVYLVFDYM-------------ETDLHAVIRANILEPVHKQ 112
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC----- 234
+ +++ +++LH G+++RD+K NILL+ E HV++ADFG+
Sbjct: 113 -----------YVVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 235 ------KLQIYLDKTTDTFCGTPDYM----------APEIIKGLK-YNQCVDWWSFGILL 277
+ + +++ T+ F + APEI+ G Y + +D WS G +L
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 278 YEMHVGQSPFSGCD---------------EDELFWSICNE-----------RPRFPQF-- 309
E+ G+ F G +E SI + + Q
Sbjct: 222 GEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNK 281
Query: 310 -------------------LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
+ EA ++L LL + KR+ S +D + H +
Sbjct: 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRI------SANDALKHPFV--- 332
Query: 351 DWQALEKRELEPPFRPRVIEPF 372
EP + P
Sbjct: 333 --SIFHNPNEEPNCDHIITIPI 352
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 78.1 bits (192), Expect = 1e-15
Identities = 53/237 (22%), Positives = 91/237 (38%), Gaps = 44/237 (18%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT--LIERKVLALGTK 124
F+L + +G GSFG+++L T+ A+K E+ + L E K+ +
Sbjct: 9 FRLGRKIGSGSFGEIYLGTNIQTNEEVAIKL-------ENVKTKHPQLLYESKIYRILQG 61
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+ ++ + VM+ L G L DL + S +
Sbjct: 62 GTGIPNVRWFGVEGDYNVLVMDLL-GPSL---------EDLFNF-----------CSRKL 100
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIADFGMCKLQIYLD 241
A ++++ + F+H K ++RD+K DN L+ V I DFG+ K Y D
Sbjct: 101 SLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKK--YRD 158
Query: 242 KTTDT---------FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+T GT Y + G++ ++ D S G +L G P+ G
Sbjct: 159 TSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQG 215
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 77.3 bits (190), Expect = 2e-15
Identities = 53/289 (18%), Positives = 89/289 (30%), Gaps = 88/289 (30%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL----ALG 122
+ +++ LG G F V+L+ + A+K +K + E L E ++L
Sbjct: 39 YHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSD 94
Query: 123 TKHP---YLCHLFCTFQTDS----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
P + L F+ H+ V E L G L + N
Sbjct: 95 PNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHL---------LKWIIKSNY---- 140
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILLDYE----------- 223
+ +++ G+ +LH K I++ D+K +NILL
Sbjct: 141 ------QGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 224 --------------------------------------GHVRIADFGMCKLQIYLDKTTD 245
V+IAD G ++ K
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA---CWVHKHFT 251
Query: 246 TFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
T Y + E++ G YN D WS + +E+ G F +E
Sbjct: 252 EDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEE 300
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 77.2 bits (190), Expect = 2e-15
Identities = 57/292 (19%), Positives = 106/292 (36%), Gaps = 63/292 (21%)
Query: 25 DNGQGESSHHSKQCRHSRSSQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLA 84
++G + S+Q R + T + P + +++ ++G GS+G V A
Sbjct: 13 NSGTQHTVSGSQQEGQQRKQHHSSKPTASMPRPHSDWQIPDRYEIRHLIGTGSYGHVCEA 72
Query: 85 ELKGTDYYYAVKCLKKDVVLEDD-DVECTLIERKVLALGTKHPYLCHLF-----CTFQTD 138
K A+K K V ED D + L E +L H ++ + +
Sbjct: 73 YDKLEKRVVAIK--KILRVFEDLIDCKRILREIAILNR-LNHDHVVKVLDIVIPKDVEKF 129
Query: 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM--FHIQQSGRFDEGRARFYAAEI 196
L+ V+E + D + + HI+ +
Sbjct: 130 DELYVVLEIA-------------DSDFKKLFRTPVYLTELHIK-----------TLLYNL 165
Query: 197 VSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPD---- 252
+ G++++H GI++RDLK N L++ + V++ DFG+ + Y + +P
Sbjct: 166 LVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDM 225
Query: 253 -----------------------YMAPEIIKGLK-YNQCVDWWSFGILLYEM 280
Y APE+I + Y + +D WS G + E+
Sbjct: 226 NLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAEL 277
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 75.9 bits (187), Expect = 3e-15
Identities = 51/239 (21%), Positives = 90/239 (37%), Gaps = 46/239 (19%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI--ERKVLALGTK 124
F++ K +G G+FG++ L + T+ Y A+K LE + E +
Sbjct: 11 FRVGKKIGCGNFGELRLGKNLYTNEYVAIK-------LEPMKSRAPQLHLEYRFYKQLGS 63
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+ ++ + V+E L G L DL + + F
Sbjct: 64 GDGIPQVYYFGPCGKYNAMVLELL-GPSL---------EDLFDLCDR-----------TF 102
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH-----VRIADFGMCKLQIY 239
A +++S M ++H K ++YRD+K +N L+ G+ + I DF + K Y
Sbjct: 103 SLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAK--EY 160
Query: 240 LDKTTDT---------FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
+D T GT YM+ G + ++ D + G + G P+ G
Sbjct: 161 IDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQG 219
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 75.1 bits (185), Expect = 3e-15
Identities = 53/237 (22%), Positives = 88/237 (37%), Gaps = 44/237 (18%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECT--LIERKVLALGTK 124
++L + +G GSFG ++L A+K E + IE K+ +
Sbjct: 11 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKL-------ECVKTKHPQLHIESKIYKMMQG 63
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+ + + VME L G L DL + S +F
Sbjct: 64 GVGIPTIRWCGAEGDYNVMVMELL-GPSL---------EDLFNF-----------CSRKF 102
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH---VRIADFGMCKLQIYLD 241
A +++S + ++H K ++RD+K DN L+ V I DFG+ K Y D
Sbjct: 103 SLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKK--YRD 160
Query: 242 KTTDT---------FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289
T GT Y + G++ ++ D S G +L ++G P+ G
Sbjct: 161 ARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQG 217
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 70.5 bits (173), Expect = 2e-13
Identities = 56/273 (20%), Positives = 100/273 (36%), Gaps = 62/273 (22%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-DVECTLIERKVLALG 122
+++ + ++G+GS+G V+LA K T+ A+K K + + ED D + L E +L
Sbjct: 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIK--KVNRMFEDLIDCKRILREITILNR- 81
Query: 123 TKHPYLCHLF-----CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
K Y+ L+ L+ V+E + + DL
Sbjct: 82 LKSDYIIRLYDLIIPDDLLKFDELYIVLE------------------IADS----DLKKL 119
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGM---- 233
+ E + ++ G F+H+ GI++RDLK N LL+ + V++ DFG+
Sbjct: 120 FKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTI 179
Query: 234 --------CKLQIYLDKTTDTFCGTPDYM----------APEIIKGLK-YNQCVDWWSFG 274
++ + APE+I + Y + +D WS G
Sbjct: 180 NSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTG 239
Query: 275 ILLYEMHVGQSPFSGCDEDELFWSICNERPRFP 307
+ E+ + P FP
Sbjct: 240 CIFAELLNMLQSHINDPTN--------RFPLFP 264
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 1e-12
Identities = 32/262 (12%), Positives = 67/262 (25%), Gaps = 75/262 (28%)
Query: 40 HSRSSQSQANITPATTIPRFRKYDLED---------------FQLLKVLGKGSFGKVFLA 84
H S + + ++L + + G ++ A
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMTTSLEALPTGTVLTDKSGRQWKLKSFQTRDNQGILYEA 61
Query: 85 ELKGT--------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHL----- 131
T +++K KD L E+ K +
Sbjct: 62 APTSTLTCDSGPQKQKFSLKLDAKDGRL--------FNEQNFFQRAAKPLQVNKWKKLYS 113
Query: 132 ----------FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
D + F V+ L G L + +
Sbjct: 114 TPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL-------------QSA------LDVSPK 153
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY--EGHVRIADFGMCKLQI- 238
E A ++ + FLH+ V+ ++ +NI +D + V +A +G
Sbjct: 154 HVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCP 213
Query: 239 ------YLDKTTDTFCGTPDYM 254
Y++ + G +++
Sbjct: 214 SGKHVAYVEGSRSPHEGDLEFI 235
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 3e-12
Identities = 49/253 (19%), Positives = 84/253 (33%), Gaps = 58/253 (22%)
Query: 33 HHSKQCRHSRSSQSQANITPATTIPRFRKYDLED-----FQLLKVLGKGSFGKVFLAELK 87
HH ++ + P L+D + L K +G G FG ++LA
Sbjct: 2 HHHHHHSSGVDLGTENLYFQSMPFPE--GKVLDDMEGNQWVLGKKIGSGGFGLIYLAFPT 59
Query: 88 GTDYYYAVKCLKKD---------------VVLEDDDVECTLIERKVLALGTKHPYLCHLF 132
A +K + V + D ++ + +++ LG Y L
Sbjct: 60 NKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLT 119
Query: 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFY 192
F+ S+ F VME L G DL Q+G F +
Sbjct: 120 -EFKGRSYRFMVMERL----------------------GIDLQKISGQNGTFKKSTVLQL 156
Query: 193 AAEIVSGMRFLHKKGIVYRDLKLDNILLDY--EGHVRIADFGMCKLQIYLDKTT------ 244
++ + ++H+ V+ D+K N+LL Y V +AD+G+ Y
Sbjct: 157 GIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLADYGLSY--RYCPNGNHKQYQE 214
Query: 245 ---DTFCGTPDYM 254
GT ++
Sbjct: 215 NPRKGHNGTIEFT 227
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 66.7 bits (163), Expect = 4e-12
Identities = 40/216 (18%), Positives = 78/216 (36%), Gaps = 52/216 (24%)
Query: 67 FQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKD------------VVLEDDDV 109
+++ +G+G FG ++LA++ G+D VK D + + +
Sbjct: 37 WKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQI 96
Query: 110 ECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYL 169
+ + RK+ LG Y S+ F +M+ G DL + + E
Sbjct: 97 QKWIRTRKLKYLGVPK-YWGSGLHDKNGKSYRFMIMDRF-GSDL---------QKIYEA- 144
Query: 170 NGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY--EGHVR 227
+ RF + I+ + ++H+ V+ D+K N+LL+Y V
Sbjct: 145 ----------NAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLLNYKNPDQVY 194
Query: 228 IADFGMCKLQIYLDKTTDT---------FCGTPDYM 254
+ D+G+ Y + GT ++
Sbjct: 195 LVDYGLAY--RYCPEGVHKAYAADPKRCHDGTIEFT 228
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 63.4 bits (153), Expect = 4e-11
Identities = 40/339 (11%), Positives = 93/339 (27%), Gaps = 57/339 (16%)
Query: 54 TTIPRFRK-YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCL---------KKDVV 103
F E Q + +G+G FG+VF T A+K +
Sbjct: 8 KGPVPFSHCLPTEKLQRCEKIGEGVFGEVFQTIADHTPV--AIKIIAIEGPDLVNGSHQK 65
Query: 104 LEDDDVECTLIERKVLAL----GTKHPYLCHL----FCTFQTDSHLFFVMEYLNGGDLIP 155
++ + +I +++ L + L L ++ N
Sbjct: 66 TFEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSA 125
Query: 156 AGLTKAERD-----LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIV 209
+D ++E+ GG + ++ A+ ++ + +
Sbjct: 126 NDRPDFFKDDQLFIVLEFEFGGIDLEQMRTK-LSSLATAKSILHQLTASLAVAEASLRFE 184
Query: 210 YRDLKLDNILLDYEGHVRIAD-----------FGMCKLQIYLDKTTDTFCGTPDYM---- 254
+RDL N+LL ++ G+ I + G +
Sbjct: 185 HRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLERDGIVVFCDVSM 244
Query: 255 APEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW------SICNERPRFPQ 308
++ G Q + P+S + W + + +
Sbjct: 245 DEDLFTGDGDYQFDIYRLMKKENNNRWGEYHPYS-----NVLWLHYLTDKMLKQMTFKTK 299
Query: 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
+ K I + ++ + + + +S D++
Sbjct: 300 CNTPAMKQIKRKI--QEFHRTMLN--FSSATDLLCQHSL 334
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 50.6 bits (120), Expect = 1e-06
Identities = 65/472 (13%), Positives = 129/472 (27%), Gaps = 167/472 (35%)
Query: 55 TIPRFRKYD--------LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED 106
+ R + Y L + + + G GK ++A V
Sbjct: 130 NVSRLQPYLKLRQALLELRPAKNVLIDGVLGSGKTWVALD----------------VCLS 173
Query: 107 DDVECTLIERKV--LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERD 164
V+C + + K+ L L + ++ V+E L L L + + +
Sbjct: 174 YKVQCKM-DFKIFWLNLKNCN----------SPET----VLEMLQ--KL----LYQIDPN 212
Query: 165 LMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD--LKLDNILLDY 222
+ + D +I+ R +A R L K Y + L L N+ +
Sbjct: 213 ---WTSRSDHSSNIKL--RIHSIQAEL--------RRLLKSK--PYENCLLVLLNV-QNA 256
Query: 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV 282
+ + CK+ + TT + + I L +
Sbjct: 257 K-AWNAFNLS-CKILL----TTR------FKQVTDFLSAATTTH--------ISLDHHSM 296
Query: 283 GQSPFSGCDE-DELFWSICNERPRFPQFLSVEAKNI------LVHLLDKDTTKRLGSTQC 335
+P DE L + R PQ L E ++ +D
Sbjct: 297 TLTP----DEVKSLLLKYLDCR---PQDLPREVLTTNPRRLSIIAESIRDGLATW----- 344
Query: 336 NSGDDVVAHEYFRGLDWQALEK------RELEPP-FRPR----VIEPFSSP--------- 375
+ ++ ++ L LEP +R + P S+
Sbjct: 345 ---------DNWKHVNCDKLTTIIESSLNVLEPAEYRKMFDRLSVFPPSAHIPTILLSLI 395
Query: 376 WIKLSSKD-----------SAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTIL 424
W + D S + Q + + ++ Y + E + R+I+
Sbjct: 396 WFDVIKSDVMVVVNKLHKYSLVEKQPKESTISIPSI---YLELKVKLEN--EYALHRSIV 450
Query: 425 ES----------------MDQTQFQGFSY--TNPNATDFLHALDVKYFDKSF 458
+ +DQ + + N + + + + D F
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSHIGHHLKNIEHPERMTLFRMVFLDFRF 502
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 494 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.95 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.92 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.85 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.74 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.32 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.21 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 99.06 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 99.0 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.84 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.31 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 98.27 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 98.2 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 98.08 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.91 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 97.86 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.86 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 97.67 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 97.44 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 97.32 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 97.25 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 97.11 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 97.06 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 97.03 | |
| 3f7w_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.02 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 96.99 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 96.84 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 96.82 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 96.79 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 96.49 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 96.32 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 96.25 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 95.82 | |
| 3mes_A | 424 | Choline kinase; malaria, structural genomics, stru | 95.69 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 95.66 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 94.23 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.98 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 91.72 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 88.57 | |
| 1cja_A | 342 | Protein (actin-fragmin kinase); transferase; HET: | 87.87 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 81.18 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-73 Score=558.91 Aligned_cols=275 Identities=36% Similarity=0.650 Sum_probs=254.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
...++|+++++||+|+||+||+|+++.+++.||||++.+.........+....|..++. .++|||||+++++|++++++
T Consensus 29 ~~~~dy~i~~~lG~G~fg~V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~ 107 (311)
T 4aw0_A 29 KRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKL 107 (311)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEE
T ss_pred CCccccEEEEEEecccCeEEEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEE
Confidence 34579999999999999999999999999999999998876655666778889999988 58999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|||||||+ ||+|..++.+.+.++|.+++.|++||+.||+|||++|||||||||+||||+
T Consensus 108 yivmEy~~---------------------gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDlKPeNILl~ 166 (311)
T 4aw0_A 108 YFGLSYAK---------------------NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLN 166 (311)
T ss_dssp EEEECCCT---------------------TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEC
T ss_pred EEEEecCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCCHHHeEEc
Confidence 99999999 677778888889999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
.+|++||+|||+|+..... .....+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|
T Consensus 167 ~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i 246 (311)
T 4aw0_A 167 EDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKI 246 (311)
T ss_dssp TTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred CCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 9999999999999864322 23456789999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcC
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~ 358 (494)
.++.+.+|..+|+++++||.+||++||++|||+.++.+..+|++||||+++||+.|.++
T Consensus 247 ~~~~~~~p~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~idw~~l~~~ 305 (311)
T 4aw0_A 247 IKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ 305 (311)
T ss_dssp HHTCCCCCTTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS
T ss_pred HcCCCCCCcccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCCCHHHhcCC
Confidence 99999999999999999999999999999999988778889999999999999999765
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-72 Score=552.21 Aligned_cols=282 Identities=42% Similarity=0.797 Sum_probs=249.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
+.+.++|++++.||+|+||+||+|++. .+++.||||++++...... .......|..++. .++|||||+++++|++
T Consensus 20 ~~~p~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~~~~~-~~~~~~~E~~il~-~l~HpnIv~l~~~~~~ 97 (304)
T 3ubd_A 20 KADPSQFELLKVLGQGSFGKVFLVKKISGSDARQLYAMKVLKKATLKVR-DRVRTKMERDILV-EVNHPFIVKLHYAFQT 97 (304)
T ss_dssp CCCGGGEEEEEEEECGGGCEEEEEEECSSTTTTCEEEEEEEESEEEEEE-ECC------CCCC-CCCCTTEECEEEEEEE
T ss_pred cCCccccEEEEEEecCCCeEEEEEEEccCCCCCEEEEEEEEehHHcChH-HHHHHHHHHHHHH-HCCCCCCCeEEEEEEE
Confidence 345679999999999999999999984 4688999999987644322 2234566777776 6899999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
++.+|||||||+ ||+|..++.+.+.+++.+++.|++||+.||+|||++|||||||||+|
T Consensus 98 ~~~~~ivmEy~~---------------------gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~N 156 (304)
T 3ubd_A 98 EGKLYLILDFLR---------------------GGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPEN 156 (304)
T ss_dssp TTEEEEEECCCT---------------------TCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGG
T ss_pred CCEEEEEEEcCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCHHH
Confidence 999999999999 66677788888999999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.+|++||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.
T Consensus 157 ILl~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~ 236 (304)
T 3ubd_A 157 ILLDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMT 236 (304)
T ss_dssp EEECTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred eEEcCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHHHHHH
Confidence 99999999999999999865555556678899999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 298 SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 298 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+|.+..+.+|..+|+++++||.+||++||++||++.. .+++|+++||||+++||+.+.+++++|||+|
T Consensus 237 ~i~~~~~~~p~~~s~~~~~li~~~L~~dP~~R~ta~~-~~~~eil~Hp~f~~idw~~l~~~~~~pP~~P 304 (304)
T 3ubd_A 237 MILKAKLGMPQFLSPEAQSLLRMLFKRNPANRLGAGP-DGVEEIKRHSFFSTIDWNKLYRREIHPPFKP 304 (304)
T ss_dssp HHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCST-TTHHHHHTSGGGTTCCHHHHHTTCSCCSSCC
T ss_pred HHHcCCCCCCCcCCHHHHHHHHHHcccCHHHCCCCCc-CCHHHHHcCccccCCCHHHHHhCCCCcCcCC
Confidence 9999999999999999999999999999999998754 3689999999999999999999999999998
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-71 Score=594.61 Aligned_cols=325 Identities=34% Similarity=0.614 Sum_probs=274.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH--hcCCCCceeeEEEEEEcC
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA--LGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~--~~~~hp~Iv~l~~~~~~~ 138 (494)
.+.+++|+++++||+|+||+||+|+++.+|+.||||++.+..+...........|+.++. ..++|||||+++++|++.
T Consensus 185 ~~slddf~i~k~LG~G~fG~V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~ 264 (689)
T 3v5w_A 185 HLTMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTP 264 (689)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECS
T ss_pred CCchHHeEEEEEEecccCeEEEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEEC
Confidence 567899999999999999999999999999999999998876555555555666655543 356899999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+++|||||||+ ||+|..++.+.+.|+|..+++|++||+.||+|||++|||||||||+||
T Consensus 265 ~~lylVmEy~~---------------------GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLKPeNI 323 (689)
T 3v5w_A 265 DKLSFILDLMN---------------------GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANI 323 (689)
T ss_dssp SEEEEEECCCC---------------------SCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGE
T ss_pred CEEEEEEecCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCchHHe
Confidence 99999999999 777788898999999999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-CCCCCCcchHHHHHHHHHHHHhCCCCCCCC---CHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-GLKYNQCVDWWSFGILLYEMHVGQSPFSGC---DEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---~~~~ 294 (494)
||+.+|+|||+|||+|+.. ......+.|||+.|||||++. +..|+.++|||||||+||||++|.+||.+. +..+
T Consensus 324 Lld~~G~vKL~DFGlA~~~--~~~~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~~~~~ 401 (689)
T 3v5w_A 324 LLDEHGHVRISDLGLACDF--SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHE 401 (689)
T ss_dssp EECTTSCEEECCCTTCEEC--SSCCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCCCHHH
T ss_pred EEeCCCCEEecccceeeec--CCCCCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999863 334566789999999999997 468999999999999999999999999764 4557
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCC
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSS 374 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~ 374 (494)
+...+....+.+|..+|+++++||.+||++||.+|+|+.. .+++||++||||+++||+.|..++++|||+|.+.....
T Consensus 402 i~~~i~~~~~~~p~~~S~~a~dLI~~lL~~dP~~Rl~~~~-~ga~ei~~HpfF~~idW~~l~~~~~~pP~~P~~~~~~~- 479 (689)
T 3v5w_A 402 IDRMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG-RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVNA- 479 (689)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCGGGCTTCSS-STHHHHTTSGGGTTCCHHHHHTTCSCCSCCCCTTCSST-
T ss_pred HHHhhcCCCCCCCccCCHHHHHHHHHHccCCHhHCCCCCC-CCHHHHhcCccccCCCHHHHHcCCCCcCccCCCCCCCc-
Confidence 7888899999999999999999999999999999998744 47999999999999999999999999999998763211
Q ss_pred cccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCC
Q psy8309 375 PWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441 (494)
Q Consensus 375 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 441 (494)
.+..|+++||++++...+. ...+++.|.||+|+.+.
T Consensus 480 ----------------------~~~fD~~~fd~e~~~~~~~---------~~~d~~~f~~Fs~~~~~ 515 (689)
T 3v5w_A 480 ----------------------ADAFDIGSFDEEDTKGIKL---------LDSDQELYRNFPLTISE 515 (689)
T ss_dssp ----------------------TBCCC---------CCCCC---------CHHHHTTTTTCCEECHH
T ss_pred ----------------------CCCCCCccCCccccCCCCC---------CchHHHHHhCCCccCcc
Confidence 1567888888887765421 22357889999997654
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-69 Score=556.57 Aligned_cols=334 Identities=46% Similarity=0.888 Sum_probs=299.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++....+||||++++++|++.+.
T Consensus 48 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 127 (396)
T 4dc2_A 48 SLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 127 (396)
T ss_dssp -CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChhHcEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCE
Confidence 46678999999999999999999999999999999999987665555666778888888876799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 128 ~~lV~E~~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl 186 (396)
T 4dc2_A 128 LFFVIEYVN---------------------GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 186 (396)
T ss_dssp EEEEEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred EEEEEEcCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE
Confidence 999999999 66777788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC---------C
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC---------D 291 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---------~ 291 (494)
+.+|++||+|||+|+..........+.|||+.|+|||++.+..|+.++|||||||++|||++|.+||.+. .
T Consensus 187 ~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~~~~~~~~~~~ 266 (396)
T 4dc2_A 187 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 266 (396)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTTTC------CC
T ss_pred CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhCCCCCcccccccccchhh
Confidence 9999999999999986555556677889999999999999999999999999999999999999999642 3
Q ss_pred HHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCC
Q psy8309 292 EDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEP 371 (494)
Q Consensus 292 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~ 371 (494)
...++..|....+.+|..++.++++||++||++||.+|||+....+++||++||||++++|+.+.++++.|||+|.+.
T Consensus 267 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~i~w~~l~~~~~~pp~~p~~~-- 344 (396)
T 4dc2_A 267 EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS-- 344 (396)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTTCCHHHHHTTCSCCSCCCCCC--
T ss_pred HHHHHHHHhccccCCCCcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccCCCHHHHHcCCCCCCCcCCCC--
Confidence 455778899999999999999999999999999999999875444689999999999999999999999999999998
Q ss_pred CCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCcc
Q psy8309 372 FSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNAT 443 (494)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 443 (494)
++.|++|||.+|+.+.+..+|.+...+...+|..|.||+|+++...
T Consensus 345 --------------------------~~~d~~~fd~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 390 (396)
T 4dc2_A 345 --------------------------GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLLM 390 (396)
T ss_dssp --------------------------SSTTGGGSCHHHHTSCCCCCCCCHHHHTTSCGGGGTTCCEECC---
T ss_pred --------------------------CccchhhcChhhccCCCccCCCcchhhccccccccCCcEeECcccc
Confidence 7899999999999999998998877777778889999999999765
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-70 Score=551.81 Aligned_cols=333 Identities=53% Similarity=1.003 Sum_probs=296.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++....+||||++++++|++.+.
T Consensus 19 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~ 98 (353)
T 3txo_A 19 RLGIDNFEFIRVLGKGSFGKVMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDR 98 (353)
T ss_dssp ----CCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEeeCCCEEEEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999887555566777888899998866689999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 99 ~~lv~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NILl 157 (353)
T 3txo_A 99 LFFVMEFVN---------------------GGDLMFHIQKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLL 157 (353)
T ss_dssp EEEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCCHHHEEE
Confidence 999999999 66777788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+|+..........+.|||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 158 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 237 (353)
T 3txo_A 158 DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAIL 237 (353)
T ss_dssp CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999864445556677899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
.+.+.+|..+++++++||.+||++||.+||++.+..+++||++||||++++|+.+..++++|||+|.+.
T Consensus 238 ~~~~~~p~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~~w~~l~~~~~~~p~~p~~~----------- 306 (353)
T 3txo_A 238 NDEVVYPTWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQLNHRQIEPPFRPRIK----------- 306 (353)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-----------
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCCCHHHHhcCcCCCCccCCCC-----------
Confidence 999999999999999999999999999999875445779999999999999999999999999999987
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCc
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNA 442 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 442 (494)
+..|++|||++|+.+.+..+|.+...+...+|..|.||+|+++.+
T Consensus 307 -----------------~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 351 (353)
T 3txo_A 307 -----------------SREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPEL 351 (353)
T ss_dssp -----------------STTCCTTSCHHHHTSCCCCCCCCTTSGGGSCGGGGTTCCEECC--
T ss_pred -----------------CcccccccCcccccCCCcCCCccccccCcccccccCCceeeCccc
Confidence 788999999999999998888876666667788999999999764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-68 Score=538.53 Aligned_cols=331 Identities=55% Similarity=0.982 Sum_probs=296.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|+++++||+|+||+||+|+++.+++.||||++++.........+....|+.++....+||||++++++|++.+.
T Consensus 16 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 95 (353)
T 2i0e_A 16 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 95 (353)
T ss_dssp ---CTTEEEEEEEEEETTEEEEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSE
T ss_pred CCchHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCE
Confidence 45678999999999999999999999999999999999886554555667788899888765589999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 96 ~~lv~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll 154 (353)
T 2i0e_A 96 LYFVMEYVN---------------------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 154 (353)
T ss_dssp EEEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEeccCCHHHEEE
Confidence 999999999 66677788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+++..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 155 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 234 (353)
T 2i0e_A 155 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 234 (353)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999864444556678899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
...+.+|..+++++++||.+||.+||.+||++.. .++++|++||||++++|+.+..++++|||+|.+.
T Consensus 235 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~-~~~~~i~~h~~f~~~~w~~l~~~~~~~p~~p~~~----------- 302 (353)
T 2i0e_A 235 EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGP-EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAC----------- 302 (353)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSCTTSCTTCST-THHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-----------
T ss_pred hCCCCCCCCCCHHHHHHHHHHhhcCHHHcCCCCC-CCHHHHhcCccccCCCHHHHHhCCCCCCcCCCCC-----------
Confidence 9999999999999999999999999999998754 3789999999999999999999999999999887
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCc
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNA 442 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 442 (494)
+. |++|||.+|+.+.+..++.+...+...++..|.||+|+++..
T Consensus 303 -----------------~~-~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 346 (353)
T 2i0e_A 303 -----------------GR-NAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEF 346 (353)
T ss_dssp -----------------CC---CHHHHHHHHSCCCCCCCCHHHHHHSCTTTTCSCCEECTTC
T ss_pred -----------------Cc-chhhccchhccCCcccCCccccccccccccccCCCeeeCccc
Confidence 56 999999999998887777665444445778999999999865
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-67 Score=575.75 Aligned_cols=334 Identities=55% Similarity=0.978 Sum_probs=304.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|+++++||+|+||+||+|+++.+++.||||++++.........+....|+.++....+||+|++++++|++.+.
T Consensus 337 ~~~~~~f~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~ 416 (674)
T 3pfq_A 337 RMKLTDFNFLMVLGKGSFGKVMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDR 416 (674)
T ss_dssp ---CTTEEEEEESSBTTTBCEEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSE
T ss_pred cccccceEEEEEEccCCCEEEEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCE
Confidence 45678999999999999999999999999999999999886555556667788899998866689999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+||||||++ ||+|..++...+.+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 417 ~~lV~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~gIiHrDLKp~NILl 475 (674)
T 3pfq_A 417 LYFVMEYVN---------------------GGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVML 475 (674)
T ss_dssp EEEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTSEECCCCCSTTEEE
T ss_pred EEEEEeCcC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEeccCChhhEEE
Confidence 999999999 66777788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+|+..........+.+||+.|+|||++.+..|+.++|||||||+||||++|.+||.+.+..+++..|.
T Consensus 476 ~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 555 (674)
T 3pfq_A 476 DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIM 555 (674)
T ss_dssp CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999875555566778899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
...+.+|..+++++++||.+||++||.+||++.. .+++||++||||++++|+.+.+++++|||+|.+.
T Consensus 556 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~-~~~~ei~~h~ff~~i~w~~l~~~~~~pp~~p~~~----------- 623 (674)
T 3pfq_A 556 EHNVAYPKSMSKEAVAICKGLMTKHPGKRLGCGP-EGERDIKEHAFFRYIDWEKLERKEIQPPYKPKAS----------- 623 (674)
T ss_dssp SSCCCCCTTSCHHHHHHHHHHSCSSSTTCTTCST-THHHHHHSSGGGSSCCHHHHTTTCSCCSCCCBCC-----------
T ss_pred hCCCCCCccCCHHHHHHHHHHccCCHHHCCCCCC-CcHHHHhcCccccCCCHHHHHhCCCCCCCCCcCC-----------
Confidence 9999999999999999999999999999998743 3679999999999999999999999999988553
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccchhccccccccccCCcC
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDFLHALDVKYFDKSFTA 460 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~~~~~~~~~~d~~f~~ 460 (494)
+ .|++|||..||.
T Consensus 624 ------------------------------------------------------------------~-~~~~~f~~~~~~ 636 (674)
T 3pfq_A 624 ------------------------------------------------------------------G-RNAENFDRFFTR 636 (674)
T ss_dssp ------------------------------------------------------------------G-GGHHHHTTTTTS
T ss_pred ------------------------------------------------------------------C-CchhhcCchhcc
Confidence 1 267788888899
Q ss_pred CCCCCCCchhHHhhhccccccccccccCCCCCCC
Q psy8309 461 ERPCLTPVDRTILESMDQTQFQGFSYTNPNATDP 494 (494)
Q Consensus 461 ~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 494 (494)
++|.++|++..++.+++|++|.||||+||.++.+
T Consensus 637 ~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 670 (674)
T 3pfq_A 637 HPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKP 670 (674)
T ss_dssp SCSSCCCCCHHHHTTCCGGGGTTCCEECSSCCCC
T ss_pred CCCccCCCchhhhhcccccccCCCcccChhhhch
Confidence 9999999999999999999999999999998864
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-67 Score=532.42 Aligned_cols=330 Identities=60% Similarity=1.086 Sum_probs=261.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++....+||||++++++|++.+.
T Consensus 13 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~ 92 (345)
T 1xjd_A 13 KLKIEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKEN 92 (345)
T ss_dssp ---CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCE
Confidence 45678999999999999999999999999999999999876554455667788888888876799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 93 ~~lv~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 151 (345)
T 1xjd_A 93 LFFVMEYLN---------------------GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILL 151 (345)
T ss_dssp EEEEEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCCCChhhEEE
Confidence 999999999 66677788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+++..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|.
T Consensus 152 ~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 231 (345)
T 1xjd_A 152 DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIR 231 (345)
T ss_dssp CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999864444455678899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
...+.+|..+++++++||.+||..||.+||++. ++|++||||++++|+.+..+++.||++|.+.
T Consensus 232 ~~~~~~p~~~s~~~~~li~~lL~~dp~~R~~~~-----~~i~~hp~f~~~~w~~l~~~~~~~p~~p~~~----------- 295 (345)
T 1xjd_A 232 MDNPFYPRWLEKEAKDLLVKLFVREPEKRLGVR-----GDIRQHPLFREINWEELERKEIDPPFRPKVK----------- 295 (345)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHSCSSGGGSBTTB-----SCGGGSGGGTTCCHHHHHTTCSCC------------------
T ss_pred hCCCCCCcccCHHHHHHHHHHhcCCHhHcCCCh-----HHHHcCccccCCCHHHHhhCCCCCCcCCCCC-----------
Confidence 999999999999999999999999999999642 3899999999999999999999999999987
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCccc
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATD 444 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~ 444 (494)
++.|++|||.+|+.+.+..++.+.......++..|.||+|+++....
T Consensus 296 -----------------~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~ 342 (345)
T 1xjd_A 296 -----------------SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGMER 342 (345)
T ss_dssp ------------------------------------------------CCTTTTCCC-------
T ss_pred -----------------CcchhhhcchhhcccCccCCcccccccccccccccCCCeeeChhhhh
Confidence 78899999999998877777666554555678899999999887543
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-67 Score=525.43 Aligned_cols=328 Identities=46% Similarity=0.873 Sum_probs=289.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.+++|+++++||+|+||+||+|+++.+++.||||++++..............|..++. .++||||++++++|++.+.+
T Consensus 2 ~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~l~~~~~~~~~~ 80 (337)
T 1o6l_A 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEE
T ss_pred CChHHeEEEEEEecCCCeEEEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHH-hCCCCcCcceEEEEEeCCEE
Confidence 45789999999999999999999999999999999998765545556677888888887 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 81 ~lv~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 139 (337)
T 1o6l_A 81 CFVMEYAN---------------------GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp EEEEECCT---------------------TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred EEEEeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCCHHHEEEC
Confidence 99999999 666777788888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+|++||+|||+++..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|..
T Consensus 140 ~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~~ 219 (337)
T 1o6l_A 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCHHHHHHHHHc
Confidence 99999999999998644445556778999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSS 381 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~ 381 (494)
..+.+|..+++++++||.+||++||.+|||+.. .+++||++||||++++|+.+.++++.||++|.+.
T Consensus 220 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~g~~~-~~~~ei~~h~~f~~~~~~~~~~~~~~pp~~p~~~------------ 286 (337)
T 1o6l_A 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT------------ 286 (337)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCST-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCS------------
T ss_pred CCCCCCCCCCHHHHHHHHHHhhcCHHHhcCCCC-CCHHHHHcCCCcCCCCHHHHHhCCCCCCCCCCCC------------
Confidence 999999999999999999999999999998643 3799999999999999999999999999999987
Q ss_pred CCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccc-cCc------ccCCCccCeeeeCC
Q psy8309 382 KDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTI-LES------MDQTQFQGFSYTNP 440 (494)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~-~~~------~~~~~f~~f~~~~~ 440 (494)
++.|++|||.+|+.+....+|.+... +.. .+|..|.||+|+++
T Consensus 287 ----------------~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 336 (337)
T 1o6l_A 287 ----------------SEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp ----------------STTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred ----------------CcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCC
Confidence 78899999999998877766654311 111 14688999999875
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-66 Score=524.81 Aligned_cols=332 Identities=46% Similarity=0.893 Sum_probs=296.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|++++.||+|+||.||+|+++.+++.||||++++..............|+.++....+||||++++++|++.+.
T Consensus 5 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~ 84 (345)
T 3a8x_A 5 PLGLQDFDLLRVIGRGSYAKVLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESR 84 (345)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred CCchhheEEEEEEEecCCeEEEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987666666777788899888866699999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 85 ~~lv~e~~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 143 (345)
T 3a8x_A 85 LFFVIEYVN---------------------GGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVLL 143 (345)
T ss_dssp EEEEECCCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence 999999999 66667778888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---------CC
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG---------CD 291 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~---------~~ 291 (494)
+.+|++||+|||+++..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.. ..
T Consensus 144 ~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~ 223 (345)
T 3a8x_A 144 DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNT 223 (345)
T ss_dssp CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTTTC-------C
T ss_pred CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhCCCCcCCccccccccccc
Confidence 999999999999998644445556778999999999999999999999999999999999999999975 34
Q ss_pred HHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCC
Q psy8309 292 EDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEP 371 (494)
Q Consensus 292 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~ 371 (494)
...++..|....+.+|..++.++++||.+||++||.+||++....+++||++||||++++|+.+.++++.|||+|.+.
T Consensus 224 ~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~~~w~~~~~~~~~~p~~p~~~-- 301 (345)
T 3a8x_A 224 EDYLFQVILEKQIRIPRSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRNVDWDMMEQKQVVPPFKPNIS-- 301 (345)
T ss_dssp HHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC--
T ss_pred HHHHHHHHHcCCCCCCCCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCCCCHHHHHhCCCCCCcCCCCC--
Confidence 556778888999999999999999999999999999999875444679999999999999999999999999999987
Q ss_pred CCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCC
Q psy8309 372 FSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 441 (494)
Q Consensus 372 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 441 (494)
++.|++|||.+|+.+....++.+.......++..|.||+|.++.
T Consensus 302 --------------------------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 345 (345)
T 3a8x_A 302 --------------------------GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 345 (345)
T ss_dssp --------------------------TTTCGGGSCHHHHTSCSSCCCCCHHHHTTSCGGGGTTCCEECCC
T ss_pred --------------------------CcchhhhcCcccccCcccCCCccccccccccccccCCCEeeCCC
Confidence 78899999999998887777766544444567889999999873
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-66 Score=528.34 Aligned_cols=330 Identities=42% Similarity=0.777 Sum_probs=255.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++...++||||++++++|++.+.
T Consensus 34 ~~~~~~y~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~ 113 (373)
T 2r5t_A 34 HAKPSDFHFLKVIGKGSFGKVLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADK 113 (373)
T ss_dssp TCCGGGEEEEEEEECCTTCEEEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSE
T ss_pred CCChhheEEEEEEeeCCCeEEEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCE
Confidence 45678999999999999999999999999999999999987666666666777787776557899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.+.+.+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 114 ~~lv~E~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll 172 (373)
T 2r5t_A 114 LYFVLDYIN---------------------GGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL 172 (373)
T ss_dssp EEEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence 999999999 66777788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+++..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 173 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~~~~~~i~ 252 (373)
T 2r5t_A 173 DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNIL 252 (373)
T ss_dssp CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBHHHHHHHHH
T ss_pred CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCHHHHHHHHH
Confidence 99999999999999864444556678899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
.....+|..++.++++||.+||++||.+||++.+ ++++|++||||++++|+.+.++++.|||+|.+.
T Consensus 253 ~~~~~~~~~~~~~~~~li~~lL~~dp~~R~~~~~--~~~~i~~h~~f~~~~w~~l~~~~~~pp~~p~~~----------- 319 (373)
T 2r5t_A 253 NKPLQLKPNITNSARHLLEGLLQKDRTKRLGAKD--DFMEIKSHVFFSLINWDDLINKKITPPFNPNVS----------- 319 (373)
T ss_dssp HSCCCCCSSSCHHHHHHHHHHTCSSGGGSTTTTT--THHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCC-----------
T ss_pred hcccCCCCCCCHHHHHHHHHHcccCHHhCCCCCC--CHHHHhCCccccCCCHHHHHhCCCCCCCCCCCC-----------
Confidence 9999999999999999999999999999999853 689999999999999999999999999999987
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCC---CCcc-ccC--cccCCCccCeeeeCCC
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTP---VDRT-ILE--SMDQTQFQGFSYTNPN 441 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~---~~~~-~~~--~~~~~~f~~f~~~~~~ 441 (494)
++.|++|||.+|+.+....+. .+.. ... ...+..|.||+|.++.
T Consensus 320 -----------------~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 369 (373)
T 2r5t_A 320 -----------------GPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPT 369 (373)
T ss_dssp -----------------C-------------------------------------------------
T ss_pred -----------------CcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCch
Confidence 788999999999887643221 1111 111 1235679999999875
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-65 Score=497.75 Aligned_cols=255 Identities=34% Similarity=0.550 Sum_probs=217.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++++.............+|..++. .++|||||+++++|++++.+||
T Consensus 12 ig~Y~i~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~i 90 (275)
T 3hyh_A 12 IGNYQIVKTLGEGSFGKVKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLR-LLRHPHIIKLYDVIKSKDEIIM 90 (275)
T ss_dssp --CCEEEEEEEC---CCEEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEE
T ss_pred eeCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHH-HCCCCCCCeEEEEEEECCEEEE
Confidence 579999999999999999999999999999999998876655566677888999888 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||| +|+|..++.+.+.+++.+++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 91 vmEy~----------------------~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~IiHRDiKP~NILl~~~ 148 (275)
T 3hyh_A 91 VIEYA----------------------GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEH 148 (275)
T ss_dssp EEECC----------------------CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTTTEEECTT
T ss_pred EEeCC----------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCChHHeEECCC
Confidence 99999 44667788888999999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
|++||+|||+|+... ......+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+..+++.+|.++
T Consensus 149 ~~vkl~DFGla~~~~-~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~~~~~~~i~~~ 227 (275)
T 3hyh_A 149 LNVKIADFGLSNIMT-DGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESIPVLFKNISNG 227 (275)
T ss_dssp CCEEECCSSCC----------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHT
T ss_pred CCEEEeecCCCeecC-CCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHcC
Confidence 999999999998632 3344567899999999999999886 58999999999999999999999999999999999999
Q ss_pred CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 303 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+.+|..+|+++++||.+||++||++|| +++|+++||||+
T Consensus 228 ~~~~p~~~s~~~~~li~~~L~~dP~~R~------s~~eil~hpw~k 267 (275)
T 3hyh_A 228 VYTLPKFLSPGAAGLIKRMLIVNPLNRI------SIHEIMQDDWFK 267 (275)
T ss_dssp CCCCCTTSCHHHHHHHHHHSCSSGGGSC------CHHHHHHCHHHH
T ss_pred CCCCCCCCCHHHHHHHHHHccCChhHCc------CHHHHHcCcccc
Confidence 9999999999999999999999999999 689999999996
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-65 Score=508.80 Aligned_cols=258 Identities=26% Similarity=0.471 Sum_probs=225.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|++++.||+|+||+||+|+++.+|+.||||++.+... .....+...+|..++. .++|||||+++++|++++.+|
T Consensus 22 sme~Y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~y 99 (350)
T 4b9d_A 22 SMEKYVRLQKIGEGSFGKAILVKSTEDGRQYVIKEINISRM-SSKEREESRREVAVLA-NMKHPNIVQYRESFEENGSLY 99 (350)
T ss_dssp CCCCEEEEEEC------CEEEEEETTTCCEEEEEEEECTTS-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEE
T ss_pred cccceEEeEEEecCCCeEEEEEEECCCCCEEEEEEEehHHC-CHHHHHHHHHHHHHHH-HCCCCCCCcEEEEEEECCEEE
Confidence 36899999999999999999999999999999999987643 3445677888999988 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
||||||+ ||+|..++... ..++|.+++.|+.||+.||+|||++|||||||||+||||
T Consensus 100 iVmEy~~---------------------gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl 158 (350)
T 4b9d_A 100 IVMDYCE---------------------GGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL 158 (350)
T ss_dssp EEEECCT---------------------TCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTCEETTCCGGGEEE
T ss_pred EEEeCCC---------------------CCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCCHHHEEE
Confidence 9999999 55666666543 467999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||+||||++|++||.+.+..+++.+|.
T Consensus 159 ~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~ 238 (350)
T 4b9d_A 159 TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVLKII 238 (350)
T ss_dssp CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 99999999999999864333334557899999999999999999999999999999999999999999999999999999
Q ss_pred hCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
++.+ .++..+|+++++||.+||++||++|| +++|+++||||+.
T Consensus 239 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~e~l~hp~~~~ 282 (350)
T 4b9d_A 239 SGSFPPVSLHYSYDLRSLVSQLFKRNPRDRP------SVNSILEKGFIAK 282 (350)
T ss_dssp HTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHTSHHHHT
T ss_pred cCCCCCCCccCCHHHHHHHHHHccCChhHCc------CHHHHhcCHHhhc
Confidence 8765 56778999999999999999999999 6899999999963
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-64 Score=503.81 Aligned_cols=253 Identities=27% Similarity=0.462 Sum_probs=226.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|..+|. .++|||||+++++|++++.+|||
T Consensus 74 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~iv 149 (346)
T 4fih_A 74 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVV 149 (346)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGGCS---SGGGGHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEEeEEeecCcCeEEEEEEECCCCCEEEEEEEecCchh---HHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEE
Confidence 5699999999999999999999999999999999765332 2334667888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++.+ +.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 150 mEy~~---------------------gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~~g 207 (346)
T 4fih_A 150 MEFLE---------------------GGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 207 (346)
T ss_dssp ECCCT---------------------TEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EeCCC---------------------CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEECCCC
Confidence 99999 5555655554 6799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
++||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|.....
T Consensus 208 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 287 (346)
T 4fih_A 208 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 287 (346)
T ss_dssp CEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSC
T ss_pred CEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 99999999998755555566789999999999999999999999999999999999999999999999999999987633
Q ss_pred ---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 305 ---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 305 ---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..+..+|+++++||.+||++||++|| +++|+++||||+.
T Consensus 288 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~------ta~e~l~Hp~~~~ 329 (346)
T 4fih_A 288 PRLKNLHKVSPSLKGFLDRLLVRDPAQRA------TAAELLKHPFLAK 329 (346)
T ss_dssp CCCSCGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHTTCGGGGG
T ss_pred CCCCccccCCHHHHHHHHHHcCCChhHCc------CHHHHhcCHhhcC
Confidence 33457999999999999999999999 6899999999974
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-62 Score=493.86 Aligned_cols=314 Identities=38% Similarity=0.721 Sum_probs=280.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
...+++|++++.||+|+||.||+|+++.+++.||||++.+.........+....|..++. .++||||+++++++++.+.
T Consensus 37 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~ 115 (350)
T 1rdq_E 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSE
T ss_pred CCCHHHCEEEEEeecCcCcEEEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEcCCE
Confidence 456789999999999999999999999999999999998765544556677788888887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ ||+|..++.+.+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 116 ~~lv~e~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll 174 (350)
T 1rdq_E 116 LYMVMEYVA---------------------GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174 (350)
T ss_dssp EEEEEECCT---------------------TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEcCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCccceEEE
Confidence 999999999 66677778888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+++.. .....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 175 ~~~g~~kL~DFg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i~ 251 (350)
T 1rdq_E 175 DQQGYIQVTDFGFAKRV---KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp CTTSCEEECCCTTCEEC---SSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEcccccceec---cCCcccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCHHHHHHHHH
Confidence 99999999999999853 234557799999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLS 380 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~ 380 (494)
.+.+.+|..++.++++||.+||+.||.+||++.. .+++||++||||++++|..+.+++++||++|.+.
T Consensus 252 ~~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~-~~~~ei~~h~~f~~~~w~~~~~~~~~~p~~p~~~----------- 319 (350)
T 1rdq_E 252 SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLK-NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK----------- 319 (350)
T ss_dssp HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSST-TTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-----------
T ss_pred cCCCCCCCCCCHHHHHHHHHHhhcCHHhccCCcc-CCHHHHHhCcCcCCCCHHHHhhccCCCCCCCCCC-----------
Confidence 9999999999999999999999999999997543 3689999999999999999999999999999987
Q ss_pred CCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCe
Q psy8309 381 SKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGF 435 (494)
Q Consensus 381 ~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f 435 (494)
++.|++||| +|+.+....++.+ ..+..|.||
T Consensus 320 -----------------~~~~~~~f~-~~~~~~~~~~~~~------~~~~~f~~f 350 (350)
T 1rdq_E 320 -----------------GPGDTSNFD-DYEEEEIRVSINE------KCGKEFTEF 350 (350)
T ss_dssp -----------------STTCCTTSC-CCCCCCCCCCSSC------CSTTTTTTC
T ss_pred -----------------Ccccccccc-cccccccccCCCc------chhhhcCCC
Confidence 788999999 5776665433321 234678776
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-63 Score=512.48 Aligned_cols=323 Identities=35% Similarity=0.609 Sum_probs=272.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++. .++|||||+++++|++.++
T Consensus 65 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~ 143 (410)
T 3v8s_A 65 RMKAEDYEVVKVIGRGAFGEVQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMA-FANSPWVVQLFYAFQDDRY 143 (410)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred ccCccccEEEEEEEcCCCEEEEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCE
Confidence 345689999999999999999999999999999999998754433334445667887877 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.. ..+++..++.|+.||+.||+|||++||+||||||+||||
T Consensus 144 ~~lV~E~~~---------------------gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~givHrDLKp~NILl 201 (410)
T 3v8s_A 144 LYMVMEYMP---------------------GGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNMLL 201 (410)
T ss_dssp EEEEECCCT---------------------TEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCCHHHeeE
Confidence 999999999 5555555554 579999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCC----CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLK----YNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~----~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+.+|++||+|||+|+....... ...+.+||+.|+|||++.+.. |+.++|||||||++|||++|.+||.+.+..++
T Consensus 202 ~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~ 281 (410)
T 3v8s_A 202 DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGT 281 (410)
T ss_dssp CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHHHH
T ss_pred CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChhhH
Confidence 9999999999999986432221 245789999999999998766 88999999999999999999999999999999
Q ss_pred HHHHHhCC--CCCCc--cCCHHHHHHHHhhccCCCCC--CCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 296 FWSICNER--PRFPQ--FLSVEAKNILVHLLDKDTTK--RLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 296 ~~~i~~~~--~~~p~--~~s~~~~~li~~lL~~dP~~--R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+.+|.... +.+|. .+++++++||.+||..+|.+ |+ +++||++||||++++|+.+..+++.||++|.+.
T Consensus 282 ~~~i~~~~~~~~~p~~~~~s~~~~~li~~lL~~~~~rlgR~------~~~ei~~Hp~f~~~~w~~~~~~~~~~p~~p~~~ 355 (410)
T 3v8s_A 282 YSKIMNHKNSLTFPDDNDISKEAKNLICAFLTDREVRLGRN------GVEEIKRHLFFKNDQWAWETLRDTVAPVVPDLS 355 (410)
T ss_dssp HHHHHTHHHHCCCCTTCCCCHHHHHHHHHHSSCGGGCTTSS------CHHHHHTSGGGCCSSCCSTTGGGSCCSCCCCCS
T ss_pred HHHHHhccccccCCCcccccHHHHHHHHHHccChhhhCCCC------CHHHHhcCccccCCCHHHHhhcccCCCCCCcCC
Confidence 99998653 45554 69999999999999977766 66 789999999999999999999999999999998
Q ss_pred CCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCC-CCCccccCcccCCCccCeeeeCCCc
Q psy8309 370 EPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLT-PVDRTILESMDQTQFQGFSYTNPNA 442 (494)
Q Consensus 370 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~-~~~~~~~~~~~~~~f~~f~~~~~~~ 442 (494)
++.|++|||..++......+ +..... ..+|..|.||+|++++.
T Consensus 356 ----------------------------~~~d~~~fd~~~~~~~~~~~~~~~~~~--~~~~~~f~~f~~~~~~~ 399 (410)
T 3v8s_A 356 ----------------------------SDIDTSNFDDLEEDKGEEETFPIPKAF--VGNQLPFVGFTYYSNRR 399 (410)
T ss_dssp ----------------------------STTCCTTSCCCCSCCSCCCCCCCCSSC--CCTTGGGTTCCEECC--
T ss_pred ----------------------------CccchhhcCCccccccccccCCCchhh--cccccccccceEeCccc
Confidence 78999999987776543333 222221 24578999999999865
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-62 Score=487.61 Aligned_cols=282 Identities=43% Similarity=0.843 Sum_probs=258.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+....|..++. .++||||+++++++++...+
T Consensus 3 ~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~Iv~~~~~~~~~~~~ 81 (318)
T 1fot_A 3 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS-IVTHPFIIRMWGTFQDAQQI 81 (318)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCBTTBCCEEEEEECSSEE
T ss_pred CChHHcEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHh-hCCCCCCceEeEEEEeCCEE
Confidence 46789999999999999999999999999999999998765444455667777888877 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~lv~e~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~NIll~ 140 (318)
T 1fot_A 82 FMIMDYIE---------------------GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 140 (318)
T ss_dssp EEEECCCC---------------------SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred EEEEeCCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChheEEEc
Confidence 99999999 666777888888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+|++||+|||+++.. .....+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+.+.+|..
T Consensus 141 ~~g~~kL~Dfg~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 217 (318)
T 1fot_A 141 KNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 217 (318)
T ss_dssp TTSCEEECCCSSCEEC---SSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecCcceec---CCccccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 9999999999999853 3345678999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
..+.+|..+++++++||.+||..||.+||++.+ .+++|+++||||++++|+.+..++++||+.|.+.
T Consensus 218 ~~~~~p~~~~~~~~~li~~lL~~dp~~R~~~~~-~~~~~i~~hp~f~~~~~~~~~~~~~~~p~~p~~~ 284 (318)
T 1fot_A 218 AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ-NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 284 (318)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSST-TTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred CCCCCCCCCCHHHHHHHHHHhccCHHHcCCCcC-CCHHHHhcCccccCCCHHHHHhCCCCCCCCCCcC
Confidence 999999999999999999999999999998754 3899999999999999999999999999999876
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-63 Score=504.64 Aligned_cols=253 Identities=26% Similarity=0.447 Sum_probs=226.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|++++.||+|+||+||+|+++.+|+.||||++.+.... ..+.+.+|..+|. .++|||||+++++|++++.+|||
T Consensus 151 ~~y~~~~~iG~G~fG~V~~a~~~~tg~~vAiK~i~~~~~~---~~~~~~~Ei~il~-~l~HpnIV~l~~~~~~~~~~~iV 226 (423)
T 4fie_A 151 SYLDNFIKIGEGSTGIVCIATVRSSGKLVAVKKMDLRKQQ---RRELLFNEVVIMR-DYQHENVVEMYNSYLVGDELWVV 226 (423)
T ss_dssp GTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEESTTCS---SGGGHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEE
T ss_pred HhcEeeeEeccCcCcEEEEEEECCCCCEEEEEEEeccchh---HHHHHHHHHHHHH-hCCCCCCCceEEEEEECCEEEEE
Confidence 4699999999999999999999999999999999765322 2345678888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+ ||+|..++. .+.+++.+++.|+.||+.||+|||++|||||||||+||||+.+|
T Consensus 227 mEy~~---------------------gG~L~~~i~-~~~l~e~~~~~~~~qil~aL~ylH~~~IiHRDiKp~NILl~~~g 284 (423)
T 4fie_A 227 MEFLE---------------------GGALTDIVT-HTRMNEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDG 284 (423)
T ss_dssp EECCT---------------------TEEHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSTTTEEECTTC
T ss_pred EeCCC---------------------CCcHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHHEEEcCCC
Confidence 99999 555555554 46799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC-
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER- 303 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~- 303 (494)
+|||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++..|....
T Consensus 285 ~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~~~~~~~i~~~~~ 364 (423)
T 4fie_A 285 RVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRDNLP 364 (423)
T ss_dssp CEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC
T ss_pred CEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHHcCCC
Confidence 9999999999875555556678899999999999999999999999999999999999999999999999999998763
Q ss_pred --CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 304 --PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 304 --~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+..+..+|+++++||.+||++||++|| +++|+|+||||+.
T Consensus 365 ~~~~~~~~~s~~~~dli~~~L~~dP~~R~------ta~ell~Hp~~~~ 406 (423)
T 4fie_A 365 PRLKNLHKVSPSLKGFLDRLLVRDPAQRA------TAAELLKHPFLAK 406 (423)
T ss_dssp CCCSCTTSSCHHHHHHHHHHSCSSTTTSC------CHHHHTTCGGGGG
T ss_pred CCCcccccCCHHHHHHHHHHcCCChhHCc------CHHHHhcCHHhcC
Confidence 334467999999999999999999999 6899999999974
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-62 Score=501.63 Aligned_cols=329 Identities=35% Similarity=0.592 Sum_probs=264.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++. .++||||++++++|++.++
T Consensus 57 ~~~~~~f~~~~~lG~G~fG~V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~-~~~hp~Iv~l~~~~~~~~~ 135 (412)
T 2vd5_A 57 RLQRDDFEILKVIGRGAFSEVAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLV-NGDRRWITQLHFAFQDENY 135 (412)
T ss_dssp SCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHH-HSCTTTBCCEEEEEECSSE
T ss_pred cCChhhEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHH-hcCCCCeeeEEEEEeeCCE
Confidence 355689999999999999999999999999999999998754444444555677888887 4799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+|||||+ ||+|..++.+. ..+++..++.|+.||+.||+|||++||+||||||+|||
T Consensus 136 ~~lVmE~~~---------------------gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 194 (412)
T 2vd5_A 136 LYLVMEYYV---------------------GGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL 194 (412)
T ss_dssp EEEEECCCC---------------------SCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEEEcCCC---------------------CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccCHHHee
Confidence 999999999 55666677665 47999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhC-------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIK-------GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~-------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
|+.+|++||+|||+++....... .....+||+.|+|||++. +..|+.++|||||||++|||++|++||.+.+
T Consensus 195 ld~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~ 274 (412)
T 2vd5_A 195 LDRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADS 274 (412)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred ecCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCC
Confidence 99999999999999986433222 234579999999999997 4579999999999999999999999999999
Q ss_pred HHHHHHHHHhC--CCCCC---ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 292 EDELFWSICNE--RPRFP---QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 292 ~~~~~~~i~~~--~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
..+++.+|... ...+| ..+++++++||++||. +|.+|++. .+++||++||||++++|+.+. +..|||+|
T Consensus 275 ~~~~~~~i~~~~~~~~~p~~~~~~s~~~~dli~~lL~-~p~~Rlgr---~~~~ei~~Hpff~~i~w~~l~--~~~~p~~p 348 (412)
T 2vd5_A 275 TAETYGKIVHYKEHLSLPLVDEGVPEEARDFIQRLLC-PPETRLGR---GGAGDFRTHPFFFGLDWDGLR--DSVPPFTP 348 (412)
T ss_dssp HHHHHHHHHTHHHHCCCC----CCCHHHHHHHHTTSS-CGGGCTTT---TTHHHHHTSGGGTTCCSTTST--TSCCSCCC
T ss_pred HHHHHHHHHhcccCcCCCccccCCCHHHHHHHHHHcC-ChhhcCCC---CCHHHHhcCCCcCCCCHHHHh--hcCCCCCC
Confidence 99999998863 23444 5799999999999999 99999864 379999999999999999995 57899999
Q ss_pred cccCCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCC-----CCC-ccccCcccCCCccCeeeeCC
Q psy8309 367 RVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLT-----PVD-RTILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~-----~~~-~~~~~~~~~~~f~~f~~~~~ 440 (494)
.+. ++.|++|||...+......+ ..+ ........+..|.||||+++
T Consensus 349 ~~~----------------------------~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~g~~~~~~ 400 (412)
T 2vd5_A 349 DFE----------------------------GATDTCNFDLVEDGLTAMVSGGGETLSDIREGAPLGVHLPFVGYSYSCM 400 (412)
T ss_dssp C---------------------------------CCSSCC--CCCCCTTSSSSSCCTTTC-----CCTTGGGTTCCBSCC
T ss_pred cCC----------------------------CcccccccCcccccccccccccCCCcccccCCCccccCCCCCCCcccCc
Confidence 987 78899999975433221110 000 00001123567999999987
Q ss_pred Cccch
Q psy8309 441 NATDF 445 (494)
Q Consensus 441 ~~~~~ 445 (494)
...+.
T Consensus 401 ~~~~~ 405 (412)
T 2vd5_A 401 ALRDS 405 (412)
T ss_dssp CCCGG
T ss_pred ccccc
Confidence 65433
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-62 Score=505.28 Aligned_cols=325 Identities=35% Similarity=0.617 Sum_probs=265.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+||+|+++.+++.||||++++..............|+.++. .++||||++++++|++.+.
T Consensus 70 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~-~~~hp~Iv~l~~~~~~~~~ 148 (437)
T 4aw2_A 70 RLHREDFEILKVIGRGAFGEVAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLV-NGDSKWITTLHYAFQDDNN 148 (437)
T ss_dssp SCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHH-HSCTTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEEeCCCEEEEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEeeCCE
Confidence 345679999999999999999999999999999999998754433334444667777777 4799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|||||||+ ||+|..++.+ .+.+++..++.|+.||+.||+|||++|||||||||+|||
T Consensus 149 ~~lV~Ey~~---------------------gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~giiHrDLKp~NIL 207 (437)
T 4aw2_A 149 LYLVMDYYV---------------------GGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL 207 (437)
T ss_dssp EEEEECCCT---------------------TCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred EEEEEecCC---------------------CCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCeEecccCHHHee
Confidence 999999999 5566667766 578999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
|+.+|++||+|||+|+....... .....+||+.|+|||++. +..|+.++|||||||++|||++|.+||.+.+..
T Consensus 208 l~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~~ 287 (437)
T 4aw2_A 208 MDMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLV 287 (437)
T ss_dssp ECTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred EcCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCChh
Confidence 99999999999999976433222 234578999999999997 567999999999999999999999999999999
Q ss_pred HHHHHHHhC--CCCCCc---cCCHHHHHHHHhhccCCCCC--CCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 294 ELFWSICNE--RPRFPQ---FLSVEAKNILVHLLDKDTTK--RLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 294 ~~~~~i~~~--~~~~p~---~~s~~~~~li~~lL~~dP~~--R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+++.+|... .+.+|. .+++++++||++||..+|.+ |+ +++|+++||||++++|+.+ ++++|||+|
T Consensus 288 ~~~~~i~~~~~~~~~p~~~~~~s~~~~dLi~~lL~~~~~r~~r~------~~~eil~Hpff~~i~w~~l--~~~~~p~~P 359 (437)
T 4aw2_A 288 ETYGKIMNHKERFQFPTQVTDVSENAKDLIRRLICSREHRLGQN------GIEDFKKHPFFSGIDWDNI--RNCEAPYIP 359 (437)
T ss_dssp HHHHHHHTHHHHCCCCSSCCCSCHHHHHHHHTTSSCGGGCTTTT------TTHHHHTSGGGTTCCTTTG--GGSCCSCCC
T ss_pred HHHHhhhhccccccCCcccccCCHHHHHHHHHHhcccccccCCC------CHHHHhCCCccCCCCHHHH--hhCCCCCCC
Confidence 999999753 355564 48999999999999987766 65 6899999999999999999 478999999
Q ss_pred cccCCCCCcccccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccc-cCcccCCCccCeeeeCCCcc
Q psy8309 367 RVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTI-LESMDQTQFQGFSYTNPNAT 443 (494)
Q Consensus 367 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~-~~~~~~~~f~~f~~~~~~~~ 443 (494)
.+. ++.|++|||.+++......++..... .....+..|.||+|++++..
T Consensus 360 ~~~----------------------------~~~d~~~fd~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~ 409 (437)
T 4aw2_A 360 EVS----------------------------SPTDTSNFDVDDDCLKNSETMPPPTHTAFSGHHLPFVGFTYTSSCVL 409 (437)
T ss_dssp CCS----------------------------STTCCTTSCCC------------------CCTTGGGTTCCEESSCTT
T ss_pred cCC----------------------------CccchhhcCCcccccccccCCCCCccccccccCccccCCCcCCchhh
Confidence 988 78899999988765443322221111 11223567999999998754
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-61 Score=483.56 Aligned_cols=245 Identities=28% Similarity=0.406 Sum_probs=215.8
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..+.|++.+.||+|+||+||+|+++.+|+.||||+++++... ..|..++. .++|||||+++++|++++.+|
T Consensus 56 ~~~~~~~~~~lG~G~fG~Vy~a~~~~~g~~vAiK~i~~~~~~--------~~E~~il~-~l~HpnIV~l~~~~~~~~~~~ 126 (336)
T 4g3f_A 56 EVHWMTHQPRVGRGSFGEVHRMKDKQTGFQCAVKKVRLEVFR--------VEELVACA-GLSSPRIVPLYGAVREGPWVN 126 (336)
T ss_dssp TTTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCC--------THHHHTTT-TCCCTTBCCEEEEEEETTEEE
T ss_pred chhheEeCcEeccCCCeEEEEEEECCCCCEEEEEEECHHHhH--------HHHHHHHH-hCCCCCCCcEEEEEEECCEEE
Confidence 457899999999999999999999999999999999875332 24666666 689999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||||+ ||+|..++.+.+.+++.+++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 127 ivmEy~~---------------------gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDlKp~NILl~~ 185 (336)
T 4g3f_A 127 IFMELLE---------------------GGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSS 185 (336)
T ss_dssp EEECCCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEECT
T ss_pred EEEeccC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceecccCHHHEEEeC
Confidence 9999999 6677778888899999999999999999999999999999999999999999
Q ss_pred CC-CEEEeecCceeeeeccCC-----cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 223 EG-HVRIADFGMCKLQIYLDK-----TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 223 ~g-~vkL~DFGla~~~~~~~~-----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
+| ++||+|||+|+....... ...+.|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++
T Consensus 186 ~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~ 265 (336)
T 4g3f_A 186 DGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLC 265 (336)
T ss_dssp TSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCSCCH
T ss_pred CCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHH
Confidence 98 699999999986432211 234578999999999999999999999999999999999999999998888888
Q ss_pred HHHHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+|....+ .+|+.+++++++||.+||++||.+|| ++.|+++
T Consensus 266 ~~i~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------sa~el~~ 309 (336)
T 4g3f_A 266 LKIASEPPPIREIPPSCAPLTAQAIQEGLRKEPVHRA------SAMELRR 309 (336)
T ss_dssp HHHHHSCCGGGGSCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHcCCCCchhcCccCCHHHHHHHHHHccCCHhHCc------CHHHHHH
Confidence 99988765 35778999999999999999999999 5677754
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-61 Score=470.47 Aligned_cols=251 Identities=25% Similarity=0.479 Sum_probs=217.5
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----CCeeE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----DSHLF 142 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~~~~~ 142 (494)
|++.++||+|+||+||+|+++.++..||||++.+... .....+.+..|..++. .++|||||+++++|++ +..+|
T Consensus 28 ~~~~~~iG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~~~~~~ 105 (290)
T 3fpq_A 28 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIV 105 (290)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEEEETTEEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEeeccCCCcEEE
Confidence 4788899999999999999999999999999987543 3445567788888887 5899999999999975 35689
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLKp~NILl 220 (494)
||||||+ ||+|..++.+.+.+++..++.|+.||+.||+|||++| ||||||||+||||
T Consensus 106 lvmEy~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~ylH~~~~~IiHRDlKp~NILl 164 (290)
T 3fpq_A 106 LVTELMT---------------------SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 164 (290)
T ss_dssp EEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCCCCCGGGEEE
T ss_pred EEEeCCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCEEecccChhheeE
Confidence 9999999 6667778888889999999999999999999999999 9999999999999
Q ss_pred CC-CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHHH
Q psy8309 221 DY-EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFWS 298 (494)
Q Consensus 221 ~~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~~ 298 (494)
+. +|++||+|||+|+. .......+.|||+.|||||++.+ .|+.++|||||||+||||++|++||.+.+ ...++..
T Consensus 165 ~~~~g~vKl~DFGla~~--~~~~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~~~~~~~~~ 241 (290)
T 3fpq_A 165 TGPTGSVKIGDLGLATL--KRASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 241 (290)
T ss_dssp SSTTSCEEECCTTGGGG--CCTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred ECCCCCEEEEeCcCCEe--CCCCccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCCcHHHHHHH
Confidence 84 89999999999974 23445667899999999999976 69999999999999999999999998654 4556666
Q ss_pred HHhCCC--CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 299 ICNERP--RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 299 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+..+.. .++..+++++++||.+||++||++|| +++|+++||||++
T Consensus 242 i~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------s~~e~l~Hp~~~~ 288 (290)
T 3fpq_A 242 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY------SIKDLLNHAFFQE 288 (290)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGGGC-
T ss_pred HHcCCCCCCCCccCCHHHHHHHHHHccCChhHCc------CHHHHhcCccccC
Confidence 665532 34567899999999999999999999 6899999999974
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-60 Score=495.70 Aligned_cols=301 Identities=48% Similarity=0.917 Sum_probs=256.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|+++.+++.||||++++..............|..++. .++||||+++++++.+.+.
T Consensus 144 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~l~~~~~~~~~ 222 (446)
T 4ejn_A 144 RVTMNEFEYLKLLGKGTFGKVILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQ-NSRHPFLTALKYSFQTHDR 222 (446)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHC-------------CCC-CCSCTTSCCEEEEEEETTE
T ss_pred CCChHHcEEeEEEeeCcCEEEEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHH-hCCCCeEeeEEEEEeeCCE
Confidence 456789999999999999999999999999999999998765445555566677777766 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NIL 219 (494)
+|+|||||+ ||+|..++...+.+++..++.++.||+.||+|||+ +||+||||||+|||
T Consensus 223 ~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~giiHrDlkp~NIl 281 (446)
T 4ejn_A 223 LCFVMEYAN---------------------GGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLM 281 (446)
T ss_dssp EEEEECCCS---------------------SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCCCGGGEE
T ss_pred EEEEEeeCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCCEEECCCCHHHEE
Confidence 999999999 56666778888899999999999999999999998 99999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
|+.+|++||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+++..|
T Consensus 282 l~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~i 361 (446)
T 4ejn_A 282 LDKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI 361 (446)
T ss_dssp ECSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred ECCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 99999999999999985444444566789999999999999999999999999999999999999999999999999999
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCccccc
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKL 379 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~ 379 (494)
......+|..+++++++||.+||++||.+||++.. .+++|+++||||++++|+.+..+++.|||+|.+.
T Consensus 362 ~~~~~~~p~~~~~~~~~li~~~L~~dP~~R~~~~~-~t~~ell~hp~f~~~~~~~~~~~~~~pp~~p~~~---------- 430 (446)
T 4ejn_A 362 LMEEIRFPRTLGPEAKSLLSGLLKKDPKQRLGGGS-EDAKEIMQHRFFAGIVWQHVYEKKLSPPFKPQVT---------- 430 (446)
T ss_dssp HHCCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCST-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCSCS----------
T ss_pred HhCCCCCCccCCHHHHHHHHHHcccCHHHhCCCCC-CCHHHHHhCccccCCCHHHHhhCcCCCCccCCCC----------
Confidence 99999999999999999999999999999997543 3799999999999999999999999999999988
Q ss_pred CCCCCCCCccchhhhhhccccccCCCCccccCC
Q psy8309 380 SSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAE 412 (494)
Q Consensus 380 ~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~ 412 (494)
++.|++|||++||.+
T Consensus 431 ------------------~~~~~~~~~~~~~~~ 445 (446)
T 4ejn_A 431 ------------------SETDTRYFDEEFTAQ 445 (446)
T ss_dssp ------------------STTCCTTC-------
T ss_pred ------------------CccchhhcchhhhcC
Confidence 789999999999875
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-59 Score=482.19 Aligned_cols=258 Identities=22% Similarity=0.349 Sum_probs=222.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------D 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------~ 138 (494)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .........++|..+|. .++|||||++++++.. .
T Consensus 54 ~~Y~~~~~lG~G~fG~V~~a~~~~t~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~~~ 131 (398)
T 4b99_A 54 DEYEIIETIGNGAYGVVSSARRRLTGQQVAIKKIPNAF-DVVTNAKRTLRELKILK-HFKHDNIIAIKDILRPTVPYGEF 131 (398)
T ss_dssp SSEEEEEEEEECSSCEEEEEEETTTCCEEEEEEETTTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSSCTTTC
T ss_pred CCeEEEEEEecccCeEEEEEEECCCCCEEEEEEECccc-cchHHHHHHHHHHHHHH-hcCCCCcceEeeeeecccccccC
Confidence 57999999999999999999999999999999997653 23445567788999988 5799999999999764 4
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|||||||. |+|..++.+.+.+++.+++.|+.||+.||+|||++|||||||||+||
T Consensus 132 ~~~~ivmE~~~----------------------g~L~~~i~~~~~l~~~~~~~~~~qil~al~ylH~~~iiHRDlKP~NI 189 (398)
T 4b99_A 132 KSVYVVLDLME----------------------SDLHQIIHSSQPLTLEHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNL 189 (398)
T ss_dssp CCEEEEEECCS----------------------EEHHHHHTSSSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred CEEEEEEeCCC----------------------CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCcCCCcCcccc
Confidence 68999999995 35677788888999999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeec----cCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIY----LDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~----~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
|++.+|.+||+|||+|+.... ......+.|||+.|||||++.+. .|+.++||||+||++|||++|++||.+.+..
T Consensus 190 l~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 190 LVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp EECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 999999999999999985322 12335578999999999999875 4699999999999999999999999999999
Q ss_pred HHHHHHHhCCCCC-------------------------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 294 ELFWSICNERPRF-------------------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 294 ~~~~~i~~~~~~~-------------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
+++..|....... .+.+++++++||.+||.+||.+|| +++|+|
T Consensus 270 ~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~------ta~e~L 343 (398)
T 4b99_A 270 HQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRMLRFEPSARI------SAAAAL 343 (398)
T ss_dssp HHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSTTTSC------CHHHHT
T ss_pred HHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHCcCChhHCc------CHHHHh
Confidence 9888886421111 124789999999999999999999 689999
Q ss_pred cCCCcCCCCh
Q psy8309 343 AHEYFRGLDW 352 (494)
Q Consensus 343 ~h~~f~~~~w 352 (494)
+||||+...+
T Consensus 344 ~Hp~f~~~~~ 353 (398)
T 4b99_A 344 RHPFLAKYHD 353 (398)
T ss_dssp TSGGGTTTCC
T ss_pred cCHhhCcCCC
Confidence 9999987643
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-59 Score=467.78 Aligned_cols=308 Identities=42% Similarity=0.787 Sum_probs=244.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+..++|++++.||+|+||.||+|++. .+++.||||++++..... .........|..++. .++||||+++++++.
T Consensus 13 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~ 91 (327)
T 3a62_A 13 KIRPECFELLRVLGKGGYGKVFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILE-EVKHPFIVDLIYAFQ 91 (327)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEECSSTTTTCEEEEEEECCC--------------HHHHHH-HCCCTTBCCEEEEEE
T ss_pred CCCHHHeEEEEEEEeCCCEEEEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHH-hCCCCCccceeEEEE
Confidence 345679999999999999999999985 688999999998764322 233445667888877 579999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+.+.+|+|||||+ |++|..++...+.+++..++.++.||+.||.|||++||+||||||+
T Consensus 92 ~~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~ 150 (327)
T 3a62_A 92 TGGKLYLILEYLS---------------------GGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGIIYRDLKPE 150 (327)
T ss_dssp CSSCEEEEEECCT---------------------TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCTT
T ss_pred cCCEEEEEEeCCC---------------------CCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEEcccCCHH
Confidence 9999999999998 5666777777888999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|||++.+|++||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+
T Consensus 151 Nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 230 (327)
T 3a62_A 151 NIMLNHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTI 230 (327)
T ss_dssp TEEECTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred HeEECCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 99999999999999999976444444556778999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcc
Q psy8309 297 WSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPW 376 (494)
Q Consensus 297 ~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~ 376 (494)
..|......+|..++.++++||.+||..||.+||++.. .+++++++||||++++|+.+..+++.||++|.+.
T Consensus 231 ~~i~~~~~~~p~~~~~~~~~li~~~L~~dp~~R~~~~~-~~~~e~l~hp~f~~~~~~~~~~~~~~~p~~p~~~------- 302 (327)
T 3a62_A 231 DKILKCKLNLPPYLTQEARDLLKKLLKRNAASRLGAGP-GDAGEVQAHPFFRHINWEELLARKVEPPFKPLLQ------- 302 (327)
T ss_dssp HHHHHTCCCCCTTSCHHHHHHHHHHSCSCGGGSTTSST-TTHHHHHHSGGGSSCCHHHHHTTCSCCSCCCC---------
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHHHhcCHhhccCCCC-CCHHHHHcCCcccCCCHHHHhhccCCCCCCCCcC-------
Confidence 99999999999999999999999999999999998754 3799999999999999999999999999999887
Q ss_pred cccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCC
Q psy8309 377 IKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPV 419 (494)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~ 419 (494)
...|.++||..|+.+.+..+|.
T Consensus 303 ---------------------~~~~~~~~~~~~~~~~~~~~~~ 324 (327)
T 3a62_A 303 ---------------------SEEDVSQFDSKFTRQTPVDSPD 324 (327)
T ss_dssp -------------------------------------------
T ss_pred ---------------------ChhhhhhcchhhhccccCCCCC
Confidence 6788999999998877665553
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-59 Score=494.38 Aligned_cols=286 Identities=37% Similarity=0.662 Sum_probs=255.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|+++++||+|+||+||+|+++.+|+.||||++.+..............|..++. .++||||++++++|++.+.
T Consensus 181 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~ 259 (543)
T 3c4z_A 181 PMGEDWFLDFRVLGRGGFGEVFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILA-KVHSRFIVSLAYAFETKTD 259 (543)
T ss_dssp CCCGGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred cCChhheEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHH-hcCCCCEeeEEEEEeeCCE
Confidence 456789999999999999999999999999999999998765544455667888998887 4799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+|+|||||+| |+|..++.. ...+++..++.|+.||+.||+|||++||+||||||+
T Consensus 260 l~lVmE~~~g---------------------g~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gIvHrDLKP~ 318 (543)
T 3c4z_A 260 LCLVMTIMNG---------------------GDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPE 318 (543)
T ss_dssp EEEEECCCTT---------------------CBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGG
T ss_pred EEEEEEeccC---------------------CCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHHcCCcccCCChH
Confidence 9999999994 455555544 347999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----CH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC----DE 292 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~ 292 (494)
||||+.+|++||+|||+++............+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+. ..
T Consensus 319 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~~~~~~ 398 (543)
T 3c4z_A 319 NVLLDDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVEN 398 (543)
T ss_dssp GEEECTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTTCCCCH
T ss_pred HEEEeCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCccchhH
Confidence 99999999999999999986544344455679999999999999999999999999999999999999999875 45
Q ss_pred HHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 293 DELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 293 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.++...|......+|..+++++++||.+||++||.+||++.+ .++++|++||||++++|..+.++.+.|||+|...
T Consensus 399 ~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~-~~a~ei~~Hpff~~i~w~~l~~~~~~pp~~P~~~ 474 (543)
T 3c4z_A 399 KELKQRVLEQAVTYPDKFSPASKDFCEALLQKDPEKRLGFRD-GSCDGLRTHPLFRDISWRQLEAGMLTPPFVPDSR 474 (543)
T ss_dssp HHHHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCCCBT-TBSHHHHTSGGGTTCCHHHHHTTCSCCSCCCCSS
T ss_pred HHHHHHHhhcccCCCcccCHHHHHHHHHhccCCHhHCCCCcc-cCHHHHHcCccccCCCHHHHHcCCCCCCCCCCcc
Confidence 778888999999999999999999999999999999998755 3789999999999999999999999999999764
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-59 Score=461.08 Aligned_cols=256 Identities=27% Similarity=0.427 Sum_probs=200.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+...+|..++. .++|||||+++++|.+.+
T Consensus 4 l~dy~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~--~~~~~~~~~~E~~il~-~l~HpnIV~~~~~~~~~~~~~~ 80 (299)
T 4g31_A 4 LTDFEPIQCLGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALA-KLEHPGIVRYFNAWLEKNTTEK 80 (299)
T ss_dssp HHHEEEEEEEEECC--EEEEEEETTTCCEEEEEEEEECS--SHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEEC----
T ss_pred chhCEEeeEEecCCCeEEEEEEECCCCCEEEEEEEeccC--CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEecCcccc
Confidence 357999999999999999999999999999999997642 3344566778988887 579999999999997644
Q ss_pred --------eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCC---CHHHHHHHHHHHHHHHHHHHhCCC
Q psy8309 140 --------HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF---DEGRARFYAAEIVSGMRFLHKKGI 208 (494)
Q Consensus 140 --------~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l---~e~~~~~~~~qi~~aL~yLH~~gi 208 (494)
++|||||||+ ||+|..++...+.+ ++..++.|+.||+.||+|||++||
T Consensus 81 ~~~~~~~~~l~ivmE~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~~~I 139 (299)
T 4g31_A 81 LQPSSPKVYLYIQMQLCR---------------------KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGL 139 (299)
T ss_dssp ------CEEEEEEEECCC---------------------SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred ccccCCCcEEEEEEecCC---------------------CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHHCcC
Confidence 4899999999 55555666655543 456689999999999999999999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccC------------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHH
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD------------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGIL 276 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~------------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi 276 (494)
|||||||+||||+.+|++||+|||+|+...... ....+.|||+.|||||++.+..|+.++|||||||+
T Consensus 140 iHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvi 219 (299)
T 4g31_A 140 MHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLI 219 (299)
T ss_dssp CCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCCCCTHHHHHHHHHH
T ss_pred ccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHH
Confidence 999999999999999999999999998643221 12245689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCH-HHHHHHHHhCCCCCC---ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 277 LYEMHVGQSPFSGCDE-DELFWSICNERPRFP---QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 277 l~ell~G~~Pf~~~~~-~~~~~~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
+|||++ ||.+... ...+..+.+. .+| ...++++++||.+||++||.+|| ++.|+++||||++++|
T Consensus 220 lyell~---Pf~~~~~~~~~~~~~~~~--~~p~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~eil~h~~~~~~~~ 288 (299)
T 4g31_A 220 LFELLY---PFSTQMERVRTLTDVRNL--KFPPLFTQKYPCEYVMVQDMLSPSPMERP------EAINIIENAVFEDLDF 288 (299)
T ss_dssp HHHHHS---CCSSHHHHHHHHHHHHTT--CCCHHHHHHCHHHHHHHHHHTCSSGGGSC------CHHHHHTSGGGCCC--
T ss_pred HHHHcc---CCCCccHHHHHHHHHhcC--CCCCCCcccCHHHHHHHHHHcCCChhHCc------CHHHHhcCHhhCCCCC
Confidence 999996 8865422 2333344433 334 34678889999999999999999 6899999999999999
Q ss_pred hH
Q psy8309 353 QA 354 (494)
Q Consensus 353 ~~ 354 (494)
..
T Consensus 289 p~ 290 (299)
T 4g31_A 289 PG 290 (299)
T ss_dssp --
T ss_pred CC
Confidence 43
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-58 Score=467.80 Aligned_cols=281 Identities=33% Similarity=0.654 Sum_probs=254.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|+++.+++.||||++.+..............|..++. .++|||||+++++|++.+.
T Consensus 11 ~v~~~~y~i~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~ 89 (384)
T 4fr4_A 11 DVNFDHFEILRAIGKGSFGKVCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQ-GLEHPFLVNLWYSFQDEED 89 (384)
T ss_dssp CCCGGGEEEEEEEECCTTCCEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSE
T ss_pred CCChHHeEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCE
Confidence 566789999999999999999999999999999999998765555566677888998887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||. ||+|..++...+.+++..++.|+.||+.||.|||++||+||||||+||||
T Consensus 90 ~~lv~e~~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~givHrDlkp~NIll 148 (384)
T 4fr4_A 90 MFMVVDLLL---------------------GGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILL 148 (384)
T ss_dssp EEEEECCCT---------------------TEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEecCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCcHHHeEE
Confidence 999999999 66777788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCC---CCHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSG---CDEDE 294 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~---~~~~~ 294 (494)
+.+|++||+|||+++.. .......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|..||.+ ....+
T Consensus 149 ~~~g~vkL~DFG~a~~~-~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~ 227 (384)
T 4fr4_A 149 DEHGHVHITDFNIAAML-PRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKE 227 (384)
T ss_dssp CTTSCEEECCCTTCEEC-CTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCTTSCHHH
T ss_pred CCCCCEEEeccceeeec-cCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCCCccHHH
Confidence 99999999999999863 33445667899999999999974 4589999999999999999999999974 34567
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+...+......+|..++.++++||.+||+.||.+||+ +++++++||||++++|+.+.++++.|||+|...
T Consensus 228 ~~~~~~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~s-----~~~~l~~hp~f~~~~w~~~~~~~~~p~~~p~~~ 297 (384)
T 4fr4_A 228 IVHTFETTVVTYPSAWSQEMVSLLKKLLEPNPDQRFS-----QLSDVQNFPYMNDINWDAVFQKRLIPGFIPNKG 297 (384)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHSCSSGGGSCC-----SHHHHHTSGGGTTCCHHHHHTTCSCCCCCCSCC
T ss_pred HHHHHhhcccCCCCcCCHHHHHHHHHHhcCCHhHhcc-----cHHHHHcChhhhcCCHHHHHhCCCCCCCCCCCC
Confidence 7778888889999999999999999999999999995 389999999999999999999999999999754
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-58 Score=463.37 Aligned_cols=252 Identities=22% Similarity=0.391 Sum_probs=205.9
Q ss_pred CCceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
++|++++.||+|+||+||+|+++ .+++.||||++.+.. .......|..++....+|||||+++++|++.+++
T Consensus 21 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~~~~vAiK~i~~~~-----~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~ 95 (361)
T 4f9c_A 21 NVFKIEDKIGEGTFSSVYLATAQLQVGPEEKIALKHLIPTS-----HPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHV 95 (361)
T ss_dssp GTCEEEEEEEECSSEEEEEEEEEBTTSCEEEEEEEEECTTS-----CHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEE
T ss_pred CcEEEEEEEecccCcEEEEEEEcccCCCCCEEEEEEEcccc-----CHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEE
Confidence 57999999999999999999986 468899999986542 2345678888888666899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|||||||+|| +|...+ +.+++.+++.|+.||+.||+|||++|||||||||+|||++
T Consensus 96 ~lvmE~~~g~---------------------~L~~~~---~~l~~~~~~~~~~qll~al~ylH~~gIiHRDiKPeNiLl~ 151 (361)
T 4f9c_A 96 VIAMPYLEHE---------------------SFLDIL---NSLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYN 151 (361)
T ss_dssp EEEEECCCCC---------------------CHHHHH---TTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEE
T ss_pred EEEEeCCCcc---------------------cHHHHH---cCCCHHHHHHHHHHHHHHHHHHHHCCeEeCcCCHHHeEEe
Confidence 9999999954 444444 3599999999999999999999999999999999999998
Q ss_pred CC-CCEEEeecCceeeeecc----------------------------CCcccccCCCCCccChhhhCCC-CCCCcchHH
Q psy8309 222 YE-GHVRIADFGMCKLQIYL----------------------------DKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWW 271 (494)
Q Consensus 222 ~~-g~vkL~DFGla~~~~~~----------------------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~Diw 271 (494)
.+ |++||+|||+|+..... .....+.|||+.|||||++.+. .|+.++|||
T Consensus 152 ~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiW 231 (361)
T 4f9c_A 152 RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMW 231 (361)
T ss_dssp TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCHHHHTTCSCCCTHHHHH
T ss_pred CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCHHHHcCCCCCCCccchh
Confidence 77 89999999999753211 1123456899999999999876 589999999
Q ss_pred HHHHHHHHHHhCCCCCCC-CCHHHHHHHHHh--------------------------------------CCC--------
Q psy8309 272 SFGILLYEMHVGQSPFSG-CDEDELFWSICN--------------------------------------ERP-------- 304 (494)
Q Consensus 272 SlGvil~ell~G~~Pf~~-~~~~~~~~~i~~--------------------------------------~~~-------- 304 (494)
|+||++|||++|++||.. .+..+.+..|.. ...
T Consensus 232 SlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~p~~~~~ 311 (361)
T 4f9c_A 232 SAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLCERLRGMDSSTPKLTSD 311 (361)
T ss_dssp HHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHHHHHC------------
T ss_pred hhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHHHhhccccccccccccc
Confidence 999999999999999954 445455444431 000
Q ss_pred --------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 305 --------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 305 --------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
.....+|++++|||.+||+.||++|+ +++|+|+||||++++
T Consensus 312 ~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~------ta~eaL~Hp~f~~i~ 360 (361)
T 4f9c_A 312 IQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRI------TAEEALLHPFFKDMS 360 (361)
T ss_dssp ----------CTTCCHHHHHHHHHHTCSCTTTSC------CHHHHHTSGGGTTC-
T ss_pred cccccccccccccCCHHHHHHHHHHCcCChhHCc------CHHHHhcCcccCCCC
Confidence 11135789999999999999999999 689999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-57 Score=488.67 Aligned_cols=260 Identities=24% Similarity=0.448 Sum_probs=233.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+.+|..+|. .++|||||+++++|++.+.+||
T Consensus 156 l~~Y~i~~~lG~G~fg~V~~~~~~~tg~~~AiK~i~~~~---~~~~~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~i 231 (573)
T 3uto_A 156 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMS-VLRHPTLVNLHDAFEDDNEMVM 231 (573)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHH-HTCCTTBCCEEEEEECSSEEEE
T ss_pred ccccEEEEEEeeccCeEEEEEEECCCCCEEEEEEEeccc---hhhHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEE
Confidence 578999999999999999999999999999999997642 334456778888887 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||+ ||+|..++. +.+.|++.+++.|++||+.||+|||++||+||||||+|||++.
T Consensus 232 v~E~~~---------------------gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHRDlKp~Nill~~ 290 (573)
T 3uto_A 232 IYEFMS---------------------GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 290 (573)
T ss_dssp EEECCC---------------------CCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEeecC---------------------CCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeccCChhhccccC
Confidence 999999 556666665 4468999999999999999999999999999999999999986
Q ss_pred C--CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 223 E--GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 ~--g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+ |++||+|||+|+.. .......+.|||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 291 ~~~~~vKl~DFG~a~~~-~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~~~~~~i~ 369 (573)
T 3uto_A 291 KRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 369 (573)
T ss_dssp SSCCCEEECCCSSCEEC-CTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEeeccceeEc-cCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHHHHHHHHH
Confidence 4 89999999999864 33445567899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
...+.++ ..+|+++++||.+||++||.+|| +++|+|+||||+..+|...
T Consensus 370 ~~~~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~------t~~e~l~Hpw~~~~~~~~~ 422 (573)
T 3uto_A 370 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM------TIHQALEHPWLTPGNAPGR 422 (573)
T ss_dssp TTCCCCCSGGGTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSTTTSCCCCTTT
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCc------CHHHHhcCcCcCCCCCCCc
Confidence 8877765 46899999999999999999999 6899999999999888653
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-57 Score=479.29 Aligned_cols=285 Identities=38% Similarity=0.646 Sum_probs=253.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|+++++||+|+||.||+|+++.+|+.||||++.+..............|..++. .++|||||+++++|++.+.
T Consensus 180 ~~~~~~f~~~~~LG~G~fG~Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~-~l~hp~Iv~l~~~~~~~~~ 258 (576)
T 2acx_A 180 PVTKNTFRQYRVLGKGGFGEVCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILE-KVNSRFVVSLAYAYETKDA 258 (576)
T ss_dssp CCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred CccccceEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHH-HcCCCCEeeEEEEEeeCCE
Confidence 356789999999999999999999999999999999998765544555667788888887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+|||||+ ||+|..++...+ .+++..++.|+.||+.||+|||++||+||||||+||
T Consensus 259 l~lVmEy~~---------------------gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~gIvHrDLKPeNI 317 (576)
T 2acx_A 259 LCLVLTLMN---------------------GGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENI 317 (576)
T ss_dssp EEEEECCCC---------------------SCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred EEEEEEcCC---------------------CCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCchheE
Confidence 999999999 555666666544 499999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----CHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC----DEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~----~~~~ 294 (494)
||+.+|++||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+. ...+
T Consensus 318 Lld~~g~vKL~DFGla~~~~-~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~~~~~~~~ 396 (576)
T 2acx_A 318 LLDDHGHIRISDLGLAVHVP-EGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREE 396 (576)
T ss_dssp EECTTSCEEECCCTTCEECC-TTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSSSCCCHHH
T ss_pred EEeCCCCeEEEecccceecc-cCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccccchhHHH
Confidence 99999999999999998632 233445679999999999999999999999999999999999999999875 3466
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+...+......+|..+++++++||.+||++||.+|||+.. .+++||++||||++++|+.+..+.++|||+|...
T Consensus 397 i~~~i~~~~~~~p~~~s~~~~dLI~~lL~~dP~~R~g~~~-~sa~eil~HpfF~~i~w~~l~~~~~~pp~~p~~~ 470 (576)
T 2acx_A 397 VERLVKEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRG-GSAREVKEHPLFKKLNFKRLGAGMLEPPFKPDPQ 470 (576)
T ss_dssp HHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTCSS-SHHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHhhcccccCCccCCHHHHHHHHHhccCCHHHcCCCCC-CCHHHHHhChhhccCCHHHHhcCCCCCCCCCCcc
Confidence 7778888888899999999999999999999999998743 3789999999999999999999999999999764
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-57 Score=445.19 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=216.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|.+.+.||+|+||+||+|++. .++..||||+++.. .....+.+..|..++. .++|||||++++++
T Consensus 9 ~I~r~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~-~l~HpnIV~l~g~~ 84 (299)
T 4asz_A 9 HIKRHNIVLKRELGEGAFGKVFLAECYNLCPEQDKILVAVKTLKDA---SDNARKDFHREAELLT-NLQHEHIVKFYGVC 84 (299)
T ss_dssp BCCGGGEEEEEEEEC--CCCEEEEEECSCC----CEEEEEEEECSC---CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEE
T ss_pred ccCHHHeEEeeEEeeCCCcEEEEEEECCcccCCCCEEEEEEEeCCC---ChHHHHHHHHHHHHHH-hCCCCCCccEEEEE
Confidence 355679999999999999999999875 36788999999754 3445566788888887 58999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+++.+|||||||+||+|.+.+........ +...-.....+++.++..++.||+.||+|||+++||||||||
T Consensus 85 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~--------~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDlKp 156 (299)
T 4asz_A 85 VEGDPLIMVFEYMKHGDLNKFLRAHGPDAV--------LMAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLAT 156 (299)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHHTSHHHH--------HC----CCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCcHHHHHHhcCcccc--------cccccCCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccCH
Confidence 999999999999996665321111000000 000001234799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+||||+.++++||+|||+|+....... .....+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.+.
T Consensus 157 ~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~ 236 (299)
T 4asz_A 157 RNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSN 236 (299)
T ss_dssp GGEEECGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred hhEEECCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999999999999985322221 2334579999999999999999999999999999999998 9999999999
Q ss_pred HHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 293 DELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 293 ~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+++..|..+. +..|..+++++.+||.+||+.||++|| ++++| |+|++
T Consensus 237 ~~~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RP------s~~~i--~~~L~ 285 (299)
T 4asz_A 237 NEVIECITQGRVLQRPRTCPQEVYELMLGCWQREPHMRK------NIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHH--HHHHH
T ss_pred HHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc------CHHHH--HHHHH
Confidence 99999998764 578889999999999999999999999 56777 44554
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-56 Score=446.60 Aligned_cols=266 Identities=27% Similarity=0.356 Sum_probs=211.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|.+.++||+|+||+||+|+++ .++..||||+++.. .....+.+..|..++. .++|||||++++++
T Consensus 37 ~i~~~d~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~---~~~~~~~f~~E~~il~-~l~HpnIV~l~g~~ 112 (329)
T 4aoj_A 37 HIKRRDIVLKWELGEGAFGKVFLAECHNLLPEQDKMLVAVKALKEA---SESARQDFQREAELLT-MLQHQHIVRFFGVC 112 (329)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEESSSCC---CEEEEEEEESCC---SHHHHHHHHHHHHHHT-TCCCTTBCCEEEEE
T ss_pred ccCHHHeEEEEEEccCCCcEEEEEEECCcccCCCCeEEEEEEECcC---CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEE
Confidence 355679999999999999999999875 36889999999753 3445567788988887 57999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchh--HHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM--FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~--~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
.+.+.+|||||||++|+|.+.+..... ...+. ......+.+++.++..|+.||+.||+|||+++||||||
T Consensus 113 ~~~~~~~lV~Ey~~~G~L~~~l~~~~~--------~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDL 184 (329)
T 4aoj_A 113 TEGRPLLMVFEYMRHGDLNRFLRSHGP--------DAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDL 184 (329)
T ss_dssp CSSSSEEEEEECCTTCBHHHHHHTSSC--------C-----------CCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred EECCEEEEEEEcCCCCcHHHHHHhcCc--------ccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhcCCeecccc
Confidence 999999999999997766321110000 00000 00112357999999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~ 290 (494)
||+||||+.++++||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||+||||+| |+.||.+.
T Consensus 185 Kp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~ 264 (329)
T 4aoj_A 185 ATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQL 264 (329)
T ss_dssp CGGGEEEETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSS
T ss_pred cHhhEEECCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999998543222 22345789999999999999999999999999999999999 99999999
Q ss_pred CHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 291 DEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 291 ~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..+++..|..+ .+..|..+++++.+||.+||++||++|| +++||+++
T Consensus 265 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~cl~~dP~~RP------s~~ei~~~ 313 (329)
T 4aoj_A 265 SNTEAIDCITQGRELERPRACPPEVYAIMRGCWQREPQQRH------SIKDVHAR 313 (329)
T ss_dssp CHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHCCSSTTTSC------CHHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCcccccHHHHHHHHHHcCcChhHCc------CHHHHHHH
Confidence 999999988875 5778899999999999999999999999 56777653
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-56 Score=443.04 Aligned_cols=259 Identities=25% Similarity=0.364 Sum_probs=205.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..+++++.+.||+|+||+||+|+++. .||||+++... ......+.+..|..++. .++|||||++++++. ++.
T Consensus 32 ei~~~~l~l~~~iG~G~fG~Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~f~~E~~il~-~l~HpNIV~l~g~~~-~~~ 105 (307)
T 3omv_A 32 EIEASEVMLSTRIGSGSFGTVYKGKWHG---DVAVKILKVVD-PTPEQFQAFRNEVAVLR-KTRHVNILLFMGYMT-KDN 105 (307)
T ss_dssp BCCTTSCCEEEECCCCSSSEEEEEESSS---EEEEEECCCSS-CCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSS
T ss_pred EEcHHHeEEeeEEeeCCCcEEEEEEECC---cEEEEEEEecC-CCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEE-CCe
Confidence 5667899999999999999999998654 38999987542 23445667788888887 689999999999875 567
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|||||||+ ||+|..++.. .+.+++.++..|+.||+.||+|||++|||||||||+|||
T Consensus 106 ~~iVmEy~~---------------------gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~~~IiHRDlKp~NIL 164 (307)
T 3omv_A 106 LAIVTQWCE---------------------GSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIF 164 (307)
T ss_dssp CEEEEECCS---------------------SCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCCSSSEE
T ss_pred EEEEEEcCC---------------------CCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCccCHHHEE
Confidence 999999999 5555666654 467999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
|+.++++||+|||+|+..... .....+.+||+.|||||++.+. .|+.++|||||||+||||+||+.||.+.+...
T Consensus 165 l~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~~~ 244 (307)
T 3omv_A 165 LHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRD 244 (307)
T ss_dssp EETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHH
T ss_pred ECCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCChHH
Confidence 999999999999999853321 2234567999999999999643 58999999999999999999999999876655
Q ss_pred HHHHHHhCCC------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 295 LFWSICNERP------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 295 ~~~~i~~~~~------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
....+..... .++..+++++++||.+||++||++||++.+....-|.++|++
T Consensus 245 ~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~Le~l~~~l 302 (307)
T 3omv_A 245 QIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSSIELLQHSL 302 (307)
T ss_dssp HHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHHHHHHHTTC
T ss_pred HHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHhccC
Confidence 5555544322 245678999999999999999999995433222233455554
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-56 Score=439.86 Aligned_cols=271 Identities=23% Similarity=0.320 Sum_probs=217.3
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
+.+...++++++.||+|+||+||+|+.. .+++.||||+++... .....+.+..|..++. .++|||||+++++
T Consensus 21 ~ei~~~~~~~~~~lG~G~fG~Vykg~~~~~~~~~~~~~VAvK~l~~~~--~~~~~~~f~~E~~il~-~l~HpNIV~l~g~ 97 (308)
T 4gt4_A 21 KEISLSAVRFMEELGEDRFGKVYKGHLFGPAPGEQTQAVAIKTLKDKA--EGPLREEFRHEAMLRA-RLQHPNVVCLLGV 97 (308)
T ss_dssp CBCCGGGEEEEEEEEECSSCEEEEEEEC-------CEEEEEEECCC-C--CC-CHHHHHHHHHHHH-HCCCTTBCCEEEE
T ss_pred ccCCHHHCeEeeEeccCCCcEEEEEEEcCCccCCCCeEEEEEEECccc--ChHHHHHHHHHHHHHH-hCCCCCCCCcceE
Confidence 3466789999999999999999999864 467889999997542 3334456778888887 5799999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
+.+.+.+|||||||++|+|.+.+...... ...+...........+++.++..++.||+.||+|||+++|||||||
T Consensus 98 ~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~-----~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHRDLK 172 (308)
T 4gt4_A 98 VTKDQPLSMIFSYCSHGDLHEFLVMRSPH-----SDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLA 172 (308)
T ss_dssp ECSSSSCEEEEECCSSCBHHHHHHTTCSS-----CCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EEECCEEEEEEEcCCCCcHHHHHHhhCcc-----ccccccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCCCCCCcc
Confidence 99999999999999977663221110000 0000000011123579999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|+||||+.++++||+|||+|+...... ....+.+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+
T Consensus 173 ~~NILl~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~ 252 (308)
T 4gt4_A 173 TRNVLVYDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYS 252 (308)
T ss_dssp GGGEEECGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCC
T ss_pred ccceEECCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCC
Confidence 999999999999999999998533222 23445789999999999999999999999999999999998 999999999
Q ss_pred HHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 292 EDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 292 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..++...|.++. ++.|..+++++.+||.+||+.||.+|| ++.||+++
T Consensus 253 ~~~~~~~i~~~~~~~~p~~~~~~~~~li~~C~~~dP~~RP------s~~ei~~~ 300 (308)
T 4gt4_A 253 NQDVVEMIRNRQVLPCPDDCPAWVYALMIECWNEFPSRRP------RFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHHHHcCCCCCCcccchHHHHHHHHHHcCCChhHCc------CHHHHHHH
Confidence 999999988764 567889999999999999999999999 56677653
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-55 Score=440.86 Aligned_cols=271 Identities=26% Similarity=0.368 Sum_probs=213.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCC-----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++++.||+|+||+||+|++..++ +.||||+++... .....+....|..++....+|||||+++++|
T Consensus 60 Ei~~~~~~l~~~LG~G~fG~Vy~a~~~~~~~~~~~k~VAvK~l~~~~--~~~~~~~~~~E~~il~~l~hhpnIV~l~g~~ 137 (353)
T 4ase_A 60 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGAC 137 (353)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred EecHHHeEEeeEEecCCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--ChHHHHHHHHHHHHHHHcCCCCcEEEEEEEE
Confidence 456689999999999999999999987653 679999997642 3344566788999988666679999999998
Q ss_pred Ec-CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 136 QT-DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 136 ~~-~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
.. .+.+|||||||++|+|.+.+........ .......-.....+++.++..|+.||+.||+|||+++|||||||
T Consensus 138 ~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~~~iiHRDLK 212 (353)
T 4ase_A 138 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFV-----PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLA 212 (353)
T ss_dssp CCTTSCCEEEEECCTTEEHHHHHHHTGGGBC-----CC-------CTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred EecCCEEEEEEEcCCCCCHHHHHHhcccccc-----cccccchhhccccCCHHHHHHHHHHHHHHHHhHhhCCeecCccC
Confidence 65 4679999999996665322111000000 00000000113468999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|+|||++.++.+||+|||+|+....... ...+.+||+.|||||++.+..|+.++|||||||+||||+| |..||.+.+
T Consensus 213 ~~NILl~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~ 292 (353)
T 4ase_A 213 ARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 292 (353)
T ss_dssp GGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeeCCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCC
Confidence 9999999999999999999985332222 2345789999999999999999999999999999999998 999999876
Q ss_pred HHH-HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 292 EDE-LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 292 ~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..+ +...+..+ ++..|..+++++.+||.+||+.||++|| ++.||++|
T Consensus 293 ~~~~~~~~i~~g~~~~~p~~~~~~~~~li~~c~~~dP~~RP------t~~eil~~ 341 (353)
T 4ase_A 293 IDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP------TFSELVEH 341 (353)
T ss_dssp CSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCcChhHCc------CHHHHHHH
Confidence 544 44445443 5778899999999999999999999999 67888876
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-54 Score=435.33 Aligned_cols=288 Identities=41% Similarity=0.775 Sum_probs=244.9
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.....++|++++.||+|+||.||+|++. .+++.||||++++..... ....+....|..++....+||||+++++++
T Consensus 49 ~~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 128 (355)
T 1vzo_A 49 EKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAF 128 (355)
T ss_dssp CCCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEE
T ss_pred ccccccceEEEEEeccCCCEEEEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEE
Confidence 3556789999999999999999999985 588999999997653221 122233455667776544799999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
...+.+|+|||||+ |++|..++...+.+++..++.++.||+.||.|||++||+||||||
T Consensus 129 ~~~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dlkp 187 (355)
T 1vzo_A 129 QTETKLHLILDYIN---------------------GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKL 187 (355)
T ss_dssp EETTEEEEEECCCC---------------------SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred eeCceEEEEeecCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCH
Confidence 99999999999999 556666777778899999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeecc-CCcccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCCC--
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYL-DKTTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSGC-- 290 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~-~~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~~-- 290 (494)
+||||+.+|.+||+|||+++..... .......+||+.|+|||++.+ ..++.++|||||||++|||++|..||...
T Consensus 188 ~NIll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 267 (355)
T 1vzo_A 188 ENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGE 267 (355)
T ss_dssp GGEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTS
T ss_pred HHEEECCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCCc
Confidence 9999999999999999999853221 223445689999999999986 35789999999999999999999999743
Q ss_pred --CHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccc
Q psy8309 291 --DEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRV 368 (494)
Q Consensus 291 --~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~ 368 (494)
....+...+....+.+|..++..+++||.+||..||.+||++.. .+++|+++|+||+.++|+.+..++++||+.|.+
T Consensus 268 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~~~~~-~s~~ell~h~~f~~~~~~~l~~~~~~~p~~p~~ 346 (355)
T 1vzo_A 268 KNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP-RDADEIKEHLFFQKINWDDLAAKKVPAPFKPVI 346 (355)
T ss_dssp CCCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSST-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCC
T ss_pred cchHHHHHHHHhccCCCCCcccCHHHHHHHHHHhhhCHHHhcCCCC-CCHHHHHcCcchhcCChhHhhhccCCCCCCCcc
Confidence 34566777788888899999999999999999999999997643 389999999999999999999999999999988
Q ss_pred c
Q psy8309 369 I 369 (494)
Q Consensus 369 ~ 369 (494)
.
T Consensus 347 ~ 347 (355)
T 1vzo_A 347 R 347 (355)
T ss_dssp C
T ss_pred c
Confidence 7
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-53 Score=427.37 Aligned_cols=259 Identities=33% Similarity=0.581 Sum_probs=235.0
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|++++.||+|+||.||+|++..+|+.||||++.+... ..........|..++. .++||||+++++++.+.+.+|
T Consensus 13 ~~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~ 90 (328)
T 3fe3_A 13 HIGNYRLLKTIGKGNFAKVKLARHILTGREVAIKIIDKTQL-NPTSLQKLFREVRIMK-ILNHPNIVKLFEVIETEKTLY 90 (328)
T ss_dssp EETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEhhcC-CHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCEEE
Confidence 35789999999999999999999999999999999987543 3445566778888887 578999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ |++|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 91 lv~e~~~---------------------~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~ivHrDlkp~NIll~~ 149 (328)
T 3fe3_A 91 LIMEYAS---------------------GGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDA 149 (328)
T ss_dssp EEECCCT---------------------TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred EEEECCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCEeccCCCHHHEEEcC
Confidence 9999999 6666777878889999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
++.+||+|||+++.. .........+||+.|+|||++.+..+. .++|||||||++|+|++|.+||.+.+..++...+..
T Consensus 150 ~~~~kl~DFG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~ 228 (328)
T 3fe3_A 150 DMNIKIADFGFSNEF-TVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLR 228 (328)
T ss_dssp TSCEEECSTTCCGGG-SSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCEEEeeccCceec-CCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Confidence 999999999998753 233445678999999999999988875 799999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
+.+.+|..+++++.+||.+||..||.+|| +++|+++||||+...
T Consensus 229 ~~~~~p~~~s~~~~~li~~~L~~dP~~R~------t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 229 GKYRIPFYMSTDCENLLKRFLVLNPIKRG------TLEQIMKDRWINAGH 272 (328)
T ss_dssp CCCCCCTTSCHHHHHHHHHHCCSSTTTSC------CHHHHTTCTTTTTTC
T ss_pred CCCCCCCCCCHHHHHHHHHHCCCChhHCc------CHHHHhcCHhhcCCC
Confidence 99999999999999999999999999999 689999999998654
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-53 Score=430.00 Aligned_cols=265 Identities=28% Similarity=0.416 Sum_probs=236.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh---hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED---DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
++|++++.||+|+||.||+|+++.+|+.||||++++...... ...+....|..++. .++||||++++++|++.+.+
T Consensus 12 ~~y~~~~~LG~G~fg~V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~ 90 (361)
T 2yab_A 12 DFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILR-QVLHPNIITLHDVYENRTDV 90 (361)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEE
T ss_pred hceEEeeEEeeCcCEEEEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHH-hCCCcCCCcEEEEEEeCCEE
Confidence 579999999999999999999999999999999987543221 13456677888887 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||+ ||+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 91 ~lv~e~~~---------------------gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~ 149 (361)
T 2yab_A 91 VLILELVS---------------------GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLL 149 (361)
T ss_dssp EEEEECCC---------------------SCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred EEEEEcCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEe
Confidence 99999999 666677787788999999999999999999999999999999999999998
Q ss_pred CCC----CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 222 YEG----HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 222 ~~g----~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
.++ ++||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++.
T Consensus 150 ~~~~~~~~vkl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~~~~~~ 228 (361)
T 2yab_A 150 DKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 228 (361)
T ss_dssp CTTSSSCCEEECCCSSCEECC-TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred CCCCCccCEEEEecCCceEcC-CCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 887 79999999998633 2334566789999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcC
Q psy8309 298 SICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358 (494)
Q Consensus 298 ~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~ 358 (494)
.|....+.++ ..+++++++||.+||..||.+|| +++|+++||||++++|.....+
T Consensus 229 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------t~~e~l~hp~~~~~~~~~~~~~ 287 (361)
T 2yab_A 229 NITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRL------TIQEALRHPWITPVDTQQAMVR 287 (361)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHTSTTTSCSSHHHHHHH
T ss_pred HHHhcCCCCCchhccCCCHHHHHHHHHHCCCChhHCc------CHHHHhcCcCcCCCchhhhhhc
Confidence 9999888776 46899999999999999999999 6899999999999999876543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-54 Score=433.30 Aligned_cols=270 Identities=28% Similarity=0.459 Sum_probs=235.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||||++.+.... ...|..++....+||||+++++++++.+.+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~-------~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~l 93 (342)
T 2qr7_A 21 TDGYEVKEDIGVGSYSVCKRCIHKATNMEFAVKIIDKSKRD-------PTEEIEILLRYGQHPNIITLKDVYDDGKYVYV 93 (342)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTTCC-------CHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred cccEEEEEEEeeCCCEEEEEEEECCCCCEEEEEEEEcccCC-------hHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEE
Confidence 35899999999999999999999999999999999875321 12455566655689999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||+ ||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||+..+
T Consensus 94 v~E~~~---------------------gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givHrDlkp~NIl~~~~ 152 (342)
T 2qr7_A 94 VTELMK---------------------GGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDE 152 (342)
T ss_dssp EECCCC---------------------SCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred EEeCCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEeccCCHHHEEEecC
Confidence 999999 66667778888899999999999999999999999999999999999998543
Q ss_pred -C---CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC---CCHHHHH
Q psy8309 224 -G---HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG---CDEDELF 296 (494)
Q Consensus 224 -g---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~---~~~~~~~ 296 (494)
+ .+||+|||+++..........+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+ .+..+++
T Consensus 153 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 232 (342)
T 2qr7_A 153 SGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANGPDDTPEEIL 232 (342)
T ss_dssp SCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSSTTSCHHHHH
T ss_pred CCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCCCcCCHHHHH
Confidence 3 59999999998654444556678999999999999988899999999999999999999999986 4667888
Q ss_pred HHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 297 WSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 297 ~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
..|..+.+.++ ..+++++++||.+||..||.+|| ++.++++||||. +|+.+...++.+|+.|...
T Consensus 233 ~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------t~~~il~hp~~~--~~~~~~~~~~~~~~~p~~~ 301 (342)
T 2qr7_A 233 ARIGSGKFSLSGGYWNSVSDTAKDLVSKMLHVDPHQRL------TAALVLRHPWIV--HWDQLPQYQLNRQDAPHLV 301 (342)
T ss_dssp HHHHHCCCCCCSTTTTTSCHHHHHHHHHHTCSSTTTSC------CHHHHTTSHHHH--TGGGSCCSCCCCCCCHHHH
T ss_pred HHHccCCcccCccccccCCHHHHHHHHHHCCCChhHCc------CHHHHhcCCeec--CccccccccCCCccchhhh
Confidence 88888877665 46899999999999999999999 689999999995 5999888888888877643
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-51 Score=429.36 Aligned_cols=273 Identities=23% Similarity=0.340 Sum_probs=208.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-----C
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-----D 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-----~ 138 (494)
.++|++++.||+|+||+||+|+++.+++.||||++.+. ............|..++. .++|||||++++++.. .
T Consensus 52 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~-~l~h~niv~l~~~~~~~~~~~~ 129 (458)
T 3rp9_A 52 PDRYEIRHLIGTGSYGHVCEAYDKLEKRVVAIKKILRV-FEDLIDCKRILREIAILN-RLNHDHVVKVLDIVIPKDVEKF 129 (458)
T ss_dssp CTTEEECCC-------CEEEEEECC--CEEEEEEECST-TSSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCTTTC
T ss_pred CCCeEEeeEeeecCCeEEEEEEECCCCcEEEEEEechh-hcCHHHHHHHHHHHHHHH-hCCCCCCCceEEEEecCCcccC
Confidence 36899999999999999999999999999999999764 234445667788988888 4799999999999943 4
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+|+||||+ +++|..++.....+++..++.++.||+.||+|||++|||||||||+||
T Consensus 130 ~~~~lv~e~~----------------------~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~iiHrDlKp~NI 187 (458)
T 3rp9_A 130 DELYVVLEIA----------------------DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANC 187 (458)
T ss_dssp CCEEEEECCC----------------------SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGE
T ss_pred ceEEEEEecc----------------------ccchhhhcccCCCCCHHHHHHHHHHHHHHHHHHHhCCcCCCCCChhhE
Confidence 6799999998 456777788888899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC---------------------------CcccccCCCCCccChhhh-CCCCCCCcchH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD---------------------------KTTDTFCGTPDYMAPEII-KGLKYNQCVDW 270 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~---------------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~Di 270 (494)
||+.++++||+|||+++...... ......+||+.|+|||++ .+..|+.++||
T Consensus 188 Ll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~Di 267 (458)
T 3rp9_A 188 LVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDV 267 (458)
T ss_dssp EECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCHHHHTTCCCCCTHHHH
T ss_pred EECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHH
Confidence 99999999999999997532111 123456899999999986 46679999999
Q ss_pred HHHHHHHHHHHh-----------CCCCCCCCCH--------------------HHHHHHHHh--CCC-------------
Q psy8309 271 WSFGILLYEMHV-----------GQSPFSGCDE--------------------DELFWSICN--ERP------------- 304 (494)
Q Consensus 271 wSlGvil~ell~-----------G~~Pf~~~~~--------------------~~~~~~i~~--~~~------------- 304 (494)
|||||+||||++ |.++|.+.+. .+.+..|.+ +.+
T Consensus 268 wSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~ 347 (458)
T 3rp9_A 268 WSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTPSEEDIEALEKEDA 347 (458)
T ss_dssp HHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHCCCCHHHHHTSSCHHH
T ss_pred HHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcCCCCHHHHhhcCCHHH
Confidence 999999999998 7888876541 122222211 000
Q ss_pred ----------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 305 ----------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 305 ----------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
.....+++++++||.+||..||.+|| +++|+++||||+++.|..++.....+...|
T Consensus 348 ~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~------t~~e~L~Hp~f~~~~~~~~e~~~~~~~~~~ 419 (458)
T 3rp9_A 348 KRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRI------TINECLAHPFFKEVRIAEVETNATEKVRLP 419 (458)
T ss_dssp HHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHHSGGGTTTCCGGGCCCCSSCCCCS
T ss_pred HHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccC------CHHHHhcCHhhhhcCCCccCCCCCCCCCCC
Confidence 01134699999999999999999999 689999999999999998876555444433
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=424.86 Aligned_cols=256 Identities=27% Similarity=0.475 Sum_probs=227.8
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|.++.+|+.||+|++.+... ..........|..++. .++||||+++++++.+.+.+|+|
T Consensus 11 ~~Y~i~~~LG~G~fg~V~~~~~~~~~~~~a~K~i~~~~~-~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~~~~~~lv 88 (444)
T 3soa_A 11 EEYQLFEELGKGAFSVVRRCVKVLAGQEYAAMIINTKKL-SARDHQKLEREARICR-LLKHPNIVRLHDSISEEGHHYLI 88 (444)
T ss_dssp HHEEEEEEEEEC--CEEEEEEETTTTEEEEEEEEESCSC-HHHHHHHHHHHHHHHH-HCCBTTBCCEEEEEECSSEEEEE
T ss_pred CCeEEEEEeccCCCeEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHH-hCCCcCCCeEEEEEEECCEEEEE
Confidence 589999999999999999999999999999999987543 2334556678888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC---
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD--- 221 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~--- 221 (494)
||||. ||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 89 ~E~~~---------------------gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~~givHrDlKp~NIll~~~~ 147 (444)
T 3soa_A 89 FDLVT---------------------GGELFEDIVAREYYSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKL 147 (444)
T ss_dssp ECCCB---------------------CCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSSTTEEESBSS
T ss_pred EEeCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEeccC
Confidence 99999 666677788888999999999999999999999999999999999999998
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.+||+|||+++............+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..|..
T Consensus 148 ~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~~~~~~~i~~ 227 (444)
T 3soa_A 148 KGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIKA 227 (444)
T ss_dssp TTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccHHHHHHHHHh
Confidence 46889999999997644444444567899999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 ERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+...+|. .+++++++||.+||+.||.+|| ++.|+++||||++
T Consensus 228 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------ta~e~L~hp~~~~ 273 (444)
T 3soa_A 228 GAYDFPSPEWDTVTPEAKDLINKMLTINPSKRI------TAAEALKHPWISH 273 (444)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHHSCTTHH
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCC------CHHHHhcCccccC
Confidence 8877663 6899999999999999999999 6899999999964
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-51 Score=406.58 Aligned_cols=264 Identities=27% Similarity=0.415 Sum_probs=233.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh---hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED---DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.|++.+.||+|+||.||+|+++.+++.||||++.+...... ...+....|..++. .++||||+++++++.+...+
T Consensus 11 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~ 89 (326)
T 2y0a_A 11 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPNVITLHEVYENKTDV 89 (326)
T ss_dssp HHEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred cceEeceEEeeCCCeEEEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEE
Confidence 479999999999999999999999999999999987543221 13456777888887 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||+ |++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 90 ~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~NIll~ 148 (326)
T 2y0a_A 90 ILILELVA---------------------GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 148 (326)
T ss_dssp EEEEECCC---------------------SCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEES
T ss_pred EEEEEcCC---------------------CCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeEcCCCCHHHEEEe
Confidence 99999999 556666777778899999999999999999999999999999999999999
Q ss_pred CCC----CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 222 YEG----HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 222 ~~g----~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
.++ .+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 149 ~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~ 227 (326)
T 2y0a_A 149 DRNVPKPRIKIIDFGLAHKID-FGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 227 (326)
T ss_dssp CSSSSSCCEEECCCTTCEECC-TTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHH
T ss_pred cCCCCCCCEEEEECCCCeECC-CCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHHHHHH
Confidence 888 89999999998643 2334456789999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhc
Q psy8309 298 SICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357 (494)
Q Consensus 298 ~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~ 357 (494)
.+......++ ..++.++++||.+||..||.+|| +++|+++||||++.+|.....
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~e~l~hp~~~~~~~~~~~~ 285 (326)
T 2y0a_A 228 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM------TIQDSLQHPWIKPKDTQQALS 285 (326)
T ss_dssp HHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSGGGSC------CHHHHHHSTTTSCCSHHHHHH
T ss_pred HHHhcCCCcCccccccCCHHHHHHHHHHccCChhhCC------CHHHHhcCCCccCCcchhhhh
Confidence 9888777765 46899999999999999999999 689999999999999876543
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-52 Score=419.95 Aligned_cols=257 Identities=32% Similarity=0.516 Sum_probs=226.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|++++.||+|+||.||+|++..+++.||||++.+..............|..++. .++||||+++++++.+.+.+|
T Consensus 7 ~i~~Y~i~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~ 85 (336)
T 3h4j_B 7 HIGPYIIRETLGEGSFGKVKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLK-LLRHPHIIKLYDVITTPTDIV 85 (336)
T ss_dssp EETTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEE
T ss_pred ccCCEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEE
Confidence 4679999999999999999999999999999999998654333333445667877776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||+ +|+|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 86 lv~E~~----------------------~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~ 143 (336)
T 3h4j_B 86 MVIEYA----------------------GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDD 143 (336)
T ss_dssp EEECCC----------------------CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCCCCCSTTTEEECT
T ss_pred EEEECC----------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCchhhEEEcC
Confidence 999999 3455667777789999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
++.+||+|||++... .......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+....+++..+..
T Consensus 144 ~~~~kl~DFG~s~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~ 222 (336)
T 3h4j_B 144 NLNVKIADFGLSNIM-TDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNS 222 (336)
T ss_dssp TCCEEECCSSCTBTT-TTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSSTTCBCCCCS
T ss_pred CCCEEEEEeccceec-cCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccHHHHHHHHHc
Confidence 999999999998753 23344567789999999999998876 7899999999999999999999998777666666767
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
....+|..+++++++||.+||..||.+|| +++|+++||||+.
T Consensus 223 ~~~~~p~~~s~~~~~li~~~L~~dP~~Rp------t~~eil~hp~~~~ 264 (336)
T 3h4j_B 223 CVYVMPDFLSPGAQSLIRRMIVADPMQRI------TIQEIRRDPWFNV 264 (336)
T ss_dssp SCCCCCTTSCHHHHHHHHTTSCSSGGGSC------CHHHHTTCHHHHT
T ss_pred CCCCCcccCCHHHHHHHHHHcCCChhHCc------CHHHHHhChhhcc
Confidence 77788999999999999999999999999 6899999999974
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-50 Score=397.44 Aligned_cols=258 Identities=24% Similarity=0.436 Sum_probs=217.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+++.||||++..... ..........|..++. .++||||+++++++.+.+.+|+
T Consensus 1 l~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 78 (292)
T 3o0g_A 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCceeeeEecCCCCeEEEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHh-cCCCCCEeeEEeEEEeCCEEEE
Confidence 4689999999999999999999999999999999986542 3344456677887777 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||. |+.+.......+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 79 v~e~~~---------------------~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ivH~dikp~Nil~~~~ 137 (292)
T 3o0g_A 79 VFEFCD---------------------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp EEECCS---------------------EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEecCC---------------------CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCC
Confidence 999997 22222333446789999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCC-CCCCCHHHHHHHHHh
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP-FSGCDEDELFWSICN 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~P-f~~~~~~~~~~~i~~ 301 (494)
|.+||+|||+++............+||+.|+|||++.+.. ++.++|||||||++|||++|..| |.+.+..+....+..
T Consensus 138 ~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~~~~~~~~~~~i~~ 217 (292)
T 3o0g_A 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp SCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcCCCCHHHHHHHHHH
Confidence 9999999999986544444456678999999999998766 89999999999999999987766 667777777776653
Q ss_pred C--C---------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 E--R---------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~--~---------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
. . ......++.++++||.+||+.||.+|| +++|+++||||+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~hp~f~~~ 289 (292)
T 3o0g_A 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI------SAEEALQHPYFSDF 289 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGGGTTC
T ss_pred HhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCC------CHHHHhcCcccccC
Confidence 1 0 011235789999999999999999999 68999999999864
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-51 Score=401.59 Aligned_cols=255 Identities=28% Similarity=0.485 Sum_probs=221.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..+|++++.||+|+||.||+|++..+++.||||++..... ...+....|..++. .++||||+++++++...+.+|+
T Consensus 19 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~l 94 (297)
T 3fxz_A 19 KKKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWV 94 (297)
T ss_dssp GGTBCCCEEEEEETTEEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred hhceeeeeeeccCCCeEEEEEEECCCCcEEEEEEeecccc---cHHHHHHHHHHHHh-cCCCCCCCeEeEEEEECCEEEE
Confidence 3589999999999999999999999999999999976532 22345567777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||.|| +|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 95 v~e~~~~~---------------------~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~ 152 (297)
T 3fxz_A 95 VMEYLAGG---------------------SLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMD 152 (297)
T ss_dssp EEECCTTC---------------------BHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEECCCCC---------------------CHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEECCC
Confidence 99999954 45555544 469999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE- 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~- 302 (494)
|.+||+|||+++............+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.......+...
T Consensus 153 ~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~ 232 (297)
T 3fxz_A 153 GSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNG 232 (297)
T ss_dssp CCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHC
T ss_pred CCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Confidence 9999999999986544445556778999999999999999999999999999999999999999998887776666533
Q ss_pred --CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 --RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 --~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
....|..++..+++||.+||+.||.+|| +++|+++||||+..
T Consensus 233 ~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~ell~h~~~~~~ 276 (297)
T 3fxz_A 233 TPELQNPEKLSAIFRDFLNRCLEMDVEKRG------SAKELLQHQFLKIA 276 (297)
T ss_dssp SCCCSCGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHTTCGGGGGC
T ss_pred CCCCCCccccCHHHHHHHHHHccCChhHCc------CHHHHhhChhhccc
Confidence 3345678999999999999999999999 68999999999743
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-51 Score=428.45 Aligned_cols=260 Identities=35% Similarity=0.568 Sum_probs=234.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
....++|.+++.||+|+||.||+|+++.+|+.||||++.+..............|..++. .++||||+++++++.+.+.
T Consensus 12 ~~~~~~Y~l~~~LG~G~fg~V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~-~l~HpnIv~l~~~~~~~~~ 90 (476)
T 2y94_A 12 RVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLK-LFRHPHIIKLYQVISTPSD 90 (476)
T ss_dssp CCEETTEEEEEEEECCSSSCEEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSE
T ss_pred CceecCEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCE
Confidence 345679999999999999999999999999999999998764433445566778888886 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 91 ~~lv~E~~~---------------------gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDLkp~NIll 149 (476)
T 2y94_A 91 IFMVMEYVS---------------------GGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLL 149 (476)
T ss_dssp EEEEEECCS---------------------SEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGGEEE
T ss_pred EEEEEeCCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcccccHHHEEE
Confidence 999999999 56667777778889999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
+.++.+||+|||+++... ......+.+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+...++.+|
T Consensus 150 ~~~~~vkL~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i 228 (476)
T 2y94_A 150 DAHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKI 228 (476)
T ss_dssp CTTCCEEECCCSSCEECC-TTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSSSHHHHHHH
T ss_pred ecCCCeEEEeccchhhcc-ccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCCHHHHHHHH
Confidence 999999999999998632 3344567799999999999998776 68999999999999999999999999999999999
Q ss_pred HhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 300 ~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..+....|..+++++++||.+||..||.+|| +++|+++||||+.
T Consensus 229 ~~~~~~~p~~~s~~~~~Li~~~L~~dP~~Rp------t~~eil~hp~~~~ 272 (476)
T 2y94_A 229 CDGIFYTPQYLNPSVISLLKHMLQVDPMKRA------TIKDIREHEWFKQ 272 (476)
T ss_dssp HTTCCCCCTTCCHHHHHHHHHHTCSSTTTSC------CHHHHHTCHHHHT
T ss_pred hcCCcCCCccCCHHHHHHHHHHcCCCchhCc------CHHHHHhCHHhhh
Confidence 9999999999999999999999999999999 6899999999975
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=411.61 Aligned_cols=255 Identities=27% Similarity=0.492 Sum_probs=227.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|.++.+++.||||++.+... ..........|..++. .++||||+++++++.+.+..|+|
T Consensus 29 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~~avK~~~~~~~-~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~lv 106 (362)
T 2bdw_A 29 DNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFHYLV 106 (362)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEE
T ss_pred cCeEEeeEEecCCCeEEEEEEECCCCCEEEEEEEEcccC-CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEEE
Confidence 579999999999999999999999999999999987543 3345566778888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||. ||+|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.++
T Consensus 107 ~e~~~---------------------gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~ivH~Dlkp~NIll~~~~ 165 (362)
T 2bdw_A 107 FDLVT---------------------GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKA 165 (362)
T ss_dssp ECCCC---------------------SCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEESCSS
T ss_pred EecCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecCC
Confidence 99999 556666777778899999999999999999999999999999999999998654
Q ss_pred ---CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 225 ---HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 225 ---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++..|..
T Consensus 166 ~~~~~kl~DfG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~~~~~~~i~~ 244 (362)
T 2bdw_A 166 KGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244 (362)
T ss_dssp TTCCEEECCCTTCBCCT-TCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecCcceEec-CCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 59999999997532 23334567899999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 ERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+.+.+|. .+++++++||.+||..||.+|| ++.++++||||..
T Consensus 245 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~hp~~~~ 290 (362)
T 2bdw_A 245 GAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI------TADQALKVPWICN 290 (362)
T ss_dssp TCCCCCTTGGGGSCHHHHHHHHHHSCSSGGGSC------CHHHHTTSHHHHT
T ss_pred CCCCCCcccccCCCHHHHHHHHHHcCCChhhCc------CHHHHhcCcccCC
Confidence 8877763 6899999999999999999999 6899999999975
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-51 Score=418.14 Aligned_cols=274 Identities=27% Similarity=0.443 Sum_probs=213.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC--ee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--HL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--~~ 141 (494)
.++|++++.||+|+||.||+|.++.+++.||||++.+. ............|..++....+||||+++++++...+ .+
T Consensus 8 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~i~~~-~~~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~ 86 (388)
T 3oz6_A 8 LRKYELVKKLGKGAYGIVWKSIDRRTGEVVAVKKIFDA-FQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDV 86 (388)
T ss_dssp HTTEEEEEC-------CEEEEEETTTCCEEEEEEECC---CCHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCE
T ss_pred cCceEEEEEeeeCCCeEEEEEEECCCCCEEEEEEeccc-ccChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEE
Confidence 46899999999999999999999999999999999764 2344556677888888886556999999999998654 79
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||. ++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 87 ~lv~e~~~----------------------~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NIll~ 143 (388)
T 3oz6_A 87 YLVFDYME----------------------TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILLN 143 (388)
T ss_dssp EEEEECCS----------------------EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEC
T ss_pred EEEecccC----------------------cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHhCCEEeCCCCHHHeEEc
Confidence 99999996 244445544 5799999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeecc---------------------CCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYL---------------------DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYE 279 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~---------------------~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~e 279 (494)
.+|.+||+|||+|+..... .......+||+.|+|||++.+ ..|+.++|||||||++||
T Consensus 144 ~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 223 (388)
T 3oz6_A 144 AECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGE 223 (388)
T ss_dssp TTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred CCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHH
Confidence 9999999999999853211 112345689999999999987 679999999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhC--CCC---------------------------------------------CCccCCH
Q psy8309 280 MHVGQSPFSGCDEDELFWSICNE--RPR---------------------------------------------FPQFLSV 312 (494)
Q Consensus 280 ll~G~~Pf~~~~~~~~~~~i~~~--~~~---------------------------------------------~p~~~s~ 312 (494)
|++|.+||.+.+..+.+..|... .+. .+..+++
T Consensus 224 ll~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (388)
T 3oz6_A 224 ILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDIFTKWKNLLLKINPKADCNE 303 (388)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCCHHHHHHHHHHHCTTCCCCH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHhCcchhhhcccccccccCCH
Confidence 99999999999988887777531 000 1125789
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC---ChhHHhcCcCCCCCccc
Q psy8309 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL---DWQALEKRELEPPFRPR 367 (494)
Q Consensus 313 ~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~---~w~~l~~~~~~pp~~p~ 367 (494)
++++||.+||+.||.+|| +++|+++||||+.+ +|+....+.+.+|+.|.
T Consensus 304 ~~~dll~~~L~~dP~~R~------t~~e~l~Hp~~~~~~~~~~~~~~~~~~~~~~~~~ 355 (388)
T 3oz6_A 304 EALDLLDKLLQFNPNKRI------SANDALKHPFVSIFHNPNEEPNCDHIITIPINDN 355 (388)
T ss_dssp HHHHHHHHHCCSSGGGSC------CHHHHTTSTTTTTTCCGGGCCCCSSCCCCC----
T ss_pred HHHHHHHHhhccCcccCC------CHHHHhCCHHHHHhcCCccCCCCCCCCCCCcccc
Confidence 999999999999999999 68999999998765 45444444455555443
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-51 Score=412.85 Aligned_cols=259 Identities=27% Similarity=0.466 Sum_probs=221.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC--hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+..... ....+....|..++. .++||||+++++++.+.+.+|
T Consensus 24 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~ 102 (351)
T 3c0i_A 24 DVYELCEVIGKGPFSVVRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICH-MLKHPHIVELLETYSSDGMLY 102 (351)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEE
T ss_pred cceEEeeEEeeCCCEEEEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEE
Confidence 57999999999999999999999999999999997543221 123456677888887 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|||||+||+| ...+. ....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 103 lv~e~~~g~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivHrDlkp~NI 161 (351)
T 3c0i_A 103 MVFEFMDGADL---------------------CFEIVKRADAGFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCV 161 (351)
T ss_dssp EEEECCSSCBH---------------------HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEEeCCCCCCH---------------------HHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChHHe
Confidence 99999996555 33332 234689999999999999999999999999999999999
Q ss_pred eeCCCCC---EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 219 LLDYEGH---VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 219 Ll~~~g~---vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
|++.++. +||+|||+++............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+. ..++
T Consensus 162 l~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~-~~~~ 240 (351)
T 3c0i_A 162 LLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGT-KERL 240 (351)
T ss_dssp EECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSS-HHHH
T ss_pred EEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCc-HHHH
Confidence 9987665 99999999986544333455678999999999999999999999999999999999999999875 4567
Q ss_pred HHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 296 FWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 296 ~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
+..+..+...++ ..+++++++||.+||..||.+|| ++.++++||||++.+|
T Consensus 241 ~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~e~l~hp~~~~~~~ 295 (351)
T 3c0i_A 241 FEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERI------TVYEALNHPWLKERDR 295 (351)
T ss_dssp HHHHHHTCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC------CHHHHHTSHHHHTHHH
T ss_pred HHHHHcCCCCCCccccccCCHHHHHHHHHHCCCChhHCc------CHHHHhcChhhcCCcc
Confidence 778888777665 46899999999999999999999 6899999999987544
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=402.45 Aligned_cols=259 Identities=27% Similarity=0.472 Sum_probs=213.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|++. +++.||||++.... ...........|..++. .++||||+++++++.+.+.+|+
T Consensus 20 ~~~y~~~~~lG~G~~g~V~~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~l 96 (311)
T 3niz_A 20 MEKYQKLEKVGEGTYGVVYKAKDS-QGRIVALKRIRLDA-EDEGIPSTAIREISLLK-ELHHPNIVSLIDVIHSERCLTL 96 (311)
T ss_dssp SCEEEEEEEEEECSSCEEEEEEET-TSCEEEEEEEC-------CHHHHHHHHHHHHH-HCCCTTBCCEEEEECCSSCEEE
T ss_pred HhhhHhhhhccCCCCeEEEEEEEC-CCCEEEEEEEeccc-ccchhhHHHHHHHHHHH-HcCCCCEeeeeeEEccCCEEEE
Confidence 579999999999999999999985 58899999997653 23334456677888887 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||.+ +|...+.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 97 v~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp~NIl~~~ 154 (311)
T 3niz_A 97 VFEFMEK----------------------DLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINS 154 (311)
T ss_dssp EEECCSE----------------------EHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred EEcCCCC----------------------CHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCchHhEEECC
Confidence 9999972 33444443 356999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+|.+||+|||+++............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 155 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~~ 234 (311)
T 3niz_A 155 DGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234 (311)
T ss_dssp TCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTTTHHHHHHH
T ss_pred CCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHH
Confidence 999999999999864333344455689999999999986 5689999999999999999999999998877666666543
Q ss_pred C--CCC----------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 302 E--RPR----------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 302 ~--~~~----------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
. .+. +...+++++++||.+||+.||.+|| +++|+++||||++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~f~~~~ 308 (311)
T 3niz_A 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRI------SARDAMNHPYFKDLD 308 (311)
T ss_dssp HHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSC------CHHHHHTSGGGTTSC
T ss_pred HHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCC------CHHHHhcCcccccCC
Confidence 1 100 1134688999999999999999999 689999999999987
Q ss_pred hh
Q psy8309 352 WQ 353 (494)
Q Consensus 352 w~ 353 (494)
++
T Consensus 309 ~~ 310 (311)
T 3niz_A 309 PQ 310 (311)
T ss_dssp TT
T ss_pred cc
Confidence 63
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-50 Score=404.42 Aligned_cols=253 Identities=24% Similarity=0.428 Sum_probs=225.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||+|++... .........|..++. .++||||+++++++.+.+.+|+
T Consensus 4 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~a~K~~~~~----~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~l 78 (321)
T 1tki_A 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVK----GTDQVLVKKEISILN-IARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC----THHHHHHHHHHHHHH-HSCCTTBCCEEEEEEETTEEEE
T ss_pred hhceEeeeEEecCCCeEEEEEEECCCCcEEEEEEEecC----cccHHHHHHHHHHHH-hCCCCCCCeEeEEEecCCEEEE
Confidence 46899999999999999999999999999999998753 223445667888877 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||+ |++|..++... ..+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 79 v~e~~~---------------------g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~givH~Dlkp~NIl~~~ 137 (321)
T 1tki_A 79 IFEFIS---------------------GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EECCCC---------------------CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEeCC---------------------CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEEEcc
Confidence 999999 55556666554 47999999999999999999999999999999999999997
Q ss_pred --CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 223 --EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 --~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+++..+.
T Consensus 138 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 216 (321)
T 1tki_A 138 RRSSTIKIIEFGQARQLK-PGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp SSCCCEEECCCTTCEECC-TTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCCCCEEEEECCCCeECC-CCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCHHHHHHHHH
Confidence 7899999999998632 2334456789999999999999889999999999999999999999999999999999999
Q ss_pred hCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.....++. .++.++++||.+||..||.+|| ++.|+++||||+.
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~Rp------t~~e~l~hp~~~~ 263 (321)
T 1tki_A 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM------TASEALQHPWLKQ 263 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSHHHHS
T ss_pred cCCCCCChhhhccCCHHHHHHHHHHcCCChhHCc------CHHHHhcChhhcc
Confidence 98887763 6899999999999999999999 6899999999975
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-50 Score=406.60 Aligned_cols=262 Identities=25% Similarity=0.410 Sum_probs=212.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
..+++|++++.||+|+||.||+|++..+++.||||+++.... ..........|..++. .++||||+++++++.+.+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 108 (329)
T 3gbz_A 31 TSIDRYRRITKLGEGTYGEVYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLK-ELQHRNIIELKSVIHHNHRL 108 (329)
T ss_dssp -CGGGEEEEEEEEECSSSEEEEEEETTTTEEEEEEECCCCC---------CHHHHHHGG-GCCCTTBCCEEEEEEETTEE
T ss_pred cchhhEEEEEEEEecCCeEEEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHH-HcCCCCcceEEEEEecCCEE
Confidence 456799999999999999999999999999999999976532 2233345567777776 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||+. ++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 109 ~lv~e~~~----------------------~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ivH~Dlkp~NIll~ 166 (329)
T 3gbz_A 109 HLIFEYAE----------------------NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLS 166 (329)
T ss_dssp EEEEECCS----------------------EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEE
T ss_pred EEEEecCC----------------------CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEECCCCCHHHEEEe
Confidence 99999996 36677778888899999999999999999999999999999999999994
Q ss_pred -----CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 222 -----YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 222 -----~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
.++.+||+|||+++............+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.
T Consensus 167 ~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 246 (329)
T 3gbz_A 167 VSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQ 246 (329)
T ss_dssp C-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred cCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCHHHH
Confidence 45569999999987543333444566899999999999875 489999999999999999999999999988887
Q ss_pred HHHHHhCC--C----------------CCC------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 296 FWSICNER--P----------------RFP------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 296 ~~~i~~~~--~----------------~~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
...+.... + .+| ..+++++++||.+||+.||.+|| +++|+++||
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~hp 320 (329)
T 3gbz_A 247 LFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI------SAKNALEHP 320 (329)
T ss_dssp HHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSC------CHHHHHTSG
T ss_pred HHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCC------CHHHHhCCc
Confidence 77775421 0 011 12789999999999999999999 689999999
Q ss_pred CcCCCChh
Q psy8309 346 YFRGLDWQ 353 (494)
Q Consensus 346 ~f~~~~w~ 353 (494)
||++++|+
T Consensus 321 ~f~~~~~~ 328 (329)
T 3gbz_A 321 YFSHNDFD 328 (329)
T ss_dssp GGSSSCSC
T ss_pred ccCCCCCC
Confidence 99999995
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-50 Score=393.34 Aligned_cols=259 Identities=31% Similarity=0.582 Sum_probs=228.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+.+++|++++.||+|+||.||+|+++.++..||||++.+..............|..++. .++||||+++++++.+.+.
T Consensus 5 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 83 (279)
T 3fdn_A 5 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDATR 83 (279)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSE
T ss_pred eeecccEEEeeEEecCCCeEEEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHH-cCCCCCCcchhheEecCCE
Confidence 456789999999999999999999999999999999997654333333455666777776 5789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
.|+||||++ +++|...+.....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 84 ~~lv~e~~~---------------------~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~H~dlkp~Nili 142 (279)
T 3fdn_A 84 VYLILEYAP---------------------LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 142 (279)
T ss_dssp EEEEECCCT---------------------TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCEECCCCGGGEEE
T ss_pred EEEEEecCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecccCChHhEEE
Confidence 999999998 55666677777889999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|.+||+|||++... ........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 143 ~~~~~~~l~Dfg~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 220 (279)
T 3fdn_A 143 GSAGELKIADFGWSVHA--PSSRRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220 (279)
T ss_dssp CTTSCEEECSCCEESCC----------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEEeccccccC--CcccccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcHHHHHHHHH
Confidence 99999999999988642 2233455689999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.....+|..+++++++||.+||..||.+|| +++|+++||||++
T Consensus 221 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~e~l~h~~~~~ 263 (279)
T 3fdn_A 221 RVEFTFPDFVTEGARDLISRLLKHNPSQRP------MLREVLEHPWITA 263 (279)
T ss_dssp HTCCCCCTTSCHHHHHHHHHHCCSSGGGSC------CHHHHHHCHHHHH
T ss_pred hCCCCCCCcCCHHHHHHHHHHhccChhhCC------CHHHHhhCccccC
Confidence 999999999999999999999999999999 6899999999974
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-50 Score=396.58 Aligned_cols=257 Identities=30% Similarity=0.545 Sum_probs=217.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-----------------------hhHHHHHHHHHHH
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-----------------------DDVECTLIERKVL 119 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----------------------~~~~~~~~e~~~l 119 (494)
..++|++.+.||+|+||.||+|+++.+++.||||++.+...... ...+....|..++
T Consensus 11 ~~~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l 90 (298)
T 2zv2_A 11 QLNQYTLKDEIGKGSYGVVKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAIL 90 (298)
T ss_dssp EETTEEEEEEEEC--CCEEEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHH
T ss_pred eecceEEEeEEeecCCEEEEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHH
Confidence 45799999999999999999999999999999999976543211 1234567788888
Q ss_pred HhcCCCCceeeEEEEEEc--CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHH
Q psy8309 120 ALGTKHPYLCHLFCTFQT--DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIV 197 (494)
Q Consensus 120 ~~~~~hp~Iv~l~~~~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~ 197 (494)
. .++||||+++++++.+ ...+|+||||+++|+|.+ +...+.+++..++.++.||+
T Consensus 91 ~-~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~----------------------~~~~~~~~~~~~~~~~~qi~ 147 (298)
T 2zv2_A 91 K-KLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVME----------------------VPTLKPLSEDQARFYFQDLI 147 (298)
T ss_dssp H-TCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCC----------------------SSCSSCCCHHHHHHHHHHHH
T ss_pred H-hCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHH----------------------HhhcCCCCHHHHHHHHHHHH
Confidence 7 5799999999999987 678999999999777642 12345799999999999999
Q ss_pred HHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC---CCCcchHHHHH
Q psy8309 198 SGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK---YNQCVDWWSFG 274 (494)
Q Consensus 198 ~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlG 274 (494)
.||+|||++||+||||||+|||++.+|.+||+|||+++............+||+.|+|||++.+.. ++.++||||||
T Consensus 148 ~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG 227 (298)
T 2zv2_A 148 KGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG 227 (298)
T ss_dssp HHHHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHH
T ss_pred HHHHHHHHCCeeccCCCHHHEEECCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHH
Confidence 999999999999999999999999999999999999986443333445678999999999998765 47889999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 275 ILLYEMHVGQSPFSGCDEDELFWSICNERPRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 275 vil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
|++|+|++|..||.+.+...+...+......+| ..+++++++||.+||+.||.+|| +++|+++||||+
T Consensus 228 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~------s~~e~l~hp~~~ 297 (298)
T 2zv2_A 228 VTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPDQPDIAEDLKDLITRMLDKNPESRI------VVPEIKLHPWVT 297 (298)
T ss_dssp HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC------CHHHHTTCHHHH
T ss_pred HHHHHHHHCCCCCCCccHHHHHHHHhcccCCCCCccccCHHHHHHHHHHhhcChhhCC------CHHHHhcCcccc
Confidence 999999999999999988888888888777666 46899999999999999999999 689999999985
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-50 Score=393.11 Aligned_cols=259 Identities=31% Similarity=0.610 Sum_probs=232.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|++..++..||||++.+..............|..++. .++||||+++++++.+.+.
T Consensus 10 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 88 (284)
T 2vgo_A 10 KFTIDDFDIGRPLGKGKFGNVYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQS-HLRHPNILRMYNYFHDRKR 88 (284)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSE
T ss_pred chhhhhceeeheecCCCCeEEEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHh-cCCCCCEeeEEEEEEcCCE
Confidence 466789999999999999999999999999999999997654333333455667777777 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ +++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 89 ~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~ 147 (284)
T 2vgo_A 89 IYLMLEFAP---------------------RGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIHRDIKPENLLM 147 (284)
T ss_dssp EEEEECCCT---------------------TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCSGGGEEE
T ss_pred EEEEEEeCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCHHHEEE
Confidence 999999998 55666677777889999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|.+||+|||++.... .......+||+.|+|||++.+..++.++||||||+++|+|++|..||...+..+....+.
T Consensus 148 ~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 225 (284)
T 2vgo_A 148 GYKGELKIADFGWSVHAP--SLRRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIV 225 (284)
T ss_dssp CTTCCEEECCCTTCEECS--SSCBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEEEecccccccCc--ccccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCHhHHHHHHh
Confidence 999999999999987532 233456789999999999999999999999999999999999999999999989999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.....+|..++.++++||.+||..||.+|| +++++++||||+.
T Consensus 226 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~ll~h~~~~~ 268 (284)
T 2vgo_A 226 NVDLKFPPFLSDGSKDLISKLLRYHPPQRL------PLKGVMEHPWVKA 268 (284)
T ss_dssp TTCCCCCTTSCHHHHHHHHHHSCSSGGGSC------CHHHHHTCHHHHH
T ss_pred ccccCCCCcCCHHHHHHHHHHhhcCHhhCC------CHHHHhhCHHHHh
Confidence 998999999999999999999999999999 6899999999974
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-50 Score=400.37 Aligned_cols=243 Identities=23% Similarity=0.315 Sum_probs=187.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH-hcCCCCceeeEEEEEEcCC----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA-LGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~-~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.+|.+.+.||+|+||+||+|++ +|+.||||+++... ......|.+++. ..++|||||++++++.+++
T Consensus 3 r~i~L~~~iG~G~fG~Vy~~~~--~g~~VAvK~l~~~~------~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~ 74 (303)
T 3hmm_A 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSRE------ERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEEECSSSEEEEEEE--TTEEEEEEEECGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECccc------hhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCce
Confidence 4789999999999999999987 57889999996541 223344555543 2579999999999998654
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCccc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK--------GIVYR 211 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~--------givHr 211 (494)
.+|||||||+| |+|..++.. ..+++..+..++.||+.||+|||++ +||||
T Consensus 75 ~~~lV~Ey~~~---------------------gsL~~~l~~-~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHR 132 (303)
T 3hmm_A 75 QLWLVSDYHEH---------------------GSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp EEEEEEECCTT---------------------CBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECS
T ss_pred EEEEEecCCCC---------------------CcHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeec
Confidence 68999999994 555556654 4689999999999999999999987 99999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCCC------CCCCcchHHHHHHHHHHHH
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKGL------KYNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~ell 281 (494)
||||+||||+.+|++||+|||+|+....... ...+.+||+.|||||++.+. .|+.++|||||||+||||+
T Consensus 133 DlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~ 212 (303)
T 3hmm_A 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred cCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHH
Confidence 9999999999999999999999986543322 22356899999999999765 3678999999999999999
Q ss_pred hCCCCCCCC---------------CHHHHHHHHHhC--CCCCCcc-----CCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 282 VGQSPFSGC---------------DEDELFWSICNE--RPRFPQF-----LSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 282 ~G~~Pf~~~---------------~~~~~~~~i~~~--~~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
||.+||... ...++...+... ++.+|.. .+..+.+|+.+||+.||++|| ++.
T Consensus 213 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~l~~li~~cl~~dP~~RP------t~~ 286 (303)
T 3hmm_A 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL------TAL 286 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHTTCCSSGGGSC------CHH
T ss_pred HCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHHHHHHHHHHcccCHhHCc------CHH
Confidence 998765321 223444444443 3455543 235788999999999999999 566
Q ss_pred hhhc
Q psy8309 340 DVVA 343 (494)
Q Consensus 340 eil~ 343 (494)
||++
T Consensus 287 ei~~ 290 (303)
T 3hmm_A 287 RIKK 290 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 6664
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-50 Score=401.74 Aligned_cols=261 Identities=26% Similarity=0.444 Sum_probs=204.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||||+++... ..........|..++. .++||||+++++++.+.+.+|+
T Consensus 4 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~l 80 (317)
T 2pmi_A 4 SSQFKQLEKLGNGTYATVYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMK-ELKHENIVRLYDVIHTENKLTL 80 (317)
T ss_dssp ---------------CEEEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHT-TCCBTTBCCEEEEECCTTEEEE
T ss_pred ccceeEeeEECCCCCEEEEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHH-hcCCCCcceEEEEEEECCeEEE
Confidence 468999999999999999999999999999999997653 2223345667888777 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS------GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
||||+. |+| ..++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 81 v~e~~~-~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~ivH~Dlkp~N 138 (317)
T 2pmi_A 81 VFEFMD-NDL---------------------KKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQN 138 (317)
T ss_dssp EEECCC-CBH---------------------HHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred EEEecC-CCH---------------------HHHHHhccccccccCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCChHH
Confidence 999997 233 3333322 469999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
||++.+|.+||+|||+++............+||+.|+|||++.+ ..++.++|||||||++|||++|.+||.+.+..+..
T Consensus 139 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~ 218 (317)
T 2pmi_A 139 LLINKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218 (317)
T ss_dssp EEECTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred eEEcCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 99999999999999999864333334456689999999999987 46899999999999999999999999999888877
Q ss_pred HHHHhC--CC--------------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 297 WSICNE--RP--------------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 297 ~~i~~~--~~--------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
..|... .+ ..+..++.++++||.+||+.||.+|| +++|++
T Consensus 219 ~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp------t~~e~l 292 (317)
T 2pmi_A 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLNPDMRL------SAKQAL 292 (317)
T ss_dssp HHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSSGGGSC------CHHHHT
T ss_pred HHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCCcccCC------CHHHHh
Confidence 776531 00 01225789999999999999999999 689999
Q ss_pred cCCCcCCCChhHH
Q psy8309 343 AHEYFRGLDWQAL 355 (494)
Q Consensus 343 ~h~~f~~~~w~~l 355 (494)
+||||++..|...
T Consensus 293 ~hp~f~~~~~~~~ 305 (317)
T 2pmi_A 293 HHPWFAEYYHHAS 305 (317)
T ss_dssp TSGGGGGGCC---
T ss_pred CChhhhcccchhh
Confidence 9999998877543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-50 Score=396.71 Aligned_cols=271 Identities=25% Similarity=0.379 Sum_probs=213.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||.||+|++..+++.||||++.... ...........|..++. .++||||+++++++.+.+.+|+
T Consensus 2 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~l 79 (311)
T 4agu_A 2 MEKYEKIGKIGEGSYGVVFKCRNRDTGQIVAIKKFLESE-DDPVIKKIALREIRMLK-QLKHPNLVNLLEVFRRKRRLHL 79 (311)
T ss_dssp -CCEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCCC-C-HHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred cccceEeeEEeecCCeEEEEEEeCCCCcEEEEEEeeccc-cchHHHHHHHHHHHHHH-hCCCCCccchhheeecCCeEEE
Confidence 468999999999999999999999999999999987652 22333455667777777 5789999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+. |+.|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 80 v~e~~~---------------------~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~~ivH~dlkp~Nil~~~~ 138 (311)
T 4agu_A 80 VFEYCD---------------------HTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKH 138 (311)
T ss_dssp EEECCS---------------------EEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEEeCC---------------------CchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCChhhEEEcCC
Confidence 999998 45555566667789999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
|.+||+|||++.............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+...
T Consensus 139 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~ 218 (311)
T 4agu_A 139 SVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRKT 218 (311)
T ss_dssp SCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHH
Confidence 99999999999864433444556789999999999976 66899999999999999999999999998877766554321
Q ss_pred -------------------CCCCC------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 303 -------------------RPRFP------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 303 -------------------~~~~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
....| ..++.++.+||.+||..||.+|| +++|+++||||+++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~f~~~~ 292 (311)
T 4agu_A 219 LGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL------TCEQLLHHPYFENIR 292 (311)
T ss_dssp HCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSC------CHHHHHTSGGGTTCC
T ss_pred hcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcC------CHHHHhcChHHHhcc
Confidence 01111 35789999999999999999999 689999999999998
Q ss_pred hhHHhcCcCCCC
Q psy8309 352 WQALEKRELEPP 363 (494)
Q Consensus 352 w~~l~~~~~~pp 363 (494)
|.....+....|
T Consensus 293 ~~~~~~~~~~~~ 304 (311)
T 4agu_A 293 EIEDLAKEHDKP 304 (311)
T ss_dssp ------------
T ss_pred CHHHHHHhhccH
Confidence 877665555544
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=397.15 Aligned_cols=266 Identities=28% Similarity=0.408 Sum_probs=234.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh---hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED---DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.++|++.+.||+|+||.||+|+++.+++.||||++.+...... ...+....|..++. .++||||+++++++.+.+.
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 89 (321)
T 2a2a_A 11 EDFYDIGEELGSGQFAIVKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILR-QVLHHNVITLHDVYENRTD 89 (321)
T ss_dssp HHHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSE
T ss_pred hccEEEeeEeeecCCEEEEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHH-hCCCCCcceEEEEEecCCE
Confidence 3579999999999999999999999999999999987543221 13456677888887 5789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||++ |++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 90 ~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH~dikp~NIl~ 148 (321)
T 2a2a_A 90 VVLILELVS---------------------GGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIML 148 (321)
T ss_dssp EEEEECCCC---------------------SCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEEcCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCChHHEEE
Confidence 999999998 55666677777889999999999999999999999999999999999999
Q ss_pred CCCC----CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 221 DYEG----HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 221 ~~~g----~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
+.++ .+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+..
T Consensus 149 ~~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~ 227 (321)
T 2a2a_A 149 LDKNIPIPHIKLIDFGLAHEIE-DGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETL 227 (321)
T ss_dssp SCTTSSSCCEEECCCTTCEECC-TTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSHHHHH
T ss_pred ecCCCCcCCEEEccCccceecC-ccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCHHHHH
Confidence 9988 79999999998633 233345668999999999999999999999999999999999999999999999999
Q ss_pred HHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcC
Q psy8309 297 WSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358 (494)
Q Consensus 297 ~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~ 358 (494)
..+......++ ..++.++++||.+||..||.+|| +++|+++||||.+++|.....+
T Consensus 228 ~~i~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~e~l~hp~~~~~~~~~~~~~ 287 (321)
T 2a2a_A 228 ANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRL------TIQEALRHPWITPVDNQQAMVR 287 (321)
T ss_dssp HHHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSTTTSC------CHHHHHHSTTTSCSSHHHHHHH
T ss_pred HHHHhcccccChhhhcccCHHHHHHHHHHcCCChhhCc------CHHHHhcCccccCCCccccccc
Confidence 99988877665 46899999999999999999999 6899999999999999876543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-50 Score=409.59 Aligned_cols=262 Identities=21% Similarity=0.330 Sum_probs=215.3
Q ss_pred CCCCceEeeEeccC--CceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 63 DLEDFQLLKVLGKG--SFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 63 ~~~~y~~~~~LG~G--~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
..++|++++.||+| +||.||+|+++.+++.||||++.+... ..........|..++. .++|||||+++++|.+.+.
T Consensus 23 ~~~~y~~~~~lG~G~~~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 100 (389)
T 3gni_B 23 EGGCYELLTVIGKGFEDLMTVNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSK-LFNHPNIVPYRATFIADNE 100 (389)
T ss_dssp CGGGEEEEEEEEEETTTTEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTE
T ss_pred CCCcEEEEecccCCcCCceEEEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHH-hCCCCCCCcEeEEEEECCE
Confidence 35689999999999 999999999999999999999987533 3445566667888877 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+|||||++ ++|..++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 101 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~NI 159 (389)
T 3gni_B 101 LWVVTSFMAY---------------------GSAKDLICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHI 159 (389)
T ss_dssp EEEEEECCTT---------------------CBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEEEccCC---------------------CCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHE
Confidence 9999999994 4555555554 6799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
||+.+|.+||+|||++....... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+
T Consensus 160 ll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 239 (389)
T 3gni_B 160 LISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKD 239 (389)
T ss_dssp EECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred EEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999886532211 22334589999999999988 6799999999999999999999999988
Q ss_pred CCHHHHHHHHHhCCC----------------------------------------------CCCccCCHHHHHHHHhhcc
Q psy8309 290 CDEDELFWSICNERP----------------------------------------------RFPQFLSVEAKNILVHLLD 323 (494)
Q Consensus 290 ~~~~~~~~~i~~~~~----------------------------------------------~~p~~~s~~~~~li~~lL~ 323 (494)
.+..+.+..+..+.. .++..+++++++||.+||+
T Consensus 240 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~ 319 (389)
T 3gni_B 240 MPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPYHRTFSPHFHHFVEQCLQ 319 (389)
T ss_dssp CCSTTHHHHC--------------------------------------------------------CCHHHHHHHHHHTC
T ss_pred CCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCccccccCHHHHHHHHHHhh
Confidence 766555444332211 2345689999999999999
Q ss_pred CCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 324 KDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 324 ~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.||.+|| +++|+++||||+++.|.
T Consensus 320 ~dP~~Rp------ta~ell~hp~f~~~~~~ 343 (389)
T 3gni_B 320 RNPDARP------SASTLLNHSFFKQIKRR 343 (389)
T ss_dssp SCTTTSC------CHHHHTTSGGGGGC---
T ss_pred cCcccCC------CHHHHhcCHHHHHHhhc
Confidence 9999999 68999999999988763
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-50 Score=414.58 Aligned_cols=251 Identities=28% Similarity=0.458 Sum_probs=208.1
Q ss_pred CCCCceEe-eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----
Q psy8309 63 DLEDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT---- 137 (494)
Q Consensus 63 ~~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~---- 137 (494)
..++|.+. ++||+|+||+||+|+++.+++.||||++.+. .....|..++....+||||++++++|..
T Consensus 59 ~~~~y~~~~~~LG~G~~g~V~~~~~~~~~~~vAiK~~~~~--------~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~ 130 (400)
T 1nxk_A 59 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 130 (400)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred ccccceeccceeeeccCeEEEEEEECCCCCEEEEEEeCcc--------hhHHHHHHHHHHhcCCCCcceEeEEEeecccC
Confidence 45688887 7999999999999999999999999999643 2345666666666799999999999876
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
..++|||||||+ ||+|..++...+ .+++.+++.++.||+.||.|||++||+||||||
T Consensus 131 ~~~~~lv~E~~~---------------------gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp 189 (400)
T 1nxk_A 131 RKCLLIVMECLD---------------------GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 189 (400)
T ss_dssp EEEEEEEEECCC---------------------SEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CcEEEEEEEeCC---------------------CCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCc
Confidence 678999999999 555666666543 599999999999999999999999999999999
Q ss_pred CceeeCC---CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 216 DNILLDY---EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~---~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
+|||++. ++.+||+|||+++... ......+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+.
T Consensus 190 ~Nill~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 190 ENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECC------------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred ceEEEecCCCCccEEEEecccccccC-CCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 9999998 7899999999998532 23334577899999999999999999999999999999999999999987654
Q ss_pred H----HHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 293 D----ELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 293 ~----~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
. .+...+..+...+| ..++.++++||.+||..||.+|| +++|+++||||.+
T Consensus 269 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------t~~eil~hp~~~~ 327 (400)
T 1nxk_A 269 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM------TITEFMNHPWIMQ 327 (400)
T ss_dssp CSSCCSHHHHHHHTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSHHHHT
T ss_pred ccccHHHHHHHHcCcccCCCcccccCCHHHHHHHHHHCCCChhHCc------CHHHHhcCccccC
Confidence 3 25566777776665 46899999999999999999999 6899999999964
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-49 Score=403.86 Aligned_cols=253 Identities=32% Similarity=0.540 Sum_probs=208.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++++.||+|+||.||+|+++.+++.||||++.+..... .....|..++. .++||||+++++++.+.+.+|
T Consensus 18 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~ 92 (361)
T 3uc3_A 18 DSDRYDFVKDIGSGNFGVARLMRDKLTKELVAVKYIERGAAID----ENVQREIINHR-SLRHPNIVRFKEVILTPTHLA 92 (361)
T ss_dssp CTTTEEEEEEESSSTTSSEEEEEETTTCCEEEEEEEESSTTSC----HHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred CCCcEEEEEEeccCCCEEEEEEEECCCCcEEEEEEEecCcccc----HHHHHHHHHHH-hCCCCCCCcEEEEEeeCCEEE
Confidence 4578999999999999999999999999999999997653222 34556777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|||||. ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 93 lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~ivH~Dlkp~Nill~~ 151 (361)
T 3uc3_A 93 IIMEYAS---------------------GGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDG 151 (361)
T ss_dssp EEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCSCCCCGGGEEECS
T ss_pred EEEEeCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEEcC
Confidence 9999998 5666677777889999999999999999999999999999999999999987
Q ss_pred CCC--EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCc-chHHHHHHHHHHHHhCCCCCCCCCH----HHH
Q psy8309 223 EGH--VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQC-VDWWSFGILLYEMHVGQSPFSGCDE----DEL 295 (494)
Q Consensus 223 ~g~--vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~-~DiwSlGvil~ell~G~~Pf~~~~~----~~~ 295 (494)
++. +||+|||+++... ........+||+.|+|||++.+..++.+ +|||||||++|+|++|..||.+.+. ...
T Consensus 152 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~~~~~~~~ 230 (361)
T 3uc3_A 152 SPAPRLKICDFGYSKSSV-LHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKT 230 (361)
T ss_dssp SSSCCEEECCCCCC----------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----CCCHHHH
T ss_pred CCCceEEEeecCcccccc-ccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCccHHHHHHH
Confidence 775 9999999987422 2334456789999999999988888655 8999999999999999999987543 556
Q ss_pred HHHHHhCCCCCCc--cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 296 FWSICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 296 ~~~i~~~~~~~p~--~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
...+......+|. .+++++++||.+||..||.+|| ++.|+++||||.
T Consensus 231 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------s~~ell~hp~f~ 279 (361)
T 3uc3_A 231 IQRILSVKYSIPDDIRISPECCHLISRIFVADPATRI------SIPEIKTHSWFL 279 (361)
T ss_dssp HHHHHTTCCCCCTTSCCCHHHHHHHHHHSCSCTTTSC------CHHHHHTSHHHH
T ss_pred HHHHhcCCCCCCCcCCCCHHHHHHHHHHccCChhHCc------CHHHHHhCcchh
Confidence 6677777777765 5899999999999999999999 689999999995
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-49 Score=397.73 Aligned_cols=261 Identities=27% Similarity=0.472 Sum_probs=235.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
....+|.+.+.||+|+||.||+|+++.+++.||+|++.+.........+....|..++. .++||||+++++++.+.+.+
T Consensus 38 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 116 (335)
T 2owb_A 38 RSRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFV 116 (335)
T ss_dssp TTTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEE
T ss_pred ccCCceEEEEEEeeCCCeEEEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeE
Confidence 34578999999999999999999999999999999998775555556667777888877 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||+. |++|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 117 ~lv~e~~~---------------------~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 175 (335)
T 2owb_A 117 FVVLELCR---------------------RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLN 175 (335)
T ss_dssp EEEECCCT---------------------TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEEC
T ss_pred EEEEecCC---------------------CCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCEecCCCchhEEEc
Confidence 99999998 555566677778899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....+.+..+..
T Consensus 176 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~ 255 (335)
T 2owb_A 176 EDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKK 255 (335)
T ss_dssp TTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCCHHHHHHHHhc
Confidence 99999999999998654344445667899999999999999999999999999999999999999999998888889999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
....+|..++.++++||.+||..||.+|| +++|+++|+||...
T Consensus 256 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~ell~~~~~~~~ 298 (335)
T 2owb_A 256 NEYSIPKHINPVAASLIQKMLQTDPTARP------TINELLNDEFFTSG 298 (335)
T ss_dssp TCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CGGGGGGSHHHHTS
T ss_pred CCCCCCccCCHHHHHHHHHHccCChhHCc------CHHHHhcCccccCC
Confidence 88899999999999999999999999999 67899999999753
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-49 Score=391.31 Aligned_cols=256 Identities=26% Similarity=0.470 Sum_probs=209.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||.||+|++ .+++.||||++..... ..........|..++. .++||||+++++++.+.+.+|+
T Consensus 1 ~~~y~~~~~lg~G~~g~V~~~~~-~~~~~~aiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 77 (288)
T 1ob3_A 1 MEKYHGLEKIGEGTYGVVYKAQN-NYGETFALKKIRLEKE-DEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVL 77 (288)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEE-TTSCEEEEEEECCSSG-GGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEE
T ss_pred CccchhhhhcccCCCEEEEEEEc-CCCCEEEEEEEecccc-ccccchhHHHHHHHHH-hcCCCCEeeeeeEEccCCeEEE
Confidence 36899999999999999999998 6788999999976432 2223345667777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+.+ +|...+.. .+.+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 v~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~ 135 (288)
T 1ob3_A 78 VFEHLDQ----------------------DLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINR 135 (288)
T ss_dssp EEECCSE----------------------EHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred EEEecCC----------------------CHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEcC
Confidence 9999962 44445544 367999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+|.+||+|||+++............+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+....+..
T Consensus 136 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~ 215 (288)
T 1ob3_A 136 EGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215 (288)
T ss_dssp TSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 9999999999987533223334456899999999999764 589999999999999999999999999888777766653
Q ss_pred C--CC---------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 E--RP---------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~--~~---------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
. .+ .+...+++++++||.+||+.||.+|| +++|+++||||++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~e~l~hp~f~~~ 287 (288)
T 1ob3_A 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI------TAKQALEHAYFKEN 287 (288)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC------CHHHHHTSGGGGC-
T ss_pred HHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCC------CHHHHhcCcchhhc
Confidence 1 00 01235789999999999999999999 68999999999865
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-49 Score=411.58 Aligned_cols=264 Identities=27% Similarity=0.402 Sum_probs=213.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++++.||+|+||.||+|+++.+++.||||++.+. ............|..++. .++||||+++++++...
T Consensus 25 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~-~~~~~~~~~~~~E~~~l~-~l~h~nIv~l~~~~~~~~~~~~ 102 (432)
T 3n9x_A 25 PDNYIIKHLIGRGSYGYVYLAYDKNTEKNVAIKKVNRM-FEDLIDCKRILREITILN-RLKSDYIIRLYDLIIPDDLLKF 102 (432)
T ss_dssp CTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECST-TTSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCTTTC
T ss_pred cCCEEEEEEEeecCCEEEEEEEECCCCcEEEEEEeCch-hcChHHHHHHHHHHHHHH-HcCCCCcceEEEEEecCCCCcC
Confidence 46899999999999999999999999999999999764 234445567788888887 47899999999999876
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+|+||||+. ++|...+.....+++..++.++.||+.||+|||++||+||||||+||
T Consensus 103 ~~~~lv~e~~~----------------------~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~LH~~givHrDlkp~NI 160 (432)
T 3n9x_A 103 DELYIVLEIAD----------------------SDLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANC 160 (432)
T ss_dssp CCEEEEEECCS----------------------EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred CeEEEEEecCC----------------------cCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCCCCCCCHHHe
Confidence 67999999984 46777788888899999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC----------------------CcccccCCCCCccChhhh-CCCCCCCcchHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD----------------------KTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGI 275 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~----------------------~~~~~~~gt~~y~aPE~l-~~~~~~~~~DiwSlGv 275 (494)
||+.+|.+||+|||+++...... ......+||+.|+|||++ .+..|+.++|||||||
T Consensus 161 Ll~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~ 240 (432)
T 3n9x_A 161 LLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGC 240 (432)
T ss_dssp EECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHH
T ss_pred EECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHH
Confidence 99999999999999998643221 123567899999999996 5567999999999999
Q ss_pred HHHHHHh-----------CCCCCCCCCH-----------------HHHHHHHHh------------------------CC
Q psy8309 276 LLYEMHV-----------GQSPFSGCDE-----------------DELFWSICN------------------------ER 303 (494)
Q Consensus 276 il~ell~-----------G~~Pf~~~~~-----------------~~~~~~i~~------------------------~~ 303 (494)
++|||++ |.++|.+.+. .+.+..|.+ ..
T Consensus 241 il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~ 320 (432)
T 3n9x_A 241 IFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNINKPEVIKYIKLFP 320 (432)
T ss_dssp HHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSC
T ss_pred HHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCC
Confidence 9999998 5555555431 122222211 11
Q ss_pred CCCC-------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhc
Q psy8309 304 PRFP-------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357 (494)
Q Consensus 304 ~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~ 357 (494)
...+ ..+++++++||.+||..||.+|| +++|+++||||+++.|...+.
T Consensus 321 ~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~------ta~e~L~Hp~f~~~~~~~~e~ 375 (432)
T 3n9x_A 321 HRKPINLKQKYPSISDDGINLLESMLKFNPNKRI------TIDQALDHPYLKDVRKKKLEN 375 (432)
T ss_dssp CCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHTCGGGTTTCCTTTC-
T ss_pred CCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCC------CHHHHhcChhhhhccCcccCc
Confidence 1111 35899999999999999999999 689999999999999977654
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=397.53 Aligned_cols=267 Identities=30% Similarity=0.442 Sum_probs=223.7
Q ss_pred CCceEe-eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 65 EDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 65 ~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+.|.+. +.||+|+||.||+|+++.+++.||||++.+... ..........|..++.....||||+++++++.+.+.+|+
T Consensus 28 ~~y~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~l 106 (327)
T 3lm5_A 28 NFYILTSKELGRGKFAVVRQCISKSTGQEYAAKFLKKRRR-GQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIIL 106 (327)
T ss_dssp HHEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESEET-TEECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEE
T ss_pred hEEeeccceeCCCCCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEE
Confidence 467777 899999999999999999999999999987543 233455677888888876688999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|||||.+|+| ..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 107 v~e~~~~~~L---------------------~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~~givH~Dikp~NIl~~ 165 (327)
T 3lm5_A 107 ILEYAAGGEI---------------------FSLCLPELAEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLS 165 (327)
T ss_dssp EEECCTTEEG---------------------GGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEES
T ss_pred EEEecCCCcH---------------------HHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeecCcCChHHEEEe
Confidence 9999996555 334432 36799999999999999999999999999999999999999
Q ss_pred C---CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 222 Y---EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 222 ~---~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
. ++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+.+..
T Consensus 166 ~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 244 (327)
T 3lm5_A 166 SIYPLGDIKIVDFGMSRKIG-HACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244 (327)
T ss_dssp CBTTBCCEEECCGGGCEEC----------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHH
T ss_pred cCCCCCcEEEeeCccccccC-CccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCchHHHHH
Confidence 8 7899999999998632 23334567899999999999999999999999999999999999999999999888888
Q ss_pred HHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcC
Q psy8309 299 ICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360 (494)
Q Consensus 299 i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~ 360 (494)
+......++ ..+++++++||.+||+.||.+|| +++++++||||++++|+.+.....
T Consensus 245 i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~~ll~h~~~~~~~~~~~~~~~~ 304 (327)
T 3lm5_A 245 ISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRP------TAEICLSHSWLQQWDFENLFHPEE 304 (327)
T ss_dssp HHHTCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC------CHHHHTTCGGGCCCCTTCC-----
T ss_pred HHhcccccCchhhcccCHHHHHHHHHHcCCChhhCc------CHHHHhCCHhhcccccccccCccC
Confidence 877655443 46899999999999999999999 689999999999999987654433
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-49 Score=388.14 Aligned_cols=260 Identities=27% Similarity=0.476 Sum_probs=234.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
...+|++.+.||+|+||.||+|+++.+++.||+|++.+.........+....|..++. .++||||+++++++.+.+.+|
T Consensus 13 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 91 (294)
T 2rku_A 13 SRRRYVRGRFLGKGGFAKCFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHR-SLAHQHVVGFHGFFEDNDFVF 91 (294)
T ss_dssp TTEEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEE
T ss_pred cccceEEEEEEeecCCEEEEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHH-hCCCCCEeeeeeeeccCCEEE
Confidence 4568999999999999999999999999999999998765555556666777888777 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||+. |++|...+...+.+++.+++.++.||+.||+|||++||+||||||+|||++.
T Consensus 92 lv~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~ 150 (294)
T 2rku_A 92 VVLELCR---------------------RRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNE 150 (294)
T ss_dssp EEEECCT---------------------TCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECT
T ss_pred EEEecCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhEEEcC
Confidence 9999998 5555666777788999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
++.+||+|||++.............+||+.|+|||++.+..++.++||||||+++|+|++|..||.+....+.+..+...
T Consensus 151 ~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~ 230 (294)
T 2rku_A 151 DLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKN 230 (294)
T ss_dssp TCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTT
T ss_pred CCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhhc
Confidence 99999999999986543444455678999999999999999999999999999999999999999999988888899888
Q ss_pred CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 ~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
...+|..+++++.+||.+||+.||.+|| +++|+++||||...
T Consensus 231 ~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~ll~~~~~~~~ 272 (294)
T 2rku_A 231 EYSIPKHINPVAASLIQKMLQTDPTARP------TINELLNDEFFTSG 272 (294)
T ss_dssp CCCCCTTSCHHHHHHHHHHTCSSGGGSC------CGGGGGGSHHHHTS
T ss_pred cCCCccccCHHHHHHHHHHcccChhhCc------CHHHHhhChheecC
Confidence 8889999999999999999999999999 67899999999753
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-49 Score=404.96 Aligned_cols=257 Identities=27% Similarity=0.452 Sum_probs=223.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|.++.+++.||+|++.+.. .........|..++. .++||||+++++++.+...+|+
T Consensus 50 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~~a~K~~~~~~---~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~l 125 (387)
T 1kob_A 50 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVL 125 (387)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCEEEEEEEECCCCCEEEEEEecccc---hhhHHHHHHHHHHHH-hCCCcCCCeEEEEEEeCCEEEE
Confidence 468999999999999999999999999999999997642 223345667777776 6799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||.| |+|..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 126 v~E~~~g---------------------g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDlkp~NIll~~ 184 (387)
T 1kob_A 126 ILEFLSG---------------------GELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 184 (387)
T ss_dssp EEECCCC---------------------CBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEcCCC---------------------CcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeecccchHHeEEec
Confidence 9999994 4555555544 47999999999999999999999999999999999999974
Q ss_pred --CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 223 --EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 --~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..+.
T Consensus 185 ~~~~~vkL~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~i~ 263 (387)
T 1kob_A 185 KKASSVKIIDFGLATKLN-PDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 263 (387)
T ss_dssp TTCCCEEECCCTTCEECC-TTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred CCCCceEEEecccceecC-CCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4779999999998632 2333445689999999999999999999999999999999999999999999988998888
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
.....++ ..+++++++||.+||..||.+|| +++|+++||||++..+
T Consensus 264 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------t~~ell~hp~~~~~~~ 313 (387)
T 1kob_A 264 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL------TVHDALEHPWLKGDHS 313 (387)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHTSTTTSSCCT
T ss_pred hCCCCCCccccccCCHHHHHHHHHHcCCChhHCc------CHHHHhhCccccCCcc
Confidence 8766554 46899999999999999999999 6899999999987543
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7e-50 Score=400.08 Aligned_cols=253 Identities=34% Similarity=0.518 Sum_probs=199.2
Q ss_pred CCceEe---eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 65 EDFQLL---KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 65 ~~y~~~---~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
++|++. +.||+|+||.||+|+++.+++.||||++.+. .......|..++....+||||+++++++.+....
T Consensus 8 ~~y~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~ 81 (325)
T 3kn6_A 8 QHYDLDLKDKPLGEGSFSICRKCVHKKSNQAFAVKIISKR------MEANTQKEITALKLCEGHPNIVKLHEVFHDQLHT 81 (325)
T ss_dssp HHEEECTTSCCSEEETTEEEEEEEETTTCCEEEEEEEEGG------GHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred hccccccCCCccccCCCeEEEEEEECCCCCEEEEEEEChh------hhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEE
Confidence 356664 7899999999999999999999999999754 2234556777777555699999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||+ ||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++
T Consensus 82 ~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~ 140 (325)
T 3kn6_A 82 FLVMELLN---------------------GGELFERIKKKKHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFT 140 (325)
T ss_dssp EEEECCCC---------------------SCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEE
T ss_pred EEEEEccC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCeecCCCHHHEEEe
Confidence 99999998 566677788888999999999999999999999999999999999999998
Q ss_pred CCC---CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-------
Q psy8309 222 YEG---HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD------- 291 (494)
Q Consensus 222 ~~g---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~------- 291 (494)
.++ .+||+|||+++............+||+.|+|||++.+..|+.++|||||||++|+|++|..||.+.+
T Consensus 141 ~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~ 220 (325)
T 3kn6_A 141 DENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDRSLTCTS 220 (325)
T ss_dssp C----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHHHHHHSSCTTC-------CCC
T ss_pred cCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcccccccc
Confidence 766 7999999999865444445567789999999999999999999999999999999999999998643
Q ss_pred HHHHHHHHHhCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 292 EDELFWSICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 292 ~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
..+++..+..+.+.++. .+++++++||.+||..||.+|| ++.++++||||++.
T Consensus 221 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------t~~ell~h~w~~~~ 277 (325)
T 3kn6_A 221 AVEIMKKIKKGDFSFEGEAWKNVSQEAKDLIQGLLTVDPNKRL------KMSGLRYNEWLQDG 277 (325)
T ss_dssp HHHHHHHHTTTCCCCCSHHHHTSCHHHHHHHHHHHCCCTTTCC------CTTTSTTCGGGCTT
T ss_pred HHHHHHHHHcCCCCCCcccccCCCHHHHHHHHHHCCCChhHCC------CHHHHhcChhhccC
Confidence 35677888888777663 5899999999999999999999 56789999999863
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-49 Score=404.27 Aligned_cols=256 Identities=29% Similarity=0.438 Sum_probs=217.1
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEe
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEY 147 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~ 147 (494)
...+.||+|+||.||+|+++.+|+.||||+++... ....+....|..++. .++||||+++++++.+.+.+|+||||
T Consensus 92 ~~~~~lG~G~~g~Vy~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~lv~E~ 167 (373)
T 2x4f_A 92 SKTEILGGGRFGQVHKCEETATGLKLAAKIIKTRG---MKDKEEVKNEISVMN-QLDHANLIQLYDAFESKNDIVLVMEY 167 (373)
T ss_dssp EEEEECC-----CEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEEEEEC
T ss_pred ecceEEecCcCEEEEEEEEcCCCcEEEEEEEcccc---cccHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEEEEeC
Confidence 33678999999999999999999999999997642 234456677888877 57999999999999999999999999
Q ss_pred cCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee--CCCC
Q psy8309 148 LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL--DYEG 224 (494)
Q Consensus 148 ~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl--~~~g 224 (494)
|++|+ |..++.. ...+++..++.++.||+.||.|||++||+||||||+|||+ +.++
T Consensus 168 ~~~~~---------------------L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~ 226 (373)
T 2x4f_A 168 VDGGE---------------------LFDRIIDESYNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAK 226 (373)
T ss_dssp CTTCE---------------------EHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEEEETTTT
T ss_pred CCCCc---------------------HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcccccCCHHHEEEecCCCC
Confidence 99554 4444443 3469999999999999999999999999999999999999 5678
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP 304 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~ 304 (494)
.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.+..|.....
T Consensus 227 ~~kl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~i~~~~~ 305 (373)
T 2x4f_A 227 QIKIIDFGLARRYK-PREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACRW 305 (373)
T ss_dssp EEEECCCSSCEECC-TTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHHTCC
T ss_pred cEEEEeCCCceecC-CccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhccC
Confidence 99999999998643 23334556899999999999999999999999999999999999999999999999999988776
Q ss_pred CCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 305 RFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 305 ~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
.++ ..+++++++||.+||+.||.+|| +++|+++||||++..|...
T Consensus 306 ~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------s~~e~l~hp~~~~~~~~~~ 354 (373)
T 2x4f_A 306 DLEDEEFQDISEEAKEFISKLLIKEKSWRI------SASEALKHPWLSDHKLHSR 354 (373)
T ss_dssp CSCSGGGTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSHHHHCHHHHHH
T ss_pred CCChhhhccCCHHHHHHHHHHcCCChhhCC------CHHHHhcCcCcCCCchhhh
Confidence 655 46899999999999999999999 6899999999998876543
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-49 Score=417.75 Aligned_cols=253 Identities=29% Similarity=0.461 Sum_probs=208.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++++.||+|+||+||+|+++.+++.||||++.+.. ...........|..++. .++||||++++++|...
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vAiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~~ 138 (464)
T 3ttj_A 61 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEE 138 (464)
T ss_dssp ETTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEESGG-GSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCCCeEEEEEEECCCCCEEEEEEECccc-cChHHHHHHHHHHHHHH-hCCCCCCCcEEEEEccCCcccc
Confidence 468999999999999999999999999999999998652 34445667778888887 57999999999999755
Q ss_pred -CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 -SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 -~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+|+|||||.+ ++...+. ..+++..++.++.||+.||+|||++||+||||||+|
T Consensus 139 ~~~~~lv~E~~~~----------------------~l~~~~~--~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDlkp~N 194 (464)
T 3ttj_A 139 FQDVYLVMELMDA----------------------NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 194 (464)
T ss_dssp CCEEEEEEECCSE----------------------EHHHHHT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred CCeEEEEEeCCCC----------------------CHHHHHh--hcCCHHHHHHHHHHHHHHHHHHHHCCcccCCCChHh
Confidence 467999999973 2333332 358999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|||+.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.+.
T Consensus 195 Ill~~~~~~kl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~~~~~~ 273 (464)
T 3ttj_A 195 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 273 (464)
T ss_dssp EEECTTSCEEECCCCCC------CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEeCCCCEEEEEEEeeeecC-CCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999998632 2334556789999999999999999999999999999999999999999998888777
Q ss_pred HHHhC----------------------CC-----CC----Ccc-----------CCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 SICNE----------------------RP-----RF----PQF-----------LSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ~i~~~----------------------~~-----~~----p~~-----------~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
.|... .+ .+ |.. .++++++||.+||..||.+||
T Consensus 274 ~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~----- 348 (464)
T 3ttj_A 274 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----- 348 (464)
T ss_dssp HHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----
T ss_pred HHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHHHHHHHcCCChhhCC-----
Confidence 76541 01 11 111 156799999999999999999
Q ss_pred CChhhhhcCCCcCC
Q psy8309 336 NSGDDVVAHEYFRG 349 (494)
Q Consensus 336 ~~~~eil~h~~f~~ 349 (494)
+++|+++||||+.
T Consensus 349 -ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 349 -SVDDALQHPYINV 361 (464)
T ss_dssp -CHHHHHTSTTTGG
T ss_pred -CHHHHhcChhhhh
Confidence 6899999999984
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-49 Score=392.65 Aligned_cols=261 Identities=31% Similarity=0.510 Sum_probs=216.3
Q ss_pred CCCceEe-eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 64 LEDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 64 ~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+.|++. ++||+|+||.||+|+++.+++.||||++.+.. .........|..++....+||||+++++++.+.+.+|
T Consensus 11 ~~~y~i~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~ 87 (316)
T 2ac3_A 11 EDVYQLQEDVLGEGAHARVQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFY 87 (316)
T ss_dssp TTSCEECCCCCCCCSSEEEEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEE
T ss_pred ceeEEecCceecCCceEEEEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEE
Confidence 4679985 78999999999999999999999999997652 2344567788888876678999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||||++ |++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 88 lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~Nil~~~ 146 (316)
T 2ac3_A 88 LVFEKMR---------------------GGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEH 146 (316)
T ss_dssp EEEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESC
T ss_pred EEEEcCC---------------------CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCceeCCCCHHHEEEcc
Confidence 9999999 5566667777788999999999999999999999999999999999999998
Q ss_pred CCC---EEEeecCceeeeeccC-------CcccccCCCCCccChhhhCC-----CCCCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 223 EGH---VRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKG-----LKYNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 223 ~g~---vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~-----~~~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
++. +||+|||++....... ......+||+.|+|||++.+ ..++.++|||||||++|||++|..||
T Consensus 147 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf 226 (316)
T 2ac3_A 147 PNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPF 226 (316)
T ss_dssp SSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSC
T ss_pred CCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCC
Confidence 876 9999999987532111 12234679999999999975 45889999999999999999999999
Q ss_pred CCCC---------------HHHHHHHHHhCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 288 SGCD---------------EDELFWSICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 288 ~~~~---------------~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+.. ...++..+..+...+|. .++.++++||.+||..||.+|| +++|+++||||+
T Consensus 227 ~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~e~l~hp~~~ 300 (316)
T 2ac3_A 227 VGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDKDWAHISCAAKDLISKLLVRDAKQRL------SAAQVLQHPWVQ 300 (316)
T ss_dssp CCCCCSCSCC----CCHHHHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHHSTTCC
T ss_pred cccccccccccccccchhHHHHHHHHHhccCcccCchhcccCCHHHHHHHHHHhhCChhhCC------CHHHHhcChhhc
Confidence 8754 34567778888888773 6899999999999999999999 689999999999
Q ss_pred CCChhH
Q psy8309 349 GLDWQA 354 (494)
Q Consensus 349 ~~~w~~ 354 (494)
+..|+.
T Consensus 301 ~~~~~~ 306 (316)
T 2ac3_A 301 GCAPEN 306 (316)
T ss_dssp ------
T ss_pred CCCCcc
Confidence 876643
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-49 Score=418.14 Aligned_cols=258 Identities=30% Similarity=0.520 Sum_probs=224.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh----------hhHHHHHHHHHHHHhcCCCCceeeEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED----------DDVECTLIERKVLALGTKHPYLCHLF 132 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~----------~~~~~~~~e~~~l~~~~~hp~Iv~l~ 132 (494)
..++|++++.||+|+||.||+|+++.+++.||||++.+...... ...+....|..++. .++||||++++
T Consensus 34 i~~~Y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~ 112 (504)
T 3q5i_A 34 IGESYFKVRKLGSGAYGEVLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLK-SLDHPNIIKLF 112 (504)
T ss_dssp GGGTEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHH-TCCCTTBCCEE
T ss_pred cccceEEEeEecccCCeEEEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHH-hCCCCCCCeEE
Confidence 35689999999999999999999999999999999987543221 33456778888887 57999999999
Q ss_pred EEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 133 ~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
+++.+...+|+|||||+ ||+|...+...+.+++..++.++.||+.||.|||++||+|||
T Consensus 113 ~~~~~~~~~~lv~e~~~---------------------gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~D 171 (504)
T 3q5i_A 113 DVFEDKKYFYLVTEFYE---------------------GGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNIVHRD 171 (504)
T ss_dssp EEEECSSEEEEEEECCT---------------------TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred EEEEcCCEEEEEEecCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeCC
Confidence 99999999999999999 566667777788999999999999999999999999999999
Q ss_pred CCCCceeeCCCC---CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 213 LKLDNILLDYEG---HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 213 LKp~NILl~~~g---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
|||+|||++.++ .+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+
T Consensus 172 lkp~Nil~~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~ 249 (504)
T 3q5i_A 172 IKPENILLENKNSLLNIKIVDFGLSSFFS-KDYKLRDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGG 249 (504)
T ss_dssp CSGGGEEESSTTCCSSEEECCCTTCEECC-TTSCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred CcHHHEEEecCCCCccEEEEECCCCEEcC-CCCccccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCC
Confidence 999999999876 69999999998632 3344556789999999999985 699999999999999999999999999
Q ss_pred CCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 290 CDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 290 ~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+..+++..|..+.+.++ ..+++++++||.+||..||.+|| +++|+++||||+..
T Consensus 250 ~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------t~~e~l~h~~~~~~ 308 (504)
T 3q5i_A 250 QNDQDIIKKVEKGKYYFDFNDWKNISDEAKELIKLMLTYDYNKRC------TAEEALNSRWIKKY 308 (504)
T ss_dssp SSHHHHHHHHHHCCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC------CHHHHHTSHHHHHT
T ss_pred CCHHHHHHHHHcCCCCCCccccCCCCHHHHHHHHHHcCCChhHCC------CHHHHhcCHhhhhc
Confidence 999999999999887776 57899999999999999999999 68999999999753
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-49 Score=397.16 Aligned_cols=257 Identities=25% Similarity=0.447 Sum_probs=213.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||||++..... ....+....|..++. .++||||+++++++.+.+..|+
T Consensus 6 ~~~y~i~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~l 82 (323)
T 3tki_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYL 82 (323)
T ss_dssp TTCEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhceeeeEEecCCCEEEEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHH-hCCCCCCCeEEEEEecCCeEEE
Confidence 5799999999999999999999999999999999975432 122234566777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||+| ++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 83 v~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NIll~~~ 141 (323)
T 3tki_A 83 FLEYCSG---------------------GELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141 (323)
T ss_dssp EEECCTT---------------------EEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred EEEcCCC---------------------CcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccccchHHEEEeCC
Confidence 9999994 4555566677789999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSI 299 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i 299 (494)
+.+||+|||+++...... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ..+..+
T Consensus 142 ~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~~~ 221 (323)
T 3tki_A 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221 (323)
T ss_dssp CCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCTTSHHHHHH
T ss_pred CCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCchHHHHHHHH
Confidence 999999999997533221 22346789999999999988775 78999999999999999999999876543 333333
Q ss_pred HhCCCCCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 300 CNERPRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 300 ~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.......+ ..++.++++||.+||..||.+|| +++|+++||||+..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~eil~h~~~~~~ 268 (323)
T 3tki_A 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARI------TIPDIKKDRWYNKP 268 (323)
T ss_dssp HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHTTCTTTTCC
T ss_pred hcccccCCccccCCHHHHHHHHHHccCChhhCc------CHHHHhhChhhccc
Confidence 33333322 57899999999999999999999 68999999999854
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.1e-50 Score=389.30 Aligned_cols=260 Identities=31% Similarity=0.553 Sum_probs=200.2
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+++|++.+.||+|+||.||+|++..+++.||||++.+..............|..++. .++||||+++++++.+.+.+|
T Consensus 9 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~ 87 (278)
T 3cok_A 9 KIEDFKVGNLLGKGSFAGVYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHC-QLKHPSILELYNYFEDSNYVY 87 (278)
T ss_dssp SGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TBCCTTBCCEEEEEECSSEEE
T ss_pred ccccceeeeeecCCCceEEEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHH-hCCCCCeEeEEEEEccCCeEE
Confidence 3578999999999999999999999999999999997654333334456677777776 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||++ +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 88 lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nili~ 146 (278)
T 3cok_A 88 LVLEMCH---------------------NGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLT 146 (278)
T ss_dssp EEEECCT---------------------TEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEECSSCCGGGEEEC
T ss_pred EEEecCC---------------------CCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEEc
Confidence 9999998 44555556554 6799999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+..
T Consensus 147 ~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~ 226 (278)
T 3cok_A 147 RNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVL 226 (278)
T ss_dssp TTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCSSCCCSCC-----CCS
T ss_pred CCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhHHHHHHHHhh
Confidence 99999999999998643333344567899999999999999999999999999999999999999998877777777776
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
....+|..++.++++||.+||..||.+|| +++++++||||.+.
T Consensus 227 ~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~~l~h~~~~~~ 269 (278)
T 3cok_A 227 ADYEMPSFLSIEAKDLIHQLLRRNPADRL------SLSSVLDHPFMSRN 269 (278)
T ss_dssp SCCCCCTTSCHHHHHHHHHHSCSSGGGSC------CHHHHTTSTTTC--
T ss_pred cccCCccccCHHHHHHHHHHcccCHhhCC------CHHHHhcCccccCC
Confidence 77788889999999999999999999999 68999999999753
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-49 Score=383.47 Aligned_cols=261 Identities=27% Similarity=0.481 Sum_probs=230.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|.++.+++.||+|++..... ..........|..++. .++||||+++++++.+.+..|+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 82 (284)
T 3kk8_A 5 SDNYDVKEELGKGAFSVVRRCVHKTTGLEFAAKIINTKKL-SARDFQKLEREARICR-KLQHPNIVRLHDSIQEESFHYL 82 (284)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEE
T ss_pred hhhhhhhhhhcCcCCeEEEEEEEcCCCceEEEEEeecccC-CHHHHHHHHHHHHHHH-HcCCCCcCeEEEEEEcCCEEEE
Confidence 4689999999999999999999999999999999976543 3444566677888877 4799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+. |++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 83 v~e~~~---------------------~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~Nil~~~~ 141 (284)
T 3kk8_A 83 VFDLVT---------------------GGELFEDIVAREFYSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASK 141 (284)
T ss_dssp EECCCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEESSS
T ss_pred EEecCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCcCCCCHHHEEEecC
Confidence 999998 55666677777889999999999999999999999999999999999999876
Q ss_pred CC---EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GH---VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~---vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+. +||+|||++.... ........+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 142 ~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~~~~~ 220 (284)
T 3kk8_A 142 AKGAAVKLADFGLAIEVN-DSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIK 220 (284)
T ss_dssp STTCCEEECCCTTCEECC-SSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCcEEEeeceeeEEcc-cCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCchhHHHHHHH
Confidence 65 9999999997532 2333455789999999999999999999999999999999999999999999999999998
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhH
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~ 354 (494)
.+...+| ..+++++++||.+||+.||.+|| +++|+++||||++..+..
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 221 AGAYDYPSPEWDTVTPEAKSLIDSMLTVNPKKRI------TADQALKVPWICNRERVA 272 (284)
T ss_dssp HTCCCCCTTTTTTSCHHHHHHHHHHSCSSTTTSC------CHHHHTTSHHHHSCCCGG
T ss_pred hccccCCchhhcccCHHHHHHHHHHcccChhhCC------CHHHHhcCccccCChhHH
Confidence 8876665 36899999999999999999999 689999999998876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-50 Score=421.87 Aligned_cols=260 Identities=32% Similarity=0.532 Sum_probs=230.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|+++++||+|+||.||+|+++.+++.||||++.+..............|..++. .++||||+++++++.+.+.+|+
T Consensus 25 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 103 (484)
T 3nyv_A 25 SDRYKGQRVLGKGSFGEVILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLK-QLDHPNIMKLYEFFEDKGYFYL 103 (484)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEE
T ss_pred cCceEEeeEEecCCCEEEEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHH-hCCCCCCCcEEEEEEeCCEEEE
Confidence 458999999999999999999999999999999998765554556677788888887 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee---
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL--- 220 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl--- 220 (494)
|||||. |++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 104 v~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 162 (484)
T 3nyv_A 104 VGEVYT---------------------GGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESK 162 (484)
T ss_dssp EECCCC---------------------SCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSS
T ss_pred EEecCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHHHEEEecC
Confidence 999998 56666777788899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.++.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+.
T Consensus 163 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 240 (484)
T 3nyv_A 163 SKDANIRIIDFGLSTHFE-ASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVE 240 (484)
T ss_dssp STTCCEEECCTTHHHHBC-CCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCcEEEEeeeeeEEcc-cccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCHHHHHHHHH
Confidence 567899999999987532 2334456789999999999987 69999999999999999999999999999999999999
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.+.+.++ ..+++++++||.+||+.||.+|| ++.|+++||||+...++
T Consensus 241 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------s~~e~l~h~~~~~~~~~ 291 (484)
T 3nyv_A 241 KGKYTFELPQWKKVSESAKDLIRKMLTYVPSMRI------SARDALDHEWIQTYTKE 291 (484)
T ss_dssp HCCCCCCSGGGGGSCHHHHHHHHHHTCSSGGGSC------CHHHHHTSHHHHHHTC-
T ss_pred cCCCCCCCcccccCCHHHHHHHHHHCCCChhHCc------CHHHHhhChhhcccccc
Confidence 8876654 46899999999999999999999 68999999999865543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=397.89 Aligned_cols=254 Identities=35% Similarity=0.542 Sum_probs=206.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++.+.||+|+||.||+|+++.+++.||||++++.. ..+....|..++. .++||||+++++++.+.+.+|+
T Consensus 52 ~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~l 125 (349)
T 2w4o_A 52 SDFFEVESELGRGATSIVYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLL-RLSHPNIIKLKEIFETPTEISL 125 (349)
T ss_dssp GGTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEC---------------CHHHH-HCCCTTBCCEEEEEECSSEEEE
T ss_pred cCcEEEeeEEeeCCCEEEEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHH-hCCCCCCcceeeeEecCCeEEE
Confidence 457999999999999999999999999999999997642 2234556777777 5789999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC-
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY- 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~- 222 (494)
||||++ |++|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++.
T Consensus 126 v~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIll~~~ 184 (349)
T 2w4o_A 126 VLELVT---------------------GGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATP 184 (349)
T ss_dssp EECCCC---------------------SCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEESSS
T ss_pred EEEeCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEecCCCcccEEEecC
Confidence 999999 5566667777788999999999999999999999999999999999999976
Q ss_pred --CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q psy8309 223 --EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSI 299 (494)
Q Consensus 223 --~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i 299 (494)
++.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|||++|..||.+.... .++..+
T Consensus 185 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~i 263 (349)
T 2w4o_A 185 APDAPLKIADFGLSKIVE-HQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRI 263 (349)
T ss_dssp STTCCEEECCCC-----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTCHHHHHHHH
T ss_pred CCCCCEEEccCccccccC-cccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcccHHHHHHH
Confidence 8899999999987532 233345678999999999999999999999999999999999999999876544 467778
Q ss_pred HhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 300 CNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 300 ~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
......++ ..++.++++||.+||..||.+|| ++.++++||||.+..
T Consensus 264 ~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~e~l~hp~~~~~~ 313 (349)
T 2w4o_A 264 LNCEYYFISPWWDEVSLNAKDLVRKLIVLDPKKRL------TTFQALQHPWVTGKA 313 (349)
T ss_dssp HTTCCCCCTTTTTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSTTTTSTT
T ss_pred HhCCCccCCchhhhCCHHHHHHHHHHccCChhhCc------CHHHHhcCcccCCCc
Confidence 77665443 46899999999999999999999 689999999998654
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=415.95 Aligned_cols=258 Identities=31% Similarity=0.530 Sum_probs=221.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.++..||||++.+..... ........|..++. .++||||++++++|.+...+|+
T Consensus 36 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 113 (494)
T 3lij_A 36 SEMYQRVKKLGSGAYGEVLLCRDKVTHVERAIKIIRKTSVST-SSNSKLLEEVAVLK-LLDHPNIMKLYDFFEDKRNYYL 113 (494)
T ss_dssp HHHEEEEEEEECC---EEEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEE
T ss_pred hcCeEEeeEEecCCCEEEEEEEECCCCcEEEEEEEeccccCc-hHHHHHHHHHHHHH-hCCCCCCCeEEEEEEeCCEEEE
Confidence 347999999999999999999999999999999998754322 23455677888776 6799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||. ||+|...+.....+++..++.++.||+.||.|||++||+||||||+|||++..
T Consensus 114 v~e~~~---------------------~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~Nil~~~~ 172 (494)
T 3lij_A 114 VMECYK---------------------GGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESK 172 (494)
T ss_dssp EEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEESCS
T ss_pred EEecCC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCChhhEEEeCC
Confidence 999999 55666677777889999999999999999999999999999999999999764
Q ss_pred ---CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 ---GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 ---g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+.
T Consensus 173 ~~~~~~kl~DfG~a~~~~-~~~~~~~~~gt~~y~aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 250 (494)
T 3lij_A 173 EKDALIKIVDFGLSAVFE-NQKKMKERLGTAYYIAPEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVE 250 (494)
T ss_dssp STTCCEEECCCTTCEECB-TTBCBCCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCcEEEEECCCCeECC-CCccccccCCCcCeeCHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 459999999998633 3344556789999999999875 69999999999999999999999999999999999999
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
.+...++ ..+++++++||.+||+.||.+|| ++.++++||||+...+
T Consensus 251 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------s~~e~l~hp~~~~~~~ 300 (494)
T 3lij_A 251 KGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRRI------SAQQALEHPWIKEMCS 300 (494)
T ss_dssp HTCCCCCSGGGTTSCHHHHHHHHHHTCSSTTTSC------CHHHHHTCHHHHHHHH
T ss_pred hCCCCCCchhcccCCHHHHHHHHHHCCCChhhCc------cHHHHhcCcccccCcc
Confidence 8877665 36899999999999999999999 6899999999986543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-49 Score=398.05 Aligned_cols=258 Identities=26% Similarity=0.481 Sum_probs=207.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||.||+|+++.+++.||||++..... .........|..++. .++||||+++++++.+.+.+|+
T Consensus 1 l~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~l 77 (324)
T 3mtl_A 1 METYIKLDKLGEGTYATVYKGKSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLK-DLKHANIVTLHDIIHTEKSLTL 77 (324)
T ss_dssp CCSEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHS-CCCCTTBCCEEEEEECSSCEEE
T ss_pred CCceEEEEEEcCCCCEEEEEEEECCCCcEEEEEEEecccc--cccchhHHHHHHHHH-hcCCCCCCeeeeEEeeCCEEEE
Confidence 4689999999999999999999999999999999975421 111112235666666 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+. ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 78 v~e~~~----------------------~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH~Dikp~NIl~~~ 135 (324)
T 3mtl_A 78 VFEYLD----------------------KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINE 135 (324)
T ss_dssp EEECCS----------------------EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEESSCCGGGEEECT
T ss_pred Eecccc----------------------cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCcCHHHEEECC
Confidence 999996 2444455543 46999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
+|.+||+|||+++............+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+....+..
T Consensus 136 ~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~i~~ 215 (324)
T 3mtl_A 136 RGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215 (324)
T ss_dssp TCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred CCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHH
Confidence 999999999999864433444456689999999999987 5689999999999999999999999999988887776654
Q ss_pred C--CC---CC-------------------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 302 E--RP---RF-------------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 302 ~--~~---~~-------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
. .+ .+ +..+++++++||.+||+.||.+|| +++|+++||||.++.
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~hp~f~~~~ 289 (324)
T 3mtl_A 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRI------SAEDAMKHPFFLSLG 289 (324)
T ss_dssp HHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSC------CHHHHTTSGGGGGGC
T ss_pred HhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCC------CHHHHhcChhhhhcc
Confidence 1 10 01 124789999999999999999999 689999999998765
Q ss_pred h
Q psy8309 352 W 352 (494)
Q Consensus 352 w 352 (494)
+
T Consensus 290 ~ 290 (324)
T 3mtl_A 290 E 290 (324)
T ss_dssp S
T ss_pred c
Confidence 4
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-48 Score=380.24 Aligned_cols=252 Identities=30% Similarity=0.540 Sum_probs=225.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+++.++..||+|++.+... ...+....|..++. .++||||+++++++.+...+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~a~k~~~~~~~---~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 84 (277)
T 3f3z_A 9 QYYTLENTIGRGSWGEVKIAVQKGTRIRRAAKKIPKYFV---EDVDRFKQEIEIMK-SLDHPNIIRLYETFEDNTDIYLV 84 (277)
T ss_dssp HHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred hhEEeeeEEeecCCEEEEEEEeCCCCcEEEEEeehhhcc---chHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCeEEEE
Confidence 479999999999999999999999999999999976532 23455677888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee---C
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---D 221 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl---~ 221 (494)
|||++ |++|...+...+.+++..++.++.||+.||+|||++||+||||||+|||+ +
T Consensus 85 ~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~~~ 143 (277)
T 3f3z_A 85 MELCT---------------------GGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDS 143 (277)
T ss_dssp EECCC---------------------SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEESSSS
T ss_pred EeccC---------------------CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHHEEEecCC
Confidence 99998 55666677777889999999999999999999999999999999999999 7
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.+||+|||++.... ........+||+.|+|||++.+. ++.++|||||||++|+|++|..||.+.+..+....+..
T Consensus 144 ~~~~~~l~Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~ 221 (277)
T 3f3z_A 144 PDSPLKLIDFGLAARFK-PGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIRE 221 (277)
T ss_dssp TTCCEEECCCTTCEECC-TTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCcEEEEecccceecc-CccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCHHHHHHHHHh
Confidence 88999999999997533 33445567899999999999874 99999999999999999999999999999999999999
Q ss_pred CCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 ERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+...+|. .+++++++||.+||+.||.+|| ++.++++||||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~------s~~~~l~h~~~~~ 267 (277)
T 3f3z_A 222 GTFTFPEKDWLNVSPQAESLIRRLLTKSPKQRI------TSLQALEHEWFEK 267 (277)
T ss_dssp CCCCCCHHHHTTSCHHHHHHHHHHTCSSTTTSC------CHHHHTTSHHHHH
T ss_pred CCCCCCchhhhcCCHHHHHHHHHHccCChhhCc------CHHHHhcCHHHhc
Confidence 8888875 6899999999999999999999 6899999999964
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-48 Score=383.06 Aligned_cols=266 Identities=28% Similarity=0.420 Sum_probs=227.6
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC------hhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE------DDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~------~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
..++|++.+.||+|+||.||+|+++.+++.||||++....... ....+....|..++....+||||+++++++.
T Consensus 15 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~ 94 (298)
T 1phk_A 15 FYENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYE 94 (298)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEE
T ss_pred hhhccceeeeecCCCceEEEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeec
Confidence 3579999999999999999999999999999999997643111 1223456678888876557999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+.+|+||||++ |++|..++.....+++..++.++.||+.||.|||++||+||||||+
T Consensus 95 ~~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~ 153 (298)
T 1phk_A 95 TNTFFFLVFDLMK---------------------KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPE 153 (298)
T ss_dssp CSSEEEEEEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred cCCeEEEEEeccC---------------------CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCcc
Confidence 9999999999998 5566667777788999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK------GLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
|||++.+|.+||+|||++.... ........+||+.|+|||++. ...++.++|||||||++|+|++|..||.+.
T Consensus 154 Nil~~~~~~~kl~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~ 232 (298)
T 1phk_A 154 NILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHR 232 (298)
T ss_dssp GEEECTTCCEEECCCTTCEECC-TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCS
T ss_pred eEEEcCCCcEEEecccchhhcC-CCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCc
Confidence 9999999999999999997633 233445678999999999985 456899999999999999999999999999
Q ss_pred CHHHHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHh
Q psy8309 291 DEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALE 356 (494)
Q Consensus 291 ~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~ 356 (494)
+..+....+..+...++ ..++.++++||.+||..||.+|| +++++++||||++..|+.+.
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~~~~~~~ 296 (298)
T 1phk_A 233 KQMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY------TAEEALAHPFFQQYVVEEVR 296 (298)
T ss_dssp SHHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC------CHHHHTTSGGGCTTC-----
T ss_pred cHHHHHHHHhcCCcccCcccccccCHHHHHHHHHHccCCcccCC------CHHHHHhChHhhhccchhhc
Confidence 98888888888766554 36899999999999999999999 68999999999999887764
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=386.46 Aligned_cols=259 Identities=24% Similarity=0.348 Sum_probs=210.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC--hhhHHHHHHHHHHHHh--cCCCCceeeEEEEEEcC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE--DDDVECTLIERKVLAL--GTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~--~~~~~~~~~e~~~l~~--~~~hp~Iv~l~~~~~~~ 138 (494)
..++|++++.||+|+||.||+|+++.+++.||||++....... .........|..++.. .++||||+++++++...
T Consensus 7 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~ 86 (308)
T 3g33_A 7 ATSRYEPVAEIGVGAYGTVYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATS 86 (308)
T ss_dssp ---CCEEEEEECCSSSCCEEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEEC
T ss_pred cccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeecc
Confidence 3568999999999999999999999999999999997543211 1111233445555442 23699999999999876
Q ss_pred C-----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCC--CCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 139 S-----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR--FDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 139 ~-----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~--l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
. .+++||||+. ++|..++..... +++..++.++.||+.||+|||++||+||
T Consensus 87 ~~~~~~~~~lv~e~~~----------------------~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~ 144 (308)
T 3g33_A 87 RTDREIKVTLVFEHVD----------------------QDLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHR 144 (308)
T ss_dssp CSSSEEEEEEEEECCC----------------------CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred CCCCceeEEEEehhhh----------------------cCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccC
Confidence 5 5899999995 355556665543 9999999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
||||+|||++.++.+||+|||+++.. .........+||+.|+|||++.+..++.++|||||||++|||++|.+||.+.+
T Consensus 145 Dlkp~Nil~~~~~~~kl~Dfg~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 223 (308)
T 3g33_A 145 DLKPENILVTSGGTVKLADFGLARIY-SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 223 (308)
T ss_dssp CCCTTTEEECTTSCEEECSCSCTTTS-TTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSS
T ss_pred CCCHHHEEEcCCCCEEEeeCcccccc-CCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999998753 22334456789999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHHhCCC-----CC----------------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 292 EDELFWSICNERP-----RF----------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 292 ~~~~~~~i~~~~~-----~~----------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..+...++..... .+ ...+++++++||.+||+.||.+|| ++.|+++|
T Consensus 224 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~h 297 (308)
T 3g33_A 224 EADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRI------SAFRALQH 297 (308)
T ss_dssp HHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSC------CHHHHHTS
T ss_pred HHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCC------CHHHHhcC
Confidence 8888877764210 00 135789999999999999999999 68999999
Q ss_pred CCcCCC
Q psy8309 345 EYFRGL 350 (494)
Q Consensus 345 ~~f~~~ 350 (494)
|||+..
T Consensus 298 ~~~~~~ 303 (308)
T 3g33_A 298 SYLHKD 303 (308)
T ss_dssp TTC---
T ss_pred ccccCC
Confidence 999863
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-49 Score=382.19 Aligned_cols=259 Identities=34% Similarity=0.545 Sum_probs=221.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++++.||+|+||.||+|+++.+++.||||++................|..++. .++||||+++++++.+.+.+
T Consensus 8 ~~~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 86 (276)
T 2h6d_A 8 VKIGHYVLGDTLGVGTFGKVKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLK-LFRHPHIIKLYQVISTPTDF 86 (276)
T ss_dssp CEETTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEE
T ss_pred ceeccEEEEeeecCCCCeEEEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHh-cCCCCCEeEEEEEEecCCeE
Confidence 45679999999999999999999999999999999997654333344556677877777 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ |++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 87 ~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~ 145 (276)
T 2h6d_A 87 FMVMEYVS---------------------GGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLD 145 (276)
T ss_dssp EEEEECCC---------------------SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSSCCCCCGGGEEEC
T ss_pred EEEEeccC---------------------CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChhhEEEC
Confidence 99999998 556666777778899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.++.+||+|||++.... ........+||+.|+|||++.+..+ +.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 146 ~~~~~~l~dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 224 (276)
T 2h6d_A 146 AHMNAKIADFGLSNMMS-DGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIR 224 (276)
T ss_dssp TTSCEEECCCCGGGCCC-C-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCEEEeecccccccC-CCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCcHHHHHHHhh
Confidence 99999999999987532 2233445679999999999998776 689999999999999999999999999889999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.....+|..++.++.+||.+||+.||.+|| +++|+++||||++
T Consensus 225 ~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~~l~h~~~~~ 267 (276)
T 2h6d_A 225 GGVFYIPEYLNRSVATLLMHMLQVDPLKRA------TIKDIREHEWFKQ 267 (276)
T ss_dssp HCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHSHHHHT
T ss_pred cCcccCchhcCHHHHHHHHHHccCChhhCC------CHHHHHhChhhcc
Confidence 888888999999999999999999999999 6899999999974
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=394.69 Aligned_cols=251 Identities=25% Similarity=0.425 Sum_probs=211.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC----CCCceeeEEEEEEcC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT----KHPYLCHLFCTFQTD 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~----~hp~Iv~l~~~~~~~ 138 (494)
..++|++++.||+|+||.||+|++..+++.||||++++. .........|..++.... .||||+++++++...
T Consensus 33 ~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~ 108 (360)
T 3llt_A 33 LNNAFLVIRKMGDGTFGRVLLCQHIDNKKYYAVKVVRNI----KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYY 108 (360)
T ss_dssp ETTTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC----HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET
T ss_pred ecCEEEEEEEEcccCCeEEEEEEECCCCeEEEEEEeccc----hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeEC
Confidence 346899999999999999999999999999999999743 223344556777776432 499999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+.+|+||||+ +|+ |..++... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 109 ~~~~lv~e~~-~~~---------------------L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~ 166 (360)
T 3llt_A 109 DHMCLIFEPL-GPS---------------------LYEIITRNNYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPE 166 (360)
T ss_dssp TEEEEEECCC-CCB---------------------HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CeeEEEEcCC-CCC---------------------HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCcc
Confidence 9999999999 544 44445443 35999999999999999999999999999999999
Q ss_pred ceeeCC-------------------------CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHH
Q psy8309 217 NILLDY-------------------------EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWW 271 (494)
Q Consensus 217 NILl~~-------------------------~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~Diw 271 (494)
||||+. ++.+||+|||+++.. .......+||+.|+|||++.+..|+.++|||
T Consensus 167 NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Diw 243 (360)
T 3llt_A 167 NILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFK---SDYHGSIINTRQYRAPEVILNLGWDVSSDMW 243 (360)
T ss_dssp GEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEET---TSCCCSCCSCGGGCCHHHHTTCCCCTTHHHH
T ss_pred cEEEccccccccccchhcccccccccccccCCCCEEEEeccCceec---CCCCcCccCcccccCcHHHcCCCCCCccchH
Confidence 999975 789999999999752 3344567899999999999999999999999
Q ss_pred HHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-------------------------------------------
Q psy8309 272 SFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ------------------------------------------- 308 (494)
Q Consensus 272 SlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~------------------------------------------- 308 (494)
||||++|+|++|..||.+.+..+....+......+|.
T Consensus 244 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~ 323 (360)
T 3llt_A 244 SFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323 (360)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTCSCHHHHHHHHTCCCH
T ss_pred HHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccccchhhhhhhhhcccc
Confidence 9999999999999999998887777766543333321
Q ss_pred ---cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 309 ---FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 309 ---~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
..++++.+||.+||+.||.+|| ++.|+++||||+
T Consensus 324 ~~~~~~~~l~~li~~~L~~dP~~Rp------ta~elL~hp~f~ 360 (360)
T 3llt_A 324 YKIIKHELFCDFLYSILQIDPTLRP------SPAELLKHKFLE 360 (360)
T ss_dssp HHHCCCHHHHHHHHHHCCSSGGGSC------CHHHHTTSGGGC
T ss_pred cccchHHHHHHHHHHHhcCChhhCC------CHHHHhcCcccC
Confidence 1247788999999999999999 689999999995
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-49 Score=397.28 Aligned_cols=260 Identities=27% Similarity=0.467 Sum_probs=221.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh-----hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED-----DDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~-----~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
++|++++.||+|+||.||+|+++.+++.||||++++...... ........|..++. .++||||+++++++.+.+
T Consensus 24 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~Iv~~~~~~~~~~ 102 (335)
T 3dls_A 24 QKYSTMSPLGSGAFGFVWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILS-RVEHANIIKVLDIFENQG 102 (335)
T ss_dssp HHEEEEEECSSSSSCSEEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHT-TCCCTTBCCEEEEEECSS
T ss_pred cceEEEeEEEecCCEEEEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHH-hCCCCCEeeEEEEEeeCC
Confidence 589999999999999999999999999999999987643222 12233456777776 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+||||+.+ |.+|..++...+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 103 ~~~lv~e~~~~--------------------g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIl 162 (335)
T 3dls_A 103 FFQLVMEKHGS--------------------GLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIV 162 (335)
T ss_dssp EEEEEEECCTT--------------------SCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EEEEEEEeCCC--------------------CccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeEEeccCHHHEE
Confidence 99999999873 3477778888889999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
++.++.+||+|||+++... ........+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.... .
T Consensus 163 l~~~~~~kL~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~------~ 235 (335)
T 3dls_A 163 IAEDFTIKLIDFGSAAYLE-RGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELE------E 235 (335)
T ss_dssp ECTTSCEEECCCTTCEECC-TTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGG------G
T ss_pred EcCCCcEEEeecccceECC-CCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHH------H
Confidence 9999999999999998633 3344556789999999999998876 789999999999999999999997633 2
Q ss_pred HHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC------CChhHHhcC
Q psy8309 299 ICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG------LDWQALEKR 358 (494)
Q Consensus 299 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~------~~w~~l~~~ 358 (494)
+.......|..+++++++||.+||..||.+|| +++++++||||++ .+|+.+...
T Consensus 236 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp------s~~ell~hp~~~~~~~~~~~~~~~~~~~ 295 (335)
T 3dls_A 236 TVEAAIHPPYLVSKELMSLVSGLLQPVPERRT------TLEKLVTDPWVTQPVNLADYTWEEVFRV 295 (335)
T ss_dssp GTTTCCCCSSCCCHHHHHHHHHHTCSSGGGSC------CHHHHHHCTTTTCCCCGGGCCHHHHC--
T ss_pred HHhhccCCCcccCHHHHHHHHHHccCChhhCc------CHHHHhcCccccCCccccccCHHHHhhh
Confidence 33445566778999999999999999999999 6899999999964 667776543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-48 Score=386.48 Aligned_cols=253 Identities=26% Similarity=0.451 Sum_probs=219.5
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|+..+.||+|+||.||+|+++.+|+.||||++.... ....+....|..++. .++||||+++++++...+.+|+||
T Consensus 46 ~~~~~~~lg~G~~g~V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~lv~ 121 (321)
T 2c30_A 46 LLDSYVKIGEGSTGIVCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMR-DYQHFNVVEMYKSYLVGEELWVLM 121 (321)
T ss_dssp HEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hhhccEEeccCCCeEEEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHH-hCCCCCcceEEEEEEECCEEEEEE
Confidence 4888899999999999999999999999999997542 233445667777776 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
||++||+ |..++. ...+++..+..++.||+.||.|||++||+||||||+|||++.+|.
T Consensus 122 e~~~~~~---------------------L~~~l~-~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NIll~~~~~ 179 (321)
T 2c30_A 122 EFLQGGA---------------------LTDIVS-QVRLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGR 179 (321)
T ss_dssp CCCCSCB---------------------HHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTCC
T ss_pred ecCCCCC---------------------HHHHHH-hcCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHEEECCCCc
Confidence 9999554 444443 357999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCC-
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERP- 304 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~- 304 (494)
+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+....+.....
T Consensus 180 ~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~ 259 (321)
T 2c30_A 180 VKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPP 259 (321)
T ss_dssp EEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSSCC
T ss_pred EEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHhcCCCC
Confidence 9999999988644433445567899999999999999999999999999999999999999999988888887776543
Q ss_pred --CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 305 --RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 305 --~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
..+..+++++++||.+||+.||.+|| +++|+++||||...
T Consensus 260 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~hp~~~~~ 301 (321)
T 2c30_A 260 KLKNSHKVSPVLRDFLERMLVRDPQERA------TAQELLDHPFLLQT 301 (321)
T ss_dssp CCTTGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHHTSGGGGGC
T ss_pred CcCccccCCHHHHHHHHHHccCChhhCc------CHHHHhcChhhccC
Confidence 23346899999999999999999999 68999999999753
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-49 Score=414.61 Aligned_cols=256 Identities=30% Similarity=0.544 Sum_probs=223.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||+||+|+++.+++.||||++.+.... .........|..++. .++||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~l 98 (486)
T 3mwu_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASAK-NKDTSTILREVELLK-KLDHPNIMKLFEILEDSSSFYI 98 (486)
T ss_dssp HHHEEEEEEEECCSSSEEEEEEETTTCCEEEEEEEEHHHHB-CSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEE
T ss_pred hcceEEeEEEeecCCEEEEEEEECCCCCEEEEEEEeccccc-chHHHHHHHHHHHHH-hCCCCCcCeEEEEEEcCCEEEE
Confidence 35899999999999999999999999999999999765332 234456778888887 4799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC--
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-- 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~-- 221 (494)
|||||. |++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 99 v~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~Nil~~~~ 157 (486)
T 3mwu_A 99 VGELYT---------------------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157 (486)
T ss_dssp EECCCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEESSS
T ss_pred EEEcCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEeccCchHHEEEecC
Confidence 999999 566666777778999999999999999999999999999999999999995
Q ss_pred -CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 -YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 -~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.++.+||+|||+++... ........+||+.|+|||++.+ .|+.++|||||||++|+|++|.+||.+.+..+++..+.
T Consensus 158 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~~~~~~i~ 235 (486)
T 3mwu_A 158 EKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (486)
T ss_dssp STTCCEEECSCSCTTTBC-CC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEEEECCcCeECC-CCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 45679999999987532 2334456789999999999987 59999999999999999999999999999999999999
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+...++ ..+++++++||.+||..||.+|| ++.++++||||+..
T Consensus 236 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------t~~~~l~hp~~~~~ 283 (486)
T 3mwu_A 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI------TATQCLEHPWIQKY 283 (486)
T ss_dssp HTCCCSCSGGGGGSCHHHHHHHHHHTCSSTTTSC------CHHHHHHCHHHHHT
T ss_pred hCCCCCCCcccCCCCHHHHHHHHHHcCCChhhCc------CHHHHhcCHhhccC
Confidence 8876554 46899999999999999999999 68999999999754
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-49 Score=392.78 Aligned_cols=267 Identities=25% Similarity=0.380 Sum_probs=218.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
..+++|++++.||+|+||.||+|+++.+++.||||++.... ...........|..++. .++||||+++++++.+.+.+
T Consensus 22 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 99 (331)
T 4aaa_A 22 QSMEKYENLGLVGEGSYGMVMKCRNKDTGRIVAIKKFLESD-DDKMVKKIAMREIKLLK-QLRHENLVNLLEVCKKKKRW 99 (331)
T ss_dssp BCGGGEEEEEEGGGGTTSSEEEEEETTTCCEEEEEEEESCS-SCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEE
T ss_pred hhhhhheeeeEEeecCCEEEEEEEECCCCceEEEEEEecCC-CchHHHHHHHHHHHHHh-hCCCCCEeeEEEEeecCCEE
Confidence 35689999999999999999999999999999999987642 22333445567777777 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||+. |+.|.......+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 100 ~lv~e~~~---------------------~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~dlkp~Nil~~ 158 (331)
T 4aaa_A 100 YLVFEFVD---------------------HTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVS 158 (331)
T ss_dssp EEEEECCS---------------------EEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEC
T ss_pred EEEEecCC---------------------cchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCEEccCcChheEEEc
Confidence 99999998 444555556667899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.+|.+||+|||+++............+||+.|+|||++.+. .++.++|||||||++|+|++|.+||.+.+..+....+.
T Consensus 159 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 238 (331)
T 4aaa_A 159 QSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIM 238 (331)
T ss_dssp TTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHH
T ss_pred CCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHH
Confidence 99999999999997644444445567899999999999875 78999999999999999999999999988777666554
Q ss_pred hC-------------------CCCCC------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NE-------------------RPRFP------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~-------------------~~~~p------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.. ...+| ..+++++++||.+||+.||.+|| ++.|+++||||+.
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp------t~~ell~hp~f~~ 312 (331)
T 4aaa_A 239 MCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP------FCAELLHHDFFQM 312 (331)
T ss_dssp HHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC------CGGGGGGSHHHHG
T ss_pred HHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCC------CHHHHhcCchhcc
Confidence 21 01111 25789999999999999999999 6789999999998
Q ss_pred CChhHHhc
Q psy8309 350 LDWQALEK 357 (494)
Q Consensus 350 ~~w~~l~~ 357 (494)
..|.....
T Consensus 313 ~~~~~~~~ 320 (331)
T 4aaa_A 313 DGFAERFS 320 (331)
T ss_dssp GGHHHHHH
T ss_pred CChhhhhh
Confidence 77766543
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-48 Score=396.34 Aligned_cols=256 Identities=28% Similarity=0.465 Sum_probs=210.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++++.||+|+||.||+|+++.+|+.||||++.+.. ...........|..++. .++||||+++++++....
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~hpnIv~l~~~~~~~~~~~~ 101 (367)
T 1cm8_A 24 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLK-HMRHENVIGLLDVFTPDETLDD 101 (367)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHH-HCCBTTBCCCSEEECSCSSTTT
T ss_pred cceEEEeEEeeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHH-hCCCcCCCCceeeEecCCcccc
Confidence 358999999999999999999999999999999997642 23445566778888887 578999999999998763
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+||||+ + ++|...+.. +.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 102 ~~~~~lv~e~~-~---------------------~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~N 158 (367)
T 1cm8_A 102 FTDFYLVMPFM-G---------------------TDLGKLMKH-EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 158 (367)
T ss_dssp CCCCEEEEECC-S---------------------EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred CceEEEEEecC-C---------------------CCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCccccCcCHHH
Confidence 469999999 3 344444444 679999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
||++.+|.+||+|||+++.. .......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+
T Consensus 159 Ill~~~~~~kl~Dfg~a~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l 235 (367)
T 1cm8_A 159 LAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 235 (367)
T ss_dssp EEECTTCCEEECCCTTCEEC---CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred EEEcCCCCEEEEeeeccccc---ccccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCHHHHH
Confidence 99999999999999999863 233456789999999999987 67999999999999999999999999999887777
Q ss_pred HHHHhC--CC-----------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNE--RP-----------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~--~~-----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..|... .+ .+...+++++++||.+||..||.+|| +++|+++||
T Consensus 236 ~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~~R~------t~~e~l~hp 309 (367)
T 1cm8_A 236 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV------TAGEALAHP 309 (367)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC------CHHHHHHSG
T ss_pred HHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChhHCC------CHHHHhcCh
Confidence 766531 10 12245789999999999999999999 689999999
Q ss_pred CcCCCChh
Q psy8309 346 YFRGLDWQ 353 (494)
Q Consensus 346 ~f~~~~w~ 353 (494)
||+.+.+.
T Consensus 310 ~f~~~~~~ 317 (367)
T 1cm8_A 310 YFESLHDT 317 (367)
T ss_dssp GGTTTC--
T ss_pred HHHhhcCC
Confidence 99987653
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-48 Score=397.10 Aligned_cols=269 Identities=27% Similarity=0.436 Sum_probs=211.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++++.||+|+||.||+|+++.+++.||||++.+.. ...........|..++. .++||||+++++++...+
T Consensus 24 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~ 101 (371)
T 2xrw_A 24 LKRYQNLKPIGSGAQGIVCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMK-CVNHKNIIGLLNVFTPQKSLEE 101 (371)
T ss_dssp ETTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSCCSTTT
T ss_pred hhheeEeeeeEecCCEEEEEEEECCCCceEEEEEecccc-CChHHHHHHHHHHHHHH-hcCCCCccceEEeecccccccc
Confidence 468999999999999999999999999999999997642 23445556777888877 579999999999998765
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+|||||.+ +|...+. ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 102 ~~~~~lv~e~~~~----------------------~l~~~~~--~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dlkp~N 157 (371)
T 2xrw_A 102 FQDVYIVMELMDA----------------------NLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 157 (371)
T ss_dssp CCEEEEEEECCSE----------------------EHHHHHH--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred ccceEEEEEcCCC----------------------CHHHHHh--hccCHHHHHHHHHHHHHHHHHHHHCCeecccCCHHH
Confidence 78999999962 3344443 458999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.+|.+||+|||+++... ........+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.
T Consensus 158 Il~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 236 (371)
T 2xrw_A 158 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWN 236 (371)
T ss_dssp EEECTTSCEEECCCCC-----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred EEEcCCCCEEEEEeecccccc-cccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 999999999999999997532 2223445789999999999999999999999999999999999999999998888777
Q ss_pred HHHhCCC----------------------CCC---------c-----------cCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 SICNERP----------------------RFP---------Q-----------FLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ~i~~~~~----------------------~~p---------~-----------~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
.+..... .+. . ..+.++++||.+||..||.+||
T Consensus 237 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~~R~----- 311 (371)
T 2xrw_A 237 KVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLLSKMLVIDASKRI----- 311 (371)
T ss_dssp HHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSGGGSC-----
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHHHHHHCcCChhhCC-----
Confidence 7764311 110 0 1157899999999999999999
Q ss_pred CChhhhhcCCCcCCCChhHHhcCcCCCCCccc
Q psy8309 336 NSGDDVVAHEYFRGLDWQALEKRELEPPFRPR 367 (494)
Q Consensus 336 ~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~ 367 (494)
+++|+++||||+.. .........||..|.
T Consensus 312 -t~~e~l~hp~~~~~--~~~~~~~~~~~~~~~ 340 (371)
T 2xrw_A 312 -SVDEALQHPYINVW--YDPSEAEAPPPKIPD 340 (371)
T ss_dssp -CHHHHHHSHHHHTT--CCHHHHTCCCCCCCT
T ss_pred -CHHHHhCCcchhhh--cCccccCCCCCCCCC
Confidence 68999999999853 333333445555543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-48 Score=378.61 Aligned_cols=253 Identities=29% Similarity=0.522 Sum_probs=214.1
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|.+.+.||+|+||.||+|+++.++..||+|++.+.. .....+....|..++. .++||||+++++++.+...+|+|
T Consensus 22 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~lv 98 (285)
T 3is5_A 22 DLFIFKRKLGSGAFGDVHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLK-SLDHPNIIKIFEVFEDYHNMYIV 98 (285)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred hheeecceeccCCCeEEEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHH-hCCCchHHhHHHheecCCeEEEE
Confidence 58999999999999999999999999999999998753 2233456677888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHh----hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI----QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l----~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|||+++|+| ...+ .....+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 99 ~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dikp~NIl~ 157 (285)
T 3is5_A 99 METCEGGEL---------------------LERIVSAQARGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILF 157 (285)
T ss_dssp ECCCSCCBH---------------------HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEE
T ss_pred EEeCCCCcH---------------------HHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHhCCEEECCCCHHHEEE
Confidence 999996555 3333 234689999999999999999999999999999999999999
Q ss_pred ---CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 ---DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ---~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.++.+||+|||+++... ........+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.+..+...
T Consensus 158 ~~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~il~~ll~g~~pf~~~~~~~~~~ 235 (285)
T 3is5_A 158 QDTSPHSPIKIIDFGLAELFK-SDEHSTNAAGTALYMAPEVFKR-DVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235 (285)
T ss_dssp SSSSTTCCEEECCCCCCCC-----------CTTGGGCCHHHHTT-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred ecCCCCCCEEEEeeecceecC-CcccCcCcccccCcCChHHhcc-CCCcccCeehHHHHHHHHHhCCCCCCCCCHHHHHh
Confidence 556889999999997532 2333456789999999999874 78999999999999999999999999999888888
Q ss_pred HHHhCCCCCC---ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 298 SICNERPRFP---QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 298 ~i~~~~~~~p---~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+......++ ..+++++.+||.+||+.||.+|| ++.|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~e~l~hp~f~~ 284 (285)
T 3is5_A 236 KATYKEPNYAVECRPLTPQAVDLLKQMLTKDPERRP------SAAQVLHHEWFKQ 284 (285)
T ss_dssp HHHHCCCCCCC--CCCCHHHHHHHHHHTCSCTTTSC------CHHHHHTSGGGGC
T ss_pred hhccCCcccccccCcCCHHHHHHHHHHccCChhhCc------CHHHHhcCHHhhc
Confidence 8876665544 34799999999999999999999 6899999999975
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-49 Score=394.06 Aligned_cols=281 Identities=25% Similarity=0.422 Sum_probs=220.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+.... ..........|..++. .++||||+++++++.+.+.+|
T Consensus 26 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~ 104 (345)
T 3hko_A 26 KKYHLKGAIGQGSYGVVRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMK-KLHHPNIARLYEVYEDEQYIC 104 (345)
T ss_dssp HHEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEEE
T ss_pred hheeecceeeecCCeEEEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHH-hCCCCCcceeehhhccCCeEE
Confidence 5899999999999999999999999999999999765332 2345567778888887 578999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhh------------------hhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHH
Q psy8309 143 FVMEYLNGGDLIPAGLTKAER------------------DLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFL 203 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~------------------~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yL 203 (494)
+|||||+||+|.+.+...... .......++.+..... ....+++..++.++.||+.||+||
T Consensus 105 lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~L 184 (345)
T 3hko_A 105 LVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYL 184 (345)
T ss_dssp EEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred EEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHH
Confidence 999999988774322100000 0000000000000000 012356788999999999999999
Q ss_pred HhCCCccccCCCCceeeCCCC--CEEEeecCceeeeeccCC----cccccCCCCCccChhhhCC--CCCCCcchHHHHHH
Q psy8309 204 HKKGIVYRDLKLDNILLDYEG--HVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGI 275 (494)
Q Consensus 204 H~~givHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGv 275 (494)
|++||+||||||+|||++.++ .+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||
T Consensus 185 H~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~ 264 (345)
T 3hko_A 185 HNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGV 264 (345)
T ss_dssp HHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHH
T ss_pred HHCCccccCCChhhEEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHH
Confidence 999999999999999998877 899999999985322111 2345689999999999976 67899999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 276 LLYEMHVGQSPFSGCDEDELFWSICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 276 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
++|||++|..||.+.+..+....+......++. .+++++++||.+||+.||.+|| ++.++++||||+++.
T Consensus 265 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~~l~hp~~~~~~ 338 (345)
T 3hko_A 265 LLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYNVLSPLARDLLSNLLNRNVDERF------DAMRALQHPWISQFS 338 (345)
T ss_dssp HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGGGGGSCHHHHHHHHHHSCSCTTTSC------CHHHHHHSHHHHTTS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcccccCCHHHHHHHHHHcCCChhHCC------CHHHHhcChhhccCh
Confidence 999999999999999999999999888766543 4899999999999999999999 689999999999876
Q ss_pred h
Q psy8309 352 W 352 (494)
Q Consensus 352 w 352 (494)
|
T Consensus 339 ~ 339 (345)
T 3hko_A 339 D 339 (345)
T ss_dssp S
T ss_pred H
Confidence 5
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-48 Score=388.36 Aligned_cols=252 Identities=26% Similarity=0.375 Sum_probs=206.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||+||+|+++.+++.||||++..... ........+.|...+....+||||+++++++.+.+.+|+
T Consensus 56 ~~~y~~~~~LG~G~~g~Vy~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~l 134 (311)
T 3p1a_A 56 QQSFQRLSRLGHGSYGEVFKVRSKEDGRLYAVKRSMSPFR-GPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYL 134 (311)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTSCEEEEEEESSSCC-SHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEE
T ss_pred hhheeeeheeccCCCeEEEEEEECCCCeEEEEEEeccccc-ChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEE
Confidence 3689999999999999999999999999999999876432 233444555666666666799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+. ++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 135 v~e~~~----------------------~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~ 192 (311)
T 3p1a_A 135 QTELCG----------------------PSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGP 192 (311)
T ss_dssp EEECCC----------------------CBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECG
T ss_pred EEeccC----------------------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHEEECC
Confidence 999993 344444444 456999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
++.+||+|||+++... ........+||+.|+|||++.+ .++.++|||||||++|||++|..||.+.. ....+..+
T Consensus 193 ~~~~kl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~~---~~~~~~~~ 267 (311)
T 3p1a_A 193 RGRCKLGDFGLLVELG-TAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNMELPHGGE---GWQQLRQG 267 (311)
T ss_dssp GGCEEECCCTTCEECC-------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSHH---HHHHHTTT
T ss_pred CCCEEEccceeeeecc-cCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCcc---HHHHHhcc
Confidence 9999999999987532 2333456679999999999987 79999999999999999999977765432 23344433
Q ss_pred CC--CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 303 RP--RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 303 ~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.. .++..+++++++||.+||+.||.+|| +++|+++||||++
T Consensus 268 ~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp------t~~ell~hp~~~~ 310 (311)
T 3p1a_A 268 YLPPEFTAGLSSELRSVLVMMLEPDPKLRA------TAEALLALPVLRQ 310 (311)
T ss_dssp CCCHHHHTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHTSGGGSC
T ss_pred CCCcccccCCCHHHHHHHHHHcCCChhhCc------CHHHHHhCccccC
Confidence 22 23457899999999999999999999 6899999999974
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-48 Score=391.38 Aligned_cols=256 Identities=27% Similarity=0.474 Sum_probs=223.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-----hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-----DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
++|++.+.||+|+||.||+|+++.+|+.||||++....... ....+....|..++....+||||+++++++...+
T Consensus 94 ~~y~~~~~lg~G~~g~Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~ 173 (365)
T 2y7j_A 94 QKYDPKDVIGRGVSSVVRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSS 173 (365)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSS
T ss_pred hhcccceEEecCCCEEEEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCC
Confidence 47999999999999999999999999999999997643111 1123456678888876558999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
..|+||||+. |++|..++.....+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 174 ~~~lv~e~~~---------------------g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~gi~H~Dlkp~NIl 232 (365)
T 2y7j_A 174 FMFLVFDLMR---------------------KGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENIL 232 (365)
T ss_dssp EEEEEECCCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EEEEEEEeCC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEE
Confidence 9999999999 5566667777788999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC------CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG------LKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~------~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
++.+|.+||+|||++.... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..
T Consensus 233 ~~~~~~ikl~DfG~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 311 (365)
T 2y7j_A 233 LDDNMQIRLSDFGFSCHLE-PGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQI 311 (365)
T ss_dssp ECTTCCEEECCCTTCEECC-TTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ECCCCCEEEEecCcccccC-CCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCCHH
Confidence 9999999999999987533 3344556789999999999863 36889999999999999999999999999988
Q ss_pred HHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 294 ELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 294 ~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.....+..+...++ ..++.++.+||.+||..||.+|| +++++++||||+
T Consensus 312 ~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~ell~hp~f~ 364 (365)
T 2y7j_A 312 LMLRMIMEGQYQFSSPEWDDRSSTVKDLISRLLQVDPEARL------TAEQALQHPFFE 364 (365)
T ss_dssp HHHHHHHHTCCCCCHHHHSSSCHHHHHHHHHHSCSSTTTSC------CHHHHHHSGGGC
T ss_pred HHHHHHHhCCCCCCCcccccCCHHHHHHHHHHcCCChhHCc------CHHHHhcCcccC
Confidence 88888888877665 46899999999999999999999 689999999996
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=379.16 Aligned_cols=260 Identities=27% Similarity=0.452 Sum_probs=224.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh---hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED---DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
++|++++.||+|+||.||+|+++.+++.||+|++++...... ...+....|..++. .++||||+++++++.+.+.+
T Consensus 5 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 83 (283)
T 3bhy_A 5 DHYEMGEELGSGQFAIVRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILR-EIRHPNIITLHDIFENKTDV 83 (283)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred hhhhhHHhhcccCceEEEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHH-hCCCCCeeehhheecCCCeE
Confidence 479999999999999999999999999999999987543221 13456677888887 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ |++|..++.....+++..++.++.||+.||.|||++||+||||||+||+++
T Consensus 84 ~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~ 142 (283)
T 3bhy_A 84 VLILELVS---------------------GGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLL 142 (283)
T ss_dssp EEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEES
T ss_pred EEEEeecC---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCChHHEEEe
Confidence 99999998 556666777778899999999999999999999999999999999999999
Q ss_pred CCC----CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 222 YEG----HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 222 ~~g----~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
.++ .+||+|||++..... .......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+..+...
T Consensus 143 ~~~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 221 (283)
T 3bhy_A 143 DKNVPNPRIKLIDFGIAHKIEA-GNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLT 221 (283)
T ss_dssp CSSSSSCCEEECCCTTCEECC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHH
T ss_pred cCCCCCCceEEEecccceeccC-CCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcchHHHHH
Confidence 887 899999999975322 233445679999999999999999999999999999999999999999999988888
Q ss_pred HHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 298 SICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 298 ~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.+......++ ..++.++++||.+||..||.+|| ++.++++||||+.+.|.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~~l~h~~~~~~~~~ 275 (283)
T 3bhy_A 222 NISAVNYDFDEEYFSNTSELAKDFIRRLLVKDPKRRM------TIAQSLEHSWIKAIRRR 275 (283)
T ss_dssp HHHTTCCCCCHHHHTTCCHHHHHHHHTTSCSSGGGSC------CHHHHHHCHHHHHHHHC
T ss_pred HhHhcccCCcchhcccCCHHHHHHHHHHccCCHhHCc------CHHHHHhCHHHHHHHHH
Confidence 8887776665 46899999999999999999999 68999999999876553
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=399.14 Aligned_cols=255 Identities=25% Similarity=0.384 Sum_probs=211.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
.++|++++.||+|+||+||+|++..+++.||||++....... ..|..++. .++||||++++++|..
T Consensus 6 ~~~y~~~~~lG~G~fg~V~~a~~~~~~~~vAiK~~~~~~~~~-------~~E~~il~-~l~hpnIv~l~~~~~~~~~~~~ 77 (383)
T 3eb0_A 6 SKKYSLGKTLGTGSFGIVCEVFDIESGKRFALKKVLQDPRYK-------NRELDIMK-VLDHVNIIKLVDYFYTTGDEEP 77 (383)
T ss_dssp CTTEEEEEEEECC-CEEEEEEEETTTCCEEEEEEEECCTTSC-------CHHHHHHT-TCCCTTBCCEEEEEEEC-----
T ss_pred cceEEEEEEEEeccCEEEEEEEECCCCCEEEEEEEecCcchH-------HHHHHHHH-HcCCCCccchhheeeecCcccc
Confidence 468999999999999999999999999999999987542211 24666666 5799999999999843
Q ss_pred --------------------------------CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCC
Q psy8309 138 --------------------------------DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFD 185 (494)
Q Consensus 138 --------------------------------~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~ 185 (494)
..++++|||||++ +|. ..+..++...+.++
T Consensus 78 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~L~-----------------~~l~~~~~~~~~l~ 139 (383)
T 3eb0_A 78 KPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPD-TLH-----------------KVLKSFIRSGRSIP 139 (383)
T ss_dssp --------------------------------CCEEEEEECCCSE-EHH-----------------HHHHHHHHTTCCCC
T ss_pred cccccccccccccccccccccccccccccCCCceEEEEEEecCCc-cHH-----------------HHHHHHHhcCCCCC
Confidence 4458999999973 431 12333445667899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC-CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-
Q psy8309 186 EGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK- 263 (494)
Q Consensus 186 e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~- 263 (494)
+..++.++.||+.||.|||++||+||||||+|||++ .++.+||+|||+++... ........+||+.|+|||++.+..
T Consensus 140 ~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~ 218 (383)
T 3eb0_A 140 MNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLI-PSEPSVAYICSRFYRAPELMLGATE 218 (383)
T ss_dssp HHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECC-TTSCCCCCCCCSSCCCHHHHTTCSS
T ss_pred HHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccC-CCCCCcCcccCCCccCHHHhcCCCC
Confidence 999999999999999999999999999999999998 68999999999998643 334455678999999999998754
Q ss_pred CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC-----------------CCC------------CCccCCHHH
Q psy8309 264 YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-----------------RPR------------FPQFLSVEA 314 (494)
Q Consensus 264 ~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-----------------~~~------------~p~~~s~~~ 314 (494)
|+.++|||||||++|||++|.+||.+.+..+.+..|... ... +|..+++++
T Consensus 219 ~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 298 (383)
T 3eb0_A 219 YTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTLKAKDWRKILPEGTPSLA 298 (383)
T ss_dssp CCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCCCCCCHHHHSCTTCCHHH
T ss_pred CCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCccCcccHHhhCCCCCCHHH
Confidence 999999999999999999999999999888877776531 011 355689999
Q ss_pred HHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 315 KNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 315 ~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
++||.+||..||.+|| ++.|+++||||+++.
T Consensus 299 ~~li~~~L~~dP~~R~------t~~e~l~hp~f~~~~ 329 (383)
T 3eb0_A 299 IDLLEQILRYEPDLRI------NPYEAMAHPFFDHLR 329 (383)
T ss_dssp HHHHHHHCCSSGGGSC------CHHHHHTSGGGHHHH
T ss_pred HHHHHHHccCChhhCC------CHHHHhcCHHHHHHH
Confidence 9999999999999999 689999999998653
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-48 Score=391.22 Aligned_cols=257 Identities=23% Similarity=0.364 Sum_probs=212.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
+++|++++.||+|+||.||+|+++.+++.||||++..... ..........|..++. .++||||+++++++..
T Consensus 16 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 93 (351)
T 3mi9_A 16 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQ-LLKHENVVNLIEICRTKASPYN 93 (351)
T ss_dssp GGGEEEEEECSSCSTTSEEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHH-HCCCTTBCCEEEEEEEC-----
T ss_pred ccceeEEEEEecCCCcEEEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHH-hccCCCcccHhheeeccccccc
Confidence 5799999999999999999999999999999999976533 2223345567888887 5789999999999987
Q ss_pred --CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 138 --DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 138 --~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
.+.+|+|||||.+ ++...+. ....+++.+++.++.||+.||.|||++||+|||||
T Consensus 94 ~~~~~~~lv~e~~~~----------------------~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlk 151 (351)
T 3mi9_A 94 RCKGSIYLVFDFCEH----------------------DLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMK 151 (351)
T ss_dssp ---CEEEEEEECCSE----------------------EHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred cCCceEEEEEeccCC----------------------CHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCC
Confidence 4579999999972 3333333 33679999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeec----cCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIY----LDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~----~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
|+|||++.+|.+||+|||+++.... ........+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+
T Consensus 152 p~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 231 (351)
T 3mi9_A 152 AANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQG 231 (351)
T ss_dssp GGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCC
T ss_pred HHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999975331 1222345689999999999986 4589999999999999999999999999
Q ss_pred CCHHHHHHHHHhCCCCCCcc--------------------------------CCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 290 CDEDELFWSICNERPRFPQF--------------------------------LSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 290 ~~~~~~~~~i~~~~~~~p~~--------------------------------~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
.+..+....+......++.. .++++++||.+||+.||.+|| +
T Consensus 232 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t 305 (351)
T 3mi9_A 232 NTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI------D 305 (351)
T ss_dssp SSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSCSSGGGSC------C
T ss_pred CChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhcCChhhCC------C
Confidence 98888777765421111110 278899999999999999999 6
Q ss_pred hhhhhcCCCcCCC
Q psy8309 338 GDDVVAHEYFRGL 350 (494)
Q Consensus 338 ~~eil~h~~f~~~ 350 (494)
++|+++||||.+.
T Consensus 306 ~~e~l~hp~f~~~ 318 (351)
T 3mi9_A 306 SDDALNHDFFWSD 318 (351)
T ss_dssp HHHHHTSGGGGSS
T ss_pred HHHHhCCCCcCCC
Confidence 8999999999764
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-48 Score=387.67 Aligned_cols=257 Identities=26% Similarity=0.398 Sum_probs=215.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe---
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH--- 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~--- 140 (494)
.++|++++.||+|+||.||+|+++.+++.||||+++...............|..++. .++||||+++++++.....
T Consensus 11 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~~ 89 (311)
T 3ork_A 11 SDRYELGEILGFGGMSEVHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHPAIVAVYDTGEAETPAGP 89 (311)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCC-CCCCTTBCCEEEEEEEEETTEE
T ss_pred cCcEEEEEEEccCCCEEEEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHH-cCCCCCcceEEEeeeccCCCCc
Confidence 468999999999999999999999999999999998765444445556667776665 5799999999999886553
Q ss_pred -eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 -LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 -~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.|+||||++ |++|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 90 ~~~lv~e~~~---------------------g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~Nil 148 (311)
T 3ork_A 90 LPYIVMEYVD---------------------GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIM 148 (311)
T ss_dssp EEEEEEECCC---------------------EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred ccEEEEecCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCCcCCCCHHHEE
Confidence 499999998 5666677777889999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+..
T Consensus 149 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~ 228 (311)
T 3ork_A 149 ISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 228 (311)
T ss_dssp EETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred EcCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHH
Confidence 9999999999999987532221 2234567999999999999999999999999999999999999999999988888
Q ss_pred HHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 297 WSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 297 ~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
..+.......+ ..++.++.+||.+||+.||.+|| +..+++.|+|++
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R~------~~~~~l~~~l~~ 278 (311)
T 3ork_A 229 YQHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRY------QTAAEMRADLVR 278 (311)
T ss_dssp HHHHHCCCCCHHHHSTTCCHHHHHHHHHHTCSSGGGSC------SSHHHHHHHHHH
T ss_pred HHHhcCCCCCcccccCCCCHHHHHHHHHHHhcCHhhCh------hhHHHHHHHHHH
Confidence 87777665443 45899999999999999999999 567889999875
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-48 Score=402.98 Aligned_cols=263 Identities=28% Similarity=0.479 Sum_probs=210.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-----hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-----DDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-----~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.++|.+.+.||+|+||.||+|.++.+++.||||++.+..... .........|..++. .++||||+++++++..
T Consensus 134 ~~~y~~~~~LG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~- 211 (419)
T 3i6u_A 134 RDEYIMSKTLGSGACGEVKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILK-KLNHPCIIKIKNFFDA- 211 (419)
T ss_dssp HTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHH-HCCCTTBCCCCEEEES-
T ss_pred hccEEEEeEEeeCCCeEEEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHH-hCCCCCEeeEEEEEec-
Confidence 368999999999999999999999999999999998754321 112223567888887 5799999999999864
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|+|||||++ |+|..++...+.+++..++.++.||+.||+|||++||+||||||+||
T Consensus 212 ~~~~lv~e~~~~---------------------g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~NI 270 (419)
T 3i6u_A 212 EDYYIVLELMEG---------------------GELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENV 270 (419)
T ss_dssp SEEEEEEECCTT---------------------CBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred CceEEEEEcCCC---------------------CcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChHhE
Confidence 568999999994 45555666778899999999999999999999999999999999999
Q ss_pred eeCCCC---CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 219 LLDYEG---HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 219 Ll~~~g---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|++.++ .+||+|||+++... ......+.+||+.|+|||++.+ ..|+.++|||||||++|+|++|.+||.+...
T Consensus 271 ll~~~~~~~~~kl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 271 LLSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp EESSSSSSCCEEECCSSTTTSCC------------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred EEecCCCcceEEEeecccceecC-CCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 997654 59999999998532 2334456789999999999864 5688999999999999999999999987543
Q ss_pred -HHHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHh
Q psy8309 293 -DELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALE 356 (494)
Q Consensus 293 -~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~ 356 (494)
..+...+..+...++ ..+++++++||.+||+.||.+|| +++|+++||||++.+|....
T Consensus 350 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~e~l~hp~~~~~~~~~~~ 412 (419)
T 3i6u_A 350 QVSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF------TTEEALRHPWLQDEDMKRKF 412 (419)
T ss_dssp SCCHHHHHHTTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHHSGGGCCHHHHHHH
T ss_pred hHHHHHHHhcCCCCCCchhhcccCHHHHHHHHHHccCChhHCc------CHHHHhCCcccCChhHHHHH
Confidence 345556666665554 36899999999999999999999 68999999999998887643
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-48 Score=379.78 Aligned_cols=261 Identities=23% Similarity=0.384 Sum_probs=202.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++++.||+|+||.||+|++..+++.||||+++... ..........|...+...++||||+++++++.+.+..
T Consensus 4 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~ 81 (290)
T 3fme_A 4 VKADDLEPIMELGRGAYGVVEKMRHVPSGQIMAVKRIRATV--NSQEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDV 81 (290)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEC-----CHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSE
T ss_pred ccHHhhhhHHhcCCCCCeEEEEEEecCCCeEEEEEEeeccc--CcHHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCE
Confidence 45679999999999999999999999999999999997642 2333344555666656678999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NILl 220 (494)
|+||||+++ +|. + .+.........+++..++.++.||+.||.|||++ ||+||||||+|||+
T Consensus 82 ~lv~e~~~~-~l~------------~-----~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~i~H~dlkp~Nil~ 143 (290)
T 3fme_A 82 WICMELMDT-SLD------------K-----FYKQVIDKGQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLI 143 (290)
T ss_dssp EEEEECCSE-EHH------------H-----HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHSCCCCCCCSGGGCEE
T ss_pred EEEEehhcc-chH------------H-----HHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhcCCeecCCCCHHHEEE
Confidence 999999973 331 1 1122233457899999999999999999999998 99999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhh----CCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII----KGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~ 295 (494)
+.++.+||+|||+++... ........+||+.|+|||++ .+..++.++|||||||++|+|++|..||.. ......
T Consensus 144 ~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~ 222 (290)
T 3fme_A 144 NALGQVKMCDFGISGYLV-DDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGTPFQQ 222 (290)
T ss_dssp CTTCCEEBCCC----------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCCCSCHHHH
T ss_pred CCCCCEEEeecCCccccc-ccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccccCchHHH
Confidence 999999999999987532 23334455799999999996 566789999999999999999999999986 344444
Q ss_pred HHHHH-hCCCCCC-ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 296 FWSIC-NERPRFP-QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 296 ~~~i~-~~~~~~p-~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
...+. ...+..+ ..+++++++||.+||+.||.+|| +++|+++||||+.
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------t~~e~l~hp~f~~ 272 (290)
T 3fme_A 223 LKQVVEEPSPQLPADKFSAEFVDFTSQCLKKNSKERP------TYPELMQHPFFTL 272 (290)
T ss_dssp HHHHHHSCCCCCCTTTSCHHHHHHHHHHTCSSGGGSC------CHHHHTTSHHHHH
T ss_pred HHHHhccCCCCcccccCCHHHHHHHHHHhhcChhhCc------CHHHHHhCccccc
Confidence 44443 3444443 47899999999999999999999 6899999999963
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=381.69 Aligned_cols=253 Identities=33% Similarity=0.605 Sum_probs=220.8
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++.+.||+|+||.||+|+++.+++.||||+++.... ........|..++. .++||||+++++++.+.+.+|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~lv 84 (304)
T 2jam_A 9 KTFIFMEVLGSGAFSEVFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLK-KIKHENIVTLEDIYESTTHYYLV 84 (304)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECC---------HHHHHHHHHH-HCCCTTBCCEEEEEECSSEEEEE
T ss_pred ccceeeeeccCCCCceEEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHH-hCCCCCeeehhhhcccCCEEEEE
Confidence 589999999999999999999999999999999986432 12234556777777 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee---C
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---D 221 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl---~ 221 (494)
|||++ |++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||+ +
T Consensus 85 ~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dikp~NIl~~~~~ 143 (304)
T 2jam_A 85 MQLVS---------------------GGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPE 143 (304)
T ss_dssp ECCCC---------------------SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCSCCGGGCEESSSS
T ss_pred EEcCC---------------------CccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCCHHHEEEecCC
Confidence 99998 55666677777889999999999999999999999999999999999999 7
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.++.+||+|||+++.. ........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..++...+..
T Consensus 144 ~~~~~kl~Dfg~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~i~~ 221 (304)
T 2jam_A 144 ENSKIMITDFGLSKME--QNGIMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKIKE 221 (304)
T ss_dssp TTCCEEBCSCSTTCCC--CCBTTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHH
T ss_pred CCCCEEEccCCcceec--CCCccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHc
Confidence 8899999999998742 22334456799999999999999999999999999999999999999999999999999988
Q ss_pred CCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+...++ ..+++++++||.+||..||.+|| +++++++||||++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~~l~h~~~~~~ 268 (304)
T 2jam_A 222 GYYEFESPFWDDISESAKDFICHLLEKDPNERY------TCEKALSHPWIDGN 268 (304)
T ss_dssp CCCCCCTTTTTTSCHHHHHHHHHHHCSSTTTSC------CHHHHHTSHHHHSS
T ss_pred CCCCCCccccccCCHHHHHHHHHHcCCChhHCc------CHHHHhcCccccCC
Confidence 765543 56899999999999999999999 68999999999753
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-47 Score=381.75 Aligned_cols=253 Identities=26% Similarity=0.382 Sum_probs=208.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CCee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DSHL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~~~ 141 (494)
.++|++++.||+|+||.||+|++..+++.||||+++.. .......|..++.....||||+++++++.+ ....
T Consensus 35 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~ 108 (330)
T 3nsz_A 35 QDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTP 108 (330)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEecccCCeEEEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCce
Confidence 46899999999999999999999999999999998743 224566788888765569999999999998 6789
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
++||||+.+++| ...+. .+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 109 ~lv~e~~~~~~l---------------------~~~~~---~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp~Nil~~ 164 (330)
T 3nsz_A 109 ALVFEHVNNTDF---------------------KQLYQ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID 164 (330)
T ss_dssp EEEEECCCCCCH---------------------HHHGG---GCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEE
T ss_pred EEEEeccCchhH---------------------HHHHH---hCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEc
Confidence 999999995544 43432 489999999999999999999999999999999999999
Q ss_pred CCC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Q psy8309 222 YEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGC-DEDELFWS 298 (494)
Q Consensus 222 ~~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~ 298 (494)
.++ .+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||... +..+....
T Consensus 165 ~~~~~~kl~Dfg~a~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~~~~~~~~l~~ 243 (330)
T 3nsz_A 165 HEHRKLRLIDWGLAEFYH-PGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVR 243 (330)
T ss_dssp TTTTEEEECCCTTCEECC-TTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHH
T ss_pred CCCCEEEEEeCCCceEcC-CCCccccccccccccChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCcccCCchHHHHHH
Confidence 777 89999999998533 2334556789999999999987 67999999999999999999999999543 33332222
Q ss_pred H-------------HhCCCCC------------------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhh
Q psy8309 299 I-------------CNERPRF------------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDV 341 (494)
Q Consensus 299 i-------------~~~~~~~------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei 341 (494)
+ ......+ +..+++++++||.+||+.||.+|| +++|+
T Consensus 244 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------ta~e~ 317 (330)
T 3nsz_A 244 IAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL------TAREA 317 (330)
T ss_dssp HHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHHHTTSCSSGGGSC------CHHHH
T ss_pred HHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHHHHHhcCCcccCC------CHHHH
Confidence 2 1122111 223799999999999999999999 68999
Q ss_pred hcCCCcCCCChh
Q psy8309 342 VAHEYFRGLDWQ 353 (494)
Q Consensus 342 l~h~~f~~~~w~ 353 (494)
++||||+++.|+
T Consensus 318 l~hp~f~~~~~~ 329 (330)
T 3nsz_A 318 MEHPYFYTVVKD 329 (330)
T ss_dssp HTSGGGTTCC--
T ss_pred hcCccHhhhccC
Confidence 999999999875
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-48 Score=390.09 Aligned_cols=269 Identities=26% Similarity=0.477 Sum_probs=228.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhh--------------HHHHHHHHHHHHhcCCCCc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD--------------VECTLIERKVLALGTKHPY 127 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~--------------~~~~~~e~~~l~~~~~hp~ 127 (494)
...++|++++.||+|+||.||+|++ +++.||||++.......... ......|..++. .++|||
T Consensus 28 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~ 104 (348)
T 2pml_X 28 KYINDYRIIRTLNQGKFNKIILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIIT-DIKNEY 104 (348)
T ss_dssp EEETTEEEEEEEECCSSCCEEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHT-TCCCTT
T ss_pred cccCceEEEEEEcCCCCeEEEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHH-hCCCCC
Confidence 3467999999999999999999998 88999999997654332211 256677888877 578999
Q ss_pred eeeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8309 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHK 205 (494)
Q Consensus 128 Iv~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~ 205 (494)
|+++++++.+.+.+|+||||+++|+|.+.... ...+.. ...+++..++.++.||+.||.|||+
T Consensus 105 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~---------------~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 169 (348)
T 2pml_X 105 CLTCEGIITNYDEVYIIYEYMENDSILKFDEY---------------FFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN 169 (348)
T ss_dssp BCCCSEEEESSSEEEEEEECCTTCBSSEESSS---------------EESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cceEEEEEeeCCeEEEEEeccCCCcHHHHHHH---------------hhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc
Confidence 99999999999999999999997777432000 000333 5689999999999999999999999
Q ss_pred -CCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCC-cchHHHHHHHHHHHHh
Q psy8309 206 -KGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQ-CVDWWSFGILLYEMHV 282 (494)
Q Consensus 206 -~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~-~~DiwSlGvil~ell~ 282 (494)
+||+||||||+|||++.++.+||+|||++.... .......+||+.|+|||++.+. .++. ++|||||||++|||++
T Consensus 170 ~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~ 247 (348)
T 2pml_X 170 EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV--DKKIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFY 247 (348)
T ss_dssp TSCEECCCCCGGGEEECTTSCEEECCCTTCEECB--TTEECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred cCCEeecCCChHhEEEcCCCcEEEeccccccccc--cccccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999999998532 2245567899999999999987 6766 9999999999999999
Q ss_pred CCCCCCCCCH-HHHHHHHHhCCCCCC-------------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 283 GQSPFSGCDE-DELFWSICNERPRFP-------------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 283 G~~Pf~~~~~-~~~~~~i~~~~~~~p-------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
|..||.+.+. .++...+..+...+| ..++.++++||.+||+.||.+|| ++.|++
T Consensus 248 g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rp------s~~e~l 321 (348)
T 2pml_X 248 NVVPFSLKISLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERI------TSEDAL 321 (348)
T ss_dssp SSCSSCCSSCSHHHHHHHTSCCCCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSC------CHHHHH
T ss_pred CCCCCCCCCcHHHHHHHHhccCcCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCC------CHHHHh
Confidence 9999998776 788888888877777 67899999999999999999999 689999
Q ss_pred cCCCcCCCChhHHh
Q psy8309 343 AHEYFRGLDWQALE 356 (494)
Q Consensus 343 ~h~~f~~~~w~~l~ 356 (494)
+||||++++|..+.
T Consensus 322 ~hp~f~~~~~~~~~ 335 (348)
T 2pml_X 322 KHEWLADTNIEDLR 335 (348)
T ss_dssp TSGGGTTCCHHHHH
T ss_pred cCccccCCCHHHHH
Confidence 99999999998875
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-48 Score=391.17 Aligned_cols=260 Identities=25% Similarity=0.375 Sum_probs=211.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh--hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED--DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~--~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
.++|++++.||+|+||.||+|+++.+|+.||||++........ ........|..++. .++||||+++++++.+.+.+
T Consensus 9 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 87 (346)
T 1ua2_A 9 AKRYEKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNIIGLLDAFGHKSNI 87 (346)
T ss_dssp ----CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH-HCCCTTBCCEEEEECCTTCC
T ss_pred hcccEEEeEEeecCCEEEEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHh-hCCCCCCCeEEEEEeeCCce
Confidence 4689999999999999999999999999999999976432211 11234567777777 57899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+||||+.+ +|...+... ..+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 88 ~lv~e~~~~----------------------~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp~Nil~ 145 (346)
T 1ua2_A 88 SLVFDFMET----------------------DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLL 145 (346)
T ss_dssp EEEEECCSE----------------------EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred EEEEEcCCC----------------------CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCCHHHEEE
Confidence 999999972 344444443 469999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i 299 (494)
+.+|.+||+|||+++............+||+.|+|||++.+. .++.++|||||||++|||++|.+||.+.+..+.+..|
T Consensus 146 ~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~~~~~~~i 225 (346)
T 1ua2_A 146 DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRI 225 (346)
T ss_dssp CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHH
T ss_pred cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCHHHHHHHH
Confidence 999999999999997543333445567899999999999764 5899999999999999999999999999988888777
Q ss_pred HhC--CC---CC-----------------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 300 CNE--RP---RF-----------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 300 ~~~--~~---~~-----------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
... .+ .+ ...++.++++||.+||..||.+|| +++|+++||||++..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~h~~f~~~~ 299 (346)
T 1ua2_A 226 FETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI------TATQALKMKYFSNRP 299 (346)
T ss_dssp HHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC------CHHHHHTSGGGTSSS
T ss_pred HHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCC------CHHHHhcChhhhcCC
Confidence 642 10 01 134679999999999999999999 689999999998765
Q ss_pred h
Q psy8309 352 W 352 (494)
Q Consensus 352 w 352 (494)
|
T Consensus 300 ~ 300 (346)
T 1ua2_A 300 G 300 (346)
T ss_dssp C
T ss_pred C
Confidence 4
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=376.17 Aligned_cols=246 Identities=26% Similarity=0.415 Sum_probs=209.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|++..++..||||++................|..++. .++||||+++++++.+.+.+|+
T Consensus 10 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~l 88 (294)
T 4eqm_A 10 NERYKIVDKLGGGGMSTVYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSS-QLSHQNIVSMIDVDEEDDCYYL 88 (294)
T ss_dssp ETTEEEEEEEEEETTEEEEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHT-TCCBTTBCCEEEEEECSSEEEE
T ss_pred hccEEEEEEEccCCCEEEEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHh-cCCCCCCceEEEeeeeCCeEEE
Confidence 468999999999999999999999999999999997655445555666777877776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||++ |++|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 89 v~e~~~---------------------g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~Dlkp~Nil~~~~ 147 (294)
T 4eqm_A 89 VMEYIE---------------------GPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSN 147 (294)
T ss_dssp EEECCC---------------------SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTT
T ss_pred EEeCCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHEEECCC
Confidence 999999 56666777788899999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
|.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+..+...++...
T Consensus 148 ~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~~~~~~~~~~~ 227 (294)
T 4eqm_A 148 KTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAIKHIQD 227 (294)
T ss_dssp SCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCHHHHHHHHHSS
T ss_pred CCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCChHHHHHHHhhc
Confidence 999999999987532211 2234567999999999999999999999999999999999999999998887776666554
Q ss_pred CCC-----CCccCCHHHHHHHHhhccCCCCCCCC
Q psy8309 303 RPR-----FPQFLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 303 ~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
... ++..+++.+.++|.+||++||.+||+
T Consensus 228 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~ 261 (294)
T 4eqm_A 228 SVPNVTTDVRKDIPQSLSNVILRATEKDKANRYK 261 (294)
T ss_dssp CCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCS
T ss_pred cCCCcchhcccCCCHHHHHHHHHHhcCCHhHccc
Confidence 332 24568999999999999999999994
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=397.49 Aligned_cols=257 Identities=25% Similarity=0.377 Sum_probs=208.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
..+|+++++||+|+||.||+|+++.+++.||||++.+.... ..+|..++. .++|||||+++++|..
T Consensus 53 ~~~y~~~~~lG~G~fg~Vy~~~~~~~~~~vaiK~~~~~~~~-------~~~E~~il~-~l~hpniv~l~~~~~~~~~~~~ 124 (420)
T 1j1b_A 53 EVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRF-------KNRELQIMR-KLDHCNIVRLRYFFYSSGEKKD 124 (420)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEECCTTS-------CCHHHHHHH-TCCCTTBCCEEEEEEEEETTTT
T ss_pred cceEEeeeEEeeCCCEEEEEEEECCCCcEEEEEEecccchh-------HHHHHHHHH-HcCCCCccceeeEEeccCCCCc
Confidence 34799999999999999999999999999999998754221 124666776 5799999999999853
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..++++||||+.++ |. + .+..+......+++..++.++.||+.||.|||++||+||||||+|
T Consensus 125 ~~~~~lv~e~~~~~-l~------------~-----~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 186 (420)
T 1j1b_A 125 EVYLNLVLDYVPET-VY------------R-----VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQN 186 (420)
T ss_dssp EEEEEEEEECCCEE-HH------------H-----HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCSGGG
T ss_pred ceeEEeehhccccc-HH------------H-----HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCChhh
Confidence 23478999999732 10 0 011122345789999999999999999999999999999999999
Q ss_pred eeeCCC-CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 218 ILLDYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~~~-g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
|||+.+ +.+||+|||+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.
T Consensus 187 ILl~~~~~~~kl~DFG~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~~~~ 265 (420)
T 1j1b_A 187 LLLDPDTAVLKLCDFGSAKQLV-RGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQ 265 (420)
T ss_dssp EEEETTTTEEEECCCTTCEECC-TTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEeCCCCeEEeccchhhhhcc-cCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 999965 568999999998643 23344567899999999999775 799999999999999999999999999887777
Q ss_pred HHHHHhC-----------------CCC------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 296 FWSICNE-----------------RPR------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 296 ~~~i~~~-----------------~~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
+.+|... ... ++..+++++++||.+||..||.+|| ++.|+++|||
T Consensus 266 l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R~------t~~e~l~hp~ 339 (420)
T 1j1b_A 266 LVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL------TPLEACAHSF 339 (420)
T ss_dssp HHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGG
T ss_pred HHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHCC------CHHHHhCCHh
Confidence 6666531 112 2345789999999999999999999 6899999999
Q ss_pred cCCCChh
Q psy8309 347 FRGLDWQ 353 (494)
Q Consensus 347 f~~~~w~ 353 (494)
|+++.|.
T Consensus 340 f~~~~~~ 346 (420)
T 1j1b_A 340 FDELRDP 346 (420)
T ss_dssp GGGGGCT
T ss_pred hcccccc
Confidence 9876553
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=378.81 Aligned_cols=261 Identities=30% Similarity=0.535 Sum_probs=218.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||+|++.... .........|..++. .++||||+++++++...+.+|+
T Consensus 18 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~aiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 93 (302)
T 2j7t_A 18 NEVWEIVGELGDGAFGKVYKAKNKETGALAAAKVIETKS---EEELEDYIVEIEILA-TCDHPYIVKLLGAYYHDGKLWI 93 (302)
T ss_dssp GGTEEEEEEEECSTTCCEEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHH-HCCCTTBCCEEEEEECC-CEEE
T ss_pred ccceeecceeccCCCeEEEEEEEcCCCcEEEEEEecCCC---HHHHHHHHHHHHHHh-cCCCCCEeeeeeeeeeCCeEEE
Confidence 468999999999999999999999999999999997542 334456677888887 4799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+++| +|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 94 v~e~~~~~---------------------~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~Nil~~~ 152 (302)
T 2j7t_A 94 MIEFCPGG---------------------AVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTL 152 (302)
T ss_dssp EEECCTTE---------------------EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEECT
T ss_pred EEEeCCCC---------------------cHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcCCcccCCCCHHHEEECC
Confidence 99999944 44444443 467999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhh-----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII-----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l-----~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+|.+||+|||++.............+||+.|+|||++ .+..++.++|||||||++|+|++|..||...+......
T Consensus 153 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~ 232 (302)
T 2j7t_A 153 EGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLL 232 (302)
T ss_dssp TSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHH
T ss_pred CCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCCHHHHHH
Confidence 9999999999875422222233456799999999998 46779999999999999999999999999998888887
Q ss_pred HHHhCCCC---CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 298 SICNERPR---FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 298 ~i~~~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
.+...... .+..++.++.+||.+||..||.+|| ++.++++||||+++.|...
T Consensus 233 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~~~~~~ 287 (302)
T 2j7t_A 233 KIAKSDPPTLLTPSKWSVEFRDFLKIALDKNPETRP------SAAQLLEHPFVSSITSNKA 287 (302)
T ss_dssp HHHHSCCCCCSSGGGSCHHHHHHHHHHSCSCTTTSC------CHHHHTTSTTTTTCCCCHH
T ss_pred HHhccCCcccCCccccCHHHHHHHHHHcccChhhCC------CHHHHhcChHHhhhccchh
Confidence 77765432 3567899999999999999999999 6899999999999987654
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=388.44 Aligned_cols=254 Identities=22% Similarity=0.364 Sum_probs=213.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-----S 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-----~ 139 (494)
.+|++++.||+|+||.||+|++..+++.||||++... ...........|..++. .++||||+++++++... .
T Consensus 27 ~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 103 (364)
T 3qyz_A 27 PRYTNLSYIGEGAYGMVCSAYDNLNKVRVAIKKISPF--EHQTYCQRTLREIKILL-RFRHENIIGINDIIRAPTIEQMK 103 (364)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCT--TCHHHHHHHHHHHHHHH-HCCCTTBCCCCEEECCSSTTTCC
T ss_pred ccEEEEEEeecCCCeEEEEEEECCCCeEEEEEEeccc--cCcHHHHHHHHHHHHHH-hcCCCCCccceeEEecCCccccc
Confidence 5899999999999999999999999999999999753 23344566778888887 57999999999999765 4
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+||||+. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 104 ~~~iv~e~~~----------------------~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIl 160 (364)
T 3qyz_A 104 DVYIVQDLME----------------------TDLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLL 160 (364)
T ss_dssp CEEEEEECCS----------------------EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEE
T ss_pred eEEEEEcccC----------------------cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCChHhEE
Confidence 7899999996 345555543 57999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
|+.++.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||.+.+..+.
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~ 240 (364)
T 3qyz_A 161 LNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240 (364)
T ss_dssp ECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGGGH
T ss_pred ECCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChHHH
Confidence 99999999999999986432221 1345689999999998754 5589999999999999999999999999887777
Q ss_pred HHHHHhC--CC------------------------C-----CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICNE--RP------------------------R-----FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~~--~~------------------------~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..|... .+ . ++..+++++++||.+||+.||.+|| ++.|+++|
T Consensus 241 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~h 314 (364)
T 3qyz_A 241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI------EVEQALAH 314 (364)
T ss_dssp HHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCSSTTTSC------CHHHHHTS
T ss_pred HHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCCChhhCC------CHHHHhcC
Confidence 6666421 00 0 1145789999999999999999999 68999999
Q ss_pred CCcCCC
Q psy8309 345 EYFRGL 350 (494)
Q Consensus 345 ~~f~~~ 350 (494)
|||+..
T Consensus 315 p~~~~~ 320 (364)
T 3qyz_A 315 PYLEQY 320 (364)
T ss_dssp GGGTTT
T ss_pred cchhhc
Confidence 999876
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-47 Score=386.12 Aligned_cols=252 Identities=24% Similarity=0.384 Sum_probs=216.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
..|++++.||+|+||.||+|++..+++.||||++................|..++. .++||||+++++++.+.+.+|+|
T Consensus 54 ~~y~~~~~lG~G~~g~Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~lv 132 (348)
T 1u5q_A 54 KLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLV 132 (348)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEE
T ss_pred hheeeeeEEccCCCEEEEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCeEEEE
Confidence 45999999999999999999999999999999997654334445566778888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+.| ++...+ .....+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 133 ~e~~~g----------------------~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~ 190 (348)
T 1u5q_A 133 MEYCLG----------------------SASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEP 190 (348)
T ss_dssp EECCSE----------------------EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETT
T ss_pred EecCCC----------------------CHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEECCC
Confidence 999962 233333 345689999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
|.+||+|||+++.. ......+||+.|+|||++. +..++.++|||||||++|||++|.+||.+.+..+....+.
T Consensus 191 ~~~kL~DfG~a~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~ 266 (348)
T 1u5q_A 191 GLVKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIA 266 (348)
T ss_dssp TEEEECCCTTCBSS----SSBCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCEEEeeccCceec----CCCCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 99999999998753 2234678999999999984 5678999999999999999999999999988877777776
Q ss_pred hCCCC--CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPR--FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..... .+..+++++++||.+||+.||.+|| +++++++||||..
T Consensus 267 ~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~~ll~h~~~~~ 311 (348)
T 1u5q_A 267 QNESPALQSGHWSEYFRNFVDSCLQKIPQDRP------TSEVLLKHRFVLR 311 (348)
T ss_dssp HSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHTTCHHHHS
T ss_pred hcCCCCCCCCCCCHHHHHHHHHHcccChhhCc------CHHHHhhChhhhc
Confidence 65432 2457899999999999999999999 6899999999964
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-47 Score=377.75 Aligned_cols=252 Identities=28% Similarity=0.451 Sum_probs=207.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|++ ++..||||++.+... ..........|..++. .++||||+++++++.+...
T Consensus 33 ~i~~~~y~i~~~lG~G~~g~V~~~~~--~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~ 108 (309)
T 3p86_A 33 DIPWCDLNIKEKIGAGSFGTVHRAEW--HGSDVAVKILMEQDF-HAERVNEFLREVAIMK-RLRHPNIVLFMGAVTQPPN 108 (309)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEE--TTEEEEEEEECCCCC-SHHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSTTC
T ss_pred cCChhHceeeeEeecCCCeEEEEEEE--CCCcEEEEEecCCCC-CHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEECCc
Confidence 34567999999999999999999976 567799999976532 3445566778888887 4789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCC
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG---RFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKL 215 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLKp 215 (494)
+|+||||+++ ++|..++...+ .+++..++.++.||+.||+|||++| |+||||||
T Consensus 109 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~~~ivH~Dikp 167 (309)
T 3p86_A 109 LSIVTEYLSR---------------------GSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKS 167 (309)
T ss_dssp CEEEEECCTT---------------------CBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHHHTSSSCCCCTTCCG
T ss_pred eEEEEecCCC---------------------CcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHHHcCCCCEECCCCCh
Confidence 9999999994 45555555544 3999999999999999999999999 99999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+..+.
T Consensus 168 ~NIll~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~~~~ 247 (309)
T 3p86_A 168 PNLLVDKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQV 247 (309)
T ss_dssp GGEEECTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCHHHH
T ss_pred hhEEEeCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 99999999999999999997543333345567899999999999999999999999999999999999999999988888
Q ss_pred HHHHH--hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 296 FWSIC--NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 296 ~~~i~--~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
...+. .....+|..+++++.+||.+||..||.+|| ++.++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~~ll~ 291 (309)
T 3p86_A 248 VAAVGFKCKRLEIPRNLNPQVAAIIEGCWTNEPWKRP------SFATIMD 291 (309)
T ss_dssp HHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc------CHHHHHH
Confidence 77774 345677889999999999999999999999 5677765
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-48 Score=392.00 Aligned_cols=262 Identities=29% Similarity=0.507 Sum_probs=219.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|+++.++..||+|++... ...........|..++. .++||||+++++++.+.+.
T Consensus 29 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~va~K~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 105 (360)
T 3eqc_A 29 ELKDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGE 105 (360)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECC--CCHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEETTE
T ss_pred ccccccceeeeeecCCCCeEEEEEEECCCCcEEEEEEeccc--cCHHHHHHHHHHHHHHH-HCCCCCEEEEeEEEEECCE
Confidence 45567999999999999999999999999999999999765 23344556677777776 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NIL 219 (494)
+|+||||++ |++|..++...+.+++..++.++.||+.||.|||++ ||+||||||+|||
T Consensus 106 ~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~~~i~H~dlkp~Nil 164 (360)
T 3eqc_A 106 ISICMEHMD---------------------GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL 164 (360)
T ss_dssp EEEEECCCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEE
T ss_pred EEEEEECCC---------------------CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEcCCccHHHEE
Confidence 999999999 556666777778899999999999999999999996 9999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH--
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW-- 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~-- 297 (494)
++.++.+||+|||+++... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..++..
T Consensus 165 ~~~~~~~kl~Dfg~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~ 242 (360)
T 3eqc_A 165 VNSRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMF 242 (360)
T ss_dssp ECTTCCEEECCCCCCHHHH--HHC----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCHHHHHHHH
T ss_pred ECCCCCEEEEECCCCcccc--cccccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHh
Confidence 9999999999999986432 223445689999999999999999999999999999999999999998776544322
Q ss_pred ----------------------------------------HHHhCC-CCCC-ccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 ----------------------------------------SICNER-PRFP-QFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ----------------------------------------~i~~~~-~~~p-~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
.+.... +..+ ..++.++++||.+||..||.+||
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----- 317 (360)
T 3eqc_A 243 GCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA----- 317 (360)
T ss_dssp C------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCHHHHHHHHHHHCSSTTTSC-----
T ss_pred cccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccHHHHHHHHHHhhcChhhCC-----
Confidence 222222 2222 35799999999999999999999
Q ss_pred CChhhhhcCCCcCCCChhH
Q psy8309 336 NSGDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 336 ~~~~eil~h~~f~~~~w~~ 354 (494)
+++|+++||||++.+|+.
T Consensus 318 -t~~ell~hp~~~~~~~~~ 335 (360)
T 3eqc_A 318 -DLKQLMVHAFIKRSDAEE 335 (360)
T ss_dssp -CHHHHHTSHHHHHHHHSC
T ss_pred -CHHHHhhChHhhcchHhh
Confidence 689999999998766544
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-47 Score=372.10 Aligned_cols=252 Identities=24% Similarity=0.354 Sum_probs=208.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||||++++... ........+.|...+....+||||+++++++.+.+.+|+
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~l 88 (289)
T 1x8b_A 10 TTEFHELEKIGSGEFGSVFKCVKRLDGCIYAIKRSKKPLA-GSVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLI 88 (289)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCCT-TSHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEE
T ss_pred cchhhhhhhhcCCCceEEEEEEEcCCCceEEEEEeccccc-ccHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEE
Confidence 3589999999999999999999999999999999986533 233445667777777765599999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS----GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
||||+++|+| ..++... +.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 89 v~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dikp~NIl 147 (289)
T 1x8b_A 89 QNEYCNGGSL---------------------ADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIF 147 (289)
T ss_dssp EEECCTTCBH---------------------HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EEEecCCCcH---------------------HHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHHhCCEeecCCCHHHEE
Confidence 9999995554 4444433 67999999999999999999999999999999999999
Q ss_pred eCCCC-------------------CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHH
Q psy8309 220 LDYEG-------------------HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYE 279 (494)
Q Consensus 220 l~~~g-------------------~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~e 279 (494)
++.+| .+||+|||++.... .....+||+.|+|||++.+. .++.++|||||||++|+
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~ 223 (289)
T 1x8b_A 148 ISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRIS----SPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVC 223 (289)
T ss_dssp EC--------------------CCCEEECCCTTCEETT----CSCCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHH
T ss_pred EcCCCCCcccccccccccccCCceEEEEcccccccccC----CccccCCCccccChhHhcCCCCCCchhhHHHHHHHHHH
Confidence 98544 79999999987532 23345699999999999876 56789999999999999
Q ss_pred HHhCCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 280 MHVGQSPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 280 ll~G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
|++|.+|+.... ....+..+ .+.+|..+++++++||.+||+.||.+|| ++.++++||||.+.
T Consensus 224 l~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~ 286 (289)
T 1x8b_A 224 AAGAEPLPRNGD---QWHEIRQGRLPRIPQVLSQEFTELLKVMIHPDPERRP------SAMALVKHSVLLSA 286 (289)
T ss_dssp HTTCCCCCSSSH---HHHHHHTTCCCCCSSCCCHHHHHHHHHHTCSSGGGSC------CHHHHHTCTTC---
T ss_pred HhcCCCCCcchh---HHHHHHcCCCCCCCcccCHHHHHHHHHHhCCCcccCC------CHHHHhhChHhhhh
Confidence 999998875543 33444444 3467788999999999999999999999 68999999999864
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-48 Score=395.28 Aligned_cols=257 Identities=26% Similarity=0.416 Sum_probs=209.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
..+|+++++||+|+||+||+|++..++. ||+|.+.+..... .+|..++. .++||||++++++|....
T Consensus 39 ~~~Y~~~~~lG~G~~g~V~~a~~~~~~~-~aikk~~~~~~~~-------~~E~~il~-~l~h~niv~l~~~~~~~~~~~~ 109 (394)
T 4e7w_A 39 EIAYTNCKVIGNGSFGVVFQAKLVESDE-VAIKKVLQDKRFK-------NRELQIMR-IVKHPNVVDLKAFFYSNGDKKD 109 (394)
T ss_dssp EEEEEEEEEEEEETTEEEEEEEETTTEE-EEEEEEECCTTSC-------CHHHHHHH-TCCCTTBCCEEEEEEEESSSSS
T ss_pred cceEEEeEEEeeCCCeEEEEEEECCCCe-EEEEEEecCcchH-------HHHHHHHH-hCCCCCcceEEEEEEecCCCCC
Confidence 3579999999999999999999988877 7888775542211 14666666 579999999999996543
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+|||||+++.+. .+.........+++..++.++.||+.||+|||++||+||||||+|
T Consensus 110 ~~~~~lv~e~~~~~l~~------------------~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivHrDlkp~N 171 (394)
T 4e7w_A 110 EVFLNLVLEYVPETVYR------------------ASRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQN 171 (394)
T ss_dssp CEEEEEEEECCSEEHHH------------------HHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred ceEEEEEeeccCccHHH------------------HHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCCHHH
Confidence 489999999743210 111223345789999999999999999999999999999999999
Q ss_pred eeeC-CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 218 ILLD-YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
|||+ .++.+||+|||+++... ........+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.+..+.
T Consensus 172 ill~~~~~~~kL~DFG~a~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 250 (394)
T 4e7w_A 172 LLLDPPSGVLKLIDFGSAKILI-AGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQ 250 (394)
T ss_dssp EEEETTTTEEEECCCTTCEECC-TTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHH
T ss_pred EEEcCCCCcEEEeeCCCccccc-CCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHHHH
Confidence 9999 79999999999998643 33445567899999999999775 599999999999999999999999999988777
Q ss_pred HHHHHhC--C---------------CC------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 296 FWSICNE--R---------------PR------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 296 ~~~i~~~--~---------------~~------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
+..|... . .. ++..+++++++||.+||+.||.+|| ++.|+++|||
T Consensus 251 l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~------t~~e~l~hp~ 324 (394)
T 4e7w_A 251 LVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL------TAIEALCHPF 324 (394)
T ss_dssp HHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC------CHHHHHTSGG
T ss_pred HHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC------CHHHHhcChh
Confidence 7666531 0 11 2345889999999999999999999 6899999999
Q ss_pred cCCCChhH
Q psy8309 347 FRGLDWQA 354 (494)
Q Consensus 347 f~~~~w~~ 354 (494)
|+++.|..
T Consensus 325 f~~~~~~~ 332 (394)
T 4e7w_A 325 FDELRTGE 332 (394)
T ss_dssp GSTTTSSC
T ss_pred hhhhcccc
Confidence 99987743
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=397.07 Aligned_cols=251 Identities=26% Similarity=0.389 Sum_probs=209.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-----cCCCCceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-----GTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-----~~~hp~Iv~l~~~~~~~ 138 (494)
..+|+++++||+|+||.||+|++..+++.||||+++... ........|..++.. ..+|+||+++++++...
T Consensus 96 ~~ry~~~~~LG~G~fg~V~~a~~~~~~~~vAvK~~~~~~----~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 171 (429)
T 3kvw_A 96 AYRYEVLKVIGKGSFGQVVKAYDHKVHQHVALKMVRNEK----RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR 171 (429)
T ss_dssp TTTEEEEEEEEESSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET
T ss_pred cCcEEEEEEcccCccEEEEEEEECCCCcEEEEEEECCcc----chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccC
Confidence 457999999999999999999999999999999997542 223344455555443 23788999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+++|+||||+. ++|..++... ..+++..++.++.||+.||+|||++||+||||||+
T Consensus 172 ~~~~lv~e~~~----------------------~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~ 229 (429)
T 3kvw_A 172 NHICMTFELLS----------------------MNLYELIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPE 229 (429)
T ss_dssp TEEEEEECCCC----------------------CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHHTEECSCCSGG
T ss_pred CeEEEEEeccC----------------------CCHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHH
Confidence 99999999995 3444455543 35999999999999999999999999999999999
Q ss_pred ceeeCCCCC--EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 217 NILLDYEGH--VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 217 NILl~~~g~--vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
||||+.++. +||+|||+++. ......+.+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+
T Consensus 230 NILl~~~~~~~vkL~DFG~a~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~~ 306 (429)
T 3kvw_A 230 NILLKQQGRSGIKVIDFGSSCY---EHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGD 306 (429)
T ss_dssp GEEESSTTSCCEEECCCTTCEE---TTCCCCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHH
T ss_pred HeEEccCCCcceEEeeccccee---cCCcccccCCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHHH
Confidence 999999987 99999999975 2334556789999999999999999999999999999999999999999998887
Q ss_pred HHHHHHhCC--C------------------C---------------------------------------CCccCCHHHH
Q psy8309 295 LFWSICNER--P------------------R---------------------------------------FPQFLSVEAK 315 (494)
Q Consensus 295 ~~~~i~~~~--~------------------~---------------------------------------~p~~~s~~~~ 315 (494)
.+..+.... + . ++...+++++
T Consensus 307 ~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 386 (429)
T 3kvw_A 307 QLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPPESREWGNALKGCDDPLFL 386 (429)
T ss_dssp HHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECSTTCSCHHHHTTTCCCHHHH
T ss_pred HHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCccchhhHhhccccchHHHH
Confidence 776665310 0 0 1123478899
Q ss_pred HHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 316 NILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 316 ~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+||.+||+.||.+|| +++|+++||||+.
T Consensus 387 dli~~~L~~dP~~Rp------ta~e~L~Hpw~~~ 414 (429)
T 3kvw_A 387 DFLKQCLEWDPAVRM------TPGQALRHPWLRR 414 (429)
T ss_dssp HHHHHHTCSSTTTSC------CHHHHHTSTTTC-
T ss_pred HHHHHHCCCChhhCC------CHHHHhCChhhcc
Confidence 999999999999999 6899999999985
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=389.77 Aligned_cols=254 Identities=27% Similarity=0.439 Sum_probs=199.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD------ 138 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~------ 138 (494)
++|++++.||+|+||.||+|.+..+|+.||||++.+.. ...........|..++. .++||||+++++++...
T Consensus 29 ~~y~~~~~lG~G~~g~V~~a~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~~~ 106 (367)
T 2fst_X 29 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLEEF 106 (367)
T ss_dssp TTEEEEEECC----CCEEEEEETTTTEEEEEEECSSTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSGGGC
T ss_pred CceEEeeEEeecCCeEEEEEEECCCCCEEEEEEeCccc-cCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEecCCccccC
Confidence 68999999999999999999999999999999997642 23345566778888887 57899999999999764
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+|+|||++ +++| ...+.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 107 ~~~~lv~e~~-~~~L---------------------~~~~~~-~~l~~~~~~~i~~qi~~aL~~LH~~givH~Dlkp~NI 163 (367)
T 2fst_X 107 NDVYLVTHLM-GADL---------------------NNIVKC-QKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL 163 (367)
T ss_dssp CCCEEEEECC-CEEC---------------------C------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGE
T ss_pred CeEEEEeccc-CCCH---------------------HHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCeeeCCCCHhhE
Confidence 6689999998 4444 333333 5799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|++.++.+||+|||+++... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|++||.+.+..+.+.
T Consensus 164 ll~~~~~~kL~DFG~a~~~~---~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~l~ 240 (367)
T 2fst_X 164 AVNEDCELKILDFGLARHTA---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240 (367)
T ss_dssp EECTTCCEEECC------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EECCCCCEEEeecccccccc---ccCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 99999999999999997532 23445789999999999987 679999999999999999999999999998877776
Q ss_pred HHHhC--C---------------------CCCC--------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 298 SICNE--R---------------------PRFP--------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 298 ~i~~~--~---------------------~~~p--------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.|... . ...+ ...++++++||.+||..||.+|| +++|+++|||
T Consensus 241 ~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~------t~~e~L~hp~ 314 (367)
T 2fst_X 241 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI------TAAQALAHAY 314 (367)
T ss_dssp HHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGG
T ss_pred HHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcccCc------CHHHHhcChh
Confidence 66531 1 0111 24689999999999999999999 6899999999
Q ss_pred cCCCCh
Q psy8309 347 FRGLDW 352 (494)
Q Consensus 347 f~~~~w 352 (494)
|+....
T Consensus 315 ~~~~~~ 320 (367)
T 2fst_X 315 FAQYHD 320 (367)
T ss_dssp GTTTCC
T ss_pred hhhccC
Confidence 987644
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-47 Score=378.50 Aligned_cols=260 Identities=28% Similarity=0.429 Sum_probs=220.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEE--cCCe
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQ--TDSH 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~--~~~~ 140 (494)
.++|++++.||+|+||.||+|.++.+++.||||++++..... .........|..++. .++||||+++++++. +...
T Consensus 4 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~ 82 (305)
T 2wtk_C 4 IGKYLMGDLLGEGSYGKVKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLR-RLRHKNVIQLVDVLYNEEKQK 82 (305)
T ss_dssp -CCBCCCCEEEECSSCEEEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECC---C
T ss_pred ccceeEeeEEecCCCeEEEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHH-hcCCCCeeEEEEEEEcCCCCe
Confidence 468999999999999999999999999999999998653322 234456677777776 579999999999984 4568
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+||||+.+| +...+.. ...+++..++.++.||+.||.|||++||+||||||+||
T Consensus 83 ~~lv~e~~~~~----------------------l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~H~dlkp~NI 140 (305)
T 2wtk_C 83 MYMVMEYCVCG----------------------MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNL 140 (305)
T ss_dssp EEEEEECCSEE----------------------HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEEEehhccCC----------------------HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHHHCCeeecCCCcccE
Confidence 99999999843 2223332 45799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeec--cCCcccccCCCCCccChhhhCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIY--LDKTTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
|++.+|.+||+|||++..... .........||+.|+|||++.+.. ++.++|||||||++|||++|..||.+.+..+
T Consensus 141 l~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~ 220 (305)
T 2wtk_C 141 LLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYK 220 (305)
T ss_dssp EECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred EEcCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCchHHH
Confidence 999999999999999975322 122234567999999999998754 3789999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 295 LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 295 ~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
....+......+|..+++++.+||.+||..||.+|| +++++++||||+....
T Consensus 221 ~~~~i~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~~~~~~~~~~ 272 (305)
T 2wtk_C 221 LFENIGKGSYAIPGDCGPPLSDLLKGMLEYEPAKRF------SIRQIRQHSWFRKKHP 272 (305)
T ss_dssp HHHHHHHCCCCCCSSSCHHHHHHHHHHTCSSTTTSC------CHHHHHHSHHHHSCCC
T ss_pred HHHHHhcCCCCCCCccCHHHHHHHHHHccCChhhCC------CHHHHhcCcccccCCC
Confidence 999999999999999999999999999999999999 6899999999986543
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-47 Score=368.97 Aligned_cols=257 Identities=25% Similarity=0.442 Sum_probs=215.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||||++..... ....+....|..++. .++||||+++++++.+.+..|+
T Consensus 6 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 82 (276)
T 2yex_A 6 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYL 82 (276)
T ss_dssp HHHEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEE
T ss_pred ecceEEEEEeecCCCcEEEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHH-hcCCCCceeeeeEEEcCCEEEE
Confidence 3589999999999999999999999999999999976532 234455667777776 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+++| +|..++.....+++..++.++.||+.||.|||++||+||||||+||+++.+
T Consensus 83 v~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nil~~~~ 141 (276)
T 2yex_A 83 FLEYCSGG---------------------ELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 141 (276)
T ss_dssp EEECCTTE---------------------EGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTT
T ss_pred EEEecCCC---------------------cHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCChHHEEEccC
Confidence 99999854 445556666789999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSI 299 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i 299 (494)
|.+||+|||++....... ......+||+.|+|||++.+..+ +.++|||||||++|+|++|..||.+.+.. ..+..+
T Consensus 142 ~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 221 (276)
T 2yex_A 142 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 221 (276)
T ss_dssp CCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCTTSHHHHHH
T ss_pred CCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCchHHHHHHHh
Confidence 999999999987533221 22446789999999999988775 78999999999999999999999876543 334444
Q ss_pred HhCCCCC--CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 300 CNERPRF--PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 300 ~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
....... +..+++++++||.+||..||.+|| +++|+++||||++.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~~~~~~~~ 268 (276)
T 2yex_A 222 KEKKTYLNPWKKIDSAPLALLHKILVENPSARI------TIPDIKKDRWYNKP 268 (276)
T ss_dssp HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHTTCTTTTCC
T ss_pred hhcccccCchhhcCHHHHHHHHHHCCCCchhCC------CHHHHhcCccccCh
Confidence 4433333 246899999999999999999999 68999999999864
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-48 Score=385.25 Aligned_cols=255 Identities=26% Similarity=0.401 Sum_probs=204.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++++.||+|+||.||+|+++.+++.||||+++... .....+....|..++. .++||||++++++|.+..
T Consensus 5 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~~ 81 (332)
T 3qd2_B 5 LTDFEPIQCMGRGGFGVVFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALA-KLEHPGIVRYFNAWLETPPEKW 81 (332)
T ss_dssp HHHEEEEEEEECC-CSEEEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHT-SCCCTTBCCEEEEEEECCSCHH
T ss_pred hhcCceeeEecCCCCeEEEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHH-hCCCCCEeeEEEEEEEeccchh
Confidence 358999999999999999999999999999999997642 3344566778888887 579999999999986543
Q ss_pred -----------------------------------------------------eeEEEEEecCCCCCccccchhhhhhhh
Q psy8309 140 -----------------------------------------------------HLFFVMEYLNGGDLIPAGLTKAERDLM 166 (494)
Q Consensus 140 -----------------------------------------------------~~~lv~E~~~~g~L~~~~~~~~~~~l~ 166 (494)
.+|+|||||+||+
T Consensus 82 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~-------------- 147 (332)
T 3qd2_B 82 QEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKEN-------------- 147 (332)
T ss_dssp HHHHHC--------------------------------------------CCCEEEEEEECCCSSC--------------
T ss_pred hhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCC--------------
Confidence 3899999999554
Q ss_pred hHhcCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--
Q psy8309 167 EYLNGGDLMFHIQQSG---RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD-- 241 (494)
Q Consensus 167 ~~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~-- 241 (494)
|..++.... ..++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++......
T Consensus 148 -------L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~ 220 (332)
T 3qd2_B 148 -------LKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEE 220 (332)
T ss_dssp -------HHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC---
T ss_pred -------HHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEeecCcccccccchhh
Confidence 444555443 34566789999999999999999999999999999999999999999999998643221
Q ss_pred ----------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC-CCccC
Q psy8309 242 ----------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPR-FPQFL 310 (494)
Q Consensus 242 ----------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~-~p~~~ 310 (494)
......+||+.|+|||++.+..++.++|||||||++|||++|..|+.. .......+...... .+...
T Consensus 221 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~ 298 (332)
T 3qd2_B 221 QTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--RVRIITDVRNLKFPLLFTQK 298 (332)
T ss_dssp -----------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--HHHHHHHHHTTCCCHHHHHH
T ss_pred ccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--HHHHHHHhhccCCCcccccC
Confidence 123456799999999999999999999999999999999999877532 22333334333221 12356
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
++++++||.+||+.||.+|| +++|+++||||+++
T Consensus 299 ~~~~~~li~~~l~~~p~~Rp------s~~~~l~~~~f~~~ 332 (332)
T 3qd2_B 299 YPQEHMMVQDMLSPSPTERP------EATDIIENAIFENL 332 (332)
T ss_dssp CHHHHHHHHHHHCSSGGGSC------CHHHHHHSTTCCCC
T ss_pred ChhHHHHHHHHccCCCCcCC------CHHHHhhchhhhcC
Confidence 78899999999999999999 68999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=385.94 Aligned_cols=255 Identities=27% Similarity=0.439 Sum_probs=212.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee---
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL--- 141 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~--- 141 (494)
++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ...........|..++. .++||||+++++++...+..
T Consensus 42 ~~y~~~~~lG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~~~~~ 119 (371)
T 4exu_A 42 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLK-HMQHENVIGLLDVFTPASSLRNF 119 (371)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSSTTC
T ss_pred ccEEEEeEEecCCCeEEEEEEECCCCCEEEEEEecccc-cchhHHHHHHHHHHHHH-hcCCCCchhhhhheeccCCcccc
Confidence 58999999999999999999999999999999997653 23344566677887777 57899999999999987765
Q ss_pred ---EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 142 ---FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 142 ---~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
|+||||+. ++|...+ ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 120 ~~~~lv~e~~~----------------------~~l~~~~--~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NI 175 (371)
T 4exu_A 120 YDFYLVMPFMQ----------------------TDLQKIM--GMEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 175 (371)
T ss_dssp CCCEEEEECCC----------------------EEHHHHT--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGE
T ss_pred eeEEEEEcccc----------------------ccHHHHh--hcCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCcCHHHe
Confidence 99999996 2333333 23599999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|++.++.+||+|||+++.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 176 ll~~~~~~kL~Dfg~a~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~ 252 (371)
T 4exu_A 176 AVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 252 (371)
T ss_dssp EECTTCCEEECSTTCC-----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred EECCCCCEEEEecCccccc---ccCcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Confidence 9999999999999999753 233456789999999999987 679999999999999999999999999988877777
Q ss_pred HHHhCC--C-----------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 298 SICNER--P-----------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 298 ~i~~~~--~-----------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.+.... + .++..+++++++||.+||+.||.+|| ++.|+++|||
T Consensus 253 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~ 326 (371)
T 4exu_A 253 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL------TAAQALTHPF 326 (371)
T ss_dssp HHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTTTSC------CHHHHHTSGG
T ss_pred HHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChhhcC------CHHHHhcCcc
Confidence 665310 0 01235789999999999999999999 6899999999
Q ss_pred cCCCChhH
Q psy8309 347 FRGLDWQA 354 (494)
Q Consensus 347 f~~~~w~~ 354 (494)
|+.+.+..
T Consensus 327 f~~~~~~~ 334 (371)
T 4exu_A 327 FEPFRDPE 334 (371)
T ss_dssp GTTTCCGG
T ss_pred cccCCCcc
Confidence 99876544
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=369.60 Aligned_cols=254 Identities=25% Similarity=0.470 Sum_probs=214.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----CC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----DS 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~~ 139 (494)
...|++.+.||+|+||.||+|.+..++..||+|++..... ..........|..++. .++||||+++++++.. ..
T Consensus 25 ~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~va~k~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 102 (290)
T 1t4h_A 25 GRFLKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKK 102 (290)
T ss_dssp SCEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCE
T ss_pred ceeEEeeeeccCCCCeEEEEeEecCCceEEEEEEecchhh-CHHHHHHHHHHHHHHH-hCCCCCeeeeeeeeccccCCCc
Confidence 3468999999999999999999999999999999986533 3444556677777776 5799999999999875 46
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCCc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDN 217 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLKp~N 217 (494)
.+|+||||++ |++|..++...+.+++..++.++.||+.||.|||++| |+||||||+|
T Consensus 103 ~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~~~i~H~dikp~N 161 (290)
T 1t4h_A 103 CIVLVTELMT---------------------SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDN 161 (290)
T ss_dssp EEEEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGG
T ss_pred eEEEEEEecC---------------------CCCHHHHHHHccCCCHHHHHHHHHHHHHHHHHHHcCCCCEEECCCCHHH
Confidence 7999999999 5566667777788999999999999999999999999 9999999999
Q ss_pred eeeC-CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHH
Q psy8309 218 ILLD-YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDEL 295 (494)
Q Consensus 218 ILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~ 295 (494)
||++ .++.+||+|||++... ........+||+.|+|||++.+ .++.++|||||||++|+|++|..||.+.. ....
T Consensus 162 il~~~~~~~~kl~Dfg~~~~~--~~~~~~~~~~t~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~~~~~~ 238 (290)
T 1t4h_A 162 IFITGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI 238 (290)
T ss_dssp EEESSTTSCEEECCTTGGGGC--CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHH
T ss_pred EEEECCCCCEEEeeCCCcccc--cccccccccCCcCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcCcHHHH
Confidence 9998 7899999999998642 2334456789999999999875 59999999999999999999999998854 4444
Q ss_pred HHHHHhCC--CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 296 FWSICNER--PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 296 ~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
...+..+. ..++...++++.+||.+||+.||.+|| +++|+++||||++
T Consensus 239 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~h~~f~~ 288 (290)
T 1t4h_A 239 YRRVTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY------SIKDLLNHAFFQE 288 (290)
T ss_dssp HHHHTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGGGC-
T ss_pred HHHHhccCCccccCCCCCHHHHHHHHHHccCChhhCC------CHHHHhhCccccc
Confidence 55554432 234566789999999999999999999 6899999999985
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=384.57 Aligned_cols=255 Identities=27% Similarity=0.408 Sum_probs=216.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC-------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG-------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFC 133 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~ 133 (494)
.+..++|++++.||+|+||.||+|++.. ++..||||+++.. ...........|..++....+||||+++++
T Consensus 77 ~~~~~~~~~~~~LG~G~fg~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 154 (370)
T 2psq_A 77 EFPRDKLTLGKPLGEGCFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 154 (370)
T ss_dssp BCCGGGEEEEEEESCCSSSEEEEEEEETCSTTCTTCEEEEEEEECCTT--CBHHHHHHHHHHHHHHHHSCCCTTBCCEEE
T ss_pred cccHHHCEeeeEEeeCCCeeEEEEEEecccCcCcCcceeEEEEEecCC--cCHHHHHHHHHHHHHHHHhcCCCCEeeEEE
Confidence 4556899999999999999999999763 4567999999765 234556678889988886448999999999
Q ss_pred EEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----------------cCCCCHHHHHHHHHHHH
Q psy8309 134 TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----------------SGRFDEGRARFYAAEIV 197 (494)
Q Consensus 134 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----------------~~~l~e~~~~~~~~qi~ 197 (494)
++.+.+.+|+||||+++|+| ..++.. ...+++.++..++.||+
T Consensus 155 ~~~~~~~~~lv~e~~~~g~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 213 (370)
T 2psq_A 155 ACTQDGPLYVIVEYASKGNL---------------------REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 213 (370)
T ss_dssp EECSSSSCEEEEECCTTCBH---------------------HHHHHHTCCC-----------CCCCCCHHHHHHHHHHHH
T ss_pred EEccCCCEEEEEEcCCCCCH---------------------HHHHHhhCCccccccccccccccccCCHHHHHHHHHHHH
Confidence 99999999999999996665 333332 24589999999999999
Q ss_pred HHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHH
Q psy8309 198 SGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGI 275 (494)
Q Consensus 198 ~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGv 275 (494)
.||+|||++||+||||||+||||+.+|.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||
T Consensus 214 ~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~ 293 (370)
T 2psq_A 214 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 293 (370)
T ss_dssp HHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCCCcHHHHHHHHH
Confidence 99999999999999999999999999999999999998532222 1233456788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 276 LLYEMHV-GQSPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 276 il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
++|||++ |..||.+.+..+++..+..+ .+..|..++.++.+||.+||..||.+|| ++.|++++
T Consensus 294 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------t~~ell~~ 358 (370)
T 2psq_A 294 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP------TFKQLVED 358 (370)
T ss_dssp HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 9999999 99999999888888877765 4567788999999999999999999999 56777653
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-47 Score=389.60 Aligned_cols=255 Identities=25% Similarity=0.393 Sum_probs=212.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC-CCCceeeEEEEEEcCCeeE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~l~~~~~~~~~~~ 142 (494)
..+|++++.||+|+||.||+|.+.. ++.||||++.+... ..........|..++.... .||||+++++++...+.+|
T Consensus 55 ~~~y~~~~~LG~G~fg~Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~ 132 (390)
T 2zmd_A 55 GRIYSILKQIGSGGSSKVFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIY 132 (390)
T ss_dssp TEEEEEEEEEECCSSEEEEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEE
T ss_pred CCceEEEEEEccCCCeEEEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEE
Confidence 3569999999999999999999865 88899999976532 3445567778888887544 3799999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+||| +. +++|..++...+.+++.+++.++.||+.||.|||++||+||||||+||||+
T Consensus 133 lv~E-~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivHrDlkp~NIll~- 189 (390)
T 2zmd_A 133 MVME-CG---------------------NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV- 189 (390)
T ss_dssp EEEE-CC---------------------SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHTTTCCCCCCCGGGEEES-
T ss_pred EEEe-cC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCHHHEEEE-
Confidence 9999 44 567777888888999999999999999999999999999999999999995
Q ss_pred CCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCC-----------CCCCCcchHHHHHHHHHHHHhCCCCCCC
Q psy8309 223 EGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKG-----------LKYNQCVDWWSFGILLYEMHVGQSPFSG 289 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~ell~G~~Pf~~ 289 (494)
++.+||+|||+++...... ......+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+
T Consensus 190 ~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~ 269 (390)
T 2zmd_A 190 DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 269 (390)
T ss_dssp SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchh
Confidence 6899999999997532221 12346789999999999975 3689999999999999999999999987
Q ss_pred CC-HHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 290 CD-EDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 290 ~~-~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.. ....+..+... ...+|...+.++++||.+||..||.+|| ++.|+++||||+.
T Consensus 270 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~ell~hp~~~~ 326 (390)
T 2zmd_A 270 IINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI------SIPELLAHPYVQI 326 (390)
T ss_dssp CCCHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC------CHHHHHTSHHHHS
T ss_pred hhHHHHHHHHHhCccccCCCCccchHHHHHHHHHHcccChhhCC------CHHHHhhCcCccc
Confidence 53 44556666654 3456778899999999999999999999 6899999999974
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=382.47 Aligned_cols=266 Identities=23% Similarity=0.361 Sum_probs=210.8
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCC-eEEEeeeeccccccChhhHHHHHHHHHHHHhc-----CCCCceeeEEEEEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD-YYYAVKCLKKDVVLEDDDVECTLIERKVLALG-----TKHPYLCHLFCTFQ 136 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~-~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~-----~~hp~Iv~l~~~~~ 136 (494)
..++|++++.||+|+||.||+|+++.++ ..||||++++. .........|..++... ..+++++.+++++.
T Consensus 17 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~ 92 (355)
T 2eu9_A 17 LQERYEIVGNLGEGTFGKVVECLDHARGKSQVALKIIRNV----GKYREAARLEINVLKKIKEKDKENKFLCVLMSDWFN 92 (355)
T ss_dssp ETTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEE
T ss_pred ecccEEEEEEeeccCCeEEEEEEecCCCceEEEEEEEccc----ccchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeee
Confidence 3579999999999999999999998776 78999999753 22334455566665531 23344999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
..+++|+||||+. | ++...+... ..+++.+++.++.||+.||.|||++||+|||||
T Consensus 93 ~~~~~~lv~e~~~-~---------------------~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~ivH~Dlk 150 (355)
T 2eu9_A 93 FHGHMCIAFELLG-K---------------------NTFEFLKENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLK 150 (355)
T ss_dssp ETTEEEEEEECCC-C---------------------BHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCC
T ss_pred eCCeEEEEEeccC-C---------------------ChHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCC
Confidence 9999999999994 2 333344333 479999999999999999999999999999999
Q ss_pred CCceee-------------------CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHH
Q psy8309 215 LDNILL-------------------DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGI 275 (494)
Q Consensus 215 p~NILl-------------------~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGv 275 (494)
|+|||+ +.++.+||+|||+++.. .......+||+.|+|||++.+..++.++|||||||
T Consensus 151 p~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 227 (355)
T 2eu9_A 151 PENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFD---HEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGC 227 (355)
T ss_dssp GGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEET---TSCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHH
T ss_pred HHHEEEecccccccccccccccccccCCCcEEEeecCccccc---cccccCCcCCCcccCCeeeecCCCCCccchHHHHH
Confidence 999999 56789999999999752 33345678999999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------------------------ccCC
Q psy8309 276 LLYEMHVGQSPFSGCDEDELFWSICNERPRFP--------------------------------------------QFLS 311 (494)
Q Consensus 276 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s 311 (494)
++|||++|..||.+.+..+....+......+| ...+
T Consensus 228 il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (355)
T 2eu9_A 228 ILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCKPLKSYMLQDSLEH 307 (355)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHH
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCCcccccccccchhH
Confidence 99999999999998887665554433211111 1124
Q ss_pred HHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCC
Q psy8309 312 VEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363 (494)
Q Consensus 312 ~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp 363 (494)
.++.+||.+||+.||.+|| ++.|+++||||++++|+........+|
T Consensus 308 ~~l~~li~~~L~~dP~~Rp------t~~e~l~hp~f~~~~~~~~~~~~~~~p 353 (355)
T 2eu9_A 308 VQLFDLMRRMLEFDPAQRI------TLAEALLHPFFAGLTPEERSFHTSRNP 353 (355)
T ss_dssp HHHHHHHHHHTCSSTTTSC------CHHHHTTSGGGGGCCHHHHC-------
T ss_pred HHHHHHHHHHhcCChhhCc------CHHHHhcChhhcCCChhhccccccCCC
Confidence 5789999999999999999 689999999999999988765554444
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=372.29 Aligned_cols=257 Identities=28% Similarity=0.464 Sum_probs=219.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE--cCCee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ--TDSHL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~--~~~~~ 141 (494)
.++|++++.||+|+||.||+|+++.+++.||+|++..... .....+....|..++. .++||||+++++++. ....+
T Consensus 5 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~ 82 (279)
T 2w5a_A 5 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLR-ELKHPNIVRYYDRIIDRTNTTL 82 (279)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEECTTC-CHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEEGGGTEE
T ss_pred hhheeeehhccCCCCcEEEEEEECCCCcEEEEEEEEcccC-CHHHHHHHHHHHHHHH-hcCCCCCCeEEEEEecCCCceE
Confidence 5799999999999999999999999999999999986532 3344556777888877 479999999999874 46789
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccccc
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----SGRFDEGRARFYAAEIVSGMRFLHKKG-----IVYRD 212 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yLH~~g-----ivHrD 212 (494)
|+||||+++|+| ..++.. ...+++..++.++.||+.||+|||++| |+|||
T Consensus 83 ~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~ivH~d 141 (279)
T 2w5a_A 83 YIVMEYCEGGDL---------------------ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 141 (279)
T ss_dssp EEEEECCTTEEH---------------------HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHHC------CCCC
T ss_pred EEEEeCCCCCCH---------------------HHHHHhhcccCCCCCHHHHHHHHHHHHHHHHHHhcccCCCCeeEEec
Confidence 999999995554 444433 345999999999999999999999999 99999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|||+|||++.++.+||+|||+++............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 142 l~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 142 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp CSGGGEEECSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cchhhEEEcCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 99999999999999999999987533222223456799999999999999999999999999999999999999999998
Q ss_pred HHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 293 DELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 293 ~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.++...+..+.. .+|..++.++++||.+||..||.+|| +++|+++|+|+.+
T Consensus 222 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~ll~~~~~~~ 273 (279)
T 2w5a_A 222 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP------SVEEILENPLILE 273 (279)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHTSTTCCG
T ss_pred HHHHHHHhhcccccCCcccCHHHHHHHHHHcCCCcccCC------CHHHHHhChhhhh
Confidence 888888887654 67788999999999999999999999 6899999999964
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=374.57 Aligned_cols=261 Identities=27% Similarity=0.452 Sum_probs=218.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
...++|++++.||+|+||.||+|+++.+|+.||||++.... .......|..++. .++||||+++++++...+.+
T Consensus 26 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~-----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 99 (314)
T 3com_A 26 QPEEVFDVLEKLGEGSYGSVYKAIHKETGQIVAIKQVPVES-----DLQEIIKEISIMQ-QCDSPHVVKYYGSYFKNTDL 99 (314)
T ss_dssp ----CEEEEEECC----CEEEEEEETTTCCEEEEEEEETTS-----CCHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEE
T ss_pred cchhhhhhheeeccCCCeEEEEEEECCCCCEEEEEecCchH-----HHHHHHHHHHHHH-hCCCCCCccEEEEEEeCCEE
Confidence 34568999999999999999999999999999999997642 2345667777777 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+||||+.+ ++|..++. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 100 ~lv~e~~~~---------------------~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dl~p~Nil~ 158 (314)
T 3com_A 100 WIVMEYCGA---------------------GSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILL 158 (314)
T ss_dssp EEEEECCTT---------------------EEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEeecCCC---------------------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCCcCCCcCHHHEEE
Confidence 999999984 45555554 45689999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.......+.
T Consensus 159 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 238 (314)
T 3com_A 159 NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIP 238 (314)
T ss_dssp CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHH
T ss_pred CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCChHHHHHHHh
Confidence 99999999999999764433334456789999999999999999999999999999999999999999888777666665
Q ss_pred hCC---CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 301 NER---PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 301 ~~~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
... ...+..++.++.+||.+||..||.+|| +++++++||||++..+...
T Consensus 239 ~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------t~~~ll~~~~~~~~~~~~~ 290 (314)
T 3com_A 239 TNPPPTFRKPELWSDNFTDFVKQCLVKSPEQRA------TATQLLQHPFVRSAKGVSI 290 (314)
T ss_dssp HSCCCCCSSGGGSCHHHHHHHHHHTCSCTTTSC------CHHHHTTSHHHHTCCCGGG
T ss_pred cCCCcccCCcccCCHHHHHHHHHHccCChhhCc------CHHHHHhCHHHhcCCcchH
Confidence 443 233567899999999999999999999 6899999999998766544
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-47 Score=380.31 Aligned_cols=260 Identities=29% Similarity=0.512 Sum_probs=213.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-----ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-----EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
++|++++.||+|+||.||+|+++.+++.||||++.+.... ..........|..++. .++||||+++++++....
T Consensus 10 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~ 88 (322)
T 2ycf_A 10 DEYIMSKTLGSGACGEVKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILK-KLNHPCIIKIKNFFDAED 88 (322)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECC---------------CHHHHHHHHH-HCCCTTBCCEEEEEESSS
T ss_pred hceeEeeEEecCCCEEEEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHH-hCCCCCCceEeeEEcCCc
Confidence 5899999999999999999999999999999999765321 1122334567777777 579999999999997765
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+||||++ |++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 89 -~~lv~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~dlkp~NIl 146 (322)
T 2ycf_A 89 -YYIVLELME---------------------GGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVL 146 (322)
T ss_dssp -EEEEEECCT---------------------TEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEE
T ss_pred -eEEEEecCC---------------------CCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHHHEE
Confidence 899999998 4455566667788999999999999999999999999999999999999
Q ss_pred eCCCCC---EEEeecCceeeeeccCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 220 LDYEGH---VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 220 l~~~g~---vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
++.++. +||+|||+++... ........+||+.|+|||++. ...++.++|||||||++|+|++|..||.+....
T Consensus 147 ~~~~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 225 (322)
T 2ycf_A 147 LSSQEEDCLIKITDFGHSKILG-ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 225 (322)
T ss_dssp ESSSSSSCCEEECCCTTCEECC-CCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTCS
T ss_pred EecCCCCCeEEEccCccceecc-cccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchH
Confidence 987765 9999999998532 222234567999999999973 567899999999999999999999999865433
Q ss_pred -HHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhH
Q psy8309 294 -ELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 294 -~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~ 354 (494)
.+...+..+...++ ..++.++++||.+||..||.+|| +++++++||||++.+|..
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp------s~~~~l~h~~~~~~~~~~ 285 (322)
T 2ycf_A 226 VSLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARF------TTEEALRHPWLQDEDMKR 285 (322)
T ss_dssp SCHHHHHHHTCCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHTSGGGCCHHHHH
T ss_pred HHHHHHHHhCccccCchhhhhcCHHHHHHHHHHcccCHhhCC------CHHHHhhCcCcCCHHHHH
Confidence 45555666655543 46899999999999999999999 689999999999887754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=381.45 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=209.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC-CCceeeEEEEEEcCCee
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK-HPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~l~~~~~~~~~~ 141 (494)
.-.+|++++.||+|+||.||+|.+. +++.||||++.... ...........|..++..... ||||+++++++.+...+
T Consensus 7 ~~~~y~i~~~lG~G~~g~Vy~~~~~-~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 84 (343)
T 3dbq_A 7 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 84 (343)
T ss_dssp SSCEEEEEEEESCCSSEEEEEEECT-TSCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEE
T ss_pred ecCEEEEEEEEecCCCeEEEEEEeC-CCCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEE
Confidence 3468999999999999999999874 58889999997653 234445667778888875332 39999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||+ . +++|..++...+.+++.+++.++.||+.||.|||++||+||||||+|||++
T Consensus 85 ~lv~e~-~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iiHrDikp~NIll~ 142 (343)
T 3dbq_A 85 YMVMEC-G---------------------NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 142 (343)
T ss_dssp EEEECC-C---------------------SEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred EEEEeC-C---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEE
Confidence 999995 4 567777888888999999999999999999999999999999999999997
Q ss_pred CCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCC-----------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKG-----------LKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
++.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 143 -~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~ 221 (343)
T 3dbq_A 143 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221 (343)
T ss_dssp -TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcch
Confidence 68999999999975322211 2345689999999999864 678999999999999999999999998
Q ss_pred CCC-HHHHHHHHHh--CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 289 GCD-EDELFWSICN--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 289 ~~~-~~~~~~~i~~--~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+.. ....+..+.. ....+|...+.++++||.+||+.||.+|| ++.|+++||||+.
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dp~~Rp------t~~e~l~hp~~~~ 279 (343)
T 3dbq_A 222 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI------SIPELLAHPYVQI 279 (343)
T ss_dssp TCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC------CHHHHHTSHHHHS
T ss_pred hhhhHHHHHHHHhcCCcccCCcccCCHHHHHHHHHHcCCChhHCC------CHHHHHhCccccc
Confidence 753 3344445543 34567788899999999999999999999 6899999999963
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-49 Score=401.96 Aligned_cols=251 Identities=15% Similarity=0.107 Sum_probs=203.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh--cCCCCceeeEE-------EE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLF-------CT 134 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~--~~~hp~Iv~l~-------~~ 134 (494)
.++|++.+.||+|+||.||+|+++.+|+.||||++.+.........+....|..++.. .++|||||+++ ++
T Consensus 72 ~~~y~~~~~lG~G~~g~V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~ 151 (377)
T 3byv_A 72 PRTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDL 151 (377)
T ss_dssp CEEEEEEEEEEEETTEEEEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEE
T ss_pred CceEEEcceeecCCCEEEEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhh
Confidence 4689999999999999999999999999999999987655555566677778754432 35899999998 77
Q ss_pred EEcCCe-----------------eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCH-------HHHH
Q psy8309 135 FQTDSH-----------------LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE-------GRAR 190 (494)
Q Consensus 135 ~~~~~~-----------------~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e-------~~~~ 190 (494)
+++.+. .|+||||+. | +|..++...+.+++ ..+.
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~-g---------------------~L~~~l~~~~~~~~~~~~l~~~~~~ 209 (377)
T 3byv_A 152 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-S---------------------NLQTFGEVLLSHSSTHKSLVHHARL 209 (377)
T ss_dssp EECTTSCSEEEC------CEEESEEEEEECCS-E---------------------EHHHHHHHHHHTTTTTHHHHHHHHH
T ss_pred hhccCCccccccccCCCceEEEEEEEEEeccC-C---------------------CHHHHHHhccccccccccccHHHHH
Confidence 776543 889999993 3 44555555445555 7888
Q ss_pred HHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC--------
Q psy8309 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-------- 262 (494)
Q Consensus 191 ~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-------- 262 (494)
.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++. ........+| +.|+|||++.+.
T Consensus 210 ~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~---~~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~ 285 (377)
T 3byv_A 210 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR---DGARVVSSVS-RGFEPPELEARRATISYHRD 285 (377)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEE---TTCEEECCCC-TTCCCHHHHHHHTSTHHHHC
T ss_pred HHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhhee---cCCcccCCCC-cCccChhhhccccccccccc
Confidence 8999999999999999999999999999999999999999999985 2334556788 999999999887
Q ss_pred ---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 263 ---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 263 ---~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
.|+.++|||||||++|||++|..||.+.+.......+.. .+..+++++++||.+||+.||.+|| ++.
T Consensus 286 ~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~L~~dp~~Rp------t~~ 355 (377)
T 3byv_A 286 RRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR----SCKNIPQPVRALLEGFLRYPKEDRL------LPL 355 (377)
T ss_dssp CEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS----SCCCCCHHHHHHHHHHTCSSGGGCC------CHH
T ss_pred ccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh----hccCCCHHHHHHHHHHcCCCchhCC------CHH
Confidence 899999999999999999999999987665444433332 2356899999999999999999999 689
Q ss_pred hhhcCCCcCCC
Q psy8309 340 DVVAHEYFRGL 350 (494)
Q Consensus 340 eil~h~~f~~~ 350 (494)
++++||||+++
T Consensus 356 e~l~hp~f~~~ 366 (377)
T 3byv_A 356 QAMETPEYEQL 366 (377)
T ss_dssp HHHTSHHHHHH
T ss_pred HHhhChHHHHH
Confidence 99999999865
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=376.22 Aligned_cols=261 Identities=25% Similarity=0.415 Sum_probs=212.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
.++|++++.||+|+||.||+|++..+++.||||++.... ........|..++....+||||+++++++..
T Consensus 23 ~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~ 98 (326)
T 2x7f_A 23 AGIFELVELVGNGTYGQVYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGM 98 (326)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CC
T ss_pred CCcEEEEEEeccCCCEEEEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccc
Confidence 568999999999999999999999999999999997542 2234566777777765589999999999987
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+.+|+||||+.+| +|..++... ..+++..++.++.||+.||.|||++||+||||||
T Consensus 99 ~~~~~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp 157 (326)
T 2x7f_A 99 DDQLWLVMEFCGAG---------------------SVTDLIKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 157 (326)
T ss_dssp CCEEEEEEECCTTE---------------------EHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSG
T ss_pred cceEEEEEEcCCCC---------------------cHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCcH
Confidence 56899999999944 445555443 5799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
+|||++.++.+||+|||++.............+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.
T Consensus 158 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 237 (326)
T 2x7f_A 158 QNVLLTENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDM 237 (326)
T ss_dssp GGEEECTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTS
T ss_pred HHEEEcCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCC
Confidence 999999999999999999875433333345668999999999997 567899999999999999999999999998
Q ss_pred CHHHHHHHHHhCCCC--CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 291 DEDELFWSICNERPR--FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 291 ~~~~~~~~i~~~~~~--~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
+.......+...... .+..++.++++||.+||..||.+|| +++++++||||++..+...
T Consensus 238 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~hp~~~~~~~~~~ 298 (326)
T 2x7f_A 238 HPMRALFLIPRNPAPRLKSKKWSKKFQSFIESCLVKNHSQRP------ATEQLMKHPFIRDQPNERQ 298 (326)
T ss_dssp CHHHHHHHHHHSCCCCCSCSCSCHHHHHHHHHHCCSSGGGSC------CHHHHHTSHHHHCCTTHHH
T ss_pred cHHHHHHHhhcCccccCCccccCHHHHHHHHHHhccChhhCC------CHHHHhhChHHhhCccccc
Confidence 887777776654332 2457899999999999999999999 6899999999998766543
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=371.40 Aligned_cols=254 Identities=31% Similarity=0.526 Sum_probs=221.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.+.|++++.||+|+||.||+|++..+++.||||++..... .........|..++. .++||||+++++++.+...+|+
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 97 (303)
T 3a7i_A 21 EELFTKLEKIGKGSFGEVFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLS-QCDSPYVTKYYGSYLKDTKLWI 97 (303)
T ss_dssp GGTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEETTTC--STTHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEE
T ss_pred HHHHHHhhhhcccCCeEEEEEEECCCCcEEEEEEeccccc--HHHHHHHHHHHHHHH-hCCCCCEeEEEEEEecCCeEEE
Confidence 3579999999999999999999999999999999976532 334556777887777 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+++| +|..++. .+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 98 v~e~~~~~---------------------~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Nil~~~~ 155 (303)
T 3a7i_A 98 IMEYLGGG---------------------SALDLLE-PGPLDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEH 155 (303)
T ss_dssp EEECCTTE---------------------EHHHHHT-TSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EEEeCCCC---------------------cHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCCChheEEECCC
Confidence 99999844 4444443 3579999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
|.+||+|||++.............+||+.|+|||++.+..++.++|||||||++|+|++|..||...+..+....+....
T Consensus 156 ~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~ 235 (303)
T 3a7i_A 156 GEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNN 235 (303)
T ss_dssp SCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSC
T ss_pred CCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCCCCCCcCHHHHHHHhhcCC
Confidence 99999999999764433334456789999999999999999999999999999999999999999988887777776543
Q ss_pred -CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 304 -PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 304 -~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
..++..++.++++||.+||..||.+|| +++++++||||.
T Consensus 236 ~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~~~~~~ 275 (303)
T 3a7i_A 236 PPTLEGNYSKPLKEFVEACLNKEPSFRP------TAKELLKHKFIL 275 (303)
T ss_dssp CCCCCSSCCHHHHHHHHHHCCSSGGGSC------CHHHHTTCHHHH
T ss_pred CCCCccccCHHHHHHHHHHcCCChhhCc------CHHHHhhChhhh
Confidence 456778999999999999999999999 689999999995
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-47 Score=372.78 Aligned_cols=259 Identities=30% Similarity=0.541 Sum_probs=223.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|+++.+++.||||++.+... ..........|..++. .++||||+++++++.+.+.+|+
T Consensus 21 ~~~y~i~~~lg~G~~g~V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~l 98 (287)
T 2wei_A 21 AERYNIVCMLGKGSFGEVLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLK-KLDHPNIMKLFEILEDSSSFYI 98 (287)
T ss_dssp HHHEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSEEEE
T ss_pred hhcceeeEEEcCCCCEEEEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHH-hccCCCccEEEEEEeCCCeEEE
Confidence 3589999999999999999999999999999999976543 2334556778888887 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+. |++|...+...+.+++..++.++.||+.||.|||++||+||||||+|||++.+
T Consensus 99 v~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~NIlv~~~ 157 (287)
T 2wei_A 99 VGELYT---------------------GGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESK 157 (287)
T ss_dssp EECCCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESCS
T ss_pred EEEccC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCChhhEEEecC
Confidence 999998 55555666667789999999999999999999999999999999999999764
Q ss_pred C---CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 224 G---HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 224 g---~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+ .+||+|||++.... .........||+.|+|||++.+ .++.++||||||+++|+|++|..||.+.+..+....+.
T Consensus 158 ~~~~~~kL~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~ 235 (287)
T 2wei_A 158 EKDCDIKIIDFGLSTCFQ-QNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVE 235 (287)
T ss_dssp STTCCEEECSTTGGGTBC-CCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCcccEEEeccCcceeec-CCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 4 69999999987532 2233344568999999999987 48999999999999999999999999999988888888
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.+...++ ..+++++++||.+||..||.+|| +++++++||||++..|+
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~ell~hp~~~~~~~~ 286 (287)
T 2wei_A 236 TGKYAFDLPQWRTISDDAKDLIRKMLTFHPSLRI------TATQCLEHPWIQKYSSE 286 (287)
T ss_dssp HCCCCCCSGGGTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHSHHHHHHCCC
T ss_pred cCCCCCCchhhhhcCHHHHHHHHHHcccChhhCc------CHHHHhcCHHHhccccC
Confidence 8766544 46899999999999999999999 68999999999876553
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-47 Score=377.18 Aligned_cols=260 Identities=26% Similarity=0.414 Sum_probs=213.7
Q ss_pred CCceEeeEeccCCceEEEEEEEe-CCCeEEEeeeeccccccChhhHHHHHHHHHHHHh--cCCCCceeeEEEEEE-----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELK-GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLFCTFQ----- 136 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~-~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~--~~~hp~Iv~l~~~~~----- 136 (494)
++|++++.||+|+||.||+|++. .+++.||||+++...... ........|..++.. .++||||+++++++.
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~ 89 (326)
T 1blx_A 11 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 89 (326)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred hceeeeeeecccccEEEEEEEecCCCCEEEEEEEeccCcccc-cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccC
Confidence 68999999999999999999995 678999999997643221 111123344444432 348999999999987
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
....+|+||||+. |+|..++... ..+++..++.++.||+.||.|||++||+|||||
T Consensus 90 ~~~~~~lv~e~~~----------------------~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~gi~H~dlk 147 (326)
T 1blx_A 90 RETKLTLVFEHVD----------------------QDLTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLK 147 (326)
T ss_dssp SEEEEEEEEECCS----------------------CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCC
T ss_pred CCceEEEEEecCC----------------------CCHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHCCceeccCC
Confidence 5678999999996 2444555543 359999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
|+|||++.+|.+||+|||+++... ........+||+.|+|||++.+..++.++|||||||++|+|++|.+||.+.+..+
T Consensus 148 p~Nili~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 226 (326)
T 1blx_A 148 PQNILVTSSGQIKLADFGLARIYS-FQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVD 226 (326)
T ss_dssp GGGEEECTTCCEEECSCCSCCCCC-GGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred HHHeEEcCCCCEEEecCccccccc-CCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 999999999999999999987532 2223456789999999999999999999999999999999999999999998888
Q ss_pred HHHHHHhC--C-------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 295 LFWSICNE--R-------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 295 ~~~~i~~~--~-------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.+..+... . ..++..++.++++||.+||..||.+|| ++.|+++||||
T Consensus 227 ~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~e~l~hp~~ 300 (326)
T 1blx_A 227 QLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI------SAYSALSHPYF 300 (326)
T ss_dssp HHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC------CHHHHHTSGGG
T ss_pred HHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCC------CHHHHhcCccc
Confidence 77777531 0 012346899999999999999999999 68999999999
Q ss_pred CCCChhH
Q psy8309 348 RGLDWQA 354 (494)
Q Consensus 348 ~~~~w~~ 354 (494)
++++|..
T Consensus 301 ~~~~~~~ 307 (326)
T 1blx_A 301 QDLERCK 307 (326)
T ss_dssp TTCCCCC
T ss_pred cccchhh
Confidence 9987643
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-47 Score=381.58 Aligned_cols=277 Identities=25% Similarity=0.348 Sum_probs=207.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeE----EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY----YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~----~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+..++|++++.||+|+||.||+|++..++.. ||+|++.... ..........|..++. .++||||+++++++.
T Consensus 9 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~~K~~~~~~--~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~ 85 (325)
T 3kex_A 9 IFKETELRKLKVLGSGVFGTVHKGVWIPEGESIKIPVCIKVIEDKS--GRQSFQAVTDHMLAIG-SLDHAHIVRLLGLCP 85 (325)
T ss_dssp BCCTTTEEEEEEEECCSSCEEEEEEECCTTCSCCEEEEEEEECCTT--SCSCBCSCCHHHHHHH-TCCCTTBCCEEEEEC
T ss_pred hcCHhHceeeeeeeecCCceEEEEEEcCCCceEEEEEEEEeccccc--cHHHHHHHHHHHHHHh-cCCCCCcCeEEEEEc
Confidence 45668999999999999999999999988876 5555554321 1122223445666666 579999999999886
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+..++||||+.+|+| ..++.. .+.+++..+..++.||+.||+|||++||+||||||
T Consensus 86 -~~~~~~v~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dikp 143 (325)
T 3kex_A 86 -GSSLQLVTQYLPLGSL---------------------LDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGMVHRNLAA 143 (325)
T ss_dssp -BSSEEEEEECCTTCBS---------------------HHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTCCCSCCSS
T ss_pred -CCccEEEEEeCCCCCH---------------------HHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCCCCCccch
Confidence 5678999999995554 445544 35799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.+|++||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 144 ~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 144 RNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp TTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred heEEECCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 99999999999999999997532221 12345678889999999998899999999999999999999 9999999888
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc-------------------------CCC
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA-------------------------HEY 346 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~-------------------------h~~ 346 (494)
.++...+... ....|..++.++.+||.+||..||.+||+ +.++++ +|.
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps------~~el~~~l~~~~~~~~~~~~~~~~~~~~~~~~p~ 297 (325)
T 3kex_A 224 AEVPDLLEKGERLAQPQICTIDVYMVMVKCWMIDENIRPT------FKELANEFTRMARDPPRYLVIKRESGPGIAPGPE 297 (325)
T ss_dssp THHHHHHHTTCBCCCCTTBCTTTTHHHHHHTCSCTTTSCC------HHHHHHHHHHHTTSHHHHBCCCSSSSCCCBCCCC
T ss_pred HHHHHHHHcCCCCCCCCcCcHHHHHHHHHHcCCChhhCcC------HHHHHHHHHHHHhcchhhhccccCCCCCCCCCCc
Confidence 8887777765 45667788999999999999999999994 455543 567
Q ss_pred cCCCChhHHhcCcCCCCCcccc
Q psy8309 347 FRGLDWQALEKRELEPPFRPRV 368 (494)
Q Consensus 347 f~~~~w~~l~~~~~~pp~~p~~ 368 (494)
+.+++|..+..+.++|++.|..
T Consensus 298 ~~~~~~~~~~~~~~~~~~~~~~ 319 (325)
T 3kex_A 298 PHGLTNKKLEEVELEPELDLDL 319 (325)
T ss_dssp CCC-------------------
T ss_pred cccchhhcccccccchhccCCc
Confidence 7777777777777777776654
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-47 Score=376.14 Aligned_cols=266 Identities=27% Similarity=0.487 Sum_probs=194.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|++..+++.||||++..... .........|..++. .++||||+++++++...+.
T Consensus 11 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~ 87 (303)
T 2vwi_A 11 SINRDDYELQEVIGSGATAVVQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMS-QCHHPNIVSYYTSFVVKDE 87 (303)
T ss_dssp --CCCCCEEEEECC---CCCEEEEEC----CEEEEECCC------------------CCC-CCCCTTBCCEEEEEESSSC
T ss_pred ccchhhhhhhheeccccceEEEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHh-hcCCCCEeeEEEEEeecCC
Confidence 3456799999999999999999999999999999999875422 223344556666665 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh--------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ--------QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~--------~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
.|+||||+++|+| ..++. ..+.+++..++.++.||+.||.|||++||+|||
T Consensus 88 ~~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~d 146 (303)
T 2vwi_A 88 LWLVMKLLSGGSV---------------------LDIIKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRD 146 (303)
T ss_dssp EEEEEECCTTCBH---------------------HHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHHHHHHHHTTCCCCC
T ss_pred cEEEehhccCCch---------------------HHHHHHHhhccccccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCCC
Confidence 9999999996665 33332 245699999999999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeecc-----CCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCC
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYL-----DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~-----~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~P 286 (494)
|||+|||++.+|.+||+|||++...... .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..|
T Consensus 147 l~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~p 226 (303)
T 2vwi_A 147 VKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAP 226 (303)
T ss_dssp CSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999999999999998643211 112345679999999999976 5689999999999999999999999
Q ss_pred CCCCCHHHHHHHHHhCCC----------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHh
Q psy8309 287 FSGCDEDELFWSICNERP----------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALE 356 (494)
Q Consensus 287 f~~~~~~~~~~~i~~~~~----------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~ 356 (494)
|.+............... ..+..++.++++||.+||..||.+|| ++.++++||||++..++.+.
T Consensus 227 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~~~~~~~ 300 (303)
T 2vwi_A 227 YHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRP------TAAELLRHKFFQKAKNKEFL 300 (303)
T ss_dssp TTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSC------CHHHHHTSTTC---------
T ss_pred CccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCc------CHHHHhhChhhhcCCCCccc
Confidence 998777666555544322 12346789999999999999999999 68999999999988776544
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-46 Score=385.34 Aligned_cols=254 Identities=28% Similarity=0.445 Sum_probs=207.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCC-----ceeeEEEEEEcC
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP-----YLCHLFCTFQTD 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp-----~Iv~l~~~~~~~ 138 (494)
.++|++++.||+|+||+||+|+++.+++.||||+++.. .........|..++.....|+ +|+++++++...
T Consensus 53 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~ 128 (382)
T 2vx3_A 53 MDRYEIDSLIGKGSFGQVVKAYDRVEQEWVAIKIIKNK----KAFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR 128 (382)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET
T ss_pred eeeEEEEEEEeecCCEEEEEEEEcCCCcEEEEEEEecc----HHHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccC
Confidence 57999999999999999999999999999999999753 223344555666655433344 599999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHH--hCCCccccCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLH--KKGIVYRDLK 214 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH--~~givHrDLK 214 (494)
+.+|+||||+. ++|...+... +.+++..++.++.||+.||.||| ++||+|||||
T Consensus 129 ~~~~lv~e~~~----------------------~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~~~ivHrDlk 186 (382)
T 2vx3_A 129 NHLCLVFEMLS----------------------YNLYDLLRNTNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLK 186 (382)
T ss_dssp TEEEEEEECCC----------------------CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHTSTTTCEECCCCS
T ss_pred CceEEEEecCC----------------------CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHHHHhccCCCCEEcCCCC
Confidence 99999999995 2455555543 46999999999999999999999 5799999999
Q ss_pred CCceeeC--CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 215 LDNILLD--YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 215 p~NILl~--~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|+||||+ .++.+||+|||+++.. .......+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 187 p~NIll~~~~~~~~kL~DFG~a~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 187 PENILLCNPKRSAIKIVDFGSSCQL---GQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp GGGEEESSTTSCCEEECCCTTCEET---TCCCCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccEEEecCCCCcEEEEeccCceec---ccccccccCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999995 4788999999999853 2334567899999999999999999999999999999999999999999988
Q ss_pred HHHHHHHHhCCCCCC------------------c------------------c---------------------------
Q psy8309 293 DELFWSICNERPRFP------------------Q------------------F--------------------------- 309 (494)
Q Consensus 293 ~~~~~~i~~~~~~~p------------------~------------------~--------------------------- 309 (494)
.+.+..|.......| . .
T Consensus 264 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ 343 (382)
T 2vx3_A 264 VDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVETGGPGGRRAGESGHTV 343 (382)
T ss_dssp HHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTTTTSGGGTTTTCTTCCH
T ss_pred HHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhccccCCCccccccccccc
Confidence 888777764211000 0 0
Q ss_pred -CCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 310 -LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 310 -~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
.++++++||.+||+.||++|| +++|+++||||++..|
T Consensus 344 ~~~~~~~dli~~mL~~dP~~Rp------ta~e~L~hp~f~~~~~ 381 (382)
T 2vx3_A 344 ADYLKFKDLILRMLDYDPKTRI------QPYYALQHSFFKKTAD 381 (382)
T ss_dssp HHHHHHHHHHHHHTCSCTTTSC------CHHHHTTSGGGCC---
T ss_pred hhhHHHHHHHHHhcCCChhhCC------CHHHHhcCcccccCCC
Confidence 014789999999999999999 6899999999987654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=379.34 Aligned_cols=259 Identities=25% Similarity=0.392 Sum_probs=212.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD----- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~----- 138 (494)
.++|++.+.||+|+||.||+|+++.+|+.||||++... ...........|..++. .++||||+++++++...
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 86 (353)
T 2b9h_A 10 SSDFQLKSLLGEGAYGVVCSATHKPTGEIVAIKKIEPF--DKPLFALRTLREIKILK-HFKHENIITIFNIQRPDSFENF 86 (353)
T ss_dssp CTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCC--SSHHHHHHHHHHHHHHH-HCCCTTBCCEEEECCCSCSTTC
T ss_pred ccceEEeeEEcCCCCeEEEEEEECCCCcEEEEEeeccc--ccchHHHHHHHHHHHHH-hCcCCCcCCeeeeecccccCcc
Confidence 46899999999999999999999999999999999643 23344456677888887 57999999999987754
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
..+|+||||+. ++|...+.. +.+++..++.++.||+.||.|||++||+||||||+||
T Consensus 87 ~~~~lv~e~~~----------------------~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~ivH~Dlkp~Ni 143 (353)
T 2b9h_A 87 NEVYIIQELMQ----------------------TDLHRVIST-QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNL 143 (353)
T ss_dssp CCEEEEECCCS----------------------EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGE
T ss_pred ceEEEEEeccC----------------------ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHe
Confidence 68999999996 244444443 5799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCC----------cccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDK----------TTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~----------~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
|++.+|.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|+|++|.+||
T Consensus 144 l~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf 223 (353)
T 2b9h_A 144 LINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIF 223 (353)
T ss_dssp EECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSC
T ss_pred EEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCC
Confidence 999999999999999975322111 1234689999999998764 67999999999999999999999999
Q ss_pred CCCCHHHHHHHHHh--CC----------------------CCC--------CccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 288 SGCDEDELFWSICN--ER----------------------PRF--------PQFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 288 ~~~~~~~~~~~i~~--~~----------------------~~~--------p~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
.+.+..+....+.. +. ... +..+++++++||.+||..||.+||
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp----- 298 (353)
T 2b9h_A 224 PGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGIDLLQRMLVFDPAKRI----- 298 (353)
T ss_dssp CCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSGGGSC-----
T ss_pred CCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHHHHHHhcCcCcccCC-----
Confidence 99887666555432 10 111 136889999999999999999999
Q ss_pred CChhhhhcCCCcCCCChhH
Q psy8309 336 NSGDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 336 ~~~~eil~h~~f~~~~w~~ 354 (494)
+++|+++||||+.+.|..
T Consensus 299 -t~~ell~hp~~~~~~~~~ 316 (353)
T 2b9h_A 299 -TAKEALEHPYLQTYHDPN 316 (353)
T ss_dssp -CHHHHHTSGGGTTTCCTT
T ss_pred -CHHHHhcCccccccCCcc
Confidence 689999999999876643
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=377.60 Aligned_cols=255 Identities=26% Similarity=0.433 Sum_probs=210.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH---- 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~---- 140 (494)
++|.+.+.||+|+||.||+|+++.+|+.||||++.+.. ...........|..++. .++||||+++++++.....
T Consensus 24 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~~ 101 (353)
T 3coi_A 24 KTYVSPTHVGSGAYGSVCSAIDKRSGEKVAIKKLSRPF-QSEIFAKRAYRELLLLK-HMQHENVIGLLDVFTPASSLRNF 101 (353)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEESSTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSGGGC
T ss_pred ceEEEeeeEecCCCeEEEEEEECCCCCEEEEEEecccc-cchHHHHHHHHHHHHHH-hcCCCCcccHhheEecccccccc
Confidence 58999999999999999999999999999999997642 23344556677888877 5789999999999988764
Q ss_pred --eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 --LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 --~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+||||+. |+| ...+. ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 102 ~~~~lv~e~~~-~~l---------------------~~~~~--~~~~~~~~~~i~~qi~~al~~LH~~~ivH~dlkp~NI 157 (353)
T 3coi_A 102 YDFYLVMPFMQ-TDL---------------------QKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNL 157 (353)
T ss_dssp CCCEEEEECCS-EEG---------------------GGTTT--SCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGE
T ss_pred eeEEEEecccc-CCH---------------------HHHhc--CCCCHHHHHHHHHHHHHHHHHHHHCCcccCCCCHHHE
Confidence 499999996 233 22332 3589999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|++.+|.+||+|||+++.. .......+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.+.+..+.+.
T Consensus 158 l~~~~~~~kl~Dfg~~~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~ 234 (353)
T 3coi_A 158 AVNEDCELKILDFGLARHA---DAEMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLT 234 (353)
T ss_dssp EECTTCCEEECSTTCTTC-----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSCHHHHHH
T ss_pred eECCCCcEEEeecccccCC---CCCccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Confidence 9999999999999998752 223445689999999999987 678999999999999999999999999988777666
Q ss_pred HHHhC----------------------------C---CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 298 SICNE----------------------------R---PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 298 ~i~~~----------------------------~---~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.+... . ...+..+++++++||.+||..||.+|| ++.++++|||
T Consensus 235 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~Rp------t~~e~l~hp~ 308 (353)
T 3coi_A 235 QILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVDKRL------TAAQALTHPF 308 (353)
T ss_dssp HHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTTTSC------CHHHHHTSGG
T ss_pred HHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcccCC------CHHHHhcCcc
Confidence 65431 0 112346799999999999999999999 6899999999
Q ss_pred cCCCChhH
Q psy8309 347 FRGLDWQA 354 (494)
Q Consensus 347 f~~~~w~~ 354 (494)
|+.+.+..
T Consensus 309 f~~~~~~~ 316 (353)
T 3coi_A 309 FEPFRDPE 316 (353)
T ss_dssp GTTTCCGG
T ss_pred hhhccCcc
Confidence 99876543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=376.27 Aligned_cols=274 Identities=24% Similarity=0.352 Sum_probs=199.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++|++++.||+|+||.||+|+++.++. .||||+++.... .....+....|..++. .++||||+++++++...
T Consensus 20 i~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~ 97 (323)
T 3qup_A 20 IPEQQFTLGRMLGKGEFGSVREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMK-EFDHPHVAKLVGVSLRS 97 (323)
T ss_dssp CC---CEEEEEEEEETTEEEEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHT-TCCCTTBCCCCEEEECC
T ss_pred cChhHeEEeceecccCCeEEEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHH-HCCCCceehhhceeecc
Confidence 345689999999999999999999887765 799999976532 3344566778888887 57999999999999887
Q ss_pred Cee------EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc------CCCCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 139 SHL------FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS------GRFDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 139 ~~~------~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~------~~l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
... |+||||+.+|+| ..++... ..+++..++.++.||+.||.|||++
T Consensus 98 ~~~~~~~~~~~v~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~ 156 (323)
T 3qup_A 98 RAKGRLPIPMVILPFMKHGDL---------------------HAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSSR 156 (323)
T ss_dssp -------CEEEEEECCTTCBH---------------------HHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccCCCccEEEEEeccCCcH---------------------HHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHcC
Confidence 665 999999996555 3344322 2699999999999999999999999
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-C
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-G 283 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G 283 (494)
||+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |
T Consensus 157 ~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g 236 (323)
T 3qup_A 157 NFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRG 236 (323)
T ss_dssp TCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CcccCCCCcceEEEcCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCC
Confidence 99999999999999999999999999997532221 11223457789999999999999999999999999999999 9
Q ss_pred CCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCC-ChhhhhcCCCcCCCChhHHhcC
Q psy8309 284 QSPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCN-SGDDVVAHEYFRGLDWQALEKR 358 (494)
Q Consensus 284 ~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~-~~~eil~h~~f~~~~w~~l~~~ 358 (494)
.+||.+.+..+....+..+ ....+..+++++++||.+||+.||.+||++.+.. .+++++.|+|+....+..|...
T Consensus 237 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~~~~pl~~~ 313 (323)
T 3qup_A 237 QTPYAGIENAEIYNYLIGGNRLKQPPECMEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLSTSQDPLYIN 313 (323)
T ss_dssp CCTTTTCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC--------------
T ss_pred CCCccccChHHHHHHHhcCCCCCCCCccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcCCCCCCCCCC
Confidence 9999999888888887765 4567788999999999999999999999432110 1688999999987666555433
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-47 Score=386.21 Aligned_cols=278 Identities=21% Similarity=0.307 Sum_probs=223.3
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEE-----EeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAE-----LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~-----~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
..+..++|++++.||+|+||.||+|+ +..++..||||+++.. ...........|..++. .++||||++++++
T Consensus 66 ~~~~~~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~hpnIv~~~~~ 142 (367)
T 3l9p_A 66 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIIS-KFNHQNIVRCIGV 142 (367)
T ss_dssp CBCCGGGEEEEEECCCCSSSCEEEEEECC-----CCEEEEEEECCSS--CCHHHHHHHHHHHHHHH-HCCCTTBCCEEEE
T ss_pred hhcCHhHeEEeeEeeeCCCEEEEEEEEccCCCCCcceeEEEEecccc--cChhhHHHHHHHHHHHH-hCCCCCCCeEEEE
Confidence 45567899999999999999999999 4557789999999753 23444456777888877 4799999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-------GRFDEGRARFYAAEIVSGMRFLHKKG 207 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~yLH~~g 207 (494)
+.+....|+|||||+|| +|..++... ..+++..++.++.||+.||+|||++|
T Consensus 143 ~~~~~~~~lv~e~~~~g---------------------~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 201 (367)
T 3l9p_A 143 SLQSLPRFILLELMAGG---------------------DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 201 (367)
T ss_dssp ECSSSSCEEEEECCTTE---------------------EHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EecCCCCEEEEEeCCCC---------------------CHHHHHHhhccccCccccccHHHHHHHHHHHHHHHHHHHhCC
Confidence 99999999999999954 444555443 35999999999999999999999999
Q ss_pred CccccCCCCceeeCCCC---CEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh
Q psy8309 208 IVYRDLKLDNILLDYEG---HVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV 282 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g---~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~ 282 (494)
|+||||||+||||+.+| .+||+|||+++..... .......+||+.|+|||++.+..++.++|||||||++|||++
T Consensus 202 ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt 281 (367)
T 3l9p_A 202 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 281 (367)
T ss_dssp CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 99999999999999665 4999999999743221 223445678999999999999999999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcC
Q psy8309 283 -GQSPFSGCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360 (494)
Q Consensus 283 -G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~ 360 (494)
|.+||.+.+..++...+..+. ...|..++.++.+||.+||+.||.+|| ++.+|++|.++-.-+.+ +....+
T Consensus 282 ~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~eil~~l~~~~~~~~-~~~~~~ 354 (367)
T 3l9p_A 282 LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP------NFAIILERIEYCTQDPD-VINTAL 354 (367)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHHHHHHHHCHH-HHTCCC
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCCHhHCc------CHHHHHHHHHHHhhChh-hccCCC
Confidence 999999999999888887754 566778999999999999999999999 68899998776433332 223344
Q ss_pred CCCCcccc
Q psy8309 361 EPPFRPRV 368 (494)
Q Consensus 361 ~pp~~p~~ 368 (494)
++.+.|.+
T Consensus 355 p~~~~~~~ 362 (367)
T 3l9p_A 355 PIEYGPLV 362 (367)
T ss_dssp CCC-----
T ss_pred ccccCCch
Confidence 44444443
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-47 Score=377.95 Aligned_cols=251 Identities=26% Similarity=0.441 Sum_probs=207.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC--ee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--HL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--~~ 141 (494)
.++|++.++||+|+||.||+|+++.+++.||||++..... .........|..++. .++||||+++++++.... .+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 84 (319)
T 4euu_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLK-KLNHKNIVKLFAIEEETTTRHK 84 (319)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECTTTCCE
T ss_pred CCCEEEEEEecCCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHH-hcCCCCcceEEEEeecCCCceE
Confidence 4689999999999999999999999999999999986532 223455667888887 578999999999998765 88
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG---RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
|+||||+++| +|..++.... .+++..++.++.||+.||.|||++||+||||||+||
T Consensus 85 ~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~NI 143 (319)
T 4euu_A 85 VLIMEFCPCG---------------------SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (319)
T ss_dssp EEEEECCTTC---------------------BHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEEEeCCCCC---------------------CHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCEecCCCCHHHE
Confidence 9999999955 4444554432 399999999999999999999999999999999999
Q ss_pred ee----CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC--------CCCCCCcchHHHHHHHHHHHHhCCCC
Q psy8309 219 LL----DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK--------GLKYNQCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 219 Ll----~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~--------~~~~~~~~DiwSlGvil~ell~G~~P 286 (494)
|+ +.++.+||+|||+++... ........+||+.|+|||++. +..++.++|||||||++|||++|..|
T Consensus 144 ll~~~~~~~~~~kL~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~p 222 (319)
T 4euu_A 144 MRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (319)
T ss_dssp EEEECTTSCEEEEECCCTTCEECC-TTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCS
T ss_pred EEeccCCCCceEEEccCCCceecC-CCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 99 788889999999998643 333445678999999999986 57899999999999999999999999
Q ss_pred CCCCC----HHHHHHHHHhCCC-------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 287 FSGCD----EDELFWSICNERP-------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 287 f~~~~----~~~~~~~i~~~~~-------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
|.... ..+....+..+.+ .++..++..+.+||.+||+.||++|| +
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~dP~~R~------s 296 (319)
T 4euu_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW------G 296 (319)
T ss_dssp EECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC------C
T ss_pred CCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccCChhhhc------c
Confidence 97432 3455666655433 12234567899999999999999999 6
Q ss_pred hhhhhcCC
Q psy8309 338 GDDVVAHE 345 (494)
Q Consensus 338 ~~eil~h~ 345 (494)
++|+++||
T Consensus 297 ~~ell~h~ 304 (319)
T 4euu_A 297 FDQFFAET 304 (319)
T ss_dssp HHHHHHHH
T ss_pred HHHhhhcc
Confidence 89999987
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=371.96 Aligned_cols=258 Identities=24% Similarity=0.396 Sum_probs=208.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE-------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ------- 136 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~------- 136 (494)
.++|++++.||+|+||.||+|+++.+++.||||++... .....+....|..++. .++||||+++++++.
T Consensus 10 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~~ 85 (320)
T 2i6l_A 10 GSRYMDLKPLGCGGNGLVFSAVDNDCDKRVAIKKIVLT---DPQSVKHALREIKIIR-RLDHDNIVKVFEILGPSGSQLT 85 (320)
T ss_dssp TTTEEEEEECC-----CEEEEEETTTTEEEEEEEEECC---SHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECTTSCBCC
T ss_pred CCceeEEEEeccCCCeEEEEEEECCCCeEEEEEEEecC---ChHHHHHHHHHHHHHH-hcCCCCeeEEEEeccccccccc
Confidence 35899999999999999999999999999999998754 3445566778888887 579999999999884
Q ss_pred -------cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 137 -------TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 137 -------~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
....+|+||||+. | +|...+. .+.+++..++.++.||+.||+|||++||+
T Consensus 86 ~~~~~~~~~~~~~lv~e~~~-~---------------------~L~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 142 (320)
T 2i6l_A 86 DDVGSLTELNSVYIVQEYME-T---------------------DLANVLE-QGPLLEEHARLFMYQLLRGLKYIHSANVL 142 (320)
T ss_dssp C----CCSCSEEEEEEECCS-E---------------------EHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCB
T ss_pred cccccccccCceeEEeeccC-C---------------------CHHHHhh-cCCccHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 4478999999996 2 4444443 46799999999999999999999999999
Q ss_pred cccCCCCceeeC-CCCCEEEeecCceeeeecc---CCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCC
Q psy8309 210 YRDLKLDNILLD-YEGHVRIADFGMCKLQIYL---DKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQ 284 (494)
Q Consensus 210 HrDLKp~NILl~-~~g~vkL~DFGla~~~~~~---~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~ 284 (494)
||||||+|||++ .++.+||+|||+++..... ........||+.|+|||++.+ ..++.++|||||||++|||++|.
T Consensus 143 H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 222 (320)
T 2i6l_A 143 HRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGK 222 (320)
T ss_dssp CCCCSGGGEEEETTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEEcCCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCC
Confidence 999999999997 5679999999998753211 122344568999999999865 67999999999999999999999
Q ss_pred CCCCCCCHHHHHHHHHhCCCC------------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCC
Q psy8309 285 SPFSGCDEDELFWSICNERPR------------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334 (494)
Q Consensus 285 ~Pf~~~~~~~~~~~i~~~~~~------------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~ 334 (494)
.||.+.+..+....+....+. ++..++.++++||.+||+.||.+||
T Consensus 223 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp---- 298 (320)
T 2i6l_A 223 TLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAVDFLEQILTFSPMDRL---- 298 (320)
T ss_dssp CSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHHHHHHTTSCSSGGGSC----
T ss_pred CCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHHHHHHHHcCCCccccC----
Confidence 999998887777766543211 1245899999999999999999999
Q ss_pred CCChhhhhcCCCcCCCChhH
Q psy8309 335 CNSGDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 335 ~~~~~eil~h~~f~~~~w~~ 354 (494)
+++|+++||||+..+|..
T Consensus 299 --t~~ell~hp~~~~~~~p~ 316 (320)
T 2i6l_A 299 --TAEEALSHPYMSIYSFPM 316 (320)
T ss_dssp --CHHHHHTSHHHHTTCC--
T ss_pred --CHHHHhCCcccccccCcc
Confidence 689999999999887754
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-47 Score=386.29 Aligned_cols=251 Identities=24% Similarity=0.359 Sum_probs=203.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcC-------CCCceeeEEEEEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-------KHPYLCHLFCTFQ 136 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~-------~hp~Iv~l~~~~~ 136 (494)
.++|++++.||+|+||+||+|++..+++.||||++++. .........|..++.... +|+||++++++|.
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~----~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~ 111 (397)
T 1wak_A 36 NGRYHVIRKLGWGHFSTVWLSWDIQGKKFVAMKVVKSA----EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFK 111 (397)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSC----HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEE
T ss_pred CCeEEEEEEeeecCCeeEEEEEecCCCeEEEEEEEecC----CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeeccee
Confidence 46899999999999999999999999999999999754 233445666777766421 3889999999998
Q ss_pred ----cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhC-CCc
Q psy8309 137 ----TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKK-GIV 209 (494)
Q Consensus 137 ----~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~-giv 209 (494)
+..++|+||||+. +++...+... +.+++..++.++.||+.||.|||++ ||+
T Consensus 112 ~~~~~~~~~~lv~e~~~----------------------~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~~giv 169 (397)
T 1wak_A 112 ISGVNGTHICMVFEVLG----------------------HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRII 169 (397)
T ss_dssp EEETTEEEEEEEECCCC----------------------CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEE
T ss_pred ecCCCCceEEEEEeccC----------------------ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 5678999999994 2333333332 5799999999999999999999999 999
Q ss_pred cccCCCCceeeCCCC-------------------------------------------------CEEEeecCceeeeecc
Q psy8309 210 YRDLKLDNILLDYEG-------------------------------------------------HVRIADFGMCKLQIYL 240 (494)
Q Consensus 210 HrDLKp~NILl~~~g-------------------------------------------------~vkL~DFGla~~~~~~ 240 (494)
||||||+||||+.++ .+||+|||+++..
T Consensus 170 HrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~--- 246 (397)
T 1wak_A 170 HTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWV--- 246 (397)
T ss_dssp CCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGGCCEEECCGGGCEET---
T ss_pred cCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccccceEeccccccccc---
Confidence 999999999999876 7999999999753
Q ss_pred CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH------HHHHHHHHh-------------
Q psy8309 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE------DELFWSICN------------- 301 (494)
Q Consensus 241 ~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~------~~~~~~i~~------------- 301 (494)
.......+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+. ......+..
T Consensus 247 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~ 326 (397)
T 1wak_A 247 HKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIELLGKVPRKLIVAG 326 (397)
T ss_dssp TBCSCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHHHHHHHHHHCSCCHHHHHHC
T ss_pred cccCccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHHHHHHHHhcCCCChHHhhcc
Confidence 2334556899999999999999999999999999999999999999986542 222222221
Q ss_pred -----------------------------CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 -----------------------------ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 -----------------------------~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
....++...+.++++||.+||+.||.+|| ++.|+++||||++
T Consensus 327 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~e~l~hp~~~~ 397 (397)
T 1wak_A 327 KYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA------TAAECLRHPWLNS 397 (397)
T ss_dssp TTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC------CHHHHHTSGGGGC
T ss_pred cccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC------CHHHHhhCccccC
Confidence 11123344567899999999999999999 6899999999974
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.3e-48 Score=391.54 Aligned_cols=258 Identities=16% Similarity=0.163 Sum_probs=193.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHH---HHHhcCCCCceeeEE-------E
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK---VLALGTKHPYLCHLF-------C 133 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~---~l~~~~~hp~Iv~l~-------~ 133 (494)
..+|++++.||+|+||.||+|+++.+++.||||++.+..............|.. ++. . +||||++++ +
T Consensus 61 ~~~y~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~-~-~hp~iv~~~~~~~~p~d 138 (371)
T 3q60_A 61 ERKLKLVEPLRVGDRSVVFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLL-G-ESPEEARDRRRLLLPSD 138 (371)
T ss_dssp EEEEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHH-C-----------CBCCCCE
T ss_pred ceeeeeeeeccCCCCEEEEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhc-c-cChhhhhhceeEEeeeh
Confidence 346999999999999999999999999999999998864434444455555543 333 3 799988765 4
Q ss_pred EEEcC-----------------CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHH------
Q psy8309 134 TFQTD-----------------SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRA------ 189 (494)
Q Consensus 134 ~~~~~-----------------~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~------ 189 (494)
++... ..+|+|||||. |+| ..++... ..+++...
T Consensus 139 ~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L---------------------~~~l~~~~~~~~~~~~~~~~vk 196 (371)
T 3q60_A 139 AVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDL---------------------ELLFSTLDFVYVFRGDEGILAL 196 (371)
T ss_dssp EEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEH---------------------HHHHHHHHHSCCCCHHHHHHHH
T ss_pred heecCCCCCeeeccCCcccceeeeEEEEecCCC-CCH---------------------HHHHHHhccccchhhhhhhhhH
Confidence 55433 34899999997 444 4444432 23444444
Q ss_pred HHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC--CCCCCc
Q psy8309 190 RFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG--LKYNQC 267 (494)
Q Consensus 190 ~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~--~~~~~~ 267 (494)
..++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.. ........||+.|+|||++.+ ..|+.+
T Consensus 197 ~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~ 273 (371)
T 3q60_A 197 HILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKV---GTRGPASSVPVTYAPREFLNASTATFTHA 273 (371)
T ss_dssp HHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEET---TCEEEGGGSCGGGCCHHHHTCSEEECCHH
T ss_pred HHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeec---CCCccCccCCcCCcChhhccCCCCCcCcc
Confidence 566799999999999999999999999999999999999999999853 223324567799999999988 779999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCCHHH--HHHH-----HHhCCCCCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 268 VDWWSFGILLYEMHVGQSPFSGCDEDE--LFWS-----ICNERPRFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 268 ~DiwSlGvil~ell~G~~Pf~~~~~~~--~~~~-----i~~~~~~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
+|||||||++|||++|..||.+..... .+.. .....+.++ ..+++++++||.+||+.||++|| ++
T Consensus 274 ~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~ 347 (371)
T 3q60_A 274 LNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGRFLNFDRRRRL------LP 347 (371)
T ss_dssp HHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHHHTCSSTTTCC------CH
T ss_pred ccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHHHcCCChhhCC------CH
Confidence 999999999999999999998764321 1110 111222333 47899999999999999999999 68
Q ss_pred hhhhcCCCcCCCChhH
Q psy8309 339 DDVVAHEYFRGLDWQA 354 (494)
Q Consensus 339 ~eil~h~~f~~~~w~~ 354 (494)
+++++||||+++.|..
T Consensus 348 ~e~l~hp~f~~~~~~~ 363 (371)
T 3q60_A 348 LEAMETPEFLQLQNEI 363 (371)
T ss_dssp HHHTTSHHHHHHHHHH
T ss_pred HHHhcCHHHHHHHHHH
Confidence 9999999999988764
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=375.50 Aligned_cols=252 Identities=27% Similarity=0.405 Sum_probs=206.7
Q ss_pred CCCceEeeEeccCCceEEEEEEE-eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-----cCCCCceeeEEEEEEc
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAEL-KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-----GTKHPYLCHLFCTFQT 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~-~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-----~~~hp~Iv~l~~~~~~ 137 (494)
.++|++++.||+|+||.||+|.+ +.+++.||||+++.. .........|..++.. ...|++|+++++++..
T Consensus 13 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~vavK~~~~~----~~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~ 88 (339)
T 1z57_A 13 SARYEIVDTLGEGAFGKVVECIDHKAGGRHVAVKIVKNV----DRYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEH 88 (339)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEECSS----HHHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEE
T ss_pred cCceEEEEEEecCCCeEEEEEEecCCCCcEEEEEEEecC----CchhHHHHHHHHHHHHhhhcCCCCceeeEeeeccccc
Confidence 46899999999999999999998 568899999999753 2233445556655543 2345579999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+.+|+||||+ +|+ |..++...+ .+++..++.++.||+.||+|||++||+||||||
T Consensus 89 ~~~~~lv~e~~-~~~---------------------l~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 146 (339)
T 1z57_A 89 HGHICIVFELL-GLS---------------------TYDFIKENGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKP 146 (339)
T ss_dssp TTEEEEEEECC-CCB---------------------HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred CCcEEEEEcCC-CCC---------------------HHHHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHHCCCcCCCCCH
Confidence 99999999999 444 444555443 689999999999999999999999999999999
Q ss_pred CceeeCC-------------------CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHH
Q psy8309 216 DNILLDY-------------------EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGIL 276 (494)
Q Consensus 216 ~NILl~~-------------------~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi 276 (494)
+|||++. ++.+||+|||+++.. .......+||+.|+|||++.+..++.++|||||||+
T Consensus 147 ~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 223 (339)
T 1z57_A 147 ENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYD---DEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCI 223 (339)
T ss_dssp GGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEET---TSCCCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHH
T ss_pred HHEEEeccccccccCCccccccccccCCCceEeeCcccccC---ccccccccCCccccChHHhhCCCCCcchhhHHHHHH
Confidence 9999987 678999999999752 333456789999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCC--------------------------------------------ccCCH
Q psy8309 277 LYEMHVGQSPFSGCDEDELFWSICNERPRFP--------------------------------------------QFLSV 312 (494)
Q Consensus 277 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p--------------------------------------------~~~s~ 312 (494)
+|||++|..||.+.+..+....+......+| ...++
T Consensus 224 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 303 (339)
T 1z57_A 224 LIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACKPLKEFMLSQDVEHE 303 (339)
T ss_dssp HHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCCCGGGGCSCCSHHHH
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCcchhhhcccchhhHH
Confidence 9999999999998887766554432111111 22357
Q ss_pred HHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 313 EAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 313 ~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
++.+||.+||+.||.+|| ++.|+++||||+.+
T Consensus 304 ~l~~li~~~L~~dP~~Rp------t~~ell~hp~f~~~ 335 (339)
T 1z57_A 304 RLFDLIQKMLEYDPAKRI------TLREALKHPFFDLL 335 (339)
T ss_dssp HHHHHHHHHTCSSTTTSC------CHHHHTTSGGGGGG
T ss_pred HHHHHHHHHhCcCccccc------CHHHHhcCHHHHHH
Confidence 789999999999999999 68999999999865
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=373.94 Aligned_cols=263 Identities=21% Similarity=0.288 Sum_probs=212.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||.||+|++..+++.||||++...... .....|..++....+||||+++++++...+..|+|
T Consensus 9 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv 83 (330)
T 2izr_A 9 PNFRVGKKIGCGNFGELRLGKNLYTNEYVAIKLEPMKSRA-----PQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMV 83 (330)
T ss_dssp TTEEEEEECCC-CTTSEEEEEETTTTEEEEEEEEETTCSS-----CCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEE
T ss_pred CCeEEEEEeeccCCceEEEEEECCCCcEEEEEEeccccch-----HHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEE
Confidence 5899999999999999999999999999999998764321 23456777777544999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||+ +|+| ..++.. .+.+++..++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 84 ~e~~-~~~L---------------------~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~iiHrDlkp~Nill~~~ 141 (330)
T 2izr_A 84 LELL-GPSL---------------------EDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRP 141 (330)
T ss_dssp EECC-CCBH---------------------HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECCG
T ss_pred EEeC-CCCH---------------------HHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCHHHeeeccC
Confidence 9999 6555 334443 4689999999999999999999999999999999999999998
Q ss_pred CC-----EEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-
Q psy8309 224 GH-----VRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC- 290 (494)
Q Consensus 224 g~-----vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~- 290 (494)
+. +||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 142 ~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~ 221 (330)
T 2izr_A 142 GNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLK 221 (330)
T ss_dssp GGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCccccc
Confidence 87 99999999986432221 134678999999999999999999999999999999999999999874
Q ss_pred --CHHHHHHHHHhCCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc----------CCCcCCCChh
Q psy8309 291 --DEDELFWSICNERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA----------HEYFRGLDWQ 353 (494)
Q Consensus 291 --~~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~----------h~~f~~~~w~ 353 (494)
+..+.+..+.......| ..++ ++++||..||..||.+||++ ++|++ ..+...++|.
T Consensus 222 ~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~------~~l~~~l~~~~~~~~~~~~~~~dw~ 294 (330)
T 2izr_A 222 ADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDY------DYLRKLFTDLFDRKGYMFDYEYDWI 294 (330)
T ss_dssp CSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCH------HHHHHHHHHHHHHTTCCCSCCCTTT
T ss_pred cccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCH------HHHHHHHHHHHHHcCCCCCCCccCC
Confidence 44455666654433333 2244 99999999999999999954 44433 3445568887
Q ss_pred HHhcCcCCCCC
Q psy8309 354 ALEKRELEPPF 364 (494)
Q Consensus 354 ~l~~~~~~pp~ 364 (494)
.+.+.+|+
T Consensus 295 ---~~~~~~p~ 302 (330)
T 2izr_A 295 ---GKQLPTPV 302 (330)
T ss_dssp ---TSCCCCCC
T ss_pred ---CCCcCCCC
Confidence 35556665
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-47 Score=382.48 Aligned_cols=260 Identities=25% Similarity=0.357 Sum_probs=199.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe--
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH-- 140 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~-- 140 (494)
.+++|++.+.||+|+||.||+|+++.+++.||||++.+...... ....+...+. .++||||++++++|.....
T Consensus 21 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~~----~~~~~~~~l~-~l~h~niv~~~~~~~~~~~~~ 95 (360)
T 3e3p_A 21 EMDRFQVERMAGQGTFGTVQLGKEKSTGMSVAIKKVIQDPRFRN----RELQIMQDLA-VLHHPNIVQLQSYFYTLGERD 95 (360)
T ss_dssp HHTTEEEC----------CEEEEETTTCCEEEEEEEECCTTCCC----HHHHHHHHHH-HHCCTTBCCEEEEEEEECSSC
T ss_pred hccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEecCccccH----HHHHHHHHHH-hcCCCCcccHHHhhhcccccc
Confidence 46799999999999999999999999999999999866432222 2233444444 3589999999999976433
Q ss_pred -----eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--hCCCccccC
Q psy8309 141 -----LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH--KKGIVYRDL 213 (494)
Q Consensus 141 -----~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH--~~givHrDL 213 (494)
+|+||||+.++.+ ..+.........+++..++.++.||+.||.||| ++||+||||
T Consensus 96 ~~~~~~~lv~e~~~~~l~------------------~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~~~ivH~Dl 157 (360)
T 3e3p_A 96 RRDIYLNVVMEYVPDTLH------------------RCCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDI 157 (360)
T ss_dssp TTCEEEEEEEECCSCBHH------------------HHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTTTCCBCSCC
T ss_pred ccceeEEEEeecccccHH------------------HHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCCCCeecCcC
Confidence 8999999984211 012223445678999999999999999999999 999999999
Q ss_pred CCCceeeCC-CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 214 KLDNILLDY-EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 214 Kp~NILl~~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
||+||||+. ++.+||+|||+++... ........+||+.|+|||++.+.. ++.++|||||||++|||++|.+||.+.+
T Consensus 158 kp~NIll~~~~~~~kl~Dfg~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 236 (360)
T 3e3p_A 158 KPHNVLVNEADGTLKLCDFGSAKKLS-PSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236 (360)
T ss_dssp CGGGEEEETTTTEEEECCCTTCBCCC-TTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHEEEeCCCCcEEEeeCCCceecC-CCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCC
Confidence 999999997 8999999999998533 333445678999999999997655 8999999999999999999999999998
Q ss_pred HHHHHHHHHhCC--------------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 292 EDELFWSICNER--------------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 292 ~~~~~~~i~~~~--------------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
..+.+..+.... ...+...++++++||.+||+.||.+|| ++.
T Consensus 237 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ 310 (360)
T 3e3p_A 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPEERM------KPY 310 (360)
T ss_dssp HHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHHTCSSGGGSC------CHH
T ss_pred hHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHHhccCccccC------CHH
Confidence 887777765310 011122578999999999999999999 689
Q ss_pred hhhcCCCcCCCCh
Q psy8309 340 DVVAHEYFRGLDW 352 (494)
Q Consensus 340 eil~h~~f~~~~w 352 (494)
|+++||||+++.+
T Consensus 311 e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 311 EALCHPYFDELHD 323 (360)
T ss_dssp HHTTSGGGGGGGC
T ss_pred HHhcCccccccCC
Confidence 9999999987643
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=377.97 Aligned_cols=260 Identities=25% Similarity=0.383 Sum_probs=219.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChh---hHHHHHHHHHHHHhcC-CCCceeeEEEEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD---DVECTLIERKVLALGT-KHPYLCHLFCTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~---~~~~~~~e~~~l~~~~-~hp~Iv~l~~~~~~ 137 (494)
...++|++++.||+|+||.||+|+++.+++.||||++.+....... .......|..++.... .||||+++++++..
T Consensus 40 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~ 119 (320)
T 3a99_A 40 PLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFER 119 (320)
T ss_dssp CCTTTEEEEEECSSSSSCEEEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEEC
T ss_pred CccCceEEEEEEeeCCCeEEEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEec
Confidence 3457899999999999999999999999999999999875432211 1122345666666433 47999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+..++|||++.+ +++|..++...+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 120 ~~~~~lv~e~~~~--------------------~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~N 179 (320)
T 3a99_A 120 PDSFVLILERPEP--------------------VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDEN 179 (320)
T ss_dssp SSEEEEEEECCSS--------------------EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCcEEEEEEcCCC--------------------CccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcEeCCCCHHH
Confidence 9999999999973 36677778888899999999999999999999999999999999999
Q ss_pred eeeC-CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 218 ILLD-YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
||++ .++.+||+|||+++... .......+||+.|+|||++.+..+ +.++|||||||++|||++|..||...+
T Consensus 180 Ill~~~~~~~kL~Dfg~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~---- 253 (320)
T 3a99_A 180 ILIDLNRGELKLIDFGSGALLK--DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE---- 253 (320)
T ss_dssp EEEETTTTEEEECCCTTCEECC--SSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH----
T ss_pred EEEeCCCCCEEEeeCccccccc--cccccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh----
Confidence 9999 78999999999998532 333455789999999999987665 688999999999999999999997542
Q ss_pred HHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHH
Q psy8309 296 FWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355 (494)
Q Consensus 296 ~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l 355 (494)
.+......++..+++++++||.+||..||.+|| +++++++||||+++.+..-
T Consensus 254 --~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~ll~hp~~~~~~~~~~ 305 (320)
T 3a99_A 254 --EIIRGQVFFRQRVSSECQHLIRWCLALRPSDRP------TFEEIQNHPWMQDVLLPQE 305 (320)
T ss_dssp --HHHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSC------CHHHHHTSGGGSSCCCHHH
T ss_pred --hhhcccccccccCCHHHHHHHHHHccCChhhCc------CHHHHhcCHhhcCccCccc
Confidence 355667778889999999999999999999999 6899999999998876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=372.10 Aligned_cols=253 Identities=23% Similarity=0.347 Sum_probs=212.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.+..++|++.+.||+|+||.||+|+++.++. .||||+++.. ...........|..++. .++||||+++++++.+
T Consensus 45 ~~~~~~y~i~~~lG~G~~g~V~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~ 121 (325)
T 3kul_A 45 EIEASRIHIEKIIGSGDSGEVCYGRLRVPGQRDVPVAIKALKAG--YTERQRRDFLSEASIMG-QFDHPNIIRLEGVVTR 121 (325)
T ss_dssp BCCGGGEEEEEEEEETTTEEEEEEEECCTTSCCEEEEEEEECTT--CCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECG
T ss_pred ccChhHeEEeeEEEeCCCcEEEEEEEecCCCCCceEEEEecCCC--CCHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEe
Confidence 4567899999999999999999999986554 5999999764 23444556777888877 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
.+.+|+||||++| ++|..++.. .+.+++..+..++.||+.||.|||++||+||||||+
T Consensus 122 ~~~~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~Dlkp~ 180 (325)
T 3kul_A 122 GRLAMIVTEYMEN---------------------GSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSDLGYVHRDLAAR 180 (325)
T ss_dssp GGCCEEEEECCTT---------------------CBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred CCccEEEeeCCCC---------------------CcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 9999999999994 455555644 368999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
||||+.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 181 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 181 NVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp GEEECTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred eEEECCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999999999999864322211 223346788999999998899999999999999999999 9999999999
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.++...+..+ ....|..+++++.+||.+||..||.+|| ++.+|++
T Consensus 261 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~eil~ 306 (325)
T 3kul_A 261 RDVISSVEEGYRLPAPMGCPHALHQLMLDCWHKDRAQRP------RFSQIVS 306 (325)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHHcCCCCCCCCCcCHHHHHHHHHHccCChhhCc------CHHHHHH
Confidence 8888888765 4566788999999999999999999999 4566663
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=378.43 Aligned_cols=256 Identities=24% Similarity=0.368 Sum_probs=203.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc--------ChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL--------EDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~--------~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.++|++++.||+|+||.||+|.+.. +..||||++...... .....+....|..++. .++||||+++++++
T Consensus 21 ~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~ 98 (362)
T 3pg1_A 21 QSPYTVQRFISSGSYGAVCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLN-HFHHPNILGLRDIF 98 (362)
T ss_dssp TCSCEEEEEEEEETTEEEEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEE
T ss_pred ccceEEeEEeccCCCEEEEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHH-hCCCcCccceeeeE
Confidence 4689999999999999999999865 888999999654321 1223466778888887 57899999999998
Q ss_pred Ec-----CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 136 QT-----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 136 ~~-----~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
.. ...+|+||||+. |+|...+. ....+++..++.++.||+.||.|||++||+
T Consensus 99 ~~~~~~~~~~~~lv~e~~~----------------------~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 156 (362)
T 3pg1_A 99 VHFEEPAMHKLYLVTELMR----------------------TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHEAGVV 156 (362)
T ss_dssp EECCTTTCCEEEEEEECCS----------------------EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred EeccCCCcceEEEEEccCC----------------------CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCcCE
Confidence 53 447899999996 23333443 335799999999999999999999999999
Q ss_pred cccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 210 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
||||||+|||++.++.+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|+|++|..||.
T Consensus 157 H~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~ 235 (362)
T 3pg1_A 157 HRDLHPGNILLADNNDITICDFNLAREDT-ADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFR 235 (362)
T ss_dssp CCCCCGGGEEECTTCCEEECCTTC----------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCC
T ss_pred ecCCChHHEEEcCCCCEEEEecCcccccc-cccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCC
Confidence 99999999999999999999999997532 2333455689999999999987 679999999999999999999999999
Q ss_pred CCCHHHHHHHHHhC--CC----------------------C--------CCccCCHHHHHHHHhhccCCCCCCCCCCCCC
Q psy8309 289 GCDEDELFWSICNE--RP----------------------R--------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCN 336 (494)
Q Consensus 289 ~~~~~~~~~~i~~~--~~----------------------~--------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~ 336 (494)
+.+..+....+... .+ . .+..+++.+.+||.+||+.||.+||
T Consensus 236 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------ 309 (362)
T 3pg1_A 236 GSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQRRI------ 309 (362)
T ss_dssp CSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSC------
T ss_pred CCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChhhCC------
Confidence 98887777766431 00 1 1235689999999999999999999
Q ss_pred ChhhhhcCCCcCCC
Q psy8309 337 SGDDVVAHEYFRGL 350 (494)
Q Consensus 337 ~~~eil~h~~f~~~ 350 (494)
++.|+++||||+++
T Consensus 310 t~~ell~hp~f~~~ 323 (362)
T 3pg1_A 310 STEQALRHPYFESL 323 (362)
T ss_dssp CHHHHHTSGGGTTT
T ss_pred CHHHHHcCchhhhc
Confidence 68999999999986
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-47 Score=379.45 Aligned_cols=249 Identities=30% Similarity=0.475 Sum_probs=180.2
Q ss_pred CCCceEee-EeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----C
Q psy8309 64 LEDFQLLK-VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----D 138 (494)
Q Consensus 64 ~~~y~~~~-~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~ 138 (494)
.++|++++ +||+|+||.||+|+++.+++.||||++.... ....|...+...++||||+++++++.. .
T Consensus 27 ~~~y~i~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~ 98 (336)
T 3fhr_A 27 TDDYQLSKQVLGLGVNGKVLECFHRRTGQKCALKLLYDSP--------KARQEVDHHWQASGGPHIVCILDVYENMHHGK 98 (336)
T ss_dssp GGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEESSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTE
T ss_pred cceeEecceeeeeCCCeEEEEEEECCCCCEEEEEEecCcH--------HHHHHHHHHHHhcCCCChHHHHHHHhhccCCC
Confidence 46899965 6999999999999999999999999996531 122333333446799999999999986 5
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
..+|+|||||+ ||+|..++...+ .+++.+++.++.||+.||.|||++||+||||||+
T Consensus 99 ~~~~lv~e~~~---------------------gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~dlkp~ 157 (336)
T 3fhr_A 99 RCLLIIMECME---------------------GGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPE 157 (336)
T ss_dssp EEEEEEEECCT---------------------TEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECSCCSGG
T ss_pred ceEEEEEeccC---------------------CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCHH
Confidence 56999999999 555566666543 6999999999999999999999999999999999
Q ss_pred ceeeCCC---CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 217 NILLDYE---GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~---g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
|||++.+ +.+||+|||+++... .......+||+.|+|||++.+..++.++|||||||++|+|++|..||.+....
T Consensus 158 NIll~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 158 NLLYTSKEKDAVLKLTDFGFAKETT--QNALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp GEEESCSSTTCCEEECCCTTCEEC------------------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred HEEEEecCCCceEEEeccccceecc--ccccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 9999864 559999999997532 33345678999999999999989999999999999999999999999876654
Q ss_pred HH----HHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 294 EL----FWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 294 ~~----~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.. ...+......+| ..+++++++||.+||..||.+|| +++|+++||||++
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~~~~ 293 (336)
T 3fhr_A 236 AISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERL------TITQFMNHPWINQ 293 (336)
T ss_dssp ---------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSC------CHHHHHHSHHHHT
T ss_pred hhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCc------CHHHHhcCccccc
Confidence 43 223333333333 46899999999999999999999 6899999999975
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-46 Score=365.78 Aligned_cols=258 Identities=29% Similarity=0.495 Sum_probs=210.0
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|....+||+|+||.||+|++..++..||||++.... .........|..++. .++||||+++++++...+.+
T Consensus 19 ~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~ 94 (295)
T 2clq_A 19 YEYDENGDRVVLGKGTYGIVYAGRDLSNQVRIAIKEIPERD---SRYSQPLHEEIALHK-HLKHKNIVQYLGSFSENGFI 94 (295)
T ss_dssp ECBCTTSSBCEEEECSSSEEEEEEETTTCCEEEEEEEECCC---C---HHHHHHHHHHH-TCCCTTBCCEEEEEEETTEE
T ss_pred ccccCCCCcEEEeecCcEEEEEEEECCCCeEEEEEEccCCc---hHHHHHHHHHHHHHH-hCCCCCEeeEeeEEEeCCcE
Confidence 44556667779999999999999999999999999997642 233455667777776 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
++||||+++| +|..++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 95 ~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~Ni 153 (295)
T 2clq_A 95 KIFMEQVPGG---------------------SLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNV 153 (295)
T ss_dssp EEEEECCSEE---------------------EHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred EEEEEeCCCC---------------------CHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHhCCEEccCCChhhE
Confidence 9999999954 444455443 3567899999999999999999999999999999999
Q ss_pred eeCC-CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC--CCCcchHHHHHHHHHHHHhCCCCCCCCCHH-H
Q psy8309 219 LLDY-EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILLYEMHVGQSPFSGCDED-E 294 (494)
Q Consensus 219 Ll~~-~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~--~~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~ 294 (494)
|++. ++.+||+|||+++.............||+.|+|||++.+.. ++.++|||||||++|+|++|..||...... .
T Consensus 154 l~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~ 233 (295)
T 2clq_A 154 LINTYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQA 233 (295)
T ss_dssp EEETTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGGSSHHH
T ss_pred EEECCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCCCchhH
Confidence 9987 89999999999986433333345678999999999997643 899999999999999999999999764332 2
Q ss_pred HHHH--HHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 295 LFWS--ICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 295 ~~~~--i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.... .....+.+|..+++++++||.+||..||.+|| ++++++.||||+..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~ll~~~~~~~~ 285 (295)
T 2clq_A 234 AMFKVGMFKVHPEIPESMSAEAKAFILKCFEPDPDKRA------CANDLLVDEFLKVS 285 (295)
T ss_dssp HHHHHHHHCCCCCCCTTSCHHHHHHHHHTTCSSTTTSC------CHHHHHTSGGGCC-
T ss_pred HHHhhccccccccccccCCHHHHHHHHHHccCChhhCC------CHHHHhcChhhhhc
Confidence 2222 23445677889999999999999999999999 68999999999864
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-46 Score=369.48 Aligned_cols=272 Identities=21% Similarity=0.298 Sum_probs=222.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|+++ .+++.||||++.... ..........|..++. .++||||+++++++
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~ 97 (322)
T 1p4o_A 21 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMK-EFNCHHVVRLLGVV 97 (322)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGG-GCCCTTBCCEEEEE
T ss_pred cchhhheeeeeEeccCCceEEEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHH-hcCCCCEeeeEEEE
Confidence 345578999999999999999999987 467889999997542 2334445667777776 57999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----------cCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----------SGRFDEGRARFYAAEIVSGMRFLHK 205 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----------~~~l~e~~~~~~~~qi~~aL~yLH~ 205 (494)
.+.+..|+||||+.+|+|. .++.. ...+++..+..++.||+.||.|||+
T Consensus 98 ~~~~~~~lv~e~~~~~~L~---------------------~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~ 156 (322)
T 1p4o_A 98 SQGQPTLVIMELMTRGDLK---------------------SYLRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA 156 (322)
T ss_dssp CSSSSCEEEEECCTTCBHH---------------------HHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCCccEEEEEeCCCCcHH---------------------HHHHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH
Confidence 9999999999999976653 23322 2467999999999999999999999
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV- 282 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~- 282 (494)
+||+||||||+|||++.+|.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 157 ~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 236 (322)
T 1p4o_A 157 NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 236 (322)
T ss_dssp TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHT
T ss_pred CCCccCCCccceEEEcCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhc
Confidence 999999999999999999999999999987532221 12234567899999999999899999999999999999999
Q ss_pred CCCCCCCCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC------CCcCCCChhHH
Q psy8309 283 GQSPFSGCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH------EYFRGLDWQAL 355 (494)
Q Consensus 283 G~~Pf~~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h------~~f~~~~w~~l 355 (494)
|..||.+.+..+....+..+. ...+..++.++++||.+||..||.+|| ++.|+++| ++|+.++|...
T Consensus 237 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~e~l~~L~~~~~~~~~~~~~~~~ 310 (322)
T 1p4o_A 237 AEQPYQGLSNEQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP------SFLEIISSIKEEMEPGFREVSFYYS 310 (322)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHHHGGGSCTTHHHHCSTTS
T ss_pred CCCccccCCHHHHHHHHHcCCcCCCCCCCCHHHHHHHHHHcCCCcccCc------CHHHHHHHHHHhhccCCcccccccc
Confidence 899999999888888887654 456778999999999999999999999 56667665 77777766555
Q ss_pred hcCcCCC
Q psy8309 356 EKRELEP 362 (494)
Q Consensus 356 ~~~~~~p 362 (494)
...++++
T Consensus 311 ~~~~~~~ 317 (322)
T 1p4o_A 311 EENKLPE 317 (322)
T ss_dssp TTC----
T ss_pred cccCCCC
Confidence 4444433
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-46 Score=378.60 Aligned_cols=276 Identities=26% Similarity=0.369 Sum_probs=210.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEE-----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++++.||+|+||.||+|++ ..+++.||||++++. ...........|..++....+||||+++++++
T Consensus 18 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpniv~~~~~~ 95 (359)
T 3vhe_A 18 EFPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEG--ATHSEHRALMSELKILIHIGHHLNVVNLLGAC 95 (359)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cccccceeeceeecCCCCceEEEEEeccccccccceEEEEEEecCc--CCHHHHHHHHHHHHHHHhhcCCcceeeeeeee
Confidence 35567999999999999999999994 456789999999764 23344566788888888666899999999999
Q ss_pred EcCC-eeEEEEEecCCCCCccccchhhhhh-----------------------h---------------hhHhcCCchhH
Q psy8309 136 QTDS-HLFFVMEYLNGGDLIPAGLTKAERD-----------------------L---------------MEYLNGGDLMF 176 (494)
Q Consensus 136 ~~~~-~~~lv~E~~~~g~L~~~~~~~~~~~-----------------------l---------------~~~~~gg~L~~ 176 (494)
.+.+ .+|+|||||++|+|.+.+....... + ..+..+..+..
T Consensus 96 ~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 175 (359)
T 3vhe_A 96 TKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSD 175 (359)
T ss_dssp CSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------------------------------------
T ss_pred ecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccch
Confidence 8765 4999999999887744322111000 0 00000000000
Q ss_pred Hhh-------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--Cccccc
Q psy8309 177 HIQ-------QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTF 247 (494)
Q Consensus 177 ~l~-------~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~ 247 (494)
... ....+++..++.++.||+.||.|||++||+||||||+||||+.++.+||+|||+++...... ......
T Consensus 176 ~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~ 255 (359)
T 3vhe_A 176 VEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDA 255 (359)
T ss_dssp --------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--C
T ss_pred hhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhcccc
Confidence 000 01238999999999999999999999999999999999999999999999999997532211 123456
Q ss_pred CCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH-HHHh-CCCCCCccCCHHHHHHHHhhccC
Q psy8309 248 CGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW-SICN-ERPRFPQFLSVEAKNILVHLLDK 324 (494)
Q Consensus 248 ~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~-~i~~-~~~~~p~~~s~~~~~li~~lL~~ 324 (494)
.||+.|+|||++.+..++.++|||||||++|||++ |..||.+....+... .+.. .....|..+++++.++|.+||..
T Consensus 256 ~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~ 335 (359)
T 3vhe_A 256 RLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHG 335 (359)
T ss_dssp EECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCS
T ss_pred CCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchhHHHHHHHHcCCCCCCCCCCCHHHHHHHHHHccC
Confidence 78999999999999999999999999999999998 999999876544443 3333 35667788999999999999999
Q ss_pred CCCCCCCCCCCCChhhhhcC
Q psy8309 325 DTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 325 dP~~R~~~~~~~~~~eil~h 344 (494)
||.+|| ++.|+++|
T Consensus 336 dP~~Rp------s~~ell~~ 349 (359)
T 3vhe_A 336 EPSQRP------TFSELVEH 349 (359)
T ss_dssp SGGGSC------CHHHHHHH
T ss_pred ChhhCC------CHHHHHHH
Confidence 999999 57788765
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=375.48 Aligned_cols=255 Identities=29% Similarity=0.413 Sum_probs=217.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCC-------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGT-------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFC 133 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~-------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~ 133 (494)
.+..++|++++.||+|+||.||+|++..+ +..||||+++.. ...........|..++....+||||+++++
T Consensus 65 ~i~~~~y~i~~~LG~G~~g~Vy~a~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~ 142 (382)
T 3tt0_A 65 ELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLG 142 (382)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEETSSTTCTTCEEEEEEEEECTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred ccchhheEeeeEEecCCCeEEEEEEEccccccccccceEEEEEeeccc--cCHHHHHHHHHHHHHHHHhcCCchhhhhee
Confidence 44567999999999999999999998654 357999999765 334555677888888886559999999999
Q ss_pred EEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc----------------CCCCHHHHHHHHHHHH
Q psy8309 134 TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS----------------GRFDEGRARFYAAEIV 197 (494)
Q Consensus 134 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~ 197 (494)
++.+.+.+|+||||+.+|+| ..++... ..+++..++.++.||+
T Consensus 143 ~~~~~~~~~lv~e~~~~g~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~ 201 (382)
T 3tt0_A 143 ACTQDGPLYVIVEYASKGNL---------------------REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVA 201 (382)
T ss_dssp EECSSSSCEEEEECCTTCBH---------------------HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHH
T ss_pred eeccCCceEEEEEecCCCcH---------------------HHHHHHhcccccccccccccccccccCHHHHHHHHHHHH
Confidence 99999999999999995554 4444433 3599999999999999
Q ss_pred HHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHH
Q psy8309 198 SGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGI 275 (494)
Q Consensus 198 ~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGv 275 (494)
.||.|||++||+||||||+||||+.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||
T Consensus 202 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~ 281 (382)
T 3tt0_A 202 RGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGV 281 (382)
T ss_dssp HHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHH
T ss_pred HHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHH
Confidence 99999999999999999999999999999999999997532221 2234456788999999999999999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 276 LLYEMHV-GQSPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 276 il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
++|||++ |..||.+.+..++...+..+ ....|..+++++.+||.+||..||.+|| +++|++++
T Consensus 282 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~ell~~ 346 (382)
T 3tt0_A 282 LLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP------TFKQLVED 346 (382)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 9999999 99999999988888888765 5567788999999999999999999999 57777764
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-46 Score=371.92 Aligned_cols=273 Identities=23% Similarity=0.346 Sum_probs=213.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++++.||+|+||.||+|++.. +++.||||++++.. ..........|..++. .++||||+++++++
T Consensus 43 ~~~~~~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~ 119 (343)
T 1luf_A 43 EYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMA-EFDNPNIVKLLGVC 119 (343)
T ss_dssp BCCGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEE
T ss_pred EecHHHCeeeeeeeecCCeeEEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHH-hCCCCCEEEEEEEE
Confidence 3456799999999999999999999984 56889999997652 3344556777888887 57999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhH----HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF----HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~----~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
.+.+.+|+||||+++|+|.+.+........... ...++.. .......+++.+++.++.||+.||.|||++||+||
T Consensus 120 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~ 198 (343)
T 1luf_A 120 AVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSL-SHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHR 198 (343)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTCC-----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCS
T ss_pred ccCCceEEEEecCCCCcHHHHHHHhCccccccc-ccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 999999999999997776432111100000000 0000000 00012579999999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFS 288 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~ 288 (494)
||||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 199 Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 278 (343)
T 1luf_A 199 DLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYY 278 (343)
T ss_dssp CCSGGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTT
T ss_pred CCCcceEEECCCCeEEEeecCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCC
Confidence 999999999999999999999987432211 22344578999999999998899999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 289 GCDEDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+.+..++...+..+. ..+|..++.++.+||.+||+.||.+|| ++.++++
T Consensus 279 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~~~~ 328 (343)
T 1luf_A 279 GMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP------SFCSIHR 328 (343)
T ss_dssp TSCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred CCChHHHHHHHhCCCcCCCCCCCCHHHHHHHHHHcccCcccCC------CHHHHHH
Confidence 999988888887765 456788999999999999999999999 5666664
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-45 Score=367.02 Aligned_cols=259 Identities=28% Similarity=0.473 Sum_probs=198.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
...+++|++++.||+|+||.||+|+++.+++.||||++.... ........+.|...+...++||||+++++++.+.+.
T Consensus 21 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~ 98 (318)
T 2dyl_A 21 QAEINDLENLGEMGSGTCGQVWKMRFRKTGHVIAVKQMRRSG--NKEENKRILMDLDVVLKSHDCPYIVQCFGTFITNTD 98 (318)
T ss_dssp ECCGGGEEEEEEC------CEEEEEETTTCCEEEEEEEETTS--CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSE
T ss_pred hhhhccccccceeeecCCeeEEEEEEecCCeEEEEEEecccc--cchHHHHHHHHHHHHHHhcCCCceeeEEEEEecCCc
Confidence 345789999999999999999999999999999999997652 223333445555555557899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHh-hhcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI-QQSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l-~~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLKp~NI 218 (494)
+|+||||+. + .+.... ...+.+++..++.++.||+.||.|||++ ||+||||||+||
T Consensus 99 ~~lv~e~~~-~---------------------~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~i~H~dlkp~Ni 156 (318)
T 2dyl_A 99 VFIAMELMG-T---------------------CAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNI 156 (318)
T ss_dssp EEEEECCCS-E---------------------EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHHCCCCCCCCGGGE
T ss_pred EEEEEeccC-C---------------------cHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhCCEEeCCCCHHHE
Confidence 999999993 2 112222 2356899999999999999999999995 999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDE 292 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~ 292 (494)
|++.++.+||+|||++..... .......+||+.|+|||++. +..++.++|||||||++|||++|..||.. ...
T Consensus 157 l~~~~~~~kl~dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (318)
T 2dyl_A 157 LLDERGQIKLCDFGISGRLVD-DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235 (318)
T ss_dssp EECTTSCEEECCCTTC---------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTTCCSH
T ss_pred EECCCCCEEEEECCCchhccC-CccccccCCCccccChhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCCCCcc
Confidence 999999999999999875322 23344567999999999995 55689999999999999999999999987 455
Q ss_pred HHHHHHHHhCCC-CCC--ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 293 DELFWSICNERP-RFP--QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 293 ~~~~~~i~~~~~-~~p--~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+....+..... .+| ..++.++++||.+||..||.+|| +++++++||||++.
T Consensus 236 ~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~ 290 (318)
T 2dyl_A 236 FEVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLTKDHRKRP------KYNKLLEHSFIKRY 290 (318)
T ss_dssp HHHHHHHHHSCCCCCCSSSCCCHHHHHHHHHHTCSCTTTSC------CHHHHTTSHHHHHH
T ss_pred HHHHHHHhccCCCCCCccCCCCHHHHHHHHHHccCChhHCc------CHHHHhhCHHHHhc
Confidence 566666666543 333 35899999999999999999999 68999999999753
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-46 Score=385.83 Aligned_cols=253 Identities=27% Similarity=0.420 Sum_probs=187.2
Q ss_pred CceE-eeEeccCCceEEEEEEEe--CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE--cCCe
Q psy8309 66 DFQL-LKVLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ--TDSH 140 (494)
Q Consensus 66 ~y~~-~~~LG~G~fG~V~~~~~~--~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~--~~~~ 140 (494)
.|++ .++||+|+||.||+|+++ .+++.||||++..... ......|..++. .++||||++++++|. ....
T Consensus 21 ~y~~~g~~lG~G~~g~Vy~~~~~~~~~~~~vaiK~~~~~~~-----~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~~ 94 (405)
T 3rgf_A 21 LFEYEGCKVGRGTYGHVYKAKRKDGKDDKDYALKQIEGTGI-----SMSACREIALLR-ELKHPNVISLQKVFLSHADRK 94 (405)
T ss_dssp HEECSSCCCC-----EEEEEEESSSSCCCCEEEEECSSSSC-----CHHHHHHHHHHH-HCCCTTBCCCCEEEEETTTTE
T ss_pred hhhhcCcEeeecCCeEEEEEEEccCCCCeEEEEEEECCCCC-----CHHHHHHHHHHH-hcCCCCeeeEeeEEecCCCCe
Confidence 4666 458999999999999976 4688999999976422 124567888887 578999999999995 4779
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh---------hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ---------QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~---------~~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
+|+||||+.+ +| ...+. ....+++..++.++.||+.||.|||++||+||
T Consensus 95 ~~lv~e~~~~-~l---------------------~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~~~ivH~ 152 (405)
T 3rgf_A 95 VWLLFDYAEH-DL---------------------WHIIKFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHR 152 (405)
T ss_dssp EEEEEECCSE-EH---------------------HHHHHHHHHHC-------CCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred EEEEEeCCCC-CH---------------------HHHHHHhccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCEeCC
Confidence 9999999963 22 22222 12359999999999999999999999999999
Q ss_pred cCCCCceee----CCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhC
Q psy8309 212 DLKLDNILL----DYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVG 283 (494)
Q Consensus 212 DLKp~NILl----~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G 283 (494)
||||+|||| +.++.+||+|||+++...... ......+||+.|+|||++.+. .|+.++|||||||++|||++|
T Consensus 153 Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g 232 (405)
T 3rgf_A 153 DLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTS 232 (405)
T ss_dssp CCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHS
T ss_pred CcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhC
Confidence 999999999 678999999999997532211 233457899999999999874 599999999999999999999
Q ss_pred CCCCCCCCHH---------HHHHHHHhC--CCC---C---------------------------------CccCCHHHHH
Q psy8309 284 QSPFSGCDED---------ELFWSICNE--RPR---F---------------------------------PQFLSVEAKN 316 (494)
Q Consensus 284 ~~Pf~~~~~~---------~~~~~i~~~--~~~---~---------------------------------p~~~s~~~~~ 316 (494)
.+||.+.... +.+..|... .+. + ....++++.+
T Consensus 233 ~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 312 (405)
T 3rgf_A 233 EPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYMEKHKVKPDSKAFH 312 (405)
T ss_dssp SCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHHTTTCCTTSHHHH
T ss_pred CCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHhhcCCCCCHHHHH
Confidence 9999876542 344444321 100 0 0112778999
Q ss_pred HHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 317 ILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 317 li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
||.+||..||.+|| +++|+++||||.+..|
T Consensus 313 Ll~~~L~~dP~~R~------ta~e~L~hp~f~~~~~ 342 (405)
T 3rgf_A 313 LLQKLLTMDPIKRI------TSEQAMQDPYFLEDPL 342 (405)
T ss_dssp HHHHHSCSSGGGSC------CHHHHHTSGGGTSSSC
T ss_pred HHHHHccCCcccCC------CHHHHhcChhhccCCC
Confidence 99999999999999 6899999999987543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-46 Score=374.39 Aligned_cols=261 Identities=23% Similarity=0.396 Sum_probs=192.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|.++.+++.||||+++... ..........|...+...++||||+++++++.+.+.
T Consensus 18 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~ 95 (327)
T 3aln_A 18 DFTAEDLKDLGEIGRGAYGSVNKMVHKPSGQIMAVKRIRSTV--DEKEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGD 95 (327)
T ss_dssp CCCSCSEEC-CEEEECSSEEEEEEEETTTTEEEEEEEEECCC--CHHHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSE
T ss_pred ccCHHHhhehheeccCCCEEEEEEEEcCCCCEEEEEEeeccc--CchHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCc
Confidence 456789999999999999999999999999999999997642 233444556666656667899999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhC-CCccccCC
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-----QSGRFDEGRARFYAAEIVSGMRFLHKK-GIVYRDLK 214 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~yLH~~-givHrDLK 214 (494)
+|+||||+.+ +| ...+. ....+++..+..++.||+.||.|||++ ||+|||||
T Consensus 96 ~~lv~e~~~~-~l---------------------~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~ivH~dlk 153 (327)
T 3aln_A 96 CWICMELMST-SF---------------------DKFYKYVYSVLDDVIPEEILGKITLATVKALNHLKENLKIIHRDIK 153 (327)
T ss_dssp EEEEECCCSE-EH---------------------HHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHHHSCCCSCCC
T ss_pred eEEEEeecCC-Ch---------------------HHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHHHhccCCEeECCCC
Confidence 9999999973 22 22222 256799999999999999999999999 99999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhh----CCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l----~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
|+|||++.+|.+||+|||+++.... .......+||+.|+|||++ .+..++.++|||||||++|+|++|..||.+.
T Consensus 154 p~NIll~~~~~~kl~Dfg~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 232 (327)
T 3aln_A 154 PSNILLDRSGNIKLCDFGISGQLVD-SIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232 (327)
T ss_dssp GGGEEEETTTEEEECCCSSSCC-------------------------------CCSHHHHHHHHHHHHHHHHSCCCSSCC
T ss_pred HHHEEEcCCCCEEEccCCCceeccc-ccccccCCCCccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 9999999999999999999875322 2233345799999999999 5667999999999999999999999999875
Q ss_pred CH-HHHHHHHHhCC-CCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh
Q psy8309 291 DE-DELFWSICNER-PRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 291 ~~-~~~~~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w 352 (494)
+. .+....+..+. +.++ ..+++++++||.+||..||.+|| ++.++++||||...++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 233 NSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRP------KYKELLKHPFILMYEE 294 (327)
T ss_dssp -------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSC------CHHHHTTSHHHHHHHH
T ss_pred chHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCc------CHHHHHhChHHHHhHh
Confidence 43 22222333222 2222 35899999999999999999999 6899999999975443
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-45 Score=357.09 Aligned_cols=251 Identities=22% Similarity=0.377 Sum_probs=212.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|++.. ++.||||++.+... ..+....|..++. .++||||+++++++.+.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~~-~~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 79 (269)
T 4hcu_A 6 VIDPSELTFVQEIGSGQFGLVHLGYWLN-KDKVAIKTIREGAM----SEEDFIEEAEVMM-KLSHPKLVQLYGVCLEQAP 79 (269)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETT-TEEEEEEEECTTSB----CHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSS
T ss_pred EeChhhceeeheecCCCccEEEEEEecC-CCeEEEEEeccccc----CHHHHHHHHHHHH-hCCCCCEeeEEEEEecCCc
Confidence 3456799999999999999999999874 56799999986532 2244667888877 5789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+||||+++ ++|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 80 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Nil 138 (269)
T 4hcu_A 80 ICLVFEFMEH---------------------GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCL 138 (269)
T ss_dssp EEEEEECCTT---------------------CBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eEEEEEeCCC---------------------CcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCeecCCcchheEE
Confidence 9999999994 455555543 456999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..+...
T Consensus 139 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~~~~~~ 218 (269)
T 4hcu_A 139 VGENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVE 218 (269)
T ss_dssp ECGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EcCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCHHHHHH
Confidence 9999999999999987432111 12234457788999999998899999999999999999999 999999999998888
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+... ....|..+++++.+||.+||+.||.+|| ++.++++|
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~ll~~ 260 (269)
T 4hcu_A 219 DISTGFRLYKPRLASTHVYQIMNHCWRERPEDRP------AFSRLLRQ 260 (269)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHhcCccCCCCCcCCHHHHHHHHHHccCCcccCc------CHHHHHHH
Confidence 88776 4556778899999999999999999999 57777765
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-46 Score=368.73 Aligned_cols=249 Identities=29% Similarity=0.387 Sum_probs=206.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++.+.||+|+||.||+|+++.+++.||+|++.+. ..........|..++. .++||||+++++++.+.+.+
T Consensus 7 ~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~ 82 (310)
T 3s95_A 7 FRPSDLIHGEVLGKGCFGQAIKVTHRETGEVMVMKELIRF---DEETQRTFLKEVKVMR-CLEHPNVLKFIGVLYKDKRL 82 (310)
T ss_dssp ECGGGEEEEEEEECCSSEEEEEEEETTTCCEEEEEEESCC---CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEE
T ss_pred eChhHeeccceecCCCCEEEEEEEECCCCcEEEEEEeccC---CHHHHHHHHHHHHHHH-hCCCcCcccEEEEEecCCee
Confidence 4567999999999999999999999999999999998653 3445566777888877 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+||||++ |++|..++.. ...+++.++..++.||+.||+|||++||+||||||+|||+
T Consensus 83 ~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nil~ 141 (310)
T 3s95_A 83 NFITEYIK---------------------GGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLV 141 (310)
T ss_dssp EEEEECCT---------------------TCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSTTSEEE
T ss_pred EEEEEecC---------------------CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCcCeEEE
Confidence 99999999 4555556665 5679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCc--------------ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKT--------------TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~--------------~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~P 286 (494)
+.++.+||+|||+++........ ....+||+.|+|||++.+..++.++|||||||++|||++|..|
T Consensus 142 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~ 221 (310)
T 3s95_A 142 RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNA 221 (310)
T ss_dssp CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCS
T ss_pred CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCC
Confidence 99999999999999753222111 1256899999999999999999999999999999999999999
Q ss_pred CCCCCHHH-----HHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 287 FSGCDEDE-----LFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 287 f~~~~~~~-----~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
|....... ....... ...|..+++++.+||.+||+.||.+|| ++.++++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~~l~~ 275 (310)
T 3s95_A 222 DPDYLPRTMDFGLNVRGFLD--RYCPPNCPPSFFPITVRCCDLDPEKRP------SFVKLEH 275 (310)
T ss_dssp STTTSCBCTTSSBCHHHHHH--HTCCTTCCTTHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred CcchhhhHHHHhhhhhcccc--ccCCCCCCHHHHHHHHHHccCChhhCc------CHHHHHH
Confidence 87533211 0111111 134677889999999999999999999 5677765
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-46 Score=376.50 Aligned_cols=254 Identities=24% Similarity=0.385 Sum_probs=202.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc----------CCCCceeeE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG----------TKHPYLCHL 131 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~----------~~hp~Iv~l 131 (494)
+...+|++++.||+|+||.||+|+++.+++.||||++.+.. ........|..++... ..||||+++
T Consensus 16 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~ 91 (373)
T 1q8y_A 16 YKDARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDK----VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKL 91 (373)
T ss_dssp ETTTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCH----HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCC
T ss_pred ccCCeEEEEEeeeecCCeEEEEEEecCCCcEEEEEEecCCc----cchhhhhHHHHHHHHhhcccccchhccccchHHHH
Confidence 34579999999999999999999999999999999997542 2233445566555532 138999999
Q ss_pred EEEEEcCC----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8309 132 FCTFQTDS----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHK 205 (494)
Q Consensus 132 ~~~~~~~~----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~ 205 (494)
++++...+ .+++|||++ +| +|..++.. .+.+++..++.++.||+.||+|||+
T Consensus 92 ~~~~~~~~~~~~~~~lv~e~~-~~---------------------~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~ 149 (373)
T 1q8y_A 92 LDHFNHKGPNGVHVVMVFEVL-GE---------------------NLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR 149 (373)
T ss_dssp CEEEEEEETTEEEEEEEECCC-CE---------------------EHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHhhccCCCCceEEEEEecC-CC---------------------CHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh
Confidence 99998654 899999999 44 44445544 3469999999999999999999999
Q ss_pred C-CCccccCCCCceeeC------CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHH
Q psy8309 206 K-GIVYRDLKLDNILLD------YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLY 278 (494)
Q Consensus 206 ~-givHrDLKp~NILl~------~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ 278 (494)
+ ||+||||||+||||+ ..+.+||+|||+++.. .......+||+.|+|||++.+..++.++|||||||++|
T Consensus 150 ~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ 226 (373)
T 1q8y_A 150 RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIF 226 (373)
T ss_dssp TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET---TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHH
T ss_pred cCCEEecCCChHHeEEeccCCCcCcceEEEccccccccc---CCCCCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHH
Confidence 8 999999999999994 4447999999999753 23344568999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCH------HHHHHHHH------------------------------------------hCCCCCCccC
Q psy8309 279 EMHVGQSPFSGCDE------DELFWSIC------------------------------------------NERPRFPQFL 310 (494)
Q Consensus 279 ell~G~~Pf~~~~~------~~~~~~i~------------------------------------------~~~~~~p~~~ 310 (494)
||++|..||.+.+. .+....+. .....++..+
T Consensus 227 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (373)
T 1q8y_A 227 ELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDE 306 (373)
T ss_dssp HHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHH
T ss_pred HHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchhhhhhhcccCCcch
Confidence 99999999986542 22222221 2233455567
Q ss_pred CHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 311 SVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 311 s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
+.++++||.+||+.||.+|| +++|+++||||++.
T Consensus 307 ~~~~~~li~~~L~~dP~~Rp------t~~ell~hp~f~~~ 340 (373)
T 1q8y_A 307 AKEISDFLSPMLQLDPRKRA------DAGGLVNHPWLKDT 340 (373)
T ss_dssp HHHHHHHHGGGGCSSTTTCB------CHHHHHTCGGGTTC
T ss_pred HHHHHHHHHHHhccCccccC------CHHHHhhChhhhcc
Confidence 78999999999999999999 68999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-46 Score=362.87 Aligned_cols=249 Identities=21% Similarity=0.308 Sum_probs=208.0
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEeCCC-------eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEE
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLF 132 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-------~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~ 132 (494)
..+..++|++.+.||+|+||.||+|+++.++ ..||+|++.+. .....+....|..++. .++||||++++
T Consensus 3 ~~i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~~~va~K~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~ 78 (289)
T 4fvq_A 3 HKIRNEDLIFNESLGQGTFTKIFKGVRREVGDYGQLHETEVLLKVLDKA---HRNYSESFFEAASMMS-KLSHKHLVLNY 78 (289)
T ss_dssp CBCCGGGEEEEEEEEEETTEEEEEEEEEEECGGGCEEEEEEEEEEECGG---GGGGHHHHHHHHHHHH-TSCCTTBCCEE
T ss_pred EEechhHeeeeeeeccCCCceEEEEEEecccccccccchhhhhhhcccc---cHHHHHHHHHHHHHHH-hCCCCCEeEEE
Confidence 4566789999999999999999999998877 46999999764 2334456677777777 57899999999
Q ss_pred EEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 133 ~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
+++.+.+..|+||||+. |++|..++...+ .+++..++.++.||+.||.|||++||+||
T Consensus 79 ~~~~~~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~ 137 (289)
T 4fvq_A 79 GVCVCGDENILVQEFVK---------------------FGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEENTLIHG 137 (289)
T ss_dssp EEECCTTCCEEEEECCT---------------------TCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCC
T ss_pred EEEEeCCCCEEEEECCC---------------------CCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhhCCeECC
Confidence 99999999999999999 445555665554 49999999999999999999999999999
Q ss_pred cCCCCceeeCCCCC--------EEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHh
Q psy8309 212 DLKLDNILLDYEGH--------VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHV 282 (494)
Q Consensus 212 DLKp~NILl~~~g~--------vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~ 282 (494)
||||+|||++.++. +||+|||++... .......||+.|+|||++.+ ..++.++|||||||++|||++
T Consensus 138 Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~ 213 (289)
T 4fvq_A 138 NVCAKNILLIREEDRKTGNPPFIKLSDPGISITV----LPKDILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICS 213 (289)
T ss_dssp CCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTT----SCHHHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHT
T ss_pred CcCcceEEEecCCcccccccceeeeccCcccccc----cCccccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHc
Confidence 99999999998887 999999998642 22344568999999999987 679999999999999999999
Q ss_pred CC-CCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 283 GQ-SPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 283 G~-~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
|. +||...+. .....+......+|...+.++++||.+||+.||.+|| +++++++|
T Consensus 214 g~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~~ 269 (289)
T 4fvq_A 214 GGDKPLSALDS-QRKLQFYEDRHQLPAPKAAELANLINNCMDYEPDHRP------SFRAIIRD 269 (289)
T ss_dssp TTCCTTTTSCH-HHHHHHHHTTCCCCCCSSCTTHHHHHHHSCSSGGGSC------CHHHHHHH
T ss_pred CCCCCccccch-HHHHHHhhccCCCCCCCCHHHHHHHHHHcCCChhHCc------CHHHHHHH
Confidence 54 55555444 4444555667778888899999999999999999999 57778764
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=365.09 Aligned_cols=274 Identities=27% Similarity=0.374 Sum_probs=213.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|.+. .++..||||+++.. ......+....|..++. .++||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~ 95 (314)
T 2ivs_A 19 EFPRKNLVLGKTLGEGEFGKVVKATAFHLKGRAGYTTVAVKMLKEN--ASPSELRDLLSEFNVLK-QVNHPHVIKLYGAC 95 (314)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEETGGGCSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEE
T ss_pred ccchhheeeeeeecccCCeeEEEEEEeccCcccCcceEEEEeccCC--CCHHHHHHHHHHHHHHh-hCCCCceeeEEEEE
Confidence 445679999999999999999999984 45588999999764 23445566777888887 57999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhc-CCch---hHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN-GGDL---MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~-gg~L---~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
.+.+.+|+||||+.+|+|.+.+....... ..+.. ++.. .........+++.+++.++.||+.||.|||++||+||
T Consensus 96 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~ 174 (314)
T 2ivs_A 96 SQDGPLLLIVEYAKYGSLRGFLRESRKVG-PGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHR 174 (314)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHTTTST-TEEC----------------CEECHHHHHHHHHHHHHHHHHHHHTTEECC
T ss_pred ecCCceEEEEeecCCCCHHHHHHHHhhcc-CCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHHCCCccc
Confidence 99999999999999666632211100000 00000 0000 0000012348999999999999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCC
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFS 288 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~ 288 (494)
||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.
T Consensus 175 dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~ 254 (314)
T 2ivs_A 175 DLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYP 254 (314)
T ss_dssp CCSGGGEEEETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSST
T ss_pred ccchheEEEcCCCCEEEccccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 9999999999999999999999975322221 1234467889999999999899999999999999999999 999999
Q ss_pred CCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 289 GCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 289 ~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+....++...+... ....|..+++++.+||.+||+.||.+|| ++.|+++|
T Consensus 255 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~l~~~ 305 (314)
T 2ivs_A 255 GIPPERLFNLLKTGHRMERPDNCSEEMYRLMLQCWKQEPDKRP------VFADISKD 305 (314)
T ss_dssp TCCGGGHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred CCCHHHHHHHhhcCCcCCCCccCCHHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 98888888777665 3566788999999999999999999999 56777754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-45 Score=363.42 Aligned_cols=258 Identities=28% Similarity=0.471 Sum_probs=206.8
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------- 137 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------- 137 (494)
++|++++.||+|+||.||+|++..+++.||||++... .........|..++. .++||||+++++++.+
T Consensus 6 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 80 (303)
T 1zy4_A 6 SDFEEIAVLGQGAFGQVVKARNALDSRYYAIKKIRHT----EEKLSTILSEVMLLA-SLNHQYVVRYYAAWLERRNFVKP 80 (303)
T ss_dssp HHEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEEE----HHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEECCCCCC-
T ss_pred ccchhhheeccCCcEEEEEEEEcCCCeEEEEEEEecc----HHHHHHHHHHHHHHH-hcCchHHHHHHHHHHhhcchhhh
Confidence 5799999999999999999999999999999999653 234456677777776 5799999999998865
Q ss_pred ------CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCcc
Q psy8309 138 ------DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVY 210 (494)
Q Consensus 138 ------~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givH 210 (494)
...+|+||||+++ ++|..++... ..+++..++.++.||+.||+|||++||+|
T Consensus 81 ~~~~~~~~~~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H 139 (303)
T 1zy4_A 81 MTAVKKKSTLFIQMEYCEN---------------------GTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHSQGIIH 139 (303)
T ss_dssp -----CEEEEEEEEECCCS---------------------CBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred hcccccCCceEEEEecCCC---------------------CCHHHhhhccccccchHHHHHHHHHHHHHHHHHHhCCeec
Confidence 4578999999994 4555555543 36788999999999999999999999999
Q ss_pred ccCCCCceeeCCCCCEEEeecCceeeeecc--------------CCcccccCCCCCccChhhhCCC-CCCCcchHHHHHH
Q psy8309 211 RDLKLDNILLDYEGHVRIADFGMCKLQIYL--------------DKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGI 275 (494)
Q Consensus 211 rDLKp~NILl~~~g~vkL~DFGla~~~~~~--------------~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGv 275 (494)
|||||+|||++.+|.+||+|||+++..... .......+||+.|+|||++.+. .++.++|||||||
T Consensus 140 ~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ 219 (303)
T 1zy4_A 140 RDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGI 219 (303)
T ss_dssp SCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCSCCCTHHHHHHHHH
T ss_pred ccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHH
Confidence 999999999999999999999998742211 1223456799999999999865 6899999999999
Q ss_pred HHHHHHhCCCCCCC-CCHHHHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 276 LLYEMHVGQSPFSG-CDEDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 276 il~ell~G~~Pf~~-~~~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
++|+|++ ||.. .+..+....+......+| ...+..+++||.+||+.||.+|| +++++++||||...
T Consensus 220 il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 220 IFFEMIY---PFSTGMERVNILKKLRSVSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKRP------GARTLLNSGWLPVK 290 (303)
T ss_dssp HHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGSC------CHHHHHHSSCSCCC
T ss_pred HHHHHHh---ccCCchhHHHHHHhccccccccCccccccchHHHHHHHHHHHhcCcccCc------CHHHHhCCCCcCCC
Confidence 9999998 5543 344556666666555544 45677899999999999999999 68999999999988
Q ss_pred ChhHHhc
Q psy8309 351 DWQALEK 357 (494)
Q Consensus 351 ~w~~l~~ 357 (494)
.++...+
T Consensus 291 ~~~~~~~ 297 (303)
T 1zy4_A 291 HQDEVIK 297 (303)
T ss_dssp CHHHHHH
T ss_pred ChHHHHH
Confidence 8876643
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-45 Score=361.81 Aligned_cols=254 Identities=21% Similarity=0.291 Sum_probs=203.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
...++|++.+.||+|+||.||+|++..+++.||||++.+..............|..++. .++||||+++++++...+.+
T Consensus 31 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~ 109 (309)
T 2h34_A 31 TQFGPYRLRRLVGRGGMGDVYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAG-RLQEPHVVPIHDFGEIDGQL 109 (309)
T ss_dssp ---CCEEEEEEEEECSSSEEEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEE
T ss_pred cEeccEEEEEEEcCCCCeeEEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHh-hcCCCCeeEEEEEEeeCCeE
Confidence 34679999999999999999999999999999999998764444444566677777776 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+||||++ |++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 110 ~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp~NIl~~ 168 (309)
T 2h34_A 110 YVDMRLIN---------------------GVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVS 168 (309)
T ss_dssp EEEEECCC---------------------CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEC
T ss_pred EEEEEecC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcCCcCCCChHHEEEc
Confidence 99999998 556667777778899999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.++.+||+|||++....... ......+||+.|+|||++.+..++.++||||||+++|+|++|..||.+.+...+...+.
T Consensus 169 ~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~ 248 (309)
T 2h34_A 169 ADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGSPPYQGDQLSVMGAHIN 248 (309)
T ss_dssp TTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHHHHHHHHHH
T ss_pred CCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchHHHHHHHhc
Confidence 99999999999987532221 22335679999999999999999999999999999999999999999877665544444
Q ss_pred hCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 301 NERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 301 ~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
.... .++..++.++.+||.+||..||.+||+ ++++++
T Consensus 249 ~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~-----s~~~l~ 288 (309)
T 2h34_A 249 QAIPRPSTVRPGIPVAFDAVIARGMAKNPEDRYV-----TCGDLS 288 (309)
T ss_dssp SCCCCGGGTSTTCCTHHHHHHHHHTCSSGGGSCS-----SHHHHH
T ss_pred cCCCCccccCCCCCHHHHHHHHHhccCCHHHHHH-----hHHHHH
Confidence 3322 234678999999999999999999994 355555
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=367.85 Aligned_cols=271 Identities=24% Similarity=0.340 Sum_probs=211.9
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEEEeCCCeEE--EeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY--AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~--AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
..+..++|++.+.||+|+||.||+|+++.++..+ |||.++.. ...........|..++....+||||+++++++.+
T Consensus 20 p~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~v~iK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~ 97 (327)
T 1fvr_A 20 PVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEH 97 (327)
T ss_dssp SBCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEE
T ss_pred ccccHHHccceeeeecCCCceEEEEEEccCCcccceeeeeeccc--cchHHHHHHHHHHHHHHhccCCCchhhhceeeee
Confidence 3466789999999999999999999999988865 99988753 2233445567788888754499999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+.+|+||||+++|+|.+.+........ .............+++..++.++.||+.||.|||++||+||||||+|
T Consensus 98 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~N 172 (327)
T 1fvr_A 98 RGYLYLAIEYAPHGNLLDFLRKSRVLET-----DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARN 172 (327)
T ss_dssp TTEEEEEECCCTTCBHHHHHHTTCHHHH-----CHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCceEEEEecCCCCCHHHHHHhcccccc-----cccccccccccccCCHHHHHHHHHHHHHHHHHHHhCCccCCCCccce
Confidence 9999999999996665321110000000 00000000122479999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||++.++.+||+|||+++.... ........+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..++.
T Consensus 173 Il~~~~~~~kL~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~ 251 (327)
T 1fvr_A 173 ILVGENYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 251 (327)
T ss_dssp EEECGGGCEEECCTTCEESSCE-ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHH
T ss_pred EEEcCCCeEEEcccCcCccccc-cccccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHH
Confidence 9999999999999999874221 122334567899999999998889999999999999999998 99999999988888
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..+..+ ....|..+++++++||.+||..||.+|| +++++++|
T Consensus 252 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~~ 294 (327)
T 1fvr_A 252 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP------SFAQILVS 294 (327)
T ss_dssp HHGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHhhcCCCCCCCCCCCHHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 887765 4566778999999999999999999999 57778765
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-45 Score=357.49 Aligned_cols=251 Identities=23% Similarity=0.404 Sum_probs=209.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|+++ ++..||||+++.... .......|..++. .++||||+++++++.+.+.
T Consensus 20 ~~~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 93 (283)
T 3gen_A 20 EIDPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMM-NLSHEKLVQLYGVCTKQRP 93 (283)
T ss_dssp BCCGGGEEEEEECC---CEEEEEEEET-TTEEEEEEEECTTSB----CHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSS
T ss_pred cCCHHHHHhHhhcCCCCCceEEEEEEc-CCCeEEEEEecCCCC----CHHHHHHHHHHHh-cCCCCCEeeEEEEEecCCC
Confidence 455679999999999999999999876 566799999986532 2234667777777 5789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+||||+.+ ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 94 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 152 (283)
T 3gen_A 94 IFIITEYMAN---------------------GCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL 152 (283)
T ss_dssp EEEEECCCTT---------------------CBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGEE
T ss_pred eEEEEeccCC---------------------CcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCccCCCCccceEE
Confidence 9999999994 455555554 467999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+...
T Consensus 153 i~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~~~~~~ 232 (283)
T 3gen_A 153 VNDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAE 232 (283)
T ss_dssp ECTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred EcCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccChhHHHH
Confidence 9999999999999987432111 11233457788999999998899999999999999999998 999999999888888
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+... ....|..+++++.+||.+||+.||.+|| +++++++|
T Consensus 233 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~ll~~ 274 (283)
T 3gen_A 233 HIAQGLRLYRPHLASEKVYTIMYSCWHEKADERP------TFKILLSN 274 (283)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC------CHHHHHHH
T ss_pred HHhcccCCCCCCcCCHHHHHHHHHHccCChhHCc------CHHHHHHH
Confidence 88876 3455678899999999999999999999 57777765
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-46 Score=377.78 Aligned_cols=253 Identities=25% Similarity=0.376 Sum_probs=212.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|+++.+++.||||+++.. ...........|..++. .++||||+++++++...+.
T Consensus 110 ~~~~~~~~~~~~lG~G~~g~V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~ 186 (377)
T 3cbl_A 110 VLNHEDLVLGEQIGRGNFGEVFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILK-QYSHPNIVRLIGVCTQKQP 186 (377)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHT-TCCCTTBCCEEEEECSSSS
T ss_pred EEchHHeEEeeEeccCCCCeEEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEecCCC
Confidence 45567999999999999999999999999999999998754 22333445667777776 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+|||||++ |+|..++... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 187 ~~lv~e~~~~---------------------g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Nil 245 (377)
T 3cbl_A 187 IYIVMELVQG---------------------GDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCL 245 (377)
T ss_dssp CEEEEECCTT---------------------CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred cEEEEEcCCC---------------------CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCcCCcccCHHHEE
Confidence 9999999994 4555555544 46999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
++.++.+||+|||+++....... ......+++.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 246 ~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~~~~~ 325 (377)
T 3cbl_A 246 VTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTR 325 (377)
T ss_dssp ECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCHHHHH
T ss_pred EcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999975221110 1112235678999999998899999999999999999998 99999999888877
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+..+ ....|..+++++.+||.+||+.||.+|| +++++++
T Consensus 326 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------s~~~i~~ 367 (377)
T 3cbl_A 326 EFVEKGGRLPCPELCPDAVFRLMEQCWAYEPGQRP------SFSTIYQ 367 (377)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc------CHHHHHH
Confidence 777654 4567788999999999999999999999 4566653
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=356.34 Aligned_cols=242 Identities=19% Similarity=0.226 Sum_probs=200.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++.+.||+|+||.||+|++..+++.||||++...... .....|..++....+|++|+++++++......|+
T Consensus 9 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~l 83 (298)
T 1csn_A 9 GVHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSDA-----PQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVL 83 (298)
T ss_dssp TTTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTTS-----CCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEeecCCEEEEEEEECCCCcEEEEEEeccCCcc-----HHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEE
Confidence 46899999999999999999999999999999998754221 2345566677755589999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||+ +|+| ..++... ..+++..++.++.||+.||+|||++||+||||||+|||++.
T Consensus 84 v~e~~-~~~L---------------------~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~ 141 (298)
T 1csn_A 84 VIDLL-GPSL---------------------EDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGR 141 (298)
T ss_dssp EEECC-CCBH---------------------HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECC
T ss_pred EEEec-CCCH---------------------HHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCEecCCCCHHHEEecc
Confidence 99999 5544 4455543 46999999999999999999999999999999999999988
Q ss_pred CCC-----EEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 223 EGH-----VRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 223 ~g~-----vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
+|. +||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.
T Consensus 142 ~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 221 (298)
T 1csn_A 142 PNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGL 221 (298)
T ss_dssp SSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSC
T ss_pred CCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchh
Confidence 776 99999999986432211 235668999999999999999999999999999999999999999874
Q ss_pred ---CHHHHHHHHHhCCCC-----CCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 291 ---DEDELFWSICNERPR-----FPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 291 ---~~~~~~~~i~~~~~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
...+.+..+...... ++..+++++++||.+||+.||.+||++
T Consensus 222 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~ 271 (298)
T 1csn_A 222 KAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 271 (298)
T ss_dssp CSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred hccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCH
Confidence 344555555433221 234689999999999999999999954
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-45 Score=353.24 Aligned_cols=251 Identities=24% Similarity=0.402 Sum_probs=211.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++++.||+|+||.||+|+++ ++..||||+++.... .......|..++. .++||||+++++++.+...
T Consensus 4 ~l~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 77 (268)
T 3sxs_A 4 ELKREEITLLKELGSGQFGVVKLGKWK-GQYDVAVKMIKEGSM----SEDEFFQEAQTMM-KLSHPKLVKFYGVCSKEYP 77 (268)
T ss_dssp BCCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECBTTB----CHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSS
T ss_pred EechhheeeeeeeccCCCceEEEEEec-CceeEEEEEeccCCC----cHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCc
Confidence 345679999999999999999999876 456799999976532 2244667877777 4789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+||||+++ ++|..++... ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 78 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 136 (268)
T 3sxs_A 78 IYIVTEYISN---------------------GCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCL 136 (268)
T ss_dssp EEEEEECCTT---------------------CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEEESSCSGGGEE
T ss_pred eEEEEEccCC---------------------CcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCcCcceEE
Confidence 9999999994 4455555554 35999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+...
T Consensus 137 ~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~ 216 (268)
T 3sxs_A 137 VDRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVL 216 (268)
T ss_dssp ECTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHH
T ss_pred ECCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccChHHHHH
Confidence 99999999999999975322211 1223456778999999999899999999999999999999 999999999888888
Q ss_pred HHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 298 SICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 298 ~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+.... ...|...++++.+||.+||+.||.+|| ++.++++|
T Consensus 217 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~ll~~ 258 (268)
T 3sxs_A 217 KVSQGHRLYRPHLASDTIYQIMYSCWHELPEKRP------TFQQLLSS 258 (268)
T ss_dssp HHHTTCCCCCCTTSCHHHHHHHHHTTCSSGGGSC------CHHHHHHH
T ss_pred HHHcCCCCCCCCcChHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 877664 445677899999999999999999999 57777764
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-46 Score=367.03 Aligned_cols=253 Identities=29% Similarity=0.462 Sum_probs=205.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChh---hHHHHHHHHHHHHhc---CCCCceeeEEEEEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD---DVECTLIERKVLALG---TKHPYLCHLFCTFQ 136 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~---~~~~~~~e~~~l~~~---~~hp~Iv~l~~~~~ 136 (494)
..++|++.+.||+|+||.||+|+++.+++.||||++......... .......|..++... .+||||+++++++.
T Consensus 29 ~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~ 108 (312)
T 2iwi_A 29 FEAEYRLGPLLGKGGFGTVFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFE 108 (312)
T ss_dssp ----CEEEEEEEEETTEEEEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-
T ss_pred hhhceEEeeEEEcCCCEEEEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEe
Confidence 356899999999999999999999999999999999765332211 111223455555432 28999999999999
Q ss_pred cCCeeEEEEEe-cCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEY-LNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~-~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
..+..++|||+ +. +++|..++...+.+++..++.++.||+.||+|||++||+||||||
T Consensus 109 ~~~~~~~v~e~~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 167 (312)
T 2iwi_A 109 TQEGFMLVLERPLP---------------------AQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKD 167 (312)
T ss_dssp ----CEEEEECCSS---------------------EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTEECCCCSG
T ss_pred cCCeEEEEEEecCC---------------------CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeecCCCh
Confidence 99999999999 66 566777777788899999999999999999999999999999999
Q ss_pred CceeeC-CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCC-CcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 216 DNILLD-YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 216 ~NILl~-~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~-~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
+|||++ .++.+||+|||+++... .......+||+.|+|||++.+..+. .++|||||||++|+|++|+.||...
T Consensus 168 ~Nil~~~~~~~~kl~dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~--- 242 (312)
T 2iwi_A 168 ENILIDLRRGCAKLIDFGSGALLH--DEPYTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERD--- 242 (312)
T ss_dssp GGEEEETTTTEEEECCCSSCEECC--SSCBCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH---
T ss_pred hhEEEeCCCCeEEEEEcchhhhcc--cCcccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCCh---
Confidence 999999 88999999999988532 3334567899999999999876664 5899999999999999999999753
Q ss_pred HHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 294 ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 294 ~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
..+......++..++.++++||.+||..||.+|| +++|+++||||+..
T Consensus 243 ---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~e~l~~~~~~~~ 290 (312)
T 2iwi_A 243 ---QEILEAELHFPAHVSPDCCALIRRCLAPKPSSRP------SLEEILLDPWMQTP 290 (312)
T ss_dssp ---HHHHHTCCCCCTTSCHHHHHHHHHHTCSSTTTSC------CHHHHHHSTTTCC-
T ss_pred ---HHHhhhccCCcccCCHHHHHHHHHHccCChhhCc------CHHHHhcChhhcCc
Confidence 2455677788899999999999999999999999 68999999999865
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-45 Score=353.23 Aligned_cols=251 Identities=28% Similarity=0.451 Sum_probs=200.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
.+..++|++.+.||+|+||.||+|++. +..||||+++...... ....+....|..++. .++||||+++++++.+.+
T Consensus 3 ~~~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~ 79 (271)
T 3dtc_A 3 EIDFAELTLEEIIGIGGFGKVYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFA-MLKHPNIIALRGVCLKEP 79 (271)
T ss_dssp BCCTTSEEEEEEEEEETTEEEEEEEET--TEEEEEEEC----------CHHHHHHHHHHHH-HCCCTTBCCEEEEECCC-
T ss_pred ccchhheeeeeeeccCCCeEEEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHH-hcCCCCEeeEEEEEecCC
Confidence 356789999999999999999999975 6789999997653322 233455667777777 579999999999999999
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC---CccccCCCC
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG---IVYRDLKLD 216 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g---ivHrDLKp~ 216 (494)
.+|+||||+++| +|..++ ..+.+++..++.++.||+.||.|||++| |+||||||+
T Consensus 80 ~~~lv~e~~~~~---------------------~L~~~~-~~~~~~~~~~~~i~~~l~~~l~~lH~~~~~~i~H~dikp~ 137 (271)
T 3dtc_A 80 NLCLVMEFARGG---------------------PLNRVL-SGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSS 137 (271)
T ss_dssp -CEEEEECCTTE---------------------EHHHHH-TSSCCCHHHHHHHHHHHHHHHHHHHHSSSSCCCCSCCSGG
T ss_pred ceEEEEEcCCCC---------------------CHHHHh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCCceeecCCchH
Confidence 999999999944 444444 3468999999999999999999999999 999999999
Q ss_pred ceeeCC--------CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 217 NILLDY--------EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 217 NILl~~--------~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
|||++. ++.+||+|||+++... ........||+.|+|||++.+..++.++||||||+++|+|++|..||.
T Consensus 138 Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~ 215 (271)
T 3dtc_A 138 NILILQKVENGDLSNKILKITDFGLAREWH--RTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFR 215 (271)
T ss_dssp GEEESSCCSSSCCSSCCEEECCCCC---------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTT
T ss_pred HEEEecccccccccCcceEEccCCcccccc--cccccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 999986 7889999999987532 223345679999999999999899999999999999999999999999
Q ss_pred CCCHHHHHHHHHhCC--CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 289 GCDEDELFWSICNER--PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 289 ~~~~~~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+.+.......+.... ..+|..+++++.+||.+||+.||.+|| ++.|+++|
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~e~l~~ 267 (271)
T 3dtc_A 216 GIDGLAVAYGVAMNKLALPIPSTCPEPFAKLMEDCWNPDPHSRP------SFTNILDQ 267 (271)
T ss_dssp TSCHHHHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred CCCHHHHHHhhhcCCCCCCCCcccCHHHHHHHHHHhcCCcccCc------CHHHHHHH
Confidence 988888777776554 455678999999999999999999999 56777754
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-46 Score=384.45 Aligned_cols=270 Identities=24% Similarity=0.322 Sum_probs=204.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
..+|++.++||+|+||+|+. ....+++.||||++.+.... ....|..++....+|||||++++++.+...+|+
T Consensus 23 ~~~y~~~~~LG~G~~G~V~~-~~~~~~~~vAvK~~~~~~~~------~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~l 95 (432)
T 3p23_A 23 KISFCPKDVLGHGAEGTIVY-RGMFDNRDVAVKRILPECFS------FADREVQLLRESDEHPNVIRYFCTEKDRQFQYI 95 (432)
T ss_dssp TEEEEEEEEEEECGGGCEEE-EEESSSSEEEEEEECTTTEE------ECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEE
T ss_pred cEEEecCCeeecCcCEEEEE-EEEeCCeEEEEEEECHHHHH------HHHHHHHHHHhccCCCCcCeEEEEEecCCEEEE
Confidence 35799999999999999764 44567889999999764321 134577777755589999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||. |+|..++... ..+.+..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 96 v~E~~~----------------------g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlKp~NIll~~ 153 (432)
T 3p23_A 96 AIELCA----------------------ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISM 153 (432)
T ss_dssp EEECCS----------------------EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHHTTCCCCCCSTTSEEECC
T ss_pred EEECCC----------------------CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHHCcCEeCCCCHHHEEEec
Confidence 999995 2445555443 34666678899999999999999999999999999999954
Q ss_pred C---C--CEEEeecCceeeeeccC---CcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy8309 223 E---G--HVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHV-GQSPFSGC 290 (494)
Q Consensus 223 ~---g--~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~ 290 (494)
+ + .+||+|||+|+...... ......+||+.|+|||++. +..++.++|||||||++|||++ |.+||...
T Consensus 154 ~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il~ellt~g~~pf~~~ 233 (432)
T 3p23_A 154 PNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKS 233 (432)
T ss_dssp CBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHHHHHHTTSCBTTBST
T ss_pred CCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHHHHHHcCCCCCcchh
Confidence 2 3 58899999998543221 2344578999999999998 4567889999999999999999 99999766
Q ss_pred CHHHHHHHHHhCCCC---CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCCh---------hHHhcC
Q psy8309 291 DEDELFWSICNERPR---FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW---------QALEKR 358 (494)
Q Consensus 291 ~~~~~~~~i~~~~~~---~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w---------~~l~~~ 358 (494)
........+...... .+...+..+++||.+||+.||.+|| +++++++||||.+++| +.++..
T Consensus 234 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~evl~hp~f~~~~~~~~~~~~~~~~~~~~ 307 (432)
T 3p23_A 234 LQRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRP------SAKHVLKHPFFWSLEKQLQFFQDVSDRIEKE 307 (432)
T ss_dssp TTHHHHHHTTCCCCTTSCTTCHHHHHHHHHHHHHSCSSGGGSC------CHHHHHTSTTTCCHHHHHHHHHHHHHHCSCS
T ss_pred hHHHHHHHhccCCccccCccccccHHHHHHHHHHHhCCHhhCC------CHHHHHhCccccChHHHHHHHHHHHHHhhcc
Confidence 544433222222221 1234567799999999999999999 6899999999999988 334445
Q ss_pred cCCCCCcccc
Q psy8309 359 ELEPPFRPRV 368 (494)
Q Consensus 359 ~~~pp~~p~~ 368 (494)
...+|+++.+
T Consensus 308 ~~~~~~~~~l 317 (432)
T 3p23_A 308 SLDGPIVKQL 317 (432)
T ss_dssp CSSCHHHHHH
T ss_pred cccchHHHHH
Confidence 5555655543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-45 Score=356.88 Aligned_cols=251 Identities=23% Similarity=0.352 Sum_probs=201.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++|++.+.||+|+||.||+|++..+ +..||||+++.. ......+....|..++. .++||||+++++++. .
T Consensus 12 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~-~ 87 (281)
T 1mp8_A 12 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-E 87 (281)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC-S
T ss_pred EehHHeEEEeEeeecCCeeEEEEEEecCCCCceEEEEEecccc--CCHHHHHHHHHHHHHHH-hCCCCccceEEEEEc-c
Confidence 4567999999999999999999998654 457999998754 23344556677777776 579999999999984 5
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+.+|+||||+. +++|..++... ..+++..++.++.||+.||.|||++||+||||||+|
T Consensus 88 ~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 146 (281)
T 1mp8_A 88 NPVWIIMELCT---------------------LGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 146 (281)
T ss_dssp SSCEEEEECCT---------------------TEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred CccEEEEecCC---------------------CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCeecccccHHH
Confidence 67899999998 45555566544 379999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+.
T Consensus 147 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~~~~ 226 (281)
T 1mp8_A 147 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 226 (281)
T ss_dssp EEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred EEECCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCHHHH
Confidence 9999999999999999875322211 1234457889999999998899999999999999999996 9999999888888
Q ss_pred HHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 296 FWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 296 ~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
...+..+ ...+|..+++++.+||.+||..||.+|| ++.++++
T Consensus 227 ~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~ 269 (281)
T 1mp8_A 227 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP------RFTELKA 269 (281)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCc------CHHHHHH
Confidence 8888765 4567788999999999999999999999 5667664
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-45 Score=368.32 Aligned_cols=275 Identities=27% Similarity=0.384 Sum_probs=208.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|++. .++..||||+++... ..........|..++....+||||+++++++
T Consensus 41 ~~~~~~y~~~~~lG~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~ 118 (344)
T 1rjb_A 41 EFPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGAC 118 (344)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccCHHHceeeeeecCCCCceeEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 455689999999999999999999973 466789999997542 2334456778888888544899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhh---hhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDL---MEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l---~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
...+.+|+||||+++|+|.+.+......-- ..+..... .........+++..++.++.||+.||+|||++||+|||
T Consensus 119 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~-~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~D 197 (344)
T 1rjb_A 119 TLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKR-LEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRD 197 (344)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHTTTTCC----------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETT
T ss_pred eeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcc-cccccccccCCHHHHHHHHHHHHHHHHHHHhCCcccCC
Confidence 999999999999997766332111100000 00000000 00000123489999999999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCC
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSG 289 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~ 289 (494)
|||+|||++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|+|++ |..||.+
T Consensus 198 ikp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~ 277 (344)
T 1rjb_A 198 LAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPG 277 (344)
T ss_dssp CSGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTT
T ss_pred CChhhEEEcCCCcEEeCCCccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCccc
Confidence 999999999999999999999875332221 1334567889999999998899999999999999999998 9999998
Q ss_pred CCHHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 290 CDEDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 290 ~~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
......+..+... .+..|..+++++.+||.+||..||.+|| ++.++++|
T Consensus 278 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~l~~~ 328 (344)
T 1rjb_A 278 IPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP------SFPNLTSF 328 (344)
T ss_dssp CCCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred CCcHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCCchhCc------CHHHHHHH
Confidence 7765555555543 3456778999999999999999999999 57777765
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-45 Score=373.92 Aligned_cols=277 Identities=17% Similarity=0.186 Sum_probs=198.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCC-----CeEEEeeeeccccccChhhHH--------HHHHHHHHHHhcCCCCc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGT-----DYYYAVKCLKKDVVLEDDDVE--------CTLIERKVLALGTKHPY 127 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~-----~~~~AiK~~~k~~~~~~~~~~--------~~~~e~~~l~~~~~hp~ 127 (494)
....++|++++.||+|+||.||+|.++.+ ++.||||++.........+.. ..+.|...+ ..++|||
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~-~~l~h~~ 109 (364)
T 3op5_A 31 DMAAAAWKVGLPIGQGGFGCIYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRT-RKLKYLG 109 (364)
T ss_dssp CTTCCEEEEEEECCCC-CCEEEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHH-TTCSCCC
T ss_pred ccCCCeEEEEEEEecCCCeEEEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHH-hhccCCC
Confidence 34556999999999999999999998765 578999998764211111111 112222223 3578999
Q ss_pred eeeEEEEEEcC----CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHH
Q psy8309 128 LCHLFCTFQTD----SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRF 202 (494)
Q Consensus 128 Iv~l~~~~~~~----~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~y 202 (494)
|+++++++... .++||||||| ||+| ..++... +.+++..++.++.||+.||+|
T Consensus 110 iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L---------------------~~~~~~~~~~l~~~~~~~i~~qi~~~l~~ 167 (364)
T 3op5_A 110 VPKYWGSGLHDKNGKSYRFMIMDRF-GSDL---------------------QKIYEANAKRFSRKTVLQLSLRILDILEY 167 (364)
T ss_dssp SCCEEEEEEEEETTEEEEEEEEECE-EEEH---------------------HHHHHHTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred CCeEEeeeeeccCCcceEEEEEeCC-CCCH---------------------HHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 99999998865 5689999999 5544 4445444 679999999999999999999
Q ss_pred HHhCCCccccCCCCceeeC--CCCCEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCcchHHHH
Q psy8309 203 LHKKGIVYRDLKLDNILLD--YEGHVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSF 273 (494)
Q Consensus 203 LH~~givHrDLKp~NILl~--~~g~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSl 273 (494)
||++||+||||||+||||+ .++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||
T Consensus 168 lH~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 247 (364)
T 3op5_A 168 IHEHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEIL 247 (364)
T ss_dssp HHHTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHH
T ss_pred HHHCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHH
Confidence 9999999999999999999 88999999999997643221 11245569999999999999999999999999
Q ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHh-----CCC-----CC-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 274 GILLYEMHVGQSPFSGCDEDELFWSICN-----ERP-----RF-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 274 Gvil~ell~G~~Pf~~~~~~~~~~~i~~-----~~~-----~~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
||++|||++|..||.+......+..... ... .+ +..++.++.+||..||..||.+||++ ++|+
T Consensus 248 G~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~------~~l~ 321 (364)
T 3op5_A 248 GYCMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLY------ENLR 321 (364)
T ss_dssp HHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCH------HHHH
T ss_pred HHHHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCH------HHHH
Confidence 9999999999999986432222211110 000 01 24678999999999999999999954 4433
Q ss_pred ----------cCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 343 ----------AHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 343 ----------~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
..++-..+||..+.+....+|..+
T Consensus 322 ~~l~~~~~~~~~~~~~~~dw~~~~~~~~~~~~~~ 355 (364)
T 3op5_A 322 DILLQGLKAIGSKDDGKLDLSVVENGGLKAKTIT 355 (364)
T ss_dssp HHHHHHHHHTTCCCCCCCCC--------------
T ss_pred HHHHHHHHHcCCCcCCccceEeccCCccchhhhh
Confidence 345667789998887777666443
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=362.72 Aligned_cols=255 Identities=26% Similarity=0.392 Sum_probs=213.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-------CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-------GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFC 133 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-------~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~ 133 (494)
.+..++|++.+.||+|+||.||+|++. .++..||||+++.. ...........|..++....+||||+++++
T Consensus 31 ~~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~ 108 (334)
T 2pvf_A 31 EFPRDKLTLGKPLGEGAFGQVVMAEAVGIDKDKPKEAVTVAVKMLKDD--ATEKDLSDLVSEMEMMKMIGKHKNIINLLG 108 (334)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTCSTTCC---CEEEEEECCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEE
T ss_pred cCCHhHeEEeeEEeecCceeEEEeEeccccccccccceEEEEeeeccC--CcHHHHHHHHHHHHHHHHhhcCCCEeeEEE
Confidence 445689999999999999999999975 45678999999764 234455667788888886559999999999
Q ss_pred EEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc----------------CCCCHHHHHHHHHHHH
Q psy8309 134 TFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS----------------GRFDEGRARFYAAEIV 197 (494)
Q Consensus 134 ~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~----------------~~l~e~~~~~~~~qi~ 197 (494)
++.+.+.+|+||||+.+|+| ..++... ..+++..++.++.||+
T Consensus 109 ~~~~~~~~~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 167 (334)
T 2pvf_A 109 ACTQDGPLYVIVEYASKGNL---------------------REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLA 167 (334)
T ss_dssp EECSSSCCEEEEECCTTCBH---------------------HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHH
T ss_pred EEccCCceEEEEECCCCCcH---------------------HHHHHHhccccccccccccccccccCCHHHHHHHHHHHH
Confidence 99999999999999996655 3333332 3589999999999999
Q ss_pred HHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHH
Q psy8309 198 SGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGI 275 (494)
Q Consensus 198 ~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGv 275 (494)
.||.|||++||+||||||+|||++.+|.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||
T Consensus 168 ~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 247 (334)
T 2pvf_A 168 RGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGV 247 (334)
T ss_dssp HHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHH
T ss_pred HHHHHHHhCCeeCCCCccceEEEcCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHH
Confidence 999999999999999999999999999999999999975332211 123346788999999999889999999999999
Q ss_pred HHHHHHh-CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 276 LLYEMHV-GQSPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 276 il~ell~-G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
++|||++ |..||.+.+..++...+..+ ....|..++.++.+||.+||..||.+|| ++.+++++
T Consensus 248 il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~~ 312 (334)
T 2pvf_A 248 LMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPANCTNELYMMMRDCWHAVPSQRP------TFKQLVED 312 (334)
T ss_dssp HHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCCccCCHHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 9999999 99999999988888877765 3566788999999999999999999999 56777754
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=354.72 Aligned_cols=254 Identities=27% Similarity=0.395 Sum_probs=200.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
....+|++.+.||+|+||.||+|++..+++.||||++................|..++. .++||||+++++++...+.+
T Consensus 29 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~ 107 (310)
T 2wqm_A 29 NTLANFRIEKKIGRGQFSEVYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLK-QLNHPNVIKYYASFIEDNEL 107 (310)
T ss_dssp SSGGGEEEEEEEECC--CEEEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEE
T ss_pred ccccceEEEEeecCCCCceEEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCcE
Confidence 45679999999999999999999999999999999998754445555666778888887 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
|+||||+.+|+| ..++. ....+++..++.++.||+.||.|||++||+||||||+|
T Consensus 108 ~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dl~p~N 166 (310)
T 2wqm_A 108 NIVLELADAGDL---------------------SRMIKHFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPAN 166 (310)
T ss_dssp EEEEECCCSCBH---------------------HHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGG
T ss_pred EEEEecCCCCCH---------------------HHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCcHHH
Confidence 999999996655 33333 35679999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC--CHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC--DEDEL 295 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~--~~~~~ 295 (494)
||++.+|.+||+|||++..............||+.|+|||++.+..++.++|||||||++|+|++|..||.+. +....
T Consensus 167 Il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~ 246 (310)
T 2wqm_A 167 VFITATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSL 246 (310)
T ss_dssp EEECTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---CCHHHH
T ss_pred EEEcCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccchhHHHH
Confidence 9999999999999999876443333445668999999999999999999999999999999999999999764 33455
Q ss_pred HHHHHhCCCC-C-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 296 FWSICNERPR-F-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 296 ~~~i~~~~~~-~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
...+...... . +..+++++++||.+||..||.+|| ++++++.
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~il~ 290 (310)
T 2wqm_A 247 CKKIEQCDYPPLPSDHYSEELRQLVNMCINPDPEKRP------DVTYVYD 290 (310)
T ss_dssp HHHHHTTCSCCCCTTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHhhcccCCCCcccccCHHHHHHHHHHcCCChhhCC------CHHHHHH
Confidence 5555554322 2 257899999999999999999999 5677775
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=370.39 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=202.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe---CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~---~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.+...+|++.+.||+|+||.||+|+++ .++..||||+++.. ......+....|..++. .++||||+++++++.+
T Consensus 41 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~niv~~~~~~~~ 117 (373)
T 2qol_A 41 ELDATNISIDKVVGAGEFGEVCSGRLKLPSKKEISVAIKTLKVG--YTEKQRRDFLGEASIMG-QFDHPNIIRLEGVVTK 117 (373)
T ss_dssp BCCGGGCCCCEEEEECSSSEEEEC-CBCTTSCBCCEEEEECCTT--CCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECS
T ss_pred hcCHhhceeeeEEeeCCCeEEEEEEEecCCCCceeEEEEEecCc--cCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEee
Confidence 456779999999999999999999987 56778999999764 23444556777888877 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
.+.+|+||||+++ ++|..++... ..+++.++..++.||+.||+|||++||+||||||+
T Consensus 118 ~~~~~lv~e~~~~---------------------~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~ 176 (373)
T 2qol_A 118 SKPVMIVTEYMEN---------------------GSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSDMGYVHRDLAAR 176 (373)
T ss_dssp SSSCEEEEECCTT---------------------CBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCceEEEEeCCCC---------------------CcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeCCCCCcc
Confidence 9999999999994 4555566554 47999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
|||++.++.+||+|||+++........ .....+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 177 NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 177 NILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp GEEECTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred eEEEcCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999754322111 122345788999999999999999999999999999998 9999999988
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.++...+..+ ....+..++.++.+||.+||+.||.+|| ++.++++
T Consensus 257 ~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP------s~~~i~~ 302 (373)
T 2qol_A 257 QDVIKAVDEGYRLPPPMDCPAALYQLMLDCWQKDRNNRP------KFEQIVS 302 (373)
T ss_dssp HHHHHHHHTTEECCCCTTCBHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccccHHHHHHHHHHhCcChhhCc------CHHHHHH
Confidence 8888877765 3455667899999999999999999999 4566664
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-45 Score=364.35 Aligned_cols=253 Identities=24% Similarity=0.366 Sum_probs=202.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEE----EeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYY----AVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~----AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+..++|++++.||+|+||.||+|++..+++.+ |+|.+... ...........|..++. .++||||+++++++.
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~ 87 (327)
T 3poz_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMA-SVDNPHVCRLLGICL 87 (327)
T ss_dssp ECCGGGEEEEEEEEEETTEEEEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHH-HCCBTTBCCEEEEEE
T ss_pred hcCHHHcccceEEeeCCCeEEEEEEEcCCCceEEEEEEEeecccc--cCHHHHHHHHHHHHHHH-hCCCCCEeEEEEEEe
Confidence 345679999999999999999999998887765 66655432 12234456777888887 579999999999998
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
+.. .++|+||+.+ |+|..++.. .+.+++..++.++.||+.||.|||++||+||||||
T Consensus 88 ~~~-~~~v~e~~~~---------------------g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivH~Dikp 145 (327)
T 3poz_A 88 TST-VQLITQLMPF---------------------GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAA 145 (327)
T ss_dssp SSS-EEEEEECCTT---------------------CBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCC-eEEEEEecCC---------------------CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCeeCCCCCh
Confidence 765 7899999994 455555554 46799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+.
T Consensus 146 ~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 146 RNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp GGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred heEEECCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 999999999999999999875322221 1233456889999999999999999999999999999999 9999999888
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.++...+... ....|..++.++.+||.+||+.||.+|| ++.++++|
T Consensus 226 ~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~ell~~ 272 (327)
T 3poz_A 226 SEISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP------KFRELIIE 272 (327)
T ss_dssp GGHHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSCGGGSC------CHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhhCC------CHHHHHHH
Confidence 7777776654 4566778999999999999999999999 56777764
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-44 Score=351.26 Aligned_cols=250 Identities=24% Similarity=0.381 Sum_probs=204.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhH----HHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDV----ECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~----~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+..++|++.+.||+|+||.||+|++..+++.||||++........... +....|..++. .++||||+++++++.
T Consensus 15 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~ 93 (287)
T 4f0f_A 15 TLADNEIEYEKQIGKGGFGLVHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMS-NLNHPNIVKLYGLMH 93 (287)
T ss_dssp BCCSTTEEEEEECCCCSSSCEEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHT-TCCCTTBCCEEEEET
T ss_pred hhhhccceehhccccCCceeEEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHH-hCCCCCchhhheeec
Confidence 3456799999999999999999999999999999999976533222221 45667877777 579999999999997
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDL 213 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDL 213 (494)
+.. ++||||+++| +|...+. ....+++..++.++.||+.||+|||++| |+||||
T Consensus 94 ~~~--~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~ivH~di 150 (287)
T 4f0f_A 94 NPP--RMVMEFVPCG---------------------DLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPIVHRDL 150 (287)
T ss_dssp TTT--EEEEECCTTC---------------------BHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCCBCSCC
T ss_pred CCC--eEEEEecCCC---------------------CHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCeecCCC
Confidence 665 6999999954 4444444 3457999999999999999999999999 999999
Q ss_pred CCCceeeCCCCC-----EEEeecCceeeeeccCCcccccCCCCCccChhhhC--CCCCCCcchHHHHHHHHHHHHhCCCC
Q psy8309 214 KLDNILLDYEGH-----VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK--GLKYNQCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 214 Kp~NILl~~~g~-----vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~--~~~~~~~~DiwSlGvil~ell~G~~P 286 (494)
||+|||++.++. +||+|||+++.. .......+||+.|+|||++. ...++.++|||||||++|||++|..|
T Consensus 151 kp~Nil~~~~~~~~~~~~kl~Dfg~~~~~---~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 227 (287)
T 4f0f_A 151 RSPNIFLQSLDENAPVCAKVADFGLSQQS---VHSVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGP 227 (287)
T ss_dssp SGGGEEESCCCTTCSCCEEECCCTTCBCC---SSCEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCT
T ss_pred CcceEEEeccCCCCceeEEeCCCCccccc---cccccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCC
Confidence 999999998887 999999998742 33445678999999999994 45688999999999999999999999
Q ss_pred CCCCCHHHH--HHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 287 FSGCDEDEL--FWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 287 f~~~~~~~~--~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
|...+.... ...+... .+.+|..+++++.+||.+||+.||.+|| +++++++
T Consensus 228 f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~ 282 (287)
T 4f0f_A 228 FDEYSYGKIKFINMIREEGLRPTIPEDCPPRLRNVIELCWSGDPKKRP------HFSYIVK 282 (287)
T ss_dssp TTTCCCCHHHHHHHHHHSCCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred CccccccHHHHHHHHhccCCCCCCCcccCHHHHHHHHHHhcCChhhCc------CHHHHHH
Confidence 987654333 4444433 4567788999999999999999999999 5666664
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=348.79 Aligned_cols=247 Identities=21% Similarity=0.302 Sum_probs=209.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC--
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-- 138 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-- 138 (494)
.+..++|++++.||+|+||.||+|+++ +..||||+++.... ..........|..++. .++||||+++++++.+.
T Consensus 6 ~i~~~~y~~~~~lg~G~~g~V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 81 (271)
T 3kmu_A 6 GIDFKQLNFLTKLNENHSGELWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLR-IFSHPNVLPVLGACQSPPA 81 (271)
T ss_dssp CCCGGGCEEEEEEEEETTEEEEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGC-CCSCTTEECEEEEECTTTS
T ss_pred CCCHHHhHHHHHhcCCCcceEEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHH-hcCCCchhheEEEEccCCC
Confidence 456789999999999999999999985 67799999986532 3334455667777766 57999999999999987
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCC--CccccCC
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLK 214 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLK 214 (494)
..+++||||++ ||+|..++.... .+++..++.++.||+.||.|||++| |+|||||
T Consensus 82 ~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~~~i~H~dik 140 (271)
T 3kmu_A 82 PHPTLITHWMP---------------------YGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAFLHTLEPLIPRHALN 140 (271)
T ss_dssp SSCEEEEECCT---------------------TCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHHHTTSSSCCTTCCCS
T ss_pred CCeEeeecccC---------------------CCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCCCceecCCCc
Confidence 78999999999 455556666554 5899999999999999999999999 9999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCC---cchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQ---CVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~---~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
|+|||++.+|.++|+|||++.. ......+||+.|+|||++.+..++. ++|||||||++|||++|..||.+.+
T Consensus 141 p~Nil~~~~~~~~l~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 215 (271)
T 3kmu_A 141 SRSVMIDEDMTARISMADVKFS-----FQSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLS 215 (271)
T ss_dssp GGGEEECTTSCEEEEGGGSCCT-----TSCTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSC
T ss_pred cceEEEcCCcceeEEeccceee-----ecccCccCCccccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 9999999999999999998653 2234567999999999998876555 7999999999999999999999998
Q ss_pred HHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+....+... .+.+|..+++++.+||.+||+.||.+|| +++++++
T Consensus 216 ~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~~il~ 263 (271)
T 3kmu_A 216 NMEIGMKVALEGLRPTIPPGISPHVSKLMKICMNEDPAKRP------KFDMIVP 263 (271)
T ss_dssp HHHHHHHHHHSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred hHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 88887777654 4567788999999999999999999999 5666664
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=358.55 Aligned_cols=256 Identities=26% Similarity=0.401 Sum_probs=208.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC-CCceeeEEEEEEcCCee
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK-HPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~-hp~Iv~l~~~~~~~~~~ 141 (494)
..++|++++.||+|+||.||+|++. +++.||||++..... ..........|..++..... ||||+++++++.+.+.+
T Consensus 26 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~ 103 (313)
T 3cek_A 26 KGRIYSILKQIGSGGSSKVFQVLNE-KKQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYI 103 (313)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEECT-TCCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEE
T ss_pred ccceEEEEEEecCCCCEEEEEEEcC-CCcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEE
Confidence 3468999999999999999999885 478899999976532 34455667778887775433 79999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||+ . +++|..++...+.+++..++.++.||+.||.|||++||+||||||+|||++
T Consensus 104 ~lv~e~-~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~ 161 (313)
T 3cek_A 104 YMVMEC-G---------------------NIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV 161 (313)
T ss_dssp EEEECC-C---------------------SEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEEE
T ss_pred EEEEec-C---------------------CCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCceecCCCcccEEEE
Confidence 999994 4 567777888888999999999999999999999999999999999999996
Q ss_pred CCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCC-----------CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKG-----------LKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~-----------~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
++.+||+|||+++....... .....+||+.|+|||++.+ ..++.++|||||||++|||++|..||.
T Consensus 162 -~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~ 240 (313)
T 3cek_A 162 -DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 240 (313)
T ss_dssp -TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTT
T ss_pred -CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchh
Confidence 58999999999875322211 2345679999999999976 468899999999999999999999998
Q ss_pred CCC-HHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 289 GCD-EDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 289 ~~~-~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
... .......+... ...+|...+.++++||.+||..||.+|| +++|+++||||+.
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~h~~~~~ 298 (313)
T 3cek_A 241 QIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKCCLKRDPKQRI------SIPELLAHPYVQI 298 (313)
T ss_dssp TCCSHHHHHHHHHCTTSCCCCCCCSCHHHHHHHHHHTCSSTTTSC------CHHHHHTSHHHHC
T ss_pred hHHHHHHHHHHHHhcccccCCcccchHHHHHHHHHHccCCcccCc------CHHHHhcCccccC
Confidence 753 33444455543 3456778899999999999999999999 6899999999974
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=355.19 Aligned_cols=251 Identities=25% Similarity=0.393 Sum_probs=214.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|.++.++..||||++... ....+....|..++. .++||||+++++++.+.+.
T Consensus 9 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~----~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~ 83 (288)
T 3kfa_A 9 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPP 83 (288)
T ss_dssp BCCGGGEEEEEESGGGTTCSEEEEEEGGGTEEEEEEEECSC----STHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSS
T ss_pred cccccceeEEeecCCCCceeEEEeEecCCCEEEEEEecCcC----HHHHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCC
Confidence 34567999999999999999999999999999999999754 234456677888887 5789999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+||||+. |++|..++... ..+++..++.++.||+.||.|||++||+||||||+||
T Consensus 84 ~~~v~e~~~---------------------~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dikp~Ni 142 (288)
T 3kfa_A 84 FYIITEFMT---------------------YGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 142 (288)
T ss_dssp EEEEEECCT---------------------TEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHHTCCCSCCSGGGE
T ss_pred EEEEEEcCC---------------------CCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHCCccCCCCCcceE
Confidence 999999998 45555566543 4599999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
|++.++.+||+|||++....... .......||+.|+|||++.+..++.++||||||+++|+|++ |.+||.+.+.....
T Consensus 143 l~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~~~~~ 222 (288)
T 3kfa_A 143 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 222 (288)
T ss_dssp EECGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EEcCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987532211 12233457889999999998899999999999999999999 99999998888877
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+... ....|..+++++.+||.+||..||.+|| +++++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~~~~ 264 (288)
T 3kfa_A 223 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP------SFAEIHQ 264 (288)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHhccCCCCCCCCCCHHHHHHHHHHhCCChhhCc------CHHHHHH
Confidence 777655 4566788999999999999999999999 4666654
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=358.94 Aligned_cols=273 Identities=27% Similarity=0.348 Sum_probs=209.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEE-----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAEL-----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~-----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|++ ..+++.||||+++... .....+....|..++....+||||+++++++
T Consensus 19 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~ 96 (313)
T 1t46_A 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (313)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred ccChhhhhHHHhhCccCCcceEEEEEeeccccchhhhhHHHhcCcch--hHHHHHHHHHHHHHHhhcccCCCeeeEEEEE
Confidence 45567999999999999999999986 3567899999997652 2334566778888887544999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+.+..|+||||+++|+|.+.+.......... .............+++..++.++.||+.||.|||++||+||||||
T Consensus 97 ~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp 173 (313)
T 1t46_A 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICS---KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (313)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC-----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred ecCCCcEEEEecCCCCCHHHHHHhcccccccc---cccccccccccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCcc
Confidence 99999999999999666532111100000000 000000001123599999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 174 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ceEEEcCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 999999999999999999875322211 1234567889999999999899999999999999999998 9999988766
Q ss_pred HHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 293 DELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 293 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
......+... ....+..++.++.+||.+||..||.+|| ++.|++++
T Consensus 254 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~~ 301 (313)
T 1t46_A 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP------TFKQIVQL 301 (313)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred hhHHHHHhccCCCCCCcccCCHHHHHHHHHHcCCCchhCc------CHHHHHHH
Confidence 5555444433 3345678999999999999999999999 56777753
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=378.29 Aligned_cols=277 Identities=19% Similarity=0.221 Sum_probs=214.5
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|+++++||+|+||.||+|++..+++.||||++....... ....|..++.....|++|+.+..++...+..||
T Consensus 6 ~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~~-----~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~l 80 (483)
T 3sv0_A 6 GNKFRLGRKIGSGSFGEIYLGTNIQTNEEVAIKLENVKTKHP-----QLLYESKIYRILQGGTGIPNVRWFGVEGDYNVL 80 (483)
T ss_dssp TTTEECCCCCEECSSCEEEEEEETTTCCEEEEEEEETTCSSC-----CHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEE
T ss_pred CCcEEEEEEEeeCCCEEEEEEEECCCCcEEEEEEeccccccH-----HHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEE
Confidence 468999999999999999999999999999999987643221 245677777755556788888888888999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee--
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL-- 220 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl-- 220 (494)
||||+ +|+| ..++.. .+.+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 81 vme~~-g~sL---------------------~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIvHrDIKP~NILl~~ 138 (483)
T 3sv0_A 81 VMDLL-GPSL---------------------EDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGL 138 (483)
T ss_dssp EEECC-CCBH---------------------HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECC
T ss_pred EEECC-CCCH---------------------HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCEeecccCcceEEEec
Confidence 99999 5544 444443 4579999999999999999999999999999999999999
Q ss_pred -CCCCCEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-
Q psy8309 221 -DYEGHVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD- 291 (494)
Q Consensus 221 -~~~g~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~- 291 (494)
+.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||+||||++|..||.+..
T Consensus 139 ~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 139 GRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 6889999999999986433221 1236789999999999999999999999999999999999999998744
Q ss_pred --HHHHHHHHHhCCC-----CCCccCCHHHHHHHHhhccCCCCCCCCCCCCC----ChhhhhcCCCcCCCChhHHhcCcC
Q psy8309 292 --EDELFWSICNERP-----RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCN----SGDDVVAHEYFRGLDWQALEKREL 360 (494)
Q Consensus 292 --~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~----~~~eil~h~~f~~~~w~~l~~~~~ 360 (494)
..+.+..+..... .++..++.++.+||..||..||.+||++.++. .+-....|+|+..+||+.+..++.
T Consensus 219 ~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~~L~~l~~~~~~~~~~~~dW~~~~~~~~ 298 (483)
T 3sv0_A 219 GTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKRLFRDLFIREGFQFDYVFDWTILKYQQS 298 (483)
T ss_dssp SSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHHHHHHHHHHTTCCCSSCCHHHHHTC---
T ss_pred hhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHHHHcCCCccCCcCchhhccccc
Confidence 3444444443221 22356899999999999999999999653211 011223589999999999988877
Q ss_pred CCCCccc
Q psy8309 361 EPPFRPR 367 (494)
Q Consensus 361 ~pp~~p~ 367 (494)
.++..|.
T Consensus 299 ~~~~~p~ 305 (483)
T 3sv0_A 299 QIASAPP 305 (483)
T ss_dssp -------
T ss_pred cccCCCC
Confidence 6665553
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=356.65 Aligned_cols=252 Identities=27% Similarity=0.365 Sum_probs=201.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEE----EeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAE----LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~----~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+....|..++. .++||||+++++++.
T Consensus 6 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~ 81 (295)
T 3ugc_A 6 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILK-SLQHDNIVKYKGVCY 81 (295)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEECTTCSSCCEEEEEEEESCC---CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC
T ss_pred cCCHHHhhhhheeeccCCEEEEEEEEecccCCCCcEEEEEEcccC---CHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEe
Confidence 4556799999999999999999999 5678899999999754 3444556778888887 579999999999986
Q ss_pred c--CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 137 T--DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 137 ~--~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
. ...+|+||||+++ ++|..++... ..+++..+..++.||+.||.|||++||+||||
T Consensus 82 ~~~~~~~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Di 140 (295)
T 3ugc_A 82 SAGRRNLKLIMEYLPY---------------------GSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 140 (295)
T ss_dssp HHHHTSCEEEEECCTT---------------------CBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHHHHTTCCCSCC
T ss_pred cCCCCceEEEEEeCCC---------------------CCHHHHHHhcccccCHHHHHHHHHHHHHHHHHHhcCCcccCCC
Confidence 5 4569999999994 4555556554 35999999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 141 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~ 220 (295)
T 3ugc_A 141 ATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 220 (295)
T ss_dssp SGGGEEEEETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSH
T ss_pred CHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCC
Confidence 9999999999999999999997532221 1223345778899999999999999999999999999999999998653
Q ss_pred CHH----------------HHHHHHH-hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 291 DED----------------ELFWSIC-NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 291 ~~~----------------~~~~~i~-~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
... .....+. ......|..+++++.+||.+||..||.+|| ++.|+++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~el~~ 284 (295)
T 3ugc_A 221 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP------SFRDLAL 284 (295)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC------CHHHHHH
T ss_pred hHHHHhhhcCccccchhHHHHHHHHhccCcCCCCcCcCHHHHHHHHHHcCCChhhCC------CHHHHHH
Confidence 221 1222222 235566788999999999999999999999 4566653
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=358.95 Aligned_cols=254 Identities=24% Similarity=0.339 Sum_probs=208.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCC----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTD----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+...+|++.+.||+|+||.||+|+++.++ ..||||+++... ..........|..++. .++||||+++++++.
T Consensus 40 ~i~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~ 116 (333)
T 1mqb_A 40 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMG-QFSHHNIIRLEGVIS 116 (333)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC
T ss_pred cCChHHhhcccEEecCCCeEEEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEe
Confidence 456789999999999999999999987653 459999997542 3344456677888877 579999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
+.+.+|+||||+. |++|..++... +.+++..+..++.||+.||.|||++||+||||||
T Consensus 117 ~~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp 175 (333)
T 1mqb_A 117 KYKPMMIITEYME---------------------NGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 175 (333)
T ss_dssp SSSSEEEEEECCT---------------------TEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCCCcEEEEeCCC---------------------CCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCh
Confidence 9999999999999 44555556543 6799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+
T Consensus 176 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 176 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred heEEECCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 999999999999999999875332211 1223346789999999999999999999999999999998 999999998
Q ss_pred HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 292 EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 292 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..++...+..+ ....+..++.++.+||.+||+.||.+|| ++.+++++
T Consensus 256 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~~ 303 (333)
T 1mqb_A 256 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP------KFADIVSI 303 (333)
T ss_dssp HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSC------CHHHHHHH
T ss_pred HHHHHHHHHCCCcCCCcccCCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 88888888765 4566778999999999999999999999 56666653
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-45 Score=363.85 Aligned_cols=259 Identities=21% Similarity=0.319 Sum_probs=212.1
Q ss_pred CCCCCCCceEeeEeccCCceEEEEEE-----EeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 60 RKYDLEDFQLLKVLGKGSFGKVFLAE-----LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 60 ~~~~~~~y~~~~~LG~G~fG~V~~~~-----~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
..+..++|++++.||+|+||.||+|+ +..++..||||++... ...........|..++. .++||||++++++
T Consensus 25 ~~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~ 101 (327)
T 2yfx_A 25 KEVPRKNITLIRGLGHGAFGEVYEGQVSGMPNDPSPLQVAVKTLPEV--CSEQDELDFLMEALIIS-KFNHQNIVRCIGV 101 (327)
T ss_dssp CBCCGGGCEEEEECC--CSSCEEEEEC--------CCEEEEEECCSS--CCHHHHHHHHHHHHHHH-HCCCTTBCCEEEE
T ss_pred ccCChhheEEEEEEcCCCCeeEEEEEEcCCCCCCccceEEEEEeccc--cchhhHHHHHHHHHHHh-hCCCCCCCeEEEE
Confidence 34566799999999999999999999 5567889999999753 23344556677888777 4699999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-------GRFDEGRARFYAAEIVSGMRFLHKKG 207 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-------~~l~e~~~~~~~~qi~~aL~yLH~~g 207 (494)
+.+...+|+||||+++| +|..++... ..+++..++.++.||+.||.|||++|
T Consensus 102 ~~~~~~~~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~~~ 160 (327)
T 2yfx_A 102 SLQSLPRFILMELMAGG---------------------DLKSFLRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEENH 160 (327)
T ss_dssp ECSSSSCEEEEECCTTE---------------------EHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred EcCCCCcEEEEecCCCC---------------------cHHHHHHhhcccccccccccHHHHHHHHHHHHHHHHHHhhCC
Confidence 99999999999999954 444455443 35899999999999999999999999
Q ss_pred CccccCCCCceeeCCC---CCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh
Q psy8309 208 IVYRDLKLDNILLDYE---GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV 282 (494)
Q Consensus 208 ivHrDLKp~NILl~~~---g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~ 282 (494)
|+||||||+|||++.+ +.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++
T Consensus 161 i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt 240 (327)
T 2yfx_A 161 FIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFS 240 (327)
T ss_dssp CCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHc
Confidence 9999999999999954 469999999986422111 22334568999999999998899999999999999999998
Q ss_pred -CCCCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 283 -GQSPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 283 -G~~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
|..||.+.+..+....+..+ ....+..++..+.+||.+||..||.+|| ++.++++|.|+-
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~~l~~~ 302 (327)
T 2yfx_A 241 LGYMPYPSKSNQEVLEFVTSGGRMDPPKNCPGPVYRIMTQCWQHQPEDRP------NFAIILERIEYC 302 (327)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHHHHHH
T ss_pred CCCCCCCCcCHHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhcCChhhCc------CHHHHHHHHHHH
Confidence 99999999888888877765 4556778999999999999999999999 689999998763
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=375.49 Aligned_cols=240 Identities=25% Similarity=0.455 Sum_probs=204.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC-
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS- 139 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~- 139 (494)
.+..++|++++.||+|+||.||+|.++ ++.||||+++... ..+....|..++. .++||||+++++++....
T Consensus 189 ~i~~~~~~~~~~lG~G~fg~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~-~l~h~niv~~~~~~~~~~~ 260 (450)
T 1k9a_A 189 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKG 260 (450)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEET--TEEEEEEEESSCT-----TSHHHHHHHHHHH-TCCCTTBCCEEEEEECTTS
T ss_pred ccChHHeEEEeeecCcCCeeEEEEEec--CCeEEEEEeCCch-----HHHHHHHHHHHHH-hccCCCEEEEEEEEEcCCC
Confidence 456789999999999999999999875 5689999997642 3345677888887 579999999999987655
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+|||||++ |+|..++...+ .+++..+..++.||+.||+|||++||+||||||+|
T Consensus 261 ~~~iv~e~~~~---------------------g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~N 319 (450)
T 1k9a_A 261 GLYIVTEYMAK---------------------GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 319 (450)
T ss_dssp CEEEEEECCTT---------------------CBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred ceEEEEEecCC---------------------CcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhh
Confidence 79999999994 45555666544 37999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||++.++.+||+|||+++... .......+|+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 320 ill~~~~~~kl~DfG~a~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 396 (450)
T 1k9a_A 320 VLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 396 (450)
T ss_dssp EEECTTSCEEECCCTTCEECC---------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCTTTHH
T ss_pred EEECCCCCEEEeeCCCccccc---ccccCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999998532 22334468899999999999999999999999999999998 99999998888888
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..+..+ .+..|..+++++.+||.+||..||.+||++
T Consensus 397 ~~i~~~~~~~~p~~~~~~l~~li~~cl~~dp~~Rpt~ 433 (450)
T 1k9a_A 397 PRVEKGYKMDAPDGCPPAVYDVMKNCWHLDAATRPTF 433 (450)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSCCH
T ss_pred HHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 777765 567788999999999999999999999943
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=375.38 Aligned_cols=250 Identities=27% Similarity=0.366 Sum_probs=192.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.+.|.+.++||+|+||+||.+ ...+|+.||||++... .......|..++....+|||||++++++.+.+.+|+
T Consensus 14 ~~~~~~~~~LG~G~~g~V~~~-~~~~g~~vAvK~~~~~------~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~l 86 (434)
T 2rio_A 14 KNLVVSEKILGYGSSGTVVFQ-GSFQGRPVAVKRMLID------FCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYI 86 (434)
T ss_dssp SSCEEEEEEEEECSTTCEEEE-EESSSSEEEEEEEEGG------GHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEE
T ss_pred hheeeccCeEeeCCCeEEEEE-EEECCeEEEEEEEcHH------HHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEE
Confidence 345667799999999999875 4567899999998653 223456788888766699999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCC-------CHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF-------DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l-------~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
|||||. |+ |..++...+.. ++..+..++.||+.||+|||++||+||||||+
T Consensus 87 v~E~~~-gs---------------------L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDLkp~ 144 (434)
T 2rio_A 87 ALELCN-LN---------------------LQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQ 144 (434)
T ss_dssp EECCCS-EE---------------------HHHHHHTC------------CCHHHHHHHHHHHHHHHHHTTEECCCCSGG
T ss_pred EEecCC-CC---------------------HHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHHCCccccCCChH
Confidence 999995 33 34444433222 33356789999999999999999999999999
Q ss_pred ceeeCCC-------------CCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCC-------CCCCCcchHHH
Q psy8309 217 NILLDYE-------------GHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKG-------LKYNQCVDWWS 272 (494)
Q Consensus 217 NILl~~~-------------g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~-------~~~~~~~DiwS 272 (494)
||||+.+ +.+||+|||+++....... .....+||+.|+|||++.+ ..++.++||||
T Consensus 145 NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwS 224 (434)
T 2rio_A 145 NILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFS 224 (434)
T ss_dssp GEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTSCCCCCCTHHHHHH
T ss_pred hEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccccccCcchhhhhHh
Confidence 9999764 4899999999986432211 1235689999999999976 67899999999
Q ss_pred HHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCC-------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 273 FGILLYEMHV-GQSPFSGCDEDELFWSICNERPRFP-------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 273 lGvil~ell~-G~~Pf~~~~~~~~~~~i~~~~~~~p-------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
|||++|||++ |..||.+....+ ..+..+...++ ..+++++++||.+||+.||.+|| ++.++++|
T Consensus 225 lG~il~ellt~g~~Pf~~~~~~~--~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp------s~~eil~h 296 (434)
T 2rio_A 225 MGCVFYYILSKGKHPFGDKYSRE--SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMIDHDPLKRP------TAMKVLRH 296 (434)
T ss_dssp HHHHHHHHHTTSCCTTCSTTTHH--HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTCSSGGGSC------CHHHHHTS
T ss_pred HHHHHHHHHhCCCCCCCCchhhH--HHHhcCCCCcccccccccccchHHHHHHHHHHhhCChhhCC------CHHHHHhC
Confidence 9999999999 999998765443 34555444332 23568899999999999999999 68999999
Q ss_pred CCcCCC
Q psy8309 345 EYFRGL 350 (494)
Q Consensus 345 ~~f~~~ 350 (494)
|||...
T Consensus 297 p~f~~~ 302 (434)
T 2rio_A 297 PLFWPK 302 (434)
T ss_dssp GGGSCH
T ss_pred CccCCc
Confidence 999754
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-44 Score=348.25 Aligned_cols=250 Identities=22% Similarity=0.374 Sum_probs=211.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
++.++|++.+.||+|+||.||+|++. ++..||||++.+... ..+....|..++. .++||||+++++++.+.+.+
T Consensus 5 i~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vaiK~~~~~~~----~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~ 78 (267)
T 3t9t_A 5 IDPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPI 78 (267)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTTB----CHHHHHHHHHHHH-TCCCTTBCCEEEEECSSSSC
T ss_pred EchhheeeeeEecCCCceeEEEEEec-CCCeEEEEEccccCC----CHHHHHHHHHHHH-hCCCCCEeeEEEEEccCCCe
Confidence 45679999999999999999999986 567799999986532 2245667777777 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+||||+++ ++|..++... +.+++..+..++.||+.||.|||++||+||||||+||++
T Consensus 79 ~lv~e~~~~---------------------~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dl~p~Nili 137 (267)
T 3t9t_A 79 CLVTEFMEH---------------------GCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV 137 (267)
T ss_dssp EEEECCCTT---------------------CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCCGGGEEE
T ss_pred EEEEeCCCC---------------------CcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCchheEEE
Confidence 999999994 4555555544 568999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeecc-CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYL-DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
+.++.+||+|||+++..... ........||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..+....
T Consensus 138 ~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~~~~~~ 217 (267)
T 3t9t_A 138 GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVED 217 (267)
T ss_dssp CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHH
T ss_pred CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCHHHHHHH
Confidence 99999999999998743211 111234467889999999998899999999999999999999 9999999998888888
Q ss_pred HHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 299 ICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 299 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..+ ....|..++.++.+||.+||+.||.+|| ++.+++++
T Consensus 218 i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~ll~~ 258 (267)
T 3t9t_A 218 ISTGFRLYKPRLASTHVYQIMNHCWRERPEDRP------AFSRLLRQ 258 (267)
T ss_dssp HHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HhcCCcCCCCccCcHHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 8776 3455778899999999999999999999 56777653
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=358.99 Aligned_cols=254 Identities=27% Similarity=0.401 Sum_probs=208.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|++.+.||+|+||.||+|++. .+++.||||++++.. ..........|..++....+||||+++++++.
T Consensus 24 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~ 101 (316)
T 2xir_A 24 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 101 (316)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred cchhheeeeeEEcCCCceeEEEEEEecCCccccceEEEEEecccCC--CcHHHHHHHHHHHHHHhcccCCCeeeEEEEEe
Confidence 45679999999999999999999864 467899999997652 33445567788888886558999999999988
Q ss_pred cCC-eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC----------------CCCHHHHHHHHHHHHHH
Q psy8309 137 TDS-HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG----------------RFDEGRARFYAAEIVSG 199 (494)
Q Consensus 137 ~~~-~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~----------------~l~e~~~~~~~~qi~~a 199 (494)
..+ .+|+||||+++|+| ..++.... .+++..++.++.||+.|
T Consensus 102 ~~~~~~~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 160 (316)
T 2xir_A 102 KPGGPLMVIVEFCKFGNL---------------------STYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKG 160 (316)
T ss_dssp CTTSCCEEEEECCTTEEH---------------------HHHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHH
T ss_pred cCCCceEEEEEcCCCCcH---------------------HHHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHH
Confidence 754 59999999995554 44444332 38999999999999999
Q ss_pred HHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHH
Q psy8309 200 MRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILL 277 (494)
Q Consensus 200 L~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil 277 (494)
|.|||++||+||||||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++
T Consensus 161 l~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il 240 (316)
T 2xir_A 161 MEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLL 240 (316)
T ss_dssp HHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred HHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHH
Confidence 9999999999999999999999999999999999875322111 23345688999999999999999999999999999
Q ss_pred HHHHh-CCCCCCCCCHHH-HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 278 YEMHV-GQSPFSGCDEDE-LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 278 ~ell~-G~~Pf~~~~~~~-~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
|+|++ |..||.+....+ ....+..+ ....|..+++++.++|.+||..||.+|| ++.++++|
T Consensus 241 ~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~~ 304 (316)
T 2xir_A 241 WEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP------TFSELVEH 304 (316)
T ss_dssp HHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHhCCCCCCcccchhHHHHHHhccCccCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 99998 999998876443 34444443 4566788999999999999999999999 57888865
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-44 Score=354.86 Aligned_cols=254 Identities=24% Similarity=0.340 Sum_probs=203.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC---CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG---TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++|.+.+.||+|+||.||+|+... ++..||||+++... ...........|..++. .++||||+++++++.+.
T Consensus 31 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~ 108 (313)
T 3brb_A 31 IDRNLLILGKILGEGEFGSVMEGNLKQEDGTSLKVAVKTMKLDN-SSQREIEEFLSEAACMK-DFSHPNVIRLLGVCIEM 108 (313)
T ss_dssp CCGGGEEEEEEEEC-CCCCEEEEEEECTTSCEEEEEEEEC---C-CCHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEC-
T ss_pred cCHHHeeeccceeecCCeEEEEEEEeccCCceeEEEEEEEeccc-cchhHHHHHHHHHHHHh-cCCCCCeeeeeEEEeec
Confidence 456799999999999999999998875 56689999997653 23444566777888877 57999999999999876
Q ss_pred C-----eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHh------hhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy8309 139 S-----HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI------QQSGRFDEGRARFYAAEIVSGMRFLHKKG 207 (494)
Q Consensus 139 ~-----~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l------~~~~~l~e~~~~~~~~qi~~aL~yLH~~g 207 (494)
+ ..|+||||+.+|+| ..++ .....+++..++.++.||+.||.|||++|
T Consensus 109 ~~~~~~~~~~v~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ 167 (313)
T 3brb_A 109 SSQGIPKPMVILPFMKYGDL---------------------HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRN 167 (313)
T ss_dssp ------CEEEEEECCTTCBH---------------------HHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHTTT
T ss_pred cccCCcccEEEEecccCCCH---------------------HHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 5 45999999996555 3333 23457999999999999999999999999
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CC
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQ 284 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~ 284 (494)
|+||||||+|||++.++.+||+|||+++...... .......|++.|+|||++.+..++.++|||||||++|+|++ |.
T Consensus 168 ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~ 247 (313)
T 3brb_A 168 FLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGM 247 (313)
T ss_dssp CCCCCCSGGGEEECTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cccCCCCcceEEEcCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCC
Confidence 9999999999999999999999999987532221 12234467889999999999999999999999999999999 99
Q ss_pred CCCCCCCHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 285 SPFSGCDEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 285 ~Pf~~~~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+||.+.+..+....+..+ ....|..+++++.+||.+||..||.+|| ++.++++|
T Consensus 248 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~l~~~ 302 (313)
T 3brb_A 248 TPYPGVQNHEMYDYLLHGHRLKQPEDCLDELYEIMYSCWRTDPLDRP------TFSVLRLQ 302 (313)
T ss_dssp CSSTTCCGGGHHHHHHTTCCCCCBTTCCHHHHHHHHHTTCSSGGGSC------CHHHHHHH
T ss_pred CCCccCCHHHHHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 999998888888887765 4567788999999999999999999999 56777654
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=359.23 Aligned_cols=254 Identities=23% Similarity=0.348 Sum_probs=204.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccc--ccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDV--VLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~--~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.+..++|++++.||+|+||.||+|++..+++.||+|+..|.. ............|..++. .++||||+++++++...
T Consensus 11 ~l~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~ 89 (327)
T 3lzb_A 11 ILKETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMA-SVDNPHVCRLLGICLTS 89 (327)
T ss_dssp ECCTTTEEEEEEEEECSSEEEEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHT-TCCBTTBCCCCEEEESS
T ss_pred ccCHhHceEEEEeeeCCCeEEEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHH-hCCCCCeeEEEEEEecC
Confidence 345679999999999999999999999888876555433321 122334556777888877 57999999999999876
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
. .++|+||+.+ |+|..++.. .+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 90 ~-~~~v~~~~~~---------------------g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~N 147 (327)
T 3lzb_A 90 T-VQLITQLMPF---------------------GCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 147 (327)
T ss_dssp S-EEEEECCCSS---------------------CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred C-ceEEEEecCC---------------------CcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhCCCcCCCCCHHH
Confidence 5 8899999984 455555554 4679999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
||++.++.+||+|||+++....... ......||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..+
T Consensus 148 Il~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~~ 227 (327)
T 3lzb_A 148 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 227 (327)
T ss_dssp EEEEETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGGG
T ss_pred EEEcCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999975322211 2233457889999999999999999999999999999999 999999988888
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+...+... ....|..++.++.+||.+||..||.+|| ++.|+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~ 271 (327)
T 3lzb_A 228 ISSILEKGERLPQPPICTIDVYMIMRKCWMIDADSRP------KFRELII 271 (327)
T ss_dssp HHHHHHTTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHcCCCCCCCccCCHHHHHHHHHHcCCChhHCc------CHHHHHH
Confidence 87777655 3566778999999999999999999999 5677775
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=351.36 Aligned_cols=259 Identities=21% Similarity=0.257 Sum_probs=200.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++.+.||+|+||.||+|++..+++.||||++....... ....|..++....+|++|..+..++...+..++
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~~-----~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 4hgt_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKHP-----QLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp ---CEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEC---CC-----CHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred CCceEEeeeecCCCCeEEEEEEEcCCCceEEEEeecccccch-----HHHHHHHHHHHhcCCCCCCeeeeecCCCCceEE
Confidence 368999999999999999999999999999999876543221 245566666644444555566666688889999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee--
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL-- 220 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl-- 220 (494)
||||+ +|+| ..++.. .+.+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 83 v~e~~-~~~L---------------------~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~ 140 (296)
T 4hgt_A 83 VMELL-GPSL---------------------EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp EEECC-CCBH---------------------HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECC
T ss_pred EEEcc-CCCH---------------------HHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeecCCCCHHHeeeec
Confidence 99999 5554 334442 4579999999999999999999999999999999999999
Q ss_pred -CCCCCEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 221 -DYEGHVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 221 -~~~g~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
+.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.+.
T Consensus 141 ~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred cCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 7889999999999986432221 23456899999999999999999999999999999999999999986432
Q ss_pred ---HHHHHHHHhCCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc----------CCCcCCCChhH
Q psy8309 293 ---DELFWSICNERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA----------HEYFRGLDWQA 354 (494)
Q Consensus 293 ---~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~----------h~~f~~~~w~~ 354 (494)
...+..+.......| ..+++++.+||.+||+.||.+||+ ++++++ ..+-..+||+.
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt------~~~l~~~l~~~~~~~~~~~~~~~dw~~ 294 (296)
T 4hgt_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPD------YSYLRQLFRNLFHRQGFSYDYVFDWNM 294 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCC------HHHHHHHHHHHHHHHTCCTTCCCGGGG
T ss_pred hhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCC------HHHHHHHHHHHHHHhCCCccCccchhh
Confidence 233334433332233 567999999999999999999995 455543 45556677765
Q ss_pred H
Q psy8309 355 L 355 (494)
Q Consensus 355 l 355 (494)
+
T Consensus 295 ~ 295 (296)
T 4hgt_A 295 L 295 (296)
T ss_dssp C
T ss_pred c
Confidence 4
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-44 Score=351.47 Aligned_cols=252 Identities=26% Similarity=0.321 Sum_probs=209.9
Q ss_pred CCCCCCceEee-EeccCCceEEEEEEE--eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLK-VLGKGSFGKVFLAEL--KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~-~LG~G~fG~V~~~~~--~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.+...+|++.+ .||+|+||.||+|.+ +.+++.||||+++... ......+....|..++. .++||||+++++++ .
T Consensus 12 ~~~~~~y~~~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~-~ 88 (291)
T 1xbb_A 12 YLDRKLLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQ-QLDNPYIVRMIGIC-E 88 (291)
T ss_dssp BCCGGGEEEEEEEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHH-TCCCTTBCCEEEEE-E
T ss_pred eecchhhhhccCccccccCeeeEeeeecCCCceeeEEEEeecccc-cCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEE-C
Confidence 34567899998 999999999999954 5667899999997653 22334556777888887 57999999999999 5
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+.+|+||||+. |++|..++...+.+++..++.++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~N 147 (291)
T 1xbb_A 89 AESWMLVMEMAE---------------------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARN 147 (291)
T ss_dssp SSSEEEEEECCT---------------------TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CCCcEEEEEeCC---------------------CCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCeEcCCCCcce
Confidence 678899999998 55666777777889999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCc---ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKT---TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~---~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
||++.++.+||+|||+++........ .....||+.|+|||++.+..++.++|||||||++|+|++ |..||.+.+..
T Consensus 148 il~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 227 (291)
T 1xbb_A 148 VLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGS 227 (291)
T ss_dssp EEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHH
T ss_pred EEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCHH
Confidence 99999999999999999764322211 223456789999999998889999999999999999999 99999999888
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
++...+..+ .+.+|..+++++.++|.+||+.||.+||+ +.+++
T Consensus 228 ~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps------~~~l~ 271 (291)
T 1xbb_A 228 EVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPG------FAAVE 271 (291)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCC------HHHHH
T ss_pred HHHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCcC------HHHHH
Confidence 888877765 45677889999999999999999999994 56655
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=350.03 Aligned_cols=252 Identities=24% Similarity=0.318 Sum_probs=211.7
Q ss_pred CCCCCceEee-EeccCCceEEEEEEEe--CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLK-VLGKGSFGKVFLAELK--GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~-~LG~G~fG~V~~~~~~--~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++|.+.+ .||+|+||.||+|.++ .++..||||+++.. ......+....|..++. .++||||+++++++ ..
T Consensus 6 ~~~~~~~i~~~~lg~G~~g~Vy~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~-~~ 81 (287)
T 1u59_A 6 LKRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMH-QLDNPYIVRLIGVC-QA 81 (287)
T ss_dssp CCGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEE-ES
T ss_pred ccHHHhhhhhccccccCceeEEEeEeccCCCcceEEEEecCCc--cchhHHHHHHHHHHHHH-hCCCCCEeEEEEEe-cC
Confidence 3456888887 9999999999999864 56788999999764 23445566778888887 46999999999999 45
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+.+|+||||+.+ ++|..++.. ...+++..++.++.||+.||.|||++||+||||||+|
T Consensus 82 ~~~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~N 140 (287)
T 1u59_A 82 EALMLVMEMAGG---------------------GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARN 140 (287)
T ss_dssp SSEEEEEECCTT---------------------EEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CCcEEEEEeCCC---------------------CCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHCCEeeCCCchhe
Confidence 679999999994 455555543 3569999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..
T Consensus 141 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 220 (287)
T 1u59_A 141 VLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 220 (287)
T ss_dssp EEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTH
T ss_pred EEEcCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCHH
Confidence 9999999999999999986422211 1233457899999999998899999999999999999998 99999998888
Q ss_pred HHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 294 ELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 294 ~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
++...+..+ .+.+|..+++++.+||.+||..||.+|| ++.++++|
T Consensus 221 ~~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~~ 266 (287)
T 1u59_A 221 EVMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRP------DFLTVEQR 266 (287)
T ss_dssp HHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHhcCCcCCCCCCcCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 888887765 4667889999999999999999999999 57778766
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-44 Score=377.33 Aligned_cols=251 Identities=25% Similarity=0.387 Sum_probs=213.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|+++.++..||||+++... ...+....|..++. .++||||+++++++.....
T Consensus 216 ~~~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~-~l~hpniv~l~~~~~~~~~ 290 (495)
T 1opk_A 216 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPP 290 (495)
T ss_dssp BCCGGGEEEEEESGGGTTSSEEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSS
T ss_pred ccCHHHceeeeEecCCCCeEEEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHH-hcCCCCEeeEEEEEecCCc
Confidence 455678999999999999999999999999999999997642 23456778888887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|||||||.+ |+|..++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 291 ~~lv~E~~~~---------------------g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 349 (495)
T 1opk_A 291 FYIITEFMTY---------------------GNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNC 349 (495)
T ss_dssp CEEEEECCTT---------------------CBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred EEEEEEccCC---------------------CCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhE
Confidence 9999999994 4555566543 4689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||+.++.+||+|||+++....... ......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++.
T Consensus 350 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~~~~~ 429 (495)
T 1opk_A 350 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 429 (495)
T ss_dssp EECGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHH
T ss_pred EECCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999985322111 1223456789999999998899999999999999999999 99999998888877
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+..+ ....|..+++++.+||.+||+.||.+|| ++.+|++
T Consensus 430 ~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP------s~~el~~ 471 (495)
T 1opk_A 430 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP------SFAEIHQ 471 (495)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCcChhHCc------CHHHHHH
Confidence 777654 4566788999999999999999999999 4566653
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=359.94 Aligned_cols=268 Identities=25% Similarity=0.370 Sum_probs=210.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCe-----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDY-----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.+.||+|+||.||+|.+..++. .||+|++.... ..........|..++....+||||+++++++
T Consensus 42 ~~~~~~~~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~ 119 (333)
T 2i1m_A 42 EFPRNNLQFGKTLGAGAFGKVVEATAFGLGKEDAVLKVAVKMLKSTA--HADEKEALMSELKIMSHLGQHENIVNLLGAC 119 (333)
T ss_dssp BCCTTSEEEEEEEEECSSEEEEEEEETTCSSSCCCCEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHceeeeEeccCCCcceEEEEecCCCcccchhHHHHHhccccc--ChHHHHHHHHHHHHHHhhcCCCCeeeEEEEE
Confidence 4566899999999999999999999977664 79999997642 3344566778888888544899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+.+.+|+||||+++|+|.+.+...... . .... ........+++..+..++.||+.||.|||++||+||||||
T Consensus 120 ~~~~~~~lv~e~~~~g~L~~~l~~~~~~--~----~~~~-~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ivH~Dlkp 192 (333)
T 2i1m_A 120 THGGPVLVITEYCCYGDLLNFLRRKSRV--L----ETDP-AFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAA 192 (333)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHHHHH--H----SCC--------CCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSG
T ss_pred ecCCceEEEEecCCCCcHHHHHHHhccc--c----cccc-cccccccccCHHHHHHHHHHHHHHHHHHhcCCcccCCccc
Confidence 9999999999999976663321111000 0 0000 0001135689999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+...
T Consensus 193 ~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 272 (333)
T 2i1m_A 193 RNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILV 272 (333)
T ss_dssp GGCEEEGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCS
T ss_pred ceEEECCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccch
Confidence 999999999999999999975322221 1234567889999999999899999999999999999998 9999998766
Q ss_pred HHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
......+... ....|...++++.+||.+||+.||.+|| ++.++++
T Consensus 273 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~ 319 (333)
T 2i1m_A 273 NSKFYKLVKDGYQMAQPAFAPKNIYSIMQACWALEPTHRP------TFQQICS 319 (333)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred hHHHHHHHhcCCCCCCCCCCCHHHHHHHHHHhccChhhCc------CHHHHHH
Confidence 5555555443 3445677899999999999999999999 5677765
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=363.60 Aligned_cols=254 Identities=20% Similarity=0.212 Sum_probs=193.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC---CCeEEEeeeeccccccChhhH--------HHHHHHHHHHHhcCCCCcee
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG---TDYYYAVKCLKKDVVLEDDDV--------ECTLIERKVLALGTKHPYLC 129 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~--------~~~~~e~~~l~~~~~hp~Iv 129 (494)
....++|++++.||+|+||.||+|++.. ++..||||++.+.......+. .....|...+. .++||||+
T Consensus 33 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~-~l~h~ni~ 111 (345)
T 2v62_A 33 DMEGNQWVLGKKIGSGGFGLIYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERK-QLDYLGIP 111 (345)
T ss_dssp CTTSCEEEEEEEC------CEEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHH-TCSCCCCC
T ss_pred cccCceEEEEeeEeecCCeEEEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhc-cccccCcc
Confidence 3455789999999999999999999987 788999999876421111111 12334444444 57999999
Q ss_pred eEEEEEEc----CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8309 130 HLFCTFQT----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK 205 (494)
Q Consensus 130 ~l~~~~~~----~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~ 205 (494)
++++++.. ...+|+||||| +|+| ..++...+.+++.+++.++.||+.||+|||+
T Consensus 112 ~~~~~~~~~~~~~~~~~lv~e~~-~~~L---------------------~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 112 LFYGSGLTEFKGRSYRFMVMERL-GIDL---------------------QKISGQNGTFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp CEEEEEEEESSSCEEEEEEEECE-EEEH---------------------HHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred eeecccccccCCCcEEEEEEecc-CCCH---------------------HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 99999988 78999999999 5544 4455556689999999999999999999999
Q ss_pred CCCccccCCCCceeeCCCC--CEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHH
Q psy8309 206 KGIVYRDLKLDNILLDYEG--HVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGIL 276 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi 276 (494)
+||+||||||+|||++.++ .+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||+
T Consensus 170 ~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 249 (345)
T 2v62_A 170 NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYC 249 (345)
T ss_dssp TTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHH
T ss_pred CCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHH
Confidence 9999999999999999887 99999999997642211 11245689999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCC--CHHHHHHHHHhCCCCCCc---------cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 277 LYEMHVGQSPFSGC--DEDELFWSICNERPRFPQ---------FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 277 l~ell~G~~Pf~~~--~~~~~~~~i~~~~~~~p~---------~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+|||++|..||.+. +..............+|. .++.++++||.+||..||.+|| ++++|++
T Consensus 250 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~l~~ 321 (345)
T 2v62_A 250 MLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKP------NYQALKK 321 (345)
T ss_dssp HHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCC------CHHHHHH
T ss_pred HHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCC------CHHHHHH
Confidence 99999999999652 333332222222222332 6889999999999999999999 4566653
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=372.47 Aligned_cols=249 Identities=26% Similarity=0.432 Sum_probs=203.1
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC--ee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS--HL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~--~~ 141 (494)
.++|++.++||+|+||.||+|+++.+++.||||++..... .........|..++. .++||||+++++++...+ ..
T Consensus 8 ~~~y~i~~~LG~G~~g~Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~-~l~hpnIv~~~~~~~~~~~~~~ 84 (396)
T 4eut_A 8 NHLWLLSDILGQGATANVFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLK-KLNHKNIVKLFAIEEETTTRHK 84 (396)
T ss_dssp SEEEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHH-HCCCTTBCCEEEEEECTTTCCE
T ss_pred CCceEEEEEEEcCCCeEEEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHH-hcCCCCCCeEEEeeccCCCCee
Confidence 4589999999999999999999999999999999986532 233455667888887 578999999999998765 78
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc---CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS---GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~---~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
|+|||||+|| +|..++... ..+++..++.++.||+.||+|||++||+||||||+||
T Consensus 85 ~lv~e~~~~g---------------------~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NI 143 (396)
T 4eut_A 85 VLIMEFCPCG---------------------SLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNI 143 (396)
T ss_dssp EEEECCCTTE---------------------EHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGE
T ss_pred EEEEecCCCC---------------------CHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEEECCcCHHHE
Confidence 9999999954 444455433 2399999999999999999999999999999999999
Q ss_pred ee----CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC--------CCCCCcchHHHHHHHHHHHHhCCCC
Q psy8309 219 LL----DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG--------LKYNQCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 219 Ll----~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~--------~~~~~~~DiwSlGvil~ell~G~~P 286 (494)
|+ +.++.+||+|||+++... ........+||+.|+|||++.+ ..++.++|||||||++|||++|..|
T Consensus 144 ll~~~~~~~~~~kL~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~P 222 (396)
T 4eut_A 144 MRVIGEDGQSVYKLTDFGAARELE-DDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLP 222 (396)
T ss_dssp EEEECTTSCEEEEECCGGGCEECC-CGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred EEeecCCCceeEEEecCCCceEcc-CCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 99 777889999999998632 2333456789999999999865 5678899999999999999999999
Q ss_pred CCC----CCHHHHHHHHHhCCCC-------------------------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 287 FSG----CDEDELFWSICNERPR-------------------------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 287 f~~----~~~~~~~~~i~~~~~~-------------------------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
|.. ....+.+.++..+.+. ++..++..+.++|.+||+.||++|+ +
T Consensus 223 f~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~dP~~R~------s 296 (396)
T 4eut_A 223 FRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCW------G 296 (396)
T ss_dssp EECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCCCTTTSC------C
T ss_pred CCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhccChhhhc------c
Confidence 964 3345666666655431 1133567889999999999999999 5
Q ss_pred hhhhhc
Q psy8309 338 GDDVVA 343 (494)
Q Consensus 338 ~~eil~ 343 (494)
++++++
T Consensus 297 ~~e~l~ 302 (396)
T 4eut_A 297 FDQFFA 302 (396)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 666654
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=348.68 Aligned_cols=253 Identities=23% Similarity=0.351 Sum_probs=207.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC---CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG---TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~---~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.+..++|++.+.||+|+||.||+|++.. ++..||||++.+.. .....+....|..++. .++||||+++++++.+
T Consensus 8 ~~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~ 84 (281)
T 3cc6_A 8 GIAREDVVLNRILGEGFFGEVYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMK-NLDHPHIVKLIGIIEE 84 (281)
T ss_dssp SCCGGGEEEEEEEEECSSSEEEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHH-HHCCTTBCCEEEEECS
T ss_pred eecccceEEEEEEEecCCeeEEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHH-hCCCCCcceEEEEEcC
Confidence 3456799999999999999999999764 34569999997652 3344566777888877 4689999999999875
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+..|+||||+.+ ++|..++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 85 -~~~~~v~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~ 142 (281)
T 3cc6_A 85 -EPTWIIMELYPY---------------------GELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESINCVHRDIAVR 142 (281)
T ss_dssp -SSCEEEEECCTT---------------------CBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGG
T ss_pred -CCCEEEEecCCC---------------------CCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHCCcccCCCccc
Confidence 467899999994 4555555544 46999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++ |..||...+..+
T Consensus 143 Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~~~ 222 (281)
T 3cc6_A 143 NILVASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKD 222 (281)
T ss_dssp GEEEEETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCGGG
T ss_pred eEEECCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCChHH
Confidence 99999999999999999875322111 2234567889999999998899999999999999999998 999999887777
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
....+... ....|..+++.+.+||.+||..||.+|| ++.|++++
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~ell~~ 267 (281)
T 3cc6_A 223 VIGVLEKGDRLPKPDLCPPVLYTLMTRCWDYDPSDRP------RFTELVCS 267 (281)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHhcCCCCCCCCCCCHHHHHHHHHHccCCchhCc------CHHHHHHH
Confidence 77776654 4566778999999999999999999999 56777754
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=349.45 Aligned_cols=253 Identities=24% Similarity=0.314 Sum_probs=203.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEE----EeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAE----LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~----~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+....|++++.||+|+||.||+|+ +..+++.||||++.... ..........|..++. .++||||+++++++.
T Consensus 17 ~~~~~~~~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~ 93 (302)
T 4e5w_A 17 HFEKRFLKRIRDLGEGHFGKVELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILR-NLYHENIVKYKGICT 93 (302)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHH-TCCCTTBCCEEEEEE
T ss_pred hhhhhhhhhhhccCCCCceEEEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHH-hCCCCCeeeeeeEEe
Confidence 3455689999999999999999999 56789999999997653 3334556777888887 579999999999998
Q ss_pred cC--CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 137 TD--SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 137 ~~--~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
.. ..+|+||||+++ ++|..++. ....+++..++.++.||+.||+|||++||+||||
T Consensus 94 ~~~~~~~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~di 152 (302)
T 4e5w_A 94 EDGGNGIKLIMEFLPS---------------------GSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSRQYVHRDL 152 (302)
T ss_dssp C---CCEEEEEECCTT---------------------CBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred cCCCceEEEEEEeCCC---------------------CcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcCCcccCCC
Confidence 77 679999999994 45555663 3467999999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
||+|||++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++|..|+...
T Consensus 153 kp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 153 AARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp SGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred chheEEEcCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 9999999999999999999998643322 1233557888999999999989999999999999999999999886422
Q ss_pred --------------CH-HHHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 291 --------------DE-DELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 291 --------------~~-~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.. ......+.. .....|..+++++.+||.+||+.||.+|| +++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~ 295 (302)
T 4e5w_A 233 MALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCPPNCPDEVYQLMRKCWEFQPSNRT------SFQNLIE 295 (302)
T ss_dssp HHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC------CHHHHHH
T ss_pred hhHHhhccCCcccccCHHHHHHHHhccCCCCCCCCCCHHHHHHHHHHcCCCCCCCC------CHHHHHH
Confidence 11 122223332 34566788999999999999999999999 4566653
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=369.45 Aligned_cols=248 Identities=26% Similarity=0.394 Sum_probs=208.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|+++. +..||||+++... ...+....|..++. .++||||+++++++. .+.
T Consensus 184 ~i~~~~~~~~~~lG~G~fg~V~~~~~~~-~~~vavK~~~~~~----~~~~~~~~E~~~l~-~l~h~~iv~l~~~~~-~~~ 256 (454)
T 1qcf_A 184 EIPRESLKLEKKLGAGQFGEVWMATYNK-HTKVAVKTMKPGS----MSVEAFLAEANVMK-TLQHDKLVKLHAVVT-KEP 256 (454)
T ss_dssp BCCGGGEEEEEEEECCSSEEEEEEEETT-TEEEEEEEECTTS----BCHHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSS
T ss_pred eechHHeEEEEEcccCCceEEEEEEECC-ccEEEEEEecCCC----ccHHHHHHHHHHHh-hCCCCCEeeEEEEEe-CCc
Confidence 4566799999999999999999999864 5679999997642 23456778888887 579999999999986 678
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+|||||.+| +|..++... ..+++..+..++.||+.||+|||++||+||||||+||
T Consensus 257 ~~lv~e~~~~g---------------------~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ivHrDlkp~Ni 315 (454)
T 1qcf_A 257 IYIITEFMAKG---------------------SLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANI 315 (454)
T ss_dssp CEEEECCCTTC---------------------BHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTCCCSSCSGGGE
T ss_pred cEEEEeecCCC---------------------cHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCCHHHE
Confidence 99999999954 445555533 3689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||+.++.+||+|||+++...... .......+|+.|+|||++.+..++.++|||||||+||||++ |..||.+.+..++.
T Consensus 316 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~~~~~ 395 (454)
T 1qcf_A 316 LVSASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVI 395 (454)
T ss_dssp EECTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EECCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999997532111 11223456789999999998899999999999999999999 99999999988888
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
..+..+ ....|..+++++.+||.+||..||.+||+ +++|+
T Consensus 396 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RPt------~~~i~ 436 (454)
T 1qcf_A 396 RALERGYRMPRPENCPEELYNIMMRCWKNRPEERPT------FEYIQ 436 (454)
T ss_dssp HHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSCC------HHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhHCcC------HHHHH
Confidence 887765 45667889999999999999999999994 55555
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=346.93 Aligned_cols=248 Identities=24% Similarity=0.358 Sum_probs=206.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee-
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL- 141 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~- 141 (494)
.|++.++||+|+||.||+|++..++. .||+|++.+. ......+....|..++. .++||||+++++++.+.+..
T Consensus 22 ~~~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~aiK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 98 (298)
T 3pls_A 22 VTHSDRVIGKGHFGVVYHGEYIDQAQNRIQCAIKSLSRI--TEMQQVEAFLREGLLMR-GLNHPNVLALIGIMLPPEGLP 98 (298)
T ss_dssp EEEEEEEEEEETTEEEEEEEEECSSSCEEEEEEEEETTC--CSHHHHHHHHHHHHHHH-TCCCTTBCCCCEEECCSSSCC
T ss_pred EEccCceeccCCCceEEEEEEecCCCceeeeeeeecccc--ccHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEecCCCCc
Confidence 57778999999999999999876554 7999998753 33445566778888887 57999999999999877665
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
++||||+.+ ++|..++.. ...+++..++.++.||+.||+|||++||+||||||+|||+
T Consensus 99 ~~v~e~~~~---------------------~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i~H~dikp~Nili 157 (298)
T 3pls_A 99 HVLLPYMCH---------------------GDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAEQKFVHRDLAARNCML 157 (298)
T ss_dssp EEEECCCTT---------------------CBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE
T ss_pred EEEEecccC---------------------CCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCcceEEE
Confidence 999999984 455555554 4578999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeec----cCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIY----LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~----~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
+.+|.+||+|||+++.... .........||+.|+|||++.+..++.++|||||||++|+|++ |.+||...+..+.
T Consensus 158 ~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~~~~~~~ 237 (298)
T 3pls_A 158 DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDL 237 (298)
T ss_dssp CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCGGGH
T ss_pred cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCccCCHHHH
Confidence 9999999999999874221 1122345578899999999999999999999999999999999 6666777777777
Q ss_pred HHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 296 FWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 296 ~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
...+.... ...|..+++++.+||.+||+.||.+|| +++++++
T Consensus 238 ~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~ll~ 280 (298)
T 3pls_A 238 THFLAQGRRLPQPEYCPDSLYQVMQQCWEADPAVRP------TFRVLVG 280 (298)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHhhcCCCCCCCccchHHHHHHHHHHccCChhhCc------CHHHHHH
Confidence 77776553 556778999999999999999999999 5666664
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-44 Score=357.71 Aligned_cols=247 Identities=24% Similarity=0.335 Sum_probs=192.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC--
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS-- 139 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~-- 139 (494)
+..++|+++++||+|+||.||+|++. ++.||||++.... ........|..++. .++||||+++++++....
T Consensus 21 ~~~~~y~~~~~lg~G~~g~Vy~~~~~--~~~vavK~~~~~~----~~~~~~~~E~~~l~-~l~hpniv~~~~~~~~~~~~ 93 (322)
T 3soc_A 21 FQSMPLQLLEVKARGRFGCVWKAQLL--NEYVAVKIFPIQD----KQSWQNEYEVYSLP-GMKHENILQFIGAEKRGTSV 93 (322)
T ss_dssp ETTEEEEEEEEEECSTTCEEEEEEET--TEEEEEEEECGGG----HHHHHHHHHHHTST-TCCCTTBCCEEEEEEEECSS
T ss_pred cchhhchhhheecccCceEEEEEEEC--CCEEEEEEeecCc----hHHHHHHHHHHHHh-cCCCCCchhhcceeccCCCC
Confidence 45679999999999999999999875 6889999996542 22223334555554 579999999999998754
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC----------C
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK----------G 207 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~----------g 207 (494)
.+|+|||||++ |+|..++.. ..+++..++.++.||+.||.|||++ |
T Consensus 94 ~~~~~lv~e~~~~---------------------g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~LH~~~~~l~~~~~~~ 151 (322)
T 3soc_A 94 DVDLWLITAFHEK---------------------GSLSDFLKA-NVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPA 151 (322)
T ss_dssp SEEEEEEEECCTT---------------------CBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHTCCEEEETTEEECE
T ss_pred CceEEEEEecCCC---------------------CCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHhhccccccccCCC
Confidence 47999999994 455555544 4699999999999999999999999 9
Q ss_pred CccccCCCCceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCC-----CCCCcchHHHHHHHHHHH
Q psy8309 208 IVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGL-----KYNQCVDWWSFGILLYEM 280 (494)
Q Consensus 208 ivHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~-----~~~~~~DiwSlGvil~el 280 (494)
|+||||||+|||++.++.+||+|||+++....... .....+||+.|+|||++.+. .++.++|||||||++|||
T Consensus 152 ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el 231 (322)
T 3soc_A 152 ISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWEL 231 (322)
T ss_dssp EECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred EEeCCCChHhEEECCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHH
Confidence 99999999999999999999999999976433222 23446899999999999873 456788999999999999
Q ss_pred HhCCCCCCCCC----------------HHHHHHHHHhCC--CCCCcc-----CCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 281 HVGQSPFSGCD----------------EDELFWSICNER--PRFPQF-----LSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 281 l~G~~Pf~~~~----------------~~~~~~~i~~~~--~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
++|..||.+.. ...+...+.... +.++.. .+.++.+||.+||+.||.+|| +
T Consensus 232 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------s 305 (322)
T 3soc_A 232 ASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEECWDHDAEARL------S 305 (322)
T ss_dssp HTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHHHTCSSGGGSC------C
T ss_pred HhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHHHccCChhhCc------C
Confidence 99999997642 222333333222 222221 245699999999999999999 4
Q ss_pred hhhhhc
Q psy8309 338 GDDVVA 343 (494)
Q Consensus 338 ~~eil~ 343 (494)
+.|+++
T Consensus 306 ~~ell~ 311 (322)
T 3soc_A 306 AGCVGE 311 (322)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 566664
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=346.74 Aligned_cols=242 Identities=21% Similarity=0.252 Sum_probs=194.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++.+.||+|+||.||+|++..+++.||||++...... .....|..++.....|+++..+..++......|+
T Consensus 8 ~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~~~-----~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~l 82 (296)
T 3uzp_A 8 GNRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVM 82 (296)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEEESCSSC-----CHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEE
T ss_pred ccEEEEEEEEccCCCeEEEEEEEcCCCcEEEEEEecCCcch-----hHHHHHHHHHHHhhcCCCCCccccccCCCCceEE
Confidence 36899999999999999999999999999999998764321 2355677777754334445566666678889999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee--
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL-- 220 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl-- 220 (494)
||||+ +|+| ..++. ....+++..++.++.||+.||.|||++||+||||||+|||+
T Consensus 83 v~e~~-~~~L---------------------~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dlkp~NIl~~~ 140 (296)
T 3uzp_A 83 VMELL-GPSL---------------------EDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGL 140 (296)
T ss_dssp EEECC-CCBH---------------------HHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECC
T ss_pred EEEec-CCCH---------------------HHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHeEEec
Confidence 99999 5554 33444 34579999999999999999999999999999999999999
Q ss_pred -CCCCCEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC-
Q psy8309 221 -DYEGHVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD- 291 (494)
Q Consensus 221 -~~~g~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~- 291 (494)
+.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++|..||.+.+
T Consensus 141 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 141 GKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp GGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 4889999999999986433222 1346689999999999999999999999999999999999999998643
Q ss_pred --HHHHHHHHHhCCCCCC-----ccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 292 --EDELFWSICNERPRFP-----QFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 292 --~~~~~~~i~~~~~~~p-----~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..+.+..+.......| ..+++++.+||.+||+.||.+||++
T Consensus 221 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~ 268 (296)
T 3uzp_A 221 ATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDY 268 (296)
T ss_dssp SSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCH
T ss_pred hhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCH
Confidence 3344444444333333 6789999999999999999999943
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-44 Score=349.91 Aligned_cols=253 Identities=28% Similarity=0.418 Sum_probs=200.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC-CC--eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG-TD--YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~-~~--~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++|++++.||+|+||.||+|++.. ++ ..||||+++..........+....|..++. .++||||+++++++.+.
T Consensus 15 ~~~~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~h~~i~~~~~~~~~~ 93 (291)
T 1u46_A 15 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SLDHRNLIRLYGVVLTP 93 (291)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH-HCCCTTBCCEEEEECSS
T ss_pred cchhHeeeeeeecCCCceeEEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHH-hCCCCCcccEEEEEccC
Confidence 445799999999999999999998754 33 368999998765444556667778888887 47999999999999876
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
. .++||||+.+| +|..++.. .+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 94 ~-~~~v~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dikp~N 151 (291)
T 1u46_A 94 P-MKMVTELAPLG---------------------SLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 151 (291)
T ss_dssp S-CEEEEECCTTC---------------------BHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred C-ceeeEecccCC---------------------CHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCCcccCCCchhe
Confidence 5 89999999954 44445544 3579999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++||||||+++|+|++ |..||.+.+..
T Consensus 152 ili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~~ 231 (291)
T 1u46_A 152 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 231 (291)
T ss_dssp EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred EEEcCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCHH
Confidence 9999999999999999876432221 1234567889999999998889999999999999999999 99999999998
Q ss_pred HHHHHHHhCC--CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 294 ELFWSICNER--PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 294 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+....+.... ...+..++.+++++|.+||..||.+|| ++.++++
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~ 277 (291)
T 1u46_A 232 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP------TFVALRD 277 (291)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHccCCCCCCCcCcCHHHHHHHHHHccCCcccCc------CHHHHHH
Confidence 8888887654 344568999999999999999999999 5677775
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=346.51 Aligned_cols=245 Identities=25% Similarity=0.439 Sum_probs=199.7
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-C
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-S 139 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-~ 139 (494)
.+..++|++++.||+|+||.||+|++. ++.||||+++... ..+....|..++. .++||||+++++++... +
T Consensus 17 ~~~~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~~-----~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~ 88 (278)
T 1byg_A 17 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKG 88 (278)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHT-TCCCTTBCCEEEEECCC--
T ss_pred cCChhhceEEeEEecCCCceEEEEEEc--CCEEEEEEecchh-----HHHHHHHHHHHHH-hCCCCCEeeEEEEEEcCCC
Confidence 355689999999999999999999874 7789999997542 3445667777776 57999999999997654 5
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+||||+++| +|..++...+ .+++..+..++.||+.||.|||++||+||||||+|
T Consensus 89 ~~~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~H~dlkp~N 147 (278)
T 1byg_A 89 GLYIVTEYMAKG---------------------SLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 147 (278)
T ss_dssp CCEEEECCCTTE---------------------EHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred ceEEEEecCCCC---------------------CHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhCCccccCCCcce
Confidence 799999999954 4444554433 38999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||++.++.+||+|||++.... .......+|+.|+|||++.+..++.++||||||+++|+|++ |..||...+..+..
T Consensus 148 il~~~~~~~~l~Dfg~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~ 224 (278)
T 1byg_A 148 VLVSEDNVAKVSDFGLTKEAS---STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 224 (278)
T ss_dssp EEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred EEEeCCCcEEEeecccccccc---ccccCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 999999999999999987532 22334568999999999998899999999999999999998 99999998888887
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+..+ .+..+..+++++.++|.+||..||.+|| ++.++++
T Consensus 225 ~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~ 266 (278)
T 1byg_A 225 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP------SFLQLRE 266 (278)
T ss_dssp HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHhcCCCCCCcccCCHHHHHHHHHHhcCChhhCC------CHHHHHH
Confidence 777655 4567788999999999999999999999 4566553
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-44 Score=358.25 Aligned_cols=250 Identities=25% Similarity=0.341 Sum_probs=200.4
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||+|+++ +++.||||++... .....+....|..++. .++||||+++++++.+.+.+|
T Consensus 37 ~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~~ 111 (321)
T 2qkw_B 37 ATNNFDHKFLIGHGVFGKVYKGVLR-DGAKVALKRRTPE---SSQGIEEFETEIETLS-FCRHPHLVSLIGFCDERNEMI 111 (321)
T ss_dssp CCCCCSCCCCSCBCSSSEEEEEECT-TCCEEEEEECCSC---CSSHHHHHHHHHHGGG-SCCCTTBCCEEEECCCTTCCE
T ss_pred HHhccCccceeecCCCeeEEEEEEC-CCCEEEEEEeccc---ChHHHHHHHHHHHHHH-hCCCCCEeeEEEEEcCCCeEE
Confidence 3468999999999999999999964 6788999988754 2334556677777776 679999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh----cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ----SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~----~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+||||+++|+|.+ ++.. ...+++..+..++.||+.||.|||++||+||||||+||
T Consensus 112 lv~e~~~~~~L~~---------------------~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~ivH~dlkp~Ni 170 (321)
T 2qkw_B 112 LIYKYMENGNLKR---------------------HLYGSDLPTMSMSWEQRLEICIGAARGLHYLHTRAIIHRDVKSINI 170 (321)
T ss_dssp EEEECCTTCBTGG---------------------GSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCSTTE
T ss_pred EEEEcCCCCcHHH---------------------HHhccCCCccccCHHHHHHHHHHHHHHHHHhcCCCeecCCCCHHHE
Confidence 9999999776633 3322 23689999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
|++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++|+.||.+....+..
T Consensus 171 l~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~~ 250 (321)
T 2qkw_B 171 LLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMV 250 (321)
T ss_dssp EECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSCC
T ss_pred EECCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHHH
Confidence 99999999999999997532211 2234456999999999999889999999999999999999999999765432211
Q ss_pred -------HHHHhCC------C----CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 297 -------WSICNER------P----RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 297 -------~~i~~~~------~----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.....+. . .++...+.++.++|.+||+.||++|| ++.|+++|
T Consensus 251 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~ell~~ 309 (321)
T 2qkw_B 251 NLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRP------SMGDVLWK 309 (321)
T ss_dssp CHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCc------CHHHHHHH
Confidence 1111111 1 12234567799999999999999999 57788765
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-44 Score=355.58 Aligned_cols=251 Identities=27% Similarity=0.368 Sum_probs=205.4
Q ss_pred CCCCCceEeeEeccCCceEEEEEE----EeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE-
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAE----LKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ- 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~----~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~- 136 (494)
+..++|++++.||+|+||.||+|+ +..+++.||||++... .....+....|..++. .++||||+++++++.
T Consensus 20 ~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~ 95 (327)
T 3lxl_A 20 FEERHLKYISQLGKGNFGSVELCRYDPLGDNTGALVAVKQLQHS---GPDQQRDFQREIQILK-ALHSDFIVKYRGVSYG 95 (327)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEECTTSSSCSEEEEEEEESSC---CHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEC
T ss_pred hchhhhhhhhhccCCCCeEEEEEEeccCCCCcceEEEEEEeccC---CHHHHHHHHHHHHHHH-hcCCCceeEEEEEEec
Confidence 456799999999999999999999 4678899999999764 3344456777888887 579999999999987
Q ss_pred -cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 137 -TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 137 -~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
+...+|+||||+++ ++|..++.. ...+++..++.++.||+.||.|||++||+|||||
T Consensus 96 ~~~~~~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ivH~Dik 154 (327)
T 3lxl_A 96 PGRQSLRLVMEYLPS---------------------GCLRDFLQRHRARLDASRLLLYSSQICKGMEYLGSRRCVHRDLA 154 (327)
T ss_dssp SSSCEEEEEEECCTT---------------------CBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTEECSCCS
T ss_pred CCCceEEEEEeecCC---------------------CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCC
Confidence 45679999999994 455555554 3569999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
|+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||....
T Consensus 155 p~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 234 (327)
T 3lxl_A 155 ARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPS 234 (327)
T ss_dssp GGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred hhhEEECCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCcccc
Confidence 9999999999999999999986432221 2234568889999999999899999999999999999999999996543
Q ss_pred HH---------------HHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 ED---------------ELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~---------------~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.. .+...+.. .....|..+++++.+||.+||..||.+|| +++++++
T Consensus 235 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~ell~ 296 (327)
T 3lxl_A 235 AEFLRMMGCERDVPALSRLLELLEEGQRLPAPPACPAEVHELMKLCWAPSPQDRP------SFSALGP 296 (327)
T ss_dssp HHHHHHCC----CCHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred chhhhhcccccccccHHHHHHHhhcccCCCCCCcccHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 22 22223332 24566778999999999999999999999 4566643
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=346.13 Aligned_cols=250 Identities=26% Similarity=0.406 Sum_probs=191.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|++.. .||||+++... ......+....|..++. .++||||++++++ .....
T Consensus 20 ei~~~~y~~~~~lG~G~~g~Vy~~~~~~---~vavK~~~~~~-~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~-~~~~~ 93 (289)
T 3og7_A 20 EIPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLR-KTRHVNILLFMGY-STAPQ 93 (289)
T ss_dssp BCCTTSCEEEEEEEECSSEEEEEEESSS---EEEEEEESCSS-CCHHHHHHHHHHHHHHT-TCCCTTBCCEEEE-ECSSS
T ss_pred ccCccceeeeeEecCCCCeEEEEEEEcC---ceEEEEEeccC-CCHHHHHHHHHHHHHHH-hCCCCcEEEEEee-ccCCc
Confidence 4456799999999999999999998654 39999997653 23445566777888877 5899999999995 46677
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+++||||+.+ ++|..++. ....+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 94 ~~lv~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i~H~Dlkp~Nil 152 (289)
T 3og7_A 94 LAIVTQWCEG---------------------SSLYHHLHASETKFEMKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIF 152 (289)
T ss_dssp CEEEEECCCE---------------------EEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred cEEEEEecCC---------------------CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCcccccCccceEE
Confidence 9999999994 45555554 3457999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeec--cCCcccccCCCCCccChhhhC---CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIY--LDKTTDTFCGTPDYMAPEIIK---GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~--~~~~~~~~~gt~~y~aPE~l~---~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~ 294 (494)
++.++.+||+|||+++.... ........+||+.|+|||++. +..++.++|||||||++|+|++|..||.+.+..+
T Consensus 153 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~~ 232 (289)
T 3og7_A 153 LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRD 232 (289)
T ss_dssp EETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCCCHH
T ss_pred ECCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccchHH
Confidence 99999999999999875321 122234567999999999997 5678899999999999999999999998865544
Q ss_pred H-HHHHHhCCC-----CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 L-FWSICNERP-----RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~-~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
. ...+..... .++..+++++++||.+||..||.+|| +++++++
T Consensus 233 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~ell~ 281 (289)
T 3og7_A 233 QIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERP------SFPRILA 281 (289)
T ss_dssp HHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCC------CHHHHHH
Confidence 4 444444332 22346889999999999999999999 5666664
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-43 Score=343.49 Aligned_cols=248 Identities=25% Similarity=0.388 Sum_probs=206.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++++.||+|+||.||+|++. ++..||||++..... .......|..++. .++||||+++++++. .+..
T Consensus 10 v~~~~y~~~~~lg~G~~g~Vy~~~~~-~~~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~h~~i~~~~~~~~-~~~~ 82 (279)
T 1qpc_A 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMK-QLQHQRLVRLYAVVT-QEPI 82 (279)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHhhhheeeecCCCCeEEEEEEEc-CCcEEEEEEecCCcc----cHHHHHHHHHHHH-hCCCcCcceEEEEEc-CCCc
Confidence 44579999999999999999999975 456799999976432 2345667888877 579999999999986 4568
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
|+||||+.+|+| ..++... ..+++..+..++.||+.||+|||++||+||||||+|||
T Consensus 83 ~~v~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dikp~Nil 141 (279)
T 1qpc_A 83 YIITEYMENGSL---------------------VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (279)
T ss_dssp EEEEECCTTCBH---------------------HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EEEEecCCCCCH---------------------HHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccCCCHhhEE
Confidence 999999995544 4444433 26999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
++.++.+||+|||++........ ......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+...
T Consensus 142 ~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~ 221 (279)
T 1qpc_A 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221 (279)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred EcCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCHHHHHH
Confidence 99999999999999975332211 1233457889999999998889999999999999999999 999999998888888
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+..+ ....|..+++++.+||.+||..||.+|| +++++++
T Consensus 222 ~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~~l~~ 262 (279)
T 1qpc_A 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP------TFDYLRS 262 (279)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHhcccCCCCcccccHHHHHHHHHHhccChhhCC------CHHHHHH
Confidence 87765 4456778999999999999999999999 4566653
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=347.16 Aligned_cols=246 Identities=25% Similarity=0.381 Sum_probs=192.7
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc-CCCCceeeEEEEEEc---
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG-TKHPYLCHLFCTFQT--- 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~-~~hp~Iv~l~~~~~~--- 137 (494)
...++|++++.||+|+||.||+|++ +++.||||++... .......|..++... ++||||+++++++..
T Consensus 5 ~~~~~y~~~~~lg~G~~g~V~~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~ 76 (301)
T 3q4u_A 5 TVARDITLLECVGKGRYGEVWRGSW--QGENVAVKIFSSR------DEKSWFRETELYNTVMLRHENILGFIASDMTSRH 76 (301)
T ss_dssp CCGGGCEEEEEEEECSSEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET
T ss_pred cccCcEEEEEeeccCCCcEEEEEEE--CCEEEEEEEeccc------cchhhHHHHHHHHHhhccCcCeeeEEEeeccccC
Confidence 3457999999999999999999987 6788999998653 223344555555533 799999999998654
Q ss_pred -CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCC
Q psy8309 138 -DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH--------KKGI 208 (494)
Q Consensus 138 -~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH--------~~gi 208 (494)
...+|+||||+++| +|..++. ...+++..+..++.||+.||.||| ++||
T Consensus 77 ~~~~~~lv~e~~~~g---------------------~L~~~l~-~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~i 134 (301)
T 3q4u_A 77 SSTQLWLITHYHEMG---------------------SLYDYLQ-LTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAI 134 (301)
T ss_dssp TEEEEEEEECCCTTC---------------------BHHHHHT-TCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCEE
T ss_pred CCceeEEehhhccCC---------------------CHHHHHh-hcccCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCe
Confidence 35689999999944 5555553 457999999999999999999999 9999
Q ss_pred ccccCCCCceeeCCCCCEEEeecCceeeeeccCCc----ccccCCCCCccChhhhCCC------CCCCcchHHHHHHHHH
Q psy8309 209 VYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEIIKGL------KYNQCVDWWSFGILLY 278 (494)
Q Consensus 209 vHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~------~~~~~~DiwSlGvil~ 278 (494)
+||||||+|||++.++.+||+|||+++........ ....+||+.|+|||++.+. .++.++|||||||++|
T Consensus 135 vH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~ 214 (301)
T 3q4u_A 135 AHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLW 214 (301)
T ss_dssp ECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHH
T ss_pred ecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHH
Confidence 99999999999999999999999999764332221 2345899999999999887 4557999999999999
Q ss_pred HHHhC----------CCCCCCCC----HHHHHHHHHhC---CCCCCc-----cCCHHHHHHHHhhccCCCCCCCCCCCCC
Q psy8309 279 EMHVG----------QSPFSGCD----EDELFWSICNE---RPRFPQ-----FLSVEAKNILVHLLDKDTTKRLGSTQCN 336 (494)
Q Consensus 279 ell~G----------~~Pf~~~~----~~~~~~~i~~~---~~~~p~-----~~s~~~~~li~~lL~~dP~~R~~~~~~~ 336 (494)
||++| ..||.... .......+... .+.+|. ..++++.+||.+||+.||.+||
T Consensus 215 el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------ 288 (301)
T 3q4u_A 215 EVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTSLAKLMKECWYQNPSARL------ 288 (301)
T ss_dssp HHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHCCSSGGGSC------
T ss_pred HHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHHHHHHHHHHhhcChhhCC------
Confidence 99999 89996532 22333333322 233332 2557899999999999999999
Q ss_pred Chhhhhc
Q psy8309 337 SGDDVVA 343 (494)
Q Consensus 337 ~~~eil~ 343 (494)
++.++++
T Consensus 289 s~~~i~~ 295 (301)
T 3q4u_A 289 TALRIKK 295 (301)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 5666664
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.8e-43 Score=378.50 Aligned_cols=245 Identities=24% Similarity=0.331 Sum_probs=203.1
Q ss_pred CCCCceEee-EeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLK-VLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~-~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
..+++.+.+ .||+|+||.||+|.++. ++..||||++++. ......+....|..++. .++|||||++++++.. +
T Consensus 333 ~~~~~~~~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~-~l~hpniv~l~~~~~~-~ 408 (613)
T 2ozo_A 333 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMH-QLDNPYIVRLIGVCQA-E 408 (613)
T ss_dssp CTTSEEEEEEEEEECSSSEEEEEEEECSSCEEEEEEEECCCC--CSSTTHHHHHHHHHHHT-TCCCTTBCCEEEEEES-S
T ss_pred cccceeEcCcEEecCCCcEEEEEEEecCCCcEEEEEEEcCCC--CChHHHHHHHHHHHHHH-hCCCCCEeeEEEEecc-C
Confidence 345677776 89999999999998863 5667999999865 23345567788888887 5799999999999986 5
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
.+|+|||||.+ |+|..++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 409 ~~~lv~E~~~~---------------------g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~iiHrDlkp~NI 467 (613)
T 2ozo_A 409 ALMLVMEMAGG---------------------GPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRNLAARNV 467 (613)
T ss_dssp SEEEEEECCTT---------------------CBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred CeEEEEEeCCC---------------------CcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCcCCHHHE
Confidence 69999999994 455555543 35699999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
||+.++.+||+|||+++....... ......+|+.|+|||++.+..|+.++|||||||+||||++ |..||.+.+..+
T Consensus 468 Ll~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~ 547 (613)
T 2ozo_A 468 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 547 (613)
T ss_dssp EEEETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCSHH
T ss_pred EEcCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCHHH
Confidence 999999999999999975322111 1123346789999999998899999999999999999998 999999998888
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+...|..+ .+.+|..+++++.+||.+||..||.+||++
T Consensus 548 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~ 586 (613)
T 2ozo_A 548 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDF 586 (613)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSTTTSCCH
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCChhHCcCH
Confidence 88888765 456788899999999999999999999954
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-44 Score=355.90 Aligned_cols=249 Identities=22% Similarity=0.339 Sum_probs=182.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE------
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ------ 136 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~------ 136 (494)
...+|++.++||+|+||.||+|+++.+++.||||++.+. ..........|..++....+||||+++++++.
T Consensus 26 ~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~ 102 (337)
T 3ll6_A 26 GELRLRVRRVLAEGGFAFVYEAQDVGSGREYALKRLLSN---EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEES 102 (337)
T ss_dssp TTEEEEEEEEEECCSSEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTS
T ss_pred cCceEEEEEEEccCCceEEEEEEECCCCcEEEEEEecCC---chHHHHHHHHHHHHHHHhccCCChhhcccccccccccc
Confidence 345899999999999999999999999999999998654 33444566778888876557999999999994
Q ss_pred --cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCC--Cc
Q psy8309 137 --TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ---QSGRFDEGRARFYAAEIVSGMRFLHKKG--IV 209 (494)
Q Consensus 137 --~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~yLH~~g--iv 209 (494)
....+++||||+. | +|..++. ..+.+++..++.++.||+.||.|||++| |+
T Consensus 103 ~~~~~~~~lv~e~~~-g---------------------~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~~~iv 160 (337)
T 3ll6_A 103 DTGQAEFLLLTELCK-G---------------------QLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPII 160 (337)
T ss_dssp TTSSEEEEEEEECCS-E---------------------EHHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHTSSSCCB
T ss_pred ccCCceEEEEEEecC-C---------------------CHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCEE
Confidence 4456899999995 3 3333333 3567999999999999999999999999 99
Q ss_pred cccCCCCceeeCCCCCEEEeecCceeeeeccCC------------cccccCCCCCccChhhh---CCCCCCCcchHHHHH
Q psy8309 210 YRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK------------TTDTFCGTPDYMAPEII---KGLKYNQCVDWWSFG 274 (494)
Q Consensus 210 HrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~------------~~~~~~gt~~y~aPE~l---~~~~~~~~~DiwSlG 274 (494)
||||||+||||+.++.+||+|||+++....... .....+||+.|+|||++ .+..++.++||||||
T Consensus 161 H~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG 240 (337)
T 3ll6_A 161 HRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALG 240 (337)
T ss_dssp CCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTSCSSHHHHHHHHH
T ss_pred EccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHH
Confidence 999999999999999999999999975322111 11255799999999998 566789999999999
Q ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 275 ILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 275 vil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
|++|+|++|..||.+........... ....+...+..+.+||.+||+.||.+|| +++|+++|
T Consensus 241 ~il~el~~g~~p~~~~~~~~~~~~~~--~~~~~~~~~~~~~~li~~~l~~~p~~Rp------s~~e~l~~ 302 (337)
T 3ll6_A 241 CILYLLCFRQHPFEDGAKLRIVNGKY--SIPPHDTQYTVFHSLIRAMLQVNPEERL------SIAEVVHQ 302 (337)
T ss_dssp HHHHHHHHSSCCC------------C--CCCTTCCSSGGGHHHHHHHSCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHHhCCCCCcchhHHHhhcCcc--cCCcccccchHHHHHHHHHccCChhhCc------CHHHHHHH
Confidence 99999999999998765443332221 2233456788899999999999999999 67888876
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=346.46 Aligned_cols=249 Identities=23% Similarity=0.364 Sum_probs=203.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE-EcCCe
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF-QTDSH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~-~~~~~ 140 (494)
..|++.+.||+|+||.||+|++..+ ...||+|.+.+. ...........|..++. .++||||+++++++ ..++.
T Consensus 25 ~~y~~~~~lg~G~~g~Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 101 (298)
T 3f66_A 25 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSEGS 101 (298)
T ss_dssp EEEEEEEEEEEETTEEEEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHH-TCCCTTBCCCCEEECCSSSC
T ss_pred eehhhcceeeecCCceEEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHH-hCCCCCEeeeeeEEEcCCCc
Confidence 4799999999999999999997543 346899998753 33445566778888877 57999999999985 55678
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.|+||||+.+ ++|..++.. ...+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 102 ~~~v~e~~~~---------------------~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~~~i~H~dikp~Nil 160 (298)
T 3f66_A 102 PLVVLPYMKH---------------------GDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCM 160 (298)
T ss_dssp CEEEEECCTT---------------------CBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred eEEEEeCCCC---------------------CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEE
Confidence 9999999994 455556654 456899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC----CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD----KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|+|++ |.+||.+.+..+
T Consensus 161 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~~ 240 (298)
T 3f66_A 161 LDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 240 (298)
T ss_dssp ECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCTTT
T ss_pred ECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCHHH
Confidence 9999999999999987532211 12334567889999999999999999999999999999999 778888887777
Q ss_pred HHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 LFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
....+..+.. ..|..++.++.++|.+||..||.+|| ++.++++
T Consensus 241 ~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------s~~ell~ 284 (298)
T 3f66_A 241 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP------SFSELVS 284 (298)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 7777766543 45678899999999999999999999 4666664
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=346.35 Aligned_cols=243 Identities=27% Similarity=0.400 Sum_probs=203.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------- 137 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------- 137 (494)
.+|++++.||+|+||.||+|+++.+++.||||++.... .....|..++. .++||||+++++++..
T Consensus 11 ~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~-~l~h~~i~~~~~~~~~~~~~~~~ 82 (284)
T 2a19_B 11 MDFKEIELIGSGGFGQVFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALA-KLDHVNIVHYNGCWDGFDYDPET 82 (284)
T ss_dssp HHEEEEEEEECSSSCCEEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHH-HCCCTTBCCEEEEEEEEEEC---
T ss_pred cccceeeeeccCCceEEEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHH-hCCCCCEEEEeeeEeccccCccc
Confidence 57999999999999999999999999999999997542 12345666766 5799999999999865
Q ss_pred ---------CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy8309 138 ---------DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKK 206 (494)
Q Consensus 138 ---------~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~ 206 (494)
...+|+||||+++| +|..++.. ...+++..++.++.||+.||.|||++
T Consensus 83 ~~~~~~~~~~~~~~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 141 (284)
T 2a19_B 83 SSKNSSRSKTKCLFIQMEFCDKG---------------------TLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSK 141 (284)
T ss_dssp ------CCEEEEEEEEECCCCSC---------------------BHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccccccccCcceEEEEEeccCCC---------------------CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 45689999999944 55555543 36799999999999999999999999
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCC
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSP 286 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~P 286 (494)
||+||||||+|||++.++.+||+|||+++.... .......+||+.|+|||++.+..++.++|||||||++|+|++|..|
T Consensus 142 ~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~ 220 (284)
T 2a19_B 142 KLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKN-DGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDT 220 (284)
T ss_dssp TEECSCCSGGGEEEEETTEEEECCCTTCEESSC-CSCCCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSS
T ss_pred CeeeccCCHHHEEEcCCCCEEECcchhheeccc-cccccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCc
Confidence 999999999999999999999999999876332 3334456799999999999999999999999999999999999998
Q ss_pred CCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 287 FSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 287 f~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
|... ......+... .++..++.++++||.+||..||.+|| ++.|+++|.+.
T Consensus 221 ~~~~--~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rp------s~~e~l~~l~~ 271 (284)
T 2a19_B 221 AFET--SKFFTDLRDG--IISDIFDKKEKTLLQKLLSKKPEDRP------NTSEILRTLTV 271 (284)
T ss_dssp HHHH--HHHHHHHHTT--CCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHHHHH
T ss_pred chhH--HHHHHHhhcc--cccccCCHHHHHHHHHHccCChhhCc------CHHHHHHHHHH
Confidence 8532 2334444433 35677899999999999999999999 68899988764
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=346.06 Aligned_cols=243 Identities=26% Similarity=0.499 Sum_probs=194.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.++.++|++.+.||+|+||.||+|++. ++.||||++... ...+....|..++. .++||||+++++++. +.
T Consensus 4 ~i~~~~~~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~--~~ 73 (307)
T 2eva_A 4 MIDYKEIEVEEVVGRGAFGVVCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLS-RVNHPNIVKLYGACL--NP 73 (307)
T ss_dssp BCCGGGEEEEEEEECCSSSEEEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHH-HCCCTTBCCEEEBCT--TT
T ss_pred cCCHhHeeeeeEeecCCCceEEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHh-cCCCCCcCeEEEEEc--CC
Confidence 356789999999999999999999875 677999998643 23455677887877 579999999999886 45
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHh---CCCccccCC
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG---RFDEGRARFYAAEIVSGMRFLHK---KGIVYRDLK 214 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~yLH~---~givHrDLK 214 (494)
.|+||||++|| +|..++.... .+++..+..++.||+.||.|||+ +||+|||||
T Consensus 74 ~~lv~e~~~~~---------------------~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlk 132 (307)
T 2eva_A 74 VCLVMEYAEGG---------------------SLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLK 132 (307)
T ss_dssp TEEEEECCTTC---------------------BHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCS
T ss_pred cEEEEEcCCCC---------------------CHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCC
Confidence 89999999954 4455555443 47889999999999999999999 899999999
Q ss_pred CCceeeCCCCC-EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC--
Q psy8309 215 LDNILLDYEGH-VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD-- 291 (494)
Q Consensus 215 p~NILl~~~g~-vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~-- 291 (494)
|+|||++.++. +||+|||++.... .......||+.|+|||++.+..++.++|||||||++|||++|..||....
T Consensus 133 p~NIll~~~~~~~kl~Dfg~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~~ 209 (307)
T 2eva_A 133 PPNLLLVAGGTVLKICDFGTACDIQ---THMTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGP 209 (307)
T ss_dssp GGGEEEETTTTEEEECCCCC---------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTTCSS
T ss_pred hhHEEEeCCCCEEEEcccccccccc---cccccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhhCcc
Confidence 99999999887 7999999987432 22334579999999999999999999999999999999999999998543
Q ss_pred HHHHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.......+.. ..+.++..++..+.+||.+||+.||.+|| +++++++
T Consensus 210 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~ell~ 256 (307)
T 2eva_A 210 AFRIMWAVHNGTRPPLIKNLPKPIESLMTRCWSKDPSQRP------SMEEIVK 256 (307)
T ss_dssp HHHHHHHHHTTCCCCCBTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHHhcCCCCCcccccCHHHHHHHHHHhcCChhhCc------CHHHHHH
Confidence 3334444443 34566778999999999999999999999 5677765
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-43 Score=380.45 Aligned_cols=243 Identities=27% Similarity=0.347 Sum_probs=203.1
Q ss_pred CceEe-eEeccCCceEEEEEEE--eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 66 DFQLL-KVLGKGSFGKVFLAEL--KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 66 ~y~~~-~~LG~G~fG~V~~~~~--~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
.+.+. +.||+|+||.||+|.+ +.+++.||||+++... ......+....|..++. .++|||||++++++.. +.++
T Consensus 369 ~~~l~~~~LG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~-~l~hpnIv~l~~~~~~-~~~~ 445 (635)
T 4fl3_A 369 LLTLEDKELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQ-QLDNPYIVRMIGICEA-ESWM 445 (635)
T ss_dssp GEEEEEEEEEECSSEEEEEEEEECSSCEEEEEEEEECGGG-GCGGGHHHHHHHHHHHH-HCCCTTBCCEEEEEES-SSEE
T ss_pred hccccCCEeccCCCEEEEEEEEcCCCcceEEEEEEecccc-CCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEec-CCEE
Confidence 34443 4899999999999965 4567889999997653 23344567788888888 4789999999999975 5689
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|||||. ||+|..++...+.+++..++.++.||+.||+|||++|||||||||+||||+.
T Consensus 446 lv~E~~~---------------------~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~iiHrDLkp~NILl~~ 504 (635)
T 4fl3_A 446 LVMEMAE---------------------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVT 504 (635)
T ss_dssp EEEECCT---------------------TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEEE
T ss_pred EEEEccC---------------------CCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCEeCCCCChHhEEEeC
Confidence 9999999 5666777878888999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWS 298 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~ 298 (494)
++.+||+|||+++...... .......||+.|+|||++.+..|+.++|||||||++|||++ |..||.+.+..++...
T Consensus 505 ~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~~~~~~~ 584 (635)
T 4fl3_A 505 QHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAM 584 (635)
T ss_dssp TTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHH
T ss_pred CCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHH
Confidence 9999999999987532211 11233457889999999999999999999999999999998 9999999999888888
Q ss_pred HHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 299 ICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 299 i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
+..+ ....|..+++++.+||.+||..||.+||++
T Consensus 585 i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RPs~ 619 (635)
T 4fl3_A 585 LEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGF 619 (635)
T ss_dssp HHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred HHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCcCH
Confidence 8765 456788999999999999999999999943
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=351.30 Aligned_cols=252 Identities=23% Similarity=0.315 Sum_probs=199.0
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE----c
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ----T 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~----~ 137 (494)
+..++|++++.||+|+||.||+|+++.+++.||||++... ..........|..++. .++||||+++++++. .
T Consensus 26 i~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 101 (317)
T 2buj_A 26 IDNKHYLFIQKLGEGGFSYVDLVEGLHDGHFYALKRILCH---EQQDREEAQREADMHR-LFNHPNILRLVAYCLRERGA 101 (317)
T ss_dssp ETTEEEEEEEEEEC--CEEEEEEEETTTCCEEEEEEEEES---SHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEEEETT
T ss_pred ECCeEEEEEEEecCCCCeEEEEEEecCCCcEEEEEEEecC---CHHHHHHHHHHHHHHh-hcCCCCeeeEEEEEEeccCC
Confidence 3456899999999999999999999999999999998653 3345556677888777 579999999999987 3
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
...+|+||||+.+|+| ..++. ....+++..++.++.||+.||.|||++||+||||
T Consensus 102 ~~~~~lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ivH~dl 160 (317)
T 2buj_A 102 KHEAWLLLPFFKRGTL---------------------WNEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDL 160 (317)
T ss_dssp EEEEEEEEECCTTCBH---------------------HHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCC
T ss_pred CceeEEEEEeCCCCcH---------------------HHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCC
Confidence 4589999999996555 33343 3567999999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCC---------cccccCCCCCccChhhhCCCC---CCCcchHHHHHHHHHHHH
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDK---------TTDTFCGTPDYMAPEIIKGLK---YNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~---------~~~~~~gt~~y~aPE~l~~~~---~~~~~DiwSlGvil~ell 281 (494)
||+|||++.++.+||+|||++........ ......||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 161 kp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~ 240 (317)
T 2buj_A 161 KPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMM 240 (317)
T ss_dssp CGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHH
T ss_pred CHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999998875321110 012346899999999998654 689999999999999999
Q ss_pred hCCCCCCCCC--HHHHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 282 VGQSPFSGCD--EDELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 282 ~G~~Pf~~~~--~~~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+|..||.... .......+.. .....+..++.++.+||.+||+.||.+|| +++++++|
T Consensus 241 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------s~~~ll~~ 300 (317)
T 2buj_A 241 FGEGPYDMVFQKGDSVALAVQNQLSIPQSPRHSSALWQLLNSMMTVDPHQRP------HIPLLLSQ 300 (317)
T ss_dssp HSSCTTHHHHHTTSCHHHHHHCC--CCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred hCCCChhhhhcccchhhHHhhccCCCCccccCCHHHHHHHHHHhhcChhhCC------CHHHHHHH
Confidence 9999995421 1112222222 12233457899999999999999999999 57888864
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=360.69 Aligned_cols=250 Identities=24% Similarity=0.358 Sum_probs=197.6
Q ss_pred CCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE-cCCe
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ-TDSH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~-~~~~ 140 (494)
..|++.+.||+|+||.||+|+...+ +..||||.++.. ...........|..++. .++||||+++++++. .++.
T Consensus 89 ~~~~~~~~LG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~ 165 (373)
T 3c1x_A 89 LIVHFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSEGS 165 (373)
T ss_dssp EEEEEEEEEECCSSSEEEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTST-TCCCTTBCCCCEEECCCSSC
T ss_pred ceeecCcEeeeCCCeEEEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHH-hCCCCCcceEEEEEEcCCCC
Confidence 3588999999999999999998643 346899998753 23445566777877776 579999999999865 4568
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.|+||||++ ||+|..++... ..+++..+..++.||+.||.|||++||+||||||+|||
T Consensus 166 ~~lv~e~~~---------------------~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIl 224 (373)
T 3c1x_A 166 PLVVLPYMK---------------------HGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCM 224 (373)
T ss_dssp CEEEEECCT---------------------TCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEE
T ss_pred eEEEEECCC---------------------CCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHHCCEecCccchheEE
Confidence 899999999 44555566544 46899999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC----CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD----KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~----~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 225 l~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~~~ 304 (373)
T 3c1x_A 225 LDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 304 (373)
T ss_dssp ECTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCSSC
T ss_pred ECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCHHH
Confidence 9999999999999997532211 11233467889999999999999999999999999999999 789998877777
Q ss_pred HHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 295 LFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 295 ~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
....+..+. ...|..++.++.++|.+||..||.+|| ++.+++++
T Consensus 305 ~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dp~~RP------s~~ell~~ 349 (373)
T 3c1x_A 305 ITVYLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP------SFSELVSR 349 (373)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhhCc------CHHHHHHH
Confidence 776776653 455778999999999999999999999 56777653
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=365.12 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=205.4
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|.++.+ ..||||+++.... ..+....|..++. .++||||+++++++.+ +.
T Consensus 180 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~-~~ 252 (452)
T 1fmk_A 180 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EP 252 (452)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTT-EEEEEEECCTTSS----CHHHHHHHHHHHH-HCCCTTBCCEEEEECS-SS
T ss_pred ccChhHceeeeeecCCCCeEEEEEEECCC-ceEEEEEeccCCC----CHHHHHHHHHHHH-hCCCCCEeeEEEEEcC-Cc
Confidence 45567899999999999999999998765 5599999976432 2345677888887 5799999999999876 78
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+|||||++|+ |..++.. ...+++..+..++.||+.||+|||++||+||||||+||
T Consensus 253 ~~iv~e~~~~gs---------------------L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivHrDlkp~Ni 311 (452)
T 1fmk_A 253 IYIVTEYMSKGS---------------------LLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 311 (452)
T ss_dssp CEEEECCCTTCB---------------------HHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eEEEehhhcCCC---------------------HHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCChhhE
Confidence 999999999554 4445543 35699999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
|++.++.+||+|||+++...... .......||+.|+|||++.+..++.++|||||||++|||++ |..||.+.+..+..
T Consensus 312 ll~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~~~~~ 391 (452)
T 1fmk_A 312 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 391 (452)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EECCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999997532211 11233457789999999998899999999999999999999 99999999988888
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+..+ ....|..+++++.+||.+||..||.+|| +++++++
T Consensus 392 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------t~~~l~~ 433 (452)
T 1fmk_A 392 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP------TFEYLQA 433 (452)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHccCChhhCc------CHHHHHH
Confidence 888765 4566788999999999999999999999 4666664
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=347.95 Aligned_cols=230 Identities=28% Similarity=0.454 Sum_probs=189.1
Q ss_pred CCCCceEe-eEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----
Q psy8309 63 DLEDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT---- 137 (494)
Q Consensus 63 ~~~~y~~~-~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~---- 137 (494)
..++|.++ ++||+|+||.||+|.++.+++.||||++... .....|..++....+||||+++++++..
T Consensus 15 ~~~~y~~~~~~lg~G~~g~V~~~~~~~~~~~vaiK~~~~~--------~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~ 86 (299)
T 3m2w_A 15 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 86 (299)
T ss_dssp GGGTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccchhhcCcccccCCCeEEEEEEEcCCCcEEEEEEeccc--------HHHHHHHHHHHHhccCCCchhHHhhhhhhcCC
Confidence 35689888 7899999999999999999999999999643 2345666677667799999999999987
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC--CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG--RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~--~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
...+|+||||++ |++|..++...+ .+++..++.++.||+.||.|||++||+||||||
T Consensus 87 ~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~H~dlkp 145 (299)
T 3m2w_A 87 RKCLLIVMECLD---------------------GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 145 (299)
T ss_dssp EEEEEEEECCCC---------------------SCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CceEEEEEeecC---------------------CCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCCCH
Confidence 778999999999 455555665543 699999999999999999999999999999999
Q ss_pred CceeeCC---CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 216 DNILLDY---EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~---~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
+|||++. ++.+||+|||++.... +..|+.++|||||||++|||++|..||.+.+.
T Consensus 146 ~Nil~~~~~~~~~~kl~Dfg~a~~~~----------------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 146 ENLLYTSKRPNAILKLTDFGFAKETT----------------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp GGEEESSSSTTCCEEECCCTTCEECT----------------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred HHEEEecCCCCCcEEEeccccccccc----------------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9999998 7899999999986421 24578899999999999999999999987665
Q ss_pred HHHHHH----HHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 293 DELFWS----ICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 293 ~~~~~~----i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
...... +......+| ..+++++++||.+||..||.+|| +++|+++||||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rp------s~~e~l~hp~~~~ 262 (299)
T 3m2w_A 204 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM------TITEFMNHPWIMQ 262 (299)
T ss_dssp ----CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSC------CHHHHHTSHHHHT
T ss_pred hhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCC------CHHHHhcChhhcc
Confidence 443221 222333444 46899999999999999999999 6899999999975
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=358.00 Aligned_cols=238 Identities=16% Similarity=0.174 Sum_probs=188.5
Q ss_pred CCCCCceEeeEeccCCceEEEEE-----EEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc--CCCCceeeEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLA-----ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG--TKHPYLCHLFCT 134 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~-----~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~--~~hp~Iv~l~~~ 134 (494)
...++|++.+.||+|+||.||+| .+..+++.||||+++... ......|..++... ..|+||++++++
T Consensus 62 ~~~~~y~~~~~lG~G~~g~Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~ 135 (365)
T 3e7e_A 62 LGSKLVYVHHLLGEGAFAQVYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSA 135 (365)
T ss_dssp CSSSEEEEEEEEEECSSEEEEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEE
T ss_pred ECCEEEEEEEEeeccCCEEEEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhhee
Confidence 44578999999999999999999 467788999999997542 22334455554432 239999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-----hcCCCCHHHHHHHHHHHHHHHHHHHhCCCc
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-----QSGRFDEGRARFYAAEIVSGMRFLHKKGIV 209 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-----~~~~l~e~~~~~~~~qi~~aL~yLH~~giv 209 (494)
+...+..|+|||||+||+| ..++. ....+++..++.++.||+.||+|||++|||
T Consensus 136 ~~~~~~~~lv~e~~~~g~L---------------------~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~iv 194 (365)
T 3e7e_A 136 HLFQNGSVLVGELYSYGTL---------------------LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHDCEII 194 (365)
T ss_dssp EECSSCEEEEECCCCSCBH---------------------HHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred eecCCCcEEEEeccCCCcH---------------------HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 9999999999999995554 44554 346799999999999999999999999999
Q ss_pred cccCCCCceeeCC-----------CCCEEEeecCceeeee--ccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHH
Q psy8309 210 YRDLKLDNILLDY-----------EGHVRIADFGMCKLQI--YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGIL 276 (494)
Q Consensus 210 HrDLKp~NILl~~-----------~g~vkL~DFGla~~~~--~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi 276 (494)
||||||+||||+. ++.+||+|||+|+... .........+||+.|+|||++.+..|+.++|||||||+
T Consensus 195 HrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~i 274 (365)
T 3e7e_A 195 HGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAAT 274 (365)
T ss_dssp CCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHH
T ss_pred cCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHH
Confidence 9999999999998 8999999999997532 12233456789999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCc-cCCHHHHHHHHhhccCCCCCCCC
Q psy8309 277 LYEMHVGQSPFSGCDEDELFWSICNERPRFPQ-FLSVEAKNILVHLLDKDTTKRLG 331 (494)
Q Consensus 277 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~-~~s~~~~~li~~lL~~dP~~R~~ 331 (494)
+|||++|+.||........ .+ ...++. ..++.+.+++..||..+|.+|+.
T Consensus 275 l~elltg~~pf~~~~~~~~--~~---~~~~~~~~~~~~~~~~~~~~l~~~p~~r~~ 325 (365)
T 3e7e_A 275 VYCMLFGTYMKVKNEGGEC--KP---EGLFRRLPHLDMWNEFFHVMLNIPDCHHLP 325 (365)
T ss_dssp HHHHHHSSCCCEEEETTEE--EE---CSCCTTCSSHHHHHHHHHHHHCCCCTTCCC
T ss_pred HHHHHhCCCccccCCCCce--ee---chhccccCcHHHHHHHHHHHcCCCCCCcch
Confidence 9999999999965432110 00 011111 24678999999999999999984
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-43 Score=356.99 Aligned_cols=244 Identities=17% Similarity=0.215 Sum_probs=194.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCC--------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceee----
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGT--------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH---- 130 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~--------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~---- 130 (494)
..++|++.+.||+|+||.||+|+++.+ ++.||||++.+. .....|..++. .++||||++
T Consensus 40 ~~~~y~~~~~lg~G~~g~Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~-~l~h~niv~~~~~ 110 (352)
T 2jii_A 40 SGRQWKLKSFQTRDNQGILYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQ-RAAKPLQVNKWKK 110 (352)
T ss_dssp TSCEEEEEEEEEEETTEEEEEEEECC-----------CEEEEEEETT--------STHHHHHHHHH-HHCCHHHHHHHHH
T ss_pred cCCeEEEEEEecCCCCeEEEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHH-Hhcccchhhhhhh
Confidence 357999999999999999999999874 789999999754 13456666666 357888876
Q ss_pred -----------EEEEEEc-CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHH
Q psy8309 131 -----------LFCTFQT-DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEI 196 (494)
Q Consensus 131 -----------l~~~~~~-~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi 196 (494)
+++++.. ...+|+||||+ +|+| ..++... +.+++..++.++.||
T Consensus 111 ~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L---------------------~~~l~~~~~~~l~~~~~~~i~~qi 168 (352)
T 2jii_A 111 LYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSL---------------------QSALDVSPKHVLSERSVLQVACRL 168 (352)
T ss_dssp HTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEH---------------------HHHHHHSGGGCCCHHHHHHHHHHH
T ss_pred hccCCccCccchhhccccCCcEEEEEecCC-CcCH---------------------HHHHHhCCcCCCCHHHHHHHHHHH
Confidence 6677765 78999999999 5544 4455554 689999999999999
Q ss_pred HHHHHHHHhCCCccccCCCCceeeCCCC--CEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCc
Q psy8309 197 VSGMRFLHKKGIVYRDLKLDNILLDYEG--HVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQC 267 (494)
Q Consensus 197 ~~aL~yLH~~givHrDLKp~NILl~~~g--~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~ 267 (494)
+.||.|||++||+||||||+|||++.++ .+||+|||+++...... ......+||+.|+|||++.+..++.+
T Consensus 169 ~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 248 (352)
T 2jii_A 169 LDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRR 248 (352)
T ss_dssp HHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHH
T ss_pred HHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHccCCCCch
Confidence 9999999999999999999999999998 89999999997533211 12244589999999999999999999
Q ss_pred chHHHHHHHHHHHHhCCCCCCCCC--HHHHHHHH---HhCCCCCC------ccCCHHHHHHHHhhccCCCCCCCCCCCCC
Q psy8309 268 VDWWSFGILLYEMHVGQSPFSGCD--EDELFWSI---CNERPRFP------QFLSVEAKNILVHLLDKDTTKRLGSTQCN 336 (494)
Q Consensus 268 ~DiwSlGvil~ell~G~~Pf~~~~--~~~~~~~i---~~~~~~~p------~~~s~~~~~li~~lL~~dP~~R~~~~~~~ 336 (494)
+|||||||++|||++|..||.+.. ...+...+ ......++ ..++.++++||.+||..||.+||
T Consensus 249 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp------ 322 (352)
T 2jii_A 249 SDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP------ 322 (352)
T ss_dssp HHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC------
T ss_pred hhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC------
Confidence 999999999999999999998753 33333322 22333332 24699999999999999999999
Q ss_pred Chhhhhc
Q psy8309 337 SGDDVVA 343 (494)
Q Consensus 337 ~~~eil~ 343 (494)
+++++++
T Consensus 323 s~~~l~~ 329 (352)
T 2jii_A 323 PYAMLRN 329 (352)
T ss_dssp CHHHHHH
T ss_pred CHHHHHH
Confidence 4566653
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=348.62 Aligned_cols=245 Identities=25% Similarity=0.376 Sum_probs=192.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-cCCCCceeeEEEEEEcC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQTD---- 138 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-~~~hp~Iv~l~~~~~~~---- 138 (494)
.++|++++.||+|+||.||+|+++ ++.||||++... .......|..++.. .++||||+++++++...
T Consensus 36 ~~~y~~~~~lg~G~~g~V~~~~~~--~~~vavK~~~~~------~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~ 107 (337)
T 3mdy_A 36 AKQIQMVKQIGKGRYGEVWMGKWR--GEKVAVKVFFTT------EEASWFRETEIYQTVLMRHENILGFIAADIKGTGSW 107 (337)
T ss_dssp HHHCEEEEEEEEETTEEEEEEEET--TEEEEEEEEEGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGG
T ss_pred ccceEEEeEeecCCCeEEEEEEEC--CceEEEEEEecc------ccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCC
Confidence 468999999999999999999875 788999998643 12233445555543 35999999999999887
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------CCcc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK--------GIVY 210 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~--------givH 210 (494)
..+|+||||+++ |+|..++.. ..+++..++.++.||+.||.|||++ ||+|
T Consensus 108 ~~~~lv~e~~~~---------------------g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH 165 (337)
T 3mdy_A 108 TQLYLITDYHEN---------------------GSLYDYLKS-TTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAH 165 (337)
T ss_dssp CEEEEEECCCTT---------------------CBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCBCCEEC
T ss_pred CceEEEEeccCC---------------------CcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCEEe
Confidence 789999999994 455555543 4799999999999999999999999 9999
Q ss_pred ccCCCCceeeCCCCCEEEeecCceeeeeccCCc----ccccCCCCCccChhhhCCCCCCCc------chHHHHHHHHHHH
Q psy8309 211 RDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT----TDTFCGTPDYMAPEIIKGLKYNQC------VDWWSFGILLYEM 280 (494)
Q Consensus 211 rDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~----~~~~~gt~~y~aPE~l~~~~~~~~------~DiwSlGvil~el 280 (494)
|||||+|||++.++.+||+|||+++........ ....+||+.|+|||++.+..++.. +|||||||++|||
T Consensus 166 ~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el 245 (337)
T 3mdy_A 166 RDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV 245 (337)
T ss_dssp SCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHH
Confidence 999999999999999999999999753322211 235689999999999998777765 9999999999999
Q ss_pred HhC----------CCCCCCCC----HHHHHHHHH-h--CCCCCCc-----cCCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 281 HVG----------QSPFSGCD----EDELFWSIC-N--ERPRFPQ-----FLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 281 l~G----------~~Pf~~~~----~~~~~~~i~-~--~~~~~p~-----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
++| ..||.... .......+. . ..+.+|. .+++++.+||.+||+.||.+|| ++
T Consensus 246 ~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~ 319 (337)
T 3mdy_A 246 ARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQMGKLMTECWAHNPASRL------TA 319 (337)
T ss_dssp HTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHHHHHHHHHHSCSSGGGSC------CH
T ss_pred HhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHHHHHHHHHhhhhChhhCC------CH
Confidence 999 77776432 122222222 2 2334443 4567799999999999999999 56
Q ss_pred hhhhcC
Q psy8309 339 DDVVAH 344 (494)
Q Consensus 339 ~eil~h 344 (494)
.++++|
T Consensus 320 ~ell~~ 325 (337)
T 3mdy_A 320 LRVKKT 325 (337)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 777764
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=346.41 Aligned_cols=246 Identities=26% Similarity=0.336 Sum_probs=198.5
Q ss_pred CceEeeEeccCCceEEEEEEE----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAEL----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DS 139 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~ 139 (494)
.|++++.||+|+||.||+|.. ..+++.||||++++. ...........|..++. .++||||+++++++.+ ..
T Consensus 32 ~~~~~~~lG~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~~~~~~ 108 (318)
T 3lxp_A 32 YLKKIRDLGEGHFGKVSLYCYDPTNDGTGEMVAVKALKAD--AGPQHRSGWKQEIDILR-TLYHEHIIKYKGCCEDAGAA 108 (318)
T ss_dssp GEEEEEEEEECSSEEEEEEEECSCC--CCEEEEEEEECTT--CCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTTT
T ss_pred HHhhhheecCCCCeEEEEEEEccCCCCCCcEEEEEEeccc--cChHHHHHHHHHHHHHH-hCCCcchhhEEEEEecCCCc
Confidence 459999999999999988764 457889999999865 23344566778888887 5789999999999987 46
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
.+|+||||+++ ++|..++.. ..+++..++.++.||+.||.|||++||+||||||+|||
T Consensus 109 ~~~lv~e~~~~---------------------~~L~~~l~~-~~~~~~~~~~i~~~l~~~l~~LH~~~ivH~Dikp~Nil 166 (318)
T 3lxp_A 109 SLQLVMEYVPL---------------------GSLRDYLPR-HSIGLAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVL 166 (318)
T ss_dssp EEEEEECCCTT---------------------CBHHHHGGG-SCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred eEEEEEecccC---------------------CcHHHHHhh-CCCCHHHHHHHHHHHHHHHHHHHhCCccCCCCchheEE
Confidence 89999999994 455555544 35999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH---
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED--- 293 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~--- 293 (494)
++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|+|++|..||......
T Consensus 167 ~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~~~~~ 246 (318)
T 3lxp_A 167 LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLE 246 (318)
T ss_dssp ECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHHHHHH
T ss_pred EcCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccchhhhh
Confidence 99999999999999986432221 233456888999999999989999999999999999999999999754321
Q ss_pred ------------HHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 294 ------------ELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 294 ------------~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
.+...+.. .....|..++.++.+||.+||+.||.+|| ++++++
T Consensus 247 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp------s~~ell 302 (318)
T 3lxp_A 247 LIGIAQGQMTVLRLTELLERGERLPRPDKCPAEVYHLMKNCWETEASFRP------TFENLI 302 (318)
T ss_dssp HHCSCCHHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHH
T ss_pred hhcccccchhHHHHHHHHhcccCCCCCccccHHHHHHHHHHcCCCcccCc------CHHHHH
Confidence 11222222 24556778999999999999999999999 566666
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=370.92 Aligned_cols=249 Identities=26% Similarity=0.392 Sum_probs=208.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|+++.+ ..||||+++.... ..+....|..++. .++||||+++++++.+ +.
T Consensus 263 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~-~~vavK~~~~~~~----~~~~~~~E~~~l~-~l~hpniv~~~~~~~~-~~ 335 (535)
T 2h8h_A 263 EIPRESLRLEVKLGQGCFGEVWMGTWNGT-TRVAIKTLKPGTM----SPEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EP 335 (535)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEETTT-EEEEEEEECTTSS----CHHHHHHHHHHHH-HCCCTTBCCEEEEECS-SS
T ss_pred ecchhhhhhheecccCCCeEEEEEEECCC-ceEEEEEeCCCCC----CHHHHHHHHHHHH-hCCCCCEeeEEEEEee-cc
Confidence 45567899999999999999999998765 5599999986432 2345677888887 5799999999999876 78
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|||||||.+| +|..++.. ...+++.++..++.||+.||+|||++||+||||||+||
T Consensus 336 ~~lv~e~~~~g---------------------sL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ivHrDlkp~NI 394 (535)
T 2h8h_A 336 IYIVTEYMSKG---------------------SLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 394 (535)
T ss_dssp CEEEECCCTTE---------------------EHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred ceEeeehhcCC---------------------cHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeeCCCCCHhhE
Confidence 99999999954 44555543 35699999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||+.++.+||+|||+++...... .......+|..|+|||++.+..++.++|||||||+||||++ |..||.+....++.
T Consensus 395 ll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~~~~~ 474 (535)
T 2h8h_A 395 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 474 (535)
T ss_dssp EECGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCHHHHH
T ss_pred EEcCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999987532111 11223457789999999998899999999999999999999 99999999988888
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+..+ ....|..++.++.+||.+||..||.+|| ++++|+.
T Consensus 475 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~RP------t~~~l~~ 516 (535)
T 2h8h_A 475 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP------TFEYLQA 516 (535)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHcCCCCCCCCCCCHHHHHHHHHHcCCChhHCc------CHHHHHH
Confidence 888765 4566788999999999999999999999 4566654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-44 Score=383.23 Aligned_cols=273 Identities=25% Similarity=0.349 Sum_probs=214.0
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-----
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----- 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----- 137 (494)
..++|++.+.||+|+||.||+|.++.+|+.||||+++.. ...........|..++. .++||||+++++++..
T Consensus 12 ~~grY~i~~~LG~G~fG~Vyla~~~~tg~~VAVKvi~~~--~~~~~~~~~~~Ei~iL~-~L~HpnIV~l~~v~~~~~~~~ 88 (676)
T 3qa8_A 12 TCGPWEMKERLGTGGFGYVLRWIHQDTGEQVAIKQCRQE--LSPKNRERWCLEIQIMK-KLNHPNVVSAREVPDGLQKLA 88 (676)
T ss_dssp -----CCCCCCCBCSSSBCCCCCCTTTTCCEEECCCCSC--CCHHHHHHHHHHHHHHH-HCCBTTBCCEEECCTTTCCCC
T ss_pred CCCCeEEEEEEeeCCCeEEEEEEECCCCcEEEEEEeccc--CCHHHHHHHHHHHHHHH-hCCCCCCCceeeeeccccccc
Confidence 347899999999999999999999999999999999764 23445566778888887 5799999999999766
Q ss_pred -CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC---CCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 138 -DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG---RFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 138 -~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~---~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
.+..|+|||||+|| +|..++.... .+++..++.++.||+.||+|||++||+||||
T Consensus 89 ~~~~~~LVmEy~~gg---------------------sL~~~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs~gIVHrDL 147 (676)
T 3qa8_A 89 PNDLPLLAMEYCEGG---------------------DLRKYLNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDL 147 (676)
T ss_dssp TTSSCCCEEECCSSC---------------------BHHHHHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHHTTBCCCCC
T ss_pred CCCeEEEEEEeCCCC---------------------CHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHHCCCccCCC
Confidence 77889999999954 4555555433 6999999999999999999999999999999
Q ss_pred CCCceeeCCCCC---EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 214 KLDNILLDYEGH---VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~---vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
||+|||++.+|. +||+|||+++.. .........+||+.|+|||++.+..++.++|||||||++|+|++|..||.+.
T Consensus 148 KP~NILl~~~g~~~~vKL~DFG~a~~~-~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 148 KPENIVLQPGPQRLIHKIIDLGYAKEL-DQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CSTTEEEECCSSSCEEEECSCCCCCBT-TSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHeEeecCCCceeEEEccccccccc-ccccccccccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 999999998775 999999999853 2333445678999999999999999999999999999999999999999765
Q ss_pred CHHHHHHH--------------HHhCCCC----------CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 291 DEDELFWS--------------ICNERPR----------FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 291 ~~~~~~~~--------------i~~~~~~----------~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
.....+.. ...+... ++..+++++.+||.+||..||.+|| ++.++++|||
T Consensus 227 ~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRP------Ta~elL~hp~ 300 (676)
T 3qa8_A 227 WQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRG------TDPQNPNVGC 300 (676)
T ss_dssp CHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---------CCTTCCCCTT
T ss_pred cchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCc------CHHHHhcCHH
Confidence 43221100 0111111 1234678999999999999999999 4577899999
Q ss_pred cCCCChhHHhcCcCCCCCcccc
Q psy8309 347 FRGLDWQALEKRELEPPFRPRV 368 (494)
Q Consensus 347 f~~~~w~~l~~~~~~pp~~p~~ 368 (494)
|+. ++.+..+++-+.|.+..
T Consensus 301 F~~--l~~iL~~kil~~f~~~~ 320 (676)
T 3qa8_A 301 FQA--LDSILSLKLLSVMNMVS 320 (676)
T ss_dssp HHH--HHHHHCCCEEECCCSSS
T ss_pred HHH--HHHHHhccccccccccc
Confidence 987 56777777666664433
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-43 Score=350.19 Aligned_cols=252 Identities=24% Similarity=0.378 Sum_probs=188.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-cCCCCceeeEEEEEEc--
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQT-- 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-~~~hp~Iv~l~~~~~~-- 137 (494)
.+.+++|++++.||+|+||.||+|+. +++.||||++.... ......|..++.. .++||||+++++.+..
T Consensus 9 ~~~~~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~------~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~ 80 (336)
T 3g2f_A 9 SLDLDNLKLLELIGRGRYGAVYKGSL--DERPVAVKVFSFAN------RQNFINEKNIYRVPLMEHDNIARFIVGDERVT 80 (336)
T ss_dssp CCCTTSEEEEEEEEECSSEEEEEEEE--TTEEEEEEEEEGGG------HHHHHHHHHHHTSTTCCCTTBCCEEEEEEEEC
T ss_pred CcChHHhheeeecccCCCeEEEEEEE--CCeEEEEEEeeccc------hhhHHHHHHHHHHHhccCcchhhheecccccc
Confidence 46678999999999999999999976 67889999997542 2233344444432 4799999999976542
Q ss_pred ---CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhC--------
Q psy8309 138 ---DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKK-------- 206 (494)
Q Consensus 138 ---~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~-------- 206 (494)
...+|+|||||++ |+|..++.. ..+++..++.++.||+.||.|||++
T Consensus 81 ~~~~~~~~lv~e~~~~---------------------g~L~~~l~~-~~~~~~~~~~i~~qi~~~L~~LH~~~~~~~~~~ 138 (336)
T 3g2f_A 81 ADGRMEYLLVMEYYPN---------------------GSLXKYLSL-HTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYK 138 (336)
T ss_dssp TTSCEEEEEEECCCTT---------------------CBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCCGGGCB
T ss_pred cCCCceEEEEEecCCC---------------------CcHHHHHhh-cccchhHHHHHHHHHHHHHHHHHhhhccccccc
Confidence 3468999999994 455555544 3458899999999999999999999
Q ss_pred -CCccccCCCCceeeCCCCCEEEeecCceeeeecc--------CCcccccCCCCCccChhhhCC-------CCCCCcchH
Q psy8309 207 -GIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL--------DKTTDTFCGTPDYMAPEIIKG-------LKYNQCVDW 270 (494)
Q Consensus 207 -givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~--------~~~~~~~~gt~~y~aPE~l~~-------~~~~~~~Di 270 (494)
||+||||||+||||+.+|.+||+|||+++..... .......+||+.|+|||++.+ ..++.++||
T Consensus 139 ~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~Di 218 (336)
T 3g2f_A 139 PAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDM 218 (336)
T ss_dssp CCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHH
T ss_pred cceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCcccccccccccccch
Confidence 9999999999999999999999999999753211 122335679999999999987 456778999
Q ss_pred HHHHHHHHHHHhCCCCCCCC-CH----------------HHHHHHHHh---CCCCCCcc------CCHHHHHHHHhhccC
Q psy8309 271 WSFGILLYEMHVGQSPFSGC-DE----------------DELFWSICN---ERPRFPQF------LSVEAKNILVHLLDK 324 (494)
Q Consensus 271 wSlGvil~ell~G~~Pf~~~-~~----------------~~~~~~i~~---~~~~~p~~------~s~~~~~li~~lL~~ 324 (494)
|||||++|||++|..||... .. .+....+.. ..+.+|.. +++++.+||.+||..
T Consensus 219 wslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~ 298 (336)
T 3g2f_A 219 YALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPEAWKENSLAVRSLKETIEDCWDQ 298 (336)
T ss_dssp HHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCTTCCCCSHHHHHHHHHHHHHSCS
T ss_pred HHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCcccccccchHHHHHHHHHHHhcC
Confidence 99999999999997665322 11 111122221 23444443 345899999999999
Q ss_pred CCCCCCCCCCCCChhhh------hcCCCcC
Q psy8309 325 DTTKRLGSTQCNSGDDV------VAHEYFR 348 (494)
Q Consensus 325 dP~~R~~~~~~~~~~ei------l~h~~f~ 348 (494)
||.+||+ +.|+ +.++|-+
T Consensus 299 dP~~Rps------~~e~l~~L~~ll~~~~~ 322 (336)
T 3g2f_A 299 DAEARLT------AQXAEERMAELMMIWER 322 (336)
T ss_dssp SGGGSCC------HHHHHHHHHHHHHCCCC
T ss_pred ChhhCcc------hHHHHHHHHHHHHHHHh
Confidence 9999994 5666 4456654
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=352.03 Aligned_cols=252 Identities=25% Similarity=0.344 Sum_probs=196.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++.+.||+|+||.||+|++. +++.||||++....... .......|..++. .++||||+++++++.+.+..+
T Consensus 28 ~~~~y~~~~~lg~G~~g~V~~~~~~-~~~~vavK~~~~~~~~~--~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~~~ 103 (326)
T 3uim_A 28 ASDNFSNKNILGRGGFGKVYKGRLA-DGTLVAVKRLKEERTQG--GELQFQTEVEMIS-MAVHRNLLRLRGFCMTPTERL 103 (326)
T ss_dssp TTTSSCSTTEEECCSSSEEEEECCS-SSCCEEEEECCC-------CCCHHHHHHHGGG-TCCCTTBCCCCEEECCSSCCE
T ss_pred HhhccccceeEecCCCcEEEEEEec-CCCEEEEEEeccccCch--HHHHHHHHHHHHH-hccCCCccceEEEEecCCceE
Confidence 4568999999999999999999854 68889999997653221 1123566776666 578999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc----CCCCHHHHHHHHHHHHHHHHHHHhC---CCccccCCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS----GRFDEGRARFYAAEIVSGMRFLHKK---GIVYRDLKL 215 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~----~~l~e~~~~~~~~qi~~aL~yLH~~---givHrDLKp 215 (494)
+||||+.+|+| ..++... ..+++..++.++.||+.||+|||++ ||+||||||
T Consensus 104 lv~e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~ivH~Dlkp 162 (326)
T 3uim_A 104 LVYPYMANGSV---------------------ASCLRERPESQPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKA 162 (326)
T ss_dssp EEEECCTTCBH---------------------HHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHHSSSSCEECCCCSG
T ss_pred EEEEeccCCCH---------------------HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEeCCCch
Confidence 99999995544 4444433 3599999999999999999999999 999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC----
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC---- 290 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~---- 290 (494)
+|||++.++.+||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|+|++|..||...
T Consensus 163 ~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~~ 242 (326)
T 3uim_A 163 ANILLDEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLAN 242 (326)
T ss_dssp GGEEECTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHHHTT
T ss_pred hhEEECCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHHHHHhCCCccccccccc
Confidence 99999999999999999998643222 2244567999999999999889999999999999999999999999521
Q ss_pred CHHHHHHHHHhC---------------CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 291 DEDELFWSICNE---------------RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 291 ~~~~~~~~i~~~---------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
............ ...++...+.++.+||.+||+.||.+|| ++.|+++|-
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------s~~ell~~L 306 (326)
T 3uim_A 243 DDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERP------KMSEVVRML 306 (326)
T ss_dssp TSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSC------CHHHHHHHH
T ss_pred ccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCC------CHHHHHHHh
Confidence 111111111111 0112233457899999999999999999 578888764
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-42 Score=372.83 Aligned_cols=252 Identities=23% Similarity=0.350 Sum_probs=207.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.+..++|++.+.||+|+||.||+|++..+ +..||||+++.. ......+....|..++. .++||||+++++++.
T Consensus 386 ~i~~~~y~i~~~LG~G~fG~Vy~a~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~- 461 (656)
T 2j0j_A 386 EIQRERIELGRCIGEGQFGDVHQGIYMSPENPAMAVAIKTCKNC--TSDSVREKFLQEALTMR-QFDHPHIVKLIGVIT- 461 (656)
T ss_dssp BCCGGGEEEEEEEECCSSCCEEEEEECCSSSCCEEEEEEECSST--TCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEC-
T ss_pred ccccccEEEeeEEeeCCCEEEEEEEEecCCCccEEEEEEEeccc--CCHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEe-
Confidence 34567899999999999999999998654 457999988653 23344456677777777 579999999999985
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
++.+|+||||++ ||+|..++... ..+++..+..++.||+.||.|||++||+||||||+
T Consensus 462 ~~~~~lv~E~~~---------------------~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~givHrDikp~ 520 (656)
T 2j0j_A 462 ENPVWIIMELCT---------------------LGELRSFLQVRKFSLDLASLILYAYQLSTALAYLESKRFVHRDIAAR 520 (656)
T ss_dssp SSSCEEEEECCT---------------------TCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred cCceEEEEEcCC---------------------CCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCccccccchH
Confidence 567999999999 45555566544 46999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
|||++.+|.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+..+
T Consensus 521 NILl~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~ 600 (656)
T 2j0j_A 521 NVLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 600 (656)
T ss_dssp GEEEEETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHHH
T ss_pred hEEEeCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999999975322111 1233457889999999998899999999999999999997 999999999988
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
....+..+ .+.+|..+++++.+||.+||..||.+|| ++.++++
T Consensus 601 ~~~~i~~~~~~~~~~~~~~~l~~li~~~l~~dP~~RP------s~~el~~ 644 (656)
T 2j0j_A 601 VIGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP------RFTELKA 644 (656)
T ss_dssp HHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHcCCCCCCCccccHHHHHHHHHHcCCChhHCc------CHHHHHH
Confidence 88888765 4567889999999999999999999999 5666664
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=341.53 Aligned_cols=246 Identities=25% Similarity=0.314 Sum_probs=195.4
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-ChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-EDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
|...+.||+|+||.||+|++ ++..||||++...... ..........|..++. .++||||+++++++.+.+..|+||
T Consensus 33 ~~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~-~l~h~~i~~~~~~~~~~~~~~lv~ 109 (307)
T 2nru_A 33 SVGGNKMGEGGFGVVYKGYV--NNTTVAVKKLAAMVDITTEELKQQFDQEIKVMA-KCQHENLVELLGFSSDGDDLCLVY 109 (307)
T ss_dssp TTTCCEEEECSSEEEEEEES--SSCEEEEEEECCCTTSCTTTHHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCEEEE
T ss_pred cccCCccccCCCeEEEEEEE--CCceEEEEEEecccCcchHHHHHHHHHHHHHHH-hcCCCCeEEEEEEEecCCceEEEE
Confidence 44568999999999999986 5778999999764322 2334556677887877 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhh---hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ---QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~---~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||+++|+| ..++. ....+++..++.++.||+.||.|||++||+||||||+|||++.
T Consensus 110 e~~~~~~L---------------------~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~H~dlkp~Nili~~ 168 (307)
T 2nru_A 110 VYMPNGSL---------------------LDRLSCLDGTPPLSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDE 168 (307)
T ss_dssp ECCTTCBH---------------------HHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECT
T ss_pred EecCCCcH---------------------HHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhcCCeecCCCCHHHEEEcC
Confidence 99996554 33333 3456999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHH----HH
Q psy8309 223 EGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE----LF 296 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~----~~ 296 (494)
++.+||+|||+++....... .....+||+.|+|||++.+ .++.++|||||||++|+|++|.+||.+..... +.
T Consensus 169 ~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~ 247 (307)
T 2nru_A 169 AFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHREPQLLLDIK 247 (307)
T ss_dssp TCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBSSSBTTHHH
T ss_pred CCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcchHHHHHHH
Confidence 99999999999875332111 2345679999999999976 58999999999999999999999998754332 22
Q ss_pred HHHHhCC-----------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNER-----------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~~-----------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+.... ...+...+..+.++|.+||..||.+|| +++++++
T Consensus 248 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rp------s~~~l~~ 299 (307)
T 2nru_A 248 EEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRP------DIKKVQQ 299 (307)
T ss_dssp HHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSC------CHHHHHH
T ss_pred HHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCc------CHHHHHH
Confidence 2222211 122334567899999999999999999 5677764
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-43 Score=353.07 Aligned_cols=246 Identities=17% Similarity=0.184 Sum_probs=191.1
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-----ChhhHHHHHHHHHHHHhcC--------CCCce
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-----EDDDVECTLIERKVLALGT--------KHPYL 128 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----~~~~~~~~~~e~~~l~~~~--------~hp~I 128 (494)
+..++|++++.||+|+||+||+|++ +++.||||++.+.... .....+....|..++.... .||||
T Consensus 17 ~~~~~y~~~~~lG~G~~g~V~~~~~--~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~~~~~~~h~ni 94 (336)
T 2vuw_A 17 LPTEKLQRCEKIGEGVFGEVFQTIA--DHTPVAIKIIAIEGPDLVNGSHQKTFEEILPEIIISKELSLLSGEVCNRTEGF 94 (336)
T ss_dssp SCHHHHHTCEEEEEETTEEEEEEEE--TTEEEEEEEEEESCSSCBTTBCCBCHHHHHHHHHHHHHHHHGGGCSSSBCCCB
T ss_pred cccccchheeeecccCceEEEEEEe--CCceEEEEEEecCCccccccccchhHHHHHHHHHHHHHHHHhhccccccCCch
Confidence 3457899999999999999999987 6789999999875321 2233455667777765432 47777
Q ss_pred eeEEEEEE-----------------c-------------CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHh
Q psy8309 129 CHLFCTFQ-----------------T-------------DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178 (494)
Q Consensus 129 v~l~~~~~-----------------~-------------~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l 178 (494)
|++.+.+. + .+.+|||||||++|++ ...+
T Consensus 95 v~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g~l---------------------l~~~ 153 (336)
T 2vuw_A 95 IGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID---------------------LEQM 153 (336)
T ss_dssp CCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCCEE---------------------TGGG
T ss_pred hhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCCcc---------------------HHHH
Confidence 77776643 2 7899999999996654 2223
Q ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHH-hCCCccccCCCCceeeCCCC--------------------CEEEeecCceeee
Q psy8309 179 QQSGRFDEGRARFYAAEIVSGMRFLH-KKGIVYRDLKLDNILLDYEG--------------------HVRIADFGMCKLQ 237 (494)
Q Consensus 179 ~~~~~l~e~~~~~~~~qi~~aL~yLH-~~givHrDLKp~NILl~~~g--------------------~vkL~DFGla~~~ 237 (494)
.+ +.+++..++.++.||+.||+||| ++||+||||||+||||+.+| .+||+|||+|+..
T Consensus 154 ~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~DFG~a~~~ 232 (336)
T 2vuw_A 154 RT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIIDYTLSRLE 232 (336)
T ss_dssp TT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECCCTTCBEE
T ss_pred Hh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEeeccccEec
Confidence 22 56899999999999999999999 99999999999999999987 8999999999864
Q ss_pred eccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHH-HHHHHhCCCCCCCCCH-HHHHHHHHhC---CCC----CCc
Q psy8309 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGIL-LYEMHVGQSPFSGCDE-DELFWSICNE---RPR----FPQ 308 (494)
Q Consensus 238 ~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvi-l~ell~G~~Pf~~~~~-~~~~~~i~~~---~~~----~p~ 308 (494)
.. ...+||+.|+|||++.+.. +.++||||||++ .++++.|..||.+... ......+... ... .+.
T Consensus 233 ~~-----~~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 306 (336)
T 2vuw_A 233 RD-----GIVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMK 306 (336)
T ss_dssp ET-----TEEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCCCSHHHH
T ss_pred CC-----CcEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCcccchhhhh
Confidence 32 2458999999999999876 899999998777 7888899999954321 2233344422 111 123
Q ss_pred cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh-cCCCcC
Q psy8309 309 FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV-AHEYFR 348 (494)
Q Consensus 309 ~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil-~h~~f~ 348 (494)
.+++++++||.+||++| +++|++ +||||+
T Consensus 307 ~~s~~~~dli~~~L~~d-----------sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 307 QIKRKIQEFHRTMLNFS-----------SATDLLCQHSLFK 336 (336)
T ss_dssp HHHHHHHHHHHHGGGSS-----------SHHHHHHHCGGGC
T ss_pred hcCHHHHHHHHHHhccC-----------CHHHHHhcCCCcC
Confidence 57899999999999976 589999 999995
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-43 Score=365.13 Aligned_cols=250 Identities=14% Similarity=0.093 Sum_probs=189.7
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-Cc----------------
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-PY---------------- 127 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-p~---------------- 127 (494)
..|.+.++||+|+||+||+|++..+|+.||||+++..........+....|..++. .+.| ++
T Consensus 78 ~~~~~~~~LG~G~fG~Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~-~l~~~~~~~~~~~~~~~~~~~~~ 156 (413)
T 3dzo_A 78 RTLVRGTVLGQEDPYAYLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLR-LLRGIKNQKQAKVHLRFIFPFDL 156 (413)
T ss_dssp EEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGG-GSTTCCSHHHHHHHTCBCCCCEE
T ss_pred eeEEEecccccCCCEEEEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHH-hhccCCCHHHHHHhcccccchhh
Confidence 46889999999999999999999999999999998543333333445556666655 4554 21
Q ss_pred -----eeeEEEEEEc-----CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-------hcCCCCHHHHH
Q psy8309 128 -----LCHLFCTFQT-----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-------QSGRFDEGRAR 190 (494)
Q Consensus 128 -----Iv~l~~~~~~-----~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-------~~~~l~e~~~~ 190 (494)
...+..++.. ...++++|+++. | +|..++. ..+.+++..+.
T Consensus 157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---------------------~L~~ll~~l~~~~~~~~~l~~~~~~ 214 (413)
T 3dzo_A 157 VKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQ-S---------------------NLQTFGEVLLSHSSTHKSLVHHARL 214 (413)
T ss_dssp EECCC---------------CCSEEEEEECCS-E---------------------EHHHHHHHHHHHTTTSHHHHHHHHH
T ss_pred cccCCCCccccccCCCccccccceEEEeehhc-C---------------------CHHHHHHHhhcccccCCCCCHHHHH
Confidence 1111111121 224667777653 3 3333332 23457788899
Q ss_pred HHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhh----------C
Q psy8309 191 FYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEII----------K 260 (494)
Q Consensus 191 ~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l----------~ 260 (494)
.++.||+.||+|||++||+||||||+||||+.+|.+||+|||+++.. .....+.+| +.|+|||++ .
T Consensus 215 ~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~---~~~~~~~~g-~~y~aPE~~~~~~~~~~~~~ 290 (413)
T 3dzo_A 215 QLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRD---GASAVSPIG-RGFAPPETTAERMLPFGQHH 290 (413)
T ss_dssp HHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEET---TEEECCCCC-TTTCCHHHHHHHTSTTGGGC
T ss_pred HHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeec---CCccccCCC-CceeCchhhhcccccccccc
Confidence 99999999999999999999999999999999999999999998753 223556788 999999999 6
Q ss_pred CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhh
Q psy8309 261 GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDD 340 (494)
Q Consensus 261 ~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~e 340 (494)
+..|+.++|||||||++|||++|+.||.+.+..+....+.... ..+++++++||.+||+.||.+|| ++.+
T Consensus 291 ~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dP~~Rp------t~~~ 360 (413)
T 3dzo_A 291 PTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFRSC----KNIPQPVRALLEGFLRYPKEDRL------LPLQ 360 (413)
T ss_dssp CEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGSSC----CCCCHHHHHHHHHHTCSSGGGSC------CHHH
T ss_pred CcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHhhc----ccCCHHHHHHHHHHccCChhhCc------CHHH
Confidence 6678999999999999999999999998877655555544432 35789999999999999999999 6899
Q ss_pred hhcCCCcCCCC
Q psy8309 341 VVAHEYFRGLD 351 (494)
Q Consensus 341 il~h~~f~~~~ 351 (494)
+++||||+.+.
T Consensus 361 ~l~~~~~~~~~ 371 (413)
T 3dzo_A 361 AMETPEYEQLR 371 (413)
T ss_dssp HTTSHHHHHHH
T ss_pred HHhCHHHHHHH
Confidence 99999998763
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-42 Score=343.25 Aligned_cols=252 Identities=26% Similarity=0.363 Sum_probs=203.0
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEE----eCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAEL----KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~----~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+...+|++++.||+|+||.||+|+. ..+++.||||++... .....+....|..++. .++||||+++++++.
T Consensus 37 ~~~~~~y~~~~~lg~G~~g~V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~-~l~h~~iv~~~~~~~ 112 (326)
T 2w1i_A 37 QFEERHLKFLQQLGKGNFGSVEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILK-SLQHDNIVKYKGVCY 112 (326)
T ss_dssp CCCGGGEEEEEEEECCSSEEEEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC
T ss_pred ccCHHHceeeeeeccCCCeEEEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEE
Confidence 34567899999999999999999994 568899999999764 3344556777888887 579999999999987
Q ss_pred cCC--eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 137 TDS--HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 137 ~~~--~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
..+ .+++||||++ |++|..++... ..+++..++.++.||+.||.|||++||+||||
T Consensus 113 ~~~~~~~~lv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~di 171 (326)
T 2w1i_A 113 SAGRRNLKLIMEYLP---------------------YGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL 171 (326)
T ss_dssp C----CCEEEECCCT---------------------TCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred ecCCCceEEEEECCC---------------------CCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCEeccCC
Confidence 654 7899999999 44555566554 46999999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
||+|||++.++.+||+|||+++....... ......||+.|+|||++.+..++.++|||||||++|||++|..||...
T Consensus 172 kp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 172 ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp CGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred CcceEEEcCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 99999999999999999999986432221 123345788899999999888999999999999999999999998643
Q ss_pred CH------------H----HHHHHHHh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 291 DE------------D----ELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 291 ~~------------~----~~~~~i~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.. . .+...+.. ..+..|..++.++.+||.+||..||.+|| ++.|+++
T Consensus 252 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------s~~el~~ 315 (326)
T 2w1i_A 252 PAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDEIYMIMTECWNNNVNQRP------SFRDLAL 315 (326)
T ss_dssp HHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHSCSSGGGSC------CHHHHHH
T ss_pred HHHHHHhhccccchhhhHHHHHHHhhcCCCCCCCCcccHHHHHHHHHHcCCChhhCc------CHHHHHH
Confidence 11 0 11222222 24566788999999999999999999999 4666653
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-42 Score=342.28 Aligned_cols=244 Identities=23% Similarity=0.341 Sum_probs=196.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc-CCCCceeeEEEEEEcCC----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG-TKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~-~~hp~Iv~l~~~~~~~~---- 139 (494)
++|++.+.||+|+||.||+|++ +++.||||++.+. .......|..++... ++||||+++++++....
T Consensus 42 ~~y~~~~~lg~G~~g~Vy~~~~--~~~~vavK~~~~~------~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~ 113 (342)
T 1b6c_B 42 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 113 (342)
T ss_dssp HHCEEEEEEEEETTEEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCC
T ss_pred ccEEEEeeecCCCCcEEEEEEE--cCccEEEEEeCch------hHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccc
Confidence 5899999999999999999987 5788999998653 223455677776643 79999999999999876
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHH--------hCCCccc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLH--------KKGIVYR 211 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH--------~~givHr 211 (494)
.+|+||||+++ |+|..++.+ ..+++..++.++.||+.||.||| ++||+||
T Consensus 114 ~~~lv~e~~~~---------------------g~L~~~l~~-~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~ivH~ 171 (342)
T 1b6c_B 114 QLWLVSDYHEH---------------------GSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 171 (342)
T ss_dssp CEEEEECCCTT---------------------CBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred eeEEEEeecCC---------------------CcHHHHHhc-cCccHHHHHHHHHHHHHHHHHHHHHHhhhcccCCeeeC
Confidence 89999999994 455555544 47999999999999999999999 8999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCCCC------CCCcchHHHHHHHHHHHH
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKGLK------YNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~ell 281 (494)
||||+||||+.++.+||+|||+++....... .....+||+.|+|||++.+.. ++.++|||||||++|||+
T Consensus 172 Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~ 251 (342)
T 1b6c_B 172 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 251 (342)
T ss_dssp CCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHH
Confidence 9999999999999999999999976433222 234568999999999998763 346899999999999999
Q ss_pred hC----------CCCCCCCC-----HHHHHHHHHhC--CCCCCc-----cCCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 282 VG----------QSPFSGCD-----EDELFWSICNE--RPRFPQ-----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 282 ~G----------~~Pf~~~~-----~~~~~~~i~~~--~~~~p~-----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
+| ..||.... ...+...+... .+.+|. ..+..+.+||.+||..||.+|| ++.
T Consensus 252 tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp------s~~ 325 (342)
T 1b6c_B 252 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL------TAL 325 (342)
T ss_dssp TTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHHHHHHHHHHCCSSGGGSC------CHH
T ss_pred hccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHHHHHHHHHHhccChhhCC------CHH
Confidence 99 78997642 34444444443 233443 2346789999999999999999 567
Q ss_pred hhhcC
Q psy8309 340 DVVAH 344 (494)
Q Consensus 340 eil~h 344 (494)
++++|
T Consensus 326 ~i~~~ 330 (342)
T 1b6c_B 326 RIKKT 330 (342)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77765
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=343.56 Aligned_cols=250 Identities=24% Similarity=0.416 Sum_probs=200.8
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||.||+|+++.+ ||+|+++.... .....+....|..++. .++||||+++++++.+.+.
T Consensus 29 ~i~~~~~~~~~~lg~G~~g~V~~~~~~~~---~avk~~~~~~~-~~~~~~~~~~e~~~l~-~l~h~~iv~~~~~~~~~~~ 103 (319)
T 2y4i_B 29 DIPFEQLEIGELIGKGRFGQVYHGRWHGE---VAIRLIDIERD-NEDQLKAFKREVMAYR-QTRHENVVLFMGACMSPPH 103 (319)
T ss_dssp SSCCSCEECCCBCCCSSSSEEEEEEESSS---EEEEECCCCSC-CCCCCCCCCTTGGGGT-TCCCTTBCCCCEEEECSSC
T ss_pred cCCHHHeEEeeEeccCCceEEEEEEEcCe---EEEEEeecCCC-CHHHHHHHHHHHHHHh-cCCCCCEeEEEEEEecCCc
Confidence 45678999999999999999999998653 89999876432 1222223345555555 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
+|+||||+. |++|..++...+ .+++..++.++.||+.||+|||++||+||||||+|||
T Consensus 104 ~~iv~e~~~---------------------~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i~H~dlkp~NIl 162 (319)
T 2y4i_B 104 LAIITSLCK---------------------GRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVF 162 (319)
T ss_dssp EEEECBCCC---------------------SEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTTCCCCCCCSTTEE
T ss_pred eEEEeeccc---------------------CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCChhhEE
Confidence 999999999 445555565544 7999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeec-----cCCcccccCCCCCccChhhhCC---------CCCCCcchHHHHHHHHHHHHhCCC
Q psy8309 220 LDYEGHVRIADFGMCKLQIY-----LDKTTDTFCGTPDYMAPEIIKG---------LKYNQCVDWWSFGILLYEMHVGQS 285 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~-----~~~~~~~~~gt~~y~aPE~l~~---------~~~~~~~DiwSlGvil~ell~G~~ 285 (494)
++ +|.+||+|||+++.... .........||+.|+|||++.+ ..++.++|||||||++|||++|..
T Consensus 163 ~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~ 241 (319)
T 2y4i_B 163 YD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREW 241 (319)
T ss_dssp EC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred Ee-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCC
Confidence 98 78999999999764211 1122344569999999999975 457899999999999999999999
Q ss_pred CCCCCCHHHHHHHHHhCCCCC--CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 286 PFSGCDEDELFWSICNERPRF--PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 286 Pf~~~~~~~~~~~i~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
||.+.........+..+.... +..++.++.+||.+||..||.+|| ++.++++
T Consensus 242 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rp------t~~~l~~ 295 (319)
T 2y4i_B 242 PFKTQPAEAIIWQMGTGMKPNLSQIGMGKEISDILLFCWAFEQEERP------TFTKLMD 295 (319)
T ss_dssp SSSSCCHHHHHHHHHTTCCCCCCCSSCCTTHHHHHHHHHCSSTTTSC------CHHHHHH
T ss_pred CCCCCCHHHHHHHhccCCCCCCCcCCCCHHHHHHHHHHhcCChhhCc------CHHHHHH
Confidence 999999888888877654322 236889999999999999999999 5667764
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-40 Score=323.26 Aligned_cols=217 Identities=17% Similarity=0.149 Sum_probs=178.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||.||+|++..+++.||||++................|..++. .++||||+++++++.+.+..|+
T Consensus 30 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~-~l~hp~iv~~~~~~~~~~~~~l 108 (286)
T 3uqc_A 30 NGRYRLLIFHGGVPPLQFWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLS-RIDKPGVARVLDVVHTRAGGLV 108 (286)
T ss_dssp TTTEEEEEEEEBSTTCEEEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEE
T ss_pred cCcEEEEEEEcccCCeEEEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHh-cCCCCCcceeeEEEEECCcEEE
Confidence 368999999999999999999999999999999998765544555566777877776 6799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||++| ++|..++.. + ....++..++.||+.||+|||++||+||||||+||||+.+
T Consensus 109 v~e~~~g---------------------~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~givH~Dikp~NIll~~~ 165 (286)
T 3uqc_A 109 VAEWIRG---------------------GSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSID 165 (286)
T ss_dssp EEECCCE---------------------EEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTTCCCCCCSGGGEEEETT
T ss_pred EEEecCC---------------------CCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCCCccCCCCcccEEEcCC
Confidence 9999994 455555533 2 4566788899999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH---HHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW---SIC 300 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~---~i~ 300 (494)
|.+||+++| |++ .++.++|||||||++|||++|+.||.+.+..+.+. ++.
T Consensus 166 g~~kl~~~~--------------------~~~-------~~~~~~Di~slG~il~elltg~~Pf~~~~~~~~~~~~~~~~ 218 (286)
T 3uqc_A 166 GDVVLAYPA--------------------TMP-------DANPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAERDT 218 (286)
T ss_dssp SCEEECSCC--------------------CCT-------TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCCCSEECCBCT
T ss_pred CCEEEEecc--------------------ccC-------CCCchhHHHHHHHHHHHHHHCCCCCCcCCcchhhHHHHHHh
Confidence 999998443 333 37899999999999999999999998866433211 111
Q ss_pred hCCCC----CCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 301 NERPR----FPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 301 ~~~~~----~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..... ++..+++++++||.+||++||.+| ++
T Consensus 219 ~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~ 253 (286)
T 3uqc_A 219 AGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SA 253 (286)
T ss_dssp TSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CH
T ss_pred ccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CH
Confidence 22222 235689999999999999999999 64
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-41 Score=367.25 Aligned_cols=241 Identities=23% Similarity=0.344 Sum_probs=193.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC-CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe--
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG-TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH-- 140 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~-~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~-- 140 (494)
.++|++++.||+|+||.||+|.+.. +++.||||++... ...........|..++. .++||||+++++++...+.
T Consensus 79 ~~~y~i~~~lg~G~~g~Vy~a~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~-~l~hp~iv~~~~~~~~~~~~~ 155 (681)
T 2pzi_A 79 AGQYEVKGCIAHGGLGWIYLALDRNVNGRPVVLKGLVHS--GDAEAQAMAMAERQFLA-EVVHPSIVQIFNFVEHTDRHG 155 (681)
T ss_dssp TTTEEEEEEEEEETTEEEEEEEEGGGTTEEEEEEESCSS--CCHHHHHHHHHHHGGGG-GCCCTTBCCEEEEEEEECTTS
T ss_pred CCceEEEEEEeeCCCeEEEEEEEcCCCCcEEEEEEeCcc--CCHHHHHHHHHHHHHHH-hcCCCCcCeEeeeEeecCCCC
Confidence 4789999999999999999999976 7899999998753 22334455667777776 5799999999999987665
Q ss_pred ---eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 141 ---LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 141 ---~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.||||||++||+|. ..+.. .+++.+++.++.||+.||.|||++|||||||||+|
T Consensus 156 ~~~~~lv~E~~~g~~L~---------------------~~~~~--~l~~~~~~~~~~qi~~aL~~lH~~giiHrDlkp~N 212 (681)
T 2pzi_A 156 DPVGYIVMEYVGGQSLK---------------------RSKGQ--KLPVAEAIAYLLEILPALSYLHSIGLVYNDLKPEN 212 (681)
T ss_dssp CEEEEEEEECCCCEECC-------------------------C--CCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGG
T ss_pred CceeEEEEEeCCCCcHH---------------------HHHhC--CCCHHHHHHHHHHHHHHHHHHHHCCCeecccChHH
Confidence 79999999976663 22322 79999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|||+.+ .+||+|||+++... .....+||+.|+|||++.+. ++.++|||||||++|+|++|.+||.+.....+
T Consensus 213 Ill~~~-~~kl~DFG~a~~~~----~~~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l~~g~~~~~~~~~~~~-- 284 (681)
T 2pzi_A 213 IMLTEE-QLKLIDLGAVSRIN----SFGYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAALTLDLPTRNGRYVDGL-- 284 (681)
T ss_dssp EEECSS-CEEECCCTTCEETT----CCSCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHHHSCCCEETTEECSSC--
T ss_pred eEEeCC-cEEEEecccchhcc----cCCccCCCccccCHHHHcCC-CCCceehhhhHHHHHHHHhCCCCCcccccccc--
Confidence 999875 99999999998532 22567899999999999764 58999999999999999999999875321100
Q ss_pred HHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 298 SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 298 ~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
. ........++.+.+||.+||.+||.+||+ ..+.+.|+|+.
T Consensus 285 --~--~~~~~~~~~~~l~~li~~~l~~dP~~R~~------~~~~l~~~l~~ 325 (681)
T 2pzi_A 285 --P--EDDPVLKTYDSYGRLLRRAIDPDPRQRFT------TAEEMSAQLTG 325 (681)
T ss_dssp --C--TTCHHHHHCHHHHHHHHHHTCSSGGGSCS------SHHHHHHHHHH
T ss_pred --c--ccccccccCHHHHHHHhhhccCChhhCCC------HHHHHHHHHHH
Confidence 0 00000124688999999999999999994 56677888875
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-35 Score=313.72 Aligned_cols=194 Identities=15% Similarity=0.035 Sum_probs=140.6
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccC-------hhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE-------DDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~-------~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
....++.|+.|.+..++..-.|+.||+|++.+..... +...+...+|..+|.+...|+||+++++++++++.+
T Consensus 238 w~~~~~~~~~~~h~~~rr~~fg~~~~~K~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~ 317 (569)
T 4azs_A 238 WQNQPYAGAGLAHKRSRRYFFGEDYVCKFFYYDMPHGILTAEESQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSG 317 (569)
T ss_dssp EECC-C--------CCEEEEECSSEEEEEEESSCSTTCSCHHHHHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEE
T ss_pred hhhccccCCcccccccccccccceeEEEEEecccccccchhhhhHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEE
Confidence 3456788999999998888899999999998753221 223455778999998766899999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|||||||+ |++|...+...+.+++. .|+.||+.||+|||++|||||||||+||||+
T Consensus 318 yLVMEyv~---------------------G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~~GIIHRDIKPeNILL~ 373 (569)
T 4azs_A 318 WLVMEKLP---------------------GRLLSDMLAAGEEIDRE---KILGSLLRSLAALEKQGFWHDDVRPWNVMVD 373 (569)
T ss_dssp EEEEECCC---------------------SEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHHTTCEESCCCGGGEEEC
T ss_pred EEEEecCC---------------------CCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHHCCceeccCchHhEEEC
Confidence 99999999 67777888888888875 4789999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCC
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPF 287 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf 287 (494)
.+|++||+|||+|+..........+.|||+.|||||++.+ .+..++|+||+|+++++|++|..++
T Consensus 374 ~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~~~~~~ 438 (569)
T 4azs_A 374 ARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQPWSNW 438 (569)
T ss_dssp TTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCTTHHHH
T ss_pred CCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhccccchh
Confidence 9999999999999875554555677899999999999987 4677899999999999887765443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=6.7e-29 Score=264.17 Aligned_cols=187 Identities=20% Similarity=0.154 Sum_probs=140.4
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChh-----hHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDD-----DVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~-----~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
...++||+|+||.||+|. ..+..+|+|........... ..+....|..++. .++||||+++..++...+..|
T Consensus 339 ~~~~~LG~G~fg~Vy~~~--~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~E~~il~-~l~h~nIv~~~~~~~~~~~~~ 415 (540)
T 3en9_A 339 IPEHLIGKGAEADIKRDS--YLDFDVIIKERVKKGYRDERLDENIRKSRTAREARYLA-LVKDFGIPAPYIFDVDLDNKR 415 (540)
T ss_dssp ---------CCEEEEEEE--CSSCEEEEEEECCCTTSCHHHHHHHHHHHHHHHHHHHH-HGGGGTCCCCCEEEEETTTTE
T ss_pred CCCCEEeeCCCEEEEEEE--ECCCeEEEEEEecccccchhhhhHHHHHHHHHHHHHHH-hcCCCCcCceEEEEEeCCccE
Confidence 345689999999999994 45667899987553332221 2344678888887 469999996666666778889
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
||||||+|| +|..++.. +..++.||+.||+|||++||+||||||+|||++.
T Consensus 416 lVmE~~~gg---------------------sL~~~l~~--------~~~i~~qi~~aL~~LH~~gIiHrDiKp~NILl~~ 466 (540)
T 3en9_A 416 IMMSYINGK---------------------LAKDVIED--------NLDIAYKIGEIVGKLHKNDVIHNDLTTSNFIFDK 466 (540)
T ss_dssp EEEECCCSE---------------------EHHHHSTT--------CTHHHHHHHHHHHHHHHTTEECTTCCTTSEEESS
T ss_pred EEEECCCCC---------------------CHHHHHHH--------HHHHHHHHHHHHHHHHHCcCccCCCCHHHEEECC
Confidence 999999954 44444443 5689999999999999999999999999999998
Q ss_pred CCCEEEeecCceeeeeccCC-------cccccCCCCCccChhhhCC--CCCCCcchHHHHHHHHHHHHhCCCCCC
Q psy8309 223 EGHVRIADFGMCKLQIYLDK-------TTDTFCGTPDYMAPEIIKG--LKYNQCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~-------~~~~~~gt~~y~aPE~l~~--~~~~~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
.+||+|||+++....... ...+.+||+.|||||++.+ ..|+..+|+||..+-..+.+.++.+|.
T Consensus 467 --~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~v~~r~rY~ 539 (540)
T 3en9_A 467 --DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKDVERRARYV 539 (540)
T ss_dssp --SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHHHHTCSCCC
T ss_pred --eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHHHHhccccC
Confidence 999999999986432211 1246789999999999987 678889999999999998888777763
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=1.4e-25 Score=219.18 Aligned_cols=157 Identities=19% Similarity=0.112 Sum_probs=117.4
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh---------------hhHHHHHHHHHHHHhcCCCCceeeEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED---------------DDVECTLIERKVLALGTKHPYLCHLF 132 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---------------~~~~~~~~e~~~l~~~~~hp~Iv~l~ 132 (494)
.+.+.||+|+||.||+|++ .+|+.||||+++....... ........|..++.. ++| +++.
T Consensus 93 ~~~~~iG~G~~g~Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~-l~~---~~v~ 167 (282)
T 1zar_A 93 AIGKLMGEGKESAVFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQK-LQG---LAVP 167 (282)
T ss_dssp EEEEEEEECSSEEEEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHH-TTT---SSSC
T ss_pred EecCEeccCCCceEEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHh-ccC---CCcC
Confidence 3449999999999999999 8899999999975321111 134556788888875 444 4555
Q ss_pred EEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCcccc
Q psy8309 133 CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRD 212 (494)
Q Consensus 133 ~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrD 212 (494)
+++.. +..|+|||||+||+|. . + ....+..++.||+.||.|||++||+|||
T Consensus 168 ~~~~~-~~~~lvmE~~~g~~L~---------------------~-l------~~~~~~~i~~qi~~~l~~lH~~giiHrD 218 (282)
T 1zar_A 168 KVYAW-EGNAVLMELIDAKELY---------------------R-V------RVENPDEVLDMILEEVAKFYHRGIVHGD 218 (282)
T ss_dssp CEEEE-ETTEEEEECCCCEEGG---------------------G-C------CCSCHHHHHHHHHHHHHHHHHTTEECSC
T ss_pred eEEec-cceEEEEEecCCCcHH---------------------H-c------chhhHHHHHHHHHHHHHHHHHCCCEeCC
Confidence 54443 5679999999976663 2 1 1123456999999999999999999999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC----------CCCCCcchHHH
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG----------LKYNQCVDWWS 272 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~----------~~~~~~~DiwS 272 (494)
|||+|||++ +|.+||+|||+|+ ++..|+|||.+.+ ..|+..+|+|.
T Consensus 219 lkp~NILl~-~~~vkl~DFG~a~-------------~~~~~~a~e~l~rdv~~i~~~f~~~~~~~~~~~~ 274 (282)
T 1zar_A 219 LSQYNVLVS-EEGIWIIDFPQSV-------------EVGEEGWREILERDVRNIITYFSRTYRTEKDINS 274 (282)
T ss_dssp CSTTSEEEE-TTEEEECCCTTCE-------------ETTSTTHHHHHHHHHHHHHHHHHHHHCCCCCHHH
T ss_pred CCHHHEEEE-CCcEEEEECCCCe-------------ECCCCCHHHHHHHHHHHHHHHHHHhcCCCCChHH
Confidence 999999999 9999999999986 3456899999864 34555566654
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=1.6e-21 Score=187.90 Aligned_cols=143 Identities=19% Similarity=0.100 Sum_probs=102.4
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeE--EEeeeeccccccCh---------------------hhHHHHHHHHHHHHhcC
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYY--YAVKCLKKDVVLED---------------------DDVECTLIERKVLALGT 123 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~--~AiK~~~k~~~~~~---------------------~~~~~~~~e~~~l~~~~ 123 (494)
|++.+.||+|+||.||+|.+..+|+. ||||+++....... ........|..++.. +
T Consensus 49 ~~i~~~ig~G~~g~Vy~a~~~~~g~~~~vAvK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~-l 127 (258)
T 1zth_A 49 TAMGGVISTGKEANVFYADGVFDGKPVAMAVKIYRIETSEFDKMDEYLYGDERFDMRRISPKEKVFIWTEKEFRNLER-A 127 (258)
T ss_dssp EEEEEEEEECSSEEEEEEEEEETTEEEEEEEEEECCC-------GGGTTTCTTSCC----CHHHHHHHHHHHHHHHHH-H
T ss_pred hhhCCEEeecceEEEEEEEEcCCCcEeeEEEEEEECCccchhhHHHhhcccchhhhhccChHHHHHHHHHHHHHHHHH-H
Confidence 68899999999999999999888888 99999765321100 011245566666653 4
Q ss_pred CCCce--eeEEEEEEcCCeeEEEEEecCC-CCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHH
Q psy8309 124 KHPYL--CHLFCTFQTDSHLFFVMEYLNG-GDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGM 200 (494)
Q Consensus 124 ~hp~I--v~l~~~~~~~~~~~lv~E~~~~-g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL 200 (494)
.|++| +.++.. +..+|||||+.+ |.+ ...|...... .++..+..++.||+.||
T Consensus 128 ~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~-----------------~~~L~~~~~~---~~~~~~~~i~~qi~~~l 183 (258)
T 1zth_A 128 KEAGVSVPQPYTY----MKNVLLMEFIGEDELP-----------------APTLVELGRE---LKELDVEGIFNDVVENV 183 (258)
T ss_dssp HHTTCCCCCEEEE----ETTEEEEECCEETTEE-----------------CCBHHHHGGG---GGGSCHHHHHHHHHHHH
T ss_pred HhCCCCCCeEEEc----CCCEEEEEecCCCCCc-----------------cccHHHHhhc---cChHHHHHHHHHHHHHH
Confidence 45432 333332 367899999942 433 1233322211 23567788999999999
Q ss_pred HHHH-hCCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 201 RFLH-KKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 201 ~yLH-~~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.||| ++||+||||||+|||++. .++|+|||+|..
T Consensus 184 ~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~ 218 (258)
T 1zth_A 184 KRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVT 218 (258)
T ss_dssp HHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEE
T ss_pred HHHHHHCCEEeCCCCHHHEEEcC--cEEEEECccccc
Confidence 9999 999999999999999988 999999999874
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.74 E-value=5.8e-19 Score=177.79 Aligned_cols=136 Identities=13% Similarity=0.088 Sum_probs=91.5
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-----------ChhhHHH--------HHHHHHHHHhcCCCCc
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-----------EDDDVEC--------TLIERKVLALGTKHPY 127 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----------~~~~~~~--------~~~e~~~l~~~~~hp~ 127 (494)
|++...||.|+||.||+|.+. +|+.||||+++..... ....... ...|...|.. +.+.+
T Consensus 97 Y~I~~~IG~Gk~a~VY~a~d~-~G~~vAvKi~r~~~~sfr~v~~~r~~~~~~~~~~~~~~~rl~A~kE~~nL~r-L~~~g 174 (397)
T 4gyi_A 97 YSVGSRIGVGKESDIMIVADE-KGKQKVLKIHRLGRISFRTVKANRDYLRNRSTGSWMYLSRLAAIKEFAFMKA-LYEEG 174 (397)
T ss_dssp SEEEEEEEECSSEEEEEEECT-TCCEEEEEEECTTEECCCCCC--CEECTTSCHHHHHHHHHHHHHHHHHHHHH-HHHTT
T ss_pred EEecCEeeeCCceEEEEEECC-CCCEEEEEEEecccccHHHHHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH-HHhcC
Confidence 899999999999999999874 6889999998643211 0000001 1123333332 22222
Q ss_pred e--eeEEEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh
Q psy8309 128 L--CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK 205 (494)
Q Consensus 128 I--v~l~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~ 205 (494)
+ ...++. . ..+|||||+.|++|. .. .....+..++.||+.+|.+||+
T Consensus 175 v~vp~p~~~---~-~~~LVME~i~G~~L~---------------------~l------~~~~~~~~l~~qll~~l~~lH~ 223 (397)
T 4gyi_A 175 FPVPEPIAQ---S-RHTIVMSLVDALPMR---------------------QV------SSVPDPASLYADLIALILRLAK 223 (397)
T ss_dssp CSCCCEEEE---E-TTEEEEECCSCEEGG---------------------GC------CCCSCHHHHHHHHHHHHHHHHH
T ss_pred CCCCeeeec---c-CceEEEEecCCccHh---------------------hh------cccHHHHHHHHHHHHHHHHHHH
Confidence 2 122221 1 237999999865442 11 1123456788999999999999
Q ss_pred CCCccccCCCCceeeCCCC----------CEEEeecCcee
Q psy8309 206 KGIVYRDLKLDNILLDYEG----------HVRIADFGMCK 235 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g----------~vkL~DFGla~ 235 (494)
+|||||||||.|||++.+| .+.|+||+-+.
T Consensus 224 ~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V 263 (397)
T 4gyi_A 224 HGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMV 263 (397)
T ss_dssp TTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCE
T ss_pred CCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCcc
Confidence 9999999999999998877 38999999664
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.32 E-value=5.7e-12 Score=120.80 Aligned_cols=142 Identities=14% Similarity=0.009 Sum_probs=103.9
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+..|++...+|.|+.+.||++... +..|++|+......... .....|..++.....+..+.++++++.+.+..|+
T Consensus 13 l~~~~~~~~~~g~s~~~v~~~~~~--~~~~vlK~~~~~~~~~~---~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~l 87 (263)
T 3tm0_A 13 IEKYRCVKDTEGMSPAKVYKLVGE--NENLYLKMTDSRYKGTT---YDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNL 87 (263)
T ss_dssp HTTSEEEECCSCCSSSEEEEEECS--SCEEEEEEECGGGTTST---TCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEE
T ss_pred hccceeEeeccCCCCCeEEEEECC--CCcEEEEeCCcccCCCH---HHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEE
Confidence 357999999999999999999743 56799999875321111 2345666666644456778899999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh------------------
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK------------------ 205 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~------------------ 205 (494)
|||+++|.+| ...+ .+......++.+++.+|..||+
T Consensus 88 v~e~i~G~~l---------------------~~~~-----~~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~ 141 (263)
T 3tm0_A 88 LMSEADGVLC---------------------SEEY-----EDEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAE 141 (263)
T ss_dssp EEECCSSEEH---------------------HHHC-----CTTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHH
T ss_pred EEEecCCeeh---------------------hhcc-----CCcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHH
Confidence 9999996544 2211 0112234567788888888887
Q ss_pred -----------------------------------------CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 -----------------------------------------KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 -----------------------------------------~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
..++|+|++|.|||++.++.+.|+||+.+..
T Consensus 142 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 142 LDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 4589999999999998755567999998764
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.21 E-value=3e-11 Score=115.12 Aligned_cols=83 Identities=13% Similarity=-0.032 Sum_probs=56.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCC-ceeeEEEEEEcCCeeE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP-YLCHLFCTFQTDSHLF 142 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp-~Iv~l~~~~~~~~~~~ 142 (494)
..++.+..+.+.|..+.||++.. .+|..|++|+..... . .....|..++.....+. .+.+++++....+..|
T Consensus 19 ~~~~~~~~~~~gg~~~~v~~~~~-~~g~~~vlK~~~~~~---~---~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~ 91 (264)
T 1nd4_A 19 LFGYDWAQQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGA---L---NELQDEAARLSWLATTGVPCAAVLDVVTEAGRDW 91 (264)
T ss_dssp TTTCEEEECSCTTSSCEEEEEEC-TTSCCEEEEEECSCT---T---SCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEE
T ss_pred cCCCceEecccCCCCceEEEEec-CCCCeEEEEeCCccc---c---hhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCE
Confidence 44677655555677799999964 456679999976531 1 12344555554332332 2667888888888899
Q ss_pred EEEEecCCCCC
Q psy8309 143 FVMEYLNGGDL 153 (494)
Q Consensus 143 lv~E~~~~g~L 153 (494)
+||||++|.+|
T Consensus 92 ~v~e~i~G~~l 102 (264)
T 1nd4_A 92 LLLGEVPGQDL 102 (264)
T ss_dssp EEEECCSSEET
T ss_pred EEEEecCCccc
Confidence 99999998777
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=99.06 E-value=7.7e-10 Score=111.09 Aligned_cols=142 Identities=15% Similarity=0.250 Sum_probs=98.6
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeec--cccccChhhHHHHHHHHHHHHhcC-CCCceeeEEEEEEcC---Cee
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLK--KDVVLEDDDVECTLIERKVLALGT-KHPYLCHLFCTFQTD---SHL 141 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~--k~~~~~~~~~~~~~~e~~~l~~~~-~hp~Iv~l~~~~~~~---~~~ 141 (494)
..++.|+.|.++.||++... +..+++|+.. ..... ........|..++.... .+..+++++.++.+. +..
T Consensus 41 ~~~~~l~~G~sn~~y~v~~~--~~~~vlr~~~~p~~~~~--~~~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~ 116 (359)
T 3dxp_A 41 LSVEQFKGGQSNPTFKLVTP--GQTYVMRAKPGPKSKLL--PSAHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRA 116 (359)
T ss_dssp CEEEECCC-CCSCEEEEECS--SCEEEEECCCC------------CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSC
T ss_pred ceEEEcCCcccceEEEEEEC--CceEEEEeCCCCCCCCC--CcHHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCe
Confidence 34678999999999998754 3568888876 33211 11223445666665432 245678888888776 458
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh----------------
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK---------------- 205 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~---------------- 205 (494)
|+||||++|..+.+. ....+++.+...++.+++.+|..||+
T Consensus 117 ~~vme~v~G~~l~~~-----------------------~~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~ 173 (359)
T 3dxp_A 117 FYIMEFVSGRVLWDQ-----------------------SLPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGN 173 (359)
T ss_dssp EEEEECCCCBCCCCT-----------------------TCTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSC
T ss_pred EEEEEecCCeecCCC-----------------------ccccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCC
Confidence 999999997665221 11235677777888888888888886
Q ss_pred ------------------------------------------CCCccccCCCCceeeCCCCC--EEEeecCceee
Q psy8309 206 ------------------------------------------KGIVYRDLKLDNILLDYEGH--VRIADFGMCKL 236 (494)
Q Consensus 206 ------------------------------------------~givHrDLKp~NILl~~~g~--vkL~DFGla~~ 236 (494)
.+++|+|++|.|||++.++. +.|+||+.+..
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 174 YFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp HHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred chHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 36899999999999998764 68999999875
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=99.00 E-value=4.3e-10 Score=110.29 Aligned_cols=182 Identities=18% Similarity=0.209 Sum_probs=107.3
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCc--eeeEEEEEEcCC---eeEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY--LCHLFCTFQTDS---HLFFV 144 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~--Iv~l~~~~~~~~---~~~lv 144 (494)
++.++.|....||++. ..+++|+.... ........|..++.....+.. +.+++......+ ..|+|
T Consensus 25 i~~~~~G~~n~v~~v~-----~~~vlR~~~~~-----~~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~v 94 (304)
T 3sg8_A 25 IEISGEGNDCIAYEIN-----RDFIFKFPKHS-----RGSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAG 94 (304)
T ss_dssp CCEEEECSSEEEEEST-----TSEEEEEESSH-----HHHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEE
T ss_pred eEecCCCCcceEEEEC-----CEEEEEecCCc-----chHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEE
Confidence 3569999999999874 34889986432 234456667777654333332 345544443333 35899
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-------------------
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK------------------- 205 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~------------------- 205 (494)
||+++|.+|..... ..++..+...++.|++..|..||+
T Consensus 95 m~~i~G~~l~~~~~-----------------------~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~ 151 (304)
T 3sg8_A 95 FTKIKGVPLTPLLL-----------------------NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKIN 151 (304)
T ss_dssp EECCCCEECCHHHH-----------------------HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHH
T ss_pred EcccCCeECCcccc-----------------------ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHH
Confidence 99999877642111 122333333333344333333332
Q ss_pred ---------------------------------------CCCccccCCCCceeeCC--CCCEEEeecCceeeeeccCCcc
Q psy8309 206 ---------------------------------------KGIVYRDLKLDNILLDY--EGHVRIADFGMCKLQIYLDKTT 244 (494)
Q Consensus 206 ---------------------------------------~givHrDLKp~NILl~~--~g~vkL~DFGla~~~~~~~~~~ 244 (494)
..++|+|++|.|||++. .+.+.|+||+.+........
T Consensus 152 ~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~D-- 229 (304)
T 3sg8_A 152 EDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDND-- 229 (304)
T ss_dssp HHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHH--
T ss_pred HHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHH--
Confidence 24799999999999998 45678999999875321111
Q ss_pred cccCCCCCc---cChhhhCC--CCCC------------CcchHHHHHHHHHHHHhCCCCCC
Q psy8309 245 DTFCGTPDY---MAPEIIKG--LKYN------------QCVDWWSFGILLYEMHVGQSPFS 288 (494)
Q Consensus 245 ~~~~gt~~y---~aPE~l~~--~~~~------------~~~DiwSlGvil~ell~G~~Pf~ 288 (494)
......+ ..|+.... ..|. ...++|++|.++|.+.+|..+|.
T Consensus 230 --l~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 230 --FISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp --HHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred --HHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 1111111 23333211 0111 12589999999999999998874
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=4.6e-06 Score=81.57 Aligned_cols=76 Identities=16% Similarity=0.119 Sum_probs=51.3
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC-C-ceeeEEEEEE-cCCeeEEEEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH-P-YLCHLFCTFQ-TDSHLFFVME 146 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h-p-~Iv~l~~~~~-~~~~~~lv~E 146 (494)
++.++.|....||++ +..+++|+-.. .........|..++.....+ + .+.+.+.+.. ..+..|+|||
T Consensus 24 v~~l~~G~~n~v~~v-----g~~~VlR~~~~-----~~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e 93 (306)
T 3tdw_A 24 VESLGEGFRNYAILV-----NGDWVFRFPKS-----QQGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYR 93 (306)
T ss_dssp EEEEEECSSEEEEEE-----TTTEEEEEESS-----HHHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEE
T ss_pred eeecCCCcceeEEEE-----CCEEEEEecCC-----chHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEe
Confidence 456899999999988 34588898532 22345566787777654333 2 3556666654 4566789999
Q ss_pred ecCCCCCcc
Q psy8309 147 YLNGGDLIP 155 (494)
Q Consensus 147 ~~~~g~L~~ 155 (494)
+++|..|..
T Consensus 94 ~i~G~~l~~ 102 (306)
T 3tdw_A 94 KVQGQILGE 102 (306)
T ss_dssp CCCSEECHH
T ss_pred ccCCeECch
Confidence 999887743
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=7e-06 Score=78.32 Aligned_cols=82 Identities=13% Similarity=-0.010 Sum_probs=54.8
Q ss_pred CceEeeEeccCCce-EEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 66 DFQLLKVLGKGSFG-KVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 66 ~y~~~~~LG~G~fG-~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
.|+.. .+..|..| .||+......+..+.+|+-... .......|...|...-.+--+.+++.++.+.+..|+|
T Consensus 26 g~~~~-~~~~G~S~~~v~rl~~~~~~~~~~lk~~~~~------~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lv 98 (272)
T 4gkh_A 26 GYRWA-RDNVGQSGATIYRLYGKPNAPELFLKHGKGS------VANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLL 98 (272)
T ss_dssp TCEEE-EEECSSSSCEEEEEECCTTCCCEEEEEEETH------HHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred CCeEE-EccCCCcCCeEEEEEecCCCeEEEEEECCCC------CHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEE
Confidence 34433 34445554 6998887777777999986543 2334455666665433333367888888999999999
Q ss_pred EEecCCCCCc
Q psy8309 145 MEYLNGGDLI 154 (494)
Q Consensus 145 ~E~~~~g~L~ 154 (494)
||+++|.++.
T Consensus 99 me~l~G~~~~ 108 (272)
T 4gkh_A 99 TTAIPGKTAF 108 (272)
T ss_dssp EECCCSEEHH
T ss_pred EEeeCCcccc
Confidence 9999986653
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=98.20 E-value=4.5e-06 Score=84.63 Aligned_cols=82 Identities=20% Similarity=0.195 Sum_probs=47.7
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccc-cCh---hhHHHHHHHHHHHHhcCCC-C-ceeeEEEEEEcCCeeE
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV-LED---DDVECTLIERKVLALGTKH-P-YLCHLFCTFQTDSHLF 142 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~-~~~---~~~~~~~~e~~~l~~~~~h-p-~Iv~l~~~~~~~~~~~ 142 (494)
..+.||.|..+.||++....+++.|+||....... ... ........|..++.....+ | .+.+++.+ +.+..+
T Consensus 34 ~~~~lg~G~~n~vyrv~~~~~~~~~vvK~~~~~~r~~~~~~~~~~~r~~~E~~~L~~l~~~~~~~vP~~~~~--d~~~~~ 111 (397)
T 2olc_A 34 TCQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAV 111 (397)
T ss_dssp EEEECCSSSSEEEEEEEC----CEEEEEEECCC-------CCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTE
T ss_pred EEEECCCCceEEEEEEEECCCCcEEEEEecchhhcccCCCCcCcHHHHHHHHHHHHHhhhhCCCCcCeEEEE--cCCccE
Confidence 35789999999999997665667799998653211 000 1123345566666532222 3 34455543 345578
Q ss_pred EEEEecCCCC
Q psy8309 143 FVMEYLNGGD 152 (494)
Q Consensus 143 lv~E~~~~g~ 152 (494)
+|||+++|..
T Consensus 112 lvmE~l~g~~ 121 (397)
T 2olc_A 112 TVMEDLSHLK 121 (397)
T ss_dssp EEECCCTTSE
T ss_pred EEEEeCCCcc
Confidence 9999998743
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=98.08 E-value=2.7e-05 Score=76.64 Aligned_cols=31 Identities=16% Similarity=0.284 Sum_probs=28.0
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.+++|+|+++.|||++.++.+.|+||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 5799999999999998888999999998753
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.91 E-value=7.8e-05 Score=74.13 Aligned_cols=85 Identities=12% Similarity=0.056 Sum_probs=51.4
Q ss_pred eEeeEe-ccCCceEEEEEEEe---C---CCeEEEeeeecccc---ccChhhHHHHHHHHHHHHhcCCC--CceeeEEEEE
Q psy8309 68 QLLKVL-GKGSFGKVFLAELK---G---TDYYYAVKCLKKDV---VLEDDDVECTLIERKVLALGTKH--PYLCHLFCTF 135 (494)
Q Consensus 68 ~~~~~L-G~G~fG~V~~~~~~---~---~~~~~AiK~~~k~~---~~~~~~~~~~~~e~~~l~~~~~h--p~Iv~l~~~~ 135 (494)
...+.| +.|..+.+|++... . ++..+++|+..... ..... ....|..++.....+ -.+.+++.+.
T Consensus 23 ~~~~~l~~~G~~n~~y~v~~~~~~~~~~~~~~~vlR~~~~~~~~~~~~~~---~~~~E~~~l~~L~~~~~vpvP~v~~~~ 99 (357)
T 3ats_A 23 TVESGVDSTGMSSETIILTARWQQDGRSIQQKLVARVAPAAEDVPVFPTY---RLDHQFEVIRLVGELTDVPVPRVRWIE 99 (357)
T ss_dssp EEEEEECTTSSEEEEEEEEEEEEETTEEEEEEEEEEECCCGGGCCSSSCC---CHHHHHHHHHHHHHHCCSCCCCEEEEE
T ss_pred EEEEECCCCCccceEEEEEEecccCCCCCCceEEEEeCCCCCccccCchh---HHHHHHHHHHHHhhcCCCCCCcEEEEc
Confidence 445778 88999999998754 1 15568899875432 11111 223344443322122 2456677766
Q ss_pred EcC---CeeEEEEEecCCCCCcc
Q psy8309 136 QTD---SHLFFVMEYLNGGDLIP 155 (494)
Q Consensus 136 ~~~---~~~~lv~E~~~~g~L~~ 155 (494)
.+. +..|+|||+++|..+.+
T Consensus 100 ~~~~~~g~~~~v~e~l~G~~l~~ 122 (357)
T 3ats_A 100 TTGDVLGTPFFLMDYVEGVVPPD 122 (357)
T ss_dssp CSSTTTSSCEEEEECCCCBCCCB
T ss_pred cCCCccCCceEEEEecCCCChhh
Confidence 654 35689999999888754
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=97.86 E-value=8e-05 Score=76.05 Aligned_cols=78 Identities=6% Similarity=0.001 Sum_probs=46.0
Q ss_pred HhCCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCC--CCCccChhhhCCCCC---CCcchHHHHHHHHH
Q psy8309 204 HKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCG--TPDYMAPEIIKGLKY---NQCVDWWSFGILLY 278 (494)
Q Consensus 204 H~~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~g--t~~y~aPE~l~~~~~---~~~~DiwSlGvil~ 278 (494)
+...++|+|++|.|||++.++ ++|+||+.+.......... ...+ ...|++|+......- ....++.++...+|
T Consensus 230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G~p~~Dla-~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 307 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYGPMGFDIG-AYLGNLILAFFAQDGHATQENDRKEYKQWILRTIEQTW 307 (420)
T ss_dssp BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEECHHHHHH-HHHHHHHHHHHHGGGGCCSSCCSHHHHHHHHHHHHHHH
T ss_pred CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccCchHHHHH-HHHHHHHHHHHhcccccccccchHHHHHHHHHHHHHHH
Confidence 456899999999999998877 9999999887532111111 0111 123555555432111 11233446777777
Q ss_pred HHHhC
Q psy8309 279 EMHVG 283 (494)
Q Consensus 279 ell~G 283 (494)
+.+.+
T Consensus 308 ~~y~~ 312 (420)
T 2pyw_A 308 NLFNK 312 (420)
T ss_dssp HHHHH
T ss_pred HHHHH
Confidence 77653
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=97.67 E-value=9.8e-06 Score=82.24 Aligned_cols=48 Identities=38% Similarity=0.649 Sum_probs=41.1
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhccccccccccccCCCCCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDP 494 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 494 (494)
++.|++|||.+||.+++.++|.+...++.++|.+|.||||+||.++++
T Consensus 345 ~~~d~~~fd~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 392 (396)
T 4dc2_A 345 GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPLLMSA 392 (396)
T ss_dssp SSTTGGGSCHHHHTSCCCCCCCCHHHHTTSCGGGGTTCCEECC-----
T ss_pred CccchhhcChhhccCCCccCCCcchhhccccccccCCcEeECcccccc
Confidence 567999999999999999999999999999999999999999998763
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=97.44 E-value=0.0011 Score=64.21 Aligned_cols=29 Identities=21% Similarity=0.239 Sum_probs=25.4
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.++|+|+.|.||+ ..++.+.|+||..+..
T Consensus 174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 4899999999999 5677899999998764
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=97.32 E-value=0.00064 Score=66.38 Aligned_cols=78 Identities=19% Similarity=0.117 Sum_probs=55.4
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCC--CCceeeEEEEEEcCCeeEEEEE
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK--HPYLCHLFCTFQTDSHLFFVME 146 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~--hp~Iv~l~~~~~~~~~~~lv~E 146 (494)
-.+.|+.|....||++.. .+..|++|+.... .......|...|..... ...+++++.+....+..|+|||
T Consensus 40 ~~~~l~gG~~n~~y~v~~--~~~~~vlK~~~~~------~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme 111 (312)
T 3jr1_A 40 HKEKLYSGEMNEIWLIND--EVQTVFVKINERS------YRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLE 111 (312)
T ss_dssp EEEEECCSSSSEEEEEES--SSCEEEEEEEEGG------GHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEE
T ss_pred eeEEeCCccceeeeEEEE--CCCeEEEEeCCcc------cHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEE
Confidence 457799999999999874 4566889987543 12334455555543222 3567788888888889999999
Q ss_pred ecCCCCCc
Q psy8309 147 YLNGGDLI 154 (494)
Q Consensus 147 ~~~~g~L~ 154 (494)
+++|..+.
T Consensus 112 ~l~G~~~~ 119 (312)
T 3jr1_A 112 ALNKSKNK 119 (312)
T ss_dssp CCCCCCCC
T ss_pred eccCCCCC
Confidence 99998763
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=97.25 E-value=0.00055 Score=68.77 Aligned_cols=158 Identities=16% Similarity=0.166 Sum_probs=85.0
Q ss_pred CCCceEeeEeccCCceEEEEEEEeC-------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKG-------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
.+++++ +.|..|-...+|++.... ++..|++|+.... . ........|..++.....+....++++.+.
T Consensus 50 ~~~l~v-~~lsGG~TN~~y~v~~~~~~~~~~~~~~~~vlR~~g~~-~---~~~~~~~rE~~vl~~L~~~gv~P~ll~~~~ 124 (379)
T 3feg_A 50 PEELRV-YPVSGGLSNLLFRCSLPDHLPSVGEEPREVLLRLYGAI-L---QGVDSLVLESVMFAILAERSLGPQLYGVFP 124 (379)
T ss_dssp GGGCCC-EEC-----CCEEEEECCTTSCCCSSCCSEEEEEECC-------CCHHHHHHHHHHHHHHHHTTSSCCEEEEET
T ss_pred cCceEE-EEcCCcccccEEEEEeCCCccccCCCCCeEEEEECCCc-c---chHHHHHHHHHHHHHHHhcCCCCeEEEEcC
Confidence 345553 567778889999998642 3467899986331 1 123334466666654333434467777765
Q ss_pred cCCeeEEEEEecCCCCCccccchhh--hhhhhhHhcCCchhHHhhhc-----CCC--CHHHHHHHHHHHHH---------
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKA--ERDLMEYLNGGDLMFHIQQS-----GRF--DEGRARFYAAEIVS--------- 198 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~--~~~l~~~~~gg~L~~~l~~~-----~~l--~e~~~~~~~~qi~~--------- 198 (494)
+ .+||||++|.+|....+... ...+.+.+ ..+... ... -..++..|..++-.
T Consensus 125 ~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~L------a~LH~~~~~~~~~~~~l~~~i~~w~~~~~~~~~~~~~~~ 194 (379)
T 3feg_A 125 E----GRLEQYIPSRPLKTQELREPVLSAAIATKM------AQFHGMEMPFTKEPHWLFGTMERYLKQIQDLPPTGLPEM 194 (379)
T ss_dssp T----EEEEECCSEEECCGGGGGCHHHHHHHHHHH------HHHHTCCCSSCCSCCHHHHHHHHHHHHHHHCCCCSCCSC
T ss_pred C----ccEEEEecCccCChhHhCCHHHHHHHHHHH------HHHhCCCCCCCCCcccHHHHHHHHHHHHHhccCcccchh
Confidence 4 29999999877753322211 01111111 111111 011 12344444444321
Q ss_pred ----------HHHHHH----h----CCCccccCCCCceeeCCC----CCEEEeecCceee
Q psy8309 199 ----------GMRFLH----K----KGIVYRDLKLDNILLDYE----GHVRIADFGMCKL 236 (494)
Q Consensus 199 ----------aL~yLH----~----~givHrDLKp~NILl~~~----g~vkL~DFGla~~ 236 (494)
.+..|. . ..++|+|+.+.|||++.+ +.+.|+||..+..
T Consensus 195 ~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 195 NLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp CHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred hhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 223332 2 259999999999999876 7899999998764
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.11 E-value=0.0027 Score=61.91 Aligned_cols=29 Identities=17% Similarity=0.077 Sum_probs=25.4
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
..++|+|+++.|||++ + .+.|+||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 4689999999999998 4 899999998764
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=97.06 E-value=0.0025 Score=62.00 Aligned_cols=159 Identities=18% Similarity=0.169 Sum_probs=77.4
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH---h-cCCCCceeeEE-E--EEEcC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA---L-GTKHPYLCHLF-C--TFQTD 138 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~---~-~~~hp~Iv~l~-~--~~~~~ 138 (494)
+..-++.|+.|....||++... .+ .|++|+..... ....+. .|..++. . .+.-|.++... + +....
T Consensus 23 ~~~~~~~i~~G~~n~~~~v~~~-~g-~~vlk~~~~~~--~~~~l~---~e~~~l~~L~~~g~~vP~~~~~~~g~~~~~~~ 95 (322)
T 2ppq_A 23 SLTSYKGIAEGVENSNFLLHTT-KD-PLILTLYEKRV--EKNDLP---FFLGLMQHLAAKGLSCPLPLPRKDGELLGELS 95 (322)
T ss_dssp CEEEEEEECC---EEEEEEEES-SC-CEEEEEECC-----CCHHH---HHHHHHHHHHHTTCCCCCBCCBTTCCSCEEET
T ss_pred cceEeeccCCCcccceEEEEeC-Cc-cEEEEEeCCCC--CHHHHH---HHHHHHHHHHHCCCCCCcccCCCCCCEEEEEC
Confidence 3445677888999999998753 33 58899887531 111222 2333322 1 22334444211 0 11234
Q ss_pred CeeEEEEEecCCCCCccccchhhhhh-------hhhHhcCC--------chhHHhh-------hcCCCCHHHHHHHHHHH
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERD-------LMEYLNGG--------DLMFHIQ-------QSGRFDEGRARFYAAEI 196 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~-------l~~~~~gg--------~L~~~l~-------~~~~l~e~~~~~~~~qi 196 (494)
+..+++|++++|..+.... ...... +.....+. .+..+.. ....+... +...+
T Consensus 96 g~~~~l~~~l~G~~~~~~~-~~~~~~~g~~La~lH~~~~~~~~~~~~~~~~~~w~~~~~~~~~~~~~~~~~----l~~~l 170 (322)
T 2ppq_A 96 GRPAALISFLEGMWLRKPE-AKHCREVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKG----LREEI 170 (322)
T ss_dssp TEEEEEEECCCCBCCSSCC-HHHHHHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTT----HHHHH
T ss_pred CEEEEEEEeCCCcCCCCCC-HHHHHHHHHHHHHHHHHhccCCCcccCccChHHHHHHHHHHHHHHHhhhhh----hHHHH
Confidence 6679999999987663211 000000 11110000 0000000 00001000 01123
Q ss_pred HHHHHHHHh-------CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 197 VSGMRFLHK-------KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 197 ~~aL~yLH~-------~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
...++.|+. .+++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 171 ~~~~~~l~~~~~~~~~~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 171 RPEIDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp HHHHHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHHHHHHHhhCcccCCcccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 334455542 4799999999999998776568999998764
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=97.03 E-value=0.00013 Score=72.79 Aligned_cols=46 Identities=37% Similarity=0.686 Sum_probs=40.4
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhccccccccccccCCCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNAT 492 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~ 492 (494)
++.|++|||++|+.+.|.++|.+...+..++|++|.||+|++|.+.
T Consensus 307 ~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 352 (353)
T 3txo_A 307 SREDVSNFDPDFIKEEPVLTPIDEGHLPMINQDEFRNFEYVSPELQ 352 (353)
T ss_dssp STTCCTTSCHHHHTSCCCCCCCCTTSGGGSCGGGGTTCCEECC---
T ss_pred CcccccccCcccccCCCcCCCccccccCcccccccCCceeeCcccC
Confidence 4578999999999999999999998899999999999999999764
|
| >3f7w_A Putative fructosamine-3-kinase; YP_290396.1, structural GENO joint center for structural genomics, JCSG, protein structu initiative, PSI-2; 1.85A {Thermobifida fusca YX} | Back alignment and structure |
|---|
Probab=97.02 E-value=0.01 Score=56.76 Aligned_cols=81 Identities=15% Similarity=0.028 Sum_probs=50.0
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCC--CceeeEEEEEEcCCeeEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKH--PYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~h--p~Iv~l~~~~~~~~~~~l 143 (494)
+..-++.+|.|..+.||+++. .+|+.|.+|+.......... ....|...|...... --+++++.+. .-++
T Consensus 16 ~v~~v~~~g~G~~~~vyrv~l-~DG~~~~vK~~~~~~~~~~~---~~~~Ea~~L~~L~~~~~vpvP~v~~~~----~~~l 87 (288)
T 3f7w_A 16 EVAAVAERGHSHRWHLYRVEL-ADGTPLFVKALPDDAPALDG---LFRAEALGLDWLGRSFGSPVPQVAGWD----DRTL 87 (288)
T ss_dssp CEEEEEEEEEETTEEEEEEEE-TTSCEEEEEECCTTCCCCTT---HHHHHHHHHHHHTCSTTCCSCCEEEEE----TTEE
T ss_pred CeEEEEecCCCCCeEEEEEEE-CCCCEEEEEEeCCCCcchhh---HHHHHHHHHHHHHhhCCCCcceEEecc----CceE
Confidence 455678899999999999975 46778999986543221111 233455555432222 1234444432 3478
Q ss_pred EEEecCCCCCc
Q psy8309 144 VMEYLNGGDLI 154 (494)
Q Consensus 144 v~E~~~~g~L~ 154 (494)
||||+.++...
T Consensus 88 v~e~l~~~~~~ 98 (288)
T 3f7w_A 88 AMEWVDERPPT 98 (288)
T ss_dssp EEECCCCCCCC
T ss_pred EEEeecccCCC
Confidence 99999877653
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0018 Score=66.26 Aligned_cols=77 Identities=14% Similarity=0.122 Sum_probs=48.5
Q ss_pred EeeEeccCCceEEEEEEEeC-------CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 69 LLKVLGKGSFGKVFLAELKG-------TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~-------~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
-++.|+.|....||++.... .+..|++|+..... . ......|..++.....+....++++.+.+
T Consensus 77 ~v~~l~gG~tN~~y~v~~~~~~~~~~~~~~~~vlRi~~~~~--~---~~~li~E~~~l~~L~~~g~~P~l~~~~~~---- 147 (429)
T 1nw1_A 77 RISRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNPE--T---ESHLVAESVIFTLLSERHLGPKLYGIFSG---- 147 (429)
T ss_dssp EEEEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSCC--C---HHHHHHHHHHHHHHHHTTSSSCEEEEETT----
T ss_pred EEEEeCCCcccceEEEEeCCCccccCCCCceEEEEEeCCCC--c---HHHHHHHHHHHHHHHhCCCCCcEEEEeCC----
Confidence 35678889999999998653 24678999884321 1 12233566655533233334677776643
Q ss_pred EEEEEecCCCCCc
Q psy8309 142 FFVMEYLNGGDLI 154 (494)
Q Consensus 142 ~lv~E~~~~g~L~ 154 (494)
.+|+||++|.+|.
T Consensus 148 g~v~e~l~G~~l~ 160 (429)
T 1nw1_A 148 GRLEEYIPSRPLS 160 (429)
T ss_dssp EEEECCCCEEECC
T ss_pred CEEEEEeCCcccC
Confidence 3899999976664
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=96.84 E-value=0.011 Score=53.92 Aligned_cols=120 Identities=17% Similarity=0.138 Sum_probs=78.5
Q ss_pred chhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCC
Q psy8309 173 DLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGT 250 (494)
Q Consensus 173 ~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt 250 (494)
+|...++ ...+|+|+++|.++.|.+.+|.-+-. ..-..+=+-|..|+|..+|.|.+.+ +.+. ...
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~------------~~~ 100 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD------------AGE 100 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc------------ccc
Confidence 3444454 35689999999999999999877622 2222334457899999999998874 2211 112
Q ss_pred CCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhCCCCCCccCCHHHHHHHHhhccC
Q psy8309 251 PDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDK 324 (494)
Q Consensus 251 ~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~ 324 (494)
..+.|||... ...+.+.=|+|||++||..+- |-++ .-+..+|+.+..||..|..-
T Consensus 101 ~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL~e------------------~eE~eLS~~LE~LL~~Mt~~ 156 (229)
T 2yle_A 101 PPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGLKE------------------NEERELSPPLEQLIDHMANT 156 (229)
T ss_dssp ------CCSS-SSSCHHHHHHHHHHHHHHHHTTTCCT------------------TEEECCCHHHHHHHHHHTTC
T ss_pred cCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCCCc------------------ccchhhCHHHHHHHHHHHhc
Confidence 2456887763 345677889999999999885 3222 12456899999999999865
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=96.82 E-value=0.019 Score=58.93 Aligned_cols=78 Identities=12% Similarity=0.165 Sum_probs=47.6
Q ss_pred EeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 69 ~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
-++.|+.|-...+|++.....+..|++|+..... ...+ ....|..++.....+....++++.+. + .+||||+
T Consensus 112 ~i~~lsgG~tN~~y~v~~~~~~~~~vLRi~g~~~---~~~i-dR~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I 183 (458)
T 2qg7_A 112 EFQIINGGITNILIKVKDMSKQAKYLIRLYGPKT---DEII-NREREKKISCILYNKNIAKKIYVFFT--N--GRIEEFM 183 (458)
T ss_dssp EEEEECC--CEEEEEEEETTTTEEEEEEEECC-C---CSCS-CHHHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECC
T ss_pred EEEEcCCCeEeEEEEEEECCCCceEEEEECCCCh---hhhc-CHHHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEee
Confidence 3567888999999999876545678999875421 1111 11355555554334444567887773 2 3599999
Q ss_pred CCCCCc
Q psy8309 149 NGGDLI 154 (494)
Q Consensus 149 ~~g~L~ 154 (494)
+|.+|.
T Consensus 184 ~G~~l~ 189 (458)
T 2qg7_A 184 DGYALS 189 (458)
T ss_dssp CSEECC
T ss_pred CCccCC
Confidence 986664
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=96.79 E-value=0.003 Score=62.95 Aligned_cols=29 Identities=24% Similarity=0.358 Sum_probs=24.7
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
+++|+|+.+.|||++.++ +.|+||..+..
T Consensus 213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 699999999999998654 89999998764
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=96.49 E-value=0.00069 Score=67.39 Aligned_cols=45 Identities=38% Similarity=0.797 Sum_probs=39.8
Q ss_pred cccccccCCcCCCCCCCCchhHHhhhccccccccccccCCCCCCC
Q psy8309 450 DVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNATDP 494 (494)
Q Consensus 450 ~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 494 (494)
|++|||..|+.+++.++|.+...+.+++|.+|.||+|++|.++.|
T Consensus 305 ~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~~~ 349 (353)
T 2i0e_A 305 NAENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFLKP 349 (353)
T ss_dssp --CHHHHHHHHSCCCCCCCCHHHHHHSCTTTTCSCCEECTTCCCC
T ss_pred chhhccchhccCCcccCCccccccccccccccCCCeeeCccccCh
Confidence 899999999999999999998888889999999999999988764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0046 Score=60.56 Aligned_cols=31 Identities=35% Similarity=0.397 Sum_probs=27.5
Q ss_pred CCCccccCCCCceeeCCC----CCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYE----GHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~----g~vkL~DFGla~~ 236 (494)
..++|+|+.+.|||++.+ +.+.|+||+.+..
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~ 217 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL 217 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence 479999999999999875 6799999998875
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=96.25 E-value=0.00088 Score=66.39 Aligned_cols=46 Identities=41% Similarity=0.746 Sum_probs=8.9
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhccccccccccccCCCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNAT 492 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~~~ 492 (494)
++.|++|||.+|+.+.|.+++.+...+..++|..|.||+|+++.+.
T Consensus 296 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 341 (345)
T 1xjd_A 296 SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSFMNPGME 341 (345)
T ss_dssp -------------------------------CCTTTTCCC------
T ss_pred CcchhhhcchhhcccCccCCcccccccccccccccCCCeeeChhhh
Confidence 5679999999999999999998888888899999999999998765
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=95.82 E-value=0.06 Score=52.83 Aligned_cols=31 Identities=23% Similarity=0.285 Sum_probs=27.9
Q ss_pred CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
..++|+|+.+.|||++.++.+.|+||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 4699999999999999888999999998765
|
| >3mes_A Choline kinase; malaria, structural genomics, structural genomics consortium, SGC, transferase; HET: ADP DME PT3; 2.35A {Cryptosporidium parvum} | Back alignment and structure |
|---|
Probab=95.69 E-value=0.028 Score=57.04 Aligned_cols=29 Identities=21% Similarity=0.452 Sum_probs=26.1
Q ss_pred CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 207 GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 207 givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.++|+|+.+.||+ +.++.+.|+||..|..
T Consensus 263 ~~~H~D~~~~N~l-~~~~~~~~IDwe~a~~ 291 (424)
T 3mes_A 263 VFAHNDLQENNLL-QTQNNIRMIDYEYSAI 291 (424)
T ss_dssp EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred eEECCCCCcccee-cCCCcEEEEecccCCc
Confidence 5899999999999 7888999999998764
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=95.66 E-value=0.0033 Score=62.12 Aligned_cols=44 Identities=41% Similarity=0.715 Sum_probs=39.5
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhccccccccccccCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPN 490 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~~~~~ 490 (494)
++.|++|||..|+.+++.++|.+...+...+|.+|.||+|++|.
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 345 (345)
T 3a8x_A 302 GEFGLDNFDSQFTNEPVQLTPDDDDIVRKIDQSEFEGFEYINPL 345 (345)
T ss_dssp TTTCGGGSCHHHHTSCSSCCCCCHHHHTTSCGGGGTTCCEECCC
T ss_pred CcchhhhcCcccccCcccCCCccccccccccccccCCCEeeCCC
Confidence 35689999999999999999998888888999999999999984
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=94.23 E-value=0.01 Score=58.41 Aligned_cols=44 Identities=36% Similarity=0.647 Sum_probs=27.7
Q ss_pred ccccccccccCCcCCCCCCCCchh-HHhhhc------cccccccccccCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDR-TILESM------DQTQFQGFSYTNPN 490 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~-~~~~~~------~~~~f~~f~~~~~~ 490 (494)
++.|++|||.+|+.+++.++|.++ ..+..+ +|.+|.||||++++
T Consensus 287 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~ 337 (337)
T 1o6l_A 287 SEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIADW 337 (337)
T ss_dssp STTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECCC
T ss_pred CcchhhcccchhccCccCcCCCcccccccccccccccccccCCCceecCCC
Confidence 456899999999999999988764 233333 57899999999875
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.98 E-value=0.17 Score=50.91 Aligned_cols=29 Identities=24% Similarity=0.329 Sum_probs=25.2
Q ss_pred CccccCCCCceee------CCCCCEEEeecCceee
Q psy8309 208 IVYRDLKLDNILL------DYEGHVRIADFGMCKL 236 (494)
Q Consensus 208 ivHrDLKp~NILl------~~~g~vkL~DFGla~~ 236 (494)
++|+|+.+.|||+ +.++.+.++||-.|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 6899999999999 4567799999998864
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=91.72 E-value=0.037 Score=59.82 Aligned_cols=41 Identities=39% Similarity=0.790 Sum_probs=35.3
Q ss_pred CCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCCCcc
Q psy8309 403 KYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNPNAT 443 (494)
Q Consensus 403 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 443 (494)
+|||.+|+.+.+..+|.+...+...+|..|.||+|+++.+.
T Consensus 628 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~~ 668 (674)
T 3pfq_A 628 ENFDRFFTRHPPVLTPPDQEVIRNIDQSEFEGFSFVNSEFL 668 (674)
T ss_dssp HHHTTTTTSSCSSCCCCCHHHHTTCCGGGGTTCCEECSSCC
T ss_pred hhcCchhccCCCccCCCchhhhhcccccccCCCcccChhhh
Confidence 68999999999988988877667778899999999998763
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=88.57 E-value=0.14 Score=51.64 Aligned_cols=44 Identities=20% Similarity=0.342 Sum_probs=29.7
Q ss_pred ccccccccccCCcCCCC-CCCCchhHHhhhccccccccccccCCCCC
Q psy8309 447 HALDVKYFDKSFTAERP-CLTPVDRTILESMDQTQFQGFSYTNPNAT 492 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p-~lt~~~~~~~~~~~~~~f~~f~~~~~~~~ 492 (494)
++.|++|||..++.+.+ ..+|.+.... .+|.+|.||||+++...
T Consensus 356 ~~~d~~~fd~~~~~~~~~~~~~~~~~~~--~~~~~f~~f~~~~~~~~ 400 (410)
T 3v8s_A 356 SDIDTSNFDDLEEDKGEEETFPIPKAFV--GNQLPFVGFTYYSNRRY 400 (410)
T ss_dssp STTCCTTSCCCCSCCSCCCCCCCCSSCC--CTTGGGTTCCEECC---
T ss_pred CccchhhcCCccccccccccCCCchhhc--ccccccccceEeCcccc
Confidence 45789999988877643 3344444333 46999999999988653
|
| >1cja_A Protein (actin-fragmin kinase); transferase; HET: AMP; 2.90A {Physarum polycephalum} SCOP: d.144.1.3 | Back alignment and structure |
|---|
Probab=87.87 E-value=9 Score=37.01 Aligned_cols=152 Identities=18% Similarity=0.185 Sum_probs=76.3
Q ss_pred CCCCCCCCCCCCC---ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceee
Q psy8309 54 TTIPRFRKYDLED---FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCH 130 (494)
Q Consensus 54 ~~~~~~~~~~~~~---y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~ 130 (494)
.+.+....++... ++.++..-.|..|. |.|.- ++..|+||-.. . .+.+.+.-.......+..|...-
T Consensus 55 ~p~~~i~~i~w~~l~~v~~I~~s~~Gstgv-ff~~t--d~~~~VVK~s~--~-----l~~E~l~s~LA~~LGlpiP~~Ri 124 (342)
T 1cja_A 55 VSYNDIGDINWKNLQQFKGIERSEKGTEGL-FFVET--ESGVFIVKRST--N-----IESETFCSLLCMRLGLHAPKVRV 124 (342)
T ss_dssp CBCSCTTCCCTTCGGGEEEEEECCSTTSCE-EEEEE--SSCEEEEECCT--T-----HHHHHHHHHHHHHHTCCCCCEEE
T ss_pred CcCCcccccccccccCeeEEEeccCCCCCe-EEEEe--CCCEEEEeCcH--H-----HHHHHHHHHHHHHhCCCCCCeeE
Confidence 3334445555444 77777777787554 54444 35568899542 1 11111111111122445555322
Q ss_pred EEEE----------------------EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHH
Q psy8309 131 LFCT----------------------FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188 (494)
Q Consensus 131 l~~~----------------------~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~ 188 (494)
+... -...+...++|||.+|..|....... + ...+.++.
T Consensus 125 v~~~~~E~~e~~~~L~~~~~~~~~l~~l~~~~~~l~meyv~G~~L~e~~~~~-----------------~--~~~f~~~~ 185 (342)
T 1cja_A 125 VSSNSEEGTNMLECLAAIDKSFRVITTLANQANILLMELVRGITLNKLTTTS-----------------A--PEVLTKST 185 (342)
T ss_dssp EESSSHHHHHHHHHHHHHCSSSCHHHHHTTCSEEEEEECCCEEESTTCCSSS-----------------H--HHHSCHHH
T ss_pred EeeCcHHHHHHHHHHHHhhhhhHHHHHhhcccceehhhhcCCCccccchhhh-----------------h--hhhcCHHH
Confidence 2211 00122466999999966553211000 0 01123333
Q ss_pred HHHHHHHHHHHHHHHHhCC----C-ccccCCCCceeeCCCCC-EEEeecCceee
Q psy8309 189 ARFYAAEIVSGMRFLHKKG----I-VYRDLKLDNILLDYEGH-VRIADFGMCKL 236 (494)
Q Consensus 189 ~~~~~~qi~~aL~yLH~~g----i-vHrDLKp~NILl~~~g~-vkL~DFGla~~ 236 (494)
.+.+++ +.++..+..++ . .+.--.++|||++.++. +.++|-+++..
T Consensus 186 ~k~LG~--Ii~FDi~InN~DR~Pl~W~n~GN~~NIL~~~~n~~~~~IDhn~af~ 237 (342)
T 1cja_A 186 MQQLGS--LMALDVIVNNSDRLPIAWTNEGNLDNIMLSERGATVVPIDSKIIPL 237 (342)
T ss_dssp HHHHHH--HHHHHHHHTCCSSSCSSSCSCCCGGGEEEESBTTCEEECSCCCCCC
T ss_pred HHhhch--hheehhhhcCCccCcccccCCCChhheEEeCCCCeEEEEcCCcccc
Confidence 222111 45666676653 1 11235889999987554 88999998764
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=81.18 E-value=0.31 Score=48.39 Aligned_cols=45 Identities=31% Similarity=0.465 Sum_probs=0.5
Q ss_pred ccccccccccCCcCCCCCCC---CchhHHh-hh--ccccccccccccCCCC
Q psy8309 447 HALDVKYFDKSFTAERPCLT---PVDRTIL-ES--MDQTQFQGFSYTNPNA 491 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt---~~~~~~~-~~--~~~~~f~~f~~~~~~~ 491 (494)
++.|++|||.+|+.+++..+ +.+.... .+ -.+..|.||||+++..
T Consensus 320 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~~~ 370 (373)
T 2r5t_A 320 GPNDLRHFDPEFTEEPVPNAIGKAPDSVLVTASVKEAAEAFLGFSYAPPTD 370 (373)
T ss_dssp C--------------------------------------------------
T ss_pred CcchhhhcCcccccccccccccCCccccccccccccccccCCCCcccCchh
Confidence 45689999999999874422 1221111 11 2356799999998764
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 494 | ||||
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-107 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 4e-08 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 3e-93 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 4e-05 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-90 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 8e-85 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-83 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 6e-83 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 3e-79 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 2e-73 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 3e-72 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 3e-72 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 6e-72 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-71 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 8e-71 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 2e-70 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 1e-69 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 9e-69 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 1e-68 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-68 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 8e-68 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-65 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 2e-64 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 3e-64 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 3e-64 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 5e-64 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 2e-63 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-63 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 4e-63 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-61 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-60 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 1e-59 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 4e-59 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 7e-59 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-58 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 4e-58 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 8e-58 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-57 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 3e-57 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-56 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 5e-56 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 5e-56 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 7e-56 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 8e-56 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-54 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-54 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-54 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 2e-52 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 3e-52 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 5e-52 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 4e-51 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 1e-50 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-50 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 3e-50 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 3e-50 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 7e-50 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 4e-49 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 5e-48 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 6e-48 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 6e-47 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 1e-46 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-45 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-43 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 1e-34 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 1e-13 |
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 318 bits (817), Expect = e-107
Identities = 195/374 (52%), Positives = 248/374 (66%), Gaps = 54/374 (14%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+EDF L K+LGKGSFGKVFLAE K T+ ++A+K LKKDVVL DDDVECT++E++VL+L
Sbjct: 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAW 60
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+HP+L H+FCTFQT +LFFVMEYLNGGDL M+HIQ +
Sbjct: 61 EHPFLTHMFCTFQTKENLFFVMEYLNGGDL---------------------MYHIQSCHK 99
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
FD RA FYAAEI+ G++FLH KGIVYRDLKLDNILLD +GH++IADFGMCK + D
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDAK 159
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T+TFCGTPDY+APEI+ G KYN VDWWSFG+LLYEM +GQSPF G DE+ELF SI +
Sbjct: 160 TNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219
Query: 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363
P +P++L EAK++LV L ++ KRLG D+ H FR ++W+ LE++E++PP
Sbjct: 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGVRG-----DIRQHPLFREINWEELERKEIDPP 274
Query: 364 FRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTI 423
FRP+V P D FDK F E+P L+ DR +
Sbjct: 275 FRPKVKSP----------------------------FDCSNFDKEFLNEKPRLSFADRAL 306
Query: 424 LESMDQTQFQGFSY 437
+ SMDQ F+ FS+
Sbjct: 307 INSMDQNMFRNFSF 320
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 52.4 bits (125), Expect = 4e-08
Identities = 17/40 (42%), Positives = 23/40 (57%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSY 486
D FDK F E+P L+ DR ++ SMDQ F+ FS+
Sbjct: 281 SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 284 bits (728), Expect = 3e-93
Identities = 151/386 (39%), Positives = 214/386 (55%), Gaps = 58/386 (15%)
Query: 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA 120
K + DF LK+LGKG+FGKV L K T YYA+K L+K+V++ D+V T+ E +VL
Sbjct: 1 KVTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ 60
Query: 121 LGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ 180
T+HP+L L FQT L FVMEY NGG+L FH+ +
Sbjct: 61 N-TRHPFLTALKYAFQTHDRLCFVMEYANGGEL---------------------FFHLSR 98
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
F E RARFY AEIVS + +LH + +VYRD+KL+N++LD +GH++I DFG+CK I
Sbjct: 99 ERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISD 158
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
T TFCGTP+Y+APE+++ Y + VDWW G+++YEM G+ PF D + LF I
Sbjct: 159 GATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELIL 218
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKREL 360
E RFP+ LS EAK++L LL KD +RLG + +V+ H +F ++WQ + +++L
Sbjct: 219 MEEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVVQKKL 277
Query: 361 EPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVD 420
PPF+P+V +D +YFD FTA+ +TP D
Sbjct: 278 LPPFKPQVTSE----------------------------VDTRYFDDEFTAQSITITPPD 309
Query: 421 R-------TILESMDQTQFQGFSYTN 439
R + + +Q F+ F Y
Sbjct: 310 RYDSLGLLELDQREEQEMFEDFDYIA 335
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 43.2 bits (101), Expect = 4e-05
Identities = 15/49 (30%), Positives = 23/49 (46%), Gaps = 7/49 (14%)
Query: 447 HALDVKYFDKSFTAERPCLTPVDR-------TILESMDQTQFQGFSYTN 488
+D +YFD FTA+ +TP DR + + +Q F+ F Y
Sbjct: 287 SEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIA 335
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 275 bits (704), Expect = 3e-90
Identities = 103/309 (33%), Positives = 161/309 (52%), Gaps = 26/309 (8%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
RK EDF+ K+LG+GSF V LA T YA+K L+K +++++ V ER V+
Sbjct: 3 RKKRPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVM 62
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+ HP+ L+ TFQ D L+F + Y G+L + +I+
Sbjct: 63 SR-LDHPFFVKLYFTFQDDEKLYFGLSYAKNGEL---------------------LKYIR 100
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ G FDE RFY AEIVS + +LH KGI++RDLK +NILL+ + H++I DFG K+
Sbjct: 101 KIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP 160
Query: 240 LDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
K ++F GT Y++PE++ + D W+ G ++Y++ G PF +E +F
Sbjct: 161 ESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQ 220
Query: 298 SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357
I FP+ +A++++ LL D TKRLG + + AH +F + W+ L +
Sbjct: 221 KIIKLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQ 280
Query: 358 RELEPPFRP 366
+ PP
Sbjct: 281 Q--TPPKLT 287
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 262 bits (670), Expect = 8e-85
Identities = 130/374 (34%), Positives = 193/374 (51%), Gaps = 58/374 (15%)
Query: 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
Y L+DFQ+L+ LG GSFG+V L + YYA+K LKK++V+ VE T ER +L++
Sbjct: 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSI 60
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
HP++ ++ TFQ +F +M+Y+ GG+L +++S
Sbjct: 61 -VTHPFIIRMWGTFQDAQQIFMIMDYIEGGEL---------------------FSLLRKS 98
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
RF A+FYAAE+ + +LH K I+YRDLK +NILLD GH++I DFG K Y+
Sbjct: 99 QRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAK---YVP 155
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301
T T CGTPDY+APE++ YN+ +DWWSFGIL+YEM G +PF + + + I N
Sbjct: 156 DVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215
Query: 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELE 361
RFP F + + K++L L+ +D ++RLG+ Q N +DV H +F+ + W+ L R +E
Sbjct: 216 AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ-NGTEDVKNHPWFKEVVWEKLLSRNIE 274
Query: 362 PPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDR 421
P+ P + + D FDK + E
Sbjct: 275 TPYEPPIQQG---------------------------QGDTSQFDK-YPEEDINYGVQG- 305
Query: 422 TILESMDQTQFQGF 435
E F+ F
Sbjct: 306 ---EDPYADLFRDF 316
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 257 bits (657), Expect = 2e-83
Identities = 81/290 (27%), Positives = 140/290 (48%), Gaps = 30/290 (10%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
R++ LEDF++ + LGKG FG V+LA K + + A+K L K + + E ++
Sbjct: 1 RQWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQ 60
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
+ +HP + L+ F + ++ ++EY G + +Q
Sbjct: 61 SH-LRHPNILRLYGYFHDATRVYLILEYAPLGTV---------------------YRELQ 98
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
+ +FDE R Y E+ + + + H K +++RD+K +N+LL G ++IADFG
Sbjct: 99 KLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAP- 157
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
T CGT DY+ PE+I+G +++ VD WS G+L YE VG+ PF E + I
Sbjct: 158 -SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRI 216
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349
FP F++ A++++ LL + ++R +V+ H +
Sbjct: 217 SRVEFTFPDFVTEGARDLISRLLKHNPSQRP------MLREVLEHPWITA 260
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 259 bits (662), Expect = 6e-83
Identities = 114/383 (29%), Positives = 170/383 (44%), Gaps = 62/383 (16%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-- 121
+ DF + +++G+G FG+V+ T YA+KCL K + L ER +L+L
Sbjct: 3 MNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVS 62
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
P++ + F T L F+++ +NGGDL +H+ Q
Sbjct: 63 TGDCPFIVCMSYAFHTPDKLSFILDLMNGGDL---------------------HYHLSQH 101
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
G F E RFYAAEI+ G+ +H + +VYRDLK NILLD GHVRI+D G+ +
Sbjct: 102 GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACD--FSK 159
Query: 242 KTTDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGC---DEDELFW 297
K GT YMAPE++ KG+ Y+ DW+S G +L+++ G SPF D+ E+
Sbjct: 160 KKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDR 219
Query: 298 SICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357
P S E +++L LL +D +RLG +V +FR LDWQ +
Sbjct: 220 MTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG-RGAQEVKESPFFRSLDWQMVFL 278
Query: 358 RELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLT 417
++ PP P E ++ A D+ FD+ T L
Sbjct: 279 QKYPPPLIPPRGEVNAA-----------------------DAFDIGSFDEEDTKGIKLLD 315
Query: 418 PVDRTILESMDQTQFQGFSYTNP 440
DQ ++ F T
Sbjct: 316 S---------DQELYRNFPLTIS 329
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 249 bits (636), Expect = 3e-79
Identities = 122/392 (31%), Positives = 195/392 (49%), Gaps = 61/392 (15%)
Query: 44 SQSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVV 103
++++ + P L+ F +K LG GSFG+V L + K + +YA+K L K V
Sbjct: 20 AKAKEDFLKKWETPSQNTAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKV 79
Query: 104 LEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAER 163
++ +E TL E+++L P+L L +F+ +S+L+ VMEY+ GG++
Sbjct: 80 VKLKQIEHTLNEKRILQA-VNFPFLVKLEFSFKDNSNLYMVMEYVAGGEM---------- 128
Query: 164 DLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223
H+++ GRF E ARFYAA+IV +LH ++YRDLK +N+L+D +
Sbjct: 129 -----------FSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQ 177
Query: 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG 283
G++++ DFG K T T CGTP+ +APEII YN+ VDWW+ G+L+YEM G
Sbjct: 178 GYIQVTDFGFAKRVKG---RTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAG 234
Query: 284 QSPFSGCDEDELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343
PF +++ I + + RFP S + K++L +LL D TKR G+ + N +D+
Sbjct: 235 YPPFFADQPIQIYEKIVSGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLK-NGVNDIKN 293
Query: 344 HEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVK 403
H++F DW A+ +R++E PF P+ P D
Sbjct: 294 HKWFATTDWIAIYQRKVEAPFIPKFKGP----------------------------GDTS 325
Query: 404 YFDKSFTAERPCLTPVDRTILESMDQTQFQGF 435
FD + E ++ + +F F
Sbjct: 326 NFDD-YEEEEIRVSINE------KCGKEFTEF 350
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 231 bits (591), Expect = 2e-73
Identities = 74/299 (24%), Positives = 131/299 (43%), Gaps = 39/299 (13%)
Query: 60 RKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKV 118
R + ED ++++ LG G+FGKV+ A+ K T A K + ++++E ++E +
Sbjct: 6 RDLNPEDFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDI 62
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
LA HP + L F +++L+ ++E+ GG + +
Sbjct: 63 LAS-CDHPNIVKLLDAFYYENNLWILIEFCAGGAV--------------------DAVML 101
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ E + + + + + +LH I++RDLK NIL +G +++ADFG+
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNT 161
Query: 239 YLDKTTDTFCGTPDYMAPEII-----KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293
+ D+F GTP +MAPE++ K Y+ D WS GI L EM + P +
Sbjct: 162 RTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221
Query: 294 ELFWSICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349
+ I P P S K+ L L+K+ R ++Q ++ H +
Sbjct: 222 RVLLKIAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARWTTSQ------LLQHPFVTV 274
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 230 bits (586), Expect = 3e-72
Identities = 118/339 (34%), Positives = 177/339 (52%), Gaps = 33/339 (9%)
Query: 45 QSQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAEL---KGTDYYYAVKCLKKD 101
+ + A K +E+F+LLKVLG G++GKVFL T YA+K LKK
Sbjct: 4 TVKHELRTANLTGHAEKVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKA 63
Query: 102 VVLED-DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTK 160
+++ E T ER+VL + P+L L FQT++ L +++Y+NGG+L
Sbjct: 64 TIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGEL------- 116
Query: 161 AERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220
H+ Q RF E + Y EIV + LHK GI+YRD+KL+NILL
Sbjct: 117 --------------FTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILL 162
Query: 221 DYEGHVRIADFGMC-KLQIYLDKTTDTFCGTPDYMAPEIIKGLK--YNQCVDWWSFGILL 277
D GHV + DFG+ + + FCGT +YMAP+I++G +++ VDWWS G+L+
Sbjct: 163 DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLM 222
Query: 278 YEMHVGQSPFSGCDEDELFWSIC----NERPRFPQFLSVEAKNILVHLLDKDTTKRLGST 333
YE+ G SPF+ E I P +PQ +S AK+++ LL KD KRLG
Sbjct: 223 YELLTGASPFTVDGEKNSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCG 282
Query: 334 QCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPF 372
D++ H +F+ ++W L +++ PF+P + +
Sbjct: 283 P-RDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIRDEL 320
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 227 bits (581), Expect = 3e-72
Identities = 69/279 (24%), Positives = 120/279 (43%), Gaps = 27/279 (9%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
ED+++L +G GS+G+ K K L + + + + + E +L K
Sbjct: 4 EDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGS-MTEAEKQMLVSEVNLLRE-LK 61
Query: 125 HPYLCHLFCTF--QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP + + +T++ L+ VMEY GGDL + ++
Sbjct: 62 HPNIVRYYDRIIDRTNTTLYIVMEYCEGGDL------------ASVITK-----GTKERQ 104
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKG-----IVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
DE ++ ++ H++ +++RDLK N+ LD + +V++ DFG+ ++
Sbjct: 105 YLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL 164
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
+ F GTP YM+PE + + YN+ D WS G LLYE+ PF+ + EL
Sbjct: 165 NHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQKELAG 224
Query: 298 SICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
I + R P S E I+ +L+ R +
Sbjct: 225 KIREGKFRRIPYRYSDELNEIITRMLNLKDYHRPSVEEI 263
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 228 bits (582), Expect = 6e-72
Identities = 73/287 (25%), Positives = 121/287 (42%), Gaps = 35/287 (12%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ + + +G+G+ G V+ A T A++ + + E + E V+ K
Sbjct: 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQ---QQPKKELIINEILVMRE-NK 75
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
+P + + ++ L+ VMEYL GG L +
Sbjct: 76 NPNIVNYLDSYLVGDELWVVMEYLAGGSL----------------------TDVVTETCM 113
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
DEG+ E + + FLH +++RD+K DNILL +G V++ DFG C
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKR 173
Query: 245 DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-- 302
T GTP +MAPE++ Y VD WS GI+ EM G+ P+ + + I
Sbjct: 174 STMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233
Query: 303 -RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+ P+ LS ++ L LD D KR S +++ H++ +
Sbjct: 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRG------SAKELLQHQFLK 274
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 228 bits (582), Expect = 2e-71
Identities = 65/352 (18%), Positives = 136/352 (38%), Gaps = 38/352 (10%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L+ + + + LG G+FG V + T +A K + + D E E + +++
Sbjct: 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTP---HESDKETVRKEIQTMSV-L 80
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+HP L +L F+ D+ + + E+++GG+L + +
Sbjct: 81 RHPTLVNLHDAFEDDNEMVMIYEFMSGGEL--------------------FEKVADEHNK 120
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL--DYEGHVRIADFGMCKLQIYLD 241
E A Y ++ G+ +H+ V+ DLK +NI+ +++ DFG+ +
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTA-HLDPK 179
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301
++ GT ++ APE+ +G D WS G+L Y + G SPF G ++DE ++ +
Sbjct: 180 QSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKS 239
Query: 302 ERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357
+S + K+ + LL D R+ + + H + + +
Sbjct: 240 CDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM------TIHQALEHPWLTPGNAPGRD- 292
Query: 358 RELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSF 409
++ ++ + + + + + H +F
Sbjct: 293 SQIPSSRYTKIRDSIKTKYDAWPEPLPPLGRISNYSSLRKHRPQEYSIRDAF 344
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 227 bits (579), Expect = 8e-71
Identities = 74/330 (22%), Positives = 134/330 (40%), Gaps = 39/330 (11%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+ + +L+ LG G+FG V K T + K + D E ++
Sbjct: 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTP---YPLDKYTVKNEISIMNQ-L 83
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
HP L +L F+ + ++E+L+GG+L + +
Sbjct: 84 HHPKLINLHDAFEDKYEMVLILEFLSGGEL--------------------FDRIAAEDYK 123
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY--EGHVRIADFGMCKLQIYLD 241
E Y + G++ +H+ IV+ D+K +NI+ + V+I DFG+ ++ D
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLAT-KLNPD 182
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301
+ T ++ APEI+ D W+ G+L Y + G SPF+G D+ E ++
Sbjct: 183 EIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKR 242
Query: 302 ERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEK 357
F + +S EAK+ + +LL K+ KRL + D + H + +G D L
Sbjct: 243 CDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL------TVHDALEHPWLKG-DHSNLTS 295
Query: 358 RELEPPFRPRVIEPFSSPWIKLSSKDSAIP 387
R + ++ + + + AI
Sbjct: 296 RIPSSRY-NKIRQKIKEKYADWPAPQPAIG 324
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 223 bits (569), Expect = 2e-70
Identities = 67/291 (23%), Positives = 136/291 (46%), Gaps = 36/291 (12%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+ED+ L++ LG+G++G+V LA + T+ AVK + D E E + +
Sbjct: 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMK--RAVDCPENIKKEICINKM-L 60
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
H + + + + + +EY +GG+L I+
Sbjct: 61 NHENVVKFYGHRREGNIQYLFLEYCSGGEL---------------------FDRIEPDIG 99
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD-- 241
E A+ + ++++G+ +LH GI +RD+K +N+LLD +++I+DFG+ + Y +
Sbjct: 100 MPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRE 159
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
+ + CGT Y+APE++K +++ + VD WS GI+L M G+ P+ + +S
Sbjct: 160 RLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219
Query: 301 NERPRF---PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
E+ + + + +L +L ++ + R+ + D+ ++
Sbjct: 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARI------TIPDIKKDRWYN 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 222 bits (568), Expect = 1e-69
Identities = 76/344 (22%), Positives = 125/344 (36%), Gaps = 50/344 (14%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK 117
F K D E F L+ +G GSFG V+ A A+K + ++ + + E +
Sbjct: 8 FFKDDPEKLFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVR 67
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
L +HP + + + VMEY G
Sbjct: 68 FLQK-LRHPNTIQYRGCYLREHTAWLVMEYCLGSAS---------------------DLL 105
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
E + G+ +LH +++RD+K NILL G V++ DFG +
Sbjct: 106 EVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIM 165
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
++F GTP +MAPE+I + +Y+ VD WS GI E+ + P +
Sbjct: 166 ----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 221
Query: 295 LFWSICNERPRFPQ--FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
+ I Q S +N + L K R + + ++ H +
Sbjct: 222 ALYHIAQNESPALQSGHWSEYFRNFVDSCLQKIPQDRP------TSEVLLKHRFV----- 270
Query: 353 QALEKRELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQVLFQ 396
RE P +I+ +L D+ +M ++LFQ
Sbjct: 271 ----LRERPPTVIMDLIQRTKDAVREL---DNLQYRKMKKILFQ 307
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 220 bits (562), Expect = 9e-69
Identities = 86/319 (26%), Positives = 148/319 (46%), Gaps = 42/319 (13%)
Query: 63 DLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
D+ D + VLG G+F +V LAE K T A+KC+ K + + E VL
Sbjct: 6 DIRDIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKAL--EGKEGSMENEIAVLHK 63
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
KHP + L +++ HL+ +M+ ++GG+L I +
Sbjct: 64 -IKHPNIVALDDIYESGGHLYLIMQLVSGGEL---------------------FDRIVEK 101
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL---DYEGHVRIADFGMCKLQI 238
G + E A +++ +++LH GIV+RDLK +N+L D + + I+DFG+ K++
Sbjct: 102 GFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMED 161
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298
+ T CGTP Y+APE++ Y++ VD WS G++ Y + G PF ++ +LF
Sbjct: 162 PGSVLS-TACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQ 220
Query: 299 ICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQA 354
I F +S AK+ + HL++KD KR + + + H + G
Sbjct: 221 ILKAEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF------TCEQALQHPWIAGDTA-- 272
Query: 355 LEKRELEPPFRPRVIEPFS 373
+ + ++ + F+
Sbjct: 273 -LDKNIHQSVSEQIKKNFA 290
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 220 bits (561), Expect = 1e-68
Identities = 72/337 (21%), Positives = 131/337 (38%), Gaps = 77/337 (22%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+DF+ + LG G+ G VF K + A K + + ++ + E +VL
Sbjct: 6 DDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLE--IKPAIRNQIIRELQVLHE-CN 62
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
PY+ + F +D + ME+++GG L ++++GR
Sbjct: 63 SPYIVGFYGAFYSDGEISICMEHMDGGSL---------------------DQVLKKAGRI 101
Query: 185 DEGRARFYAAEIVSGMRFLH-KKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
E + ++ G+ +L K I++RD+K NIL++ G +++ DFG+ +D
Sbjct: 102 PEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSG--QLIDSM 159
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI---- 299
++F GT YM+PE ++G Y+ D WS G+ L EM VG+ P D EL
Sbjct: 160 ANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQV 219
Query: 300 ---------------------------------------CNERPRFPQ-FLSVEAKNILV 319
P+ P S+E ++ +
Sbjct: 220 EGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVN 279
Query: 320 HLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALE 356
L K+ +R ++ H + + D + ++
Sbjct: 280 KCLIKNPAERA------DLKQLMVHAFIKRSDAEEVD 310
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 218 bits (556), Expect = 2e-68
Identities = 75/300 (25%), Positives = 128/300 (42%), Gaps = 44/300 (14%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE------DDDVECTLIERKV 118
E+++ ++LG+G V K T YAVK + + E TL E +
Sbjct: 3 ENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDI 62
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
L + HP + L T++T++ F V + + G+L ++
Sbjct: 63 LRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGEL---------------------FDYL 101
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQI 238
+ E R ++ + LHK IV+RDLK +NILLD + ++++ DFG Q+
Sbjct: 102 TEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSC-QL 160
Query: 239 YLDKTTDTFCGTPDYMAPEIIKG------LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292
+ CGTP Y+APEII+ Y + VD WS G+++Y + G PF +
Sbjct: 161 DPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQ 220
Query: 293 DELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+ I + +F S K+++ L KR + ++ +AH +F+
Sbjct: 221 MLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY------TAEEALAHPFFQ 274
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 217 bits (554), Expect = 8e-68
Identities = 82/318 (25%), Positives = 132/318 (41%), Gaps = 40/318 (12%)
Query: 59 FRKYDLED-FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKD-VVLEDDDVECTLIER 116
FR+ +++D + + LG G F V K T YA K +KK V IER
Sbjct: 3 FRQENVDDYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIER 62
Query: 117 KVLALGT-KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLM 175
+V L +HP + L ++ + + ++E + GG+L
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGEL---------------------F 101
Query: 176 FHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG----HVRIADF 231
+ + E A + +I++G+ +LH I + DLK +NI+L ++I DF
Sbjct: 102 DFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDF 161
Query: 232 GMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291
G+ +I GTP+++APEI+ D WS G++ Y + G SPF G
Sbjct: 162 GLAH-KIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 292 EDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
+ E ++ F S AK+ + LL KD KR+ + D + H +
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM------TIQDSLQHPWI 274
Query: 348 RGLDWQ-ALEKRELEPPF 364
+ D Q AL P F
Sbjct: 275 KPKDTQQALSSAWSHPQF 292
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 212 bits (541), Expect = 1e-65
Identities = 67/335 (20%), Positives = 132/335 (39%), Gaps = 46/335 (13%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
E + + + LG+G FG V + Y K +K + D E +L + +
Sbjct: 5 EKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKV----KGTDQVLVKKEISILNI-AR 59
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H + HL +F++ L + E+++G D+ E +N +
Sbjct: 60 HRNILHLHESFESMEELVMIFEFISGLDI------------FERIN--------TSAFEL 99
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY--EGHVRIADFGMCKLQIYLDK 242
+E Y ++ ++FLH I + D++ +NI+ ++I +FG + Q+
Sbjct: 100 NEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR-QLKPGD 158
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302
P+Y APE+ + + D WS G L+Y + G +PF ++ +I N
Sbjct: 159 NFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNA 218
Query: 303 RPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKR 358
F + +S+EA + + LL K+ R+ + + + H + + +K
Sbjct: 219 EYTFDEEAFKEISIEAMDFVDRLLVKERKSRM------TASEALQHPWLK-------QKI 265
Query: 359 ELEPPFRPRVIEPFSSPWIKLSSKDSAIPIQMPQV 393
E R ++ L KD + + ++
Sbjct: 266 ERVSTKVIRTLKHRRYYH-TLIKKDLNMVVSAARI 299
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (529), Expect = 2e-64
Identities = 63/292 (21%), Positives = 126/292 (43%), Gaps = 42/292 (14%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+ +G+GSF V+ T A L+ L + + E ++L +HP
Sbjct: 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRK-LTKSERQRFKEEAEMLKG-LQHP 68
Query: 127 YLCHLFCTFQT----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
+ + ++++ + V E + G L ++++
Sbjct: 69 NIVRFYDSWESTVKGKKCIVLVTELMTSGTL---------------------KTYLKRFK 107
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDNILLDYE-GHVRIADFGMCKLQIY 239
R + +I+ G++FLH + I++RDLK DNI + G V+I D G+ L+
Sbjct: 108 VMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLK-- 165
Query: 240 LDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFWS 298
GTP++MAPE+ + KY++ VD ++FG+ + EM + P+S + +++
Sbjct: 166 RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 224
Query: 299 ICN--ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+ + + F + E K I+ + ++ +R S D++ H +F+
Sbjct: 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY------SIKDLLNHAFFQ 270
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (528), Expect = 3e-64
Identities = 65/278 (23%), Positives = 110/278 (39%), Gaps = 37/278 (13%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ + +G GSFG V+ + G AVK L ++ E VL
Sbjct: 6 PDGQITVGQRIGSGSFGTVYKGKWHGD---VAVKMLNVTA-PTPQQLQAFKNEVGVLR-K 60
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
T+H + + T L V ++ G L +L+
Sbjct: 61 TRHVNILLFMG-YSTAPQLAIVTQWCEGSSL------------YHHLH--------IIET 99
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
+F+ + A + GM +LH K I++RDLK +NI L + V+I DFG+ ++
Sbjct: 100 KFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG 159
Query: 243 T--TDTFCGTPDYMAPEIIKGLK---YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
+ + G+ +MAPE+I+ Y+ D ++FGI+LYE+ GQ P+S + +
Sbjct: 160 SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQII 219
Query: 298 SICNERPRFPQF------LSVEAKNILVHLLDKDTTKR 329
+ P K ++ L K +R
Sbjct: 220 FMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDER 257
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 207 bits (528), Expect = 3e-64
Identities = 65/277 (23%), Positives = 118/277 (42%), Gaps = 25/277 (9%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
+ ++L ++LG G +V LA AVK L+ D+ + E + A
Sbjct: 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAA-LN 65
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
HP + ++ T + ++ + Y+ +MEY++G L + G
Sbjct: 66 HPAIVAVYDTGEAETPAGPLP-YI----------------VMEYVDGVTLRDIVHTEGPM 108
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT- 243
RA A+ + F H+ GI++RD+K NI++ V++ DFG+ + +
Sbjct: 109 TPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSV 168
Query: 244 --TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301
T GT Y++PE +G + D +S G +LYE+ G+ PF+G + +
Sbjct: 169 TQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAYQHVR 228
Query: 302 ERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQ 334
E P P + LS + +++ L K+ R +
Sbjct: 229 EDPIPPSARHEGLSADLDAVVLKALAKNPENRYQTAA 265
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 208 bits (529), Expect = 5e-64
Identities = 71/328 (21%), Positives = 124/328 (37%), Gaps = 26/328 (7%)
Query: 58 RFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERK 117
+ D D + V+G+G+FG+V A +K + DD E +
Sbjct: 3 IYPVLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELE 62
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
VL HP + +L + +L+ +EY G+L+ R
Sbjct: 63 VLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLL-----DFLRKSRVLETDPAFAIA 117
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
+ + +AA++ GM +L +K ++RDL NIL+ +IADFG+ + Q
Sbjct: 118 NSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQ 177
Query: 238 IYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELF 296
K T +MA E + Y D WS+G+LL+E+ +G +P+ G EL+
Sbjct: 178 EVYVKKT-MGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELY 236
Query: 297 WSIC-NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQAL 355
+ R P E +++ + +R S ++ L
Sbjct: 237 EKLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP------SFAQILVS----------L 280
Query: 356 EK--RELEPPFRPRVIEPFSSPWIKLSS 381
+ E + + E F+ I S+
Sbjct: 281 NRMLEERKTYVNTTLYEKFTYAGIDCSA 308
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 207 bits (527), Expect = 2e-63
Identities = 74/280 (26%), Positives = 118/280 (42%), Gaps = 16/280 (5%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD-----YYYAVKCLKKDVVLEDDDVECTLIERK 117
E+ + KVLG G+FGKV A G AVK LK+ + + E + E K
Sbjct: 35 PRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELK 92
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDL---IPAGLTKAERDLMEYLNGGDL 174
++ H + +L ++ + EY GDL + + K D +EY N L
Sbjct: 93 MMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRL 152
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
+ +A ++ GM FL K V+RDL N+L+ + V+I DFG+
Sbjct: 153 EEE-EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLA 211
Query: 235 KLQIYLDKTT--DTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMH-VGQSPFSGCD 291
+ + +MAPE + Y D WS+GILL+E+ +G +P+ G
Sbjct: 212 RDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIP 271
Query: 292 EDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKR 329
D F+ + + P + + E I+ D+ KR
Sbjct: 272 VDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (521), Expect = 2e-63
Identities = 64/276 (23%), Positives = 112/276 (40%), Gaps = 33/276 (11%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
++++ +LL+ +GKG FG V L + +G AVKC+K D + L E V+
Sbjct: 5 NMKELKLLQTIGKGEFGDVMLGDYRGNKV--AVKCIKND-----ATAQAFLAEASVMTQ- 56
Query: 123 TKHPYLCHLF-CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+H L L + L+ V EY+ G L ++YL +
Sbjct: 57 LRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSL------------VDYL-------RSRGR 97
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLD 241
++ ++ M +L V+RDL N+L+ + +++DFG+ K
Sbjct: 98 SVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK---EAS 154
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC 300
T DT + APE ++ K++ D WSFGILL+E+ G+ P+ ++ +
Sbjct: 155 STQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVE 214
Query: 301 -NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
+ P ++ + D R Q
Sbjct: 215 KGYKMDAPDGCPPAVYEVMKNCWHLDAAMRPSFLQL 250
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 204 bits (520), Expect = 4e-63
Identities = 67/291 (23%), Positives = 121/291 (41%), Gaps = 40/291 (13%)
Query: 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVEC---TLIERKVLA-L 121
+Q+ +LG G FG V+ + A+K ++KD + + ++ +E +L +
Sbjct: 5 QYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKV 64
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+ + L F+ ++E DL I +
Sbjct: 65 SSGFSGVIRLLDWFERPDSFVLILERPEPV--------------------QDLFDFITER 104
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE-GHVRIADFGMCKLQIYL 240
G E AR + +++ +R H G+++RD+K +NIL+D G +++ DFG L
Sbjct: 105 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLK-- 162
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSI 299
D F GT Y PE I+ +Y + WS GILLY+M G PF +E I
Sbjct: 163 DTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEE------I 216
Query: 300 CNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350
+ F Q +S E ++++ L + R + +++ H + + +
Sbjct: 217 IRGQVFFRQRVSSECQHLIRWCLALRPSDRP------TFEEIQNHPWMQDV 261
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 200 bits (509), Expect = 1e-61
Identities = 64/285 (22%), Positives = 119/285 (41%), Gaps = 35/285 (12%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D +D LK LG G FG V + +G Y A+K +K+ + ED+ +E E KV+
Sbjct: 2 DPKDLTFLKELGTGQFGVVKYGKWRGQ-YDVAIKMIKEGSMSEDEFIE----EAKVMMN- 55
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
H L L+ +F + EY+ G L L + +
Sbjct: 56 LSHEKLVQLYGVCTKQRPIFIITEYMANGCL--------------------LNYLREMRH 95
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
RF + ++ M +L K ++RDL N L++ +G V+++DFG+ + + +
Sbjct: 96 RFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY 155
Query: 243 TTDT-FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC 300
T+ + PE++ K++ D W+FG+L++E+ +G+ P+ E I
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHIA 215
Query: 301 N-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
R P S + I+ + +R + ++++
Sbjct: 216 QGLRLYRPHLASEKVYTIMYSCWHEKADERP------TFKILLSN 254
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 198 bits (504), Expect = 1e-60
Identities = 73/276 (26%), Positives = 110/276 (39%), Gaps = 31/276 (11%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELK---GTDYYYAVKCLKKDVVLEDDDVECTLIERKVL 119
+D +LL+ LG GSFG V E G AVKCLK DV+ + + ++ + E +
Sbjct: 6 GEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAM 65
Query: 120 ALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ 179
H L L+ T + V E G L L +
Sbjct: 66 HS-LDHRNLIRLYGVVLTP-PMKMVTELAPLGSL--------------------LDRLRK 103
Query: 180 QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIY 239
G F G YA ++ GM +L K ++RDL N+LL V+I DFG+ +
Sbjct: 104 HQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQ 163
Query: 240 LDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295
D + + APE +K ++ D W FG+ L+EM GQ P+ G + ++
Sbjct: 164 NDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQI 223
Query: 296 FWSICNERPRF--PQFLSVEAKNILVHLLDKDTTKR 329
I E R P+ + N++V R
Sbjct: 224 LHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDR 259
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 196 bits (499), Expect = 1e-59
Identities = 63/287 (21%), Positives = 113/287 (39%), Gaps = 17/287 (5%)
Query: 57 PRFRKYDL--EDFQLLKVLGKGSFGKVFLAELKGTDYY-----YAVKCLKKDVVLEDDDV 109
P+ + + + ++ +G+G+FG+VF A G Y AVK LK++ D
Sbjct: 3 PKLLSLEYPRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQ 60
Query: 110 ECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDL---IPAGLTKAERDLM 166
E ++A +P + L + + EY+ GDL + + L
Sbjct: 61 ADFQREAALMAE-FDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLS 119
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
A ++ +GM +L ++ V+RDL N L+ V
Sbjct: 120 HSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVV 179
Query: 227 RIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVG 283
+IADFG+ + D K +M PE I +Y D W++G++L+E+ G
Sbjct: 180 KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYG 239
Query: 284 QSPFSGCDEDELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
P+ G +E+ + + + P+ +E N++ K R
Sbjct: 240 LQPYYGMAHEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADR 286
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 196 bits (498), Expect = 4e-59
Identities = 73/335 (21%), Positives = 133/335 (39%), Gaps = 55/335 (16%)
Query: 64 LEDFQLL-KVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
++D+++ +VLG G GKV K T +A+K L+ E ++
Sbjct: 10 IDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQD--------CPKARREVELHWRA 61
Query: 123 TKHPYLCHLFCTFQT----DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
++ P++ + ++ L VME L+GG+L +
Sbjct: 62 SQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGEL------------FSRI-------QD 102
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD---YEGHVRIADFGMCK 235
+ F E A I +++LH I +RD+K +N+L +++ DFG K
Sbjct: 103 RGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 162
Query: 236 LQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295
+ + T C TP Y+APE++ KY++ D WS G+++Y + G PF +
Sbjct: 163 -ETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAI 221
Query: 296 FWS----ICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347
I + FP +S E K ++ +LL + T+R+ + + + H +
Sbjct: 222 SPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM------TITEFMNHPWI 275
Query: 348 RGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSK 382
K P RV++ W + +
Sbjct: 276 MQ-----STKVPQTPLHTSRVLKEDKERWEDVKEE 305
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 194 bits (493), Expect = 7e-59
Identities = 77/291 (26%), Positives = 130/291 (44%), Gaps = 28/291 (9%)
Query: 56 IPRFRKYDL--EDFQLLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLED 106
+P +++L + L K LG+G+FG+V LAE G D AVK LK D +
Sbjct: 2 LPEDPRWELPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--E 59
Query: 107 DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM 166
D+ + E +++ + KH + +L D L+ ++EY + G+L R+ +
Sbjct: 60 KDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL---------REYL 110
Query: 167 EYLNGGDLMFHIQQS----GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222
+ L + S + A ++ GM +L K ++RDL N+L+
Sbjct: 111 QARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTE 170
Query: 223 EGHVRIADFGMCKL--QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM 280
+ ++IADFG+ + I K T +MAPE + Y D WSFG+LL+E+
Sbjct: 171 DNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 230
Query: 281 -HVGQSPFSGCDEDELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
+G SP+ G +ELF + R P + E ++ ++R
Sbjct: 231 FTLGGSPYPGVPVEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQR 281
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 193 bits (491), Expect = 2e-58
Identities = 59/280 (21%), Positives = 109/280 (38%), Gaps = 33/280 (11%)
Query: 60 RKYDLEDFQLLKVLGKGSFGKVFLAELKGTD---YYYAVKCLKKDVVLEDDDVECTLIER 116
++ D+ ++ +V+G G FG+V LK + A+K LK + L E
Sbjct: 21 KEIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSGYT--EKQRRDFLSEA 78
Query: 117 KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
++ HP + HL + + + E++ G L F
Sbjct: 79 SIMGQ-FDHPNVIHLEGVVTKSTPVMIITEFMENGSL--------------------DSF 117
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
Q G+F + I +GM++L V+RDL NIL++ +++DFG+ +
Sbjct: 118 LRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRF 177
Query: 237 -----QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGC 290
+ + APE I+ K+ D WS+GI+++E+ G+ P+
Sbjct: 178 LEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237
Query: 291 DEDELFWSIC-NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
++ +I + R P +++ KD R
Sbjct: 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHR 277
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (487), Expect = 4e-58
Identities = 61/273 (22%), Positives = 100/273 (36%), Gaps = 32/273 (11%)
Query: 65 EDFQLLKV-LGKGSFGKVFLAELKGTD--YYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
++ + + LG G+FG V + A+K LK+ E D E + E +++
Sbjct: 8 DNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQ 65
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
+PY+ L Q L VME GG L F + +
Sbjct: 66 -LDNPYIVRLIGVCQ-AEALMLVMEMAGGGPL--------------------HKFLVGKR 103
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---QI 238
++ GM++L +K V+RDL N+LL + +I+DFG+ K
Sbjct: 104 EEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADD 163
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFW 297
+ APE I K++ D WS+G+ ++E GQ P+ E+
Sbjct: 164 SYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMA 223
Query: 298 SIC-NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
I +R P E ++ R
Sbjct: 224 FIEQGKRMECPPECPPELYALMSDCWIYKWEDR 256
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 191 bits (485), Expect = 8e-58
Identities = 68/283 (24%), Positives = 109/283 (38%), Gaps = 35/283 (12%)
Query: 59 FRKYDLEDFQLLKVLGKGSFGKVFLAEL--KGTDYYYAVKCLKKDVVLEDDDVECTLIER 116
+ LED K LG G+FG V K AVK LK + + + L E
Sbjct: 5 RKLLTLED----KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEA 59
Query: 117 KVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
V+ +PY+ + + +S + +ME G L
Sbjct: 60 NVMQQ-LDNPYIVRMIGICEAESWML----------------------VMEMAELGPLNK 96
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
++QQ+ + ++ GM++L + V+RDL N+LL + + +I+DFG+ K
Sbjct: 97 YLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKA 156
Query: 237 ---QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDE 292
K + APE I K++ D WSFG+L++E GQ P+ G
Sbjct: 157 LRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216
Query: 293 DELFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQ 334
E+ + ER P E +++ D R G
Sbjct: 217 SEVTAMLEKGERMGCPAGCPREMYDLMNLCWTYDVENRPGFAA 259
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 189 bits (481), Expect = 2e-57
Identities = 59/270 (21%), Positives = 108/270 (40%), Gaps = 29/270 (10%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
D + ++ +G G FG V L D A+K +++ + E+D +E E +V+
Sbjct: 3 DPSELTFVQEIGSGQFGLVHLGYWLNKDKV-AIKTIREGAMSEEDFIE----EAEVMM-K 56
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
HP L L+ + + V E++ G L + Q G
Sbjct: 57 LSHPKLVQLYGVCLEQAPICLVFEFMEHGCL--------------------SDYLRTQRG 96
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK 242
F ++ GM +L + +++RDL N L+ ++++DFGM + +
Sbjct: 97 LFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY 156
Query: 243 T-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC 300
T + + +PE+ +Y+ D WSFG+L++E+ G+ P+ E+ I
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDIS 216
Query: 301 N-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
R P+ S I+ H + R
Sbjct: 217 TGFRLYKPRLASTHVYQIMNHCWKERPEDR 246
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 189 bits (481), Expect = 3e-57
Identities = 66/278 (23%), Positives = 113/278 (40%), Gaps = 29/278 (10%)
Query: 57 PRFRKY--DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLI 114
P + K+ + D + LG G +G+V+ K AVK LK+D + +VE L
Sbjct: 7 PNYDKWEMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDTM----EVEEFLK 62
Query: 115 ERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDL 174
E V+ KHP L L + + + E++ G+L
Sbjct: 63 EAAVMKE-IKHPNLVQLLGVCTREPPFYIITEFMTYGNL-------------------LD 102
Query: 175 MFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMC 234
+ A +I S M +L KK ++RDL N L+ V++ADFG+
Sbjct: 103 YLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLS 162
Query: 235 KLQIYLDKTTDTFC-GTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDE 292
+L T + APE + K++ D W+FG+LL+E+ G SP+ G D
Sbjct: 163 RLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKR 329
+++ + + R P+ + ++ + + R
Sbjct: 223 SQVYELLEKDYRMERPEGCPEKVYELMRACWQWNPSDR 260
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 187 bits (475), Expect = 3e-56
Identities = 61/310 (19%), Positives = 109/310 (35%), Gaps = 57/310 (18%)
Query: 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT-KHPY 127
L LG+G F V+ A K T+ A+K +K E D R++ L HP
Sbjct: 2 KLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPN 61
Query: 128 LCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEG 187
+ L F S++ V +++ + S
Sbjct: 62 IIGLLDAFGHKSNISLVFDFMETDLE---------------------VIIKDNSLVLTPS 100
Query: 188 RARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTF 247
+ Y + G+ +LH+ I++RDLK +N+LLD G +++ADFG+ K ++
Sbjct: 101 HIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQ 160
Query: 248 CGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNERPRF 306
T Y APE++ G + Y VD W+ G +L E+ + G + + I
Sbjct: 161 VVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLGTP 220
Query: 307 PQ----------------------------FLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338
+ + +++ L + R+ +
Sbjct: 221 TEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI------TA 274
Query: 339 DDVVAHEYFR 348
+ +YF
Sbjct: 275 TQALKMKYFS 284
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (472), Expect = 5e-56
Identities = 58/286 (20%), Positives = 106/286 (37%), Gaps = 32/286 (11%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD-YYYAVKCLKKDVVLEDDDVECTLIERKVLAL 121
E +L + +G+G FG V + AV D E L E +
Sbjct: 5 QRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNCTSDSVREKFLQEALTMR- 63
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS 181
HP++ L T++ ++ +ME G+L F +
Sbjct: 64 QFDHPHIVKLIGVI-TENPVWIIMELCTLGEL--------------------RSFLQVRK 102
Query: 182 GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYL 240
D YA ++ + + +L K V+RD+ N+L+ V++ DFG+ + ++
Sbjct: 103 YSLDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST 162
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299
+MAPE I ++ D W FG+ ++E+ + G PF G +++ I
Sbjct: 163 YYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222
Query: 300 CN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344
N ER P +++ D ++R ++ A
Sbjct: 223 ENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP------RFTELKAQ 262
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (473), Expect = 5e-56
Identities = 68/309 (22%), Positives = 120/309 (38%), Gaps = 47/309 (15%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
E +L LG+G FG+V++ GT A+K LK + + ++ E +V+
Sbjct: 15 PRESLRLEVKLGQGCFGEVWMGTWNGTTRV-AIKTLKPGTMSPEAFLQ----EAQVMK-K 68
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
+H L L+ + ++ V EY++ G L +
Sbjct: 69 LRHEKLVQLYAVVSEE-PIYIVTEYMSKGSL-------------------LDFLKGETGK 108
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-QIYLD 241
+ AA+I SGM ++ + V+RDL+ NIL+ ++ADFG+ +L +
Sbjct: 109 YLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY 168
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC 300
+ APE ++ D WSFGILL E+ G+ P+ G E+ +
Sbjct: 169 TARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVE 228
Query: 301 N-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA--HEYFRGLDWQALEK 357
R P +++ K+ +R + + + A +YF
Sbjct: 229 RGYRMPCPPECPESLHDLMCQCWRKEPEERP------TFEYLQAFLEDYF---------- 272
Query: 358 RELEPPFRP 366
EP ++P
Sbjct: 273 TSTEPQYQP 281
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 7e-56
Identities = 77/288 (26%), Positives = 111/288 (38%), Gaps = 17/288 (5%)
Query: 54 TTIPRFRKYDL--EDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLED 106
T +P K++ K LG G+FGKV A G AVK LK
Sbjct: 10 TQLPYDHKWEFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HL 67
Query: 107 DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLM 166
+ E + E KVL+ H + +L + EY GDL + +RD
Sbjct: 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDL--LNFLRRKRDSF 125
Query: 167 EYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHV 226
+ D ++ ++ GM FL K ++RDL NILL +
Sbjct: 126 ICSKTSPAIME-DDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRIT 184
Query: 227 RIADFGMCKLQIYLDKTTDT--FCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVG 283
+I DFG+ + +MAPE I Y D WS+GI L+E+ +G
Sbjct: 185 KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLG 244
Query: 284 QSPFSGCDEDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKR 329
SP+ G D F+ + E R P+ E +I+ D D KR
Sbjct: 245 SSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKR 292
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 8e-56
Identities = 62/316 (19%), Positives = 114/316 (36%), Gaps = 34/316 (10%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
+F+ +KVLG G+FG V+ + K++ I + + +
Sbjct: 9 TEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASV 68
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+P++C L T + + + + G L L + +
Sbjct: 69 DNPHVCRLLGICLTS-TVQLITQLMPFGCL--------------------LDYVREHKDN 107
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDK- 242
+ +I GM +L + +V+RDL N+L+ HV+I DFG+ KL +K
Sbjct: 108 IGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKE 167
Query: 243 -TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC 300
+ +MA E I Y D WS+G+ ++E+ G P+ G E+ +
Sbjct: 168 YHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227
Query: 301 N-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRE 359
ER P +++ I+V D R +++ F +
Sbjct: 228 KGERLPQPPICTIDVYMIMVKCWMIDADSRP------KFRELIIE--FSKMARDPQRYLV 279
Query: 360 LEPPFRPRVIEPFSSP 375
++ R + P S
Sbjct: 280 IQGDERMHLPSPTDSN 295
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (461), Expect = 2e-54
Identities = 63/270 (23%), Positives = 107/270 (39%), Gaps = 29/270 (10%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
E +L++ LG G FG+V++ G AVK LK+ + D L E ++
Sbjct: 11 PRETLKLVERLGAGQFGEVWMGYYNGHTKV-AVKSLKQGSMSPDA----FLAEANLMKQ- 64
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
+H L L+ T ++ + EY+ G L+
Sbjct: 65 LQHQRLVRLYA-VVTQEPIYIITEYMENGSLVD-------------------FLKTPSGI 104
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK-LQIYLD 241
+ + AA+I GM F+ ++ ++RDL+ NIL+ +IADFG+ + ++
Sbjct: 105 KLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY 164
Query: 242 KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC 300
+ + APE I + D WSFGILL E+ G+ P+ G E+ ++
Sbjct: 165 TAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLE 224
Query: 301 N-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
R P E ++ + R
Sbjct: 225 RGYRMVRPDNCPEELYQLMRLCWKERPEDR 254
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (461), Expect = 4e-54
Identities = 69/284 (24%), Positives = 112/284 (39%), Gaps = 18/284 (6%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDY-----YYAVKCLKKDVVLEDDDVECTLIERK 117
+ +L K LG+G+FG+V A+ G D AVK LK+ + + E K
Sbjct: 11 PRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGAT--HSEHRALMSELK 68
Query: 118 VLALGTKHPYLCHLF-CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF 176
+L H + +L + L ++E+ G+L + R +
Sbjct: 69 ILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNL-----STYLRSKRNEFVPYKVAP 123
Query: 177 HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236
Y+ ++ GM FL + ++RDL NILL + V+I DFG+ +
Sbjct: 124 EDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARD 183
Query: 237 QIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG-QSPFSGCDED 293
+MAPE I Y D WSFG+LL+E+ SP+ G D
Sbjct: 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 243
Query: 294 ELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQC 335
E F E R R P + + E ++ + ++R ++
Sbjct: 244 EEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRPTFSEL 287
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 6e-54
Identities = 67/319 (21%), Positives = 124/319 (38%), Gaps = 55/319 (17%)
Query: 65 EDFQLLKVLGKGSFGKVFLA-ELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-- 121
+ ++ + +G+G++GKVF A +LK + A+K ++ E+ T+ E VL
Sbjct: 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQT-GEEGMPLSTIREVAVLRHLE 65
Query: 122 GTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-Q 180
+HP + LF L + E+++ + +
Sbjct: 66 TFEHPNVVRLFDVCTVSRTDRETKLTL----------------VFEHVDQDLTTYLDKVP 109
Query: 181 SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYL 240
+ +++ G+ FLH +V+RDLK NIL+ G +++ADFG+ ++ +
Sbjct: 110 EPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ 169
Query: 241 DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300
T + T Y APE++ Y VD WS G + EM + F G + + I
Sbjct: 170 MALT-SVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKIL 228
Query: 301 N---------------------------ERPRFPQFLSVEAKNILVHLLDKDTTKRLGST 333
+ +F + K++L+ L + KR+
Sbjct: 229 DVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI--- 285
Query: 334 QCNSGDDVVAHEYFRGLDW 352
S ++H YF+ L+
Sbjct: 286 ---SAYSALSHPYFQDLER 301
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 179 bits (454), Expect = 2e-52
Identities = 75/383 (19%), Positives = 131/383 (34%), Gaps = 73/383 (19%)
Query: 46 SQANITPATTIPRFRKYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLE 105
S+ AT + + KV+G GSFG V+ A+L + A+K + +D +
Sbjct: 1 SKVTTVVATPGQGPDRPQEVSYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK 60
Query: 106 DDDVECTLIERKVLALGTKHPYLCHLFCTFQT------DSHLFFVMEYLNGGDLIPAGLT 159
+ +++ I RK+ H + L F + + +L V++Y+
Sbjct: 61 NRELQ---IMRKL-----DHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVY------ 106
Query: 160 KAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219
+ + + Y ++ + ++H GI +RD+K N+L
Sbjct: 107 ------------RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154
Query: 220 LDYEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLY 278
LD + +++ DFG K + + C I Y +D WS G +L
Sbjct: 155 LDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 214
Query: 279 EMHVGQSPFSGCDEDELFWSICN-----------------ERPRFPQF------------ 309
E+ +GQ F G + I +FPQ
Sbjct: 215 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPR 274
Query: 310 LSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369
EA + LL+ T RL + + AH +F L ++ P
Sbjct: 275 TPPEAIALCSRLLEYTPTARL------TPLEACAHSFFDELRD-----PNVKLPNGRDTP 323
Query: 370 EPFSSPWIKLSSKDSAIPIQMPQ 392
F+ +LSS I +P
Sbjct: 324 ALFNFTTQELSSNPPLATILIPP 346
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (447), Expect = 3e-52
Identities = 72/317 (22%), Positives = 131/317 (41%), Gaps = 58/317 (18%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+E+FQ ++ +G+G++G V+ A K T A+K ++ D + + E +L
Sbjct: 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKE-L 58
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
HP + L T++ L+ V E+L+
Sbjct: 59 NHPNIVKLLDVIHTENKLYLVFEFLHQDLK--------------------KFMDASALTG 98
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
+ Y +++ G+ F H +++RDLK N+L++ EG +++ADFG+ + +T
Sbjct: 99 IPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRT 158
Query: 244 TDTFCGTPDYMAPEIIKGLKYN-QCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC-- 300
T Y APEI+ G KY VD WS G + EM ++ F G E + + I
Sbjct: 159 YTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFRT 218
Query: 301 ----------------NERPRFPQF-----------LSVEAKNILVHLLDKDTTKRLGST 333
+ +P FP++ L + +++L +L D KR+ +
Sbjct: 219 LGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISAK 278
Query: 334 QCNSGDDVVAHEYFRGL 350
+AH +F+ +
Sbjct: 279 AA------LAHPFFQDV 289
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 177 bits (448), Expect = 5e-52
Identities = 57/323 (17%), Positives = 116/323 (35%), Gaps = 58/323 (17%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
++ ++ L +G+G+FG+VF A + T A+K + + ++ L E K+L L
Sbjct: 8 EVSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMEN-EKEGFPITALREIKILQL- 65
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
KH + +L +T + + + + ++
Sbjct: 66 LKHENVVNLIEICRTKASPYNRCKGS-------------IYLVFDFCEHDLAGLLSNVLV 112
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL----QI 238
+F + +++G+ ++H+ I++RD+K N+L+ +G +++ADFG+ + +
Sbjct: 113 KFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKN 172
Query: 239 YLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297
T Y PE++ G + Y +D W G ++ EM G E
Sbjct: 173 SQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQLA 232
Query: 298 SICNERPRFPQ--------------------------------FLSVEAKNILVHLLDKD 325
I A +++ LL D
Sbjct: 233 LISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLD 292
Query: 326 TTKRLGSTQCNSGDDVVAHEYFR 348
+R+ DD + H++F
Sbjct: 293 PAQRI------DSDDALNHDFFW 309
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 4e-51
Identities = 62/312 (19%), Positives = 115/312 (36%), Gaps = 40/312 (12%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERK 117
E + + LG+GSFG V+ KG + A+K + + + L E
Sbjct: 18 AREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEAS 75
Query: 118 VLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH 177
V+ ++ L +ME + GDL + + L M +
Sbjct: 76 VMKE-FNCHHVVRLLGVVSQGQPTLVIMELMTRGDL---------KSYLRSL--RPAMAN 123
Query: 178 IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQ 237
+ A EI GM +L+ V+RDL N ++ + V+I DFGM +
Sbjct: 124 NPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDI 183
Query: 238 IYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDE 294
D + +M+PE +K + D WSFG++L+E+ + + P+ G ++
Sbjct: 184 YETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQ 243
Query: 295 LFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353
+ + P ++ + R S +++
Sbjct: 244 VLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP------SFLEII----------S 287
Query: 354 ALEKRELEPPFR 365
++++ E+EP FR
Sbjct: 288 SIKE-EMEPGFR 298
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 174 bits (441), Expect = 1e-50
Identities = 62/334 (18%), Positives = 120/334 (35%), Gaps = 63/334 (18%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+ L +G+G++G V A A+K + + TL E K+L +H
Sbjct: 10 YTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILLR-FRHE 66
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ + + + YL + +L G D ++ + ++
Sbjct: 67 NIIGINDIIRAPTIEQMKDVYL-----------------VTHLMGAD-LYKLLKTQHLSN 108
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL---QIYLDKT 243
++ +I+ G++++H +++RDLK N+LL+ ++I DFG+ ++
Sbjct: 109 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGF 168
Query: 244 TDTFCGTPDYMAPEII-KGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302
+ T Y APEI+ Y + +D WS G +L EM + F G + I
Sbjct: 169 LTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGI 228
Query: 303 RPRFPQF-------------------------------LSVEAKNILVHLLDKDTTKRLG 331
Q +A ++L +L + KR+
Sbjct: 229 LGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI- 287
Query: 332 STQCNSGDDVVAHEYFRGLDWQALEKRELEPPFR 365
+ +AH Y + ++ E PF+
Sbjct: 288 -----EVEQALAHPYLEQY-YDPSDEPIAEAPFK 315
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 2e-50
Identities = 58/276 (21%), Positives = 102/276 (36%), Gaps = 32/276 (11%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTD----YYYAVKCLKKDVVLEDDDVECTLIERKV 118
KV+G G FG+V+ LK + A+K LK + L E +
Sbjct: 5 HPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGI 62
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
+ H + L + + EY+ G F
Sbjct: 63 MGQ-FSHHNIIRLEGVISKYKPMMIITEYMENGA--------------------LDKFLR 101
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL-- 236
++ G F + I +GM++L V+RDL NIL++ +++DFG+ ++
Sbjct: 102 EKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLE 161
Query: 237 -QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDE 294
TT + APE I K+ D WSFGI+++E+ G+ P+ E
Sbjct: 162 DDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
Query: 295 LFWSICN-ERPRFPQFLSVEAKNILVHLLDKDTTKR 329
+ +I + R P +++ ++ +R
Sbjct: 222 VMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARR 257
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 171 bits (435), Expect = 3e-50
Identities = 58/269 (21%), Positives = 105/269 (39%), Gaps = 33/269 (12%)
Query: 71 KVLGKGSFGKVFLAEL---KGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPY 127
+V+G+G FG V+ L G + AVK L + + +V L E ++ HP
Sbjct: 33 EVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRIT--DIGEVSQFLTEGIIMKD-FSHPN 89
Query: 128 LCHLF-CTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ L +++ V+ Y+ GDL F ++
Sbjct: 90 VLSLLGICLRSEGSPLVVLPYMKHGDL--------------------RNFIRNETHNPTV 129
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKL----QIYLDK 242
+ ++ GM+FL K V+RDL N +LD + V++ADFG+ + +
Sbjct: 130 KDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVH 189
Query: 243 TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEM-HVGQSPFSGCDEDELFWSIC- 300
+MA E ++ K+ D WSFG+LL+E+ G P+ + ++ +
Sbjct: 190 NKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQ 249
Query: 301 NERPRFPQFLSVEAKNILVHLLDKDTTKR 329
R P++ +++ R
Sbjct: 250 GRRLLQPEYCPDPLYEVMLKCWHPKAEMR 278
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 172 bits (436), Expect = 3e-50
Identities = 68/330 (20%), Positives = 122/330 (36%), Gaps = 75/330 (22%)
Query: 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG 122
+ +D+QL++ LG+G + +VF A + VK LK + E K+L
Sbjct: 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKP------VKKKKIKREIKILENL 86
Query: 123 TKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG 182
P + L + + + E++N D Q
Sbjct: 87 RGGPNIITLADIVKDPVSRTPAL-------------------VFEHVNNTDFKQLYQ--- 124
Query: 183 RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG-HVRIADFGMCKLQIYLD 241
+ RFY EI+ + + H GI++RD+K N+++D+E +R+ D+G+ + +
Sbjct: 125 TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEF-YHPG 183
Query: 242 KTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPF-SGCDEDELFWSI 299
+ + + + PE++ + Y+ +D WS G +L M + PF G D + I
Sbjct: 184 QEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRI 243
Query: 300 CN-----------------------------ERPRFPQF--------LSVEAKNILVHLL 322
R R+ +F +S EA + L LL
Sbjct: 244 AKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLL 303
Query: 323 DKDTTKRLGSTQCNSGDDVVAHEYFRGLDW 352
D RL + + + H YF +
Sbjct: 304 RYDHQSRL------TAREAMEHPYFYTVVK 327
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 170 bits (430), Expect = 7e-50
Identities = 64/315 (20%), Positives = 123/315 (39%), Gaps = 60/315 (19%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
+E + L+ +G+G++G V+ A+ +A+K ++ + ++ T+ E +L
Sbjct: 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEK-EDEGIPSTTIREISILKE-L 57
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
KH + L+ T L V E+L+ G
Sbjct: 58 KHSNIVKLYDVIHTKKRLVLVFEHLDQDLK---------------------KLLDVCEGG 96
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
+ A+ + ++++G+ + H + +++RDLK N+L++ EG ++IADFG+ + +
Sbjct: 97 LESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRK 156
Query: 244 TDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN- 301
T Y AP+++ G KY+ +D WS G + EM G F G E + I
Sbjct: 157 YTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216
Query: 302 ----------------------------ERPRFPQFLSVEAKNILVHLLDKDTTKRLGST 333
F + L ++L +L D +R+
Sbjct: 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI--- 273
Query: 334 QCNSGDDVVAHEYFR 348
+ + H YF+
Sbjct: 274 ---TAKQALEHAYFK 285
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 168 bits (426), Expect = 4e-49
Identities = 52/315 (16%), Positives = 92/315 (29%), Gaps = 54/315 (17%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
++L + +G GSFG ++L A+K IE K+ +
Sbjct: 9 YRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVK-----TKHPQLHIESKIYKMMQGGV 63
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ + + VME L S +F
Sbjct: 64 GIPTIRWCGAEGDYNVMVMELLGPSLE---------------------DLFNFCSRKFSL 102
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL---LDYEGHVRIADFGMCKL------- 236
A +++S + ++H K ++RD+K DN L V I DFG+ K
Sbjct: 103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162
Query: 237 QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296
Q + GT Y + G++ ++ D S G +L ++G P+ G
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKR 222
Query: 297 WSICNER--------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348
+ E L + + + + + R
Sbjct: 223 QKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYL---RQLFRNLFHR 279
Query: 349 -------GLDWQALE 356
DW L+
Sbjct: 280 QGFSYDYVFDWNMLK 294
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 167 bits (423), Expect = 5e-48
Identities = 71/324 (21%), Positives = 127/324 (39%), Gaps = 60/324 (18%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTK 124
++ L+ +G G++G V A T A+K L + + + E ++L +
Sbjct: 18 AVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKH-MR 75
Query: 125 HPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRF 184
H + L F D L ++ +M ++ G + + + +
Sbjct: 76 HENVIGLLDVFTPDETLDDFTDFYL---------------VMPFM--GTDLGKLMKHEKL 118
Query: 185 DEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKTT 244
E R +F +++ G+R++H GI++RDLK N+ ++ + ++I DFG+ + D
Sbjct: 119 GEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QADSEM 175
Query: 245 DTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
+ T Y APE+I ++Y Q VD WS G ++ EM G++ F G D + I
Sbjct: 176 TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQLKEIMKVT 235
Query: 304 PRFPQF-------------------------------LSVEAKNILVHLLDKDTTKRLGS 332
P S A N+L +L D +R+
Sbjct: 236 GTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV-- 293
Query: 333 TQCNSGDDVVAHEYFRGLDWQALE 356
+ + +AH YF L E
Sbjct: 294 ----TAGEALAHPYFESLHDTEDE 313
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 165 bits (418), Expect = 6e-48
Identities = 46/283 (16%), Positives = 92/283 (32%), Gaps = 46/283 (16%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHP 126
+++ + +G+GSFG +F + A+K + D E + L
Sbjct: 7 YKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRR-----SDAPQLRDEYRTYKLLAGCT 61
Query: 127 YLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDE 186
+ +++ Q H V++ L +F
Sbjct: 62 GIPNVYYFGQEGLHNVLVIDLLGPSLE---------------------DLLDLCGRKFSV 100
Query: 187 GRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD-----YEGHVRIADFGMCKL----- 236
A ++++ ++ +H+K +VYRD+K DN L+ + + DFGM K
Sbjct: 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160
Query: 237 --QIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED- 293
Q + GT YM+ G + ++ D + G + G P+ G
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKAAT 220
Query: 294 --ELFWSICNERPRFP-----QFLSVEAKNILVHLLDKDTTKR 329
+ + I ++ P E + + +
Sbjct: 221 NKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDAT 263
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (411), Expect = 6e-47
Identities = 62/318 (19%), Positives = 125/318 (39%), Gaps = 60/318 (18%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
++ ++ L+ +G+G++G VF A+ + T A+K ++ D ++ L E +L
Sbjct: 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKE-L 58
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
KH + L +D L V E+ + + +G
Sbjct: 59 KHKNIVRLHDVLHSDKKLTLVFEFCDQDLK---------------------KYFDSCNGD 97
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
D + + +++ G+ F H + +++RDLK N+L++ G +++A+FG+ + +
Sbjct: 98 LDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC 157
Query: 244 TDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSP-FSGCDEDELFWSICN 301
T Y P+++ G K Y+ +D WS G + E+ P F G D D+ I
Sbjct: 158 YSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217
Query: 302 ERPRFPQF-----------------------------LSVEAKNILVHLLDKDTTKRLGS 332
+ L+ +++L +LL + +R+
Sbjct: 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI-- 275
Query: 333 TQCNSGDDVVAHEYFRGL 350
S ++ + H YF
Sbjct: 276 ----SAEEALQHPYFSDF 289
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 162 bits (410), Expect = 1e-46
Identities = 58/307 (18%), Positives = 101/307 (32%), Gaps = 67/307 (21%)
Query: 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT- 123
L + +GKG FG+V+ + +G + AVK + E ++
Sbjct: 3 RTIVLQESIGKGRFGEVWRGKWRGEEV--AVKIFSSR------EERSWFREAEIYQTVML 54
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
+H + D+ + + + +Y G L ++ +
Sbjct: 55 RHENILGFIAADNKDNGTWTQLWLV-----------------SDYHEHGSLFDYLNRYTV 97
Query: 184 FDEGRARFYAAEIVSGMRFLH--------KKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
EG + A SG+ LH K I +RDLK NIL+ G IAD G+
Sbjct: 98 TVEGMIKL-ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 156
Query: 236 L----QIYLDKTTDTFCGTPDYMAPEII------KGLKYNQCVDWWSFGILLYEMHVGQS 285
+D + GT YMAPE++ K + + D ++ G++ +E+ S
Sbjct: 157 RHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCS 216
Query: 286 PFSGCDEDELFWSICNE-----------------RPRFPQFLSV-----EAKNILVHLLD 323
++ +L + RP P I+
Sbjct: 217 IGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWY 276
Query: 324 KDTTKRL 330
+ RL
Sbjct: 277 ANGAARL 283
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 160 bits (406), Expect = 1e-45
Identities = 76/350 (21%), Positives = 132/350 (37%), Gaps = 70/350 (20%)
Query: 57 PRFRKYDL--------EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD 108
P F + +L E +Q L +G G++G V A T AVK L +
Sbjct: 2 PTFYRQELNKTIWEVPERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIH 60
Query: 109 VECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEY 168
+ T E ++L KH + L F L + L+ +
Sbjct: 61 AKRTYRELRLLKH-MKHENVIGLLDVFTPARSLEEFNDVY----------------LVTH 103
Query: 169 LNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228
L G D + +I + + + +F +I+ G++++H I++RDLK N+ ++ + ++I
Sbjct: 104 LMGAD-LNNIVKCQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKI 162
Query: 229 ADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPF 287
DFG+ + D + T Y APEI+ YNQ VD WS G ++ E+ G++ F
Sbjct: 163 LDFGLA---RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLF 219
Query: 288 SGCDEDELFWSICNERPRFPQFL-------------------------------SVEAKN 316
G D + I L + A +
Sbjct: 220 PGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVD 279
Query: 317 ILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
+L +L D+ KR+ + +AH YF + + + P+
Sbjct: 280 LLEKMLVLDSDKRI------TAAQALAHAYFA--QYHDPDDEPVADPYDQ 321
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 155 bits (392), Expect = 2e-43
Identities = 71/345 (20%), Positives = 121/345 (35%), Gaps = 71/345 (20%)
Query: 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGT 123
L+ +Q LK +G G+ G V A D A+K L + + E ++
Sbjct: 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMKC-V 73
Query: 124 KHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGR 183
H + L F L + +ME ++
Sbjct: 74 NHKNIISLLNVFTPQKTLEEFQDVYL---------------VMELMDANLCQVIQM---E 115
Query: 184 FDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCKLQIYLDKT 243
D R + +++ G++ LH GI++RDLK NI++ + ++I DFG+ +
Sbjct: 116 LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFMM 175
Query: 244 TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303
T + T Y APE+I G+ Y + VD WS G ++ EM + F G D + + + +
Sbjct: 176 TP-YVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVIEQL 234
Query: 304 PRFP------------------------------------------QFLSVEAKNILVHL 321
+ + +A+++L +
Sbjct: 235 GTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKM 294
Query: 322 LDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
L D KR+ S DD + H Y W + E PP
Sbjct: 295 LVIDPAKRI------SVDDALQHPYIN--VWYDPAEVEAPPPQIY 331
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 131 bits (329), Expect = 1e-34
Identities = 52/369 (14%), Positives = 113/369 (30%), Gaps = 88/369 (23%)
Query: 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKV-------- 118
+ L++ LG G F V+LA+ + + A+K ++ D V + + + ++V
Sbjct: 15 YILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKVYTEAAEDEIKLLQRVNDADNTKE 74
Query: 119 LALGTKHPYLCHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHI 178
++G H + + + VM + +
Sbjct: 75 DSMGANHILKLLDHFNHKGPNGVHVVMVF------------------EVLGENLLALIKK 116
Query: 179 QQSGRFDEGRARFYAAEIVSGMRFL-HKKGIVYRDLKLDNILLDYEGHVRI---ADFGMC 234
+ + + +++ G+ ++ + GI++ D+K +N+L++
Sbjct: 117 YEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADL 176
Query: 235 KLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDE 294
+ D+ T +Y +PE++ G + D WS L++E+ G F +
Sbjct: 177 GNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHS 236
Query: 295 LFW------------------------------------------------SICNERPRF 306
+ E+ +F
Sbjct: 237 YTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKF 296
Query: 307 PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366
+ + E + L +L D KR +V H + + L E+ P R
Sbjct: 297 SKDEAKEISDFLSPMLQLDPRKRA------DAGGLVNHPWLKD----TLGMEEIRVPDRE 346
Query: 367 RVIEPFSSP 375
P
Sbjct: 347 LYGSGSDIP 355
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 67.5 bits (164), Expect = 1e-13
Identities = 30/167 (17%), Positives = 50/167 (29%), Gaps = 20/167 (11%)
Query: 69 LLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYL 128
+ K++G+G VF + VK K V+ +
Sbjct: 4 IGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHT-SFKKVKEKRDYGDLHFSVLAIRSA 61
Query: 129 CHLFCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGR 188
+ F Q L Y G+ + LME ++ R
Sbjct: 62 RNEFRALQKLQGLAVPKVYAWEGNAV----------LMEL-------IDAKELYRVRVEN 104
Query: 189 ARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRIADFGMCK 235
I+ + + +GIV+ DL N+L+ E + I DF
Sbjct: 105 PDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSV 150
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 494 | |||
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.92 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.35 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.94 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.68 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 96.95 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.81 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 96.43 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 94.65 |
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-74 Score=571.96 Aligned_cols=328 Identities=46% Similarity=0.869 Sum_probs=291.3
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.+++|+++++||+|+||+||+|+++.+|+.||||++++..............|..+|. .++|||||+++++|++.+.+
T Consensus 2 i~l~dy~~~~~lG~G~fg~V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~-~l~hp~Iv~l~~~~~~~~~~ 80 (337)
T d1o6la_ 2 VTMNDFDYLKLLGKGTFGKVILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQ-NTRHPFLTALKYAFQTHDRL 80 (337)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCCTTBCCEEEEEECSSEE
T ss_pred CchHhcEEEEEEecCcCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hCCCCCEEEEEeeecccccc
Confidence 56889999999999999999999999999999999998876555666778889999887 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||+ ||+|..++.+.+.++|..++.|++||+.||+|||++|||||||||+||||+
T Consensus 81 ~iv~ey~~---------------------gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~iiHRDlKP~NILl~ 139 (337)
T d1o6la_ 81 CFVMEYAN---------------------GGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLD 139 (337)
T ss_dssp EEEEECCT---------------------TCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEEC
T ss_pred ccceeccC---------------------CCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcCccccccCHHHeEec
Confidence 99999999 667777888889999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+|++||+|||+|+..........+.|||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++..+..
T Consensus 140 ~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~i~~ 219 (337)
T d1o6la_ 140 KDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILM 219 (337)
T ss_dssp TTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHH
T ss_pred CCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHHHHHHHHhc
Confidence 99999999999998755555566788999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCC
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSS 381 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~ 381 (494)
+.+.+|..+|+++++||.+||++||.+|+++.. .+++|+++||||++++|+.+..+++.||++|.+.
T Consensus 220 ~~~~~p~~~s~~~~dli~~~L~~dP~~R~~~~~-~~~~eil~Hp~f~~i~~~~l~~~~~~~p~~P~~~------------ 286 (337)
T d1o6la_ 220 EEIRFPRTLSPEAKSLLAGLLKKDPKQRLGGGP-SDAKEVMEHRFFLSINWQDVVQKKLLPPFKPQVT------------ 286 (337)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSSTTTSTTCST-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCS------------
T ss_pred CCCCCCccCCHHHHHHHHhhccCCchhhccccc-ccHHHHHcCcccccCCHHHHHhCCCCCCCCCCCC------------
Confidence 999999999999999999999999999998644 2689999999999999999999999999999887
Q ss_pred CCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccc-------cCcccCCCccCeeeeCC
Q psy8309 382 KDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTI-------LESMDQTQFQGFSYTNP 440 (494)
Q Consensus 382 ~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~-------~~~~~~~~f~~f~~~~~ 440 (494)
.+.|+++||.+++.+....++.+... .....|+.|+||+|+.+
T Consensus 287 ----------------~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~v~d 336 (337)
T d1o6la_ 287 ----------------SEVDTRYFDDEFTAQSITITPPDRYDSLGLLELDQREEQEMFEDFDYIAD 336 (337)
T ss_dssp ----------------STTCCTTSCHHHHTSCCC--------------------CCTTTTCCEECC
T ss_pred ----------------ChhhhhhcCchhhhccCCCCCCccccccccccccchhhhhccCCCEeeCC
Confidence 67889999999888776665544221 11234678999999863
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-72 Score=558.87 Aligned_cols=320 Identities=61% Similarity=1.105 Sum_probs=261.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|+++++||+|+||+||+|+++.+++.||||++++.........+..+.|+.++...++|||||++++++++++++||
T Consensus 1 iddy~i~~~iG~G~fg~Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yi 80 (320)
T d1xjda_ 1 IEDFILHKMLGKGSFGKVFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFF 80 (320)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEE
T ss_pred CCCeEEeeEEecCCCcEEEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeE
Confidence 47899999999999999999999999999999999876555556677788888887767899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||+ ||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 vmEy~~---------------------~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~iiHrDikp~NiL~~~~ 139 (320)
T d1xjda_ 81 VMEYLN---------------------GGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKD 139 (320)
T ss_dssp EEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCCGGGEEECTT
T ss_pred EEeecC---------------------CCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCcccceeecCC
Confidence 999999 66777888888999999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhCC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNER 303 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~ 303 (494)
|++||+|||+++............+||+.|+|||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|..+.
T Consensus 140 ~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~~~~~~i~~~~ 219 (320)
T d1xjda_ 140 GHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDN 219 (320)
T ss_dssp SCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCC
T ss_pred CceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHHcCC
Confidence 99999999999865555555667899999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcccccCCCC
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPWIKLSSKD 383 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~~~~~~~~ 383 (494)
+.+|..+|+++++||.+||++||.+||++ ..++++||||++++|+.+..++++||++|.+.
T Consensus 220 ~~~p~~~s~~~~dli~~~L~~dP~~R~s~-----~~~l~~hpff~~~~~~~l~~~~~~pp~~p~~~-------------- 280 (320)
T d1xjda_ 220 PFYPRWLEKEAKDLLVKLFVREPEKRLGV-----RGDIRQHPLFREINWEELERKEIDPPFRPKVK-------------- 280 (320)
T ss_dssp CCCCTTSCHHHHHHHHHHSCSSGGGSBTT-----BSCGGGSGGGTTCCHHHHHTTCSCC---------------------
T ss_pred CCCCccCCHHHHHHHHHhcccCCCCCcCH-----HHHHHhCchhccCCHHHHHhcCCCCCCCCCCC--------------
Confidence 99999999999999999999999999954 24799999999999999999999999999887
Q ss_pred CCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeee
Q psy8309 384 SAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSY 437 (494)
Q Consensus 384 ~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 437 (494)
++.|++|||.++..+.+..++.+.....+.+|..|+||+|
T Consensus 281 --------------~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 281 --------------SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp ---------------------------------------------CCTTTTCCC
T ss_pred --------------CccchhhcChHhhhCCccCCCCcccccCchhhcccCcCcC
Confidence 7789999999998877777777777777888999999997
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=1.6e-68 Score=529.88 Aligned_cols=282 Identities=43% Similarity=0.843 Sum_probs=259.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.+++|++++.||+|+||+||+|+++.+|+.||||++++.........+....|..++. .++|||||++++++++.+.+
T Consensus 1 ~sl~dy~i~~~lG~G~fg~Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~ 79 (316)
T d1fota_ 1 YSLQDFQILRTLGTGSFGRVHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLS-IVTHPFIIRMWGTFQDAQQI 79 (316)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-SCCBTTBCCEEEEEECSSEE
T ss_pred CchhHeEEEEEEecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH-hccCcChhheeeeEeeCCee
Confidence 35789999999999999999999999999999999998765555556677888888887 67999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|+|||||. ||++...+.....+++..++.++.||+.||+|||++|||||||||+||||+
T Consensus 80 ~ivmE~~~---------------------gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NILl~ 138 (316)
T d1fota_ 80 FMIMDYIE---------------------GGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLD 138 (316)
T ss_dssp EEEECCCC---------------------SCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEEC
T ss_pred eeEeeecC---------------------CccccccccccccccccHHHHHHHHHHHhhhhhccCcEEccccCchheeEc
Confidence 99999999 666777888888999999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+|++||+|||+|+.. .....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+++.+|.+
T Consensus 139 ~~g~vkL~DFG~a~~~---~~~~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~~ 215 (316)
T d1fota_ 139 KNGHIKITDFGFAKYV---PDVTYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILN 215 (316)
T ss_dssp TTSCEEECCCSSCEEC---SSCBCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHHH
T ss_pred CCCCEEEecCccceEe---ccccccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCCCCCcCHHHHHHHHHc
Confidence 9999999999999863 3345578999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 302 ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 302 ~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
+...+|..++++++++|.+||.+||.+|+++.+ .+++|+++||||++++|+.+.+++++||++|.+.
T Consensus 216 ~~~~~p~~~s~~~~~li~~~L~~dp~~R~~~~r-~t~~~il~Hp~f~~i~~~~l~~~~~~~p~~p~~~ 282 (316)
T d1fota_ 216 AELRFPPFFNEDVKDLLSRLITRDLSQRLGNLQ-NGTEDVKNHPWFKEVVWEKLLSRNIETPYEPPIQ 282 (316)
T ss_dssp CCCCCCTTSCHHHHHHHHHHTCSCTTTCTTSST-TTTHHHHTSGGGSSCCHHHHHTTCSCCSCCCCC-
T ss_pred CCCCCCCCCCHHHHHHHHHHhhhCHHhccccch-hhHHHHHcCcccccCCHHHHHhCCCCcCCCCCcC
Confidence 999999999999999999999999999997654 3899999999999999999999999999998765
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=2.8e-67 Score=528.03 Aligned_cols=283 Identities=40% Similarity=0.770 Sum_probs=260.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
...+++|++++.||+|+||+||+|+++.+|+.||||++.+.........+..+.|..++. .++|||||+++++|.+...
T Consensus 37 ~~~ld~y~i~~~lG~G~fg~Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~ 115 (350)
T d1rdqe_ 37 TAQLDQFDRIKTLGTGSFGRVMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQ-AVNFPFLVKLEFSFKDNSN 115 (350)
T ss_dssp CCCGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSE
T ss_pred CCCccCeEEEEEeecCcCcEEEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHH-HcCCCcEeecccccccccc
Confidence 345789999999999999999999999999999999998765555566677888998887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+. ||+|..++.+.+.+++.+++.|+.||+.||.|||++|||||||||+||||
T Consensus 116 ~~~v~e~~~---------------------~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHRDIKP~NILl 174 (350)
T d1rdqe_ 116 LYMVMEYVA---------------------GGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLI 174 (350)
T ss_dssp EEEEEECCT---------------------TCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred ccccccccc---------------------ccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCEecCcCCHHHccc
Confidence 999999998 66677788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|++||+|||+|+.. .....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+...++.+|.
T Consensus 175 ~~~g~ikL~DFG~a~~~---~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~i~ 251 (350)
T d1rdqe_ 175 DQQGYIQVTDFGFAKRV---KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251 (350)
T ss_dssp CTTSCEEECCCTTCEEC---SSCBCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCCEEeeeceeeeec---ccccccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCCCCCcCHHHHHHHHh
Confidence 99999999999999863 234557889999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+.+.+|..+++++++||++||.+||.+|+.... .+++|+++||||++++|+.+..++++||++|.+.
T Consensus 252 ~~~~~~p~~~s~~~~~li~~~L~~dP~kR~~~~r-~t~~ell~Hp~f~~~~~~~~~~~~~~~p~~p~~~ 319 (350)
T d1rdqe_ 252 SGKVRFPSHFSSDLKDLLRNLLQVDLTKRFGNLK-NGVNDIKNHKWFATTDWIAIYQRKVEAPFIPKFK 319 (350)
T ss_dssp HCCCCCCTTCCHHHHHHHHHHSCSCTTTCTTSST-TTTHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred cCCCCCCccCCHHHHHHHHHHhhhCHHhcccccc-ccHHHHHcCccccCCCHHHHHhcCCCcCccCCCC
Confidence 9999999999999999999999999999975433 3799999999999999999999999999999887
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-67 Score=514.72 Aligned_cols=280 Identities=36% Similarity=0.650 Sum_probs=251.0
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|+++++||+|+||+||+|+++.+++.||||++.+.........+....|..++. .++|||||+++++|++++.+|
T Consensus 6 ~p~dy~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~ 84 (288)
T d1uu3a_ 6 RPEDFKFGKILGEGSFSTVVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMS-RLDHPFFVKLYFTFQDDEKLY 84 (288)
T ss_dssp CGGGEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-HCCSTTBCCEEEEEECSSEEE
T ss_pred CCCCCEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHH-HcCCCCeeEEEEEEEECCEEE
Confidence 4578999999999999999999999999999999998765555556677888998887 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
+|||||+ ||+|..++...+.+++..++.++.||+.||+|||++|||||||||+|||++.
T Consensus 85 ivmEy~~---------------------gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~NIll~~ 143 (288)
T d1uu3a_ 85 FGLSYAK---------------------NGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNE 143 (288)
T ss_dssp EEECCCT---------------------TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECT
T ss_pred EEEEccC---------------------CCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhccccEEcCcCCccccccCC
Confidence 9999999 6677778888899999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+|++||+|||+|+..... .....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 144 ~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~ 223 (288)
T d1uu3a_ 144 DMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKII 223 (288)
T ss_dssp TSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhhCCCCCCCcCHHHHHHHHH
Confidence 999999999999864322 223456789999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcc
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRP 366 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p 366 (494)
+..+.+|..+++++++||.+||++||.+|||+.+.....+|++||||++++|+.|.++ .||..|
T Consensus 224 ~~~~~~p~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i~w~~l~~~--~pP~l~ 287 (288)
T d1uu3a_ 224 KLEYDFPEKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESVTWENLHQQ--TPPKLT 287 (288)
T ss_dssp TTCCCCCTTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTCCCTTGGGS--CCCCCC
T ss_pred cCCCCCCccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCCCHHHhhcC--CCCCCC
Confidence 9999999999999999999999999999999887777788999999999999999754 455544
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-65 Score=519.19 Aligned_cols=322 Identities=34% Similarity=0.603 Sum_probs=256.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHH--hcCCCCceeeEEEEEEcCCe
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLA--LGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~--~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+++|+++++||+|+||.||+|+++.+|+.||||++.+..............|+.++. ..++|||||+++++|++.+.
T Consensus 2 slddy~i~~~lG~G~fg~Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~ 81 (364)
T d1omwa3 2 TMNDFSVHRIIGRGGFGEVYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDK 81 (364)
T ss_dssp CSTTEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSE
T ss_pred CHHhCeeeeEEecCCCeEEEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCE
Confidence 5789999999999999999999999999999999998765433333333444443332 25689999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.+.+.+++..++.|+.||+.||+|||++|||||||||+||||
T Consensus 82 ~~ivmE~~~---------------------gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlKP~NILl 140 (364)
T d1omwa3 82 LSFILDLMN---------------------GGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILL 140 (364)
T ss_dssp EEEEECCCC---------------------SCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEEecC---------------------CCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeeccceeEE
Confidence 999999999 66777788888999999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCH---HHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDE---DELF 296 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~---~~~~ 296 (494)
+.+|.+||+|||+|+... .......+||+.|||||++.+ ..|+.++|||||||++|||++|+.||.+.+. .++.
T Consensus 141 ~~~g~iKl~DFGla~~~~--~~~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~ 218 (364)
T d1omwa3 141 DEHGHVRISDLGLACDFS--KKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEID 218 (364)
T ss_dssp CSSSCEEECCCTTCEECS--SSCCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSSCHHHHH
T ss_pred cCCCcEEEeeeceeeecC--CCcccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHHHHHHHH
Confidence 999999999999998532 344566789999999999974 5799999999999999999999999987543 3445
Q ss_pred HHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccccCCCCCcc
Q psy8309 297 WSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVIEPFSSPW 376 (494)
Q Consensus 297 ~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~~~~~~~~ 376 (494)
..+....+.+|..+|+++++||.+||++||.+||++.. .+++|+++||||++++|..+..++++||++|......
T Consensus 219 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~-~~a~eil~Hp~f~~i~~~~~~~~~~~~p~~p~~~~~~---- 293 (364)
T d1omwa3 219 RMTLTMAVELPDSFSPELRSLLEGLLQRDVNRRLGCLG-RGAQEVKESPFFRSLDWQMVFLQKYPPPLIPPRGEVN---- 293 (364)
T ss_dssp HHSSSCCCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSS-STHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC-------
T ss_pred HhcccCCCCCCCCCCHHHHHHHHHHcccCHHHhCCCcc-cCHHHHHcCccccCCCHHHHhcCCCCcCcCCCCCCCC----
Confidence 55566777888999999999999999999999998644 3689999999999999999999999999998765210
Q ss_pred cccCCCCCCCCccchhhhhhccccccCCCCccccCCCCCCCCCCccccCcccCCCccCeeeeCC
Q psy8309 377 IKLSSKDSAIPIQMPQVLFQLHALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSYTNP 440 (494)
Q Consensus 377 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~~~~ 440 (494)
..+..|+++||++++..... ...+++.|.+|++..+
T Consensus 294 -------------------~~~~~d~~~~~~~~~~~~~~---------~~~~~~~~~~~~~~~~ 329 (364)
T d1omwa3 294 -------------------AADAFDIGSFDEEDTKGIKL---------LDSDQELYRNFPLTIS 329 (364)
T ss_dssp ------------------------------------CCC---------CSSSSGGGTTCCEECH
T ss_pred -------------------cCCccccccCChhhccCCCC---------CChHHHHHhcCCccCc
Confidence 11345667777665543221 1234567888888764
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-64 Score=484.44 Aligned_cols=258 Identities=31% Similarity=0.587 Sum_probs=237.2
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
++.+++|++++.||+|+||+||+|+++.+++.||||++.+..............|..++. .++|||||++++++.+++.
T Consensus 2 ~~~l~dy~i~~~iG~G~fg~Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~ 80 (263)
T d2j4za1 2 QWALEDFEIGRPLGKGKFGNVYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQS-HLRHPNILRLYGYFHDATR 80 (263)
T ss_dssp CCCGGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHH-TCCCTTBCCEEEEEECSSE
T ss_pred CcchhHeEEEEEEecCCCcEEEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHH-hcCCCCCCeEEEEEEECCE
Confidence 466889999999999999999999999999999999998765444455566778888887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||+ ||+|..++.+.+.+++.+++.++.||+.||+|||++|||||||||+||||
T Consensus 81 ~~ivmEy~~---------------------~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~ivHrDiKp~Nill 139 (263)
T d2j4za1 81 VYLILEYAP---------------------LGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLL 139 (263)
T ss_dssp EEEEEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEE
T ss_pred EEEEEeecC---------------------CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCeeeeeecccccee
Confidence 999999999 66677788888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+.+|.+||+|||+|+... .......+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.
T Consensus 140 ~~~~~~kl~DFG~a~~~~--~~~~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 217 (263)
T d2j4za1 140 GSAGELKIADFGWSVHAP--SSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 217 (263)
T ss_dssp CTTSCEEECCCCSCSCCC--CCCCEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred cCCCCEeecccceeeecC--CCcccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHHHHHHHHH
Confidence 999999999999997532 334556789999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 301 NERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 301 ~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+..+.+|..+|+++++||.+||++||.+|| +++|+++||||.
T Consensus 218 ~~~~~~p~~~s~~~~~li~~~L~~dp~~R~------t~~eil~hp~~~ 259 (263)
T d2j4za1 218 RVEFTFPDFVTEGARDLISRLLKHNPSQRP------MLREVLEHPWIT 259 (263)
T ss_dssp TTCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHTCHHHH
T ss_pred cCCCCCCccCCHHHHHHHHHHccCCHhHCc------CHHHHHcCcCcC
Confidence 999999999999999999999999999999 689999999995
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.5e-61 Score=470.31 Aligned_cols=270 Identities=27% Similarity=0.414 Sum_probs=231.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh---hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED---DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~---~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+.|++++.||+|+||+||+|+++.+|+.||||++++...... ...+...+|..++. .++|||||+++++|++.+.+
T Consensus 10 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~ 88 (293)
T d1jksa_ 10 DYYDTGEELGSGQFAVVKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILK-EIQHPNVITLHEVYENKTDV 88 (293)
T ss_dssp GTEEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHH-HCCCTTBCCEEEEEECSSEE
T ss_pred cCEEEeEEEecCCCeEEEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEE
Confidence 459999999999999999999999999999999987544322 23566778888887 57999999999999999999
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
|||||||+ ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+|||++
T Consensus 89 ~iv~E~~~---------------------gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~ivHrDiKp~Nill~ 147 (293)
T d1jksa_ 89 ILILELVA---------------------GGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLL 147 (293)
T ss_dssp EEEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEES
T ss_pred EEEEEcCC---------------------CccccchhccccccchhHHHHHHHHHHHHHHhhhhcceeecccccceEEEe
Confidence 99999999 666677788888999999999999999999999999999999999999999
Q ss_pred CCC----CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 222 YEG----HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 222 ~~g----~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
.+| .+||+|||+|+.. .......+.+||+.|+|||++.+..|+.++|||||||++|||++|..||.+.+..+.+.
T Consensus 148 ~~~~~~~~vkl~DfG~a~~~-~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~ 226 (293)
T d1jksa_ 148 DRNVPKPRIKIIDFGLAHKI-DFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226 (293)
T ss_dssp CSSSSSCCEEECCCTTCEEC-TTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cCCCcccceEecchhhhhhc-CCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHHHHHH
Confidence 877 4999999999863 33344566789999999999999999999999999999999999999999999999999
Q ss_pred HHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCC
Q psy8309 298 SICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPP 363 (494)
Q Consensus 298 ~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp 363 (494)
+|......++ ..+|+++++||.+||+.||.+|| +++|+++||||++.+|.........+|
T Consensus 227 ~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~eil~hp~~~~~~~~~~l~~~~~~P 290 (293)
T d1jksa_ 227 NVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRM------TIQDSLQHPWIKPKDTQQALSSAWSHP 290 (293)
T ss_dssp HHHTTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSTTTCC-------------C
T ss_pred HHHhcCCCCCchhcCCCCHHHHHHHHHHccCChhHCc------CHHHHhcCcccCCCChhHhhccCCCCc
Confidence 9999887766 47899999999999999999999 689999999999999987655544443
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-61 Score=471.41 Aligned_cols=252 Identities=29% Similarity=0.502 Sum_probs=223.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||+||+|+++.+|+.||||++++... ...+...+|..++. .++|||||+++++|.+.+++|||
T Consensus 20 ~~Y~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~~~~~~~---~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~iv 95 (293)
T d1yhwa1 20 KKYTRFEKIGQGASGTVYTAMDVATGQEVAIRQMNLQQQ---PKKELIINEILVMR-ENKNPNIVNYLDSYLVGDELWVV 95 (293)
T ss_dssp TTBCSCEECCCSSSCEEEEEEBTTTCCEEEEEEEEGGGC---SCHHHHHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEE
T ss_pred cccEEEEEEecCcCcEEEEEEECCCCCEEEEEEEecccC---hHHHHHHHHHHHHH-hCCCCCEeeEeEEEEECCEEEEE
Confidence 479999999999999999999999999999999986532 23456778888887 58999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEG 224 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g 224 (494)
||||+|| +|...+. .+.+++.+++.|+.||+.||+|||++|||||||||+|||++.+|
T Consensus 96 mEy~~gg---------------------~L~~~~~-~~~l~~~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~ 153 (293)
T d1yhwa1 96 MEYLAGG---------------------SLTDVVT-ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDG 153 (293)
T ss_dssp EECCTTC---------------------BHHHHHH-HSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTTC
T ss_pred EEecCCC---------------------cHHHHhh-ccCCCHHHHHHHHHHHHHHHHHHHHCCCcccCCcHHHeEECCCC
Confidence 9999954 4554443 45799999999999999999999999999999999999999999
Q ss_pred CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy8309 225 HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-- 302 (494)
Q Consensus 225 ~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-- 302 (494)
++||+|||+|+............+||+.|+|||++.+..|+.++|||||||++|||++|.+||.+.+..+....+...
T Consensus 154 ~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~~~~~~~~~~~~ 233 (293)
T d1yhwa1 154 SVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGT 233 (293)
T ss_dssp CEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHHCS
T ss_pred cEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCCCCCCCCHHHHHHHHHhCCC
Confidence 999999999987554455567789999999999999999999999999999999999999999998887777766643
Q ss_pred -CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 303 -RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 303 -~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
.+..|..+|+++++||.+||++||.+|| +++|+++||||+
T Consensus 234 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~eil~Hp~~~ 274 (293)
T d1yhwa1 234 PELQNPEKLSAIFRDFLNRCLDMDVEKRG------SAKELLQHQFLK 274 (293)
T ss_dssp CCCSSGGGSCHHHHHHHHHHTCSSTTTSC------CHHHHTTCGGGG
T ss_pred CCCCCcccCCHHHHHHHHHHccCChhHCc------CHHHHhcCHhhC
Confidence 3345678999999999999999999999 689999999996
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-61 Score=467.58 Aligned_cols=255 Identities=25% Similarity=0.450 Sum_probs=215.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... ....+....|..++. .++|||||++++++.+++.+||
T Consensus 4 ~~dy~~~~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~-~l~HpnIv~~~~~~~~~~~~~i 80 (271)
T d1nvra_ 4 VEDWDLVQTLGEGAYGEVQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINK-MLNHENVVKFYGHRREGNIQYL 80 (271)
T ss_dssp TTEEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECC---------CHHHHHHHHH-TCCCTTBCCEEEEEEETTEEEE
T ss_pred CcceEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHH-hCCCCCEeeEeeeeccCceeEE
Confidence 5799999999999999999999999999999999976532 223345677888887 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|||||+ ||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||++.+
T Consensus 81 vmEy~~---------------------gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~IiHrDiKp~NILl~~~ 139 (271)
T d1nvra_ 81 FLEYCS---------------------GGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDER 139 (271)
T ss_dssp EEECCT---------------------TEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTT
T ss_pred EEeccC---------------------CCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCccCcccHHHEEECCC
Confidence 999999 55556667777889999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHH-HHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDED-ELFWSI 299 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~-~~~~~i 299 (494)
|.+||+|||+|+...... ....+.+||+.|||||++.+..| +.++|||||||++|||++|++||.+.+.. ..+..+
T Consensus 140 ~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~~~~~~~~ 219 (271)
T d1nvra_ 140 DNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDW 219 (271)
T ss_dssp CCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTTSHHHHHH
T ss_pred CCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChHHHHHHHH
Confidence 999999999998643322 23456789999999999988876 57899999999999999999999876543 333344
Q ss_pred HhCCCCC--CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 300 CNERPRF--PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 300 ~~~~~~~--p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
....... +..+|+++++||.+||+.||++|| +++|+++||||+
T Consensus 220 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------t~~eil~hpwf~ 264 (271)
T d1nvra_ 220 KEKKTYLNPWKKIDSAPLALLHKILVENPSARI------TIPDIKKDRWYN 264 (271)
T ss_dssp HTTCTTSTTGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHTTCTTTT
T ss_pred hcCCCCCCccccCCHHHHHHHHHHcCCChhHCc------CHHHHhcCHhhC
Confidence 4333222 257899999999999999999999 689999999996
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.8e-60 Score=469.94 Aligned_cols=254 Identities=32% Similarity=0.588 Sum_probs=211.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|+++++||+|+||+||+|+++.+++.||||++.+.... ........|..++. .++|||||+++++|++++.+|||
T Consensus 9 d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~lv 85 (307)
T d1a06a_ 9 DIYDFRDVLGTGAFSEVILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLH-KIKHPNIVALDDIYESGGHLYLI 85 (307)
T ss_dssp GTEEEEEESBSGGGGGEEEEEETTTCCEEEEEEEEC------------CHHHHHHH-TCCCTTBCCEEEEEECSSEEEEE
T ss_pred cceEEEEEEeeccCeEEEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEEE
Confidence 4699999999999999999999999999999999876432 22345667888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC---
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD--- 221 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~--- 221 (494)
||||+ ||+|..++...+.+++.+++.++.||+.||+|||++||+||||||+|||+.
T Consensus 86 mE~~~---------------------gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~iiHrDiKp~Nil~~~~~ 144 (307)
T d1a06a_ 86 MQLVS---------------------GGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLD 144 (307)
T ss_dssp ECCCC---------------------SCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEESSSS
T ss_pred EeccC---------------------CCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhceeeeEEecccceeecccC
Confidence 99999 666777888888999999999999999999999999999999999999995
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
.+|.+||+|||+|+.. .......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..++...|..
T Consensus 145 ~~~~vkl~DFG~a~~~-~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~~~~~~i~~ 223 (307)
T d1a06a_ 145 EDSKIMISDFGLSKME-DPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLFEQILK 223 (307)
T ss_dssp TTCCEEECCC-------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHT
T ss_pred CCceEEEeccceeEEc-cCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHhc
Confidence 5789999999999853 233445678899999999999999999999999999999999999999999999999999998
Q ss_pred CCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 302 ERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 302 ~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
....++ ..+|+++++||.+||++||.+|| +++|+++||||++
T Consensus 224 ~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~eil~hp~~~~ 269 (307)
T d1a06a_ 224 AEYEFDSPYWDDISDSAKDFIRHLMEKDPEKRF------TCEQALQHPWIAG 269 (307)
T ss_dssp TCCCCCTTTTTTSCHHHHHHHHHHSCSSGGGSC------CHHHHHHSTTTTS
T ss_pred cCCCCCCccccCCCHHHHHHHHHHccCCHhHCc------CHHHHhcCHhhCC
Confidence 876554 57899999999999999999999 6899999999975
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-60 Score=462.97 Aligned_cols=255 Identities=27% Similarity=0.466 Sum_probs=212.8
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CCee
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DSHL 141 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~~~ 141 (494)
.++|++++.||+|+||+||+|+++.+|+.||||++.+... .+...+....|..++. .++|||||++++++.+ .+.+
T Consensus 3 ~edy~~~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~ 80 (269)
T d2java1 3 AEDYEVLYTIGTGSYGRCQKIRRKSDGKILVWKELDYGSM-TEAEKQMLVSEVNLLR-ELKHPNIVRYYDRIIDRTNTTL 80 (269)
T ss_dssp GGGEEEEEEEEECSSEEEEEEEETTTCCEEEEEEECCTTS-CHHHHHHHHHHHHHTT-SCCCTTBCCEEEEEEC----CE
T ss_pred chhCEEeEEEecCCCeEEEEEEECCCCCEEEEEEEChhhC-CHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEeCCCCEE
Confidence 4789999999999999999999999999999999987643 3445566777888876 6899999999999865 5679
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh----hcCCCCHHHHHHHHHHHHHHHHHHHhCC-----Ccccc
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ----QSGRFDEGRARFYAAEIVSGMRFLHKKG-----IVYRD 212 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~----~~~~l~e~~~~~~~~qi~~aL~yLH~~g-----ivHrD 212 (494)
|+|||||+||+| ..++. ..+.+++..++.++.||+.||+|||++| |||||
T Consensus 81 ~ivmEy~~~g~L---------------------~~~i~~~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrD 139 (269)
T d2java1 81 YIVMEYCEGGDL---------------------ASVITKGTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRD 139 (269)
T ss_dssp EEEEECCTTEEH---------------------HHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------
T ss_pred EEEEecCCCCcH---------------------HHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCc
Confidence 999999995554 44443 4568999999999999999999999976 99999
Q ss_pred CCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 213 LKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 213 LKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
|||+||||+.+|.+||+|||+|+..........+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+.
T Consensus 140 iKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~ 219 (269)
T d2java1 140 LKPANVFLDGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 219 (269)
T ss_dssp CCGGGEEECTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CchhhcCcCCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCH
Confidence 99999999999999999999998644444455678999999999999999999999999999999999999999999999
Q ss_pred HHHHHHHHhCCC-CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 293 DELFWSICNERP-RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 293 ~~~~~~i~~~~~-~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
.++..+|.++.. .+|..+|+++++||.+||+.||.+|| +++|+++|||.
T Consensus 220 ~~~~~~i~~~~~~~~~~~~s~~l~~li~~~L~~dp~~Rp------s~~ell~hp~i 269 (269)
T d2java1 220 KELAGKIREGKFRRIPYRYSDELNEIITRMLNLKDYHRP------SVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHTSTTC
T ss_pred HHHHHHHHcCCCCCCCcccCHHHHHHHHHHcCCChhHCc------CHHHHHhCCcC
Confidence 999999988765 56788999999999999999999999 68999999994
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-60 Score=464.69 Aligned_cols=254 Identities=27% Similarity=0.509 Sum_probs=223.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|++++.||+|+||+||+|+++.+++.||||++++. .....+....|..++. .++|||||++++++.+.+.+|||
T Consensus 12 d~Y~i~~~iG~G~fg~Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~-~l~HpnIv~l~~~~~~~~~~~lv 87 (288)
T d2jfla1 12 DFWEIIGELGDGAFGKVYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILA-SCDHPNIVKLLDAFYYENNLWIL 87 (288)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHH-HCCCTTBCCEEEEEEETTEEEEE
T ss_pred cCeEEeEEEeeCCCcEEEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHH-hCCCCCCCeEEEEEeeCCeEEEE
Confidence 4689999999999999999999999999999999764 2334456678888887 57999999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
||||+ ||+|..++.+ .+.+++.+++.++.||+.||+|||++||+||||||+||||+.+
T Consensus 88 mEy~~---------------------~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~~~ivHrDiKp~NIll~~~ 146 (288)
T d2jfla1 88 IEFCA---------------------GGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLD 146 (288)
T ss_dssp EECCT---------------------TEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred EecCC---------------------CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEEEeecChhheeECCC
Confidence 99999 5555656544 4679999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhC-----CCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK-----GLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~-----~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
|.+||+|||+|+..........+.+||+.|||||++. +..|+.++|||||||++|||++|.+||.+.+..+++.+
T Consensus 147 ~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~~~~~~ 226 (288)
T d2jfla1 147 GDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVLLK 226 (288)
T ss_dssp SCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGGGHHHH
T ss_pred CCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHHHHHHH
Confidence 9999999999986443334455789999999999984 45689999999999999999999999999999999999
Q ss_pred HHhCCC---CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 299 ICNERP---RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 299 i~~~~~---~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
|..+.+ ..|..+|+++++||.+||++||.+|| +++|+++||||+.
T Consensus 227 i~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------t~~ell~hp~~~~ 274 (288)
T d2jfla1 227 IAKSEPPTLAQPSRWSSNFKDFLKKCLEKNVDARW------TTSQLLQHPFVTV 274 (288)
T ss_dssp HHHSCCCCCSSGGGSCHHHHHHHHHHSCSSTTTSC------CHHHHTTSGGGCC
T ss_pred HHcCCCCCCCccccCCHHHHHHHHHHccCChhHCc------CHHHHhcCcccCC
Confidence 887753 34568999999999999999999999 6899999999974
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.4e-59 Score=471.57 Aligned_cols=258 Identities=24% Similarity=0.452 Sum_probs=229.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++.+.. ....+.+..|..++. .++|||||+++++|++++.+||
T Consensus 25 l~~Y~i~~~lG~G~fg~Vy~~~~~~~g~~vAvK~i~~~~---~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~i 100 (350)
T d1koaa2 25 LDHYDIHEELGTGAFGVVHRVTERATGNNFAAKFVMTPH---ESDKETVRKEIQTMS-VLRHPTLVNLHDAFEDDNEMVM 100 (350)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTTEEEEEEEECCCS---HHHHHHHHHHHHHHH-HTCCTTBCCEEEEEEETTEEEE
T ss_pred ccCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEEcccc---hhhHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEE
Confidence 578999999999999999999999999999999997652 334456778888887 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||+ ||+|..++. ..+.+++.+++.|+.||+.||+|||++|||||||||+||||+.
T Consensus 101 vmE~~~---------------------gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHrDiKp~NIll~~ 159 (350)
T d1koaa2 101 IYEFMS---------------------GGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTT 159 (350)
T ss_dssp EECCCC---------------------SCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEcCC---------------------CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhcCCeeeeechhHeeecc
Confidence 999999 555556664 4568999999999999999999999999999999999999964
Q ss_pred --CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 223 --EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 --~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+|.+||+|||+|+.. .......+.+||+.|||||++.+..|+.++|||||||++|||++|++||.+.+..+++.+|.
T Consensus 160 ~~~~~vkL~DFG~a~~~-~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~ 238 (350)
T d1koaa2 160 KRSNELKLIDFGLTAHL-DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVK 238 (350)
T ss_dssp TTSCCEEECCCTTCEEC-CTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHH
T ss_pred CCCCeEEEeecchheec-ccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 688999999999863 33444567899999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChh
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQ 353 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~ 353 (494)
.....++ ..+|+++++||.+||.+||++|| +++|+++||||+..+|.
T Consensus 239 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------t~~eil~hp~~~~~~~~ 289 (350)
T d1koaa2 239 SCDWNMDDSAFSGISEDGKDFIRKLLLADPNTRM------TIHQALEHPWLTPGNAP 289 (350)
T ss_dssp HTCCCSCCGGGGGCCHHHHHHHHHHCCSSGGGSC------CHHHHHHSTTTSCTTCC
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCc------CHHHHhcCcccCCCCCC
Confidence 8877665 46899999999999999999999 68999999999987663
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-59 Score=463.77 Aligned_cols=287 Identities=41% Similarity=0.782 Sum_probs=246.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEE---eCCCeEEEeeeeccccccC-hhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAEL---KGTDYYYAVKCLKKDVVLE-DDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~---~~~~~~~AiK~~~k~~~~~-~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..+++|++++.||+|+||+||+|++ +.+|+.||||++++..... ....+....|..++.+..+||||++++++++
T Consensus 20 ~~~l~~y~~~~~IG~G~fg~Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~ 99 (322)
T d1vzoa_ 20 KVGIENFELLKVLGTGAYGKVFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQ 99 (322)
T ss_dssp CCCGGGEEEEEEEEETTTEEEEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEE
T ss_pred ccchhceEEEEEEecCCCeEEEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeec
Confidence 45678999999999999999999997 4478999999998754332 2234456678888875445589999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
+...+|+||||+. ||+|..++...+.+++..++.++.||+.||+|||++||+||||||+
T Consensus 100 ~~~~~~~v~e~~~---------------------~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~ivHrDiKp~ 158 (322)
T d1vzoa_ 100 TETKLHLILDYIN---------------------GGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLE 158 (322)
T ss_dssp ETTEEEEEECCCC---------------------SCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGG
T ss_pred cCCceeeeeeccc---------------------ccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCEEeccCCcc
Confidence 9999999999998 6677778888899999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeec-cCCcccccCCCCCccChhhhCCC--CCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIY-LDKTTDTFCGTPDYMAPEIIKGL--KYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~-~~~~~~~~~gt~~y~aPE~l~~~--~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
|||++.+|.+||+|||+|+.... ......+.+||+.|+|||.+.+. .++.++|||||||+||||++|..||.+.+..
T Consensus 159 Nill~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~ 238 (322)
T d1vzoa_ 159 NILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEK 238 (322)
T ss_dssp GEEECTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSC
T ss_pred ceeecCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99999999999999999986432 22334567899999999999765 4788999999999999999999999876543
Q ss_pred ----HHHHHHHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCccccc
Q psy8309 294 ----ELFWSICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRVI 369 (494)
Q Consensus 294 ----~~~~~i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~~ 369 (494)
.+........+.+|..+|+++++||.+||++||.+||++.. .+++|+++||||++++|+.+..++++||++|.+.
T Consensus 239 ~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~l~~dP~~R~s~~~-~t~~eil~Hpff~~i~~~~l~~~~~~~p~~p~~~ 317 (322)
T d1vzoa_ 239 NSQAEISRRILKSEPPYPQEMSALAKDLIQRLLMKDPKKRLGCGP-RDADEIKEHLFFQKINWDDLAAKKVPAPFKPVIR 317 (322)
T ss_dssp CCHHHHHHHHHHCCCCCCTTSCHHHHHHHHHHTCSSGGGSTTSST-TTHHHHHTSGGGTTCCHHHHHTTCSCCSCCCCCC
T ss_pred HHHHHHHHhcccCCCCCcccCCHHHHHHHHHHcccCHHHcCCCCc-ccHHHHHcCHhhcCCCHHHHHhCCCCcCCCCCCC
Confidence 34444556778888999999999999999999999998644 2799999999999999999999999999999887
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-60 Score=470.80 Aligned_cols=260 Identities=29% Similarity=0.502 Sum_probs=219.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
..++|++++.||+|+||+||+|+++.+|+.||||++++.. .........+|..++. .++|||||+++++|.+.+++|
T Consensus 4 ~~d~y~~~~~iG~G~fg~V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~-~l~HpnIv~l~~~~~~~~~~~ 80 (322)
T d1s9ja_ 4 KDDDFEKISELGAGNGGVVFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLH-ECNSPYIVGFYGAFYSDGEIS 80 (322)
T ss_dssp CGGGEEEEEEEECCSSCCEEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGG-GCCCTTBCCEEEEEECSSEEE
T ss_pred CccCCEEEEEEecCCCeEEEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEE
Confidence 4579999999999999999999999999999999998652 3344556778888887 689999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHrDLKp~NILl~ 221 (494)
+|||||+ ||+|..++.+.+.+++..++.++.||+.||.|||+ +||+||||||+||||+
T Consensus 81 iVmEy~~---------------------gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~~~IiHRDiKP~NILl~ 139 (322)
T d1s9ja_ 81 ICMEHMD---------------------GGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVN 139 (322)
T ss_dssp EEEECCT---------------------TEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHHHCCCCSCCSGGGEEEC
T ss_pred EEEEcCC---------------------CCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCEEccccCHHHeeEC
Confidence 9999999 66677788888899999999999999999999997 5999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH-----
Q psy8309 222 YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF----- 296 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~----- 296 (494)
.+|++||+|||+|+... .....+.+||+.|||||++.+..|+.++|||||||++|||++|+.||.+.+..+..
T Consensus 140 ~~~~vkl~DFGla~~~~--~~~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~~~~~~~~~~ 217 (322)
T d1s9ja_ 140 SRGEIKLCDFGVSGQLI--DSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGC 217 (322)
T ss_dssp TTCCEEECCCCCCHHHH--HHTC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCTTHHHHHC--
T ss_pred CCCCEEEeeCCCccccC--CCccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCHHHHHHHHHH
Confidence 99999999999998532 23345689999999999999999999999999999999999999999876543221
Q ss_pred -------------------------------------HHHHhC-CCCCCc-cCCHHHHHHHHhhccCCCCCCCCCCCCCC
Q psy8309 297 -------------------------------------WSICNE-RPRFPQ-FLSVEAKNILVHLLDKDTTKRLGSTQCNS 337 (494)
Q Consensus 297 -------------------------------------~~i~~~-~~~~p~-~~s~~~~~li~~lL~~dP~~R~~~~~~~~ 337 (494)
..+... .+.+|. .+|.++++||.+||..||.+|| +
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~------t 291 (322)
T d1s9ja_ 218 QVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAERA------D 291 (322)
T ss_dssp ----------------------------CCCCHHHHHHHHHTSCCCCCCBTTBCHHHHHHHHHHTCSSTTTSC------C
T ss_pred HhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCccccCCHHHHHHHHHHcCCChhHCc------C
Confidence 111111 112222 4689999999999999999999 6
Q ss_pred hhhhhcCCCcCCCChhH
Q psy8309 338 GDDVVAHEYFRGLDWQA 354 (494)
Q Consensus 338 ~~eil~h~~f~~~~w~~ 354 (494)
++|+++||||+..+|+.
T Consensus 292 a~e~L~Hpf~~~~~~~~ 308 (322)
T d1s9ja_ 292 LKQLMVHAFIKRSDAEE 308 (322)
T ss_dssp HHHHHTSHHHHHHHHSC
T ss_pred HHHHhhCHhhCcCCccc
Confidence 89999999998766643
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=7e-59 Score=466.76 Aligned_cols=255 Identities=27% Similarity=0.461 Sum_probs=226.2
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+..|..++. .++|||||+++++|++++.+||
T Consensus 28 ~d~Y~i~~~lG~G~fg~V~~a~~~~~~~~vAiK~i~~~~---~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~i 103 (352)
T d1koba_ 28 YDYYDILEELGSGAFGVVHRCVEKATGRVFVAKFINTPY---PLDKYTVKNEISIMN-QLHHPKLINLHDAFEDKYEMVL 103 (352)
T ss_dssp GGTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCS---HHHHHHHHHHHHHHT-TCCSTTBCCEEEEEECSSEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCCEEEEEEECCcc---hhHHHHHHHHHHHHH-hCCCCCCCcEEEEEEECCEEEE
Confidence 467999999999999999999999999999999997653 223345667888877 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC-
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD- 221 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~- 221 (494)
|||||+ ||+|...+... .++++.+++.++.||+.||+|||++|||||||||+||||+
T Consensus 104 vmE~~~---------------------gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~~iiHRDiKp~NILl~~ 162 (352)
T d1koba_ 104 ILEFLS---------------------GGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET 162 (352)
T ss_dssp EEECCC---------------------CCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEEcCC---------------------CChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCeeecccccccccccc
Confidence 999999 45555555444 4799999999999999999999999999999999999998
Q ss_pred -CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 222 -YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 222 -~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
.+|.+||+|||+|+.. .......+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..+++.+|.
T Consensus 163 ~~~~~vkL~DFGla~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~~i~ 241 (352)
T d1koba_ 163 KKASSVKIIDFGLATKL-NPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVK 241 (352)
T ss_dssp TTCCCEEECCCTTCEEC-CTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHHHHHHHHH
T ss_pred cCCCeEEEeecccceec-CCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5789999999999864 33445567789999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 301 NERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 301 ~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
...+.+| ..+|+++++||.+||++||.+|| +++|+++||||++.
T Consensus 242 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------s~~eil~Hp~~~~~ 289 (352)
T d1koba_ 242 RCDWEFDEDAFSSVSPEAKDFIKNLLQKEPRKRL------TVHDALEHPWLKGD 289 (352)
T ss_dssp HCCCCCCSSTTTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHTSTTTSSC
T ss_pred hCCCCCCcccccCCCHHHHHHHHHHccCChhHCc------CHHHHhcCHhhCCC
Confidence 8877665 46899999999999999999999 68999999999864
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=4.4e-59 Score=460.23 Aligned_cols=251 Identities=24% Similarity=0.390 Sum_probs=223.7
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
.|++++.||+|+||+||+|+++.+++.||||++.+.........+...+|..++. .++|||||+++++|.+++.+|+||
T Consensus 16 ~y~~l~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~iv~ 94 (309)
T d1u5ra_ 16 LFSDLREIGHGSFGAVYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQ-KLRHPNTIQYRGCYLREHTAWLVM 94 (309)
T ss_dssp HEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEEEE
T ss_pred hcEeeEEEecCCCeEEEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHH-HCCCCCEeeEEEEEEECCEEEEEE
Confidence 4999999999999999999999999999999998765555556667888998887 589999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|||. ||++...+...+.+++.+++.++.||+.||.|||++|||||||||+||||+.+|.
T Consensus 95 E~~~---------------------~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~~iiHrDiKp~NILl~~~~~ 153 (309)
T d1u5ra_ 95 EYCL---------------------GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGL 153 (309)
T ss_dssp ECCS---------------------EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCBCCCCSGGGEEEETTTE
T ss_pred EecC---------------------CCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCEeccCCCcceEEECCCCC
Confidence 9998 5555556667788999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCC---CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG---LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~---~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
+||+|||+|+.. ......+||+.|||||++.+ ..|+.++|||||||++|||++|..||.+.+..+.+.++...
T Consensus 154 ~Kl~DFG~a~~~----~~~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~~~~~~~i~~~ 229 (309)
T d1u5ra_ 154 VKLGDFGSASIM----APANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQN 229 (309)
T ss_dssp EEECCCTTCBSS----SSBCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHS
T ss_pred EEEeeccccccc----CCCCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCHHHHHHHHHhC
Confidence 999999999752 23456789999999999975 35899999999999999999999999999988888888776
Q ss_pred CCC-C-CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 303 RPR-F-PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 303 ~~~-~-p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
... + +..+|+++++||.+||+.||.+|| +++|+++||||.
T Consensus 230 ~~~~~~~~~~s~~~~~li~~~L~~dP~~Rp------t~~ell~Hp~~~ 271 (309)
T d1u5ra_ 230 ESPALQSGHWSEYFRNFVDSCLQKIPQDRP------TSEVLLKHRFVL 271 (309)
T ss_dssp CCCCCSCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHTTCHHHH
T ss_pred CCCCCCCCCCCHHHHHHHHHHCcCChhHCc------CHHHHHhCHHhc
Confidence 543 2 346899999999999999999999 689999999995
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=4.5e-58 Score=446.18 Aligned_cols=258 Identities=29% Similarity=0.434 Sum_probs=228.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh------hhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED------DDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~------~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.++|++++.||+|+||+||+|+++.+++.||||++++...... ...+...+|..++.....|||||+++++|++
T Consensus 2 ~~~y~~~~~iG~G~~g~V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~ 81 (277)
T d1phka_ 2 YENYEPKEILGRGVSSVVRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYET 81 (277)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEC
T ss_pred cccCEEceEEecCcCeEEEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeeccc
Confidence 3689999999999999999999999999999999987543321 1234567888888865569999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
++++|||||||+ ||+|..++...+.+++.+++.|+.||+.||+|||++||+||||||+|
T Consensus 82 ~~~~~ivmE~~~---------------------~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~~ivHrDlkp~N 140 (277)
T d1phka_ 82 NTFFFLVFDLMK---------------------KGELFDYLTEKVTLSEKETRKIMRALLEVICALHKLNIVHRDLKPEN 140 (277)
T ss_dssp SSEEEEEEECCT---------------------TCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGG
T ss_pred CcceEEEEEcCC---------------------CchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHcCCcccccccce
Confidence 999999999999 66677788888999999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhC------CCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIK------GLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~------~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
||++.++.+||+|||+++... ........+||+.|+|||++. ...|+.++||||+||++|||++|++||.+.+
T Consensus 141 ill~~~~~~kl~DFG~a~~~~-~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~ 219 (277)
T d1phka_ 141 ILLDDDMNIKLTDFGFSCQLD-PGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 219 (277)
T ss_dssp EEECTTCCEEECCCTTCEECC-TTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred EEEcCCCCeEEccchheeEcc-CCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCC
Confidence 999999999999999998643 344456678999999999985 3457899999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 292 EDELFWSICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 292 ~~~~~~~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
..+....|.++...++ ..+|+++++||.+||+.||.+|| +++||++||||+.
T Consensus 220 ~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~~p~~R~------s~~eil~h~~~~~ 275 (277)
T d1phka_ 220 QMLMLRMIMSGNYQFGSPEWDDYSDTVKDLVSRFLVVQPQKRY------TAEEALAHPFFQQ 275 (277)
T ss_dssp HHHHHHHHHHTCCCCCTTTGGGSCHHHHHHHHHHCCSSGGGSC------CHHHHTTSGGGCT
T ss_pred HHHHHHHHHhCCCCCCCcccccCCHHHHHHHHHHccCChhHCc------CHHHHHcCHHHHH
Confidence 9999999998876554 37999999999999999999999 6899999999975
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-58 Score=443.02 Aligned_cols=250 Identities=26% Similarity=0.490 Sum_probs=216.0
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----CCeeE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT----DSHLF 142 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~----~~~~~ 142 (494)
|++.+.||+|+||+||+|+++.+++.||+|++.+... .....+...+|..++. .++|||||+++++|++ ...+|
T Consensus 11 ~~~~~~iG~G~fg~Vy~~~~~~~~~~va~K~i~~~~~-~~~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~~~~~~~ 88 (270)
T d1t4ha_ 11 LKFDIEIGRGSFKTVYKGLDTETTVEVAWCELQDRKL-TKSERQRFKEEAEMLK-GLQHPNIVRFYDSWESTVKGKKCIV 88 (270)
T ss_dssp EEEEEEEEECSSEEEEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHT-TCCCTTBCCEEEEEEEESSSCEEEE
T ss_pred EEeeeEEecCcCcEEEEEEECCCCeEEEEEEEchhhC-CHHHHHHHHHHHHHHH-hCCCCCeeeEEEEEeeccccCCEEE
Confidence 4788899999999999999999999999999987543 3445566778888887 6899999999999975 45689
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCC--CccccCCCCceee
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKG--IVYRDLKLDNILL 220 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~g--ivHrDLKp~NILl 220 (494)
+|||||+ ||+|..++.+.+.+++..++.++.||+.||+|||++| |+||||||+||||
T Consensus 89 ivmE~~~---------------------~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~yLH~~~~~IiHrDiKp~NILl 147 (270)
T d1t4ha_ 89 LVTELMT---------------------SGTLKTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFI 147 (270)
T ss_dssp EEEECCC---------------------SCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTSSSCCCCSCCCGGGEEE
T ss_pred EEEeCCC---------------------CCcHHHHHhccccccHHHHHHHHHHHHHHHHHHHHCCCCEEeCCcChhhcee
Confidence 9999999 6666777888889999999999999999999999999 9999999999999
Q ss_pred C-CCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCC-CHHHHHHH
Q psy8309 221 D-YEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGC-DEDELFWS 298 (494)
Q Consensus 221 ~-~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~-~~~~~~~~ 298 (494)
+ .+|.+||+|||+|+.. ......+.+||+.|||||++.+ .|+.++|||||||++|||++|+.||.+. +..+++..
T Consensus 148 ~~~~~~~Kl~DFGla~~~--~~~~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~~~~~~~~~ 224 (270)
T d1t4ha_ 148 TGPTGSVKIGDLGLATLK--RASFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQNAAQIYRR 224 (270)
T ss_dssp SSTTSCEEECCTTGGGGC--CTTSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCSSHHHHHHH
T ss_pred eCCCCCEEEeecCcceec--cCCccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcccHHHHHHH
Confidence 6 5799999999999742 3344567899999999999976 6999999999999999999999999865 45566666
Q ss_pred HHhCCC--CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 299 ICNERP--RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 299 i~~~~~--~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+..+.. .++...++++++||.+||++||++|| +++|+++||||+
T Consensus 225 i~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R~------s~~ell~Hp~fk 270 (270)
T d1t4ha_ 225 VTSGVKPASFDKVAIPEVKEIIEGCIRQNKDERY------SIKDLLNHAFFQ 270 (270)
T ss_dssp HTTTCCCGGGGGCCCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGGGC
T ss_pred HHcCCCCcccCccCCHHHHHHHHHHccCCHhHCc------CHHHHhCCcccC
Confidence 665533 34567899999999999999999999 689999999996
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-58 Score=454.72 Aligned_cols=253 Identities=24% Similarity=0.431 Sum_probs=226.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
.++|++++.||+|+||+||+|+++.+++.||||++++.. ........|..+|. .++|||||+++++|++++++||
T Consensus 4 ~~rY~i~~~lG~G~fg~Vy~~~~~~~~~~~AiK~i~~~~----~~~~~~~~Ei~il~-~l~HpnIv~~~~~~~~~~~~~l 78 (321)
T d1tkia_ 4 YEKYMIAEDLGRGEFGIVHRCVETSSKKTYMAKFVKVKG----TDQVLVKKEISILN-IARHRNILHLHESFESMEELVM 78 (321)
T ss_dssp TTTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECCCT----HHHHHHHHHHHHHH-HSCCTTBCCEEEEEEETTEEEE
T ss_pred ccceEEEEEEecCCCeEEEEEEECCCCcEEEEEEEcCCc----ccHHHHHHHHHHHH-hCCCCCCCeEEEEEEECCEEEE
Confidence 468999999999999999999999999999999998652 22334667888887 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcC-CCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSG-RFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~-~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||+ ||+|..++...+ .+++.+++.|+.||+.||+|||++||+||||||+|||++.
T Consensus 79 vmE~~~---------------------gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~iiHrDlKp~NIll~~ 137 (321)
T d1tkia_ 79 IFEFIS---------------------GLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT 137 (321)
T ss_dssp EECCCC---------------------CCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESS
T ss_pred EEecCC---------------------CCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCCCcccccccceeecC
Confidence 999999 566677776654 7999999999999999999999999999999999999985
Q ss_pred C--CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Q psy8309 223 E--GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSIC 300 (494)
Q Consensus 223 ~--g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~ 300 (494)
+ +.+||+|||+++.. .......+.+||+.|+|||++.+..|+.++|||||||++|+|++|.+||.+.+..+++.+|.
T Consensus 138 ~~~~~ikl~DFG~~~~~-~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~~~~~~i~ 216 (321)
T d1tkia_ 138 RRSSTIKIIEFGQARQL-KPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIM 216 (321)
T ss_dssp SSCCCEEECCCTTCEEC-CTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHHHHHHHHH
T ss_pred CCceEEEEcccchhhcc-ccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHHHHHHHHH
Confidence 5 47999999999863 33344566789999999999999999999999999999999999999999999999999999
Q ss_pred hCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 301 NERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 301 ~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
+..+.+|. .+|+++++||.+||++||.+|| +++|+++||||+.
T Consensus 217 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------s~~eil~hp~~~~ 263 (321)
T d1tkia_ 217 NAEYTFDEEAFKEISIEAMDFVDRLLVKERKSRM------TASEALQHPWLKQ 263 (321)
T ss_dssp HTCCCCCHHHHTTSCHHHHHHHHTTSCSSGGGSC------CHHHHHHSHHHHS
T ss_pred hCCCCCChhhccCCCHHHHHHHHHHccCChhHCc------CHHHHhcCHhhcc
Confidence 99888874 6899999999999999999999 6899999999964
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-57 Score=447.03 Aligned_cols=255 Identities=25% Similarity=0.362 Sum_probs=213.9
Q ss_pred eEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccCh--hhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLED--DDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVM 145 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~--~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~ 145 (494)
+.+++||+|+||+||+|+++.+|+.||||++++...... .......+|..++. .++|||||+++++|.+++++||||
T Consensus 1 E~l~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~-~l~hpnIv~~~~~~~~~~~~~ivm 79 (299)
T d1ua2a_ 1 EKLDFLGEGQFATVYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQ-ELSHPNIIGLLDAFGHKSNISLVF 79 (299)
T ss_dssp CEEEEEEEETTEEEEEEECSSCCSEEEEEEC------------CTHHHHHHHHHH-HCCCTTBCCEEEEECCTTCCEEEE
T ss_pred CcceEeccCcCeEEEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHH-hCCCCCEeEEEeeeccCCceeehh
Confidence 357899999999999999999999999999976533221 12345678888887 579999999999999999999999
Q ss_pred EecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCC
Q psy8309 146 EYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGH 225 (494)
Q Consensus 146 E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~ 225 (494)
|||. |+.+.......+.+++.+++.++.||+.||+|||++||+||||||+|||++.+|.
T Consensus 80 E~~~---------------------~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiHrDiKp~NIli~~~~~ 138 (299)
T d1ua2a_ 80 DFME---------------------TDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGV 138 (299)
T ss_dssp ECCS---------------------EEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEEECTTCC
T ss_pred hhhc---------------------chHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceecccCCcceEEecCCCc
Confidence 9998 4455555666778999999999999999999999999999999999999999999
Q ss_pred EEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC--
Q psy8309 226 VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE-- 302 (494)
Q Consensus 226 vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~-- 302 (494)
+||+|||+|+..........+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+++.+|.+.
T Consensus 139 ~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~~~~l~~i~~~~~ 218 (299)
T d1ua2a_ 139 LKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFETLG 218 (299)
T ss_dssp EEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHC
T ss_pred cccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCHHHHHHHHHHhcC
Confidence 999999999864444445567789999999999875 45899999999999999999999999999998888877641
Q ss_pred CC------------------CC--------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 303 RP------------------RF--------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 303 ~~------------------~~--------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.+ .+ ...+++++++||.+||+.||++|| +++|+++||||++.
T Consensus 219 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~------sa~e~L~Hp~f~~~ 286 (299)
T d1ua2a_ 219 TPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARI------TATQALKMKYFSNR 286 (299)
T ss_dssp CCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSC------CHHHHHTSGGGTSS
T ss_pred CCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCc------CHHHHhCCHhhCCC
Confidence 00 00 124689999999999999999999 68999999999864
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-57 Score=439.91 Aligned_cols=253 Identities=26% Similarity=0.406 Sum_probs=218.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhh---HHHHHHHHHHHHhcC-CCCceeeEEEEEEcCCe
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDD---VECTLIERKVLALGT-KHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~---~~~~~~e~~~l~~~~-~hp~Iv~l~~~~~~~~~ 140 (494)
++|++.++||+|+||+||+|+++.+|+.||||++++........ ......|..++.... .|||||+++++|++.+.
T Consensus 4 ~~Y~i~~~lG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~ 83 (273)
T d1xwsa_ 4 SQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDS 83 (273)
T ss_dssp TTEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSE
T ss_pred CeEEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCe
Confidence 58999999999999999999999999999999998764433211 122446777776432 59999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+||||+.+ ++++...+...+.+++.+++.++.||+.||+|||++||+||||||+|||+
T Consensus 84 ~~lv~e~~~~--------------------~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~iiHrDiKp~NIll 143 (273)
T d1xwsa_ 84 FVLILERPEP--------------------VQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILI 143 (273)
T ss_dssp EEEEEECCSS--------------------EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEE
T ss_pred EEEEEEeccC--------------------cchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCccccCcccceEE
Confidence 9999999974 34566677788899999999999999999999999999999999999999
Q ss_pred CCC-CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCC-CCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 221 DYE-GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKY-NQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 221 ~~~-g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~-~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
+.+ +.+||+|||+|+.. ......+.+||+.|+|||++.+..+ +.++|||||||++|||++|+.||.+. ..
T Consensus 144 ~~~~~~vkl~DFG~a~~~--~~~~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~------~~ 215 (273)
T d1xwsa_ 144 DLNRGELKLIDFGSGALL--KDTVYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHD------EE 215 (273)
T ss_dssp ETTTTEEEECCCTTCEEC--CSSCBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSH------HH
T ss_pred ecCCCeEEECccccceec--ccccccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCc------hH
Confidence 854 79999999999853 2344567889999999999987665 67899999999999999999999763 25
Q ss_pred HHhCCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCC
Q psy8309 299 ICNERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLD 351 (494)
Q Consensus 299 i~~~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~ 351 (494)
+..+...++..+|+++++||.+||++||++|| +++|+++||||+++.
T Consensus 216 i~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~------s~~eil~hp~~~~~~ 262 (273)
T d1xwsa_ 216 IIRGQVFFRQRVSSECQHLIRWCLALRPSDRP------TFEEIQNHPWMQDVL 262 (273)
T ss_dssp HHHCCCCCSSCCCHHHHHHHHHHTCSSGGGSC------CHHHHHTSGGGSSCC
T ss_pred HhhcccCCCCCCCHHHHHHHHHHccCCHhHCc------CHHHHhcCHhhCCCC
Confidence 77788889999999999999999999999999 689999999998764
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-56 Score=439.25 Aligned_cols=258 Identities=29% Similarity=0.481 Sum_probs=216.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++++... .........+|..++. .++|||||+++++|++++++|+
T Consensus 1 ~d~Y~~~~~lG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~-~l~Hp~Iv~~~~~~~~~~~~~i 78 (298)
T d1gz8a_ 1 MENFQKVEKIGEGTYGVVYKARNKLTGEVVALKKIRLDTE-TEGVPSTAIREISLLK-ELNHPNIVKLLDVIHTENKLYL 78 (298)
T ss_dssp CTTEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHT-TCCCTTBCCEEEEEEETTEEEE
T ss_pred CCCCEeccEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-ChHHHHHHHHHHHHHH-hCCCCcEEEeccccccccceeE
Confidence 4799999999999999999999999999999999976532 2334456778988887 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHH-hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~-l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||.++ .+... ......+++.+++.++.||+.||+|||++|||||||||+|||++.
T Consensus 79 v~e~~~~~---------------------~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~~~IiHrDiKpeNIl~~~ 137 (298)
T d1gz8a_ 79 VFEFLHQD---------------------LKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINT 137 (298)
T ss_dssp EEECCSEE---------------------HHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECT
T ss_pred EEeecCCc---------------------hhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhcCCEEccccCchheeecc
Confidence 99999632 22222 233567999999999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHh
Q psy8309 223 EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICN 301 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~ 301 (494)
++.+||+|||+|+............+||+.|+|||++.... ++.++|+|||||++|+|++|+.||.+.+..+.+.++..
T Consensus 138 ~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~~~~~~~i~~ 217 (298)
T d1gz8a_ 138 EGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFRIFR 217 (298)
T ss_dssp TSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHH
T ss_pred cCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHhhCCCCCCCCCHHHHHHHHHH
Confidence 99999999999986544455566778999999999988766 57899999999999999999999999988887777653
Q ss_pred CC------------------CCCC-----------ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 ER------------------PRFP-----------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~~------------------~~~p-----------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
.. ..++ ..+|+++++||.+||..||.+|| +++|+++||||+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~------t~~ell~H~ff~~~ 289 (298)
T d1gz8a_ 218 TLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRI------SAKAALAHPFFQDV 289 (298)
T ss_dssp HHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSC------CHHHHHTSGGGTTC
T ss_pred hcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCc------CHHHHhCCHhhccC
Confidence 10 0111 24689999999999999999999 68999999999876
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.3e-57 Score=451.93 Aligned_cols=251 Identities=28% Similarity=0.448 Sum_probs=212.3
Q ss_pred CCCCceEee-EeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc----
Q psy8309 63 DLEDFQLLK-VLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT---- 137 (494)
Q Consensus 63 ~~~~y~~~~-~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~---- 137 (494)
-+++|+++. +||+|+||+||+|+++.+++.||||++++. ....+|..++.+..+|||||+++++|++
T Consensus 9 i~~~y~i~~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~--------~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~ 80 (335)
T d2ozaa1 9 IIDDYKVTSQVLGLGINGKVLQIFNKRTQEKFALKMLQDC--------PKARREVELHWRASQCPHIVRIVDVYENLYAG 80 (335)
T ss_dssp GGGTEEEEEEEEEECSSCEEEEEEETTTCCEEEEEEEECS--------HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETT
T ss_pred cccCEEEeeEEeeeccCeEEEEEEECCCCCEEEEEEECCc--------HHHHHHHHHHHHhcCCCCCCeEEEEEeecccC
Confidence 357999875 699999999999999999999999999653 2345677776666799999999999976
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
+.++|||||||+ ||+|..++.+. ..|++.+++.|+.||+.||+|||++||+||||||
T Consensus 81 ~~~~~ivmEy~~---------------------gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~iiHRDiKp 139 (335)
T d2ozaa1 81 RKCLLIVMECLD---------------------GGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKP 139 (335)
T ss_dssp EEEEEEEEECCC---------------------SEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHHHHTTEECCCCSG
T ss_pred CCEEEEEEECCC---------------------CCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHHHHcCCccccccc
Confidence 467999999999 56666677654 4799999999999999999999999999999999
Q ss_pred CceeeCC---CCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCH
Q psy8309 216 DNILLDY---EGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~---~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 292 (494)
+|||++. ++.+||+|||+|+... ......+.+||+.|||||++.+..|+.++|||||||++|+|++|++||.+.+.
T Consensus 140 ~NIll~~~~~~~~~Kl~DFG~a~~~~-~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~ 218 (335)
T d2ozaa1 140 ENLLYTSKRPNAILKLTDFGFAKETT-SHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 218 (335)
T ss_dssp GGEEESCSSTTCCEEECCCTTCEECC-CCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTC
T ss_pred cccccccccccccccccccceeeecc-CCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCH
Confidence 9999986 5679999999998643 34455678899999999999999999999999999999999999999988765
Q ss_pred HHHHHH----HHhCCCCCCc----cCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 293 DELFWS----ICNERPRFPQ----FLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 293 ~~~~~~----i~~~~~~~p~----~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
.+.... +......+|. .+|+++++||++||++||++|| +++|+++||||..
T Consensus 219 ~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------s~~eil~hp~~~~ 277 (335)
T d2ozaa1 219 LAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRM------TITEFMNHPWIMQ 277 (335)
T ss_dssp C--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSC------CHHHHHHSHHHHT
T ss_pred HHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCc------CHHHHHcCHHhhC
Confidence 554443 3445555653 6899999999999999999999 6899999999953
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-56 Score=437.63 Aligned_cols=259 Identities=25% Similarity=0.400 Sum_probs=214.4
Q ss_pred CCceEeeEeccCCceEEEEEEEeCC-CeEEEeeeeccccccChhhHHHHHHHHHHHHh--cCCCCceeeEEEEEEc----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGT-DYYYAVKCLKKDVVLEDDDVECTLIERKVLAL--GTKHPYLCHLFCTFQT---- 137 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~-~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~--~~~hp~Iv~l~~~~~~---- 137 (494)
++|++++.||+|+||+||+|+++.+ ++.||||++++.... ........+|..++.. ..+||||++++++|..
T Consensus 7 ~~Y~i~~~LG~G~fg~V~~a~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~ 85 (305)
T d1blxa_ 7 QQYECVAEIGEGAYGKVFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTD 85 (305)
T ss_dssp GTEEEEEEEEEETTEEEEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECS
T ss_pred CCEEEEEEEecccCeEEEEEEEECCCCEEEEEEEEehhhcc-chHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccc
Confidence 6899999999999999999999765 678999999765332 2222234455555442 3589999999999863
Q ss_pred -CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHH-hhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 -DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFH-IQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 -~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~-l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
..++|++||||.+| .+... ......+++..++.++.||+.||+|||++|||||||||
T Consensus 86 ~~~~~~~~~e~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~~~ivHrDiKp 144 (305)
T d1blxa_ 86 RETKLTLVFEHVDQD---------------------LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKP 144 (305)
T ss_dssp SEEEEEEEEECCSCB---------------------HHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCG
T ss_pred cCceEEEEEEeccCC---------------------chhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHhCCEEecCCCc
Confidence 35789999999844 33222 23456799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+|||++.+|.+||+|||+++.. .......+.+||+.|+|||++.+..|+.++|||||||++|||++|++||.+.+..+.
T Consensus 145 ~NILi~~~~~~kl~dfg~~~~~-~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~~~~ 223 (305)
T d1blxa_ 145 QNILVTSSGQIKLADFGLARIY-SFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQ 223 (305)
T ss_dssp GGEEECTTCCEEECSCCSCCCC-CGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHH
T ss_pred cEEEEcCCCCeeecchhhhhhh-cccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCHHHH
Confidence 9999999999999999998753 233445678999999999999999999999999999999999999999999998888
Q ss_pred HHHHHhC--C-------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 296 FWSICNE--R-------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 296 ~~~i~~~--~-------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+.+|... . ..++..+++++++||.+||++||++|| +++|+++||||+
T Consensus 224 ~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~------sa~e~L~Hpff~ 297 (305)
T d1blxa_ 224 LGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRI------SAYSALSHPYFQ 297 (305)
T ss_dssp HHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSC------CHHHHHTSGGGT
T ss_pred HHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCc------CHHHHhcChhhc
Confidence 8877531 0 012346799999999999999999999 689999999999
Q ss_pred CCCh
Q psy8309 349 GLDW 352 (494)
Q Consensus 349 ~~~w 352 (494)
++++
T Consensus 298 ~i~~ 301 (305)
T d1blxa_ 298 DLER 301 (305)
T ss_dssp TCCC
T ss_pred Cchh
Confidence 9875
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=2.9e-55 Score=428.87 Aligned_cols=256 Identities=25% Similarity=0.439 Sum_probs=215.3
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|+++++||+|+||+||+|+++ +|+.||||++++... .........+|..++. .++|||||+++++|.+.+.+|+
T Consensus 1 ~~~Y~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~-~l~hpnIv~~~~~~~~~~~~~i 77 (286)
T d1ob3a_ 1 MEKYHGLEKIGEGTYGVVYKAQNN-YGETFALKKIRLEKE-DEGIPSTTIREISILK-ELKHSNIVKLYDVIHTKKRLVL 77 (286)
T ss_dssp CCSEEEEEEEEEETTEEEEEEEET-TSCEEEEEEECCSSG-GGCCCHHHHHHHHGGG-GCCCTTBCCEEEEEECSSCEEE
T ss_pred CCCceeccEEecCCCcEEEEEEeC-CCCEEEEEEEehhhc-ChHHHHHHHHHHHHHH-hCCCCcEEeeeeecccCCceeE
Confidence 478999999999999999999985 778999999976532 3334566778888887 5799999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
+||++. ++.+.......+.+++..++.++.||+.||+|||++|||||||||+||||+.+
T Consensus 78 ~~e~~~---------------------~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~IvHrDiKp~NIll~~~ 136 (286)
T d1ob3a_ 78 VFEHLD---------------------QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINRE 136 (286)
T ss_dssp EEECCS---------------------EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTT
T ss_pred EEEeeh---------------------hhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccCcEEecCCCCceeeEcCC
Confidence 999997 45555566677899999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhC
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWSICNE 302 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~ 302 (494)
|.+||+|||+|.............+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+..+.+.++...
T Consensus 137 ~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~~~~~~~i~~~ 216 (286)
T d1ob3a_ 137 GELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFRI 216 (286)
T ss_dssp SCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHH
T ss_pred CCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCHHHHHHHHHHh
Confidence 999999999987644444445667899999999999764 5799999999999999999999999999888877776531
Q ss_pred --C---------------------------CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCC
Q psy8309 303 --R---------------------------PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRG 349 (494)
Q Consensus 303 --~---------------------------~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~ 349 (494)
. ..++..++++++|||++||++||++|| +++|+++||||++
T Consensus 217 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~------s~~ell~Hp~f~~ 286 (286)
T d1ob3a_ 217 LGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRI------TAKQALEHAYFKE 286 (286)
T ss_dssp HCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSC------CHHHHHTSGGGGC
T ss_pred hCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCc------CHHHHhcCcccCc
Confidence 0 012345789999999999999999999 6899999999974
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=3.5e-55 Score=426.41 Aligned_cols=254 Identities=26% Similarity=0.404 Sum_probs=215.0
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----e
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS----H 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~----~ 140 (494)
++|++++.||+|+||+||+|+++.+|+.||||++++..............|..++. .++|||||++++++...+ .
T Consensus 7 drY~i~~~lG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~-~~~hpniv~~~~~~~~~~~~~~~ 85 (277)
T d1o6ya_ 7 DRYELGEILGFGGMSEVHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAA-ALNHPAIVAVYDTGEAETPAGPL 85 (277)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEEEECSSSEE
T ss_pred ceeEEeEEEeeCCCeEEEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHH-hcCCCCCCcccceeeeccCCCce
Confidence 57999999999999999999999999999999998875555556667788888887 589999999999998754 3
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|||||||+ |++|...+...+.+++.+++.++.||+.||+|||++||+||||||+||||
T Consensus 86 ~~lvmE~~~---------------------g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~lH~~~iiHrDiKP~NIll 144 (277)
T d1o6ya_ 86 PYIVMEYVD---------------------GVTLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMI 144 (277)
T ss_dssp EEEEEECCC---------------------EEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred EEEEEECCC---------------------CCEehhhhcccCCCCHHHHHHHHHHHHHHHHHHHhCCccCccccCccccc
Confidence 899999999 66667778888899999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
+.++.++|+|||.++...... ....+.+||+.|||||++.+..|+.++|||||||++|||++|.+||.+.+..++..
T Consensus 145 ~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~~~~~ 224 (277)
T d1o6ya_ 145 SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY 224 (277)
T ss_dssp ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHH
T ss_pred CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHHHHHH
Confidence 999999999999987532221 23456789999999999999999999999999999999999999999999999988
Q ss_pred HHHhCCCCCC----ccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCC
Q psy8309 298 SICNERPRFP----QFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEY 346 (494)
Q Consensus 298 ~i~~~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~ 346 (494)
++....+..| ..+|+++++||.+||++||.+||+ ++++++ |+|
T Consensus 225 ~~~~~~~~~~~~~~~~~s~~l~~li~~~L~~dp~~R~~-----sa~~l~-~~l 271 (277)
T d1o6ya_ 225 QHVREDPIPPSARHEGLSADLDAVVLKALAKNPENRYQ-----TAAEMR-ADL 271 (277)
T ss_dssp HHHHCCCCCGGGTSSSCCHHHHHHHHHHTCSSGGGSCS-----SHHHHH-HHH
T ss_pred HHHhcCCCCCchhccCCCHHHHHHHHHHccCCHhHCHh-----HHHHHH-HHH
Confidence 8888766544 568999999999999999999994 456654 444
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=8.3e-55 Score=425.50 Aligned_cols=251 Identities=25% Similarity=0.374 Sum_probs=212.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.+..++|++.+.||+|+||+||+|+++.+++.||||+++++. ...+...+|..++. .++|||||++++++.+.+.
T Consensus 13 ei~~~~~~~~~~iG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~----~~~~~~~~E~~il~-~l~HpnIv~~~~~~~~~~~ 87 (287)
T d1opja_ 13 EMERTDITMKHKLGGGQYGEVYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMK-EIKHPNLVQLLGVCTREPP 87 (287)
T ss_dssp BCCGGGEEEEEETTTTTTSSEEEEEEGGGTEEEEEEECCTTC----SCHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSS
T ss_pred EecHHHeEEeeEEeeCCCeEEEEEEECCCCeEEEEEEECCcc----chHHHHHHHHHHHH-hCCCCCEecCCccEeeCCe
Confidence 456679999999999999999999999999999999997642 23456778888887 5799999999999999999
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh--cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ--SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~--~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+|||||++| +|..++.. ...+++..++.++.||+.||+|||++||+||||||+||
T Consensus 88 ~~iv~E~~~~g---------------------~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~~iiHrDlKp~NI 146 (287)
T d1opja_ 88 FYIITEFMTYG---------------------NLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNC 146 (287)
T ss_dssp CEEEEECCTTC---------------------BHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eEEEeecccCc---------------------chHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHCCcccCccccCeE
Confidence 99999999954 55555543 35789999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCc-ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCC-CCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKT-TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS-PFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~-~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~-Pf~~~~~~~~~ 296 (494)
||+.+|.+||+|||+|+........ .....||+.|+|||++.+..|+.++|||||||++|||++|.. ||.+.+..+++
T Consensus 147 Ll~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~~~~~~~~ 226 (287)
T d1opja_ 147 LVGENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVY 226 (287)
T ss_dssp EECGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHH
T ss_pred EECCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCcchHHHHH
Confidence 9999999999999999853322221 233458999999999999999999999999999999999555 55666776666
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+..+ .+.+|..+++++++||.+||+.||.+|| +++||++
T Consensus 227 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------s~~ei~~ 268 (287)
T d1opja_ 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRP------SFAEIHQ 268 (287)
T ss_dssp HHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHhcCCCCCCCccchHHHHHHHHHHcCCCHhHCc------CHHHHHH
Confidence 666544 5677889999999999999999999999 5677754
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-55 Score=434.39 Aligned_cols=274 Identities=27% Similarity=0.390 Sum_probs=212.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCe-----EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDY-----YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~-----~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|+++++||+|+||+||+|+++.+++ .||+|++.+.. ..........|..++....+|||||++++++.
T Consensus 34 i~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~ 111 (325)
T d1rjba_ 34 FPRENLEFGKVLGSGAFGKVMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACT 111 (325)
T ss_dssp CCGGGEEEEEEEEECSSEEEEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred CCHHHeEEeeEEeeCCCeEEEEEEEcCCCcccceeEEEEEEecccc--CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEe
Confidence 456799999999999999999999987653 68999987542 22334466788888876669999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhh---hhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAER---DLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDL 213 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~---~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDL 213 (494)
+.+.+|+|||||+||+|.+.+...... ....+... .........+.+++..++.|+.||+.||+|||++|||||||
T Consensus 112 ~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDl 190 (325)
T d1rjba_ 112 LSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQ-KRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDL 190 (325)
T ss_dssp SSSSCEEEEECCTTCBHHHHHHTTTTCC----------------------CCHHHHHHHHHHHHHHHHHHHHTTEEETTC
T ss_pred eCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccc-cccccccccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccC
Confidence 999999999999977774432211100 00000000 00001122346899999999999999999999999999999
Q ss_pred CCCceeeCCCCCEEEeecCceeeeeccCCc--ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy8309 214 KLDNILLDYEGHVRIADFGMCKLQIYLDKT--TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGC 290 (494)
Q Consensus 214 Kp~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~ 290 (494)
||+|||++.+|++||+|||+|+........ ..+.+||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 191 Kp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~ 270 (325)
T d1rjba_ 191 AARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGI 270 (325)
T ss_dssp SGGGEEEETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred chhccccccCCeEEEeeccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCC
Confidence 999999999999999999999864333222 335678999999999999999999999999999999997 99999988
Q ss_pred CHHHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 291 DEDELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 291 ~~~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+..+.+.+++.. .+..|..+++++++||.+||+.||++|| +++||++|
T Consensus 271 ~~~~~~~~~~~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP------t~~ei~~~ 320 (325)
T d1rjba_ 271 PVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKRP------SFPNLTSF 320 (325)
T ss_dssp CCSHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred CHHHHHHHHHhcCCCCCCCCcCCHHHHHHHHHHcCCChhHCc------CHHHHHHH
Confidence 777767676655 4566789999999999999999999999 67888765
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=7.5e-54 Score=421.13 Aligned_cols=253 Identities=23% Similarity=0.373 Sum_probs=205.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCe---EEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDY---YYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~---~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
.+..++|++.++||+|+||+||+|+++.+++ .||||.+... ......+....|..++. .++|||||++++++.+
T Consensus 22 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~ 98 (299)
T d1jpaa_ 22 EIDISCVKIEQVIGAGEFGEVCSGHLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMG-QFDHPNVIHLEGVVTK 98 (299)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEECC---CCEEEEEEECCSS--CCHHHHHHHHHHHHHHT-TCCCTTBCCEEEEECS
T ss_pred hhChhhcEEeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHH-hCCCCCCccEEEEEee
Confidence 3556799999999999999999999987664 5888888654 23445566788988887 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLD 216 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~ 216 (494)
.+.+|+|||||++ |+|..++.. .+.+++.++..++.||+.||+|||++||+||||||+
T Consensus 99 ~~~~~iv~Ey~~~---------------------g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~~~iiHrDlKp~ 157 (299)
T d1jpaa_ 99 STPVMIITEFMEN---------------------GSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAAR 157 (299)
T ss_dssp SSSCEEEEECCTT---------------------EEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGG
T ss_pred CCEEEEEEEecCC---------------------CcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhhCCCccCccccc
Confidence 9999999999994 455555554 457999999999999999999999999999999999
Q ss_pred ceeeCCCCCEEEeecCceeeeeccCCc-----ccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCC
Q psy8309 217 NILLDYEGHVRIADFGMCKLQIYLDKT-----TDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGC 290 (494)
Q Consensus 217 NILl~~~g~vkL~DFGla~~~~~~~~~-----~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~ 290 (494)
||||+.++++||+|||+|+........ .....||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.
T Consensus 158 NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~ 237 (299)
T d1jpaa_ 158 NILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDM 237 (299)
T ss_dssp GEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTC
T ss_pred eEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCC
Confidence 999999999999999999853322111 122468999999999999999999999999999999998 89999999
Q ss_pred CHHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 291 DEDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 291 ~~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
+..++...|..+ .+..|..++.++.+||.+||+.||.+|| ++.||++
T Consensus 238 ~~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~P~~RP------s~~ei~~ 285 (299)
T d1jpaa_ 238 TNQDVINAIEQDYRLPPPMDCPSALHQLMLDCWQKDRNHRP------KFGQIVN 285 (299)
T ss_dssp CHHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSTTTSC------CHHHHHH
T ss_pred CHHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCCHhHCc------CHHHHHH
Confidence 999998888765 4667788999999999999999999999 4566654
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.6e-53 Score=424.73 Aligned_cols=254 Identities=25% Similarity=0.372 Sum_probs=209.9
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc--CCe
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT--DSH 140 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~--~~~ 140 (494)
..++|++++.||+|+||+||+|+++.+|+.||||++++. .......|..+|.....||||++++++|.. ...
T Consensus 33 ~~d~y~i~~~LG~G~fg~V~~a~~~~~~~~vAiK~i~~~------~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~ 106 (328)
T d3bqca1 33 NQDDYQLVRKLGRGKYSEVFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRT 106 (328)
T ss_dssp CGGGEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSS------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCS
T ss_pred CCcCeEEEEEEecCcCeEEEEEEECCCCCEEEEEEECHH------HHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCc
Confidence 346899999999999999999999999999999999753 234567788888765579999999999984 467
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
+|+|||||.+|+| ... .+.+++.+++.++.||+.||+|||++||+||||||+||||
T Consensus 107 ~~~v~e~~~~~~L---------------------~~~---~~~l~e~~i~~i~~qil~aL~~LH~~gIvHrDiKp~NILi 162 (328)
T d3bqca1 107 PALVFEHVNNTDF---------------------KQL---YQTLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMI 162 (328)
T ss_dssp EEEEEECCCSCBG---------------------GGT---TTSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE
T ss_pred eeEEEeecCCCcH---------------------HHH---hcCCCHHHHHHHHHHHHHHHHHHhhcccccccccccceEE
Confidence 9999999996655 222 3469999999999999999999999999999999999999
Q ss_pred CCCC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCC-HHHHHH
Q psy8309 221 DYEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCD-EDELFW 297 (494)
Q Consensus 221 ~~~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~-~~~~~~ 297 (494)
+.++ .+||+|||+|+.. .........+||+.|+|||++.+. .|+.++|||||||++|||++|..||.... ..+...
T Consensus 163 ~~~~~~vkl~DFG~a~~~-~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~~~~~~~ 241 (328)
T d3bqca1 163 DHEHRKLRLIDWGLAEFY-HPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241 (328)
T ss_dssp ETTTTEEEECCGGGCEEC-CTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHH
T ss_pred cCCCCeeeecccccceec-cCCCcccccccCccccCcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCchhHHHHH
Confidence 8765 5999999999863 334456677899999999998875 48999999999999999999999997654 332222
Q ss_pred HHHh-------------CCC------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhh
Q psy8309 298 SICN-------------ERP------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDD 340 (494)
Q Consensus 298 ~i~~-------------~~~------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~e 340 (494)
.+.. ... .....+++++++||++||.+||.+|| |++|
T Consensus 242 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~------ta~e 315 (328)
T d3bqca1 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRL------TARE 315 (328)
T ss_dssp HHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHHHHHSCSSGGGSC------CHHH
T ss_pred HHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHHHHHccCChhHCc------CHHH
Confidence 2211 000 01134789999999999999999999 6899
Q ss_pred hhcCCCcCCCChh
Q psy8309 341 VVAHEYFRGLDWQ 353 (494)
Q Consensus 341 il~h~~f~~~~w~ 353 (494)
+|+||||+++.|+
T Consensus 316 ~L~Hp~F~~v~~~ 328 (328)
T d3bqca1 316 AMEHPYFYTVVKD 328 (328)
T ss_dssp HHTSGGGTTSCCC
T ss_pred HhcCcccCCCCCC
Confidence 9999999999985
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=411.94 Aligned_cols=249 Identities=22% Similarity=0.382 Sum_probs=205.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+.++|++++.||+|+||+||+|+++ ++..||||++++... ..+....|..++. .++|||||++++++..++.+|
T Consensus 3 dp~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~i~~~~~----~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~ 76 (263)
T d1sm2a_ 3 DPSELTFVQEIGSGQFGLVHLGYWL-NKDKVAIKTIREGAM----SEEDFIEEAEVMM-KLSHPKLVQLYGVCLEQAPIC 76 (263)
T ss_dssp CCSCEEEEEEEECCSSCCEEEEEET-TTEEEEEEECCSSSS----CHHHHHHHHHHHH-HCCCTTBCCEEEEECSSSSCE
T ss_pred ChHHcEEEEEEeeCCCeEEEEEEEC-CCCEEEEEEECCCcC----cHHHHHHHHHHHH-hcCCCCcccccceeccCCceE
Confidence 4578999999999999999999986 456799999976432 2245677888887 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+|||||++| +|..++.. ...+++..+..++.||+.||+|||+++|+||||||+||||+
T Consensus 77 lv~E~~~~g---------------------~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~iiHrDlKp~Nill~ 135 (263)
T d1sm2a_ 77 LVFEFMEHG---------------------CLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVG 135 (263)
T ss_dssp EEEECCTTC---------------------BHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCCCTTCSGGGEEEC
T ss_pred EEEEecCCC---------------------cHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccceeecccchhheeec
Confidence 999999954 55555544 35789999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++ |.+||...+..+++..+
T Consensus 136 ~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~~~~~~~~~i 215 (263)
T d1sm2a_ 136 ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215 (263)
T ss_dssp GGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSCCHHHHHHHH
T ss_pred CCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCCCHHHHHHHH
Confidence 999999999999986433222 2334679999999999999999999999999999999999 68888888888888888
Q ss_pred HhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 300 CNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 300 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
..+ .+..|...++++.+||.+||+.||++|| +++||++|
T Consensus 216 ~~~~~~~~p~~~~~~l~~li~~cl~~~p~~Rp------s~~~il~~ 255 (263)
T d1sm2a_ 216 STGFRLYKPRLASTHVYQIMNHCWKERPEDRP------AFSRLLRQ 255 (263)
T ss_dssp HHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HhcCCCCCccccCHHHHHHHHHHccCCHhHCc------CHHHHHHH
Confidence 775 4566788999999999999999999999 67888876
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.4e-53 Score=413.65 Aligned_cols=258 Identities=24% Similarity=0.426 Sum_probs=222.4
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEE
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~l 143 (494)
+++|++++.||+|+||+||+|+++.+++.||||++++.. ...........|..++. .++||||++++++|.+...+++
T Consensus 1 ~~ry~~i~~LG~G~fg~V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~~~~~~i 78 (292)
T d1unla_ 1 MQKYEKLEKIGEGTYGTVFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLK-ELKHKNIVRLHDVLHSDKKLTL 78 (292)
T ss_dssp CCSEEEEEEEEECSSSEEEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEECSSEEEE
T ss_pred CCCCEeeeEEecCcCeEEEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHH-hcCcCCEEeeccccccccceeE
Confidence 468999999999999999999999999999999997653 34456677888988887 5899999999999999999999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYE 223 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~ 223 (494)
|+|++. |+.+...+...+.+++..++.++.|++.||+|||++||+||||||+|||++.+
T Consensus 79 v~~~~~---------------------~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~IvHrDiKP~NIli~~~ 137 (292)
T d1unla_ 79 VFEFCD---------------------QDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRN 137 (292)
T ss_dssp EEECCS---------------------EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEECTT
T ss_pred Eeeecc---------------------ccccccccccccccchhHHHHHHHHHHHHHHHhhcCCEeeecccCcccccccC
Confidence 999998 55666677788899999999999999999999999999999999999999999
Q ss_pred CCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCC-CCCCHHHHHHHHHh
Q psy8309 224 GHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPF-SGCDEDELFWSICN 301 (494)
Q Consensus 224 g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf-~~~~~~~~~~~i~~ 301 (494)
+.+||+|||.|+.............+++.|+|||++.+.. ++.++|||||||++|||++|..|| .+.+..+.+.++..
T Consensus 138 ~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~~~~~~~~ 217 (292)
T d1unla_ 138 GELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIFR 217 (292)
T ss_dssp CCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCCSSHHHHHHHHHH
T ss_pred CceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhCCCCCCCCCCHHHHHHHHHh
Confidence 9999999999987554445555667889999999998765 699999999999999999999885 56666666666542
Q ss_pred C-----------------------------CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcCCC
Q psy8309 302 E-----------------------------RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGL 350 (494)
Q Consensus 302 ~-----------------------------~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~ 350 (494)
. ....+..+++++++||.+||+.||.+|| +++|+|+||||+++
T Consensus 218 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~------sa~e~L~Hp~f~~~ 289 (292)
T d1unla_ 218 LLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRI------SAEEALQHPYFSDF 289 (292)
T ss_dssp HHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSC------CHHHHTTSGGGSSC
T ss_pred hcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCc------CHHHHhcChhhcCC
Confidence 1 0112245789999999999999999999 68999999999864
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-54 Score=419.50 Aligned_cols=258 Identities=24% Similarity=0.334 Sum_probs=217.2
Q ss_pred CCCCceEeeE-eccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC
Q psy8309 63 DLEDFQLLKV-LGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS 139 (494)
Q Consensus 63 ~~~~y~~~~~-LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~ 139 (494)
..++|.+.+. ||+|+||+||+|.++. ++..||||++++. ......+..++|..++. .++|||||++++++++ +
T Consensus 6 ~~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vAvK~l~~~--~~~~~~~~~~~E~~il~-~l~HpnIv~l~g~~~~-~ 81 (285)
T d1u59a_ 6 KRDNLLIADIELGCGNFGSVRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMH-QLDNPYIVRLIGVCQA-E 81 (285)
T ss_dssp CGGGEEEEEEEEECCTTEEEEEEEEC---CCEEEEEEEECSS--CCHHHHHHHHHHHHHHH-HCCCTTBCCEEEEEES-S
T ss_pred cccCeEECCcEEecccCeEEEEEEEecCCCcEEEEEEEEChh--cCHHHHHHHHHHHHHHH-hCCCCCEeeEeeeecc-C
Confidence 3467888885 9999999999998764 4557999999764 23455667888998888 5799999999999875 4
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
.+|||||||+ ||+|..++.. .+.+++..+..++.||+.||+|||++||+||||||+||
T Consensus 82 ~~~lvmE~~~---------------------~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~~~iiHrDlKp~Ni 140 (285)
T d1u59a_ 82 ALMLVMEMAG---------------------GGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNV 140 (285)
T ss_dssp SEEEEEECCT---------------------TEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGE
T ss_pred eEEEEEEeCC---------------------CCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHhCCeecCcCchhhe
Confidence 6899999999 4455555443 46799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
||+.++.+||+|||+|+...... ......+||+.|||||++.+..|+.++|||||||++|||++ |..||.+.+..+
T Consensus 141 ll~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~~~ 220 (285)
T d1u59a_ 141 LLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPE 220 (285)
T ss_dssp EEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCTHH
T ss_pred eeccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCHHH
Confidence 99999999999999998643222 12335579999999999999999999999999999999998 999999988888
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+...|.++ .+.+|..+++++.+||.+||+.||++||++. ++.+.|+|.|+.
T Consensus 221 ~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~p~~RPs~~---~i~~~L~~~~~~ 272 (285)
T d1u59a_ 221 VMAFIEQGKRMECPPECPPELYALMSDCWIYKWEDRPDFL---TVEQRMRACYYS 272 (285)
T ss_dssp HHHHHHTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSCCHH---HHHHHHHHHHHH
T ss_pred HHHHHHcCCCCCCCCcCCHHHHHHHHHHcCCCHhHCcCHH---HHHHHHHHHHHH
Confidence 88888875 5678899999999999999999999999653 355567888763
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-53 Score=422.65 Aligned_cols=257 Identities=22% Similarity=0.354 Sum_probs=211.7
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
+++|++++.||+|+||+||+|+++.+|+.||||++.+... .+.......+|..+|. .++||||+++++++..
T Consensus 9 ~~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~-~l~h~nii~~~~~~~~~~~~~~ 86 (318)
T d3blha1 9 VSKYEKLAKIGQGTFGEVFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQ-LLKHENVVNLIEICRTKASPYN 86 (318)
T ss_dssp GGGEEEEEEEEECSSSEEEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHH-HCCCTTBCCEEEEEEC------
T ss_pred cCCEEEEEEEecCcCeEEEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHH-HhcCCCccceEeeeeccccccc
Confidence 5799999999999999999999999999999999976543 3334456778988887 5799999999999865
Q ss_pred --CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 138 --DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 138 --~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+++|+|||||. ++.+.........+++..++.++.||+.||+|||++||+||||||
T Consensus 87 ~~~~~~~iv~e~~~---------------------~~~~~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~~~ivHrDlKp 145 (318)
T d3blha1 87 RCKGSIYLVFDFCE---------------------HDLAGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKA 145 (318)
T ss_dssp ----CEEEEEECCC---------------------EEHHHHHTCTTCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCG
T ss_pred ccCceEEEEEeccC---------------------CCccchhhhcccccccHHHHHHHHHHHHHHHHhccCCEEecCcCc
Confidence 456899999997 344444555667899999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeec----cCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIY----LDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGC 290 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~----~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~ 290 (494)
+||||+.++.+||+|||+++.... ......+.+||+.|+|||++.+. .|+.++|||||||++|||++|++||.+.
T Consensus 146 ~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~ 225 (318)
T d3blha1 146 ANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGN 225 (318)
T ss_dssp GGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCS
T ss_pred hheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCC
Confidence 999999999999999999975321 12234456899999999999865 6899999999999999999999999998
Q ss_pred CHHHHHHHHHhCCCCCC--------------------------------ccCCHHHHHHHHhhccCCCCCCCCCCCCCCh
Q psy8309 291 DEDELFWSICNERPRFP--------------------------------QFLSVEAKNILVHLLDKDTTKRLGSTQCNSG 338 (494)
Q Consensus 291 ~~~~~~~~i~~~~~~~p--------------------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ 338 (494)
+..+....+......++ ...+++++|||.+||+.||++|| ++
T Consensus 226 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~~R~------sa 299 (318)
T d3blha1 226 TEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRI------DS 299 (318)
T ss_dssp SHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHSCSSTTTSC------CH
T ss_pred CHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHCcCChhHCc------CH
Confidence 88877776653211111 01377899999999999999999 68
Q ss_pred hhhhcCCCcCC
Q psy8309 339 DDVVAHEYFRG 349 (494)
Q Consensus 339 ~eil~h~~f~~ 349 (494)
+|+++||||+.
T Consensus 300 ~elL~Hpff~~ 310 (318)
T d3blha1 300 DDALNHDFFWS 310 (318)
T ss_dssp HHHHHSGGGSS
T ss_pred HHHHcChhhcc
Confidence 99999999974
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=409.49 Aligned_cols=249 Identities=23% Similarity=0.400 Sum_probs=216.3
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLF 142 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~ 142 (494)
+.++|++++.||+|+||+||+|+++ ++..||||++++... ..+..+.|..++. .++|||||++++++.+++.+|
T Consensus 2 ~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~l~~~~~----~~~~~~~Ev~~~~-~l~HpnIv~~~g~~~~~~~~~ 75 (258)
T d1k2pa_ 2 DPKDLTFLKELGTGQFGVVKYGKWR-GQYDVAIKMIKEGSM----SEDEFIEEAKVMM-NLSHEKLVQLYGVCTKQRPIF 75 (258)
T ss_dssp CCCCCCCCCCCCEETTEEEEEEEET-TTEEEEEEEEESSSS----CHHHHHHHHHHHH-TCCCTTBCCEEEEECCSSSEE
T ss_pred ChHHCEEeEEEecCCCeEEEEEEEC-CCCEEEEEEECcCcC----CHHHHHHHHHHHH-hcCCCceeeEEEEEeeCCceE
Confidence 4579999999999999999999985 677899999987533 2235677888887 579999999999999999999
Q ss_pred EEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeC
Q psy8309 143 FVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLD 221 (494)
Q Consensus 143 lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~ 221 (494)
+||||+++| ++..++. ....+++..+..++.||+.||+|||++||+||||||+|||++
T Consensus 76 iv~Ey~~~g---------------------~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~iiH~dlk~~Nill~ 134 (258)
T d1k2pa_ 76 IITEYMANG---------------------CLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN 134 (258)
T ss_dssp EEEECCTTE---------------------EHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTTBCCSCCSGGGEEEC
T ss_pred EEEEccCCC---------------------cHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcCcccccccceeEEEc
Confidence 999999954 4444433 456799999999999999999999999999999999999999
Q ss_pred CCCCEEEeecCceeeeeccCC-cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHH
Q psy8309 222 YEGHVRIADFGMCKLQIYLDK-TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSI 299 (494)
Q Consensus 222 ~~g~vkL~DFGla~~~~~~~~-~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i 299 (494)
.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||+| |+.||.+.+..++..+|
T Consensus 135 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~~~~~~i 214 (258)
T d1k2pa_ 135 DQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214 (258)
T ss_dssp TTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHHHHHHHH
T ss_pred CCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHHHHHHHH
Confidence 999999999999975332222 2334679999999999999999999999999999999998 89999999999999999
Q ss_pred HhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 300 CNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 300 ~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.++ .+..|...++++++||.+||+.||++|| ++++|++|
T Consensus 215 ~~~~~~~~p~~~~~~l~~li~~cl~~dP~~RP------t~~eil~~ 254 (258)
T d1k2pa_ 215 AQGLRLYRPHLASEKVYTIMYSCWHEKADERP------TFKILLSN 254 (258)
T ss_dssp HTTCCCCCCTTCCHHHHHHHHHTTCSSGGGSC------CHHHHHHH
T ss_pred HhCCCCCCcccccHHHHHHHHHHccCCHhHCc------CHHHHHHH
Confidence 875 5567888999999999999999999999 67888876
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-54 Score=415.70 Aligned_cols=251 Identities=25% Similarity=0.342 Sum_probs=209.3
Q ss_pred eEeccCCceEEEEEEEeC--CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEEEEec
Q psy8309 71 KVLGKGSFGKVFLAELKG--TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFVMEYL 148 (494)
Q Consensus 71 ~~LG~G~fG~V~~~~~~~--~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~ 148 (494)
+.||+|+||+||+|.++. +++.||||+++... ......+..+.|..++. .++|||||+++++++++ ..|||||||
T Consensus 13 k~iG~G~fG~Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~-~l~HpnIv~~~g~~~~~-~~~lvmE~~ 89 (277)
T d1xbba_ 13 KELGSGNFGTVKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQ-QLDNPYIVRMIGICEAE-SWMLVMEMA 89 (277)
T ss_dssp EEEEECSSEEEEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHH-TCCCTTBCCEEEEEESS-SEEEEEECC
T ss_pred CCcccCCCeEEEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHH-hCCCCCCceEEEEeccC-CEEEEEEcC
Confidence 479999999999998754 56789999997653 23444567788998887 57999999999999754 578999999
Q ss_pred CCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCCCCCEEE
Q psy8309 149 NGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDYEGHVRI 228 (494)
Q Consensus 149 ~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~~g~vkL 228 (494)
+ ||+|..++.+...+++..+..++.||+.||+|||++|||||||||+||||+.+|.+||
T Consensus 90 ~---------------------~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~iiHrDlKp~Nill~~~~~~kl 148 (277)
T d1xbba_ 90 E---------------------LGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKI 148 (277)
T ss_dssp T---------------------TEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEE
T ss_pred C---------------------CCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCCcccCCCcchhhcccccCcccc
Confidence 9 5666777888889999999999999999999999999999999999999999999999
Q ss_pred eecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHHHHHhC-C
Q psy8309 229 ADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFWSICNE-R 303 (494)
Q Consensus 229 ~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~~i~~~-~ 303 (494)
+|||+++....... ......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+..++...|..+ .
T Consensus 149 ~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~~~~~~~i~~~~~ 228 (277)
T d1xbba_ 149 SDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGER 228 (277)
T ss_dssp CCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHHHHHTTCC
T ss_pred cchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCHHHHHHHHHcCCC
Confidence 99999986432222 1234579999999999999999999999999999999998 99999999998888888765 5
Q ss_pred CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 304 PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 304 ~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+.+|..+++++++||.+||+.||++||++. .+.+.|+|+|+.
T Consensus 229 ~~~p~~~~~~~~~li~~cl~~dp~~RPs~~---~i~~~L~~~~~~ 270 (277)
T d1xbba_ 229 MGCPAGCPREMYDLMNLCWTYDVENRPGFA---AVELRLRNYYYD 270 (277)
T ss_dssp CCCCTTCCHHHHHHHHHHTCSSTTTSCCHH---HHHHHHHHHHHH
T ss_pred CCCCcccCHHHHHHHHHHcCCCHhHCcCHH---HHHHHhhCHHhh
Confidence 778899999999999999999999999542 133346777664
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-53 Score=414.63 Aligned_cols=250 Identities=26% Similarity=0.386 Sum_probs=202.6
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++++.||+|+||+||+|+.++ .||||+++.... .....+....|..++. .++|||||++++++. .+.+
T Consensus 5 i~~~~~~~~~~lG~G~fg~Vy~~~~~~---~vAvK~~~~~~~-~~~~~~~~~~E~~~l~-~l~HpnIv~~~~~~~-~~~~ 78 (276)
T d1uwha_ 5 IPDGQITVGQRIGSGSFGTVYKGKWHG---DVAVKMLNVTAP-TPQQLQAFKNEVGVLR-KTRHVNILLFMGYST-APQL 78 (276)
T ss_dssp CCTTCCCCCSEEEECSSCEEEEEESSS---EEEEEECCCSSC-CTTHHHHHHHHHHHHT-TCCCTTBCCEEEEEC-SSSC
T ss_pred cccccEEEEEEEeeCCCcEEEEEEECC---EEEEEEEEcccC-CHHHHHHHHHHHHHHH-hCCCCCEeeeeEEEe-ccEE
Confidence 456789999999999999999997543 499999976532 3445667778888887 579999999999764 5678
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
|+|||||+ ||+|..++.. .+.+++..+..++.||+.||+|||++|||||||||+||||
T Consensus 79 ~lv~Ey~~---------------------~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~ivHrDlKp~NiLl 137 (276)
T d1uwha_ 79 AIVTQWCE---------------------GSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL 137 (276)
T ss_dssp EEEEECCC---------------------EEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE
T ss_pred EEEEecCC---------------------CCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhcCCEeccccCHHHEEE
Confidence 99999999 5556666654 4679999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeecc--CCcccccCCCCCccChhhhCCC---CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYL--DKTTDTFCGTPDYMAPEIIKGL---KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDEL 295 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~--~~~~~~~~gt~~y~aPE~l~~~---~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~ 295 (494)
+.++++||+|||+|+..... .....+.+||+.|||||++.+. .|+.++|||||||+||||++|+.||.+.+....
T Consensus 138 ~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~~~~ 217 (276)
T d1uwha_ 138 HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQ 217 (276)
T ss_dssp ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCCHHH
T ss_pred cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCChHHH
Confidence 99999999999999753321 2234567899999999999753 489999999999999999999999998766554
Q ss_pred HHH-HHhCCC-----CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWS-ICNERP-----RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~-i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
... +..+.. .++..+++++++||.+||+.||.+|| +++||++|
T Consensus 218 ~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RP------t~~~il~~ 266 (276)
T d1uwha_ 218 IIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERP------LFPQILAS 266 (276)
T ss_dssp HHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCc------CHHHHHHH
Confidence 444 443321 23567899999999999999999999 57788765
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-53 Score=426.78 Aligned_cols=255 Identities=27% Similarity=0.442 Sum_probs=210.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~---- 139 (494)
.++|++++.||+|+||+||+|+++.+|+.||||++++.. ......+...+|..+|. .++|||||+++++|...+
T Consensus 17 ~~~Y~~i~~lG~G~fg~V~~~~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~-~l~hpniv~l~~~~~~~~~~~~ 94 (346)
T d1cm8a_ 17 RAVYRDLQPVGSGAYGAVCSAVDGRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLK-HMRHENVIGLLDVFTPDETLDD 94 (346)
T ss_dssp BSSEEEEEEC------CEEEEEETTTCCEEEEEECSSTT-SSHHHHHHHHHHHHHHH-HCCBTTBCCCSEEECSCSSTTT
T ss_pred CCcEEEEEEEecCCCeEEEEEEECCCCCEEEEEEEchhh-cChHHHHHHHHHHHHHH-hcCCCCeeEEEEEeccCccccc
Confidence 368999999999999999999999999999999998653 34556677888999987 579999999999998765
Q ss_pred --eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 --HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 --~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
++|+|||||. .+|.. +.+.+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 95 ~~~~~lv~e~~~----------------------~~l~~-~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~IiHrDiKp~N 151 (346)
T d1cm8a_ 95 FTDFYLVMPFMG----------------------TDLGK-LMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGN 151 (346)
T ss_dssp CCCCEEEEECCS----------------------EEHHH-HHHHCCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGG
T ss_pred cceEEEEEeccc----------------------ccHHH-HHHhccccHHHHHHHHHHHHHHHHHHHhCCCcccccCcch
Confidence 5799999993 23333 3345689999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCC-CCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGL-KYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~-~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
||++.++.+||+|||+|+.. .......+||+.|+|||++.+. .++.++|||||||++|||++|++||.+.+....+
T Consensus 152 IL~~~~~~~kl~Dfg~a~~~---~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~ 228 (346)
T d1cm8a_ 152 LAVNEDCELKILDFGLARQA---DSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228 (346)
T ss_dssp EEECTTCCEEECCCTTCEEC---CSSCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHH
T ss_pred hhcccccccccccccceecc---CCccccccccccccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCChHHHH
Confidence 99999999999999999863 3345567899999999998764 5789999999999999999999999998877666
Q ss_pred HHHHhCCC-------------------------------CCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNERP-------------------------------RFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~~~-------------------------------~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+..... ..+..+++++++||.+||..||.+|| +++|+++||
T Consensus 229 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~------ta~eiL~Hp 302 (346)
T d1cm8a_ 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAEQRV------TAGEALAHP 302 (346)
T ss_dssp HHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTTTSC------CHHHHHHSG
T ss_pred HHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCChhHCc------CHHHHhcCh
Confidence 55432110 12245789999999999999999999 689999999
Q ss_pred CcCCCCh
Q psy8309 346 YFRGLDW 352 (494)
Q Consensus 346 ~f~~~~w 352 (494)
||+.+.+
T Consensus 303 ~f~~~~~ 309 (346)
T d1cm8a_ 303 YFESLHD 309 (346)
T ss_dssp GGTTTC-
T ss_pred hhCcCCC
Confidence 9998764
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-53 Score=426.82 Aligned_cols=252 Identities=26% Similarity=0.385 Sum_probs=209.6
Q ss_pred CceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------CC
Q psy8309 66 DFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------DS 139 (494)
Q Consensus 66 ~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------~~ 139 (494)
+|+.+++||+|+||+||+|+++.+|+.||||++.++.... .+|..++. .++|||||+++++|.. ..
T Consensus 21 ~Y~~~k~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~~~~-------~~Ei~il~-~l~h~niv~~~~~~~~~~~~~~~~ 92 (350)
T d1q5ka_ 21 SYTDTKVIGNGSFGVVYQAKLCDSGELVAIKKVLQDKRFK-------NRELQIMR-KLDHCNIVRLRYFFYSSGEKKDEV 92 (350)
T ss_dssp EEEEEEEEEEETTEEEEEEEETTTCCEEEEEEEECCSSSC-------CHHHHHHH-HCCCTTBCCEEEEEEEC--CCSCC
T ss_pred CcEeeeEEeeCcCeEEEEEEECCCCCEEEEEEECccchHH-------HHHHHHHH-hcCCCCCCcEEEEEEecCccCCce
Confidence 7999999999999999999999999999999997653221 24667776 5799999999999853 34
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
++|||||||++|.+ ..+.........+++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 93 ~~~lv~Ey~~~~~~------------------~~l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~~~IiHrDiKp~NIL 154 (350)
T d1q5ka_ 93 YLNLVLDYVPETVY------------------RVARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLL 154 (350)
T ss_dssp EEEEEEECCSEEHH------------------HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEE
T ss_pred EEEEEEeccCCccH------------------HHHHhhhhccCCCCHHHHHHHHHHHHHHHHHHHhcCCcccCCCcceEE
Confidence 68999999974321 012223445678999999999999999999999999999999999999
Q ss_pred eCCCC-CEEEeecCceeeeeccCCcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 220 LDYEG-HVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g-~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
|+.++ .+||+|||+++.. .......+.+||+.|+|||++.+ ..|+.++|||||||++|||++|.+||.+.+..+.+.
T Consensus 155 l~~~~~~~kl~DFG~a~~~-~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~~~~l~ 233 (350)
T d1q5ka_ 155 LDPDTAVLKLCDFGSAKQL-VRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 233 (350)
T ss_dssp ECTTTCCEEECCCTTCEEC-CTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSHHHHHH
T ss_pred EecCCCceeEecccchhhc-cCCcccccccccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCHHHHHH
Confidence 99876 8999999999864 33445567789999999999875 569999999999999999999999999988888777
Q ss_pred HHHhC-----------------CCCC------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC
Q psy8309 298 SICNE-----------------RPRF------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR 348 (494)
Q Consensus 298 ~i~~~-----------------~~~~------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~ 348 (494)
+|... ...+ ...+++++++||.+||+.||++|| ++.|+++||||+
T Consensus 234 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~------ta~e~L~Hp~f~ 307 (350)
T d1q5ka_ 234 EIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL------TPLEACAHSFFD 307 (350)
T ss_dssp HHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGGGG
T ss_pred HHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc------CHHHHhcCHhhc
Confidence 76531 1111 235789999999999999999999 689999999997
Q ss_pred CC
Q psy8309 349 GL 350 (494)
Q Consensus 349 ~~ 350 (494)
++
T Consensus 308 ~~ 309 (350)
T d1q5ka_ 308 EL 309 (350)
T ss_dssp GG
T ss_pred cc
Confidence 65
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-53 Score=412.96 Aligned_cols=253 Identities=25% Similarity=0.403 Sum_probs=212.9
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCee
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHL 141 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~ 141 (494)
+..++|++++.||+|+||.||+|+++ ++..||||++++... ..+....|..++. .++|||||++++++. ++.+
T Consensus 10 i~~~~~~~~~~iG~G~fg~Vy~~~~~-~~~~vAvK~~~~~~~----~~~~~~~E~~~l~-~l~HpnIv~~~g~~~-~~~~ 82 (272)
T d1qpca_ 10 VPRETLKLVERLGAGQFGEVWMGYYN-GHTKVAVKSLKQGSM----SPDAFLAEANLMK-QLQHQRLVRLYAVVT-QEPI 82 (272)
T ss_dssp CCGGGEEEEEEEEEETTEEEEEEEET-TTEEEEEEEECTTSS----CHHHHHHHHHHHH-HCCCTTBCCEEEEEC-SSSC
T ss_pred cCHHHeEEeEEEecCCCcEEEEEEEC-CCCEEEEEEEccCcC----CHHHHHHHHHHHH-hCCCCCEeEEEeeec-cCCe
Confidence 44579999999999999999999976 567799999976432 2345778888887 579999999999875 4678
Q ss_pred EEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 142 FFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ--QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 142 ~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
|+|||||++|+| ..++. ....+++.++..++.||+.||.|||++||+||||||+|||
T Consensus 83 ~iv~Ey~~~g~L---------------------~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ivHrDiKp~NIl 141 (272)
T d1qpca_ 83 YIITEYMENGSL---------------------VDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL 141 (272)
T ss_dssp EEEEECCTTCBH---------------------HHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEE
T ss_pred EEEEEeCCCCcH---------------------HHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCccchhhee
Confidence 999999996655 33332 2236999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELFW 297 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~~ 297 (494)
|+.++.+||+|||+|+...... .......||+.|||||++.+..|+.++|||||||++|||+| |.+||...+..++..
T Consensus 142 l~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~~~~~~~~~~~ 221 (272)
T d1qpca_ 142 VSDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQ 221 (272)
T ss_dssp ECTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHHH
T ss_pred eecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhCCCCCCCCCCHHHHHH
Confidence 9999999999999998643222 12345679999999999998899999999999999999999 567777888888888
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc--CCCcC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA--HEYFR 348 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~--h~~f~ 348 (494)
.+..+ .+..|..+++++++||.+||+.||++|| ++++|++ |+||.
T Consensus 222 ~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~Rp------t~~ei~~~L~~~ft 269 (272)
T d1qpca_ 222 NLERGYRMVRPDNCPEELYQLMRLCWKERPEDRP------TFDYLRSVLEDFFT 269 (272)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHHHHHHHH
T ss_pred HHHhcCCCCCcccChHHHHHHHHHHcCCCHhHCc------CHHHHHHHhhhhhh
Confidence 88765 5667889999999999999999999999 5788877 77774
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-53 Score=410.35 Aligned_cols=263 Identities=27% Similarity=0.427 Sum_probs=214.3
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCe
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSH 140 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~ 140 (494)
.++.++|++.+.||+|+||+||+|+++.+. .||||+++.... ..+....|..++. .++|||||++++++.+ +.
T Consensus 13 ~i~~~~~~i~~~iG~G~fg~Vy~~~~~~~~-~vAiK~l~~~~~----~~~~~~~E~~~l~-~l~h~nIv~~~g~~~~-~~ 85 (285)
T d1fmka3 13 EIPRESLRLEVKLGQGCFGEVWMGTWNGTT-RVAIKTLKPGTM----SPEAFLQEAQVMK-KLRHEKLVQLYAVVSE-EP 85 (285)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEETTTE-EEEEEECCTTSS----CHHHHHHHHHHHH-HCCCTTBCCEEEEECS-SS
T ss_pred EcCHHHEEEeeEEeeCCCeEEEEEEECCCC-EEEEEEECcccC----CHHHHHHHHHHHH-hcccCCEeEEEEEEec-CC
Confidence 355689999999999999999999987764 599999976532 2345677888877 5899999999999854 56
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh--hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ--QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~--~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+|+|||||++|+| ...+. ..+.+++.++..++.||+.||+|||++||+||||||+||
T Consensus 86 ~~lv~Ey~~~g~l---------------------~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ivH~DlKp~NI 144 (285)
T d1fmka3 86 IYIVTEYMSKGSL---------------------LDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANI 144 (285)
T ss_dssp CEEEECCCTTCBH---------------------HHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGE
T ss_pred eEEEEEecCCCch---------------------hhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhheecccccceEE
Confidence 8999999996554 33332 346799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||+.+|++||+|||+++...... ......+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+....+++
T Consensus 145 ll~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~~~~~~~~~ 224 (285)
T d1fmka3 145 LVGENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVL 224 (285)
T ss_dssp EECGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCHHHHH
T ss_pred EECCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCCCCCHHHHH
Confidence 99999999999999997532222 22344679999999999999999999999999999999999 56667777888888
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc--CCCcCCCChhHHhcCcCCCCCccc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA--HEYFRGLDWQALEKRELEPPFRPR 367 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~--h~~f~~~~w~~l~~~~~~pp~~p~ 367 (494)
..+..+ .+.+|..+++++++||.+||+.||++|| ++++|++ |+||.. .+|++.|.
T Consensus 225 ~~i~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------s~~~i~~~L~~~~~~----------~~p~~~p~ 282 (285)
T d1fmka3 225 DQVERGYRMPCPPECPESLHDLMCQCWRKEPEERP------TFEYLQAFLEDYFTS----------TEPQYQPG 282 (285)
T ss_dssp HHHHTTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHHHHHTTTSC----------SCCCCCCS
T ss_pred HHHHhcCCCCCCcccCHHHHHHHHHHcccCHhHCc------CHHHHHHHHhhhhcC----------CCCCCCCC
Confidence 888765 4577889999999999999999999999 6788877 888864 35677664
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-52 Score=407.46 Aligned_cols=252 Identities=22% Similarity=0.351 Sum_probs=205.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
+..++|++++.||+|+||+||+|++..+ +..||||.++.. ......+....|..++. .++|||||++++++. +
T Consensus 4 i~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~-~l~HpnIv~l~~~~~-~ 79 (273)
T d1mp8a_ 4 IQRERIELGRCIGEGQFGDVHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMR-QFDHPHIVKLIGVIT-E 79 (273)
T ss_dssp CCGGGEEEEEEEEECSSSEEEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC-S
T ss_pred cCHHHeEEEEEEeeCCCcEEEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEe-c
Confidence 4457999999999999999999998754 356888888653 34445566778888887 579999999999996 5
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
+.+|+|||||++ |++..++. ..+.+++..++.++.||+.||+|||++||+||||||+|
T Consensus 80 ~~~~iv~E~~~~---------------------g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDlKp~N 138 (273)
T d1mp8a_ 80 NPVWIIMELCTL---------------------GELRSFLQVRKYSLDLASLILYAYQLSTALAYLESKRFVHRDIAARN 138 (273)
T ss_dssp SSCEEEEECCTT---------------------EEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred CeEEEEEEeccC---------------------CcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcccCeeccccchhh
Confidence 789999999994 44554443 44679999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccC-CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLD-KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDEL 295 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~-~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~ 295 (494)
||++.++.+||+|||+|+...... ......+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..++
T Consensus 139 Ill~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~~~ 218 (273)
T d1mp8a_ 139 VLVSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDV 218 (273)
T ss_dssp EEEEETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGGGH
T ss_pred eeecCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHHHH
Confidence 999999999999999998643222 23445678999999999999999999999999999999998 9999999999999
Q ss_pred HHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 296 FWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 296 ~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+.++.++. +.+|..+++++++||.+||..||.+|| +++||++|
T Consensus 219 ~~~i~~~~~~~~~~~~~~~~~~li~~cl~~dp~~Rp------s~~ei~~~ 262 (273)
T d1mp8a_ 219 IGRIENGERLPMPPNCPPTLYSLMTKCWAYDPSRRP------RFTELKAQ 262 (273)
T ss_dssp HHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHcCCCCCCCCCCCHHHHHHHHHHcCCCHhHCc------CHHHHHHH
Confidence 99988764 678889999999999999999999999 57888765
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-52 Score=404.02 Aligned_cols=253 Identities=24% Similarity=0.345 Sum_probs=205.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCC----eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTD----YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~----~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
++..++|++.++||+|+||.||+|.++.++ ..||||+++.. .........++|..++. .++|||||++++++.
T Consensus 3 ei~~~~~~~~~~iG~G~fG~Vy~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~-~l~H~nIv~~~g~~~ 79 (283)
T d1mqba_ 3 EIHPSCVTRQKVIGAGEFGEVYKGMLKTSSGKKEVPVAIKTLKAG--YTEKQRVDFLGEAGIMG-QFSHHNIIRLEGVIS 79 (283)
T ss_dssp BCCTTTEEEEEEEEECSSSEEEEEEEEC---CCEEEEEEEEECTT--CCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEEC
T ss_pred cCCHHHeEeeeEEeeCCCeEEEEEEEeCCCCEEEEEEEEEEECcc--cChHHHHHHHHHHHHHH-hcCCCCEeeeeEEEe
Confidence 345678999999999999999999988765 46999999754 23344456778888887 579999999999999
Q ss_pred cCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
+.+.+++|||||.+| .+...+. ..+.+++.++..++.||+.||+|||++||+||||||
T Consensus 80 ~~~~~~~v~e~~~~~---------------------~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~~~iiHrDlKp 138 (283)
T d1mqba_ 80 KYKPMMIITEYMENG---------------------ALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAA 138 (283)
T ss_dssp SSSSEEEEEECCTTE---------------------EHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCCceEEEEEecccC---------------------cchhhhhcccccccHHHHHHHHHHHHHhhhhccccccccCcccc
Confidence 999999999999844 4444444 446799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
+||||+.++.+||+|||+++....... ......||+.|||||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 139 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~~~~ 218 (283)
T d1mqba_ 139 RNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 218 (283)
T ss_dssp GGEEECTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccccCC
Confidence 999999999999999999986332221 2234568999999999999999999999999999999999 566667777
Q ss_pred HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+++..+..+ ++..|..++.++++||.+||+.||++|| ++.||++
T Consensus 219 ~~~~~~~i~~~~~~~~~~~~~~~l~~li~~cl~~~p~~RP------t~~eil~ 265 (283)
T d1mqba_ 219 NHEVMKAINDGFRLPTPMDCPSAIYQLMMQCWQQERARRP------KFADIVS 265 (283)
T ss_dssp HHHHHHHHHTTCCCCCCTTCBHHHHHHHHHHTCSSTTTSC------CHHHHHH
T ss_pred HHHHHHHHhccCCCCCchhhHHHHHHHHHHHCcCCHhHCc------CHHHHHH
Confidence 88888777765 5677788999999999999999999999 4667764
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.8e-52 Score=410.33 Aligned_cols=270 Identities=26% Similarity=0.346 Sum_probs=202.5
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ 136 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~ 136 (494)
+..++|++++.||+|+||+||+|++.. +++.||||+++... .....+..+.|..++....+|+||+.+++++.
T Consensus 10 i~~~~y~~~~~iG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~ 87 (299)
T d1ywna1 10 FPRDRLKLGKPLGRGAFGQVIEADAFGIDKTATCRTVAVKMLKEGA--THSEHRALMSELKILIHIGHHLNVVNLLGACT 87 (299)
T ss_dssp CCGGGEEEEEEEEECSSCEEEEEEEESTTSSSCEEEEEEEEC------CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC
T ss_pred ccHHHEEEeeEEeecCCeEEEEEEEcCCCcccCCeEEEEEEEcccc--CcHHHHHHHHHHHHHHhhcCCCeEEEeeeeec
Confidence 445789999999999999999999865 35689999997642 33445566777777777778999999999877
Q ss_pred cC-CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 137 TD-SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 137 ~~-~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.. ..+++|||||++|+|.+.+........ .............+++.+++.++.||+.||+|||++|||||||||
T Consensus 88 ~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ivHrDlKp 162 (299)
T d1ywna1 88 KPGGPLMVIVEFCKFGNLSTYLRSKRNEFV-----PYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAA 162 (299)
T ss_dssp STTSCCEEEEECCTTCBHHHHHHHTGGGBC-----C-----------CBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCG
T ss_pred cCCCeEEEEEEecCCCcHHHHHHhcccccc-----ccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHhCCCcCCcCCc
Confidence 54 579999999997776432211110000 000000111234689999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG-QSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~~ 292 (494)
+||||+.+|++||+|||+|+....... ...+.+||+.|||||++.+..|+.++|||||||++|||++| .+||.+.+.
T Consensus 163 ~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~~ 242 (299)
T d1ywna1 163 RNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 242 (299)
T ss_dssp GGEEECGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCC
T ss_pred cceeECCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999985332222 23456899999999999999999999999999999999986 678987765
Q ss_pred HHHHHHH-Hh-CCCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 293 DELFWSI-CN-ERPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 293 ~~~~~~i-~~-~~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+.+..+ .. ..+.+|..+++++++||.+||+.||++|| +++||++|
T Consensus 243 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rp------t~~eil~~ 290 (299)
T d1ywna1 243 DEEFCRRLKEGTRMRAPDYTTPEMYQTMLDCWHGEPSQRP------TFSELVEH 290 (299)
T ss_dssp SHHHHHHHHHTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHHHhcCCCCCCCccCCHHHHHHHHHHcCCChhHCc------CHHHHHHH
Confidence 5544444 33 35677889999999999999999999999 67888876
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-52 Score=417.57 Aligned_cols=256 Identities=27% Similarity=0.419 Sum_probs=204.6
Q ss_pred CCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc------
Q psy8309 64 LEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT------ 137 (494)
Q Consensus 64 ~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~------ 137 (494)
+++|+++++||+|+||+||+|+++.+|+.||||++++.. ...........|..++. .++|||||+++++|..
T Consensus 16 ~~~Y~i~~~LG~G~fg~V~~~~d~~t~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~-~l~hpnIv~~~~~f~~~~~~~~ 93 (355)
T d2b1pa1 16 LKRYQNLKPIGSGAQGIVCAAYDAVLDRNVAIKKLSRPF-QNQTHAKRAYRELVLMK-CVNHKNIISLLNVFTPQKTLEE 93 (355)
T ss_dssp ETTEEEEEECSCC--CEEEEEEETTTTEEEEEEEEESTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCCSTTT
T ss_pred cCCeEEEEEeecCcCeEEEEEEECCCCCEEEEEEEChhh-cCHHHHHHHHHHHHHHH-hcCCCCeeEEEEEEeccccccc
Confidence 368999999999999999999999999999999998764 34455567788888887 4799999999999964
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..++|+|||||.++. ...+ ...+++..++.+++||+.||+|||++||+||||||+|
T Consensus 94 ~~~~~iv~Ey~~~~l----------------------~~~~--~~~~~~~~i~~~~~qil~gl~~LH~~giiHrDlKP~N 149 (355)
T d2b1pa1 94 FQDVYLVMELMDANL----------------------CQVI--QMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSN 149 (355)
T ss_dssp CCEEEEEEECCSEEH----------------------HHHH--TSCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred CceeEEEEeccchHH----------------------HHhh--hcCCCHHHHHHHHHHHHHHHHHhhhcccccccCCccc
Confidence 478999999997332 2222 3578999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFW 297 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~ 297 (494)
||++.++.+|++|||+++... ........+||+.|+|||++.+..|+.++||||+||++|||++|++||.+.+......
T Consensus 150 il~~~~~~~kl~df~~~~~~~-~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~~~~~~ 228 (355)
T d2b1pa1 150 IVVKSDCTLKILDFGLARTAG-TSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWN 228 (355)
T ss_dssp EEECTTCCEEECCCCC----------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSHHHHHH
T ss_pred cccccccceeeechhhhhccc-cccccccccccccccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCHHHHHH
Confidence 999999999999999988533 3444566789999999999999999999999999999999999999999988777666
Q ss_pred HHHh----------------------CCCCCC--------------------ccCCHHHHHHHHhhccCCCCCCCCCCCC
Q psy8309 298 SICN----------------------ERPRFP--------------------QFLSVEAKNILVHLLDKDTTKRLGSTQC 335 (494)
Q Consensus 298 ~i~~----------------------~~~~~p--------------------~~~s~~~~~li~~lL~~dP~~R~~~~~~ 335 (494)
++.. ...... ...++++++||++||..||++||
T Consensus 229 ~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~----- 303 (355)
T d2b1pa1 229 KVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLLSKMLVIDPAKRI----- 303 (355)
T ss_dssp HHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHHHHHHSCSSTTTSC-----
T ss_pred HHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCc-----
Confidence 5542 111110 12467899999999999999999
Q ss_pred CChhhhhcCCCcCCCCh
Q psy8309 336 NSGDDVVAHEYFRGLDW 352 (494)
Q Consensus 336 ~~~~eil~h~~f~~~~w 352 (494)
+++|+|+||||+..-|
T Consensus 304 -ta~elL~Hpw~~~~~~ 319 (355)
T d2b1pa1 304 -SVDDALQHPYINVWYD 319 (355)
T ss_dssp -CHHHHHTSTTTGGGCC
T ss_pred -CHHHHhcCcccCCCCC
Confidence 7899999999986433
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.2e-52 Score=415.05 Aligned_cols=255 Identities=22% Similarity=0.349 Sum_probs=207.1
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCC----e
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDS----H 140 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~----~ 140 (494)
++|++++.||+|+||+||+|+++.+|+.||||++++.. .....+..+.|..+|. .++||||+++++++.... .
T Consensus 8 ~rY~~~~~LG~G~fg~Vy~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~Ei~il~-~l~hp~iv~~~~~~~~~~~~~~~ 84 (345)
T d1pmea_ 8 PRYTNLSYIGEGAYGMVCSAYDNVNKVRVAIKKISPFE--HQTYCQRTLREIKILL-RFRHENIIGINDIIRAPTIEQMK 84 (345)
T ss_dssp TTEEEEEECC---CCCEEEEEETTTCSEEEEEEECCTT--CHHHHHHHHHHHHHHH-HCCCTTBCCCCEEECCSSTTTCC
T ss_pred CCeEEEEEEeeccCeEEEEEEECCCCcEEEEEEEehhc--ChHHHHHHHHHHHHHH-HcCCCCCCcEEEEEeeccccccc
Confidence 46999999999999999999999999999999997642 3445567788999988 579999999999997653 2
Q ss_pred eEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceee
Q psy8309 141 LFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILL 220 (494)
Q Consensus 141 ~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl 220 (494)
.+++++++. ||+|..++.. +.+++..++.++.||+.||+|||++|||||||||+||||
T Consensus 85 ~~~l~~~~~---------------------~g~L~~~l~~-~~l~~~~i~~i~~qil~al~yLH~~~iiHRDIKp~NILl 142 (345)
T d1pmea_ 85 DVYLVTHLM---------------------GADLYKLLKT-QHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL 142 (345)
T ss_dssp CEEEEEECC---------------------CEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE
T ss_pred eEEEEEeec---------------------CCchhhhhhc-CCCCHHHHHHHHHHHHHHHHHHHHCCCcCCCCCcceEEE
Confidence 344455566 5566666654 579999999999999999999999999999999999999
Q ss_pred CCCCCEEEeecCceeeeeccC---CcccccCCCCCccChhhhCC-CCCCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHH
Q psy8309 221 DYEGHVRIADFGMCKLQIYLD---KTTDTFCGTPDYMAPEIIKG-LKYNQCVDWWSFGILLYEMHVGQSPFSGCDEDELF 296 (494)
Q Consensus 221 ~~~g~vkL~DFGla~~~~~~~---~~~~~~~gt~~y~aPE~l~~-~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~ 296 (494)
+.+|.+||+|||+|+...... ......+||+.|+|||++.. ..|+.++||||+||++|||++|++||.+.+..+..
T Consensus 143 ~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~~~~~ 222 (345)
T d1pmea_ 143 NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQL 222 (345)
T ss_dssp CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHH
T ss_pred CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCHHHHH
Confidence 999999999999997643222 22456789999999999854 56889999999999999999999999988876665
Q ss_pred HHHHhC--C------------------------CC-----CCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCC
Q psy8309 297 WSICNE--R------------------------PR-----FPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHE 345 (494)
Q Consensus 297 ~~i~~~--~------------------------~~-----~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~ 345 (494)
..+... . .. ....+++++++||.+||+.||.+|| +++|+++||
T Consensus 223 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~------ta~e~L~hp 296 (345)
T d1pmea_ 223 NHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRI------EVEQALAHP 296 (345)
T ss_dssp HHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSTTTSC------CHHHHHTSG
T ss_pred HHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccCChhHCc------CHHHHhcCH
Confidence 544321 0 00 1235789999999999999999999 689999999
Q ss_pred CcCCC
Q psy8309 346 YFRGL 350 (494)
Q Consensus 346 ~f~~~ 350 (494)
||+..
T Consensus 297 f~~~~ 301 (345)
T d1pmea_ 297 YLEQY 301 (345)
T ss_dssp GGTTT
T ss_pred hhccC
Confidence 99754
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.3e-52 Score=416.95 Aligned_cols=253 Identities=27% Similarity=0.402 Sum_probs=210.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC-----C
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD-----S 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~-----~ 139 (494)
++|++++.||+|+||+||+|+++.+|+.||||++++.. ..........+|..+|. .++|||||+++++|... .
T Consensus 18 ~rY~i~~~LG~G~fg~Vy~a~~~~~~~~vAiK~i~~~~-~~~~~~~~~~~Ei~il~-~l~h~~iv~~~~~~~~~~~~~~~ 95 (348)
T d2gfsa1 18 ERYQNLSPVGSGAYGSVCAAFDTKTGLRVAVKKLSRPF-QSIIHAKRTYRELRLLK-HMKHENVIGLLDVFTPARSLEEF 95 (348)
T ss_dssp TTEEEEEECGGGTTSSEEEEEETTTTEEEEEEECSCTT-SSHHHHHHHHHHHHHHH-HCCCTTBCCCSEEECSCSSTTTC
T ss_pred CCeEEEEEEecCCCeEEEEEEECCCCCEEEEEEECchh-cChHHHHHHHHHHHHHH-hcCCCCeeeEEEEEeeccccccC
Confidence 58999999999999999999999999999999998753 34445567788999887 57999999999999743 3
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCcee
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNIL 219 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NIL 219 (494)
..+++|+++. ||+|..++. .+++++.+++.++.||+.||+|||++||+||||||+|||
T Consensus 96 ~~~~i~~~~~---------------------gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~LH~~giiHrDiKp~NIL 153 (348)
T d2gfsa1 96 NDVYLVTHLM---------------------GADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA 153 (348)
T ss_dssp CCCEEEEECC---------------------SEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCGGGEE
T ss_pred ceEEEEEeec---------------------CCchhhhcc-cccccHHHHHHHHHHHHHHHHHHHhCCCcccccCCcccc
Confidence 3456677777 455555553 457999999999999999999999999999999999999
Q ss_pred eCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCC-CCCcchHHHHHHHHHHHHhCCCCCCCCCHHHHHHH
Q psy8309 220 LDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLK-YNQCVDWWSFGILLYEMHVGQSPFSGCDEDELFWS 298 (494)
Q Consensus 220 l~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~-~~~~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~ 298 (494)
++.+|.+|++|||++.. ......+.+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......
T Consensus 154 i~~~~~~kl~dfg~a~~---~~~~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~~~~~~~ 230 (348)
T d2gfsa1 154 VNEDCELKILDFGLARH---TDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKL 230 (348)
T ss_dssp ECTTCCEEECCC----C---CTGGGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHH
T ss_pred ccccccccccccchhcc---cCcccccccccccccCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCHHHHHHH
Confidence 99999999999999874 234456678999999999987755 68999999999999999999999999988877777
Q ss_pred HHhCCCCC-------------------------------CccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCc
Q psy8309 299 ICNERPRF-------------------------------PQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYF 347 (494)
Q Consensus 299 i~~~~~~~-------------------------------p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f 347 (494)
|....... ...+++++++||.+||+.||.+|| +++|+++||||
T Consensus 231 i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~------ta~elL~Hp~f 304 (348)
T d2gfsa1 231 ILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKRI------TAAQALAHAYF 304 (348)
T ss_dssp HHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGGSC------CHHHHHTSGGG
T ss_pred HHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhhCc------CHHHHhcCHhh
Confidence 65421111 125789999999999999999999 68999999999
Q ss_pred CCC
Q psy8309 348 RGL 350 (494)
Q Consensus 348 ~~~ 350 (494)
+.+
T Consensus 305 ~~~ 307 (348)
T d2gfsa1 305 AQY 307 (348)
T ss_dssp TTT
T ss_pred CCC
Confidence 864
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.1e-52 Score=409.64 Aligned_cols=270 Identities=24% Similarity=0.326 Sum_probs=215.9
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeE--EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYY--YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~--~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
.++.++|++.++||+|+||+||+|+++.++.. ||||.+++. ......+....|..++....+|||||++++++.++
T Consensus 6 ~i~~~~~~~~~~iG~G~fg~Vy~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~ 83 (309)
T d1fvra_ 6 VLDWNDIKFQDVIGEGNFGQVLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHR 83 (309)
T ss_dssp BCCGGGCEEEEEEECGGGCEEEEEEEEETTEEEEEEEEEEECC--------CHHHHHHHHHTTCCCCTTBCCEEEEEEET
T ss_pred ccCHHHcEEEEEEeeCCCcEEEEEEECCCCeEEEEEEEEECcc--cChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecC
Confidence 45778999999999999999999999988875 566766543 23334556788998888544899999999999999
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCce
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNI 218 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NI 218 (494)
+.+|+|||||+||+|.+.+........ ...+.........+++.++..++.||+.||.|||++||+||||||+||
T Consensus 84 ~~~~iV~ey~~~g~L~~~l~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NI 158 (309)
T d1fvra_ 84 GYLYLAIEYAPHGNLLDFLRKSRVLET-----DPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNI 158 (309)
T ss_dssp TEEEEEECCCTTCBHHHHHHTTCHHHH-----CHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGE
T ss_pred CeeEEEEEecCCCcHHHHHhhcccccc-----chhhhccccccCCCCHHHHHHHHHHHHHHHHhhhcCCccccccccceE
Confidence 999999999997776432211110000 000011112346799999999999999999999999999999999999
Q ss_pred eeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCHHHHHH
Q psy8309 219 LLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG-QSPFSGCDEDELFW 297 (494)
Q Consensus 219 Ll~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~~~~~~~ 297 (494)
|++.++.+||+|||+|+.... .......+||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+..+++.
T Consensus 159 L~~~~~~~kl~DfG~a~~~~~-~~~~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~ 237 (309)
T d1fvra_ 159 LVGENYVAKIADFGLSRGQEV-YVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYE 237 (309)
T ss_dssp EECGGGCEEECCTTCEESSCE-ECCC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHH
T ss_pred EEcCCCceEEccccccccccc-cccccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHH
Confidence 999999999999999975322 2334456799999999999999999999999999999999996 57899999999999
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.|.++ .+.+|..+++++++||.+||+.||++|| +++||++|
T Consensus 238 ~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~RP------s~~eil~~ 279 (309)
T d1fvra_ 238 KLPQGYRLEKPLNCDDEVYDLMRQCWREKPYERP------SFAQILVS 279 (309)
T ss_dssp HGGGTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHhcCCCCCCccCCHHHHHHHHHHcCCChhHCc------CHHHHHHH
Confidence 88765 6777889999999999999999999999 67889876
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-51 Score=402.90 Aligned_cols=269 Identities=28% Similarity=0.381 Sum_probs=212.2
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCC-------eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEE
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTD-------YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCT 134 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~-------~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~ 134 (494)
+..++|++++.||+|+||.||+|++..++ ..||||+++++ ...........|...+....+|||||+++++
T Consensus 10 i~~~~~~l~~~iG~G~fg~Vy~~~~~~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~ 87 (299)
T d1fgka_ 10 LPRDRLVLGKPLGEGAFGQVVLAEAIGLDKDKPNRVTKVAVKMLKSD--ATEKDLSDLISEMEMMKMIGKHKNIINLLGA 87 (299)
T ss_dssp CCGGGEEEEEECC-----CEEEEEEECC----CCCEEEEEEECCCTT--CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEE
T ss_pred ccHHHeEEeeEEeecCCcEEEEEEEcCCCcccccCceEEEEEEECcc--cChHHHHHHHHHHHHHHHhcCCCeEEecccc
Confidence 45689999999999999999999987664 47999999875 2344556677788888766699999999999
Q ss_pred EEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 135 FQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 135 ~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
+.+++.+|+|||||++|+|.+.+.......+ .............+++.++..++.||+.||+|||++||||||||
T Consensus 88 ~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~-----~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~~~ivHrDiK 162 (299)
T d1fgka_ 88 CTQDGPLYVIVEYASKGNLREYLQARRPPGL-----EYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLA 162 (299)
T ss_dssp ECSSSSCEEEECCCTTCBHHHHHHTTSCC-----------------CCCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred cccCCeEEEEEEccCCCcHHHHHHhhcCCcc-----ccccccccCccccCCHHHHHHHHHHHHHHHHHhhhCCEEeeeec
Confidence 9999999999999997766332111100000 00000011123569999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~ 291 (494)
|+|||++.+|.+||+|||+++...... ......+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+
T Consensus 163 p~NiLl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~ 242 (299)
T d1fgka_ 163 ARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVP 242 (299)
T ss_dssp GGGEEECTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccceeecCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCC
Confidence 999999999999999999998643222 22445689999999999999999999999999999999998 799999999
Q ss_pred HHHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 292 EDELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 292 ~~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..+++..+.++ .+.+|..+++++++||.+||+.||.+|| ++.||++
T Consensus 243 ~~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~dP~~Rp------s~~eil~ 289 (299)
T d1fgka_ 243 VEELFKLLKEGHRMDKPSNCTNELYMMMRDCWHAVPSQRP------TFKQLVE 289 (299)
T ss_dssp HHHHHHHHHTTCCCCCCSSCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHccCCHhHCc------CHHHHHH
Confidence 98888888765 5677889999999999999999999999 5677764
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-52 Score=400.79 Aligned_cols=252 Identities=28% Similarity=0.417 Sum_probs=201.8
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCC---CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGT---DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~---~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
++.++|++++.||+|+||.||+|+++.+ ...||||++++.........+....|..++. .++|||||++++++.+
T Consensus 5 i~~~d~~~~~~iG~G~fg~Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~-~l~H~nIv~~~g~~~~- 82 (273)
T d1u46a_ 5 IGEKDLRLLEKLGDGSFGVVRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMH-SLDHRNLIRLYGVVLT- 82 (273)
T ss_dssp CCGGGEEEEEECC----CCCEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHH-HCCCTTBCCEEEEECS-
T ss_pred EchHHeEEEEEEecCCCeEEEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHH-hCCCCCEEEEEEEEee-
Confidence 3457899999999999999999987643 2468999998876555566677888988887 5799999999999975
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+++|||||++|+| ...+. ..+.+++..+..++.||+.||.|||++||+||||||+|
T Consensus 83 ~~~~lv~e~~~~~~l---------------------~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~iiHrDikp~N 141 (273)
T d1u46a_ 83 PPMKMVTELAPLGSL---------------------LDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARN 141 (273)
T ss_dssp SSCEEEEECCTTCBH---------------------HHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGG
T ss_pred cchheeeeeecCcch---------------------hhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCCEeeeeecHHH
Confidence 578999999995543 43333 44679999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC---cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK---TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDED 293 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~ 293 (494)
|||+.++.+||+|||+++....... .....+||+.|+|||++.+..|+.++|||||||++|||++ |.+||.+.+..
T Consensus 142 Ill~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 142 LLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp EEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred hccccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 9999999999999999986432222 2334568889999999999999999999999999999998 89999999999
Q ss_pred HHHHHHHhCC--CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 294 ELFWSICNER--PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 294 ~~~~~i~~~~--~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
++..+|.... +..|..+++++++||.+||..||++|| ++.+|+
T Consensus 222 ~~~~~i~~~~~~~~~~~~~~~~l~~li~~cl~~dp~~RP------t~~ei~ 266 (273)
T d1u46a_ 222 QILHKIDKEGERLPRPEDCPQDIYNVMVQCWAHKPEDRP------TFVALR 266 (273)
T ss_dssp HHHHHHHTSCCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHH
T ss_pred HHHHHHHhCCCCCCCcccccHHHHHHHHHHcCCChhHCc------CHHHHH
Confidence 9999998764 455678999999999999999999999 456664
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-51 Score=407.25 Aligned_cols=251 Identities=24% Similarity=0.369 Sum_probs=205.7
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCCCeE----EEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcC
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGTDYY----YAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTD 138 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~----~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~ 138 (494)
..++|+++++||+|+||+||+|+++.+|+. ||+|.++.. ......+....|..++. .++|||||++++++.++
T Consensus 7 k~~dy~~~~~lG~G~fG~Vy~~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~-~l~HpnIv~l~g~~~~~ 83 (317)
T d1xkka_ 7 KETEFKKIKVLGSGAFGTVYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMA-SVDNPHVCRLLGICLTS 83 (317)
T ss_dssp CTTTEEEEEEEEECSSEEEEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHH-HCCCTTBCCEEEEEESS
T ss_pred CHHHCEEeeEEecCCCeEEEEEEEcCCCCEEEEEEEEEEeccc--cCHHHHHHHHHHHHHHH-hCCCCCEeeEEEEEecC
Confidence 346899999999999999999999888764 677766543 23344567788988888 57999999999999865
Q ss_pred CeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhh-hcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 139 SHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQ-QSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 139 ~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~-~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
..+++||++.+|+ |...+. ....+++..++.++.||+.||+|||++|||||||||+|
T Consensus 84 -~~~~v~e~~~~~~---------------------l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~~~iiHrDlKp~N 141 (317)
T d1xkka_ 84 -TVQLITQLMPFGC---------------------LLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDRRLVHRDLAARN 141 (317)
T ss_dssp -SEEEEEECCTTCB---------------------HHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCCGGG
T ss_pred -CeeEEEEeccCCc---------------------ccccccccccCCCHHHHHHHHHHHHHHHHHHHHcCcccCcchhhc
Confidence 5678889998544 444444 45689999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDE 294 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~ 294 (494)
|||+.++++||+|||+|+....... ......||+.|||||++.+..|+.++|||||||++|||+| |.+||.+.+..+
T Consensus 142 Ill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~~ 221 (317)
T d1xkka_ 142 VLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASE 221 (317)
T ss_dssp EEEEETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGGG
T ss_pred ceeCCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHHH
Confidence 9999999999999999985332222 2334568999999999999999999999999999999998 899999988888
Q ss_pred HHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 295 LFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 295 ~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
+...+..+ .+..|..+++++++||.+||..||.+|| ++.||+.|
T Consensus 222 ~~~~i~~~~~~~~p~~~~~~~~~li~~cl~~dP~~RP------s~~eil~~ 266 (317)
T d1xkka_ 222 ISSILEKGERLPQPPICTIDVYMIMVKCWMIDADSRP------KFRELIIE 266 (317)
T ss_dssp HHHHHHHTCCCCCCTTBCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHHHHcCCCCCCCcccCHHHHHHHHHhCCCChhhCc------CHHHHHHH
Confidence 88888765 4678889999999999999999999999 67889887
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-51 Score=396.67 Aligned_cols=245 Identities=25% Similarity=0.431 Sum_probs=203.6
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEE-cCC
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQ-TDS 139 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~-~~~ 139 (494)
.++.++|++++.||+|+||.||+|+++ |..||||+++++. ..+...+|..++. .++|||||++++++. ..+
T Consensus 3 ~i~~~~~~~~~~lG~G~fg~Vy~~~~~--~~~vAvK~i~~~~-----~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~ 74 (262)
T d1byga_ 3 ALNMKELKLLQTIGKGEFGDVMLGDYR--GNKVAVKCIKNDA-----TAQAFLAEASVMT-QLRHSNLVQLLGVIVEEKG 74 (262)
T ss_dssp BCCGGGEEEEEEEEECSSCEEEEEEET--TEEEEEEECCCCC-------HHHHHTHHHHT-TCCCTTBCCEEEEECCC--
T ss_pred ccCHHHeEEeEEEecCCCeEEEEEEEC--CeEEEEEEECcHH-----HHHHHHHHHHHHH-hCCCCCEeeEEEEEEecCC
Confidence 466789999999999999999999984 5679999997642 3355678888887 579999999999885 456
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc--CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS--GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDN 217 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~--~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~N 217 (494)
.+|+||||+++ |+|..++... ..+++..++.++.||+.||.|||+++|+||||||+|
T Consensus 75 ~~~lv~ey~~~---------------------g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH~~~ivH~dlkp~N 133 (262)
T d1byga_ 75 GLYIVTEYMAK---------------------GSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARN 133 (262)
T ss_dssp CCEEEECCCTT---------------------EEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGG
T ss_pred cEEEEEeccCC---------------------CCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccccCceeccccchHh
Confidence 79999999994 4555555443 358999999999999999999999999999999999
Q ss_pred eeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCHHHHH
Q psy8309 218 ILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDEDELF 296 (494)
Q Consensus 218 ILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~~~~~ 296 (494)
||++.+|++||+|||+++.. .......+||+.|+|||++.+..|+.++|||||||++|||++ |++||...+..++.
T Consensus 134 il~~~~~~~kl~dfg~s~~~---~~~~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~~~~ 210 (262)
T d1byga_ 134 VLVSEDNVAKVSDFGLTKEA---SSTQDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVV 210 (262)
T ss_dssp EEECTTSCEEECCCCC---------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGGGHH
T ss_pred heecCCCCEeecccccceec---CCCCccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHHHHH
Confidence 99999999999999999853 233445678999999999999999999999999999999998 89999999988999
Q ss_pred HHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 297 WSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 297 ~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
..|.++ ++.+|..+++++++||.+||..||.+|| ++.++++
T Consensus 211 ~~i~~~~~~~~~~~~~~~~~~li~~cl~~dP~~Rp------s~~~l~~ 252 (262)
T d1byga_ 211 PRVEKGYKMDAPDGCPPAVYEVMKNCWHLDAAMRP------SFLQLRE 252 (262)
T ss_dssp HHHTTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHcCCCCCCCccCCHHHHHHHHHHcccCHhHCc------CHHHHHH
Confidence 888764 6788899999999999999999999999 5666665
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.1e-51 Score=401.54 Aligned_cols=271 Identities=22% Similarity=0.314 Sum_probs=214.1
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT 137 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~ 137 (494)
..++|++++.||+|+||+||+|++++ +++.||||++++. ..........+|..++. .++||||+++++++.+
T Consensus 11 p~~~~~~~~~lG~G~fG~Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~-~l~h~niv~~~~~~~~ 87 (301)
T d1lufa_ 11 PRNNIEYVRDIGEGAFGRVFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMA-EFDNPNIVKLLGVCAV 87 (301)
T ss_dssp CGGGCEEEEEEEECSSCEEEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHH-TCCCTTBCCEEEEECS
T ss_pred CHHHcEEeEEEeeCCCeEEEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHH-hcCCCCcccceeeecc
Confidence 35789999999999999999999874 5678999999764 23445566788998887 5799999999999999
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCC--c-hhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCC
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGG--D-LMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLK 214 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg--~-L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLK 214 (494)
.+.+++||||+.+|+|.+.+............... . ..........+++..+..++.||+.||+|||++||||||||
T Consensus 88 ~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlK 167 (301)
T d1lufa_ 88 GKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167 (301)
T ss_dssp SSSCEEEEECCTTCBHHHHHHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCS
T ss_pred CCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEc
Confidence 99999999999988875433221111110000000 0 00011123468999999999999999999999999999999
Q ss_pred CCceeeCCCCCEEEeecCceeeeeccC--CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCC
Q psy8309 215 LDNILLDYEGHVRIADFGMCKLQIYLD--KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG-QSPFSGCD 291 (494)
Q Consensus 215 p~NILl~~~g~vkL~DFGla~~~~~~~--~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~ 291 (494)
|+||||+.++++||+|||+|+...... ....+.+||+.|+|||++.+..|+.++|||||||++|||++| .+||.+.+
T Consensus 168 p~NILld~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~ 247 (301)
T d1lufa_ 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMA 247 (301)
T ss_dssp GGGEEECGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSC
T ss_pred ccceEECCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCC
Confidence 999999999999999999997532222 223457899999999999999999999999999999999998 57899999
Q ss_pred HHHHHHHHHhCC-CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhh
Q psy8309 292 EDELFWSICNER-PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVV 342 (494)
Q Consensus 292 ~~~~~~~i~~~~-~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil 342 (494)
..++...+..+. +..|..+++++.+||.+||+.||++|| ++.||+
T Consensus 248 ~~e~~~~v~~~~~~~~p~~~~~~~~~li~~cl~~~P~~RP------t~~ev~ 293 (301)
T d1lufa_ 248 HEEVIYYVRDGNILACPENCPLELYNLMRLCWSKLPADRP------SFCSIH 293 (301)
T ss_dssp HHHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHH
T ss_pred HHHHHHHHHcCCCCCCCccchHHHHHHHHHHcCCChhHCc------CHHHHH
Confidence 999999988765 457889999999999999999999999 456664
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-50 Score=396.90 Aligned_cols=272 Identities=27% Similarity=0.347 Sum_probs=214.1
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEe-----CCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELK-----GTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~-----~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++.++||+|+||.||+|+++ .+++.||||++++.. ..........|..++....+|||||++++++
T Consensus 19 ~~~~~~~~l~~~iG~G~fg~Vy~a~~~~~~~~~~~~~vAvK~i~~~~--~~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~ 96 (311)
T d1t46a_ 19 EFPRNRLSFGKTLGAGAFGKVVEATAYGLIKSDAAMTVAVKMLKPSA--HLTEREALMSELKVLSYLGNHMNIVNLLGAC 96 (311)
T ss_dssp BCCGGGEEEEEEEEECSSEEEEEEEEESSSSTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEE
T ss_pred cCCHHHeEEeeEEeecCCeEEEEEEEeccccCCCCeEEEEEEECccc--CHHHHHHHHHHHHHHHhccCCCCEEEEEEEE
Confidence 456689999999999999999999875 456789999998652 3445556778888888656899999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
.+...+|+|||||++|+|.+.+.......+..- ............+++..+..|+.||+.||+|||++|||||||||
T Consensus 97 ~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~---~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp 173 (311)
T d1t46a_ 97 TIGGPTLVITEYCCYGDLLNFLRRKRDSFICSK---TSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAA 173 (311)
T ss_dssp CSSSSCEEEEECCTTEEHHHHHHHTTTTC-----------------CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSG
T ss_pred eeCCEEEEEEEcCCCCCHHHHHHhccccccccc---cccccccccccCCCHHHHHHHHHHHHHHHHHHHhCCeeeccccc
Confidence 999999999999997776433222111111000 00001112334799999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHh-CCCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHV-GQSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~-G~~Pf~~~~~ 292 (494)
+|||++.++.+||+|||+++....... .....+||+.|+|||++.+..++.++|||||||++|||++ |.+||.+.+.
T Consensus 174 ~NIl~~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 174 RNILLTHGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp GGEEEETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred ccccccccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999985332221 2344689999999999999999999999999999999998 7888888777
Q ss_pred HHHHHHHHhC--CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE--RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~--~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+.+.++... .+..|..+++++++||.+||+.||.+|| ++++|++
T Consensus 254 ~~~~~~~i~~~~~~~~~~~~~~~l~~Li~~cl~~dP~~RP------s~~~il~ 300 (311)
T d1t46a_ 254 DSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRP------TFKQIVQ 300 (311)
T ss_dssp SHHHHHHHHHTCCCCCCTTSCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHHhcCCCCCCcccccHHHHHHHHHHcCCChhHCc------CHHHHHH
Confidence 6766666543 4566778999999999999999999999 5666664
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.4e-50 Score=396.80 Aligned_cols=263 Identities=21% Similarity=0.268 Sum_probs=216.5
Q ss_pred CCCCCCceEeeEeccCCceEEEEEEEeC-----CCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 61 KYDLEDFQLLKVLGKGSFGKVFLAELKG-----TDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 61 ~~~~~~y~~~~~LG~G~fG~V~~~~~~~-----~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
.+..++|++++.||+|+||.||+|.++. ++..||||++++. ...........|..++. .++|||||++++++
T Consensus 16 ei~~~~~~l~~~lG~G~fG~Vy~a~~~~~~~~~~~~~VAvK~~~~~--~~~~~~~~~~~E~~il~-~l~h~nIv~~~~~~ 92 (308)
T d1p4oa_ 16 EVAREKITMSRELGQGSFGMVYEGVAKGVVKDEPETRVAIKTVNEA--ASMRERIEFLNEASVMK-EFNCHHVVRLLGVV 92 (308)
T ss_dssp BCCGGGEEEEEEEEECSSSEEEEEEEEEEETTEEEEEEEEEECCTT--SCHHHHHHHHHHHHHGG-GCCCTTBCCEEEEE
T ss_pred eecHHHeEEeeEEeeCCCeEEEEEEECCcccCCCCcEEEEEEECcc--cChHHHHHHHHHHHHHH-HcCCCCEeeeeeEE
Confidence 4566899999999999999999999864 3568999999764 23445556778888887 57999999999999
Q ss_pred EcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCC
Q psy8309 136 QTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKL 215 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp 215 (494)
..++.+++|||||++|+|.+....... ..........+++..+..++.||+.||.|||+++|+||||||
T Consensus 93 ~~~~~~~lv~e~~~~g~l~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~~~ivHrDlk~ 161 (308)
T d1p4oa_ 93 SQGQPTLVIMELMTRGDLKSYLRSLRP-----------AMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAA 161 (308)
T ss_dssp CSSSSCEEEEECCTTCBHHHHHHHHHH-----------HHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHHTTCBCSCCSG
T ss_pred ecCCceeEEEeecCCCCHHHHHHhccc-----------ccccccccCCCCHHHHHHHHHHHHHHHHHHhhCCeeeceEcC
Confidence 999999999999998776432111100 000011223578999999999999999999999999999999
Q ss_pred CceeeCCCCCEEEeecCceeeeeccCC--cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhC-CCCCCCCCH
Q psy8309 216 DNILLDYEGHVRIADFGMCKLQIYLDK--TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVG-QSPFSGCDE 292 (494)
Q Consensus 216 ~NILl~~~g~vkL~DFGla~~~~~~~~--~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G-~~Pf~~~~~ 292 (494)
+||||+.++++||+|||+++....... .....+||+.|+|||.+.+..|+.++|||||||++|||++| .+||.+.+.
T Consensus 162 ~NiLld~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 162 RNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp GGEEECTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred CceeecCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 999999999999999999975332222 23445799999999999999999999999999999999997 589999999
Q ss_pred HHHHHHHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhc
Q psy8309 293 DELFWSICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVA 343 (494)
Q Consensus 293 ~~~~~~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~ 343 (494)
.+.+..+.++ .+..|..+++.+.+||.+||+.||.+|| ++++|++
T Consensus 242 ~~~~~~i~~~~~~~~p~~~~~~l~~li~~cl~~~P~~RP------s~~~il~ 287 (308)
T d1p4oa_ 242 EQVLRFVMEGGLLDKPDNCPDMLFELMRMCWQYNPKMRP------SFLEIIS 287 (308)
T ss_dssp HHHHHHHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHH
T ss_pred HHHHHHHHhCCCCCCcccchHHHHHHHHHHcCCChhHCc------CHHHHHH
Confidence 9999988875 4567789999999999999999999999 5677765
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.3e-49 Score=391.06 Aligned_cols=262 Identities=20% Similarity=0.235 Sum_probs=204.5
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||+||+|+++.+|+.||||++...... .....|..++.....|++|+.+.+++.+.+..++|
T Consensus 7 ~rY~l~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~~-----~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~iv 81 (299)
T d1ckia_ 7 NRYRLGRKIGSGSFGDIYLGTDIAAGEEVAIKLECVKTKH-----PQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMV 81 (299)
T ss_dssp TTEEEEEEEEECSSSEEEEEEETTTTEEEEEEEEESCTTS-----CCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEE
T ss_pred CEEEEeEEEeeCCCcEEEEEEECCCCCEEEEEEEchhccC-----HHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEE
Confidence 4699999999999999999999999999999998764321 13456777877544556677778888899999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhH-HhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC-
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMF-HIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY- 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~-~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~- 222 (494)
||||. +.+.. .....+.+++..+..++.||+.||+|||++|||||||||+|||++.
T Consensus 82 me~~~----------------------~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iiHrDiKp~NIl~~~~ 139 (299)
T d1ckia_ 82 MELLG----------------------PSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLG 139 (299)
T ss_dssp EECCC----------------------CBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECCG
T ss_pred EEEcC----------------------CchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCCeeeccCCHhhcccccc
Confidence 99994 23333 3344568999999999999999999999999999999999999864
Q ss_pred --CCCEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCCHH
Q psy8309 223 --EGHVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCDED 293 (494)
Q Consensus 223 --~g~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~~ 293 (494)
+..+||+|||+|+...... ....+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+....
T Consensus 140 ~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 140 KKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp GGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred CCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 4579999999998643221 1234678999999999999999999999999999999999999999876554
Q ss_pred HHHHHHH---hCC-----CCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcCCCcC-------CCChhHHh
Q psy8309 294 ELFWSIC---NER-----PRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAHEYFR-------GLDWQALE 356 (494)
Q Consensus 294 ~~~~~i~---~~~-----~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h~~f~-------~~~w~~l~ 356 (494)
.....+. ... ..++..+|+++.+||..||..||.+||++. .+.++++|+|.+ ..||+.+.
T Consensus 220 ~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~---~i~~~l~~~~~~~~~~~~~~~Dw~~~~ 294 (299)
T d1ckia_ 220 TKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYS---YLRQLFRNLFHRQGFSYDYVFDWNMLK 294 (299)
T ss_dssp -----HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHH---HHHHHHHHHHHHHTCCCSCCCHHHHGG
T ss_pred HHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHH---HHHHHHHHHHHHcCCCCCCCcCchhhc
Confidence 4333221 111 123457899999999999999999999653 345777777653 25676664
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-48 Score=379.79 Aligned_cols=247 Identities=24% Similarity=0.343 Sum_probs=200.0
Q ss_pred eEeeEeccCCceEEEEEEEeCCC---eEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEc-CCeeEE
Q psy8309 68 QLLKVLGKGSFGKVFLAELKGTD---YYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQT-DSHLFF 143 (494)
Q Consensus 68 ~~~~~LG~G~fG~V~~~~~~~~~---~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~-~~~~~l 143 (494)
.+.++||+|+||+||+|++..++ ..||||++++. ......+..+.|..++. .++|||||++++++.. +..+++
T Consensus 30 ~~~~~iG~G~fg~Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~-~l~HpnIv~~~g~~~~~~~~~~l 106 (311)
T d1r0pa_ 30 HFNEVIGRGHFGCVYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMK-DFSHPNVLSLLGICLRSEGSPLV 106 (311)
T ss_dssp EEEEEEEEETTEEEEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHH-TCCCTTBCCCCEEEEETTTEEEE
T ss_pred ccceEEeecCCeEEEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHH-hCCCCCEeEEeEEEEecCCceEE
Confidence 34689999999999999986543 36899999753 34556677889998888 5799999999998765 568999
Q ss_pred EEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC
Q psy8309 144 VMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQ-SGRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY 222 (494)
Q Consensus 144 v~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~ 222 (494)
|||||++| +|..++.. ...+++..+..++.||+.||.|||++||+||||||+||||+.
T Consensus 107 v~E~~~~g---------------------~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH~~~iiHrDLK~~NILl~~ 165 (311)
T d1r0pa_ 107 VLPYMKHG---------------------DLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDE 165 (311)
T ss_dssp EEECCTTC---------------------BHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECT
T ss_pred EEEEeecC---------------------chhhhhccccccchHHHHHHHHHHHHHhhhhhcccCcccCCccHHhEeECC
Confidence 99999954 44444443 346788889999999999999999999999999999999999
Q ss_pred CCCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCC-CCHHHHHH
Q psy8309 223 EGHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSG-CDEDELFW 297 (494)
Q Consensus 223 ~g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~-~~~~~~~~ 297 (494)
++.+||+|||+++....... ......||+.|+|||.+.+..++.++|||||||++|||++|..||.. .+..++..
T Consensus 166 ~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~~~~~~~ 245 (311)
T d1r0pa_ 166 KFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITV 245 (311)
T ss_dssp TCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC------CHH
T ss_pred CCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCCHHHHHH
Confidence 99999999999985322211 22335789999999999999999999999999999999997666654 45555666
Q ss_pred HHHhC-CCCCCccCCHHHHHHHHhhccCCCCCCCCCCCCCChhhhhcC
Q psy8309 298 SICNE-RPRFPQFLSVEAKNILVHLLDKDTTKRLGSTQCNSGDDVVAH 344 (494)
Q Consensus 298 ~i~~~-~~~~p~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~eil~h 344 (494)
.+..+ .+..|..+++++.+||.+||..||++|| +++||++|
T Consensus 246 ~i~~g~~~~~p~~~~~~l~~li~~cl~~dP~~RP------s~~ei~~~ 287 (311)
T d1r0pa_ 246 YLLQGRRLLQPEYCPDPLYEVMLKCWHPKAEMRP------SFSELVSR 287 (311)
T ss_dssp HHHTTCCCCCCTTCCHHHHHHHHHHTCSSGGGSC------CHHHHHHH
T ss_pred HHHcCCCCCCcccCcHHHHHHHHHHcCCCHhHCc------CHHHHHHH
Confidence 66654 5667888999999999999999999999 67888876
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=3.3e-47 Score=372.77 Aligned_cols=241 Identities=19% Similarity=0.238 Sum_probs=197.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
++|++++.||+|+||+||+|+++.+|+.||||++.+... .. ....|..++....+|+||+.+++++......|+|
T Consensus 5 ~~Y~i~~~iG~G~fG~Vy~a~~~~~~~~vAvK~~~~~~~--~~---~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~v 79 (293)
T d1csna_ 5 VHYKVGRRIGEGSFGVIFEGTNLLNNQQVAIKFEPRRSD--AP---QLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLV 79 (293)
T ss_dssp TTEEEEEEEEECSSCEEEEEEETTTTEEEEEEEEECCTT--SC---CHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEE
T ss_pred CceEEEEEEecCCCeEEEEEEECCCCCEEEEEEEccccC--cH---HHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEE
Confidence 579999999999999999999999999999999866422 12 2345556666444679999999999999999999
Q ss_pred EEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhc-CCCCHHHHHHHHHHHHHHHHHHHhCCCccccCCCCceeeCC-
Q psy8309 145 MEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQS-GRFDEGRARFYAAEIVSGMRFLHKKGIVYRDLKLDNILLDY- 222 (494)
Q Consensus 145 ~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~yLH~~givHrDLKp~NILl~~- 222 (494)
|||| |++|...+... ..+++..+..++.|++.||+|||++||+||||||+||||+.
T Consensus 80 me~~----------------------~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~giiHrDiKp~Nili~~~ 137 (293)
T d1csna_ 80 IDLL----------------------GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRP 137 (293)
T ss_dssp EECC----------------------CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCCGGGEEECCS
T ss_pred EEec----------------------CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHCCceeccCCccceeecCc
Confidence 9998 44555555544 47999999999999999999999999999999999999974
Q ss_pred ----CCCEEEeecCceeeeeccC-------CcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCCCCCCCC
Q psy8309 223 ----EGHVRIADFGMCKLQIYLD-------KTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQSPFSGCD 291 (494)
Q Consensus 223 ----~g~vkL~DFGla~~~~~~~-------~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~ 291 (494)
++.+||+|||+|+...... ....+.+||+.|||||++.+..|+.++|||||||++|||++|..||.+..
T Consensus 138 ~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~ 217 (293)
T d1csna_ 138 NSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 217 (293)
T ss_dssp SSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred ccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCcc
Confidence 5789999999998643211 22446789999999999999999999999999999999999999997643
Q ss_pred ---HHHHHHHHHhCCC-----CCCccCCHHHHHHHHhhccCCCCCCCCC
Q psy8309 292 ---EDELFWSICNERP-----RFPQFLSVEAKNILVHLLDKDTTKRLGS 332 (494)
Q Consensus 292 ---~~~~~~~i~~~~~-----~~p~~~s~~~~~li~~lL~~dP~~R~~~ 332 (494)
..+.+..+..... .++..+++++.+++..|+..+|.+||..
T Consensus 218 ~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y 266 (293)
T d1csna_ 218 AATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDY 266 (293)
T ss_dssp SCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCH
T ss_pred chhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCH
Confidence 3344444433221 2235688999999999999999999954
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=9.2e-47 Score=380.39 Aligned_cols=269 Identities=22% Similarity=0.318 Sum_probs=203.2
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh----------cCCCCceeeEEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL----------GTKHPYLCHLFCT 134 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~----------~~~hp~Iv~l~~~ 134 (494)
.+|+++++||+|+||+||+|+++.+|+.||||+++++.. ..+....|..++.. .+.|+||++++++
T Consensus 13 ~rY~i~~~LG~G~fg~Vy~~~~~~~g~~vAvKvi~~~~~----~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~ 88 (362)
T d1q8ya_ 13 ARYILVRKLGWGHFSTVWLAKDMVNNTHVAMKIVRGDKV----YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDH 88 (362)
T ss_dssp TTEEEEEEEEECSSEEEEEEEETTTTEEEEEEEECSCHH----HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEE
T ss_pred CcEEEEEEEeeCCCeEEEEEEECCCCCEEEEEEEecccc----chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEE
Confidence 469999999999999999999999999999999986532 22333445444432 1357899999988
Q ss_pred EEc--CCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh-CCCccc
Q psy8309 135 FQT--DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK-KGIVYR 211 (494)
Q Consensus 135 ~~~--~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~-~givHr 211 (494)
+.. ....+++|+++..+.. ............+++..++.++.||+.||+|||+ +||+||
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~------------------~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~~~~IvHr 150 (362)
T d1q8ya_ 89 FNHKGPNGVHVVMVFEVLGEN------------------LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHT 150 (362)
T ss_dssp EEEEETTEEEEEEEECCCCEE------------------HHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHHTTCEECS
T ss_pred eeeccccceeeeeeecccccc------------------cccccccccccCCcHHHHHHHHHHHHHHHHHHhhhcCcccc
Confidence 764 4677888888764322 1122233445689999999999999999999998 899999
Q ss_pred cCCCCceeeCCCCC------EEEeecCceeeeeccCCcccccCCCCCccChhhhCCCCCCCcchHHHHHHHHHHHHhCCC
Q psy8309 212 DLKLDNILLDYEGH------VRIADFGMCKLQIYLDKTTDTFCGTPDYMAPEIIKGLKYNQCVDWWSFGILLYEMHVGQS 285 (494)
Q Consensus 212 DLKp~NILl~~~g~------vkL~DFGla~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwSlGvil~ell~G~~ 285 (494)
||||+||||+.+|. ++|+|||.+... .......+||+.|+|||++.+..|+.++|+||+||++++|++|+.
T Consensus 151 DlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~ 227 (362)
T d1q8ya_ 151 DIKPENVLMEIVDSPENLIQIKIADLGNACWY---DEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDF 227 (362)
T ss_dssp CCSGGGEEEEEEETTTTEEEEEECCCTTCEET---TBCCCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCChhHeeeeccCcccccceeeEeeccccccc---ccccccccccccccChhhccccCCCccccccchHHHHHHHHHCCC
Confidence 99999999987764 999999998753 334566789999999999999999999999999999999999999
Q ss_pred CCCCCCHH------HHHHHHH------------------------------------------hCCCCCCccCCHHHHHH
Q psy8309 286 PFSGCDED------ELFWSIC------------------------------------------NERPRFPQFLSVEAKNI 317 (494)
Q Consensus 286 Pf~~~~~~------~~~~~i~------------------------------------------~~~~~~p~~~s~~~~~l 317 (494)
||...+.. +....+. .....++...++++++|
T Consensus 228 pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dl 307 (362)
T d1q8ya_ 228 LFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSKDEAKEISDF 307 (362)
T ss_dssp CC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHHHHHTTCCCHHHHHHHHHH
T ss_pred CCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhhcccccccCcccCHHHHHH
Confidence 99754321 1111110 01112233457889999
Q ss_pred HHhhccCCCCCCCCCCCCCChhhhhcCCCcCCCChhHHhcCcCCCCCcccc
Q psy8309 318 LVHLLDKDTTKRLGSTQCNSGDDVVAHEYFRGLDWQALEKRELEPPFRPRV 368 (494)
Q Consensus 318 i~~lL~~dP~~R~~~~~~~~~~eil~h~~f~~~~w~~l~~~~~~pp~~p~~ 368 (494)
|.+||+.||.+|| |++|+|+||||+++.+ ...++.|.+|..
T Consensus 308 l~~mL~~dP~~Rp------ta~e~L~Hp~f~~~~~----~~~~~~p~~~~~ 348 (362)
T d1q8ya_ 308 LSPMLQLDPRKRA------DAGGLVNHPWLKDTLG----MEEIRVPDRELY 348 (362)
T ss_dssp HGGGGCSSTTTCB------CHHHHHTCGGGTTCTT----CTTCCCTTSCTT
T ss_pred HHHHCCCChhHCc------CHHHHhcCcccCCCCC----cccCCCCCcccC
Confidence 9999999999999 6899999999996643 334555555544
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=367.39 Aligned_cols=243 Identities=22% Similarity=0.307 Sum_probs=188.9
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-cCCCCceeeEEEEEEcCC----
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLFCTFQTDS---- 139 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-~~~hp~Iv~l~~~~~~~~---- 139 (494)
.+|.+.+.||+|+||.||+|++ +|+.||||+++.. .......|.+++.. .++|||||++++++.+.+
T Consensus 3 ~~~~l~~~iG~G~fg~Vy~~~~--~g~~vAvK~~~~~------~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~ 74 (303)
T d1vjya_ 3 RTIVLQESIGKGRFGEVWRGKW--RGEEVAVKIFSSR------EERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWT 74 (303)
T ss_dssp GGEEEEEEEECCSSSEEEEEEE--TTEEEEEEEECGG------GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSE
T ss_pred cEEEEEEEEeeCCCeEEEEEEE--CCEEEEEEEECcc------chhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcce
Confidence 4789999999999999999986 5788999998653 22344556555542 468999999999998654
Q ss_pred eeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh--------CCCccc
Q psy8309 140 HLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK--------KGIVYR 211 (494)
Q Consensus 140 ~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~--------~givHr 211 (494)
.+|+|||||+ +|+|..++++ ..+++..+..++.|++.||.|||+ +|||||
T Consensus 75 ~~~lv~Ey~~---------------------~g~L~~~l~~-~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHr 132 (303)
T d1vjya_ 75 QLWLVSDYHE---------------------HGSLFDYLNR-YTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHR 132 (303)
T ss_dssp EEEEEEECCT---------------------TCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECS
T ss_pred EEEEEEeccc---------------------CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeecc
Confidence 6899999999 5555666655 468999999999999999999996 599999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCC----cccccCCCCCccChhhhCCCC------CCCcchHHHHHHHHHHHH
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDK----TTDTFCGTPDYMAPEIIKGLK------YNQCVDWWSFGILLYEMH 281 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~----~~~~~~gt~~y~aPE~l~~~~------~~~~~DiwSlGvil~ell 281 (494)
||||+||||+.+|.+||+|||+++....... .....+||+.|||||++.+.. ++.++|||||||+||||+
T Consensus 133 DlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~ 212 (303)
T d1vjya_ 133 DLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIA 212 (303)
T ss_dssp CCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred ccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHh
Confidence 9999999999999999999999986543322 234578999999999997653 567899999999999999
Q ss_pred hCCCCCCCC---------------CHHHHHHHHHhCC--CCCCcc-----CCHHHHHHHHhhccCCCCCCCCCCCCCChh
Q psy8309 282 VGQSPFSGC---------------DEDELFWSICNER--PRFPQF-----LSVEAKNILVHLLDKDTTKRLGSTQCNSGD 339 (494)
Q Consensus 282 ~G~~Pf~~~---------------~~~~~~~~i~~~~--~~~p~~-----~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ 339 (494)
+|.+||... ........+.... +.+|.. ...++.+|+.+||..||++|| ++.
T Consensus 213 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~l~~li~~cl~~dp~~Rp------s~~ 286 (303)
T d1vjya_ 213 RRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAKIMRECWYANGAARL------TAL 286 (303)
T ss_dssp HTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHHHHHHHHTTCCSSGGGSC------CHH
T ss_pred hCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHHHHHHHHHHcccCHhHCc------CHH
Confidence 998887431 1233333333332 344432 234689999999999999999 567
Q ss_pred hhhc
Q psy8309 340 DVVA 343 (494)
Q Consensus 340 eil~ 343 (494)
||++
T Consensus 287 ei~~ 290 (303)
T d1vjya_ 287 RIKK 290 (303)
T ss_dssp HHHH
T ss_pred HHHH
Confidence 7764
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.92 E-value=2.2e-25 Score=202.96 Aligned_cols=167 Identities=18% Similarity=0.086 Sum_probs=115.2
Q ss_pred ceEeeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-----Ch----------hhHHHHHHHHHHHHhcCCCCceeeE
Q psy8309 67 FQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-----ED----------DDVECTLIERKVLALGTKHPYLCHL 131 (494)
Q Consensus 67 y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-----~~----------~~~~~~~~e~~~l~~~~~hp~Iv~l 131 (494)
+.+.+.||+|+||.||+|++. +|+.||||+++..... .. ........|...+. .+.|++++..
T Consensus 2 ~~vg~~IG~G~~g~Vy~a~~~-~g~~vAvKi~r~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~-~l~~~~v~~~ 79 (191)
T d1zara2 2 DAIGKLMGEGKESAVFNCYSE-KFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQ-KLQGLAVPKV 79 (191)
T ss_dssp SEEEEEEEECSSEEEEEEEET-TTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHH-HTTTSSSCCE
T ss_pred chhCCEeeeCcceEEEEEECC-CCCEEEEEEEecccchhhhhhhhhhhccHHHHHHHHHHHHHHHHHHH-HccCCCcceE
Confidence 457899999999999999874 6889999987642111 00 01122234555555 4689999988
Q ss_pred EEEEEcCCeeEEEEEecCCCCCccccchhhhhhhhhHhcCCchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHhCCCccc
Q psy8309 132 FCTFQTDSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLNGGDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHKKGIVYR 211 (494)
Q Consensus 132 ~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~~givHr 211 (494)
+++. ..+++|||++++.+ ..+++..+..++.||+.||.|||++||+||
T Consensus 80 ~~~~----~~~lvme~~~~~~~----------------------------~~l~~~~~~~i~~ql~~~l~~lH~~giiHr 127 (191)
T d1zara2 80 YAWE----GNAVLMELIDAKEL----------------------------YRVRVENPDEVLDMILEEVAKFYHRGIVHG 127 (191)
T ss_dssp EEEE----TTEEEEECCCCEEG----------------------------GGCCCSCHHHHHHHHHHHHHHHHHTTEECS
T ss_pred EEec----CCEEEEEeeccccc----------------------------cchhhHHHHHHHHHHHHHHHHHhhCCEEEc
Confidence 7653 23799999984322 124556677899999999999999999999
Q ss_pred cCCCCceeeCCCCCEEEeecCceeeeeccCCcccccCCCCCccCh------hhhCCCCCCCcchHHHHHHHH
Q psy8309 212 DLKLDNILLDYEGHVRIADFGMCKLQIYLDKTTDTFCGTPDYMAP------EIIKGLKYNQCVDWWSFGILL 277 (494)
Q Consensus 212 DLKp~NILl~~~g~vkL~DFGla~~~~~~~~~~~~~~gt~~y~aP------E~l~~~~~~~~~DiwSlGvil 277 (494)
||||+|||++.+ .++|+|||+|.... ..... .|... +.+ ...|+.++|+||+.--+
T Consensus 128 DiKP~NILv~~~-~~~liDFG~a~~~~--~~~~~------~~l~rd~~~~~~~f-~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 128 DLSQYNVLVSEE-GIWIIDFPQSVEVG--EEGWR------EILERDVRNIITYF-SRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CCSTTSEEEETT-EEEECCCTTCEETT--STTHH------HHHHHHHHHHHHHH-HHHHCCCCCHHHHHHHH
T ss_pred cCChhheeeeCC-CEEEEECCCcccCC--CCCcH------HHHHHHHHHHHHHH-cCCCCCcccHHHHHHHH
Confidence 999999999865 48999999987521 11111 11111 111 35688999999976433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.35 E-value=9.4e-07 Score=81.73 Aligned_cols=85 Identities=13% Similarity=-0.019 Sum_probs=55.3
Q ss_pred CCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEEEcCCeeEEE
Q psy8309 65 EDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTFQTDSHLFFV 144 (494)
Q Consensus 65 ~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~~~~~~~~lv 144 (494)
+.|++.+..+.|+-+.||++. ..+..+.||+.......... ....|...+...-.+--+.+++.+..+++..|+|
T Consensus 14 ~~~~~~~~~~G~s~~~v~rv~--~~~~~~vlk~~~~~~~~~~~---~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv 88 (263)
T d1j7la_ 14 EKYRCVKDTEGMSPAKVYKLV--GENENLYLKMTDSRYKGTTY---DVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLL 88 (263)
T ss_dssp TTSEEEECSCCCSSSEEEEEE--CSSCEEEEEEECGGGTTSTT---CHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEE
T ss_pred hceEEEEcCCCCCCCcEEEEE--eCCCeEEEEEcCCCcccchh---hHHHHHHHHHHHhccCCCCcEEEEEecCCceEEE
Confidence 467777776666667999875 44555788887654322222 2334555544322343356777888888999999
Q ss_pred EEecCCCCCc
Q psy8309 145 MEYLNGGDLI 154 (494)
Q Consensus 145 ~E~~~~g~L~ 154 (494)
|++++|.++.
T Consensus 89 ~~~l~G~~~~ 98 (263)
T d1j7la_ 89 MSEADGVLCS 98 (263)
T ss_dssp EECCSSEEHH
T ss_pred EEeccccccc
Confidence 9999987663
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.94 E-value=1.2e-05 Score=79.04 Aligned_cols=82 Identities=18% Similarity=0.163 Sum_probs=47.7
Q ss_pred eeEeccCCceEEEEEEEeCCCeEEEeeeecccccc-C---hhhHHHHHHHHHHHHhcCCC--CceeeEEEEEEcCCeeEE
Q psy8309 70 LKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVL-E---DDDVECTLIERKVLALGTKH--PYLCHLFCTFQTDSHLFF 143 (494)
Q Consensus 70 ~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~-~---~~~~~~~~~e~~~l~~~~~h--p~Iv~l~~~~~~~~~~~l 143 (494)
.+.||.|....||++....+++.|+||.-...... . .....+...|...|.....+ ..+++++.+ +....++
T Consensus 31 ~~eig~G~~N~vfrV~~~~~~~svivKqa~p~~r~~g~~~~~~~~R~~~E~~~L~~~~~~~p~~vP~v~~~--d~~~~~l 108 (392)
T d2pula1 31 CQEIGDGNLNYVFHIYDQEHDRALIIKQAVPYAKVVGESWPLTIDRARIESSALIRQGEHVPHLVPRVFYS--DTEMAVT 108 (392)
T ss_dssp EEECCSSSSEEEEEEEC----CEEEEEEECCGGGC--CCCCCCTTHHHHHHHHHHHHHTTCGGGSCCEEEE--ETTTTEE
T ss_pred EEEeCCCceEeEEEEEeCCCCeEEEEecCCchhcccCCCCCCCHHHHHHHHHHHHHhhhhCCCCcceEEEE--cCCCCEE
Confidence 56789999999999988777788999965421100 0 11223344565555533222 345566544 4556679
Q ss_pred EEEecCCCCC
Q psy8309 144 VMEYLNGGDL 153 (494)
Q Consensus 144 v~E~~~~g~L 153 (494)
|||++.+..+
T Consensus 109 vmE~L~~~~~ 118 (392)
T d2pula1 109 VMEDLSHLKI 118 (392)
T ss_dssp EECCCTTSEE
T ss_pred EEeccCCccc
Confidence 9999987554
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.68 E-value=7.9e-05 Score=67.86 Aligned_cols=155 Identities=15% Similarity=0.093 Sum_probs=80.9
Q ss_pred EeccCC-ceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHhc-CCCCceeeEEEEEEcCCeeEEEEEecC
Q psy8309 72 VLGKGS-FGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLALG-TKHPYLCHLFCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 72 ~LG~G~-fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~-~~hp~Iv~l~~~~~~~~~~~lv~E~~~ 149 (494)
.+..|. -+.||++.. ..+..+.+|+...... .. ...|...+... ...--+.+++.+..+.+..++||++++
T Consensus 17 ~~~~G~s~~~v~r~~~-~~~~~~vlK~~~~~~~---~~---l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~ 89 (255)
T d1nd4a_ 17 QQTIGCSDAAVFRLSA-QGRPVLFVKTDLSGAL---NE---LQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVP 89 (255)
T ss_dssp ECSCTTSSCEEEEEEC-TTSCCEEEEEECSCTT---SC---HHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCS
T ss_pred EcCCcccCCeEEEEEe-CCCCEEEEEeCCccCH---hH---HHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeee
Confidence 344454 368898874 3455688898654421 11 22333333211 122336777888888889999999999
Q ss_pred CCCCccccchhh--hhhhhhH---hcCC---------chhHHh-------hh----cCCCCHHHHHHHHHHHHHHHHHHH
Q psy8309 150 GGDLIPAGLTKA--ERDLMEY---LNGG---------DLMFHI-------QQ----SGRFDEGRARFYAAEIVSGMRFLH 204 (494)
Q Consensus 150 ~g~L~~~~~~~~--~~~l~~~---~~gg---------~L~~~l-------~~----~~~l~e~~~~~~~~qi~~aL~yLH 204 (494)
|-++........ ...+.+. +... .+...+ .. ...+...... ......+..+.
T Consensus 90 G~~~~~~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~l~ 166 (255)
T d1nd4a_ 90 GQDLLSSHLAPAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQG---LAPAELFARLK 166 (255)
T ss_dssp SEETTTSCCCHHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTT---CCHHHHHHHHH
T ss_pred ccccccccccHHHHHHHHHHHHHHHccCChhhCCCcccchhhHHHHHHHHHHhhhccccccchhhh---hHHHHHHHHHH
Confidence 887755332211 1111111 1100 000000 00 0000000000 01112233333
Q ss_pred hC-------CCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 205 KK-------GIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 205 ~~-------givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.+ .++|+|+.|.|||++.++.+-|+||+.+..
T Consensus 167 ~~~~~~~~~~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 167 ARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp HTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HhCCccCCceEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 32 379999999999999776678999998764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=96.95 E-value=0.0012 Score=62.41 Aligned_cols=154 Identities=10% Similarity=0.026 Sum_probs=77.0
Q ss_pred CCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh----cCCCCceeeE--EEEEEcCCeeEEEEEecC
Q psy8309 76 GSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL----GTKHPYLCHL--FCTFQTDSHLFFVMEYLN 149 (494)
Q Consensus 76 G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~----~~~hp~Iv~l--~~~~~~~~~~~lv~E~~~ 149 (494)
|.--.||+++. .+|..|++|+.+.... . .+.+..|...+.. .+..+..+.. -..+......+.+++++.
T Consensus 33 s~EN~vy~v~~-~dg~~~VlK~~rp~~~-s---~~~i~~E~~~l~~L~~~gipv~~p~~~~g~~~~~~~~~~~~l~~~~~ 107 (325)
T d1zyla1 33 SYENRVYQFQD-EDRRRFVVKFYRPERW-T---ADQILEEHQFALQLVNDEVPVAAPVAFNGQTLLNHQGFYFAVFPSVG 107 (325)
T ss_dssp CSSSEEEEECC-TTCCCEEEEEECTTTS-C---HHHHHHHHHHHHHHHHTTCSBCCCCCBTTBSCEEETTEEEEEEECCC
T ss_pred cccceeEEEEc-CCCCEEEEEEeCCCCC-C---HHHHHHHHHHHHHHHhcCCCCCCceecCCCeeeeeeeEEEEEEeecC
Confidence 33468999975 4567799999865421 1 2223334333322 1122222211 123345677899999998
Q ss_pred CCCCccccchhh------hhhhhhHhcC---------------CchhHHhhhcCCCCHHHHHHHHHHHHHHHHHHHh---
Q psy8309 150 GGDLIPAGLTKA------ERDLMEYLNG---------------GDLMFHIQQSGRFDEGRARFYAAEIVSGMRFLHK--- 205 (494)
Q Consensus 150 ~g~L~~~~~~~~------~~~l~~~~~g---------------g~L~~~l~~~~~l~e~~~~~~~~qi~~aL~yLH~--- 205 (494)
|..+........ ...+.....+ ......+.....++......+...+-..++.+..
T Consensus 108 G~~~~~~~~~~~~~lG~~LA~lH~~~~~~~~~~r~~~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~ 187 (325)
T d1zyla1 108 GRQFEADNIDQMEAVGRYLGRMHQTGRKQLFIHRPTIGLNEYLIEPRKLFEDATLIPSGLKAAFLKATDELIAAVTAHWR 187 (325)
T ss_dssp CEECCSSCHHHHHHHHHHHHHHHHHHTSSCCSSSCBCSHHHHTHHHHHHHHTCSSSCTTTHHHHHHHHHHHHHHHHHHCC
T ss_pred CcCCCCCCHHHHHHHHHHHHHHHhhcccCCccccCCCCHHHHhhhhHHHHHHcCcCCHHHHHHHHHHHHHHHHHHHHhcc
Confidence 766532111000 0111111111 1111122222333333333333333333333332
Q ss_pred ----CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 206 ----KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 206 ----~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
.++||+|+.|.|||++. | ..++||+-|..
T Consensus 188 ~~~p~~liHgDlh~~NvL~~~-~-~~~IDFdd~~~ 220 (325)
T d1zyla1 188 EDFTVLRLHGDCHAGNILWRD-G-PMFVDLDDARN 220 (325)
T ss_dssp SCSCCEECCSSCSGGGEEESS-S-EEECCCTTCCE
T ss_pred ccCCceeecCCCCcccEEEeC-C-ceEEechhccc
Confidence 36899999999999974 3 45899998764
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.81 E-value=0.0018 Score=62.87 Aligned_cols=82 Identities=16% Similarity=0.205 Sum_probs=52.5
Q ss_pred CCCCceEeeEeccCCceEEEEEEEeCC-------CeEEEeeeeccccccChhhHHHHHHHHHHHHhcCCCCceeeEEEEE
Q psy8309 63 DLEDFQLLKVLGKGSFGKVFLAELKGT-------DYYYAVKCLKKDVVLEDDDVECTLIERKVLALGTKHPYLCHLFCTF 135 (494)
Q Consensus 63 ~~~~y~~~~~LG~G~fG~V~~~~~~~~-------~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~l~~~~ 135 (494)
..+++++ +.|+.|---.+|++..... .+.|.+++.-.. ... .....|..++.....+.-..++++++
T Consensus 41 ~~~~l~v-~~l~GGltN~~y~v~~~~~~~~~~~~~~~vllRi~g~~----~~~-idr~~E~~i~~~ls~~gl~Pkll~~~ 114 (395)
T d1nw1a_ 41 PLEHLRI-SRIKGGMSNMLFLCRLSEVYPPIRNEPNKVLLRVYFNP----ETE-SHLVAESVIFTLLSERHLGPKLYGIF 114 (395)
T ss_dssp CGGGEEE-EEECCCTTEEEEEEEECTTSCCSSSCCSEEEEEEECSC----CCH-HHHHHHHHHHHHHHHTTSSSCEEEEE
T ss_pred CccceEE-EEcCCccccceEEEEeCCCCccccCCCCcEEEEecCCc----chh-hHHHHHHHHHHHHHhCCCCCeEEEEc
Confidence 3455555 5788899999999987532 345667766422 112 23345666665444555556888887
Q ss_pred EcCCeeEEEEEecCCCCCc
Q psy8309 136 QTDSHLFFVMEYLNGGDLI 154 (494)
Q Consensus 136 ~~~~~~~lv~E~~~~g~L~ 154 (494)
.+ .+|+||++|-.|.
T Consensus 115 ~~----g~I~efi~g~~l~ 129 (395)
T d1nw1a_ 115 SG----GRLEEYIPSRPLS 129 (395)
T ss_dssp TT----EEEECCCCEEECC
T ss_pred CC----ceEEEEeccccCC
Confidence 53 6899999986664
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=96.43 E-value=0.0094 Score=55.45 Aligned_cols=170 Identities=18% Similarity=0.115 Sum_probs=80.9
Q ss_pred CCCCCceEeeEeccCCceEEEEEEEeCCCeEEEeeeeccccccChhhHHHHHHHHHHHHh-cCCCCceeeEE---EEEEc
Q psy8309 62 YDLEDFQLLKVLGKGSFGKVFLAELKGTDYYYAVKCLKKDVVLEDDDVECTLIERKVLAL-GTKHPYLCHLF---CTFQT 137 (494)
Q Consensus 62 ~~~~~y~~~~~LG~G~fG~V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~e~~~l~~-~~~hp~Iv~l~---~~~~~ 137 (494)
+.+....-.+.|..|---+.|+++.. .|+ |++|+..+.. ....+.....-...|.. ....|..+... .+...
T Consensus 15 Y~lg~~~~~~~i~~G~~N~ny~v~t~-~g~-yVLri~~~~~--~~~~l~~~~~~l~~L~~~g~pvp~pi~~~~g~~~~~~ 90 (316)
T d2ppqa1 15 YDVGSLTSYKGIAEGVENSNFLLHTT-KDP-LILTLYEKRV--EKNDLPFFLGLMQHLAAKGLSCPLPLPRKDGELLGEL 90 (316)
T ss_dssp BCCCCEEEEEEECC---EEEEEEEES-SCC-EEEEEECC-----CCHHHHHHHHHHHHHHTTCCCCCBCCBTTCCSCEEE
T ss_pred CCCCCceEeecCCCCcccCeEEEEEC-CCc-EEEEEcCCCC--CHHHHHHHHHHHHhhhhccccccccceecCCCcceee
Confidence 45555666677788888999998754 344 8999986531 22333322222222221 22333333211 11223
Q ss_pred CCeeEEEEEecCCCCCccccchhhhhhhhhHhc-------CC-------chh-------HHhhhcCCCCHHHHHHHHHHH
Q psy8309 138 DSHLFFVMEYLNGGDLIPAGLTKAERDLMEYLN-------GG-------DLM-------FHIQQSGRFDEGRARFYAAEI 196 (494)
Q Consensus 138 ~~~~~lv~E~~~~g~L~~~~~~~~~~~l~~~~~-------gg-------~L~-------~~l~~~~~l~e~~~~~~~~qi 196 (494)
......++.++.|........... ..+...+. .. ... .................+..+
T Consensus 91 ~~~~~~~~~~~~g~~~~~~~~~~~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 169 (316)
T d2ppqa1 91 SGRPAALISFLEGMWLRKPEAKHC-REVGKALAAMHLASEGFEIKRPNALSVDGWKVLWDKSEERADEVEKGLREEIRPE 169 (316)
T ss_dssp TTEEEEEEECCCCBCCSSCCHHHH-HHHHHHHHHHHHHTTTCCCCCBCTTSHHHHHHHHHHHGGGGGGTSTTHHHHHHHH
T ss_pred ecccceeeeecccccccccchhHH-HHHHHHHHhhhhhhhhcccccccccchhhcchhhhHHHHhhhhcchhHHHHHHHH
Confidence 456677778877755532211111 11100000 00 000 000000011111122233333
Q ss_pred HHHHHHHHh----CCCccccCCCCceeeCCCCCEEEeecCceee
Q psy8309 197 VSGMRFLHK----KGIVYRDLKLDNILLDYEGHVRIADFGMCKL 236 (494)
Q Consensus 197 ~~aL~yLH~----~givHrDLKp~NILl~~~g~vkL~DFGla~~ 236 (494)
...+.-.+. .|+||+|+.++||+++.++.+-|.||+.|..
T Consensus 170 ~~~~~~~~~~~L~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 170 IDYLAAHWPKDLPAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp HHHHHHHCCCSSCEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred HHhhhccCccccccccccCCcchhhhhcccccceeEeccccccc
Confidence 333333332 4799999999999999887778999998764
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=94.65 E-value=0.0033 Score=59.15 Aligned_cols=40 Identities=43% Similarity=0.772 Sum_probs=8.8
Q ss_pred ccccccccccCCcCCCCCCCCchhHHhhhccccccccccc
Q psy8309 447 HALDVKYFDKSFTAERPCLTPVDRTILESMDQTQFQGFSY 486 (494)
Q Consensus 447 ~~~~~~~~d~~f~~~~p~lt~~~~~~~~~~~~~~f~~f~~ 486 (494)
++.|++|||.++..+.|.+++.++.++.++||+.|.||||
T Consensus 281 ~~~d~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~f~~f~~ 320 (320)
T d1xjda_ 281 SPFDCSNFDKEFLNEKPRLSFADRALINSMDQNMFRNFSF 320 (320)
T ss_dssp -------------------------------CCTTTTCCC
T ss_pred CccchhhcChHhhhCCccCCCCcccccCchhhcccCcCcC
Confidence 4578999999999999999999999999999999999998
|